PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gahloth, D; Fisher, K; Payne, KAP; Cliff, M; Levy, C; Leys, D				Gahloth, Deepankar; Fisher, Karl; Payne, Karl A. P.; Cliff, Matthew; Levy, Colin; Leys, David			Structural and biochemical characterization of the prenylated flavin mononucleotide-dependent indole-3-carboxylic acid decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYLATION; BIOSYNTHESIS; DEGRADATION; RESOLUTION; BENZENE; MODELS; INDOLE; UBIX	The ubiquitous UbiD family of reversible decarboxylases is implicated in a wide range of microbial processes and depends on the prenylated flavin mononucleotide cofactor for catalysis. However, only a handful of UbiD family members have been characterized in detail, and comparison between these has suggested considerable variability in enzyme dynamics and mechanism linked to substrate specificity. In this study, we provide structural and biochemical insights into the indole-3carboxylic acid decarboxylase, representing an UbiD enzyme activity distinct from those previously studied. Structural insights from crystal structure determination combined with small-angle X-ray scattering measurements reveal that the enzyme likely undergoes an open-closed transition as a consequence of domain motion, an event that is likely coupled to catalysis. We also demonstrate that the indole-3-carboxylic acid decarboxylase can be coupled with carboxylic acid reductase to produce indole-3-carboxyaldehyde from indole + CO2 under ambient conditions. These insights provide further evidence for a common mode of action in the widespread UbiD enzyme family.	[Gahloth, Deepankar; Fisher, Karl; Payne, Karl A. P.; Cliff, Matthew; Levy, Colin; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Manchester	Leys, D (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	david.leys@manchester.ac.uk		Cliff, Matthew/0000-0002-7482-0234; Levy, Colin/0000-0002-9724-310X	European Research Council (ERC) [pre-FAB ADG_695013]	European Research Council (ERC)(European Research Council (ERC)European Commission)	The work was supported by European Research Council (ERC) grant pre-FAB ADG_695013. We thank Diamond Light Source for access (proposal number MX12788) for the data collection. We also thank Prof Toyokazy Yoshida (Gifu University) for providing us with the sequence of Arthrobacter nicotiana decarboxylase. We acknowledge Reynard Spiess (Manchester) for assistance in high resolution mass spectrophotometry.	Abu Laban N, 2010, ENVIRON MICROBIOL, V12, P2783, DOI 10.1111/j.1462-2920.2010.02248.x; Aleku GA, 2020, NAT CHEM BIOL, V16, P1255, DOI 10.1038/s41589-020-0603-0; Bailey SS, 2018, J BIOL CHEM, V293, P2272, DOI 10.1074/jbc.RA117.000881; Balaikaite A, 2020, ACS CHEM BIOL, V15, P2466, DOI 10.1021/acschembio.0c00456; Becker J, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.02.016; Bednarek P, 2005, PLANT PHYSIOL, V138, P1058, DOI 10.1104/pp.104.057794; Bergmann FD, 2011, ARCH MICROBIOL, V193, P241, DOI 10.1007/s00203-010-0667-4; Budovska M, 2013, BIOORGAN MED CHEM, V21, P6623, DOI 10.1016/j.bmc.2013.08.020; Costantini S, 2008, BIOINFORMATION, V2, P271, DOI 10.6026/97320630002271; Eerhart AJJE, 2012, ENERG ENVIRON SCI, V5, P6407, DOI 10.1039/c2ee02480b; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gahloth D, 2017, NAT CHEM BIOL, V13, P975, DOI [10.1038/nchembio.2434, 10.1038/NCHEMBIO.2434]; Hagemeier J, 2001, P NATL ACAD SCI USA, V98, P753, DOI 10.1073/pnas.021551098; Hu MX, 2010, INDIAN J MICROBIOL, V50, P362, DOI 10.1007/s12088-011-0142-1; Jensen ED, 2021, MICROB BIOTECHNOL, V14, P2617, DOI 10.1111/1751-7915.13774; Kawanabe K, 2021, J BIOSCI BIOENG, V132, P18, DOI 10.1016/j.jbiosc.2021.03.001; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Llevot A, 2016, MACROMOL RAPID COMM, V37, P9, DOI 10.1002/marc.201500474; Marshall S. A., 2019, METHODS; Marshall SA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25278-z; Marshall SA, 2017, ARCH BIOCHEM BIOPHYS, V632, P209, DOI 10.1016/j.abb.2017.07.014; Marshall SA, 2017, J BIOL CHEM, V292, P4623, DOI 10.1074/jbc.M116.762732; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meckenstock RU, 2016, J MOL MICROB BIOTECH, V26, P92, DOI 10.1159/000441358; Mori Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22504-6; Omura H, 1998, EUR J BIOCHEM, V253, P480, DOI 10.1046/j.1432-1327.1998.2530480.x; Payer SE, 2017, ANGEW CHEM INT EDIT, V56, P13893, DOI 10.1002/anie.201708091; Payne KAP, 2021, ACS CATAL, V11, P2865, DOI 10.1021/acscatal.0c05042; Payne KAP, 2019, ACS CATAL, V9, P2854, DOI 10.1021/acscatal.8b04862; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Weber HE, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03472-16; Werpy T., 2004, TOP VALUE ADDED CHEM, DOI [DOI 10.2172/15008859, 10.2172/15008859]; White MD, 2015, NATURE, V522, P502, DOI 10.1038/nature14559; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshida T, 2002, BIOSCI BIOTECH BIOCH, V66, P2388, DOI 10.1271/bbb.66.2388	40	1	1	6	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101771	10.1016/j.jbc.2022.101771	http://dx.doi.org/10.1016/j.jbc.2022.101771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35218772	gold, Green Published			2022-12-26	WOS:000793617400009
J	Komuro, M; Nagane, M; Fukuyama, T; Luo, XL; Hiraki, S; Miyanabe, M; Ishikawa, M; Niwa, C; Murakami, H; Okamoto, M; Yamashita, T				Komuro, Mariko; Nagane, Masaki; Fukuyama, Tomoki; Luo, Xiaolin; Hiraki, Shinobu; Miyanabe, Masakatsu; Ishikawa, Miyuki; Niwa, Chiaki; Murakami, Hironobu; Okamoto, Mariko; Yamashita, Tadashi			Sphingomyelin maintains the cutaneous barrier via regulation of the STAT3 pathway	FASEB JOURNAL			English	Article						cutaneous barrier; sphingomyelin; STAT3	ATOPIC-DERMATITIS; SKIN BARRIER; SIGNAL TRANSDUCER; TRANSCRIPTION 3; LIPID RAFTS; STRATUM-CORNEUM; FILAGGRIN; EXPRESSION; CELLS; ACTIVATOR	Epidermal tissues play vital roles in maintaining homeostasis and preventing the dysregulation of the cutaneous barrier. Sphingomyelin (SM), a sphingolipid synthesized by sphingomyelin synthase (SMS) 1 and 2, is involved in signal transduction via modulation of lipid-raft functions. Though the implications of SMS on inflammatory diseases have been reported, its role in dermatitis has not been clarified. In this study, we investigated the role of SM in the cutaneous barrier using a dermatitis model established by employing Sgms1 and 2 deficient mice. SM deficiency impaired the cutaneous inflammation and upregulated signal transducer and activator of transcription 3 (STAT3) phosphorylation in epithelial tissues. Furthermore, using mouse embryonic fibroblast cells, the sensitivity of STAT3 to Interleukin-6 stimulation was increased in Sgms-deficient cells. Using tofacitinib, a clinical JAK inhibitor, the study showed that SM deficiency might participate in STAT3 phosphorylation via JAK activation. Overall, these results demonstrate that SM is essential for maintaining the cutaneous barrier via the STAT3 pathway, suggesting SM could be a potential therapeutic target for dermatitis treatment.	[Komuro, Mariko; Nagane, Masaki; Ishikawa, Miyuki; Niwa, Chiaki; Yamashita, Tadashi] Azabu Univ, Sch Vet Med, Lab Biochem, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2522472, Japan; [Nagane, Masaki] Azabu Univ, Ctr Human & Anim Symbiosis Sci, Sagamihara, Kanagawa, Japan; [Fukuyama, Tomoki] Azabu Univ, Sch Vet Med, Lab Pharmacol, Sagamihara, Kanagawa, Japan; [Luo, Xiaolin; Hiraki, Shinobu; Miyanabe, Masakatsu] Genuine R&D Co Ltd, Fukuoka, Japan; [Murakami, Hironobu] Azabu Univ, Sch Vet Med, Lab Anim Hlth 2, Sagamihara, Kanagawa, Japan; [Okamoto, Mariko] Azabu Univ, Sch Vet Med, Lab Vet Immunol, Sagamihara, Kanagawa, Japan	Azabu University; Azabu University; Azabu University; Azabu University; Azabu University	Yamashita, T (corresponding author), Azabu Univ, Sch Vet Med, Lab Biochem, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2522472, Japan.	yamashita@azabu-u.ac.jp	Murakami, Hironobu/O-3452-2017	Murakami, Hironobu/0000-0002-7560-4445	Japan Society for the Promotion of Science [17K08140, 19K20452]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	GENUINE R&D Co., Ltd.; Japan Society for the Promotion of Science, Grant/Award Number: 17K08140 and 19K20452	Amano W, 2015, J ALLERGY CLIN IMMUN, V136, P667, DOI 10.1016/j.jaci.2015.03.051; Ando J, 2015, P NATL ACAD SCI USA, V112, P4558, DOI 10.1073/pnas.1418088112; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Barcelo-Coblijn G, 2011, P NATL ACAD SCI USA, V108, P19569, DOI 10.1073/pnas.1115484108; Belmonte F, 2015, AM J PHYSIOL-HEART C, V309, pH271, DOI 10.1152/ajpheart.00517.2014; Berdyshev E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98006; Bhattacharya S, 2018, J INVEST DERMATOL, V138, P1052, DOI 10.1016/j.jid.2017.11.033; Bieberich E, 2018, CHEM PHYS LIPIDS, V216, P114, DOI 10.1016/j.chemphyslip.2018.08.003; Bissonnette R, 2016, BRIT J DERMATOL, V175, P902, DOI 10.1111/bjd.14871; Cao YY, 2019, ARTIF CELL NANOMED B, V47, P3774, DOI 10.1080/21691401.2019.1667817; Chalfant CE, 2000, METHOD ENZYMOL, V312, P420; de Jong PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035070; Ding T, 2008, J LIPID RES, V49, P376, DOI 10.1194/jlr.M700401-JLR200; Elias PM, 2014, J ALLERGY CLIN IMMUN, V134, P781, DOI 10.1016/j.jaci.2014.05.048; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Fukuyama T, 2015, J PHARMACOL EXP THER, V354, P394, DOI 10.1124/jpet.115.223784; Gowda S, 2011, AM J PHYSIOL-LUNG C, V300, pL430, DOI 10.1152/ajplung.00208.2010; Graefe C, 2019, MOL BIOL REP, V46, P4631, DOI 10.1007/s11033-019-04851-2; Gupta VR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000073; Han NR, 2016, BIOMED PHARMACOTHER, V79, P71, DOI 10.1016/j.biopha.2016.01.046; Higurashi S, 2015, J DAIRY SCI, V98, P6706, DOI 10.3168/jds.2015-9529; Hillmer EJ, 2016, CYTOKINE GROWTH F R, V31, P1, DOI 10.1016/j.cytogfr.2016.05.001; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; IMOKAWA G, 1991, J INVEST DERMATOL, V96, P523, DOI 10.1111/1523-1747.ep12470233; Katsuyama Y, 2017, INT J COSMETIC SCI, V39, P49, DOI 10.1111/ics.12347; Kim JH, 2015, J ALLERGY CLIN IMMUN, V136, P205, DOI 10.1016/j.jaci.2015.04.026; Lee DY, 2017, BIOMOL THER, V25, P535, DOI 10.4062/biomolther.2017.006; Lee SY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02881; Li WJ, 2016, BBA-MOL CELL RES, V1863, P1579, DOI 10.1016/j.bbamcr.2016.04.006; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Lyu YN, 2014, CHINESE MED J-PEKING, V127, P2389, DOI 10.3760/cma.j.issn.0366-6999.20140558; Mansouri Y, 2015, J CLIN MED, V4, P858, DOI 10.3390/jcm4050858; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Nagane M, 2018, RADIAT RES, V189, P519, DOI 10.1667/RR14781.1; Nagane M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195151; Nagane M, 2013, BIOCHEM BIOPH RES CO, V437, P420, DOI 10.1016/j.bbrc.2013.06.093; Nojiri H, 2018, ARCH DERMATOL RES, V310, P495, DOI 10.1007/s00403-018-1833-9; Nomoto K, 2018, EXP DERMATOL, V27, P827, DOI 10.1111/exd.13497; Nomura T, 2008, J INVEST DERMATOL, V128, P1436, DOI 10.1038/sj.jid.5701205; Ogawa Y, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5404093; Ohnishi T, 2017, FASEB J, V31, P3816, DOI 10.1096/fj.201601225RR; Otsuka A, 2014, J ALLERGY CLIN IMMUN, V133, P139, DOI 10.1016/j.jaci.2013.07.027; PINNAGODA J, 1990, CONTACT DERMATITIS, V22, P164, DOI 10.1111/j.1600-0536.1990.tb01553.x; Ramana CV, 2005, BIOCHEM BIOPH RES CO, V327, P727, DOI 10.1016/j.bbrc.2004.12.074; Roskoski R, 2016, PHARMACOL RES, V111, P784, DOI 10.1016/j.phrs.2016.07.038; Ryu WI, 2018, J DERMATOL SCI, V90, P313, DOI 10.1016/j.jdermsci.2018.02.017; Sahle FF, 2015, SKIN PHARMACOL PHYS, V28, P42, DOI 10.1159/000360009; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Seltmann J, 2015, J ALLERGY CLIN IMMUN, V135, P1659, DOI 10.1016/j.jaci.2015.01.048; Shen CP, 2018, DERMATITIS, V29, P219, DOI 10.1097/DER.0000000000000392; Siedlikowski S., 2019, EMJ DERAMTOL, V7, P89; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spessott W, 2010, J BIOL CHEM, V285, P41472, DOI 10.1074/jbc.M110.150011; Tan Q, 2017, MOL MED REP, V16, P8863, DOI 10.3892/mmr.2017.7689; Thyssen JP, 2014, J ALLERGY CLIN IMMUN, V134, P792, DOI 10.1016/j.jaci.2014.06.014; Toshima K, 2019, INT IMMUNOL, V31, P211, DOI 10.1093/intimm/dxy082; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vannella KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1938; Yamamoto Mina, 2007, Allergol Int, V56, P139, DOI 10.2332/allergolint.O-06-458; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yi L, 2017, MUCOSAL IMMUNOL, V10, P1491, DOI 10.1038/mi.2017.10	66	1	1	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22111	10.1096/fj.202100721RR	http://dx.doi.org/10.1096/fj.202100721RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35230716	hybrid			2022-12-26	WOS:000772957100010
J	Lentini, JM; Bargabos, R; Chen, C; Fu, D				Lentini, Jenna M.; Bargabos, Rachel; Chen, Chen; Fu, Dragony			Methyltransferase METTL8 is required for 3-methylcytosine modification in human mitochondrial tRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						m3C; 3-methylcytosine; METTL8; methyltransferase-like 8; mt; mitochondrial; MTS; mitochondrial targeting sequence; ORF; open reading frame; PHA; Positive Hybridization in the Absence of Modification; RFP; red fluorescent protein; RT; reverse transcriptase; sgRNAs; sequence guide RNAs	BINDING PROTEIN ABP140; POSTTRANSCRIPTIONAL MODIFICATIONS; ANTICODON; TRANSLATION; DEFICIENCY; TRNAS(SER); PREDICTION; LANDSCAPE; DOMAIN; M(3)C	A subset of eukaryotic tRNAs is methylated in the anticodon loop, forming 3-methylcytosine (m3C) modifications. In mammals, the number of tRNAs containing m3C modifications has been expanded to include mitochondrial (mt) tRNA-SerUGA and mt-tRNA-Thr-UGU. However, whereas the enzymes catalyzing m3C formation in nuclear-encoded tRNAs have been identified, the proteins responsible for m3C modification in mt-tRNAs are unknown. Here, we show that m3C formation in human mt-tRNAs is dependent upon the methyltransferase-Like 8 (METTL8) enzyme. We find that METTL8 is a mitochondria-associated protein that interacts with mitochondrial seryl-tRNA synthetase, as well as with mttRNAs containing m3C. We demonstrate that human cells deficient in METTL8 exhibit loss of m3C modification in mttRNAs, but not nuclear-encoded tRNAs. Consistent with the mitochondrial import of METTL8, the formation of m3C in METTL8-deficient cells could be rescued by re-expression of WT METTL8, but not by a METTL8 variant lacking the N-terminal mitochondrial localization signal. Notably, we found METTL8-deficiency in human cells causes alterations in the native migration pattern of mt-tRNA-Ser-UGA, suggesting a role for m3C in tRNA folding. Altogether, these findings demonstrate that METTL8 is required for m3C formation in mt-tRNAs and uncover a potential function for m3C modification in mitochondrial tRNA structure.	[Lentini, Jenna M.; Bargabos, Rachel; Chen, Chen; Fu, Dragony] Univ Rochester, Dept Biol, Ctr RNA Biol, Rochester, NY 14627 USA	University of Rochester	Fu, D (corresponding author), Univ Rochester, Dept Biol, Ctr RNA Biol, Rochester, NY 14627 USA.	dragonyfu@rochester.edu		Fu, Dragony/0000-0002-8725-8658; Chen, Chen/0000-0002-4803-0183; Lentini, Jenna/0000-0002-4069-4102	National Science Foundation CAREER Award [1552126]	National Science Foundation CAREER Award(National Science Foundation (NSF))	Funding and additional information-This work was supported by National Science Foundation CAREER Award 1552126 to D. F.	Agris Paul F, 2017, Enzymes, V41, P1, DOI 10.1016/bs.enz.2017.03.005; Arimbasseri AG, 2016, RNA, V22, P1400, DOI 10.1261/rna.056259.116; Arimbasseri AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005671; Asano K, 2018, NUCLEIC ACIDS RES, V46, P1565, DOI 10.1093/nar/gky068; Auffinger P, 1999, J MOL BIOL, V292, P467, DOI 10.1006/jmbi.1999.3080; Auffinger P, 2001, RNA, V7, P334, DOI 10.1017/S1355838201002382; Badri KR, 2008, MOL CELL BIOL, V28, P6358, DOI 10.1128/MCB.00333-08; Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6; Colin E, 2021, HAEMATOLOGICA, V106, P3202, DOI 10.3324/haematol.2021.279138; Cui J, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1186; D'Silva S, 2011, RNA, V17, P1100, DOI 10.1261/rna.2652611; D'Souza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102; de Crecy-Lagard V, 2021, TRENDS MICROBIOL, V29, P41, DOI 10.1016/j.tim.2020.06.010; Dewe JM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00214-17; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Grosjean H., 2005, FINE TUNING RNA FUNC, V24; Gu H, 2018, STEM CELL REP, V10, P1807, DOI 10.1016/j.stemcr.2018.03.022; Han L, 2017, RNA, V23, P406, DOI 10.1261/rna.059667.116; Hanada T, 2001, GENES CELLS, V6, P1019, DOI 10.1046/j.1365-2443.2001.00491.x; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; Ignatova VV, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4551; Jakkaraju S, 2005, DEV CELL, V9, P39, DOI 10.1016/j.devcel.2005.04.015; Kingston RE, 2003, CURR PROTOC MOL BIOL, V63, DOI DOI 10.1002/0471142727.MB0901S63; Kirino Yohei, 2005, RNA Biol, V2, P41, DOI 10.4161/rna.2.2.1610; Koenig T, 2008, J PROTEOME RES, V7, P3708, DOI 10.1021/pr700859x; Lamichhane TN, 2016, RNA, V22, P583, DOI 10.1261/rna.054064.115; Lamichhane TN, 2011, RNA, V17, P1846, DOI 10.1261/rna.2628611; Lee SA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115432; Lentini JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16321-6; Lin H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04250-4; Mao S, 2021, ACS CHEM BIOL, V16, P76, DOI 10.1021/acschembio.0c00735; Noma A, 2011, RNA, V17, P1111, DOI 10.1261/rna.2653411; Olejniczak M, 2006, BIOCHIMIE, V88, P943, DOI 10.1016/j.biochi.2006.06.005; Pan T, 2018, CELL RES, V28, P395, DOI 10.1038/s41422-018-0013-y; Pereira M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123738; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Phizicky EM, 2015, RNA, V21, P483, DOI 10.1261/rna.049932.115; Putz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407; Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Richter U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06471-z; Sakurai M, 2005, NUCLEIC ACIDS RES, V33, P1653, DOI 10.1093/nar/gki309; Schmidt TGM, 2013, PROTEIN EXPRES PURIF, V92, P54, DOI 10.1016/j.pep.2013.08.021; Suzuki T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18068-6; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2021, NAT REV MOL CELL BIO, V22, P375, DOI 10.1038/s41580-021-00342-0; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; The M, 2016, J AM SOC MASS SPECTR, V27, P1719, DOI 10.1007/s13361-016-1460-7; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Vare VYP, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010029; Watanabe Y, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00109; Williford A., 2021, IMPLEMENTATION EVALU; Woodson SA, 2009, METHOD ENZYMOL, V469, P189, DOI 10.1016/S0076-6879(09)69009-1; Xu L, 2017, J BIOL CHEM, V292, P14695, DOI 10.1074/jbc.M117.798298; Yeon SY, 2018, PATHOL ONCOL RES, V24, P617, DOI 10.1007/s12253-017-0287-2; YOKOGAWA T, 1991, NUCLEIC ACIDS RES, V19, P6101, DOI 10.1093/nar/19.22.6101; Zhang KJ, 2020, HUM MUTAT, V41, P600, DOI 10.1002/humu.23976; Zhang LH, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100968	60	3	3	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101788	10.1016/j.jbc.2022.101788	http://dx.doi.org/10.1016/j.jbc.2022.101788			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35247384	Green Published, gold			2022-12-26	WOS:000793502000010
J	Vasileva, E; Spadaro, D; Rouaud, F; King, JM; Flinois, A; Shah, J; Sluysmans, S; Mean, I; Jond, L; Turner, JR; Citi, S				Vasileva, Ekaterina; Spadaro, Domenica; Rouaud, Florian; King, Jonathan M.; Flinois, Arielle; Shah, Jimit; Sluysmans, Sophie; Mean, Isabelle; Jond, Lionel; Turner, Jerrold R.; Citi, Sandra			Cingulin binds to the ZU5 domain of scaffolding protein ZO-1 to promote its extended conformation, stabilization, and tight junction accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL JUNCTIONS; ACTIN; COMPLEX; EXPRESSION; IDENTIFICATION; LOCALIZATION; PARACINGULIN; POLYPEPTIDE; INTERACTS; MECHANISM	Zonula occludens-1 (ZO-1), the major scaffolding protein of tight junctions (TJs), recruits the cytoskeleton-associated proteins cingulin (CGN) and paracingulin (CGNL1) to TJs by binding to their N-terminal ZO-1 interaction motif. The conformation of ZO-1 can be either folded or extended, depending on cytoskeletal tension and intramolecular and intermolecular interactions, and only ZO-1 in the extended conformation recruits the transcription factor DbpA to TJs. However, the sequences of ZO-1 that interact with CGN and CGNL1 and the role of TJ proteins in ZO-1 TJ assembly are not known. Here, we used glutathione-S-transferase pulldowns and immunofluorescence microscopy to show that CGN and CGNL1 bind to the C-terminal ZU5 domain of ZO-1 and that this domain is required for CGN and CGNL1 recruitment to TJs and to phase-separated ZO-1 condensates in cells. We show that KO of CGN, but not CGNL1, results in decreased accumulation of ZO-1 at TJs. Furthermore, ZO-1 lacking the ZU5 domain showed decreased accumulation at TJs, was detectable along lateral contacts, had a higher mobile fraction than full-length ZO-1 by fluorescence recovery after photo bleaching analysis, and had a folded conformation, as determined by structured illumination microscopy of its N-terminal and C-terminal ends. The CGN-ZU5 interaction promotes the extended conformation of ZO-1, since binding of the CGN- ZO-1 interaction motif region to ZO-1 resulted in its interaction with DbpA in cells and in vitro. Together, these results show that binding of CGN to the ZU5 domain of ZO-1 promotes ZO-1 stabilization and accumulation at TJs by promoting its extended conformation.	[Vasileva, Ekaterina; Spadaro, Domenica; Rouaud, Florian; Flinois, Arielle; Shah, Jimit; Sluysmans, Sophie; Mean, Isabelle; Jond, Lionel; Citi, Sandra] Univ Geneva, Fac Sci, Dept Cell Biol, Geneva, Switzerland; [King, Jonathan M.; Turner, Jerrold R.] Brigham & Womens Hosp, Dept Pathol, Lab Mucosal Barrier Pathobiol, 75 Francis St, Boston, MA 02115 USA; [King, Jonathan M.; Turner, Jerrold R.] Harvard Med Sch, Boston, MA 02115 USA; [King, Jonathan M.] Trinity Univ, Biol Dept, San Antonio, TX USA	University of Geneva; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Trinity University	Citi, S (corresponding author), Univ Geneva, Fac Sci, Dept Cell Biol, Geneva, Switzerland.	Sandra.Citi@unige.ch	King, Jonathan/GXH-4010-2022	King, Jonathan/0000-0003-1791-0636; Flinois, Arielle/0000-0002-7763-5632; Sluysmans, Sophie/0000-0002-6094-5482	Swiss National Fund for Scientific Research [31003A_152899, 31003A_172809, 31003A_130520, 31003A_14997]; National Institutes of Health [R01DK61931, R01DK68271]; National Science Foundation [1229702]	Swiss National Fund for Scientific Research(Swiss National Science Foundation (SNSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This study was supported by the Swiss National Fund for Scientific Research (N. 31003A_152899, N. 31003A_172809, N. 31003A_130520, and N.31003A_14997 [to S. C.]), by the National Institutes of Health (grants R01DK61931 and R01DK68271 [to J. R. T.]), and by the National Science Foundation (Major Research Instrumentation grant: no. 1229702 [to J. M. K.]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; BALDA MS, 1993, J CELL BIOL, V123, P293, DOI 10.1083/jcb.123.2.293; Beutel O, 2019, CELL, V179, P923, DOI 10.1016/j.cell.2019.10.011; Cardellini P, 1996, DEV DYNAM, V207, P104, DOI 10.1002/(SICI)1097-0177(199609)207:1<104::AID-AJA10>3.0.CO;2-0; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Citi S, 2020, CURR BIOL, V30, pR83, DOI 10.1016/j.cub.2019.11.060; Citi S, 2012, ANN NY ACAD SCI, V1257, P125, DOI 10.1111/j.1749-6632.2012.06506.x; Colom A., 2020, BIORXIV, DOI [10.1101/2020.05.14.095364, DOI 10.1101/2020.05.14.095364]; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; D'Atri F, 2002, J BIOL CHEM, V277, P27757, DOI 10.1074/jbc.M203717200; D'Atri F, 2001, FEBS LETT, V507, P21, DOI 10.1016/S0014-5793(01)02936-2; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fesenko I, 2000, MECH DEVELOP, V96, P51, DOI 10.1016/S0925-4773(00)00368-3; Fialka I, 1996, J CELL BIOL, V132, P1115, DOI 10.1083/jcb.132.6.1115; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Guerrera D, 2016, J BIOL CHEM, V291, P11016, DOI 10.1074/jbc.M115.712935; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Huo L, 2011, EMBO J, V30, P665, DOI 10.1038/emboj.2010.353; Itoh M, 2012, P NATL ACAD SCI USA, V109, P9905, DOI 10.1073/pnas.1115063109; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Maiers JL, 2013, J CELL SCI, V126, P3904, DOI 10.1242/jcs.126565; Mangan AJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12426; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Nie M, 2009, EMBO REP, V10, P1125, DOI 10.1038/embor.2009.182; Odenwald MA, 2018, J BIOL CHEM, V293, P17317, DOI 10.1074/jbc.RA118.003908; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Otani T, 2020, TRENDS CELL BIOL, V30, P805, DOI 10.1016/j.tcb.2020.08.004; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Paschoud S, 2012, J BIOL CHEM, V287, P13159, DOI 10.1074/jbc.M111.315622; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Rouaud F, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183399; Rouaud F, 2019, TISSUE BARRIERS, V7, DOI 10.1080/21688370.2019.1653748; Schwayer C, 2019, CELL, V179, P937, DOI 10.1016/j.cell.2019.10.006; Shah J, 2018, CELL REP, V25, P2132, DOI 10.1016/j.celrep.2018.10.088; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Sluysmans S, 2021, MOL BIOL CELL, V32, DOI 10.1091/mbc.E21-07-0355; Spadaro D, 2017, CURR BIOL, V27, P3783, DOI 10.1016/j.cub.2017.11.014; Spadaro D, 2014, J BIOL CHEM, V289, P22500, DOI 10.1074/jbc.M114.556449; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Tsukita S, 2019, TRENDS BIOCHEM SCI, V44, P141, DOI 10.1016/j.tibs.2018.09.008; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Unbekandt M, 2014, J MOL MED, V92, P217, DOI 10.1007/s00109-014-1133-6; Van Itallie CM, 2013, J BIOL CHEM, V288, P13775, DOI 10.1074/jbc.M113.466193; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vasileva E, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2018.1539596; Vasileva E, 2017, ANN NY ACAD SCI, V1405, P160, DOI 10.1111/nyas.13391; Wang YB, 2014, J AM SOC NEPHROL, V25, P250, DOI 10.1681/ASN.2013040429; Wittchen ES, 2000, J CELL BIOL, V151, P825, DOI 10.1083/jcb.151.4.825; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Yano T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33418-7; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zihni C, 2016, NAT REV MOL CELL BIO, V17, P564, DOI 10.1038/nrm.2016.80	57	2	3	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101797	10.1016/j.jbc.2022.101797	http://dx.doi.org/10.1016/j.jbc.2022.101797			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35259394	Green Published, Green Accepted, gold			2022-12-26	WOS:000793617400005
J	Pique-Fandino, L; Gallois, S; Pavard, S; Rozzi, FVR				Pique-Fandino, Laura; Gallois, Sandrine; Pavard, Samuel; Rozzi, Fernando V. Ramirez			Reproductive seasonality in the Baka Pygmies, environmental factors and climatic changes	PLOS ONE			English	Article							BIRTH SEASONALITY; HUNTER-GATHERERS; LONGEVITY; DYNAMICS; CAMEROON; ECOLOGY; ORIGINS; AFRICA; TRENDS; FOOD	Reproductive seasonality is a phenomenon common to human and animal populations and driven by, among others, climatic variables. Given the currently changing climate and its impacts on both the environment and human lives, the question arises of its potential effects on reproductive seasonality. Few studies have specifically explored the seasonality of reproduction among hunter-gatherers and anyone investigated how current climate change might affect this phenomenon. In this study we addressed reproductive seasonality in the Baka Pygmy living in African rain forests. Since reproductive seasonality can be linked to weather patterns, we explore this possibility. However, climatic variables driving weather patterns have changed over the years, so we assessed whether this has influenced the Baka reproductive pattern. Based on 34 years of written birth records and oral questionnaires from 13 years of systematic fieldwork, we observed a bimodal birth pattern with two birth peaks at 6-month intervals. Our results demonstrate that precipitation at conception or at birth potentially has effects, respectively negative and positive on the monthly number of births; and temperature has a role in controlling other variables that do affect the reproductive pattern. Changing weather patterns appear to be affecting the reproductive seasonality in the Baka, suggesting that attention needs to be given to the influence of global climate change on forager societies.	[Pique-Fandino, Laura; Pavard, Samuel; Rozzi, Fernando V. Ramirez] Univ Paris, Musee Homme, CNRS, Museum Natl Hist Nat,Ecoanthropol EA, Paris, France; [Gallois, Sandrine] Univ Oberta Catalunya, Barcelona, Spain; [Rozzi, Fernando V. Ramirez] Univ Paris, Fac Chirurg Dent, EA 2496, Montrouge, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; UOC Universitat Oberta de Catalunya; UDICE-French Research Universities; Universite Paris Cite	Rozzi, FVR (corresponding author), Univ Paris, Musee Homme, CNRS, Museum Natl Hist Nat,Ecoanthropol EA, Paris, France.; Rozzi, FVR (corresponding author), Univ Paris, Fac Chirurg Dent, EA 2496, Montrouge, France.	fernando.ramirez-rozzi@mnhn.fr		Ramirez Rozzi, Fernando/0000-0002-8537-3839	CNRS; IRD; Wenner-Gren Foundation [7810]; National Geographic [8863-10]; Agence Nationale de la Recherche under the Blanc SVSE7-2011 GrowinAP programme	CNRS(Centre National de la Recherche Scientifique (CNRS)); IRD; Wenner-Gren Foundation; National Geographic(National Geographic Society); Agence Nationale de la Recherche under the Blanc SVSE7-2011 GrowinAP programme(French National Research Agency (ANR))	Thanks to X. Garde, B. Bordage and to all the staff of IRD Yaounde for their logistical support; to the nuns at the Le Bosquet mission for their kind hospitality and especially to P. Kalo, J. B. Etoa and other Baka collaborators for their help, assistance and friendship. We also want to thank A. Epelboin for his useful comments on the previous manuscript; Elisa Bergas Masso, who provided us with high quality meteorological data without which the study could not be carried out, and Mikel Larranaga Arcay. This study was supported by the CNRS and IRD, and by grants from the Wenner-Gren Foundation (7810) (FRR), the National Geographic (8863-10) (FRR) and the Agence Nationale de la Recherche under the Blanc SVSE7-2011 GrowinAP programme (FRR).	Antonio-Nkondjio C, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3753-8; BAILEY RC, 1992, J BIOSOC SCI, V24, P393, DOI 10.1017/S0021932000019957; BANTJE H, 1987, SOC SCI MED, V24, P733, DOI 10.1016/0277-9536(87)90110-9; Becker NSA, 2011, AM J PHYS ANTHROPOL, V145, P390, DOI 10.1002/ajpa.21512; Becker NSA., 2013, EUR J HUM GENET, V21, P1, DOI [10.1038/ejhg.2012.161, DOI 10.1038/EJHG.2012.161]; Berry I, 2018, AM J TROP MED HYG, V98, P534, DOI 10.4269/ajtmh.17-0620; Betti J.L., 2004, AFRICAN STUDY MONOGR, V25, P1, DOI DOI 10.14989/68229; Boesch C, 2000, CHIMPANZEES TAI FORE; Boland MR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57377-9; Buckles KS, 2013, REV ECON STAT, V95, P711, DOI 10.1162/REST_a_00314; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cavalli-Sforza LL, 1986, AFRICAN PYGMIES; CONDON RG, 1982, HUM ECOL, V10, P495, DOI 10.1007/BF01531169; COWGILL UM, 1966, MAN, V1, P232, DOI 10.2307/2796349; Cypryjanski J, 2019, DEMOGR RES, V40, P1441, DOI 10.4054/DemRes.2019.40.49; Diamond Jared, 1997, WHY IS SEX FUN EVOLU; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Dorelien AM, 2016, DEMOGR RES, V34, P761, DOI 10.4054/DemRes.2016.34.27; Dounias E., 2001, AFR ST MON SUPP ISS, V26, P135, DOI DOI 10.14989/68403; Douros K, 2019, AM J PHYS ANTHROPOL, V170, P447, DOI 10.1002/ajpa.23923; Dubost G, 2017, ZOOL STUD, V56, DOI 10.6620/ZS.2017.56-02; Duda R., 2018, REV DETHNO COLOGIE, V14; DUDA R, 2017, THESIS; Ellison PT, 2005, HUMAN BIRTH SEASONAL; Fellman J, 2019, TWIN RES HUM GENET, V22, P187, DOI 10.1017/thg.2019.18; FERGUSON AG, 1987, SOC SCI MED, V25, P793, DOI 10.1016/0277-9536(87)90037-2; Ford JD, 2012, AM J PUBLIC HEALTH, V102, P1260, DOI 10.2105/AJPH.2012.300752; Gagnon A, 2012, AM J HUM BIOL, V24, P654, DOI 10.1002/ajhb.22287; Gallois S, 2020, ECON BOT; Gallois S, 2016, REV ETHNOECOLOGIE, DOI [10.4000/ethnoecologie.2818, DOI 10.4000/ETHNOECOLOGIE.2818]; Gallois S, 2020, ECON BOT, V74, P46, DOI 10.1007/s12231-020-09489-x; Grech V, 2003, J BIOSOC SCI, V35, P95, DOI 10.1017/S0021932003000956; Hayashi Koji, 2008, African Study Monographs, V29, P73; He DH, 2007, THEOR POPUL BIOL, V72, P274, DOI 10.1016/j.tpb.2007.04.004; Heldstab SA, 2021, BIOL REV, V96, P66, DOI 10.1111/brv.12646; Herteliu C, 2015, HUM REPROD, V30, P2202, DOI 10.1093/humrep/dev129; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hsu MJ, 2001, PRIMATES, V42, P15, DOI 10.1007/BF02640685; International Labour Organization, 2017, INDIGENOUS PEOPLES C; Jensen CB, 2015, EARLY HUM DEV, V91, P361, DOI 10.1016/j.earlhumdev.2015.03.010; Karlsson L, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010018; Khajavi A, 2016, ANN EPIDEMIOL, V26, P846, DOI 10.1016/j.annepidem.2016.09.009; Knott CD, 2005, CAM S BIO EVOL ANTHR, V44, P351, DOI 10.1017/CBO9780511542343.013; LAM DA, 1991, SOC BIOL, V38, P51; Lam DA, 1996, DEMOGRAPHY, V33, P291, DOI 10.2307/2061762; LECLERC C, 2012, ADOPTION AGR CHEZ PY; LESLIE PW, 1989, AM J PHYS ANTHROPOL, V79, P103, DOI 10.1002/ajpa.1330790111; LEVINE RJ, 1994, ANN NY ACAD SCI, V709, P29, DOI 10.1111/j.1749-6632.1994.tb30386.x; LEVINE RJ, 1988, FERTIL STERIL, V49, P900; MacVicar S, 2017, SOC SCI MED, V187, P39, DOI 10.1016/j.socscimed.2017.06.021; Maley J, 1998, REV PALAEOBOT PALYNO, V99, P157, DOI 10.1016/S0034-6667(97)00047-X; Martinez-Bakker M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2438; McNutt JW, 2019, J ZOOL, V309, P153, DOI 10.1111/jzo.12712; Molua EL, 2006, CLIMATE RES, V30, P255, DOI 10.3354/cr030255; Molua EL, 2002, ENVIRON DEV ECON, V7, P529, DOI 10.1017/S1355770X02000311; Oishi T., 2012, AFR STUDY MONOGR SUP, V43, P15; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Pemberton TJ, 2018, HUM GENET, V137, P487, DOI 10.1007/s00439-018-1902-3; Perry GH, 2014, P NATL ACAD SCI USA, V111, pE3596, DOI 10.1073/pnas.1402875111; Philibert A, 2013, J BIOSOC SCI, V45, P547, DOI 10.1017/S0021932012000703; Plana V, 2004, PHILOS T ROY SOC B, V359, P1585, DOI 10.1098/rstb.2004.1535; Rau R., 2006, SEASONALITY HUMAN MO; Reyes-Garcia V, 2020, HUM NATURE-INT BIOS, V31, P203, DOI 10.1007/s12110-020-09375-4; Reyes-Garcia V, 2019, FOOD SECUR, V11, P109, DOI 10.1007/s12571-018-0882-4; Rozzi FVR, 2018, P NATL ACAD SCI USA, V115, pE6126, DOI 10.1073/pnas.1719637115; Rozzi FVR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8672; Ruiu G., 2017, HIST LIFE COURSE STU, V4, P145, DOI DOI 10.51964/HLCS9342; Ruiu G, 2020, EUR J POPUL, V36, P141, DOI 10.1007/s10680-019-09524-1; Sato H., 2000, AFR STUDY MONOGR, V21, P67, DOI DOI 10.14989/68193; Schnittker J, 2018, SSM-POPUL HLTH, V4, P307, DOI 10.1016/j.ssmph.2018.03.008; Terashima, 2003, AFR STUDY MONOGR, V24, P1, DOI DOI 10.14989/68220; Verdu P, 2010, BIOL LETTERS, V6, P858, DOI 10.1098/rsbl.2010.0192; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Vincens A, 1999, J BIOGEOGR, V26, P879, DOI 10.1046/j.1365-2699.1999.00333.x; Wang CT, 2017, PSYCHIAT RES, V253, P189, DOI 10.1016/j.psychres.2017.03.030; WILMSEN EN, 1982, SOC SCI INFORM, V21, P95, DOI 10.1177/053901882021001006; WILMSEN EN, 1978, FED PROC, V37, P65; Yasuoka H., 2012, AFR STUDY MONOGR SUP, V43, P85; Yasuoka Hirokazu, 2006, African Study Monographs Supplementary Issue, V33, P95; Zhang Y, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6058	81	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264761	10.1371/journal.pone.0264761	http://dx.doi.org/10.1371/journal.pone.0264761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259192	Green Published, gold			2022-12-26	WOS:000835141200023
J	Rocha, TM; Mendes, JFF; Murari, TB; Nascimento, AS; Cordeiro, AJA; Ramalho, WM; Scorza, FA; Almeida, ACG; Moret, MA				Rocha Filho, Tarcisio M.; Mendes, Jose F. F.; Murari, Thiago B.; Nascimento Filho, Aloisio S.; Cordeiro, Antonio J. A.; Ramalho, Walter M.; Scorza, Fulvio A.; Almeida, Antonio-Carlos G.; Moret, Marcelo A.			Optimization of COVID-19 vaccination and the role of individuals with a high number of contacts: A model based approach	PLOS ONE			English	Article								We report strong evidence of the importance of contact hubs (or superspreaders) in mitigating the current COVID-19 pandemic. Contact hubs have a much larger number of contacts than the average in the population, and play a key role on the effectiveness of vaccination strategies. By using an age-structures compartmental SEIAHRV (Susceptible, Exposed, Infected symptomatic, Asymptomatic, Hospitalized, Recovered, Vaccinated) model, calibrated from available demographic and COVID-19 incidence, and considering separately those individuals with a much greater number of contacts than the average in the population, we show that carefully choosing who will compose the first group to be vaccinated can impact positively the total death toll and the demand for health services. This is even more relevant in countries with a lack of basic resources for proper vaccination and a significant reduction in social isolation. In order to demonstrate our approach we show the effect of hypothetical vaccination scenarios in two countries of very different scales and mitigation policies, Brazil and Portugal.	[Rocha Filho, Tarcisio M.] Univ Brasilia, Int Ctr Condensed Matter Phys, Brasilia, DF, Brazil; [Rocha Filho, Tarcisio M.] Univ Brasilia, Inst Fis, Brasilia, DF, Brazil; [Mendes, Jose F. F.] Univ Aveiro, Dept Fis, Aveiro, Portugal; [Mendes, Jose F. F.] Univ Aveiro, I3N, Aveiro, Portugal; [Murari, Thiago B.; Nascimento Filho, Aloisio S.; Cordeiro, Antonio J. A.; Moret, Marcelo A.] Ctr Univ SENAI CIMATEC, Salvador, BA, Brazil; [Cordeiro, Antonio J. A.] Inst Fed Educ & Tecnol Bahia, Feira De Santana, BA, Brazil; [Ramalho, Walter M.] Univ Brasilia, FCE & Nucleo Med Trop, Brasilia, DF, Brazil; [Scorza, Fulvio A.] Univ Fed Sao Paulo EPM UNIFESP, Disciplina Neurociencia, Escola Paulista Med, Sao Paulo, SP, Brazil; [Almeida, Antonio-Carlos G.] Univ Fed Sao Joao del Rei UFSJ, Sao Joao Del Rei, MG, Brazil; [Moret, Marcelo A.] Univ Estado Bahia, Salvador, BA, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Aveiro; Universidade de Aveiro; Universidade de Brasilia; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Joao del-Rei; Universidade do Estado Bahia	Rocha, TM (corresponding author), Univ Brasilia, Int Ctr Condensed Matter Phys, Brasilia, DF, Brazil.; Rocha, TM (corresponding author), Univ Brasilia, Inst Fis, Brasilia, DF, Brazil.	marciano@fis.unb.br	da Rocha Filho, Tarcísio Marciano/AAD-1316-2019; ALMEIDA, ANTÔNIO-CARLOS GUIMARÃES/B-8028-2008; Murari, Thiago Barros/N-4638-2014; Moret, Marcelo A./O-3485-2018	da Rocha Filho, Tarcísio Marciano/0000-0002-7865-4085; ALMEIDA, ANTÔNIO-CARLOS GUIMARÃES/0000-0003-4893-338X; Murari, Thiago Barros/0000-0001-5598-2679; Moret, Marcelo A./0000-0003-0051-6309	National Council of Technological and Scientific Development - CNPq [302449/2019-1, 309617/2020-0, 305291/2018-1]; Bahia State Research Support Foundation (Brazil) [BOL0723/2017]; i3N - Fundacao para a Ciencia e Tecnologia/MEC (Portugal) [UIDB/50025/2020, UIDP/50025/2020]	National Council of Technological and Scientific Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Bahia State Research Support Foundation (Brazil); i3N - Fundacao para a Ciencia e Tecnologia/MEC (Portugal)	This work received financial support from the National Council of Technological and Scientific 242 Development - CNPq (grant numbers 302449/2019-1 FAS, 309617/2020-0 ACGA, 243 305291/2018-1 MAM), Bahia State Research Support Foundation (BOL0723/2017 AJAC) 244 (Brazil) and i3N (grant numbers UIDB/50025/2020 & UIDP/50025/2020) - Fundacao para a 245 Ciencia e Tecnologia/MEC (Portugal). The funders had no role in study design, data collection 246 and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2017, J THEOR BIOL, V419, P1, DOI 10.1016/j.jtbi.2017.01.041; [Anonymous], FUNDACAO FRANCISCO M; [Anonymous], COVID 19 DASHBOARD C; [Anonymous], NEW YORK TIMES; [Anonymous], DIRECAO GERAL SAUDE; Beraud G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133203; Centers for Disease Control and Prevention, CDC IS MAK COVID 19; Cho SW, 2020, ECONOMET J, V23, P323, DOI 10.1093/ectj/utaa025; de Waroux OL, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3073-1; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; ECDC, 2021, OV IMPL COVID 19 VAC; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Goltsev AV, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128702; IBGE, US; Ibuka Y, 2016, J EPIDEMIOL COMMUN H, V70, P162, DOI 10.1136/jech-2015-205777; Kabir R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050416; Kartoglu UH, 2020, VACCINE, V38, P5393, DOI 10.1016/j.vaccine.2020.06.056; Kiti MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104786; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Kwok KO, 2020, J INFECTION, V80, pE32, DOI 10.1016/j.jinf.2020.03.027; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Leung K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08241-1; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Luyten Jeroen., 2020, COVID EC VETTED REAL, V57, P1; Magpantay FMG, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0151; Mahmud I, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080864; Manfredi P, 2005, EPIDEMIOL INFECT, V133, P87, DOI 10.1017/S0950268804003152; Melegaro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170459; Ministerio da Saude do Brasil, COR BRAS; Ministerio da Saude do Brasil, PLAN NAC OP VAC COVI; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ndwandwe D, 2021, CURR OPIN IMMUNOL, V71, P111, DOI 10.1016/j.coi.2021.07.003; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Rahmandad H, 2020, ESTIMATING COVID 19, DOI 10.1101/2020.06.24.20139451; Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268; Russell Timothy W, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.12.2000256; Sheridan A, 2020, P NATL ACAD SCI USA, V117, P20468, DOI 10.1073/pnas.2010068117; Tegally H., 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; van Riel D, 2020, NAT MATER, V19, P810, DOI 10.1038/s41563-020-0746-0; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P510, DOI 10.1001/jama.2020.11787; World Health Organization, NOV COR 2019 NCOV SI; World Health Organization, COR DIS COVID 19 DAS; Zhou T, 2020, J EVID-BASED MED, V13, P3, DOI 10.1111/jebm.12376; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	52	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0262433	10.1371/journal.pone.0262433	http://dx.doi.org/10.1371/journal.pone.0262433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259169	gold, Green Published			2022-12-26	WOS:000835141200005
J	Lee, WK; Zhu, XG; Park, S; Zhu, YJ; Zhao, L; Meltzer, P; Cheng, SY				Lee, Woo Kyung; Zhu, Xuguang; Park, Sunmi; Zhu, Yuelin Jack; Zhao, Li; Meltzer, Paul; Cheng, Sheue-Yann			Regulation of cancer stem cell activity by thyroid hormone receptor beta	ONCOGENE			English	Article							TR-BETA; EXPRESSION; CARCINOMA; GENE; MUTATION; IDENTIFICATION; TUMORIGENESIS; ASSOCIATION; INHIBITION; PATHWAY	Increasing numbers of cancer stem cell markers have been recently identified. It is not known, however, whether a member of the nuclear receptor superfamily, thyroid hormone receptor beta (TR beta), can function to regulate cancer stem cell (CSC) activity. Using anaplastic thyroid cancer cells (ATC) as a model, we highlight the role of TR beta in CSC activity. ATC is one of the most aggressive solid cancers in humans and is resistant to currently available therapeutics. Recent studies provide evidence that CSC activity underlies aggressiveness and therapeutic resistance of ATC. Here we show that TR beta inhibits CSC activity by suppressing tumor-sphere formation of human ATC cells and their tumor-initiating capacity. TR beta suppresses the expression of CSC regulators, including ALDH, KLF2, SOX2, b-catenin, and ABCG2, in ATC cell-induced xenograft tumors. Single-cell transcriptomic analysis shows that TR beta reduces CSC population in ATC-induced xenograft tumors. Analysis of The Cancer Genome Atlas (TCGA) database demonstrates that the inhibition of CSC capacity by TR beta contributes to favorable clinical outcomes in human cancer. Our studies show that TR beta is a newly identified transcription regulator that acts to suppress CSC activity and that TR beta could be considered as a molecular target for therapeutic intervention of ATC.	[Lee, Woo Kyung; Zhu, Xuguang; Park, Sunmi; Zhao, Li; Cheng, Sheue-Yann] NCI, Lab Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhu, Yuelin Jack; Meltzer, Paul] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cheng, SY (corresponding author), NCI, Lab Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	chengs@mail.nih.gov	Doolittle, Woo Kyung Lee/CAJ-0252-2022	Doolittle, Woo Kyung Lee/0000-0002-6737-3173	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ando S, 2001, J CLIN ENDOCR METAB, V86, P5572, DOI 10.1210/jc.86.11.5572; Aranda A, 2009, TRENDS ENDOCRIN MET, V20, P318, DOI 10.1016/j.tem.2009.03.011; Ayob AZ, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0426-4; Bolf EL, 2020, MOL CANCER RES, V18, P1443, DOI 10.1158/1541-7786.MCR-20-0282; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Carr FE, 2016, ENDOCRINOLOGY, V157, P3278, DOI 10.1210/en.2015-2046; Enomoto K, 2017, J CLIN ENDOCR METAB, V102, P2268, DOI 10.1210/jc.2016-3771; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Guigon CJ, 2011, ONCOGENE, V30, P3381, DOI 10.1038/onc.2011.50; Haghpanah V, 2016, LIFE SCI, V146, P34, DOI 10.1016/j.lfs.2015.12.057; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Iwasaki Y, 2010, ANN SURG ONCOL, V17, P2222, DOI 10.1245/s10434-010-0956-9; Jazdzewski K, 2011, J CLIN ENDOCR METAB, V96, pE546, DOI 10.1210/jc.2010-1594; Jean E, 2011, J CELL MOL MED, V15, P119, DOI 10.1111/j.1582-4934.2009.00942.x; Jerzak KJ, 2018, BREAST CANCER RES TR, V171, P709, DOI 10.1007/s10549-018-4844-5; Joseph B, 2007, J CLIN ENDOCR METAB, V92, P4766, DOI 10.1210/jc.2007-0812; Kim WG, 2014, THYROID, V24, P260, DOI 10.1089/thy.2013.0054; Kim WG, 2013, BBA-GEN SUBJECTS, V1830, P3928, DOI 10.1016/j.bbagen.2012.04.002; Kim WG, 2013, ENDOCRINOLOGY, V154, P25, DOI 10.1210/en.2012-1728; Lee CH, 2016, ONCOTARGET, V7, P1215, DOI 10.18632/oncotarget.6261; Lee WK., 2021, J CANC METASTASIS TR, V7, P27; Lee WK, 2020, ENDOCR-RELAT CANCER, V27, P209, DOI 10.1530/ERC-19-0482; Lee WK, 2019, EUR J ENDOCRINOL, V181, P139, DOI 10.1530/EJE-18-1025; Lee WK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102867; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065095; Li Z, 2002, CANCER RES, V62, P1939; Lopez-Mateo I, 2020, THYROID, V30, P116, DOI 10.1089/thy.2019.0175; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; Marlow LA, 2010, J CLIN ENDOCR METAB, V95, P5338, DOI 10.1210/jc.2010-1421; Molinaro E, 2017, NAT REV ENDOCRINOL, V13, P644, DOI 10.1038/nrendo.2017.76; Park JW, 2013, AM J CANCER RES, V3, P302; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Ravi N, 2020, CANCERS, V12, DOI 10.3390/cancers12030680; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Silva JM, 2002, ONCOGENE, V21, P4307, DOI 10.1038/sj.onc.1205534; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smallridge RC, 2012, THYROID, V22, P1104, DOI 10.1089/thy.2012.0302; Smallridge RC, 2012, J CLIN ENDOCR METAB, V97, P2566, DOI 10.1210/jc.2012-1314; Subbiah V, 2018, J CLIN ONCOL, V36, P7, DOI 10.1200/JCO.2017.73.6785; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tiedje V, 2018, ENDOCR-RELAT CANCER, V25, pR153, DOI 10.1530/ERC-17-0435; Tuttle RM, 2017, THYROID, V27, P751, DOI 10.1089/thy.2017.0102	45	1	1	2	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2022	41	16					2315	2325		10.1038/s41388-022-02242-9	http://dx.doi.org/10.1038/s41388-022-02242-9		MAR 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0N1NW	35256781	Green Accepted			2022-12-26	WOS:000765674100004
J	Horcharoensuk, P; Yang-en, S; Narkwichean, A; Rungsiwiwut, R				Horcharoensuk, Pongsatorn; Yang-en, Sunantha; Narkwichean, Amarin; Rungsiwiwut, Ruttachuk			Proline-based solution maintains cell viability and stemness of canine adipose-derived mesenchymal stem cells after hypothermic storage	PLOS ONE			English	Article							STROMAL CELLS; PROSTAGLANDIN-E2; IMMUNOMODULATION; CRYOPRESERVATION	Transportation of mesenchymal stem cells (MSCs) under hypothermic conditions in 0.9% normal saline solution (NSS) might increase cell death and alter the stemness of MSCs. The present study aimed to evaluate the effect of proline-based solution (PL-BS) on cell viability and the stemness of newly established canine adipose-derived mesenchymal stem cells (cAD-MSCs) under hypothermic conditions. Characterized cAD-MSCs were stored in 1, 10, and 100 mM PL-BS or NSS at 4 degrees C for 6, 9, and 12 hours prior to an evaluation. The results demonstrated that storage in 1 mM PL-BS for 6 hours decreased cell apoptosis and proliferation ability, but improved cell viability and mitochondrial membrane potential. cAD-MSCs maintained their high expression of CD44 and CD90, but had a low expression of CD34 and MHC class II. Trilineage differentiation ability of cAD-MSCs was not affected by storage in 1 mM PL-BS. Gene expression analysis demonstrated that immunomodulatory genes, including IDO, HGF, PGE-2, and IL-6, were upregulated in cAD-MSCs stored in 1 mM PL-BS. In conclusion, PL-BS can be effectively applied for storing cAD-MSCs under hypothermic conditions. These findings provide a new solution for effective handling of cAD-MSCs which might be promising for clinical applications.	[Horcharoensuk, Pongsatorn; Yang-en, Sunantha; Rungsiwiwut, Ruttachuk] Srinakharinwirot Univ, Fac Med, Dept Anat, Bangkok, Thailand; [Narkwichean, Amarin] Srinakharinwirot Univ, Fac Med, Dept Obstet & Gynaecol, Nakhon Nayok, Thailand	Srinakharinwirot University; Srinakharinwirot University	Rungsiwiwut, R (corresponding author), Srinakharinwirot Univ, Fac Med, Dept Anat, Bangkok, Thailand.	ruttachuk@swu.ac.th	Rungsiwiwut, Ruttachuk/Q-2224-2019	Rungsiwiwut, Ruttachuk/0000-0002-1448-2309	Faculty of Medicine, Srinakharinwirot University [MED-GRAD-150, 511/2563, MEDRES-200, 217/2563]	Faculty of Medicine, Srinakharinwirot University	Faculty of Medicine, Srinakharinwirot University (MED-GRAD-150; 511/2563 and MEDRES-200; 217/2563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2011, VITAM HORM, V87, P39, DOI 10.1016/B978-0-12-386015-6.00023-8; Aoyama T., 2017, MESENCHYMAL STEM CEL, P279; ARDAILLOU N, 1990, KIDNEY INT, V38, P1151, DOI 10.1038/ki.1990.326; Bauer SR., 2004, HDB STEM CELLS, P805, DOI DOI 10.1016/B978-012436643-5/50163-2; Bhattacharya S., 2018, CRYOPRESERVATION BIO, P7; Blumberg N, 2018, TRANSFUS APHER SCI, V57, P127, DOI 10.1016/j.transci.2018.02.021; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Cao ZY, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01830-4; Chen Y, 2013, CELL TRANSPLANT, V22, P1075, DOI 10.3727/096368912X657602; Correia C, 2016, STEM CELL TRANSL MED, V5, P658, DOI 10.5966/sctm.2015-0238; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dorronsoro A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78864-4; Dou MJ, 2019, CRYOBIOLOGY, V91, P23, DOI 10.1016/j.cryobiol.2019.11.002; Freimark D, 2011, CRYOBIOLOGY, V63, P67, DOI 10.1016/j.cryobiol.2011.05.002; Fuller BJ, 2013, CRYOLETTERS, V34, P432; Galvez-Martin P, 2014, EUR J PHARM BIOPHARM, V86, P459, DOI 10.1016/j.ejpb.2013.11.002; Gniadek TJ, 2018, TRANSFUSION, V58, P461, DOI 10.1111/trf.14429; GOLDSTEIN RH, 1986, J BIOL CHEM, V261, P8734; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Heidari Reza, 2019, Journal of Basic and Clinical Physiology and Pharmacology, V30, P91, DOI 10.1515/jbcpp-2017-0221; Hendriks KDW, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2013-1; Kaul S, 2008, AMINO ACIDS, V34, P315, DOI 10.1007/s00726-006-0407-x; Kresic N, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/4176292; Lee BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26298; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; Lin TH, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0730-z; Lu XM, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/8178643; Maraldi T, 2015, STEM CELL TRANSL MED, V4, P539, DOI 10.5966/sctm.2014-0266; Mbongue JC, 2015, VACCINES-BASEL, V3, P703, DOI 10.3390/vaccines3030703; Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI [10.1089/ten.tea.2007.0207, 10.1089/tea.2007.0207]; Nofianti Chyara Elisa, 2018, Stem Cell Investig, V5, P19, DOI 10.21037/sci.2018.05.04; Ou JX, 2018, CELL, V173, P851, DOI 10.1016/j.cell.2018.03.010; Pal R, 2008, J TISSUE ENG REGEN M, V2, P436, DOI 10.1002/term.109; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rodriguez-Fuentes DE, 2021, ARCH MED RES, V52, P93, DOI 10.1016/j.arcmed.2020.08.006; Russell KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167442; Saeedi Pardis, 2019, Stem Cell Investig, V6, P34, DOI 10.21037/sci.2019.08.11; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; Samuel D, 2000, PROTEIN SCI, V9, P344; Sciezynska A, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051043; Screven R, 2014, VET IMMUNOL IMMUNOP, V161, P21, DOI 10.1016/j.vetimm.2014.06.002; Shyam H, 2017, REGEN MED, V12, P111, DOI 10.2217/rme-2016-0162; Sohn HS, 2013, CYTOTHERAPY, V15, P460, DOI 10.1016/j.jcyt.2012.10.015; Sun WW, 2016, CELL STRESS CHAPERON, V21, P367, DOI 10.1007/s12192-015-0663-3; Swioklo S., 2017, BIOPROCESSING CELL B, P187; Takemitsu H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-150; Voga M, 2021, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.610240; Voga M, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00278; Wu YD, 2019, MOL MED REP, V19, P2189, DOI 10.3892/mmr.2019.9842; Yang HM, 2018, RES VET SCI, V119, P19, DOI 10.1016/j.rvsc.2018.05.011; Zhang FL, 2017, PEERJ, V5, DOI 10.7717/peerj.3301; Zhang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep26326	55	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264773	10.1371/journal.pone.0264773	http://dx.doi.org/10.1371/journal.pone.0264773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231072	Green Published, gold			2022-12-26	WOS:000849744700045
J	Park, S; Kim, J; Lee, C				Park, Sehwan; Kim, Junkyeong; Lee, Changgil			Residual tensile force estimation method for earth anchor using elasto-magnetic sensing system	PLOS ONE			English	Article							GROUND ANCHOR	The earth anchor method is used to prevent landslides, and repair and reinforce cut or steep slopes due to its benefits of ease of construction and economic feasibility. However, the loss of anchor force has become a problem, which may cause failure and collapse of slopes when the anchor force drops below the design anchor force. While numerous studies have been conducted to solve this problem, measuring the residual tensile force of existing earth anchors remains a challenge, as prior studies required sensors to be installed inside structural members at the time of construction. Therefore, to address this limitation, an experiment was performed in this study to develop an elasto-magnetic (EM) sensor for measuring tensile force based on the EM effect, which could be installed on externally exposed anchor heads. The commercial software ANSYS Maxwell was used to analyze the optimal sensor design for the experiment. Additionally, a series of tests to measure the tensile force was conducted by fabricating the sensor based on the numerical analysis results. The area of BH curves measured by developed EM sensor was increased according to the decrease of tensile force. Also, The tensile force estimation equation was derived and verified using measured data. According to the results, the proposed method can be one of the solution for measuring residual tensile force of earth anchor.	[Park, Sehwan; Kim, Junkyeong] Adv Inst Convergence Technol, Safety Inspect Infrastruct Lab, Suwon, Gyeonggi Do, South Korea; [Lee, Changgil] Korea Railrd Res Inst, Adv Railrd Civil Engn Div, Uiwang Si, Gyeonggi Do, South Korea	Korea Railroad Research Institute (KRRI)	Kim, J (corresponding author), Adv Inst Convergence Technol, Safety Inspect Infrastruct Lab, Suwon, Gyeonggi Do, South Korea.; Lee, C (corresponding author), Korea Railrd Res Inst, Adv Railrd Civil Engn Div, Uiwang Si, Gyeonggi Do, South Korea.	junkyeong@snu.ac.kr; tolc81@krri.re.kr		Lee, Changgil/0000-0002-4915-1737	Infrastructure and Transportation Technology Promotion Research Program - Ministry of Land, Infrastructure and Transport of Korean government [20CTAP-C157163-01]; National Research Foundation of Korea(NRF) - Korea government(MSIT) [NRF-2020R1C1C1004437]; R&D Program, Korea Railroad Research Institute [PK2203B3]	Infrastructure and Transportation Technology Promotion Research Program - Ministry of Land, Infrastructure and Transport of Korean government(Ministry of Land, Infrastructure & Transport (MOLIT), Republic of Korea); National Research Foundation of Korea(NRF) - Korea government(MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); R&D Program, Korea Railroad Research Institute	This research was supported by a grant (20CTAP-C157163-01) from Infrastructure and Transportation Technology Promotion Research Program funded by Ministry of Land, Infrastructure and Transport of Korean government, National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) (No. NRF-2020R1C1C1004437) and the R&D Program, Korea Railroad Research Institute, Project No. PK2203B3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sehwan Park was was received a salary from Ministry of Land, Infrastructure and Transport of Korean government and National Research Foundation of Korea and Changgil Lee was received a salary from Korea Railroad Research Institute.	[Anonymous], 2019, AUD REP; Choi SW, 2013, SENSORS-BASEL, V13, P3739, DOI 10.3390/s130303739; DAVIS N, 1971, J PHYS D APPL PHYS, V4, P1034, DOI 10.1088/0022-3727/4/7/321; Feng H, 2019, STRUCT HEALTH MONIT, V18, P1982, DOI 10.1177/1475921718814733; Guo XX, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19194098; Hong SW., 2002, J KOREAN SOC OCEAN E, V16, P44; Hsu SC, 2007, ENG GEOL, V90, P17, DOI 10.1016/j.enggeo.2006.11.004; Jang T, 2021, J PHYS COMMUN, V5, DOI 10.1088/2399-6528/ac0545; Kim DH, 2017, THESIS INJE U; Kim J, 2020, STRUCT HEALTH MONIT, V19, P281, DOI 10.1177/1475921719842340; Kim J, 2019, J SENSORS, V2019, DOI 10.1155/2019/2469647; Kim NK, 2001, J KOREAN GEOTECH SOC, V17, P59; Kim YS, 2011, SMART STRUCT SYST, V7, P303, DOI 10.12989/sss.2011.7.4.303; KITTEL C, 1949, REV MOD PHYS, V21, P541, DOI 10.1103/RevModPhys.21.541; Kwon IB, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10238437; Lee Bongjik, 2015, [JOURNAL of THE KOREAN GEOENVIRONMENTAL SOCIETY, 한국지반환경공학회 논문집], V16, P15, DOI 10.14481/jkges.2015.16.10.15; Li L, 2004, THESIS IOWA STATE U; Liew SS, 2003, BGA INT C FDN; Lin QG, 2021, EUR J PHYS, V42, DOI 10.1088/1361-6404/abd4c8; Moerman W, 2005, J STRUCT ENG, V131, P322, DOI 10.1061/(ASCE)0733-9445(2005)131:2(322); Roy D, 2015, DEPENDENCE MAGNETIC; WonPyoHong, 2004, [Journal of the Korean Society of Civil Engineers C, 대한토목학회 논문집C], V24, P125; Yhim SS., 1999, J KOREAN SOC CIV ENG, V19, P177; 김래현, 2002, [Journal of the Korean Society of Civil Engineers C, 대한토목학회 논문집C], V22, P585	24	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264078	10.1371/journal.pone.0264078	http://dx.doi.org/10.1371/journal.pone.0264078			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231051	Green Published, gold			2022-12-26	WOS:000849744700013
J	Hong, WH; Lo, SF; Wu, HC; Chiu, MC				Hong, Wei-Hsien; Lo, Sui-Foon; Wu, Hsin-Chieh; Chiu, Min-Chi			Effects of compression garment on muscular efficacy, proprioception, and recovery after exercise-induced muscle fatigue onset for people who exercise regularly	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; PHYSICAL-ACTIVITY; WATER IMMERSION; KNEE; PERFORMANCE; MEN; RELIABILITY; BENEFITS; POSITION; HEALTHY	Fatigue is a major cause of exercise-induced muscle damage (EIMD). Compression garments (CGs) can aid post-exercise recovery, therefore, this study explored the effects of CGs on muscular efficacy, proprioception, and recovery after exercise-induced muscle fatigue in people who exercise regularly. Twelve healthy participants who exercised regularly were enrolled in this study. Each participant completed an exercise-induced muscle fatigue test while wearing a randomly assigned lower-body CG or sports pants (SP); after at least 7 days, the participant repeated the test while wearing the other garment. The dependent variables were muscle efficacy, proprioception (displacements of center of pressure/COP, and absolute error), and fatigue recovery (muscle oxygen saturation/SmO2, deoxygenation and reoxygenation rate, and subjective muscle soreness). A two-way repeated measure analysis of variance was conducted to determine the effect of garment type. The results indicated that relative to SP use, CG use can promote muscle efficacy, proprioception in ML displacement of COP, and fatigue recovery. Higher deoxygenation and reoxygenation rates were observed with CG use than with SP use. For CG use, SmO2 quickly returned to baseline value after 10 min of rest and was maintained at a high level until after 1 h of rest, whereas for SP use, SmO2 increased with time after fatigue onset. ML displacement of COP quickly returned to baseline value after 10 min of rest and subsequently decreased until after 1 hour of rest. Relative to SP use, CG use was associated with a significantly lower ML displacement after 20 min of rest. In conclusion, proprioception and SmO2 recovery was achieved after 10 min of rest; however, at least 24 h may be required for recovery pertaining to muscle efficacy and soreness regardless of CG or SP use.	[Hong, Wei-Hsien] China Med Univ, Dept Sports Med, Taichung, Taiwan; [Lo, Sui-Foon] China Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Wu, Hsin-Chieh] Chaoyang Univ Technol, Dept Ind Engn & Management, Taichung, Taiwan; [Chiu, Min-Chi] Natl Chin Yi Univ Technol, Dept Ind Engn & Management, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chaoyang University of Technology; National Chin-Yi University of Technology	Chiu, MC (corresponding author), Natl Chin Yi Univ Technol, Dept Ind Engn & Management, Taichung, Taiwan.	mcchiu@ncut.edu.tw						Ali A, 2011, J STRENGTH COND RES, V25, P1385, DOI 10.1519/JSC.0b013e3181d6848e; Amonette WE, 2012, J STRENGTH COND RES, V26, P1749, DOI 10.1519/JSC.0b013e3182576f1e; ATWATER SW, 1990, PHYS THER, V70, P79, DOI 10.1093/ptj/70.2.79; Baige K, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.582514; Baum Jaxon T, 2020, Int J Exerc Sci, V13, P890; Bhambhani YN, 1997, MED SCI SPORT EXER, V29, P402, DOI 10.1097/00005768-199703000-00017; Bisson EJ, 2011, GAIT POSTURE, V33, P83, DOI 10.1016/j.gaitpost.2010.10.001; Blangsted AK, 2005, ACTA PHYSIOL SCAND, V183, P379, DOI 10.1111/j.1365-201X.2005.01411.x; Born DP, 2013, INT J SPORT PHYSIOL, V8, P4, DOI 10.1123/ijspp.8.1.4; Davies V, 2009, J STRENGTH COND RES, V23, P1786, DOI 10.1519/JSC.0b013e3181b42589; Denegar CR, 1998, RES SPORTS MED INT J, V8, P163, DOI DOI 10.1080/15438629809512525; Ding H, 2001, BRIT J SPORT MED, V35, P441, DOI 10.1136/bjsm.35.6.441; Doan BK, 2003, J SPORT SCI, V21, P601, DOI 10.1080/0264041031000101971; Duffield R, 2010, J SCI MED SPORT, V13, P136, DOI 10.1016/j.jsams.2008.10.006; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Friden T, 2001, J ORTHOP SPORT PHYS, V31, P567, DOI 10.2519/jospt.2001.31.10.567; Fromy B, 1998, BRAIN RES, V811, P166, DOI 10.1016/S0006-8993(98)00973-1; Ghai S, 2018, GAIT POSTURE, V60, P258, DOI 10.1016/j.gaitpost.2016.08.008; Gill ND, 2006, BRIT J SPORT MED, V40, P260, DOI 10.1136/bjsm.2005.022483; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; Gorostiaga EM, 2010, J STRENGTH COND RES, V24, P1138, DOI 10.1519/JSC.0b013e3181cf769f; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hill JA, 2015, SPORTS ENG, V18, P115, DOI 10.1007/s12283-015-0170-x; Jaakkola T, 2017, BIOMED HUM KINET, V9, P107, DOI 10.1515/bhk-2017-0016; Jakeman JR, 2010, EUR J APPL PHYSIOL, V109, P1137, DOI 10.1007/s00421-010-1464-0; Kao CH., 2019, NATL SPORTS, P213; Kasai N, 2021, EUR J APPL PHYSIOL, V121, P2981, DOI 10.1007/s00421-021-04748-8; Kato E, 2018, J STRENGTH COND RES, V32, P1174, DOI 10.1519/JSC.0000000000001919; Kraemer WJ, 2010, J STRENGTH COND RES, V24, P804, DOI 10.1519/JSC.0b013e3181d33025; Kuster MS, 1999, MED SCI SPORT EXER, V31, P368, DOI 10.1097/00005768-199903000-00003; Lattanzio PJ, 1997, CLIN J SPORT MED, V7, P22, DOI 10.1097/00042752-199701000-00005; Lin HT, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11156697; Markovic G, 2007, J SPORT SCI, V25, P1355, DOI 10.1080/02640410601021713; Marks Ray, 1994, Physiotherapy Canada, V46, P37; MCCULLY KK, 1994, J APPL PHYSIOL, V77, P5, DOI 10.1152/jappl.1994.77.1.5; McLean S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150201; McManus CJ, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.1.015007; Michael JS, 2014, GAIT POSTURE, V39, P804, DOI 10.1016/j.gaitpost.2013.11.001; Miura K, 2004, ARTHROSCOPY, V20, P414, DOI 10.1016/j.arthro.2004.01.007; Mizuno S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178620; Murthy G, 2001, J ORTHOP RES, V19, P436, DOI 10.1016/S0736-0266(00)90019-6; Negyesi J, 2021, EUR J APPL PHYSIOL, V121, P219, DOI 10.1007/s00421-020-04507-1; Olsson L., 2004, ADV PHYSIOTHER, V6, P37, DOI DOI 10.1080/14038190310009894; Oranchuk DJ, 2019, SCAND J MED SCI SPOR, V29, P484, DOI 10.1111/sms.13375; Pereira MIR, 2007, SPORTS MED, V37, P615, DOI 10.2165/00007256-200737070-00005; Powers ME., 1996, STRENGTH COND J, V18, P18; Pruscino CL, 2013, EUR J APPL PHYSIOL, V113, P1585, DOI 10.1007/s00421-012-2576-5; Ribeiro F, 2007, EUR REV AGING PHYS A, V4, P71, DOI 10.1007/s11556-007-0026-x; Riemann BL, 2002, J ATHL TRAINING, V37, P80; Roberts LA, 2015, J PHYSIOL-LONDON, V593, P4285, DOI 10.1113/JP270570; Sayers SP, 1999, MED SCI SPORT EXER, V31, P572, DOI 10.1097/00005768-199904000-00013; Scanlan AT, 2008, INT J SPORT PHYSIOL, V3, P424, DOI 10.1123/ijspp.3.4.424; Susco TM, 2004, J ATHL TRAINING, V39, P241; Upton CM, 2017, J STRENGTH COND RES, V31, P2977, DOI 10.1519/JSC.0000000000002145; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Van Tiggelen D, 2008, SCAND J MED SCI SPOR, V18, P62, DOI 10.1111/j.1600-0838.2007.00649.x; Wannop JW, 2016, J STRENGTH COND RES, V30, P1093, DOI 10.1519/JSC.0000000000001195; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Watanuki S., 1994, ANN PHYSL ANTHR, V3, P121; Wilcock IM, 2006, SPORTS MED, V36, P747, DOI 10.2165/00007256-200636090-00003; Woo MT, 2018, GAIT POSTURE, V66, P63, DOI 10.1016/j.gaitpost.2018.08.011; Yaggie J, 2004, J SPORT REHABIL, V13, P312, DOI 10.1123/jsr.13.4.312; Zhang L, 2019, HUM MOVEMENT SCI, V67, DOI 10.1016/j.humov.2019.102519	63	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264569	10.1371/journal.pone.0264569	http://dx.doi.org/10.1371/journal.pone.0264569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226703	Green Published, gold			2022-12-26	WOS:000793394000033
J	Motuma, A; Regassa, LD; Gobena, T; Roba, KT; Berhane, Y; Worku, A				Motuma, Aboma; Regassa, Lemma Demissie; Gobena, Tesfaye; Roba, Kedir Teji; Berhane, Yemane; Worku, Alemayehu			Almost all working adults have at least one risk factor for non-communicable diseases: Survey of working adults in Eastern Ethiopia	PLOS ONE			English	Article							BURDEN; OBESITY; DETERMINANTS; OVERWEIGHT; MAGNITUDE; EMPLOYEES; PROFILE	Introduction The disease burden and mortality related to Non-communicable Diseases (NCD) increased in the last couple of decades in Ethiopia. As a result, an estimated 300,000 deaths per annum were due to NCD. According to a World Health Organization report, 39% of the total deaths in Ethiopia were attributable to NCD. Rapid urbanization characterized by unhealthy lifestyles such as tobacco and/or alcohol use, physical inactivity, low fruits and vegetable consumption, and overweight drive the rising burden of NCD. However, studies on risk factors for NCD and associated variables are limited among working adults in Eastern Ethiopia. Therefore, this study aimed to examine the magnitude of the risk factors of NCD and associated factors among working adults in Eastern Ethiopia. Methods A cross-sectional study was carried out among 1,200 working adults in Eastern Ethiopia that were selected using a simple random sampling technique from December 2018 to February 2019. Data were collected following the World Health Organization Stepwise Approach to NCD Risk Factor Surveillance (WHO STEP) instruments translated into the local language. A total of five risk factors were included in the study. The Negative Binomial Regression Model was used to determine the association between NCD risk factor scores and other independent variables. Adjusted incidence rate ratio (AIRR) with a 95% Confidence Interval (CI) was used to report the findings while the association was declared significant at a p-value of less than 0.05. STATA version 16.1 was used for data clearing, validating and statistical analysis. Results Totally, 1,164 (97% response rate) participants were employed for analysis. Overall, 95.8% (95% CI: 94.4-96.7%) of the participants had at least one of the five risk factors of NCD. Furthermore, the proportion of participants that had all NCD risk factors was 0.3%. Among the participants, 47.5% were alcohol drinkers, 5.1% were current smokers, 35.5% were overweight, 49.1% exercise low physical activity, and 95% had less than five portions of fruits and vegetables intake per day. Higher risk factor scores were associated with those of advanced age (AIRR = 1.24; 95% CI: 1.01-1.53 in 35-44 age group and AIRR = 1.28; 95% CI: 1.01-1.62 in 45-54 age group), and the ones who are higher educational level (AIRR = 1.23; 95% CI: 1.07-1.43 for those who have completed secondary school and AIRR = 1.29; 95% CI: 1.11-1.50 for those who have completed college education). Conclusion The overwhelming majority (95.8%) of the participants had at least one risk factor for non-communicable diseases. The risk score of non-communicable diseases was higher among those with advanced age and who completed secondary and above levels of education. In a nutshell, the finding shows the need for lifestyle modification and comprehensive non-communicable diseases prevention programs for working adults in Eastern Ethiopia.	[Motuma, Aboma; Roba, Kedir Teji] Haramaya Univ, Coll Hlth & Med Sci, Sch Nursing & Midwifery, Harar, Ethiopia; [Regassa, Lemma Demissie] Haramaya Univ, Coll Hlth & Med Sci, Sch Publ Hlth, Epidemiol & Biostat Dept, Harar, Ethiopia; [Gobena, Tesfaye] Haramaya Univ, Coll Hlth & Med Sci, Dept Environm Hlth Sci, Harar, Ethiopia; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Dept Epidemiol & Biostat, Addis Ababa, Ethiopia; [Worku, Alemayehu] Addis Ababa Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Addis Ababa, Ethiopia	Haramaya University; Haramaya University; Haramaya University; Addis Continental Institute of Public Health; Addis Ababa University	Motuma, A (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Sch Nursing & Midwifery, Harar, Ethiopia.	abomaabdi1@gmial.com	Regassa, Lemma Demissie/V-3091-2019	Regassa, Lemma Demissie/0000-0002-5461-5348; Motuma, Aboma/0000-0003-0149-173X				Abebe SM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015496; Ahmed SH, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7101-x; Al-Badri Husham J Abd, 2017, PLoS One, V12, pe0184989, DOI 10.1371/journal.pone.0184989; Alemseged F, 2012, ETHIOP J HEALTH SCI, V22, P19; Amenu K, 2017, ETHIOP J HEALTH DEV, V31, P348; [Anonymous], 2014, ETH HOSP ALL QUAL EH; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Bigna JJ, 2019, LANCET GLOB HEALTH, V7, pE1295, DOI 10.1016/S2214-109X(19)30370-5; Bollyky TJ, 2017, HEALTH AFFAIR, V36, P1866, DOI 10.1377/hlthaff.2017.0708; Dagne S, 2019, DIABETES METAB SYNDR, V12, P391, DOI 10.2147/DMSO.S179699; Dahal S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257037; Demilew YM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216446; Fine LJ, 2004, AM J PREV MED, V27, P18, DOI 10.1016/j.amepre.2004.04.017; Gakage L., 2015, INT J AFR NURS SCI, V3, P76, DOI [10.1016/j.ijans.2015.09.002, DOI 10.1016/J.IJANS.2015.09.002]; Gebremariam LW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27519-6; Gebreyes YF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194819; Gelibo T, 2017, ETHIOP J HEALTH DEV, V31, P355; Getachew T, 2017, ETHIOP J HEALTH DEV, V31, P312; Girum Tadele, 2020, Int J Chronic Dis, V2020, P3679528, DOI 10.1155/2020/3679528; Gouda HN, 2019, LANCET GLOB HEALTH, V7, pE1375, DOI 10.1016/S2214-109X(19)30374-2; Janakiraman B, 2020, DIABETES METAB SYNDR, V13, P343, DOI 10.2147/DMSO.S235981; Juma K, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010201; Juma PA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5826-6; Kassa M., 2019, NONCOMMUNICABLE DIS; Kattel S., 2021, UNVEILING MODERN PAN, P5; Motuma A, 2020, DIABET METAB SYND OB, V13, P4941, DOI 10.2147/DMSO.S283270; Mudie K, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020409; Olakunle OS, 2014, PAN AFR MED J, V18, DOI [10.11604/pamj.2014.18.32.3553, 10.11694/pamj.supp.2014.18.1.3260]; Olawuyi AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203587; Retsagi E, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08833-z; Shiferaw F, 2018, ETHIOP J HEALTH DEV, V32, P170; Sivanantham P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245254; Sodergren M, 2014, MATURITAS, V77, P41, DOI 10.1016/j.maturitas.2013.09.010; Tran QB., 2020, J GLOBAL HLTH SCI, V2; Ugwuja EI, 2013, ANN MED HEALTH SCI R, V3, P13, DOI 10.4103/2141-9248.109462; Vos T., 2020, LANCET, V396, P1204, DOI [10.1016/s0140-6736(20)30925-9, 10.1016/S0140-6736(20)30925-9, DOI 10.1016/S0140-6736(20)30925-9]; Wesonga R, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0486-6; World Health Organization, 2005, WHO STEPWISE APPR CH; World Health Organization, 2021, GLOB HLTH EST LEAD C; World Health Organization, 2018, NONC DIS; Yosef T, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09646-w; Zenu S, 2021, J MULTIDISCIP HEALTH, V14, P1561, DOI 10.2147/JMDH.S313741; Zhang YR, 2018, PEERJ, V6, DOI 10.7717/peerj.4505	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264698	10.1371/journal.pone.0264698	http://dx.doi.org/10.1371/journal.pone.0264698			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226698	gold, Green Published, Green Accepted			2022-12-26	WOS:000793394000040
J	Branch-Elliman, W; Ferguson, R; Doros, G; Woods, P; Leatherman, S; Strymish, J; Datta, R; Goswami, R; Jankowich, MD; Shah, NR; Taylor, TH; Page, ST; Schiller, SJ; Shannon, C; Hau, C; Flynn, M; Holmberg, E; Visnaw, K; Dhond, R; Brophy, M; Monach, PA				Branch-Elliman, Westyn; Ferguson, Ryan; Doros, Gheorghe; Woods, Patricia; Leatherman, Sarah; Strymish, Judith; Datta, Rupak; Goswami, Rekha; Jankowich, Matthew D.; Shah, Nishant R.; Taylor, Thomas H.; Page, Sarah T.; Schiller, Sara J.; Shannon, Colleen; Hau, Cynthia; Flynn, Maura; Holmberg, Erika; Visnaw, Karen; Dhond, Rupali; Brophy, Mary; Monach, Paul A.			Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial	PLOS ONE			English	Article								Importance and objective The aim of this pragmatic, embedded, adaptive trial was to measure the effectiveness of the subcutaneous anti-IL-6R antibody sarilumab, when added to an evolving standard of care (SOC), for clinical management of inpatients with moderate to severe COVID-19 disease. Design Two-arm, randomized, open-label controlled trial comparing SOC alone to SOC plus sarilumab. The trial used a randomized play-the-winner design and was fully embedded within the electronic health record (EHR) system. Setting 5 VA Medical Centers. Participants Hospitalized patients with clinical criteria for moderate to severe COVID-19 but not requiring mechanical ventilation, and a diagnostic test positive for SARS-CoV-2. Interventions Sarilumab, 200 or 400 mg subcutaneous injection. SOC was not pre-specified and could vary over time, e.g., to include antiviral or other anti-inflammatory drugs. Main outcomes and measures The primary outcome was intubation or death within 14 days of randomization. All data were extracted remotely from the EHR. Results Among 162 eligible patients, 53 consented, and 50 were evaluated for the primary endpoint of intubation or death. This occurred in 5/20 and 1/30 of participants in the sarilumab and SOC arms respectively, with the majority occurring in the initial 9 participants (3/4 in the sarilumab and 1/5 in the SOC) before the sarilumab dose was increased to 400 mg and before remdesivir and dexamethasone were widely adopted. After interim review, the unblinded Data Monitoring Committee recommended that the study be stopped due to concern for safety: a high probability that rates of intubation or death were higher with addition of sarilumab to SOC (92.6%), and a very low probability (3.4%) that sarilumab would be found to be superior. Conclusions and relevance This randomized trial of patients hospitalized due to respiratory compromise from COVID-19 but not mechanical ventilation found no benefit from subcutaneous sarilumab when added to an evolving SOC. The numbers of patients and events were too low to allow definitive conclusions to be drawn, but this study contributes valuable information about the role of subcutaneous IL-6R inhibition in the treatment of hospitalized COVID-19 patients. Methods developed and piloted during this trial will be useful in conducting future studies more efficiently.	[Branch-Elliman, Westyn; Ferguson, Ryan; Doros, Gheorghe; Woods, Patricia; Leatherman, Sarah; Strymish, Judith; Page, Sarah T.; Schiller, Sara J.; Shannon, Colleen; Hau, Cynthia; Flynn, Maura; Holmberg, Erika; Visnaw, Karen; Dhond, Rupali; Brophy, Mary; Monach, Paul A.] VA Boston Healthcare Syst, Boston, MA 02115 USA; [Branch-Elliman, Westyn] Harvard Med Sch, Boston, MA 02115 USA; [Ferguson, Ryan; Dhond, Rupali] Boston Univ, Evans Dept Med, Sect Gen Internal Med, Sch Med, Boston, MA 02215 USA; [Doros, Gheorghe] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02215 USA; [Datta, Rupak] VA Connecticut Healthcare Syst, Hosp Epidemiol & Infect Prevent Program, West Haven, CT USA; [Datta, Rupak] Yale Sch Med, Sect Infect Dis, New Haven, CT USA; [Goswami, Rekha] VA Maine Healthcare Syst, Sect Infect Dis, Togus, ME USA; [Jankowich, Matthew D.] Brown Univ, Alpert Med Sch, Providence VA Med Ctr, Div Pulm & Crit Care Med,Dept Med, Providence, RI 02912 USA; [Shah, Nishant R.] Brown Univ, Providence VA Med Ctr, Dept Med, Div Cardiol,Alpert Med Sch, Providence, RI 02912 USA; [Taylor, Thomas H.] White River Jct VA Med Ctr, Infect Dis & Rheumatol, Hartford, VT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Branch-Elliman, W (corresponding author), VA Boston Healthcare Syst, Boston, MA 02115 USA.; Branch-Elliman, W (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	wbranche@bidmc.harvard.edu		/0000-0003-3816-7407; Branch-Elliman, Westyn/0000-0002-9658-5124; Woods, Patricia/0000-0001-5646-4216; Dhond, Rupali/0000-0002-8186-1296	NIH NHLBI [1K12HL138049-01]	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	WBE was supported by NIH NHLBI 1K12HL138049-01. This material is the result of work supported with resources and the use of facilities the VISN-1 Clinical Trials Network and the VA Boston Healthcare System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, OPEN FORUM INFECT DI; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Branch-Elliman W, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa490; Branch-Elliman W, 2020, CONT CLIN TRIAL COMM, V19, DOI 10.1016/j.conctc.2020.100614; Chambers DA, 2016, JAMA-J AM MED ASSOC, V315, P1941, DOI 10.1001/jama.2016.3867; Fiore LD, 2011, CLIN TRIALS, V8, P183, DOI [10.1177/1740774510395635, 10.1177/1740774511398368]; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Grieve AP, 2017, PHARM STAT, V16, P64, DOI 10.1002/pst.1778; Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Lescure FX, 2021, LANCET RESP MED, V9, P522, DOI 10.1016/S2213-2600(21)00099-0; Morris G, 2021, CYTOKINE, V144, DOI 10.1016/j.cyto.2021.155593; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Rosas IO, 2021, NEW ENGL J MED, V384, P1503, DOI 10.1056/NEJMoa2028700; Salama C, 2021, NEW ENGL J MED, V384, P20, DOI 10.1056/NEJMoa2030340; Salvarani C, 2021, JAMA INTERN MED, V181, P24, DOI 10.1001/jamainternmed.2020.6615; Schulert GS, 2018, ARTHRIT CARE RES, V70, P409, DOI 10.1002/acr.23277; Si S, 2020, THER CLIN RISK MANAG, V16, P705, DOI 10.2147/TCRM.S223468; Snow TAC, 2021, INTENS CARE MED, V47, P641, DOI 10.1007/s00134-021-06416-z; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836; US Food and Drug Administration, 2020, FDA GUID COND CLIN T; Veiga VC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n84; Woods P, 2021, CONT CLIN TRIAL COMM, V23, DOI 10.1016/j.conctc.2021.100804; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117	27	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263591	10.1371/journal.pone.0263591	http://dx.doi.org/10.1371/journal.pone.0263591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213547	Green Published, gold			2022-12-26	WOS:000787811000025
J	Evans, LE; Dolsak, N; Prakash, A				Evans, Laura E.; Dolsak, Nives; Prakash, Aseem			Do windy areas have more wind turbines: An empirical analysis of wind installed capacity in Native tribal nations	PLOS ONE			English	Article							NATURAL-RESOURCES; RENEWABLE ENERGY; ECONOMIC-GROWTH	The decarbonization of the electricity sector is leading to a substantial increase in the demand for wind energy. Will tribal nations, which account for 7.8% of utility-scale wind capacity, benefit from this policy shift? To examine why tribal nations vary in translating wind energy potential into wind installed capacity, we have constructed an original dataset of the potential as well as the location of wind turbines across tribal nations. Our statistical analysis of 286 tribal nations suggests that wind energy potential is not associated with wind installed capacity. Instead, casino square footage, a proxy for tribal nation's administrative capacity and business acumen, is associated with wind installed capacity. Political orientation plays a role as well: tribal nations are more likely to have wind installed capacity when they value tribal sovereignty. While tribes suffering from natural disasters do not install more wind turbines, those receiving federal grants for wind energy projects, and located in states that already have a substantial number of wind turbines, are more apt to have wind turbines. Surprisingly, tribes located in states with renewable portfolio standards do notshow an association with installed wind turbines capacity.	[Evans, Laura E.] Univ Washington, Evans Sch Publ Policy & Governance, Seattle, WA 98195 USA; [Dolsak, Nives] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA; [Prakash, Aseem] Univ Washington, Dept Polit Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Prakash, A (corresponding author), Univ Washington, Dept Polit Sci, Seattle, WA 98195 USA.	aseem@uw.edu		Dolsak, Nives/0000-0002-8325-3155				Akee RKQ, 2015, J ECON PERSPECT, V29, P185, DOI 10.1257/jep.29.3.185; Aklin M., 2021, ENERGY RES SOC SCI, V79, DOI [10.1016/j.erss.2021.102132, DOI 10.1016/J.ERSS.2021.102132]; Apsaalooke Nation, COMMERCIAL WIND DEV; Auty R., 2001, RESOURCE ABUNDANCE E; Bird L, 2005, ENERG POLICY, V33, P1397, DOI 10.1016/j.enpol.2003.12.018; Bronin S., 2013, TULANE ENV LAW J, P221; Brookshire D, 2013, ENERG POLICY, V62, P1506, DOI 10.1016/j.enpol.2013.07.021; Brosemer K, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101661; Carley S, 2018, NAT ENERGY, V3, P754, DOI 10.1038/s41560-018-0202-4; Council of Energy Resource Tribes, 2008, CERT MEMBER TRIBES; Dolsak N, 2022, ANNU REV POLIT SCI; Dreveskracht R., 2012, ENERGY LAW J, V33, P431; Friedman L., 2020, NEW YORK TIMES; Gylfason T, 2006, WORLD ECON, V29, P1091, DOI 10.1111/j.1467-9701.2006.00807.x; Havranek T, 2016, WORLD DEV, V88, P134, DOI 10.1016/j.worlddev.2016.07.016; Maguire K, 2016, LAND ECON, V92, P468, DOI 10.3368/le.92.3.468; Maruca M, 2019, WILLIAM MARY ENV L P, V34, P391; Meisen P., 2009, RENEWABLE ENERGY TRI, DOI [10.1021/ac900217q, DOI 10.1021/AC900217Q]; Metwaly MK, 2020, IEEE ACCESS, V8, P181547, DOI 10.1109/ACCESS.2020.3024846; Milbrandt A., 2018, TECHNO EC RENEWABLE; Mohamad F, 2021, ENERGY, V223, DOI 10.1016/j.energy.2021.120105; Mohamad F, 2018, ENERGIES, V11, DOI 10.3390/en11092278; National Conference of State Legislatures, 2021, STATE RENEWABLE PORT; Neal L, 2007, AM INDIAN LAW REV, V32, P219; Office of Indian Energy Policy and Programs Office U.S. Department of Energy, 2009, ARCHIVED TRIBAL ENER; Office of Indian Energy Policy and Programs Office U.S. Department of Energy, 2019, TRIBAL ENERGY PROJEC; Office of Indian Energy Policy and Programs U.S. Department of Energy, 2017, SENECA NATION CELEBR; Pasqualetti MJ, 2016, SOC NATUR RESOUR, V29, P885, DOI 10.1080/08941920.2015.1107794; Powell DE, 2015, J POLIT ECOL, V22, P53, DOI 10.2458/v22i1.21078; Rand J, 2017, ENERGY RES SOC SCI, V29, P135, DOI 10.1016/j.erss.2017.05.019; Ravotti N., 2017, AM INDIAN LAW REV, V41, P279; Ray A, 2017, GLOBAL ENVIRON CHANG, V46, P104, DOI 10.1016/j.gloenvcha.2017.07.002; Rephann T. J., 1997, Tourism Economics, V3, P161; Sullivan B., 2010, ARIZ LAW R, V52, P823; Teh J, 2018, IEEE ACCESS, V6, P26765, DOI 10.1109/ACCESS.2018.2824238; Teh J, 2016, IEEE T RELIAB, V65, P1081, DOI 10.1109/TR.2015.2495173; U.S. Bureau of Indian Affairs. U.S. Department of the Interior, BIA AIAN NATL LAR; U.S. Energy Information Administration, 2020, MONTHL EN REV; U.S. Federal Emergency Management Agency, 2020, DECLARED DISASTERS; U.S. Fish and Wildlife Service, 2021, FEDERAL AVIATION ADM; Upton GB, 2017, ENERG ECON, V66, P205, DOI 10.1016/j.eneco.2017.06.003; Walker D. M., 2013, Journal of Gambling Business and Economics, V7, P80; Walker DM, 2011, CONTEMP ECON POLICY, V29, P101, DOI 10.1111/j.1465-7287.2010.00198.x; Yin HT, 2010, ENERG POLICY, V38, P1140, DOI 10.1016/j.enpol.2009.10.067; Zanocco C, 2019, GLOBAL ENVIRON CHANG, V59, DOI 10.1016/j.gloenvcha.2019.101984; Zimmerman MG, 2021, ENERGY RES SOC SCI, V72, DOI 10.1016/j.erss.2020.101874	46	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0261752	10.1371/journal.pone.0261752	http://dx.doi.org/10.1371/journal.pone.0261752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213552	gold, Green Published			2022-12-26	WOS:000787811000005
J	Hebert, AE; Kreaden, US; Yankovsky, A; Guo, DJ; Li, Y; Lee, SH; Liu, Y; Soito, AB; Massachi, S; Slee, AE				Hebert, April E.; Kreaden, Usha S.; Yankovsky, Ana; Guo, Dongjing; Li, Yang; Lee, Shih-Hao; Liu, Yuki; Soito, Angela B.; Massachi, Samira; Slee, April E.			Methodology to standardize heterogeneous statistical data presentations for combining time-to-event oncologic outcomes	PLOS ONE			English	Article							CLINICAL-TRIALS; AGGREGATE DATA; METAANALYSIS; CANCER	Survival analysis following oncological treatments require specific analysis techniques to account for data considerations, such as failure to observe the time of event, patient withdrawal, loss to follow-up, and differential follow up. These techniques can include Kaplan-Meier and Cox proportional hazard analyses. However, studies do not always report overall survival (OS), disease-free survival (DFS), or cancer recurrence using hazard ratios, making the synthesis of such oncologic outcomes difficult. We propose a hierarchical utilization of methods to extract or estimate the hazard ratio to standardize time-to-event outcomes so that study inclusion into meta-analyses can be maximized. We also provide proof-of concept results from a statistical analysis that compares OS, DFS, and cancer recurrence for robotic surgery to open and non-robotic minimally invasive surgery. In our example, use of the proposed methodology would allow for the increase in data inclusion from 108 hazard ratios reported to 240 hazard ratios reported or estimated, resulting in an increase of 122%. While there are publications summarizing the motivation for these analyses, and comprehensive papers describing strategies to obtain estimates from published time-dependent analyses, we are not aware of a manuscript that describes a prospective framework for an analysis of this scale focusing on the inclusion of a maximum number of publications reporting on long-term oncologic outcomes incorporating various presentations of statistical data.	[Hebert, April E.; Kreaden, Usha S.; Yankovsky, Ana; Guo, Dongjing; Li, Yang; Lee, Shih-Hao; Liu, Yuki] Intuit Surg, Sunnyvale, CA USA; [Soito, Angela B.] ABS Consulting LLC, Oakland, CA USA; [Massachi, Samira] Stratevi, Santa Monica, CA USA; [Slee, April E.] New Arch Consulting, Issaquah, WA 98027 USA		Slee, AE (corresponding author), New Arch Consulting, Issaquah, WA 98027 USA.	april.slee.15@ucl.ac.uk						Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2090; Antoniou GA, 2020, J VASC SURG, V71, P1002, DOI 10.1016/j.jvs.2019.05.037; Collins R, 2020, NEW ENGL J MED, V382, P674, DOI 10.1056/NEJMsb1901642; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Malloy EJ, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/7518035; Mathoulin-Pelissier S, 2008, J CLIN ONCOL, V26, P3721, DOI 10.1200/JCO.2007.14.1192; Metelli S, 2020, EVID-BASED MENT HEAL, V23, P83, DOI 10.1136/ebmental-2019-300129; Michiels S, 2005, INT J TECHNOL ASSESS, V21, P119, DOI 10.1017/S0266462305050154; O'Sullivan KE, 2019, INTERACT CARDIOV TH, V28, P526, DOI 10.1093/icvts/ivy315; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Rohatgi A., 2020, WEBPLOTDIGITIZER V44; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Royston P, 2011, STAT MED, V30, P2409, DOI 10.1002/sim.4274; Tewari A, 2012, EUR UROL, V62, P1, DOI 10.1016/j.eururo.2012.02.029; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tierney JF, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003019; van Houwelingen HC, 2005, STAT MED, V24, P2823, DOI 10.1002/sim.2248; Wiecek W., RGUYOTR THIS FUNCTIO; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303	22	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0263661	10.1371/journal.pone.0263661	http://dx.doi.org/10.1371/journal.pone.0263661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202406	Green Published, gold			2022-12-26	WOS:000773224600016
J	Farmer, NA; Doerr, JC				Farmer, Nicholas A.; Doerr, Jennifer C.			Limiting factors for queen conch (Lobatus gigas) reproduction: A simulation-based evaluation	PLOS ONE			English	Article							STROMBUS-GIGAS; BEHAVIORAL FACILITATION; POPULATION-STRUCTURE; FISHING PRESSURE; HABITAT; MOVEMENT; DENSITY; CONSEQUENCES; GASTROPODA; ABUNDANCE	Queen conch are among the most economically, socially, and culturally important fishery resources in the Caribbean. Despite a multitude of fisheries management measures enacted across the region, populations are depleted and failing to recover. It is believed that queen conch are highly susceptible to depensatory processes, impacting reproductive success and contributing to the lack of recovery. We developed a model of reproductive dynamics to evaluate how variations in biological factors such as population density, movement speeds, rest periods between mating events, scent tracking, visual perception of conspecifics, sexual facilitation, and barriers to movement affect reproductive success and overall reproductive output. We compared simulation results to empirical observations of mating and spawning frequencies from conch populations in the central Bahamas and Florida Keys. Our results confirm that low probability of mate finding associated with decreased population density is the primary driver behind observed breeding behavior in the field, but is insufficient to explain observed trends. Specifically, sexual facilitation coupled with differences in movement speeds and ability to perceive conspecifics may explain the observed lack of mating at low densities and differences between mating frequencies in the central Bahamas and Florida Keys, respectively. Our simulations suggest that effective management strategies for queen conch should aim to protect high-density reproductive aggregations and critical breeding habitats.	[Farmer, Nicholas A.] NOAA, Fisheries Southeast Reg Off, St Petersburg, FL 33701 USA; [Doerr, Jennifer C.] NOAA, Fisheries Southeast Fisheries Sci Ctr, Galveston, TX USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Farmer, NA (corresponding author), NOAA, Fisheries Southeast Reg Off, St Petersburg, FL 33701 USA.	nick.farmer@noaa.gov						Acosta CA, 2006, FISHERIES, V31, P601, DOI 10.1577/1548-8446(2006)31[601:ITSOCQ]2.0.CO;2; Acosta Charles A., 2001, Proceedings of the Gulf and Caribbean Fisheries Institute, V52, P212; Aranda DA, 2014, B MAR SCI, V90, P813, DOI 10.5343/bms.2013.1072; Aranda DA, 2011, J INVERTEBR PATHOL, V106, P174, DOI 10.1016/j.jip.2010.09.004; Allee WC, 1931, AM J SOCIOL, V37, P386, DOI 10.1086/215731; [Anonymous], 2019, FED REGISTER; Appeldoorn R.S., 1993, REPROD SPAWNING POTE; Appeldoorn R. S., 1994, QUEEN CONCH BIOL FIS, P301; Appeldoorn Richard S., 1995, ICES Marine Science Symposia, V199, P13; Appeldoorn RS, 1988, MEMORIA SOC CIENCIAS, V48, P275; Audesirk T., 1985, NEUROBIOLOGY BEHAV, V8; AUDESIRK TE, 1977, BEHAV BIOL, V20, P235, DOI 10.1016/S0091-6773(77)90799-4; Becker R, 1988, COMPUTER SCI SERIES; Bene C, 2003, MAR ECOL-P S Z N I, V24, P45, DOI 10.1046/j.1439-0485.2003.03782.x; Berg Carl J. Jr., 1995, ICES Marine Science Symposia, V199, P247; Beverton R.J.H., 1957, FISH INVEST SER, P19; Booker C., 2011, SURVEYS QUEEN CONCH, P28; Bouzat JL, 2010, CONSERV GENET, V11, P463, DOI 10.1007/s10592-010-0049-0; BROWNELL WN, 1981, MAR FISH REV, V43, P1; Cala de la Hera YR., 2012, P GULF CARIB FISH I, V64, P342; Cala YR, 2013, REV BIOL TROP, V61, P645; Camarena T., 2007, P GULF CARIBBEAN FIS, V59, P321; Charles GH., 1966, PHYSIOL MOLLUSCA, V2, P455; Sanchez FC, 2019, REV BIOL TROP, V67, P708; Sanchez FC, 2019, AQUACULT INT, V27, P437, DOI 10.1007/s10499-018-0336-1; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; CREWS D, 1975, SCIENCE, V189, P1059, DOI 10.1126/science.1172294; CREWS D, 1985, SCIENCE, V227, P77, DOI 10.1126/science.3964961; CREWS D, 1986, P NATL ACAD SCI USA, V83, P9547, DOI 10.1073/pnas.83.24.9547; D'Asaro C. N., 1965, Bulletin of Marine Science of the Gulf and Caribbean, V15, P359; Davies MS, 2007, P ROY SOC B-BIOL SCI, V274, P1233, DOI 10.1098/rspb.2007.0046; Davis M., 1984, Journal of Shellfish Research, V4, P17; de Jesus-Navarrete A, 2003, B MAR SCI, V73, P219; Delgado GA, 2004, FISH B-NOAA, V102, P278; Delgado GA, 2020, B MAR SCI, V96, P707, DOI 10.5343/bms.2019.0098; Doerr JC, 2013, CARIBB J SCI, V47, P251, DOI 10.18475/cjos.v47i3.a13; Dujon AM, 2019, CAN J ZOOL, V97, P436, DOI 10.1139/cjz-2018-0106; Ehrhardt N.M., 2008, CONCH STROMBUS GIGAS; FAO, 2020, FISH AQ STAT GLOB AQ; FIELD LH, 1977, PAC SCI, V31, P1; Frenkiel L., 2009, P GULF CARIBBEAN FIS, V61, P498; Garcia-Sais JR., 2012, FINAL REPORT CARIBBE; Gascoigne J, 2004, MAR ECOL PROG SER, V284, P185, DOI 10.3354/meps284185; Glazer R.A., 1994, QUEEN CONCH BIOL FIS, P79; Glazer RA, 2004, B MAR SCI, V75, P205; Glazer Robert, 1998, Proceedings of the Gulf and Caribbean Fisheries Institute, V50, P78; Glazer Robert A., 2003, Gulf and Caribbean Research, V14, P79; HESSE KO, 1979, B MAR SCI, V29, P303; JEPPESEN LL, 1976, ANIM BEHAV, V24, P275, DOI 10.1016/S0003-3472(76)80036-X; Joosse J., 1983, P317; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; MARTINMORA E, 1995, ECOLOGY, V76, P981, DOI 10.2307/1939361; McCarthy K., 2007, SEDAR14DW4 NAT MAR F; Medley P., 2008, MONITORING MANAGING; Murray A., 2019, ESTIMATES ABUNDANCE; Ng TPT, 2013, BIOL REV, V88, P683, DOI 10.1111/brv.12023; Nielsen SN, 2000, ENVIRONM & ECOL MODE, P195; Odum P, 1987, P GULF CARIB FISH I, V38, P294; Pederson TL, 2019, Particles: a graph based particle simulator based on D3-force. R package version 0.2.2; Phillips MA., 2010, P 63 GULF CARIBBEAN, P427; Prince J. H., 1955, Texas Reports on Biology and Medicine, V13, P323; R Core Team, 2021, R LANG ENV STAT; RANDALL JOHN E., 1964, BULL MAR SCI GULF CARIBBEAN, V14, P246; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Rossetto M, 2015, CAN J FISH AQUAT SCI, V72, P1503, DOI 10.1139/cjfas-2013-0623; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Stieglitz TC, 2017, MAR ECOL PROG SER, V571, P139, DOI 10.3354/meps12123; Stoner A.W., 2010, QUEEN CONCH STOCK AS; Stoner AW, 2019, REV FISH SCI AQUAC, V27, P51, DOI 10.1080/23308249.2018.1480008; Stoner AW, 2012, B MAR SCI, V88, P89, DOI 10.5343/bms.2011.1044; STONER AW, 1992, FISH B-NOAA, V90, P161; Stoner AW, 2000, MAR ECOL PROG SER, V202, P297, DOI 10.3354/meps202297; STONER AW, 1992, B MAR SCI, V51, P287; STONER AW, 1994, FISH B-NOAA, V92, P171; Stoner AW, 1996, FISH B-NOAA, V94, P551; Stoner AW, 2003, MAR ECOL PROG SER, V257, P275, DOI 10.3354/meps257275; Stoner AW, 1997, B MAR SCI, V61, P559; Tewfik A, 2003, AQUAT CONSERV, V13, P473, DOI 10.1002/aqc.562; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Tiley K, 2018, J INVERTEBR PATHOL, V157, P4, DOI 10.1016/j.jip.2018.07.004; Tiley K, 2018, J INVERTEBR PATHOL, V155, P32, DOI 10.1016/j.jip.2018.04.007; Torres-Rosado Z.A., 1987, THESIS U PUERTO RICO; Weil M. E., 1984, Journal of Shellfish Research, V4, P45	84	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0251219	10.1371/journal.pone.0251219	http://dx.doi.org/10.1371/journal.pone.0251219			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263325	gold, Green Submitted, Green Published			2022-12-26	WOS:000804638700045
J	Xu, XF; Gu, HH; Li, HW; Gao, SZ; Shi, XH; Shen, J; Li, B; Wang, H; Zheng, KL; Shao, Z; Cheng, P; Cha, ZS; Peng, SY; Nie, YZ; Li, ZS; Guo, SW; Qian, BH; Jin, G				Xu, Xiongfei; Gu, Haihui; Li, Hongwei; Gao, Suizhi; Shi, Xiaohan; Shen, Jing; Li, Bo; Wang, Huan; Zheng, Kailian; Shao, Zhuo; Cheng, Peng; Cha, Zhanshan; Peng, Siying; Nie, Yongzhan; Li, Zhaoshen; Guo, Shiwei; Qian, Baohua; Jin, Gang			Large-cohort humanized NPI mice reconstituted with CD34(+) hematopoietic stem cells are feasible for evaluating preclinical cancer immunotherapy	FASEB JOURNAL			English	Article						bispecific antibody; cancer immunotherapy; checkpoint blockade; chimeric antigen receptor T cell; humanized mouse; T cell	HUMAN IMMUNE-SYSTEM; MOUSE MODEL; BLOOD; THERAPY	Cancer immunotherapy has achieved impressive therapeutic effects in many cancers, while only a small subset of patients benefit from it and some patients even have experienced severe toxicity. It is urgent to develop a feasible large-cohort humanized mouse model to evaluate the pre-clinical efficacy and safety of cancer immunotherapy. Furthermore, developing potentially effective combination therapy between cancer immunotherapy and other therapies also needs humanized mouse model to adequately mimic clinical actual setting. Herein, we established a humanized mouse model engrafted with less human CD34(+) HSCs than ever before and then evaluated reconstitution efficiency and the profiles of human immune cells in this humanized mouse model. Also, this humanized mouse model was used to evaluate the preclinical efficacy and safety of cancer immunotherapy. For each batch of CD34(+) HSCs humanized mouse model, a relatively-large cohort with over 25% human CD45(+) cells in peripheral blood was established. This humanized mouse model could efficiently reconstitute human innate and adaptive immune cells. This humanized mouse model supported patient-derived xenograft tumor growth and tumor infiltration of PD-1(+) human T cells. Furthermore, therapeutic efficacy, re-activation of tumor-infiltrated T cells, and side effects of checkpoint blockade therapy could be monitored in this humanized mouse model. Human T cells from this humanized mouse model were successfully engineered with CD19-CAR. CD19 CAR-T cells could effectively deplete B cells and suppress tumor growth of acute lymphoblastic leukemia in vivo in this humanized mouse model. This humanized mouse model also could be used to demonstrate the efficacy of bispecific antibodies, such as anti-CD19/CD3. Overall, our work provides a feasible large-cohort humanized mouse model for evaluating a variety of cancer immunotherapy approaches including checkpoint inhibitors, adoptive cell therapy, and bispecific antibody therapy, and demonstrates that human T cells from this humanized mouse model possess anti-tumor activities in vitro and in vivo.	[Xu, Xiongfei; Gao, Suizhi; Shi, Xiaohan; Shen, Jing; Li, Bo; Wang, Huan; Zheng, Kailian; Shao, Zhuo; Cheng, Peng; Guo, Shiwei; Jin, Gang] Naval Med Univ, Changhai Hosp, Dept Hepatobiliary Pancreat Surg, Shanghai 200433, Peoples R China; [Xu, Xiongfei; Li, Zhaoshen; Guo, Shiwei; Jin, Gang] Naval Med Univ, Changhai Hosp, Shanghai Inst Pancreat Dis, Shanghai, Peoples R China; [Gu, Haihui; Cha, Zhanshan; Qian, Baohua] Naval Med Univ, Changhai Hosp, Dept Transfus Med, Shanghai 200433, Peoples R China; [Li, Hongwei; Nie, Yongzhan] Air Force Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China; [Li, Hongwei; Nie, Yongzhan] Air Force Mil Med Univ, Xijing Hosp Digest Dis, Natl Clin Res Ctr Digest Dis, Xian, Peoples R China; [Peng, Siying] BEIJING IDMO Co Ltd, Beijing, Peoples R China; [Li, Zhaoshen] Naval Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Jin, Gang] Shanghai Univ, Shanghai Inst Adv Commun & Data Sci, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Air Force Military Medical University; Naval Medical University; Shanghai University	Jin, G (corresponding author), Naval Med Univ, Changhai Hosp, Dept Hepatobiliary Pancreat Surg, Shanghai 200433, Peoples R China.; Qian, BH (corresponding author), Naval Med Univ, Changhai Hosp, Dept Transfus Med, Shanghai 200433, Peoples R China.	qianbh1963@163.com; jingang@smmu.edu.cn		Xu, Xiongfei/0000-0001-9532-4582	National Natural Science Foundation of China [81972913, 82172712, 81672830, 81570185, 81970165]; Shanghai Municipal Education Commission [2017-01-07-00-07-E00012]; Beijing Municipal Science & Technology Commission [Z181100001918043]; Shanghai Science and Technology Committee [19140902301, 16140903800]; Clinical Research and Cultivation Project of Shanghai Municipal Hospital [SHDC12019X13]; Shanghai Zhangjiang National Innovation Demonstration Zone Special Development Fund [ZJ2017-ZD-014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Clinical Research and Cultivation Project of Shanghai Municipal Hospital; Shanghai Zhangjiang National Innovation Demonstration Zone Special Development Fund	National Natural Science Foundation of China, Grant/Award Number: 81972913, 82172712, 81672830, 81570185 and 81970165; Shanghai Municipal Education Commission, Grant/Award Number: 2017-01-07-00-07-E00012; Beijing Municipal Science & Technology Commission, Grant/Award Number: Z181100001918043; Shanghai Science and Technology Committee, Grant/Award Number: 19140902301 and 16140903800; Clinical Research and Cultivation Project of Shanghai Municipal Hospital, Grant/Award Number: SHDC12019X13; Shanghai Zhangjiang National Innovation Demonstration Zone Special Development Fund, Grant/Award Number: ZJ2017-ZD-014	Andre MC, 2010, J IMMUNOL, V185, P2710, DOI 10.4049/jimmunol.1000583; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Buder-Bakhaya K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01474; Carstens JL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15095; Christofi T, 2019, CANCERS, V11, DOI 10.3390/cancers11101472; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; De La Rochere P, 2018, TRENDS IMMUNOL, V39, P748, DOI 10.1016/j.it.2018.07.001; Dobosz P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02965; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Guo SW, 2019, FASEB J, V33, P873, DOI 10.1096/fj.201800617R; Hargadon KM, 2018, INT IMMUNOPHARMACOL, V62, P29, DOI 10.1016/j.intimp.2018.06.001; Hegde PS, 2020, IMMUNITY, V52, P17, DOI 10.1016/j.immuni.2019.12.011; Ishiguro T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4291; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kang YK, 2016, BLOOD RES, V51, P31, DOI 10.5045/br.2016.51.1.31; Kennedy LB, 2020, CA-CANCER J CLIN, V70, P86, DOI 10.3322/caac.21596; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P394, DOI 10.1038/nrclinonc.2016.65; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Li J, 2019, SCI TRANSL MED, V11, DOI [10.1126/scitranslmed.aax8861, 10.3390/su11185015]; Liu LQ, 2017, CLIN CANCER RES, V23, P1506, DOI 10.1158/1078-0432.CCR-16-0666; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Meraz IM, 2019, CANCER IMMUNOL RES, V7, P1267, DOI 10.1158/2326-6066.CIR-18-0874; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Przepiorka D, 2015, CLIN CANCER RES, V21, P4035, DOI 10.1158/1078-0432.CCR-15-0612; Rader C, 2020, CURR OPIN BIOTECH, V65, P9, DOI 10.1016/j.copbio.2019.11.020; Stadler CR, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1091555; Sun LPL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4802; Vargas FA, 2018, CANCER CELL, V33, P649, DOI 10.1016/j.ccell.2018.02.010; Wang MA, 2018, FASEB J, V32, P1537, DOI 10.1096/fj.201700740R; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Zhang J, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1258504; Zhao Y, 2018, GUT, V67, P1845, DOI 10.1136/gutjnl-2017-315201	36	2	2	6	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22244	10.1096/fj.202101548RR	http://dx.doi.org/10.1096/fj.202101548RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CJ	35262964				2022-12-26	WOS:000772944700001
J	Jakop, U; Muller, K; Muller, P; Neuhauser, S; Rodriguez, IC; Grunewald, S; Schiller, J; Engel, KM				Jakop, Ulrike; Mueller, Karin; Mueller, Peter; Neuhauser, Stefanie; Rodriguez, Isabel Callealta; Grunewald, Sonja; Schiller, Jurgen; Engel, Kathrin M.			Seminal lipid profiling and antioxidant capacity: A species comparison	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; TOF MASS-SPECTROMETRY; BIOLOGICAL-MEMBRANES; OXIDATIVE STRESS; BOAR SPERMATOZOA; SPERM TRANSPORT; GERM-CELLS; PHOSPHOLIPIDS; QUALITY; LYSOPHOSPHOLIPIDS	On their way to the oocyte, sperm cells are subjected to oxidative stress, which may trigger the oxidation of phospholipids (PL). Applying MALDI-TOF MS, HPTLC and ESI-IT MS, we comparatively analyzed the PL compositions of semen and blood of species differing in their reproductive systems and types of nutrition (bull, boar, stallion, lion and man) with regard to the sensitivity to oxidation as well as the accumulation of harmful lyso-PL (LPL), transient products of lipid oxidation. In addition, the protective capacity of seminal fluid (SF) was also examined. The PL composition of erythrocytes and blood plasma is similar across the species, while pronounced differences exist for sperm and SF. Since the blood function is largely conserved across mammalian species, but the reproductive systems may vary in many aspects, the obtained results suggest that the PL composition is not determined by the type of nutrition, but by the relatedness of species and by functional requirements of cell membranes such as fluidity. Sperm motion and fertilization of oocytes require a rather flexible membrane, which is accomplished by significant moieties of unsaturated fatty acyl residues in sperm lipids of most species, but implies a higher risk of oxidation. Due to a high content of plasmalogens (alkenyl ether lipids), bull sperm are most susceptible to oxidation. Our data indicate that bull sperm possess the most effective protective power in SF. Obviously, a co-evolution of PL composition and protective mechanisms has occurred in semen and is related to the reproductive characteristics. Although the protective capacity in human SF seems well developed, we recorded the most pronounced individual contaminations with LPL in human semen. Probably, massive oxidative challenges related to lifestyle factors interfere with natural conditions.	[Jakop, Ulrike; Mueller, Karin] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Jakop, Ulrike] Inst Reprod Farm Anim Schonow eV, Bernau, Germany; [Mueller, Peter] Humboldt Univ, Dept Biol, Berlin, Germany; [Neuhauser, Stefanie] Free Univ Berlin, Equine Clin, Bad Saarow Pieskow, Germany; [Rodriguez, Isabel Callealta] Univ Pretoria, Fac Vet Sci, Pretoria, South Africa; [Grunewald, Sonja; Schiller, Jurgen; Engel, Kathrin M.] Univ Leipzig, Training Ctr European Acad Androl, Dept Dermatol, Leipzig, Germany; [Engel, Kathrin M.] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, Leipzig, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Humboldt University of Berlin; Free University of Berlin; University of Pretoria; Leipzig University; Leipzig University	Engel, KM (corresponding author), Univ Leipzig, Training Ctr European Acad Androl, Dept Dermatol, Leipzig, Germany.; Engel, KM (corresponding author), Univ Leipzig, Fac Med, Inst Med Phys & Biophys, Leipzig, Germany.	kathrin.engel@medizin.uni-leipzig.de	Engel, Kathrin M/AAQ-1309-2021	Engel, Kathrin M/0000-0003-0611-7042; Muller, Karin/0000-0003-1749-4863; Callealta, Isabel/0000-0002-7028-4139	German Research Council [DFG SCHI 476/12-2, DFG MU 1520/4-2]	German Research Council(German Research Foundation (DFG))	This work was supported by the German Research Council (https://www.dfg.de/).JS: DFG SCHI 476/12-2 KM: DFG MU 1520/4-2 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2020, REPRODUCTION, V159, pR189, DOI 10.1530/REP-19-0452; ALVAREZ JG, 1995, MOL REPROD DEV, V42, P334, DOI 10.1002/mrd.1080420311; Arnhold J, 2002, BBA-GEN SUBJECTS, V1572, P91, DOI 10.1016/S0304-4165(02)00271-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brien M, 2017, PLACENTA, V55, P54, DOI 10.1016/j.placenta.2017.05.004; Bromfield JJ, 2014, J ASSIST REPROD GEN, V31, P627, DOI 10.1007/s10815-014-0243-y; Broniec A, 2011, FREE RADICAL BIO MED, V50, P892, DOI 10.1016/j.freeradbiomed.2011.01.002; Castellano CA, 2010, J ANIM SCI, V88, P2346, DOI 10.2527/jas.2009-2779; CUMMINS JM, 1985, J REPROD FERTIL, V75, P153, DOI 10.1530/jrf.0.0750153; Dean JM, 2018, PROTEIN CELL, V9, P196, DOI 10.1007/s13238-017-0423-5; du Plessis SS, 2015, ASIAN J ANDROL, V17, P230, DOI 10.4103/1008-682X.135123; Ernst AM, 2010, FEBS LETT, V584, P1713, DOI 10.1016/j.febslet.2009.12.060; Esmaeili V, 2015, ANDROLOGY-US, V3, P450, DOI 10.1111/andr.12024; Fellmann P, 1994, Methods Mol Biol, V27, P161; Fuchs B, 2012, MINI-REV MED CHEM, V12, P74, DOI 10.2174/138955712798868931; Fuchs B, 2009, THERIOGENOLOGY, V71, P568, DOI 10.1016/j.theriogenology.2008.08.023; Fuchs Beate, 2008, V49, P541, DOI 10.1007/978-1-4020-8831-5_21; Furland NE, 2007, J BIOL CHEM, V282, P18151, DOI 10.1074/jbc.M700709200; Garcia-Rincon J, 2016, BBA-BIOENERGETICS, V1857, P415, DOI 10.1016/j.bbabio.2016.01.003; Garcia-Vazquez FA, 2016, ASIAN J ANDROL, V18, P844, DOI 10.4103/1008-682X.186880; Iizuka-Hishikawa Y, 2017, J BIOL CHEM, V292, P12065, DOI [10.1074/jbc.M117.791277, 10.1074/jbc.m117.791277]; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; Lessig J, 2004, COMP BIOCHEM PHYS B, V137, P265, DOI 10.1016/j.cbpc.2003.12.001; Lessig J, 2009, CURR MED CHEM, V16, P2021; Liebisch G, 2020, J LIPID RES, V61, P1539, DOI 10.1194/jlr.S120001025; Lueders I, 2012, THERIOGENOLOGY, V78, P696, DOI 10.1016/j.theriogenology.2012.02.026; Garcia BM, 2011, REPROD DOMEST ANIM, V46, P141, DOI 10.1111/j.1439-0531.2010.01609.x; MORROT G, 1989, BIOCHEMISTRY-US, V28, P3456, DOI 10.1021/bi00434a046; MULLER K, 1994, BIOCHEMISTRY-US, V33, P9968; Nagata Makoto, 2005, Current Drug Targets - Inflammation and Allergy, V4, P503, DOI 10.2174/1568010054526322; Nicolson GL, 2014, BBA-BIOMEMBRANES, V1838, P1451, DOI 10.1016/j.bbamem.2013.10.019; Nimptsch A, 2014, LIPIDS, V49, P287, DOI 10.1007/s11745-013-3870-7; Nimptsch A, 2013, ANAL BIOANAL CHEM, V405, P6675, DOI 10.1007/s00216-013-7147-z; Nowicka-Bauer K, 2018, J PHYSIOL PHARMACOL, V69, P403, DOI 10.26402/jpp.2018.3.05; Petkovic M, 2001, ANAL BIOCHEM, V289, P202, DOI 10.1006/abio.2000.4926; Plante G, 2016, CELL TISSUE RES, V363, P105, DOI 10.1007/s00441-015-2289-2; Pyttel S, 2012, CHEM PHYS LIPIDS, V165, P861, DOI 10.1016/j.chemphyslip.2012.11.001; Rickard JP, 2020, THERIOGENOLOGY, V150, P96, DOI 10.1016/j.theriogenology.2020.02.018; Rickard JP, 2019, THERIOGENOLOGY, V137, P104, DOI 10.1016/j.theriogenology.2019.05.044; ROBINSON BS, 1992, J BIOL CHEM, V267, P1746; Saez F, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4521786; Samanta L, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0358-6; Schiller J, 1999, ANAL BIOCHEM, V267, P46, DOI 10.1006/abio.1998.3001; Schiller J, 2003, CHEM PHYS LIPIDS, V126, P85, DOI 10.1016/S0009-3084(03)00097-5; Speake B. K., 2003, Male fertility and lipid metabolism, P96; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Svetlichnyy V, 2014, CHEM PHYS LIPIDS, V177, P41, DOI 10.1016/j.chemphyslip.2013.11.001; Ulrich K, 2019, FREE RADICAL BIO MED, V140, P14, DOI 10.1016/j.freeradbiomed.2019.05.035; Wathes DC, 2007, BIOL REPROD, V77, P190, DOI 10.1095/biolreprod.107.060558; WHO, 2010, WHO LAB MAN EX PROC, V5th	50	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264675	10.1371/journal.pone.0264675	http://dx.doi.org/10.1371/journal.pone.0264675			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259184	Green Published, gold			2022-12-26	WOS:000835141200021
J	Xu, S; Arnetz, JE; Arnetz, BB				Xu, Sonnet; Arnetz, Judith E.; Arnetz, Bengt B.			Applying machine learning to explore the association between biological stress and near misses in emergency medicine residents	PLOS ONE			English	Article							CORTISOL; DHEA; DEHYDROEPIANDROSTERONE; METABOLISM; BURNOUT	Physician stress is associated with near misses and adverse medical events. However, little is known about physiological mechanisms linking stress to such events. We explored the utility of machine learning to determine whether the catabolic stress hormone cortisol and the anabolic, anti-stress hormone dehydroepiandrosterone sulfate (DHEA-S), as well as the cortisol to DHEA-S ratio relate to near misses in emergency medicine residents during active duty in a trauma 1 emergency department. Compared to statistical models better suited for inference, machine learning models allow for prediction in situations that have not yet occurred, and thus better suited for clinical applications. This exploratory study used multiple machine learning models to determine possible relationships between biomarkers and near misses. Of the various models tested, support vector machine with radial bias function kernels and support vector machine with linear kernels performed the best, with training accuracies of 85% and 79% respectively. When evaluated on a test dataset, both models had prediction accuracies of around 80%. The pre-shift cortisol to DHEA-S ratio was shown to be the most important predictor in interpretable models tested. Results suggest that interventions that help emergency room physicians relax before they begin their shift could reduce risk of errors and improve patient and physician outcomes. This pilot demonstrates promising results regarding using machine learning to better understand the stress biology of near misses. Future studies should use larger groups and relate these variables to information in electronic medical records, such as objective and patient-reported quality measures.	[Xu, Sonnet] Troy High Sch, Troy, MI 48098 USA; [Arnetz, Judith E.; Arnetz, Bengt B.] Michigan State Univ, Coll Human Med, Dept Family Med, Grand Rapids, MI USA	Michigan State University; Michigan State University College of Human Medicine	Xu, S (corresponding author), Troy High Sch, Troy, MI 48098 USA.	sonnet.xu@gmail.com	Arnetz, Bengt/G-1685-2011	Arnetz, Bengt/0000-0001-7173-4333; Xu, Sonnet/0000-0003-2891-937X	Blue Cross Blue Shield of Michigan Foundation	Blue Cross Blue Shield of Michigan Foundation	BBA, grant numbers - N/A, Blue Cross Blue Shield of Michigan Foundation, https://www.bcbsm.com/The sponsors played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt W, 2006, J CLIN ENDOCR METAB, V91, P2548, DOI 10.1210/jc.2005-2258; Arnetz BB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016479; Bakker A., 2014, BURNOUT RES, V1, P112, DOI [10.1016/j.burn.2014.04.003, DOI 10.1016/J.BURN.2014.04.003]; Batista P., 2016, J MOL BIOMARKERS DIA, V07; Bozorgmehr A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250842; Butcher SK, 2005, AGING CELL, V4, P319, DOI 10.1111/j.1474-9726.2005.00178.x; Bzdok Danilo, 2018, Nat Methods, V15, P233, DOI 10.1038/nmeth.4642; Cay M., 2017, NORTH CLIN ISTANB; Cruz JA, 2006, CANCER INFORM, V2, P59; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Elliott ML, 2021, MOL PSYCHIATR, V26, P3829, DOI 10.1038/s41380-019-0626-7; Farago E, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19153309; Golpour P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186449; Hastie T, 2013, ELEMENTS STAT LEARNI; Heaney JLJ, 2014, J AGING PHYS ACTIV, V22, P465, DOI [10.1123/JAPA.2012-0082, 10.1123/japa.2012-0082]; Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002; Kaczor Eric E, 2020, Proc Annu Hawaii Int Conf Syst Sci, V2020, P3729; Kamin HS, 2017, HORM BEHAV, V89, P69, DOI 10.1016/j.yhbeh.2016.11.018; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kroboth PD, 2003, J CLIN PSYCHOPHARM, V23, P96, DOI 10.1097/00004714-200302000-00014; Langarizadeh Mostafa, 2016, Acta Inform Med, V24, P364, DOI 10.5455/aim.2016.24.364-369; Majd Tahereh Mohammadi, 2018, Iranian Biomedical Journal, V22, P374, DOI 10.29252/.22.6.374; Morales J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214858; Parry RM, 2010, PHARMACOGENOMICS J, V10, P292, DOI 10.1038/tpj.2010.56; Rotenstein LS, 2018, JAMA-J AM MED ASSOC, V320, P1131, DOI 10.1001/jama.2018.12777; Schafer KM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249833; Shayan Zahra, 2015, Glob J Health Sci, V8, P41, DOI 10.5539/gjhs.v8n7p41; SIMES RJ, 1985, J CHRON DIS, V38, P171, DOI 10.1016/0021-9681(85)90090-6; Sprague J, 2011, EMOTION, V11, P61, DOI 10.1037/a0021788; Stehman CR, 2019, WEST J EMERG MED, V20, P485, DOI 10.5811/westjem.2019.4.40970; Toker S., 2017, HDB STRESS HLTH, P168; Toren Orly, 2021, Int J Qual Health Care, V33, DOI 10.1093/intqhc/mzab031; van der Heijden M, 2014, J BIOMED INFORM, V48, P94, DOI 10.1016/j.jbi.2013.12.007; West CP, 2018, J INTERN MED, V283, P516, DOI 10.1111/joim.12752; Zwain IH, 1999, ENDOCRINOLOGY, V140, P880, DOI 10.1210/en.140.2.880	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264957	10.1371/journal.pone.0264957	http://dx.doi.org/10.1371/journal.pone.0264957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259166	Green Published, gold			2022-12-26	WOS:000835141200034
J	Figueiredo, AM; Cardoso, AC; Pereira, BLB; Silva, RAC; Della Ripa, AFG; Pinelli, TFB; Oliveira, BC; Rafacho, BPM; Ishikawa, LLW; Azevedo, PS; Okoshi, K; Fernandes, AAH; Zornoff, LAM; Minicucci, MF; Polegato, BF; Paiva, SAR				Figueiredo, Amanda Menezes; Cardoso, Ana Carolina; Buzati Pereira, Bruna Leticia; Candido Silva, Renata Aparecida; Goncalves Della Ripa, Andrea Freitas; Bachiega Pinelli, Tatiana Fernanda; Oliveira, Bruna Camargo; Murino Rafacho, Bruna Paola; Watanabe Ishikawa, Larissa Lumi; Azevedo, Paula Schmidt; Okoshi, Katashi; Henrique Fernandes, Ana Angelica; Mamede Zornoff, Leonardo Antonio; Minicucci, Marcos Ferreira; Polegato, Bertha Furlan; Rupp Paiva, Sergio Alberto			Acai supplementation (Euterpe oleracea Mart.) attenuates cardiac remodeling after myocardial infarction in rats through different mechanistic pathways	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID PROFILE; ANTIOXIDANT CAPACITY; DENSITY-LIPOPROTEIN; LIVER-INJURY; METABOLISM; INFLAMMATION; REPAIR; QUANTITATION; EXPRESSION	Myocardial infarction has a high mortality rate worldwide. Therefore, clinical intervention in cardiac remodeling after myocardial infarction is essential. Acai pulp is a natural product and has been considered a functional food because of its antioxidant/anti-inflammatory properties. The aim of the present study was to analyze the effect of acai pulp supplementation on cardiac remodeling after myocardial infarction in rats. After 7 days of surgery, male Wistar rats were assigned to six groups: sham animals fed standard chow (SA0, n = 14), fed standard chow with 2% acai pulp (SA2, n = 12) and fed standard chow with 5% acai pulp (SA5, n = 14), infarcted animals fed standard chow (IA0, n = 12), fed standard chow with 2% acai pulp (IA2, n = 12), and fed standard chow with 5% acai pulp (IA5, n = 12). After 3 months of supplementation, echocardiography and euthanasia were performed. Acai pulp supplementation, after myocardial infarction, improved energy metabolism, attenuated oxidative stress (lower concentration of malondialdehyde, P = 0.023; dose-dependent effect), modulated the inflammatory process (lower concentration of interleukin-10, P<0.001; dose-dependent effect) and decreased the deposit of collagen (lower percentage of interstitial collagen fraction, P<0.001; dose-dependent effect). In conclusion, acai pulp supplementation attenuated cardiac remodeling after myocardial infarction in rats. Also, different doses of acai pulp supplementation have dose-dependent effects on cardiac remodeling.	[Figueiredo, Amanda Menezes; Cardoso, Ana Carolina; Buzati Pereira, Bruna Leticia; Candido Silva, Renata Aparecida; Goncalves Della Ripa, Andrea Freitas; Bachiega Pinelli, Tatiana Fernanda; Oliveira, Bruna Camargo; Murino Rafacho, Bruna Paola; Azevedo, Paula Schmidt; Okoshi, Katashi; Mamede Zornoff, Leonardo Antonio; Minicucci, Marcos Ferreira; Polegato, Bertha Furlan; Rupp Paiva, Sergio Alberto] Univ Estadual Paulista, Botucatu Med Sch, Internal Med Dept, UNESP, Botucatu, SP, Brazil; [Watanabe Ishikawa, Larissa Lumi; Henrique Fernandes, Ana Angelica] Univ Estadual Paulista, Inst Biosci, Chem & Biochem Dept, UNESP, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Figueiredo, AM (corresponding author), Univ Estadual Paulista, Botucatu Med Sch, Internal Med Dept, UNESP, Botucatu, SP, Brazil.	amanda.mfigueiredo@yahoo.com.br	Azevedo, Paula Schmidt/S-1597-2019; Minicucci, Marcos F/A-9094-2008; Zornoff, Leonardo/A-5612-2008; Polegato, Bertha Furlan/E-8842-2012; Okoshi, Katashi/A-3955-2011; Paiva, Sergio AR/A-5101-2008	Azevedo, Paula Schmidt/0000-0002-5843-6232; Minicucci, Marcos F/0000-0002-5980-4367; Zornoff, Leonardo/0000-0002-9831-8820; Polegato, Bertha Furlan/0000-0002-2875-9532; Okoshi, Katashi/0000-0001-8980-8839; Paiva, Sergio AR/0000-0003-4412-1990; Menezes Figueiredo, Amanda/0000-0001-6746-828X	Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES), Brazil	Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported in part by Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES), Brazil. The funding source had no involvement in study design, in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the article for publication. There was no additional external funding received for this study.	Alegre P, 2020, ARQ BRAS CARDIOL, V114, P78, DOI 10.36660/abc.20180140; Alessandra-Perini J, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2183-z; Azevedo PS, 2013, CARDIOL REV, V21, P135, DOI 10.1097/CRD.0b013e318274956d; Barbosa PO, 2021, BIOMED PHARMACOTHER, V139, DOI 10.1016/j.biopha.2021.111627; Barbosa PO, 2016, NUTRITION, V32, P674, DOI 10.1016/j.nut.2015.12.030; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Burneiko RCM, 2006, FOOD CHEM TOXICOL, V44, P1167, DOI 10.1016/j.fct.2006.01.004; Carey AN, 2017, NUTR NEUROSCI, V20, P238, DOI [10.1080/1028415X.2015.1115213, 10.1080/1028415x.2015.1115213]; Christia P, 2013, J HISTOCHEM CYTOCHEM, V61, P555, DOI 10.1369/0022155413493912; Guerra JFD, 2011, J CLIN BIOCHEM NUTR, V49, P188, DOI 10.3164/jcbn.11-02; Daiber A, 2021, REDOX BIOL, V42, DOI 10.1016/j.redox.2021.101875; de Bem GF, 2018, J NUTR BIOCHEM, V52, P70, DOI 10.1016/j.jnutbio.2017.09.021; Carvalho MMD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44563-y; de Moura RS, 2016, J CARDIOVASC PHARM, V68, P19, DOI 10.1097/FJC.0000000000000347; de Oliveira PRB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143721; de Souza MO, 2012, NUTR RES, V32, P976, DOI 10.1016/j.nutres.2012.10.001; de Souza MO, 2010, NUTRITION, V26, P804, DOI 10.1016/j.nut.2009.09.007; Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014; Fragoso MF, 2018, FOOD CHEM TOXICOL, V121, P237, DOI 10.1016/j.fct.2018.08.078; Fragoso MF, 2013, FOOD CHEM TOXICOL, V58, P68, DOI 10.1016/j.fct.2013.04.011; Frangogiannis NG, 2015, CURR OPIN CARDIOL, V30, P240, DOI 10.1097/HCO.0000000000000158; Kim DO, 2003, J AGR FOOD CHEM, V51, P6509, DOI 10.1021/jf0343074; Kim H, 2018, FOOD FUNCT, V9, P3097, DOI 10.1039/c8fo00595h; Li GL, 2012, FOOD CHEM TOXICOL, V50, P363, DOI 10.1016/j.fct.2011.10.036; Liu TT, 2014, LIFE SCI, V101, P27, DOI 10.1016/j.lfs.2014.02.004; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Martinez RM, 2018, FOODS, V7, DOI 10.3390/foods7110178; Mathias Livia Maria Beraldo Simoes, 2019, Cell Physiol Biochem, V53, P388, DOI 10.33594/000000145; Minicucci MF, 2011, CLIN CARDIOL, V34, P410, DOI 10.1002/clc.20922; Minicucci MF, 2010, ARQ BRAS CARDIOL, V94, P645, DOI 10.1590/S0066-782X2010005000023; da Silva PPM, 2014, FOOD SCI NUTR, V2, P321, DOI 10.1002/fsn3.105; Rafacho BPM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177521; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Nielsen F, 1997, CLIN CHEM, V43, P1209; Oliveira BC, 2021, ARQ BRAS CARDIOL, V116, P1127, DOI 10.36660/abc.20190397; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Pala D, 2018, CLIN NUTR, V37, P618, DOI 10.1016/j.clnu.2017.02.001; Pereira BLB, 2017, J NUTR BIOCHEM, V46, P117, DOI 10.1016/j.jnutbio.2017.05.010; Pfeffer JM, 2000, CARDIOVASC DRUG THER, V14, P579, DOI 10.1023/A:1007890126061; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; Poulose SM, 2017, NUTR NEUROSCI, V20, P305, DOI [10.1080/1028415x.2015.1125654, 10.1080/1028415X.2015.1125654]; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rodrigues RB, 2006, J AGR FOOD CHEM, V54, P4162, DOI 10.1021/jf058169p; Sadowska-Krepa E, 2015, BIOL SPORT, V32, P161, DOI 10.5604/20831862.1144419; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8604, DOI 10.1021/jf0609779; Silva DF, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-175; Slama M, 2005, AM J PHYSIOL-HEART C, V289, pH1131, DOI 10.1152/ajpheart.00345.2004; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Tei C, 1997, J AM SOC ECHOCARDIOG, V10, P169, DOI 10.1016/S0894-7317(97)70090-7; Teixeira L. N., 2008, Revista Ceres, V55, P297; Turillazzi E, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-188; Xie CH, 2011, ATHEROSCLEROSIS, V216, P327, DOI 10.1016/j.atherosclerosis.2011.02.035; Zapata-Sudo G, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-227; Zhou JY, 2018, EXP THER MED, V15, P166, DOI 10.3892/etm.2017.5427; Zornoff LAM, 2006, NUTRITION, V22, P146, DOI 10.1016/j.nut.2005.05.008; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V93, P434, DOI 10.1590/S0066-782X2009001000018; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V92, P157, DOI 10.1590/S0066-782X2009000200013	62	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264854	10.1371/journal.pone.0264854	http://dx.doi.org/10.1371/journal.pone.0264854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245316	Green Published, gold			2022-12-26	WOS:000799799100039
J	Shrestha, LB; Yadav, GK; Pradhan, S; Sharma, A; Pandit, T; Chhetry, R; Khanal, B				Shrestha, Lok Bahadur; Yadav, Gopal K.; Pradhan, Saugat; Sharma, Abhilasha; Pandit, Tejendra; Chhetry, Roshan; Khanal, Basudha			Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal	PLOS ONE			English	Article							VIRUS COINFECTION; VIRAL-HEPATITIS; HIV/AIDS	Introduction This study was conducted with an objective to analyze prevalence and risk factors associated with co-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) in HIV-positive patients with reference to their CD4+ T cell status. Materials and methods HIV-positive patients visiting the HIV clinic for CD4+ T cells testing at B.P. Koirala Institute of Health Sciences were tested for Hepatitis B and Hepatitis C. Data regarding age, gender, mode of HIV transmission, duration of HIV diagnosis, antiretroviral therapy status, antiretroviral therapy duration, hepatitis B or C status, and CD4+ T cells count were collected via face-to-face interview, and hospital records. The data were entered in Microsoft Excel 2019 v16.0 (Microsoft, WA, USA) and statistical analysis was performed by using statistical package for social sciences, IBM SPSS (R) v21 (IBM, Armonk, New York). Results Out of 474 HIV-positive patients, HIV-HBV, HIV-HCV, and HIV-HBV-HCV co-infections were seen in 2.95% (14/474), 18.14% (86/474), and 2.53% (12/474) respectively. The primary route of infection was intra-venous drug use (IVDU) in those co-infected with HBV only (8, 57.14%), HCV only (46, 53.49%), and both HBV and HCV (8, 66.67%). HIV patients infected via IVDU were 2.40 times more likely to have HIV-HCV co-infection as compared to those infected via sexual route (AOR 2.40, 95% CI: 1.49,3.86). Similarly, HIV patients with CD4+ T cells count less than 350 cells/mm(3) were more likely to have HIV-HBV-HCV co-infection as compared to those with CD4 count equal to and more than 350 cells/mm(3) (AOR 13.84, 95% CI: 2.90,66.10). Conclusion HIV-positive patients are at high risk of hepatitis B and/or hepatitis C co-infection. Intravenous drug use, and lower CD4+T cells count are the most important risk predictors of co-infection. All HIV-positive patients should be carefully screened with hepatitis B and hepatitis C tests during their follow-up.	[Shrestha, Lok Bahadur; Pradhan, Saugat; Sharma, Abhilasha; Pandit, Tejendra; Khanal, Basudha] BP Koirala Inst Hlth Sci, Dept Microbiol & Infect Dis, Dharan, Nepal; [Yadav, Gopal K.] Kalaiya Hosp, Dept Emergency Med, Bara, Nepal; [Chhetry, Roshan] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal	B.P. Koirala Institute of Health Sciences; B.P. Koirala Institute of Health Sciences	Shrestha, LB (corresponding author), BP Koirala Inst Hlth Sci, Dept Microbiol & Infect Dis, Dharan, Nepal.	lok.shrestha@bpkihs.edu	Yadav, Gopal Kumar/ABD-8595-2021; Shrestha, Lok Bahadur/L-2385-2017; Shrestha, Lok Bahadur/AFB-8034-2022	Yadav, Gopal Kumar/0000-0002-2195-9152; Shrestha, Lok Bahadur/0000-0002-0054-0715; Pradhan, Saugat/0000-0002-5124-6460				Anderson ES, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233927; [Anonymous], 2016, CONSOLIDATED GUIDELI, V2nd; Assefa Y, 2020, INT J INFECT DIS, V100, P273, DOI 10.1016/j.ijid.2020.09.011; Baltazar CS, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09012-w; Bhattarai M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9241679; Boateng R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215377; Case KK, 2019, AIDS, V33, pS197, DOI 10.1097/QAD.0000000000002440; Choy CY, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4020087; George J, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/673815; Gupta S, 2006, WORLD J GASTROENTERO, V12, P6879, DOI 10.3748/wjg.v12.i42.6879; Ionita G, 2017, INT J INFECT DIS, V60, P64, DOI 10.1016/j.ijid.2017.04.011; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Kinkel HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134455; Lemoine M, 2013, FUTURE VIROL, V8, P371, DOI 10.2217/FVL.13.11; Levi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010; Modi AA, 2007, AIDS REV, V9, P25; National Centre for AIDS and STD Control (NCASC), HIV EP UPD NEP NAT H; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pappoe F, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4027-y; Shrestha D. B., 2021, Kathmandu University Medical Journal (KUMJ), V19, P128; Su S, 2018, J MED VIROL, V90, P518, DOI [10.1002/jmv.24, 10.1002/jmv.24988]; Vallet-Pichard A, 2004, J HEPATOL, V41, P156, DOI 10.1016/j.jhep.2004.05.001; Wang SP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004665; World Health Organization (WHO), GLOB HLTH SECT STRAT	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264791	10.1371/journal.pone.0264791	http://dx.doi.org/10.1371/journal.pone.0264791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239716	gold, Green Published			2022-12-26	WOS:000776002200077
J	Berghaus, N; Schreiner, S; Granzow, M; Muller-Tidow, C; Hegenbart, U; Schonland, SO; Huhn, S				Berghaus, Natalie; Schreiner, Sarah; Granzow, Martin; Mueller-Tidow, Carsten; Hegenbart, Ute; Schoenland, Stefan O.; Huhn, Stefanie			Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement	PLOS ONE			English	Article							BONE-MARROW; PLASMA-CELLS; CLINICAL PRESENTATION; TUMOR-CELLS; GENE; EXPRESSION	Light chain amyloidosis is one of the most common forms of systemic amyloidosis. The disease is caused by the misfolding and aggregation of immunoglobulin light chains to insoluble fibrils. These fibrils can deposit in different tissues and organs such as heart and kidney and cause organ impairments that define the clinical presentation. In this study, we present an overview of IGLV-IGLJ and IGLC germline utilization in 85 patients classified in three clinically important subgroups with dominant cardiac, renal as well as cardiac and renal involvement. We found that IGLV3 was the most frequently detected IGLV-family in patients with dominant cardiac involvement, whereas in renal patients IGLV1 were most frequently identified. For patients with dominant heart and kidney involvement IGLV6 was the most frequently detected IGLV-family. In more detailed analysis IGLV3-21 was observed as the most dominant IGLV-subfamily for patients with dominant heart involvement and IGLV1-44 as the most frequent IGLV-subfamily in the group of patients with dominant kidney involvement. For patients with dominant heart and kidney involvement IGLV6-57 was the most frequently detected IGLV-subfamily. Additionally, we were able to show an exclusive linkage between IGLJ1 and IGLC1 as well as between IGLJ2 and IGLC2 in the fully assembled IGL mRNA.	[Berghaus, Natalie; Schreiner, Sarah; Hegenbart, Ute; Schoenland, Stefan O.] Heidelberg Univ Hosp, Amyloidosis Ctr, Med Dept 5, Heidelberg, Germany; [Granzow, Martin] Heidelberg Univ Hosp, Inst Human Genet, Heidelberg, Germany; [Mueller-Tidow, Carsten] Heidelberg Univ Hosp, Med Dept 5, Heidelberg, Germany; [Mueller-Tidow, Carsten] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Huhn, Stefanie] Heidelberg Univ Hosp, Med Dept 5, Sect Multiple Myeloma, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Berghaus, N (corresponding author), Heidelberg Univ Hosp, Amyloidosis Ctr, Med Dept 5, Heidelberg, Germany.; Huhn, S (corresponding author), Heidelberg Univ Hosp, Med Dept 5, Sect Multiple Myeloma, Heidelberg, Germany.	natalie.berghaus@med.uni-heidelberg.de; stefanie.huhn@med.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [FOR 2969, HE 8472/11, SCHO 1364/2-1, HU 2400/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (https://www.dfg.de/) (Research Unit FOR 2969, projects UH: HE 8472/11, SOS: SCHO 1364/2-1, SH: HU 2400/1-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Bochtler T, 2018, BLOOD ADV, V2, P2607, DOI 10.1182/bloodadvances.2018023200; Bodi K, 2009, AMYLOID, V16, P1, DOI 10.1080/13506120802676781; Chilosi M, 1999, MODERN PATHOL, V12, P1101; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Duvaud S, 2021, NUCLEIC ACIDS RES, V49, pW216, DOI 10.1093/nar/gkab225; Gertz MA, 2017, ONCOTARGET, V8, P81735, DOI 10.18632/oncotarget.21052; Howe KL, 2021, NUCLEIC ACIDS RES, V49, pD884, DOI 10.1093/nar/gkaa942; Huhn S, 2017, BONE MARROW TRANSPL, V52, P1194, DOI 10.1038/bmt.2017.91; Huhn S, 2018, METHODS MOL BIOL, V1792, P1, DOI 10.1007/978-1-4939-7865-6_1; KAZMAN P, 2020, ELIFE; Kimmich CR, 2021, AM J HEMATOL, V96, pE253, DOI 10.1002/ajh.26191; Kourelis TV, 2017, BLOOD, V129, P299, DOI 10.1182/blood-2016-10-743997; Kriegsmann K, 2018, CYTOM PART B-CLIN CY, V94, P611, DOI 10.1002/cyto.b.21636; Lefranc MP, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8090319; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Merlini G, 2017, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2017.1.1; Palladini G, 2016, BLOOD, V128, P159, DOI 10.1182/blood-2016-01-629790; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Perfetti V, 2012, BLOOD, V119, P144, DOI 10.1182/blood-2011-05-355784; Radamaker L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09032-0; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; RIDLEY RC, 1993, BLOOD, V81, P767; Sidana S, 2021, BLOOD ADV, V5, P2101, DOI 10.1182/bloodadvances.2020003671; Swuec P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09133-w; Tamura K, 2021, MOL BIOL EVOL, V38, P3022, DOI 10.1093/molbev/msab120; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264407	10.1371/journal.pone.0264407	http://dx.doi.org/10.1371/journal.pone.0264407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213605	gold, Green Published			2022-12-26	WOS:000787811000092
J	Kaewjanthong, P; Sooksai, S; Sasano, H; Hutvagner, G; Bajan, S; McGowan, E; Boonyaratanakornkit, V				Kaewjanthong, Panthita; Sooksai, Sarintip; Sasano, Hironobu; Hutvagner, Gyorgy; Bajan, Sarah; McGowan, Eileen; Boonyaratanakornkit, Viroj			Cell-penetrating peptides containing the progesterone receptor polyproline domain inhibits EGF signaling and cell proliferation in lung cancer cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; SH3 DOMAINS; PROTEIN EXPRESSION; CLINICAL-RESPONSE; PICHIA-PASTORIS; DE-NOVO; ACTIVATION; GEFITINIB	Non-small cell lung cancer (NSCLC) accounts for the majority (80-85%) of all lung cancers. All current available treatments have limited efficacy. The epidermal growth factor receptor (EGFR) plays a critical role in the development and progression of NSCLC, with high EGFR expression associated with increased cell proliferation and poor prognosis. Thus, interfering with EGFR signaling has been shown to effectively reduce cell proliferation and help in the treatment of NSCLC. We previously demonstrated that the progesterone receptor (PR) contains a polyproline domain (PPD) that directly interacts with Src homology 3 (SH3) domain-containing molecules and expression of PR-PPD peptides inhibits NSCLC cell proliferation. In this study, we investigated whether the introduction of PR-PPD by cell-penetrating peptides (CPPs) could inhibit EGF-induced cell proliferation in NSCLC cells. PR-PPD was attached to a cancer-specific CPP, Buforin2 (BR2), to help deliver the PR-PPD into NSCLC cells. Interestingly, addition of BR2-2xPPD peptides containing two PR-PPD repeats was more effective in inhibiting NSCLC proliferation and significantly reduced EGF-induced phosphorylation of Erk1/2. BR2-2xPPD treatment induced cell cycle arrest by inhibiting the expression of cyclin D1 and CDK2 genes in EGFR-wild type A549 cells. Furthermore, the combination treatment of EGFR-tyrosine kinase inhibitors (TKIs), including Gefitinib or Erlotinib, with BR2-2xPPD peptides further suppressed the growth of NSCLC PC9 cells harboring EGFR mutations as compared to EGFR-TKIs treatment alone. Importantly, BR2-2xPPD peptides mediated growth inhibition in acquired Gefitinib- and Erlotinib- resistant lung adenocarcinoma cells. Our data suggests that PR-PPD is the minimal protein domain sufficient to inhibit NSCLC cell growth and has the potential to be developed as a novel NSCLC therapeutic agent.	[Kaewjanthong, Panthita; Boonyaratanakornkit, Viroj] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Bangkok, Thailand; [Kaewjanthong, Panthita; Boonyaratanakornkit, Viroj] Chulalongkorn Univ, Fac Allied Hlth Sci, Grad Program Clin Biochem & Mol Med, Bangkok, Thailand; [Sooksai, Sarintip] Chulalongkorn Univ, Inst Biotechnol & Genet Engn, Bangkok, Thailand; [Sasano, Hironobu] Tohoku Univ, Dept Anat Pathol, Grad Sch Med, Sendai, Miyagi, Japan; [Hutvagner, Gyorgy; Bajan, Sarah] Univ Technol Sydney, Fac Engn & IT, Sch Biomed Engn, Sydney, NSW, Australia; [Bajan, Sarah] Univ Sunshine Coast, Sch Hlth & Behav Sci, Sunshine Coast, Qld, Australia; [Bajan, Sarah] Sunshine Coast Hlth Inst, Birtinya, Australia; [McGowan, Eileen] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia; [Boonyaratanakornkit, Viroj] Chulalongkorn Univ, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Tohoku University; University of Technology Sydney; University of the Sunshine Coast; University of Technology Sydney; Chulalongkorn University	Boonyaratanakornkit, V (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Bangkok, Thailand.; Boonyaratanakornkit, V (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Grad Program Clin Biochem & Mol Med, Bangkok, Thailand.; Boonyaratanakornkit, V (corresponding author), Chulalongkorn Univ, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand.	Viroj.b@chula.ac.th		Boonyaratanakornkit, Viroj/0000-0003-1800-7836; Bajan, Sarah/0000-0001-6934-5240; Hutvagner, Gyorgy/0000-0002-7231-9446	Ratchadaphiseksomphot Endowment Fund [GB-A_61_05_37_02]; Faculty of Allied Health Sciences Research Fund [AHS_CU58006]; 100th Anniversary Chulalongkorn University for Doctoral Scholarship; 90th Anniversary Chulalongkorn University Fund; Overseas Research Experience Scholarship for Graduate Student	Ratchadaphiseksomphot Endowment Fund; Faculty of Allied Health Sciences Research Fund; 100th Anniversary Chulalongkorn University for Doctoral Scholarship; 90th Anniversary Chulalongkorn University Fund; Overseas Research Experience Scholarship for Graduate Student	This research was supported by funds from Ratchadaphiseksomphot Endowment Fund (GB-A_61_05_37_02) and from the Faculty of Allied Health Sciences Research Fund (AHS_CU58006) to V.B. and by the 100th Anniversary Chulalongkorn University for Doctoral Scholarship, the 90th Anniversary Chulalongkorn University Fund and the Overseas Research Experience Scholarship for Graduate Student to P.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Aroui S, 2009, CANCER LETT, V285, P28, DOI 10.1016/j.canlet.2009.04.044; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Benedettini E, 2010, AM J PATHOL, V177, P415, DOI 10.2353/ajpath.2010.090863; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Chen RQ, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00881-7; Cussac D, 1999, FASEB J, V13, P31, DOI 10.1096/fasebj.13.1.31; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Edwards DP, 2002, J STEROID BIOCHEM, V83, P173, DOI 10.1016/S0960-0760(02)00265-0; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ezzat K, 2012, J CONTROL RELEASE, V162, P1, DOI 10.1016/j.jconrel.2012.06.006; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gril B, 2007, INT J CANCER, V121, P407, DOI 10.1002/ijc.22674; Hayashi N, 2013, CANCER SCI, V104, P43, DOI 10.1111/cas.12027; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Ho C, 2014, J THORAC ONCOL, V9, P1180, DOI 10.1097/JTO.0000000000000225; Huang MH, 2013, MOL ONCOL, V7, P112, DOI 10.1016/j.molonc.2012.09.002; Ishibashi H, 2005, CANCER RES, V65, P6450, DOI 10.1158/0008-5472.CAN-04-3087; Jang JH, 2011, PEPTIDES, V32, P895, DOI 10.1016/j.peptides.2011.02.010; Jeong Y, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000378; Ji W, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-606; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kamada H, 2007, BIOL PHARM BULL, V30, P218, DOI 10.1248/bpb.30.218; Kanematsu T, 2003, ONCOL RES, V13, P289, DOI 10.3727/096504003108748348; Karbalaei M, 2020, J CELL PHYSIOL, V235, P5867, DOI 10.1002/jcp.29583; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kawprasertsri S, 2016, CANCER LETT, V374, P279, DOI 10.1016/j.canlet.2016.02.014; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kurochkina Natalya, 2013, Biophys Rev, V5, P29, DOI 10.1007/s12551-012-0081-z; Kuwano M, 2016, PHARMACOL THERAPEUT, V161, P97, DOI 10.1016/j.pharmthera.2016.03.002; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Lee HS, 2008, CANCER LETT, V271, P47, DOI 10.1016/j.canlet.2008.05.041; Li GF, 2015, CHEMOTHERAPY, V61, P179, DOI 10.1159/000442344; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liang H, 2020, ONCOTARGETS THER, V13, P2491, DOI 10.2147/OTT.S231257; Lim KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066084; Lindgren M, 2006, BIOCHEM PHARMACOL, V71, P416, DOI 10.1016/j.bcp.2005.10.048; Liu WJ, 2020, PHARMACOL THERAPEUT, V206, DOI 10.1016/j.pharmthera.2019.107438; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marquez-Garban DC, 2011, STEROIDS, V76, P910, DOI 10.1016/j.steroids.2011.04.015; Mendelsohn J, 2000, CLIN CANCER RES, V6, P747; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Nihira K, 2014, J PATHOL, V234, P277, DOI 10.1002/path.4354; Onn A, 2004, CLIN CANCER RES, V10, P136, DOI 10.1158/1078-0432.CCR-0373-3; Ono M, 2004, MOL CANCER THER, V3, P465; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pateetin P, 2020, J STEROID BIOCHEM, V198, DOI 10.1016/j.jsbmb.2019.105560; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; Qin A, 2020, EXPERT OPIN PHARMACO, V21, P941, DOI 10.1080/14656566.2020.1738385; Raso MG, 2009, CLIN CANCER RES, V15, P5359, DOI 10.1158/1078-0432.CCR-09-0033; Rebuzzi SE, 2020, CRIT REV ONCOL HEMAT, V146, DOI 10.1016/j.critrevonc.2019.102820; Rotow J, 2017, NAT REV CANCER, V17, P637, DOI 10.1038/nrc.2017.84; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Saito R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020609; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; SIMON JA, 1995, CHEM BIOL, V2, P53, DOI 10.1016/1074-5521(95)90080-2; Skjefstad K, 2015, STEROIDS, V98, P29, DOI 10.1016/j.steroids.2015.01.020; Skotland T, 2015, MOLECULES, V20, P13313, DOI 10.3390/molecules200713313; Song YA, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0836-8; Stabile LP, 2011, CLIN CANCER RES, V17, P154, DOI 10.1158/1078-0432.CCR-10-0992; Sugimura H, 2007, ANN THORAC SURG, V83, P409, DOI 10.1016/j.athoracsur.2006.08.046; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Vogl T, 2013, CURR OPIN BIOTECH, V24, P1094, DOI 10.1016/j.copbio.2013.02.024; Wang X, 2016, NEOPLASMA, V63, P322, DOI 10.4149/220_150817N448; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Yuan M, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0099-9; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang X, 2017, DRUG DELIV, V24, P986, DOI 10.1080/10717544.2017.1340361; Zhao D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40374; Zhao N, 2014, LUNG CANCER, V85, P66, DOI 10.1016/j.lungcan.2014.03.026	85	2	2	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264717	10.1371/journal.pone.0264717	http://dx.doi.org/10.1371/journal.pone.0264717			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235599	Green Published, gold			2022-12-26	WOS:000787073100013
J	Kelly, RL; Huehls, AM; Venkatachalam, A; Huntoon, CJ; Machida, YJ; Karnitz, LM				Kelly, Rebecca L.; Huehls, Amelia M.; Venkatachalam, Annapoorna; Huntoon, Catherine J.; Machida, Yuichi J.; Karnitz, Larry M.			Intra-S phase checkpoint kinase Chk1 dissociates replication proteins Treslin and TopBP1 through multiple mechanisms during replication stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; DNA-REPLICATION; INITIATION; ATR; PHOSPHORYLATION; PURIFICATION; EXPRESSION; SLD3; FORK	Replication stress impedes DNA polymerase progression causing activation of the ataxia telangiectasia and Rad3-related signaling pathway, which promotes the intra-S phase checkpoint activity through phosphorylation of checkpoint kinase 1 (Chk1). Chk1 suppresses replication origin firing, in part, by disrupting the interaction between the preinitiation complex components Treslin and TopBP1, an interaction that is mediated by TopBP1 BRCT domain-binding to two cyclindependent kinase (CDK) phosphorylation sites, T968 and S1000, in Treslin. Two nonexclusive models for how Chk1 regulates the Treslin-TopBP1 interaction have been proposed in the literature: in one model, these proteins dissociate due to a Chk1-induced decrease in CDK activity that reduces phosphorylation of the Treslin sites that bind TopBP1 and in the second model, Chk1 directly phosphorylates Treslin, resulting in dissociation of TopBP1. However, these models have not been formally examined. We show here that Treslin T968 phosphorylation was decreased in a Chk1-dependent manner, while Treslin S1000 phosphorylation was unchanged, demonstrating that T968 and S1000 are differentially regulated. However, CDK2-mediated phosphorylation alone did not fully account for Chk1 regulation of the Treslin-TopBP1 interaction. We also identified additional Chk1 phosphorylation sites on Treslin that contributed to disruption of the Treslin- TopBP1 interaction, including S1114. Finally, we showed that both of the proposed mechanisms regulate origin firing in cancer cell line models undergoing replication stress, with the relative roles of each mechanism varying among cell lines. This study demonstrates that Chk1 regulates Treslin through multiple mechanisms to promote efficient dissociation of Treslin and TopBP1 and furthers our understanding of Treslin regulation during the intra-S phase checkpoint.	[Kelly, Rebecca L.; Venkatachalam, Annapoorna; Machida, Yuichi J.; Karnitz, Larry M.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Huehls, Amelia M.; Huntoon, Catherine J.; Machida, Yuichi J.; Karnitz, Larry M.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Karnitz, LM (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.; Karnitz, LM (corresponding author), Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA.	karntiz.larry@mayo.edu		Machida, Yuichi/0000-0003-1414-0568	National Cancer Institute [R01 CA190473]; National Institutes of Health/General Medicine T32 Training Program [T32 GM072474]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/General Medicine T32 Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Cancer Institute (R01 CA190473) (L. M. K.) and a National Institutes of Health/General Medicine T32 Training Program Grant (T32 GM072474) (R. L. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arur S, 2014, NAT PROTOC, V9, P375, DOI 10.1038/nprot.2014.017; Besteiro MAG, 2015, MUTAT RES-REV MUTAT, V763, P168, DOI 10.1016/j.mrrev.2014.10.003; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Bleichert F, 2017, SCIENCE, V355, DOI 10.1126/science.aah6317; Boos D, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030199; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Ciardo D, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020094; Ditano JP, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86490-x; Guo C, 2015, MOL CELL, V57, P492, DOI 10.1016/j.molcel.2014.12.003; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Haland TW, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv744; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hughes BT, 2013, P NATL ACAD SCI USA, V110, P8954, DOI 10.1073/pnas.1302927110; Iyer DR, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020074; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Kotsantis P, 2018, CANCER DISCOV, V8, P537, DOI 10.1158/2159-8290.CD-17-1461; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Liu K, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00599-19; Liu TZ, 2014, MOL CELL, V56, P681, DOI 10.1016/j.molcel.2014.10.007; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Miyazawa-Onami M, 2017, EMBO REP, V18, P1752, DOI 10.15252/embr.201744206; Moiseeva TN, 2018, DNA REPAIR, V72, P99, DOI 10.1016/j.dnarep.2018.09.003; Mu RL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00344-17; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Quinet A, 2017, METHOD ENZYMOL, V591, P55, DOI 10.1016/bs.mie.2017.03.019; Sakurikar N, 2016, ONCOTARGET, V7, P1380, DOI 10.18632/oncotarget.6364; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Sansam CG, 2015, GENE DEV, V29, P555, DOI 10.1101/gad.246827.114; Smits VAJ, 2015, FEBS J, V282, P3681, DOI 10.1111/febs.13387; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	34	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101777	10.1016/j.jbc.2022.101777	http://dx.doi.org/10.1016/j.jbc.2022.101777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35231445	gold, Green Published			2022-12-26	WOS:000793617400010
J	Kelly, SL; Szyjka, CE; Strobel, EJ				Kelly, Skyler L.; Szyjka, Courtney E.; Strobel, Eric J.			Purification of synchronized Escherichia coli transcription elongation complexes by reversible immobilization on magnetic beads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE 2'-HYDROXYL ACYLATION; RNA STRUCTURE-ANALYSIS; NASCENT RNA; QUANTITATIVE-ANALYSIS; BRANCHED PATHWAY; PAUSE SITE; POLYMERASE; RIBOSWITCH; PROMOTER; INITIATION	Synchronized transcription elongation complexes (TECs) are a fundamental tool for in vitro studies of transcription and RNA folding. Transcription elongation can be synchronized by omitting one or more nucleoside triphosphates from an in vitro transcription reaction so that RNA polymerase can only transcribe to the first occurrence of the omitted nucleotide(s) in the coding DNA strand. This approach was developed over four decades ago and has been applied extensively in biochemical investigations of RNA polymerase enzymes but has not been optimized for RNA-centric assays. In this work, we describe the development of a system for isolating synchronized TECs from an in vitro transcription reaction. Our approach uses a custom 50 leader sequence, called capture sequence 3-structure cassette 1 (C3-SC1), to reversibly capture synchronized TECs on magnetic beads. We first show, using electrophoretic mobility shift and high-resolution in vitro transcription assays, that complexes isolated by this procedure, called C3-SC1TECs, are >95% pure, >98% active, highly synchronous (94% of complexes chase in <15s upon addition of saturating nucleoside triphosphates), and compatible with solid-phase transcription; the yield of this purification is similar to 8%. We then show that C3-SC1TECs perturb, but do not interfere with, the function of ZTP (5-aminoimidazole-4-carboxamide riboside 50-triphosphate)-sensing and ppGpp (guanosine-30,50 bisdiphosphate)-sensing transcriptional riboswitches. For both riboswitches, transcription using C3-SC1TECs improved the efficiency of transcription termination in the absence of ligand but did not inhibit ligand-induced transcription antitermination. Given these properties, C3-SC1TECs will likely be useful for developing biochemical and biophysical RNA assays that require high-performance, quantitative bacterial in vitro transcription.	[Kelly, Skyler L.; Szyjka, Courtney E.; Strobel, Eric J.] Univ Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Strobel, EJ (corresponding author), Univ Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	estrobel@buffalo.edu		Szyjka, Courtney/0000-0001-9991-8038; Strobel, Eric/0000-0002-7082-2881	University at Buffalo	University at Buffalo	This work was supported by startup funding from the University at Buffalo (to E. J. S.).	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2009, METHODS, V47, P37, DOI 10.1016/j.ymeth.2008.10.006; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Buenrostro JD, 2014, NAT BIOTECHNOL, V32, P562, DOI 10.1038/nbt.2880; CHAN CL, 1989, J BIOL CHEM, V264, P20796; Chatterjee S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023426118; Chauvier A, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2109026118j1of12, 10.1073/pnas.2109026118]; Chauvier A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106564118; Denny SK, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032300; Denny SK, 2018, CELL, V174, P377, DOI 10.1016/j.cell.2018.05.038; Drogalis LK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243155; Duss O, 2019, CELL, V179, P1357, DOI 10.1016/j.cell.2019.10.035; Duss O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07423-3; Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722; Fukuda S, 2020, MOL CELL, V77, P241, DOI 10.1016/j.molcel.2019.10.006; HAGLER J, 1992, J VIROL, V66, P2982, DOI 10.1128/JVI.66.5.2982-2989.1992; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Henderson KL, 2017, P NATL ACAD SCI USA, V114, pE3032, DOI 10.1073/pnas.1618675114; Heyduk E, 2018, NUCLEIC ACIDS RES, V46, P4469, DOI 10.1093/nar/gky172; Imashimizu M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0666-5; JACQUES JP, 1991, GENE DEV, V5, P707, DOI 10.1101/gad.5.5.707; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Kim PB, 2015, MOL CELL, V57, P317, DOI 10.1016/j.molcel.2015.01.001; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Kokic G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20542-0; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; Landick R, 1996, METHOD ENZYMOL, V274, P334; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Liu Y, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2115746119; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Murakami KS, 2017, P NATL ACAD SCI USA, V114, P8211, DOI 10.1073/pnas.1702741114; Nudler E, 2003, METHOD ENZYMOL, V371, P160; OLEJNIK J, 1995, P NATL ACAD SCI USA, V92, P7590, DOI 10.1073/pnas.92.16.7590; Passalacqua LFM, 2020, RNA, V26, P2062, DOI 10.1261/rna.076778.120; Pupov D, 2019, BIOCHEM BIOPH RES CO, V510, P122, DOI 10.1016/j.bbrc.2019.01.062; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Saba J, 2019, ELIFE, V8, DOI 10.7554/eLife.40981; Sen R, 2000, J BIOL CHEM, V275, P10899, DOI 10.1074/jbc.275.15.10899; Sherlock ME, 2018, P NATL ACAD SCI USA, V115, P6052, DOI 10.1073/pnas.1720406115; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Sohn YH, 2003, METHOD ENZYMOL, V371, P170; Strobel E, 2021, BIO-PROTOCOL, V11, DOI 10.21769/BioProtoc.4141; Strobel EJ, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100812; Strobel EJ, 2020, J BIOL CHEM, V295, P6401, DOI 10.1074/jbc.RA120.012641; Strobel EJ, 2019, NAT CHEM BIOL, V15, P1067, DOI 10.1038/s41589-019-0382-7; Strobel EJ, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx233; Susa M, 2002, J BIOL CHEM, V277, P15407, DOI 10.1074/jbc.M112481200; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; Vvedenskaya IO, 2014, SCIENCE, V344, P1285, DOI 10.1126/science.1253458; Watters KE, 2016, NAT STRUCT MOL BIOL, V23, P1124, DOI 10.1038/nsmb.3316; Widom JR, 2018, MOL CELL, V72, P541, DOI 10.1016/j.molcel.2018.08.046; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Winkelman JT, 2020, MOL CELL, V79, P797, DOI 10.1016/j.molcel.2020.07.006; Zhang JW, 2016, TRENDS BIOCHEM SCI, V41, P293, DOI 10.1016/j.tibs.2015.12.009	61	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101789	10.1016/j.jbc.2022.101789	http://dx.doi.org/10.1016/j.jbc.2022.101789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35247385	Green Published, gold			2022-12-26	WOS:000823106100010
J	Kind, L; Raasakka, A; Molnes, J; Aukrust, I; Bjorkhaug, L; Njolstad, PR; Kursula, P; Arnesen, T				Kind, Laura; Raasakka, Arne; Molnes, Janne; Aukrust, Ingvild; Bjorkhaug, Lise; Njolstad, Pal Rasmus; Kursula, Petri; Arnesen, Thomas			Structural and biophysical characterization of transcription factor HNF-1A as a tool to study MODY3 diabetes variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POU-DOMAIN; PROTEIN; MUTATIONS; HOMEODOMAIN; FAMILY; GENE; DIMERIZATION; RECOGNITION; SCATTERING; STABILITY	Hepatocyte nuclear factor 1A (HNF-1A) is a transcription factor expressed in several embryonic and adult tissues, modulating the expression of numerous target genes. Pathogenic variants in the HNF1A gene are known to cause maturity onset diabetes of the young 3 (MODY3 or HNF1A MODY), a disease characterized by dominant inheritance, age of onset before 25 to 35 years of age, and pancreatic beta-cell dysfunction. A precise diagnosis can alter management of this disease, as insulin can be exchanged with sulfonylurea tablets and genetic counseling differs from polygenic forms of diabetes. Therefore, more knowledge on the mechanisms of HNF-1A function and the level of pathogenicity of the numerous HNF1A variants is required for precise diagnostics. Here, we structurally and biophysically characterized an HNF-1A protein containing both the DNA-binding domain and the dimerization domain, and determined the folding and DNA-binding capacity of two established MODY3 HNF-1A variant proteins (P112L, R263C) and one variant of unknown significance (N266S). All three variants showed reduced functionality compared to the WT protein. Furthermore, while the R263C and N266S variants displayed reduced binding to an HNF-1A target promoter, we found the P112L variant was unstable in vitro and in cells. Our results support and mechanistically explain disease causality for these investigated variants and present a novel approach for the dissection of structurally unstable and DNA-binding defective variants. This study indicates that structural and biochemical investigation of HNF-1A is a valuable tool in reliable variant classification needed for precision diabetes diagnostics and management.	[Kind, Laura; Raasakka, Arne; Kursula, Petri; Arnesen, Thomas] Univ Bergen, Dept Biomed, Bergen, Norway; [Molnes, Janne; Aukrust, Ingvild; Njolstad, Pal Rasmus] Univ Bergen, Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Molnes, Janne; Aukrust, Ingvild] Haukeland Hosp, Dept Med Genet, Bergen, Norway; [Bjorkhaug, Lise] Western Norway Univ Appl Sci, Dept Safety Chem & Biomed Lab Sci, Bergen, Norway; [Njolstad, Pal Rasmus] Haukeland Hosp, Sect Endocrinol & Metab, Children & Youth Clin, Bergen, Norway; [Kursula, Petri] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Arnesen, Thomas] Univ Bergen, Dept Biol Sci, Bergen, Norway; [Arnesen, Thomas] Haukeland Hosp, Dept Surg, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Western Norway University of Applied Sciences; University of Bergen; Haukeland University Hospital; University of Oulu; University of Oulu; University of Bergen; University of Bergen; Haukeland University Hospital	Kind, L; Arnesen, T (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.; Njolstad, PR (corresponding author), Univ Bergen, Ctr Diabet Res, Dept Clin Sci, Bergen, Norway.; Njolstad, PR (corresponding author), Haukeland Hosp, Sect Endocrinol & Metab, Children & Youth Clin, Bergen, Norway.; Arnesen, T (corresponding author), Univ Bergen, Dept Biol Sci, Bergen, Norway.; Arnesen, T (corresponding author), Haukeland Hosp, Dept Surg, Bergen, Norway.	laura.kind@uib.no; Pal.Njolstad@uib.no; Thomas.arnesen@uib.no	Raasakka, Arne/AAA-5251-2020; Bjørkhaug, Lise/AAA-4356-2021; Kursula, Petri/K-1058-2012	Raasakka, Arne/0000-0002-9443-9959; Bjørkhaug, Lise/0000-0002-9695-4559; Kursula, Petri/0000-0001-8529-3751	Medical Faculty, University of Bergen, UiB, Norway; UiB Meltzer foundation project; Norwegian Graduate School in Biocatalysis; Norwegian Cancer Society [171752-PR-2009-0222]; European Research Council [293574]; Research Council of Norway [240413]; Western Norway Regional Health Authority (Strategic Fund "Personalized Medicine for Children and Adults"); Novo Nordisk Foundation [54741]; Norwegian Diabetes Association; project CALIPSOplus from the EU Framework Programme for Research and Innovation HORIZON 2020 [730872]	Medical Faculty, University of Bergen, UiB, Norway; UiB Meltzer foundation project; Norwegian Graduate School in Biocatalysis; Norwegian Cancer Society(Norwegian Cancer Society); European Research Council(European Research Council (ERC)European Commission); Research Council of Norway(Research Council of Norway); Western Norway Regional Health Authority (Strategic Fund "Personalized Medicine for Children and Adults"); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Norwegian Diabetes Association; project CALIPSOplus from the EU Framework Programme for Research and Innovation HORIZON 2020	This work was funded with a PhD fellowship by the Medical Faculty, University of Bergen, UiB, Norway (to L. K.) and by a UiB Meltzer foundation project grant (to L. K.). L. K. received a research visit grant from the Norwegian Graduate School in Biocatalysis. T. A. was supported by the Norwegian Cancer Society (Project 171752-PR-2009-0222). P. R. N. received funding from the European Research Council (AdG SELECTionPREDISPOSED #293574), the Research Council of Norway (FRIPRO grant #240413), the Western Norway Regional Health Authority (Strategic Fund "Personalized Medicine for Children and Adults"), the Novo Nordisk Foundation (grant #54741), and the Norwegian Diabetes Association. This work has been supported by the project CALIPSOplus under the Grant Agreement 730872 from the EU Framework Programme for Research and Innovation HORIZON 2020 (to P. K.).	Althari S, 2020, AM J HUM GENET, V107, P670, DOI 10.1016/j.ajhg.2020.08.016; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], PYMOL MOL GRAPHICS S; BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100; Bayle JH, 2002, J BIOL CHEM, V277, P28884, DOI 10.1074/jbc.M201983200; Bjorkhaug L, 2003, J CLIN ENDOCR METAB, V88, P920, DOI 10.1210/jc.2002-020945; Bjorkhaug L, 2005, DNA CELL BIOL, V24, P661, DOI 10.1089/dna.2005.24.661; Bjorkhaug L, 2000, BIOCHEM BIOPH RES CO, V279, P792, DOI 10.1006/bbrc.2000.4024; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; CESKA TA, 1993, EMBO J, V12, P1805, DOI 10.1002/j.1460-2075.1993.tb05828.x; Chasman D, 1999, GENE DEV, V13, P2650, DOI 10.1101/gad.13.20.2650; Chen S, 2006, CYTOGENET GENOME RES, V114, P131, DOI 10.1159/000093328; Chi YI, 2002, MOL CELL, V10, P1129, DOI 10.1016/S1097-2765(02)00704-9; Cilia E, 2014, NUCLEIC ACIDS RES, V42, pW264, DOI 10.1093/nar/gku270; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; DEFRANCESCO R, 1991, BIOCHEMISTRY-US, V30, P143, DOI 10.1021/bi00215a021; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Erdos Gabor, 2020, Curr Protoc Bioinformatics, V70, pe99, DOI 10.1002/cpbi.99; Frietze S, 2011, SUBCELL BIOCHEM, V52, P261, DOI 10.1007/978-90-481-9069-0_12; Haliyur R, 2019, J CLIN INVEST, V129, P246, DOI 10.1172/JCI121994; Hammarstrom Martin, 2006, Journal of Structural and Functional Genomics, V7, P1, DOI 10.1007/s10969-005-9003-7; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; HURLEY JH, 1992, BIOPOLYMERS, V32, P1443, DOI 10.1002/bip.360321104; Iwasaki N, 1997, DIABETES, V46, P1504, DOI 10.2337/diabetes.46.9.1504; Kappei D, 2013, EMBO J, V32, P1681, DOI 10.1038/emboj.2013.105; Landrum M. J., 2018, NUCL ACIDS; Lau HH, 2018, J HEPATOL, V68, P1033, DOI 10.1016/j.jhep.2017.11.026; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Malik V, 2018, CELL MOL LIFE SCI, V75, P1587, DOI 10.1007/s00018-018-2748-5; Manalastas-Cantos K., 2021, ATSAS 30; Miles AJ, 2018, PROTEIN SCI, V27, P1717, DOI 10.1002/pro.3474; Narayana N, 2006, J MOL BIOL, V362, P414, DOI 10.1016/j.jmb.2006.06.086; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Raasakka A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00084; Remenyi A, 2002, BIOCHEM PHARMACOL, V64, P979, DOI 10.1016/S0006-2952(02)01164-4; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rose RB, 2000, NAT STRUCT BIOL, V7, P744; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sauter P, 1998, MOL CELL BIOL, V18, P7397, DOI 10.1128/MCB.18.12.7397; Schott O, 1997, J MOL BIOL, V267, P673, DOI 10.1006/jmbi.1997.0905; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Staby L, 2017, BIOCHEM J, V474, P2509, DOI 10.1042/BCJ20160631; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thureau A, 2021, J APPL CRYSTALLOGR, V54, P1698, DOI 10.1107/S1600576721008736; Wang HY, 2002, DIABETES, V51, pS333, DOI 10.2337/diabetes.51.2007.S333; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; Yahaya T. O., 2020, OMAN MED J, V35, P126; Yang Q., 1999, BIOCHEM BIOPH RES CO; Yu M, 2008, NUCLEIC ACIDS RES, V36, P1209, DOI 10.1093/nar/gkm1131; Zhang HC, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI142244	61	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101803	10.1016/j.jbc.2022.101803	http://dx.doi.org/10.1016/j.jbc.2022.101803			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35257744	Green Published, gold			2022-12-26	WOS:000793560400011
J	Zhang, SY; Bai, P; Lei, D; Liang, YX; Zhen, S; Bakiasi, G; Pang, H; Choi, SH; Wang, CN; Tanzi, RE; Zhang, C				Zhang, Siyi; Bai, Ping; Lei, Dan; Liang, Yingxia; Zhen, Sherri; Bakiasi, Grisilda; Pang, Hao; Choi, Se Hoon; Wang, Changning; Tanzi, Rudolph E.; Zhang, Can			Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer's disease-related neuropathology in cell models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heimer ' s disease (AD) by targeting bromodomain containing	AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; GAMMA-SECRETASE; IN-VITRO; BROMODOMAIN; APP; AUTOPHAGY; NEURONS; BACE1; INFLAMMATION	Epigenetic regulation plays substantial roles in human pathophysiology, which provides opportunities for intervention in human disorders through the targeting of epigenetic pathways. Recently, emerging evidence from preclinical studies suggested the potential in developing therapeutics of Alzheimer's disease (AD) by targeting bromodomain containing protein 4 (BRD4), an epigenetic regulatory protein. However, further characterization of AD-related pathological events is urgently required. Here, we investigated the effects of pharmacological degradation or inhibition of BRD4 on AD cell models. Interestingly, we found that both degradation and inhibition of BRD4 by ARV-825 and JQ1, respectively, robustly increased the levels of amyloid-beta (A beta), which has been associated with the neuropathology of AD. Subsequently, we characterized the mechanisms by which downregulation of BRD4 increases A beta levels. We found that both degradation and inhibition of BRD4 increased the levels of BACE1, the enzyme responsible for cleavage of the amyloid-beta protein precursor (APP) to generate A beta. Consistent with A beta increase, we also found that downregulation of BRD4 increased AD-related phosphorylated Tau (pTau) protein in our 3D-AD human neural cell culture model. Therefore, our results suggest that downregulation of BRD4 would not be a viable strategy for AD intervention. Collectively, our study not only shows that BRD4 is a novel epigenetic component that regulates BACE1 and A beta levels, but also provides novel and translational insights into the targeting of BRD4 for potential clinical applications.	[Zhang, Siyi; Lei, Dan; Liang, Yingxia; Zhen, Sherri; Bakiasi, Grisilda; Choi, Se Hoon; Tanzi, Rudolph E.; Zhang, Can] Massachusetts Gen Hosp, Genet & Aging Res Unit, McCance Ctr Brain Hlth, MassGen Inst Neurodegenerat Dis MIND,Dept Neurol, Charlestown, MA 02129 USA; [Zhang, Siyi; Bai, Ping; Lei, Dan; Liang, Yingxia; Zhen, Sherri; Bakiasi, Grisilda; Choi, Se Hoon; Wang, Changning; Tanzi, Rudolph E.; Zhang, Can] Harvard Med Sch, Charlestown, MA 02129 USA; [Zhang, Siyi; Pang, Hao] China Med Univ, Dept Forens Med, Shenyang, Peoples R China; [Bai, Ping; Wang, Changning] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; China Medical University; Harvard University; Massachusetts General Hospital	Zhang, C (corresponding author), Massachusetts Gen Hosp, Genet & Aging Res Unit, McCance Ctr Brain Hlth, MassGen Inst Neurodegenerat Dis MIND,Dept Neurol, Charlestown, MA 02129 USA.; Wang, CN; Zhang, C (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.; Wang, CN (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02129 USA.	CWANG15@mgh.harvard.edu; Zhang.Can@mgh.harvard.edu	Ping, Bai/GSE-3343-2022	Ping, Bai/0000-0003-4587-8426; Zhen, Sherri/0000-0001-7263-9223	NIH [DA050860]; Cure Alzheimer's Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund	This research was supported by the NIH grant DA050860 and the Cure Alzheimer's Fund.	Ahmad SS, 2019, CNS NEUROL DISORD-DR, V18, P657, DOI 10.2174/1871527318666191011145941; Alqahtani A, 2019, FUTUR SCI OA, V5, DOI 10.4155/fsoa-2018-0115; Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Bahn G, 2019, P NATL ACAD SCI USA, V116, P12516, DOI 10.1073/pnas.1819541116; Benito E, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.202; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Brock B, 2008, J ALZHEIMERS DIS, V13, P71; Choi S. H., 2014, 3 DIMENSIONAL HUMAN; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; Davis JA, 1998, NEURON, V20, P603, DOI 10.1016/S0896-6273(00)80998-8; De Simone A, 2019, CHEMMEDCHEM, V14, P1067, DOI 10.1002/cmdc.201900174; Decker TM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01943-6; Noblejas-Lopez MD, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1387-5; DeMars KM, 2019, NEUROCHEM INT, V127, P94, DOI 10.1016/j.neuint.2019.03.004; Feng TC, 2017, J BIOL CHEM, V292, P1679, DOI 10.1074/jbc.M116.766584; Filippakopoulos P., 2010, NATURE 468; Fuso A, 2007, J ALZHEIMERS DIS, V11, P275; Fyfe I, 2018, NAT REV NEUROL, V14, DOI 10.1038/nrneurol.2018.36; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gorvin CM, 2019, J BONE MINER RES, V34, P1324, DOI 10.1002/jbmr.3695; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jin HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169226; Jung KH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0260-5; Korb E, 2015, NAT NEUROSCI, V18, P1464, DOI 10.1038/nn.4095; Kulikowski E, 2021, MED RES REV, V41, P223, DOI 10.1002/med.21730; Kwak SS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15120-3; Kwak YD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-17; Latif AL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20378-8; Li PP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10101-7; Liang YX, 2020, J ALZHEIMERS DIS, V76, P1071, DOI 10.3233/JAD-200128; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Lombardo Y, 2012, P NATL ACAD SCI USA, V109, P16558, DOI 10.1073/pnas.1206268109; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Ma C, 2019, ANGEW CHEM INT EDIT, V58, P18703, DOI 10.1002/anie.201912399; Magistri M, 2016, CURR ALZHEIMER RES, V13, P985, DOI 10.2174/1567205013666160427101832; Meakin PJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03755-2; Nativio R., 2018, DYSREGULATION EPIGEN; Nhan HS, 2015, ACTA NEUROPATHOL, V129, P1, DOI 10.1007/s00401-014-1347-2; Olley G, 2018, NAT GENET, V50, P329, DOI 10.1038/s41588-018-0042-y; Plucinska K, 2016, DIABETOLOGIA, V59, P1513, DOI 10.1007/s00125-016-3960-1; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Sakamaki JI, 2017, MOL CELL, V66, P517, DOI 10.1016/j.molcel.2017.04.027; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Singh AK, 2015, AGING CELL, V14, P595, DOI 10.1111/acel.12335; Stratton MS, 2019, CIRC RES, V125, P662, DOI 10.1161/CIRCRESAHA.119.315125; Sun Y., 2020, FRONT PHARMACOL, V11; Thompson PJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194776; Vaillant-Beuchot L, 2021, ACTA NEUROPATHOL, V141, P39, DOI 10.1007/s00401-020-02234-7; Wang HZ, 2015, BIOCHEMISTRY-US, V54, P2806, DOI 10.1021/acs.biochem.5b00329; Wang HH, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0258-7; Wang JL, 2019, J CELL MOL MED, V23, P3214, DOI 10.1111/jcmm.14196; Ward J, 2017, DISCOV MED, V23, P121; Wen X, 2017, AUTOPHAGY, V13, P1801, DOI 10.1080/15548627.2017.1364334; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zhang C, 2010, CURR ALZHEIMER RES, V7, P21, DOI 10.2174/156720510790274428; Zhang C., 2007, MOL NEURODEGENERATIO, V2; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15; Zhang C, 2010, J BIOL CHEM, V285, P28472, DOI 10.1074/jbc.M110.133520; Zhang C, 2010, J BIOL CHEM, V285, P8515, DOI 10.1074/jbc.M109.079079; Zhang X, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00427; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	68	2	2	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101794	10.1016/j.jbc.2022.101794	http://dx.doi.org/10.1016/j.jbc.2022.101794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35248531	gold, Green Published			2022-12-26	WOS:000793560400004
J	Fillmore, N; Hou, V; Sun, JH; Springer, D; Murphy, E				Fillmore, Natasha; Hou, Vincent; Sun, Junhui; Springer, Danielle; Murphy, Elizabeth			Cardiac specific knock-down of peroxisome proliferator activated receptor alpha prevents fasting-induced cardiac lipid accumulation and reduces perilipin 2	PLOS ONE			English	Article							FATTY-ACID OXIDATION; PPAR-ALPHA; INSULIN-RESISTANCE; METABOLIC RESERVE; HUMAN MYOCARDIUM; DROPLET PROTEIN; HEART; OVEREXPRESSION; HYPERTROPHY; CONTRACTILE	While fatty acid metabolism is altered under physiological conditions, alterations can also be maladaptive in diseases such as diabetes and heart failure. Peroxisome Proliferator Activated Receptor alpha (PPAR alpha) is a transcription factor that regulates fat metabolism but its role in regulating lipid storage in the heart is unclear. The aim of this study is to improve our understanding of how cardiac PPAR alpha regulates cardiac health and lipid accumulation. To study the role of cardiac PPAR alpha, tamoxifen inducible cardiac-specific PPAR alpha knockout mouse (cPPAR(-/-)) were treated for 5 days with tamoxifen and then studied after 1-2 months. Under baseline conditions, cPPAR(-/-) mice appear healthy with normal body weight and mortality is not altered. Importantly, cardiac hypertrophy or reduced cardiac function was also not observed at baseline. Mice were fasted to elevate circulating fatty acids and induce cardiac lipid accumulation. After fasting, cPPAR(-/-) mice had dramatically lower cardiac triglyceride levels than control mice. Interestingly, cPPAR(-/-) hearts also had reduced Plin2, a key protein involved in lipid accumulation and lipid droplet regulation, which may contribute to the reduction in cardiac lipid accumulation. Overall, this suggests that a decline in cardiac PPAR alpha may blunt cardiac lipid accumulation by decreasing Plin2 and that independent of differences in systemic metabolism a decline in cardiac PPAR alpha does not seem to drive pathological changes in the heart.	[Fillmore, Natasha; Hou, Vincent; Sun, Junhui; Murphy, Elizabeth] NHLBI, Lab Cardiac Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Fillmore, Natasha] North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA; [Springer, Danielle] NHLBI, Murine Phenotyping Core, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); North Dakota State University Fargo; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Fillmore, N (corresponding author), NHLBI, Lab Cardiac Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA.; Fillmore, N (corresponding author), North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA.	natasha.fillmore@ndsu.edu		Fillmore, Natasha/0000-0002-6723-0869	NIH Intramural Program	NIH Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the NIH Intramural Program (EM). https://irp.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoumi A, 2017, EXP CELL RES, V354, P85, DOI 10.1016/j.yexcr.2017.03.032; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Amen T, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109237; Banke NH, 2010, CIRC RES, V107, P233, DOI 10.1161/CIRCRESAHA.110.221713; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; Carley AN, 2005, BBA-MOL CELL BIOL L, V1734, P112, DOI 10.1016/j.bbalip.2005.03.005; CONWAY MA, 1991, LANCET, V338, P973, DOI 10.1016/0140-6736(91)91838-L; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Djouadi F, 1999, PROSTAG LEUKOTR ESS, V60, P339, DOI 10.1016/S0952-3278(99)80009-X; Duhaney TAS, 2007, HYPERTENSION, V49, P1084, DOI 10.1161/HYPERTENSIONAHA.107.086926; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hafstad AD, 2009, CARDIOVASC RES, V83, P519, DOI 10.1093/cvr/cvp132; Itabe H, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0473-y; Kalliora C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129556; Karam CN, 2017, AM J PHYSIOL-HEART C, V312, pH681, DOI 10.1152/ajpheart.00469.2016; Karbowska J, 2003, CELL MOL BIOL LETT, V8, P49; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Keung W, 2013, DIABETES, V62, P711, DOI 10.2337/db12-0259; Knight BL, 2005, BIOCHEM J, V389, P413, DOI 10.1042/BJ20041896; Kolleritsch S, 2020, CARDIOVASC RES, V116, P339, DOI 10.1093/cvr/cvz119; Labinskyy V, 2007, J PHARMACOL EXP THER, V321, P165, DOI 10.1124/jpet.106.116871; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Levin MD, 2021, GENET MED, V23, P1864, DOI 10.1038/s41436-021-01224-8; Li Shuzhen, 2018, Cell Physiol Biochem, V51, P2760, DOI 10.1159/000495969; Lin JG, 2016, LAB INVEST, V96, P791, DOI 10.1038/labinvest.2016.53; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817; Loichot C, 2006, AM J PHYSIOL-HEART C, V291, pH161, DOI 10.1152/ajpheart.01065.2004; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; LOPASCHUK GD, 1994, BBA-LIPID LIPID MET, V1213, P263, DOI 10.1016/0005-2760(94)00082-4; Luptak I, 2005, CIRCULATION, V112, P2339, DOI 10.1161/CIRCULATIONAHA.105.534594; Mardani I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43335-y; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nakamura M, 2019, CELL METAB, V29, P1119, DOI 10.1016/j.cmet.2019.01.005; Nakamura M, 2020, J PHYSIOL-LONDON, V598, P2977, DOI 10.1113/JP276747; NASCIMBEN L, 1995, CIRCULATION, V91, P1824, DOI 10.1161/01.CIR.91.6.1824; Neglia D, 2007, AM J PHYSIOL-HEART C, V293, pH3270, DOI 10.1152/ajpheart.00887.2007; Oka S, 2015, CIRC-HEART FAIL, V8, P1123, DOI 10.1161/CIRCHEARTFAILURE.115.002216; Oka S, 2012, CELL CYCLE, V11, P856, DOI 10.4161/cc.11.5.19210; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Park SY, 2005, DIABETES, V54, P2514, DOI 10.2337/diabetes.54.9.2514; Pol CJ, 2015, PPAR RES, V2015, DOI 10.1155/2015/835985; Pollak NM, 2015, J BIOL CHEM, V290, P1295, DOI 10.1074/jbc.M114.604744; Robins SJ, 2011, ARTERIOSCL THROM VAS, V31, P1208, DOI 10.1161/ATVBAHA.110.219055; Sambandam N, 2006, AM J PHYSIOL-HEART C, V290, pH87, DOI 10.1152/ajpheart.00285.2005; Schulze PC, 2016, CIRC RES, V118, P1736, DOI 10.1161/CIRCRESAHA.116.306842; Shimizu M, 2006, J BIOCHEM, V139, P563, DOI 10.1093/jb/mvj053; Shimizu M, 2004, MOL CELL BIOL, V24, P1313, DOI 10.1128/MCB.24.3.1313-1323.2004; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Sztalryd C, 2017, BBA-MOL CELL BIOL L, V1862, P1221, DOI 10.1016/j.bbalip.2017.07.009; Tsai TH, 2017, AUTOPHAGY, V13, P1130, DOI 10.1080/15548627.2017.1319544; Ueno M, 2017, AM J PHYSIOL-ENDOC M, V313, pE699, DOI 10.1152/ajpendo.00098.2017; Varghese M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41329-4; Wang L, 2021, CARDIOVASC DIABETOL, V20, DOI 10.1186/s12933-020-01188-0; Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074; Warren JS, 2017, AM J PHYSIOL-HEART C, V313, pH584, DOI 10.1152/ajpheart.00103.2017; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Young ME, 2001, J BIOL CHEM, V276, P44390, DOI 10.1074/jbc.M103826200; Zlobine I, 2016, BBA-MOL CELL BIOL L, V1861, P1555, DOI 10.1016/j.bbalip.2016.02.011; Zungu M, 2009, MOL CELL BIOCHEM, V330, P55, DOI 10.1007/s11010-009-0100-y	67	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0265007	10.1371/journal.pone.0265007	http://dx.doi.org/10.1371/journal.pone.0265007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259201	Green Published, gold			2022-12-26	WOS:000835141200039
J	Sajadi, SJ; Ahmadi, A				Sajadi, Seyed Jafar; Ahmadi, Ali			An integrated optimization model and metaheuristics for assortment planning, shelf space allocation, and inventory management of perishable products: A real application	PLOS ONE			English	Article							VIBRATION DAMPING OPTIMIZATION; DEMAND; REPLENISHMENT; ELASTICITY; ALGORITHM; DECISION; RETAIL; SUBSTITUTION	Product category management (PCM) plays a pivotal role in today's large stores. PCM manages to answer questions such as assortment planning (AP) and shelf space allocation (SSA). AP problem seeks to determine a list of products and suppliers, while SSA problem tries to design the layout of the selected products in the available shelf space. These problems aim to maximize the retailer sales under different constraints, such as limited purchasing budget, limited space of classes for displaying the products, and having at least a certain number of suppliers. This paper makes an attempt to develop an integrated mathematical model to optimize integrated AP, SSA, and inventory control problem for the perishable products. The objective of the model is to maximize the sales and retail profit, considering the costs of supplier contracting/selecting and ordering, assortment planning, holding, and procurement cost. GAMS BARON solver is hired to solve the proposed model in small and medium scales. However, because the problem is NP-hard, an evolutionary genetic algorithm (GA), and an efficient local search vibration damping optimization (VDO) algorithm are proposed. A real case study is considered to evaluate the effectiveness and capabilities of the model. Besides, some test problems of different sizes are generated and solved by the proposed metaheuristic solvers to confirm the efficient performance of proposed algorithms in solving large-scale instances.	[Sajadi, Seyed Jafar; Ahmadi, Ali] Iran Univ Sci & Technol, Dept Ind Engn, Tehran, Iran	Iran University Science & Technology	Ahmadi, A (corresponding author), Iran Univ Sci & Technol, Dept Ind Engn, Tehran, Iran.	sjsadjadi@iust.ac.ir; a.ahmadi707@gmail.com	Ahmadi, Ali/AHC-2465-2022	Ahmadi, Ali/0000-0002-7818-4562				Azadi Z, 2019, COMPUT IND ENG, V127, P625, DOI 10.1016/j.cie.2018.11.004; Boada-Collado P, 2020, M&SOM-MANUF SERV OP, V22, P582, DOI 10.1287/msom.2018.0764; Farahani P, 2012, FLEX SERV MANUF J, V24, P28, DOI 10.1007/s10696-011-9125-0; Flamand T, 2018, OMEGA-INT J MANAGE S, V81, P134, DOI 10.1016/j.omega.2017.10.006; Hajipour V, 2016, COMPUT OPER RES, V70, P87, DOI 10.1016/j.cor.2016.01.001; Hariga MA, 2007, EUR J OPER RES, V181, P239, DOI 10.1016/j.ejor.2006.06.025; Honhon D, 2010, OPER RES, V58, P1364, DOI 10.1287/opre.1090.0805; Hubner A, 2017, INT J RETAIL DISTRIB, V45, P808, DOI 10.1108/IJRDM-09-2016-0166; Hubner A, 2017, EUR J OPER RES, V261, P302, DOI 10.1016/j.ejor.2017.01.039; Hubner A, 2016, EUR J OPER RES, V250, P505, DOI 10.1016/j.ejor.2015.11.007; Hubner AH, 2013, INT J RETAIL DISTRIB, V41, P512, DOI 10.1108/IJRDM-05-2013-0104; Hwang H, 2009, COMPUT IND ENG, V56, P809, DOI 10.1016/j.cie.2008.09.012; Karki U, 2021, INT J PROD ECON, V234, DOI 10.1016/j.ijpe.2020.107943; Katsifou A, 2014, OMEGA-INT J MANAGE S, V46, P36, DOI 10.1016/j.omega.2014.02.002; Kim G, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102274; Kok AG, 2007, OPER RES, V55, P1001, DOI 10.1287/opre.1070.0409; Kok AG, 2009, INT SER OPER RES MAN, V122, P99, DOI 10.1007/978-0-387-78902-6_6; Mehdizadeh E, 2015, APPL MATH MODEL, V39, P6845, DOI 10.1016/j.apm.2015.02.027; Merlino VM, 2021, J RETAIL CONSUM SERV, V59, DOI 10.1016/j.jretconser.2020.102406; Mirjalili S, 2019, STUD COMPUT INTELL, V780, P43, DOI 10.1007/978-3-319-93025-1_4; Mou S, 2018, EUR J OPER RES, V265, P399, DOI 10.1016/j.ejor.2017.07.003; Piramuthu S, 2013, INT J PROD ECON, V144, P635, DOI 10.1016/j.ijpe.2013.04.035; Pizzi G, 2016, J RETAIL CONSUM SERV, V28, P67, DOI 10.1016/j.jretconser.2015.08.012; Reisi M, 2019, INT J PROD ECON, V211, P237, DOI 10.1016/j.ijpe.2018.12.018; Sainathan A, 2013, PROD OPER MANAG, V22, P1157, DOI 10.1111/poms.12004; Schaal K, 2018, OMEGA-INT J MANAGE S, V80, P135, DOI 10.1016/j.omega.2017.08.015; Shroff A, 2021, J REVENUE PRICING MA, V20, P116, DOI 10.1057/s41272-021-00295-1; Talebian M, 2014, EUR J OPER RES, V237, P555, DOI 10.1016/j.ejor.2014.01.045; Tan B, 2013, INT J PROD ECON, V145, P78, DOI 10.1016/j.ijpe.2012.10.002; Wang X, 2009, INT J PROD RES, V47, P2865, DOI 10.1080/00207540701725075; Wang Y, 2021, APPL SOFT COMPUT, V109, DOI 10.1016/j.asoc.2021.107528; Wang Y, 2021, KNOWL-BASED SYST, V223, DOI 10.1016/j.knosys.2021.107041; Wang Y, 2020, TRANSPORT RES E-LOG, V143, DOI 10.1016/j.tre.2020.102118; Wang Y, 2020, J CLEAN PROD, V258, DOI 10.1016/j.jclepro.2020.120590; Yucel E, 2009, EUR J OPER RES, V199, P759, DOI 10.1016/j.ejor.2008.08.004; Zhang LDL, 2020, EXPERT SYST APPL, V161, DOI 10.1016/j.eswa.2020.113733	36	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264186	10.1371/journal.pone.0264186	http://dx.doi.org/10.1371/journal.pone.0264186			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259170	Green Published, gold			2022-12-26	WOS:000835141200011
J	Fadul, M; D'Andrea, L; Alsaaod, M; Borriello, G; Di Lori, A; Stucki, D; Ciaramella, P; Steiner, A; Guccione, J				Fadul, Mahmoud; D'Andrea, Luigi; Alsaaod, Maher; Borriello, Giuliano; Di Lori, Antonio; Stucki, Dimitri; Ciaramella, Paolo; Steiner, Adrian; Guccione, Jacopo			Assessment of feeding, ruminating and locomotion behaviors in dairy cows around calving - a retrospective clinical study to early detect spontaneous disease appearance	PLOS ONE			English	Article							BODY CONDITION SCORE; LYING BEHAVIOR; PEDOMETER ALGORITHM; SUBCLINICAL KETOSIS; HEALTH DISORDERS; HOOF PATHOLOGIES; MILK-YIELD; TIME; VALIDATION; SENSOR	The study aims to verify the usefulness of new intervals-based algorithms for clinical interpretation of animal behavior in dairy cows around calving period. Thirteen activities associated with feeding-ruminating-locomotion-behaviors of 42 adult Holstein-Friesian cows were continuously monitored for the week (wk) -2, wk -1 and wk +1 relative to calving (overall 30'340 min/animal). Soon after, animals were retrospectively assigned to group-S (at least one spontaneous diseases; n = 24) and group-H (healthy; n = 18). The average activities performed by the groups, recorded by RumiWatch (R) halter and pedometer, were compared at the different weekly intervals. The average activities on the day of clinical diagnosis (dd0), as well as one (dd-1) and two days before (dd-2) were also assessed. Differences of dd0 vs. dd-1 (Delta D1), dd0 vs. wk -1 (Delta D2), and wk +1 vs. wk -1 (Delta weeks) were calculated. Variables showing significant differences between the groups were used for a univariate logistic regression, a receiver operating characteristic analysis, and a multivariate logistic regression model. At wk +1 and dd0, eating- and ruminating-time, eating- and ruminate-chews and ruminating boluses were significantly lower in group-S as compared to group-H, while other activity time was higher. For Delta D2 and Delta weeks, the differences of eating- and ruminating-time, as well as of eating-and ruminate-chews were significantly lower in group-S as compared to group-H. Concerning the locomotion behaviors, the lying time was significantly higher in group-S vs. group-H at wk +1 and dd-2. The number of strides was significantly lower in group-S compared to group-H at wk +1. The model including eating-chews, ruminate-chews and other activity time reached the highest accuracy in detecting sick cows in wk +1 (area under the curve: 81%; sensitivity: 73.7%; specificity: 82.4%). Some of the new algorithms for the clinical interpretation of cow behaviour as described in this study may contribute to monitoring animals' health around calving.	[Fadul, Mahmoud; Alsaaod, Maher; Stucki, Dimitri; Steiner, Adrian] Univ Bern, Vetsuisse Fac, Dept Clin Vet Med, Clin Ruminants, Bern, Switzerland; [D'Andrea, Luigi; Borriello, Giuliano; Di Lori, Antonio; Ciaramella, Paolo; Guccione, Jacopo] Univ Napoli Federico II, Dept Vet Med & Anim Prod, Naples, Italy	University of Bern; University of Naples Federico II	Steiner, A (corresponding author), Univ Bern, Vetsuisse Fac, Dept Clin Vet Med, Clin Ruminants, Bern, Switzerland.; Ciaramella, P (corresponding author), Univ Napoli Federico II, Dept Vet Med & Anim Prod, Naples, Italy.	paociara@unina.it; adrian.steiner@vetsuisse.unibe.ch		Borriello, Giuliano/0000-0002-4993-0511; Fadul, Mahmoud Mohamed Osman/0000-0001-9175-6679; CIARAMELLA, PAOLO/0000-0002-5518-5378				Aditya S, 2017, J DAIRY SCI, V100, P1363, DOI 10.3168/jds.2016-11796; Agrawal A, 2017, BIOINFORM BIOL INSIG, V11, DOI 10.1177/1177932217704667; Alsaaod M, 2015, J DAIRY SCI, V98, P6236, DOI 10.3168/jds.2015-9657; Alsaaod M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218546; [Anonymous], CLASSIFICATION ANAL; Arai S, 2019, J VET MED SCI, V81, P1835, DOI 10.1292/jvms.19-0487; Beer G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155796; Borchers MR, 2016, J DAIRY SCI, V99, P7458, DOI 10.3168/jds.2015-10843; Brandstetter V, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9121088; Braun U, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-164; Caja G, 2016, J DAIRY RES, V83, P136, DOI 10.1017/S0022029916000261; Calamari L, 2014, J DAIRY SCI, V97, P3635, DOI 10.3168/jds.2013-7709; D'Andrea L, 2017, J DAIRY RES, V84, P391, DOI 10.1017/S0022029917000668; Demba S, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18113925; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Dubuc J, 2017, J DAIRY SCI, V100, P3068, DOI 10.3168/jds.2016-12144; Eckelkamp EA, 2019, APPL ANIM SCI, V35, P209, DOI 10.15232/aas.2018-01801; FERGUSON JD, 1994, J DAIRY SCI, V77, P2695, DOI 10.3168/jds.S0022-0302(94)77212-X; Flower FC, 2006, J DAIRY SCI, V89, P139, DOI 10.3168/jds.S0022-0302(06)72077-X; Flower FC, 2005, J DAIRY SCI, V88, P3166, DOI 10.3168/jds.S0022-0302(05)73000-9; Gargiulo JI, 2018, J DAIRY SCI, V101, P5466, DOI 10.3168/jds.2017-13324; GILLETTE DD, 1963, AM J PHYSIOL, V204, P1115, DOI 10.1152/ajplegacy.1963.204.6.1115; Goldhawk C, 2009, J DAIRY SCI, V92, P4971, DOI 10.3168/jds.2009-2242; Gonzalez LA, 2008, J DAIRY SCI, V91, P1017, DOI 10.3168/jds.2007-0530; Guccione J, 2019, J DAIRY RES, V86, P40, DOI [10.1017/S0022029919000074, 10.1017/s0022029919000074]; Guccione J, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0726-4; Huzzey JM, 2007, J DAIRY SCI, V90, P3220, DOI 10.3168/jds.2006-807; Itle AJ, 2015, J DAIRY SCI, V98, P128, DOI 10.3168/jds.2014-7932; Ito K, 2010, J DAIRY SCI, V93, P3553, DOI 10.3168/jds.2009-2951; Jackson P., 2002, CLIN EXAMINATION FAR, V1rd; Jawor PE, 2012, J DAIRY SCI, V95, P1240, DOI 10.3168/jds.2011-4586; Kaufman EI, 2016, J DAIRY SCI, V99, P7473, DOI 10.3168/jds.2016-11185; Kaufman EI, 2016, J DAIRY SCI, V99, P5604, DOI 10.3168/jds.2015-10509; Knight CH, 2020, ANIMAL, V14, pS187, DOI 10.1017/S1751731119003276; Luchterhand KM, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00065; Mahmoud F, 2017, ANIM REPROD SCI, V187, P37, DOI 10.1016/j.anireprosci.2017.10.003; Miedema HM, 2011, APPL ANIM BEHAV SCI, V131, P8, DOI 10.1016/j.applanim.2011.01.012; Miller GA, 2020, ANIMAL, V14, P1304, DOI 10.1017/S1751731119003380; Mulligan FT, 2006, ANIM REPROD SCI, V96, P331, DOI 10.1016/j.anireprosci.2006.08.011; Overton T.R., 2004, J DAIRY SCI, V87, pE105, DOI [10.3168/jds.S0022-0302(04)70066-1, DOI 10.3168/JDS.S0022-0302(04)70066-1]; Pereira GM, 2021, J DAIRY SCI, V104, P3736, DOI 10.3168/jds.2020-18952; Pereira GM, 2020, J DAIRY SCI, V103, P3529, DOI 10.3168/jds.2019-17269; Post C, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20143863; Radostits O.M., 2007, VET MED TXB DIS CATT, VTenth Edition, P3; Roche JR, 2013, J DAIRY SCI, V96, P5811, DOI 10.3168/jds.2013-6600; Schirmann K, 2016, J DAIRY SCI, V99, P9917, DOI 10.3168/jds.2015-10548; Sepulveda-Varas P, 2014, J DAIRY SCI, V97, P6334, DOI 10.3168/jds.2014-8357; Soriani N, 2012, J ANIM SCI, V90, P4544, DOI [10.2527/jas.2011-5064, 10.2527/jas.2012-5064]; Sprecher DJ, 1997, THERIOGENOLOGY, V47, P1179, DOI 10.1016/S0093-691X(97)00098-8; Stachowicz J, 2021, P ROY SOC B-BIOL SCI, V288, DOI 10.1098/rspb.2021.0190; Stangaferro ML, 2016, J DAIRY SCI, V99, P7411, DOI 10.3168/jds.2016-10908; Steeneveld W, 2015, J DAIRY SCI, V98, P3896, DOI 10.3168/jds.2014-9101; Steensels M, 2016, ANIMAL, V10, P1493, DOI 10.1017/S1751731116000744; Strutzke S, 2019, J DAIRY SCI, V102, P690, DOI 10.3168/jds.2018-14999; Sturm V, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20051484; Stygar AH, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.634338; Thorup VM, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00037; Valros A, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8120220; Vasseur E, 2012, J DAIRY SCI, V95, P4968, DOI 10.3168/jds.2011-5176; Vergara CF, 2014, J DAIRY SCI, V97, P4127, DOI 10.3168/jds.2012-6440; Zehner N, 2017, COMPUT ELECTRON AGR, V136, P31, DOI 10.1016/j.compag.2017.02.021	61	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264834	10.1371/journal.pone.0264834	http://dx.doi.org/10.1371/journal.pone.0264834			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245319	Green Published, gold			2022-12-26	WOS:000799799100037
J	Sun, R; Lei, C; Chen, L; He, LQ; Guo, HX; Zhang, X; Feng, WK; Yan, J; McClain, CJ; Deng, ZB				Sun, Rui; Lei, Chao; Chen, Liang; He, Liqing; Guo, Haixun; Zhang, Xiang; Feng, Wenke; Yan, Jun; McClain, Craig J.; Deng, Zhongbin			Alcohol-driven metabolic reprogramming promotes development of ROR gamma t-deficient thymic lymphoma	ONCOGENE			English	Article							C-MYC; GLUTAMINE-METABOLISM; MTOR; INHIBITION; EXPRESSION; PROTEIN; DIFFERENTIATION; REQUIREMENT; ADAPTATION; GLYCOLYSIS	ROR gamma t is a master regulator of Th17 cells. Despite evidence linking ROR gamma t deficiency/inhibition with metastatic thymic T cell lymphomas, the role of ROR gamma t in lymphoma metabolism is unknown. Chronic alcohol consumption plays a causal role in many human cancers. The risk of T cell lymphoma remains unclear in humans with alcohol use disorders (AUD) after chronic ROR gamma t inhibition. Here we demonstrated that alcohol consumption accelerates ROR gamma t deficiency-induced lymphomagenesis. Loss of ROR gamma t signaling in the thymus promotes aerobic glycolysis and glutaminolysis and increases allocation of glutamine carbon into lipids. Importantly, alcohol consumption results in a shift from aerobic glycolysis to glutaminolysis. Both ROR gamma t deficiency- and alcohol-induced metabolic alterations are mediated by c-Myc, as silencing of c-Myc decreases the effects of alcohol consumption and ROR gamma t deficiency on glutaminolysis, biosynthesis, and tumor growth in vivo. The ethanol-mediated c-Myc activation coupled with increased glutaminolysis underscore the critical role of ROR gamma t-Myc signaling and translation in lymphoma.	[Sun, Rui; Lei, Chao; Chen, Liang; Yan, Jun; Deng, Zhongbin] Univ Louisville, Dept Surg, Div Immunotherapy, Louisville, KY 40292 USA; [Sun, Rui] Huazhong Univ Sci & Technol, Wuhan Hosp 4, Puai Hosp, Tongji Med Coll,Dept Oncol, Wuhan 430033, Peoples R China; [Sun, Rui; Lei, Chao; Chen, Liang; Yan, Jun; Deng, Zhongbin] Univ Louisville, Brown Canc Ctr, Louisville, KY 40292 USA; [He, Liqing; Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40292 USA; [Guo, Haixun] Univ Louisville, Dept Radiol, Louisville, KY 40292 USA; [Zhang, Xiang; Feng, Wenke; McClain, Craig J.; Deng, Zhongbin] Univ Louisville, Alcohol Res Ctr, Louisville, KY 40292 USA; [Zhang, Xiang; Feng, Wenke; McClain, Craig J.; Deng, Zhongbin] Univ Louisville, Hepatobiol & Toxicol Ctr, Louisville, KY 40292 USA; [Feng, Wenke; McClain, Craig J.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [McClain, Craig J.] Robley Rex VA Med Ctr, Louisville, KY USA	University of Louisville; Huazhong University of Science & Technology; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville	Deng, ZB (corresponding author), Univ Louisville, Dept Surg, Div Immunotherapy, Louisville, KY 40292 USA.; Deng, ZB (corresponding author), Univ Louisville, Brown Canc Ctr, Louisville, KY 40292 USA.; Deng, ZB (corresponding author), Univ Louisville, Alcohol Res Ctr, Louisville, KY 40292 USA.; Deng, ZB (corresponding author), Univ Louisville, Hepatobiol & Toxicol Ctr, Louisville, KY 40292 USA.	z0deng01@louisville.edu	Yan, Jun/A-8988-2008; Guo, Haixun/GYR-1920-2022; Lei, Chao/AFK-3169-2022	Guo, Haixun/0000-0002-9702-5444; Lei, Chao/0000-0002-5220-086X	NIH [R21AA025724, R21AI128206, R21AI159194, R01 DK115406, P50AA024337, P20GM113226]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the NIH R21AA025724, R21AI128206, R21AI159194 and R01 DK115406 (ZD), and NIH P50AA024337, P20GM113226, (CJM). We thank Dr. J. Ainsworth for editorial assistance.	Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Choi WM, 2019, CELL METAB, V30, P877, DOI 10.1016/j.cmet.2019.08.001; Chu SH, 2021, HEPATOLOGY, V73, P952, DOI 10.1002/hep.31321; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Evangelisti C, 2011, LEUKEMIA, V25, P781, DOI 10.1038/leu.2011.20; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gao YH, 2019, GUT, V68, P1311, DOI 10.1136/gutjnl-2018-316221; Gu Y, 2017, CANCER CELL, V32, P115, DOI 10.1016/j.ccell.2017.06.001; Guntermann C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91127; Guo YX, 2016, CELL REP, V17, P3206, DOI 10.1016/j.celrep.2016.11.073; He YW, 2000, J IMMUNOL, V164, P5668, DOI 10.4049/jimmunol.164.11.5668; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jun S, 2021, CELL METAB, V33, P1777, DOI 10.1016/j.cmet.2021.07.016; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kishton RJ, 2016, CELL METAB, V23, P649, DOI 10.1016/j.cmet.2016.03.008; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Liljevald M, 2016, AUTOIMMUN REV, V15, P1062, DOI 10.1016/j.autrev.2016.07.036; Ma HY, 2020, J HEPATOL, V72, P946, DOI 10.1016/j.jhep.2019.12.016; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mak TW, 2017, IMMUNITY, V46, P675, DOI 10.1016/j.immuni.2017.03.019; Nevzorova YA, 2016, J HEPATOL, V64, P628, DOI 10.1016/j.jhep.2015.11.005; Odera JO, 2020, BIOCHEM J, V477, P3075, DOI 10.1042/BCJ20200452; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pollizzi KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121710; Ramstead AG, 2020, CELL REP, V30, P2889, DOI 10.1016/j.celrep.2020.02.042; Scheepstra M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9833; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Shao T, 2018, J HEPATOL, V69, P886, DOI 10.1016/j.jhep.2018.05.021; Siler SQ, 1998, AM J PHYSIOL-ENDOC M, V275, pE897, DOI 10.1152/ajpendo.1998.275.5.E897; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Ueda E, 2002, CANCER RES, V62, P901; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Yang K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aas9818; Zakhari S, 2007, HEPATOLOGY, V46, P2032, DOI 10.1002/hep.22010	46	0	0	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2022	41	16					2287	2302		10.1038/s41388-022-02257-2	http://dx.doi.org/10.1038/s41388-022-02257-2		MAR 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0N1NW	35246617	Green Accepted			2022-12-26	WOS:000764592500001
J	Kebede, KM; Abateneh, DD; Teferi, MB; Asres, A				Kebede, Kindie Mitiku; Abateneh, Dejene Derseh; Teferi, Melkamu Beyene; Asres, Abyot			Chronic kidney disease and associated factors among adult population in Southwest Ethiopia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BLOOD-PRESSURE CONTROL; RISK; EPIDEMIOLOGY; PROTEINURIA; PROGRESSION; PREVALENCE; OBESITY; EGFR	In Ethiopia, data on the burden and determinants of chronic kidney disease (CKD) in the general population is limited. This community-based study was conducted to assess the burden and associated factors of CKD among adults in Southwest Ethiopia. The study was conducted from August 23, 2018-October 16, 2018. Study participants were selected using a random sampling method. A structured questionnaire was used to collect relevant data. Blood pressure and anthropometric indices were measured following standard procedures. About 5 ml of urine sample was collected and the dipstick test was performed immediately. A blood sample of 3-5ml was collected for serum creatinine and blood glucose level determination. The three commonest estimators of glomerular filtration rate and the National Kidney Foundation Kidney Disease Outcomes Quality Initiative were used to define and stage CKD. Data were analyzed using SPSS 21. Multivariable logistic regression was employed and p-value < 0.05 was used to indicate statistically significant results. A total of 326 participants with a mean age of 39.9(SD +/- 11.2) years were enrolled in the study. The proportions of female participants (59.8%) were relatively higher than male participants (40.2%). The mean eGFR using CKD-EPI, CG and MDRD was 124.34 (SD +/- 23.8) mL/min/1.73m(2), 110.67(SD +/- 33.0) mL/min/1.73m(2) and 131.29 (SD +/- 32.5) mL/min/1.73m(2) respectively. The prevalence of CKD was 7.4% using CKD-EPI & MDRD and 8% using CG. Similar finding using CKD-EPI & MDRD may indicate that either CKD-EPI or MDRD can be used to estimate GFR in this study area. In the age and sex-adjusted logistic regression model, hypertension was significantly associated with CKD using CKD-EPI & MDRD and age >= 40 years old was significantly associated with CKD using CG. Behavioral characteristics and other traditional risk factors were not significantly associated with CKD in the current study. The prevalence of CKD was high in the study area. Only hypertension and age >= 40 years old were significantly associated with CKD. More of the increased prevalence of CKD in the current study remained unexplained and deserves further study.	[Kebede, Kindie Mitiku; Abateneh, Dejene Derseh; Teferi, Melkamu Beyene; Asres, Abyot] Mizan Tepi Univ, Coll Med & Hlth Sci, Mizan Teferi, Ethiopia; [Abateneh, Dejene Derseh] Kotebe Metropolitan Univ, Menelik II Coll Med & Hlth Sci, Addis Ababa, Ethiopia	University of Gondar	Abateneh, DD (corresponding author), Mizan Tepi Univ, Coll Med & Hlth Sci, Mizan Teferi, Ethiopia.; Abateneh, DD (corresponding author), Kotebe Metropolitan Univ, Menelik II Coll Med & Hlth Sci, Addis Ababa, Ethiopia.	dejenieh@gmail.com		Derseh, Dejene/0000-0002-3824-7215	Mizan Tepi University	Mizan Tepi University	Funding for this study was made possible through grants offered by Mizan Tepi University,	Abu-Aisha H., 2009, ARAB J NEPHROLOGY TR, V2, P21; Afolabi MO, 2009, S AFR FAM PRACT, V51, P132, DOI 10.1080/20786204.2009.10873828; Baynes HW, 2019, SAUDI J KIDNEY DIS T, V30, P1190, DOI 10.4103/1319-2442.275462; Bianchi S, 1999, AM J KIDNEY DIS, V34, P973, DOI 10.1016/S0272-6386(99)70002-8; Chapman E, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.35; Coudene P, 2005, CLIN CHEM LAB MED, V43, P782, DOI 10.1515/CCLM.2005.133; Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765; Fiseha T, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-198; Glassock RJ, 2008, CLIN J AM SOC NEPHRO, V3, P1563, DOI 10.2215/CJN.00960208; Global HIV and AIDS Statistics, 2018 GLOB HIV STAT; Grimm RH., 1997, KIDNEY INT S; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; Iseki K, 2007, HYPERTENS RES, V30, P167, DOI 10.1291/hypres.30.167; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kalyesubula R, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0521-x; Kaze FF, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0102-9; Khan I, 2018, INT UROL NEPHROL, V50, P1113, DOI 10.1007/s11255-018-1834-9; Levey AS, 2014, DEFINITION STAGING C; Lozier M, 2016, REV PANAM SALUD PUBL, V40, P294; Matsha TE, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-75; Mekuria Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161180; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; POULTER N, 1984, J CARDIOVASC PHARM, V6, pS197, DOI 10.1097/00005344-198400061-00031; SHANNON RP, 1984, SEMIN NEPHROL, V4, P346; Silva Junior G. B. da, 2013, Asian Pacific Journal of Tropical Disease, V3, P79, DOI 10.1016/S2222-1808(13)60018-3; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124506; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Sumaili EK, 2009, NEPHROL DIAL TRANSPL, V24, P117, DOI 10.1093/ndt/gfn469; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Vupputuri S, 2003, ANN EPIDEMIOL, V13, P712, DOI 10.1016/S1047-2797(03)00066-8; World Health Organization, 2018, NONC DSEAS COUNTR PR; Wyatt CM, 2012, ANNU REV MED, V63, P147, DOI 10.1146/annurev-med-041610-134224; Wyatt CM, 2008, SEMIN NEPHROL, V28, P513, DOI 10.1016/j.semnephrol.2008.08.005; Yirsaw BD, 2012, ANN AFR MED, V11, P119, DOI 10.4103/1596-3519.93537	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264611	10.1371/journal.pone.0264611	http://dx.doi.org/10.1371/journal.pone.0264611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239741	gold, Green Published			2022-12-26	WOS:000776002200049
J	Strupat, C; Shigute, Z; Bedi, AS; Rieger, M				Strupat, Christoph; Shigute, Zemzem; Bedi, Arjun S.; Rieger, Matthias			Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia	PLOS ONE			English	Article							HEALTH-INSURANCE	Background In low-income countries, vaccination campaigns are lagging, and evidence on vaccine acceptance, a crucial public health planning input, remains scant. This is the first study that reports willingness to take COVID-19 vaccines and its socio-demographic correlates in Ethiopia, Africa's second most populous country. Methods The analysis is based on a nationally representative survey data of 2,317 households conducted in the informal economy in November 2020. It employs two logistic regression models where the two outcome variables are (i) a household head's willingness to take a COVID-19 vaccine or not, and (ii) if yes if they would also hypothetically pay (an unspecified amount) for it or not. Predictors include age, gender, education, marital status, income category, health insurance coverage, sickness due to COVID-19, chronic illness, trust in government, prior participation in voluntary activities, urban residence. Results Willingness to take the vaccine was high (88%) and significantly associated with COVID-19 cases in the family, trust in government and pro-social behavior. All other predictors such as gender, education, income, health insurance, chronic illness, urban residence did not significantly predict vaccine willingness at the 5% level. Among those willing to take the vaccine, 33% also answered that they would hypothetically pay (an unspecified amount) for it, an answer that is significantly associated with trust in government, health insurance coverage and income. Conclusion The results highlight both opportunities and challenges. There is little evidence of vaccine hesitancy in Ethiopia among household heads operating in the informal economy. The role played by trust in government and pro-social behavior in motivating this outcome suggests that policy makers need to consider these factors in the planning of COVID-19 vaccine campaigns in order to foster vaccine uptake. At the same time, as the willingness to hypothetically pay for a COVID-19 vaccine seems to be small, fairly-priced vaccines along with financial support are also needed to ensure further uptake of COVID-19 vaccines.	[Strupat, Christoph] German Dev Inst, Bonn, Germany; [Shigute, Zemzem] Addis Ababa Univ, Inst Dev & Policy Res, Addis Ababa, Ethiopia; [Shigute, Zemzem; Bedi, Arjun S.; Rieger, Matthias] Erasmus Univ, Int Inst Social Studies, Rotterdam, Netherlands	Deutsches Institut Entwicklungspolitik (DIE); Addis Ababa University; Erasmus University Rotterdam	Strupat, C (corresponding author), German Dev Inst, Bonn, Germany.	christoph.strupat@die-gdi.de		Matthias, Rieger/0000-0001-5041-6109	FriedrichEbert Foundation (FES); German Ministry for Economic Cooperation and Development (BMZ)	FriedrichEbert Foundation (FES); German Ministry for Economic Cooperation and Development (BMZ)	The survey was funded by the FriedrichEbert Foundation (FES) and the German Ministry for Economic Cooperation and Development (BMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul Kalam M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256496; Africa CDC, 2021, COVID 19 VACC PERC 1; Akpalu Y, 2020, VACCINE, V38, P2132, DOI 10.1016/j.vaccine.2020.01.029; Anderson RM, 2020, LANCET, V396, P1614, DOI 10.1016/S0140-6736(20)32318-7; Angelo AT, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257109; [Anonymous], 2013, AFROBAROMETER QUESTI; Arce JSS, 2021, NAT MED, V27, P1385, DOI 10.1038/s41591-021-01454-y; Belsti Y, 2021, J MULTIDISCIP HEALTH, V14, P1233, DOI 10.2147/JMDH.S312637; Berihun G, 2021, PATIENT PREFER ADHER, V15, P1795, DOI 10.2147/PPA.S324564; Betsch C, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0056; Brubaker J.M, 2021, WORLD BANK POLICY RE; Cerda AA, 2022, HEALTH EXPECT, V25, P506, DOI 10.1111/hex.13274; Cerda AA, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.626852; Cerda AA, 2021, APPL HEALTH ECON HEA, V19, P343, DOI 10.1007/s40258-021-00644-6; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Dereje N., 2021, MEDRXIV, DOI [10.1101/2021.02.25.21252443, DOI 10.1101/2021.02.25.21252443]; Dias-Godoi I.P., EXPERT REV PHARM OUT, V14, P1; Dinga JN, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020175; Ditekemena JD, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020153; Dupas P, 2014, ECONOMETRICA, V82, P197, DOI 10.3982/ECTA9508; Ethiopian Public Health Institute, COVID 19 WEEKL B; Freeman D, 2022, PSYCHOL MED, V52, P3127, DOI [10.1017/S0033291720005188, 10.1017/S0033291721002609]; Guidry JPD, 2021, AM J INFECT CONTROL, V49, P137, DOI 10.1016/j.ajic.2020.11.018; Harapan H, 2020, HUM VACC IMMUNOTHER, V16, P3074, DOI 10.1080/21645515.2020.1819741; ILO (International Labour Office), 2002, GB28572 ILO; Kanyanda S, 2021, ACCEPTANCE COVID 19, DOI [10.1101/ 2021.06.28.21259320, DOI 10.1101/2021.06.28.21259320, 10.1101/2021.06.28.21259320]; Korn L, 2020, P NATL ACAD SCI USA, V117, P14890, DOI 10.1073/pnas.1919666117; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Leininger J., 2021, 312021 DIE; Machingaidze S, 2021, NAT MED, V27, P1338, DOI 10.1038/s41591-021-01459-7; Malik AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100495; Neumann-Bohme S, 2020, EUR J HEALTH ECON, V21, P977, DOI 10.1007/s10198-020-01208-6; Rieger M, 2019, SOC SCI MED, V232, P374, DOI 10.1016/j.socscimed.2019.05.037; Rozek LS, 2021, INT J PUBLIC HEALTH, V66, DOI 10.3389/ijph.2021.636255; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160; Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8; Shigute Z, 2020, J DEV STUD, V56, P431, DOI 10.1080/00220388.2018.1563682; Shigute Z, 2017, SOC SCI MED, V176, P133, DOI 10.1016/j.socscimed.2017.01.035; Shitu K, 2021, TROP MED HEALTH, V49, DOI 10.1186/s41182-021-00337-9; Siegrist M, 2014, EUR PSYCHOL, V19, P23, DOI 10.1027/1016-9040/a000169; Stamm A., 2021, 192021 DIE; Verick S., 2006, IMPACT GLOBALIZATION; WHO, 2021, ETH INTR COVID 10 VA; WHO, 2021, COVID 19 AFR REG; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8	45	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264633	10.1371/journal.pone.0264633	http://dx.doi.org/10.1371/journal.pone.0264633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239711	gold, Green Published			2022-12-26	WOS:000776002200055
J	Rahman, M; Hoque, A; Roy, J				Rahman, Mukhlesur; Hoque, Ahasanul; Roy, Jayanta			Linkage disequilibrium and population structure in a core collection of Brassica napus (L.)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC DIVERSITY; FLOWERING TIME; PROGRAM STRUCTURE; SOFTWARE; GERMPLASM; CLUSTERS; POLYMORPHISM; PERFORMANCE; ACCESSIONS	Estimation of genetic diversity in rapeseed is important for sustainable breeding program to provide an option for the development of new breeding lines. The objective of this study was to elucidate the patterns of genetic diversity within and among different structural groups, and measure the extent of linkage disequilibrium (LD) of 383 globally distributed rapeseed germplasm using 8,502 single nucleotide polymorphism (SNP) markers. We divided the germplasm collection into five subpopulations (P1 to P5) according to geographic and growth habit-related patterns. All subpopulations showed moderate genetic diversity (average H = 0.22 and I = 0.34). The pairwise F-st comparison revealed a great degree of divergence (F-st > 0.24) between most of the combinations. The rutabaga type showed highest divergence with spring and winter types. Higher divergence was also found between winter and spring types. Admixture model based structure analysis, principal component and neighbor-joining tree analysis placed all subpopulations into three distinct clusters. Admixed genotype constituted 29.24% of total genotypes, while remaining 70.76% belongs to identified clusters. Overall, mean linkage disequilibrium was 0.03 and it decayed to its half maximum within < 45 kb distance for whole genome. The LD decay was slower in C genome (< 93 kb); relative to the A genome (< 21 kb) which was confirmed by availability of larger haplotype blocks in C genome than A genome. The findings regarding LD pattern and population structure will help to utilize the collection as an important resource for association mapping efforts to identify genes useful in crop improvement as well as for selection of parents for hybrid breeding.	[Rahman, Mukhlesur; Hoque, Ahasanul; Roy, Jayanta] North Dakota State Univ, Dept Pant Sci, Fargo, ND 58105 USA; [Hoque, Ahasanul] Bangladesh Agr Univ, Dept Genet & Plant Breeding, Mymensingh, Bangladesh	North Dakota State University Fargo; Bangladesh Agricultural University (BAU)	Rahman, M (corresponding author), North Dakota State Univ, Dept Pant Sci, Fargo, ND 58105 USA.	md.m.rahman@ndsu.edu	Roy, Jayanta/AGP-8871-2022; Rahman, Mukhlesur/ABB-3572-2020	Rahman, Mukhlesur/0000-0003-3355-4803; Roy, Jayanta/0000-0003-3390-958X	U.S. Department of Agriculture-National Institute of Food and Agriculture (Hatch Project) [ND01581]	U.S. Department of Agriculture-National Institute of Food and Agriculture (Hatch Project)	The study was funded by the U.S. Department of Agriculture-National Institute of Food and Agriculture (Hatch Project No. ND01581).	Ahmad R, 2014, PLANT GENET RESOUR-C, V12, P14, DOI 10.1017/S147926211300021X; Ahokas H., 2004, MTT AGRIFOOD RES FIN, P32; An H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10757-1; BECKER HC, 1992, THEOR APPL GENET, V84, P303, DOI 10.1007/BF00229487; Bernardo R, 2000, THEOR APPL GENET, V100, P552, DOI 10.1007/s001229900080; Bohn M, 1999, CROP SCI, V39, P228, DOI 10.2135/cropsci1999.0011183X003900010035x; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Bus A, 2011, THEOR APPL GENET, V123, P1413, DOI 10.1007/s00122-011-1676-7; Chen RK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227990; Chen R, 2017, BREEDING SCI, V67, P239, DOI 10.1270/jsbbs.16192; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Clarke WE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081992; Coates BS, 2009, J HERED, V100, P556, DOI 10.1093/jhered/esp028; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S; Cruz VMV, 2007, EUPHYTICA, V153, P43, DOI 10.1007/s10681-006-9233-1; Cuthbert JL, 2001, CAN J PLANT SCI, V81, P657, DOI 10.4141/P01-070; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; DIERS BW, 1994, THEOR APPL GENET, V88, P662, DOI 10.1007/BF01253968; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Erickson DB., 1990, B KANS AGR EXP STN, V656, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flad DWF, 2016, THESIS U ALBERTA ALB, DOI [10.7939/R3319S744, DOI 10.7939/R3319S744]; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gao HH, 2021, GENET RESOUR CROP EV, V68, P335, DOI 10.1007/s10722-020-00989-2; Gazave E, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00525; GEMMELL DJ, 1990, J SCI FOOD AGR, V53, P333, DOI 10.1002/jsfa.2740530306; Girke A, 2012, GENET RESOUR CROP EV, V59, P1441, DOI 10.1007/s10722-011-9772-8; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gomez-Campo C, 1999, DEV PL GEN, V4, P33; Goode EL., 2011, ENCY CANC INTERNET, P2043, DOI [10.1007/978-3-642-16483-5_3368, DOI 10.1007/978-3-642-16483-5_3368]; Gowers S, 2010, HANDB PLANT BREED, V7, P245, DOI 10.1007/978-0-387-92765-7_8; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gurung S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108179; Guryev V, 2006, PLOS GENET, V2, P1111, DOI 10.1371/journal.pgen.0020121; Gyawali S, 2013, CROP SCI, V53, P1537, DOI 10.2135/cropsci2012.10.0614; Hasan M, 2006, GENET RESOUR CROP EV, V53, P793, DOI 10.1007/s10722-004-5541-2; Hoque A, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-06922-2; Huang SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-717; Iniguez-Luy FL, 2011, PLANT GENET GENOMICS, V9, P291, DOI 10.1007/978-1-4419-7118-0_10; Iqbal MJ, 2012, THEOR APPL GENET, V125, P517, DOI 10.1007/s00122-012-1850-6; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jakobsson M, 2013, GENETICS, V193, P515, DOI 10.1534/genetics.112.144758; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kim B, 2017, EVOL BIOINFORM, V13, DOI 10.1177/1176934316688663; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li F, 2014, DNA RES, V21, P355, DOI 10.1093/dnares/dsu002; Li Li, 2011, Journal of Agricultural Science (Toronto), V3, P101; Li YL, 2018, MOL ECOL RESOUR, V18, P176, DOI 10.1111/1755-0998.12719; Liu S, 2016, THEOR APPL GENET, V129, P1203, DOI 10.1007/s00122-016-2697-z; Lu K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09134-9; Luo ZN, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00184; Malmberg MM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00508; Mandel JR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003378; Mantello CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102665; MORINAGA TOSHITARO, 1928, PROC IMP ACAD [TOKYO], V4, P620; NASS, 2020, NAT AGR STAT SERV; Pasko P, 2013, J MED FOOD, V16, P749, DOI 10.1089/jmf.2012.0250; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piazza GJ, 2001, EUR J LIPID SCI TECH, V103, P450; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian LW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1170; Qian W, 2007, THEOR APPL GENET, V115, P27, DOI 10.1007/s00122-007-0537-x; R Core Team, 2021, R LANG ENV STAT; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rahman M, 2013, CROP SCI, V53, P141, DOI 10.2135/cropsci2012.02.0095; RAKOW G, 1987, CAN J PLANT SCI, V67, P147, DOI 10.4141/cjps87-017; Raman H, 2014, PLANT BIOTECHNOL J, V12, P851, DOI 10.1111/pbi.12186; Ramasamy RK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-431; Rambaut A., 2018, FIGTREE; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Sachs MM, 2009, PLANT PHYSIOL, V149, P148, DOI 10.1104/pp.108.129205; Shete S, 2000, THEOR POPUL BIOL, V57, P265, DOI 10.1006/tpbi.2000.1452; Shiranifar B, 2020, CROP SCI, V60, P157, DOI 10.1002/csc2.20074; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; Sources LeonardC., 1994, LIPID TECH, V4, P79; Sturtevant EL., 1919, STURTEVANTS NOTES ED, P304, DOI [10.1073/pnas.5.5.168, DOI 10.1073/PNAS.5.5.168]; Sun FM, 2017, PLANT J, V92, P452, DOI 10.1111/tpj.13669; Suzuki Y, 2010, GENES GENET SYST, V85, P359, DOI 10.1266/ggs.85.359; Swanepoel N, 2015, ANIM FEED SCI TECH, V205, P10, DOI 10.1016/j.anifeedsci.2015.04.002; TAJIMA F, 1989, GENETICS, V123, P585; Torati LS, 2019, BMC GENET, V20, DOI 10.1186/s12863-018-0711-y; U. N., 1935, Japanese Journal of Botany, V7, P389; USDA, 2020, OILS WORLD MARK TRAD; vanBeuningen LT, 1997, CROP SCI, V37, P981, DOI 10.2135/cropsci1997.0011183X003700030046x; Wang N, 2014, THEOR APPL GENET, V127, P1817, DOI 10.1007/s00122-014-2343-6; Wang NA, 2011, J EXP BOT, V62, P5641, DOI 10.1093/jxb/err249; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wu J, 2014, BREEDING SCI, V64, P321, DOI 10.1270/jsbbs.64.321; Wu ZK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146383; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Xiao Y, 2010, THEOR APPL GENET, V121, P1141, DOI 10.1007/s00122-010-1378-6; Yang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151424; Yu ZX, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbaa243; Yuan M, 2004, PLANT BREEDING, V123, P9, DOI 10.1046/j.0179-9541.2003.00903.x; Zhang C, 2019, BIOINFORMATICS, V35, P1786, DOI 10.1093/bioinformatics/bty875; Zhou QH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00648	109	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0250310	10.1371/journal.pone.0250310	http://dx.doi.org/10.1371/journal.pone.0250310			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231054	Green Published, gold, Green Submitted			2022-12-26	WOS:000849744700001
J	Bolton, SJ				Bolton, Samuel J.			Proteonematalycus wagneri Kethley reveals where the opisthosoma begins in acariform mites	PLOS ONE			English	Article							PROSTIGMATA; GENUS; SOIL	It is generally thought that the anterior border of the opisthosoma of acariform mites is delineated by the disjugal furrow, but there is no evidence to support this other than the superficial appearance of tagmosis in some oribatids. It is proposed herein that the disjugal furrow is an apomorphic feature that does not correspond with any segmental borders. Although the disjugal furrow is absent from Proteonematalycus wagneri Kethley, the visible body segments of this species indicate that this furrow, when present, intersects the metapodosoma. Therefore, the disjugal furrow does not delineate the anterior border of the opisthosoma. Instead, this border is between segments D and E (segments VI and VII for all arachnids). This hypothesis can be accommodated by a new model in which the proterosoma warps upwards relative to the main body axis. This model, which is applicable to all Acariformes, if not all arachnids, explains the following phenomena: 1) the location of the gnathosomal neuromeres within the idiosoma; 2) the relatively posterior position of the paired eyes; 3) the shape of the synganglion; 4) the uneven distribution of legs in most species of acariform mites with elongate bodies.	[Bolton, Samuel J.] Florida Dept Agr & Consumer Serv, Div Plant Ind, Florida State Collect Arthropods, Gainesville, FL 32608 USA		Bolton, SJ (corresponding author), Florida Dept Agr & Consumer Serv, Div Plant Ind, Florida State Collect Arthropods, Gainesville, FL 32608 USA.	samuel.bolton77@gmail.com		Bolton, Samuel/0000-0002-5807-8519				Alberti Gerd, 1999, P515; Alzuet AB., 1984, REV SOC ENTOMOLOGICA, V43, P85; Bolton SJ, 2015, EXP APPL ACAROL, V65, P149, DOI 10.1007/s10493-014-9857-0; Bolton SJ, 2014, J NAT HIST, V48, P1359, DOI 10.1080/00222933.2013.859318; Crossley DA, 2015, P ENTOMOL SOC WASH, V117, P458, DOI 10.4289/0013-8797.117.4.458; Dogan S, 2019, SYST APPL ACAROL-UK, V24, P1162, DOI 10.11158/saa.24.7.5; Dunlop JA, 2017, ARTHROPOD STRUCT DEV, V46, P395, DOI 10.1016/j.asd.2016.05.002; Fuangarworn M, 2016, SYST APPL ACAROL-UK, V21, P255, DOI 10.11158/saa.21.2.9; Garrison NL, 2016, PEERJ, V4, DOI 10.7717/peerj.1719; GRAND JEAN F., 1934, BULL SOC ZOOL FRANCE, V59, P12; GRANDJEAN F, 1969, Acarologia (Paris), V11, P796; Hammen L. v. d., 1963, Acarologia, V5, P443; Jesionowska K, 2010, ZOOTAXA, P29; KETHLEY J, 1989, International Journal of Acarology, V15, P209; KETHLEY J, 1991, AGR ECOSYST ENVIRON, V34, P193, DOI 10.1016/0167-8809(91)90105-7; Khaustov AA, 2017, ZOOTAXA, V4303, P151, DOI 10.11646/zootaxa.4303.2.1; Klompen H, 2007, MOL PHYLOGENET EVOL, V43, P936, DOI 10.1016/j.ympev.2006.10.024; Klompen H, 2015, EXP APPL ACAROL, V67, P183, DOI 10.1007/s10493-015-9939-7; OLIVIER PAS, 1989, S AFR J ZOOL, V24, P356; Reuter E., 1909, ACTA SOC SCI FENN, V36, P1, DOI [10.5962/bhl.title.4705, DOI 10.5962/BHL.TITLE.4705]; Romashchenko AV, 2012, J INSECT PHYSIOL, V58, P903, DOI 10.1016/j.jinsphys.2012.04.004; Schmelzle Sebastian, 2010, Soil Organisms, V82, P253; Schmelzle Sebastian, 2008, Soil Organisms, V80, P233; Scholtz G., 1998, Systematics Association Special Volume Series, V55, P317; Schultz Jeffrey W., 2007, P14; Shultz JW, 2007, ZOOL J LINN SOC-LOND, V150, P221, DOI 10.1111/j.1096-3642.2007.00284.x; SNODGRASS R. E., 1948, SMITHSONIAN MISC COLL, V110, P1; Sombke A, 2019, ZOOL LETT, V5, DOI 10.1186/s40851-019-0137-z; Uusitalo M., 2010, REVISION FAMILY ALYC; van der Hammen L., 1970, Acarologia, V12, P3; Van der Hammen L., 1980, GLOSSARY ACAROLOGICA, V1; van Wijk M, 2006, EXP APPL ACAROL, V40, P205, DOI 10.1007/s10493-006-9039-9; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Walter DE, 2001, AUST J ENTOMOL, V40, P207, DOI 10.1046/j.1440-6055.2001.00226.x; Weigmann Gerd, 2001, P43; Xu X, 2015, ZOOKEYS, P121, DOI 10.3897/zookeys.488.8726; Zacharda M, 2011, J NAT HIST, V45, P641, DOI 10.1080/00222933.2010.535914	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264358	10.1371/journal.pone.0264358	http://dx.doi.org/10.1371/journal.pone.0264358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213630	Green Published, gold			2022-12-26	WOS:000787811000082
J	Yalew, GT; Muthupandian, S; Hagos, K; Negash, L; Venkatraman, G; Hagos, YM; Meles, HN; Weldehaweriat, HH; Al-Dahmoshi, HOM; Saki, M				Yalew, Gebrehiwet Tesfay; Muthupandian, Saravanan; Hagos, Kiflom; Negash, Letemichael; Venkatraman, Gopinath; Hagos, Yemane Mengsteab; Meles, Hadush Negash; Weldehaweriat, Hagos Haileslasie; Al-Dahmoshi, Hussein O. M.; Saki, Morteza			Prevalence of bacterial vaginosis and aerobic vaginitis and their associated risk factors among pregnant women from northern Ethiopia: A cross-sectional study	PLOS ONE			English	Article							ABNORMAL VAGINAL FLORA; INFECTIONS; OUTPATIENTS; SYMPTOMS	This study aimed to determine the prevalence of bacterial vaginosis (BV) and aerobic vaginitis (AV) and their associated risk factors among pregnant women from Ethiopia. Also, this study investigated the bacterial pathogens and their antibiotic resistance in AV cases. A total of 422 pregnant women from northern Ethiopia were participated in this study. Socio-demographic and clinical data were recorded. Vaginal swabs were collected and used for wet mount and Gram stain methods to evaluate the AV and BV scores according to the Nugent's and Donder's criteria, respectively. In AV cases the bacterial pathogens and their antibiotic resistance were determined using standard methods. The possible risk factors for AV and BV in pregnant women were investigated. The prevalence rates of BV and AV were 20.1% (85/422) and 8.1% (34/422), respectively. BV was more common in symptomatic vs. asymptomatic people (P < 0.001), and in second trimester vs. first trimester samples (P = 0.042). However, AV was more common in secondary school vs. primary and those who were unable to read and write (P= 0.021) and in housewife women vs. employee (P= 0.013). A total of 44 bacterial strains were isolated from AV cases, of which the coagulase-negative staphylococci (CoNS) (38.6%) and Staphylococcus aureus (29.5%) were the most predominant bacteria, respectively. The highest resistance rate was observed against penicillin (100.0%) in staphylococci, while 86.7% of them were sensitive to ciprofloxacin. The resistance rate of Enterobacteriaceae ranged from 0.0% for ciprofloxacin and chloramphenicol to 100.0% against amoxicillin/clavulanate. The prevalence of BV was higher than AV in pregnant women. This higher prevalence of BV suggests that measures should be taken to reduce the undesired consequences related to BV in the pregnancy. The circulation of drug-resistant bacteria in vaginal infections requires a global surveillance to reduce the risks to pregnant mothers and infants.	[Yalew, Gebrehiwet Tesfay; Hagos, Yemane Mengsteab; Meles, Hadush Negash; Weldehaweriat, Hagos Haileslasie] Adigrat Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Adigrat, Ethiopia; [Muthupandian, Saravanan] Saveetha Inst Med & Tech Sci SIMATS, Ctr Transdisciplinary Res, Saveetha Dent Coll, Dept Pharmacol,AMR & Nanomed Lab, Chennai, Tamil Nadu, India; [Hagos, Kiflom; Negash, Letemichael] Mekelle Univ, Coll Hlth Sci, Sch Med, Dept Microbiol & Immunol,Div Biomed Sci, Mekelle, Ethiopia; [Venkatraman, Gopinath] Univ Malaya, Univ Malaya Prote Res Ctr, Res & Innovat, Kuala Lumpur, Malaysia; [Al-Dahmoshi, Hussein O. M.] Univ Babylon, Coll Sci, Dept Biol, Hilla City, Iraq; [Saki, Morteza] Ahvaz Jundishapur Univ Med Sci, Fac Med, Dept Microbiol, Ahvaz, Iran	Saveetha Institute of Medical & Technical Science; Saveetha Dental College & Hospital; Mekelle University; Universiti Malaya; University of Babylon; Ahvaz Jundishapur University of Medical Sciences (AJUMS)	Muthupandian, S (corresponding author), Saveetha Inst Med & Tech Sci SIMATS, Ctr Transdisciplinary Res, Saveetha Dent Coll, Dept Pharmacol,AMR & Nanomed Lab, Chennai, Tamil Nadu, India.; Saki, M (corresponding author), Ahvaz Jundishapur Univ Med Sci, Fac Med, Dept Microbiol, Ahvaz, Iran.	bioinfosarn@gmail.com; mortezasaki1981@gmail.com	Saki, Morteza/R-8319-2017; Venkatraman, Dr. Gopinath/C-7001-2015	Saki, Morteza/0000-0001-7419-0116; Venkatraman, Dr. Gopinath/0000-0002-7917-8586	Mekelle University, Mekelle, Ethiopia	Mekelle University, Mekelle, Ethiopia	This research was financed by the Mekelle University, Mekelle -1871, Ethiopia.	Abdelaziz ZA, 2014, J INFECT DEV COUNTR, V8, P490, DOI 10.3855/jidc.3197; Abu ME., 2017, VAGINITIS MARRIED WO, P87; Achondou Akomoneh Elvis, 2016, Afr J Infect Dis, V10, P96, DOI 10.21010/ajid.v10i2.4; Afolabi BB, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw030; Al-Ouqaili M.T.S., 2020, OPEN MICROBIOL J, V14, P40, DOI DOI 10.2174/1874285802014010040; Al-Ouqaili MTS, 2018, ASIAN J PHARM, V12, pS1375; Al-Qaysi AK., 2020, DRUG INVENT TODAY, V14, P864; Alioua S, 2016, J CLIN DIAGN RES, V10, pCC23, DOI 10.7860/JCDR/2016/21621.8546; Gondo DCAF, 2010, REV LAT-AM ENFERM, V18, P919, DOI 10.1590/S0104-11692010000500012; Ao O.O. Awoniyi, 2015, GLOB ADV RES J MED M, V4, P57; Ayenalem S, 2010, ETHIOP J HEALTH DEV, V24, P198; Bautista CT, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0074-5; Bayigga L, 2019, AM J OBSTET GYNECOL, V220, P155, DOI 10.1016/j.ajog.2018.10.014; Bertini M, 2017, FUNDAMENTALS SEXUALL, P75; Bhujel R, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06562-1; Bilardi JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074378; Bitew A, 2017, INT J MICROBIOL, V2017, DOI 10.1155/2017/4919404; Brabin L, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0967-5; CDC, 2017, BACTERIAL VAGINOSIS; Chaponda EB, 2016, AM J TROP MED HYG, V95, P1069, DOI 10.4269/ajtmh.16-0370; Desseauve D, 2012, EUR J OBSTET GYN R B, V163, P30, DOI 10.1016/j.ejogrb.2012.04.007; Dey B. C., 2013, Scholars Journal of Applied Medical Sciences, V1, P962; Dingens AS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1073-y; Donders GGG, 2011, BJOG-INT J OBSTET GY, V118, P1163, DOI 10.1111/j.1471-0528.2011.03020.x; Donders GGG, 2005, INT CONGR SER, V1279, P118, DOI 10.1016/j.ics.2005.02.064; Donders GGG, 2017, RES MICROBIOL, V168, P845, DOI 10.1016/j.resmic.2017.04.004; Fan AP, 2013, ARCH GYNECOL OBSTET, V287, P329, DOI 10.1007/s00404-012-2571-4; Farquhar C, 2010, AIDS, V24, P153, DOI 10.1097/QAD.0b013e32832326d8; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Geng N, 2016, GYNECOL OBSTET INVES, V81, P148, DOI 10.1159/000431286; Gomaa FAM., 2017, INT J CURR MICROBIOL, V6, P906; Gupta A., 2013, INDIAN J CLIN PRACT, V23, P740, DOI 10.5958/2394-2754.2016.00021.7; Han C, 2019, EUR J CLIN MICROBIOL, V38, P233, DOI 10.1007/s10096-018-3416-2; Hassan Mahmoud F, 2020, Infect Dis Obstet Gynecol, V2020, P5842150, DOI 10.1155/2020/5842150; Hussein RA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256393; Ibrahim SM, 2014, NIGER J CLIN PRACT, V17, P154, DOI 10.4103/1119-3077.127424; Imade GE., 2015, AFR J MED MED SCI, V43, P23; Jahic Mahira, 2013, Med Arch, V67, P428, DOI 10.5455/medarh.2013.67.428-430; Juliana NCA, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.567885; Kaambo E, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00078; Kinuthia J, 2015, AIDS, V29, P2025, DOI 10.1097/QAD.0000000000000793; Kirakoya-Samadoulougou F, 2008, SEX TRANSM DIS, V35, P985, DOI 10.1097/OLQ.0b013e3181844f22; Konadu DG, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2488-z; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Krauss-Silva L, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-107; Kurewa NE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-127; Lamichhane P., 2014, INT J BIOMED ADV RES, V3809, P6; Lannon SMR, 2019, J MATERN-FETAL NEO M, V32, P2702, DOI 10.1080/14767058.2018.1446208; Machado D, 2017, PEERJ, V5, DOI 10.7717/peerj.3750; Mahon CR., 2014, TXB DIAGNOSTIC MICRO; Salinas AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74655-z; Marx G, 2010, INT J STD AIDS, V21, P549, DOI 10.1258/ijsa.2010.010005; Masand DL, 2015, J CLIN DIAGN RES, V9, pQC04, DOI 10.7860/JCDR/2015/12161.5623; Masha SC., 2017, PLOS ONE, V12, P1; Mengistie Z, 2013, J CLIN DIAGN RES, V7, P2701, DOI 10.7860/JCDR/2013/5872.3736; Mengistie Zemenu, 2014, BMC Res Notes, V7, P822, DOI 10.1186/1756-0500-7-822; Msuya Sia E, 2009, Reprod Health, V6, P4, DOI 10.1186/1742-4755-6-4; Mumtaz Shamim, 2008, J Ayub Med Coll Abbottabad, V20, P113; Nakubulwa Sarah, 2015, BMC Res Notes, V8, P573, DOI 10.1186/s13104-015-1545-6; Nelson TM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-14943-3; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Olowe OA, 2014, EUR J MICROBIOL IMMU, V4, P193, DOI 10.1556/EUJMI-D-14-00027; Pacha-Herrera D, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00303; Pal K., 2017, ASIAN PACIFIC J HEAL, V4, P15; Performance standards for antimicrobial susceptibility testing, 2018, 28 INFORMATIONAL SUP; Ray C.G., 2014, SHERRIS MED MICROBIO; Redelinghuys MJ, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00354; Redelinghuys MJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008530; Sangeetha K.T., 2015, INT, V3, P2268, DOI [10.18203/2320-6012.ijrms20150615, DOI 10.18203/2320-6012.IJRMS20150615]; Santhya KG, 2011, INT PERSPECT SEX R H, V37, P170, DOI 10.1363/3717011; Seth AR., 2017, INT J REPROD CONTRAC, V6, P4863; Shayo PA., 2012, TANZAN J HLTH RES, V14, P1, DOI [10.4314/thrb.v14i3.3, DOI 10.4314/THRB.V14I3.3]; Shimaoka M., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Sianou A, 2017, J OBSTET GYNAECOL, V37, P790, DOI 10.1080/01443615.2017.1308322; Slyker JA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-7; Son Kyung-A, 2018, Obstet Gynecol Sci, V61, P38, DOI 10.5468/ogs.2018.61.1.38; Tang Y., 2020, MEDICINE, V99, pp; Torrone EA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002511; Turner AN., 2017, AM J OBSTET GYNECOL, V215, P1; Verma I., 2017, INDIAN J OBSTET GYNE, V4, P399; Wang C, 2020, DIAGN MICR INFEC DIS, V96, DOI 10.1016/j.diagmicrobio.2019.114981; Wang ZL, 2016, TAIWAN J OBSTET GYNE, V55, P40, DOI 10.1016/j.tjog.2015.06.012; Yefet E, 2018, BJOG-INT J OBSTET GY, V125, P1069, DOI 10.1111/1471-0528.15119; Yi AW., 2019, ALTHEA MED J, V6, P186; Zarbo G., 2013, RES OBSTET GYNECOL, V2, P7	85	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0262692	10.1371/journal.pone.0262692	http://dx.doi.org/10.1371/journal.pone.0262692			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213556	Green Published, gold			2022-12-26	WOS:000787811000011
J	Yen, YF; Lai, HH; Kuo, YC; Chan, SY; Chen, LY; Chen, CC; Wang, TH; Wang, CC; Chen, M; Yen, TF; Kuo, LL; Kuo, ST; Chuang, PH				Yen, Yung-Feng; Lai, Hsin-Hao; Kuo, Yen-Chun; Chan, Shang-Yih; Chen, Lian-Yu; Chen, Chu-Chieh; Wang, Teng-Ho; Wang, Chien Chun; Chen, Marcelo; Yen, Tsen-Fang; Kuo, Li-Lan; Kuo, Shu-Ting; Chuang, Pei-Hung			Association of depression and antidepressant therapy with antiretroviral therapy adherence and health-related quality of life in men who have sex with men	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MEDICATION ADHERENCE; VIRAL LOAD; HIV; DISEASE; RELIABILITY; VALIDITY; ERA	UNAIDS' HIV treatment targets require that 90% of people living with HIV/AIDS (PLWHA) receiving antiretroviral treatment (ART) achieve viral suppression and 90% of people with viral suppression have good health-related quality of life (HRQOL). This study aimed to examine the association of depression and antidepressant therapy with ART adherence and HRQOL in HIV-infected men who have sex with men (MSM). From 2018 through 2020, HIV-infected MSMs were consecutively recruited (N= 565) for the evaluation of ART adherence and HRQOL at Taipei City Hospital HIV clinics. Non-adherence to ART was defined as a Medication Adherence Report Scale score of < 23. HRQOL in PLWHHA was evaluated using WHOQOL-BREF, Taiwan version. Overall, 14.0% had depression and 12.4% exhibited non-adherence to ART. The nonadherence proportion was 21.8% and 10.5% in depressed and nondepressed HIV-infected MSM, respectively. After adjusting for other covariates, depression was associated with a higher risk of nonadherence to ART (adjusted odds ratio = 2.02; 95% confidence interval: 1.02-4.00). Physical, psychological, social, and environmental HRQOL were significantly negatively associated with depression. Considering antidepressant therapy, ART nonadherence was significantly associated with depression without antidepressant therapy but not with antidepressant therapy. The depressed HIV-infected MSM without antidepressant therapy had worse psychological, social, environmental HRQOL than those with antidepressant therapy. Our study suggests that depression is associated with poor ART adherence and HRQOL, particularly in those without antidepressant therapy. Adequate diagnosis and treatment of depression should be provided for PLWHA to improve their ART adherence and HRQOL.	[Yen, Yung-Feng; Lai, Hsin-Hao; Chuang, Pei-Hung] Taipei City Hosp, Yangming Branch, Sect Infect Dis, Taipei, Taiwan; [Yen, Yung-Feng; Kuo, Yen-Chun] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan; [Yen, Yung-Feng; Chan, Shang-Yih; Chen, Chu-Chieh] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Yen, Yung-Feng] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Yen, Yung-Feng; Chan, Shang-Yih] Univ Taipei, Taipei, Taiwan; [Lai, Hsin-Hao] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan; [Kuo, Yen-Chun] Taipei City Hosp, Dept Psychiat, Linsen Chinese Med & Kunming Branch, Taipei, Taiwan; [Chan, Shang-Yih] Taipei City Hosp, Dept Internal Med, Yangming Branch, Taipei, Taiwan; [Chen, Lian-Yu] Taipei City Hosp, Kunming Prevent Ctr, Taipei, Taiwan; [Chen, Lian-Yu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Wang, Teng-Ho] Taipei City Hosp, Zhongxiao Branch, Sect Infect Dis, Taipei, Taiwan; [Wang, Chien Chun] Taipei City Hosp, Sect Infect Dis, Linsen Chinese Med & Kunming Branch, Taipei, Taiwan; [Chen, Marcelo] Mackay Mem Hosp, Dept Urol, Taipei, Taiwan; [Chen, Marcelo] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Yen, Tsen-Fang; Kuo, Li-Lan; Kuo, Shu-Ting] Taipei City Hosp, Dept Nursing, Linsen Chinese Med & Kunming Branch, Taipei, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); Taipei City Hospital; University of Taipei; National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; Taipei City Hospital; National Taiwan University; Taipei City Hospital; Taipei City Hospital; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Taipei City Hospital	Yen, YF (corresponding author), Taipei City Hosp, Yangming Branch, Sect Infect Dis, Taipei, Taiwan.; Yen, YF (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan.; Yen, YF (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan.; Yen, YF (corresponding author), Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan.; Yen, YF (corresponding author), Univ Taipei, Taipei, Taiwan.	dam37@tpech.gov.tw		Chen, Lian-Yu/0000-0001-9241-1613	Ministry of Science and Technology, Taiwan [MOST108-2410-H-532-001]; Department of Health, Taipei City Government, Taiwan [10801-62-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taipei City Government, Taiwan	This study was supported by two grants from the Ministry of Science and Technology, Taiwan (MOST108-2410-H-532-001) and the Department of Health, Taipei City Government, Taiwan (No. 10801-62-006). The study sponsors were not involved in the study design, the collection, analysis, or interpretation of the data, the writing of this report, or the decision to submit it for publication.	Alakkas A, 2019, J NEUROVIROL, V25, P32, DOI 10.1007/s13365-018-0682-9; Arseniou S, 2014, PSYCHIAT CLIN NEUROS, V68, P96, DOI 10.1111/pcn.12097; Chang CY, 2010, OBES SURG, V20, P1121, DOI 10.1007/s11695-008-9513-z; Chen YMA, 2007, LANCET, V369, P623, DOI 10.1016/S0140-6736(07)60291-8; Choi JY, 2013, INFECT CHEMOTHER, V45, P239, DOI 10.3947/ic.2013.45.2.239; Cooper V, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0778-6; Cottrell WN, 2013, PATIENT PREFER ADHER, V7, P141, DOI 10.2147/PPA.S40725; Do AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092842; Feuillet P, 2017, HIV MED, V18, P383, DOI 10.1111/hiv.12438; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Harris TG, 2018, AIDS, V32, P1563, DOI 10.1097/QAD.0000000000001870; Ironson G, 2005, PSYCHOSOM MED, V67, P1013, DOI 10.1097/01.psy.0000188569.58998.c8; Koppen IJN, 2018, J PEDIATR-US, V199, P132, DOI 10.1016/j.jpeds.2018.03.066; Koster ES, 2015, J ASTHMA, V52, P431, DOI 10.3109/02770903.2014.979366; Lazarus JV, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0640-4; LeMessurier J, 2018, CAN MED ASSOC J, V190, pE1350, DOI 10.1503/cmaj.180311; Leserman J, 2008, PSYCHOSOM MED, V70, P539, DOI 10.1097/PSY.0b013e3181777a5f; Monforte AD, 2005, ARCH INTERN MED, V165, P416; Nakimuli-Mpungu E, 2012, AIDS BEHAV, V16, P2101, DOI 10.1007/s10461-011-0087-8; Nanni MG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0530-4; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shumaker SA, 1997, QUAL LIFE RES, V6, P475, DOI 10.1023/A:1018499813912; So-Armah K, 2019, HIV MED, V20, P317, DOI 10.1111/hiv.12726; Taiwan Centers for Disease Control and Prevention, EPIDEMIOLOGY HIV TAI; Thompson K, 2000, SCHIZOPHR RES, V42, P241, DOI 10.1016/S0920-9964(99)00130-9; UNAIDS, 2020, FAST TRACK STRATEGY; UNAIDS, 2021, GLOBAL AIDS STRATEGY; Vedhara K, 1997, J PSYCHOSOM RES, V42, P379, DOI 10.1016/S0022-3999(96)00351-0; Watkins CC, 2012, J NEUROVIROL, V18, P277, DOI 10.1007/s13365-012-0108-z; Webster P, 2019, LANCET, V393, P2188, DOI 10.1016/S0140-6736(19)31231-0; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; World Health Organization, 2020, SURVEILLANCE HIV; Yao G, 2002, J FORMOS MED ASSOC, V101, P342; Yao G, 2007, J FORMOS MED ASSOC, V106, P592, DOI 10.1016/S0929-6646(07)60012-6	36	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264503	10.1371/journal.pone.0264503	http://dx.doi.org/10.1371/journal.pone.0264503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213633	gold, Green Published			2022-12-26	WOS:000787811000111
J	Chaussard, D; Bloch, F; Elnar, AA; Zevering, Y; Vermion, JC; Moskwa, R; Perone, JM				Chaussard, Dimitri; Bloch, Florian; Elnar, Arpine Ardzivian; Zevering, Yinka; Vermion, Jean-Charles; Moskwa, Remi; Perone, Jean-Marc			Identification of the preoperative and perioperative factors that predict postoperative endothelial cell density after Descemet membrane endothelial keratoplasty: A retrospective cohort study	PLOS ONE			English	Article							POSTERIOR LAMELLAR KERATOPLASTY; DONOR AGE; GRAFT DETACHMENT; VISUAL-ACUITY; PENETRATING KERATOPLASTY; SURGICAL INDICATION; CLINICAL-OUTCOMES; DMEK; TISSUE; DSEK	Low postoperative endothelial-cell density (ECD) plays a key role in graft failure after Descemet-membrane endothelial keratoplasty (DMEK). Identifying pre/perioperative factors that predict postoperative ECD could help improve DMEK outcomes. This retrospective study was conducted with consecutive adult patients with Fuchs-endothelial corneal dystrophy who underwent DMEK in 2015-2019 and were followed for 12 months. Patients underwent concomitant cataract surgery (triple-DMEK) or had previously undergone cataract surgery (pseudophakic-DMEK). Multivariate analyses assessed whether: patient age/sex; graft-donor age; preoperative ECD, mean keratometry, or visual acuity; triple DMEK; surgery duration; surgical difficulties; and need for rebubbling predicted 6- or 12-month ECD in the whole cohort or in subgroups with high/low ECD at 6 or 12 months. The subgroups were generated with the clinically relevant threshold of 1000 cells/mm(2). Surgeries were defined as difficult if any part was not standard. In total, 103 eyes (95 patients; average age, 71 years; 62% women) were included. Eighteen eyes involved difficult surgery (14 difficult graft preparation or unfolding cases and four others). Regardless of how the study group was defined, the only pre/perioperative variable that associated significantly with 6- and 12-month ECD was difficult surgery (p = 0.01, 0.02, 0.05, and 0.0009). Difficult surgery also associated with longer surgery duration (p = 0.002). Difficult-surgery subgroup analysis showed that difficult graft dissection associated with lower postoperative ECD (p = 0.03). This association may reflect endothelial cell loss due to excessive graft handling and/or an intrinsic unhealthiness of the endothelial cells in the graft that conferred unwanted physical properties onto the graft that complicated its preparation/unfolding.	[Chaussard, Dimitri; Bloch, Florian; Zevering, Yinka; Vermion, Jean-Charles; Moskwa, Remi; Perone, Jean-Marc] Mercy Hosp, Reg Hosp Ctr CHR Metz Thionville, Ophthalmol Dept, Metz, France; [Elnar, Arpine Ardzivian] Mercy Hosp, Reg Hosp Ctr CHR Metz Thionville Reg Hosp Ctr, Clin Res Support Unit, Metz, France; [Perone, Jean-Marc] Lorraine Univ, Inst Jean Lamour, Nancy, France	CHR Metz-Thionville; Universite de Lorraine	Perone, JM (corresponding author), Mercy Hosp, Reg Hosp Ctr CHR Metz Thionville, Ophthalmol Dept, Metz, France.; Perone, JM (corresponding author), Lorraine Univ, Inst Jean Lamour, Nancy, France.	jm.perone@chr-metz-thionville.fr		perone, jean marc/0000-0002-1427-7567; Zevering, Yinka/0000-0002-2966-0251; ELNAR, Arpine Ardzivian/0000-0002-1508-2104				[Anonymous], 1997, OPHTHALMOLOGY, V104, P1360; Armitage WJ, 2003, INVEST OPHTH VIS SCI, V44, P3326, DOI 10.1167/iovs.02-1255; Bae SS, 2020, J REFRACT SURG, V36, P661, DOI 10.3928/1081597X-20200729-02; Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; Baydoun L, 2015, JAMA OPHTHALMOL, V133, P1277, DOI 10.1001/jamaophthalmol.2015.3064; Bennett A, 2015, EYE CONTACT LENS, V41, P236, DOI 10.1097/ICL.0000000000000108; Birbal RS, 2020, AM J OPHTHALMOL, V212, P79, DOI 10.1016/j.ajo.2019.12.011; Bose S, 2013, OPHTHALMOLOGY, V120, P464, DOI 10.1016/j.ophtha.2012.08.024; Bourne WM, 2001, CORNEA, V20, P560, DOI 10.1097/00003226-200108000-00002; Brockmann T, 2019, CURR EYE RES, V44, P147, DOI 10.1080/02713683.2018.1538459; Brockmann T, 2014, ACTA OPHTHALMOL, V92, pe556, DOI 10.1111/aos.12419; Busin M, 2013, OPHTHALMOLOGY, V120, P1186, DOI 10.1016/j.ophtha.2012.11.030; Chaurasia S, 2014, OPHTHALMOLOGY, V121, P454, DOI 10.1016/j.ophtha.2013.09.032; Cheung AY, 2018, J CATARACT REFR SURG, V44, P738, DOI 10.1016/j.jcrs.2018.04.040; de Mora MRC, 2016, JAMA OPHTHALMOL, V134, P91, DOI 10.1001/jamaophthalmol.2015.4499; Duggan MJ, 2019, OPHTHALMOLOGY, V126, P946, DOI 10.1016/j.ophtha.2019.02.007; Dunker S, 2021, BRIT J OPHTHALMOL, DOI 10.1136/bjophthalmol-2020-317041; Dunker SL, 2020, OPHTHALMOLOGY, V127, P1152, DOI 10.1016/j.ophtha.2020.02.029; Feng MT, 2014, J CATARACT REFR SURG, V40, P1116, DOI 10.1016/j.jcrs.2014.04.023; Gal RL, 2008, OPHTHALMOLOGY, V115, P620, DOI 10.1016/j.ophtha.2008.01.003; Goldich Y, 2015, AM J OPHTHALMOL, V159, P155, DOI 10.1016/j.ajo.2014.10.009; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Ham L, 2016, AM J OPHTHALMOL, V171, P113, DOI 10.1016/j.ajo.2016.08.038; Ham L, 2010, CORNEA, V29, P1278, DOI 10.1097/ICO.0b013e3181cda01a; Hayashi T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68023-0; Heinzelmann S, 2016, GRAEF ARCH CLIN EXP, V254, P515, DOI 10.1007/s00417-015-3248-z; Heinzelmann S, 2014, CORNEA, V33, P644, DOI 10.1097/ICO.0000000000000106; Heinzelmann S, 2014, ACTA OPHTHALMOL, V92, pE1, DOI 10.1111/aos.12217; Hos D, 2021, OPHTHALMOLOGE, V118, P536, DOI 10.1007/s00347-021-01384-7; Inoda S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234202; Ishii N, 2016, SCI REP-UK, V6, DOI 10.1038/srep25276; Kinoshita Shigeru, 2014, Nippon Ganka Gakkai Zasshi, V118, P81; Laaser K, 2012, AM J OPHTHALMOL, V154, P47, DOI 10.1016/j.ajo.2012.01.020; Lass JH, 2008, OPHTHALMOLOGY, V115, P627, DOI [10.1016/j.ophtha.2008,01.004, 10.1016/j.ophtha.2008.01.004]; Lass JH, 2017, JAMA OPHTHALMOL, V135, P1394, DOI 10.1001/jamaophthalmol.2017.4970; Lazaridis A, 2018, CORNEA, V37, P840, DOI 10.1097/ICO.0000000000001554; Lekhanont K, 2021, CLIN OPHTHALMOL, V15, P2239, DOI 10.2147/OPTH.S310873; Leon P, 2018, AM J OPHTHALMOL, V187, P117, DOI 10.1016/j.ajo.2017.12.014; Li JY, 2012, OPHTHALMOLOGY, V119, P1126, DOI 10.1016/j.ophtha.2011.12.037; Li SQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182275; Liu MY, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/1389486; Maier AKB, 2016, CORNEA, V35, P308, DOI 10.1097/ICO.0000000000000740; Maier AKB, 2015, GRAEF ARCH CLIN EXP, V253, P895, DOI 10.1007/s00417-015-2939-9; Maier P., 2017, CURRENT T; Mannis MJ, 2013, OPHTHALMOLOGY, V120, P2419, DOI 10.1016/j.ophtha.2013.08.026; Marques RE, 2019, EUR J OPHTHALMOL, V29, P15, DOI 10.1177/1120672118757431; Matthaei M, 2015, INVEST OPHTH VIS SCI, V56, P2749, DOI 10.1167/iovs.15-16395; Mechels KB, 2017, CLIN OPHTHALMOL, V11, DOI 10.2147/OPTH.S147217; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Melles GRJ, 2006, CORNEA, V25, P879, DOI 10.1097/01.ico.0000243962.60392.4f; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Melles GRJ, 2004, CORNEA, V23, P286, DOI 10.1097/00003226-200404000-00011; Melles GRJ, 2002, CORNEA, V21, P415, DOI 10.1097/00003226-200205000-00016; Mencucci R, 2020, EYE VISION, V7, DOI 10.1186/s40662-020-00191-6; Moshiri I, 2021, CORNEA, V40, P1253, DOI 10.1097/ICO.0000000000002723; Moutsouris K, 2011, CORNEA, V30, P1369, DOI 10.1097/ICO.0b013e31820d86bd; Muller TM, 2016, OPHTHALMOLOGY, V123, P2489, DOI 10.1016/j.ophtha.2016.08.014; Musayeva A, 2020, CORNEA, V39, P1091, DOI 10.1097/ICO.0000000000002326; Oellerich S, 2020, AM J OPHTHALMOL, V211, P22, DOI 10.1016/j.ajo.2019.10.017; Oellerich S, 2017, CORNEA, V36, P1467, DOI 10.1097/ICO.0000000000001374; Pavlovic I, 2017, CORNEA, V36, P1445, DOI 10.1097/ICO.0000000000001384; Peraza-Nieves J, 2017, CORNEA, V36, P655, DOI 10.1097/ICO.0000000000001176; Perone JM, 2019, J FR OPHTALMOL, V42, P597, DOI 10.1016/j.jfo.2019.03.002; Perone JM, 2022, CORNEA, V41, P1362, DOI 10.1097/ICO.0000000000002872; Perone JM, 2019, CORNEA, V38, P1358, DOI 10.1097/ICO.0000000000002111; Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078; Price MO, 2008, OPHTHALMOLOGY, V115, P857, DOI 10.1016/j.ophtha.2007.06.033; Price MO, 2017, ANNU REV VIS SCI, V3, P69, DOI 10.1146/annurev-vision-102016-061400; Price MO, 2010, OPHTHALMOLOGY, V117, P438, DOI 10.1016/j.ophtha.2009.07.036; Rock T, 2015, GRAEF ARCH CLIN EXP, V253, P2217, DOI 10.1007/s00417-015-3103-2; Rose L, 2008, OPHTHALMOLOGY, V115, P279, DOI 10.1016/j.ophtha.2007.04.020; Sales CS, 2016, CORNEA, V35, P471, DOI 10.1097/ICO.0000000000000771; Schrittenlocher S, 2018, AM J OPHTHALMOL, V190, P171, DOI 10.1016/j.ajo.2018.03.036; Shahnazaryan D, 2020, AM J OPHTHALMOL, V218, P1, DOI 10.1016/j.ajo.2020.05.003; Siebelmann S, 2021, BRIT J OPHTHALMOL, V105, P1082, DOI 10.1136/bjophthalmol-2020-316478; Siebelmann S, 2018, AM J OPHTHALMOL, V192, P249, DOI 10.1016/j.ajo.2018.05.010; Singh A, 2017, CORNEA, V36, P1437, DOI 10.1097/ICO.0000000000001320; Sorkin N, 2018, CORNEA, V37, P678, DOI 10.1097/ICO.0000000000001564; Straiko MD, 2020, CORNEA, V39, P1267, DOI 10.1097/ICO.0000000000002398; Sugar A, 2015, JAMA OPHTHALMOL, V133, P246, DOI 10.1001/jamaophthalmol.2014.3923; Terry MA, 2005, OPHTHALMOLOGY, V112, P1541, DOI 10.1016/j.ophtha.2005.03.026; Wacker K, 2016, OPHTHALMOLOGY, V123, P154, DOI 10.1016/j.ophtha.2015.09.023; Wacker K, 2015, OPHTHALMOLOGY, V122, P1645, DOI 10.1016/j.ophtha.2015.05.005; Yang K, 2020, EXP THER MED, V20, P2794, DOI 10.3892/etm.2020.9010	84	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264401	10.1371/journal.pone.0264401	http://dx.doi.org/10.1371/journal.pone.0264401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202443	gold, Green Published			2022-12-26	WOS:000773224600040
J	Adachi-Fukunaga, S; Nakabayashi, Y; Tokuda, M				Adachi-Fukunaga, Shuhei; Nakabayashi, Yui; Tokuda, Makoto			Transgenerational changes in pod maturation phenology and seed traits of Glycine soja infested by the bean bug Riptortus pedestris	PLOS ONE			English	Article							HOST-PLANT PHENOLOGY; GREEN STEM DISORDER; EPIGENETIC INHERITANCE; TRICHOME DENSITY; HERBIVORY; HETEROPTERA; ALYDIDAE; SYNCHRONIZATION; DOMESTICATION; ATTRIBUTES	Land plants have diverse defenses against herbivores. In some cases, plant response to insect herbivory may be chronological and even transgenerational. Feeding by various stink bugs, such as the bean bug Riptortus pedestris (Hemiptera: Alydidae), induce physiological changes in soybean, called as green stem syndrome, which are characterized by delayed senescence in stems, leaves, and pods. To investigate the plant response to the bean bug feeding in the infested generation and its offspring, we studied the effects of R. pedestris infestation on Glycine soja, the ancestral wild species of soybean. Field surveys revealed that the occurrence of the autumn R. pedestris generation coincided with G. soja pod maturation in both lowland and mountainous sites. Following infestation by R. pedestris, pod maturation was significantly delayed in G. soja. When G. soja seeds obtained from infested and non-infested plants were cultivated, the progeny of infested plants exhibited much earlier pod maturation and larger-sized seed production than that of control plants, indicating that R. pedestris feeding induced transgenerational changes. Because earlier seed maturity results in asynchrony with occurrence of R. pedestris, the transgenerational changes in plant phenology are considered to be an adaptive transgenerational and chronological defense for the plant against feeding by the stink bug.	[Adachi-Fukunaga, Shuhei; Tokuda, Makoto] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima, Japan; [Nakabayashi, Yui; Tokuda, Makoto] Saga Univ, Dept Biol Resource Sci, Saga, Japan; [Adachi-Fukunaga, Shuhei] NARO, Inst Plant Protect, Koshi Res Stn, Kumamoto, Japan; [Nakabayashi, Yui] Kyoto Prefectural Univ, Dept Life & Environm Sci, Kyoto, Japan	Kagoshima University; Saga University; National Agriculture & Food Research Organization - Japan; Kyoto Prefectural University	Tokuda, M (corresponding author), Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima, Japan.; Tokuda, M (corresponding author), Saga Univ, Dept Biol Resource Sci, Saga, Japan.	tokudam@cc.saga-u.ac.jp			JSPS KAKENHI [JP17H03947, JP20K21316]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We express our thanks to Dr. N. Endo for his useful information on the green stem syndrome of soybean and to Dr. Y. Suzuki for his valuable comments for this study. We thank N. Furukawa, S. Fujita, S. Haramoto, Y. Tomozawa, A. Kita, R. Konishi, S. Kai, H. Matsuda and other members of the Laboratory of Systems Ecology for their kind support of the experiments.	Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; Agrawal AA, 2002, ECOLOGY, V83, P3408, DOI 10.1890/0012-9658(2002)083[3408:HAMEMA]2.0.CO;2; AIDE TM, 1992, BIOTROPICA, V24, P532, DOI 10.2307/2389016; Bao X., 1989, J JILIN AGR SCI, V39, P5; Boethel DJ, 2000, J ECON ENTOMOL, V93, P707, DOI 10.1603/0022-0493-93.3.707; Bogdziewicz M, 2019, ANN BOT-LONDON, V123, P707, DOI 10.1093/aob/mcy203; Brutting C, 2018, ELIFE, V7, DOI 10.7554/eLife.36268; Butt C, 2010, ENTOMOL EXP APPL, V134, P220, DOI 10.1111/j.1570-7458.2009.00963.x; Chen YH, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00125; Do Bae S, 2014, J ASIA-PAC ENTOMOL, V17, P477, DOI 10.1016/j.aspen.2014.04.006; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Harbach C, 2016, AGRON J, V108, P2263, DOI 10.2134/agronj2016.03.0155; Harbach C.J., 2016, PLANT HLTH PROG, V17, P76, DOI DOI 10.1094/PHP-RV-16-0008; Harms KE, 1997, J TROP ECOL, V13, P617, DOI 10.1017/S0266467400010750; Hill CB, 2006, CROP SCI, V46, P879, DOI 10.2135/cropsci2005.0207; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Ivashov AV, 2002, FOREST ECOL MANAG, V157, P7, DOI 10.1016/S0378-1127(00)00652-6; Jeong SC, 2019, THEOR APPL GENET, V132, P1179, DOI 10.1007/s00122-018-3271-7; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Kessler D, 2010, CURR BIOL, V20, P237, DOI 10.1016/j.cub.2009.11.071; Kidokoro T., 1978, ANN REP SOC PLANT PR, V29, P5; Kikuchi Atsushi, 2013, Proceedings of the Kansai Plant Protection Society, V55, P129; Kim S, 2010, J ASIA-PAC ENTOMOL, V13, P261, DOI 10.1016/j.aspen.2010.03.005; Konno K, 2016, ECOL MONOGR, V86, P190, DOI 10.1890/15-1420; KONO S, 1989, JPN J APPL ENTOMOL Z, V33, P128, DOI 10.1303/jjaez.33.128; Kuswantoro H, 2020, AGRIVITA, V42, P53, DOI 10.17503/agrivita.v42i1.2121; Leishman MR., 2000, SEEDS ECOLOGY REGENE, V2nd edition; Li K, 2019, CROP J, V7, P360, DOI 10.1016/j.cj.2018.07.008; Li WJ, 2021, INSECTS, V12, DOI 10.3390/insects12030255; Lu SJ, 2020, NAT GENET, V52, P428, DOI 10.1038/s41588-020-0604-7; Martemyanov VV, 2016, ECOL EVOL, V6, P7298, DOI 10.1002/ece3.2460; Martemyanov VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130988; Mizutani N., 2021, Kyushu Plant Protection Research, V67, P15; Mizutani N, 2011, JPN J APPL ENTOMOL Z, V55, P163, DOI 10.1303/jjaez.2011.163; Mlynarek JJ, 2017, FACETS, V2, P1015, DOI 10.1139/facets-2017-0041; Ouchi Y., 1982, B KAGOSHIMA AGR EXP, V10, P67; Park CG, 2016, J ASIA-PAC ENTOMOL, V19, P969, DOI 10.1016/j.aspen.2016.08.013; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Qinhua ZBXBL., 1986, SOYBEAN SCI, V4; R Core Team, 2018, R LANGUAGE ENV STAT; Rahman MM, 2018, PEST MANAG SCI, V74, P2578, DOI 10.1002/ps.5046; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Schausberger P, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01107; Scoville AG, 2011, NEW PHYTOL, V191, P251, DOI 10.1111/j.1469-8137.2011.03656.x; Sedivy EJ, 2017, NEW PHYTOL, V214, P539, DOI 10.1111/nph.14418; Tabuchi K, 2005, JPN J APPL ENTOMOL Z, V49, P99, DOI 10.1303/jjaez.2005.99; Tabuchi K, 2014, ENVIRON ENTOMOL, V43, P312, DOI 10.1603/EN13115; Tikkanen OP, 2003, OECOLOGIA, V136, P244, DOI 10.1007/s00442-003-1267-7; Turcotte MM, 2014, NEW PHYTOL, V204, P671, DOI 10.1111/nph.12935; van Asch M, 2007, ANNU REV ENTOMOL, V52, P37, DOI 10.1146/annurev.ento.52.110405.091418; Vyavhare SS, 2015, J ECON ENTOMOL, V108, P1516, DOI 10.1093/jee/tov132; Walters DR., 2011, PLANT DEFENSE WARDIN; Whitehead SR, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0034; Yukawa J, 2006, POPUL ECOL, V48, P13, DOI 10.1007/s10144-005-0233-0; Yukawa J, 2000, POPUL ECOL, V42, P105, DOI 10.1007/PL00011989	56	2	2	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263904	10.1371/journal.pone.0263904	http://dx.doi.org/10.1371/journal.pone.0263904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235584	gold, Green Published			2022-12-26	WOS:000787073100010
J	Hasick, N; Kim, RR; Xu, Y; Bone, S; Lawrence, A; Gibbs, C; Danckert, N; Todd, A				Hasick, Nicole; Kim, Ryung Rae; Xu, Yin; Bone, Simon; Lawrence, Andrea; Gibbs, Claire; Danckert, Nathan; Todd, Alison			PlexProbes enhance qPCR multiplexing by discriminating multiple targets in each fluorescent channel	PLOS ONE			English	Article							ENZYMATIC AMPLIFICATION; NEISSERIA-GONORRHOEAE; IDENTIFICATION; DIAGNOSIS; ASSAYS; PCR	The probe technology described in this paper facilitates detection and discrimination of multiple targets in a single fluorescent channel during PCR. This provides a strategy for doubling the number of targets that can be analysed simultaneously on existing PCR instruments. These probes are referred to as PlexProbes and produce fluorescence that can be switched 'on' or 'off' in the presence of target by manipulating the temperature. During PCR, fluorescence can be measured at multiple temperatures allowing discrimination of specific targets at defined temperatures. In a single fluorescent channel, a model duplex assay allowed either real-time or endpoint detection of Chlamydia trachomatis (CT) at 52 degrees C and end-point detection of Neisseria gonorrhoeae (GC) at 74 degrees C. Using this model system, as few as 40 copies of each specific target could be detected as single infection or co-infection, regardless of the presence or absence of the other target. A PlexProbe prototype assay for sexually transmitted infections (PP-STI) which simultaneously enables detection and differentiation of six targets using only three fluorescent channels was then constructed and evaluated. The PP-STI assay detects GC (2 gene targets), CT, Mycoplasma genitalium (MG), Trichomonas vaginalis (TV) and an internal control (IC). To evaluate assay performance, a panel of archived clinical samples (n = 337) were analysed using PP-STI and results compared to those obtained with a commercially available diagnostic assay. The overall agreement between results obtained with the PP-STI assay and the reference test was greater than 99.5%. PlexProbes offer a method of detecting more targets from a single diagnostic test, empowering physicians to make evidence-based treatment decisions while conserving time, labour, sample volume and reagent costs.	[Hasick, Nicole; Kim, Ryung Rae; Xu, Yin; Bone, Simon; Lawrence, Andrea; Gibbs, Claire; Danckert, Nathan; Todd, Alison] SpeeDx Pty Ltd, Eveleigh, NSW, Australia; [Danckert, Nathan] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney Inst Agr, Sydney, NSW, Australia	University of Sydney	Hasick, N (corresponding author), SpeeDx Pty Ltd, Eveleigh, NSW, Australia.	nicoleh@speedx.com.au		Danckert, Nathan/0000-0001-5416-7971; Kim, Ryung Rae/0000-0003-3810-9514	SpeeDx Pty Ltd	SpeeDx Pty Ltd	Funding: SpeeDx Pty Ltd. (https://plexpcr.com/) provided support in the form of salaries for the authors NH, RK, YX, SB, AL, CG and AT and research materials for the authors NH, RK, YX, SB, AL, CG, ND and AT. Each of these authors played a role in study design, data collection and analysis, decision to publish and preparation of the	Ball LM, 2013, J BACTERIOL, V195, P2982, DOI 10.1128/JB.00171-13; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Chakravorty S, 2010, J CLIN MICROBIOL, V48, P258, DOI 10.1128/JCM.01725-09; Choe HS, 2013, INT J INFECT DIS, V17, pE1134, DOI 10.1016/j.ijid.2013.07.011; Chow EPF, 2015, MED J AUSTRALIA, V202, P321, DOI 10.5694/mja14.00780; Chun J-Y, 2013, MED LAB OBS, V45, P30; El-Hajj HH, 2009, J CLIN MICROBIOL, V47, P1190, DOI 10.1128/JCM.02043-08; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Farrar J., 2017, MOL DIAGNOSTICS, P79; Field N, 2015, SEX TRANSM INFECT, V91, P338, DOI 10.1136/sextrans-2014-051850; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019206; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016033; Jiang YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06348-z; Lee YJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07439; Liao YQ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt004; Marras SAE, 2006, CLIN CHIM ACTA, V363, P48, DOI 10.1016/j.cccn.2005.04.037; Mokany E, 2013, CLIN CHEM, V59, P419, DOI 10.1373/clinchem.2012.192930; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Palmer HM, 2003, J CLIN MICROBIOL, V41, P835, DOI 10.1128/JCM.41.2.835-837.2003; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Tan LY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170087; Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008; Wi TEC, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25343; World Health Organization, 2019, SEXUALLY TRANSMITTED; Zeng L., 2018, BIOSENSING TECHNOLOG, P6, DOI [10.5772/intechopen.73178, DOI 10.5772/INTECHOPEN.73178]	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263329	10.1371/journal.pone.0263329	http://dx.doi.org/10.1371/journal.pone.0263329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263349	gold, Green Published			2022-12-26	WOS:000804638700037
J	Tzou, PL; Tao, KM; Pond, SLK; Shafer, RW				Tzou, Philip L.; Tao, Kaiming; Pond, Sergei L. Kosakovsky; Shafer, Robert W.			Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; MUTATIONS; SPIKE	As novel SARS-CoV-2 variants with different patterns of spike protein mutations have emerged, the susceptibility of these variants to neutralization by antibodies has been rapidly assessed. However, neutralization data are generated using different approaches and are scattered across different publications making it difficult for these data to be located and synthesized. The Stanford Coronavirus Resistance Database (CoV-RDB; ;https://covdb.stanford.edu) is designed to house comprehensively curated published data on the neutralizing susceptibility of SARS-CoV-2 variants and spike mutations to monoclonal antibodies (mAbs), convalescent plasma (CP), and vaccinee plasma (VP). As of December 31, 2021, CoV-RDB encompassed 257 publications including 91 (35%) containing 9,070 neutralizing mAb susceptibility results, 131 (51%) containing 16,773 neutralizing CP susceptibility results, and 178 (69%) containing 33,540 neutralizing VP results. The database also records which spike mutations are selected during in vitro passage of SARS-CoV-2 in the presence of mAbs and which emerge in persons receiving mAbs as treatment. The CoV-RDB interface interactively displays neutralizing susceptibility data at different levels of granularity by filtering and/or aggregating query results according to one or more experimental conditions. The CoV-RDB website provides a companion sequence analysis program that outputs information about mutations present in a submitted sequence and that also assists users in determining the appropriate mutation-detection thresholds for identifying non-consensus amino acids. The most recent data underlying the CoV-RDB can be downloaded in its entirety from a GitHub repository in a documented machine-readable format.	[Tzou, Philip L.; Tao, Kaiming; Shafer, Robert W.] Stanford Univ, Div Infect Dis, Sch Med, Stanford, CA 94305 USA; [Pond, Sergei L. Kosakovsky] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Shafer, RW (corresponding author), Stanford Univ, Div Infect Dis, Sch Med, Stanford, CA 94305 USA.	rshafer@stanford.edu			NIH - National Institutes of Allergy and Infectious Diseases (NIAID) [AI136618]	NIH - National Institutes of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was obtained from the NIH - National Institutes of Allergy and Infectious Diseases (NIAID) - grant # AI136618. PLT, KT, and RWS were funded in part by this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe KT, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142362; Antibody Society, COVID 19 BIOL TRACK; Bruxvoort KJ, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-068848; Chen XH, 2022, CLIN INFECT DIS, V74, P734, DOI 10.1093/cid/ciab646; Clemens SAC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25982-w; COVID-19 Treatment Guidelines Panel, COR DIS 2019 COVID 1; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Earle KA, 2021, VACCINE, V39, P4423, DOI 10.1016/j.vaccine.2021.05.063; Feng S, 2021, NAT MED, V27, P2032, DOI 10.1038/s41591-021-01540-1; Greaney AJ., 2021, SARS COV 2 VARIANT E, DOI [10.1101/2021.10.12.464114, DOI 10.1101/2021.10.12.464114, 10.12.464114]; Greaney AJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24435-8; Greaney AJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abi9915; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kristiansen PA, 2021, LANCET, V397, P1347, DOI 10.1016/S0140-6736(21)00527-4; Kung Y-A., 2021, ANTIBODY TITERS MEAS, p2021.07.16.21260618, DOI [10.1101/2021.07.16.21260618, DOI 10.1101/2021.07.16.21260618]; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Nie JH, 2020, NAT PROTOC, V15, DOI 10.1038/s41596-020-0394-5; Peluso MJ, 2021, SCI ADV, V7, DOI [10.1101/2021.03.03.21251639, 10.1126/sciadv.abh3409]; Pouwels KB, 2021, NAT MED, V27, P2127, DOI 10.1038/s41591-021-01548-7; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Savage HR, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009551; Schmidt F, 2020, J EXP MED, V217, DOI 10.1084/jem.20201181; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Sholukh AM, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00527-21; Starr TN, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100255; Starr Tyler N, 2021, Science, V371, P850, DOI [10.1101/2020.11.30.405472, 10.1126/science.abf9302]; Starr Tyler N, 2020, Cell, V182, P1295, DOI [10.1101/2020.06.17.157982, 10.1016/j.cell.2020.08.012]; Tan CW, 2020, NAT BIOTECHNOL, V38, P1073, DOI 10.1038/s41587-020-0631-z; Tao KM, 2021, NAT REV GENET, V22, P757, DOI 10.1038/s41576-021-00408-x; Tzou PL, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12091006; Tzou PL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225352; Vanderheiden Abigail, 2020, Curr Protoc Immunol, V131, pe116, DOI 10.1002/cpim.116; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Xie XP, 2021, NAT PROTOC, V16, P1761, DOI 10.1038/s41596-021-00491-8	43	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0261045	10.1371/journal.pone.0261045	http://dx.doi.org/10.1371/journal.pone.0261045			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263335	Green Submitted, Green Published, gold			2022-12-26	WOS:000804638700021
J	Ristinmaa, AS; Coleman, T; Cesar, L; Weinmann, AL; Mazurkewich, S; Branden, G; Hasani, M; Larsbrink, J				Ristinmaa, Amanda Sorensen; Coleman, Tom; Cesar, Leona; Weinmann, Annika Langborg; Mazurkewich, Scott; Branden, Gisela; Hasani, Merima; Larsbrink, Johan			Structural diversity and substrate preferences of three tannase enzymes encoded by the anaerobic bacterium Clostridium butyricum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENOLIC-COMPOUNDS; CRYSTAL-STRUCTURE; HYDROLASE; LEAVES; BARK	Tannins are secondary metabolites that are enriched in the bark, roots, and knots in trees and are known to hinder microbial attack. The biological degradation of water-soluble gallotannins, such as tannic acid, is initiated by tannase enzymes (EC 3.1.1.20), which are esterases able to liberate gallic acid from aromatic-sugar complexes. However, only few tannases have previously been studied in detail. Here, for the first time, we biochemically and structurally characterize three tannases from a single organism, the anaerobic bacterium Clostridium butyricum, which inhabits both soil and gut environments. The enzymes were named CbTan1-3, and we show that each one exhibits a unique substrate preference on a range of galloyl ester model substrates; CbTan1 and 3 demonstrated preference toward galloyl esters linked to glucose, while CbTan2 was more promiscuous. All enzymes were also active on oak bark extractives. Furthermore, we solved the crystal structure of CbTan2 and produced homology models for CbTan1 and 3. In each structure, the catalytic triad and gallatebinding regions in the core domain were found in very similar positions in the active site compared with other bacterial tannases, suggesting a similar mechanism of action among these enzymes, though large inserts in each enzyme showcase overall structural diversity. In conclusion, the varied structural features and substrate specificities of the C. butyricum tannases indicate that they have different biological roles and could further be used in development of new valorization strategies for renewable plant biomass.	[Ristinmaa, Amanda Sorensen; Coleman, Tom; Cesar, Leona; Mazurkewich, Scott; Larsbrink, Johan] Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Gothenburg, Sweden; [Weinmann, Annika Langborg] AstraZeneca, Pharmaceut Sci, Early Chem Dev, Gothenburg, Sweden; [Mazurkewich, Scott; Hasani, Merima; Larsbrink, Johan] Chalmers Univ Technol, Wallenberg Wood Sci Ctr, Gothenburg, Sweden; [Cesar, Leona; Branden, Gisela] Univ Gothenburg, Dept Chem & Mol Biol, Medicinaregatan 9c, S-41390 Gothenburg, Sweden; [Hasani, Merima] Chalmers Univ Technol, Dept Chem & Chem Engn, Div Forest Prod & Chem Engn, Gothenburg, Sweden	Chalmers University of Technology; AstraZeneca; Chalmers University of Technology; University of Gothenburg; Chalmers University of Technology	Larsbrink, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Gothenburg, Sweden.; Larsbrink, J (corresponding author), Chalmers Univ Technol, Wallenberg Wood Sci Ctr, Gothenburg, Sweden.	johan.larsbrink@chalmers.se	Larsbrink, Johan/A-3053-2013	Larsbrink, Johan/0000-0001-8386-2914; Cesar, Leona Carla/0000-0002-4480-2000; Sorensen Ristinmaa, Amanda/0000-0003-0120-0330; Coleman, Tom/0000-0002-1890-5831	Swedish Energy Agency [2018-004339]; Swedish Research Council [2018-004339]; Carl Trygger Foundation [CTS 19:195]; Knut and Alice Wallenberg Foundation via the Wallenberg Wood Science Center (WWSC)	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; Knut and Alice Wallenberg Foundation via the Wallenberg Wood Science Center (WWSC)	A. S. R. was funded by a research project grant for energy-oriented basic research from the Swedish Energy Agency and the Swedish Research Council awarded to J. L. (Dnr 2018-004339). T. C. was funded by a postdoctoral stipend grant from the Carl Trygger Foundation (number CTS 19:195) awarded to J. L. S. M., M. H., and J. L. would like to thank the Knut and Alice Wallenberg Foundation for support via the Wallenberg Wood Science Center (WWSC).	Abdal A. K, 2020, EURASIA J BIOSCI, V14, P259; Curiel JA, 2009, J AGR FOOD CHEM, V57, P6224, DOI 10.1021/jf901045s; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Baath JA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1213-x; BIANCO MA, 1994, J APPL TOXICOL, V14, P293, DOI 10.1002/jat.2550140409; Boer E, 2009, YEAST, V26, P323, DOI 10.1002/yea.1669; Cassir N, 2016, CLIN MICROBIOL INFEC, V22, P37, DOI 10.1016/j.cmi.2015.10.014; Chernonosov AA, 2017, REV BRAS FARMACOGN, V27, P576, DOI 10.1016/j.bjp.2017.07.001; Colby SM, 2020, ANAL CHEM, V92, P1720, DOI 10.1021/acs.analchem.9b02348; de las Rivas B, 2019, APPL MICROBIOL BIOT, V103, P603, DOI 10.1007/s00253-018-9519-y; Dilokpimol A, 2018, NEW BIOTECHNOL, V41, P9, DOI 10.1016/j.nbt.2017.11.004; Dong LB, 2021, ACTA CRYSTALLOGR D, V77, P267, DOI 10.1107/S2059798320016484; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esteban-Torres M, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.01558-18, 10.1128/AEM01558-18, 10.1128/aem.01558-18]; Feng SH, 2013, RENEW SUST ENERG REV, V26, P560, DOI 10.1016/j.rser.2013.06.024; Fernandes A, 2011, FOOD CHEM, V125, P1398, DOI 10.1016/j.foodchem.2010.10.016; Garcia-Villalba R, 2017, J FOOD COMPOS ANAL, V63, P38, DOI 10.1016/j.jfca.2017.07.034; Gellerstedt G, 2009, WOOD CHEM WOOD BIOTE, V1, P147; HAGERMAN AE, 1978, J AGR FOOD CHEM, V26, P809, DOI 10.1021/jf60218a027; HATHWAY DE, 1958, BIOCHEM J, V70, P34, DOI 10.1042/bj0700034; Jimenez N, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0154-8; Jimenez N, 2014, FOOD RES INT, V62, P397, DOI 10.1016/j.foodres.2014.03.042; Jimenez N, 2014, APPL MICROBIOL BIOT, V98, P6329, DOI 10.1007/s00253-014-5603-0; Jimenez N, 2014, APPL ENVIRON MICROB, V80, P2991, DOI 10.1128/AEM.00324-14; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanpiengjai A, 2019, PROTEIN EXPRES PURIF, V157, P36, DOI 10.1016/j.pep.2019.01.005; Kmezik C, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100500; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; M. Mirdita, 2021, bioRxiv, DOI 10.1101/2021.08.15.456425; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mazurkewich S, 2019, J BIOL CHEM, V294, P19978, DOI 10.1074/jbc.RA119.011435; Mancheno JM, 2022, MICROB BIOTECHNOL, V15, P648, DOI 10.1111/1751-7915.13732; Mirdita M, 2019, BIOINFORMATICS, V35, P2856, DOI 10.1093/bioinformatics/bty1057; Mirdita M, 2017, NUCLEIC ACIDS RES, V45, pD170, DOI 10.1093/nar/gkw1081; Mitchell A. L., 2020, MGNIFY MICROBIOME AN; Munoz J, 2020, MICROB BIOTECHNOL, V13, P1733, DOI 10.1111/1751-7915.13577; Niehaus JU, 1997, PHYTOCHEMISTRY, V45, P1555, DOI 10.1016/S0031-9422(97)00261-6; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pan J, 2020, MAR DRUGS, V18, DOI 10.3390/md18110546; Poolsawat L, 2020, AQUACULT NUTR, V26, P657, DOI 10.1111/anu.13025; Ren B, 2013, J MOL BIOL, V425, P2737, DOI 10.1016/j.jmb.2013.04.032; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P4293, DOI 10.1021/bi00773a016; Selvakumar G., 2007, Indian Journal of Microbiology, V47, P267, DOI 10.1007/s12088-007-0049-z; Shao Y, 2020, MOLECULES, V25, DOI 10.3390/molecules25040952; Sharma S, 2000, ANAL BIOCHEM, V279, P85, DOI 10.1006/abio.1999.4405; Song XC, 2021, J AGR FOOD CHEM, V69, P10856, DOI 10.1021/acs.jafc.1c02845; Tomas-Cortazar J., 2018, MICROB; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Ueda S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-87; Venter P, 2019, ANAL CHIM ACTA, V1088, P150, DOI 10.1016/j.aca.2019.08.037; Watrelot AA, 2020, J AGR FOOD CHEM, V68, P13426, DOI 10.1021/acs.jafc.9b08221; Wu MB, 2015, APPL MICROBIOL BIOT, V99, P2663, DOI 10.1007/s00253-014-6085-9; Yao J, 2011, J AGR FOOD CHEM, V59, P3812, DOI 10.1021/jf104394m	55	0	0	11	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101758	10.1016/j.jbc.2022.101758	http://dx.doi.org/10.1016/j.jbc.2022.101758			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35202648	gold, Green Published			2022-12-26	WOS:000793617400013
J	Garcia, N; Grenier, E; Buisson, A; Folcher, L				Garcia, Nathan; Grenier, Eric; Buisson, Alain; Folcher, Laurent			Diversity of plant parasitic nematodes characterized from fields of the French national monitoring programme for the Columbia root-knot nematode	PLOS ONE			English	Article							HEAVY-METALS; MELOIDOGYNE-CHITWOODI; VERTICAL-DISTRIBUTION; COMMUNITY STRUCTURE; CROP-ROTATION; SOIL; IMPACT; TILLAGE; GROWTH; POPULATIONS	Plant parasitic nematodes are highly abundant in all agrosystems and some species can have a major impact on crop yields. To avoid the use of chemical agents and to find alternative methods to manage these pests, research studies have mainly focused on plant resistance genes and biocontrol methods involving host plants or natural enemies. A specific alternative method may consist in supporting non-damaging indigenous species that could compete with damaging introduced species to decrease and keep their abundance at low level. For this purpose, knowledge about the biodiversity, structure and functioning of these indigenous communities is needed in order to carry out better risk assessments and to develop possible future management strategies. Here, we investigated 35 root crop fields in eight regions over two consecutive years. The aims were to describe plant parasitic nematode diversity and to assess the potential effects of cultivation practices and environmental variables on communities. Community biodiversity included 10 taxa of plant parasitic nematodes. Despite no significant abundance variations between the two sampling years, structures of communities varied among the different regions. Metadata collected for the past six years, characterizing the cultural practices and soils properties, made it possible to evaluate the impact of these variables both on the whole community and on each taxon separately. Our results suggest that, at a large scale, many variables drive the structuration of the communities. Soil variables, but also rainfall, explain the population density variations among the geographical areas. The effect of the variables differed among the taxa, but fields with few herbicide applications and being pH neutral with low heavy metal and nitrogen concentrations had the highest plant parasitic nematode densities. We discuss how these variables can affect nematode communities either directly or indirectly. These types of studies can help to better understand the variables driving the nematode communities structuration in order to support the abundance of indigenous non-damaging communities that could compete with the invasive species.	[Garcia, Nathan; Buisson, Alain; Folcher, Laurent] French Agcy Food Environm & Occupat Hlth & Safety, Nematol Unit, Plant Hlth Lab, Le Rheu, Ille & Vilaine, France; [Garcia, Nathan; Grenier, Eric] French Natl Inst Agr Res & Environm, Inst Genet Environm & Plant Protect, Le Rheu, Ille & Vilaine, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Garcia, N (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Nematol Unit, Plant Hlth Lab, Le Rheu, Ille & Vilaine, France.; Garcia, N (corresponding author), French Natl Inst Agr Res & Environm, Inst Genet Environm & Plant Protect, Le Rheu, Ille & Vilaine, France.	nathan.garcia@anses.fr	Grenier, Eric/AAR-8124-2020	Grenier, Eric/0000-0002-2260-1101	Brittany Regional Council; French Agency for Food, Environmental and Occupational Health Safety (ANSES)	Brittany Regional Council(Region Bretagne); French Agency for Food, Environmental and Occupational Health Safety (ANSES)	This study is part of a PhD project, funded by the Brittany Regional Council - https://www.bretagne.bzh/-and the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) -https://www.anses.fr/en - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P. K., 2012, STAT MODELS BASED CO; Anonymous, 2013, Bulletin OEPP, V43, P471, DOI 10.1111/epp.12077; [Anonymous], TERRE NET; Barton K., 2013, PACKAGE MUMIN VERSIO, V1, P18; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bongers T., 1994, IDENTIFICATION KEY N, V46; Bridge J., 2007, PLANT NEMATODES AGR; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chu KW, 2002, AQUAT TOXICOL, V61, P53, DOI 10.1016/S0166-445X(02)00017-6; Cibois P., 1997, HIST MESURE, P299; Cibois P., 1986, HIST MESURE, V1, P239, DOI [10.3406/hism.1986.1540, DOI 10.3406/HISM.1986.1540]; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Diez A, 2003, J NEMATOL, V35, P422; Duplay J, 2014, GEODERMA, V230, P318, DOI 10.1016/j.geoderma.2014.04.022; Ekschmitt K, 2006, J NEMATOL, V38, P13; FRECKMAN DW, 1993, AGR ECOSYST ENVIRON, V45, P239, DOI 10.1016/0167-8809(93)90074-Y; Garcia N, 2018, PLANT PATHOL, V67, P2019, DOI 10.1111/ppa.12914; Garcia N, 2018, NEMATOLOGY, V20, P211, DOI 10.1163/15685411-00003136; Gelman A., 2021, ARM DATA ANAL USING; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Georgieva SS, 2002, APPL SOIL ECOL, V20, P27, DOI 10.1016/S0929-1393(02)00005-7; Geosol, US; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Jensen KB, 1997, J NEMATOL, V29, P104; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kumar U, 2017, ECOTOX ENVIRON SAFE, V135, P225, DOI 10.1016/j.ecoenv.2016.10.003; Landesman WJ, 2011, PEDOBIOLOGIA, V54, P87, DOI 10.1016/j.pedobi.2010.10.002; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY, V3rd ed.; Mateille T, 2014, EUR J SOIL BIOL, V64, P53, DOI 10.1016/j.ejsobi.2014.08.002; MCSORLEY R, 1993, J NEMATOL, V25, P814; MCSORLEY R, 1990, PLANT SOIL, V123, P95, DOI 10.1007/BF00009931; McSorley R, 1997, APPL SOIL ECOL, V6, P147, DOI 10.1016/S0929-1393(97)00001-2; Neher DA, 1999, J NEMATOL, V31, P142; Nielsen UN, 2014, GLOBAL ECOL BIOGEOGR, V23, P968, DOI 10.1111/geb.12177; NORTON DC, 1989, J NEMATOL, V21, P299; Oka Y, 2000, PEST MANAG SCI, V56, P983, DOI 10.1002/1526-4998(200011)56:11<983::AID-PS233>3.0.CO;2-X; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Ou W, 2005, PEDOBIOLOGIA, V49, P139, DOI 10.1016/j.pedobi.2004.10.001; Palomares-Rius JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116890; Pankaj, 2006, Nematologia Mediterranea, V34, P175; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; PROT JC, 1981, J NEMATOL, V13, P213; Quist CW, 2016, APPL SOIL ECOL, V98, P254, DOI 10.1016/j.apsoil.2015.10.022; R, R PROJECT STAT COMPU; Rahman L, 2007, SOIL TILL RES, V95, P110, DOI 10.1016/j.still.2006.11.008; Rao R, 1995, QUESTIIO, V17, P23; Rout GR, 2003, AGRONOMIE, V23, P3, DOI 10.1051/agro:2002073; Salminen J, 1996, ECOTOX ENVIRON SAFE, V34, P184, DOI 10.1006/eesa.1996.0062; Sanchez-Moreno S, 2007, AGR ECOSYST ENVIRON, V119, P75, DOI 10.1016/j.agee.2006.06.012; Saxton KE, 2006, SOIL SCI SOC AM J, V70, P1569, DOI 10.2136/sssaj2005.0117; Schomaker CH, 1999, PHYTOPATHOLOGY, V89, P583, DOI 10.1094/PHYTO.1999.89.7.583; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Stirling G. R., 2014, Biological control of plant-parasitic nematodes: soil ecosystem management in sustainable agriculture, DOI 10.1079/9781780644158.0000; Sturz AV, 1999, PLANT PATHOL, V48, P26, DOI 10.1046/j.1365-3059.1999.00305.x; UMESH KC, 1994, J NEMATOL, V26, P286; van der Beek JG, 1998, PHYTOPATHOLOGY, V88, P658, DOI 10.1094/PHYTO.1998.88.7.658; Villenave C, 1998, NEMATROPICA, V28, P31; Villenave C., 2013, OPEN J SOIL SCI, V03, P30, DOI [10.4236/ojss.2013.31005, DOI 10.4236/OJSS.2013.31005]; Wei CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043384; WHITEHEA.AG, 1970, ANN APPL BIOL, V65, P339, DOI 10.1111/j.1744-7348.1970.tb05502.x; Winfield A.L, 1975, NATO Adv Stud Inst Ser (Life Sci), V2, P309; Wishart J, 2004, NEMATOLOGY, V6, P507, DOI 10.1163/1568541042665269; Yu ZY, 2013, ECOTOX ENVIRON SAFE, V88, P178, DOI 10.1016/j.ecoenv.2012.11.012; Zhang ZY, 2015, EUR J SOIL BIOL, V66, P40, DOI 10.1016/j.ejsobi.2014.11.006; Zhao J, 2013, APPL SOIL ECOL, V64, P135, DOI 10.1016/j.apsoil.2012.11.008	70	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0265070	10.1371/journal.pone.0265070	http://dx.doi.org/10.1371/journal.pone.0265070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259205	Green Published, gold			2022-12-26	WOS:000835141200042
J	Harawa, NT; Schrode, KM; Daniels, J; Javanbakht, M; Hotton, A; Makgoeng, S; Ragsdale, A; Schneider, J; Fujimoto, K; Bolan, R; Gorbach, P				Harawa, Nina T.; Schrode, Katrina M.; Daniels, Joseph; Javanbakht, Marjan; Hotton, Anna; Makgoeng, Solomon; Ragsdale, Amy; Schneider, John; Fujimoto, Kayo; Bolan, Robert; Gorbach, Pamina			Factors predicting incarceration history and incidence among Black and Latino men who have sex with men (MSM) residing in a major urban center	PLOS ONE			English	Article							POPULATION-BASED SAMPLE; UNITED-STATES; METHAMPHETAMINE USE; FUNDAMENTAL CAUSES; TRANSGENDER WOMEN; SOCIAL CONDITIONS; HEALTH; HIV; ASSOCIATIONS; ORIENTATION	We analyzed data from a cohort of Black and Latino men who have sex with men (MSM) in order to identify correlates of prevalent and incident incarceration, including potential predictors related to their status as sexual and gender minorities (SGMs). Baseline and follow-up self-administered survey data were examined from Los Angeles County participants' ages 18-45 years at enrollment who were either HIV negative or living with HIV, but recruited to over represent men who used drugs and men with unsuppressed HIV infection. Multivariable logistic regression models were developed to identify predictors of baseline incarceration history and of incident incarceration over study follow-up among 440 and 338 participants, respectively. Older age, Black race, low socioeconomic status, homelessness, stimulant use, and depression symptoms were associated with baseline incarceration history. The only SGM-related factor associated with baseline incarceration history was having experienced violence based on sexual orientation identity. Just one statistically significant, independent positive predictor of incident incarceration was identified: prior incarceration, whereas having four or more friends that could lend money was a statistically significant protective factor against incident incarceration. Fundamental Cause Theory provides a useful framework to explain identified predictors of incarceration. Addressing poverty, housing instability, inadequate access to health care, and their root causes is critical to reducing incarceration rates in this population, as is expanded access to both diversion and anti-recidivism programs and to evidence-based treatment for stimulant use disorders.	[Harawa, Nina T.; Gorbach, Pamina] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Harawa, Nina T.; Javanbakht, Marjan; Makgoeng, Solomon; Ragsdale, Amy; Gorbach, Pamina] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; [Harawa, Nina T.; Schrode, Katrina M.; Daniels, Joseph] Charles R Drew Univ Med & Sci, Dept Psychiat & Human Behav, Coll Med, 1621 E 120th St, Los Angeles, CA 90059 USA; [Hotton, Anna; Schneider, John] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Schneider, John] Chicago Ctr HIV Eliminat, Chicago, IL USA; [Fujimoto, Kayo] Univ Texas Hlth Sci Ctr Houston, Div Hlth Promot & Behav Sci, Houston, TX 77030 USA; [Bolan, Robert] Los Angeles LGBT Ctr, Dept Hlth Serv, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Charles R. Drew University of Medicine & Science; University of Chicago; University of Texas System; University of Texas Health Science Center Houston	Harawa, NT (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.; Harawa, NT (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA.; Harawa, NT (corresponding author), Charles R Drew Univ Med & Sci, Dept Psychiat & Human Behav, Coll Med, 1621 E 120th St, Los Angeles, CA 90059 USA.	nharawa@mednet.ucla.edu			National Institute on Drug Abuse or NIDA	National Institute on Drug Abuse or NIDA	mSTUDY is funded by the National Institute on Drug Abuse or NIDA (https://urldefense.com/v3/_https://www.drugabuse.gov/_;!!F9wkZZsI-LA!S9lD-	African Commission on Human and Peoples' Rights Inter-American Commission on Human Rights United Nations University of Pretoria. Faculty of Law, 2016, END VIOL HUM RIGHTS, Vi, P85; Alson JG, 2021, HEALTH EQUITY, V5, P49, DOI 10.1089/heq.2020.0081; Anderson-Carpenter KD, 2019, SUBST USE MISUSE, V54, P1763, DOI 10.1080/10826084.2019.1610445; Anderson-Carpenter KD, 2017, J DRUG ISSUES, V47, P383, DOI 10.1177/0022042617696917; [Anonymous], 2016, CALIFORNIA LEGISLATI; [Anonymous], 2020, GREATER LOS ANGELES; Armstrong NM, 2019, AGING MENT HEALTH, V23, P507, DOI 10.1080/13607863.2017.1423037; Bacak V, 2018, AM J PUBLIC HEALTH, V108, P994, DOI 10.2105/AJPH.2018.304500; Bailey ZD, 2021, NEW ENGL J MED, V384, P768, DOI 10.1056/NEJMms2025396; Beck A.J., 2014, SEXUAL VICTIMIZATION; BISHOP ELIZABETH TSAI, 2020, RACIAL DISPARITIES M; Bowleg L, 2020, AM J PUBLIC HEALTH, V110, pS160, DOI 10.2105/AJPH.2019.305460; Boxer P, 2009, CRIM JUSTICE BEHAV, V36, P793, DOI 10.1177/0093854809336453; Brewer R, 2022, J RACIAL ETHN HEALTH, V9, P1357, DOI 10.1007/s40615-021-01076-7; Brewer RA, 2014, AM J PUBLIC HEALTH, V104, P448, DOI 10.2105/AJPH.2013.301786; Brewer RA, 2014, JAIDS-J ACQ IMM DEF, V65, P218, DOI 10.1097/01.qai.0000434953.65620.3d; California Department of Education, 2021, 2018 19 5 YEAR COH G; California Legislative Information, 1996, COMP US ACT 1996; Chang VW, 2009, J HEALTH SOC BEHAV, V50, P245, DOI 10.1177/002214650905000301; Emerson AM, 2018, PUBLIC HEALTH NURS, V35, P273, DOI 10.1111/phn.12514; Gjersing L, 2021, INT J DRUG POLICY, V95, DOI 10.1016/j.drugpo.2021.103288; Gorbach PM, 2019, SEX TRANSM DIS, V46, P105, DOI 10.1097/OLQ.0000000000000919; Harawa NT, 2018, AM J PUBLIC HEALTH, V108, pE1, DOI [10.2105/AJPH.2018.304698, 10.2105/ajph.2018.304698]; Harawa NT, 2017, INT J DRUG POLICY, V48, P63, DOI 10.1016/j.drugpo.2017.05.013; Holzer Harry J., 2007, IZA DISCUSSION PAPER; Hotton A, 2019, AIDS CARE, V31, P370, DOI 10.1080/09540121.2018.1529294; Hotton AL, 2020, J URBAN HEALTH, V97, P623, DOI 10.1007/s11524-020-00428-8; James S. E., 2016, REPORT US TRANSGENDE; Jenness Valerie, 2007, UC IRVINE CTR EVIDEN, V2; Kipke MD, 2020, J URBAN HEALTH, V97, P653, DOI 10.1007/s11524-019-00398-6; Knox D, 2020, AM POLIT SCI REV, V114, P619, DOI 10.1017/S0003055420000039; Kutateladze BL, 2014, CRIMINOLOGY, V52, P514, DOI 10.1111/1745-9125.12047; Li KCW, 1996, AM J LAW MED, V22, P477; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Luhur W., 2021, POLICING LGBQ PEOPLE; Meyer IH, 2017, AM J PUBLIC HEALTH, V107, P267, DOI 10.2105/AJPH.2016.303576; Miaschi J, 2017, LARGEST JAILS US; Okafor CN, 2017, J URBAN HEALTH, V94, P710, DOI 10.1007/s11524-017-0172-z; Peele S, 2000, DRUG ALCOHOL DEPEN, V60, P221, DOI 10.1016/S0376-8716(00)00112-5; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Rabuy B., 2016, DETAINING POOR MONEY; Schneider JA, 2017, SOC NETWORKS, V51, P73, DOI 10.1016/j.socnet.2017.04.001; Severe M, 2021, AIDS BEHAV, V25, P1507, DOI 10.1007/s10461-020-02989-w; Shoptaw S, 2007, ADDICTION, V102, P130, DOI 10.1111/j.1360-0443.2006.01775.x; Stewart-Winter T, 2015, J AM HIST, V102, P61, DOI 10.1093/jahist/jav283; Taylor TN, 2020, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00373; Turpin R, 2021, AIDS EDUC PREV, V33, P143, DOI 10.1521/aeap.2021.33.2.143; Vagenas P, 2016, AIDS CARE, V28, P22, DOI 10.1080/09540121.2015.1062464; Valera P, 2019, INT J OFFENDER THER, V63, P1843, DOI 10.1177/0306624X19832239; Voisin DR, 2017, AIDS CARE, V29, P545, DOI 10.1080/09540121.2016.1224303; Wakefield S, 2010, ANNU REV SOCIOL, V36, P387, DOI 10.1146/annurev.soc.012809.102551; Weiser SD, 2009, AM J PUBLIC HEALTH, V99, P1459, DOI 10.2105/AJPH.2008.141655; Wilson Richard Ashby, 2021, CONN LR, V52, P1029; Zaller N, 2018, LANCET INFECT DIS, V18, P1301, DOI 10.1016/S1473-3099(18)30538-3	54	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0265034	10.1371/journal.pone.0265034	http://dx.doi.org/10.1371/journal.pone.0265034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259198	Green Published, gold			2022-12-26	WOS:000835141200040
J	Roelker, SA; Schmitt, LC; Chaudhari, AMW; Siston, RA				Roelker, Sarah A.; Schmitt, Laura C.; Chaudhari, Ajit M. W.; Siston, Robert A.			Discover your potential: The influence of kinematics on a muscle's ability to contribute to the sit-to-stand transfer	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; SUPPORT; PROGRESSION; STRATEGIES; MOVEMENT; FORCES; YOUNG; BODY	Existing methods for estimating how individual muscles contribute to a movement require extensive time and experimental resources. In this study we developed an efficient method for determining how changes to lower extremity joint kinematics affect the potential of individual muscles to contribute to whole-body center-of-mass vertical (support) and anteroposterior (progression) accelerations. A 4-link 2-dimensional model was used to assess the effect of kinematic changes on muscle function. Joint kinematics were systematically varied throughout ranges observed during the momentum transfer phase of the sit-to-stand transfer. Each muscle's potential to contribute to support and progression was computed and compared to simulated potentials estimated by traditional dynamic simulation methods for young adults and individuals with knee osteoarthritis. The new method required 4-10s to compute muscle potentials per kinematic state and computed potentials were consistent with simulated potentials. The new method identified differences in muscle potentials between groups due to kinematic differences, particularly decreased anterior pelvic tilt in young adults, and revealed kinematic and muscle strengthening modifications to increase support. The methods presented provide an efficient, systematic approach to evaluate how joint kinematic adjustments alter a muscle's ability to contribute to movement and can identify potential sources of pathologic movement and rehabilitation strategies.	[Roelker, Sarah A.] Univ Massachusetts Amherst, Dept Kinesiol, Amherst, MA USA; [Roelker, Sarah A.; Chaudhari, Ajit M. W.; Siston, Robert A.] Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA; [Schmitt, Laura C.; Chaudhari, Ajit M. W.; Siston, Robert A.] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Schmitt, Laura C.; Chaudhari, Ajit M. W.; Siston, Robert A.] Ohio State Univ, Wexner Med Ctr, Sports Med Res Inst, Columbus, OH 43210 USA; [Schmitt, Laura C.; Chaudhari, Ajit M. W.] Ohio State Univ, Sch Hlth & Rehabil Sci, Div Phys Therapy, Columbus, OH 43210 USA; [Chaudhari, Ajit M. W.; Siston, Robert A.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Chaudhari, Ajit M. W.; Siston, Robert A.] Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA	University of Massachusetts System; University of Massachusetts Amherst; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Siston, RA (corresponding author), Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA.; Siston, RA (corresponding author), Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA.; Siston, RA (corresponding author), Ohio State Univ, Wexner Med Ctr, Sports Med Res Inst, Columbus, OH 43210 USA.; Siston, RA (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.; Siston, RA (corresponding author), Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA.	siston.1@osu.edu		Chaudhari, Ajit/0000-0001-5071-7147; Roelker, Sarah/0000-0001-6451-6231	National Science Foundation Graduate Research Fellowship Program [DGE-1343012]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This research is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1343012 (SAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FC, 2003, GAIT POSTURE, V17, P159, DOI 10.1016/S0966-6362(02)00073-5; Bennell KL, 2014, ARTHRITIS RHEUMATOL, V66, P950, DOI 10.1002/art.38317; Bishara AJ, 2012, PSYCHOL METHODS, V17, P399, DOI 10.1037/a0028087; Bobbert MF, 2016, CLIN BIOMECH, V37, P83, DOI 10.1016/j.clinbiomech.2016.06.008; Brakke R, 2012, PM&R, V4, pS53, DOI 10.1016/j.pmrj.2012.02.017; Caruthers EJ, 2020, COMPUT METHOD BIOMEC, V23, P765, DOI 10.1080/10255842.2020.1764544; Caruthers EJ, 2018, ANN BIOMED ENG, V46, P579, DOI 10.1007/s10439-018-1979-9; Caruthers EJ, 2016, J APPL BIOMECH, V32, P487, DOI 10.1123/jab.2015-0291; Craig JJ., 2005, LAGRANGIAN FORMULATI, P182; Cullen MK., 2015, MUSCLE DRIVEN SIMULA; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; DOORENBOSCH CAM, 1994, J BIOMECH, V27, P1299, DOI 10.1016/0021-9290(94)90039-6; Fisher NM, 1997, DISABIL REHABIL, V19, P47, DOI 10.3109/09638289709166827; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Hurley ST, 2016, PHYS OCCUP THER GERI, V34, P169, DOI 10.1080/02703181.2016.1267293; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; Jeon W, 2021, J BIOMECH, V117, DOI 10.1016/j.jbiomech.2021.110251; Jeon W, 2019, GAIT POSTURE, V71, P138, DOI 10.1016/j.gaitpost.2019.04.030; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lin YC, 2015, J BIOMECH, V48, P340, DOI 10.1016/j.jbiomech.2014.11.019; Liu MQ, 2006, J BIOMECH, V39, P2623, DOI 10.1016/j.jbiomech.2005.08.017; Lowe W, 2009, ORTHOPEDIC MASSAGE, P153; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; SCHENKMAN M, 1990, PHYS THER, V70, P638, DOI 10.1093/ptj/70.10.638; Smidt G L, 1984, J Orthop Sports Phys Ther, V6, P25; Sonoo M, 2019, J BIOMECH, V96, DOI 10.1016/j.jbiomech.2019.109331; Tully EA, 2005, GAIT POSTURE, V22, P338, DOI 10.1016/j.gaitpost.2004.11.007; Turcot K, 2012, GAIT POSTURE, V36, P68, DOI 10.1016/j.gaitpost.2012.01.005; van Der Kruk E, 2021, J BIOMECH, V122, DOI 10.1016/j.jbiomech.2021.110411; ZAJAC FE, 1989, EXERCISE SPORT SCI R, V17, P187	30	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264080	10.1371/journal.pone.0264080	http://dx.doi.org/10.1371/journal.pone.0264080			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239690	Green Submitted, Green Published, gold			2022-12-26	WOS:000776002200019
J	Tian, WQ; Chen, SY; Chuan, FN; Zhao, WR; Zhou, B				Tian, Wen-qing; Chen, Si-yu; Chuan, Feng-ning; Zhao, Wen-rui; Zhou, Bo			Down-regulated TINAGL1 in fibroblasts impairs wound healing in diabetes	FASEB JOURNAL			English	Article						diabetes; fibroblasts; high glucose; TINAGL1; wound healing	MATRICELLULAR PROTEIN CCN1; SKIN; EXPRESSION; PERIOSTIN	Matricellular proteins, a group of extracellular matrix (ECM) proteins, are key regulators of skin repair and their dysregulation impairs wound healing in diabetes. Tubulointerstitial nephritis antigen like 1 (TINAGL1) is a new member of matricellular protein family, and the understanding of its functional role is still relatively limited. In the current study, we detected the expression of TINAGL1 in diabetic skin wound tissues through RT-PCR, ELISA and Western blot analysis, investigated the contribution of TINAGL1 to wound healing through cutaneous administration of recombinant TINAGL1 protein, and characterized its regulation by hyperglycemia through RNA-seq and signal pathway inhibition assay. We showed that TINAGL1 expression has dynamic change and reaching a peak on day-9 after wound during the wound healing process in wild-type (WT) mice. Interestingly, decreased TINAGL1 expression is detected in skin tissues of diabetic patients and mice after wound. Then, we found that high glucose (HG), an important factor that impairs wound healing, reduces the expression of TINAGL1 in fibroblasts through JNK pathway. Notably, the histology analysis, Masson trichrome assay and IHC assay showed that exogenous TINAGL1 promotes wound healing in diabetic mice by accelerating the formation of granulation tissues. Our study provides evidence that TINAGL1 has an essential role in diabetic wound healing, and meanwhile, indicates that manipulation of TINAGL1 might be a possible therapeutic approach.	[Tian, Wen-qing; Chen, Si-yu; Chuan, Feng-ning; Zhao, Wen-rui; Zhou, Bo] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing 400016, Peoples R China	Chongqing Medical University	Zhou, B (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing 400016, Peoples R China.	zhoubo915@126.com	CHEN, SI/GZL-4800-2022					Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Bergmeier V, 2018, MATRIX BIOL, V65, P59, DOI 10.1016/j.matbio.2017.07.005; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Brown LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013905; Chen H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.544; Elliott CG, 2019, TISSUE ENG PT A, V25, P1326, DOI [10.1089/ten.TEA.2018.0268, 10.1089/ten.tea.2018.0268]; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Foulsham W, 2019, OCUL SURF, V17, P374, DOI 10.1016/j.jtos.2019.06.001; He RG, 2017, MOL IMMUNOL, V90, P42, DOI 10.1016/j.molimm.2017.06.249; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kim KH, 2018, J CELL COMMUN SIGNAL, V12, P273, DOI 10.1007/s12079-018-0450-x; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kunkemoeller B, 2019, DIABETES, V68, P2016, DOI 10.2337/db18-1001; Leask Andrew, 2009, Front Biosci (Elite Ed), V1, P115; Li D, 2007, FEBS J, V274, P2506, DOI 10.1111/j.1742-4658.2007.05786.x; Lim JZM, 2017, J ROY SOC MED, V110, P104, DOI 10.1177/0141076816688346; Mukai K, 2003, J BIOL CHEM, V278, P17084, DOI 10.1074/jbc.M301477200; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Musetti SN, 2021, MOL PHARMACEUT, V18, P2032, DOI 10.1021/acs.molpharmaceut.1c00008; Okamoto H, 2012, CARDIOVASC THER, V30, pe198, DOI 10.1111/j.1755-5922.2011.00276.x; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Rousselle P, 2019, MATRIX BIOL, V75-76, P12, DOI 10.1016/j.matbio.2018.01.002; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Shan ZG, 2021, J GASTROEN HEPATOL, V36, P196, DOI 10.1111/jgh.15150; Shen M, 2019, CANCER CELL, V35, P64, DOI 10.1016/j.ccell.2018.11.016; Sun L, 2019, CANCER MANAG RES, V11, P767, DOI 10.2147/CMAR.S190390; Umeyama H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S9-S2; Yin SL, 2020, CHINESE MED J-PEKING, V133, P2236, DOI 10.1097/CM9.0000000000000949; Zheng XW, 2019, P NATL ACAD SCI USA, V116, P6985, DOI 10.1073/pnas.1900351116	29	0	0	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22235	10.1096/fj.202101438RR	http://dx.doi.org/10.1096/fj.202101438RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199864				2022-12-26	WOS:000761250800009
J	Boukebous, B; Maillot, C; Neouze, A; Esnault, H; Gao, F; Biau, D; Rousseau, MA				Boukebous, Baptiste; Maillot, Cedric; Neouze, Angele; Esnault, Helene; Gao, Fei; Biau, David; Rousseau, Marc-Antoine			Excess mortality after hip fracture during COVID-19 pandemic: More about disruption, less about virulence- Lesson from a trauma center	PLOS ONE			English	Article							MANAGEMENT; LENGTH; IMPACT; STAY; CARE	To date, literature has depicted an increase in mortality among patients with hip fractures, directly related to acute coronavirus disease 2019 (COVID-19) infection and not due to underlying comorbidities. Usual orthogeriatric pathway in our Department was disrupted during the pandemic. This study aimed to evaluate early mortality within 30 days, in 2019 and 2020 in our Level 1 trauma-center. We compared two groups of patients aged >60 years, with osteoporotic upper hip fractures, in February/March/April 2020 and February/March/April 2019, in our level 1 trauma center. A total of 102 and 79 patients met the eligibility criteria in 2019 and 2020, respectively. Mortality was evaluated, merging our database with the French open database for death from the INSEE, which is prospectively updated each month. Causes of death were recorded. Charlson Comorbidity Index was evaluated for comorbidities, Instrumental Activity of Daily Living (IADL), and Activity of Daily Living (ADL) scores were assessed for autonomy. There were no differences in age, sex, fracture type, Charlson Comorbidity Index, IADL, and ADL. 19 patients developed COVID-19 infection. The 30-day survival was 97% (95% CI, 94%-100%) in 2019 and 86% (95% CI, 79%-94%) in 2020 (HR = 5, 95%CI, 1.4-18.2, p = 0.013). In multivariable Cox'PH model, the period (2019/2020) was significantly associated to the 30-day mortality (HR = 6.4, 95%CI, 1.7-23, p = 0.005) and 6-month mortality (HR = 3.4, 95%CI, 1.2-9.2, p = 0.01). COVID infection did not modify significantly the 30-day and 6-month mortality. This series brought new important information, early mortality significantly increased because of underlying disease decompensation. Minimal comprehensive care should be maintained in all circumstances in order to avoid excess of mortality among elderly population with hip fractures.	[Boukebous, Baptiste; Maillot, Cedric; Rousseau, Marc-Antoine] Nord Univ Paris, Beaujon Bichat Hosp, AP HP, Dept Orthopaed & Traumatol Surg, Clichy, France; [Boukebous, Baptiste; Biau, David] Hop Hotel Dieu, Ctr Res Epidemiol & Stat, UMR1153, ECAMO Team,INSERM, Paris, France; [Neouze, Angele; Esnault, Helene] Nord Univ Paris, Bichat Hosp, AP HP, Dept Geriatr, Paris, France; [Gao, Fei] Ecole Hautes Etud Sante Publ, REPERES Team, Rennes, France; [Biau, David] Univ Paris, Cochin Hosp, AP PH, Dept Orthopaed & Traumatol Surg, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Boukebous, B (corresponding author), Nord Univ Paris, Beaujon Bichat Hosp, AP HP, Dept Orthopaed & Traumatol Surg, Clichy, France.; Boukebous, B (corresponding author), Hop Hotel Dieu, Ctr Res Epidemiol & Stat, UMR1153, ECAMO Team,INSERM, Paris, France.	baptiste.boukebous@aphp.fr						Baker MA, 2022, CLIN INFECT DIS, V74, P1748, DOI 10.1093/cid/ciab688; Catellani F, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.20.00617; Charlson Comorbidity Index (CCI), MDCALC; Clement ND, 2020, BONE JOINT J, V102B, P1774, DOI 10.1302/0301-620X.102B12.BJJ-2020-1395.R2; Cross AR, 2019, MICROBES INFECT, V21, P10, DOI 10.1016/j.micinf.2018.06.001; Dupley L, 2021, EUR J ORTHOP SURG TR, V31, P341, DOI 10.1007/s00590-020-02778-0; Egol KA, 2020, J ORTHOP TRAUMA, V34, P395, DOI 10.1097/BOT.0000000000001845; Ehrlich Matthew I, 2020, Arch Cancer Biol Ther, V1, P22, DOI 10.33696/cancerbiology.1.005; Giorgi PD, 2020, BONE JOINT J, V102B, P671, DOI 10.1302/0301-620X.102B6.BJJ-2020-0537; Hadfield JN, 2020, INJURY, V51, P1411, DOI 10.1016/j.injury.2020.06.006; Hirschmann MT, 2020, KNEE SURG SPORT TR A, V28, P1690, DOI 10.1007/s00167-020-06022-4; Hommel A, 2008, INJURY, V39, P1164, DOI 10.1016/j.injury.2008.01.048; Kayani B, 2020, BONE JOINT J, V102B, P1136, DOI 10.1302/0301-620X.102B9.BJJ-2020-1127.R1; Lau TW, 2013, GERIATR ORTHOP SURG, V4, P3, DOI 10.1177/2151458513484759; LeBrun DG, 2020, J ORTHOP TRAUMA, V34, P403, DOI 10.1097/BOT.0000000000001849; Liu J, 2020, AGING-US, V12, P7619, DOI 10.18632/aging.103201; Maleitzke T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246956; Markus HS, 2020, INT J STROKE, V15, P361, DOI 10.1177/1747493020923472; Vives JMM, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.20.00686; Narang A, 2021, INT ORTHOP, V45, P23, DOI 10.1007/s00264-020-04739-y; Nunez JH, 2020, INJURY, V51, P1414, DOI 10.1016/j.injury.2020.05.016; Park C, 2020, ACTA ORTHOP, V91, P556, DOI 10.1080/17453674.2020.1783621; Prestmo A., 2016, BMC GERIATR, P16, DOI [10.1186/s12877-016-0192-7, DOI 10.1186/S12877-016-0192-7]; Randelli PS, 2020, KNEE SURG SPORT TR A, V28, P1683, DOI 10.1007/s00167-020-06023-3; Shariyate MJ, 2020, ARCH BONE JT SURG-AB, V8, P297, DOI 10.22038/abjs.2020.47626.2333; Thakrar A, 2020, J ORTHOP TRAUMA, V34, pE325, DOI 10.1097/BOT.0000000000001889; Tseng M-Y., 2016, BMC MUSCULOSKEL DIS, P17, DOI [10.1186/s12891-016-0886-1, DOI 10.1186/S12891-016-0886-1]; Upadhyaya GK, 2020, J ORTHOP, V21, P287, DOI 10.1016/j.jor.2020.06.001; Walker JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206926; Zhu Y, 2020, INT ORTHOP, V44, P1565, DOI 10.1007/s00264-020-04575-0	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							0263680	10.1371/journal.pone.0263680	http://dx.doi.org/10.1371/journal.pone.0263680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213561	Green Published, gold			2022-12-26	WOS:000787811000030
J	Enyew, EB; Tareke, AA				Enyew, Ermias Bekele; Tareke, Abiyu Abadi			Vaccination status and factors associated among children age 12-23 months in Ethiopia, based on 2016 EDHS: Logit based multinomial logistic regression analysis	PLOS ONE			English	Article							IMMUNIZATION; COVERAGE	Background Childhood immunization is one of the most cost-effective prevention measures for children's mortality and morbidity, saving 2-3 million lives per year. In Ethiopia, under-five mortality rates, about 190,000 children die each year. Different research conducted in Ethiopia on childhood vaccination have focused on either vaccination coverage of individual vaccine or complete and incomplete vaccination. As far as my literature searching, studies separated the vaccination status into non-vaccinated, partially vaccinated and full vaccinated and assorted factors among children age 12-23 month in Ethiopia were limited. Therefore, the aim of this study was to identify factors associated with vaccination status among children 12-23 months of age in Ethiopia. Method A secondary data analysis was done based on the 2016 Ethiopian Demographic and Health Survey (EDHS). A total weighted sample of 1911 children age 12-23 months of age were included in the study. Logit based Multinomial logistic regression analysis was computed to distinguish factors associated with routine vaccination of children aged 12-23 months. P-value less than 0.05 was used to declare statistical significance of each independent variables, and adjusted odd ratio (AOR) with 95% confidence interval were used to present the result and STATA 14 was utilized for data management and analysis. Result Overall the prevalence of full vaccinated children was 35%, while 49% of children were partially vaccinated and 16% were non-vaccinated. In multinomial analysis, having focused ANC (at least four visits) contrasted to no ANC visits at all had 9.7 higher odd of being fully vaccinated than not vaccinated [AOR = 9.74, 95% CI = 3.52-26.94], and 5 times higher odd of being partially vaccinated than not vaccinated [AOR = 4.97, 95% CI = 2.00-12.33]. Conclusion The present study found that childhood full vaccination status was low compared with the World Health Organization targets. Frequency of ANC visit and visited by field worker were significantly associated both partially and full vaccination whereas, visited health facility last 12 months and wealth status were significantly associated with childhood full vaccination.	[Enyew, Ermias Bekele] Mettu Univ Ethiopia, Dept Hlth Informat, Mettu, Ethiopia; [Tareke, Abiyu Abadi] West Armachiho Dist Hlth Off, Gondar, Ethiopia		Enyew, EB (corresponding author), Mettu Univ Ethiopia, Dept Hlth Informat, Mettu, Ethiopia.	ermiashi@gmail.com	BEKELE, ERMIAS/HFZ-7998-2022	Bekele, Ermias/0000-0002-9310-2481				Aalemi AK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236955; Abadura SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2315-z; Asfaw AG, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.100.7879; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2018, ETH DEM HLTH SURV 20; Danielsson N, 2009, VACCINE, V27, P4462, DOI 10.1016/j.vaccine.2009.05.051; federal minister of health, 2017, HMIS INDICATOR REFER; Federal Ministry of Health (FMOH)/National Primary Health Care Development Agency (NPHCDA), 2015, COMPREHENSIVE EPI MU; Health F.D.R.o.E.M.o., 2015, HLTH SECTOR TRANSFOR; Kwak C, 2002, NURS RES, V51, P406, DOI 10.1097/00006199-200211000-00009; Lakew Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2078-6; Lee EHJ, 2008, TROP MED INT HEALTH, V13, P495, DOI 10.1111/j.1365-3156.2008.02027.x; Mbengue MAS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4493-3; Memirie ST, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1296-7; Porth JM, 2021, AM J PREV MED, V60, pS87, DOI 10.1016/j.amepre.2020.08.015; Rahman M, 2010, SALUD PUBLICA MEXICO, V52, P134; Tefera YA, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6020022; Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096; World Healh Organization, 2021, IMMUNIZATION COVERAG; world health organization, 2021, VACCINATION IMMUNIZA; World Health Organization, 2014, MEDIA CTR WORLD HLTH; World Health Organization, 2019, REP STRAT ADV GROUP; World Health Organization, 2012, WORLD HLTH STAT; Zaidi SMA, 2014, HUM VACC IMMUNOTHER, V10, P1712, DOI 10.4161/hv.28621	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264004	10.1371/journal.pone.0264004	http://dx.doi.org/10.1371/journal.pone.0264004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213589	Green Published, gold, Green Submitted			2022-12-26	WOS:000787811000043
J	Javaid, U; Iqbal, J; Mehmood, A; Uppal, AA				Javaid, Usman; Iqbal, Jamshed; Mehmood, Adeel; Uppal, Ali Arshad			Performance improvement in polymer electrolytic membrane fuel cell based on nonlinear control strategies-A comprehensive study	PLOS ONE			English	Article							EXCESS RATIO CONTROL	A Polymer Electrolytic Membrane Fuel Cell (PEMFC) is an efficient power device for automobiles, but its efficiency and life span depend upon its air delivery system. To ensure improved performance of PEMFC, the air delivery system must ensure proper regulation of Oxygen Excess Ratio (OER). This paper proposes two nonlinear control strategies, namely Integral Sliding Mode Control (ISMC) and Fast Terminal ISMC (FTISMC). Both the controllers are designed to control the OER at a constant level under load disturbances while avoiding oxygen starvation. The derived controllers are implemented in MATLAB/Simulink. The corresponding simulation results depict that FTISMC has faster tracking performance and lesser fluctuations due to load disturbances in output net power, stack voltage/power, error tracking, OER, and compressor motor voltage. Lesser fluctuations in these parameters ensure increased efficiency and thus extended life of a PEMFC. The results are also compared with super twisting algorithm STA to show the effectiveness of the proposed techniques. ISMC and FTISMC yield 7% and 20% improved performance as compared to STA. The proposed research finds potential applications in hydrogen-powered fuel cell electric vehicles.	[Javaid, Usman; Mehmood, Adeel; Uppal, Ali Arshad] COMSATS Univ Islamabad, Dept Elect & Comp Engn, Islamabad, Pakistan; [Iqbal, Jamshed] Univ Hull, Fac Sci & Engn, Dept Comp Sci & Technol, Kingston Upon Hull, N Humberside, England	COMSATS University Islamabad (CUI); University of Hull	Iqbal, J (corresponding author), Univ Hull, Fac Sci & Engn, Dept Comp Sci & Technol, Kingston Upon Hull, N Humberside, England.	j.iqbal@hull.ac.uk	Iqbal, Jamshed/AER-0153-2022	Iqbal, Jamshed/0000-0002-0795-0282				Bessas A, 2016, J CONTROL SCI ENG, V2016, DOI 10.1155/2016/7915375; Cederlof G., 2020, J POLIT ECOL, V27; Chen GR, 2020, CHEM REV, V120, P3668, DOI 10.1021/acs.chemrev.9b00821; Chong Zheng, 2021, 2021 IEEE International Systems Conference (SysCon), P01, DOI 10.1109/GLOBECOM46510.2021.9685242; Damour C., 2020, ENGINEERING, V12, P99, DOI [10.4236/eng.2020.122010, DOI 10.4236/ENG.2020.122010]; Day JK, 2020, BUILD ENVIRON, V178, DOI 10.1016/j.buildenv.2020.106920; Derbeli M., 2017, 2017 INT C GREEN ENE, P1; Edwards C., 1998, SLIDING MODE CONTROL; Fan Z, 2018, IFAC PAPERSONLINE, V51, P15, DOI 10.1016/j.ifacol.2018.10.004; Farrington JW, 2020, MAR POLLUT BULL, V150, DOI 10.1016/j.marpolbul.2019.110744; Giridhar P., 2020, ASIAN J PHARM RES DE, V8, P118, DOI [10.22270/ajprd.v8i3.729, DOI 10.22270/AJPRD.V8I3.729]; Habib K, 2020, RESOUR CONSERV RECY, V154, DOI 10.1016/j.resconrec.2019.104603; Han J, 2019, INT J HYDROGEN ENERG, V44, P18425, DOI 10.1016/j.ijhydene.2019.05.041; He HW, 2020, INT J HYDROGEN ENERG, V45, P20382, DOI 10.1016/j.ijhydene.2019.12.147; Hwang H, 2020, ENVIRON ENG RES, V25, P366, DOI 10.4491/eer.2019.117; Iqbal J, 2015, STROJ VESTN-J MECH E, V61, P465, DOI 10.5545/sv-jme.2015.2511; Javaid U, 2020, IEEE ACCESS, V8, P95823, DOI 10.1109/ACCESS.2020.2995895; Kim BM, 2021, NONLINEAR DYNAM, V103, P791, DOI 10.1007/s11071-020-06124-1; Lantto T, 2020, SUSTAINABLE TRANSPOR; Lehner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092787; Li JW, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21020349; Li Q, 2009, J POWER SOURCES, V194, P338, DOI 10.1016/j.jpowsour.2009.04.077; Liao ZH, 2021, INT J HEAT MASS TRAN, V165, DOI 10.1016/j.ijheatmasstransfer.2020.120733; Liddle B, 2020, ENERG POLICY, V145, DOI 10.1016/j.enpol.2020.111722; Luo G, 2020, J RENEW SUSTAIN ENER, V12, DOI 10.1063/5.0014788; Ma Y, 2020, INT J HYDROGEN ENERG, V45, P29705, DOI 10.1016/j.ijhydene.2019.10.089; Margolis A, 2020, BIOL PSYCHIAT, V87, pS125; Moon JW, 2020, ENERG BUILDINGS, V208, DOI 10.1016/j.enbuild.2019.109662; Muhammad S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138820; Oxenaar S, 2020, PALGRAVE HANDBOOK OF MANAGING FOSSIL FUELS AND ENERGY TRANSITIONS, P139, DOI 10.1007/978-3-030-28076-5_6; Oyebanji J.I., 2020, INT J CRIT ACCOUNT, V11, P369, DOI [10.1504/IJCA.2020.111567, DOI 10.1504/IJCA.2020.111567]; Pan YP, 2018, INT J CONTROL AUTOM, V16, P586, DOI 10.1007/s12555-017-0291-z; Pangaribowo T.., 2020, INT J ADV TRENDS COM, V9, P606, DOI [10.30534/ijatcse/2020/8491.42020, DOI 10.30534/IJATCSE/2020/8491.42020]; Peters GP, 2020, NAT CLIM CHANGE, V10, P3, DOI 10.1038/s41558-019-0659-6; Pukrushpan JT, 2004, IEEE CONTR SYST MAG, V24, P30, DOI 10.1109/MCS.2004.1275430; Quan SW, 2021, APPL ENERG, V293, DOI 10.1016/j.apenergy.2021.116919; Raimi, 2020, GLOBAL ENERGY OUTLOO; Ross J, 2010, ENTROPY-SWITZ, V12, P2199, DOI 10.3390/e12102199; Shahzad U, 2021, ENERGY, V214, DOI 10.1016/j.energy.2020.118881; Silaa MY, 2020, ENERGIES, V13, DOI 10.3390/en13174317; Singh V., 2020, THESIS LUND U; Sun L, 2018, APPL ENERG, V231, P866, DOI 10.1016/j.apenergy.2018.09.036; Ullah S, 2022, ISA T, V120, P293, DOI 10.1016/j.isatra.2021.02.045; Pham V, 2020, AIP CONF PROC, V2207, DOI 10.1063/5.0000283; Venter ZS, 2020, P NATL ACAD SCI USA, V117, P18984, DOI 10.1073/pnas.2006853117; Wang HM, 2020, APPL ENERG, V258, DOI 10.1016/j.apenergy.2019.114081; Xu J, 2020, CHINESE J ANAL CHEM, V48, P449, DOI 10.19756/j.issn.0253-3820.191235; Yang D, 2019, ENERGY, V188, DOI 10.1016/j.energy.2019.116078; Zhang GB, 2021, INT J HYDROGEN ENERG, V46, P2978, DOI 10.1016/j.ijhydene.2020.05.263; Zhang HK, 2020, INFORM SCIENCES, V511, P1, DOI 10.1016/j.ins.2019.08.005; Zhang QG, 2021, RENEW ENERG, V164, P1143, DOI 10.1016/j.renene.2020.10.105; Zhang SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187802	52	4	4	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264205	10.1371/journal.pone.0264205	http://dx.doi.org/10.1371/journal.pone.0264205			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213612	Green Published, gold			2022-12-26	WOS:000787811000061
J	Lam, B; Stepanova, M; Venkatesan, C; Garcia, I; Reyes, M; Mannan, A; Groves, S; Desai, M; Racila, A; Kolacevski, A; Henry, L; Gerber, LH; Younossi, ZM				Lam, Brian; Stepanova, Maria; Venkatesan, Chapy; Garcia, Ivan; Reyes, Mary; Mannan, Ashiq; Groves, Soleyah; Desai, Mehul; Racila, Andrei; Kolacevski, Andrej; Henry, Linda; Gerber, Lynn H.; Younossi, Zobair M.			Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system	PLOS ONE			English	Article							MORTALITY	Background Given the rapid spread of COVID-19 and its associated morbidity and mortality, healthcare providers throughout the world have been forced to constantly update and change their care delivery models. Objective To assess the outcomes of COVID-19 hospitalized patients during the course of the pandemic in a well-integrated health system. Methods The study used data from the electronic health medical records to assess trends in clinical profile and outcomes of hospitalized adult COVID-19 patients hospitalized in our 5-hospital health system from March 2020-May 2021 (n = 6865). Integration of the health system began in February 2020 and was fully actualized by March 30, 2020. Results Mortality decreased from 15% during first peak (March-May 2020; the rate includes 19% in March-April and 10% in May 2020) to 6% in summer-fall 2020, increased to 13% during the second peak (November 2020-January 2021), and dropped to 7% during the decline period (February-May 2021) (p<0.01). Resource utilization followed a similar pattern including a decrease in ICU use from 35% (first peak) to 16% (decline period), mechanical ventilation from 16% (first peak, including 45% in March 2020) to 9-11% in subsequent periods (p<0.01). Independent predictors of inpatient mortality across multiple study periods included older age, male sex, higher multi-morbidity scores, morbid obesity, and indicators of severe illness on admission such as oxygen saturation <90% and high qS0FA score (all p<0.05). However, admission during the first peak remained independently associated with increased mortality even after adjustment for patient-related factors: odds ratio = 1.8 (1.4-2.4) (p<0.0001). Conclusions The creation of a fully integrated health system allowed us to dynamically respond to the everchanging COVID-19 landscape. In this context, despite the increasing patient acuity, our mortality and resource utilization rates have improved during the pandemic.	[Lam, Brian; Stepanova, Maria; Racila, Andrei; Henry, Linda; Gerber, Lynn H.; Younossi, Zobair M.] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA 22042 USA; [Lam, Brian; Kolacevski, Andrej; Gerber, Lynn H.; Younossi, Zobair M.] Inova Hlth Syst, Inova Off Res, Falls Church, VA 22042 USA; [Lam, Brian; Stepanova, Maria; Venkatesan, Chapy; Garcia, Ivan; Reyes, Mary; Mannan, Ashiq; Groves, Soleyah; Desai, Mehul; Racila, Andrei; Henry, Linda; Gerber, Lynn H.; Younossi, Zobair M.] Inova Hlth Syst, Dept Med, Falls Church, VA 22042 USA	Inova Health System; Inova Health System; Inova Health System	Younossi, ZM (corresponding author), Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA 22042 USA.; Younossi, ZM (corresponding author), Inova Hlth Syst, Inova Off Res, Falls Church, VA 22042 USA.; Younossi, ZM (corresponding author), Inova Hlth Syst, Dept Med, Falls Church, VA 22042 USA.	Zobair.Younossi@inova.org						cdc, ASSESSING RISK FACTO; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Fernando SM, 2018, ANN INTERN MED, V168, P266, DOI 10.7326/M17-2820; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Ko JY, 2021, CLIN INFECT DIS, V72, pE695, DOI 10.1093/cid/ciaa1419; Mannan A, 2022, AM J MANAG CARE, V28, pE80, DOI 10.37765/ajmc.2022.88731; nih, CORONAVIRUS DIS 2019; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; U.S. Census Bureau, QUICKFACTS FAIRFAX C; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wang XH, 2020, RESEARCH-CHINA, V2020, DOI 10.34133/2020/2402961; Yehia BR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18039; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	14	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263417	10.1371/journal.pone.0263417	http://dx.doi.org/10.1371/journal.pone.0263417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213553	Green Published, gold			2022-12-26	WOS:000787811000022
J	Muraki, R; Teramoto, A; Sugimoto, K; Sugimoto, K; Yamada, A; Watanabe, E				Muraki, Ryosuke; Teramoto, Atsushi; Sugimoto, Keiko; Sugimoto, Kunihiko; Yamada, Akira; Watanabe, Eiichi			Automated detection scheme for acute myocardial infarction using convolutional neural network and long short-term memory	PLOS ONE			English	Article							LSTM MODEL; DEEP; CLASSIFICATION; RECOGNITION	The early detection of acute myocardial infarction, which is caused by lifestyle-related risk factors, is essential because it can lead to chronic heart failure or sudden death. Echocardiography, among the most common methods used to detect acute myocardial infarction, is a noninvasive modality for the early diagnosis and assessment of abnormal wall motion. However, depending on disease range and severity, abnormal wall motion may be difficult to distinguish from normal myocardium. As abnormal wall motion can lead to fatal complications, high accuracy is required in its detection over time on echocardiography. This study aimed to develop an automatic detection method for acute myocardial infarction using convolutional neural networks (CNNs) and long short-term memory (LSTM) in echocardiography. The short-axis view (papillary muscle level) of one cardiac cycle and left ventricular long-axis view were input into VGG16, a CNN model, for feature extraction. Thereafter, LSTM was used to classify the cases as normal myocardium or acute myocardial infarction. The overall classification accuracy reached 85.1% for the left ventricular long-axis view and 83.2% for the short-axis view (papillary muscle level). These results suggest the usefulness of the proposed method for the detection of myocardial infarction using echocardiography.	[Muraki, Ryosuke] Fujita Hlth Univ, Grad Sch Hlth Sci, Toyoake, Aichi, Japan; [Teramoto, Atsushi] Fujita Hlth Univ, Fac Radiol Technol, Sch Med Sci, Toyoake, Aichi, Japan; [Sugimoto, Keiko] Fac Med Technol, Sch Med Sci, Toyoake, Aichi, Japan; [Sugimoto, Kunihiko] Fujita Hlth Univ Hosp, Toyoake, Aichi, Japan; [Yamada, Akira; Watanabe, Eiichi] Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan	Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University	Teramoto, A (corresponding author), Fujita Hlth Univ, Fac Radiol Technol, Sch Med Sci, Toyoake, Aichi, Japan.	teramoto@fujita-hu.ac.jp			Japan Society for the Promotion of Science [21K08140]; Japan Agency for Medical Research and Development [20hk0102071h0001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This research was funded by Grants-inAid for Scientific Research from Japan Society for the Promotion of Science (https://www.jsps.go.jp/ english/e-grants/index.html, https://kaken.nii.ac.jp/ en/grant/KAKENHI-PROJECT-21K08140/, Grant Number 21K08140, awarded to EW and AT) and Japan Agency for Medical Research and Development (https://www.amed.go.jp/en/index. html, Grant Number 20hk0102071h0001, awarded to EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2021, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.390; Alazab M, 2020, IEEE ACCESS, V8, P85454, DOI 10.1109/ACCESS.2020.2991067; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Baloglu UB, 2019, PATTERN RECOGN LETT, V122, P23, DOI 10.1016/j.patrec.2019.02.016; Boulanger-Lewandowski N, 2011, P 29 INT C MACHINE L, P1881; Gadekallu TR, 2021, COMPLEX INTELL SYST, V7, P1855, DOI 10.1007/s40747-021-00324-x; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Guedes V, 2018, PROCEDIA COMPUT SCI, V138, P250, DOI 10.1016/j.procs.2018.10.036; Huang MS, 2020, CIRCULATION, V142, P1510, DOI 10.1161/CIRCULATIONAHA.120.047530; Hyeon J, 2017, INT CONF BIG DATA, P390, DOI 10.1109/BIGCOMP.2017.7881741; Jain AK, 1996, COMPUTER, V29, P31, DOI 10.1109/2.485891; Javed AR, 2021, IEEE T NETW SCI ENG, V8, P1456, DOI 10.1109/TNSE.2021.3059881; Kooi T, 2017, MED IMAGE ANAL, V35, P303, DOI 10.1016/j.media.2016.07.007; Krizhevsky Alex, 2017, Communications of the ACM, V60, P84, DOI 10.1145/3065386; Kusunose K, 2020, JACC-CARDIOVASC IMAG, V13, P374, DOI 10.1016/j.jcmg.2019.02.024; Mikolov T, 2011, INT CONF ACOUST SPEE, P5528; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sakai Y, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P4138, DOI 10.1109/EMBC.2018.8513274; Shahin AI, 2020, IEEE ACCESS, V8, P135184, DOI 10.1109/ACCESS.2020.3010326; Shimizu M, 2020, CIRCULATION, V142, DOI 10.1161/circ.142.suppl_3.15414; Sumitomo M, 2020, INT J UROL, V27, P922, DOI 10.1111/iju.14325; Sutskever I, 2020, P 21 INT C NEURAL IN, P1601; Sutskever I., 2011, P 28 INT C MACH LEAR; Teramoto A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229951; Ullah A, 2018, IEEE ACCESS, V6, P1155, DOI 10.1109/ACCESS.2017.2778011; Varshni D., 2019, P 2019 3 IEEE INT C, P1; Vece DD., 2020, EUR HEART J, V41, DOI [10.1093/ehjci/ehaa946.1221, DOI 10.1093/EHJCI/EHAA946.1221]; Wolterink JM, 2019, MED IMAGE ANAL, V51, P46, DOI 10.1016/j.media.2018.10.005; Zang HX, 2020, RENEW ENERG, V160, P26, DOI 10.1016/j.renene.2020.05.150; Zhang J, 2018, CIRCULATION, V138, P1623, DOI 10.1161/CIRCULATIONAHA.118.034338; Zhang N, 2019, RADIOLOGY, V291, P606, DOI 10.1148/radiol.2019182304; Zhou P, 2018, P COLING 2016 26 INT, P3486	35	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264002	10.1371/journal.pone.0264002	http://dx.doi.org/10.1371/journal.pone.0264002			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213592	Green Published, gold			2022-12-26	WOS:000787811000042
J	Tompkins, V; Rouse, WB; O'Leary, CA; Andrews, RJ; Moss, WN				Tompkins, Van S.; Rouse, Warren B.; O'Leary, Collin A.; Andrews, Ryan J.; Moss, Walter N.			Analyses of human cancer driver genes uncovers evolutionarily conserved RNA structural elements involved in posttranscriptional control	PLOS ONE			English	Article							MYC MESSENGER-RNA; INSIGHTS	Experimental breakthroughs have provided unprecedented insights into the genes involved in cancer. The identification of such cancer driver genes is a major step in gaining a fuller understanding of oncogenesis and provides novel lists of potential therapeutic targets. A key area that requires additional study is the posttranscriptional control mechanisms at work in cancer driver genes. This is important not only for basic insights into the biology of cancer, but also to advance new therapeutic modalities that target RNA-an emerging field with great promise toward the treatment of various cancers. In the current study we performed an in silico analysis on the transcripts associated with 800 cancer driver genes (10,390 unique transcripts) that identified 179,190 secondary structural motifs with evidence of evolutionarily ordered structures with unusual thermodynamic stability. Narrowing to one transcript per gene, 35,426 predicted structures were subjected to phylogenetic comparisons of sequence and structural conservation. This identified 7,001 RNA secondary structures embedded in transcripts with evidence of covariation between paired sites, supporting structure models and suggesting functional significance. A select set of seven structures were tested in vitro for their ability to regulate gene expression; all were found to have significant effects. These results indicate potentially widespread roles for RNA structure in posttranscriptional control of human cancer driver genes.	[Tompkins, Van S.; Rouse, Warren B.; O'Leary, Collin A.; Andrews, Ryan J.; Moss, Walter N.] Iowa State Univ, Roy J Carver Dept Biophys Biochem & Mol Biol, Ames, IA 50011 USA	Iowa State University	Moss, WN (corresponding author), Iowa State Univ, Roy J Carver Dept Biophys Biochem & Mol Biol, Ames, IA 50011 USA.	wmoss@iastate.edu	Andrews, Ryan/ABB-1272-2021	Andrews, Ryan/0000-0003-0275-0019; O'Leary, Collin/0000-0002-4246-6277; Rouse, Warren/0000-0002-5158-7572	NIH-NIGMS [R01GM133810]	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this project was provided by NIH-NIGMS (R01GM133810) to Dr. Walter Moss. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SQ, 2020, NUCLEIC ACIDS RES, V48, P1715, DOI 10.1093/nar/gkz1206; Andrews RJ, 2021, NAR GENOM BIOINFORM, V3, DOI 10.1093/nargab/lqab043; Andrews RJ, 2020, METHODS, V183, P57, DOI 10.1016/j.ymeth.2019.11.001; Andrews RJ, 2018, PEERJ, V6, DOI 10.7717/peerj.6136; Andrews RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17510-y; Chen HH, 2018, CANCER RES, V78, P4512, DOI 10.1158/0008-5472.CAN-18-0282; Davila-Calderon J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18594-3; Dietlein F, 2020, NAT GENET, V52, P208, DOI 10.1038/s41588-019-0572-y; Haniff HS, 2020, ACS CENTRAL SCI, V6, P1713, DOI 10.1021/acscentsci.0c00984; Hodson DJ, 2016, P NATL ACAD SCI USA, V113, pE2039, DOI 10.1073/pnas.1600557113; Hornig NC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154158; Incarnato D, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky486; Jacobs E, 2012, J GENET GENOMICS, V39, P535, DOI 10.1016/j.jgg.2012.08.002; Kang SJ, 2019, IMMUNITY, V50, P1007, DOI 10.1016/j.immuni.2019.03.026; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Malebary SJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91656-8; Manfredonia I, 2020, NUCLEIC ACIDS RES, V48, P12436, DOI 10.1093/nar/gkaa1053; Martinez-Jimenez F, 2020, NAT REV CANCER, V20, P555, DOI 10.1038/s41568-020-0290-x; Mo J, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01325-7; Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681; Moss WN, 2018, RNA, V24, P273, DOI 10.1261/rna.063933.117; Murakami M, 2019, IMMUNITY, V50, P812, DOI 10.1016/j.immuni.2019.03.027; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nozaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111019; O'Leary CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213758; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Rivas E, 2021, WIRES RNA, V12, DOI 10.1002/wrna.1649; Rivas E, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008387; Rivas E, 2020, BIOINFORMATICS, V36, P3072, DOI 10.1093/bioinformatics/btaa080; Rivas E, 2017, NAT METHODS, V14, P45, DOI [10.1038/NMETH.4066, 10.1038/nmeth.4066]; Roschger C, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-016-0161-y; Sreeramulu S, 2021, ANGEW CHEM INT EDIT, V60, P19191, DOI 10.1002/anie.202103693; Tan Y, 2018, BRAIN RES BULL, V143, P138, DOI 10.1016/j.brainresbull.2018.10.006; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Van Nostrand EL, 2020, NATURE, V583, P711, DOI 10.1038/s41586-020-2077-3; Wang SM, 2016, GUT, V65, P1427, DOI 10.1136/gutjnl-2014-308932; Wang T, 2021, NUCLEIC ACIDS RES, V49, pD1289, DOI 10.1093/nar/gkaa1033; Yang R, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03719-3; Yeilding NM, 1997, MOL CELL BIOL, V17, P2698, DOI 10.1128/MCB.17.5.2698; Yeilding NM, 1996, MOL CELL BIOL, V16, P3511; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhang PY, 2021, J AM CHEM SOC, V143, P13044, DOI 10.1021/jacs.1c02248	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264025	10.1371/journal.pone.0264025	http://dx.doi.org/10.1371/journal.pone.0264025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213597	gold, Green Published			2022-12-26	WOS:000787811000044
J	Schubert, R; Geoffroy, E; Gregga, I; Mulford, AJ; Aguet, F; Ardlie, K; Gerszten, R; Clish, C; Van den Berg, D; Taylor, KD; Durda, P; Johnson, WC; Cornell, E; Guo, XQ; Liu, YM; Tracy, R; Conomos, M; Blackwell, T; Papanicolaou, G; Lappalainen, T; Mikhaylova, AV; Thornton, TA; Cho, MH; Gignoux, CR; Lange, L; Lange, E; Rich, SS; Rotter, JI; Manichaikul, A; Im, HK; Wheeler, HE				Schubert, Ryan; Geoffroy, Elyse; Gregga, Isabelle; Mulford, Ashley J.; Aguet, Francois; Ardlie, Kristin; Gerszten, Robert; Clish, Clary; Van den Berg, David; Taylor, Kent D.; Durda, Peter; Johnson, W. Craig; Cornell, Elaine; Guo, Xiuqing; Liu, Yongmei; Tracy, Russell; Conomos, Matthew; Blackwell, Tom; Papanicolaou, George; Lappalainen, Tuuli; Mikhaylova, Anna, V; Thornton, Timothy A.; Cho, Michael H.; Gignoux, Christopher R.; Lange, Leslie; Lange, Ethan; Rich, Stephen S.; Rotter, Jerome, I; Manichaikul, Ani; Im, Hae Kyung; Wheeler, Heather E.		NHLBI TOPMed Consortium	Protein prediction for trait mapping in diverse populations	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; CRP PROMOTER; VARIANTS; PLASMA; LOCI; DISCOVERY; PATHWAYS; RISK	Genetically regulated gene expression has helped elucidate the biological mechanisms underlying complex traits. Improved high-throughput technology allows similar interrogation of the genetically regulated proteome for understanding complex trait mechanisms. Here, we used the Trans-omics for Precision Medicine (TOPMed) Multi-omics pilot study, which comprises data from Multi-Ethnic Study of Atherosclerosis (MESA), to optimize genetic predictors of the plasma proteome for genetically regulated proteome-wide association studies (PWAS) in diverse populations. We built predictive models for protein abundances using data collected in TOPMed MESA, for which we have measured 1,305 proteins by a SOMAscan assay. We compared predictive models built via elastic net regression to models integrating posterior inclusion probabilities estimated by fine-mapping SNPs prior to elastic net. In order to investigate the transferability of predictive models across ancestries, we built protein prediction models in all four of the TOPMed MESA populations, African American (n = 183), Chinese (n = 71), European (n = 416), and Hispanic/Latino (n = 301), as well as in all populations combined. As expected, fine-mapping produced more significant protein prediction models, especially in African ancestries populations, potentially increasing opportunity for discovery. When we tested our TOPMed MESA models in the independent European INTERVAL study, fine-mapping improved cross-ancestries prediction for some proteins. Using GWAS summary statistics from the Population Architecture using Genomics and Epidemiology (PAGE) study, which comprises similar to 50,000 Hispanic/Latinos, African Americans, Asians, Native Hawaiians, and Native Americans, we applied S-PrediXcan to perform PWAS for 28 complex traits. The most protein-trait associations were discovered, colocalized, and replicated in large independent GWAS using proteome prediction model training populations with similar ancestries to PAGE. At current training population sample sizes, performance between baseline and fine-mapped protein prediction models in PWAS was similar, highlighting the utility of elastic net. Our predictive models in diverse populations are publicly available for use in proteome mapping methods at https://doi.org/10.5281/zenodo.4837327.	[Schubert, Ryan] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [Schubert, Ryan; Gregga, Isabelle; Mulford, Ashley J.; Wheeler, Heather E.] Loyola Univ, Dept Biol, Chicago, IL 60611 USA; [Schubert, Ryan; Geoffroy, Elyse; Mulford, Ashley J.; Wheeler, Heather E.] Loyola Univ, Program Bioinformat, Chicago, IL 60611 USA; [Aguet, Francois; Ardlie, Kristin; Clish, Clary] Broad Inst, Cambridge, MA USA; [Gerszten, Robert] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Van den Berg, David] Univ Southern Calif, Los Angeles, CA 90007 USA; [Taylor, Kent D.; Guo, Xiuqing; Rotter, Jerome, I] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Dept Pediat, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Durda, Peter; Cornell, Elaine; Tracy, Russell] Univ Vermont, Lab Clin Biochem Res, Burlington, VT USA; [Johnson, W. Craig] Univ Washington, Collaborat Hlth Studies Coordinating Ctr, Seattle, WA 98195 USA; [Liu, Yongmei] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Conomos, Matthew; Mikhaylova, Anna, V; Thornton, Timothy A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Blackwell, Tom] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Papanicolaou, George] NHLBI, Epidemiol Branch, Bldg 10, Bethesda, MD 20892 USA; [Lappalainen, Tuuli] Columbia Univ, New York Genome Ctr, New York, NY USA; [Lappalainen, Tuuli] Columbia Univ, Dept Syst Biol, New York, NY USA; [Cho, Michael H.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Gignoux, Christopher R.; Lange, Leslie; Lange, Ethan] Univ Colorado, Dept Med, Div Biomed Informat & Personalized Med, Anschutz Med Campus, Aurora, CO USA; [Rich, Stephen S.; Manichaikul, Ani] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Im, Hae Kyung] Univ Chicago, Sect Genet Med, Chicago, IL 60637 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Vermont; University of Washington; University of Washington Seattle; Duke University; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Columbia University; Columbia University; Harvard University; Brigham & Women's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Virginia; University of Chicago	Wheeler, HE (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60611 USA.; Wheeler, HE (corresponding author), Loyola Univ, Program Bioinformat, Chicago, IL 60611 USA.	hwheeler1@luc.edu		Clish, Clary/0000-0001-8259-9245; Aguet, Francois/0000-0001-9414-300X; Rich, Stephen/0000-0003-3872-7793; Taylor, Kent/0000-0002-2756-4370	NIH National Human Genome Research Institute Academic Research Enhancement Award [R15 HG009569]; National Heart, Lung, and Blood Institute (NHLBI); NHLBI [N02-HL-64278]; National Center for Research Resources [UL1RR033176]; National Center for Advancing Translational Sciences, CTSI [UL1TR001881]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) [DK063491]; LABioMed [HHSN2682015000031/HHSN26800004]; National Heart, Lung and Blood Institute (NHLBI); TOPMed Informatics Research Center [3R01HL117626-02S1, HHSN268201800002I]; TOPMed Data Coordinating Center [R01HL120393, U01HL-120393, HHSN268201800001I]; National Institute for Health Research (NIHR); NIHR BioResource; NIHR [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust]; NHSBT [11-01-GEN]; NIHR Blood and Transplant Research Unit in Donor Health and Genomics [NIHR BTRU-2014-10024]; UK Medical Research Council [MR/L003120/1]; British Heart Foundation [SP/09/002, RG/13/13/30194, RG/18/13/33946]; academic coordinating centre for INTERVAL and MRL; Merck Co., Inc.; Health Data Research UK - UK Medical Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council,; Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland),; British Heart Foundation; Wellcome; Beth Israel Proteomics Platform [HHSN268201600034I];  [75N92020D00001];  [HHSN268201500003I];  [N01HC-95159];  [75N92020D00005];  [N01-HC-95160];  [75N92020D00002];  [N01-HC-95161];  [75N92020D00003];  [N01-HC-95162];  [75N92020D00006];  [N01-HC-95163];  [75N92020D00004];  [N01-HC-95164];  [75N92020D00007];  [N01-HC-95165];  [N01-HC95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC95169];  [UL1-TR-000040];  [UL1-TR-001079];  [UL1TR-001420];  [R01HL071051];  [R01HL071205];  [R01HL071250];  [R01HL071251];  [R01HL071258];  [R01HL071259]	NIH National Human Genome Research Institute Academic Research Enhancement Award; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, CTSI; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC); LABioMed; National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); TOPMed Informatics Research Center; TOPMed Data Coordinating Center; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR BioResource; NIHR [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust]; NHSBT; NIHR Blood and Transplant Research Unit in Donor Health and Genomics; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); academic coordinating centre for INTERVAL and MRL; Merck Co., Inc.(Merck & Company); Health Data Research UK - UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council,(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland),; British Heart Foundation(British Heart Foundation); Wellcome; Beth Israel Proteomics Platform; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	This work is supported by the NIH National Human Genome Research Institute Academic Research Enhancement Award R15 HG009569 (HEW). MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts 75N92020D00001, HHSN268201500003I, N01HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N92020D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC95166, N01-HC-95167, N01-HC-95168, N01-HC95169, UL1-TR-000040, UL1-TR-001079, UL1TR-001420. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Genotyping was performed at Affymetrix (Santa Clara, California, USA) and the Broad Institute of Harvard and MIT (Boston, Massachusetts, USA) using the Affymetrix Genome-Wide Human SNP Array 6.0. MESA Family is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support is provided by grants and contracts R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071258, R01HL071259, by the National Center for Research Resources, Grant UL1RR033176. Also supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR001881, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The TOPMed MESA Multi-Omics project was conducted by the University of Washington and LABioMed (HHSN2682015000031/HHSN26800004). Molecular data for the TransOmics in Precision Medicine (TOPMed) program was supported by the National Heart, Lung and Blood Institute (NHLBI). SOMAscan proteomics for NHLBI TOPMed: Multi-Ethnic Study of Atherosclerosis (MESA) (phs001416.v1.p1) was performed at the Broad Institute and Beth Israel Proteomics Platform (HHSN268201600034I). Core support including centralized genomic read mapping and genotype calling, along with variant quality metrics and filtering were provided by the TOPMed Informatics Research Center (3R01HL117626-02S1; contract HHSN268201800002I). Core support including phenotype harmonization, data management, sample-identity QC, and general program coordination were provided by the TOPMed Data Coordinating Center (R01HL120393; U01HL-120393; contract HHSN268201800001I). We gratefully acknowledge the studies and participants who provided biological samples and data for TOPMed. Participants in the INTERVAL randomised controlled trial were recruited with the active collaboration of NHS Blood and Transplant England (www.nhsbt.nhs.uk), which has supported field work and other elements of the trial. DNA extraction and genotyping was co-funded by the National Institute for Health Research (NIHR), the NIHR BioResource (http://bioresource.nihr.ac.uk) and the NIHR [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust]. The INTERVAL study was funded by NHSBT (11-01-GEN). The academic coordinating centre for INTERVAL was supported by core funding from: NIHR Blood and Transplant Research Unit in Donor Health and Genomics (NIHR BTRU-2014-10024), UK Medical Research Council (MR/L003120/1), British Heart Foundation (SP/09/002; RG/13/13/30194; RG/18/13/33946) and the NIHR [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust].; Proteomic assays were funded by the academic coordinating centre for INTERVAL and MRL, Merck & Co., Inc. A complete list of the investigators and contributors to the INTERVAL trial is provided in Di Angelantonio et al. The academic coordinating centre would like to thank blood donor centre staff and blood donors for participating in the INTERVAL trial. This work was supported by Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbeira AN, 2020, GENET EPIDEMIOL, V44, P854, DOI 10.1002/gepi.22346; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Ben-Eghan C, 2020, NATURE, V585, P184, DOI 10.1038/d41586-020-02547-3; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Di Angelantonio E, 2017, LANCET, V390, P2360, DOI 10.1016/S0140-6736(17)31928-1; Dorajoo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067650; Doumatey AP, 2012, HUM MOL GENET, V21, P3063, DOI 10.1093/hmg/dds133; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Folkersen L, 2020, NAT METAB, V2, P1135, DOI 10.1038/s42255-020-00287-2; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fryett JJ, 2020, GENET EPIDEMIOL, V44, P425, DOI 10.1002/gepi.22290; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Geoffroy E, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101850; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gogarten SM, 2019, BIOINFORMATICS, V35, P5346, DOI 10.1093/bioinformatics/btz567; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gondalia R, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP347; Gurdasani D, 2019, CELL, V179, P984, DOI 10.1016/j.cell.2019.10.004; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Han XK, 2020, EUR J EPIDEMIOL, V35, P139, DOI 10.1007/s10654-019-00598-z; Hoffmann TJ, 2018, NAT GENET, V50, P401, DOI 10.1038/s41588-018-0064-5; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Hu YM, 2020, J ALZHEIMERS DIS, V76, P883, DOI 10.3233/JAD-200203; Hunt SE, 2018, DATABASE-OXFORD, DOI [10.1093/database/bay119, 10.1186/1471-2164-11-293]; Johansson A, 2013, P NATL ACAD SCI USA, V110, P4673, DOI 10.1073/pnas.1217238110; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Keys KL, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008927; Kim JJ, 2015, PEDIATR CARDIOL, V36, P438, DOI 10.1007/s00246-014-1032-1; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Lee Y., 2018, BAYESIAN MULTISNP GE, P316471; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Ligthart S, 2018, AM J HUM GENET, V103, P691, DOI 10.1016/j.ajhg.2018.09.009; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Mann KM, 2004, HUM MOL GENET, V13, P1959, DOI 10.1093/hmg/ddh199; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Mikhaylova AV, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00261; Mogil LS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007586; Mosley JD, 2018, CIRCULATION, V138, P2469, DOI 10.1161/CIRCULATIONAHA.118.036063; Mulford AJ, 2021, HUM MOL GENET, V30, P305, DOI 10.1093/hmg/ddab029; Ngo D, 2016, CIRCULATION, V134, P270, DOI 10.1161/CIRCULATIONAHA.116.021803; Nielsen JB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20086-3; Noordam R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12958-0; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; Okoro PC, 2021, HUM GENET GENOM ADV, V2, DOI 10.1016/j.xhgg.2020.100019; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Peterson RE, 2019, CELL, V179, P589, DOI 10.1016/j.cell.2019.08.051; Pividori M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba2083; Pulit SL, 2019, HUM MOL GENET, V28, P166, DOI 10.1093/hmg/ddy327; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raffield LM, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201900278; Reiner AP, 2012, AM J HUM GENET, V91, P502, DOI 10.1016/j.ajhg.2012.07.023; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rohloff JC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.49; Salem RM, 2019, J AM SOC NEPHROL, V30, P2000, DOI 10.1681/ASN.2019030218; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Taliun D, 2021, NATURE, V590, DOI 10.1038/s41586-021-03205-y; Tang CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10206; Vinayagamoorthy N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095866; Wainberg M, 2019, NAT GENET, V51, P592, DOI 10.1038/s41588-019-0385-z; Wen XQ, 2016, ANN APPL STAT, V10, P1619, DOI 10.1214/16-AOAS952; Wen XQ, 2016, AM J HUM GENET, V98, P1114, DOI 10.1016/j.ajhg.2016.03.029; Wheeler E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002383; Wojcik GL, 2019, NATURE, V570, P514, DOI 10.1038/s41586-019-1310-4; Wuttke M, 2019, NAT GENET, V51, P957, DOI 10.1038/s41588-019-0407-x; Yamazaki Y, 2019, NAT REV NEUROL, V15, P501, DOI 10.1038/s41582-019-0228-7; Yao C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05512-x; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Zhang J., 2021, LARGE BIETHNIC STUDY, P2021; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu ZZ, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1036-8; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	86	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264341	10.1371/journal.pone.0264341	http://dx.doi.org/10.1371/journal.pone.0264341			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202437	Green Submitted, Green Published, gold			2022-12-26	WOS:000773224600033
J	Aschtgen, MS; Fragkoulis, K; Sanz, G; Normark, S; Selivanova, G; Henriques-Normark, B; Peuget, S				Aschtgen, Marie-Stephanie; Fragkoulis, Konstantinos; Sanz, Gema; Normark, Staffan; Selivanova, Galina; Henriques-Normark, Birgitta; Peuget, Sylvain			Enterobacteria impair host p53 tumor suppressor activity through mRNA destabilization	ONCOGENE			English	Article							PYOGENIC LIVER-ABSCESS; HELICOBACTER-PYLORI; COLORECTAL-CANCER; GENE; ACTIVATION; PROMOTES; TARGETS; MICROBIOTA; MODEL; RAS	Increasing evidence highlights the role of bacteria in the physiopathology of cancer. However, the underlying molecular mechanisms remains poorly understood. Several cancer-associated bacteria have been shown to produce toxins which interfere with the host defense against tumorigenesis. Here, we show that lipopolysaccharides from Klebsiella pneumoniae and other Enterobacteria strongly inhibit the host tumor suppressor p53 pathway through a novel mechanism of p53 regulation. We found that lipopolysaccharides destabilize TP53 mRNA through a TLR4-NF-kappa B-mediated inhibition of the RNA-binding factor Wig-1. Importantly, we show that K. pneumoniae disables two major tumor barriers, oncogene-induced DNA damage signaling and senescence, by impairing p53 transcriptional activity upon DNA damage and oncogenic stress. Furthermore, we found an inverse correlation between the levels of TLR4 and p53 mutation in colorectal tumors. Hence, our data suggest that the repression of p53 by Enterobacteria via TLR4 alleviates the selection pressure for p53 oncogenic mutations and shapes the genomic evolution of cancer.	[Aschtgen, Marie-Stephanie; Fragkoulis, Konstantinos; Sanz, Gema; Normark, Staffan; Selivanova, Galina; Henriques-Normark, Birgitta; Peuget, Sylvain] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; [Normark, Staffan; Henriques-Normark, Birgitta] Karolinska Univ Hosp, Clin Microbiol, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Aschtgen, MS; Peuget, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.	marie-stephanie.aschtgen@ki.se; sylvain.peuget@ki.se	Peuget, Sylvain/AAB-4730-2022	aschtgen, marie-stephanie/0000-0003-2413-8226; Peuget, Sylvain/0000-0002-3315-1935; Selivanova, Galina/0000-0002-8698-4332	Swedish Research Council; Swedish Cancer Society; Knut and Alice Wallenberg Foundation; Swedish foundation for Strategic Research; Karolinska Institute; EMBO	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish foundation for Strategic Research(Swedish Foundation for Strategic Research); Karolinska Institute(Karolinska Institutet); EMBO(European Molecular Biology Organization (EMBO))	We thank all our colleagues for sharing precious reagents and material with us, especially Dr. Yunn-Hwen Gan (National University of Singapore), Dr. Gary Huffnagle (University of Michigan) and Mr. Alexandros Petropoulos (Karolinska Institute) for bacteria strains, and Prof. Klas Wiman (Karolinska Institute) for Wig-1 antibody. We thank Ms. Aleksandra Boikova and Mr. Riccardo Bevilacqua for technical support. This study was supported by the Swedish Research Council, the Swedish Cancer Society, Knut and Alice Wallenberg Foundation, the Swedish foundation for Strategic Research and the Karolinska Institute. MSA was supported by a short-term fellowship from EMBO.	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Arandkar S, 2018, P NATL ACAD SCI USA, V115, P6410, DOI 10.1073/pnas.1719076115; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Berezow AB, 2009, MICROB PATHOGENESIS, V47, P68, DOI 10.1016/j.micpath.2009.04.015; Bergounioux J, 2012, CELL HOST MICROBE, V11, P240, DOI 10.1016/j.chom.2012.01.013; Bersani C, 2014, ONCOGENE, V33, P4407, DOI 10.1038/onc.2013.594; Bersani C, 2016, ONCOTARGET, V7, P1895, DOI 10.18632/oncotarget.6557; Bieging-Rolett KT, 2020, MOL CELL, V80, P452, DOI 10.1016/j.molcel.2020.10.022; Brennan CA, 2019, NAT REV MICROBIOL, V17, P156, DOI 10.1038/s41579-018-0129-6; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Buti L, 2011, P NATL ACAD SCI USA, V108, P9238, DOI 10.1073/pnas.1106200108; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Costa L, 2020, GUT, V69, P1582, DOI 10.1136/gutjnl-2019-318640; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; de Waal GM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65324-2; Diaz-Munoz MD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00454-2; Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P6070, DOI 10.1093/nar/gkw523; Fu LN, 1996, EMBO J, V15, P4392, DOI 10.1002/j.1460-2075.1996.tb00812.x; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gajjar M, 2012, CANCER CELL, V21, P25, DOI 10.1016/j.ccr.2011.11.016; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x; Gonzalez E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6201; Greathouse KL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1501-6; Gudkov AV, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026161; Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x; Haronikova L, 2019, NUCLEIC ACIDS RES, V47, P3257, DOI 10.1093/nar/gkz124; He XY, 2015, CELL REP, V13, P888, DOI 10.1016/j.celrep.2015.09.045; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; HORNICK DB, 1995, INFECT IMMUN, V63, P2026, DOI 10.1128/IAI.63.5.2026-2032.1995; Horvat A, 2018, ONCOGENE, V37, P5054, DOI 10.1038/s41388-018-0343-8; Huang Tzu-Wen, 2014, BMC Res Notes, V7, P13, DOI 10.1186/1756-0500-7-13; Huang WK, 2012, COLORECTAL DIS, V14, pe794, DOI 10.1111/j.1463-1318.2012.03174.x; Janic A, 2018, NAT MED, V24, P947, DOI 10.1038/s41591-018-0043-5; Jeong SW, 2012, J GASTROEN HEPATOL, V27, P248, DOI 10.1111/j.1440-1746.2011.06851.x; Jimenez N, 2009, J BACTERIOL, V191, P2228, DOI 10.1128/JB.01395-08; Joruiz SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026039; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Lam MMC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05114-7; Lan Y, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22838; Lee IR, 2016, SCI REP-UK, V6, DOI 10.1038/srep29316; Lee YK, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00587-18; Levine AJ, 2020, NAT REV CANCER, V20, P471, DOI 10.1038/s41568-020-0262-1; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Madenspacher JH, 2013, J EXP MED, V210, P891, DOI 10.1084/jem.20121674; Mei QX, 2018, PANCREATOLOGY, V18, P438, DOI 10.1016/j.pan.2018.03.005; Menendez D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001360; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Nguyen HCB, 2020, NATURE, V584, P286, DOI 10.1038/s41586-020-2576-2; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; Pai AA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006338; Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Rivas C, 2010, VIRUSES-BASEL, V2, P298, DOI 10.3390/v2010298; Sepich-Poore GD, 2021, SCIENCE, V371, P1331, DOI 10.1126/science.abc4552; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegl C, 2015, NAT REV MICROBIOL, V13, P741, DOI 10.1038/nrmicro3537; Tornesello ML, 2018, CANCERS, V10, DOI 10.3390/cancers10070213; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Wei JX, 2010, GASTROENTEROLOGY, V139, P1333, DOI 10.1053/j.gastro.2010.06.018; Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6; Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9; Zella D, 2018, P NATL ACAD SCI USA, V115, pE12005, DOI 10.1073/pnas.1815660115; Zhang MQZ, 2018, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00323	76	0	0	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2022	41	15					2173	2186		10.1038/s41388-022-02238-5	http://dx.doi.org/10.1038/s41388-022-02238-5		FEB 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J8DX	35197571	Green Published, hybrid			2022-12-26	WOS:000760099800002
J	Wu, SQ; Guo, BB; Zhang, LY; Zhu, X; Zhao, PP; Deng, JQ; Zheng, J; Li, F; Wang, YR; Zhang, SH; Zhang, Z; Lu, JC; Zhou, YF				Wu, Siqi; Guo, Binbin; Zhang, Liyuan; Zhu, Xun; Zhao, Peipei; Deng, Jieqiong; Zheng, Jian; Li, Fang; Wang, Yirong; Zhang, Shenghua; Zhang, Zheng; Lu, Jiachun; Zhou, Yifeng			A micropeptide XBP1SBM encoded by lncRNA promotes angiogenesis and metastasis of TNBC via XBP1s pathway	ONCOGENE			English	Article							NEGATIVE BREAST-CANCER; PROTEIN; METABOLISM; EXPRESSION	Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC) with a poor prognosis. To date, the mechanism of TNBC's aggressive phenotype is still unclear. Based on metabolome analysis, we found that glutamine (Gln) metabolism plays a key role in the difference between TNBC and non-TNBC. We identified a 21-amino-acid survival-associated micropeptide XBP1SBM, encoded by the lncRNA MLLT4-AS1, which was upregulated in TNBC tissues and Gln-deprived TNBC cell lines. We showed that XBP1SBM expression was upregulated by Gln-deprivation-induced XBP1s transcriptional promotion, and in turn retained XBP1s in the nuclear to enhance the expression of VEGF. Using human endothelial cells, mouse xenograft models and mouse spontaneous BC models, we found that XBP1SBM improved Gln levels and promoted angiogenesis and metastasis in TNBC. Our study showed that a TNBC-specific nutrient deficiency adaption results in aggressive TNBC, and this mechanism provides a novel potential prognostic biomarker and therapeutic target in TNBC.	[Wu, Siqi; Guo, Binbin; Deng, Jieqiong; Li, Fang; Wang, Yirong; Zhang, Shenghua; Zhang, Zheng; Zhou, Yifeng] Soochow Univ, Dept Genet, Med Coll, Suzhou 215123, Peoples R China; [Zhang, Liyuan; Zhao, Peipei] Soochow Univ, Dept Radiotherapy & Oncol, Affiliated Hosp 2, San Xiang Rd 1055, Suzhou 215004, Peoples R China; [Zhu, Xun] Soochow Univ, Dept Gen Surg, Affiliated Hosp 2, San Xiang Rd 1055, Suzhou 215004, Peoples R China; [Zheng, Jian; Zhou, Yifeng] Sun Yat Sen Univ Canc Ctr, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China; [Zheng, Jian; Zhou, Yifeng] Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China; [Lu, Jiachun] Guangzhou Med Univ, Affiliated Hosp 1, Sch Publ Hlth, Inst Chem Carcinogenesis, Guangzhou 510182, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University	Zhou, YF (corresponding author), Soochow Univ, Dept Genet, Med Coll, Suzhou 215123, Peoples R China.; Zhou, YF (corresponding author), Sun Yat Sen Univ Canc Ctr, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China.; Zhou, YF (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China.	zhouyifeng@suda.edu.cn	Wu, Siqi/GVT-6711-2022; zhang, zheng/HCH-9684-2022	Wu, Siqi/0000-0002-5051-2923; Zheng, Jian/0000-0001-9831-7038	National Scientific Foundation of China [82103263, 81772544, 81972649]; National Science Fund for Distinguished Young Scholars [82125027]; Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2017ZT07S096]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Program for Guangdong Introducing Innovative and Entrepreneurial Teams	This work was supported by The National Scientific Foundation of China grants 82103263, 81772544 and 81972649; The National Science Fund for Distinguished Young Scholars 82125027; Program for Guangdong Introducing Innovative and Entrepreneurial Teams (2017ZT07S096).	Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Bielenberg DR, 2015, CANCER J, V21, P267, DOI 10.1097/PPO.0000000000000138; Brown M, 2008, CANCER-AM CANCER SOC, V112, P737, DOI 10.1002/cncr.23243; Budczies J, 2015, INT J CANCER, V136, P1619, DOI 10.1002/ijc.29152; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chasse H, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw907; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Choi SW, 2019, BRIEF BIOINFORM, V20, P1853, DOI 10.1093/bib/bby055; Davies MPA, 2008, INT J CANCER, V123, P85, DOI 10.1002/ijc.23479; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Guo BB, 2020, EMBO J, V39, DOI 10.15252/embj.2019102190; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hu R, 2015, MOL CELL BIOL, V35, P379, DOI 10.1128/MCB.00847-14; Huang JZ, 2017, MOL CELL, V68, P171, DOI 10.1016/j.molcel.2017.09.015; Jiang YZ, 2019, CANCER CELL, V35, P428, DOI 10.1016/j.ccell.2019.02.001; Karaayvaz M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06052-0; Kaser A, 2010, CELL RES, V20, P506, DOI 10.1038/cr.2010.61; Kim RS, 2016, SCI REP-UK, V6, DOI 10.1038/srep39342; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Li F, 2019, INT J CANCER, V145, P927, DOI 10.1002/ijc.32166; Li HY, 2015, CELL SIGNAL, V27, P82, DOI 10.1016/j.cellsig.2014.09.018; Li W, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0949-7; Li W, 2017, J BIOL CHEM, V292, P5801, DOI 10.1074/jbc.M116.758508; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Liu L, 2019, NAT CELL BIOL, V21, P328, DOI 10.1038/s41556-019-0285-6; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; Mohammed RAA, 2011, MODERN PATHOL, V24, P774, DOI 10.1038/modpathol.2011.4; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shanware NP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5900; Tajan M, 2018, CELL METAB, V28, P721, DOI 10.1016/j.cmet.2018.07.005; Tian J, 2018, BRIT J CANCER, V119, P1495, DOI 10.1038/s41416-018-0287-3; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Wang YR, 2020, J EXP MED, V217, DOI 10.1084/jem.20190950; Wang YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08033-9; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; Wu H, 2015, ONCOGENE, V34, P4723, DOI 10.1038/onc.2014.400; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zhang J, 2017, EMBO J, V36, P1302, DOI 10.15252/embj.201696151	42	3	3	10	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2022	41	15					2163	2172		10.1038/s41388-022-02229-6	http://dx.doi.org/10.1038/s41388-022-02229-6		FEB 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J8DX	35197570				2022-12-26	WOS:000760099800001
J	Bloomfield, K; Wu, ZQ; Tatton, A; Calvert, C; Peel, N; Hubbard, R; Jamieson, H; Hikaka, J; Boyd, M; Bramley, D; Connolly, MJ				Bloomfield, Katherine; Wu, Zhenqiang; Tatton, Annie; Calvert, Cheryl; Peel, Nancye; Hubbard, Ruth; Jamieson, Hamish; Hikaka, Joanna; Boyd, Michal; Bramley, Dale; Connolly, Martin J.			An interRAI derived frailty index predicts acute hospitalizations in older adults residing in retirement villages: A prospective cohort study	PLOS ONE			English	Article							LONG-TERM-CARE; DISEASE; PEOPLE	ObjectivesThe development of frailty tools from electronically recorded healthcare data allows frailty assessments to be routinely generated, potentially beneficial for individuals and healthcare providers. We wished to assess the predictive validity of a frailty index (FI) derived from interRAI Community Health Assessment (CHA) for outcomes in older adults residing in retirement villages (RVs), elsewhere called continuing care retirement communities. DesignProspective cohort study. Setting and participants34 RVs across two district health boards in Auckland, Aotearoa New Zealand (NZ). 577 participants, mean age 81 years; 419 (73%) female; 410 (71%) NZ European, 147 (25%) other European, 8 Asian (1%), 7 Maori (1%), 1 Pasifika (<1%), 4 other (<1%). MethodsinterRAI-CHA FI tool was used to stratify participants into fit (0-0.12), mild (>0.12-0.24), moderate (>0.24-0.36) and severe (>0.36) frail groups at baseline (the latter two grouped due to low numbers of severely frail). Primary outcome was acute hospitalization; secondary outcomes included long-term care (LTC) entry and mortality. The relationship between frailty and outcomes were explored with multivariable Cox regression, estimating hazard ratios (HRs) and 95% confidence intervals (95%CIs). ResultsOver mean follow-up of 2.5 years, 33% (69/209) of fit, 58% (152/260) mildly frail and 79% (85/108) moderate-severely frail participants at baseline had at least one acute hospitalization. Compared to the fit group, significantly increased risk of acute hospitalization were identified in mildly frail (adjusted HR = 1.88, 95%CI = 1.41-2.51, p<0.001) and moderate-severely frail (adjusted HR = 3.52, 95%CI = 2.53-4.90, p<0.001) groups. Similar increased risk in moderate-severely frail participants was seen in LTC entry (adjusted HR = 5.60 95%CI = 2.47-12.72, p<0.001) and mortality (adjusted HR = 5.06, 95%CI = 1.71-15.02, p = 0.003). Conclusions and implicationsThe FI derived from interRAI-CHA has robust predictive validity for acute hospitalization, LTC entry and mortality. This adds to the growing literature of use of interRAI tools in this way and may assist healthcare providers with rapid identification of frailty.	[Bloomfield, Katherine; Wu, Zhenqiang; Hikaka, Joanna; Boyd, Michal; Connolly, Martin J.] Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland, New Zealand; [Bloomfield, Katherine; Tatton, Annie; Bramley, Dale; Connolly, Martin J.] Waitemat Dist Hlth Board, Auckland, New Zealand; [Calvert, Cheryl] Auckland Dist Hlth Board, Auckland, New Zealand; [Peel, Nancye; Hubbard, Ruth] Univ Queensland, Ctr Hlth Serv Res, Brisbane, Qld, Australia; [Jamieson, Hamish] Univ Otago, Dept Med, Christchurch, New Zealand	University of Auckland; Auckland District Health Board; University of Queensland; University of Otago	Bloomfield, K (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland, New Zealand.; Bloomfield, K (corresponding author), Waitemat Dist Hlth Board, Auckland, New Zealand.	katherine.bloomfield@waitematadhb.govt.nz	Wu, Zhenqiang/HGU-2637-2022; Peel, Nancye/F-5492-2010	Peel, Nancye/0000-0002-3038-8881	National Science Challenge: Ageing Well [EO-R - UOOX1901, 18450 SUB 1939]	National Science Challenge: Ageing Well	Our thanks go to the study participants and retirement village management staff for facilitating research within individual retirement villages. Thanks also to Gabrielle Peters for administration support.	Abey-Nesbit R, 2021, J GERONTOL A-BIOL, V76, P1101, DOI 10.1093/gerona/glaa265; Atkinson J., 2014, NZDEP2013 INDEX DEPR; Bloomfield K, 2021, AUSTRALAS J AGEING, V40, P66, DOI 10.1111/ajag.12863; Boyd M, 2021, INT PSYCHOGERIATR, V33, P481, DOI 10.1017/S1041610220000393; Broad JB, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035876; Brousseau AA, 2018, AGE AGEING, V47, P242, DOI 10.1093/ageing/afx168; Burn R, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-1016-8; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Connolly MJ, 2018, MATURITAS, V117, P45, DOI 10.1016/j.maturitas.2018.08.014; Connolly MJ, 2016, AGE AGEING, V45, P415, DOI 10.1093/ageing/afw037; Connolly MJ, 2021, AUSTRALAS J AGEING, V40, P177, DOI 10.1111/ajag.12898; Crisp DA, 2013, AUSTRALAS J AGEING, V32, P163, DOI 10.1111/j.1741-6612.2012.00623.x; Cuschieri S, 2019, SAUDI J ANAESTH, V13, P31, DOI 10.4103/sja.SJA_543_18; Dufour I, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1197-9; Gray LC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-71; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Hogan DB, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-56; Hubbard RE, 2017, AGE AGEING, V46, P801, DOI 10.1093/ageing/afx081; Hubbard RE, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0026-z; Jiang M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207646; Jones Lang LaSalle, 2020, NZ RET VILL AG CAR; Kerminen H, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01550-7; Kojima G, 2018, AGE AGEING, V47, P193, DOI 10.1093/ageing/afx162; Kojima G, 2018, J GERIATR PHYS THER, V41, P42, DOI 10.1519/JPT.0000000000000097; Landi F, 2004, J CLIN EPIDEMIOL, V57, P832, DOI 10.1016/j.jclinepi.2004.01.013; Larsen RT, 2020, J AM MED DIR ASSOC, V21, P766, DOI 10.1016/j.jamda.2020.01.004; Ludwig C, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0604-3; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; McKenzie K, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0170-5; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Morris JN, 2010, INTERRAI CLIN ASSESS; Peri K, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01640-6; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Vermeiren S, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.09.010; Yeung P, 2017, AOTEAROA N Z SOC WOR, V29, P84, DOI 10.11157/anzswj-vol29iss4id419	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264715	10.1371/journal.pone.0264715	http://dx.doi.org/10.1371/journal.pone.0264715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235598	Green Published, gold			2022-12-26	WOS:000787073100011
J	Kessler, D; Hevenstone, D				Kessler, Dorian; Hevenstone, Debra			The impact of unemployment benefits on birth outcomes: Quasi-experimental evidence from European linked register data	PLOS ONE			English	Article							JOB LOSS; HEALTH; INSURANCE; WEIGHT; STRESS; INCOME	Cash transfers have been shown to improve birth outcomes by improving maternal nutrition, increasing healthcare use, and reducing stress. Most of the evidence focuses on programs targeting the poorest in the US-a context with non-universal access to healthcare and strong health inequalities. It is thus unclear whether these results would apply to cash transfers targeting a less disadvantaged population and whether they apply to other contexts. We provide evidence on the impact of unemployment benefits on birth outcomes in Switzerland, where access to healthcare is near-universal and social assistance is relatively generous. Our study taps into a policy reform that reduced unemployment benefits by 56%. We use linked parent-child register data and difference-in-differences estimates as well as within sibling comparisons. We find that the reform did not impact birth outcomes when fathers were unemployed but reduced the birthweight of children when mothers were unemployed by 80g and body length by 6mm. There are stronger effects for children whose mothers were the primary earner before job loss, but effects do not differ systematically by household income. These results suggest that in the Swiss context, unemployment benefits improve birth outcomes by reducing (job search) stress rather than by improving nutrition or healthcare use. As such, cash transfers likely play a role for newborn health in most other contexts.	[Kessler, Dorian; Hevenstone, Debra] Bern Univ Appl Sci, Social Work Dept, Bern, Switzerland		Kessler, D (corresponding author), Bern Univ Appl Sci, Social Work Dept, Bern, Switzerland.	dorian.kessler@bfh.ch		, Dorian/0000-0003-0495-0858	Swiss National Science Foundation [176371]; Bern University of Applied Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bern University of Applied Sciences	This research was funded by the Swiss National Science Foundation (grant nr. 176371) and Bern University of Applied Sciences.	Aizer A, 2016, J HUM RESOUR, V51, P523, DOI [10.3368/jhr.51.3.0914-6664R, 10.3386/w18422]; Aizer A, 2014, SCIENCE, V344, P856, DOI 10.1126/science.1251872; Almond D, 2011, REV ECON STAT, V93, P387, DOI 10.1162/REST_a_00089; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Barreca A, 2015, HEALTH ECON, V24, P400, DOI 10.1002/hec.3026; Behrman JR, 2004, REV ECON STAT, V86, P586, DOI 10.1162/003465304323031139; Bharadwaj P, 2014, J PUBLIC ECON, V115, P72, DOI 10.1016/j.jpubeco.2014.04.008; Black SE, 2007, Q J ECON, V122, P409, DOI 10.1162/qjec.122.1.409; Black SE, 2015, ILR REV, V68, P833, DOI 10.1177/0019793915586381; Bockerman P, 2009, HEALTH ECON, V18, P161, DOI 10.1002/hec.1361; Brand JE, 2015, ANNU REV SOCIOL, V41, P359, DOI 10.1146/annurev-soc-071913-043237; Bukowski J, 2001, J OCCUP ENVIRON MED, V43, P377, DOI 10.1097/00043764-200104000-00016; Butikofer A, 2017, REV ECON HOUSEHOLD, V15, P433, DOI 10.1007/s11150-014-9255-8; CCO, 2018, IND INC ACC; CURRIE J, 1993, AM ECON REV, V83, P971; Currie J, 2013, J HEALTH ECON, V32, P487, DOI 10.1016/j.jhealeco.2013.01.004; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; De Cao E., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3543980, DOI 10.2139/SSRN.3543980]; Donahue SMA, 2010, OBSTET GYNECOL, V115, P357, DOI 10.1097/AOG.0b013e3181cbd5f5; Federal Council, 2006, VER 1 NOV 2006 INF A; Foster EM, 2010, HEALTH SERV RES, V45, P1083, DOI 10.1111/j.1475-6773.2010.01115.x; FSO, 2019, POP HOUS STAT STATPO; FSO, 2019, VIT STAT BEVNAT; Fu W, 2019, J HEALTH ECON, V63, P34, DOI 10.1016/j.jhealeco.2018.10.004; Haushofer J, 2016, Q J ECON, V131, P1973, DOI 10.1093/qje/qjw025; Hillier-Brown F, 2019, SCAND J PUBLIC HEALT, V47, P655, DOI 10.1177/1403494819848276; Hogberg B, 2021, INTERGENERATIONAL EF; Hoynes H, 2015, AM ECON J-ECON POLIC, V7, P172, DOI 10.1257/pol.20120179; Kataoka MC, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1694-4; Kuhn A, 2009, J HEALTH ECON, V28, P1099, DOI 10.1016/j.jhealeco.2009.09.004; Kuka E, 2020, REV ECON STAT, V102, P490, DOI 10.1162/rest_a_00865; Lindo JM, 2011, J HEALTH ECON, V30, P869, DOI 10.1016/j.jhealeco.2011.06.008; Liu T, 2021, NAT COMPUT SCI, V1, P24, DOI 10.1038/s43588-020-00005-8; Noghanibehambari H, 2020, HEALTH ECON, V29, P1813, DOI 10.1002/hec.4170; Obinger H, 1999, J EUR SOC POLICY, V9, P29, DOI 10.1177/095892879900900102; OECD, 2017, HLTH GLANC 2017 OECD; OECD, 2018, OECD EMPL OUTL, P185; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Persson P, 2018, AM ECON REV, V108, P1214, DOI 10.1257/aer.20141406; Ramakrishnan U, 1999, NUTR RES, V19, P103, DOI 10.1016/S0271-5317(98)00178-X; Regmi K, 2020, NATL BUREAU EC RES N; Ridley M, 2020, SCIENCE, V370, P1289, DOI 10.1126/science.aay0214; Schaller J, 2015, J HEALTH ECON, V43, P190, DOI 10.1016/j.jhealeco.2015.07.003; Schmieder JF, 2016, ANNU REV ECON, V8, P547, DOI 10.1146/annurev-economics-080614-115758; Schmitz H, 2011, LABOUR ECON, V18, P71, DOI 10.1016/j.labeco.2010.08.005; Schwandt H., 2018, LAST LEG SEAS INFL I; SECO, 2013, ARB SCHWEIZ 2012; Shahidi FV, 2019, SOC SCI MED, V226, P198, DOI 10.1016/j.socscimed.2019.02.047; Skrivankova V, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027834; Sun SC, 2021, ANNU REV PUBL HEALTH, V42, P363, DOI 10.1146/annurev-publhealth-090419-102442; Taylor CA, 2021, CICADIAN RHYTHM INSE, P46; Torche F, 2018, DEMOGRAPHY, V55, P1611, DOI 10.1007/s13524-018-0700-9; UNICEF-WHO, 2019, LOW BIRTHW EST LEV T	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264544	10.1371/journal.pone.0264544	http://dx.doi.org/10.1371/journal.pone.0264544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T6JP	35235603	gold, Green Published			2022-12-26	WOS:000787073100039
J	Kugeler, KJ; Williamson, J; Curns, AT; Healy, JM; Nolen, LD; Clark, TA; Martin, SW; Fischer, M				Kugeler, Kiersten J.; Williamson, John; Curns, Aaron T.; Healy, Jessica M.; Nolen, Leisha D.; Clark, Thomas A.; Martin, Stacey W.; Fischer, Marc			Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States-January-July, 2021	PLOS ONE			English	Article							PRACTICES INTERIM RECOMMENDATION; 8 US LOCATIONS; ADVISORY-COMMITTEE; COVID-19 VACCINES; FRONTLINE WORKERS; PFIZER-BIONTECH; HOSPITALIZATIONS; BNT162B2; DEATHS	As of March 2021, three COVID-19 vaccines had been authorized by the U.S. Food and Drug Administration (FDA) for use in the United States. Each has substantial efficacy in preventing COVID-19. However, as efficacy from trials was <100% for all three vaccines, disease in vaccinated people is expected to occur. We created a spreadsheet-based tool to estimate the number of symptomatic COVID-19 cases among vaccinated people (vaccine breakthrough infections) based on published vaccine efficacy (VE) data, percent of the population that has been fully vaccinated, and average number of COVID-19 cases reported per day. We estimate that approximately 199,000 symptomatic vaccine breakthrough infections (95% CI: ~183,000-214,000 cases) occurred in the United States during January-July 2021 among >156 million fully vaccinated people. With high SARS-CoV-2 transmission and increasing numbers of people vaccinated in the United States, vaccine breakthrough infections will continue to accumulate. Understanding expectations regarding number of vaccine breakthrough infections enables accurate public health messaging to help ensure that the occurrence of such cases does not negatively affect vaccine perceptions, confidence, and uptake.	[Kugeler, Kiersten J.; Williamson, John; Curns, Aaron T.; Healy, Jessica M.; Nolen, Leisha D.; Clark, Thomas A.; Martin, Stacey W.; Fischer, Marc] Ctr Dis Control & Prevent CDC, COVID 19 Response Team, Ft Collins, CO 80521 USA	Centers for Disease Control & Prevention - USA	Kugeler, KJ (corresponding author), Ctr Dis Control & Prevent CDC, COVID 19 Response Team, Ft Collins, CO 80521 USA.	bio1@cdc.gov						Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Britton A, 2021, MMWR-MORBID MORTAL W, V70, P396, DOI 10.15585/mmwr.mm7011e3; Cavanaugh AM, 2021, MMWR-MORBID MORTAL W, V70, P639, DOI 10.15585/mmwr.mm7017e2; Centers for Disease Control and Prevention, CDC COVID DAT TRACK; Centers for Disease Control Prevention, SARS COV 2 VAR CLASS; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Fowlkes A, 2021, MMWR-MORBID MORTAL W, V70, P1167, DOI 10.15585/mmwr.mm7034e4; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Janssen Biotech Inc, FDA BRIEF DOC 2021; Oliver SE, 2021, MMWR-MORBID MORTAL W, V70, P329, DOI 10.15585/mmwr.mm7009e4; Oliver SE, 2021, MMWR-MORBID MORTAL W, V69, P1653, DOI 10.15585/mmwr.mm695152e1; Oliver SE, 2020, MMWR-MORBID MORTAL W, V69, P1922, DOI 10.15585/mmwr.mm6950e2; Pilishvili T, 2021, MMWR-MORBID MORTAL W, V70, P753, DOI 10.15585/mmwr.mm7020e2externalicon; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Scobie HM, 2021, MMWR-MORBID MORTAL W, V70, P1284, DOI 10.15585/mmwr.mm7037e1; Swift MD, 2021, CLIN INFECT DIS, V73, pE1376, DOI 10.1093/cid/ciab361; Tande AJ, 2022, CLIN INFECT DIS, V74, P59, DOI 10.1093/cid/ciab229; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P674, DOI 10.15585/mmwr.mm7018e1; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; United States Food and Drug Administration, PFIZ BIONTECH EM US; United States Food and Drug Administration, MODERNATX EM US AUTH; United States Food and Drug Administration, JANSS BIOT EM US AUT	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264179	10.1371/journal.pone.0264179	http://dx.doi.org/10.1371/journal.pone.0264179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263352	Green Published, gold			2022-12-26	WOS:000804638700053
J	Mulindwa, F; Kamal, H; Castelnuovo, B; Bollinger, RC; Schwarz, JM; Brussealers, N				Mulindwa, Frank; Kamal, Habiba; Castelnuovo, Barbara; Bollinger, Robert C.; Schwarz, Jean-Marc; Brussealers, Nele			Association between integrase strand transfer inhibitor (INSTIs) use with insulin resistance and incident diabetes mellitus in persons living with HIV: A systematic review and meta-analysis protocol	PLOS ONE			English	Review							METABOLIC SYNDROME; DOLUTEGRAVIR; HYPERGLYCEMIA	IntroductionPoeple living with HIV have higher prevalence of diabetes mellitus and metabolic perturbations compared to non-HIV populations. Diabetes and metabolic syndrome co-morbidities add significant burden to HIV care. Currently, WHO recommends integrase strand transfer inhibitors (INSTIs) as the first or second line therapy in people with HIV due to overall good tolerability and safety profile. However, whether INSTI use increases the risk of incident diabetes (with or without metabolic syndrome) compared to other anti-retroviral therapies (ART) is controversial. In this systematic review and meta-analysis, we aim to examine this risk in HIV-positive populations receiving INSTIs compared to other ART regimens (not containing INSTIs).Methods and analysisThe study will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement and the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines. This protocol adheres to the Standard Protocol Items for reporting systematic reviews and meta-analyses checklist. Eligibility criteria will be original peer-reviewed published articles and conference abstracts with no language or geographical restriction; that report the ocurrence of diabetes mellitus as a discrete outcome or part of metabolic syndrome, in adult PLWHIV receiving INSTIs compared to other ART regimens. PubMed/ Medline, Web of Science, Embase and Cochrane Database of Systematic Reviews will be searched from 1st- January-2000 to 31st-January-2022. Per our a priori, screening, inclusion and data extraction will be conducted separately by two investigators, and a senior researcher will be consulted in case of disagreement. The quality of included studies will be assessed by the Newcastle-Ottawa Scale (NOS) for cohort and case-control studies and the revised Cochrane risk-of-bias tool (ROB2) for randomized controlled trials. The quantitative synthesis of the study outcomes will be explored in different subgroups and sensitivity analyses. Meta regression will also be performed to further test the predictors of the outcome.Ethics and disseminationEthical approval is waived as the study is a review of published litterature. The analyses will be presented in conferences and published as a scientific article.Trial registrartion PROSPERO registration number is; CRD42021273040.	[Mulindwa, Frank; Castelnuovo, Barbara] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Kamal, Habiba; Brussealers, Nele] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Kamal, Habiba] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden; [Bollinger, Robert C.] Johns Hopkins Univ JHU, Sch Med, Baltimore, MD USA; [Schwarz, Jean-Marc] Univ Calif San Francisco, Sch Med, San Francisco, CA USA	Makerere University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Johns Hopkins University; University of California System; University of California San Francisco	Mulindwa, F (corresponding author), Makerere Univ, Infect Dis Inst, Kampala, Uganda.	mulindwafrank93@gmail.com						Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Fong PS, 2017, INT J STD AIDS, V28, P626, DOI 10.1177/0956462416675107; Gutch Manish, 2015, Indian J Endocrinol Metab, V19, P160, DOI 10.4103/2230-8210.146874; Kassem Bourgi J. R. K., 2019, GREATER WEIGHT GAIN, DOI [10.1093/ofid/ofz491, DOI 10.1093/OFID/OFZ491]; Lamorde M, 2020, LANCET HIV, V7, pE461, DOI 10.1016/S2352-3018(20)30042-4; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; McLaughlin M, 2018, J ANTIMICROB CHEMOTH, V73, P258, DOI 10.1093/jac/dkx365; Menard A, 2017, AIDS, V31, P1499, DOI 10.1097/QAD.0000000000001495; MOOSE, MET AN OBS STUD EP C; Rebeiro PF, 2019, OPEN FORUM INFECT S2, V6, pS996, DOI DOI 10.1093/OFID/OFZ415.2492; Scholar E., 2009, XPHARM COMPREHENSIVE, P1; Shah S, 2021, CURR OPIN INFECT DIS, V34, P16, DOI 10.1097/QCO.0000000000000695; Ursenbach A, 2020, J ANTIMICROB CHEMOTH, V75, P3344, DOI 10.1093/jac/dkaa330; WHO, 2019, WHO POL AD IMPL STAT	15	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264792	10.1371/journal.pone.0264792	http://dx.doi.org/10.1371/journal.pone.0264792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235607	Green Published, gold			2022-12-26	WOS:000787073100018
J	Otsuka, K; Sawai-Ogawa, M; Kihara, A				Otsuka, Kento; Sawai-Ogawa, Megumi; Kihara, Akio			Formation of fatty alcohols-components of meibum lipids-by the fatty acyl-CoA reductase FAR2 is essential for dry eye prevention	FASEB JOURNAL			English	Article						dry eye; fatty acyl-CoA reductase; fatty alcohol; lipid; meibum lipid	GLAND DYSFUNCTION REPORT; MEIBOMIAN GLAND; INTERNATIONAL WORKSHOP; PATHOPHYSIOLOGY; SUBCOMMITTEE; PHYSIOLOGY; BARRIER; ELOVL1; ACIDS	Various lipids (mainly meibum lipids secreted by the meibomian glands) are present in the tear film lipid layer and play important roles in tear stability and the health of the cornea and conjunctiva. Many meibum lipids contain fatty alcohols (FAls) with chain lengths >= C24, but the fatty acyl-CoA reductases (FARs) that produce them remain unclear. Here, using cell-based assays, we found that the two FAR isozymes (FAR1 and FAR2) show different substrate specificities: FAR1 and FAR2 are involved in the production of C16-C18 and >= C20 FAls, respectively. Next, we generated Far2 knockout (KO) mice and examined their dry eye phenotype and meibum lipid composition. These mice showed a severe dry eye phenotype, characterized by plugged meibomian gland orifices, corneal damage, and tear film instability. The plugging was attributed to an increase in the melting point of the meibum lipids. Liquid chromatography coupled with tandem mass spectrometry revealed that FAl-containing meibum lipids (wax monoesters and types 1 omega, 2 alpha, and 2 omega wax diesters) with a hydroxyl group at position 1 were almost completely absent in Far2 KO mice. The levels of di-unsaturated (O-acyl)-omega-hydroxy fatty acids were higher in Far2 KO mice than in wild type mice, but those of tri-unsaturated ones were comparable, suggesting the presence of two synthesis pathways for type 1 omega wax diesters. These results indicate the importance of FAl-containing meibum lipids in the formation of a functional tear film lipid layer. In addition, our study provides clues to the molecular mechanism of the biosynthesis of meibum lipids.	[Otsuka, Kento; Sawai-Ogawa, Megumi; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Sapporo, Hokkaido, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788	Japan Agency for Medical Research and Development (AMED) [JP20gm0910002h0006]; MEXT \ Japan Society for the Promotion of Science (JSPS) [19J22148, 18H03976]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP20gm0910002h0006; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18H03976; MHEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 19J22148	Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Bron AJ, 2017, OCUL SURF, V15, P438, DOI 10.1016/j.jtos.2017.05.011; Butovich IA, 2017, EXP EYE RES, V163, P2, DOI 10.1016/j.exer.2017.06.020; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Craig JP, 2017, OCUL SURF, V15, P802, DOI 10.1016/j.jtos.2017.08.003; Cwiklik L, 2016, BBA-BIOMEMBRANES, V1858, P2421, DOI 10.1016/j.bbamem.2016.02.020; Dunphy JC, 2001, ENVIRON SCI TECHNOL, V35, P1223, DOI 10.1021/es001491q; Georgiev GA, 2014, SOFT MATTER, V10, P5579, DOI 10.1039/c4sm00758a; Goto H, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100605; Green-Church KB, 2011, INVEST OPHTH VIS SCI, V52, P1979, DOI 10.1167/iovs.10-6997d; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Horwath-Winter J, 2003, ARCH OPHTHALMOL-CHIC, V121, P1364, DOI 10.1001/archopht.121.10.1364; IYENGAR BTR, 1969, LIPIDS, V4, P28, DOI 10.1007/BF02531790; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Lemp MA, 2012, CORNEA, V31, P472, DOI 10.1097/ICO.0b013e318225415a; MAHADEVAN V, 1962, J LIPID RES, V3, P106; Miyamoto M, 2020, ELIFE, V9, DOI 10.7554/eLife.53582; Naganuma T, 2016, J BIOL CHEM, V291, P11676, DOI 10.1074/jbc.M116.714030; NICOLAIDES N, 1981, INVEST OPHTH VIS SCI, V20, P522; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Ohno Y, 2009, GENES CELLS, V14, P911, DOI 10.1111/j.1365-2443.2009.01319.x; Potter KA, 2011, GLIA, V59, P1009, DOI 10.1002/glia.21172; Sassa T, 2018, FASEB J, V32, P2966, DOI 10.1096/fj.201700947R; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Sawai M, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102478; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Sundberg JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205775; Tanno H, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2020.158842; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Wallace M, 2018, NAT CHEM BIOL, V14, P1021, DOI 10.1038/s41589-018-0132-2; Widjaja-Adhi MAK, 2020, FASEB J, V34, P13792, DOI 10.1096/fj.202001191R; Wolffsohn JS, 2017, OCUL SURF, V15, P539, DOI 10.1016/j.jtos.2017.05.001	36	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22216	10.1096/fj.202101733R	http://dx.doi.org/10.1096/fj.202101733R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CO	35238077				2022-12-26	WOS:000772945200001
J	Wang, GF; Dong, QC; Bai, Y; Gu, J; Tao, QP; Yue, JJ; Zhou, R; Niu, XY; Zhu, L; Song, CW; Zheng, T; Wang, D; Jin, YW; Liu, HN; Cao, C; Liu, X				Wang, Guang-Fei; Dong, Qincai; Bai, Yu; Gu, Jing; Tao, Qingping; Yue, Junjie; Zhou, Rui; Niu, Xiayang; Zhu, Lin; Song, Caiwei; Zheng, Tong; Wang, Di; Jin, Yanwen; Liu, Hainan; Cao, Cheng; Liu, Xuan			c-Abl kinase-mediated phosphorylation of gamma-tubulin promotes gamma-tubulin ring complexes assembly and microtubule nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING DOMAINS; TYROSINE KINASE; F-ACTIN; CENTROSOME; PROTEIN; GENE; CELL; MALFORMATIONS; LOCALIZATION; DYNAMICS	Cytoskeletal microtubules (MTs) are nucleated from gamma-tubulin ring complexes (gamma TuRCs) located at MT organizing centers (MTOCs), such as the centrosome. However, the exact regulatory mechanism of gamma TuRC assembly is not fully understood. Here, we showed that the nonreceptor tyrosine kinase c-Abl was associated with and phosphorylated gamma-tubulin, the essential component of the gamma TuRC, mainly on the Y443 residue by in vivo (immunofluorescence and immunoprecipitation) or in vitro (surface plasmon resonance) detection. We further demonstrated that phosphorylation deficiency significantly impaired gamma TuRC assembly, centrosome construction, and MT nucleation. c-Abl/Arg deletion and gamma-tubulin Y443F mutation resulted in an abnormal morphology and compromised spindle function during mitosis, eventually causing uneven chromosome segregation. Our findings reveal that gamma TuRC assembly and nucleation function are regulated by Abl kinase-mediated gamma-tubulin phosphorylation, revealing a fundamental mechanism that contributes to the maintenance of MT function.	[Wang, Guang-Fei; Dong, Qincai; Yue, Junjie; Zhu, Lin; Song, Caiwei; Zheng, Tong; Jin, Yanwen; Liu, Hainan; Cao, Cheng; Liu, Xuan] Beijing Inst Biotechnol, Dept Genet Engn, Beijing, Peoples R China; [Bai, Yu; Gu, Jing; Tao, Qingping; Zhou, Rui; Niu, Xiayang; Wang, Di] Anhui Univ, Inst Phys Sci, Hefei, Peoples R China	Anhui University; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Liu, HN; Cao, C; Liu, X (corresponding author), Beijing Inst Biotechnol, Dept Genet Engn, Beijing, Peoples R China.	jerrylhn@126.com; caoc@nic.bmi.ac.cn; liux931932@163.com	Cao, Cheng/GNP-6156-2022	Yue, Junjie/0000-0002-2549-9261	National Natural Science Foundation of China; China Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Cheng Cao reports financial support was provided by National Natural Science Foundation of China. Guang-Fei Wang reports financial support was provided by China Postdoctoral Science Foundation.	Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; Bastians Holger, 2015, Recent Results Cancer Res, V200, P95, DOI 10.1007/978-3-319-20291-4_5; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Diaz-Corrales FJ, 2005, NEUROSCIENCE, V133, P117, DOI 10.1016/j.neuroscience.2005.01.044; Eklund G, 2014, J BIOL CHEM, V289, P21360, DOI 10.1074/jbc.M114.562389; Estrada LD, 2011, CURR ALZHEIMER RES, V8, P643; Fuller SD, 1995, CURR BIOL, V5, P1384, DOI 10.1016/S0960-9822(95)00276-4; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Gonfloni Stefania, 2012, Int J Cell Biol, V2012, P683097, DOI 10.1155/2012/683097; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Hebron ML, 2013, HUM MOL GENET, V22, P3315, DOI 10.1093/hmg/ddt192; Hu YH, 2019, J CELL BIOL, V218, P3986, DOI 10.1083/jcb.201812144; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Ivanova EL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10081-8; Keck JM, 2011, SCIENCE, V332, P1557, DOI 10.1126/science.1205193; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; KIPREOS ET, 1992, SCIENCE, V256, P382, DOI 10.1126/science.256.5055.382; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; KRUH GD, 1990, P NATL ACAD SCI USA, V87, P5802, DOI 10.1073/pnas.87.15.5802; Kukharskyy V, 2004, EXP CELL RES, V298, P218, DOI 10.1016/j.yexcr.2004.04.016; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Magiera M. M., 2018, EXCESSIVE TUBULIN PO; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Moudjou M, 1996, J CELL SCI, V109, P875; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Shang YH, 2005, J CELL BIOL, V171, P1035, DOI 10.1083/jcb.200508184; Sulimenko V, 2006, J IMMUNOL, V176, P7243, DOI 10.4049/jimmunol.176.12.7243; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wang JYJ, 2014, MOL CELL BIOL, V34, P1188, DOI 10.1128/MCB.01454-13; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Wieczorek M, 2020, CELL, V180, P165, DOI 10.1016/j.cell.2019.12.007; Woodruff JB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0459; Yuba-Kubo A, 2005, DEV BIOL, V282, P361, DOI 10.1016/j.ydbio.2005.03.031; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	48	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101778	10.1016/j.jbc.2022.101778	http://dx.doi.org/10.1016/j.jbc.2022.101778			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35231444	Green Published, gold			2022-12-26	WOS:000793692600010
J	Ji, XJ; Zhao, LH; Umapathy, A; Fitzmaurice, B; Wang, JP; Williams, DS; Chang, B; Naggert, JK; Nishina, PM				Ji, Xiaojie; Zhao, Lihong; Umapathy, Ankita; Fitzmaurice, Bernard; Wang, Jieping; Williams, David S.; Chang, Bo; Naggert, Jurgen K.; Nishina, Patsy M.			Deficiency in Lyst function leads to accumulation of secreted proteases and reduced retinal adhesion	PLOS ONE			English	Article							CHEDIAK-HIGASHI-SYNDROME; C GENE POLYMORPHISM; OXIDATIVE STRESS; CATHEPSIN-B; NEUROPATHOLOGICAL CHANGES; DICTYOSTELIUM LVSB; PIGMENT EPITHELIUM; MOUSE MODEL; DETACHMENT; FUSION	Chediak-Higashi syndrome, caused by mutations in the Lysosome Trafficking Regulator (Lyst) gene, is a recessive hypopigmentation disorder characterized by albinism, neuropathies, neurodegeneration, and defective immune responses, with enlargement of lysosomes and lysosome-related organelles. Although recent studies have suggested that Lyst mutations impair the regulation of sizes of lysosome and lysosome-related organelle, the underlying pathogenic mechanism of Chediak-Higashi syndrome is still unclear. Here we show striking evidence that deficiency in LYST protein function leads to accumulation of photoreceptor outer segment phagosomes in retinal pigment epithelial cells, and reduces adhesion between photoreceptor outer segment and retinal pigment epithelial cells in a mouse model of Chediak-Higashi syndrome. In addition, we observe elevated levels of cathepsins, matrix metallopeptidase (MMP) 3 and oxidative stress markers in the retinal pigment epithelium of Lyst mutants. Previous reports showed that impaired degradation of photoreceptor outer segment phagosomes causes elevated oxidative stress, which could consequently lead to increases of cysteine cathepsins and MMPs in the extracellular matrix. Taken together, we conclude that the loss of LYST function causes accumulation of phagosomes in the retinal pigment epithelium and elevation of several extracellular matrix-remodeling proteases through oxidative stress, which may, in turn, reduce retinal adhesion. Our work reveals previously unreported pathogenic events in the retinal pigment epithelium caused by Lyst deficiency. The same pathogenic events may be conserved in other professional phagocytic cells, such as macrophages in the immune system, contributing to overall Chediak-Higashi syndrome pathology.	[Ji, Xiaojie; Zhao, Lihong; Fitzmaurice, Bernard; Wang, Jieping; Chang, Bo; Naggert, Jurgen K.; Nishina, Patsy M.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Ji, Xiaojie] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA; [Umapathy, Ankita; Williams, David S.] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA; [Umapathy, Ankita; Williams, David S.] Univ Calif Los Angeles, Stein Eye Inst, Los Angeles, CA USA; [Williams, David S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Williams, David S.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Williams, David S.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	Jackson Laboratory; University of Maine System; University of Maine Orono; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Naggert, JK; Nishina, PM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Juergen.Naggert@jax.org; Patsy.Nishina@jax.org			NIH [EY011996, EY027860, EY019943, CA034196];  [R01EY027442];  [P30EY000331]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This work is supported by NIH Grant EY011996 and EY027860 to P.M.N., and EY019943 to B.C. The Jackson Laboratory Scientific Services is supported by NIH Grant CA034196. Partial funding from R01EY027442 and core grant P30EY000331 (to D.S.W.) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal N, 2014, PROTEOM CLIN APPL, V8, P427, DOI 10.1002/prca.201300105; Alge-Priglinger CS, 2009, INVEST OPHTH VIS SCI, V50, P5495, DOI 10.1167/iovs.08-3193; Ali MAM, 2009, FRONT BIOSCI-LANDMRK, V14, P699, DOI 10.2741/3274; Alizadeh P, 2006, EXP EYE RES, V83, P679, DOI 10.1016/j.exer.2006.03.009; Alloatti A, 2015, IMMUNITY, V43, P1087, DOI 10.1016/j.immuni.2015.11.006; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; BENEZRA D, 1980, J PEDIAT OPHTH STRAB, V17, P68; BLUME RS, 1972, MEDICINE, V51, P247, DOI 10.1097/00005792-197207000-00001; BOULTON M, 1989, INVEST OPHTH VIS SCI, V30, P82; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; BURKHARDT JK, 1993, J EXP MED, V178, P1845, DOI 10.1084/jem.178.6.1845; Charette SJ, 2008, TRAFFIC, V9, P588, DOI 10.1111/j.1600-0854.2008.00706.x; Charette SJ, 2007, J CELL SCI, V120, P2338, DOI 10.1242/jcs.009001; Cullinane AR, 2013, TRAFFIC, V14, P749, DOI 10.1111/tra.12069; DRAEGER J, 1975, KLIN MONATSBL AUGENH, V166, P431; Durchfort N, 2012, TRAFFIC, V13, P108, DOI 10.1111/j.1600-0854.2011.01300.x; Esteve-Rudd J, 2018, P NATL ACAD SCI USA, V115, P5468, DOI 10.1073/pnas.1709211115; Fairfield H, 2015, GENOME RES, V25, P948, DOI 10.1101/gr.186882.114; Falkenstein K, 2014, J CELL SCI, V127, P4356, DOI 10.1242/jcs.138123; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; Gencer S, 2013, CHINESE J CANCER RES, V25, P322, DOI 10.3978/j.issn.1000-9604.2013.06.05; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Gonzales CR, 2008, RETINA-J RET VIT DIS, V28, P847, DOI 10.1097/IAE.0b013e3181679f79; Hammel I, 2010, J CELL MOL MED, V14, P1904, DOI 10.1111/j.1582-4934.2010.01071.x; Harris E, 2002, MOL BIOL CELL, V13, P656, DOI 10.1091/mbc.01-09-0454; HIRANO A, 1971, J NEUROPATH EXP NEUR, V30, P470, DOI 10.1097/00005072-197107000-00011; Holden B, 2014, EYE, V28, P142, DOI 10.1038/eye.2013.256; Huynh C, 2004, P NATL ACAD SCI USA, V101, P16795, DOI 10.1073/pnas.0405905101; Introne W, 1999, MOL GENET METAB, V68, P283, DOI 10.1006/mgme.1999.2927; Ji XJ, 2016, INVEST OPHTH VIS SCI, V57, P877, DOI 10.1167/iovs.15-17495; Jiang M, 2015, J CELL BIOL, V210, P595, DOI 10.1083/jcb.201410112; Jordans S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-23; Kaplan J, 2008, CURR OPIN HEMATOL, V15, P22, DOI 10.1097/MOH.0b013e3282f2bcce; Katunuma N, 2003, BIOL CHEM, V384, P883, DOI 10.1515/BC.2003.099; Kypri E, 2007, TRAFFIC, V8, P774, DOI 10.1111/j.1600-0854.2007.00567.x; Kypri E, 2013, TRAFFIC, V14, P599, DOI 10.1111/tra.12058; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Lin C, 2003, CHINESE J PHYSIOL, V46, P111; Lozano ML, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0132-6; Lu YB, 2005, J IMMUNOL, V175, P5423, DOI 10.4049/jimmunol.175.8.5423; MICELI MV, 1994, EXP CELL RES, V214, P242, DOI 10.1006/excr.1994.1254; MISRA VP, 1991, ACTA NEUROPATHOL, V81, P354, DOI 10.1007/BF00305881; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; Nandrot EF, 2006, AM J PHYSIOL-CELL PH, V290, pC1256, DOI 10.1152/ajpcell.00480.2005; Nentwich MM, 2015, WORLD J DIABETES, V6, P489, DOI 10.4239/wjd.v6.i3.489; Olsen T W, 1995, Semin Ophthalmol, V10, P17, DOI 10.3109/08820539509059976; PADGETT GA, 1968, J PATHOL BACTERIOL, V95, P509, DOI 10.1002/path.1700950224; Paraoan L, 2003, EXP EYE RES, V76, P753, DOI 10.1016/S0014-4835(03)00061-7; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; Perou CM, 1997, J BIOL CHEM, V272, P29790, DOI 10.1074/jbc.272.47.29790; Porter K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068668; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Rahman M, 2012, TRAFFIC, V13, P1680, DOI 10.1111/tra.12005; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Sundberg J., 2000, SYSTEMATIC APPROACH; SUNG JH, 1969, J NEUROPATH EXP NEUR, V28, P86, DOI 10.1097/00005072-196901000-00005; SUNG JH, 1968, J NEUROPATH EXP NEUR, V27, P156; Tardieu M, 2005, BLOOD, V106, P40, DOI 10.1182/blood-2005-01-0319; TATE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1271; Tchernev VT, 2002, MOL MED, V8, P56, DOI 10.1007/BF03402003; Trantow CM, 2011, INVEST OPHTH VIS SCI, V52, P237, DOI 10.1167/iovs.10-5479; VALENZUELA R, 1981, AM J CLIN PATHOL, V75, P591; Vidak E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030264; Vigil-De Gracia P, 2011, INT J GYNECOL OBSTET, V114, P223, DOI 10.1016/j.ijgo.2011.04.003; Vilaplana F, 2015, Arch Soc Esp Oftalmol, V90, P264, DOI 10.1016/j.oftal.2014.11.001; Volland S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125631; Ward Diane McVey, 2002, Current Molecular Medicine (Hilversum), V2, P469, DOI 10.2174/1566524023362339; Ward DM, 2000, TRAFFIC, V1, P816; WHITE JG, 1979, AM J PATHOL, V96, P781; WILLIAMS DS, 1987, INVEST OPHTH VIS SCI, V28, P184; Yagi F, 2014, SEMIN OPHTHALMOL, V29, P66, DOI 10.3109/08820538.2012.760627; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zeng R, 2012, INVEST OPHTH VIS SCI, V53, P1685, DOI 10.1167/iovs.11-8241; ZHAO HQ, 1994, LAB INVEST, V71, P25	76	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0254469	10.1371/journal.pone.0254469	http://dx.doi.org/10.1371/journal.pone.0254469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239671	Green Published, gold			2022-12-26	WOS:000776002200002
J	Nainggolan, O; Hapsari, D; Titaley, CR; Indrawati, L; Dharmayanti, I; Kristanto, AY				Nainggolan, Olwin; Hapsari, Dwi; Titaley, Christiana Rialine; Indrawati, Lely; Dharmayanti, Ika; Kristanto, Antonius Yudi			The relationship of body mass index and mid-upper arm circumference with anemia in non-pregnant women aged 19-49 years in Indonesia: Analysis of 2018 Basic Health Research data	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; IRON-DEFICIENCY; OBESITY; RISK; ASSOCIATION; PREVALENCE; OVERWEIGHT; CHILDREN	Background and objectives Anemia remains a major public health problem worldwide. This study examined the relationship between anemia and the nutritional status of non-pregnant women aged 19-49 years in Indonesia. Methods and study design The data were derived from the 2018 Basic Health Research Data of Indonesia. We used information from 11,471 non-pregnant women aged 19-49 years. The dependent variable was anemia (hemoglobin level <12 g/dL). The independent variable was women's nutritional status, a combined indicator of body mass index (BMI) and mid-upper arm circumference (MUAC). Our analysis controlled for women's age, education, physical activity, fruit and vegetable consumption, and the presence of communicable or non-communicable diseases. We performed logistic regression analyses. Results The prevalence of anemia in non-pregnant women aged 19-49 years was 22.3% (95% confidence interval [CI]: 21.4-23.3). Women with overweight and obesity were less likely to develop anemia than those with a normal BMI, regardless of their MUAC score. The highest odds for developing anemia were observed in underweight women with low MUAC scores (adjusted odds ratio [aOR] = 2.83, 95%CI: 2.19-3.68). Higher odds ratios were also observed in women with insufficient physical activity, despite their sufficient consumption of fruits or vegetables (aOR = 1.87, 95%CI: 1.06-3.28). However, women who had been diagnosed with a non-communicable disease had a reduced likelihood of developing anemia (aOR = 0.75, 95%CI: 0.67-0.83). Conclusions Strengthening health promotion activities to improve nutritional status and healthy behaviors, particularly a healthy diet, remains important for women in Indonesia to reduce the prevalence of anemia and improve their overall health status.	[Nainggolan, Olwin; Hapsari, Dwi; Indrawati, Lely; Dharmayanti, Ika; Kristanto, Antonius Yudi] Minist Hlth Republ Indonesia, Natl Inst Hlth Res & Dev, DKI Jakarta, Ctr Res & Dev Publ Hlth Efforts, Dki Jakarta, Indonesia; [Titaley, Christiana Rialine] Pattimura Univ, Fac Med, Ambon, Indonesia	Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Universitas Pattimura	Titaley, CR (corresponding author), Pattimura Univ, Fac Med, Ambon, Indonesia.	christiana_rialine@yahoo.com		Titaley, Christiana/0000-0002-3023-003X; Tjandrarini, Dwi Hapsari/0000-0001-8313-4722; Dharmayanti, Ika/0000-0001-8368-4732				Abraham Saba., 2015, BMC NUTR, V1, P12, DOI [10.1186/s40795-015-0005-y, DOI 10.1186/S40795-015-0005-Y]; Agudo A, 2005, MEASURING INTAKE FRU; Aigner E, 2014, NUTRIENTS, V6, P3587, DOI 10.3390/nu6093587; Al-alimi AA, 2018, ANEMIA, V2018, DOI 10.1155/2018/4157876; Anderson Alex Kojo, 2017, Int J Chronic Dis, V2017, P7836019, DOI 10.1155/2017/7836019; Bhandari S, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0114-3; Cao C, 2016, REPROD SCI, V23, P613, DOI 10.1177/1933719115607976; Chakraborty R, 2011, RURAL REMOTE HEALTH, V11; Chaparro CM, 2019, ANN NY ACAD SCI, V1450, P15, DOI 10.1111/nyas.14092; Eckhardt CL, 2008, EUR J CLIN NUTR, V62, P238, DOI 10.1038/sj.ejcn.1602727; Flegal KM, 2014, AM J EPIDEMIOL, V180, P288, DOI 10.1093/aje/kwu111; Gautam S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218288; Ghose B, 2016, PEERJ, V4, DOI 10.7717/peerj.1945; Ghosh S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214358; Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635; Hisa K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52798-y; Hunnicutt J, 2014, J NUTR, V144, P359, DOI 10.3945/jn.113.185124; Jones AD, 2016, EUR J CLIN NUTR, V70, P918, DOI 10.1038/ejcn.2015.229; Kariyeva GK., 2005, EGYPTIAN DEMOGRAPHIC, P169; Kim S, 2018, BIOMED RES-TOKYO, V29, P2421; Kordas K, 2013, J NUTR, V143, P175, DOI 10.3945/jn.112.167767; Kulasekaran R.A., 2012, INT J NUTR PHARM NEU, V2, P198, DOI [10.4103/2231-0738.99471, DOI 10.4103/2231-0738.99471]; Kumari S, 2019, ONE HEALTH-AMSTERDAM, V8, DOI 10.1016/j.onehlt.2019.100098; Laghari Z. A., 2017, Sindh University Research Journal -Science Series, V49, P553; Lim S, 2018, J OBES METAB SYNDR, V27, P39, DOI 10.7570/jomes.2018.27.1.39; Manios Y, 2013, J HUM NUTR DIET, V26, P470, DOI 10.1111/jhn.12025; Ministry of Health, 2013, BAS HLTH RES 2013; Ministry of Health, 2018, BAS HLTH RES 2018; Mosha T C E, 2010, Tanzan J Health Res, V12, P6; Mumu SJ., 2017, BMC PUBLIC HEALTH, V17, P1, DOI [10.1186/s12889-016-3954-4, DOI 10.1186/S12889-016-3954-4]; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Park SH, 2019, NUTR RES PRACT, V13, P543, DOI 10.4162/nrp.2019.13.6.543; Qin Y, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-10; Sadeghian Majid, 2013, J Family Reprod Health, V7, P139; Simcox JA., 2013, BONE, V23, P1; Sisay BG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235063; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Sunuwar DR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236449; Surveillance and Population Departement Prevention of Noncommunicable Diseases WHO., 2012, GLOB PHYS ACT QUEST, P1; Tan J, 2018, CHINESE MED J-PEKING, V131, P2566, DOI 10.4103/0366-6999.244109; Welke L, 2017, JOGNN-J OBST GYN NEO, V46, P148, DOI 10.1016/j.jogn.2016.06.013; WHO, 2016, GUID DAIL IR SUPL AD; WHO, 2020, LIF EXP; WHO, 2001, IR DEF AN ASS PREV; WHO, 2017, NONCOMMUNICABLE DIS; WHO/NMH/NHD, 2014, GLOB NUTR TARG 2025; Win Hla Hla, 2018, WHO South East Asia J Public Health, V7, P107, DOI 10.4103/2224-3151.239422; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization,, NONC DIS THEIR RISK; World Health Organization, 2017, GLOB AN RED EFF WOM; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Wu Y, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03222-1; Zheng H, 2020, PUBLIC HEALTH NUTR, V23, P1693, DOI 10.1017/S1368980019003604	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264685	10.1371/journal.pone.0264685	http://dx.doi.org/10.1371/journal.pone.0264685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239719	gold, Green Published			2022-12-26	WOS:000776002200062
J	Rehman, S; Ashfaq, UA; Sufyan, M; Shahid, I; Ijaz, B; Hussain, M				Rehman, Sidra; Ashfaq, Usman Ali; Sufyan, Muhammad; Shahid, Imran; Ijaz, Bushra; Hussain, Mureed			The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer's disease targeting acetylcholinesterase	PLOS ONE			English	Article							INHIBITORS; DRUG	B. vulgaris extracts possess antioxidant, anti-inflammatory along with its role in improving memory disorders. Subsequently, in vitro and in silico studies of its purified phytochemicals may expand complementary and alternative Alzheimer's therapeutic option. Super activation of acetylcholinesterase enzyme is associated explicitly with Alzheimer's disease (AD) ultimately resulting in senile dementia. Hence, acetylcholinesterase enzyme inhibition is employed as a promising approach for AD treatment. Many FDA approved drugs are unable to cure the disease progression completely. The Present study was devised to explore the potential bioactive phytochemicals of B. vulgaris as alternative therapeutic agents against AD by conducting in vitro and in silico studies. To achieve this, chemical structures of phytochemicals were recruited from PubChem. Further, these compounds were analyzed for their binding affinities towards acetylcholinesterase (AChE) enzyme. Pharmacophoric ligand-based models showed major characteristics like, HBA, HBD, hydrophobicity, aromaticity and positively ionizable surface morphology for receptor binding. Virtual screening identified three hit compounds including betanin, myricetin and folic acid with least binding score compared to the reference drug, donepezil (-17 kcal/mol). Further, in vitro studies for anti-acetylcholinesterase activity of betanin and glycine betaine were performed. Dose response analysis showed 1.271 mu M and 1.203 mu M 50% inhibitory concentration (IC50) values for betanin and glycine betaine compounds respectively. Our findings indicate that phytoconstituents of B. vulgaris can be implicated as an alternative therapeutic drug candidate for cognitive disorders like Alzheimer's disease.	[Rehman, Sidra] COMSATS Univ Islamabad CUI, Dept Biosci, Islamabad, Pakistan; [Ashfaq, Usman Ali; Sufyan, Muhammad] Govt Coll Univ Faisalabad, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan; [Shahid, Imran] Umm Al Qura Univ, Fac Med, Dept Pharmacol & Toxicol, Mecca, Saudi Arabia; [Ijaz, Bushra] Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; [Hussain, Mureed] Univ Management & Technol, Dept Life Sci, Lahore, Pakistan	COMSATS University Islamabad (CUI); Government College University Faisalabad; Umm Al Qura University; University of Punjab; University of Management & Technology (UMT)	Rehman, S (corresponding author), COMSATS Univ Islamabad CUI, Dept Biosci, Islamabad, Pakistan.	sidra.cemb@gmail.com	Ashfaq, Usman A/D-7792-2013	Ashfaq, Usman A/0000-0002-5495-805X; Shahid, Imran/0000-0002-9832-3224				Ahmad S, 2012, INT J AGRIC BIOL, V14, P605; Akhoon BA, 2020, J CHEM INF MODEL, V60, P4717, DOI 10.1021/acs.jcim.0c00496; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Anand P, 2013, ARCH PHARM RES, V36, P375, DOI 10.1007/s12272-013-0036-3; Anand P, 2012, BIOORGAN MED CHEM, V20, P521, DOI 10.1016/j.bmc.2011.05.027; Boccia MM, 2003, NEUROSCI LETT, V345, P97, DOI 10.1016/S0304-3940(03)00493-2; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; de Zwart FJ, 2003, FOOD CHEM, V83, P197, DOI 10.1016/S0308-8146(03)00063-3; Demkura PV, 2012, MOL PLANT, V5, P642, DOI 10.1093/mp/sss025; Dias MG, 2009, FOOD CHEM, V113, P808, DOI 10.1016/j.foodchem.2008.08.002; El-Beltagi HS, 2018, FRESEN ENVIRON BULL, V27, P6369; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Felder CE, 1997, J MOL GRAPH MODEL, V15, P318, DOI 10.1016/S1093-3263(98)00005-9; Huang LK, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-019-0609-7; Jain NK, 2012, ACTA POL PHARM, V69, P945; Jarrahpour A, 2012, MED CHEM RES, V21, P1984, DOI 10.1007/s00044-011-9723-0; Jastrebova J, 2003, FOOD CHEM, V80, P579, DOI 10.1016/S0308-8146(02)00506-X; Khalid H., 2021, DISCOVERY NOVEL HCV, V48, P1653; Labute P, 2007, PROTONATE 3D ASSIGNM, P1; Lin J, 2003, CURR TOP MED CHEM, V3, P1125, DOI 10.2174/1568026033452096; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Madadi E, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9091219; Massoulie J, 1999, CHEM-BIOL INTERACT, V119, P29, DOI 10.1016/S0009-2797(99)00011-3; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Massoulie J, 1991, 3 INT M CHOLINESTERA; Patkai G, 1997, CANCER LETT, V114, P105, DOI 10.1016/S0304-3835(97)04636-3; Murray AP, 2013, CURR NEUROPHARMACOL, V11, P388, DOI 10.2174/1570159X11311040004; Petersen LM, 2012, ECOL SOC, V17, DOI 10.5751/ES-04537-170226; Podvinec M., 2008, COMPUTATIONAL STRUCT, P683, DOI DOI 10.1142/9789812778789_0025; Power AE, 2003, NEUROBIOL LEARN MEM, V80, P178, DOI 10.1016/S1074-7427(03)00086-8; Rehman S, 2021, SAUDI J BIOL SCI, V28, P592, DOI 10.1016/j.sjbs.2020.10.048; RIPOLL DR, 1993, P NATL ACAD SCI USA, V90, P5128, DOI 10.1073/pnas.90.11.5128; Roy A., 2018, INT J COMPLEMENT ALT, V11, P1, DOI [10.15406/IJCAM.2018.11.00398, DOI 10.15406/IJCAM.2018.11.00398, 10.15406/ijcam.2018.11.00398]; SEIDMAN S, 1995, MOL CELL BIOL, V15, P2993; SITARAM N, 1978, LIFE SCI, V22, P1555, DOI 10.1016/0024-3205(78)90011-5; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Vali L, 2007, NUTRITION, V23, P172, DOI 10.1016/j.nut.2006.11.004	38	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264074	10.1371/journal.pone.0264074	http://dx.doi.org/10.1371/journal.pone.0264074			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239683	Green Published, gold			2022-12-26	WOS:000776002200018
J	Sivertsson, E; Friederich-Persson, M; Persson, P; Nangaku, M; Hansell, P; Palm, F				Sivertsson, Ebba; Friederich-Persson, Malou; Persson, Patrik; Nangaku, Masaomi; Hansell, Peter; Palm, Fredrik			Thyroid hormone increases oxygen metabolism causing intrarenal tissue hypoxia; a pathway to kidney disease	PLOS ONE			English	Article							IMMUNE-COMPLEX GLOMERULONEPHRITIS; UNCOUPLING PROTEIN-2; TUBULOINTERSTITIAL HYPOXIA; OXIDATIVE-PHOSPHORYLATION; SPECIES PRODUCTION; RENAL OXYGENATION; HYPERTENSIVE RAT; NITRIC-OXIDE; MITOCHONDRIA; NEPHROPATHY	The proposed mechanisms for the development of nephropathy are many, complex and often overlapping. Although recent literature strongly supports a role of kidney hypoxia as an independent pathway to nephropathy, the evidence remains inconclusive since the role of hypoxia is difficult to differentiate from confounding factors such as hyperglycemia, hypertension and oxidative stress. By increasing kidney oxygen consumption using triiodothyronine (T-3) and, thus, avoiding these confounding factors, the aim of the present study was to investigate renal hypoxia per se as a causal pathway for the development of nephropathy. Healthy Sprague-Dawley rats were treated with T-3 (10 mu g/kg/day) and the angiotensin II AT(1)-receptor antagonist candesartan (1 mg/kg in drinking water) to eliminate effects of T-3-induced renin release; and compared to a candesartan treated control group. After 7 weeks of treatment in vivo kidney function, oxygen metabolism and mitochondrial function were evaluated. T-3 did not affect glomerular filtration rate or renal blood flow, but increased total kidney oxygen consumption resulting in cortical hypoxia. Nephropathy, demonstrated as albuminuria and tubulointerstitial fibrosis, developed in T-3-treated animals. Mitochondria uncoupling mediated by uncoupling protein 2 and the adenosine nucleotide transporter was demonstrated as a mechanism causing the increased kidney oxygen consumption. Importantly, blood glucose levels, mean arterial blood pressure and oxidative stress levels were not affected by T-3. In conclusion, the present study provides further evidence for increased kidney oxygen consumption causing intrarenal tissue hypoxia, as a causal pathway for development of nephropathy.	[Sivertsson, Ebba; Friederich-Persson, Malou; Persson, Patrik; Hansell, Peter; Palm, Fredrik] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Nangaku, Masaomi] Univ Tokyo, Dept Med, Tokyo, Japan	Uppsala University; University of Tokyo	Palm, F (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Fredrik.Palm@mcb.uu.se			Swedish Research Council [2019-01730]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	FP. 2019-01730. Swedish Research Council. www.vr.se The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agras PI, 2005, J PEDIATR ENDOCR MET, V18, P319; [Anonymous], 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI DOI 10.1152/ajpregu.00720.2010; [Anonymous], 2018, AM J PHYSIOL-CELL PH, V314, pC404, DOI DOI 10.1152/ajprenal.00033.2017; BABA T, 1986, HORM METAB RES, V18, P630, DOI 10.1055/s-2007-1012391; Bernhardt WM, 2007, AM J PATHOL, V170, P830, DOI 10.2353/ajpath.2007.060455; BREZIS M, 1994, AM J PHYSIOL-RENAL, V267, pF1063, DOI 10.1152/ajprenal.1994.267.6.F1063; Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001; de Cavanagh EMV, 2006, AM J PHYSIOL-REG I, V290, pR1616, DOI 10.1152/ajpregu.00615.2005; De Leo S, 2016, LANCET, V388, P906, DOI 10.1016/S0140-6736(16)00278-6; dos Santos EA, 2007, INVEST RADIOL, V42, P157, DOI 10.1097/01.rli.0000252492.96709.36; Duval C, 2002, BIOCHEM CELL BIOL, V80, P757, DOI 10.1139/O02-158; DZAU VJ, 1982, LIFE SCI, V30, P577, DOI 10.1016/0024-3205(82)90272-7; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Eckardt Kai-Uwe, 2005, Kidney Int Suppl, pS46; Edlund J, 2009, ADV EXP MED BIOL, V645, P199, DOI 10.1007/978-0-387-85998-9_31; Fine LG, 1998, KIDNEY INT, pS74; Fontaine EM, 1996, BBA-BIOENERGETICS, V1276, P181, DOI 10.1016/0005-2728(96)00075-8; Friederich M, 2008, BBA-BIOENERGETICS, V1777, P935, DOI 10.1016/j.bbabio.2008.03.030; Friederich M, 2009, CURR DIABETES REV, V5, P120, DOI 10.2174/157339909788166800; Friederich M, 2009, ADV EXP MED BIOL, V645, P205, DOI 10.1007/978-0-387-85998-9_32; Friederich-Persson M, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13058; Friederich-Persson M, 2013, HYPERTENSION, V62, P914, DOI 10.1161/HYPERTENSIONAHA.113.01425; Friederich-Persson M, 2013, ADV EXP MED BIOL, V789, P9, DOI 10.1007/978-1-4614-7411-1_2; Haidara MA, 2009, J DIABETES COMPLICAT, V23, P130, DOI 10.1016/j.jdiacomp.2008.02.011; Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034; Harper ME, 2008, THYROID, V18, P145, DOI 10.1089/thy.2007.0250; HASHIZUME K, 1982, BIOCHEM BIOPH RES CO, V106, P920, DOI 10.1016/0006-291X(82)91798-3; HORVATH F, 1979, AM J MED, V67, P901, DOI 10.1016/0002-9343(79)90752-6; Ichihara A, 1998, AM J PHYSIOL-ENDOC M, V274, pE224, DOI 10.1152/ajpendo.1998.274.2.E224; Iglesias P, 2017, REV ENDOCR METAB DIS, V18, P131, DOI 10.1007/s11154-016-9395-7; Inoue T, 2011, J AM SOC NEPHROL, V22, P1429, DOI 10.1681/ASN.2010111143; IWAOKA T, 1982, JPN J MED, V21, P29; JORDAN SC, 1981, NEW ENGL J MED, V304, P1212, DOI 10.1056/NEJM198105143042006; Kobori H, 1997, AM J PHYSIOL-ENDOC M, V272, pE227, DOI 10.1152/ajpendo.1997.272.2.E227; Lanni A, 1997, FEBS LETT, V418, P171, DOI 10.1016/S0014-5793(97)01375-6; Lanni A, 2016, COMPR PHYSIOL, V6, P1591, DOI 10.1002/cphy.c150019; LEVY MN, 1959, AM J PHYSIOL, V196, P1336, DOI 10.1152/ajplegacy.1959.196.6.1336; LEVY MN, 1961, AM J PHYSIOL, V200, P159, DOI 10.1152/ajplegacy.1961.200.1.159; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; MICHEL B, 1994, FUNDAM CLIN PHARM, V8, P366, DOI 10.1111/j.1472-8206.1994.tb00814.x; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Nangaku M, 2004, NEPHRON EXP NEPHROL, V98, pE8, DOI 10.1159/000079927; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; OREILLY I, 1992, ACTA ENDOCRINOL-COP, V127, P542, DOI 10.1530/acta.0.1270542; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Palm F, 2006, CLIN EXP PHARMACOL P, V33, P997, DOI 10.1111/j.1440-1681.2006.04473.x; Palm F, 2011, CLIN EXP PHARMACOL P, V38, P424, DOI 10.1111/j.1440-1681.2011.05532.x; Palm F, 2010, HYPERTENSION, V55, P298, DOI 10.1161/HYPERTENSIONAHA.109.135426; Papazova DA, 2015, AM J PHYSIOL-RENAL, V308, pF22, DOI 10.1152/ajprenal.00278.2014; Pascual A, 2013, BBA-GEN SUBJECTS, V1830, P3908, DOI 10.1016/j.bbagen.2012.03.012; Persson MF, 2013, ADV EXP MED BIOL, V765, P217, DOI 10.1007/978-1-4614-4989-8_30; Pruijm M, 2018, KIDNEY INT, V93, P932, DOI 10.1016/j.kint.2017.10.020; Ries M, 2003, J MAGN RESON IMAGING, V17, P104, DOI 10.1002/jmri.10224; Rodriguez-Gomez I, 2003, HYPERTENSION, V42, P220, DOI 10.1161/01.HYP.0000081944.47230.69; Rosenberger C, 2008, KIDNEY INT, V73, P34, DOI 10.1038/sj.ki.5002567; Sayarlioglu H, 2005, RENAL FAILURE, V27, P67, DOI 10.1081/JDI-200042794; SHUPER A, 1987, ARCH DIS CHILD, V62, P811, DOI 10.1136/adc.62.8.811; Singh DK, 2008, NAT CLIN PRACT NEPHR, V4, P216, DOI 10.1038/ncpneph0757; Su JY, 2015, INT IMMUNOPHARMACOL, V26, P328, DOI 10.1016/j.intimp.2015.04.019; THOMAS WE, 1987, BIOCHEM J, V247, P315, DOI 10.1042/bj2470315; Turin TC, 2013, J AM SOC NEPHROL, V24, P1661, DOI 10.1681/ASN.2012111118; WEETMAN AP, 1985, ACTA ENDOCRINOL-COP, V109, P341, DOI 10.1530/acta.0.1090341; Welch WJ, 2006, CLIN EXP PHARMACOL P, V33, P1002, DOI 10.1111/j.1440-1681.2006.04478.x; Welch WJ, 2005, AM J PHYSIOL-HEART C, V288, pH22, DOI 10.1152/ajpheart.00626.2004; Welch WJ, 2003, KIDNEY INT, V63, P202, DOI 10.1046/j.1523-1755.2003.00729.x; Welch WJ, 2001, KIDNEY INT, V59, P230, DOI 10.1046/j.1523-1755.2001.00483.x; Yegin E, 1997, JPN HEART J, V38, P273; Yin WJ, 2012, EUR J RADIOL, V81, P1426, DOI 10.1016/j.ejrad.2011.03.045	70	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264524	10.1371/journal.pone.0264524	http://dx.doi.org/10.1371/journal.pone.0264524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239685	Green Published, gold			2022-12-26	WOS:000776002200040
J	Wammes, JD; Nakanishi, M; Van der Steen, JT; Vroomen, JLM				Wammes, Joost D.; Nakanishi, Miharu; van der Steen, Jenny T.; Vroomen, Janet L. MacNeil			The Revised Medical Care Act is associated with a decrease in hospital death for the total Japanese older adult population regardless of dementia status: An interrupted time series analysis	PLOS ONE			English	Article							OF-LIFE CARE; NURSING-HOMES; END; PLACE; PREVALENCE; PROGRAM; PEOPLE; IMPACT; POLICY	Background In 2006, Japan introduced the Revised Medical Care Act aimed to shift end-of-life care from hospitals to communities. For patients and families, dying in hospital can be highly distressing. Persons with dementia are especially susceptible to negative hospital-related outcomes. This study aims to evaluate whether the Revised Medical Care Act is associated with a decrease in the proportion of hospital deaths for older adults and persons with dementia over a 20-year period covering the reform. Methods and findings This is a population-level, repeated cross-sectional study using mortality data from Vital Statistics Japan. Participants were Japanese older adults 65 years or older with and without dementia who died between 1996 and 2016. The policy intervention was the 2006 Revised Medical Care Act that increased community care infrastructure. The primary outcome was location of death in hospital, nursing home, home, or elsewhere. The trend in the proportion of location of death, before and after the reforms was estimated using an interrupted time-series analysis. All analyses were adjusted for sex and seasonality. Of the 19,307,104 older adult decedents, 216,442 had dementia identified on their death certificate. Death in nursing home (1.10, 95% CI 1.10-1.10), home (1.08, 95% CI 1.08-1.08), and elsewhere (1.07, 95% CI 1.07-1.07) increased over time compared to hospital deaths for the total population after reform implementation. Nursing home (1.04, 95% CI 1.03-1.05) and home death (1.11, 95% CI 1.10-1.12) increased after reform implementation for persons with dementia. Conclusion This study provides evidence that the 2006 Revised Medical Care Act was associated with decreased older adults dying in hospital regardless of dementia status; however, hospital continues as the primary location of death.	[Wammes, Joost D.; Vroomen, Janet L. MacNeil] Univ Amsterdam, Dept Internal Med, Sect Geriatr Med, Amsterdam UMC, Amsterdam, Netherlands; [Nakanishi, Miharu] Tohoku Univ, Dept Psychiat Nursing, Grad Sch Med, Sendai, Miyagi, Japan; [van der Steen, Jenny T.] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [van der Steen, Jenny T.] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, Nijmegen, Netherlands	University of Amsterdam; Tohoku University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Wammes, JD (corresponding author), Univ Amsterdam, Dept Internal Med, Sect Geriatr Med, Amsterdam UMC, Amsterdam, Netherlands.	j.d.wammes@amsterdamumc.nl		Nakanishi, Miharu/0000-0001-6200-9279; Wammes, Joost/0000-0003-3260-2199	Netherlands Organization for Health Research and Development (NWO-ZonMw Veni) [091.619.060]	Netherlands Organization for Health Research and Development (NWO-ZonMw Veni)	J.L. MacNeil-Vroomen, the Netherlands Organization for Health Research and Development (NWO-ZonMw Veni, Grant number 091.619.060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama A, 2012, ARCH GERONTOL GERIAT, V54, pE383, DOI 10.1016/j.archger.2012.01.004; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Broad JB, 2013, INT J PUBLIC HEALTH, V58, P257, DOI 10.1007/s00038-012-0394-5; Dodge Hiroko H, 2012, Int J Alzheimers Dis, V2012, P956354, DOI 10.1155/2012/956354; Fukui S, 2013, J PALLIAT CARE, V29, P22, DOI 10.1177/082585971302900104; Gao W, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6030107; Hayashi T, 2011, ARCH GERONTOL GERIAT, V53, P242, DOI 10.1016/j.archger.2010.12.005; Ikegami N, 2013, J AM MED DIR ASSOC, V14, P718, DOI 10.1016/j.jamda.2013.02.008; Ikegami N, 2012, HEALTH POLICY, V105, P303, DOI 10.1016/j.healthpol.2012.01.009; International Longevity Center Japan, 2020, OV REV LONG TERM CAR; Jandoc R, 2015, J CLIN EPIDEMIOL, V68, P950, DOI 10.1016/j.jclinepi.2014.12.018; Kalseth J, 2017, PALLIATIVE MED, V31, P964, DOI 10.1177/0269216317691259; Lee CY, 2010, ASIAN NURS RES, V4, P163, DOI 10.1016/S1976-1317(11)60001-7; Lehmann J, 2018, J ALZHEIMERS DIS, V64, P735, DOI 10.3233/JAD-171128; MacNeil Vroomen J, 2020, JAMDA; Martina D, 2021, J AM MED DIR ASSOC, V22, DOI 10.1016/j.jamda.2020.12.018; Martinsson L, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-00639-5; Meeussen K, 2011, J PAIN SYMPTOM MANAG, V42, P565, DOI 10.1016/j.jpainsymman.2011.01.011; Ministry of Health Labor and Welfare, 2021, ELD CAR EST CAR SUPP; Ministry of Health Labor and Welfare, 2020, NUMB PERS WAIT LIST; Ministry of Health LaW, 2022, OV DYN SURV MED I HO; Ministry of Health LaW, 2010, FIN REP LONG TERM CA; Mukadam N, 2011, INT PSYCHOGERIATR, V23, P344, DOI 10.1017/S1041610210001717; Nakanishi M, 2019, GERIATR GERONTOL INT, V19, P829, DOI 10.1111/ggi.13729; Nakanishi M, 2015, AGEING INT, V40, P248, DOI 10.1007/s12126-014-9215-x; Nakanishi M, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.04.024; Nakanishi M, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.10.018; Nakanishi M, 2012, J AM MED DIR ASSOC, V13, P794, DOI 10.1016/j.jamda.2012.08.010; Ohmachi I, 2015, INT J GERONTOL, V9, P24, DOI 10.1016/j.ijge.2014.03.008; Okamura H, 2013, DEMENT GERIATR COGN, V36, P111, DOI 10.1159/000353444; Paddy Miranda, 2011, Nurs Stand, V26, P33; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964; Pivodic L, 2021, PALLIATIVE MED, V35, P369, DOI 10.1177/0269216320972036; Romero JP, 2014, J ALZHEIMERS DIS, V41, P213, DOI 10.3233/JAD-132765; Sakamoto H, 2018, JAPAN HLTH SYSTEM RE; Sato M, 2021, J AM MED DIR ASSOC, V22, P329, DOI 10.1016/j.jamda.2020.09.021; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Teno JM, 2016, JAMA ONCOL, V2, P957, DOI 10.1001/jamaoncol.2016.0441; Tsutsui T, 2014, INT J INTEGR CARE, V14; Vroomen JLM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241132; Worldbank, 2019, LOW MIDDL INC POP	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264624	10.1371/journal.pone.0264624	http://dx.doi.org/10.1371/journal.pone.0264624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239744	Green Published, gold			2022-12-26	WOS:000776002200052
J	Yeboah, DS; Appiah, MA; Kampitib, GB				Yeboah, Daniel Sarpong; Appiah, Maxwell Afranie; Kampitib, Grace Billi			Factors influencing the use of emergency contraceptives among reproductive age women in the Kwadaso Municipality, Ghana	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDES	Background Unintended pregnancy leads to unsafe abortion, which is one of the commonest causes of maternal deaths in developing countries including Ghana. Lots of unintended pregnancies can be avoided using emergency contraceptives (EC). Emergency contraceptives are mostly used after unprotected sexual intercourse and have a ninety-nine percent chance of preventing unintended pregnancy when taken correctly. However, unlike other modern contraceptives such as condoms, emergency contraceptives cannot prevent sexually transmitted infections. Objectives This study aimed at assessing the factors influencing the use of emergency contraceptives among reproductive-age women in the Kwadaso Municipality, Ghana. Methods A community-based descriptive cross-sectional study design was conducted in three sub-municipalities of the Kwadaso Municipality. A multistage sampling method was used to select 312 women in their reproductive age within households. A simple random sampling method was first used to select the sub-municipalities (Kwadaso Central, Asuoyeboah, and Agric-Nzema). Participants were selected from households through a systematic sampling procedure and responses were solicited from women who consented to participate in the study. The selection was strictly dependent on the number of eligible women in a household, that is, in an event where more than one woman was found in a household, a simple random sampling method was used to select only one woman from that household. STATA 15.0 was used to analyse the data. Binary logistic regression was used to find the adjusted estimates and associations between EC use and the exposure variables. P-values <= 0.05 were considered statistically significant at 95% Confidence Interval (CI). Results The findings showed that 79.67% of the women had ever used EC. Amongst them, 59.83% used EC following unexpected unprotected sex, and 24.69% used EC following failed coitus interruptus. Women's attitude towards EC (AOR = 8.52, p<0.001), religion (AOR = 4.56, p = 0.004), and monthly income (AOR = 0.29, p = 0.030) were found to have significant influence on their use of EC. Conclusion The level of EC use among the women was high. Women's attitude towards EC, religion, and monthly income were the major factors influencing the use of EC. Thus, strategies to promote EC use should emphasize on addressing the attitude of women towards EC through sex education in schools, various religious institutions, and the community at large with the services of health authorities and support from governmental and non-governmental organizations whose focus is to address the need for reproductive health services in order to reduce the misconception regarding the use of EC.	[Yeboah, Daniel Sarpong] Kumasi South Hosp, Obstet & Gynaecol Dept, Ghana Hlth Serv, Kumasi, Ashanti Region, Ghana; [Appiah, Maxwell Afranie] Ghana Hlth Serv, Dist Hlth Directorate, Obuasi, Ashanti Region, Ghana; [Kampitib, Grace Billi] Ghana Hlth Serv, Municipal Hlth Directorate, Kwadaso, Ashanti Region, Ghana	Ghana Health Service	Appiah, MA (corresponding author), Ghana Hlth Serv, Dist Hlth Directorate, Obuasi, Ashanti Region, Ghana.	2014mappiah@uhas.edu.gh	Appiah, Maxwell Afranie/AHC-7517-2022	Appiah, Maxwell Afranie/0000-0001-8050-5022				Ahmed FA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-110; Amalba A, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-114; Amoanor R, 2017, EMERGENCY CONTRACEPT; Anteneh A., 2009, ETHIOP J REPROD HLTH, V3, P16; Babatunde OA, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.74.8688; Chandra-Mouli V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-1; Dawson A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0815-2; Fekadu Y., 2017, J WOMEN HLTH CARE, V6, DOI [10.4172/2167-0420.1000383, DOI 10.4172/2167-0420.1000383]; GDHS, 2008, GHAN DEM HLTH SURV P; Ghana Statistical Service, 2019, GHAN MULT CLUST SURV; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and ICF International, 2015, GHAN DEM HLTH SURV 2; Gosavi A, 2016, SINGAP MED J, V57, P610, DOI 10.11622/smedj.2015181; Habitu YA., 2018, INT J POPUL RES, V2018, P1; Hoque ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046346; International Consortium for Emergency Contraception, 2004, EMERGENCY CONTRACEPT, V2nd; International Consortium for Emergency Contraception (ICEC), 2021, EC STAT AV GHAN; Jima A., 2017, HEAL SCI J, V10, P1; Kgosiemang B, 2018, AFR J PRIM HEALTH CA, V10, DOI 10.4102/phcfm.v10i1.1674; Lamidi EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135172; Manila Kaushal, 2014, Journal of SAFOG (South Asian Federation of Obstetrics and Gynaecology), V6, P21; Manortey S., 2016, J SCI RES REPORTS, V18, P1; Mir AS, 2010, N AM J MED SCI, V2, P359, DOI 10.4297/najms.2010.2359; Mishore Kirubel Minsamo, 2019, Int J Reprod Med, V2019, P9397876, DOI 10.1155/2019/9397876; Mishra M., 2016, INT J REPROD CONTRAC, V6, P210; Mohammed S, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-018-0082-9; National Policy Council, 1994, NAT POP POL; Parker C, 2005, FAM HLTH INT, V6; Rafie S, 2017, INTEGR PHARM RES PRA, V6, P99, DOI 10.2147/IPRP.S99541; Relwani N., 2012, NATL J COMMUNITY MED, V3, P3; Savage-Oyekunle Oluremi A, 2017, Afr. hum. rights law j., V17, P475, DOI 10.17159/1996-2096/2017/v17n2a7; Shiferaw BZ., 2015, BMC RES NOTES, V8, P1; Sibanda E, 2017, SAJOG-S AFR J OBSTET, V23, P7, DOI 10.7196/SAJOG.2017.v23i1.1091; Singh S, ABORT WORLDW 2017 UN, P1; Tessema M., 2015, GLOB J MED RES, V15, P1; WHO, 2018, EMERGENCY CONTRACEPT; WHO and Gutacmer institute, 2012, FACTS IND AB WORLDW	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264619	10.1371/journal.pone.0264619	http://dx.doi.org/10.1371/journal.pone.0264619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239714	Green Published, gold			2022-12-26	WOS:000776002200050
J	Chou, MY; Appan, D; Chang, KW; Chou, CH; Lin, CY; Gau, SSF; Huang, HS				Chou, Ming-Yi; Appan, Dhivya; Chang, Kai-Wei; Chou, Chih-Hsuan; Lin, Chia-Yi; Gau, Susan Shur-Fen; Huang, Hsien-Sung			Mouse hybrid genome mediates diverse brain phenotypes with the specificity of reciprocal crosses	FASEB JOURNAL			English	Article						brain phenotypes; mouse hybrid genome; reciprocal crosses	LOCUS-CERULEUS; BEHAVIOR; GENE; ANXIETY; STRESS; MICE; ARCHITECTURE; TRANSPORTER; EXPRESSION	Hybrid species have more genetic diversity than their parents. However, the impact of the hybrid genome of reciprocal crosses on brain function remains largely unknown. We performed behavioral, molecular, and neuronal analyses on C57BL/6J mice (B6), CAST/EiJ mice (CAST), and hybrid mice resulting from reciprocal crosses of the two strains, B6/CAST F1i and B6/CAST F1r, respectively. Hybrid mice displayed greater motor strength and coordination, food grinding, social dominance, and less sociability compared to their parental strains. Parental origin influenced body weight, locomotor speed, and heat nociception of hybrid mice. Parental origin, cell type, and the interaction of both affected expression patterns of hybrid genomes including imprinted genes. There was a correlation between affected genes and corresponding behavioral phenotypes. Hybrid genomes mediated neuronal activity in the locus coeruleus, a brain region implicated in arousal, adaptive behaviors, and sleep-wake cycle due to its norepinephrine projections throughout the central nervous system. The comprehensive brain phenotypes in these hybrid mice reveal important functional readouts associated with interactions of hybrid genomes and impacts of parental genomes.	[Chou, Ming-Yi; Appan, Dhivya; Chang, Kai-Wei; Chou, Chih-Hsuan; Lin, Chia-Yi; Gau, Susan Shur-Fen; Huang, Hsien-Sung] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Rm 1547,15th Floor,1,Sec 1,Renai Rd, Taipei 10051, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ Hosp & Coll Med, Dept Psychiat, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Huang, HS (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Rm 1547,15th Floor,1,Sec 1,Renai Rd, Taipei 10051, Taiwan.	huang.hsiensung@gmail.com	GAU, SUSAN SHUR-FEN/P-4726-2017	GAU, SUSAN SHUR-FEN/0000-0002-2718-8221; Huang, Hsien-Sung/0000-0003-2657-3635	National Health Research Institutes (NHRI) [NHRI-EX103-10316NC, NHRI-EX108-10802NI]; National Taiwan University College of Medicine [104C101-B1, 105C101-B1]; National Taiwan University Hospital [104C101-B1, 105C101-B1]; Foundation for the Advancement of Outstanding Scholarship	National Health Research Institutes (NHRI)(National Health Research Institutes - Taiwan); National Taiwan University College of Medicine(National Taiwan University); National Taiwan University Hospital(National Taiwan University); Foundation for the Advancement of Outstanding Scholarship	National Health Research Institutes (NHRI), Grant/Award Number: NHRI-EX103-10316NC and NHRI-EX108-10802NI; National Taiwan University College of Medicine and National Taiwan University Hospital, Grant/Award Number: 104C101-B1 and 105C101-B1; Foundation for the Advancement of Outstanding Scholarship	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Anchan D, 2014, BRAIN BEHAV, V4, P51, DOI 10.1002/brb3.197; Benarroch EE, 2018, CELL TISSUE RES, V373, P221, DOI 10.1007/s00441-017-2649-1; Benarroch EE, 2009, NEUROLOGY, V73, P1699, DOI 10.1212/WNL.0b013e3181c2937c; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borza R, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101526; Bowden MA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-22; Calatayud F, 2004, PHYSIOL BEHAV, V80, P465, DOI 10.1016/j.physbeh.2003.10.001; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Champagne FA, 2007, PHYSIOL BEHAV, V91, P325, DOI 10.1016/j.physbeh.2007.03.014; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ehlen JC, 2015, J NEUROSCI, V35, P13587, DOI 10.1523/JNEUROSCI.2194-15.2015; Ferreira CER, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12923; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Flint J, 2003, J NEUROBIOL, V54, P46, DOI 10.1002/neu.10161; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; FUNDELE RH, 1994, DEV GENET, V15, P515, DOI 10.1002/dvg.1020150610; Gai YC, 2016, NEURON, V90, P581, DOI 10.1016/j.neuron.2016.03.017; Gao YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36008; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Gonzalez PN, 2016, J EVOLUTION BIOL, V29, P1737, DOI 10.1111/jeb.12906; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Grijalva I, 2006, SPINAL CORD, V44, P280, DOI 10.1038/sj.sc.3101842; Han ZJ, 2020, GENOME RES, V30, P1097, DOI 10.1101/gr.257568.119; Hsu CL, 2018, HUM MOL GENET, V27, P1039, DOI 10.1093/hmg/ddy023; Jakupovic J, 2008, PHYSIOL BEHAV, V93, P467, DOI 10.1016/j.physbeh.2007.10.005; Kang Du-Seock, 2020, Advances in Biological Regulation, V75, P100654, DOI 10.1016/j.jbior.2019.100654; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kishi Yusuke, 2021, STAR Protoc, V2, P100540, DOI 10.1016/j.xpro.2021.100540; Landry CR, 2007, HEREDITY, V99, P483, DOI 10.1038/sj.hdy.6801045; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Li XM, 2014, ANESTHESIOLOGY, V121, P79, DOI 10.1097/ALN.0000000000000191; Lin CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163663; Lin CY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22753-4; Lin YS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192355; Lin YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164164; Logan RW, 2013, GENES BRAIN BEHAV, V12, P424, DOI 10.1111/gbb.12029; Loos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108563; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martin D, 2017, ACS CHEM NEUROSCI, V8, P356, DOI 10.1021/acschemneuro.6b00374; MASUKO S, 1986, J NEUROSCI, V6, P3229; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Moloney RD, 2015, GENES BRAIN BEHAV, V14, P319, DOI 10.1111/gbb.12216; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nuevo-Tapioles C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17384-1; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Rytelewska E, 2020, MOL REPROD DEV, V87, P739, DOI 10.1002/mrd.23391; Salari AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29595-0; Shen SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109382; Shi YC, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.722580; Shorter JR, 2019, G3-GENES GENOM GENET, V9, P1613, DOI 10.1534/g3.118.200847; Srivastava A, 2017, GENETICS, V206, P537, DOI 10.1534/genetics.116.198838; Stelkens RB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-283; Szabadi E, 2013, J PSYCHOPHARMACOL, V27, P659, DOI 10.1177/0269881113490326; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Thompson EM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020776; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Wahlsten D, 2003, GENES BRAIN BEHAV, V2, P71, DOI 10.1034/j.1601-183X.2003.00012.x; Wang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17383; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P540, DOI 10.1111/j.1601-183X.2006.00281.x; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	70	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22232	10.1096/fj.202101624R	http://dx.doi.org/10.1096/fj.202101624R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199866				2022-12-26	WOS:000761250800012
J	Sivinski, J; Ngo, D; Zerio, CJ; Ambrose, AJ; Watson, ER; Kaneko, LK; Kostelic, MM; Stevens, M; Ray, AM; Park, Y; Wu, CX; Marty, MT; Hoang, QQ; Zhang, DD; Lander, GC; Johnson, SM; Chapman, E				Sivinski, Jared; Ngo, Duc; Zerio, Christopher J.; Ambrose, Andrew J.; Watson, Edmond R.; Kaneko, Lynn K.; Kostelic, Marius M.; Stevens, Mckayla; Ray, Anne-Marie; Park, Yangshin; Wu, Chunxiang; Marty, Michael T.; Hoang, Quyen Q.; Zhang, Donna D.; Lander, Gabriel C.; Johnson, Steven M.; Chapman, Eli			Allosteric differences dictate GroEL complementation of E. coli	FASEB JOURNAL			English	Article						allostery; chaperone; chaperonin; ESKAPE; GroEL; GroES	ESCHERICHIA-COLI; CHAPERONIN GROEL; CRYSTAL-STRUCTURE; RHIZOBIUM-LEGUMINOSARUM; POLYPEPTIDE BINDING; REACTION CYCLE; HEAT-SHOCK; MECHANISM; RING; ATP	GroES/GroEL is the only bacterial chaperone essential under all conditions, making it a potential antibiotic target. Rationally targeting ESKAPE GroES/GroEL as an antibiotic strategy necessitates studying their structure and function. Herein, we outline the structural similarities between Escherichia coli and ESKAPE GroES/GroEL and identify significant differences in intra- and inter-ring cooperativity, required in the refolding cycle of client polypeptides. Previously, we observed that one-half of ESKAPE GroES/GroEL family members could not support cell viability when each was individually expressed in GroES/GroEL-deficient E. coli cells. Cell viability was found to be dependent on the allosteric compatibility between ESKAPE and E. coli subunits within mixed (E. coli and ESKAPE) tetradecameric GroEL complexes. Interestingly, differences in allostery did not necessarily result in differences in refolding rate for a given homotetradecameric chaperonin. Characterization of ESKAPE GroEL allostery, ATPase, and refolding rates in this study will serve to inform future studies focused on inhibitor design and mechanism of action studies.	[Sivinski, Jared; Ngo, Duc; Zerio, Christopher J.; Ambrose, Andrew J.; Kaneko, Lynn K.; Zhang, Donna D.; Chapman, Eli] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, 1703 E Mabel St,POB 210207, Tucson, AZ 85721 USA; [Watson, Edmond R.; Lander, Gabriel C.] Scripps Res, Dept Integrat Struct & Computat Biol, La Jolla, CA USA; [Kostelic, Marius M.; Marty, Michael T.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Stevens, Mckayla; Ray, Anne-Marie; Park, Yangshin; Hoang, Quyen Q.; Johnson, Steven M.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Park, Yangshin; Hoang, Quyen Q.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA; [Park, Yangshin; Hoang, Quyen Q.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN USA; [Wu, Chunxiang] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	University of Arizona; Scripps Research Institute; University of Arizona; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Yale University	Chapman, E (corresponding author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, 1703 E Mabel St,POB 210207, Tucson, AZ 85721 USA.	chapman@pharmacy.arizona.edu		Ray, Anne-Marie/0000-0003-2812-7938; Sivinski, Jared/0000-0003-2696-6279	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [R01GM120350]; NIH [5R01GM111639, 5R01GM115844, R35GM128624, T32 GM008804]	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under Award no. R01GM120350. S.M.J., Q.Q.H., and E.C. Q.Q.H. additionally acknowledge support by NIH grants 5R01GM111639 and 5R01GM115844. M.T.M. and M.M.K. were supported by NIH R35GM128624. J.S., C.J.Z., and M.M.K. are supported by NIH T32 GM008804. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH	Abdeen S, 2018, J MED CHEM, V61, P7345, DOI 10.1021/acs.jmedchem.8b00989; Abdeen S, 2016, BIOORG MED CHEM LETT, V26, P3127, DOI 10.1016/j.bmcl.2016.04.089; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; Chapman E, 2008, P NATL ACAD SCI USA, V105, P19205, DOI 10.1073/pnas.0810657105; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Chilukoti N, 2016, J BACTERIOL, V198, P486, DOI 10.1128/JB.00844-15; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Coyle JE, 1997, FOLD DES, V2, pR93, DOI 10.1016/S1359-0278(97)00046-1; Danziger O, 2003, P NATL ACAD SCI USA, V100, P13797, DOI 10.1073/pnas.2333925100; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Feltham JL, 2000, CELL, V100, P193, DOI 10.1016/S0092-8674(00)81557-3; Figueiredo L, 2004, J BIOL CHEM, V279, P1090, DOI 10.1074/jbc.M310914200; Fridmann Y, 2000, J BIOL CHEM, V275, P37951, DOI 10.1074/jbc.M007594200; Fridmann Y, 2002, BIOCHEMISTRY-US, V41, P5938, DOI 10.1021/bi020117v; Gallagher LA, 2015, J BACTERIOL, V197, P2027, DOI 10.1128/JB.00131-15; Georgescauld F, 2014, CELL, V157, P922, DOI 10.1016/j.cell.2014.03.038; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; Gould PS, 2007, CELL STRESS CHAPERON, V12, P123, DOI 10.1379/CSC-227R.1; Grallert H, 2001, J STRUCT BIOL, V135, P95, DOI 10.1006/jsbi.2001.4387; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; HOROVITZ A, 1995, P ROY SOC B-BIOL SCI, V259, P85, DOI 10.1098/rspb.1995.0013; Horovitz A, 2005, CURR OPIN STRUC BIOL, V15, P646, DOI 10.1016/j.sbi.2005.10.001; HORWICH AL, 1993, PHILOS T R SOC B, V339, P313, DOI 10.1098/rstb.1993.0030; Illingworth M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10499-4; Illingworth M, 2011, J BIOL CHEM, V286, P30401, DOI 10.1074/jbc.M111.255935; Ivic A, 1997, GENE, V194, P1, DOI 10.1016/S0378-1119(97)00087-5; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kostelic MM, 2021, ANAL CHEM, V93, P14722, DOI 10.1021/acs.analchem.1c03181; Kostelic MM, 2019, J AM SOC MASS SPECTR, V30, P1416, DOI 10.1007/s13361-019-02174-x; Kumar CMS, 2009, J BACTERIOL, V191, P6525, DOI 10.1128/JB.00652-09; Kunkle T, 2018, J MED CHEM, V61, P10651, DOI 10.1021/acs.jmedchem.8b01293; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lewin GR, 2019, P NATL ACAD SCI USA, V116, P19685, DOI 10.1073/pnas.1907619116; Liu H, 2009, FEBS LETT, V583, P2365, DOI 10.1016/j.febslet.2009.06.027; Llorca O, 1998, J BIOL CHEM, V273, P32587, DOI 10.1074/jbc.273.49.32587; LORIMER GH, 1994, STRUCTURE, V2, P1125, DOI 10.1016/S0969-2126(94)00114-6; Lu HM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000526; Ma JP, 1998, P NATL ACAD SCI USA, V95, P8502, DOI 10.1073/pnas.95.15.8502; Marty MT, 2019, J AM SOC MASS SPECTR, V30, P2174, DOI 10.1007/s13361-019-02286-4; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Mulani MS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00539; Persyn E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41201-5; Priya S, 2013, P NATL ACAD SCI USA, V110, P7199, DOI 10.1073/pnas.1219867110; Ramage B, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00352-17; Richardson A, 1999, GENETICS, V152, P1449; Richardson A, 1999, J BIOL CHEM, V274, P52, DOI 10.1074/jbc.274.1.52; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Scarff CA, 2018, JOVE-J VIS EXP, DOI 10.3791/57199; Shah R, 2016, J BACTERIOL, V198, P2692, DOI 10.1128/JB.00317-16; Shiseki K, 2001, J BIOL CHEM, V276, P11335, DOI 10.1074/jbc.M010348200; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sivinski J, 2021, MBIO, V12, DOI 10.1128/mBio.02167-20; Taguchi H, 2015, J MOL BIOL, V427, P2912, DOI 10.1016/j.jmb.2015.04.007; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Varadi M., 2021, NUCLEIC ACIDS RES, V50, P439; Weaver J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15934; Weiss C, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00080; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1994, J MOL BIOL, V243, P397, DOI 10.1006/jmbi.1994.1667; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Zahn R, 1996, P NATL ACAD SCI USA, V93, P15024, DOI 10.1073/pnas.93.26.15024	75	0	0	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22198	10.1096/fj.202101708RR	http://dx.doi.org/10.1096/fj.202101708RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199390				2022-12-26	WOS:000761250800011
J	Ajogbasile, FV; Oluniyi, PE; Kayode, AT; Akano, KO; Adegboyega, BB; Philip, C; Ogbulafor, N; Okafor, HU; Oguche, S; Wammanda, RD; Mokuolu, OA; Folarin, OA; Happi, CT				Ajogbasile, Fehintola, V; Oluniyi, Paul E.; Kayode, Adeyemi T.; Akano, Kazeem O.; Adegboyega, Benjamin B.; Philip, Courage; Ogbulafor, Nnenna; Okafor, Henrietta U.; Oguche, Stephen; Wammanda, Robinson D.; Mokuolu, Olugbenga A.; Folarin, Onikepe A.; Happi, Christian T.			Molecular profiling of the artemisinin resistance Kelch 13 gene in Plasmodium falciparum from Nigeria	PLOS ONE			English	Article							K13-PROPELLER GENE; K13 GENE; POLYMORPHISMS; MALARIA; MUTATIONS; SUSCEPTIBILITY; PARASITES; CHINA; DIHYDROARTEMISININ; ASSOCIATION	Accurate assessment and monitoring of the Plasmodium falciparum Kelch 13 (pfk13) gene associated with artemisinin resistance is critical to understand the emergence and spread of drug-resistant parasites in malaria-endemic regions. In this study, we evaluated the genomic profile of the pfk13 gene associated with artemisinin resistance in P. falciparum in Nigerian children by targeted sequencing of the pfk13 gene. Genomic DNA was extracted from 332 dried blood (DBS) spot filter paper samples from three Nigerian States. The pfk13 gene was amplified by nested polymerase chain reaction (PCR), and amplicons were sequenced to detect known and novel polymorphisms across the gene. Consensus sequences of samples were mapped to the reference gene sequence obtained from the National Center for Biotechnology Information (NCBI). Out of the 13 single nucleotide polymorphisms (SNPs) detected in the pfk13 gene, five (F451L, N664I, V487E, V692G and Q661H) have not been reported in other endemic countries to the best of our knowledge. Three of these SNPs (V692G, N664I and Q661H) and a non-novel SNP, C469C, were consistent with late parasitological failure (LPF) in two States (Enugu and Plateau States). There was no validated mutation associated with artemisinin resistance in this study. However, a correlation of our study with in vivo and in vitro phenotypes is needed to establish the functional role of detected mutations as markers of artemisinin resistance in Nigeria. This baseline information will be essential in tracking and monitoring P. falciparum resistance to artemisinin in Nigeria.	[Ajogbasile, Fehintola, V; Oluniyi, Paul E.; Kayode, Adeyemi T.; Akano, Kazeem O.; Adegboyega, Benjamin B.; Philip, Courage; Folarin, Onikepe A.; Happi, Christian T.] Redeemers Univ, African Ctr Excellence Genom Infect Dis ACEGID, Ede, Osun State, Nigeria; [Ajogbasile, Fehintola, V; Oluniyi, Paul E.; Kayode, Adeyemi T.; Akano, Kazeem O.; Folarin, Onikepe A.; Happi, Christian T.] Redeemers Univ, Fac Nat Sci, Dept Biol Sci, Ede, Osun State, Nigeria; [Ogbulafor, Nnenna] Fed Minist Hlth, Natl Malaria Eliminat Programme, Abuja, Nigeria; [Okafor, Henrietta U.] Univ Nigeria Teaching Hosp, Inst Child Hlth, Dept Pediat, Enugu, Nigeria; [Oguche, Stephen] Univ Jos, Jos Univ Teaching Hosp, Coll Hlth Sci, Dept Paediat,Fac Clin Sci, Jos, Nigeria; [Wammanda, Robinson D.] Ahmadu Bello Univ, Dept Paediat, Zaria, Nigeria; [Mokuolu, Olugbenga A.] Univ Ilorin, Dept Paediat & Child Hlth, Ilorin, Nigeria	Redeemers University; Redeemers University; University of Nigeria; University of Jos; Ahmadu Bello University; University of Ilorin	Happi, CT (corresponding author), Redeemers Univ, African Ctr Excellence Genom Infect Dis ACEGID, Ede, Osun State, Nigeria.; Happi, CT (corresponding author), Redeemers Univ, Fac Nat Sci, Dept Biol Sci, Ede, Osun State, Nigeria.	happic@run.edu.ng	Tolulope Adeyemi, Kayode/AFV-2672-2022	Oluniyi, Paul/0000-0002-2651-2149				Abubakar UF, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5020085; Ajayi NA, 2013, REV SOC BRAS MED TRO, V46, P525, DOI 10.1590/0037-8682-0098-2013; Amaratunga C, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1207-3; Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; [Anonymous], Geneious Prime 2020.0.4; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Boussaroque A, 2016, ANTIMICROB AGENTS CH, V60, P624, DOI 10.1128/AAC.01346-15; Bustamante C, 2012, J INFECT DIS, V206, P324, DOI 10.1093/infdis/jis359; Conrad MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105690; Daily JP, 2016, NEW ENGL J MED, V374, P2492, DOI 10.1056/NEJMe1604520; Dokunmu TM, 2018, BIOMED RES THER, V5, P2651, DOI 10.15419/bmrat.v5i9.474; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Gaye A, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03193-w; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Idowu AO, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2947-z; Igbasi U, 2019, TROP MED INT HEALTH, V24, P1011, DOI 10.1111/tmi.13273; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Kayode AT, 2021, INT J PARASITOL, V51, P301, DOI 10.1016/j.ijpara.2020.10.001; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim Y., 2013, NAT ED KNOWLEDGE, V4, P6; Li J, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2984-7; Madamet M, 2017, INT J ANTIMICROB AG, V49, P754, DOI 10.1016/j.ijantimicag.2017.01.032; Mathieu LC, 2020, ELIFE, V9, DOI 10.7554/eLife.51015; Mbaye A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1897-6; Mbaye A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1490-4; Mensah BA, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01423-19; Mishra N, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1636-4; Moukoko CEE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221895; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Oboh MA, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2305062; Ocan M, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2701-6; Ouattara A, 2015, AM J TROP MED HYG, V92, P1202, DOI 10.4269/ajtmh.14-0605; Oyebola KM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3314-3; Prosser C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197369; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Sanchez CP, 2008, MOL MICROBIOL, V70, P786, DOI 10.1111/j.1365-2958.2008.06413.x; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Talundzic E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02116-16, 10.1128/aac.02116-16]; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Torrentino-Madamet M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-472; Uwimana A, 2021, NAT MED, V27, P1113, DOI 10.1038/s41591-021-01365-y; Uwimana A, 2020, NAT MED, V26, P1602, DOI 10.1038/s41591-020-1005-2; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Wang XX, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-3140-0; WHO, 2020, REPORT ANTIMALARIAL; World Health Organization, 2017, STAT REP ART ART BAS; Wundermann GS, 2017, INT J TROP DIS HLTH, V21, P1, DOI [10.9734/IJTDH/2017/30914, DOI 10.9734/IJTDH/2017/30914]; Yang CY, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2634-z; Zhang J, 2019, INT J PARASITOL-DRUG, V10, P20, DOI 10.1016/j.ijpddr.2019.04.002	49	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264548	10.1371/journal.pone.0264548	http://dx.doi.org/10.1371/journal.pone.0264548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226694	Green Published, gold			2022-12-26	WOS:000793394000031
J	Gonzalez, VH; Hranitz, JM; McGonigle, MB; Manweiler, RE; Smith, DR; Barthell, JF				Gonzalez, Victor H.; Hranitz, John M.; McGonigle, Mercedes B.; Manweiler, Rachel E.; Smith, Deborah R.; Barthell, John F.			Acute exposure to sublethal doses of neonicotinoid insecticides increases heat tolerance in honey bees	PLOS ONE			English	Article							SHOCK-PROTEIN GENES; APIS-MELLIFERA; CLIMATE-CHANGE; PESTICIDE; FUNGICIDES; BEHAVIOR; IMPACTS; DELTAMETHRIN; ECTOTHERMS; HORMESIS	The European honey bee, Apis mellifera L., is the single most valuable managed pollinator in the world. Poor colony health or unusually high colony losses of managed honey bees result from a myriad of stressors, which are more harmful in combination. Climate change is expected to accentuate the effects of these stressors, but the physiological and behavioral responses of honey bees to elevated temperatures while under simultaneous influence of one or more stressors remain largely unknown. Here we test the hypothesis that exposure to acute, sublethal doses of neonicotinoid insecticides reduce thermal tolerance in honey bees. We administered to bees oral doses of imidacloprid and acetamiprid at 1/5, 1/20, and 1/100 of LD50 and measured their heat tolerance 4 h post-feeding, using both dynamic and static protocols. Contrary to our expectations, acute exposure to sublethal doses of both insecticides resulted in higher thermal tolerance and greater survival rates of bees. Bees that ingested the higher doses of insecticides displayed a critical thermal maximum from 2 degrees C to 5 degrees C greater than that of the control group, and 67%-87% reduction in mortality. Our study suggests a resilience of honey bees to high temperatures when other stressors are present, which is consistent with studies in other insects. We discuss the implications of these results and hypothesize that this compensatory effect is likely due to induction of heat shock proteins by the insecticides, which provides temporary protection from elevated temperatures.	[Gonzalez, Victor H.; McGonigle, Mercedes B.; Manweiler, Rachel E.] Univ Kansas, Undergrad Biol Program, Lawrence, KS 66045 USA; [Gonzalez, Victor H.; McGonigle, Mercedes B.; Manweiler, Rachel E.; Smith, Deborah R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Hranitz, John M.] Bloomsburg Univ, Biol & Allied Hlth Sci, Bloomsburg, PA USA; [Barthell, John F.] Univ Cent Oklahoma, Dept Biol, Edmond, OK USA	University of Kansas; University of Kansas; Pennsylvania State System of Higher Education (PASSHE); Bloomsburg University of Pennsylvania; University of Central Oklahoma	Gonzalez, VH (corresponding author), Univ Kansas, Undergrad Biol Program, Lawrence, KS 66045 USA.; Gonzalez, VH (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	vhgonza@ku.edu			National Science Foundation's REU program [DBI 1950805]	National Science Foundation's REU program	V.H.G. and J.M.H. are supported by National Science Foundation's REU program (DBI 1950805 to Charlotte Simmons, University of Central Oklahoma). J.F.B. currently serves in the Intergovernmental Personnel Act Program of the National Science Foundation (NSF). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abou-Shaara HF, 2017, INSECT SOC, V64, P455, DOI 10.1007/s00040-017-0573-8; Azpiazu C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50255-4; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bordier C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03944-x; Branchiccela B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46453-9; Burdine JD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38338-0; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Chidawanyika F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169371; Chmiel JA, 2020, FRONT ECOL EVOL, V8, DOI 10.3389/fevo.2020.00022; Colin T, 2019, ENVIRON SCI TECHNOL, V53, P8252, DOI 10.1021/acs.est.9b02452; Crall JD, 2018, SCIENCE, V362, P683, DOI 10.1126/science.aat1598; Cutler GC, 2015, PEST MANAG SCI, V71, P1368, DOI 10.1002/ps.4042; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; David A, 2016, ENVIRON INT, V88, P169, DOI 10.1016/j.envint.2015.12.011; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Delkash-Roudsari S, 2020, ECOTOX ENVIRON SAFE, V204, DOI 10.1016/j.ecoenv.2020.111108; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; DeVries ZC, 2016, COMP BIOCHEM PHYS A, V197, P52, DOI 10.1016/j.cbpa.2016.03.003; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Flores JM, 2019, SCI TOTAL ENVIRON, V653, P1111, DOI 10.1016/j.scitotenv.2018.11.004; Fox J., 2018, R COMPANION APPL REG, VThird; Garcia-Robledo C, 2018, ECOL ENTOMOL, V43, P162, DOI 10.1111/een.12481; Garcia-Robledo C, 2016, P NATL ACAD SCI USA, V113, P680, DOI 10.1073/pnas.1507681113; Gerard M, 2020, EMERG TOP LIFE SCI, V4, P77, DOI 10.1042/ETLS20190139; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gonzalez VH, 2020, ECOL ENTOMOL, V45, P688, DOI 10.1111/een.12842; Gonzalez-Tokman D, 2021, J ECON ENTOMOL, V114, P462, DOI 10.1093/jee/toaa216; Gonzalez-Tokman D, 2020, BIOL REV, V95, P802, DOI 10.1111/brv.12588; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hamblin AL, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0125; Heller S, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.114589; Hranitz JM, 2010, ALCOHOL, V44, P275, DOI 10.1016/j.alcohol.2010.02.003; Hung KLJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2140; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Karahan A, 2015, ECOTOXICOLOGY, V24, P2017, DOI 10.1007/s10646-015-1537-2; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koo J, 2015, J ASIA-PAC ENTOMOL, V18, P583, DOI 10.1016/j.aspen.2015.06.011; Le Conte Y, 2008, REV SCI TECH OIE, V27, P499; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1553, DOI 10.1139/z97-782; Moe SJ, 2013, ENVIRON TOXICOL CHEM, V32, P49, DOI 10.1002/etc.2045; Nyamukondiwa C, 2009, J THERM BIOL, V34, P406, DOI 10.1016/j.jtherbio.2009.09.002; Oyen KJ, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.165589; Patil NS, 1996, MED VET ENTOMOL, V10, P277, DOI 10.1111/j.1365-2915.1996.tb00743.x; Potts R, 2018, J INSECT PHYSIOL, V104, P33, DOI 10.1016/j.jinsphys.2017.11.006; R Core Team, 2020, R LANG ENV STAT COMP; Reitmayer CM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41876-w; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Shi JL, 2019, APIDOLOGIE, V50, P553, DOI 10.1007/s13592-019-00669-w; Therneau TMA., 2020, PACKAGE SURVIVAL ANA; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Tosi S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1711; Tosi S, 2016, J INSECT PHYSIOL, V93-94, P56, DOI 10.1016/j.jinsphys.2016.08.010; Vandame R, 1998, NEUROSCI LETT, V251, P57, DOI 10.1016/S0304-3940(98)00494-7; Vergara-Amado J, 2020, APIDOLOGIE, V51, P1091, DOI 10.1007/s13592-020-00787-w; Wang YH, 2020, ECOTOX ENVIRON SAFE, V190, DOI 10.1016/j.ecoenv.2019.110100; Wen XL, 2021, SCI TOTAL ENVIRON, V786, DOI 10.1016/j.scitotenv.2021.147443; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Zhang LJ, 2017, B ENTOMOL RES, V107, P513, DOI 10.1017/S0007485317000049; Zhang LJ, 2015, EUR J ENTOMOL, V112, P215, DOI 10.14411/eje.2015.039; Zioga E, 2020, ENVIRON RES, V189, DOI 10.1016/j.envres.2020.109873	64	1	1	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0240950	10.1371/journal.pone.0240950	http://dx.doi.org/10.1371/journal.pone.0240950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213539	Green Submitted, Green Published, gold			2022-12-26	WOS:000787811000001
J	Iyaniwura, SA; Rabiu, M; David, JF; Kong, JD				Iyaniwura, Sarafa A.; Rabiu, Musa; David, Jummy F.; Kong, Jude D.			The basic reproduction number of COVID-19 across Africa	PLOS ONE			English	Article							OUTBREAK; BURDEN; MODELS	The pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) took the world by surprise. Following the first outbreak of COVID-19 in December 2019, several models have been developed to study and understand its transmission dynamics. Although the spread of COVID-19 is being slowed down by vaccination and other interventions, there is still a need to have a clear understanding of the evolution of the pandemic across countries, states and communities. To this end, there is a need to have a clearer picture of the initial spread of the disease in different regions. In this project, we used a simple SEIR model and a Bayesian inference framework to estimate the basic reproduction number of COVID19 across Africa. Our estimates vary between 1.98 (Sudan) and 9.66 (Mauritius), with a median of 3.67 (90% Crl: 3.31-4.12). The estimates provided in this paper will help to inform COVID-19 modeling in the respective countries/regions.	[Iyaniwura, Sarafa A.] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Iyaniwura, Sarafa A.] Univ British Columbia, Inst Appl Math, Vancouver, BC, Canada; [Rabiu, Musa] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Durban, South Africa; [David, Jummy F.; Kong, Jude D.] York Univ, Lab Ind & Appl Math, Toronto, ON, Canada; [David, Jummy F.] York Univ, Fields CQAM Lab Math Publ Hlth MfPH, Toronto, ON, Canada; [Kong, Jude D.] York Univ, Africa Canada Artificial Intelligence & Data Inno, Toronto, ON, Canada; [Kong, Jude D.] York Univ, Lab Appl & Ind Math LIAM, Toronto, ON, Canada	University of British Columbia; University of British Columbia; University of Kwazulu Natal; York University - Canada; York University - Canada; York University - Canada; York University - Canada	Iyaniwura, SA (corresponding author), Univ British Columbia, Dept Math, Vancouver, BC, Canada.; Iyaniwura, SA (corresponding author), Univ British Columbia, Inst Appl Math, Vancouver, BC, Canada.	iyaniwura@math.ubc.ca	Musa, Rabiu/HDO-3158-2022	Iyaniwura, Sarafa/0000-0002-8854-2335; Rabiu, Musa/0000-0002-2626-7921	Canada's International Development Research Centre (IDRC); Swedish International Development Cooperation Agency (SIDA) [109559-001]	Canada's International Development Research Centre (IDRC); Swedish International Development Cooperation Agency (SIDA)	Dr. Jude D. Kong (J.K.) received the following awards for this project: Canada's International Development Research Centre (IDRC): https://www.idrc.ca/en and the Swedish International Development Cooperation Agency (SIDA): https://www.government.se/government-agencies/the-swedish-international-developmentcooperation-agency-sida/ (Grant No. 109559-001).	Adekunle AI, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001740; Adepoju P, 2020, NAT MED, V26, P444, DOI 10.1038/d41591-020-00004-2; Africa WHO, SENEGAL REPORTS 1 CO; AGENCY A, COVID 19 ETHIOPIA CL; AGENCY) CBA, MALI SUSPENDS FLIGHT; Alagoz O, 2021, ANN INTERN MED, V174, P50, DOI 10.7326/M20-4096; Aldila D., 2020, COMMUN MATH BIOL NEU, V2020; Amzat J, 2020, INT J INFECT DIS, V98, P218, DOI 10.1016/j.ijid.2020.06.067; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Anderson S.C., 2020, ESTIMATING IMPACT CO; Anderson SC, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008274; Anjorin AA, 2020, ASIAN PAC J TROP MED, V13, P199, DOI 10.4103/1995-7645.281612; [Anonymous], REUTERS; [Anonymous], 2005, STAT 2 M INT HLTH RE; Antwi-Boasiako J, 2021, REV ADM PUBL-RIO JAN, V55, P122, DOI 10.1590/0034-761220200507; Arroyo-Marioli F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244474; Asahi K, 2021, J GLOB HEALTH, V11, DOI [10.7189/jogh.11.05002, 10.7189/jogh.10.05002]; Atalan A, 2020, ANN MED SURG, V56, P38, DOI 10.1016/j.amsu.2020.06.010; Banda J, 2021, DEMOGR RES, V44, P459, DOI 10.4054/DemRes.2021.44.20; Behring BM, 2021, CHAOS, V31, DOI 10.1063/5.0041993; Bendavid E, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13484; Bentout S, 2020, AIMS PUBLIC HEALTH, V7, P306, DOI 10.3934/publichealth.2020026; Bloomberg, ETHIOPIA CLOSES LAND; Bouraima MB., 2020, EURASIAN J MED INVES, V4, P405; Cao J., 2020, J BIOMEDICAL RES INN, V1, P1, DOI DOI 10.31579/2690-1897/021; Centers for Disease Control and Prevention (US), 2021, CDC COVID 19 SCI BRI; Chan Sun M, 2020, COVID 19 MAURITIUS D; Cheng VCC, 2020, INFECT CONT HOSP EP, V41, P493, DOI 10.1017/ice.2020.58; com M, SUMITOMO HALTS MINES; Dan-Nwafor C, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020399; Data OW, DATA COVID 19 CORONA; Data OW, CORONAVIRUS PANDEMIC; Defimedia info (Video iF, COVID 19 PRAVIND JUG; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Dharmaratne S, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01411-0; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diggers N., GOVT SHUTS ALL SCH P; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; for Disease Control (NCDC) NC, CORONAVIRUS DIS COVI; French) MI, PRESIDENT AZALI RECO; French) SCI, DECRET PRESIDENTIEL; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; GardaWorld, COMOROS AUTHORITIES; GARDAWORLD, MADAGASCAR AUTHORITI; GARDAWORLD, GHANA AUTHORITIES IM; GARDWORLD, TUNISIA ONGOING COVI; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Gomez LF, SERO EPIDEMIOLOGICAL; health organization (WHO): African W, CORONAVIRUS COVID 19; health Organization (WHO): Namibia W, COMPREHENSIVE COVID; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; IGC, RWANDAS RESPONSE COV; Interbull Centre, 2021, NAT GEN EV FORMS PRO; Ivorra B, 2020, COMMUN NONLINEAR SCI, V88, DOI 10.1016/j.cnsns.2020.105303; Iyaniwura SA, 2021, MATH BIOSCI ENG, V18, P8905, DOI 10.3934/mbe.2021439; Jakubowski A., 2021, SELF REPORTED MASK W; Jones J. H., 2007, TECH REP; Karia Rutu, 2020, SN Compr Clin Med, V2, P1798, DOI 10.1007/s42399-020-00498-4; Karim SSA., NEW ENGL J MED; Ke RA, 2021, J THEOR BIOL, V517, DOI 10.1016/j.jtbi.2021.110621; Kong JD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252373; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liu Z, 2020, INFECT DIS MODEL, V5, P323, DOI 10.1016/j.idm.2020.03.003; Locatelli I, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248731; Lounis M., 2020, EUROPEAN J MEDICAL E, V13, DOI [10.30935/ejmets/8012, DOI 10.30935/EJMETS/8012]; Ma JL, 2020, INFECT DIS MODEL, V5, P129, DOI 10.1016/j.idm.2019.12.009; Monnahan CC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197954; Mukhtar MM., 2021, NAT IMMUNOL, P1; Mulberry N., 2021, PLoS Global Public Health, V2, DOI 10.1371/journal.pgph.0000020; Musa R., 2020, ASSESSMENT IMPACTS P; Musa SS, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00718-y; Musa SS, 2021, HETEROGENEOUS SEVERI; Musanabaganwa C, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004547; Ndairoua F, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109846; Nemzoff Cassandra, ARE STRICT LOCKDOWNS; Oana IE, 2021, WEST EUR POLIT, V44, P1232, DOI 10.1080/01402382.2021.1933310; Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227; Organization WH, 2020, CORONAVIRUS DIS 2019, P73; Otoo D, 2021, EUR J PURE APPL MATH, V14, P135, DOI 10.29020/nybg.ejpam.v14i1.3850; Park SW, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2020.0144; Perasso Antoine, 2018, ESAIM: Proceedings and Surveys, V62, P123, DOI 10.1051/proc/201862123; Perra N, 2021, PHYS REP, V913, P1, DOI 10.1016/j.physrep.2021.02.001; Peter OJ, 2021, CMC-COMPUT MATER CON, V66, P1823, DOI 10.32604/cmc.2020.012314; Peter OJ, 2021, RESULTS PHYS, V24, DOI 10.1016/j.rinp.2021.104098; Randremanana RV, 2021, INFLUENZA OTHER RESP, V15, P457, DOI 10.1111/irv.12845; Reuters, GABON BLOCKS EUROPEA; reuters, REUTERS COVID 19 TRA; Sarfo A., 2020, T INDIAN NATL ACAD E, V5, P193, DOI [10.1007/s41403-020-00145-3, DOI 10.1007/S41403-020-00145-3]; Schroder M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84487-0; Serhani M, 2021, J APPL MATH COMPUT, V66, P1, DOI 10.1007/s12190-020-01421-9; Fodjo JNS, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052554; Simos TE, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9060664; Soltesz K, 2020, NATURE, V588, pE26, DOI 10.1038/s41586-020-3025-y; Stan Development Team, 2016, RSTAN R INT STAN; statista, NUMBER CORONAVIRUS C; Stockdale JE, 2020, TRANSMISSION INTERVA, DOI [10.1101/2020.03.03.20029983, DOI 10.1101/2020.03.03.20029983, 10.1101/2020.03.03.20029983v1]; Tuite AR, 2020, CAN MED ASSOC J, V192, pE497, DOI 10.1503/cmaj.200476; UNICEF, CHAD CORONAVIRUS COV; UNICEF, UNICEF MALAWI COVID; van den Driessche P, 2008, LECT NOTES MATH, V1945, P159; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; WHO, WHO RAMPS PREPAREDNE; who, WHO CORONAVIRUS COVI; who, WHOS COVID 19 RESPON; World health organisation (WHO), SCI BRIEF TRANSMISSI; World Health Organization, 2020, DIR GEN OP REM MED B; Xu C, 2020, FRONT MED-PRC, V14, P613, DOI 10.1007/s11684-020-0787-4; Zhao S, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.00347; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050; Zhong HN, 2020, MATH BIOSCI ENG, V17, P6909, DOI 10.3934/mbe.2020357; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	115	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264455	10.1371/journal.pone.0264455	http://dx.doi.org/10.1371/journal.pone.0264455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213645	Green Submitted, gold, Green Published			2022-12-26	WOS:000787811000101
J	Lin, W; Li, YK; Shi, QZ; Liao, XR; Zeng, Y; Tian, W; Xie, XY; Liu, H				Lin, Wen; Li, Yinke; Shi, Qiongzhi; Liao, Xiangru; Zeng, Yuan; Tian, Wei; Xie, Xiangyang; Liu, Hui			Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate	PLOS ONE			English	Article							IN-VITRO; CELLULOSE-ACETATE; DRUG-RELEASE; FORMULATION; PHARMACOKINETICS; PHARMACOLOGY; DELIVERY; SYSTEM	Topiramate (TPM) was an antiepileptic agent commonly used in clinical. Studies showed that an oral preparation of TPM with extended-release manner could bring some benefits for epileptics. In this paper, controlled release push-pull osmotic pump (PPOP) tablets of sparingly water-soluble TPM were successfully prepared. This bi-layer tablet core mainly consisted of sodium chloride as osmotic promoting agent and polyethylene oxide as suspending and pushing agents. The influences of osmotic agents, pushing agents and the compositions of coating membrane on TPM release profiles were evaluated. An optimal formulation of TPM-PPOP was obtained through single-factor experiments. In vitro release tests showed that the optimum formulation could release TPM at an approximate zero-order rate up to 8 h. Pharmacokinetic behaviors of TPM-PPOP tablets were evaluated and compared with the immediate release capsules after an oral single dose in beagle dogs. Pharmacokinetics results demonstrated that the TPM-PPOP tablet was able to provide a prolonged release of TPM with longer t(max) and mean residence time. Lower fluctuations of drug plasma levels could also be achieved with TPM-PPOP tablets. These results suggested that sparely water-soluble drugs as TPM can be designed to PPOP for efficacy and safety use.	[Lin, Wen] Huangshi Love & Hlth Hosp Hubei Prov, Dept Clin Lab, Huangshi, Hubei, Peoples R China; [Li, Yinke; Shi, Qiongzhi; Liao, Xiangru; Zeng, Yuan; Tian, Wei; Xie, Xiangyang; Liu, Hui] Gen Hosp Cent Theater PLA, Dept Pharm, Wuhan, Hubei, Peoples R China		Xie, XY (corresponding author), Gen Hosp Cent Theater PLA, Dept Pharm, Wuhan, Hubei, Peoples R China.	xxysypu@163.com		Xie, Xiangyang/0000-0001-8260-3988	Natural Science Foundation of Hubei Province [2020CFB569]; Health commission of Hubei Province scientific research projects [WJ2021M218, WJ2018H0116, WJ2019H422]; Natural Science Foundation of Hubei Province	Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Health commission of Hubei Province scientific research projects; Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	NO - Initials of the authors Xiangyang Xie & Wen Lin received financial supports as followings: Natural Science Foundation of Hubei Province (Grant No. 2020CFB569), Health commission of Hubei Province scientific research projects (Grant No.WJ2021M218): Xiangyang Xie; Health commission of Hubei Province scientific research projects (Grant No. WJ2018H0116, WJ2019H422): Wen Lin. URL of each funder website: Natural Science Foundation of Hubei Province: https://jhsb.hbstd.gov.cn/main/index.jsp Health commission of Hubei Province scientific research project: https://wjw.hubei.gov.cn/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialer M, 2007, EPILEPSY RES, V73, P1, DOI 10.1016/j.eplepsyres.2006.10.008; Caldwell GW, 2005, EUR J DRUG METAB PH, V30, P151, DOI 10.1007/BF03190614; Cameron F, 2012, DRUGS, V72, P2033, DOI 10.2165/11640860-000000000-00000; Doose DR, 2002, ANTIEPILEPTIC DRUGS, V5th, P727; Dredan J, 1996, INT J PHARM, V145, P61, DOI 10.1016/S0378-5173(96)04725-4; DRESSMAN JB, 1986, PHARMACEUT RES, V3, P123, DOI 10.1023/A:1016353705970; Garnett WR, 2000, EPILEPSIA, V41, pS61; Gong W, 2015, DRUG DEV IND PHARM, V41, P464, DOI 10.3109/03639045.2013.877923; GUO JH, 1993, DRUG DEV IND PHARM, V19, P1541, DOI 10.3109/03639049309069325; Lambrecht LJ, 2011, EPILEPSIA, V52, P1877, DOI 10.1111/j.1528-1167.2011.03183.x; Liang L, 2008, US Patent, Patent No. [2008/0118557 A1, 20080118557]; Liu LX, 2008, INT J PHARM, V352, P225, DOI 10.1016/j.ijpharm.2007.10.047; Liu LX, 2008, EUR J PHARM BIOPHARM, V68, P298, DOI 10.1016/j.ejpb.2007.04.020; Liu LX, 2000, J CONTROL RELEASE, V68, P145, DOI 10.1016/S0168-3659(00)00243-1; Liu LX, 2000, J CONTROL RELEASE, V67, P309, DOI 10.1016/S0168-3659(00)00222-4; Makhija SN, 2003, J CONTROL RELEASE, V89, P5, DOI 10.1016/S0168-3659(02)00482-0; Malaterre V, 2009, EUR J PHARM BIOPHARM, V73, P311, DOI 10.1016/j.ejpb.2009.07.002; Malaterre V, 2009, DRUG DEV IND PHARM, V35, P433, DOI 10.1080/03639040802425230 ; Malaterre V, 2009, INT J PHARMACEUT, V376, P56, DOI 10.1016/j.ijpharm.2009.04.015; Marino SE, 2012, EPILEPSY BEHAV, V24, P365, DOI 10.1016/j.yebeh.2012.04.120; MCCLELLAND GA, 1991, PHARMACEUT RES, V8, P88, DOI 10.1023/A:1015890525495; Mula M, 2003, EPILEPSIA, V44, P659, DOI 10.1046/j.1528-1157.2003.05402.x; Nie SF, 2007, DRUG DEV IND PHARM, V33, P1024, DOI 10.1080/03639040601179897; Ofori-Kwakye K, 2003, INT J PHARM, V250, P431, DOI 10.1016/S0378-5173(02)00578-1; Okimoto K, 2004, INT J PHARMACEUT, V286, P81, DOI 10.1016/j.ijpharm.2004.08.002; Ouyang D, 2005, DRUG DEV IND PHARM, V31, P677, DOI 10.1080/03639040500216410; Pellock JM, 2004, EPILEPSY BEHAV, V5, P301, DOI 10.1016/j.yebeh.2004.01.009; Rowe R.C., 2009, HDB PHARM EXCIPIENTS, V6th, P522; Shah VP, 1998, PHARMACEUT RES, V15, P889, DOI 10.1023/A:1011976615750; Shank RP, 2000, EPILEPSIA, V41, pS3, DOI 10.1111/j.1528-1157.2000.tb06045.x; THEEUWES F, 1975, J PHARM SCI, V64, P1987, DOI 10.1002/jps.2600641218; Theeuwes F., 1978, U.S. Patnet, Patent No. [4111201, 4,111,201]; Theeuwes F, 1972, US Patent, Patent No. [3,845,770, 3845770]; Verma RK, 2000, DRUG DEV IND PHARM, V26, P695, DOI 10.1081/DDC-100101287; Verma RK, 2002, J CONTROL RELEASE, V79, P7, DOI 10.1016/S0168-3659(01)00550-8; Vuu I, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00107; Walsh P., 2002, PHYS DESK REFERENCE, V56, P2590; Xu HM, 2013, INT J PHARMACEUT, V458, P181, DOI 10.1016/j.ijpharm.2013.09.031; Yang MY, 2014, INT J PHARMACEUT, V465, P187, DOI [10.1016/j.ijpharm.2014.02.021, 10.1016/i.ijpharm.2014.02.021]; Zhang ZH, 2011, INT J PHARMACEUT, V410, P41, DOI 10.1016/j.ijpharm.2011.03.013	40	2	2	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264457	10.1371/journal.pone.0264457	http://dx.doi.org/10.1371/journal.pone.0264457			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213658	Green Published, gold			2022-12-26	WOS:000787811000102
J	Addo-Gyan, D; Matsushita, H; Sora, E; Nishi, T; Yuda, M; Shinzawa, N; Iwanaga, S				Addo-Gyan, Daniel; Matsushita, Haruka; Sora, Enya; Nishi, Tsubasa; Yuda, Masao; Shinzawa, Naoaki; Iwanaga, Shiroh			Chromosome splitting of Plasmodium berghei using the CRISPR/Cas9 system	PLOS ONE			English	Article							GENOME; GENES; REVEALS	Spatial arrangement of chromosomes is responsible for gene expression in Plasmodium parasites. However, methods for rearranging chromosomes have not been established, which makes it difficult to investigate its role in detail. Here, we report a method for splitting chromosome in rodent malaria parasite by CRISPR/Cas9 system using fragments in which a telomere and a centromere were incorporated. The resultant split chromosomes segregated accurately into daughter parasites by the centromere. In addition, elongation of de novo telomeres were observed, indicating its proper function. Furthermore, chromosome splitting had no effect on development of parasites. Splitting of the chromosome is expected to alter its spatial arrangement, and our method will thus be useful for investigating its biological role related with gene expression.	[Addo-Gyan, Daniel; Matsushita, Haruka; Sora, Enya; Shinzawa, Naoaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Environm Parasitol, Bunkyo Ku, Tokyo, Japan; [Nishi, Tsubasa; Yuda, Masao] Mie Univ, Dept Med, Lab Med Zool, Tsu, Mie, Japan; [Iwanaga, Shiroh] Osaka Univ, Res Inst Microbial Dis, Dept Mol Protozool, Suita, Osaka, Japan; [Iwanaga, Shiroh] Osaka Univ, Ctr Infect Dis Educ & Res CIDER, Suita, Osaka, Japan	Tokyo Medical & Dental University (TMDU); Mie University; Osaka University; Osaka University	Iwanaga, S (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Mol Protozool, Suita, Osaka, Japan.; Iwanaga, S (corresponding author), Osaka Univ, Ctr Infect Dis Educ & Res CIDER, Suita, Osaka, Japan.	iwanaga@biken.osaka-u.ac.jp		Iwanaga, Shiroh/0000-0002-4394-7267	Japan Society for the Promotion of Science (JSPS) [20H03477, 19K22527, 18K07084, 21K06985, 17H01542]; Japan Agency for Medical Research and Development (AMED) [21jm0210061h0004, 21wm0325018, 21wm0225014]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	All studies were supported by Grants-inAid for Scientific Research (20H03477 and 19K22527 to S.I. 18K07084 and 21K06985 to N.S., and 17H01542 to M.Y.), which were funded by the Japan Society for the Promotion of Science (JSPS: https://www.jsps.go.jp/), and also supported by the Japan Agency for Medical Research and Development (AMED: https://www.amed.go.jp/) under Grant Number 21jm0210061h0004 (to S.I.), 21wm0325018 (to N.S.) and 21wm0225014 (to N. S.). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2019, BRIEF FUNCT GENOMICS, V18, P302, DOI 10.1093/bfgp/elz005; Ay F, 2014, GENOME RES, V24, P974, DOI 10.1101/gr.169417.113; Bertschi NL, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.33; Bunnik EM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04295-5; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Figueiredo LM, 2002, EMBO J, V21, P815, DOI 10.1093/emboj/21.4.815; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gerald N, 2011, EUKARYOT CELL, V10, P474, DOI 10.1128/EC.00314-10; Gurung P, 2021, CELL MICROBIOL, V23, DOI 10.1111/cmi.13303; Hoeijmakers WAM, 2012, CELL MICROBIOL, V14, P1391, DOI 10.1111/j.1462-5822.2012.01803.x; Hollin T, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.618454; Iwanaga S, 2012, GENOME RES, V22, P985, DOI 10.1101/gr.124164.111; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Lee MCS, 2019, BRIEF FUNCT GENOMICS, V18, P281, DOI 10.1093/bfgp/elz012; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; McKenzie FE, 2001, EVOLUTION, V55, P1299, DOI 10.1111/j.0014-3820.2001.tb00652.x; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; PONZI M, 1985, EMBO J, V4, P2991, DOI 10.1002/j.1460-2075.1985.tb04034.x; Shinzawa N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063753; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0260176	10.1371/journal.pone.0260176	http://dx.doi.org/10.1371/journal.pone.0260176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202423	gold, Green Published, Green Submitted			2022-12-26	WOS:000773224600004
J	Calafiore, GC; Fracastoro, G				Calafiore, Giuseppe Carlo; Fracastoro, Giulia			Age structure in SIRD models for the COVID-19 pandemic-A case study on Italy data and effects on mortality	PLOS ONE			English	Article								The COVID-19 pandemic is bringing disruptive effects on the healthcare systems, economy and social life of countries all over the world. Even though the elder portion of the population is the most severely affected by the COVID-19 disease, the counter-measures introduced so far by governments took into little account the age structure, with restrictions that act uniformly on the population irrespectively of age. In this paper, we introduce a SIRD model with age classes for studying the impact on the epidemic evolution of lockdown policies applied heterogeneously on the different age groups of the population. The proposed model is then applied to age-stratified COVID-19 Italian data. The simulation results suggest that control measures focused to specific age groups may bring benefits in terms of reduction of the overall mortality rate.	[Calafiore, Giuseppe Carlo; Fracastoro, Giulia] Politecn Torino, Dept Elect & Telecommun, Turin, Italy	Polytechnic University of Turin	Fracastoro, G (corresponding author), Politecn Torino, Dept Elect & Telecommun, Turin, Italy.	giulia.fracastoro@polito.it		fracastoro, giulia/0000-0001-8495-1097				Aronna MS, 2021, EPIDEMICS-NETH, V34, DOI 10.1016/j.epidem.2021.100437; Bin M, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008604; Bonanad C, 2020, J AM MED DIR ASSOC, V21, P915, DOI 10.1016/j.jamda.2020.05.045; Calafiore G, 2021, ARXIV PREPRINT ARXIV; Calafiore GC, 2020, ANNU REV CONTROL, V50, P361, DOI 10.1016/j.arcontrol.2020.10.005; Calafiore Giuseppe C., 2014, OPTIMIZATION MODELS; Carli R, 2020, ANNU REV CONTROL, V50, P373, DOI 10.1016/j.arcontrol.2020.09.005; Centers for Disease Control and Prevention, 2020, COVID 19 RESP CDC CO; Chowdhury R, 2020, EUR J EPIDEMIOL, V35, P389, DOI 10.1007/s10654-020-00649-w; Claeson M, 2021, LANCET, V397, P259, DOI 10.1016/S0140-6736(20)32750-1; Della Rossa F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18827-5; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Kulldorf M, 2020, GREAT BARRINGTON DEC; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Nepomuceno MR, 2020, P NATL ACAD SCI USA, V117, P13881, DOI 10.1073/pnas.2008760117; O'Sullivan D, 2020, T GIS, V24, P967, DOI 10.1111/tgis.12660; Omori R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73777-8; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; STOICA P, 1985, IEEE T AUTOMAT CONTR, V30, P597, DOI 10.1109/TAC.1985.1103999; WHO, 2020, WHO COR COVID 19 DAS; Xu Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247660; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	23	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264324	10.1371/journal.pone.0264324	http://dx.doi.org/10.1371/journal.pone.0264324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202438	Green Published, gold			2022-12-26	WOS:000773224600029
J	Chen, CWS; Fan, TH				Chen, Cathy W. S.; Fan, Tsai-Hung			Public opinion concerning governments' response to the COVID-19 pandemic	PLOS ONE			English	Article							BOOTSTRAP	ObjectivesGovernments around the world have implemented numerous policies in response to the COVID-19 pandemic. This research examines the political issues resulting in public opinion concerning their responses to the pandemic via an international perspective. The objectives of this study are to: (1) measure the association and determine whether differences in political support can be attributed to the presence of approval ratings during the pandemic, and to (2) identify exceptional cases based on statistical predictions. MethodsWe collect information from several open-sourced surveys conducted between June and September 2020 of public sentiment concerning governments' response toward COVID-19. The 11 countries in our sample account for over 50% of the world's Gross Domestic Product (GDP). The study includes country-specific random effects to take into account the data's clustered structure. We consider "political partisanship" and "pre-pandemic approval ratings in 2019" as two potential explanatory variables and employ a mix-effect regression for bounded responses via variable transformation and the wild bootstrap resampling method. ResultsAccording to the wild bootstrap method, the mixed-effect regression explains 98% of the variation in approval ratings during the pandemic in September 2020. The findings reveal partisan polarization on COVID-19 policies in the U.S., with opposing supporters most likely to express negative sentiments toward the governing party. ConclusionsThe evidence suggests that approval ratings during the pandemic correlate to differences in political support and pre-pandemic approval ratings, as measured by approval ratings from the views between governing coalition supporters and opponents.	[Chen, Cathy W. S.] Feng Chia Univ, Dept Stat, Taichung, Taiwan; [Fan, Tsai-Hung] Natl Cent Univ, Grad Inst Stat, Taoyuan, Taiwan	Feng Chia University; National Central University	Chen, CWS (corresponding author), Feng Chia Univ, Dept Stat, Taichung, Taiwan.	chenws@mail.fcu.edu.tw	Chen, Cathy W. S./AAM-5546-2020	Chen, Cathy W. S./0000-0001-8727-8168	Taiwan Ministry of Science and Technology [MOST109-2118-M-035-005-MY3]	Taiwan Ministry of Science and Technology	The authors thank the Editor, the Academic Editor, and anonymous referees for their valuable time and careful comments, which have improved this paper.	Allcott H, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104254; Bol D, 2021, EUR J POLIT RES, V60, P497, DOI 10.1111/1475-6765.12401; Chen CWS, 2021, INT J INFECT DIS, V102, P327, DOI 10.1016/j.ijid.2020.10.050; Chen CWS., 2021, EC STAT, DOI [10.1016/j.ecosta.2021.03.006, DOI 10.1016/J.ECOSTA.2021.03.006]; Clinton J, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd7204; Dey M, 2020, MON LABOR REV, DOI 10.21916/mlr.2020.6; Dimock M, 2020, PEW RES CTR REPORT; Druckman JN, 2021, NAT HUM BEHAV, V5, DOI 10.1038/s41562-020-01012-5; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fetzer T, 2021, REV ECON STAT, V103, P968, DOI 10.1162/rest_a_00946; Flachaire E, 2005, COMPUT STAT DATA AN, V49, P361, DOI 10.1016/j.csda.2004.05.018; Forster T, 2021, J EUR PUBLIC POLICY, V28, P1299, DOI 10.1080/13501763.2021.1942157; Gadarian SK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249596; Herrera H, 2020, 2165 KIEL I WORLD EC; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Khamis H, 2008, J DIAGN MED SONOG, V24, P155, DOI 10.1177/8756479308317006; Kieschnick R, 2003, STAT MODEL, V3, P193, DOI 10.1191/1471082X03st053oa; LIU RY, 1988, ANN STAT, V16, P1696, DOI 10.1214/aos/1176351062; Mordecai M., 2020, PEW RES CTR; Ntv.de, 2019, MAJORITY REJECTS MER; Pak A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00241; Rich TS., 2020, DIPLOMAT 1007; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142	23	1	1	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0260062	10.1371/journal.pone.0260062	http://dx.doi.org/10.1371/journal.pone.0260062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T6JP	35235561	gold, Green Published			2022-12-26	WOS:000787073100033
J	Temesgan, WZ; Aklil, MB; Yacob, HS; Mekonnen, ET; Tegegne, ED; Tesfa, EB; Melese, EM; Seyoum, T				Temesgan, Wubedle Zelalem; Aklil, Mastewal Belayneh; Yacob, Henok Solomon; Mekonnen, Esubalew Tsega; Tegegne, Elias Derso; Tesfa, Esubalew Binega; Melese, Eshetie Melkie; Seyoum, Tewodros			Adherence to COVID-19 preventive practice and associated factors among pregnant women in Gondar city, northwest Ethiopia, 2021: Community-based cross-sectional study	PLOS ONE			English	Article							ATTENDING ANTENATAL CARE; TRANSMISSION; INFECTION; KNOWLEDGE; WUHAN	BackgroundCoronavirus disease 2019 (COVID-19) causes more than five million deaths worldwide. Pregnant women are at high risk for infection due to the physiologic change in the immune and cardiopulmonary system and also it increases the risk of severe disease, intensive care unit admission, and receive mechanical ventilation when compared with non-pregnant women. It is associated with adverse maternal and neonatal outcomes. So pregnant women need to have adhered to preventive measures to prevent COVID-19 related consequences. Therefore, this study aimed to assess adherence toCOVID-19 preventive practice and associated factors among pregnant women in Gondar city, northwest Ethiopia. MethodsA community-based cross-sectional study was conducted from July 1(st) to 30(th), 2021, in Gondar city. A cluster sampling technique was employed to select 678 pregnant women. Data were collected using a pre-tested, face-to-face interviewer-administered questionnaire. Data were entered into EPI DATA version 4.6 and exported to SPSS version 25 for analysis. Both bivariable and multivariable logistic regression analysis was fitted to identify associated factors. Adjusted odds ratio with a 95% confidence interval was used to report the association between covariates and the outcome variable. ResultsThe prevalence of good adherence to COVID-19 preventive practice was 44.8% (95% CI: 41.3, 48.7). Maternal age (<= 24 years) [AOR = 2.89, 95% CI: 1.37, 6.10], maternal education (secondary school) [AOR = 2.95, 95% CI: 1.58, 5.53] and (college and above) [AOR = 4.57,95% CI: 2.42, 8.62], having ANC follow up [AOR = 2.95, 95% CI: 1.35, 6.46] and adequate knowledge towards COVID-19 [AOR = 1.70, 95% CI: 1.20, 2.41] were significantly associated with good adherence to COVID-19 preventive practice. ConclusionIn this study, adherence towards COVID-19 preventive practice in pregnant women is low. Hence, it is important to strengthen women's awareness about COVID-19 through different media and health education. In addition, empowering women to attain ANC and special consideration should be given to women who had no formal education.	[Temesgan, Wubedle Zelalem; Aklil, Mastewal Belayneh] Univ Gondar, Coll Med & Hlth Sci, Sch Midwifery, Dept Clin Midwifery, Gondar, Ethiopia; [Yacob, Henok Solomon; Mekonnen, Esubalew Tsega; Tegegne, Elias Derso; Tesfa, Esubalew Binega; Melese, Eshetie Melkie] Univ Gondar, Coll Med & Hlth Sci, Sch Midwifery, Dept Gen Midwifery, Gondar, Ethiopia; [Seyoum, Tewodros] Univ Gondar, Coll Med & Hlth Sci, Sch Midwifery, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Temesgan, WZ (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Midwifery, Dept Clin Midwifery, Gondar, Ethiopia.	wubedlezelalem@gmail.com		Temesgan, wubedle Zelalem/0000-0002-4642-164X; Belayneh, Mastewal/0000-0002-1786-8792				Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0; Abeya S.G., 2021, PLOS ONE, V16, DOI [10.1371/journal.pone.0257373, DOI 10.1371/JOURNAL.PONE.0257373]; Aduloju OP., 2021, INT J CLIN OBSTET GY, V5, P101; Amiri A. S., 2020, SOC WORK SOC SCI REV, V2022, P1; Awadasseid A, 2020, INT J BIOL SCI, V16, P1846, DOI 10.7150/ijbs.45018; Ayele AD, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03877-4; Baye K., 2020, INT FOOD POLICY RES, P14, DOI [DOI 10.2499/P15738COLL2.133729, 10.2499/p15738coll2.133729, 10.2499/P15738COLL2.133729]; Besho M, 2021, INT J GEN MED, V14, P3563, DOI 10.2147/IJGM.S295490; Ciarambino T., 2021, COVID, V1, P230, DOI [DOI 10.3390/COVID1010019, 10.3390/covid1010019]; DATAREPORTAL, DIG ETH ALL STAT YOU; Denis M., 2021, TRANSDISCIPL INSIGHT, V4, P1; Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107; Ethiopia, WEEKLY EPIDEMIOLOGIC; Ethiopia CSA of, 2013, FED DEM REP ETH CENT, P118; Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.5.200131e; Fikadu Y, 2021, INT J WOMENS HEALTH, V13, P39, DOI 10.2147/IJWH.S291507; Kumbeni MT, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253446; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Mohamed Moselhy M., 2021, EGYPT J NURS HLTH SC, V2, P176; Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014; Musa IR, 2020, OPEN J OBSTET GYNECO, V10, P1197; Nawsherwan, 2020, IRAN J PUBLIC HEALTH, V49, P2032, DOI 10.18502/ijph.v49i11.4717; Nwafor JI, 2020, INT J GYNECOL OBSTET, V150, P121, DOI 10.1002/ijgo.13186; Ortiz-Prado E, 2020, DIAGN MICR INFEC DIS, V98, DOI 10.1016/j.diagmicrobio.2020.115094; Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017; RCM|Royal college of Midwives and the RCOG|Royal college of Obstetricians & Gynecologists, 2020, COR COVID 19 INF PRE, P1; Riley LE., 2021, AM COLL OBSTET GYNEC, V19, P1; Rishi P, 2020, INDIAN J MICROBIOL, V60, P420, DOI 10.1007/s12088-020-00908-0; Silesh M, 2021, RISK MANAG HEALTHC P, V14, P4561, DOI 10.2147/RMHP.S330932; Smith DD, 2020, AM J PERINAT, V37, P792, DOI 10.1055/s-0040-1712103; Society for Maternal-Fetal Medicine (SMFM) Statement, 2020, SARS COV 2 VACC PREG, P1; Thakur V, 2022, INFECTION, V50, P309, DOI 10.1007/s15010-021-01734-2; Wondimu W, 2020, J MULTIDISCIP HEALTH, V13, P917, DOI 10.2147/JMDH.S269359; Zhao XX, 2020, EUR J CLIN MICROBIOL, V39, P1209, DOI 10.1007/s10096-020-03897-6	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264237	10.1371/journal.pone.0264237	http://dx.doi.org/10.1371/journal.pone.0264237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235581	Green Published, gold			2022-12-26	WOS:000787073100019
J	Liu, H; Wang, LL; Xu, QH; Wang, J; Zhang, YJ; Luo, J; Liao, AH				Liu, Hong; Wang, Li-Ling; Xu, Qian-Han; Wang, Jing; Zhang, Yu-Jing; Luo, Jing; Liao, Ai-Hua			UHRF1 shapes both the trophoblast invasion and decidual macrophage differentiation in early pregnancy	FASEB JOURNAL			English	Article						CXCL2; early pregnancy; IL-1 beta; trophoblast; Uhrf1	DNA METHYLATION; CELL-LINE; RECURRENT; GENE; ACTIVATION; EXPRESSION; POLYMORPHISMS; PROLIFERATION; ENDOMETRIUM; MATURATION	Trophoblasts play critical roles in establishment and maintenance of a normal pregnancy. Their dysfunction in early pregnancy is closely related to pregnancy-related diseases. including recurrent pregnancy loss (RPL). Epigenetic modifications dynamically change during pregnancy; however, the role of the epigenetic modifier UHRF1 in trophoblast regulation remains unknown. This is the first study to show that UHRF1 expression was localized in the cytoplasm of cytotrophoblasts, syncytiotrophoblasts, and villi columns, and decreased in the villi of patients with RPL. The invasion and cell viability in a UHRF1 knockdown trophoblast cell line were significantly decreased. In addition, the mRNA expression profiles of Swan7l cells were partially altered by UHRF1 knockdown. The altered immune-related genes were screened out and the pro-inflammatory TH1-type chemokine/cytokines CXCL2 and IL-43 were identified as the most promising targets of IA in the trophoblasts, which were significantly increased in the UHRI'l knockdown Swan7l cells, villi, and serum from patients with RPL. The macrophages treated with the supernatants of UHRF1 knockdown Swan71 cells were polarized to the M1 phenotype and secreted high levels of pro-inflammatory cytokines, which might he driven by the activated MyD88/NF-kappa B signaling pathway and mediated by the increased expression of CXCR2 and IL-1R1 (CXCL2 and IL-1 beta receptors. respectively). In addition. the supernatants of UHRF1 knockdown Swan71 cells showed stronger chemotaxis to macrophages than those from the controls. Our findings highlight the previously unknown roles of UHRF1 as one of the key regulators on the trophoblasts and their cross-talk with local immune cells, and demonstrate a potential approach for RPL intervention.	[Liu, Hong; Wang, Li-Ling; Xu, Qian-Han; Wang, Jing; Zhang, Yu-Jing; Luo, Jing; Liao, Ai-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Inst Reprod Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology	Liao, AH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Inst Reprod Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China.	aihua_liao@hust.edu.cn	Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022; Wu, Jing/GZK-5063-2022	Liao, Aihua/0000-0001-8533-8315	National Key Research & Developmental Program of China [2018YFC1003900, 2018YFC1003904]	National Key Research & Developmental Program of China	National Key Research & Developmental Program of China, Grant/Award Number: 2018YFC1003900 and 2018YFC1003904	Abbas Y, 2020, HUM REPROD UPDATE, V26, P501, DOI 10.1093/humupd/dmaa017; Adan A, 2016, CURR PHARM BIOTECHNO, V17, P1213, DOI 10.2174/1389201017666160808160513; Agrawal S, 2012, REPROD BIOMED ONLINE, V24, P342, DOI 10.1016/j.rbmo.2011.11.021; Bombell S, 2008, AUST NZ J OBSTET GYN, V48, P147, DOI 10.1111/j.1479-828X.2008.00843.x; Boro M, 2017, J IMMUNOL, V199, P1660, DOI 10.4049/jimmunol.1700129; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Boukhari A, 2015, ANTICANCER RES, V35, P149; Branco MR, 2016, DEV CELL, V36, P152, DOI 10.1016/j.devcel.2015.12.027; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Cao YM, 2019, FASEB J, V33, P8294, DOI 10.1096/fj.201801696RRRR; Chen C, 2018, J EXP MED, V215, P1437, DOI 10.1084/jem.20171815; D'Ippolito S, 2016, FERTIL STERIL, V105, P111, DOI 10.1016/j.fertnstert.2015.09.027; Dong J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12455-4; Fischer Alexandra, 2012, BMC Res Notes, V5, P540, DOI 10.1186/1756-0500-5-540; Fraccaroli L, 2009, HUM REPROD, V24, P166, DOI 10.1093/humrep/den344; Gamage TKJB, 2018, EPIGENETICS-US, V13, P1154, DOI 10.1080/15592294.2018.1549462; Geisert R, 2012, CELL TISSUE RES, V349, P825, DOI 10.1007/s00441-012-1356-1; Gong J, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2710-6; Guleria I, 2000, NAT MED, V6, P589, DOI 10.1038/75074; Guo LY, 2020, CLIN EXP HYPERTENS, V42, P428, DOI 10.1080/10641963.2019.1693585; HASKILL S, 1990, P NATL ACAD SCI USA, V87, P7732, DOI 10.1073/pnas.87.19.7732; Hu QS, 2019, CANCER LETT, V452, P226, DOI 10.1016/j.canlet.2019.03.024; Hu XH, 2020, HUM REPROD, V35, P2454, DOI 10.1093/humrep/deaa223; Huppertz B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010289; Jiao D, 2019, ONCOGENE, V38, P5686, DOI 10.1038/s41388-019-0822-6; Jones PA, 2019, NAT REV CANCER, V19, P151, DOI 10.1038/s41568-019-0109-9; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02935-2; Kim JO, 2014, FERTIL STERIL, V102, P206, DOI 10.1016/j.fertnstert.2014.03.037; Krieg S, 2015, SEMIN REPROD MED, V33, P305, DOI 10.1055/s-0035-1554917; Li QY, 2021, CANCER INVEST, V39, P84, DOI 10.1080/07357907.2020.1837152; Li XY, 2019, INT J ONCOL, V54, P271, DOI 10.3892/ijo.2018.4630; Li ZH, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03142; Lin YL, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00266; Lin YL, 2019, ACTA BIOCH BIOPH SIN, V51, P598, DOI 10.1093/abbs/gmz042; Liu H, 2020, PLACENTA, V100, P122, DOI 10.1016/j.placenta.2020.08.013; Liu Y, 2020, PATHOL ONCOL RES, V26, P1079, DOI 10.1007/s12253-019-00656-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maenohara S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007042; Mao LM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02566; Marjoram L, 2015, P NATL ACAD SCI USA, V112, P2770, DOI 10.1073/pnas.1424089112; Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64; Moser G, 2015, HUM REPROD, V30, P2747, DOI 10.1093/humrep/dev266; Moser G, 2017, HISTOCHEM CELL BIOL, V147, P353, DOI 10.1007/s00418-016-1509-5; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Ngalamika O, 2015, IMMUNOL INVEST, V44, P126, DOI 10.3109/08820139.2014.938165; Obata Y, 2014, NAT IMMUNOL, V15, P571, DOI 10.1038/ni.2886; Okae H, 2018, CELL STEM CELL, V22, P50, DOI 10.1016/j.stem.2017.11.004; Pan HJ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2333-3; Piao HL, 2012, CELL MOL IMMUNOL, V9, P423, DOI 10.1038/cmi.2012.23; Porta C, 2015, SEMIN IMMUNOL, V27, P237, DOI 10.1016/j.smim.2015.10.003; Qi SS, 2019, J IMMUNOL, V203, P3045, DOI 10.4049/jimmunol.1900467; Rahmani SA, 2018, HORM MOL BIOL CLIN I, V33, DOI 10.1515/hmbci-2017-0044; Ramhorst R, 2016, CELL ADHES MIGR, V10, P197, DOI 10.1080/19336918.2015.1135285; Reis AS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6346; Russo RC, 2014, EXPERT REV CLIN IMMU, V10, P593, DOI 10.1586/1744666X.2014.894886; Pereira VCS, 2019, ARQ NEURO-PSIQUIAT, V77, P166, DOI [10.1590/0004-282X20190026, 10.1590/0004-282x20190026]; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shi XJ, 2020, BIOCHEM BIOPH RES CO, V529, P1018, DOI 10.1016/j.bbrc.2020.06.032; Sidhu H, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317692205; Subat S, 2019, J CANCER RES CLIN, V145, P675, DOI 10.1007/s00432-018-2824-0; Sun X, 2019, J EXP MED, V216, P2819, DOI 10.1084/jem.20190550; Turco MY, 2018, NATURE, V564, P263, DOI 10.1038/s41586-018-0753-3; Unoki M, 2010, BRIT J CANCER, V103, P217, DOI 10.1038/sj.bjc.6605717; Windsperger K, 2017, HUM REPROD, V32, P1208, DOI 10.1093/humrep/dex058; Yao J, 2016, J CLIN INVEST, V126, P732, DOI 10.1172/JCI81937; Yao YL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00792; Zhang HX, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181065; Zhao R, 2019, NEUROSCIENCE, V422, P99, DOI 10.1016/j.neuroscience.2019.10.048; Zhen Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00276; Zhu WQ, 2019, J ASSIST REPROD GEN, V36, P2563, DOI 10.1007/s10815-019-01614-7	71	0	0	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22247	10.1096/fj.202101647RR	http://dx.doi.org/10.1096/fj.202101647RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35262949				2022-12-26	WOS:000772957100005
J	Shan, ZL; Ghadirian, N; Lyumkis, D; Horton, NC				Shan, Zelin; Ghadirian, Niloofar; Lyumkis, Dmitry; Horton, Nancy C.			Pretransition state and apo structures of the filament-forming enzyme SgrAI elucidate mechanisms of activation and substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RESTRICTION-ENDONUCLEASE; DNA-POLYMERASE-I; CRYO-EM; ECORV ENDONUCLEASE; METABOLIC ENZYMES; METAL-IONS; SEQUENCE SELECTIVITY; CRYSTAL-STRUCTURES; BASE-STACKING; CLEAVAGE	Enzyme filamentation is a widespread phenomenon that mediates enzyme regulation and function. For the filament forming sequence-specific DNA endonuclease SgrAI, the process of filamentation both accelerates its DNA cleavage activity and expands its DNA sequence specificity, thus allowing for many additional DNA sequences to be rapidly cleaved. Both outcomes-the acceleration of DNA cleavage and the expansion of sequence specificity-are proposed to regulate critical processes in bacterial innate immunity. However, the mechanistic bases underlying these events remain unclear. Herein, we describe two new structures of the SgrAI enzyme that shed light on its catalytic function. First, we present the cryo-EM structure of filamentous SgrAI bound to intact primary site DNA and Ca2+ resolved to similar to 2.5 angstrom within the catalytic center, which represents the trapped enzyme-DNA complex prior to the DNA cleavage reaction. This structure reveals important conformational changes that contribute to the catalytic mechanism and the binding of a second divalent cation in the enzyme active site, which is expected to contribute to increased DNA cleavage activity of SgrAI in the filamentous state. Second, we present an X-ray crystal structure of DNA-free (apo) SgrAI resolved to 2.0 angstrom resolution, which reveals a disordered loop involved in DNA recognition. Collectively, these multiple new observations clarify the mechanism of expansion of DNA sequence specificity of SgrAI, including the indirect readout of sequence-dependent DNA structure, changes in protein-DNA interactions, and the disorder-to-order transition of a crucial DNA recognition element.	[Shan, Zelin; Lyumkis, Dmitry] Salk Inst Biol Sci, Lab Genet, La Jolla, CA 92037 USA; [Ghadirian, Niloofar] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Lyumkis, Dmitry] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Horton, Nancy C.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	Salk Institute; University of Arizona; Scripps Research Institute; University of Arizona	Lyumkis, D (corresponding author), Salk Inst Biol Sci, Lab Genet, La Jolla, CA 92037 USA.; Lyumkis, D (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Horton, NC (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	dlyumkis@salk.edu; nhorton@email.arizona.edu			National Science Foundation [MCB-1934291]; Hearst Foundations	National Science Foundation(National Science Foundation (NSF)); Hearst Foundations	Research reported in this publication was supported by the National Science Foundation under grant no. MCB-1934291 (to N. C. H. and D. L.) and by the Hearst Foundations (to D. L.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2013, ACTA CRYSTALLOGR D, V69, P625, DOI 10.1107/S0907444913000462; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; AGGARWAL AK, 1995, CURR OPIN STRUC BIOL, V5, P11, DOI 10.1016/0959-440X(95)80004-K; Aiyer S, 2021, METHODS MOL BIOL, V2215, P161, DOI 10.1007/978-1-0716-0966-8_8; Babic AC, 2008, J MOL BIOL, V383, P186, DOI 10.1016/j.jmb.2008.08.032; Baldwin PR, 2021, PROG BIOPHYS MOL BIO, V160, P53, DOI 10.1016/j.pbiomolbio.2020.06.003; Baldwin PR, 2020, PROG BIOPHYS MOL BIO, V150, P160, DOI 10.1016/j.pbiomolbio.2019.09.002; Barad BA, 2015, NAT METHODS, V12, P943, DOI [10.1038/NMETH.3541, 10.1038/nmeth.3541]; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bommarito S, 2000, NUCLEIC ACIDS RES, V28, P1929, DOI 10.1093/nar/28.9.1929; BRODY RS, 1981, BIOCHEMISTRY-US, V20, P1245, DOI 10.1021/bi00508a030; BROWN ID, 1988, ACTA CRYSTALLOGR B, V44, P545, DOI 10.1107/S0108768188007712; BURGERS PMJ, 1979, BIOCHEMISTRY-US, V18, P450, DOI 10.1021/bi00570a010; Carcamo WC, 2014, INT REV CEL MOL BIO, V308, P35, DOI 10.1016/B978-0-12-800097-7.00002-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng AC, 2021, PROTEIN SCI, V30, P136, DOI 10.1002/pro.3967; Chevalier B, 2004, BIOCHEMISTRY-US, V43, P14015, DOI 10.1021/bi048970c; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunten PW, 2008, NUCLEIC ACIDS RES, V36, P5405, DOI 10.1093/nar/gkn510; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Etzkorn C, 2004, J MOL BIOL, V343, P833, DOI 10.1016/j.jmb.2004.08.082; Etzkorn C, 2004, BIOCHEMISTRY-US, V43, P13256, DOI 10.1021/bi0490082; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Fasman G. D, 1975, CRC HDB BIOCH MOL BI, V3rd; FOTHERGILL M, 1995, J AM CHEM SOC, V117, P11619, DOI 10.1021/ja00152a001; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383; Grosse-Kunstleve RW, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-5; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Hingorani-Varma K, 2003, J BIOL CHEM, V278, P40392, DOI 10.1074/jbc.M304603200; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Horton JR, 2000, J MOL BIOL, V300, P1049, DOI 10.1006/jmbi.2000.3938; Horton NC, 2008, RSC BIOMOL SCI, P333; Horton NC, 2004, BIOCHEMISTRY-US, V43, P6841, DOI 10.1021/bi0499056; Horton NC, 1998, J BIOL CHEM, V273, P21721, DOI 10.1074/jbc.273.34.21721; Horton NC, 1998, J MOL BIOL, V277, P779, DOI 10.1006/jmbi.1998.1655; Horton NC, 2000, J AM CHEM SOC, V122, P3314, DOI 10.1021/ja993719j; Horton NC, 2002, BIOCHEMISTRY-US, V41, P10754, DOI 10.1021/bi020305l; Horton NC, 2002, NAT STRUCT BIOL, V9, P42, DOI 10.1038/nsb741; Horton NC, 1998, P NATL ACAD SCI USA, V95, P13489, DOI 10.1073/pnas.95.23.13489; Joshi HK, 2006, J BIOL CHEM, V281, P23852, DOI 10.1074/jbc.M512339200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Kool ET, 2001, ANNU REV BIOPH BIOM, V30, P1, DOI 10.1146/annurev.biophys.30.1.1; Lee JY, 2005, MOL CELL, V20, P155, DOI 10.1016/j.molcel.2005.08.019; Little EJ, 2011, ACTA CRYSTALLOGR D, V67, P67, DOI 10.1107/S0907444910047785; Little EJ, 2008, STRUCTURE, V16, P1828, DOI 10.1016/j.str.2008.09.009; Liu JL, 2016, ANNU REV CELL DEV BI, V32, P349, DOI 10.1146/annurev-cellbio-111315-124907; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Lynch EM, 2020, CURR OPIN CELL BIOL, V66, P28, DOI 10.1016/j.ceb.2020.04.006; Lyumkis D, 2013, STRUCTURE, V21, P1848, DOI 10.1016/j.str.2013.08.012; Ma X, 2013, BIOCHEMISTRY-US, V52, P4373, DOI 10.1021/bi3013214; Martin AM, 1999, BIOCHEMISTRY-US, V38, P8430, DOI 10.1021/bi9905359; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mizuuchi K, 1999, BIOCHEMISTRY-US, V38, P4640, DOI 10.1021/bi990054p; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2019, MOL BIOL CELL, V30, P2721, DOI 10.1091/mbc.E19-04-0224; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Oezguen N, 2007, PROTEINS, V68, P313, DOI 10.1002/prot.21397; Park CK, 2020, NAT REV MOL CELL BIO, V21, P1, DOI 10.1038/s41580-019-0188-1; Park Chad K, 2019, Biophys Rev, V11, P927, DOI 10.1007/s12551-019-00602-6; Park CK, 2010, BIOCHEMISTRY-US, V49, P8818, DOI 10.1021/bi100557v; PAULING L, 1947, J AM CHEM SOC, V69, P542, DOI 10.1021/ja01195a024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polley S, 2019, STRUCTURE, V27, P1497, DOI 10.1016/j.str.2019.08.001; Prouteau M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040160; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Sagendorf JM, 2020, NUCLEIC ACIDS RES, V48, pD277, DOI 10.1093/nar/gkz889; Sagendorf JM, 2017, NUCLEIC ACIDS RES, V45, pW89, DOI 10.1093/nar/gkx272; Sam MD, 2001, J MOL BIOL, V306, P851, DOI 10.1006/jmbi.2000.4434; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shah S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124783; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Shen QJ, 2016, J GENET GENOMICS, V43, P393, DOI 10.1016/j.jgg.2016.03.008; Simonet JC, 2020, MOL BIOL CELL, V31, P1201, DOI 10.1091/mbc.E18-10-0675; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TAUTZ N, 1990, NUCLEIC ACIDS RES, V18, P3087, DOI 10.1093/nar/18.10.3087; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P1113, DOI 10.1021/bi00004a002; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	98	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101760	10.1016/j.jbc.2022.101760	http://dx.doi.org/10.1016/j.jbc.2022.101760			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35202658	Green Published, gold			2022-12-26	WOS:000793617400007
J	Simionescu, M; Bordea, EN; Pellegrini, A				Simionescu, Mihaela; Bordea, Elena-Nicoleta; Pellegrini, Angelo			How did the COVID-19 pandemic impact the stress vulnerability of employed and non-employed nursing students in Romania?	PLOS ONE			English	Article							WORKPLACE STRESSORS; COPING STRATEGIES	In the light of the current COVID-19 pandemic, being considered a present challenge for public health, the main purpose of this work is to analyze the vulnerability to stress of a sample of nursing students in Romania considering their status on labour market (employed students in the medical system and non-employed students) before and during the COVID-19 pandemic. Employed students were more vulnerable to stress comparing to non-employed ones during the pandemic. In addition to this, the nursing students working in the medical system experienced medium vulnerability to stress during the pandemic comparing to those working before the pandemic who experienced a low vulnerability to stress. Excepting the non-employed students before the pandemic, the females were more vulnerable to stress comparing to the males in the sample and the students living in the country experienced a higher level of stress comparing to those living in the urban area. During the pandemic, most of the employed nursing students expressed their fear of getting infected with COVID-19, this representing the most stressful factor for them, while most of them mentioned the self-control as being the most proper strategy for them to cope with stress. These empirical findings have practical implications for stress control among present and future nurses, for management of medical units and for higher education nursing.	[Simionescu, Mihaela] Romanian Acad, Inst Econ Forecasting, Bucharest, Romania; [Bordea, Elena-Nicoleta; Pellegrini, Angelo] Carol Davila Univ Med & Pharm, Fac Midwifery & Nursing, Bucharest, Romania	Romanian Academy of Sciences; Carol Davila University of Medicine & Pharmacy	Simionescu, M (corresponding author), Romanian Acad, Inst Econ Forecasting, Bucharest, Romania.	mihaela.simionescu@ipe.ro						Achterberg M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81720-8; Aguiar-Quintana T, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2021.102868; Ahangarzadeh Rezaei S., 2008, J URMIA NURSING MIDW, V6, P1; Akbarbegloo M., 2011, MODERN CARE, V8, P45; Akhond MR, 2004, HAYAT, V10, P13; Aslan H, 2021, PERSPECT PSYCHIATR C, V57, P695, DOI 10.1111/ppc.12597; Bakibinga P, 2014, J RELIG HEALTH, V53, P1342, DOI 10.1007/s10943-013-9728-8; Bowden O., 2020, GLOBAL NEWS; Caplan G., 1964, PRINCIPLES PREVENTIV; Chang EM, 2006, J PROF NURS, V22, P30, DOI 10.1016/j.profnurs.2005.12.002; Dinh LP, 2020, SOC WORK EDUC, V39, P1074, DOI 10.1080/02615479.2020.1823365; Elloker S, 2003, THESIS U S AFRICA; Eslami Akbar Rasool, 2015, Glob J Health Sci, V8, P55, DOI 10.5539/gjhs.v8n6p55; Eslami Akbar Rasool, 2017, J Caring Sci, V6, P199, DOI 10.15171/jcs.2017.020; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; Gholamzadeh S., 2011, IRAN J NURSING MIDWI, V16, P42; Handra CM., 2018, ROMANIAN J OCCUPATIO, V69, P43; Harris LJM, 2013, J HOSP PALLIAT NURS, V15, P446, DOI 10.1097/NJH.0b013e3182a0de78; HOBFOLL SE, 1990, J SOC PERS RELAT, V7, P465, DOI 10.1177/0265407590074004; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Jahanshahi M, 2014, J URMIA NURSING MIDW, V12, P741; Jannati Y, 2011, J OCCUP HEALTH, V53, P123, DOI 10.1539/joh.O10015; Lambert VA, 2008, INDIAN J PALLIAT CAR, V14, P38, DOI 10.4103/0973-1075.41934; Mahmoud AB, 2020, J STRATEG MARK, DOI 10.1080/0965254X.2020.1844785; Mo YY, 2020, J NURS MANAGE, V28, P1002, DOI 10.1111/jonm.13014; Moustaka L., 2010, HLTH SCI J, V4, P210; Said RM, 2021, ENVIRON SCI POLLUT R, V28, P8791, DOI 10.1007/s11356-020-11235-8; Schwartzman R, 2020, COMMUN EDUC, V69, P502, DOI 10.1080/03634523.2020.1804602; Sheroun D, 2020, INT J SCI HEALTHCARE, V5, P280, DOI DOI 10.52403/IJSHR; Skinner EA, 2009, NEW DIR CHILD ADOLES, V124, P5, DOI 10.1002/cd.239; Sun NN, 2020, AM J INFECT CONTROL, V48, P592, DOI 10.1016/j.ajic.2020.03.018; Visconti G., 2018, OBSERVAT STUD, V4, P217; Wu Y, 2020, J PAIN SYMPTOM MANAG, V60, pE60, DOI 10.1016/j.jpainsymman.2020.04.008; Zhang YX, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.565520	34	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264920	10.1371/journal.pone.0264920	http://dx.doi.org/10.1371/journal.pone.0264920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245331	gold, Green Published			2022-12-26	WOS:000799799100043
J	Voulgari, PV; Venetsanopoulou, AI; Kalpourtzi, N; Gavana, M; Vantarakis, A; Hadjichristodoulou, C; Chlouverakis, G; Trypsianis, G; Alamanos, Y; Touloumi, G				Voulgari, Paraskevi V.; Venetsanopoulou, Aliki, I; Kalpourtzi, Natasa; Gavana, Magda; Vantarakis, Apostolos; Hadjichristodoulou, Christos; Chlouverakis, Grigoris; Trypsianis, Grigoris; Alamanos, Yannis; Touloumi, Giota		EMENO Study Grp	Thyroid dysfunction in Greece: Results from the national health examination survey EMENO	PLOS ONE			English	Article							UNITED-STATES POPULATION; IODINE-INTAKE; ALCOHOL-CONSUMPTION; TOBACCO SMOKING; SERUM TSH; PREVALENCE; HYPOTHYROIDISM; NUTRITION; GOITER; DISEASE	Background Nationwide data on thyroid disease prevalence in Greece is lacking. Using the national health examination survey EMENO data resources, we aimed to estimate the prevalence of hypothyroidism and hyperthyroidism and associated risk factors in adults living in Greece. Methods A random sample of the adults (>= 18 years) living in Greece was drawn by multi-stage stratified random sampling based on the 2011 census. During home visits, trained interviewers administered a standardized questionnaire to study participants. All participants answered questions concerning demographic parameters (e.g., age, sex, degree of urbanization, income) and questions concerning smoking habits, alcohol, dietary habits and psychological parameters such as anxiety and thyroid disease. Weighted logistic regression models were fitted to assess factors associated with thyroid disease. Results In total, 6006 individuals were recruited in the Greek Health Examination Survey EMENO (response rate 72%) of whom 5981 were eligible for this study. The prevalence of thyroid disease was 9%, where 0.4% was related to hyperthyroidism and 8.6% to hypothyroidism. The prevalence of thyroid disease was higher in women (14.9%) than men (2.7%) (p<0.001). The highest rates of thyroid disease were observed in former iodine-deficient areas. A decrease in the prevalence of thyroidopathies with increasing alcohol consumption was found. Thyroid disease was associated with anxiety in men. Multivariable regression analysis showed that age, geographic area, and smoking were related to thyroid disease. Conclusion The prevalence of thyroid disease in Greece is higher in women. Age, habits, and characteristics of geographic areas determine the distribution of thyroidopathies in Greece.	[Voulgari, Paraskevi V.; Venetsanopoulou, Aliki, I] Univ Ioannina, Med Sch, Dept Internal Med, Rheumatol Clin, Ioannina, Greece; [Kalpourtzi, Natasa; Touloumi, Giota] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Gavana, Magda] Aristotle Univ Thessaloniki, Dept Primary Hlth Care Gen Practice & Hlth Serv R, Med Sch, Thessaloniki, Greece; [Vantarakis, Apostolos] Univ Patras, Med Sch, Publ Hlth, Patras, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Med Fac, Dept Hyg & Epidemiol, Larisa, Greece; [Chlouverakis, Grigoris] Univ Crete, Sch Med, Lab Biostat, Iraklion, Greece; [Trypsianis, Grigoris] Democritus Univ Thrace, Med Sch, Lab Med Stat, Thrace, Greece; [Alamanos, Yannis] Inst Epidemiol Prevent Med & Publ Hlth, Corfu, Greece	University of Ioannina; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; University of Patras; University of Thessaly; University of Crete; Democritus University of Thrace	Voulgari, PV (corresponding author), Univ Ioannina, Med Sch, Dept Internal Med, Rheumatol Clin, Ioannina, Greece.	pvoulgar@uoi.gr	Venetsanopoulou, Aliki/GOE-5444-2022	Voulgari, Paraskevi V./0000-0002-5193-2284	European Union (European Social Fund) and national resources [MIS 376659]; Hellenic Diabetes Association [K.E. 12008]	European Union (European Social Fund) and national resources; Hellenic Diabetes Association	we declare that the EMENO survey was implemented under the Operational Program "Education and Lifelong Learning" and was cofunded by the European Union (European Social Fund) and national resources [grant number: MIS 376659]. Additional funding was obtained from the Hellenic Diabetes Association to measure glycated hemoglobin [grant number: K.E. 12008]The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2007, THYROID, V17, P1211, DOI 10.1089/thy.2006.0235; Asvold BO, 2007, ARCH INTERN MED, V167, P1428, DOI 10.1001/archinte.167.13.1428; Asvold BO, 2013, EUR J ENDOCRINOL, V169, P613, DOI 10.1530/EJE-13-0459; Balhara Yatan Pal Singh, 2013, Indian J Endocrinol Metab, V17, P580, DOI 10.4103/2230-8210.113724; Barmpari ME, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/6505814; BRAVERMAN LE, 1994, THYROID, V4, P351, DOI 10.1089/thy.1994.4.351; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Carle A, 2012, EUR J ENDOCRINOL, V167, P483, DOI 10.1530/EJE-12-0356; Chaker L, 2017, LANCET, V390, P1550, DOI 10.1016/S0140-6736(17)30703-1; Doufas AG, 1999, EUR J ENDOCRINOL, V140, P505, DOI 10.1530/eje.0.1400505; Galofre JC., 1996, EPIDEMIOLOGIA ENFERM, P95; Madariaga AG, 2014, J CLIN ENDOCR METAB, V99, P923, DOI 10.1210/jc.2013-2409; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Iddah M A, 2013, ISRN Endocrinol, V2013, P509764, DOI 10.1155/2013/509764; Kita M, 2002, J ENDOCRINOL INVEST, V25, P513, DOI 10.1007/BF03345493; Knobel M, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00048; Knudsen N, 2002, ARCH INTERN MED, V162, P439, DOI 10.1001/archinte.162.4.439; Knudsen N, 2001, CLIN ENDOCRINOL, V55, P41, DOI 10.1046/j.1365-2265.2001.01325.x; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lambrinakou S, 2017, ADV EXP MED BIOL, V987, P23, DOI 10.1007/978-3-319-57379-3_3; Langer R, 2003, EXP CLIN ENDOCR DIAB, V111, P325, DOI 10.1055/s-2003-42721; Laurberg P, 2005, LANCET, V365, P738; Laurberg P, 2004, J CLIN ENDOCR METAB, V89, P181, DOI 10.1210/jc.2003-030829; Laurberg P, 2006, EUR J ENDOCRINOL, V155, P219, DOI 10.1530/eje.1.02210; Laurberg P, 2010, BEST PRACT RES CL EN, V24, P13, DOI 10.1016/j.beem.2009.08.013; MALAMOS B, 1967, J CLIN ENDOCR METAB, V27, P1372, DOI 10.1210/jcem-27-10-1372; Markou K, 2001, THYROID, V11, P501, DOI 10.1089/105072501300176462; McLeod DSA, 2014, JAMA-J AM MED ASSOC, V311, P1563, DOI 10.1001/jama.2013.285606; Panoutsopoulos G, 2001, EUR J NUCL MED, V28, P529, DOI 10.1007/s002590100491; Ragusa F, 2019, BEST PRACT RES CL EN, V33, DOI 10.1016/j.beem.2019.101367; Samuels MH, 2016, THYROID, V26, P347, DOI 10.1089/thy.2015.0345; Scappaticcio L, 2020, CLIN ENDOCRINOL, V92, P169, DOI 10.1111/cen.14130; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Sichieri R, 2007, CLIN ENDOCRINOL, V66, P803, DOI 10.1111/j.1365-2265.2007.02816.x; Skordis N, 2006, EUR J HAEMATOL, V77, P150, DOI 10.1111/j.1600-0609.2006.00681.x; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Touloumi G, 2019, JMIR RES PROTOC, V8, P42, DOI 10.2196/10997; Vejbjerg P, 2009, CLIN ENDOCRINOL, V71, P440, DOI 10.1111/j.1365-2265.2008.03493.x; Wiersinga WM, 2013, CLIN ENDOCRINOL, V79, P145, DOI 10.1111/cen.12222; Yin XM, 2007, ANN NY ACAD SCI, V1110, P193, DOI 10.1196/annals.1423.021; Zois C, 2003, THYROID, V13, P485, DOI 10.1089/105072503322021151	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264388	10.1371/journal.pone.0264388	http://dx.doi.org/10.1371/journal.pone.0264388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245310	gold, Green Published			2022-12-26	WOS:000799799100014
J	Zhang, H; Zhu, SJ; Xing, Y; Liu, Q; Guo, Z; Cai, ZL; Shen, ZH; Xia, QQ; Sheng, HJ				Zhang, Hao; Zhu, Shujuan; Xing, Yu; Liu, Qian; Guo, Zhen; Cai, Ziling; Shen, Zihao; Xia, Qingqian; Sheng, Huajun			Effect of cryopreservation on A172 and U251 glioma cells infected with lentiviral vectors designed for CRISPR/Cas9-mediated aquaporin-8 knock-out	PLOS ONE			English	Article								Among the three existing targeted gene editing technologies, zinc-finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats-CRISPR-associated 9 (CRISPR-Cas9), the latter is widely used owing to its simplicity, efficiency, and low cost. Here, we routinely infected A172 and U251 cells with lentiviral vectors, in which aquaporin-8 (AQP8) was knocked out using CRISPR/Cas9. Our results indicated that cryopreservation did not significantly alter the viral infection efficiency, but influenced AQP8 expression in the infected cells at both protein and mRNA levels compared with the non-cryopreserved samples. Further, AQP8 expression at protein and mRNA levels in recovered cryopreserved infected cells did not significantly differ from those in the blank and negative controls, indicating that the lentivirus was still infectious at low temperatures. However, it failed to release the AQP8-targeting guide RNA in the infected cells, or the guide RNA was released, but underwent changes that caused it to malfunction in the cells with CRISPR/Cas9-mediated AQP8 knock-out. Our findings possibly provide some insights into the reliability of lentiviruses as CRISPR/Cas9 vectors.	[Zhang, Hao; Zhu, Shujuan; Liu, Qian; Guo, Zhen; Cai, Ziling; Shen, Zihao; Xia, Qingqian; Sheng, Huajun] Chongqing Med Univ, Coll Basic Med, Dept Human Anat, Chongqing, Peoples R China; [Xing, Yu] Chongqing Med Univ, Dept Forens Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Sheng, HJ (corresponding author), Chongqing Med Univ, Coll Basic Med, Dept Human Anat, Chongqing, Peoples R China.	100448@cqmu.edu.cn						Chen SS, 2019, BIOCHEM BIOPH RES CO, V509, P182, DOI 10.1016/j.bbrc.2018.12.099; Gupta D, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116636; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mo J, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI139807; Naeem M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071608; Olivo PD, 1996, CLIN MICROBIOL REV, V9, P321, DOI 10.1128/CMR.9.3.321; Ou XJ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.674467; Valyi-Nagy K, 2021, BIOPRESERV BIOBANK, V19, P60, DOI 10.1089/bio.2020.0050; Zuo EW, 2019, SCIENCE, V364, P289, DOI 10.1126/science.aav9973	9	0	0	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0263162	10.1371/journal.pone.0263162	http://dx.doi.org/10.1371/journal.pone.0263162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245307	Green Submitted, gold, Green Published			2022-12-26	WOS:000799799100003
J	Fu, Y; Sun, SS; Bi, JB; Kong, CZ; Shi, D				Fu, Yang; Sun, Shanshan; Bi, Jianbin; Kong, Chuize; Shi, Du			An HDAC9-associated immune-related signature predicts bladder cancer prognosis	PLOS ONE			English	Article							GALECTIN-1 DYSREGULATION; PROMOTES METASTASIS; PROGRESSION; HDAC9; DIFFERENTIATION; IDENTIFICATION; CISPLATIN; RECEPTOR; SURVIVAL; COMPLEX	Background The close relationship between histone deacetylase 9 (HDAC9) and immunity has attracted attention. We constructed an immune signature for HDAC9, a vital epigenetic modification, to predict the survival status and treatment benefits in bladder cancer (BC). Methods An exhaustive analysis of HDAC9 and immunology via the tumor and immune system interaction database (TISIDB) was performed, and an immune prognostic risk signature was developed based on genes enriched in the top five immune-related pathways under high HDAC9 status. Comprehensive analysis of survival curves and Cox regression were used to estimate the effectiveness of the risk signature. The relationship between immunological characteristics and the risk score was evaluated, and the mechanisms were also explored. Results In the TISIDB, HDAC9 was closely related to various immunological characteristics. The risk signature was obtained based on genes related to prognosis enriched in the top five immune-related pathways under high HDAC9 status. The survival rate of the high-risk BC patients was poor. The risk score was closely related to multiple immunological characteristics, drug sensitivity, immunotherapy benefits and biofunctions. Conclusion An immune-related prognostic signature established for HDAC9 expression status could independently predict the prognosis of BC patients. The use of this signature could help clinicians make personalized treatment decisions.	[Fu, Yang; Bi, Jianbin; Kong, Chuize; Shi, Du] China Med Univ, Dept Urol, Hosp 1, Shenyang, Peoples R China; [Sun, Shanshan] China Med Univ, Dept Pharm, Peoples Hosp, Shenyang, Peoples R China	China Medical University; China Medical University	Shi, D (corresponding author), China Med Univ, Dept Urol, Hosp 1, Shenyang, Peoples R China.	shidu_cmu@163.com			Project of Liaoning Distinguished Professor [[2012]145]; China Medical University's 2017 Discipline Promotion Program [3110117040]; Shenyang Plan Project of Science and Technology [F17-230-9-08]; China Medical University's 2018 Discipline Promotion Program; 2017 National Key R&D Program Key Projects of Precision Medical Research [2017YFC0908000]	Project of Liaoning Distinguished Professor; China Medical University's 2017 Discipline Promotion Program; Shenyang Plan Project of Science and Technology; China Medical University's 2018 Discipline Promotion Program; 2017 National Key R&D Program Key Projects of Precision Medical Research	Prof.Chuize Kong received all the award. This work was supported by the Project of Liaoning Distinguished Professor [Grant No. [2012]145], China Medical University's 2017 Discipline Promotion Program [Grant No. 3110117040], the Shenyang Plan Project of Science and Technology [Grant No. F17-230-9-08], China Medical University's 2018 Discipline Promotion Program, and the 2017 National Key R&D Program Key Projects of Precision Medical Research [No. 2017YFC0908000]. The funder participated in the conceptualization, methodology, data curation, formal analysis, project administration, writing of original draft.	Acin-Perez R, 2020, NAT METAB, V2, P974, DOI 10.1038/s42255-020-00273-8; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Bedi U, 2015, ONCOGENE, V34, P465, DOI 10.1038/onc.2013.558; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; Blois SM, 2014, MOL HUM REPROD, V20, P644, DOI 10.1093/molehr/gau021; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen XY, 2021, CANCERS, V13, DOI 10.3390/cancers13040920; Chen ZC, 2019, EBIOMEDICINE, V47, P208, DOI 10.1016/j.ebiom.2019.08.012; Cheng ST, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00295-x; Clocchiatti A, 2011, J CELL MOL MED, V15, P1833, DOI 10.1111/j.1582-4934.2011.01321.x; Di Giorgio E, 2016, EPIGENOMICS-UK, V8, P251, DOI 10.2217/epi.15.106; Ehrlich KC, 2019, EPIGENOMICS-UK, V11, P169, DOI 10.2217/epi-2018-0150; Fu Y, 2020, UROL ONCOL-SEMIN ORI, V38, DOI 10.1016/j.urolonc.2020.03.006; Gao XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097174; Geeleher P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107468; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Guo GY, 2020, ONCOL REP, V44, P2678, DOI 10.3892/or.2020.7824; Hao Q, 2015, EMBO J, V34, P2903, DOI 10.15252/embj.201591888; Hartana CA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200079; Hoffmann SC, 2007, J BIOL CHEM, V282, P22370, DOI 10.1074/jbc.M704250200; Hu DQ, 2013, MOL CELL, V51, P493, DOI 10.1016/j.molcel.2013.07.003; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jin ZX, 2015, MOL ENDOCRINOL, V29, P730, DOI 10.1210/me.2014-1365; Kang Z, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.763590; Kashiwagi E, 2018, BRIT J CANCER, V118, P213, DOI 10.1038/bjc.2017.393; Knudsen NH, 2014, DIABETES, V63, P1838, DOI 10.2337/db14-0273; Kochumon S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73347-y; Kumar DT, 2019, ADV PROTEIN CHEM STR, V115, P325, DOI 10.1016/bs.apcsb.2018.11.005; Li H, 2020, MOL MED REP, V21, P822, DOI 10.3892/mmr.2019.10869; Li JJ, 2018, CURR PROB CANCER, V42, P208, DOI 10.1016/j.currproblcancer.2018.01.004; Li JP, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08611-z; Li JX, 2021, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.598599; Li L, 2016, METHODS MOL BIOL, V1436, P31, DOI 10.1007/978-1-4939-3667-0_4; Li SM, 2017, P NATL ACAD SCI USA, V114, pE7111, DOI 10.1073/pnas.1703494114; Li Wei, 2020, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V36, P97; Li WH, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02267-2; Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464; Li XT, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-09006-w; Liu JJ, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0445-3; Losko M, 2020, CELL MOL LIFE SCI, V77, P4899, DOI 10.1007/s00018-019-03434-5; Lucio-Eterovic AK, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-243; Luo YX, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01187; Lv DJ, 2017, ONCOTARGET, V8, P13586, DOI 10.18632/oncotarget.14600; Ma L, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0998-4; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Mishra S, 2017, EXP BIOL MED, V242, P1170, DOI 10.1177/1535370217703976; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Ning YL, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000529; Oh DY, 2020, CELL, V181, P1612, DOI 10.1016/j.cell.2020.05.017; OHNISHI M, 1995, ENDOCRINOLOGY, V136, P2421, DOI 10.1210/en.136.6.2421; Pang GF, 2019, ONCOL LETT, V18, P2434, DOI 10.3892/ol.2019.10570; Parida S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102519; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Qin Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004358; Qiu S, 2019, CANCER SCI, V110, P2110, DOI 10.1111/cas.14078; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rastogi B, 2016, MOL CELL BIOCHEM, V415, P183, DOI 10.1007/s11010-016-2690-5; Ravaei Amin, 2022, Clin Exp Rheumatol, V40, P1403, DOI 10.55563/clinexprheumatol/t1srve; Roberts JT, 2006, ANN ONCOL, V17, pV118, DOI 10.1093/annonc/mdj965; Rooki H, 2013, GENE, V532, P288, DOI 10.1016/j.gene.2013.09.107; Rosik L, 2014, CANCER BIOL THER, V15, P742, DOI 10.4161/cbt.28469; Ru BB, 2019, BIOINFORMATICS, V35, P4200, DOI 10.1093/bioinformatics/btz210; Salgado E, 2018, BIOCHEM BIOPH RES CO, V503, P1087, DOI 10.1016/j.bbrc.2018.06.120; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shen CQ, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/4312629; Shewach DS, 1996, INVEST NEW DRUG, V14, P257, DOI 10.1007/BF00194528; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Spring K, 2015, ONCOGENE, V34, P5536, DOI 10.1038/onc.2015.9; Steinberg RL, 2017, UROL ONCOL-SEMIN ORI, V35, DOI 10.1016/j.urolonc.2017.07.024; Sun JL, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.730716; Sun M, 2019, INT J CANCER, V145, P2170, DOI 10.1002/ijc.32311; Sun YH, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.724107; TAGER H, 1979, NATURE, V281, P122, DOI 10.1038/281122a0; Tan GB, 2021, TRANSL ANDROL UROL, V10, P3440, DOI 10.21037/tau-21-560; Teramoto Y, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221810030; Thorsson V, 2019, IMMUNITY, V51, P411, DOI 10.1016/j.immuni.2019.08.004; Torzilli PA, 2012, SEMIN CANCER BIOL, V22, P385, DOI 10.1016/j.semcancer.2012.05.002; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Voskuilen CS, 2019, AM J SURG PATHOL, V43, P1600, DOI 10.1097/PAS.0000000000001371; Wang DL, 2018, J CANCER, V9, P4684, DOI 10.7150/jca.27381; Wang GX, 2014, DIABETES, V63, P1340, DOI 10.2337/db13-1139; Wang HZ, 2017, NATURE, V546, P426, DOI 10.1038/nature22797; Wang H, 2020, TECHNOL CANCER RES T, V19, DOI 10.1177/1533033820974017; Wang LW, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0950-7; Wang Z, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08447-7; Wiley SZ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030559; Wu TF, 2007, ANTICANCER RES, V27, P895; Wu TF, 2015, J UROLOGY, V193, P1002, DOI 10.1016/j.juro.2014.09.107; Wu X, 2020, CANCER MANAG RES, V12, P7043, DOI 10.2147/CMAR.S252772; Xia MC, 2011, CIRCULATION, V124, P2933, DOI 10.1161/CIRCULATIONAHA.111.034850; Xie ZW, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.740985; Xiong K, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0301-8; Yan KL, 2011, J BIOL CHEM, V286, P28833, DOI 10.1074/jbc.M111.233932; Yang HJ, 2018, J CELL MOL MED, V22, P1650, DOI 10.1111/jcmm.13442; Yang RQ, 2018, EXP THER MED, V16, P5215, DOI 10.3892/etm.2018.6836; Yi L, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04260-z; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zargar H, 2015, EUR UROL, V67, P241, DOI 10.1016/j.eururo.2014.09.007; Zhao J, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01494; Zhou JF, 2019, INT J BIOL SCI, V15, P812, DOI 10.7150/ijbs.31335	103	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264527	10.1371/journal.pone.0264527	http://dx.doi.org/10.1371/journal.pone.0264527			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239708	gold, Green Published			2022-12-26	WOS:000776002200041
J	Hannun, J; Dias, C; Taha, AH; Almutairi, A; Alhajyaseen, W; Sarvi, M; Al-Bosta, S				Hannun, Jamal; Dias, Charitha; Taha, Alaa Hasan; Almutairi, Abdulaziz; Alhajyaseen, Wael; Sarvi, Majid; Al-Bosta, Salim			Pedestrian flow characteristics through different angled bends: Exploring the spatial variation of velocity	PLOS ONE			English	Article							CROWD DYNAMICS; EVACUATION; SIMULATION; BEHAVIOR; FEATURES; WALKING; FASTER; IMPACT; MODEL	Common geometrical layouts could potentially be bottlenecks, particularly during emergency and high density situations. When pedestrians are interacting with such complex geometrical settings, the congestion effect might not be uniform over the bottleneck area. This study uses the trajectory data collected through a controlled laboratory experiment to explore the spatial variation of speeds when a group of people navigates through bends. Four turning angles, i.e., 45 degrees, 90 degrees, 135 degrees and 180 degrees, with a straight corridor and two speed levels, i.e., normal speed walking and slow running (jogging), were considered in these experiments. Results explained that the speeds are significantly different over the space within the bend for all angles (except 0 degrees) under both speed levels. In particular, average walking speeds are significantly lower near the inner corner of the bend as compared to the outer corner. Further, such speed variations are magnified when the angle of the bend and desired speed increase. These outcomes indicate that even smaller turning angles, e.g., 45 degrees could create bottlenecks near the inner corner of the bend, particularly when the walking speeds are high. The findings of this study could be useful in understanding the congestion and bottleneck effects associated with complex geometrical settings, and calibrating microscopic simulation tools to accurately reproduce such effects.	[Hannun, Jamal; Dias, Charitha; Taha, Alaa Hasan; Almutairi, Abdulaziz; Alhajyaseen, Wael] Qatar Univ, Dept Civil & Architectural Engn, Doha, Qatar; [Dias, Charitha; Alhajyaseen, Wael] Qatar Univ, Coll Engn, Qatar Transportat & Traff Safety Ctr, Doha, Qatar; [Sarvi, Majid] Univ Melbourne, Dept Infrastruct Engn, Melbourne, Vic, Australia; [Al-Bosta, Salim] Supreme Comm Delivery & Legacy, Al Bidda Tower,Corn St, Doha, Qatar	Qatar University; Qatar University; University of Melbourne	Dias, C (corresponding author), Qatar Univ, Dept Civil & Architectural Engn, Doha, Qatar.; Dias, C (corresponding author), Qatar Univ, Coll Engn, Qatar Transportat & Traff Safety Ctr, Doha, Qatar.	cdias@qu.edu.qa	Alhajyaseen, Wael/C-4567-2014	Alhajyaseen, Wael/0000-0003-1757-1363; Dias, Charitha/0000-0002-0773-5662	Qatar National Library	Qatar National Library(Qatar National Research Fund (QNRF))	Open access funding is provided by the Qatar National Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian J, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2019.0871; Aghabayk K, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041301; Aghabayk K, 2015, TRANSPORT RES REC, P76, DOI 10.3141/2490-09; Asano M., 2007, P 11 WORLD C TRANSP; Daamen W, 2003, TRANSPORT RES REC, P20, DOI 10.3141/1828-03; Daamen W, 2012, TRANSPORT RES REC, P69, DOI 10.3141/2316-08; Daamen W, 2010, PROCEDIA ENGINEER, V3, P53, DOI 10.1016/j.proeng.2010.07.007; Dias C, 2018, PHYS LETT A, V382, P1255, DOI 10.1016/j.physleta.2018.03.022; Dias C, 2014, J TRANSP SAF SECUR, V6, P167, DOI 10.1080/19439962.2013.831964; Dias C, 2015, TRANSPORT RES REC, P65, DOI 10.3141/2490-08; Dias C, 2014, TRANSPORT RES REC, P41, DOI 10.3141/2421-05; Dias C, 2013, SAFETY SCI, V60, P87, DOI 10.1016/j.ssci.2013.07.005; Duives DC, 2013, TRANSPORT RES C-EMER, V37, P193, DOI 10.1016/j.trc.2013.02.005; Frank GA, 2011, PHYSICA A, V390, P2135, DOI 10.1016/j.physa.2011.01.015; Gayathri H, 2017, INT J DISAST RISK RE, V25, P82, DOI 10.1016/j.ijdrr.2017.07.017; Gwynne S, 1999, BUILD ENVIRON, V34, P741, DOI 10.1016/S0360-1323(98)00057-2; Haghani M, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104760; Haghani M, 2018, TRANSPORT RES B-METH, V107, P253, DOI 10.1016/j.trb.2017.06.017; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Helbing D, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds7; HENDERSON LF, 1971, NATURE, V229, P381, DOI 10.1038/229381a0; HENDERSON LF, 1972, NATURE, V240, P353, DOI 10.1038/240353a0; Hoogendoorn SP, 2004, TRANSPORT RES REC, P83, DOI 10.3141/1878-11; Hoogendoorn SP, 2005, TRANSPORT SCI, V39, P147, DOI 10.1287/trsc.1040.0102; Kretz T, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03012; Lee RSC, 2005, J TRANSP ENG, V131, P575, DOI 10.1061/(ASCE)0733-947X(2005)131:8(575); Lian LP, 2017, FIRE SAFETY J, V91, P918, DOI 10.1016/j.firesaf.2017.04.015; Lian LP, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/08/P08024; Liao WC, 2014, TRANSP RES PROC, V2, P26, DOI 10.1016/j.trpro.2014.09.005; Parisi DR, 2005, PHYSICA A, V354, P606, DOI 10.1016/j.physa.2005.02.040; Plaue M, 2011, LECT NOTES COMPUT SC, V6952, P285, DOI 10.1007/978-3-642-24393-6_24; Rahman N. A., 2019, IOP Conference Series: Materials Science and Engineering, V572, DOI 10.1088/1757-899X/572/1/012114; Rupprecht T., 2011, INFLUENCE GEOMETRY P, P71, DOI 10.1007/978-1-4419-9725-8_7; Schadschneider A, 2011, NETW HETEROG MEDIA, V6, P545, DOI 10.3934/nhm.2011.6.545; Seyfried A, 2009, TRANSPORT SCI, V43, P395, DOI 10.1287/trsc.1090.0263; Shahhoseini Z, 2019, TRANSPORT RES B-METH, V122, P57, DOI 10.1016/j.trb.2019.01.019; Shahhoseini Z, 2018, PHYSICA A, V491, P101, DOI 10.1016/j.physa.2017.09.003; Shahhoseini Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182913; Shi XM, 2019, PHYSICA A, V522, P350, DOI 10.1016/j.physa.2019.01.086; Shi XM, 2018, J ADV TRANSPORT, DOI 10.1155/2018/1063043; Shiwakoti N, 2019, SAFETY SCI, V113, P54, DOI 10.1016/j.ssci.2018.11.016; Shiwakoti N, 2015, SAFETY SCI, V75, P15, DOI 10.1016/j.ssci.2015.01.009; Shiwakoti N, 2013, J TRANSP GEOGR, V26, P12, DOI 10.1016/j.jtrangeo.2012.08.002; Soria SA, 2012, SAFETY SCI, V50, P1584, DOI 10.1016/j.ssci.2012.03.010; Steffen B, 2011, MATHEMATICAL RESULTS IN QUANTUM PHYSICS, P254; Still K., 2021, CROWD DISASTERS; Sun L., 2014, MATH PROBL ENG; Wang J.M. Jianyu, 2020, COLLECT DYN, P167; Wolf P.R., 2014, ELEMENTS PHOTOGRAMME; Wong SC, 2010, J TRANSP ENG, V136, P234, DOI 10.1061/(ASCE)TE.1943-5436.0000086; Ye R, 2019, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/ab0c13; Zhang J, 2014, PHYSICA A, V405, P316, DOI 10.1016/j.physa.2014.03.004; Zhang J, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/02/P02002; Zhang J, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/06/P06004; Zhang J., 2012, 4 INT S AG BAS MOD S; Zhang J, 2014, TRANSP RES PROC, V2, P51, DOI 10.1016/j.trpro.2014.09.008	58	2	2	10	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264635	10.1371/journal.pone.0264635	http://dx.doi.org/10.1371/journal.pone.0264635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239720	gold, Green Published			2022-12-26	WOS:000776002200056
J	Mansour, SG; Khoury, N; Kodali, R; Virmani, S; Reese, PP; Hall, IE; Jia, YQ; Yamamoto, Y; Thiessen-Philbrook, HR; Obeid, W; Doshi, MD; Akalin, E; Bromberg, JS; Harhay, MN; Mohan, S; Muthukumar, T; Singh, P; Weng, FL; Moledina, DG; Greenberg, JH; Wilson, FP; Parikh, CR				Mansour, Sherry G.; Khoury, Nadeen; Kodali, Ravi; Virmani, Sarthak; Reese, Peter P.; Hall, Isaac E.; Jia, Yaqi; Yamamoto, Yu; Thiessen-Philbrook, Heather R.; Obeid, Wassim; Doshi, Mona D.; Akalin, Enver; Bromberg, Jonathan S.; Harhay, Meera N.; Mohan, Sumit; Muthukumar, Thangamani; Singh, Pooja; Weng, Francis L.; Moledina, Dennis G.; Greenberg, Jason H.; Wilson, Francis P.; Parikh, Chirag R.			Clinically adjudicated deceased donor acute kidney injury and graft outcomes	PLOS ONE			English	Article							ACUTE TUBULAR-NECROSIS; TRANSPLANTATION; ASSOCIATIONS; PATIENT; BIOMARKERS; CREATININE; ALLOGRAFT; DIAGNOSIS; AZOTEMIA; FAILURE	Background Acute kidney injury (AKI) in deceased donors is not associated with graft failure (GF). We hypothesize that hemodynamic AKI (hAKI) comprises the majority of donor AKI and may explain this lack of association. Methods In this ancillary analysis of the Deceased Donor Study, 428 donors with available charts were selected to identify those with and without AKI. AKI cases were classified as hAKI, intrinsic (iAKI), or mixed (mAKI) based on majority adjudication by three nephrologists. We evaluated the associations between AKI phenotypes and delayed graft function (DGF), 1-year eGFR and GF. We also evaluated differences in urine biomarkers among AKI phenotypes. Results Of the 291 (68%) donors with AKI, 106 (36%) were adjudicated as hAKI, 84 (29%) as iAKI and 101 (35%) as mAKI. Of the 856 potential kidneys, 669 were transplanted with 32% developing DGF and 5% experiencing GF. Median 1-year eGFR was 53 (IQR: 41-70) ml/min/1.73m(2). Compared to non-AKI, donors with iAKI had higher odds DGF [aOR (95%CI); 4.83 (2.29, 10.22)] and had lower 1-year eGFR [adjusted B coefficient (95% CI): -11 (-19, -3) mL/min/1.73 m(2)]. hAKI and mAKI were not associated with DGF or 1-year eGFR. Rates of GF were not different among AKI phenotypes and non-AKI. Urine biomarkers such as NGAL, LFABP, MCP-1, YKL-40, cystatin-C and albumin were higher in iAKI. Conclusion iAKI was associated with higher DGF and lower 1-year eGFR but not with GF. Clinically phenotyped donor AKI is biologically different based on biomarkers and may help inform decisions regarding organ utilization.	[Mansour, Sherry G.; Yamamoto, Yu; Moledina, Dennis G.; Greenberg, Jason H.; Wilson, Francis P.] Yale Univ, Sch Med, Clin & Translat Res Accelerator, New Haven, CT USA; [Mansour, Sherry G.; Kodali, Ravi; Virmani, Sarthak; Moledina, Dennis G.; Greenberg, Jason H.; Wilson, Francis P.] Yale Univ, Sch Med, Dept Internal Med, Sect Nephrol, New Haven, CT 06510 USA; [Khoury, Nadeen] Henry Ford Hlth Syst, Div Nephrol, Detroit, MI USA; [Reese, Peter P.] Univ Penn, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Dept Med, Philadelphia, PA 19104 USA; [Reese, Peter P.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Reese, Peter P.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Hall, Isaac E.] Univ Utah, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Salt Lake City, UT USA; [Jia, Yaqi; Thiessen-Philbrook, Heather R.; Obeid, Wassim; Parikh, Chirag R.] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21205 USA; [Doshi, Mona D.] Univ Michigan, Med Sch, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Akalin, Enver] Montefiore Med Ctr, Albert Einstein Coll Med, Montefiore Einstein Kidney Transplant Program, Bronx, NY 10467 USA; [Bromberg, Jonathan S.] Univ Maryland, Sch Med, Dept Surg, Div Transplantat, Baltimore, MD 21201 USA; [Bromberg, Jonathan S.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Harhay, Meera N.] Drexel Univ, Coll Med, Dept Internal Med, Philadelphia, PA 19104 USA; [Harhay, Meera N.] Drexel Univ, Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Harhay, Meera N.] Tower Hlth Syst, Tower Hlth Transplant Inst, W Reading, PA USA; [Mohan, Sumit] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Mohan, Sumit] Columbia Univ, Vagelos Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY USA; [Muthukumar, Thangamani] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Med, Div Nephrol & Hypertens, New York, NY USA; [Muthukumar, Thangamani] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Transplantat Med, New York, NY USA; [Singh, Pooja] Thomas Jefferson Univ Hosp, Sidney Kimmel Med Coll, Dept Med, Div Nephrol, Philadelphia, PA 19107 USA; [Weng, Francis L.] RWJBarnabas Hlth, St Barnabas Med Ctr, Livingston, NJ USA	Yale University; Yale University; Henry Ford Health System; Henry Ford Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Utah System of Higher Education; University of Utah; Johns Hopkins University; University of Michigan System; University of Michigan; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Drexel University; Drexel University; Columbia University; Columbia University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Jefferson University	Parikh, CR (corresponding author), Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21205 USA.	chirag.parikh@jhmi.edu	Khoury, Nadeen/T-2429-2019	Moledina, Dennis/0000-0002-9537-9038; Thiessen Philbrook, Heather/0000-0003-2067-0514	American Heart Association [18CDA34110151]; Patterson Trust Fund; National Institutes of Health (NIH)/National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK-93770, K24DK090203]	American Heart Association(American Heart Association); Patterson Trust Fund; National Institutes of Health (NIH)/National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This statement reflects the correct funding associated with this work: This work was supported by the American Heart Association grant 18CDA34110151 and the Patterson Trust Fund to Dr. Mansour; National Institutes of Health (NIH)/National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01DK-93770, grant K24DK090203 to Dr. Parikh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, OPTN TRANSPLANT TREN; Belcher JM, 2011, CLIN J AM SOC NEPHRO, V6, P2332, DOI 10.2215/CJN.08570811; Bellomo R, 2007, CONTRIB NEPHROL, V156, P1; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Carpenter D, 2018, CLIN J AM SOC NEPHRO, V13, P1876, DOI 10.2215/CJN.04150418; Dictus C, 2009, CLIN TRANSPLANT, V23, P2, DOI 10.1111/j.1399-0012.2009.01102.x; Diskin CJ, 2010, NEPHRON CLIN PRACT, V114, pC145, DOI 10.1159/000254387; Fishberg A M, 1937, Bull N Y Acad Med, V13, P710; Gwinner W, 2008, AM J TRANSPLANT, V8, P1684, DOI 10.1111/j.1600-6143.2008.02293.x; Hall IE, 2015, AM J TRANSPLANT, V15, P1623, DOI 10.1111/ajt.13144; Hall IE, 2019, KIDNEY INT, V95, P199, DOI 10.1016/j.kint.2018.08.047; Hall IE, 2014, CLIN J AM SOC NEPHRO, V9, P573, DOI 10.2215/CJN.08270813; Huen SC, 2015, AM J PHYSIOL-RENAL, V309, pF406, DOI 10.1152/ajprenal.00682.2014; Husain SA, 2020, KIDNEY INT REP, V5, P1906, DOI 10.1016/j.ekir.2020.08.004; Husain SA, 2020, CLIN J AM SOC NEPHRO, V15, P257, DOI 10.2215/CJN.09170819; Kumar MSA, 2006, TRANSPLANTATION, V82, P1640, DOI 10.1097/01.tp.0000250908.62948.8f; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mansour SG, 2017, KIDNEY INT REP, V2, P749, DOI 10.1016/j.ekir.2017.03.007; McGee S, 1999, JAMA-J AM MED ASSOC, V281, P1022, DOI 10.1001/jama.281.11.1022; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; MILLER TR, 1978, ANN INTERN MED, V89, P47, DOI 10.7326/0003-4819-89-1-47; Mohan S, 2018, KIDNEY INT, V94, P187, DOI 10.1016/j.kint.2018.02.016; Moledina DG, 2018, SEMIN NEPHROL, V38, P3, DOI 10.1016/j.semnephrol.2017.09.002; Moledina DG, 2017, AM J KIDNEY DIS, V70, P807, DOI 10.1053/j.ajkd.2017.06.031; Morgan C, 2007, AM J TRANSPLANT, V7, P1288, DOI 10.1111/j.1600-6143.2007.01761.x; PRU C, 1985, SEMIN NEPHROL, V5, P224; Reese PP, 2016, J AM SOC NEPHROL, V27, P1534, DOI 10.1681/ASN.2015040345; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Ugarte R, 2005, TRANSPLANTATION, V80, P794, DOI 10.1097/01.TP.0000173801.33878.BF; Van Erp AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22689-9; Wang CS, 2005, JAMA-J AM MED ASSOC, V294, P1944, DOI 10.1001/jama.294.15.1944; Xu K, 2017, J AM SOC NEPHROL, V28, P1729, DOI 10.1681/ASN.2016090974; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667; Yu K, 2020, AM J TRANSPLANT, V20, P3413, DOI 10.1111/ajt.15952	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264329	10.1371/journal.pone.0264329	http://dx.doi.org/10.1371/journal.pone.0264329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239694	Green Published, gold			2022-12-26	WOS:000776002200028
J	Singh, PK; Anvikar, A; Sinha, A				Singh, Piyoosh Kumar; Anvikar, Anup; Sinha, Abhinav			COVID-19 related knowledge, attitudes, and practices in Indian Population: An online national cross-sectional survey	PLOS ONE			English	Article							SARS	Introduction This highly contagious zoonotic corona virus (SARS-CoV-2) spread to most parts of the world (200 countries) and created a public health emergency. Due to its novel nature and indistinctness, different sources of information and suggestions were developed to guide the individuals about its transmission and prevent its infection. Responses to the active intervention efforts have posed some relevant questions on population understanding and attitudes toward COVID-19. The present study is aims to assess the COVID-19 related knowledge, attitude, and practices (KAP) in a heterogeneous Indian population. Material and methods 501 respondents across India participated in a questionnaire-based online survey from April 2020 to May 2020. The questionnaire incorporated 56 questions about demographic characteristics and KAP dimensions. The mixed (quantitative and qualitative) methods were employed to evaluate KAP dimensions. Descriptive analysis was estimated as means, SD, and proportion. The bivariate (chi (2)), correlation, and regression analysis were utilized for the response analysis. In addition, qualitative analysis, including content and thematic analysis were done for open-ended questions. Result High knowledge and positive attitude were reported in more than half of the study population, with a proportion of 58.6% and 62.1%, respectively. Education shows a significant difference in the knowledge and attitude dimensions. The good practice (50.5% of the total population) reported a significant difference in age and gender categories with the test of independence (chi 2). Prevention (56.89%) in knowledge domain and risk (17.56%), information-seeking (45.51%), prevention (51.50%), and treatment-seeking (54.29%) in attitude domains recorded low proportion. KAP variables were found in association in Pearson correlation analysis. In logistic regression analysis, knowledge was the strongest predictor for the positive attitude, whereas attitude was reported as the best predictor for good practice outcome. Conclusion The study presents a moderate level of covid related knowledge, Attitudes, and Practices in Indian population.	[Singh, Piyoosh Kumar] ICMR Natl Inst Malaria Res, Ranchi Field Unit, Delhi, India; [Anvikar, Anup; Sinha, Abhinav] ICMR Natl Inst Malaria Res, Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Singh, PK (corresponding author), ICMR Natl Inst Malaria Res, Ranchi Field Unit, Delhi, India.	drpksingh45@gmail.com	Singh, Piyoosh/GPK-7723-2022	singh, Piyoosh/0000-0001-6191-5333				Abas N.Q., 2022, PASSER J BASIC APPL, V4, P14, DOI [10.24271/psr.2021.309110.1096, DOI 10.24271/PSR.2021.309110.1096]; Al Ahdab S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10353-3; Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04; Andrews MA, 2020, INDIAN J MED RES, V151, P490, DOI 10.4103/ijmr.IJMR_2131_20; Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154; Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bajaj NC., 2021, ANN ROMANIAN SOC CEL, V25, P19746; Bhagavathula AS., 2020, NOVEL CORONAVIRUS; Bhatia R, 2020, INDIAN J MED RES, V151, P387, DOI 10.4103/ijmr.IJMR_1925_20; Bhatia R, 2020, INDIAN J MED RES, V151, P118, DOI 10.4103/ijmr.IJMR_780_20; Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161; Deng JF, 2006, PUBLIC HEALTH, V120, P15, DOI 10.1016/j.puhe.2005.10.001; Dilucca M., 2020, KNOWLEDGE ATTITUDE P; Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396; Internet and Mobile Association of India (IAMAI), 2019, IND INT REP IND MARK; Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]; Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743; Kotian SP, 2021, INT J EPIDEMIOL, V50; Kutikuppala LVS, 2021, INDIAN J RESPIR CARE, V10, P88, DOI 10.4103/ijrc.ijrc_73_20; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Masoud AT, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043971; Ministry of Health and Family Welfare Government of India, COVID 19 DASHB; Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514; Mohamad E, 2020, J KOMUN, V36; Nour MO, 2015, INT RES J MED SCI, V3, P103; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Orimbo EO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229437; Paul A, 2020, MEDRXIV; Paul A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238492; Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Rugarabamu S., 2020, MEDRXIV, V216, P1, DOI [10.1101/2020.04.26.20080820, DOI 10.1101/2020.04.26.20080820]; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; World Health Organisation, 2008, WORLD HEAL ORGAN, P1; World Health Organization, 2022, 91 WHO; World Health Organization, 2020, PROT YOURS OTH SPREA; World Health Organization (WHO), 2020, WHO ANNOUNCES COVID; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264752	10.1371/journal.pone.0264752	http://dx.doi.org/10.1371/journal.pone.0264752			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239718	gold, Green Published			2022-12-26	WOS:000776002200072
J	Huiskes, VJB; Vriezekolk, JE; van den Ende, CHM; van Dijk, L; van den Bemt, BJF				Huiskes, Victor Johan Bernard; Vriezekolk, Johanna Everdina; van den Ende, Cornelia Helena Maria; van Dijk, Liset; van den Bemt, Bartholomeus Johannes Fredericus			Impact of physician' and pharmacy staff supporting activities in usual care on patients' statin adherence	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; LONG-TERM PERSISTENCE; MEDICATION ADHERENCE; IMPROVE ADHERENCE; CLINICAL-PRACTICE; THERAPY; INTERVENTIONS; MANAGEMENT; QUALITY; RISK	Aims Little is known about usual care by physicians and pharmacy teams to support adherence to statins and whether the extent of this care is associated with adherence to statins. Objective of the study was to examine the relationship between the extent of adherence supporting activities of healthcare practitioners (HCPs) and patients' adherence to statins. Methods Cross-sectional study in 48 pharmacies and affiliated physicians' practices, between September 3, 2014 and March 20, 2015. Patients visiting the pharmacy with a statin prescription from participating prescribers were invited to participate. Usual care to support adherence was assessed among HCPs with the Quality of Standard Care questionnaire about usual care activities to support adherence. Adherence to statins was assessed among patients with the MARS-5 questionnaire. The association between the extent of HCPs' adherence supporting activities and patients' adherence was examined by means of multilevel regression analysis. Results 1,504 patients and 692 HCPs (209 physicians, 118 pharmacists and 365 pharmacy technicians) participated. No association was found between the extent of physicians' adherence supporting activities and patients' adherence to statins. The extent of adherence supporting activities by pharmacy teams in usual care was negatively associated with patients' adherence to statins (B coefficient -0.057 (95%CI: -0.112- -0.002). Conclusions This study suggests that there is no positive relationship between the extent of HCPs' adherence supporting activities in usual care and patients' adherence to statins. Other methods than questionnaires (e.g. electronic monitors (to assess adherence) and observations (to assess usual care) should be applied to confirm the results of this study.	[Huiskes, Victor Johan Bernard; van den Bemt, Bartholomeus Johannes Fredericus] Sint Maartenskliniek, Dept Pharm, Nijmegen, Netherlands; [Vriezekolk, Johanna Everdina; van den Ende, Cornelia Helena Maria] Sint Maartenskliniek, Dept Rheumatol, Nijmegen, Netherlands; [van Dijk, Liset] Netherlands Inst Hlth Serv Res, Nivel, Utrecht, Netherlands; [van Dijk, Liset] Univ Groningen, Fac Sci & Engn, Groningen Res Inst Pharm, Dept PharmacoTherapy Epidemiol & Econ PTEE, Groningen, Netherlands; [van den Bemt, Bartholomeus Johannes Fredericus] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Nijmegen, Netherlands; [van den Bemt, Bartholomeus Johannes Fredericus] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands	Sint Maartens Clinic; Sint Maartens Clinic; Netherlands Institute for Health Services Research; University of Groningen; Radboud University Nijmegen; Maastricht University	Huiskes, VJB (corresponding author), Sint Maartenskliniek, Dept Pharm, Nijmegen, Netherlands.	v.huiskes@maartenskliniek.nl						Aubert RE, 2010, AM J MANAG CARE, V16, P459; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Berglund E, 2013, PATIENT EDUC COUNS, V91, P105, DOI 10.1016/j.pec.2012.11.001; Brummel A, 2016, J MANAG CARE SPEC PH, V22, P56, DOI 10.18553/jmcp.2016.22.1.56; Butler JA, 2004, TRANSPLANTATION, V77, P786, DOI 10.1097/01.TP.0000110412.20050.36; Chee YJ, 2014, SINGAP MED J, V55, P416, DOI 10.11622/smedj.2014099; Corrao G, 2010, CLIN THER, V32, P300, DOI 10.1016/j.clinthera.2010.02.004; de Bruin M, 2010, ARCH INTERN MED, V170, P240, DOI 10.1001/archinternmed.2009.536; de Bruin M, 2009, HEALTH PSYCHOL, V28, P668, DOI 10.1037/a0015989; De Geest S, 2018, ANN INTERN MED, V169, P30, DOI 10.7326/M18-0543; Deshpande S, 2017, CURR MED RES OPIN, V33, P769, DOI 10.1080/03007995.2017.1281109; Evans CD, 2009, J MANAGE CARE PHARM, V15, P476, DOI 10.18553/jmcp.2009.15.6.476; Fernandez-Lazaro CI, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-1019-3; Gardner AJ, 2017, PATIENT PREFER ADHER, V11, P761, DOI 10.2147/PPA.S130439; Guthrie RM, 2001, CLIN THER, V23, P970, DOI 10.1016/S0149-2918(01)80084-9; Helin-Salmivaara A, 2008, CLIN THER, V30, P2228, DOI 10.1016/j.clinthera.2008.12.003; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Huiskes VJB, 2021, BRIT J CLIN PHARMACO, V87, P1082, DOI 10.1111/bcp.14467; Kamal AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197671; Kooij MJ, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00269; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lemstra M, 2014, PATIENT PREFER ADHER, V8, P211, DOI 10.2147/PPA.S55382; Mardby AC, 2007, PATIENT EDUC COUNS, V69, P158, DOI 10.1016/j.pec.2007.08.011; Nicklas LB, 2010, PSYCHOL HEALTH, V25, P601, DOI 10.1080/08870440902783610; Ofori-Asenso R, 2018, J GERONTOL A-BIOL, V73, P813, DOI 10.1093/gerona/glx169; Perreault S, 2009, EUR J CLIN PHARMACOL, V65, P1013, DOI 10.1007/s00228-009-0673-0; Salt E, 2011, DRUG DEVELOP RES, V72, P756, DOI 10.1002/ddr.20484; Schedlbauer A., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004371.pub2, DOI 10.1002/14651858.CD004371.PUB2]; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Stuurman-Bieze AGG, 2013, ANN PHARMACOTHER, V47, P1448, DOI 10.1177/1060028013501146; Sung JCY, 1998, AM J MANAG CARE, V4, P1421; Sutton S, 2014, ANN BEHAV MED, V48, P293, DOI 10.1007/s12160-014-9595-x; Timmers L, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3110-2; Tommelein E, 2014, ANN PHARMACOTHER, V48, P589, DOI 10.1177/1060028014522982; van Houtum L, 2016, HEALTH POLICY, V120, P431, DOI 10.1016/j.healthpol.2015.11.006; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Warren JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140008; World Health O, 2003, ADHERENCE LONG TERM; Wouters H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146272	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264555	10.1371/journal.pone.0264555	http://dx.doi.org/10.1371/journal.pone.0264555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226701	gold, Green Published			2022-12-26	WOS:000793394000032
J	Zhang, FY; Li, Y; Jiang, WM; Yu, XH; Zhuang, QY; Wang, SC; Yuan, LP; Wang, KC; Sun, SH; Liu, HL				Zhang, Fuyou; Li, Yang; Jiang, Wenming; Yu, Xiaohui; Zhuang, Qingye; Wang, Suchun; Yuan, Liping; Wang, Kaicheng; Sun, Shuhong; Liu, Hualei			Surveillance and genetic diversity analysis of avian astrovirus in China	PLOS ONE			English	Article							CHICKEN-ASTROVIRUS; DUCK HEPATITIS; VIRUS; GOUT	Avian astroviruses (AAstVs) have caused major problem for poultry breeding industries in China in recent years, and the goose gout caused by goose astrovirus has produced particularly great economic losses. To better understand the prevalence and genetic diversity of AAstVs in China, 1210 poultry samples collected from eight provinces were tested with reverse transcription-polymerase chain reaction (RT-PCR) to detect AAstV infections in different poultry populations. Then, Open reading frames 2 (ORF2) was amplified by specific primers, and the genetic evolution was analyzed. Our surveillance data demonstrate the diversity of AAstVs in China insofar as we detected 17 AAstVs, including seven chicken astroviruses (CAstVs), five avian nephritis viruses (ANVs), two goose astroviruses (GoAstVs), two duck astrovirus (DAstVs), and one new AAstV belonging to Avastrovirus Group 3. The positive rate of AAstV infection was 1.40%. Host analysis showed that CAstVs and ANVs were isolated from chickens, DAstVs and GoAstVs were isolated from ducks. Host-species-specific AAstVs infections were also identified in numerous samples collected at each stage of production. This study provides further evidence to better understand the epidemiology of AAstVs in different species of poultry in China.	[Zhang, Fuyou; Sun, Shuhong] Shandong Agr Univ, Tai An, Shandong, Peoples R China; [Li, Yang; Jiang, Wenming; Yu, Xiaohui; Zhuang, Qingye; Wang, Suchun; Yuan, Liping; Wang, Kaicheng; Liu, Hualei] China Anim Hlth & Epidemiol Ctr, Qingdao, Shandong, Peoples R China	Shandong Agricultural University; China Animal Health & Epidemiology Center	Sun, SH (corresponding author), Shandong Agr Univ, Tai An, Shandong, Peoples R China.; Wang, KC; Liu, HL (corresponding author), China Anim Hlth & Epidemiol Ctr, Qingdao, Shandong, Peoples R China.	wangkaicheng@cahec.cn; sunshuhong@sdau.edu.cn; liuhualei@cahec.cn		zhang, fuyou/0000-0001-7708-2751				ASPLIN FD, 1965, VET REC, V77, P1529; Bidin M, 2012, AVIAN PATHOL, V41, P555, DOI 10.1080/03079457.2012.733340; Bidin M, 2012, AVIAN PATHOL, V41, P91, DOI 10.1080/03079457.2011.642796; Bidin M, 2011, AVIAN PATHOL, V40, P173, DOI 10.1080/03079457.2011.551873; Bosch A.G.S., 2011, VIRUS TAXONOMY CLASS, P953; Bulbule NR, 2013, AVIAN PATHOL, V42, P464, DOI 10.1080/03079457.2013.828194; Chu DKW, 2012, J VIROL, V86, P13772, DOI 10.1128/JVI.02105-12; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Donato C, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050102; Fu Y, 2009, J GEN VIROL, V90, P1104, DOI 10.1099/vir.0.008599-0; GOUGH RE, 1985, AVIAN PATHOL, V14, P227, DOI 10.1080/03079458508436224; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Jin ML, 2018, ARCH VIROL, V163, P2865, DOI 10.1007/s00705-018-3932-5; Liu N, 2018, TRANSBOUND EMERG DIS, V65, P927, DOI 10.1111/tbed.12873; Liu N, 2014, ARCH VIROL, V159, P2823, DOI 10.1007/s00705-014-2141-0; Liu N, 2014, VET MICROBIOL, V170, P39, DOI 10.1016/j.vetmic.2014.01.026; Palomino-Tapia V, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12101096; Smyth V, 2013, VET REC, V173, P403, DOI 10.1136/vr.f6393; Strain E, 2008, J VIROL, V82, P5099, DOI 10.1128/JVI.01993-07; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiermann AB, 2015, REV SCI TECH OIE, V34, P277, DOI 10.20506/rst.34.1.2340; Todd D, 2009, AVIAN PATHOL, V38, P301, DOI 10.1080/03079450903055421; Todd D, 2009, AVIAN PATHOL, V38, P21, DOI 10.1080/03079450802632056; Wan CH, 2018, J VET MED SCI, V80, P798, DOI 10.1292/jvms.18-0013; Xue J, 2017, BIOLOGICALS, V47, P22, DOI 10.1016/j.biologicals.2017.03.005; Zhang XY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0153-7	26	3	3	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264308	10.1371/journal.pone.0264308	http://dx.doi.org/10.1371/journal.pone.0264308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226672	gold, Green Published			2022-12-26	WOS:000793394000015
J	Song, MJ; Lee, DS; Choi, YY; Lee, DY; Jo, HM; Lim, SY; Park, JS; Cho, YJ; Yoon, HI; Lee, JH; Lee, CT; Lee, YJ				Song, Myung Jin; Lee, Dong-Seon; Choi, Yun-Young; Lee, Da-Yun; Jo, Hye-Min; Lim, Sung Yoon; Park, Jong Sun; Cho, Young-Jae; Yoon, Ho Il; Lee, Jae Ho; Lee, Choon-Taek; Lee, Yeon Joo			Incidence of preventable cardiopulmonary arrest in a mature part-time rapid response system: A prospective cohort study	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; EMERGENCY TEAM CALLS; DEATHS; CARE	Background The purpose of a rapid response system (RRS) is to reduce the incidence of preventable cardiopulmonary arrests (CPAs) and patient deterioration in general wards. The objective of this study is to investigate the incidence and temporal trends of preventable CPAs and determine factors associated with preventable CPAs in a hospital with a mature RRS. Methods This was a single-center prospective cohort study of all CPAs occurring in the general ward between March 2017 and June 2020. The RRS operates from 07:00 to 23:00 on weekdays and from 07:00 to 12:00 on Saturdays. All CPAs were reviewed upon biweekly conference, and a panel of intensivists judged their preventability. Trends of preventable CPAs were analyzed using Poisson regression models and factors associated with preventable CPAs were analyzed using multivariable logistic regression. Results There were 253 CPAs over 40 months, and 64 (25.3%) of these were preventable. The incidence rate of CPAs was 1.07 per 1000 admissions and that of preventable CPAs was 0.27 per 1000 admissions. The number of preventable CPAs decreased by 24% each year (incidence rate ratio = 0.76; p = 0.039) without a change in the total CPA incidence. The most common contributor to the preventability was delayed response from physicians (n = 41, 64.1%). A predictable CPA with a pre-alarm sign had increased odds in the occurrence of preventable CPAs, while a cardiac cause of CPAs and RRS operating hours had decreased odds in terms of occurrence of preventable CPA. Conclusion Our study showed that one-fourth of all CPAs occurring in the general wards were preventable, and these arrests decreased each year. A mature RRS can evolve to reduce preventable CPAs with regular self-evaluation. Efforts should be directed at improving physicians' response time since a delay in their response was the most common cause of preventable CPAs.	[Song, Myung Jin; Lim, Sung Yoon; Park, Jong Sun; Cho, Young-Jae; Yoon, Ho Il; Lee, Jae Ho; Lee, Choon-Taek; Lee, Yeon Joo] Seoul Natl Univ, Bundang Hosp, Coll Med, Div Pulm & Crit Care Med,Dept Internal Med, Seongnam, South Korea; [Lee, Dong-Seon; Choi, Yun-Young; Lee, Da-Yun; Jo, Hye-Min] Seoul Natl Univ, Bundang Hosp, Interdept Crit Care Med, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, YJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Div Pulm & Crit Care Med,Dept Internal Med, Seongnam, South Korea.	yjlee1117@snubh.org	Cho, Young-Jae/D-5528-2012	Cho, Young-Jae/0000-0001-6943-4462	SNUBH Research Fund [02-2018-051]; Korea Medical Device Development Fund - Korea government (Ministry of Science and ICT) [202015X02]; Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy) [202015X02]; Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare) [202015X02]; Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety) [202015X02]	SNUBH Research Fund; Korea Medical Device Development Fund - Korea government (Ministry of Science and ICT); Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare); Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety)	The corresponding author (YJL) was supported by the SNUBH Research Fund (Grant Number 02-2018-051) and Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) (Project Number: 202015X02).	Andersen LW, 2016, RESUSCITATION, V98, P112, DOI 10.1016/j.resuscitation.2015.08.016; Barrett J, 2018, INTERN MED J, V48, P264, DOI 10.1111/imj.13676; Barwise A, 2016, CRIT CARE MED, V44, P54, DOI 10.1097/CCM.0000000000001346; BEDELL SE, 1991, JAMA-J AM MED ASSOC, V265, P2815, DOI 10.1001/jama.265.21.2815; Boniatti MM, 2014, CRIT CARE MED, V42, P26, DOI 10.1097/CCM.0b013e31829e53b9; Calzavacca P, 2010, RESUSCITATION, V81, P31, DOI 10.1016/j.resuscitation.2009.09.026; Chen J, 2015, CRIT CARE MED, V43, P2059, DOI 10.1097/CCM.0000000000001192; Choi Y, 2016, HEALTHC INFORM RES, V22, P277, DOI 10.4258/hir.2016.22.4.277; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; Galhotra S, 2007, QUAL SAF HEALTH CARE, V16, P260, DOI 10.1136/qshc.2007.022210; HAYWARD RA, 1993, ANN INTERN MED, V118, P550, DOI 10.7326/0003-4819-118-7-199304010-00010; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; Hodgetts TJ, 2002, RESUSCITATION, V54, P115, DOI 10.1016/S0300-9572(02)00098-9; Hogan H, 2012, BMJ QUAL SAF, V21, P737, DOI 10.1136/bmjqs-2011-001159; Jones D, 2006, INTENS CARE MED, V32, P1352, DOI 10.1007/s00134-006-0263-x; Jones D, 2009, CRIT CARE, V13, DOI 10.1186/cc7996; Kim Y, 2017, CRIT CARE MED, V45, pE592, DOI 10.1097/CCM.0000000000002314; Lyons PG, 2018, RESUSCITATION, V128, P191, DOI 10.1016/j.resuscitation.2018.05.013; Maharaj R, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0973-y; Moskowitz A, 2019, RESUSCITATION, V145, P15, DOI 10.1016/j.resuscitation.2019.09.003; Rhee C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7571; Roh SY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242799; Sandroni C, 2007, INTENS CARE MED, V33, P237, DOI 10.1007/s00134-006-0326-z; Sankey CB, 2016, J GEN INTERN MED, V31, P895, DOI 10.1007/s11606-016-3654-x; Subbe CP, 2019, RESUSCITATION, V141, P1, DOI 10.1016/j.resuscitation.2019.05.012; Tirkkonen J, 2020, RESUSCITATION, V149, P109, DOI 10.1016/j.resuscitation.2020.02.022; Trinkle RM, 2011, RESUSCITATION, V82, P810, DOI 10.1016/j.resuscitation.2011.03.019; Vetro J, 2011, CRIT CARE RESUSC, V13, P162; Zegers M, 2009, QUAL SAF HEALTH CARE, V18, P297, DOI 10.1136/qshc.2007.025924	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264272	10.1371/journal.pone.0264272	http://dx.doi.org/10.1371/journal.pone.0264272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213617	gold, Green Published			2022-12-26	WOS:000787811000069
J	Vos, R; Boesten, J; van den Akker, M				Vos, Rein; Boesten, Jos; van den Akker, Marjan			Fifteen-year trajectories of multimorbidity and polypharmacy in Dutch primary care-A longitudinal analysis of age and sex patterns	PLOS ONE			English	Article							GENERAL-PRACTICE; REGISTRATION NETWORK; MEDICAL-EDUCATION; HEALTH; EPIDEMIOLOGY	Objective After stratifying for age, sex and multimorbidity at baseline, our aim is to analyse time trends in incident multimorbidity and polypharmacy in the 15-year clinical trajectories of individual patients in a family medicine setting. Methods This study was carried out using data from the Registration Network Family Medicine in the South of the Netherlands. The clinical trajectories of 10037 subjects during the 15-year period (2000-2014) were analyzed in a repeated measurement of using a generalized estimating equations model as well as a multilevel random intercept model with repeated measurements to determine patterns of incident multimorbidity and polypharmacy. Hierarchical age-period-cohort models were used to generate age and cohort trajectories for comparison with prevalence trends in multimorbidity literature. Results Multimorbidity was more common in females than in males throughout the duration of the 15-year trajectory (females: 39.6%; males: 33.5%). With respective ratios of 11.7 and 5.9 between the end and the beginning of the 15-year period, the youngest female and male groups showed a substantial increase in multimorbidity prevalence. Ratios in the oldest female and male groups were 2.2 and 1.9 respectively. Females had higher levels of multimorbidity than males in the 0-24-year and 25-44-year age groups, but the levels converged to a prevalence of 92.2% in the oldest male and 90.7% in the oldest female group. Similar, albeit, moderate differences were found in polypharmacy patterns. Conclusions We sought to specify the progression of multimorbidity from an early age. As a result, our study adds to the multimorbidity literature by specifying changes in chronic disease accumulation with relation to polypharmacy, and by tracking differences in patient trajectories according to age and sex. Multimorbidity and polypharmacy are common and their prevalence is accelerating, with a relatively rapid increase in younger groups. From the point of view of family medicine, this underlines the need for a longitudinal approach and a life course perspective in patient care.	[Vos, Rein] Maastricht Univ, Dept Methodol & Stat, Maastricht, Netherlands; [Boesten, Jos; van den Akker, Marjan] Maastricht Univ, Care & Publ Hlth Res Inst, Dept Family Med, Maastricht, Netherlands; [van den Akker, Marjan] Goethe Univ Frankfurt, Inst Gen Practice, Frankfurt, Germany; [van den Akker, Marjan] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Acad Ctr Gen Practice, Leuven, Belgium	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Goethe University Frankfurt; KU Leuven	van den Akker, M (corresponding author), Maastricht Univ, Care & Publ Hlth Res Inst, Dept Family Med, Maastricht, Netherlands.; van den Akker, M (corresponding author), Goethe Univ Frankfurt, Inst Gen Practice, Frankfurt, Germany.; van den Akker, M (corresponding author), Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Acad Ctr Gen Practice, Leuven, Belgium.	m.vandenAkker@allgemeinmedizin.uni-frankfurt.de						Allison PD, 2014, QUANTITATIVE APPL SO, V2; Ashworth Mark, 2019, BMJ Open, V9, pe031649, DOI 10.1136/bmjopen-2019-031649; Bakaki PM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208047; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bell A, 2014, SOC SCI MED, V120, P21, DOI 10.1016/j.socscimed.2014.09.008; Bjur Kara A, 2019, Hosp Pediatr, V9, P281, DOI 10.1542/hpeds.2018-0091; Canizares M, 2018, J GERONTOL B-PSYCHOL, V73, P1303, DOI 10.1093/geronb/gbx004; Department of Family Medicine Maastricht University The Netherlands, RES NETW FAM MED RNF; Department of General Practice KU Leuven Belgium, INT PROJ; Falster MO, 2021, BRIT J CLIN PHARMACO, V87, P1264, DOI 10.1111/bcp.14504; Feng X, 2018, POPUL HEALTH MANAG, V21, P123, DOI 10.1089/pop.2017.0065; Ferro MA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-034544; Guisado-Clavero M, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0705-7; Guthrie B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0322-7; Heck RH, 2012, QUANT METH SER, P1; Heck RH, 2010, QUANT METH SER, P1; Horace AE, 2020, PEDIATR DRUGS, V22, P85, DOI 10.1007/s40272-019-00372-4; Gonzalez AI, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-034485; Kendir C, 2017, EUR J GEN PRACT, V24, P45, DOI 10.1080/13814788.2017.1398318; Kostev K, 2018, EUR J INTERN MED, V55, P66, DOI 10.1016/j.ejim.2018.07.014; Kudesia Prtha, 2021, J Multimorb Comorb, V11, p26335565211032880, DOI 10.1177/26335565211032880; Lash TL., 2021, MODERN EPIDEMIOLOGY, V4th; Leitliniengruppe Hessen DEGAM, 2021, S3 LEITL MULT; Makovski TT, 2019, AGEING RES REV, V53, DOI 10.1016/j.arr.2019.04.005; Masnoon N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0621-2; Maxwell CJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250567; McGrail K, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1312; Meinow B, 2015, EUR J AGEING, V12, P285, DOI 10.1007/s10433-015-0351-2; Melis R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103120; Metsemakers JFM, 1996, INT J BIOMED COMPUT, V42, P43, DOI 10.1016/0020-7101(96)01180-4; METSEMAKERS JFM, 1992, BRIT J GEN PRACT, V42, P102; Muth C, 2019, J INTERN MED, V285, P272, DOI 10.1111/joim.12842; Nguyen TN, 2019, FAM PRACT, V36, P706, DOI 10.1093/fampra/cmz023; Oktora MP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214240; Romano I, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043124; Scottish Government Polypharmacy Model of Care Group, 2018, POL GUID REAL PRESCR, V3rd; Shi Xi., 2020, J GERONTOL A, V20, P1; Singh-Manoux A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002571; Sinnott Carol, 2015, J Comorb, V5, P29, DOI 10.15256/joc.2015.5.51; Soysal P, 2019, EXP GERONTOL, V120, P62, DOI 10.1016/j.exger.2019.02.019; St Sauver JL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006413; Truyers C, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-48; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van den Akker M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212046; van Oostrom SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160264; Vetrano DL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16780-x; Vetrano DL, 2018, J AM MED DIR ASSOC, V19, P710, DOI 10.1016/j.jamda.2018.04.008; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Vos R, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-014-0213-6; Ware D, 2019, AIDS PATIENT CARE ST, V33, P354, DOI 10.1089/apc.2019.0057; Westergaard D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08475-9; Westert GP, 2005, EUR J PUBLIC HEALTH, V15, P59, DOI 10.1093/eurpub/cki116; WHO Collaborating Drug Statistics Methodology, 1997, AN THER CHEM ATC CLA; Zemedikun DT, 2018, MAYO CLIN PROC, V93, P857, DOI 10.1016/j.mayocp.2018.02.012	56	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264343	10.1371/journal.pone.0264343	http://dx.doi.org/10.1371/journal.pone.0264343			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213615	Green Published, gold			2022-12-26	WOS:000787811000078
J	Henschel, A; Feng, SF; Hamoudi, RA; Elbait, GD; Damiani, E; Waasia, F; Tay, GK; Mahboub, BH; Uddin, MH; Acuna, J; Alefishat, E; Halwani, R; Jelinek, HF; Mustafa, F; Alkaabi, N; Alsafar, AHS				Henschel, Andreas; Feng, Samuel F.; Hamoudi, Rifat A.; Elbait, Gihan Daw; Damiani, Ernesto; Waasia, Fathimathuz; Tay, Guan K.; Mahboub, Bassam H.; Uddin, Maimunah Hemayet; Acuna, Juan; Alefishat, Eman; Halwani, Rabih; Jelinek, Herbert F.; Mustafa, Farah; Alkaabi, Nawal; Alsafar, Habiba S. a		UAE COVID-19 Collaborative Partner	Travel ban effects on SARS-CoV-2 transmission lineages in the UAE as inferred by genomic epidemiology	PLOS ONE			English	Article							ALIGNMENT	Global and local whole genome sequencing of SARS-CoV-2 enables the tracing of domestic and international transmissions. We sequenced Viral RNA from 37 sampled Covid-19 patients with RT-PCR-confirmed infections across the UAE and developed time-resolved phylogenies with 69 local and 3,894 global genome sequences. Furthermore, we investigated specific clades associated with the UAE cohort and, their global diversity, introduction events and inferred domestic and international virus transmissions between January and June 2020. The study comprehensively characterized the genomic aspects of the virus and its spread within the UAE and identified that the prevalence shift of the D614G mutation was due to the later introductions of the G-variant associated with international travel, rather than higher local transmissibility. For clades spanning different emirates, the most recent common ancestors pre-date domestic travel bans. In conclusion, we observe a steep and sustained decline of international transmissions immediately following the introduction of international travel restrictions.	[Henschel, Andreas; Damiani, Ernesto] Khalifa Univ, Dept Elect Engn & Comp Sci, Abu Dhabi, U Arab Emirates; [Henschel, Andreas; Feng, Samuel F.; Elbait, Gihan Daw; Waasia, Fathimathuz; Alefishat, Eman; Alsafar, Habiba S. a] Khalifa Univ Sci & Technol, Ctr Biotechnol, Abu Dhabi, U Arab Emirates; [Feng, Samuel F.] Khalifa Univ Sci & Technol, Dept Math, Abu Dhabi, U Arab Emirates; [Hamoudi, Rifat A.; Halwani, Rabih] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates; [Hamoudi, Rifat A.; Halwani, Rabih] Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates; [Hamoudi, Rifat A.] UCL, Div Surg & Intervent Sci, London, England; [Damiani, Ernesto] Khalifa Univ Sci & Technol, Ctr Cyber Phys Syst, Abu Dhabi, U Arab Emirates; [Tay, Guan K.] Univ Western Australia, Fac Hlth & Med Sci, Div Psychiat, Crawley, WA, Australia; [Tay, Guan K.] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia; [Mahboub, Bassam H.] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates; [Mahboub, Bassam H.] Dubai Hlth Author, Dept Pulm Med, Rashid Hosp, Dubai, U Arab Emirates; [Uddin, Maimunah Hemayet; Alkaabi, Nawal] Sheikh Khalifa Med City, Dept Pediat Infect Dis, Abu Dhabi, U Arab Emirates; [Acuna, Juan] Khalifa Univ Sci & Technol, Coll Med & Hlth Sci, Dept Epidemiol & Populat Hlth, Abu Dhabi, U Arab Emirates; [Acuna, Juan] SEHA, Off Acad Affairs Directorate Res & Dev, Abu Dhabi, U Arab Emirates; [Alefishat, Eman] Khalifa Univ Sci & Technol, Coll Med & Hlth Sci, Dept Pharmacol, Abu Dhabi, U Arab Emirates; [Alefishat, Eman] Univ Jordan, Fac Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan; [Jelinek, Herbert F.] Khalifa Univ Sci & Technol, Hlth Engn Innovat Ctr, Abu Dhabi, U Arab Emirates; [Jelinek, Herbert F.; Alsafar, Habiba S. a] Khalifa Univ Sci & Technol, Coll Engn, Dept Biomed Engn, Abu Dhabi, U Arab Emirates; [Mustafa, Farah] United Arab Emirates Univ, Dept Biochem & Mol Biol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Alsafar, Habiba S. a] Khalifa Univ Sci & Technol, Coll Med & Hlth Sci, Dept Genet & Mol Biol, Abu Dhabi, U Arab Emirates	Khalifa University of Science & Technology; Khalifa University of Science & Technology; Khalifa University of Science & Technology; University of Sharjah; University of Sharjah; University of London; University College London; Khalifa University of Science & Technology; University of Western Australia; Edith Cowan University; University of Sharjah; Khalifa University of Science & Technology; Khalifa University of Science & Technology; University of Jordan; Khalifa University of Science & Technology; Khalifa University of Science & Technology; United Arab Emirates University; Khalifa University of Science & Technology	Alsafar, AHS (corresponding author), Khalifa Univ Sci & Technol, Ctr Biotechnol, Abu Dhabi, U Arab Emirates.; Alsafar, AHS (corresponding author), Khalifa Univ Sci & Technol, Coll Engn, Dept Biomed Engn, Abu Dhabi, U Arab Emirates.; Alsafar, AHS (corresponding author), Khalifa Univ Sci & Technol, Coll Med & Hlth Sci, Dept Genet & Mol Biol, Abu Dhabi, U Arab Emirates.	habiba.alsafar@ku.ac.ae	damiani, ernesto/AAI-5709-2020	damiani, ernesto/0000-0002-9557-6496; Hamoudi, Rifat/0000-0002-1402-0868; Al Kaabi, Nawal/0000-0003-2180-4158; Hemayet Uddin, Maimunah/0000-0002-1175-4145	Khalifa University	Khalifa University	The project is funded by internal funds provided by Khalifa University awarded to Dr. Habiba Alsafar and endorsed by the National COVID-19 Research Committee of UAE.	A.Green, 2020, bioRxiv, DOI 10.1101/2020.05.28.118992; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Andrews S., 2010, FASTQC QUALITY CONTR; Bhoyar RC., BIORXIV 202020200810, DOI [10.1371/journal.pone.0247115, DOI 10.1371/JOURNAL.PONE.0247115]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Candido DS, 2020, SCIENCE, V369, P1255, DOI 10.1126/science.abd2161; Deng XD, 2020, SCIENCE, V369, P582, DOI 10.1126/science.abb9263; Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Grubaugh ND, 2020, CELL, V182, P794, DOI 10.1016/j.cell.2020.06.040; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; IATA, 2019, AIR TRANSP SECT MAK; ICAO, 2020, GLOB COVID 19 AIRP S; Jarallah J, 2020, CORONAVIRUS UAE SCH; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lythgoe KA, 2021, SCIENCE, V372, P256, DOI 10.1126/science.abg0821; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; National Emergency Crisis and Disaster Management (ncema), 2020, UNITED ARAB EMIRATES; Port Authority of New York and New Jersey, 2019, ANN AIRP TRAFF REP; Pybus O, PRELIMINARY ANAL SAR; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Saha S, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.00568-20; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tayoun AA., 2020, WHOLE GENOME PHYLOGE, V05, DOI [10.1101/2020.05.06.080606, DOI 10.1101/2020.05.06.080606]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Young BE, 2020, LANCET, V396, P603, DOI 10.1016/S0140-6736(20)31757-8	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264682	10.1371/journal.pone.0264682	http://dx.doi.org/10.1371/journal.pone.0264682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235585	Green Published, gold			2022-12-26	WOS:000787073100002
J	Jentzer, JC; Wiley, BM; Anavekar, NS				Jentzer, Jacob C.; Wiley, Brandon M.; Anavekar, Nandan S.			Echocardiographic left ventricular stroke work index: An integrated noninvasive measure of shock severity	PLOS ONE			English	Article							CARDIOGENIC-SHOCK; EUROPEAN ASSOCIATION; FILLING PRESSURES; AMERICAN SOCIETY; CARDIAC POWER; MORTALITY; CARE; HEART; RECOMMENDATIONS; GUIDELINES	BackgroundEchocardiographic findings vary with shock severity, as defined by the Society for Cardiovascular Angiography and Intervention (SCAI) shock stage. Left ventricular stroke work index (LVSWI) measured by transthoracic echocardiography (TTE) can predict mortality in the cardiac intensive care unit (CICU). We sought to determine whether LVSWI could refine mortality risk stratification by the SCAI shock classification in the CICU. MethodsWe included consecutive CICU patients from 2007 to 2015 with TTE data available to calculate the LVSWI, specifically the mean arterial pressure, stroke volume index and medial mitral E/e' ratio. In-hospital mortality as a function of LVSWI was evaluated across the SCAI shock stages using logistic regression, before and after multivariable adjustment. ResultsWe included 3635 unique CICU patients, with a mean age of 68.1 +/- 14.5 years (36.5% females); 61.1% of patients had an acute coronary syndrome. The LVSWI progressively decreased with increasing shock severity, as defined by increasing SCAI shock stage. A total of 203 (5.6%) patients died during hospitalization, with higher in-hospital mortality among patients with lower LVSWI (adjusted OR 0.66 per 10 J/m2 higher) or higher SCAI shock stage (adjusted OR 1.24 per each higher stage). A LVSWI <33 J/m2 was associated with higher adjusted in-hospital mortality, particularly among patients with shock (SCAI stages C, D and E). ConclusionsThe LVSWI by TTE noninvasively characterizes the severity of shock, including both systolic and diastolic parameters, and can identify low-risk and high-risk patients at each level of clinical shock severity.	[Jentzer, Jacob C.; Wiley, Brandon M.; Anavekar, Nandan S.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Jentzer, Jacob C.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Jentzer, JC (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA.; Jentzer, JC (corresponding author), Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA.	jentzer.jacob@mayo.edu		Jentzer, Jacob/0000-0002-6366-2859				Baran DA, 2020, CATHETER CARDIO INTE, V96, P1339, DOI 10.1002/ccd.29319; Baran DA, 2019, CATHETER CARDIO INTE, V94, P29, DOI 10.1002/ccd.28329; Basir MB, 2019, CATHETER CARDIO INTE, V93, P1173, DOI 10.1002/ccd.28307; Bennett CE, 2019, J CRIT CARE, V50, P242, DOI 10.1016/j.jcrc.2018.12.012; Choi JO, 2010, ECHOCARDIOGR-J CARD, V27, P1161, DOI 10.1111/j.1540-8175.2010.01222.x; Fincke R, 2004, J AM COLL CARDIOL, V44, P340, DOI 10.1016/j.jacc.2004.03.060; Garan AR, 2020, JACC-HEART FAIL, V8, P903, DOI 10.1016/j.jchf.2020.08.012; Jentzer JC, 2021, AM HEART J, V232, P94, DOI 10.1016/j.ahj.2020.10.054; Jentzer JC, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.006956; Jentzer JC, 2020, CIRC-CARDIOVASC IMAG, V13, DOI 10.1161/CIRCIMAGING.120.011642; Jentzer JC, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007568; Jentzer JC, 2021, JACC-CARDIOVASC IMAG, V14, P321, DOI 10.1016/j.jcmg.2020.05.038; Jentzer JC, 2020, AM HEART J, V224, P57, DOI 10.1016/j.ahj.2020.02.018; Jentzer JC, 2020, CATHETER CARDIO INTE, V96, P1350, DOI 10.1002/ccd.28854; Jentzer JC, 2020, CLIN CARDIOL, V43, P516, DOI 10.1002/clc.23339; Jentzer JC, 2020, AM HEART J, V219, P37, DOI 10.1016/j.ahj.2019.10.012; Jentzer JC, 2019, J AM COLL CARDIOL, V74, P2117, DOI 10.1016/j.jacc.2019.07.077; Jentzer JC, 2019, AM HEART J, V215, P12, DOI 10.1016/j.ahj.2019.05.012; Jentzer JC, 2020, SHOCK, V53, P452, DOI 10.1097/SHK.0000000000001390; Jentzer JC, 2018, AM J CARDIOL, V122, P1773, DOI 10.1016/j.amjcard.2018.08.011; Jentzer JC, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008169; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Matthews SD, 2018, J AM COLL CARDIOL, V71, P255, DOI 10.1016/j.jacc.2017.09.1157; Mele D, 2020, J AM SOC ECHOCARDIOG, V33, P135, DOI 10.1016/j.echo.2019.09.009; Mendoza DD, 2007, AM HEART J, V153, P366, DOI 10.1016/j.ahj.2006.11.014; Mitter SS, 2017, J AM COLL CARDIOL, V69, P1451, DOI 10.1016/j.jacc.2016.12.037; Nauta JF, 2018, EUR J HEART FAIL, V20, P1303, DOI 10.1002/ejhf.1220; Ommen SR, 2000, CIRCULATION, V102, P1788; Padkins M, 2020, ESC HEART FAIL, V7, P3971, DOI 10.1002/ehf2.12995; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Schrage B, 2020, CATHETER CARDIO INTE, V96, pE213, DOI 10.1002/ccd.28707; Sharifov OF, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004766; Sionis A, 2020, J INTENSIVE CARE MED, V35, P1426, DOI 10.1177/0885066619828959; Tehrani BN, 2019, J AM COLL CARDIOL, V73, P1659, DOI 10.1016/j.jacc.2018.12.084; Thayer KL, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007099; van Diepen S, 2017, CIRCULATION, V136, pE232, DOI 10.1161/CIR.0000000000000525	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0262053	10.1371/journal.pone.0262053	http://dx.doi.org/10.1371/journal.pone.0262053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263333	gold, Green Published			2022-12-26	WOS:000804638700016
J	Hu, WH; Cai, CH; Li, YH; Kang, F; Chu, TW; Dong, SW				Hu, Wenhui; Cai, Chenhui; Li, Yuheng; Kang, Fei; Chu, Tongwei; Dong, Shiwu			Farnesoid X receptor agonist attenuates subchondral bone osteoclast fusion and osteochondral pathologies of osteoarthritis via suppressing JNK1/2/NFATc1 pathway	FASEB JOURNAL			English	Article						farnesoid X receptor; JNK1; 2; NFATc1 pathway; osteoarthritis; osteoclastogenesis; subchondral bone	CRUCIATE LIGAMENT TRANSECTION; MESENCHYMAL STEM-CELLS; CARTILAGE DEGRADATION; ARTICULAR-CARTILAGE; BILE-ACID; INHIBITION; KNEE; MODELS; INJURY; PAIN	Osteoarthritis (OA) is a prevalent degenerative disease of the joint, featured by articular cartilage destruction and subchondral bone marrow lesions. Articular cartilage and subchondral bone constitute an osteochondral unit that guarantees joint homeostasis. During OA initiation, activated osteoclasts in subchondral bone ultimately result in impaired capacities of the subchondral bone in response to mechanical stress, followed by the degradation of overlying articular cartilage. Thus, targeting osteoclasts could be a potential therapeutic option for treating OA. Here, we observed that farnesoid X receptor (FXR) expression and osteoclast fusion and activity in subchondral bone were concomitantly changed during early-stage OA in the OA mouse model established by anterior cruciate ligament transection (ACLT). Then, we explored the therapeutic effects of FXR agonist GW4064 on the osteochondral pathologies in ACLT mice. We showed that GW4064 obviously ameliorated subchondral bone deterioration, associated with reduction in tartrate-resistant acid phosphatase (TRAP) positive multinuclear osteoclast number, as well as articular cartilage degradation, which were blocked by the treatment with FXR antagonist Guggulsterone. Mechanistically, GW4064 impeded osteoclastogenesis through inhibiting subchondral bone osteoclast fusion via suppressing c-Jun N-terminal kinase (JNK) 1/2/nuclear factor of activated T-cells 1 (NFATc1) pathway. Taken together, our results present evidence for the protective effects of GW4064 against OA by blunting osteoclast-mediated aberrant subchondral bone loss and subsequent cartilage deterioration. Therefore, GW4064 demonstrates the potential as an alternative therapeutic option against OA for further drug development.	[Hu, Wenhui; Li, Yuheng; Kang, Fei; Dong, Shiwu] Third Mil Med Univ, Army Med Univ, Coll Biomed Engn, Dept Biomed Mat Sci, Chongqing, Peoples R China; [Cai, Chenhui; Chu, Tongwei] Third Mil Med Univ, Army Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Dong, Shiwu] Third Mil Med Univ, Army Med Univ, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Dong, SW (corresponding author), Third Mil Med Univ, Dept Biomed Mat Sci, Chongqing 400038, Peoples R China.; Chu, TW (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing 400037, Peoples R China.	chtw@sina.com; dongshiwu@163.com		Hu, Wenhui/0000-0002-8886-7260	Key Program of Natural Science Foundation of China [81930067]; Project of Nature Science Foundation of China [31870962]; Medical Innovation of Graduate Students in Chongqing [CYS20372]; General Program of Natural Science Foundation of Chongqing [cstc2019jcyj--msxmX0176]	Key Program of Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Innovation of Graduate Students in Chongqing; General Program of Natural Science Foundation of Chongqing	This work was supported by grants from the Key Program of Natural Science Foundation of China (81930067), the Project of Nature Science Foundation of China (31870962), the Medical Innovation of Graduate Students in Chongqing (CYS20372), and the General Program of Natural Science Foundation of Chongqing (cstc2019jcyj--msxmX0176).	Andriacchi TP, 2020, OSTEOARTHRITIS CARTI, V2; Bingham CO, 2006, ARTHRITIS RHEUM-US, V54, P3494, DOI 10.1002/art.22160; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chang EJ, 2008, J CELL SCI, V121, P2555, DOI 10.1242/jcs.028217; Chang Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082904; Chatziravdeli V, 2019, CURR GENOMICS, V20, P184, DOI 10.2174/1389202920666190422142053; Chen D, 2017, BONE RES, V5, DOI 10.1038/boneres.2016.44; Cho SW, 2013, J BONE MINER RES, V28, P2109, DOI 10.1002/jbmr.1961; Conaghan PG, 2019, NAT REV RHEUMATOL, V15, P355, DOI 10.1038/s41584-019-0221-y; Contartese D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103696; Cosenza S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15376-8; Coughlin TR, 2016, ANN NY ACAD SCI, V1383, P58, DOI 10.1111/nyas.13261; Cui Z, 2016, ANN RHEUM DIS, V75, P1714, DOI 10.1136/annrheumdis-2015-207923; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng JZ, 2021, FASEB J, V35, DOI 10.1096/fj.202100135R; Dong YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060943; Edd SN, 2018, OSTEOARTHR CARTILAGE, V26, P1425, DOI 10.1016/j.joca.2018.06.017; Fang C, 2022, ACTA PHARMACOL SIN, V43, P1299, DOI 10.1038/s41401-021-00747-9; Fang H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21184-5; Gao XL, 2018, CARDIOVASC RES, V114, P737, DOI 10.1093/cvr/cvy011; Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005; Goldring SR, 2016, NAT REV RHEUMATOL, V12, P632, DOI 10.1038/nrrheum.2016.148; Goldring SR, 2012, THER ADV MUSCULOSKEL, V4, P249, DOI 10.1177/1759720X12437353; Han CY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072069; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hayami T, 2012, BONE, V50, P1250, DOI 10.1016/j.bone.2012.03.025; Hu WH, 2021, ANN RHEUM DIS, V80, P413, DOI 10.1136/annrheumdis-2020-218089; Hu Y, 2021, BONE RES, V9, DOI 10.1038/s41413-021-00147-z; Huang XJ, 2018, BIOMED PHARMACOTHER, V107, P433, DOI 10.1016/j.biopha.2018.07.161; Hunter DJ, 2019, LANCET, V393, P1745, DOI 10.1016/S0140-6736(19)30417-9; Kitagawa F, 2013, TISSUE ENG PART C-ME, V19, P438, DOI [10.1089/ten.tec.2012.0166, 10.1089/ten.TEC.2012.0166]; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; Lu ZY, 2017, CHEM-BIOL INTERACT, V277, P62, DOI 10.1016/j.cbi.2017.08.011; Ma HL, 2007, OSTEOARTHR CARTILAGE, V15, P695, DOI 10.1016/j.joca.2006.11.005; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Ma L, 2021, INT J MOL MED, V47, DOI 10.3892/ijmm.2021.4855; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Meyer EG, 2008, AM J SPORT MED, V36, P1966, DOI 10.1177/0363546508318046; Park DR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18208-y; Pastoureau PC, 2010, OSTEOARTHR CARTILAGE, V18, pS106, DOI 10.1016/j.joca.2010.05.024; Prodromos CC, 2007, ARTHROSCOPY, V23, P1320, DOI 10.1016/j.arthro.2007.07.003; Qin HJ, 2019, BONE, V125, P140, DOI 10.1016/j.bone.2019.05.010; Sekiguchi Y, 2017, MOL MED REP, V16, P1328, DOI 10.3892/mmr.2017.6752; Shaktivesh, 2019, J MECH BEHAV BIOMED, V90, P388, DOI 10.1016/j.jmbbm.2018.10.023; Sharma AR, 2013, INT J MOL SCI, V14, P19805, DOI 10.3390/ijms141019805; Siebelt M, 2014, BONE, V66, P163, DOI 10.1016/j.bone.2014.06.009; Tavares SJS, 2021, FITOTERAPIA, V150, DOI 10.1016/j.fitote.2021.104842; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Strassle BW, 2010, OSTEOARTHR CARTILAGE, V18, P1319, DOI 10.1016/j.joca.2010.06.007; Tamimi I, 2020, BONE, V140, DOI 10.1016/j.bone.2020.115558; Tateiwa D, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080818; Temp J, 2020, OSTEOARTHR CARTILAGE, V28, P475, DOI 10.1016/j.joca.2019.11.003; Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200; van Meer BL, 2015, BRIT J SPORT MED, V49, P975, DOI 10.1136/bjsports-2013-093258; Vincent TL, 2019, SEMIN ARTHRITIS RHEU, V49, pS36, DOI 10.1016/j.semarthrit.2019.09.018; Wang TT, 2018, CYTOKINE GROWTH F R, V44, P38, DOI 10.1016/j.cytogfr.2018.10.002; Yahara Y, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.622035; Zeng C, 2015, OSTEOARTHR CARTILAGE, V23, P189, DOI 10.1016/j.joca.2014.11.014; Zeng QY, 2020, CHEM-BIOL INTERACT, V327, DOI 10.1016/j.cbi.2020.109179; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zheng Ting, 2017, J Bone Metab, V24, P207, DOI 10.11005/jbm.2017.24.4.207; Zheng T, 2017, ONCOTARGET, V8, P76558, DOI 10.18632/oncotarget.20576; Zhou F, 2019, ACTA PHARM SIN B, V9, P973, DOI 10.1016/j.apsb.2019.01.015; Zhu M, 2013, FASEB J, V27, P3344, DOI 10.1096/fj.12-220228; Zhu SA, 2019, J CLIN INVEST, V129, P1076, DOI 10.1172/JCI121561; Zhu XB, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.607764	68	0	0	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22243	10.1096/fj.202101717R	http://dx.doi.org/10.1096/fj.202101717R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CU	35224782				2022-12-26	WOS:000772945800001
J	Shen, GY; Liu, X; Lei, W; Duan, R; Yao, ZQ				Shen, Gengyang; Liu, Xin; Lei, Wei; Duan, Rong; Yao, Zhenqiang			Plumbagin is a NF-kappa B-inducing kinase inhibitor with dual anabolic and antiresorptive effects that prevents menopausal-related osteoporosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE TURNOVER MARKERS; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; CANCELLOUS BONE; CELL-GROWTH; IN-VIVO; NIK; ACTIVATION	Osteoporosis is caused by enhanced bone resorption and relatively reduced bone formation. There is an unmet need to develop new agents with both antiresorptive and anabolic effects to treat osteoporosis, although drugs with either effect alone are available. A small molecular compound, plumbagin, was reported to inhibit receptor activator of nuclear factor kappa-B ligand-induced osteoclast (OC) differentiation by inhibiting I kappa Ba phosphorylation-mediated canonical NF-kappa B activation. However, the key transcriptional factor RelA/p65 in canonical NF -kappa B pathway functions to promote OC precursor survival but not terminal OC differentiation. Here, we found that plumbagin inhibited the activity of NF -kappa B inducing kinase, the key molecule that controls noncanonical NF -kappa B signaling, in an ATP/ ADP-based kinase assay. Consistent with this, plumbagin inhibited processing of NF-kappa B2 p100 to p52 in the progenitor cells of both OCs and osteoblasts (OBs). Interestingly, plumbagin not only inhibited OC but also stimulated OB differentiation in vitro. Importantly, plumbagin prevented trabecular bone loss in ovariectomized mice. This was associated with decreased OC surfaces on trabecular surface and increased parameters of OBs, including OB surface on trabecular surface, bone formation rate, and level of serum osteocalcin, compared to vehicle-treated mice. In summary, we conclude that plumbagin is a NF -kappa B inducing kinase inhibitor with dual anabolic and antiresorptive effects on bone and could represent a new class of agent for the prevention and treatment of osteoporosis.	[Yao, Zhenqiang] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Yao, ZQ (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA.	zhenqiang_yao@urmc.rochester.edu			Core Services at Center for Musculoskeletal Research [NIH/NIAMS P30 AR069655]; National Institutes of Health [R01 AG049994]; New York State Department of Health Research Project [C34928GG]	Core Services at Center for Musculoskeletal Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health Research Project	We sincerely thank the Core Services at Center for Musculoskeletal Research (NIH/NIAMS P30 AR069655) and Lindsay Schnur for the support in micro-CT imaging and analysis. This study was funded by the National Institutes of Health grant R01 AG049994 and New York State Department of Health Research Project #C34928GG.	Anastasilakis AD, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010152; Aspenberg P, 2014, ACTA ORTHOP, V85, P1, DOI 10.3109/17453674.2013.859423; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brightbill HD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02672-0; Canbek U, 2019, J ORTHOP SURG-HONG K, V27, DOI 10.1177/2309499019875262; Capriani C, 2012, J BONE MINER RES, V27, P2419, DOI 10.1002/jbmr.1800; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Chavassieux P, 2019, J BONE MINER RES, V34, P1597, DOI 10.1002/jbmr.3735; Cheng J, 2021, RSC MED CHEM, V12, P552, DOI 10.1039/d0md00361a; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Cosman F, 2016, NEW ENGL J MED, V375, P1532, DOI 10.1056/NEJMoa1607948; Cummings SR, 2018, J BONE MINER RES, V33, P190, DOI 10.1002/jbmr.3337; Davis JL, 2019, J BONE MINER RES, V34, P2087, DOI 10.1002/jbmr.3819; DELMAS PD, 1995, BONE, V16, P603, DOI 10.1016/8756-3282(95)00113-R; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Eastell R, 2017, LANCET DIABETES ENDO, V5, P908, DOI 10.1016/S2213-8587(17)30184-5; Eastell R, 2011, J BONE MINER RES, V26, P530, DOI 10.1002/jbmr.251; ERIKSEN EF, 1990, J BONE MINER RES, V5, P311, DOI 10.1002/jbmr.5650050402; GARNERO P, 1994, J CLIN ENDOCR METAB, V79, P1693, DOI 10.1210/jc.79.6.1693; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Gilbert LC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1011, DOI 10.1152/ajpendo.00534.2004; Heim N, 2019, DENTOMAXILLOFAC RAD, V48, DOI 10.1259/dmfr.20190132; Henriksen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027482; Hodge JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021462; Iwaniec UT, 2006, J BONE MINER RES, V21, P1068, DOI 10.1359/JBMR.060402; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kuo TR, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0097-4; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Leder BZ, 2017, BONE, V98, P54, DOI 10.1016/j.bone.2017.03.006; Lei W, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64018-z; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; Li ZQ, 2020, J MED CHEM, V63, P4388, DOI 10.1021/acs.jmedchem.0c00396; Lloyd AA, 2017, P NATL ACAD SCI USA, V114, P8722, DOI 10.1073/pnas.1704460114; Looker AC, 2010, J BONE MINER RES, V25, P64, DOI 10.1359/jbmr.090706; MacKenzie SA, 2019, BONE JOINT J, V101B, P1285, DOI 10.1302/0301-620X.101B10.BJJ-2019-0599.R2; Marie PJ, 2011, EUR J ENDOCRINOL, V165, P1, DOI 10.1530/EJE-11-0132; Mashiba T, 2000, J BONE MINER RES, V15, P613, DOI 10.1359/jbmr.2000.15.4.613; Mortier J, 2010, BIOORG MED CHEM LETT, V20, P4515, DOI 10.1016/j.bmcl.2010.06.027; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Odqvist L, 2013, CLIN CANCER RES, V19, P2319, DOI 10.1158/1078-0432.CCR-12-3151; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Ponnapakkam T, 2014, DRUG DISCOV TODAY, V19, P204, DOI 10.1016/j.drudis.2013.07.015; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Qing GL, 2005, J BIOL CHEM, V280, P40578, DOI 10.1074/jbc.M508776200; Ramadass V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145164; Ren XM, 2017, FASEB J, V31, P711, DOI 10.1096/fj.201600840R; Seo Y, 2012, MOL ENDOCRINOL, V26, P414, DOI 10.1210/me.2011-1241; Shoback D., 2020, J CLIN ENDOCR METAB, V105; Sleeman A, 2019, AM J HEALTH-SYST PH, V76, P130, DOI 10.1093/ajhp/zxy022; Solling ASK, 2019, DRUG AGING, V36, P625, DOI 10.1007/s40266-019-00675-8; Soysa NS, 2010, J BONE MINER RES, V25, P809, DOI 10.1359/jbmr.091030; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Sung B, 2012, MOL CANCER THER, V11, P350, DOI 10.1158/1535-7163.MCT-11-0731; Takakura N, 2020, BONE, V135, DOI 10.1016/j.bone.2020.115316; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wasnich RD, 2000, J CLIN ENDOCR METAB, V85, P231, DOI 10.1210/jc.85.1.231; Xiu Y, 2014, J CLIN INVEST, V124, P297, DOI 10.1172/JCI66947; Xu JK, 2009, CYTOKINE GROWTH F R, V20, P7, DOI 10.1016/j.cytogfr.2008.11.007; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yan W, 2014, ACTA PHARMACOL SIN, V35, P124, DOI 10.1038/aps.2013.152; Yang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015383; Yao ZQ, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11010132; Yao ZQ, 2021, METHODS MOL BIOL, V2230, P457, DOI 10.1007/978-1-0716-1028-2_29; Yao ZQ, 2017, J BIOL CHEM, V292, P10169, DOI 10.1074/jbc.M116.771816; Yao ZQ, 2014, J BONE MINER RES, V29, P866, DOI 10.1002/jbmr.2108; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Yi XJ, 2021, J BONE MINER RES, V36, P2426, DOI 10.1002/jbmr.4447; Yoshida CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032364; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; ZHOU H, 1994, J BONE MINER RES, V9, P1489	79	2	2	6	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101767	10.1016/j.jbc.2022.101767	http://dx.doi.org/10.1016/j.jbc.2022.101767			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35235833	Green Published, gold			2022-12-26	WOS:000793692600008
J	Sun, YW; Zhang, Y; Zhang, D; Wang, GQ; Song, L; Liu, ZY				Sun, Yuwei; Zhang, Yu; Zhang, Di; Wang, Guangqin; Song, Lei; Liu, Zhiyong			In vivo CRISPR-Cas9-mediated DNA chop identifies a cochlear outer hair cell-specific enhancer	FASEB JOURNAL			English	Article						cochlea; CRISPR/Cas9; inner ear; outer hair cells; Prestin	MOTOR PROTEIN; THYROID-HORMONE; INNER-EAR; VOLTAGE-SENSOR; PRESTIN; EXPRESSION; MEMBRANE; GENE; MICE; ELECTROMOTILITY	Cochlear outer hair cells (OHCs) are essential for hearing. A short, OHC-specific enhancer is necessary but not yet available for gene therapeutic applications in OHC damage. Such damage is a major cause of deafness. Prestin is a motor protein exclusively expressed in OHCs. We hypothesized that the cis-regulatory DNA fragment deletion of Slc26a5 would affect its expression. We tested this hypothesis by conducting CRISPR/Cas9-mediated large DNA fragment deletion of mouse Slc26a5 intron regions. First, starting from a similar to 13 kbp fragment, step-by-step, we narrowed down the sequence to a 1.4 kbp segment. By deleting either a 13 kbp or 1.4 kbp fragment, we observed delayed Prestin expression. Second, we showed that 1.4 kbp was an OHC-specific enhancer because enhanced green fluorescent protein (EGFP) was highly and specifically expressed in OHCs in a transgenic mouse where Rill' was driven by the 1.4 kbp segment. More importantly, specific RIR' was also driven by its homologous 398 by fragment in human Slc26a5. This suggests that the enhancer is likely to be evolutionarily conserved across different species.	[Sun, Yuwei; Zhang, Di; Wang, Guangqin; Liu, Zhiyong] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Sun, Yuwei; Zhang, Di; Wang, Guangqin; Liu, Zhiyong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Yu; Song, Lei] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Zhang, Yu; Song, Lei] Shanghai Jiao Tong Univ, Sch Med, Ear Inst, Shanghai, Peoples R China; [Liu, Zhiyong] Shanghai Ctr Brain Sci & Brain Inspired Intellige, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, ZY (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China.; Song, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ear Inst, Shanghai, Peoples R China.	lei.song@yale.edu; Zhiyongliu@ion.ac.cn	SUN, YUWEI/GXF-6274-2022	Sun, Yuwei/0000-0001-6375-3358; WANG, GUANGQIN/0000-0002-8613-7619; LIU, ZHIYONG/0000-0002-9675-1233	National Natural Science Foundation of China [81770995, 2018YFC1003003, 81771012]; National Key R&D Program of China [2017YFA0103901]; Strategic Priority Research Program of Chinese Academy of Science [XDB32060100]; Shanghai Municipal Science and Technology Major Project [2018SHZDZX05]; Innovative Research Team of High--Level Local Universities in Shanghai; Shanghai Key Laboratory of Translational Medicine on Ear and Nose diseases [14DZ2260300]; Chinese Thousand Young Talents Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Strategic Priority Research Program of Chinese Academy of Science; Shanghai Municipal Science and Technology Major Project; Innovative Research Team of High--Level Local Universities in Shanghai; Shanghai Key Laboratory of Translational Medicine on Ear and Nose diseases; Chinese Thousand Young Talents Program	National Natural Science Foundation of China (81771012), National Key R&D Program of China (2017YFA0103901), Strategic Priority Research Program of Chinese Academy of Science (XDB32060100), Chinese Thousand Young Talents Program, Shanghai Municipal Science and Technology Major Project (2018SHZDZX05), Innovative Research Team of High--Level Local Universities in Shanghai (Z.L). National Natural Science Foundation of China (81770995) & (2018YFC1003003) to L.S. and Shanghai Key Laboratory of Translational Medicine on Ear and Nose diseases (14DZ2260300)	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Adler HJ, 2003, HEARING RES, V184, P27, DOI 10.1016/S0378-5955(03)00192-8; Ashmore J F, 1990, Neurosci Res Suppl, V12, pS39, DOI 10.1016/0921-8696(90)90007-P; Bai JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52965-1; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Brown RP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-110; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Chan CSK., 2020, DEVELOPMENT, V147; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; Chen P, 2002, DEVELOPMENT, V129, P2495; Chessum L, 2018, NATURE, V563, P696, DOI 10.1038/s41586-018-0728-4; Driver EC, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.162263; Fang J, 2012, GENESIS, V50, P124, DOI 10.1002/dvg.20810; Groves AK, 2013, ANNU REV NEUROSCI, V36, P361, DOI 10.1146/annurev-neuro-062012-170309; Homma K., 2021, HEARING RES; Jeng JY, 2020, J PHYSIOL-LONDON, V598, P3891, DOI 10.1113/JP279795; Knipper M, 2001, J BIOL CHEM, V276, P39046, DOI 10.1074/jbc.M103385200; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Legendre K, 2008, J CELL SCI, V121, P3347, DOI 10.1242/jcs.028134; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Li C, 2020, ELIFE, V9, DOI 10.7554/eLife.50491; Li C, 2020, DEV DYNAM, V249, P173, DOI 10.1002/dvdy.111; Li C, 2018, HEARING RES, V364, P12, DOI 10.1016/j.heares.2018.04.006; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Lorenzen SM, 2015, MECH DEVELOP, V138, P233, DOI 10.1016/j.mod.2015.11.001; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Petitpre C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06033-3; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2002, PFLUG ARCH EUR J PHY, V444, P99, DOI 10.1007/s00424-002-0804-2; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Shrestha BR, 2018, CELL, V174, P1229, DOI 10.1016/j.cell.2018.07.007; Song L, 2005, BIOPHYS J, V88, P2350, DOI 10.1529/biophysj.104.053579; Song L, 2008, JARO-J ASSOC RES OTO, V9, P464, DOI 10.1007/s10162-008-0140-0; Song L, 2013, P NATL ACAD SCI USA, V110, P3883, DOI 10.1073/pnas.1218341110; Sun SH, 2018, CELL, V174, P1247, DOI 10.1016/j.cell.2018.07.008; Sun SH, 2021, ELIFE, V10, DOI 10.7554/eLife.66547; Tateya T, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.177881; Teitz T, 2018, J EXP MED, V215, P1187, DOI 10.1084/jem.20172246; Wang GQ, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.196899; Weber T, 2002, P NATL ACAD SCI USA, V99, P2901, DOI 10.1073/pnas.052609899; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wiwatpanit T, 2018, NATURE, V563, P691, DOI 10.1038/s41586-018-0570-8; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yamashita T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005500; Yamashita T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045453; Zhang H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.168906; Zhang XD, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109097; Zhang Y., 2021, HEARING RES; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2003, MAMM GENOME, V14, P87, DOI 10.1007/s00335-002-2227-y; Zuo EW, 2017, CELL RES, V27, P933, DOI 10.1038/cr.2017.81	60	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22233	10.1096/fj.202100421RR	http://dx.doi.org/10.1096/fj.202100421RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CY	35225354				2022-12-26	WOS:000772946200001
J	Wear, MP; Jacobs, E; Wang, SQ; McConnell, SA; Bowen, A; Strother, C; Cordero, RJB; Crawford, CJ; Casadevall, A				Wear, Maggie P.; Jacobs, Ella; Wang, Siqing; McConnell, Scott A.; Bowen, Anthony; Strother, Camilla; Cordero, Radames J. B.; Crawford, Conor J.; Casadevall, Arturo			Cryptococcus neoformans capsule regrowth experiments reveal dynamics of enlargement and architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSACCHARIDE CAPSULE; IMMUNE-RESPONSE; DISRUPTION; VIRULENCE; ANTIBODY; CELLS	The polysaccharide capsule of fungal pathogen Cryptococcus neoformans is a critical virulence factor that has historically evaded complete characterization. Cryptococcal polysaccharides are known to either remain attached to the cell as capsular polysaccharides (CPSs) or to be shed into the extracellular space as exopolysaccharides (EPSs). While many studies have examined the properties of EPS, far less is known about CPS. In this work, we detail the development of new physical and enzymatic methods for the isolation of CPS which can be used to explore the architecture of the capsule and isolated capsular material. We show that sonication or Glucanex enzyme cocktail digestion yields soluble CPS preparations, while use of a French pressure cell press or Glucanex digestion followed by cell disruption removed the capsule and produced cell wall-associated polysaccharide aggregates that we call "capsule ghosts", implying an inherent organization that allows the CPS to exist independent of the cell wall surface. Since sonication and Glucanex digestion were noncytotoxic, it was also possible to observe the cryptococcal cells rebuilding their capsule, revealing the presence of reducing end glycans throughout the capsule. Finally, analysis of dimethyl sulfoxideextracted and sonicated CPS preparations revealed the conservation of previously identified glucuronoxylomannan motifs only in the sonicated CPS. Together, these observations provide new insights into capsule architecture and synthesis, consistent with a model in which the capsule is assembled from the cell wall outward using smaller polymers, which are then compiled into larger ones.	[Wear, Maggie P.; Jacobs, Ella; Wang, Siqing; McConnell, Scott A.; Bowen, Anthony; Strother, Camilla; Cordero, Radames J. B.; Crawford, Conor J.; Casadevall, Arturo] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Crawford, Conor J.] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Max Planck Society	Wear, MP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	mwear1@jhu.edu	Bowen, Anthony/O-4982-2015; Cordero, Radames JB/F-6912-2011	Bowen, Anthony/0000-0003-1064-8372; Crawford, Conor/0000-0002-1314-1019; Wear, Maggie/0000-0002-8581-7831; Cordero, Radames JB/0000-0002-3026-7094; McConnell, Scott/0000-0001-9997-5278	National Institutes of Health (NIH) [AI007417]; NIH [AI138953, AI052733, AI152078, HL059842]; Irish Research Council Postgraduate Award [GOIPG/2016/998]; Johns Hopkins University Center for AIDS Research [P30AI094189]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irish Research Council Postgraduate Award(Irish Research Council for Science, Engineering and Technology); Johns Hopkins University Center for AIDS Research	S. A. M. and M. P. W. were supported in part by the National Institutes of Health (NIH) Grant AI007417. E. J. was supported in part by NIH grant AI138953 to 01AI. C. J. C. was funded by Irish Research Council Postgraduate Award GOIPG/2016/998. RJBC was supported by the Johns Hopkins University Center for AIDS Research (P30AI094189). A. C. was supported in part by NIH Grants AI052733 to 16, AI152078 to 01, and HL059842 to 19. This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Lahsen H, 2001, APPL ENVIRON MICROB, V67, P5833, DOI 10.1128/AEM.67.12.5833-5839.2001; Aksenov S I, 1973, Life Sci Space Res, V11, P55; Apar DK, 2008, CHEM BIOCHEM ENG Q, V22, P113; Bryan RA, 2005, EUKARYOT CELL, V4, P465, DOI 10.1128/EC.4.2.465-475.2005; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chemat F, 2011, ULTRASON SONOCHEM, V18, P813, DOI 10.1016/j.ultsonch.2010.11.023; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Cleare W, 1999, MED MYCOL, V37, P235, DOI 10.1046/j.1365-280X.1999.00226.x; COOK W L, 1970, Sabouraudia, V7, P257; Cordero RJB, 2013, EUKARYOT CELL, V12, P1383, DOI 10.1128/EC.00163-13; Cordero RJB, 2013, J IMMUNOL, V190, P317, DOI 10.4049/jimmunol.1202324; Crawford CJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016198118; Crawford CJ, 2020, J BIOL CHEM, V295, P4327, DOI 10.1074/jbc.RA119.012251; Dragotakes Q, 2018, JOVE-J VIS EXP, DOI 10.3791/56957; Fonseca F. L., 2009, EUKARYOT; Frases S, 2008, EUKARYOT CELL, V7, P319, DOI 10.1128/EC.00378-07; Frases S, 2009, P NATL ACAD SCI USA, V106, P1228, DOI 10.1073/pnas.0808995106; Garcia-Rubio R, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02993; Gates MA, 2004, MOL MICROBIOL, V52, P13, DOI 10.1111/j.1365-2958.2003.03957.x; Jalan N, 2013, CARBOHYD POLYM, V96, P365, DOI 10.1016/j.carbpol.2013.03.057; JOERSBO M, 1992, PHYSIOL PLANTARUM, V85, P230, DOI 10.1034/j.1399-3054.1992.850215.x; KOZEL TR, 1977, INFECT IMMUN, V18, P701, DOI 10.1128/IAI.18.3.701-707.1977; Liu D, 2013, INNOV FOOD SCI EMERG, V18, P132, DOI 10.1016/j.ifset.2013.02.006; Makuuchi K, 2010, RADIAT PHYS CHEM, V79, P267, DOI 10.1016/j.radphyschem.2009.10.011; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Maxson ME, 2007, EUKARYOT CELL, V6, P95, DOI 10.1128/EC.00306-06; Maxson ME, 2007, FUNGAL GENET BIOL, V44, P180, DOI 10.1016/j.fgb.2006.07.010; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; MILNER HW, 1950, SCIENCE, V111, P633, DOI 10.1126/science.111.2893.633; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Piccioni M, 2013, INFECT IMMUN, V81, P90, DOI 10.1128/IAI.00553-12; Pierini LM, 2001, MOL MICROBIOL, V41, P105, DOI 10.1046/j.1365-2958.2001.02504.x; Rakesh V, 2008, J PHYS CHEM B, V112, P8514, DOI 10.1021/jp8018205; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Reese AJ, 2007, MOL MICROBIOL, V63, P1385, DOI 10.1111/j.1365-2958.2006.05551.x; Robertson EJ, 2014, J INFECT DIS, V209, P74, DOI 10.1093/infdis/jit435; Rosas AL, 2000, J IMMUNOL METHODS, V244, P69, DOI 10.1016/S0022-1759(00)00255-6; SIMPSON KL, 1963, J BACTERIOL, V86, P1126, DOI 10.1128/JB.86.5.1126-1127.1963; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; VARTIVARIAN SE, 1989, J BACTERIOL, V171, P6850, DOI 10.1128/jb.171.12.6850-6852.1989; Vecchiarelli A, 2013, FUTURE MICROBIOL, V8, P1107, DOI 10.2217/fmb.13.84; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; YASUOKA A, 1994, MICROBIOL IMMUNOL, V38, P851, DOI 10.1111/j.1348-0421.1994.tb02137.x; Zaragoza O, 2003, EUR J IMMUNOL, V33, P1957, DOI 10.1002/eji.200323848; Zaragoza O, 2006, MOL MICROBIOL, V59, P67, DOI 10.1111/j.1365-2958.2005.04928.x; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	49	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101769	10.1016/j.jbc.2022.101769	http://dx.doi.org/10.1016/j.jbc.2022.101769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35218774	Green Submitted, gold, Green Published			2022-12-26	WOS:000793694800001
J	Yu, YB; Li, Y; Peng, HX; Song, QX; Da, XW; Li, H; He, ZH; Ren, X; Xu, CQ; Yao, YF; Wang, QK				Yu, Yubing; Li, Yong; Peng, Huixin; Song, Qixue; Da, Xingwen; Li, Hui; He, Zuhan; Ren, Xiang; Xu, Chengqi; Yao, Yufeng; Wang, Qing K.			Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin alpha 7 on vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; INSIGHTS	Angiogenic factor AGGF1 (AngioGenic factor with G-patch and FHA (Forkhead-Associated) domain 1) blocks neointimal formation (formation of a new or thickened layer of arterial intima) after vascular injury by regulating phenotypic switching of vascular smooth muscle cells (VSMCs). However, the AGGF1 receptor on VSMCs and the underlying molecular mechanisms of its action are unknown. In this study, we used functional analysis of serial AGGF1 deletions to reveal the critical AGGF1 domain involved in VSMC phenotypic switching. This domain was required for VSMC phenotypic switching, proliferation, cell cycle regulation, and migration, as well as the regulation of cell cycle inhibitors cyclin D, p27, and p21. This domain also contains an RDDAPAS motif via which AGGF1 interacts with integrin alpha 7 (ITGA7), but not alpha 8. In addition, we show that AGGF1 enhanced the expression of contractile markers MYH11, alpha-SMA, and SM22 and inhibited MEK1/2, ERK1/2, and ELK phosphorylation in VSMCs, and that these effects were inhibited by knockdown of ITGA7, but not by knockdown of ITGA8. In vivo, deletion of the VSMC phenotypic switching domain in mice with vascular injury inhibited the functions of AGGF1 in upregulating alpha-SMA and SM22, inhibiting MEK1/2, ERK1/2, and ELK phosphorylation, in VSMC proliferation, and in blocking neointimal formation. Finally, we show the inhibitory effect of AGGF1 on neointimal formation was blocked by lentivirus-delivered shRNA targeting ITGA7. Our data demonstrate that AGGF1 interacts with its receptor integrin alpha 7 on VSMCs, and this interaction is required for AGGF1 signaling in VSMCs and for attenuation of neointimal formation after vascular injury.	[Yu, Yubing; Peng, Huixin; Song, Qixue; Da, Xingwen; Li, Hui; He, Zuhan; Ren, Xiang; Xu, Chengqi; Yao, Yufeng; Wang, Qing K.] Huazhong Univ Sci & Technol, Minist Educ, Ctr Human Genome Res, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China; [Yu, Yubing; Peng, Huixin; Song, Qixue; Da, Xingwen; Li, Hui; He, Zuhan; Ren, Xiang; Xu, Chengqi; Yao, Yufeng; Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China; [Li, Yong] Guilin Med Univ, Coll Biotechnol, Guilin, Guangxi, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guilin Medical University	Xu, CQ; Yao, YF; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Ctr Human Genome Res, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China.; Xu, CQ; Yao, YF; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	cqxu@mail.hust.edu.cn; yaoyfeng@hust.edu.cn; qingwang118@qq.com		Xu, Chengqi/0000-0002-4269-6830	National Natural Science Foundation of China [81630002, 82000439]; Fundamental Research Funds for the Central Universities' (HUST) [2172020kfyXJJS116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities' (HUST)(Fundamental Research Funds for the Central Universities)	We thank other members of the Center for Human Genome Research at HUST for their generous help and assistance. This study was supported by the National Natural Science Foundation of China grants 81630002 and 82000439 and the Fundamental Research Funds for the Central Universities' (HUST No. 2172020kfyXJJS116).	Agostoni P, 2006, AM HEART J, V151, P682, DOI 10.1016/j.ahj.2005.05.001; Anderson LL, 2016, AM HEART J, V176, P1, DOI 10.1016/j.ahj.2016.02.017; Callebaut I, 2005, BIOINFORMATICS, V21, P699, DOI 10.1093/bioinformatics/bti065; Chao JT, 2006, AM J PHYSIOL-CELL PH, V290, pC972, DOI 10.1152/ajpcell.00136.2005; Cingi E, 2004, NUCL MED COMMUN, V25, P479, DOI 10.1097/01.mnm.0000123392.39137.b6; Collaborators GMM., 2016, LANCET, V388, P1725, DOI DOI 10.1016/S0140-6736(16)31575-6; Flintoff-Dye NL, 2005, DEV DYNAM, V234, P11, DOI 10.1002/dvdy.20462; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Hsieh MJ, 2018, HEART LUNG CIRC, V27, P588, DOI 10.1016/j.hlc.2017.04.013; Huang Y, 2016, J BIOL CHEM, V291, P11030, DOI 10.1074/jbc.M115.695080; Iaconetti C, 2015, CARDIOVASC RES, V107, P522, DOI 10.1093/cvr/cvv141; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Manninen A, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600022; Martinez-Lemus LA, 2003, J VASC RES, V40, P211, DOI 10.1159/000071886; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rupp PA, 2001, CIRC RES, V89, P566, DOI 10.1161/hh1901.097747; Sanz-Gonzalez SM, 2007, CARDIOVASC RES, V75, P803, DOI 10.1016/j.cardiores.2007.05.002; Si WX, 2021, CANCER LETT, V497, P28, DOI 10.1016/j.canlet.2020.10.014; Song Y, 2016, MOL MED REP, V13, P1147, DOI 10.3892/mmr.2015.4649; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Sun Y, 2017, DRUG DEVELOP RES, V78, P283, DOI 10.1002/ddr.21399; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang JJ, 2021, ARTERIOSCL THROM VAS, V41, P2756, DOI 10.1161/ATVBAHA.121.316867; Welser JV, 2007, CIRC RES, V101, P672, DOI 10.1161/CIRCRESAHA.107.151415; Yao YF, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005889; Zamir E, 2001, J CELL SCI, V114, P3583; Zargham R, 2006, CARDIOVASC RES, V71, P170, DOI 10.1016/j.cardiores.2006.03.003; Zhou BS, 2017, ARTERIOSCL THROM VAS, V37, P675, DOI 10.1161/ATVBAHA.117.308992	30	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101759	10.1016/j.jbc.2022.101759	http://dx.doi.org/10.1016/j.jbc.2022.101759			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35202649	Green Published, gold			2022-12-26	WOS:000823106100006
J	Weber, JPD; Spiro, JE; Scheffler, M; Wolf, J; Nogova, L; Tittgemeyer, M; Maintz, D; Laue, H; Persigehl, T				Weber, Jean-Philip Daniel; Spiro, Judith Eva; Scheffler, Matthias; Wolf, Juergen; Nogova, Lucia; Tittgemeyer, Marc; Maintz, David; Laue, Hendrik; Persigehl, Thorsten			Reproducibility of dynamic contrast enhanced MRI derived transfer coefficient K-trans in lung cancer	PLOS ONE			English	Article							IMAGING BIOMARKER; DCE-MRI; PERFUSION; PARAMETERS; TUMORS; BEVACIZUMAB; VATALANIB; MARKERS; SIZE	Dynamic contrast enhanced MRI (DCE-MRI) is a useful method to monitor therapy assessment in malignancies but must be reliable and comparable for successful clinical use. The aim of this study was to evaluate the inter- and intrarater reproducibility of DCE-MRI in lung cancer. At this IRB approved single centre study 40 patients with lung cancer underwent up to 5 sequential DCE-MRI examinations. DCE-MRI were performed using a 3.0T system. The volume transfer constant K-trans was assessed by three readers using the two-compartment Tofts model. Inter- and intrarater reliability and agreement was calculated by wCV, ICC and their 95% confident intervals. DCE-MRI allowed a quantitative measurement of K-trans in 107 tumors where 91 were primary carcinomas or intrapulmonary metastases and 16 were extrapulmonary metastases. K-trans showed moderate to good interrater reliability in overall measurements (ICC 0.716-0.841; wCV 30.3-38.4%). K-trans in pulmonary lesions >= 3 cm showed a good to excellent reliability (ICC 0.773-0.907; wCV 23.0-29.4%) compared to pulmonary lesions < 3 cm showing a moderate to good reliability (ICC 0.710-0.889; wCV 31.6-48.7%). K-trans in intrapulmonary lesions showed a good reliability (ICC 0.761-0.873; wCV 28.9-37.5%) compared to extrapulmonary lesions with a poor to moderate reliability (ICC 0.018-0.680; wCV 28.1-51.8%). The overall intrarater agreement was moderate to good (ICC 0.607-0.795; wCV 24.6-30.4%). With K-trans, DCE MRI offers a reliable quantitative biomarker for early non-invasive therapy assessment in lung cancer patients, but with a coefficient of variation of up to 48.7% in smaller lung lesions.	[Weber, Jean-Philip Daniel; Maintz, David; Persigehl, Thorsten] Univ Hosp Cologne, Dept Radiol, Cologne, Germany; [Spiro, Judith Eva] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany; [Spiro, Judith Eva] German Ctr Lung Res, Comprehens Pneumol Ctr, Munich, Germany; [Scheffler, Matthias; Wolf, Juergen; Nogova, Lucia] Univ Hosp Cologne, Dept Internal Med 1, Lung Canc Grp, Cologne, Germany; [Tittgemeyer, Marc] Max Planck Inst Metab Res, Cologne, Germany; [Laue, Hendrik] Fraunhofer Inst Digital Med MEVIS, Bremen, Germany	University of Cologne; University of Munich; University of Cologne	Weber, JPD (corresponding author), Univ Hosp Cologne, Dept Radiol, Cologne, Germany.	jean.philip.weber@uk-koeln.de						Braunagel M, 2015, INVEST RADIOL, V50, P57, DOI 10.1097/RLI.0000000000000096; Brown E, 2014, FUTURE ONCOL, V10, P788, DOI 10.2217/fon.13.248; Chang YC, 2012, J MAGN RESON IMAGING, V36, P387, DOI 10.1002/jmri.23660; Chen YF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187824; ClinicalTrials.gov, 2010, NCT01047059 CLINICAL; Conte GM, 2017, RADIOL MED, V122, P294, DOI 10.1007/s11547-016-0720-8; Davenport MS, 2013, J MAGN RESON IMAGING, V38, P329, DOI 10.1002/jmri.23974; DCE MRI Technical Committee, 2012, DCE MRI QUANT PROF Q; de Langen AJ, 2011, J NUCL MED, V52, P48, DOI 10.2967/jnumed.110.078261; Di NN, 2018, J MED IMAG RADIAT ON, V62, P464, DOI 10.1111/1754-9485.12701; Hatzoglou V, 2017, CANCER MED-US, V6, P761, DOI 10.1002/cam4.1046; Heye T, 2013, RADIOLOGY, V266, P801, DOI 10.1148/radiol.12120278; Hotker AM, 2014, J MAGN RESON IMAGING, V40, P715, DOI 10.1002/jmri.24385; Ioannidis GS, 2019, IEEE J BIOMED HEALTH, V23, P1855, DOI 10.1109/JBHI.2018.2888979; Jackson A, 2003, BRIT J RADIOL, V76, P153, DOI 10.1259/bjr/70653746; Jajamovich GH, 2016, MAGN RESON MATER PHY, V29, P49, DOI 10.1007/s10334-015-0513-4; Jiang T, 2013, J HEPATOL, V58, P169, DOI 10.1016/j.jhep.2012.08.022; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Miyazaki K, 2015, EUR RADIOL, V25, P2641, DOI 10.1007/s00330-015-3666-7; Nensa F, 2014, FUTURE ONCOL, V10, P823, DOI [10.2217/fon.13.248, 10.2217/FON.13.248]; Ng CS, 2010, AM J ROENTGENOL, V194, pW134, DOI 10.2214/AJR.09.3116; Niermann KJ, 2007, J ULTRAS MED, V26, P749, DOI 10.7863/jum.2007.26.6.749; O'Connor JPB, 2017, NAT REV CLIN ONCOL, V14, P169, DOI 10.1038/nrclinonc.2016.162; Radiological Society of North America, 2019, QUANT IM BIOM ALL; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tokuda J, 2011, J MAGN RESON IMAGING, V33, P968, DOI 10.1002/jmri.22490; van den Boogaart V, 2007, EJC SUPPL, V5, P34, DOI 10.1016/S1359-6349(08)70092-2; van den Boogaart VEM, 2016, LUNG CANCER, V93, P20, DOI 10.1016/j.lungcan.2015.12.009; Wang HY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001529; Xu J, 2018, CLIN RADIOL, V73, P625, DOI 10.1016/j.crad.2018.02.013	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0265056	10.1371/journal.pone.0265056	http://dx.doi.org/10.1371/journal.pone.0265056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259199	gold, Green Published			2022-12-26	WOS:000835141200041
J	Zingela, Z; Stroud, L; Cronje, J; Fink, M; Van Wyk, S				Zingela, Zukiswa; Stroud, Louise; Cronje, Johan; Fink, Max; Van Wyk, Stephan			A prospective descriptive study on prevalence of catatonia and correlates in an acute mental health unit in Nelson Mandela Bay, South Africa	PLOS ONE			English	Article							POPULATION	Catatonia is a psychomotor abnormality caused by neurological, medical or severe psychiatric disorders and substances. Its prevalence ranges from less than 10% to just above 60%. Diagnosis may be influenced by the screening tools used. Screening of new admissions to a mental health unit for catatonia was undertaken using three instruments to determine prevalence of catatonia. Participants ranged from age 16 years and over. Recruitment took place from September 2020 to August 2021. The setting was a mental health unit within a general hospital in Nelson Mandela Metro, South Africa. Five assessors were trained by the principal investigator to apply the Bush Francis Screening Instrument (BFCSI), the Bush Francis Catatonia Rating Scale (BFCRS), and the Diagnostic and Statistical Manual 5 (DSM-5), to assess participants. Clinical and demographic data were collected using a specially designed datasheet. Data analysis was performed to identify significant associations between presence or absence of catatonia and clinical and demographic data. Up to 241 participants were screened and 44 (18.3%) had catatonia. All 44 cases were identified through the BFCSI while the DSM-5 identified only 16 (6.6%%) of the 44 cases even though the remaining 28 (63.6%) participants still required treatment for catatonic symptoms. The DSM-5 diagnostic criteria excluded staring, which was the commonest sign of catatonia identified through the BFCSI [n = 33 (75%)]. Close to half (21; 47.7%) of those with catatonia on the BFCSI had schizophrenia. The rest had bipolar disorder (12; 27.3%), substance-induced psychotic disorder (7; 15.9%) and no specified diagnosis in one (1; 2.6%). The BFCSI was very effective at identifying catatonia while the DSM-5 was inadequate, missing close to 64% (28 of 44) of cases. Predictors of catatonia in this sample were a younger age and being male. A prevalence of 18.3%, indicates that assessment for catatonia should be routinely conducted in this and similar settings.	[Zingela, Zukiswa; Stroud, Louise; Cronje, Johan] Nelson Mandela Univ, Gqeberha, South Africa; [Fink, Max] SUNY Stony Brook, New York, NY USA; [Van Wyk, Stephan] Walter Sisulu Univ, Dept Psychiat & Human Behav Sci, Mthatha, South Africa; [Van Wyk, Stephan] Nelson Mandela Acad Hosp, Mthatha, South Africa	Nelson Mandela University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Walter Sisulu University; University of Kwazulu Natal	Zingela, Z (corresponding author), Nelson Mandela Univ, Gqeberha, South Africa.	Zukiswa.Zingela@mandela.ac.za		Cronje, Johan/0000-0003-0662-7384	South African Medical Research Council [2017SAMRC0SIR0000157977]; Health and Welfare Sector Education and Training Authority [2018/2019HWSETA219986789]	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health and Welfare Sector Education and Training Authority	ZZ received funding from the South African Medical Research Council (grant tracking number 2017SAMRC0SIR0000157977) and Health and Welfare Sector Education and Training Authority (2018/2019HWSETA219986789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association AP American Psychiatric Association, DIAGNOSTIC STAT MANU; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; [Anonymous], 2004, MENTAL HLTH CARE ACT; [Anonymous], 2011, STAT S AFRICA N MAND; Bhati Mahendra T, 2007, Psychiatry (Edgmont), V4, P46; Bujang MA, 2018, MALAYS J MED SCI, V25, P122, DOI 10.21315/mjms2018.25.4.12; Bush G, 1996, ACTA PSYCHIAT SCAND, V93, P129, DOI 10.1111/j.1600-0447.1996.tb09814.x; Butcher NJ, 2018, AM J MED GENET A, V176, P2146, DOI 10.1002/ajmg.a.38708; Campbell MM, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0313-2; Campbell MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188466; Caroff S.N., 2004, CATATONIA PSYCHOPATH; Carroll BT, 2015, FUTUR NEUROL, V10, P393, DOI 10.2217/fnl.15.36; Department of Health (DoH), 2015, ETH HLTH RES PRINC P; Fink M., 2003, CATATONIA CLIN GUIDE; Frey B., 2018, SAGE ENCY ED RES MEA, DOI 10.4135/9781506326139; Iyengar Siddharth, 2018, BMJ Case Rep, V11, DOI 10.1136/bcr-2018-227175; Krippendorff, 2011, COMPUTING KRIPPENDOR, P43; Mason S, 2006, J MED ETHICS, V32, P61, DOI 10.1136/jme.2005.012302; Mekala H, 2020, CUREUS, V12, DOI 10.7759/cureus.8603; National Department of Health (NDoH) Statistics South Africa (Stats SA) South African Medical Research & Council (SAMRC) & ICF, 2019, S AFR DEM HLTH SURV; Rasmussen SA, 2016, WORLD J PSYCHIATR, V6, P391, DOI 10.5498/wjp.v6.i4.391; Rogers JP, 2021, PSYCHOL MED, DOI 10.1017/S0033291721004402; Rogers JP, 2019, LANCET PSYCHIAT, V6, P620, DOI 10.1016/S2215-0366(19)30190-7; ROSEBUSH PI, 1990, J CLIN PSYCHIAT, V51, P357; Sarkar S, 2016, ASIAN J PSYCHIATR, V23, P27, DOI 10.1016/j.ajp.2016.07.003; Sienaert P, 2011, J AFFECT DISORDERS, V135, P1, DOI 10.1016/j.jad.2011.02.012; Singh P., 2019, IRR VARIOUS COEFFICI; Stuivenga M, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00174; Tandon R, 2013, SCHIZOPHR RES, V150, P26, DOI 10.1016/j.schres.2013.04.034; Walther S, 2019, LANCET PSYCHIAT, V6, P610, DOI 10.1016/S2215-0366(18)30474-7; Wilson JE, 2015, SCHIZOPHR RES, V164, P256, DOI 10.1016/j.schres.2014.12.036; Wortzel JR, 2021, J CLIN PSYCHIAT, V82, DOI 10.4088/JCP.21m14025; Yitayih Yimenu, 2020, Psychiatry J, V2020, P8739546, DOI 10.1155/2020/8739546; Zingela Z, 2021, INT J MENT HEALTH SY, V15, DOI 10.1186/s13033-021-00505-8; Zingela Z, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040176	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264944	10.1371/journal.pone.0264944	http://dx.doi.org/10.1371/journal.pone.0264944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259194	gold, Green Published			2022-12-26	WOS:000835141200031
J	Goody, PR; Nachtsheim, L; Hosen, MR; von Krosigk, M; Christmann, D; Klussmann, JP; Zietzer, A; Breitruck, N; Jansen, F; Jansen, S				Goody, Philip Roger; Nachtsheim, Lisa; Hosen, Mohammed Rabiul; von Krosigk, Miriam; Christmann, Dominik; Klussmann, Jens Peter; Zietzer, Andreas; Breitrueck, Nils; Jansen, Felix; Jansen, Stefanie			Analysis of nocturnal, hypoxia-induced miRNAs in sleep apnea patients	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; PERIPHERAL-BLOOD; EXPRESSION; MICRORNAS; CELLS; ANGIOGENESIS; HYPERTENSION; APOPTOSIS; SIGNATURE; MIR-145	Introduction Obstructive sleep apnea syndrome (OSAS) is associated with an increased cardiovascular risk. The underlying mechanisms are largely unclear. MicroRNAs (miRNAs) are RNAs circulating in the blood that can be released into the bloodstream during hypoxia. In the present study, we investigate if OSAS-induced hypoxia results in a release of miRNAs that may mediate OSAS-associated cardiovascular damage. Methods Blood was sampled from 23 OSAS patients before and after a polygraphically monitored night. Total circulating RNA was isolated from the plasma and quantified using real-time qPCR. Using a Taqman miRNA array, the levels of 384 different miRNAs were compared between evening and morning after polysomnography. The most highly upregulated miRNA (miRNA-505) and four additionally upregulated miRNAs (miRNA-127, miRNA-133a, miRNA-145, and miRNA-181a) were then quantified in a bigger patient cohort individually. Results Apnea/Hypopnea-Index (AHI) was evaluated and averaged at 26 per hour on nocturnal polygraphy. In an initial miRNA array, a total of 4 miRNAs were significantly regulated. A significant increase of miRNA-145 was observed in the larger patient cohort. No significant changes in concentration were detected for miRNA-127, miRNA-133a, miRNA-181a, and miRNA-505 in this larger cohort. Conclusion OSAS results in the nocturnal release of miRNAs into the bloodstream. Our collected data may indicate a hypoxia-induced release of miRNAs into the bloodstream of OSAS-patients. In vitro experiments are needed to confirm the secretion of these miRNAs under hypoxia and evaluate the effect on the cardio vasculature.	[Goody, Philip Roger; Hosen, Mohammed Rabiul; Christmann, Dominik; Zietzer, Andreas; Jansen, Felix] Univ Hosp Bonn, Heart Ctr Bonn, Dept Med 2, Bonn, Germany; [Nachtsheim, Lisa; von Krosigk, Miriam; Klussmann, Jens Peter; Breitrueck, Nils; Jansen, Stefanie] Univ Cologne, Dept Otorhinolaryngol Head & Neck Surg, Cologne, Germany	University of Bonn; University of Cologne	Jansen, S (corresponding author), Univ Cologne, Dept Otorhinolaryngol Head & Neck Surg, Cologne, Germany.	stefanie.jansen@uk-koeln.de			Else-Kroner-Fresenius Foundation [2014_Kolleg.05]; Corona foundation; Deutsche Forschungsgemeinschaft DFG [397484323 -TRR 259]	Else-Kroner-Fresenius Foundation; Corona foundation; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	PRG was funded by the Else-Kroner-Fresenius Foundation (2014_Kolleg.05). FJ was supported by the Corona foundation. PRG and FJ were supported by the Deutsche Forschungsgemeinschaft DFG (Project-ID 397484323 -TRR 259 (Project B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PRG received part of his salary from the Else-Kroner-Fresenius Foundation (2014_Kolleg.05).	Aguado-Fraile E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044305; Bar C, 2019, EPIGENOMICS-UK, V11, P111, DOI 10.2217/epi-2018-0183; Blick C, 2015, BRIT J CANCER, V113, P634, DOI 10.1038/bjc.2015.203; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Colpaert RMW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070737; D'Alessandra Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080345; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Freitas LS, 2020, SLEEP BREATH, V24, P1463, DOI 10.1007/s11325-019-02003-1; Gonzaga C, 2015, J HUM HYPERTENS, V29, P705, DOI 10.1038/jhh.2015.15; Ho Matthew L, 2011, Neurol Int, V3, pe15, DOI 10.4081/ni.2011.e15; Iftikhar H, 2016, BIOESSAYS, V38, P367, DOI 10.1002/bies.201500130; Janaszak-Jasiecka A, 2018, ANGIOGENESIS, V21, P711, DOI 10.1007/s10456-018-9620-y; Khurana S, 2019, BIOMARKERS, V24, P1, DOI 10.1080/1354750X.2018.1514655; Kontaraki JE, 2014, J HUM HYPERTENS, V28, P510, DOI 10.1038/jhh.2013.117; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li AY, 2015, MOL CELL BIOCHEM, V400, P173, DOI 10.1007/s11010-014-2273-2; Marulanda-Londono E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00668; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402; Ozkan G, 2019, J CLIN HYPERTENS, V21, P1724, DOI 10.1111/jch.13704; Redline S, 2011, AM J RESP CRIT CARE, V183, P950, DOI 10.1164/ajrccm.183.7.950a; Santamaria-Martos F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49940-1; Santovito D, 2013, EXPERT OPIN THER TAR, V17, P217, DOI 10.1517/14728222.2013.745512; Santulli G, 2015, ADV EXP MED BIOL, V887, P53, DOI 10.1007/978-3-319-22380-3_4; Slouka D, 2021, BIOMARK MED, V15, P1011, DOI 10.2217/bmm-2020-0826; THORPY MJ, 1990, J CLIN NEUROPHYSIOL, V7, P67, DOI 10.1097/00004691-199001000-00006; Tietjens JR, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010440; Tregear S, 2009, J CLIN SLEEP MED, V5, P573; Valencia-Flores M, 2000, OBES RES, V8, P262, DOI 10.1038/oby.2000.31; Wei YY, 2013, ARTERIOSCL THROM VAS, V33, P449, DOI 10.1161/ATVBAHA.112.300279; Xu XF, 2015, ONCOL REP, V33, P2789, DOI 10.3892/or.2015.3900; Yuan M, 2017, MOL CELL BIOCHEM, V431, P123, DOI 10.1007/s11010-017-2982-4	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0263747	10.1371/journal.pone.0263747	http://dx.doi.org/10.1371/journal.pone.0263747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245292	Green Published, gold			2022-12-26	WOS:000799799100006
J	Olkeba, BK; Mereta, ST; Goethals, PLM; Yewhalaw, D; Debesa, G; Ambelu, A; Ahmednur, M; Boets, P; Masese, FO				Olkeba, Beekam Kebede; Mereta, Seid Tiku; Goethals, Peter L. M.; Yewhalaw, Delenasaw; Debesa, Gemechu; Ambelu, Argaw; Ahmednur, Mahmud; Boets, Pieter; Masese, Frank O.			Habitat preference of blackflies in Omo Gibe river basin (southwest Ethiopia): Implications for onchocerciasis elimination and control	PLOS ONE			English	Article							FLY DIPTERA-SIMULIIDAE; MACROINVERTEBRATE ASSEMBLAGES; HYDROPSYCHE TRICHOPTERA; ATLANTIC FOREST; LARVAE DIPTERA; SMALL STREAMS; LAND-USE; TRANSMISSION; DIVERSITY; PREDATORS	Ecological control of blackflies (Simulium damnosum) can be an alternative or additional tool to enhance onchocerciasis elimination efforts. However, limited research is conducted on the ecology of blackflies in Ethiopia. In this study, we determined the habitat preference of blackfly larvae and their relationship with aquatic macroinvertebrate predators in the Omo Gibe river basin of southwest Ethiopia. Environmental and biological data were collected from 150 sampling sites during both dry and wet seasons in 2019. Generalized Linear Models (GLMs) were used to identify factors affecting the occurrence and abundance of S. damnosum larvae. Canonical Correspondence Analysis (CCA) was used to investigate the relationship between environmental and biological variables and the abundance of S. damnosum larvae. The findings of this study indicated the abundance of S. damnosum larvae increased with increasing turbidity, alkalinity and altitude, but decreased with increasing concentrations of five-day Biological Oxygen Demand (BOD5), orthophosphate and magnesium ion. Both the presence and abundance of S. damnosum larvae decreased with the increasing abundance of stonefly larvae (Perlidae). Simulium damnosum larvae were found less likely in the presence of mayfly larvae (Baetidae) and were less abundant where Chironomidae are abundant. In conclusion, the findings of this study showed that the habitat preference of S. damnosum larvae is determined by environmental factors and that the presence and abundance of the larvae are affected by macroinvertebrate predators. It is essential to establish buffer zones as a part of watershed management to retain pollutants and prevent them from entering directly into water courses to improve water quality and the assemblages of macroinvertebrate predators and enhance biocontrol of blackflies.	[Olkeba, Beekam Kebede; Goethals, Peter L. M.; Boets, Pieter] Univ Ghent, Dept Anim Sci & Aquat Ecol, Ghent, Belgium; [Olkeba, Beekam Kebede; Mereta, Seid Tiku; Ambelu, Argaw; Ahmednur, Mahmud] Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia; [Olkeba, Beekam Kebede] Hawassa Univ, Dept Environm Hlth Sci, Hawassa, Ethiopia; [Yewhalaw, Delenasaw] Jimma Univ, Sch Med Lab Sci, Jimma, Ethiopia; [Yewhalaw, Delenasaw] Jimma Univ, Trop & Infect Dis Res Ctr, Jimma, Ethiopia; [Debesa, Gemechu] Jimma Univ, Dept Geog & Environm Studies, Jimma, Ethiopia; [Boets, Pieter] Prov Ctr Environm Res, Ghent, Belgium	Ghent University; Jimma University; Hawassa University; Jimma University; Jimma University; Jimma University	Olkeba, BK (corresponding author), Univ Ghent, Dept Anim Sci & Aquat Ecol, Ghent, Belgium.; Olkeba, BK (corresponding author), Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia.; Olkeba, BK (corresponding author), Hawassa Univ, Dept Environm Hlth Sci, Hawassa, Ethiopia.	beekamkebede@gmail.com	Masese, Frank/C-1265-2010; Ambelu, Argaw/V-8317-2018; Mereta, Seid Tiku/HIA-0661-2022; Ambelu, Argaw/GQA-6114-2022	Masese, Frank/0000-0002-5912-5049; Ambelu, Argaw/0000-0003-1898-4100; Ambelu, Argaw/0000-0003-1898-4100; Kebede, beekamkebede@gmail.com/0000-0001-5045-2206; Mereta, Seid Tiku/0000-0001-8036-4995	Department of Environmental Health Sciences and Technology, Jimma University	Department of Environmental Health Sciences and Technology, Jimma University	We would like to acknowledge Department of Environmental Health Sciences and Technology, Jimma University, for logistic support. Our gratitude goes to Seyoum Derib and Elias Haile for their support with field and laboratory activities. We are also grateful to the kindness of community of the Omo Giber river basin in southwest Ethiopia for their understanding having allowed us to access sampling sites.	Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Alencar Yamile B., 1999, Anais da Sociedade Entomologica do Brasil, V28, P327, DOI 10.1590/S0301-80591999000200017; ALLAN JD, 1982, ECOLOGY, V63, P26, DOI 10.2307/1937027; Ambelu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112221; [Anonymous], 2008, INTRO R NOTES R PROG; [Anonymous], 2014, GLOB BRIEF VECT BORN; APHA AWWA WPCF, 1995, STANDARD METHODS EXA, V19th; Barbour M.T., 1999, RAPID BIOASSESSMENT, V339; Basanez MG, 2002, AM J TROP MED HYG, V67, P669, DOI 10.4269/ajtmh.2002.67.669; Benzina I., 2019, BIOLOGIA, P1; Bernotiene Rasa, 2006, Acta Entomologica Serbica, V11, P115; Boakye DA, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-20; Bode RW, 1996, QUALITY ASSURANCE WO; Braccia A, 2006, HYDROBIOLOGIA, V573, P55, DOI 10.1007/s10750-006-0257-2; BURTON GJ, 1972, J MED ENTOMOL, V9, P289, DOI 10.1093/jmedent/9.4.289; Carvalho EM, 2010, BRAZ J BIOL, V70, P283, DOI 10.1590/S1519-69842010005000015; Chaemiso SE, 2016, MODEL EARTH SYST ENV, V2, DOI 10.1007/s40808-016-0257-9; Ciborowski JJH, 1997, J N AM BENTHOL SOC, V16, P771, DOI 10.2307/1468170; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Crosskey R. W., 1993, P241; CROSSKEY RW, 1962, B WORLD HEALTH ORGAN, V27, P483; CUPP EW, 1986, SCIENCE, V231, P740, DOI 10.1126/science.3753801; Currie DC, 2018, ZOOTAXA, V4521, P301, DOI 10.11646/zootaxa.4521.3.1; De Haas EM, 2006, J ANIM ECOL, V75, P148, DOI 10.1111/j.1365-2656.2005.01030.x; Degefu MA, 2014, REG ENVIRON CHANGE, V14, P799, DOI 10.1007/s10113-013-0538-z; DeWitt TJ, 2003, J SEA RES, V49, P143, DOI 10.1016/S1385-1101(02)00220-4; Diallo D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-286; Dobson Michael, 2013, Freshwater Reviews, V6, P1, DOI 10.1608/FRJ-6.1.450; Docile TN, 2015, REV BIOL TROP, V63, P683, DOI 10.15517/rbt.v63i3.16195; FAO, 2010, 163 FAO; Federal Ministry of Health (FMOH), 2019, ETH HLTH ACC 2016 20; Feleke SM, 2016, INTERDISCIP PERSPECT, P1; Figueiro R, 2012, MEM I OSWALDO CRUZ, V107, P362, DOI 10.1590/S0074-02762012000300011; FMoH; Ethiopia, 2012, NAT MAST PLAN NEGL T; FULLER RL, 1980, CAN J ZOOL, V58, P2239, DOI 10.1139/z80-306; Gabriels W, 2010, LIMNOLOGICA, V40, P199, DOI 10.1016/j.limno.2009.10.001; Gallardo-Mayenco A., 2002, Limnetica, V21, P47; García-Ríos Raúl, 2020, Ecol. austral, V30, P33, DOI 10.25260/EA.20.30.1.0.995; Gaudreau C, 2011, NORTHEAST NAT, V18, P127, DOI 10.1656/045.018.0201; GebreMichael T, 1996, MED VET ENTOMOL, V10, P44, DOI 10.1111/j.1365-2915.1996.tb00081.x; Gebrezgabiher G, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0567-z; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; Grant W, 2000, PARASITOL TODAY, V16, P458, DOI 10.1016/S0169-4758(00)01804-4; Griffith MB, 2001, ECOL APPL, V11, P489, DOI 10.1890/1051-0761(2001)011[0489:AOMAIR]2.0.CO;2; Hamada N, 1999, HYDROBIOLOGIA, V397, P71, DOI 10.1023/A:1003642430681; HART DD, 1986, OIKOS, V46, P88, DOI 10.2307/3565384; HEMPHILL N, 1988, OECOLOGIA, V77, P73, DOI 10.1007/BF00380928; Hopkins A., 2011, Water and sanitation-related diseases and the environment: challenges, interventions, and preventive measures, P133; Hoverman JT, 2007, OECOLOGIA, V154, P551, DOI 10.1007/s00442-007-0847-3; Jacobsen D, 2003, ARCH HYDROBIOL, V158, P145, DOI 10.1127/0003-9136/2003/0158-0145; Jacobsen D, 2008, OECOLOGIA, V154, P795, DOI 10.1007/s00442-007-0877-x; JENSEN P, 1995, DIS COLON RECTUM, V38, P195, DOI 10.1007/BF02052450; Kamga GR, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1868-8; Katabarwa M, 2008, TROP MED INT HEALTH, V13, P1196, DOI 10.1111/j.1365-3156.2008.02126.x; Klauschies T., 2019, BIORXIV, P535195; Kuhn J, 2011, FRESHWATER BIOL, V56, P2226, DOI 10.1111/j.1365-2427.2011.02648.x; Laird M., 1981, BLACKFLIES FUTURE BI, P399; Lamberton PHL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003688; Leisnham PT, 2012, ECOHEALTH, V9, P217, DOI 10.1007/s10393-012-0773-7; LODGE DM, 1987, AM MALACOL BULL, V5, P73; Malmqvist B, 1999, FRESHWATER BIOL, V42, P301, DOI 10.1046/j.1365-2427.1999.444497.x; McCreadie John W., 2006, Acta Entomologica Serbica, V11, P89; McCreadie JW, 2005, ECOL ENTOMOL, V30, P201, DOI 10.1111/j.0307-6946.2005.00681.x; MCCREADIE JW, 1993, CAN J ZOOL, V71, P358, DOI 10.1139/z93-050; Mebrahtu Y., 1980, Sinet (Addis Ababa), V3, P1; Meribo Kadu, 2017, Ethiop Med J, V55, P55; Merz JE, 2005, RIVER RES APPL, V21, P61, DOI 10.1002/rra.819; MOLYNEUX DH, 1995, PARASITOL TODAY, V11, P399, DOI 10.1016/0169-4758(95)80016-6; Nana-Djeunga HC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002824; Oliveira VC, 2014, BRAZ J BIOL, V74, P267, DOI 10.1590/1519-6984.10512; Opoku AA, 2006, WEST AFR J APPL ECOL, V9; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; Giraldo LP, 2014, REV BIOL TROP, V62, P203, DOI 10.15517/rbt.v62i0.15788; PETERSON B. V., 1960, CANADIAN JOUR ZOOL, V38, P9, DOI 10.1139/z60-002; Pinder L.C.V., 1995, P107; Pion SDS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002084; Pramual P, 2010, ENTOMOL SCI, V13, P17, DOI 10.1111/j.1479-8298.2009.00354.x; Rabha B, 2013, J VECTOR DIS, V50, P18; Ribeiro-Ferreira A, 1996, THESIS INPA FUA MANA, P76; Rivers-Moore NA, 2018, CAN J ZOOL, V96, P614, DOI 10.1139/cjz-2017-0285; SERVICE MW, 1975, ANN TROP MED PARASIT, V69, P105, DOI 10.1080/00034983.1975.11686989; Sieglstetter R, 1997, J FRESHWATER ECOL, V12, P269, DOI 10.1080/02705060.1997.9663534; Srisuka W, 2015, ACTA TROP, V149, P212, DOI 10.1016/j.actatropica.2015.05.024; Taye A, 2000, E AFR MED J, V77, P116; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Upa C, 2018, INT J EDUC RES, V6; Werner D, 2003, MED VET ENTOMOL, V17, P115, DOI 10.1046/j.1365-2915.2003.00431.x; Werner Doreen, 2006, Acta Entomologica Serbica, V11, P131; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; WHO, 2016, ONCH RIV BLINDN; Woodroofe R., 1996, OMO GIBE RIVER BASIN, DOI [10.1016/0197-0186(95)00135-2, DOI 10.1016/0197-0186(95)00135-2]; WORKNEH W, 1993, ACTA TROP, V54, P89, DOI 10.1016/0001-706X(93)90054-F; World Health Organization, 2017, GLOB VECT CONTR RESP; Zuur Alain F., 2009, P1	95	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264750	10.1371/journal.pone.0264750	http://dx.doi.org/10.1371/journal.pone.0264750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245320	gold, Green Published			2022-12-26	WOS:000799799100032
J	Kumar, A; Rajpal, S; Alambusha, R; Sharma, S; Joe, W				Kumar, Abhishek; Rajpal, Sunil; Alambusha, Ruby; Sharma, Smriti; Joe, William			Can Anganwadi services strengthening improve the association between maternal and child dietary diversity? Evidence from Project Spotlight implemented in tribal dominated Gadchiroli and Chandrapur districts of Maharashtra, India	PLOS ONE			English	Article							EVIDENCE-BASED INTERVENTIONS; LOW-INCOME; NUTRITION; BANGLADESH; PREDICTOR; INFANTS	Dietary intake is a fundamental determinant of maternal and child nutrition. This paper presents evidence on whether maternal and child dietary diversity can be improved with systemic improvements focused on strengthening training, capacity building, and behavior change communication among frontline workers to encourage improved nutritional practices among mothers and children in the intervention area. The evidence is derived from Project Spotlight intervention that was jointly implemented by Department of Women and Child Development, Government of Maharashtra and Tata Trusts in tribal dominated Gadchiroli and Chandrapur districts in Maharashtra. Based on a pre-post comparison of baseline (2019) and endline (2021) household survey data it is confirmed that there is a significant association between maternal and child dietary diversity in the study area. Notably, dietary diversity in mother-child dyads is marked with a higher consumption of fruits and vegetables as well as eggs and flesh foods. Econometric analysis further reveals that the association between maternal and child dietary diversity has improved after the systems strengthening interventions. The paper concludes that local interventions such as Project Spotlight for strengthening counselling services and coverage by frontline workers and enhancing knowledge and awareness on maternal and child dietary diversity among communities are important for improving maternal and child nutrition.	[Kumar, Abhishek] Cent Univ Gujarat, Ctr Studies Econ & Planning, Gandhinagar, Gujarat, India; [Rajpal, Sunil] FLAME Univ, Sch Liberal Educ, Lavale, Maharashtra, India; [Alambusha, Ruby; Joe, William] Delhi Univ, Inst Econ Growth, Populat Res Ctr, Enclave North Campus, Delhi, India; [Sharma, Smriti] Tata Trusts, RK Khanna Tennis Stadium, Africa Ave, New Delhi, India	Central University of Gujarat; University of Delhi	Kumar, A (corresponding author), Cent Univ Gujarat, Ctr Studies Econ & Planning, Gandhinagar, Gujarat, India.	abhishekkmr48@gmail.com		, Abhishek/0000-0001-5959-3195	The India Nutrition Initiative, Tata Trusts	The India Nutrition Initiative, Tata Trusts	This study was supported by The India Nutrition Initiative, Tata Trusts. The sponsors had no role in the design and conduct of the study.	Agrawal S, 2019, EUR J CLIN NUTR, V73, P1361, DOI 10.1038/s41430-019-0406-0; Ahmad I, 2018, INDIAN J COMMUN MED, V43, P34, DOI [10.4103/ijcm.IJCM_382_16, 10.4103/ijcm.ijcm_382_16]; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Charmarbagwala R, 2004, DETERMINANTS CHILD H; Chudasama R.K., 2013, ONLINE J HLTH ALLIED, V12; Corsi DJ, 2016, SOC SCI MED, V157, P189, DOI 10.1016/j.socscimed.2016.02.039; Cunningham K, 2021, MATERN CHILD NUTR, V17, DOI 10.1111/mcn.13143; FHI 360/LINKAGES, 2016, MINIMUM DIETARY DIVE; Girard AW, 2012, PAEDIATR PERINAT EP, V26, P191, DOI 10.1111/j.1365-3016.2012.01278.x; Global Panel, 2017, POLICY BRIEF; Hart CN, 2010, CHILD CARE HLTH DEV, V36, P396, DOI 10.1111/j.1365-2214.2010.01072.x; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Joe W, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12830; Kachwaha S., 2021, 14 POSHAN INT FOOD P; Khamis AG, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1897-5; Kim R, 2017, SOC SCI MED, V187, P144, DOI 10.1016/j.socscimed.2017.06.017; Kular S.S, 2014, INT J HUMANITIES SOC, V3, P1; Lee Seung-yeon, 2005, MCN Am J Matern Child Nurs, V30, P60; Marathe S., 2015, J COMMUNITY NUTR HLT, V4, P15; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Mishra V, 2009, ASIAN ECON J, V23, P225, DOI 10.1111/j.1467-8381.2009.02010.x; Mittal N, 2019, J DEV STUD, V55, P2424, DOI 10.1080/00220388.2018.1487054; Moursi MM, 2008, J NUTR, V138, P2448, DOI 10.3945/jn.108.093971; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Nguyen P.H., 2021, J NUTR; Nguyen PH, 2013, J NUTR, V143, P1176, DOI 10.3945/jn.112.172247; Ota E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000032.pub2; Papas MA, 2009, J NUTR EDUC BEHAV, V41, P87, DOI 10.1016/j.jneb.2008.01.005; Rah JH, 2010, EUR J CLIN NUTR, V64, P1393, DOI 10.1038/ejcn.2010.171; Rajpal S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134702; Rajpal S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093197; Ruel MT, 2010, J NUTR, V140, p2048S, DOI 10.3945/jn.110.123695; Schwarzenberg SJ, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3716; Sethi V, 2019, FOOD NUTR BULL, V40, P393, DOI 10.1177/0379572119844142; Vaivada T, 2017, CURR OPIN CLIN NUTR, V20, P204, DOI 10.1097/MCO.0000000000000365; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; WHO, 2014, WHONMHNHD143; World Health Organization, 2010, Indicators for assessing infant and young child feeding practices, part 2: measurement; World Health Organization WHO, 2008, IND ASS INF YOUNG 1	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264567	10.1371/journal.pone.0264567	http://dx.doi.org/10.1371/journal.pone.0264567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239688	gold, Green Published			2022-12-26	WOS:000776002200046
J	Yamai, T; Ikezawa, K; Hiraga, E; Kawamoto, Y; Hirao, T; Higashi, S; Daiku, K; Maeda, S; Abe, Y; Urabe, M; Kai, Y; Takada, R; Nakabori, T; Fukutake, N; Uehara, H; Fujita, M; Ohkawa, K				Yamai, Takuo; Ikezawa, Kenji; Hiraga, Erika; Kawamoto, Yasuharu; Hirao, Takeru; Higashi, Sena; Daiku, Kazuma; Maeda, Shingo; Abe, Yutaro; Urabe, Makiko; Kai, Yugo; Takada, Ryoji; Nakabori, Tasuku; Fukutake, Nobuyasu; Uehara, Hiroyuki; Fujita, Masashi; Ohkawa, Kazuyoshi			Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel	PLOS ONE			English	Article							SURVIVAL; RISK	Background Pancreatic cancer is associated with a high thromboembolism risk. We investigated the significance of early venous thromboembolism (VTE) detection in patients with unresectable metastatic pancreatic cancer (UR-MPC) who received first-line chemotherapy with gemcitabine plus nab-paclitaxel (GnP). Methods This single-center retrospective study enrolled 174 patients with UR-MPC who underwent GnP as a first-line chemotherapy from April 2017 to March 2020. The early detection of VTE (deep venous thrombosis and pulmonary thromboembolism) was defined as diagnosis by the first follow-up CT scan after the initiation of chemotherapy. We compared the patients with early detection of VTE (VTE (+) group) with the others (VTE (-) group). We examined overall survival (OS), progress free survival (PFS), severe adverse events, and predictors associated with OS using the Cox proportional hazards model. Results Early detection of VTE was observed in 17 patients (9.8%). Thirteen patients were diagnosed with VTE at treatment initiation, and four patients were diagnosed after treatment initiation. The median time to diagnosis after treatment initiation was 55 days (range: 31-71 days). Only 3 patients were symptomatic. The VTE (+) group exhibited worse OS and PFS than the VTE (-) group (OS: 259 days vs. 400 days, P < 0.001; PFS: 120 days vs. 162 days, P = 0.008). The frequency of grade 3-4 adverse events was not significantly different. Although the performance status was poorer in the VTE (+) group, VTE was identified as a statistically significant independent predictor for OS in multivariate analyses (HR, 1.87; 95% CI, 1.02-3.44; P = 0.041). Conclusions Early VTE detection is a predictor of a poor prognosis in UR-MPC patients who receive GnP as first-line chemotherapy, suggesting that screening VTE for patients with UR-MPC is crucial, even if patients are asymptomatic.	[Yamai, Takuo; Ikezawa, Kenji; Hiraga, Erika; Kawamoto, Yasuharu; Hirao, Takeru; Higashi, Sena; Daiku, Kazuma; Maeda, Shingo; Abe, Yutaro; Urabe, Makiko; Kai, Yugo; Takada, Ryoji; Nakabori, Tasuku; Fukutake, Nobuyasu; Uehara, Hiroyuki; Ohkawa, Kazuyoshi] Osaka Int Canc Inst, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; [Fujita, Masashi] Osaka Int Canc Inst, Dept Oncocardiol, Osaka, Japan		Ikezawa, K (corresponding author), Osaka Int Canc Inst, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan.	ikezawa-ke@oici.jp		Yamai, Takuo/0000-0002-5448-4763; Ikezawa, Kenji/0000-0001-7517-8960				Blom JW, 2006, J THROMB HAEMOST, V4, P529, DOI 10.1111/j.1538-7836.2006.01804.x; Blomstrand H, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07426-8; Chen JS, 2018, CANCERS, V10, DOI 10.3390/cancers10120501; Chen YG, 2020, INT J MED SCI, V17, P1449, DOI 10.7150/ijms.46254; Epstein AS, 2012, J NATL COMPR CANC NE, V10, P835, DOI 10.6004/jnccn.2012.0087; Faille Dorothee, 2018, Oncotarget, V9, P26453, DOI 10.18632/oncotarget.25458; Farge D, 2019, LANCET ONCOL, V20, pE566, DOI 10.1016/S1470-2045(19)30336-5; Frere C, 2021, WORLD J GASTROENTERO, V27, P2325, DOI 10.3748/wjg.v27.i19.2325; Frere C, 2020, CANCERS, V12, DOI 10.3390/cancers12082028; Frere C, 2020, GASTROENTEROLOGY, V158, P1346, DOI 10.1053/j.gastro.2019.12.009; Fukuda J, 2021, CANCERS, V13, DOI 10.3390/cancers13030502; Gheorghe G, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10110869; Goldstein D, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju413; Ikezawa K, 2021, JGH OPEN, V5, P679, DOI 10.1002/jgh3.12555; Key NS, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.01461; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Khorana AA, 2013, CANCER-AM CANCER SOC, V119, P648, DOI 10.1002/cncr.27772; Kondo Shunsuke, 2018, Oncotarget, V9, P16883, DOI 10.18632/oncotarget.24721; Lee JC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003472; Mandala M, 2007, ANN ONCOL, V18, P1660, DOI 10.1093/annonc/mdm284; Maraveyas A, 2012, EUR J CANCER, V48, P1283, DOI 10.1016/j.ejca.2011.10.017; Okusaka T, 2020, J GASTROENTEROL, V55, P369, DOI 10.1007/s00535-020-01666-y; Pelzer U, 2015, J CLIN ONCOL, V33, P2028, DOI 10.1200/JCO.2014.55.1481; Saad AM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4610-4; Shaib W, 2010, ANTICANCER RES, V30, P4261; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Tempero MA, 2021, J NATL COMPR CANC NE, V19, P439, DOI 10.6004/jnccn.2021.0017; Ueno H, 2016, CANCER CHEMOTH PHARM, V77, P595, DOI 10.1007/s00280-016-2972-3; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264653	10.1371/journal.pone.0264653	http://dx.doi.org/10.1371/journal.pone.0264653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231078	Green Published, gold			2022-12-26	WOS:000849744700033
J	Zhang, XR; Li, YN; Chen, XP; Jin, BH; Shu, CY; Ni, WM; Jiang, YS; Zhang, J; Ma, LJ; Shu, J				Zhang, Xirong; Li, Yini; Chen, Xiaopan; Jin, Bihui; Shu, Chongyi; Ni, Wanmao; Jiang, Yinshen; Zhang, Jing; Ma, Lijia; Shu, Jing			Single-cell transcriptome analysis uncovers the molecular and cellular characteristics of thin endometrium	FASEB JOURNAL			English	Article						infertility; single-cell RNA sequencing; thin endometrium; transcriptome	IN-VITRO FERTILIZATION; EMBRYO-TRANSFER; IMPLANTATION; THICKNESS; DECIDUALIZATION; PROGESTERONE; PREGNANCY; ADHESION; ANGIOGENESIS; RECEPTIVITY	Infertility is a social and medical problem around the world and the incidence continues to rise. Thin endometrium (TE) is a great challenge of infertility treatment, even by in vitro fertilization and embryo transfer. It is widely believed that TE impairs endometrium receptivity. However, only a few studies have explained the molecular mechanism. Herein, in order to reveal the possible mechanism, we sampled endometrium from a TE patient and a control volunteer and got a transcriptomic atlas of 18 775 individual cells which was constructed using single-cell RNA sequencing, and seven cell types have been identified. The cells were acquired during proliferative and secretory phases, respectively. The proportion of epithelial cells and stromal cells showed a significant difference between the TE group and the control group. In addition, differential expressed genes (DEGs) in diverse cell types were revealed, the enriched pathways of DEGs were found closely related to the protein synthesis in TE of both proliferative and secretory phases. Some DEGs can influence cell-type ratio and impaired endometrial receptivity in TE. Furthermore, divergent expression of estrogen receptors 1 and progesterone receptors in stromal and epithelial cells were compared in the TE sample from the control. The cellular and molecular heterogeneity found in this study provided valuable information for disclosing the mechanisms of impaired receptivity in TE.	[Zhang, Xirong; Shu, Jing] Qingdao Univ, Qingdao Med Coll, Dept Obstet & Gynecol, Qingdao, Peoples R China; [Zhang, Xirong; Chen, Xiaopan; Jin, Bihui; Shu, Chongyi; Jiang, Yinshen; Zhang, Jing; Shu, Jing] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Ctr Reprod Med,Dept Reprod Endo, Hangzhou, Peoples R China; [Li, Yini; Ma, Lijia] Westlake Univ, Sch Life Sci, Hangzhou 310014, Peoples R China; [Ni, Wanmao] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Canc Ctr,Key Lab Tumor Mol Diag & Individualized, Hangzhou, Peoples R China; [Chen, Xiaopan] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Genet & Genom Med, Hangzhou, Peoples R China; [Zhang, Jing] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Obstet, Hangzhou, Peoples R China	Qingdao University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Westlake University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Hangzhou Medical College; Zhejiang Provincial People's Hospital	Ma, LJ (corresponding author), Westlake Univ, Sch Life Sci, Hangzhou 310014, Peoples R China.; Shu, J (corresponding author), Qingdao Univ, Qingdao Med Coll, Qingdao 266073, Shangdong, Peoples R China.	malijia@westlake.edu.cn; shujing@hmc.edu.cn	Shu, Jing/G-1204-2013	Shu, Jing/0000-0003-0398-2188; Zhang, Xirong/0000-0002-9461-9191	Research Program of Medicine and Health of Zhejiang Province [2020KY414, 2020KY448]; Zhejiang Provincial Key Laboratory for Precision Diagnoais & Treatment of Major Gynecological Diseases,Hangzhou, Zhejiang Province, P.R. China, Woman's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, P.R. China [ZDFY2021-MGD/RH-0001]; Bethune Foundation for Women's Health Research Project [X-J-2019-024]; Zhejiang Provincal People's Hospital [ZRY2019B002]	Research Program of Medicine and Health of Zhejiang Province; Zhejiang Provincial Key Laboratory for Precision Diagnoais & Treatment of Major Gynecological Diseases,Hangzhou, Zhejiang Province, P.R. China, Woman's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, P.R. China; Bethune Foundation for Women's Health Research Project; Zhejiang Provincal People's Hospital	Research Program of Medicine and Health of Zhejiang Province, Grant/ Award Number: 2020KY414 to J.S. and 2020KY448 to X.C.; Zhejiang Provincial Key Laboratory for Precision Diagnoais & Treatment of Major Gynecological Diseases,Hangzhou, Zhejiang Province, P.R. China, Woman's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, P.R. China, Grant/ Award Number: ZDFY2021--MGD/RH-0001; Bethune Foundation for Women's Health Research Project, Grant/ Award Number: X-J-2019-024; The initial funding of scientific research for excellent young people of Zhejiang Provincal People's Hospital, Grant/ Award Number: ZRY2019B002	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Alfer J, 2017, GEBURTSH FRAUENHEILK, V77, P756, DOI 10.1055/s-0043-111899; Aplin JD., 2008, FEMALE SEX STEROID H; Beier HM, 1998, HUM REPROD UPDATE, V4, P448, DOI 10.1093/humupd/4.5.448; Bolnick AD, 2016, HUM REPROD, V31, P2042, DOI 10.1093/humrep/dew143; Bourgain C, 2003, HUM REPROD UPDATE, V9, P515, DOI 10.1093/humupd/dmg045; Cui N, 2019, J ENDOCRINOL INVEST, V42, P27, DOI 10.1007/s40618-018-0877-1; Davie K, 2018, CELL, V174, P982, DOI 10.1016/j.cell.2018.05.057; De Geyter C, 2000, FERTIL STERIL, V73, P106, DOI 10.1016/S0015-0282(99)00484-7; Dehbashi S, 2003, INT J GYNECOL OBSTET, V80, P49, DOI 10.1016/S0020-7292(02)00341-7; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Di Palma T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.262; Dietterich C, 2002, FERTIL STERIL, V77, P781, DOI 10.1016/S0015-0282(01)03276-9; Eftekhar M, 2018, TAIWAN J OBSTET GYNE, V57, P810, DOI 10.1016/j.tjog.2018.10.007; Elgueta R, 2016, J IMMUNOL, V197, P3970, DOI 10.4049/jimmunol.1501859; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Gao MX, 2019, GYNECOL ENDOCRINOL, V35, P544, DOI 10.1080/09513590.2018.1554035; Garcia-Alonso L, 2021, NAT GENET, V53, P1698, DOI 10.1038/s41588-021-00972-2; Halari CD, 2020, MOL HUM REPROD, V26, P784, DOI 10.1093/molehr/gaaa058; Harraz M, 2001, STEM CELLS, V19, P304, DOI 10.1634/stemcells.19-4-304; Heger A, 2012, GEBURTSH FRAUENHEILK, V72, P710, DOI 10.1055/s-0032-1315059; Hu X, 2021, J ENDOCRINOL INVEST, V44, P1609, DOI 10.1007/s40618-020-01455-7; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; Jin XY, 2017, HUM REPROD, V32, P2394, DOI 10.1093/humrep/dex312; Kemp SB, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000935; Kovacs P, 2003, HUM REPROD, V18, P2337, DOI 10.1093/humrep/deg461; Kumar V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01764-7; Ledee-Bataille N, 2002, HUM REPROD, V17, P213, DOI 10.1093/humrep/17.1.213; Li MY, 2020, EXP CELL RES, V394, DOI 10.1016/j.yexcr.2020.112153; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Lip GYH, 1997, CARDIOVASC RES, V34, P255, DOI 10.1016/S0008-6363(97)00039-4; Maekawa R, 2017, REPROD MED BIOL, V16, P206, DOI 10.1002/rmb2.12030; Meng FY, 2018, FERTIL STERIL, V109, P165, DOI 10.1016/j.fertnstert.2017.10.005; Miwa I, 2009, FERTIL STERIL, V91, P998, DOI 10.1016/j.fertnstert.2008.01.029; MOINGEON P, 1989, NATURE, V339, P312, DOI 10.1038/339312a0; Niederberger C, 2018, FERTIL STERIL, V110, P185, DOI 10.1016/j.fertnstert.2018.06.005; Okada H, 2014, J OBSTET GYNAECOL RE, V40, P1180, DOI 10.1111/jog.12392; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Sharma S, 2014, FERTIL STERIL, V102, pE130, DOI 10.1016/j.fertnstert.2014.07.447; Sharma Sunita, 2018, J Hum Reprod Sci, V11, P34, DOI [10.4103/jhrs.JHRS_9_17, 10.4103/jhrs.jhrs_9_17]; Shimomura Y, 2006, MOL HUM REPROD, V12, P491, DOI 10.1093/molehr/gal019; Simon C, 1998, J REPROD IMMUNOL, V39, P117, DOI 10.1016/S0165-0378(98)00017-5; Stoeckelhuber M, 2006, HISTOCHEM CELL BIOL, V126, P103, DOI 10.1007/s00418-005-0137-2; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Tong W, 1999, MOL CELL BIOL, V19, P2251; Vaegter KK, 2017, FERTIL STERIL, V107, P641, DOI 10.1016/j.fertnstert.2016.12.005; Wang J, 2002, CELLS TISSUES ORGANS, V172, P190, DOI 10.1159/000066970; Wang W, 2018, FERTIL STERIL, V110, pE2, DOI 10.1016/j.fertnstert.2018.07.027; Wang WX, 2020, NAT MED, V26, P1644, DOI 10.1038/s41591-020-1040-z; Wetendorf M, 2012, MOL CELL ENDOCRINOL, V357, P108, DOI 10.1016/j.mce.2011.10.028; Wu FR, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0379-1; Ye Ming-Xia, 2017, Nan Fang Yi Ke Da Xue Xue Bao, V37, P575; Yi KW, 2019, BIOL REPROD, V100, P61, DOI 10.1093/biolre/ioy175; Yuan X, 2016, REPROD BIOMED ONLINE, V33, P197, DOI 10.1016/j.rbmo.2016.05.002; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zhou Y, 2020, CANCER CELL, V38, P818, DOI 10.1016/j.ccell.2020.09.015; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	59	2	2	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22193	10.1096/fj.202101579R	http://dx.doi.org/10.1096/fj.202101579R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35201635	hybrid			2022-12-26	WOS:000761250800001
J	Nurnberger, P; von Lewinski, D; Rothenhausler, HB; Braun, C; Reinbacher, P; Kolesnik, E; Baranyi, A				Nuernberger, Patrick; von Lewinski, Dirk; Rothenhaeusler, Hans-Bernd; Braun, Celine; Reinbacher, Patrick; Kolesnik, Ewald; Baranyi, Andreas			A biopsychosocial model of severe fear of COVID-19	PLOS ONE			English	Article							GENDER-DIFFERENCES; ANXIETY DISORDERS; PREVALENCE; OUTBREAK	Introduction COVID-19 is a respiratory infection that causes not only somatic health issues, but also frequently psychosocial burdens. The aims of this study were to investigate biopsychosocial factors that might further aggravate fear of COVID-19, and to establish a biopsychosocial model of severe fear of COVID-19. Methods 368 participants were included in this study. Biopsychosocial factors observed comprised biological factors (somatic risk), psychological factors (state/trait anxiety, physical symptoms of anxiety, severe health anxiety, specific phobias, depression), and psychosocial factors (social support, financial losses, social media consumption, social contacts with COVID-19 infected people). Psychometric questionnaires included State-Trait Anxiety Inventory, Beck's Anxiety Inventory, Whiteley-Index / Illness Attitude Scales, Specific Phobia Questionnaire, WHO-5 and Social Support Survey. Results 162/368 (44.0%) participants had almost no fear, 170/368 (46.2%) participants had moderate fear, and 45/368 (12.2%) participants had severe fear of COVID-19. Female participants showed higher levels of fear of COVID-19 than male participants (gender: chi 2 = 18.47, p<0.001). However, the level of fear of COVID-19 increased in male participants when they had contact with people who were infected with COVID-19, while in contrast the level of fear of COVID-19 decreased in female participants when they had such contacts [ANCOVA: fear of COVID-19 (contact x gender): F(1,363) = 5.596, p = .019]. Moreover, participants without relationships showed higher levels of fear of COVID-19 (marital status: chi 2 = 14.582, p = 0.024). Furthermore, financial losses due to the COVID-19 were associated with higher levels of fear of COVID-19 [ANCOVA: fear of COVID-19(financial loss x gender): F(1, 363) = 22.853, p< .001]. Multiple regression analysis revealed female gender, severe health anxiety (WI-IAS) and state /trait anxiety (STAI) as significant predictors of severe fear of COVID-19. Conclusion In this study significant predictors of severe fear of COVID-19 were female gender, pre-existing state and trait anxiety, as well as severe health anxiety. The finding of significant predictors of fear of COVID-19 might contribute to detect people who might suffer most from severe, overwhelming fear of COVID-19 at an early stage.	[Nuernberger, Patrick; Rothenhaeusler, Hans-Bernd; Braun, Celine; Baranyi, Andreas] Med Univ Graz, Dept Psychiat & Psychotherapeut Med, Graz, Austria; [von Lewinski, Dirk; Kolesnik, Ewald] Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria; [Reinbacher, Patrick] Med Univ Graz, Dept Orthopaed & Traumatol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Nurnberger, P (corresponding author), Med Univ Graz, Dept Psychiat & Psychotherapeut Med, Graz, Austria.	patrick.nurnberger@gmail.com		Kolesnik, Ewald/0000-0002-9349-8068; Baranyi, Andreas/0000-0003-2389-1945; Braun, Celine/0000-0001-6964-8938; Nurnberger, Patrick/0000-0001-9827-3856				Alnazly E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247679; Apuke OD, 2021, TELEMAT INFORM, V56, DOI 10.1016/j.tele.2020.101475; Bahrami F, 2011, IRAN J PSYCHIATRY BE, V5, P83; Bueno-Notivol J, 2021, INT J CLIN HLTH PSYC, V21, DOI 10.1016/j.ijchp.2020.07.007; Bugger H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239801; Craske M., 2013, SEVERITY MEASURE SPE; D. M.Greenberg, 2020, medRxiv, DOI 10.1101/2020.09.15.20195339; Dong L, 2020, EMERG INFECT DIS, V26, P1616, DOI 10.3201/eid2607.200407; Du JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/24240; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; González-Padilla Daniel A., 2020, Int. braz j urol., V46, P120, DOI [10.1590/s1677-5538.ibju.2020.s121, 10.1590/S1677-5538.IBJU.2020.S121]; Hiller W RW., 2004, INT SKALEN FR HYPOCH; Hossain Md Mahbub, 2020, F1000Res, V9, P636, DOI 10.12688/f1000research.24457.1; Kocak O, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041836; Li XJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/19684; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Metzler B, 2020, EUR HEART J, V41, P1852, DOI 10.1093/eurheartj/ehaa314; Mukherjee S, 2021, J NEUROIMMUNE PHARM, V16, P38, DOI 10.1007/s11481-020-09974-z; Nkire N, 2021, IRISH J PSYCHOL MED, DOI 10.1017/ipm.2021.1; Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008; Ovanessian M.M., 2019, PSYCHOMETRIC PROPERT; Papadimitriou G, 2017, Psychiatriki, V28, P107, DOI 10.22365/jpsych.2017.282.107; Pesce L, 2016, EPIDEMIOL PSYCH SCI, V25, P278, DOI 10.1017/S2045796015000414; Saraswathi I, 2020, PEERJ, V8, DOI 10.7717/peerj.10164; Sherbourne C.D., 1991, MOS SOCIAL SUPPORT S; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Steer R.A., 1997, BECK ANXIETY INVENTO; Topp C.W., 2015, WHO 5 WELL BEING IND; Vanhaecht K, 2021, INT J QUAL HEALTH C, V33, DOI 10.1093/intqhc/mzaa158; Varatharaj Aravinthan, 2020, Lancet Psychiatry, V7, P875, DOI 10.1016/S2215-0366(20)30287-X; Warner V, 2008, PSYCHOL MED, V38, P1543, DOI 10.1017/S0033291708002894; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	33	0	0	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264357	10.1371/journal.pone.0264357	http://dx.doi.org/10.1371/journal.pone.0264357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226661	gold, Green Published			2022-12-26	WOS:000793394000018
J	Chakraborty, S; Rai, RK; Biswas, AK; Barik, A; Gurung, P; Praveen, D				Chakraborty, Sandipta; Rai, Rajesh Kumar; Biswas, Asit Kumar; Barik, Anamitra; Gurung, Preeti; Praveen, Devarsetty			Health care seeking behaviour and financial protection of patients with hypertension: A cross-sectional study in rural West Bengal, India	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; AWARENESS; PREVALENCE; COMMUNITIES	Background Elevated blood pressure or hypertension is responsible for around 10 million annual deaths globally, and people residing in low and middle-income countries are disproportionately affected by it. India is no exception, where low rate of treatment seeking for hypertension coupled with widespread out-of-pocket payments (OOPs) have been a challenge. This study assessed the pattern of health care seeking behaviour and financial protection along with the associated factors among hypertensive individuals in rural West Bengal, India. Method and findings A cross-sectional study was conducted in Birbhum district of the state of West Bengal, India, during 2017-2018, where 300 individuals were recruited randomly from a list of hypertensives in a population cohort. Healthcare seeking for hypertension and related financial protection in terms of-OOPs and expenses relative to monthly per-capita family expenditure, were analysed. Findings indicated that 47% of hypertensives were not on treatment. Among those under treatment, 80% preferred non-public facilities, and 91% of them had widespread OOPs. Cost of medication was a major share of expenses followed by transportation cost to access public health care facility. Multivariable logistic regression analysis indicated longer duration of disease (adjusted odds ratio (aOR): 5.68, 95% Confidence Interval (CI) 1.24-25.99) and health care seeking from non-public establishment (aOR: 34.33, CI: 4.82-244.68) were associated with more incident of OOPs. Linear regression with generalized linear model revealed presence of co-morbidities (adjusted coefficient (aCoeff) 10.28, CI: 4.96,15.61) and poorer economic groups (aCoeff(poorest) 11.27, CI 3.82,18.71; aCoeff(lower-middle )7.83, CI 0.65,15.00 and aCoeff(upper-middle) 7.25, CI: 0.80,13.70) had higher relative expenditure. Conclusion This study suggests that individuals with hypertension had poor health care seeking behaviour, preferred non-public health facilities and had suboptimal financial protection. Economically poorer individuals had higher burden of health expenditure for treatment of hypertension, which indicated gaps in equitable health care delivery for the control of hypertension.	[Chakraborty, Sandipta; Biswas, Asit Kumar] Inst Publ Hlth, Kalyani, W Bengal, India; [Chakraborty, Sandipta] All India Inst Hyg & Publ Hlth, Dept Prevent & Social Med, Kolkata, W Bengal, India; [Rai, Rajesh Kumar; Barik, Anamitra] Soc Hlth & Demog Surveillance, Suri, W Bengal, India; [Rai, Rajesh Kumar] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Rai, Rajesh Kumar] Univ Goettingen, Dept Econ, Gottingen, Germany; [Rai, Rajesh Kumar] Univ Goettingen, Ctr Modern Indian Studies, Gottingen, Germany; [Barik, Anamitra] Suri Dist Hosp, Suri, W Bengal, India; [Gurung, Preeti] Medecins Sans Frontieres, Churachandpur, Manipur, India; [Praveen, Devarsetty] George Inst Global Hlth, Primary Hlth Care Res, Hyderabad, Telangana, India; [Praveen, Devarsetty] Univ New South Wales, Fac Med, Kensington, NSW, Australia; [Praveen, Devarsetty] Manipal Acad Higher Educ, Prasanna Sch Publ Hlth, Manipal, Karnataka, India	Harvard University; Harvard T.H. Chan School of Public Health; University of Gottingen; University of Gottingen; University of New South Wales Sydney; Manipal Academy of Higher Education (MAHE)	Rai, RK (corresponding author), Soc Hlth & Demog Surveillance, Suri, W Bengal, India.; Rai, RK (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.; Rai, RK (corresponding author), Univ Goettingen, Dept Econ, Gottingen, Germany.; Rai, RK (corresponding author), Univ Goettingen, Ctr Modern Indian Studies, Gottingen, Germany.	rajesh.iips28@gmail.com	; Praveen, Devarsetty/K-8729-2014	Chakraborty, Sandipta/0000-0003-3843-8035; Praveen, Devarsetty/0000-0002-0973-943X; Rai, Rajesh Kumar/0000-0002-5249-9937	Department of Health and Family Welfare, Government of West Bengal, India; Open Access Publication Funds of the University of Goettingen, Goettingen, Germany	Department of Health and Family Welfare, Government of West Bengal, India; Open Access Publication Funds of the University of Goettingen, Goettingen, Germany	This study was supported by the Department of Health and Family Welfare, Government of West Bengal, India in the form of a fellowship to SC. This study was also supported by the Open Access Publication Funds of the University of Goettingen, Goettingen, Germany in the form of funds to RKR. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alshamsan R, 2017, J ROY SOC MED, V110, P365, DOI 10.1177/0141076817724599; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; Baker R. P., 1992, Social Science Computer Review, V10, P145; Baliga SS, 2013, COMMUNITY MED, V4, P227; Bhojani U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-990; Bovet P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-407; Brinda EM, 2015, J EPIDEMIOL COMMUN H, V69, P489, DOI 10.1136/jech-2014-204960; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Das J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7384; Directorate General of Health Services; Ministry of Health & Family Welfare Government of India, NATL PROGRAMME PREVE; Engelgau MM, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-9; Feng XL, 2014, B WORLD HEALTH ORGAN, V92, P29, DOI 10.2471/BLT.13.124495; Ghosh S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010085; Ghosh S, 2015, INT J EPIDEMIOL, V44, P98, DOI 10.1093/ije/dyu228; Glymour MM., 2016, CAUSAL DIAGRAMS, V3 ed, P183; Gupta R, 2019, J HUM HYPERTENS, V33, P575, DOI 10.1038/s41371-018-0117-3; Habib SH, 2010, DIABETES METAB SYND, V4, P41, DOI 10.1016/j.dsx.2008.04.005; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Indian Council of Medical Research; Public Health Foundation of India and Institute for Health Metrics and Evaluation, 2017, INDIA HLTH NATIONS S, V2017; Institute for Health Metrics and Evaluation (IHME), 2019, GBD INDIA COMPARE; Irazola VE, 2016, GLOB HEART, V11, P47, DOI 10.1016/j.gheart.2015.12.008; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Kanungo S, 2017, J HUM HYPERTENS, V31, P56, DOI 10.1038/jhh.2016.30; Kaur P, 2012, INT J PUBLIC HEALTH, V57, P87, DOI 10.1007/s00038-011-0303-3; Matsaganis M, 2009, EUR J HEALTH ECON, V10, P329, DOI 10.1007/s10198-008-0137-y; Ministry of Health & Family Welfare GoI, NATL HLTH POLICY 201; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; Singh AK, 2014, INDIAN J MED SPEC, V5, P7, DOI 10.7713/ijms.2013.0051; Tocci G, 2015, J HUM HYPERTENS, V29, P696, DOI 10.1038/jhh.2015.4; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116897; World Health Organization, HYP 2021; World Health Organization, 2011, IMPACT OUT OF POCKET; World Health Organization, TOP 10 CAUS DEATH 20	38	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264314	10.1371/journal.pone.0264314	http://dx.doi.org/10.1371/journal.pone.0264314			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213621	Green Published, gold			2022-12-26	WOS:000787811000075
J	Jiang, JP; Huo, J; Zhang, YY; Xu, YL; Zhao, CJ; Miao, JH				Jiang, Jianping; Huo, Juan; Zhang, Yueyun; Xu, Yongli; Zhao, Chengjian; Miao, Jianhua			SMRT sequencing of the full-length transcriptome of Gekko gecko	PLOS ONE			English	Article							GENERATION; EXPRESSION; DATABASE; GENOME	Tokay Gecko (Gekko gecko) is a rare and endangered medicinal animal in China. Its dry body has been used as an anti-asthmatic agent for two thousand years. To date, the genome and transcriptome of this species remain poorly understood. Here, we adopted single molecule real-time (SMRT) sequencing to obtain full-length transcriptome data and characterized the transcriptome structure. We identified 882,273 circular consensus (CCS) reads, including 746,317 full-length nonchimeric (FLNC) reads. The transcript cluster analysis revealed 212,964 consensus sequences, including 203,994 high-quality isoforms. In total, 111,372 of 117,888 transcripts were successfully annotated against eight databases (Nr, eggNOG, Swiss-Prot, GO, COG, KOG, Pfam and KEGG). Furthermore, 23,877 alternative splicing events, 169,128 simple sequence repeats (SSRs), 10,437 IncRNAs and 7,932 transcription factors were predicted across all transcripts. To our knowledge, this report is the first to document the G. gecko transcriptome using SMRT sequencing. The full-length transcript data might accelerate transcriptome research and lay the foundation for further research on G. gecko.	[Jiang, Jianping; Huo, Juan; Zhang, Yueyun; Xu, Yongli; Zhao, Chengjian; Miao, Jianhua] Guangxi Bot Garden Med Plants, Nanning, Guangxi, Peoples R China		Jiang, JP; Miao, JH (corresponding author), Guangxi Bot Garden Med Plants, Nanning, Guangxi, Peoples R China.	jiangjianping818@126.com; mjh1962@vip.163.com			Scientific Research Funding Project of Guangxi Botanical Garden of Medicinal Plants [202007]; Science and Technology Major Project of Guangxi [AA18242040]; National Natural Science Foundation of China [81660724]; Innovation Team for Guangxi Botanical Garden of Medicinal Plants [2019009]; Guangxi Natural Science Foundation [2018GXNSFAA29400]	Scientific Research Funding Project of Guangxi Botanical Garden of Medicinal Plants; Science and Technology Major Project of Guangxi; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team for Guangxi Botanical Garden of Medicinal Plants; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	Our work was supported by Scientific Research Funding Project of Guangxi Botanical Garden of Medicinal Plants [202007], Science and Technology Major Project of Guangxi [AA18242040]; National Natural Science Foundation of China [81660724]; Innovation Team for Guangxi Botanical Garden of Medicinal Plants [2019009]; and Guangxi Natural Science Foundation [2018GXNSFAA29400].	Abdel-Ghany SE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11706; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arslan M, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5886-8; Bao YY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-160; Chen J, 2020, PEERJ, V8, DOI 10.7717/peerj.9320; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Fang S, 2020, EXP CELL RES, V388, DOI 10.1016/j.yexcr.2019.111812; Feng K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73075-3; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gonzalez-Castellano I, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6157-4; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Guo W, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174084; Lino-Lopez GJ, 2020, TOXICON, V180, P62, DOI 10.1016/j.toxicon.2020.04.003; Jia XP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63814-x; Jianping Jiang., 2019, GENES-BASEL, V10; Joung J, 2017, NATURE, V548, P343, DOI 10.1038/nature23451; Karagianni P, 2015, BBA-MOL CELL BIOL L, V1851, P2, DOI 10.1016/j.bbalip.2014.05.001; Kingan SB, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010062; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Li H., 1996, J GUANGXI NORM U NAT, V2, P64; Li TC, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135767; Liao C., 2014, CHINESE TRADITIONAL; Liguo Wang., 2013, NUCLEIC ACIDS RES; Lou FR, 2020, INT J BIOL MACROMOL, V147, P89, DOI 10.1016/j.ijbiomac.2020.01.029; Luo H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66582-w; Qin XM, 2011, MITOCHONDR DNA, V22, P176, DOI 10.3109/19401736.2011.636440; Shi KP, 2019, COMP BIOCHEM PHYS D, V30, P169, DOI 10.1016/j.cbd.2018.12.011; Stadermann KB, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0726-6; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Wang G., 2017, ACTA CHINESE MED; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang L, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw004; You Q, 2009, MOL MED REP, V2, P573, DOI 10.3892/mmr_00000139; Zang H., 2016, JILIN J TRADITIONAL; Zhang HM, 2015, NUCLEIC ACIDS RES, V43, pD76, DOI 10.1093/nar/gku887; Zhang H, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-06894-3; Zhu SJ, 2018, GENOME RES, V28, P1067, DOI 10.1101/gr.231068.117; Zou JM., 2003, CHIN TRADIT HERB DRU	41	0	0	13	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264499	10.1371/journal.pone.026449r	http://dx.doi.org/10.1371/journal.pone.026449r			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213661				2022-12-26	WOS:000787811000109
J	Alhakamy, NA; Okbazghi, SZ; Alfaleh, MA; Abdulaal, WH; Bakhaidar, RB; Alselami, MO; Al Zahrani, M; Alqarni, HM; Alghaith, AF; Alshehri, S; Badr-Eldin, SM; Aldawsari, HM; Al-hejaili, OD; Aldhabi, BM; Mahdi, WA				Alhakamy, Nabil A.; Okbazghi, Solomon Z.; Alfaleh, Mohamed A.; Abdulaal, Wesam H.; Bakhaidar, Rana B.; Alselami, Mohammed O.; Al Zahrani, Majed; Alqarni, Hani M.; Alghaith, Adel F.; Alshehri, Sultan; Badr-Eldin, Shaimaa M.; Aldawsari, Hibah M.; Al-hejaili, Omar D.; Aldhabi, Bander M.; Mahdi, Wael A.			Wasp venom peptide improves the proapoptotic activity of alendronate sodium in A549 lung cancer cells	PLOS ONE			English	Article							ORAL BISPHOSPHONATES; CYCLE ARREST; CHEMOTHERAPY; NANOPARTICLES; THYMOQUINONE; APOPTOSIS; DELIVERY; EPIDEMIOLOGY; FORMULATION; LIPOSOMES	Background Lung cancer in men and women is considered the leading cause for cancer-related mortality worldwide. Anti-cancer peptides represent a potential untapped reservoir of effective cancer therapy. Methodology Box-Behnken response surface design was applied for formulating Alendronate sodium (ALS)-mastoparan peptide (MP) nanoconjugates using Design-Expert software. The optimization process aimed at minimizing the size of the prepared ALS-MP nanoconjugates. ALS-MP nanoconjugates' particle size, encapsulation efficiency and the release profile were determined. Cytotoxicity, cell cycle, annexin V staining and caspase 3 analyses on A549 cells were carried out for the optimized formula. Results The results revealed that the optimized formula was of 134.915.1 nm particle size. The novel ALS-MP demonstrated the lowest IC50 (1.3 +/- 0.34 mu M) in comparison to ALS-Raw (37.6 +/- 1.79 mu M). Thus, the results indicated that when optimized ALS-MP nanoconjugate was used, the IC50 of ALS was also reduced by half. Cell cycle analysis demonstrated a significantly higher percentage of cells in the G2-M phase following the treatment with optimized ALS-MP nanoconjugates. Conclusion The optimized ALS-MP formula had significantly improved the parameters related to the cytotoxic activity towards A549 cells, compared to control, MP and ALS-Raw.	[Alhakamy, Nabil A.; Bakhaidar, Rana B.; Alselami, Mohammed O.; Al Zahrani, Majed; Alqarni, Hani M.; Badr-Eldin, Shaimaa M.; Aldawsari, Hibah M.; Al-hejaili, Omar D.; Aldhabi, Bander M.] King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut, Jeddah, Saudi Arabia; [Alhakamy, Nabil A.; Aldawsari, Hibah M.] King Abdulaziz Univ, Fac Pharm, Adv Drug Delivery Res Grp, Jeddah, Saudi Arabia; [Alhakamy, Nabil A.; Aldawsari, Hibah M.] King Abdulaziz Univ, Ctr Excellence Drug Res & Pharmaceut Ind, Jeddah, Saudi Arabia; [Alhakamy, Nabil A.] King Abdulaziz Univ, Mohamed Saeed Tamer Chair Pharmaceut Ind, Jeddah, Saudi Arabia; [Okbazghi, Solomon Z.] Alexion Pharmaceut, Global Analyt & Pharmaceut Dev, New Haven, CT USA; [Alfaleh, Mohamed A.] King Abdulaziz Univ, King Fahd Med Res Ctr, Vaccines & Mmunotherapy Unit, Jeddah, Saudi Arabia; [Abdulaal, Wesam H.] King Abdulaziz Univ, Fac Sci, King Fahd Med Res Ctr, Dept Biochem,Canc & Mutagenesis Unit, Jeddah, Saudi Arabia; [Abdulaal, Wesam H.] King Abdulaziz Univ, Ctr Artificial Intelligence Precis Med, Jeddah, Saudi Arabia; [Alghaith, Adel F.; Alshehri, Sultan; Mahdi, Wael A.] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia; [Alshehri, Sultan] Almaarefa Univ, Coll Pharm, Dept Pharmaceut Sci, Ad Diriyah, Saudi Arabia; [Badr-Eldin, Shaimaa M.] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo, Egypt	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Saud University; Almaarefa University; Egyptian Knowledge Bank (EKB); Cairo University	Alhakamy, NA (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut, Jeddah, Saudi Arabia.; Alhakamy, NA (corresponding author), King Abdulaziz Univ, Fac Pharm, Adv Drug Delivery Res Grp, Jeddah, Saudi Arabia.; Alhakamy, NA (corresponding author), King Abdulaziz Univ, Ctr Excellence Drug Res & Pharmaceut Ind, Jeddah, Saudi Arabia.; Alhakamy, NA (corresponding author), King Abdulaziz Univ, Mohamed Saeed Tamer Chair Pharmaceut Ind, Jeddah, Saudi Arabia.	nalhakamy@kau.edu.sa	Badr-Eldin, Shaimaa M./J-7681-2012; MAHDI, WAEL/ABD-1707-2020	Badr-Eldin, Shaimaa M./0000-0003-1034-1653; MAHDI, WAEL/0000-0002-7083-1753; Alhakamy, Nabil/0000-0002-3826-1519	Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah [RG-10-16642]	Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah	This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, under grant no. (RG-10-16642). The authors, therefore, acknowledge with thanks DSR for technical and financial support. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.	Agardan NBM, 2016, AAPS PHARMSCITECH, V17, P968, DOI 10.1208/s12249-015-0429-3; Ahmed OAA, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12020140; Al-Asmari AK, 2018, J EVID-BASED INTEGR, V23, DOI 10.1177/2156587217751796; Alhakamy NA, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14080729; Alhakamy NA, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12080761; Alhakamy NA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050419; Alhakamy NA, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12040346; Alhakamy NA, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11120685; Awan ZA, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12070597; Badr-Eldin SM, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.642171; Balwan W.K., 2021, SAUDI J MED PHARM SC, V7, P179, DOI [10.36348/sjmps.2021.v07i04.00X, DOI 10.36348/SJMPS.2021.V07I04.003, 10.36348/sjmps.2021.v07i04.003]; Banerjee S, 2010, NUTR CANCER, V62, P938, DOI 10.1080/01635581.2010.509832; Body JJ, 1998, J CLIN ONCOL, V16, P3890, DOI 10.1200/JCO.1998.16.12.3890; Budreviciute A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.574111; Caraglia M, 2006, ENDOCR-RELAT CANCER, V13, P7, DOI 10.1677/erc.1.01094; CHESTNUT CH, 1995, AM J MED, V99, P144, DOI 10.1016/S0002-9343(99)80134-X; Czarnomysy R, 2018, J ENZYM INHIB MED CH, V33, P1006, DOI 10.1080/14756366.2018.1471687; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; El-Helw ARM, 2015, INT J NANOMED, V10, P5797, DOI 10.2147/IJN.S91556; Fahmy UA, 2020, INT J NANOMED, V15, P5253, DOI 10.2147/IJN.S258791; Fahmy UA, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12060485; Faramarzi L, 2019, ARTIF CELL NANOMED B, V47, P737, DOI 10.1080/21691401.2019.1573737; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Gali-Muhtasib HU, 2004, ANTI-CANCER DRUG, V15, P389, DOI 10.1097/00001813-200404000-00012; Ghaderi S, 2014, ADV PHARM BULL, V4, P549, DOI 10.5681/apb.2014.081; Gilad S, 2012, J MOL DIAGN, V14, P510, DOI 10.1016/j.jmoldx.2012.03.004; Herve Jean Claude, 2015, Small GTPases, V6, P43, DOI 10.1080/21541248.2015.1044811; Hilchie AL, 2016, BBA-BIOMEMBRANES, V1858, P3195, DOI 10.1016/j.bbamem.2016.09.021; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Hosny KM, 2013, EXPERT OPIN DRUG DEL, V10, P741, DOI 10.1517/17425247.2013.799136; Hu GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep27669; Huang WF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31070-9; Jain AS, 2014, BIOMED PHARMACOTHER, V68, P429, DOI 10.1016/j.biopha.2014.03.004; Lam WK, 2004, INT J TUBERC LUNG D, V8, P1045; Lason E, 2013, ACTA BIOCHIM POL, V60, P773; Mangal S, 2017, ACTA PHARMACOL SIN, V38, P782, DOI 10.1038/aps.2017.34; Md S, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13070152; Nagai H, 2017, J THORAC DIS, V9, P448, DOI 10.21037/jtd.2017.02.75; Naguib MJ, 2020, INT J PHARMACEUT, V582, DOI 10.1016/j.ijpharm.2020.119302; Naseri MH, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0204-2; Park EJ, 2016, ONCOL REP, V36, P2261, DOI 10.3892/or.2016.5019; Rennert G, 2017, CLIN CANCER RES, V23, P1684, DOI 10.1158/1078-0432.CCR-16-0547; Rouach V, 2018, J BONE ONCOL, V12, P91, DOI 10.1016/j.jbo.2018.07.011; Schirrmacher V, 2019, INT J ONCOL, V54, P407, DOI 10.3892/ijo.2018.4661; Segal E, 2011, BIOMATERIALS, V32, P4450, DOI 10.1016/j.biomaterials.2011.02.059; Sharma N, 2016, ASIAN J PHARM SCI, V11, P404, DOI 10.1016/j.ajps.2015.09.004; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Shneerson C, 2013, COMPLEMENT THER MED, V21, P417, DOI 10.1016/j.ctim.2013.05.003; Stuelten CH, 2018, NAT REV CANCER, V18, P296, DOI 10.1038/nrc.2018.15; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Taratula O, 2011, J DRUG TARGET, V19, P900, DOI 10.3109/1061186X.2011.622404; TATSUMURA T, 1993, BRIT J CANCER, V68, P1146, DOI 10.1038/bjc.1993.495; Veiga LHS, 2013, THYROID, V23, P748, DOI 10.1089/thy.2012.0532; Wang B, 2010, CELL CYCLE, V9, P870, DOI 10.4161/cc.9.5.10825; Wang HL, 2007, J PERIODONTOL, V78, P584, DOI 10.1902/jop.2007.060239; Wong VCL, 2012, CELL CYCLE, V11, P2526, DOI 10.4161/cc.20905; Yoo JH, 2018, J DAIRY SCI, V101, P3758, DOI 10.3168/jds.2017-13872; Zarogoulidis P, 2012, THER DELIV, V3, P1021, DOI 10.4155/tde.12.77; Zarogoulidis P, 2012, INT J NANOMED, V7, P1551, DOI 10.2147/IJN.S29997	59	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264093	10.1371/journal.pone.0264093	http://dx.doi.org/10.1371/journal.pone.0264093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202419	Green Published, gold			2022-12-26	WOS:000773224600020
J	Fox, A; Marino, J; Amanat, F; Oguntuyo, KY; Hahn-Holbrook, J; Lee, B; Zolla-Pazner, S; Powell, RL				Fox, Alisa; Marino, Jessica; Amanat, Fatima; Oguntuyo, Kasopefoluwa Y.; Hahn-Holbrook, Jennifer; Lee, Benhur; Zolla-Pazner, Susan; Powell, Rebecca L.			The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time	PLOS ONE			English	Article								Approximately 10% of infants infected with SARS-CoV-2 will experience COVID-19 illness requiring advanced care. A potential mechanism to protect this population is passive immunization via the milk of a previously infected person. We and others have reported on the presence of SARS-CoV-2-specific antibodies in human milk. We now report the prevalence of SARS-CoV-2 IgA in the milk of 74 COVID-19-recovered participants, and find that 89% of samples are positive for Spike-specific IgA. In a subset of these samples, 95% exhibited robust IgA activity as determined by endpoint binding titer, with 50% considered high-titer. These IgA-positive samples were also positive for Spike-specific secretory antibody. Levels of IgA antibodies and secretory antibodies were shown to be strongly positively correlated. The secretory IgA response was dominant among the milk samples tested compared to the IgG response, which was present in 75% of samples and found to be of high-titer in only 13% of cases. Our IgA durability analysis using 28 paired samples, obtained 4-6 weeks and 4-10 months after infection, found that all samples exhibited persistently significant Spike-specific IgA, with 43% of donors exhibiting increasing IgA titers over time. Finally, COVID-19 and pre-pandemic control milk samples were tested for the presence of neutralizing antibodies; 6 of 8 COVID-19 samples exhibited neutralization of Spike-pseudotyped VSV (IC50 range, 2.39-89.4ug/mL) compared to 1 of 8 controls. IgA binding and neutralization capacities were found to be strongly positively correlated. These data are highly relevant to public health, not only in terms of the protective capacity of these antibodies for breastfed infants, but also for the potential use of such antibodies as a COVID-19 therapeutic, given that secretory IgA is highly in all mucosal compartments.	[Fox, Alisa; Zolla-Pazner, Susan; Powell, Rebecca L.] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Marino, Jessica; Hahn-Holbrook, Jennifer] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Marino, Jessica; Hahn-Holbrook, Jennifer] Univ Calif Merced, Dept Psychol, Merced, CA USA; [Amanat, Fatima; Oguntuyo, Kasopefoluwa Y.; Lee, Benhur] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA; [Amanat, Fatima; Oguntuyo, Kasopefoluwa Y.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Merced; University of California System; University of California Merced; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Powell, RL (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.	Rebecca.Powell@mssm.edu		Powell, Rebecca/0000-0002-4956-7417; Hahn-Holbrook, Jennifer/0000-0002-8899-8869	NIH/NIAID [R01AI158214-01]	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	As always, we are indebted to the milk donors who make this work possible. Spike protein was generously gifted from the Krammer lab.	Arkhipova-Jenkins I, 2021, ANN INTERN MED, V174, P811, DOI 10.7326/M20-7547; Baergen RN, 2020, PEDIATR DEVEL PATHOL, V23, P177, DOI 10.1177/1093526620925569; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467; CDC, 2020, COR DIS 2019 COVID 1; Centeno-Tablante E, 2021, ANN NY ACAD SCI, V1484, P32, DOI 10.1111/nyas.14477; Demers-Mathieu V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050631; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Favara DM, 2020, EMERG MICROBES INFEC, V9, P2728, DOI 10.1080/22221751.2020.1858699; Fox A, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101735; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; Lebrao CW, 2020, J HUM LACT, V36, P609, DOI 10.1177/0890334420960433; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1525, DOI 10.1111/apa.15371; Marklund E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241104; Oguntuyo Kasopefoluwa Y, 2021, mBio, V12, DOI [10.1101/2020.08.13.20157222, 10.1128/mBio.02492-20]; Pace RM, 2021, MBIO, V12, DOI 10.1128/mBio.03192-20; Weaver LT, 1998, ARCH DIS CHILD, V78, P235, DOI 10.1136/adc.78.3.235; World Health Organization (WHO), 2020, BREASTF COVID 19 SCI	19	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0249723	10.1371/journal.pone.0249723	http://dx.doi.org/10.1371/journal.pone.0249723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263323	Green Published, gold			2022-12-26	WOS:000804638700008
J	McCoy, MG; Perez-Cremades, D; Belkin, N; Peng, WH; Zhang, BF; Chen, JS; Sachan, M; Wara, AKMK; Zhuang, RL; Cheng, HS; Feinberg, MW				McCoy, Michael G.; Perez-Cremades, Daniel; Belkin, Nathan; Peng, Wenhui; Zhang, Bofang; Chen, Jingshu; Sachan, Madhur; Wara, A. K. M. Khyrul; Zhuang, Rulin; Cheng, Henry S.; Feinberg, Mark W.			A miRNA cassette reprograms smooth muscle cells into endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; endothelial miRNA; miRNA; miRNA reprogramming; transdifferentiation	MESENCHYMAL TRANSITION; VASCULAR INFLAMMATION; HUMAN FIBROBLASTS; STEM-CELLS; MICRORNAS; DIFFERENTIATION; ACTIVATION; ATHEROSCLEROSIS; EXPRESSION; MIR-145	Cellular reprogramming through targeting microRNAs (miRNAs) holds promise for regenerative therapy due to their profound regulatory effects in proliferation, differentiation, and function. We hypothesized that transdifferentiation of vascular smooth muscle cells (SMCs) into endothelial cells (ECs) using a miRNA cassette may provide a novel approach for use in vascular disease states associated with endothelial injury or dysfunction. miRNA profiling of SMCs and ECs and iterative combinatorial miRNA transfections of human coronary SMCs revealed a 4-miRNA cassette consisting of miR-143-3p and miR-145-5p inhibitors and miR-146a-5p and miR-181b-5p mimics that efficiently produced induced endothelial cells (iECs). Transcriptome profiling, protein expression, and functional studies demonstrated that iECs exhibit high similarity to ECs. Injected iECs restored blood flow recovery even faster than conventional ECs in a murine hindlimb ischemia model. This study demonstrates that a 4-miRNA cassette is sufficient to reprogram SMCs into ECs and shows promise as a novel regenerative strategy for endothelial repair.	[McCoy, Michael G.; Perez-Cremades, Daniel; Belkin, Nathan; Peng, Wenhui; Zhang, Bofang; Chen, Jingshu; Sachan, Madhur; Wara, A. K. M. Khyrul; Zhuang, Rulin; Cheng, Henry S.; Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA; [Perez-Cremades, Daniel] Univ Valencia, INCLIVA Biomed Res Inst, Dept Physiol, Valencia, Spain; [Belkin, Nathan] Hosp Univ Penn, Dept Surg, 3400 Spruce St, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Valencia; University of Pennsylvania; Pennsylvania Medicine	Feinberg, MW (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA.	mfeinberg@bwh.harvard.edu	Zhuang, Rulin/GXG-5835-2022	Feinberg, Mark/0000-0001-9523-3859; Perez-Cremades, Daniel/0000-0002-0969-8762; McCoy, Michael/0000-0002-1981-6398; Zhang, Bofang/0000-0002-6823-7755	National Institutes of Health [HL115141, HL134849, HL148207, HL148355, HL153356]; American Heart Association [18SFRN33900144, 20SFRN35200163]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by the National Institutes of Health (HL115141, HL134849, HL148207, HL148355, HL153356 to M.W.F.), and the American Heart Association (18SFRN33900144 and 20SFRN35200163 to M.W.F.)	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Cipollone F, 2011, STROKE, V42, P2556, DOI 10.1161/STROKEAHA.110.597575; Climent M, 2015, CIRC RES, V116, P1753, DOI 10.1161/CIRCRESAHA.116.305178; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Deng L, 2015, CIRC RES, V117, P870, DOI 10.1161/CIRCRESAHA.115.306806; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300; Feng B, 2016, DIABETES, V65, P768, DOI 10.2337/db15-1033; Fernandez-Hernando C, 2018, CURR OPIN HEMATOL, V25, P227, DOI 10.1097/MOH.0000000000000424; Fontaine M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010331; Giacomelli E, 2020, CELL STEM CELL, V26, P862, DOI 10.1016/j.stem.2020.05.004; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guo LL, 2016, TUMOR BIOL, V37, P115, DOI 10.1007/s13277-015-4374-2; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Hong XC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05665-7; Hori D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174108; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Judson RL, 2013, NAT STRUCT MOL BIOL, V20, P1227, DOI 10.1038/nsmb.2665; Kane NM, 2012, STEM CELLS, V30, P643, DOI 10.1002/stem.1026; Kim J, 2018, BMB REP, V51, P65, DOI 10.5483/BMBRep.2018.51.2.011; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3798; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lin JB, 2016, FASEB J, V30, P3216, DOI 10.1096/fj.201500163R; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Nagai N, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007826; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Ni HE, 2021, ARTERIOSCL THROM VAS, V41, P2399, DOI 10.1161/ATVBAHA.120.315911; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Rippo MR, 2014, EXP GERONTOL, V56, P154, DOI 10.1016/j.exger.2014.03.002; Robbins N, 2014, JOVE-J VIS EXP, DOI 10.3791/52172; Sayed N, 2015, CIRCULATION, V131, P300, DOI 10.1161/CIRCULATIONAHA.113.007394; Song ZF, 2010, J CARDIOVASC TRANSL, V3, P246, DOI 10.1007/s12265-010-9163-0; Su YX, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1599-9; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Sun XH, 2016, CIRC RES, V118, P810, DOI 10.1161/CIRCRESAHA.115.308166; Sun XH, 2014, TRENDS CARDIOVAS MED, V24, P105, DOI 10.1016/j.tcm.2013.09.002; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Thyberg J, 2002, ARTERIOSCL THROM VAS, V22, P1509, DOI 10.1161/01.ATV.0000036415.04486.01; Treguer K, 2012, J VASC RES, V49, P447, DOI 10.1159/000339429; Wang DD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020324; Wang XH, 2013, CARDIOVASC RES, V97, P432, DOI 10.1093/cvr/cvs356; Wang Y, 2020, MOL THER-NUCL ACIDS, V20, P421, DOI 10.1016/j.omtn.2020.03.002; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yamamoto T, 2013, ARTERIOSCL THROM VAS, V33, P2218, DOI 10.1161/ATVBAHA.113.301313; Yang SZ, 2013, FASEB J, V27, P2382, DOI 10.1096/fj.12-219493	56	0	0	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22239	10.1096/fj.202101872R	http://dx.doi.org/10.1096/fj.202101872R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35235229				2022-12-26	WOS:000772957100007
J	Salinas, EY; Donahue, RP; Herrera, JM; Hu, JC; Athanasiou, KA				Salinas, Evelia Y.; Donahue, Ryan P.; Herrera, Jessica M.; Hu, Jerry C.; Athanasiou, Kyriacos A.			The functionality and translatability of neocartilage constructs are improved with the combination of fluid-induced shear stress and bioactive factors	FASEB JOURNAL			English	Article						articular cartilage; fluid-induced shear stress; mechanical stimulation; neocartilage; tissue engineering	TENSILE MECHANICAL-PROPERTIES; TEMPOROMANDIBULAR-JOINT DISC; ARTICULAR-CARTILAGE; BIOMECHANICAL PROPERTIES; CHONDROITINASE-ABC; TREATMENT REGIMEN; GROWTH-FACTORS; MINIPIG MODEL; PRIMARY CILIA; TISSUE	Neocartilage tissue engineering aims to address the shortcomings of current clinical treatments for articular cartilage indications. However, advancement is required toward neocartilage functionality (mechanical and biochemical properties) and translatability (construct size, gross morphology, passage number, cell source, and cell type). Using fluid-induced shear (FIS) stress, a potent mechanical stimulus, over four phases, this work investigates FIS stress' efficacy toward creating large neocartilage derived from highly passaged minipig costal chondrocytes, a species relevant to the preclinical regulatory process. In Phase I, FIS stress application timing was investigated in bovine articular chondrocytes and found to improve the aggregate modulus of neocartilage by 151% over unstimulated controls when stimulated during the maturation stage. In Phase II, FIS stress stimulation was translated from bovine articular chondrocytes to expanded minipig costal chondrocytes, yielding a 46% improvement in aggregate modulus over nonstimulated controls. In Phase III, bioactive factors were combined with FIS stress to improve the shear modulus by 115% over bioactive factor-only controls. The translatability of neocartilage was improved in Phase IV by utilizing highly passaged cells to form constructs more than 9-times larger in the area (11 x 17 mm), yielding an improved aggregate modulus by 134% and a flat morphology compared to free-floating, bioactive factor-only controls. Overall, this study represents a significant step toward generating mechanically robust, large constructs necessary for animal studies, and eventually, human clinical studies.	[Salinas, Evelia Y.; Donahue, Ryan P.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Irvine, Dept Biomed Engn, 3120 Nat Sci 2, Irvine, CA 92697 USA; [Herrera, Jessica M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California Irvine; University of California System; University of California San Francisco	Athanasiou, KA (corresponding author), Univ Calif Irvine, Dept Biomed Engn, 3120 Nat Sci 2, Irvine, CA 92697 USA.	athens@uci.edu		Donahue, Ryan/0000-0003-0542-1034; Salinas, Evelia/0000-0002-0343-9444	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR) [R01 DE015038]; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR078389, R01 AR067821]; California Alliance for Minority Participation	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR); HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); California Alliance for Minority Participation	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: R01 DE015038; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01 AR078389 and R01 AR067821; California Alliance for Minority Participation	Allen KD, 2006, J BIOMECH, V39, P312, DOI 10.1016/j.jbiomech.2004.11.012; [Anonymous], 2018, OSTEOARTHRITIS; ATHANASIOU KA, 1995, CLIN ORTHOP RELAT R, P254; Athanasiou KA, 1998, CLIN ORTHOP RELAT R, P269; Athanasiou KA., 2017, ARTICULAR CARTILAGE; Athanasiou KA, 2013, ANNU REV BIOMED ENG, V15, P115, DOI [10.1146/annurev-bioeng-071812-152423, 10.1146/annurev-bioeng-071812-15242]; Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; Bastow ER, 2005, J BIOL CHEM, V280, P11749, DOI 10.1074/jbc.M414495200; Berson RE, 2008, ADV EXP MED BIOL, V614, P189, DOI 10.1007/978-0-387-74911-2_22; Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072; Brama PAJ, 2000, ANN RHEUM DIS, V59, P155, DOI 10.1136/ard.59.2.155; Brown WE, 2016, TISSUE ENG PART C-ME, V22, P895, DOI [10.1089/ten.tec.2016.0184, 10.1089/ten.TEC.2016.0184]; Centers for Disease Control and Prevention, 2018, ARTHR REL STAT; Chakraborty A, 2016, ANN BIOMED ENG, V44, P3032, DOI 10.1007/s10439-016-1626-2; Christensen Bjorn Borsoe, 2015, J Exp Orthop, V2, P13, DOI 10.1186/s40634-015-0031-3; Cissell DD, 2017, TISSUE ENG PART C-ME, V23, P243, DOI 10.1089/ten.tec.2017.0018; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Dowthwaite GP, 2003, MATRIX BIOL, V22, P311, DOI 10.1016/S0945-053X(03)00037-4; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Elder BD, 2009, OSTEOARTHR CARTILAGE, V17, P114, DOI 10.1016/j.joca.2008.05.006; Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341; Elisseeff J, 2001, J ORTHOP RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7; Fisher MB, 2015, TISSUE ENG PT A, V21, P850, DOI [10.1089/ten.tea.2014.0384, 10.1089/ten.TEA.2014.0384]; Gemmiti CV, 2009, BIOTECHNOL BIOENG, V104, P809, DOI 10.1002/bit.22440; Gemmiti CV, 2006, TISSUE ENG, V12, P469, DOI 10.1089/ten.2006.12.469; Gonzalez-Leon EA, 2020, ACTA BIOMATER, V109, P73, DOI 10.1016/j.actbio.2020.04.019; Gotterbarm T, 2008, LAB ANIM-UK, V42, P71, DOI 10.1258/la.2007.06029e; Gutierrez K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00293; Huang BJ, 2018, TISSUE ENG PT A, V24, P1652, DOI [10.1089/ten.TEA.2017.0495, 10.1089/ten.tea.2017.0495]; Huang BJ, 2017, J TISSUE ENG REGEN M, V11, P2323, DOI 10.1002/term.2132; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Huwe LW, 2018, J TISSUE ENG REGEN M, V12, P1163, DOI 10.1002/term.2630; Huwe LW, 2018, TISSUE ENG PT A, V24, P516, DOI [10.1089/ten.tea.2017.0136, 10.1089/ten.TEA.2017.0136]; Kim IG, 2016, BIOMATERIALS, V85, P18, DOI 10.1016/j.biomaterials.2016.01.048; Kwon H, 2021, BIOFABRICATION, V13, DOI 10.1088/1758-5090/abd9d9; Kwon H, 2019, J TISSUE ENG REGEN M, V13, P283, DOI 10.1002/term.2791; Lee JK, 2017, NAT MATER, V16, P864, DOI [10.1038/NMAT4917, 10.1038/nmat4917]; Lee J, 2017, CELL TRANSPLANT, V26, P1673, DOI 10.1177/0963689717724794; Link JM, 2021, CARTILAGE, V13, p672S, DOI 10.1177/1947603520918653; MacBarb RF, 2013, ACTA BIOMATER, V9, P4626, DOI 10.1016/j.actbio.2012.09.037; Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.teb.2013.0271, 10.1089/ten.TEB.2013.0271]; Makris EA, 2014, BIOMATERIALS, V35, P6787, DOI 10.1016/j.biomaterials.2014.04.083; Makris EA, 2013, FASEB J, V27, P2421, DOI 10.1096/fj.12-224030; Mao Y, 2018, CARTILAGE, V9, P202, DOI 10.1177/1947603517746724; McCormick F, 2014, ARTHROSCOPY, V30, P222, DOI 10.1016/j.arthro.2013.11.001; Moore ER, 2018, J ORTHOP RES, V36, P533, DOI 10.1002/jor.23732; Murphy MK, 2015, STEM CELLS, V33, P762, DOI 10.1002/stem.1890; Murphy MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056983; Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795; Otsuki S, 2019, AM J SPORT MED, V47, P1804, DOI 10.1177/0363546519850578; PANEPINTO LM, 1986, LAB ANIM SCI, V36, P344; Pfeifer CG, 2017, TISSUE ENG PART C-ME, V23, P745, DOI [10.1089/ten.TEC.2017.0109, 10.1089/ten.tec.2017.0109]; Ruhlen R, 2014, OSTEOARTHR CARTILAGE, V22, P1071, DOI 10.1016/j.joca.2014.05.011; Salinas EY, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/aba412; Salinas EY, 2018, TISSUE ENG PART B-RE, V24, P345, DOI [10.1089/ten.teb.2018.0006, 10.1089/ten.TEB.2018.0006]; Thomas JMD, 2017, AICHE J, V63, P4233, DOI 10.1002/aic.15762; Thomas JMD, 2011, BIOTECHNOL PROGR, V27, P460, DOI 10.1002/btpr.507; Thompson CL, 2017, EUR CELLS MATER, V34, P128, DOI 10.22203/eCM.v034a09; van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806; Vapniarsky N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1802; Vapniarsky N, 2017, TISSUE ENG PART C-ME, V23, P700, DOI [10.1089/ten.tec.2017.0149, 10.1089/ten.TEC.2017.0149]; Waller KA, 2017, AM J SPORT MED, V45, P1512, DOI 10.1177/0363546516686965; Wann AKT, 2012, FASEB J, V26, P1663, DOI 10.1096/fj.11-193649; Yoon KH, 2020, AM J SPORT MED, V48, P1236, DOI 10.1177/0363546520905565; Zimmerman BK, 2015, J DENT RES, V94, P85, DOI 10.1177/0022034514553626	65	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22225	10.1096/fj.202101699R	http://dx.doi.org/10.1096/fj.202101699R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CR	35224777				2022-12-26	WOS:000772945500001
J	Gardner, KP; Tsai, S; Aldakkak, M; Gironda, S; Adams, DL				Gardner, Kirby P.; Tsai, Susan; Aldakkak, Mohammed; Gironda, Stephen; Adams, Daniel L.			CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer	PLOS ONE			English	Article							CIRCULATING TUMOR; STROMAL CELLS	The aggressive nature and metastatic potential of pancreatic cancer (PC) results in poor prognosis and high mortality. A better understanding of the underlying biology of PC and the ability of tumor cells to spread to distant sites is needed to advance the treatment of PC. The chemokine receptor CXCR4 has been heavily implicated in the spread and mobility of many solid cancers based on its role in cancer cell chemotaxis as well as increased metastatic potential. To better elucidate CXCR4's role in the metastatic spread of PC, we examined its expression on various tumor associated cells (TACs) in the peripheral blood of PC patients, including circulating tumor cells (CTCs), epithelial to mesenchymal transition cells (EMTs), and cancer associated macrophage-like cells (CAMLs). In this pilot study, blood samples were procured from 30 PC patients prior to the start of therapeutic intent. CXCR4 expression was analyzed on TACs captured from the blood samples and evaluated in relation to cell migration as well as patient clinical outcomes. In total, CTCs, EMTs, and CAMLs were found in 27%, 60%, and 97% of PC patients, respectively. High CXCR4 expression in CTCs, CAMLs, and EMTs was found to significantly relate to their increased numbers in circulation. Further, higher expression of CXCR4 in CAMLs and EMTs was significantly related to faster progression and worse survival. These data suggest that CXCR4 expression in PC is strongly related to the intravasation and presence of TACs into circulation, as well as being a possible biomarker for aggressive metastatic disease.	[Gardner, Kirby P.; Gironda, Stephen; Adams, Daniel L.] Creatv MicroTech Inc, Monmouth Jct, NJ 08852 USA; [Gardner, Kirby P.] Rutgers State Univ, Grad Sch Biomed Sci, Piscataway, NJ USA; [Tsai, Susan; Aldakkak, Mohammed] Med Coll Wisconsin Milwaukee, Milwaukee, WI USA; [Gironda, Stephen] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC USA	Rutgers State University New Brunswick; Medical College of Wisconsin; Wake Forest University	Adams, DL (corresponding author), Creatv MicroTech Inc, Monmouth Jct, NJ 08852 USA.	dan@creatvmicrotech.com		Gardner, Kirby/0000-0003-4537-1465				Adams D, 2020, J CLIN ONCOL, V38; Adams D, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.11503; Adams DL, 2017, CLIN CANCER RES, V23, P5948, DOI 10.1158/1078-0432.CCR-17-0802; Adams DL, 2016, CANCER EPIDEM BIOMAR, V25, P1037, DOI 10.1158/1055-9965.EPI-15-1221; Adams DL, 2015, CYTOM PART A, V87A, P137, DOI 10.1002/cyto.a.22613; Adams DL, 2014, P NATL ACAD SCI USA, V111, P3514, DOI 10.1073/pnas.1320198111; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Augustyn A, 2021, CLIN LUNG CANCER, V22, pE451, DOI 10.1016/j.cllc.2020.06.016; Beatty Gregory L, 2017, Am Soc Clin Oncol Educ Book, V37, P267, DOI 10.14694/EDBK_175232; Cristofanilli M., 2018, LIQUID BIOPSIES SOLI; Dangi-Garimella S, 2012, PANCREATIC CANC TUMO; Effenberger KE, 2018, CLIN CANCER RES, V24, P2844, DOI 10.1158/1078-0432.CCR-18-0120; Gardner KP, 2021, NPJ PRECIS ONCOL, V5, DOI 10.1038/s41698-021-00161-8; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Gironda DJ, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02563-x; Howlader N., 2016, SEER CANC STAT REV; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Li XQ, 2012, CANCER LETT, V322, P169, DOI 10.1016/j.canlet.2012.02.035; Liebick M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157502; Saba F, 2015, HEMATOLOGY, V20, P462, DOI 10.1179/1607845414Y.0000000220; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Sohal Davendra P S, 2017, Am Soc Clin Oncol Educ Book, V37, P301, DOI 10.14694/EDBK_175222; Thomas RM, 2008, GUT, V57, P1555, DOI 10.1136/gut.2007.143941; Wang S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2646148; Wescott MP, 2016, P NATL ACAD SCI USA, V113, P9928, DOI 10.1073/pnas.1601278113; Yang LQ, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0110-5; Zhao XH, 2019, WORLD J GASTROENTERO, V25, P138, DOI 10.3748/wjg.v25.i1.138	27	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264763	10.1371/journal.pone.0264763	http://dx.doi.org/10.1371/journal.pone.0264763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259193	Green Published, gold			2022-12-26	WOS:000835141200024
J	Komatsu, M; Nakamura, K; Takeda, T; Chiwaki, F; Banno, K; Aoki, D; Takeshita, F; Sasaki, H				Komatsu, Masayuki; Nakamura, Kanako; Takeda, Takashi; Chiwaki, Fumiko; Banno, Kouji; Aoki, Daisuke; Takeshita, Fumitaka; Sasaki, Hiroki			Aurora kinase blockade drives de novo addiction of cervical squamous cell carcinoma to druggable EGFR signalling	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; MESENCHYMAL TRANSITION; ACQUIRED-RESISTANCE; TYROSINE KINASE; LUNG-CANCER; INHIBITOR; THERAPY; HEAD; NECK; OVEREXPRESSION	Oncogenic signalling confers tumour-progression advantages; thus, its pharmacological blockade is the best strategy for cancer chemotherapy. However, drug resistance and heterogeneous dependency of tumour hamper their therapeutic potential, suggesting the necessity for a new ubiquitous modality based on evading drug resistance. Here, we proposed a denovoaddiction to oncogenic signalling (Dead-On) concept, wherein specific blockade of target molecules forces cancer cells to develop dependency on an oncogenic signalling. In cervical squamous cell carcinoma cells, Aurora A/B dual blockade elicited rapid addiction to EGFR-Erk signalling, and its pharmacological/genetic inhibition synergistically enhanced anti-cancer activities in vitro, in vivo, and in a patient-derived organoid model. The signal activation was independent of EGFR genetic status, it was triggered by receptor accumulation on the plasma membrane via Rab11-mediated endocytic recycling machinery. These findings support our novel Dead-On concept which may lead to drug discovery as well as expand the adaptation of approved targeted drugs.	[Komatsu, Masayuki; Chiwaki, Fumiko; Takeshita, Fumitaka; Sasaki, Hiroki] Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan; [Nakamura, Kanako; Takeda, Takashi; Banno, Kouji; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan	National Cancer Center - Japan; Keio University	Komatsu, M; Sasaki, H (corresponding author), Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan.	makomats@ncc.go.jp; hksasaki@ncc.go.jp	Takeda, Takashi/AAB-1391-2019	Takeda, Takashi/0000-0001-6686-5742; Chiwaki, Fumiko/0000-0002-0914-9157; Komatsu, Masayuki/0000-0003-1180-1746; BANNO, KOUJI/0000-0003-2610-2833	Pfizer [WO195177]; National Cancer Center Research and Development Fund [28-A-11, 29-A-2]	Pfizer(Pfizer); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was supported by Pfizer Investigator-Initiated Research (WO195177) Program and by the National Cancer Center Research and Development Fund (28-A-11, 29-A-2). We would like to thank Editage (www.editage.com) for English language editing.	Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Barsouk A., 2019, MED SCI, V7, P1; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Chung BM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-84; Cortot AB, 2013, CANCER RES, V73, P834, DOI 10.1158/0008-5472.CAN-12-2066; Crafton SM, 2016, CLIN THER, V38, P449, DOI 10.1016/j.clinthera.2016.02.007; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; Dotto GP, 2016, CANCER CELL, V29, P622, DOI 10.1016/j.ccell.2016.04.004; Elkabets M, 2015, CANCER CELL, V27, P533, DOI 10.1016/j.ccell.2015.03.010; Flaherty KT, 2020, JNCI-J NATL CANCER I, V112, DOI 10.1093/jnci/djz245; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Fukuoka S, 2017, ONCOTARGET, V8, P11020, DOI 10.18632/oncotarget.14209; Gabrielli B, 2015, MOL CANCER THER, V14, P2753, DOI 10.1158/1535-7163.MCT-15-0506; Gao ML, 2012, EMBO MOL MED, V4, P776, DOI 10.1002/emmm.201100944; Giles KM, 2013, MOL CANCER THER, V12, P2541, DOI 10.1158/1535-7163.MCT-13-0170; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Gonzalez-Loyola A, 2015, MOL CELL BIOL, V35, P3566, DOI 10.1128/MCB.01286-14; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hehnly H, 2014, DEV CELL, V28, P497, DOI 10.1016/j.devcel.2014.01.014; Hochegger H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120185; Huang XF, 2008, BLOOD, V111, P2854, DOI 10.1182/blood-2007-07-099325; Jani JP, 2010, MOL CANCER THER, V9, P883, DOI 10.1158/1535-7163.MCT-09-0915; Jonker CTH, 2020, J CELL SCI, V133, DOI 10.1242/jcs.231225; Kersemaekers AMF, 1999, CLIN CANCER RES, V5, P577; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li LK, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7479; Lim SM, 2018, CANCER TREAT REV, V65, P1, DOI 10.1016/j.ctrv.2018.02.006; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lin G, 2015, ONCOL LETT, V10, P901, DOI 10.3892/ol.2015.3277; Lin L, 2019, CANCERS, V11, DOI 10.3390/cancers11081156; Lou K, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw9450; Lowenberg B, 2011, BLOOD, V118, P6030, DOI 10.1182/blood-2011-07-366930; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Mehra Ranee, 2008, Clin Adv Hematol Oncol, V6, P742; Melichar B, 2015, LANCET ONCOL, V16, P395, DOI 10.1016/S1470-2045(15)70051-3; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Schilder RJ, 2009, INT J GYNECOL CANCER, V19, P929, DOI 10.1111/IGC.0b013e3181a83467; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shah KN, 2019, NAT MED, V25, P111, DOI 10.1038/s41591-018-0264-7; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Song HN, 2016, J THORAC ONCOL, V11, pE45, DOI 10.1016/j.jtho.2015.12.093; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Thalappilly S, 2010, ONCOGENE, V29, P2528, DOI 10.1038/onc.2010.1; Thomas R, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00800; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Tsuruo T, 2003, CANCER SCI, V94, P15, DOI 10.1111/j.1349-7006.2003.tb01345.x; Twu NF, 2009, EUR J OBSTET GYN R B, V142, P57, DOI 10.1016/j.ejogrb.2008.09.012; Vojnic M, 2019, J THORAC ONCOL, V14, P802, DOI 10.1016/j.jtho.2018.12.038; Vora C, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2018-000462; Wan XB, 2008, CARCINOGENESIS, V29, P1930, DOI 10.1093/carcin/bgn176; Wang SH, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0268-z; Wong GS, 2018, NAT MED, V24, P968, DOI 10.1038/s41591-018-0022-x; Xia ZB, 2013, MOL CANCER RES, V11, P1101, DOI 10.1158/1541-7786.MCR-13-0044	65	0	0	2	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2022	41	16					2326	2339		10.1038/s41388-022-02256-3	http://dx.doi.org/10.1038/s41388-022-02256-3		MAR 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0N1NW	35250028				2022-12-26	WOS:000765203000001
J	Liu, TZ; Shan, J; Liu, XL; Shang, T				Liu, Tangzhi; Shan, Jue; Liu, Xingliang; Shang, Ting			Departure efficiency evaluation of a comprehensive transport hub based on Wi-Fi probe data and a multilayer hybrid model	PLOS ONE			English	Article							AUTOMATIC FARE COLLECTION; DWELL TIME; EVACUATION; PERFORMANCE; PASSENGERS; DESIGN	Evaluation of the passenger departure efficiency of a comprehensive transport hub is essential for traffic managers. Through the evaluation, security risks in the hub can be found in time to ensure the safe departure of passengers. The attention of existing studies has focused on the analysis of the overall situation of the hub, and the quantitative description of departure status in different connection areas inside the hub is insufficient. In this study, a multilayer hybrid model based on an analytic hierarchy process and entropy weight method was established. The data collected using Wi-Fi probe technology were clustered by a K-means algorithm. The first level of the model was divided according to the connection areas of the passenger hub, and the second level was based on the number of stranded people, wait time and departure time in each connection area. It was found that the SP index has the greatest impact on departure efficiency. In addition, the impact of passenger flow aggregation on each connection area is different, and the management department should treat it accordingly. The applicability of the proposed multilayer hybrid model was verified in the example of the Chongqing north railway station.	[Liu, Tangzhi; Shan, Jue; Liu, Xingliang; Shang, Ting] Chongqing Jiaotong Univ, Coll Traff & Transportat, Chongqing, Peoples R China	Chongqing Jiaotong University	Liu, XL (corresponding author), Chongqing Jiaotong Univ, Coll Traff & Transportat, Chongqing, Peoples R China.	xingliang1125@outlook.com		Liu, Xingliang/0000-0002-3139-7755	Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJQN202100718]; Scientific and Technological Research Program of Chongqing Jiaotong University [20JDKJC-B001]	Scientific and Technological Research Program of Chongqing Municipal Education Commission; Scientific and Technological Research Program of Chongqing Jiaotong University	This study is supported by Scientific and Technological Research Program of Chongqing Municipal Education Commission (Grant No. KJQN202100718), Scientific and Technological Research Program of Chongqing Jiaotong University (Grant No. 20JDKJC-B001).	Alawad H, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10155156; Andreatta G, 2007, COMPUT OPER RES, V34, P1532, DOI 10.1016/j.cor.2005.07.024; [Anonymous], 2016, TERM MULT PASS TRANS; Applied Technology Council (ATC), 1996, ATC40; Awasthi A, 2011, MATH COMPUT MODEL, V53, P98, DOI 10.1016/j.mcm.2010.07.023; Bai Y, 2021, IEEE T INTELL TRANSP, V22, P79, DOI 10.1109/TITS.2019.2954895; Berrou J.L., 2007, PEDESTRIAN EVACUATIO, P167, DOI DOI 10.1007/978-3-540-47064-9_15; Braglia M, 2013, ADV COMPLEX SYST, V16, DOI 10.1142/S0219525913500185; Buchmueller S, 2008, WIT TRANS BUILT ENV, V103, P525, DOI 10.2495/CR080511; Chen JF., 2021, SAFETY SCI, V142, P16; Cheon SH, 2019, TRANSPORT RES C-EMER, V98, P239, DOI 10.1016/j.trc.2018.09.011; Cornet S, 2019, TRANSPORT RES C-EMER, V106, P345, DOI 10.1016/j.trc.2019.05.008; Cox T, 2006, TRANSPORT RES A-POL, V40, P244, DOI 10.1016/j.tra.2005.07.001; Daamen W, 2008, TRANSPORT RES REC, P71, DOI 10.3141/2042-08; Deluka-Tibljas A, 2011, PROMET-ZAGREB, V23, P303; Di Luzio A., 2016, IEEE INFOCOM 2016 35, P1; [杜胜品 DU Shengpin], 2006, [西南交通大学学报, Journal of Southwest Jiaotong University], V41, P284; Elzarka HM, 2017, SUSTAIN CITIES SOC, V35, P430, DOI 10.1016/j.scs.2017.08.025; Eshtaiwi M, 2018, J AIR TRANSP MANAG, V68, P28, DOI 10.1016/j.jairtraman.2017.12.004; Geng XL, 2010, EXPERT SYST APPL, V37, P6629, DOI 10.1016/j.eswa.2010.03.058; Guo YT, 2021, ACCIDENT ANAL PREV, V161, DOI 10.1016/j.aap.2021.106354; Guo YT, 2021, TRAVEL BEHAV SOC, V23, P86, DOI 10.1016/j.tbs.2020.11.004; He YC., 2018, 3 INT C ELECT ENG IN; Hora J, 2017, TRANSP RES PROC, V27, P664, DOI 10.1016/j.trpro.2017.12.103; Hsu YW, 2020, OPTIK, V202, DOI 10.1016/j.ijleo.2019.163675; Jia HF, 2015, J CENT SOUTH UNIV, V22, P3247, DOI 10.1007/s11771-015-2863-5; Kallianiotis A, 2018, INT J DISAST RISK RE, V31, P526, DOI 10.1016/j.ijdrr.2018.06.009; Kepaptsoglou K, 2013, KSCE J CIV ENG, V17, P1109, DOI 10.1007/s12205-013-0411-0; Lin SF., 2019, INT S POWER ELECT CO, V1187, P052; Long JC., BAYPORT CRUISE TERMI, P1; Lu J, 2018, TRANSPORT-VILNIUS, V33, P32, DOI 10.3846/16484142.2015.1004192; Mao CY., 2020, IEEE 5 INT C INTELLI; Mehmood U, 2019, 2019 IEEE 5TH WORLD FORUM ON INTERNET OF THINGS (WF-IOT), P165, DOI 10.1109/WF-IoT.2019.8767350; Meng FT, 2022, TRANSPORTMETRICA A, V18, P619, DOI 10.1080/23249935.2021.1886195; Miller JD., 1985, DISSERTATION; Orsini F., 2019, P 6 INT C MODELS TEC, P1; Qin Y., 2013, J INTELLIGENT LEARNI, V5, P237; Shirakawa M., 1997, INT C DIGITAL SIGNAL, V2, P699; Sipetas C, 2020, TRANSPORT RES C-EMER, V118, DOI 10.1016/j.trc.2020.102727; Souza W., 2013, 2013 IEEE PES C INNO, P1; Subedi S, 2017, IEEE J RADIO FREQ ID, V1, P144, DOI 10.1109/JRFID.2017.2765618; Sun LJ, 2014, TRANSPORT RES C-EMER, V46, P284, DOI 10.1016/j.trc.2014.06.003; Tan ZJ, 2020, TRANSPORT RES C-EMER, V119, DOI 10.1016/j.trc.2020.102761; Tang GL, 2021, AUTOMAT CONSTR, V121, DOI 10.1016/j.autcon.2020.103445; Tao SY, 2019, PROCEEDINGS OF THE SIXTH INTERNATIONAL CONFERENCE ON TRANSPORTATION ENGINEERING (ICTE 2019), P632; Tesoriere G, 2018, AIP CONF PROC, V2040, DOI 10.1063/1.5079195; Versichele M, 2012, APPL GEOGR, V32, P208, DOI 10.1016/j.apgeog.2011.05.011; Vu L, 2011, INT CONF PERVAS COMP, P54, DOI 10.1109/PERCOM.2011.5767595; Wu Y, 2021, BUILD SIMUL-CHINA, V14, P1553, DOI 10.1007/s12273-020-0754-7; Xuan RP, 2021, J THERM BIOL, V96, DOI 10.1016/j.jtherbio.2020.102806; Yao LY, 2014, SUSTAINABILITY-BASEL, V6, P4152, DOI 10.3390/su6074152; Yu W., 2020, SUSTAINABILITY-BASEL, V12, P21; Zhang GW, 2017, SAFETY SCI, V93, P222, DOI 10.1016/j.ssci.2016.12.008; Zhang ZY, 2021, J AMB INTEL HUM COMP, DOI 10.1007/s12652-021-03182-0; Zhou YY, 2019, CICTP 2019: TRANSPORTATION IN CHINA-CONNECTING THE WORLD, P6287; Zhu YW, 2021, TRANSPORT RES C-EMER, V123, DOI 10.1016/j.trc.2020.102896	56	0	0	13	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264473	10.1371/journal.pone.0264473	http://dx.doi.org/10.1371/journal.pone.0264473			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245305	gold, Green Published			2022-12-26	WOS:000799799100022
J	Lv, B; Pan, YD; Hou, DS; Chen, P; Zhang, J; Chu, YW; Li, MQ; Zeng, Y; Yang, DQ; Liu, J				Lv, Bin; Pan, Yida; Hou, Daisen; Chen, Ping; Zhang, Jun; Chu, Yiwei; Li, Mingqi; Zeng, Yan; Yang, Dongqin; Liu, Jie			RNF4 silencing induces cell growth arrest and DNA damage by promoting nuclear targeting of p62 in hepatocellular carcinoma	ONCOGENE			English	Article							E3 UBIQUITIN LIGASE; OXIDATIVE STRESS; HEPATITIS-B; AUTOPHAGY; CANCER; SUMO; PROTEIN; P62/SQSTM1; REPAIR; ANGIOGENESIS	Hepatocellular carcinoma (HCC) is one of the largest causes of cancer-related deaths worldwide owing to the limitation of effective treatment options. The ubiquitin-proteasome system has been rapidly recognized as a frequent target of deregulation leading to cancers. Enhanced DNA damage response (DDR) promotes HCC growth and prevents chemosensitivity, and ubiquitin E3 ligases are key modulators in DDR. Therefore, a better understanding of how E3 ligases regulate cell growth and DNA damage may provide novel insights in understanding the oncogenic mechanism and improving the efficacy of DNA damage therapeutic agents. Here, we performed a high-content RNAi screening targeting 52 DDR-related E3 ligases in HCC and found that ring finger protein 4 (RNF4) was essential for HCC growth. RNF4 was highly expressed in HCC tissues, and the expression levels of RNF4 were associated with poor outcomes. RNF4 silencing significantly suppressed the cell growth, and subsequently induced G2/M arrest and apoptosis of HCC cells in vitro; RNF4 silencing also demonstrated the tumor-suppressive efficacy on HCC in vivo. Moreover, RNF4 silencing increased DNA damage, and rendered HCC cells more sensitive to DNA damage drugs and radiation. We found RNF4 functionally interacts with p62, and mechanistic analyses indicated that RNF4 silencing triggered the nuclear enrichment of p62. Moreover, the p62 nuclear targeting was required for increased DNA damage and growth suppression mediated by RNF4 silencing. Thus, our findings suggest RNF4 is essential for HCC proliferation via preventing nuclear translocation of p62. RNF4 silencing promotes DNA damage and may serve as a novel strategy to suppress cell growth and increase the sensitivity of DNA damage therapeutic agents in HCC.	[Lv, Bin; Pan, Yida; Zhang, Jun; Yang, Dongqin; Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, 12 Middle Wulumuqi Rd, Shanghai, Peoples R China; [Hou, Daisen; Chen, Ping; Liu, Jie] Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, 130 Dongan Rd, Shanghai, Peoples R China; [Hou, Daisen; Chen, Ping; Chu, Yiwei; Liu, Jie] Fudan Univ, Sch Basic Med Sci, Dept Immunol, 130 Dongan Rd, Shanghai, Peoples R China; [Li, Mingqi] Univ Tennessee, Ctr Canc Res, Hlth Sci Ctr, Memphis, TN 38163 USA; [Zeng, Yan] Jilin Agr Univ, Coll Vet Med, 2888 Xincheng St, Changchun, Peoples R China	Fudan University; Fudan University; Fudan University; University of Tennessee System; University of Tennessee Health Science Center; Jilin Agricultural University	Yang, DQ; Liu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Digest Dis, 12 Middle Wulumuqi Rd, Shanghai, Peoples R China.; Liu, J (corresponding author), Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, 130 Dongan Rd, Shanghai, Peoples R China.; Liu, J (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Immunol, 130 Dongan Rd, Shanghai, Peoples R China.	kobesakura@fudan.edu.cn; jieliu@fudan.edu.cn			National Natural Science Foundation Grant of China [81770579, 81830080, 81861168038, 81970506, 81800477]	National Natural Science Foundation Grant of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation Grant of China [81770579, 81830080, 81861168038, 81970506, 81800477]. The authors thank Ying Zhao for p62 WT, p62 Delta UBA, p62 Delta PB1, p62 Delta NES and p62 Delta NLS plasmids. The authors thank Dr. Zhaohui Wu and Dr. Mingfang Lv for revising our manuscript. The authors thank Mengxiao Ge for replenishing our experimental data.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Balogh J, 2016, J HEPATOCELL CARCINO, V3, P41, DOI 10.2147/JHC.S61146; Bartolini D, 2018, TRANSL RES, V193, P54, DOI 10.1016/j.trsl.2017.11.007; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brinkmann K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00098; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Denk H, 2019, EXPERT OPIN THER TAR, V23, P393, DOI 10.1080/14728222.2019.1601703; Erpapazoglou Zoi, 2014, Cells, V3, P1027, DOI 10.3390/cells3041027; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Feng YC, 2017, AUTOPHAGY, V13, P995, DOI 10.1080/15548627.2017.1317427; Fryrear KA, 2012, BLOOD, V119, P1173, DOI 10.1182/blood-2011-06-358564; Gartner A, 2014, MOL CELL, V55, P1, DOI 10.1016/j.molcel.2014.06.022; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Goto Y, 2017, MUTAT RES-FUND MOL M, V803, P76, DOI 10.1016/j.mrfmmm.2017.07.007; Groocock LM, 2014, EMBO REP, V15, P601, DOI 10.1002/embr.201338369; Hao ZL, 2015, FRONT BIOSCI-LANDMRK, V20, P474, DOI 10.2741/4320; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jung YS, 2012, FEBS LETT, V586, P1397, DOI 10.1016/j.febslet.2012.03.052; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Lin XL, 2013, DNA CELL BIOL, V32, P220, DOI 10.1089/dna.2012.1915; Moscat J, 2016, CELL, V167, P606, DOI 10.1016/j.cell.2016.09.030; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Saito T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12030; Sanchez-Martin P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.222836; Sang YZ, 2015, ONCOTARGET, V6, P42590, DOI 10.18632/oncotarget.6052; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; SU Q, 1994, HEPATOLOGY, V20, P788, DOI 10.1002/hep.1840200404; Su YT, 2013, MOL CELL BIOL, V33, P1546, DOI 10.1128/MCB.01146-12; Sun L, 2008, J INT MED RES, V36, P1015, DOI 10.1177/147323000803600519; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Taniguchi K, 2016, FEBS LETT, V590, P2375, DOI 10.1002/1873-3468.12301; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Uckelmann M, 2017, DNA REPAIR, V56, P92, DOI 10.1016/j.dnarep.2017.06.011; Vyas R, 2013, CELL DEATH DIFFER, V20, P490, DOI 10.1038/cdd.2012.145; Wang GC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00005; Wang YN, 2016, MOL CELL, V63, P34, DOI 10.1016/j.molcel.2016.05.027; Xiang X, 2017, CANCER MED-US, V6, P2357, DOI 10.1002/cam4.1176; Yang D, 2013, CELL DEATH DIFFER, V20, P235, DOI 10.1038/cdd.2012.113; Yang DQ, 2019, EBIOMEDICINE, V47, P114, DOI 10.1016/j.ebiom.2019.08.068; Yang DQ, 2012, AUTOPHAGY, V8, P1856, DOI 10.4161/auto.22024; Yi T, 2008, CANCER RES, V68, P1843, DOI 10.1158/0008-5472.CAN-07-5944; Zhao XM, 2018, RADIAT RES, V190, P385, DOI 10.1667/RR14981.1	47	0	0	2	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2022	41	16					2275	2286		10.1038/s41388-022-02247-4	http://dx.doi.org/10.1038/s41388-022-02247-4		MAR 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0N1NW	35236966				2022-12-26	WOS:000763262700002
J	Srinivas, US; Tay, NSC; Jaynes, P; Anbuselvan, A; Ramachandran, GK; Wardyn, JD; Hoppe, MM; Hoang, PM; Peng, YF; Lim, S; Lee, MY; Peethala, PC; An, O; Shendre, A; Tan, BWQ; Jemimah, S; Lakshmanan, M; Hu, LY; Jakhar, R; Sachaphibulkij, K; Lim, LHK; Pervaiz, S; Crasta, K; Yang, H; Tan, P; Liang, C; Ho, LN; Khanchandani, V; Kappei, D; Yong, WP; Tan, DSP; Bordi, M; Campello, S; Tam, WL; Frezza, C; Jeyasekharan, AD				Srinivas, Upadhyayula S.; Tay, Norbert S. C.; Jaynes, Patrick; Anbuselvan, Akshaya; Ramachandran, Gokula K.; Wardyn, Joanna D.; Hoppe, Michal M.; Hoang, Phuong Mai; Peng, Yanfen; Lim, Sherlly; Lee, May Yin; Peethala, Praveen C.; An, Omer; Shendre, Akshay; Tan, Bryce W. Q.; Jemimah, Sherlyn; Lakshmanan, Manikandan; Hu, Longyu; Jakhar, Rekha; Sachaphibulkij, Karishma; Lim, Lina H. K.; Pervaiz, Shazib; Crasta, Karen; Yang, Henry; Tan, Patrick; Liang, Chao; Ho, Lena; Khanchandani, Vartika; Kappei, Dennis; Yong, Wei Peng; Tan, David S. P.; Bordi, Matteo; Campello, Silvia; Tam, Wai Leong; Frezza, Christian; Jeyasekharan, Anand D.			PLK1 inhibition selectively induces apoptosis in ARID1A deficient cells through uncoupling of oxygen consumption from ATP production	ONCOGENE			English	Article							POLO-LIKE KINASE-1; CLEAR-CELL; SWI/SNF COMPLEXES; TUMOR PROGRESSION; BI 6727; EXPRESSION; CANCER; DNA; PHOSPHORYLATION; TARGET	Inhibitors of the mitotic kinase PLK1 yield objective responses in a subset of refractory cancers. However, PLK1 overexpression in cancer does not correlate with drug sensitivity, and the clinical development of PLK1 inhibitors has been hampered by the lack of patient selection marker. Using a high-throughput chemical screen, we discovered that cells deficient for the tumor suppressor ARID1A are highly sensitive to PLK1 inhibition. Interestingly this sensitivity was unrelated to canonical functions of PLK1 in mediating G2/M cell cycle transition. Instead, a whole-genome CRISPR screen revealed PLK1 inhibitor sensitivity in ARID1A deficient cells to be dependent on the mitochondrial translation machinery. We find that ARID1A knock-out (KO) cells have an unusual mitochondrial phenotype with aberrant biogenesis, increased oxygen consumption/expression of oxidative phosphorylation genes, but without increased ATP production. Using expansion microscopy and biochemical fractionation, we see that a subset of PLK1 localizes to the mitochondria in interphase cells. Inhibition of PLK1 in ARID1A KO cells further uncouples oxygen consumption from ATP production, with subsequent membrane depolarization and apoptosis. Knockdown of specific subunits of the mitochondrial ribosome reverses PLK1-inhibitor induced apoptosis in ARID1A deficient cells, confirming specificity of the phenotype. Together, these findings highlight a novel interphase role for PLK1 in maintaining mitochondrial fitness under metabolic stress, and a strategy for therapeutic use of PLK1 inhibitors. To translate these findings, we describe a quantitative microscopy assay for assessment of ARID1A protein loss, which could offer a novel patient selection strategy for the clinical development of PLK1 inhibitors in cancer.	[Srinivas, Upadhyayula S.; Tay, Norbert S. C.; Jaynes, Patrick; Anbuselvan, Akshaya; Ramachandran, Gokula K.; Wardyn, Joanna D.; Hoppe, Michal M.; Hoang, Phuong Mai; Peng, Yanfen; Lim, Sherlly; Peethala, Praveen C.; An, Omer; Shendre, Akshay; Tan, Bryce W. Q.; Jemimah, Sherlyn; Yang, Henry; Khanchandani, Vartika; Kappei, Dennis; Yong, Wei Peng; Tan, David S. P.; Tam, Wai Leong; Jeyasekharan, Anand D.] Natl Univ Singapore NUS, Canc Sci Inst Singapore, Singapore, Singapore; [Lee, May Yin; Tan, Patrick; Tam, Wai Leong] ASTAR, Genome Inst Singapore GIS, Singapore, Singapore; [Lakshmanan, Manikandan] ASTAR, Inst Mol & Cell Biol IMCB, Singapore, Singapore; [Hu, Longyu; Tan, Patrick] Duke NUS Med Sch, Canc & Stem Cell Biol, Singapore, Singapore; [Jakhar, Rekha; Sachaphibulkij, Karishma; Lim, Lina H. K.; Pervaiz, Shazib; Crasta, Karen] Natl Univ Singapore NUS, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Jakhar, Rekha; Crasta, Karen] Natl Univ Hlth Syst NUHS, Ctr Hlth Longev, Singapore, Singapore; [Liang, Chao; Ho, Lena] Duke NUS Med Sch, Cardiovasc & Metab Disorders, Singapore, Singapore; [Kappei, Dennis; Tam, Wai Leong] Natl Univ Singapore NUS, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Kappei, Dennis; Jeyasekharan, Anand D.] Natl Univ Singapore NUS, NUS Ctr Canc Res N2CR, Yong Loo Lin Sch Med, Singapore, Singapore; [Yong, Wei Peng; Tan, David S. P.; Jeyasekharan, Anand D.] Natl Univ Hosp NUH, Natl Univ Canc Inst Singapore NCIS, Singapore, Singapore; [Bordi, Matteo; Campello, Silvia] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Frezza, Christian] Univ Cambridge, MRC Canc Unit, Cambridge, England	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; University of Rome Tor Vergata; University of Cambridge	Jeyasekharan, AD (corresponding author), Natl Univ Singapore NUS, Canc Sci Inst Singapore, Singapore, Singapore.; Jeyasekharan, AD (corresponding author), Natl Univ Singapore NUS, NUS Ctr Canc Res N2CR, Yong Loo Lin Sch Med, Singapore, Singapore.; Jeyasekharan, AD (corresponding author), Natl Univ Hosp NUH, Natl Univ Canc Inst Singapore NCIS, Singapore, Singapore.	csiadj@nus.edu.sg	Tan, David/HIR-2214-2022; Lee, May Yin/AAB-3450-2021	Lee, May Yin/0000-0003-2366-9463; Peng, Yanfen/0000-0003-1753-8547; Hoppe, Michal Marek/0000-0002-0364-6080; Tam, Wai Leong/0000-0003-2365-5264; Jemimah, Sherlyn/0000-0003-1974-5064; Tay, Norbert/0000-0002-4960-9250	Singapore Ministry of Health's National Medical Research Council Transition Award [NMRC/TA/0052/2016]; Cancer Science Institute of Singapore; National University of Singapore, through the National Research Foundation Singapore; Singapore Ministry of Education under its Research Centers of Excellence initiative; Singapore Ministry of Health's National Medical Research Council [NMRC/CIRG/1400/2014]	Singapore Ministry of Health's National Medical Research Council Transition Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Cancer Science Institute of Singapore; National University of Singapore, through the National Research Foundation Singapore; Singapore Ministry of Education under its Research Centers of Excellence initiative(Ministry of Education, Singapore); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	ADJ is supported by the Singapore Ministry of Health's National Medical Research Council Transition Award (NMRC/TA/0052/2016). Work in ADJ's and the Kappei laboratory is also funded by the Cancer Science Institute of Singapore, National University of Singapore, through the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centers of Excellence initiative. Part of this work was funded through a collaborative grant between ADJ and DSPT from the Singapore Ministry of Health's National Medical Research Council (NMRC/CIRG/1400/2014).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Ashizawa M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43293-5; Ayhan A, 2012, INT J GYNECOL CANCER, V22, P1310, DOI 10.1097/IGC.0b013e31826b5dcc; Bertolin G, 2018, ELIFE, V7, DOI 10.7554/eLife.38111; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Bruinsma W, 2012, TRENDS BIOCHEM SCI, V37, P534, DOI 10.1016/j.tibs.2012.09.005; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Croucher PJP, 2020, CANCER RES, V80, DOI 10.1158/1538-7445.AM2020-2019; Deribe YL, 2018, NAT MED, V24, P1047, DOI 10.1038/s41591-018-0019-5; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elsayed I, 2019, FUTURE MED CHEM, V11, P1383, DOI 10.4155/fmc-2019-0084; Fukumoto T, 2019, CANCER RES, V79, P5482, DOI 10.1158/0008-5472.CAN-19-1302; Gorlick R, 2014, PEDIATR BLOOD CANCER, V61, P158, DOI 10.1002/pbc.24616; Gutteridge REA, 2017, CANCER LETT, V394, P13, DOI 10.1016/j.canlet.2017.02.013; Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897; Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018; Hoppe MM, 2021, EMBO MOL MED, V13, DOI 10.15252/emmm.202013366; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Joukov V, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar4195; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Li ZG, 2014, MOL CELL BIOL, V34, P3642, DOI 10.1128/MCB.00814-14; Liu CR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09813-7; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Liu ZX, 2017, TRANSL ONCOL, V10, P22, DOI 10.1016/j.tranon.2016.10.003; Ma XY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01647-5; Mao TL, 2013, AM J SURG PATHOL, V37, P1342, DOI 10.1097/PAS.0b013e3182889dc3; Matsumoto T, 2009, P NATL ACAD SCI USA, V106, P14542, DOI 10.1073/pnas.0904229106; Mennuni M, 2022, EMBO REP, V23, DOI 10.15252/embr.202153054; Miller RE, 2016, MOL CANCER THER, V15, P1472, DOI 10.1158/1535-7163.MCT-15-0554; Nickerson JA, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00049; Ogiwara H, 2019, CANCER CELL, V35, P177, DOI 10.1016/j.ccell.2018.12.009; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Popov LD, 2020, J CELL MOL MED, V24, P4892, DOI 10.1111/jcmm.15194; Richter U, 2015, J CELL BIOL, V211, P373, DOI 10.1083/jcb.201504062; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Savas S, 2018, CRIT REV ONCOL HEMAT, V123, P114, DOI 10.1016/j.critrevonc.2018.01.009; Sharon D, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax2863; Shen JF, 2015, CANCER DISCOV, V5, P752, DOI 10.1158/2159-8290.CD-14-0849; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Tillberg PW, 2016, NAT BIOTECHNOL, V34, P987, DOI 10.1038/nbt.3625; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Trizzino M, 2018, CELL REP, V23, P3933, DOI 10.1016/j.celrep.2018.05.097; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wardyn JD., 2021, CURR PROTOC, V1, P286; Williamson CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13837; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Wu CJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05694-4; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yamamoto S, 2012, MODERN PATHOL, V25, P615, DOI 10.1038/modpathol.2011.189; Yao CH, 2019, ELIFE, V8, DOI 10.7554/eLife.41351; Yim H, 2013, ANTI-CANCER DRUG, V24, P999, DOI 10.1097/CAD.0000000000000007; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	60	3	3	2	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1986	2002		10.1038/s41388-022-02219-8	http://dx.doi.org/10.1038/s41388-022-02219-8		MAR 2022	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35236967				2022-12-26	WOS:000763262700001
J	Chainarong, N; Deevongkij, K; Petpichetchian, C				Chainarong, Natthicha; Deevongkij, Kittiya; Petpichetchian, Chusana			Secondary postpartum hemorrhage: Incidence, etiologies, and clinical courses in the setting of a high cesarean delivery rate	PLOS ONE			English	Article							PSEUDOANEURYSM; MORBIDITY	Objectives To evaluate the incidence, etiologies, and clinical outcomes of secondary postpartum hemorrhage in a hospital with a high cesarean section rate and to compare the etiologies of secondary postpartum hemorrhage following cesarean delivery versus vaginal delivery. Materials and methods This retrospective study included 123 women with secondary postpartum hemorrhage who were treated at a tertiary-level hospital between January 2004 and June 2018. Descriptive statistics and the chi-square test were used for data analysis. Results The incidence of secondary postpartum hemorrhage was 0.21%. The median onset of bleeding was 12 days after delivery. Fifty-two percent of the deliveries were by cesarean section. The most common etiology of secondary postpartum hemorrhage was endometritis (67.5%), followed by retained placental tissue (21.1%). Women who delivered by cesarean section had a higher rate of endometritis (80.0% vs 53.4%) and a lower rate of retained placental tissue (10.8% vs. 32.8%) than those who delivered vaginally. Surgical intervention included uterine evacuation in 29.3% and hysterectomy in 8.1% of the patients. Five percent of women were treated by embolization. Conclusions Endometritis was the most common cause of secondary postpartum hemorrhage. Women who delivered by cesarean section were less likely to have retained placental tissue but were at higher risk for endometritis and uterine pseudoaneurysm than those who delivered vaginally.	[Chainarong, Natthicha; Deevongkij, Kittiya; Petpichetchian, Chusana] Prince Songkla Univ, Fac Med, Dept Obstet & Gynecol, Hat Yai, Songkhla, Thailand	Prince of Songkla University	Petpichetchian, C (corresponding author), Prince Songkla Univ, Fac Med, Dept Obstet & Gynecol, Hat Yai, Songkhla, Thailand.	chusana020@gmail.com		Petpichetchian, Chusana/0000-0002-6357-2490				Babarinsa IA, 2011, EUR J OBSTET GYN R B, V159, P255, DOI 10.1016/j.ejogrb.2011.07.029; Boyd BK., 1995, J MATERN-FETAL NEO M, V4, P19; Debost-Legrand A, 2015, BIRTH-ISS PERINAT C, V42, P235, DOI 10.1111/birt.12175; Descargues G, 2001, EUR J OBSTET GYN R B, V97, P26, DOI 10.1016/S0301-2115(00)00482-6; Dossou M, 2015, BIRTH-ISS PERINAT C, V42, P149, DOI 10.1111/birt.12164; Eason DE, 2006, J CLIN ULTRASOUND, V34, P407, DOI 10.1002/jcu.20259; Fallahian M., 2005, ARCH IRAN MED, V8, P234; HENDERSON E, 1995, J HOSP INFECT, V29, P245, DOI 10.1016/0195-6701(95)90271-6; Hoveyda F, 2001, BRIT J OBSTET GYNAEC, V108, P927, DOI 10.1111/j.1471-0528.2001.00230.x; Leth RA, 2009, ACTA OBSTET GYN SCAN, V88, DOI 10.1080/00016340903147405; Plunk M, 2013, AM J ROENTGENOL, V200, pW143, DOI 10.2214/AJR.12.9637; Samad S, 2009, EMERG MED J, V26, P621, DOI 10.1136/emj.2008.066407; Tsai HF, 2013, TAIWAN J OBSTET GYNE, V52, P411, DOI 10.1016/j.tjog.2012.04.041; Weydert JA, 2006, ARCH PATHOL LAB MED, V130, P1538; Yi SW, 2017, J OBSTET GYNAECOL, V37, P416, DOI 10.1080/01443615.2016.1274292; Zubor P, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-80	16	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264583	10.1371/journal.pone.0264583	http://dx.doi.org/10.1371/journal.pone.0264583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231065	Green Submitted, gold, Green Published			2022-12-26	WOS:000849744700029
J	de Assis, CS; Diniz, TG; Alcantara, JOS; Brito, VPAD; do Nascimento, RAF; Nunes, MKD; Silva, AS; Evangelista, IWD; Viturino, MGM; de Lima, RLFC; Persuhn, DC				de Assis, Caroline Severo; Diniz, Taina Gomes; Scarano Alcantara, Joao Otavio; Alves de Sousa Brito, Vanessa Polyana; Ferreira do Nascimento, Rayner Anderson; dos Santos Nunes, Mayara Karla; Silva, Alexandre Sergio; de Queiroga Evangelista, Isabella Wanderley; Monteiro Viturino, Marina Goncalves; Formiga Cavalcanti de Lima, Rafaela Lira; Persuhn, Darlene Camati			Metabolic impact of the VDR rs1544410 in diabetic retinopathy	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; CORONARY-ARTERY-DISEASE; GENE POLYMORPHISMS; RISK-FACTORS; D DEFICIENCY; ASSOCIATION; BSMI; COMPLICATIONS; NEPHROPATHY; PROGRESSION	Aims To investigate the association between Bsml and DM2 in patients with and without DR and to correlate with clinical parameters in a population in northeastern Brazil. Methods Cross-sectional case-control study in which data were collected from 285 individuals, including 128 patients with DM2 and 157 with DR. Clinical, biochemical and anthropometric parameters were analyzed, in addition to the single nucleotide polymorphism (SNP) Bsml of the VDR gene (rs1544410), genotyped by PCR-RFLP. Results In the DR group we found a greater number of patients using insulin therapy (p = 0.000) and with longer duration of DM2 (p = 0.000), in addition to higher serum creatinine values (p = 0.001). Higher fasting glucose levels and higher frequency of insulinoterapy were independently observed in patients with DR and b allele carriers, when compared to BB. Conclusion The association of the bb/Bb genotypes (rs1544410) of the VDR gene with increased blood glucose levels and insulinoterapy may represent worse glicemic control in rs1544410 b allele carriers in DR Latin American individuals.	[de Assis, Caroline Severo; Diniz, Taina Gomes; Scarano Alcantara, Joao Otavio; Alves de Sousa Brito, Vanessa Polyana; Formiga Cavalcanti de Lima, Rafaela Lira; Persuhn, Darlene Camati] Univ Fed Paraiba, Postgrad Program Nutr Sci, Joao Pessoa, Paraiba, Brazil; [Ferreira do Nascimento, Rayner Anderson] Uninassau Fac, Joao Pessoa, Paraiba, Brazil; [dos Santos Nunes, Mayara Karla] Univ Fed Paraiba, Postgrad Program Dev & Technol Innovat Med DITM, Joao Pessoa, Paraiba, Brazil; [Silva, Alexandre Sergio] Univ Fed Paraiba, Dept Phys Educ, Joao Pessoa, Paraiba, Brazil; [de Queiroga Evangelista, Isabella Wanderley; Monteiro Viturino, Marina Goncalves] Univ Fed Paraiba, Lauro Wanderley Univ Hosp, Ophthalmol Otolaryngol & Oral & Maxillofacial Sur, Joao Pessoa, Paraiba, Brazil; [Formiga Cavalcanti de Lima, Rafaela Lira] Univ Fed Paraiba, Dept Nutr, Joao Pessoa, Paraiba, Brazil; [Persuhn, Darlene Camati] Univ Fed Paraiba, Dept Mol Biol, Joao Pessoa, Paraiba, Brazil	Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba	Persuhn, DC (corresponding author), Univ Fed Paraiba, Postgrad Program Nutr Sci, Joao Pessoa, Paraiba, Brazil.	darlenecp@hotmail.com	Silva, Alexandre S/N-8883-2014	Silva, Alexandre S/0000-0003-3576-9023; DE ASSIS, CAROLINE/0000-0003-0525-1418	Programa Pesquisa para o SUS - PPSUS - Paraiba State Research Foundation (FAPESQ, Paraiba, Brazil) [005/2020]; National Council for Scientific and Technological Development (CNPq, Brasilia, Brazil) Ministry of Health / Decit/SCTIE (Decit/SCTIE/MS), State Health Secretary (SES/ Paraiba/Brazil); Paraiba State Research Foundation (FAPESQ, Paraiba, Brazil) [05/2021]; Produtividade em Pesquisa PROPESQ/PRPG/UFPB grant [03/2020, PIA13262-2020]; Coordination for the Improvement of Higher Education Personnel (CAPES) [001]; National Council for Scientific and Technological Development (CNPq, Brasilia, Brazil); Coordination for the Improvement of Higher Education Personnel (CAPES, Brasilia, Brazil); State of Paraiba Research Support Foundation (FAPESQ, Paraiba, Brazil)	Programa Pesquisa para o SUS - PPSUS - Paraiba State Research Foundation (FAPESQ, Paraiba, Brazil); National Council for Scientific and Technological Development (CNPq, Brasilia, Brazil) Ministry of Health / Decit/SCTIE (Decit/SCTIE/MS), State Health Secretary (SES/ Paraiba/Brazil); Paraiba State Research Foundation (FAPESQ, Paraiba, Brazil); Produtividade em Pesquisa PROPESQ/PRPG/UFPB grant; Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq, Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES, Brasilia, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); State of Paraiba Research Support Foundation (FAPESQ, Paraiba, Brazil)	This study was supported by Public Call n. 005/2020 Programa Pesquisa para o SUS - PPSUS - Paraiba State Research Foundation (FAPESQ, Paraiba, Brazil), National Council for Scientific and Technological Development (CNPq, Brasilia, Brazil) Ministry of Health / Decit/SCTIE (Decit/SCTIE/MS), State Health Secretary (SES/ Paraiba/Brazil); Grant 05/2021, Paraiba State Research Foundation (FAPESQ, Paraiba, Brazil). It was also supported by Public Call n. 03/2020 Produtividade em Pesquisa PROPESQ/PRPG/UFPB grant n. PIA13262-2020 and Coordination for the Improvement of Higher Education Personnel (CAPES) - Financial Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank at the Lauro Wanderley University Hospital, Federal University of Paraiba and all participants in the study for participation and the financial support institutions, National Council for Scientific and Technological Development (CNPq, Brasilia, Brazil), the Coordination for the Improvement of Higher Education Personnel (CAPES, Brasilia, Brazil) and the State of Paraiba Research Support Foundation (FAPESQ, Paraiba, Brazil). The authors declare that they have no competing interests.	Al Safar H, 2018, J STEROID BIOCHEM, V175, P119, DOI 10.1016/j.jsbmb.2017.03.012; Al-Daghri NM, 2014, GENE, V542, P129, DOI 10.1016/j.gene.2014.03.044; Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385; Angel B, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0038-9; Antunes MV, 2008, REV BRAS CIENC FARM, V44, P279, DOI 10.1590/S1516-93322008000200013; Brazilian Diabetes Society, 2020, GUID BRAZ DIAB SOC C; Brazilian Society of Nephrology e-book, 2011, E BOOK BIOM NEPHR; Bucan K, 2009, COLLEGIUM ANTROPOL, V33, P99; Carvalho C, 2015, LUPUS, V24, P846, DOI 10.1177/0961203314566636; Chen YH, 2012, DIABETES CARE, V35, P803, DOI 10.2337/dc11-1955; Cobayashi F, 2015, INT J MOL SCI, V16, P12531, DOI 10.3390/ijms160612531; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cyganek K, 2006, ACTA DIABETOL, V43, P114, DOI 10.1007/s00592-006-0225-3; Duh EJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93751; Durrin LK, 1999, BBA-MOL BASIS DIS, V1453, P311, DOI 10.1016/S0925-4439(99)00007-1; Ezhilarasi K, 2018, INT J BIOL MACROMOL, V116, P346, DOI 10.1016/j.ijbiomac.2018.05.026; Faludi AA, 2017, ARQ BRAS CARDIOL, V109, P1, DOI 10.5935/abc.20170188; Ferrarezi DAF, 2013, DIABETES METAB, V39, P263, DOI 10.1016/j.diabet.2012.11.004; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gyorffy B, 2002, EUR J ENDOCRINOL, V147, P803, DOI 10.1530/eje.0.1470803; Han FF, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0477-7; Hong YJ, 2015, ENDOCRINOL METAB, V30, P469, DOI 10.3803/EnM.2015.30.4.469; Jiao JH, 2018, AFR HEALTH SCI, V18, P891, DOI 10.4314/ahs.v18i4.7; JOHNSON JA, 1994, AM J PHYSIOL, V267, pE356, DOI 10.1152/ajpendo.1994.267.3.E356; Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0; Kim JH, 2011, J KOREAN MED SCI, V26, P1068, DOI 10.3346/jkms.2011.26.8.1068; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; Liu Y, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000025934; Luo BA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030307; Maddaloni E, 2018, FRONT HORM RES, V50, P161, DOI 10.1159/000486083; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Motohashi Y, 2003, J CLIN ENDOCR METAB, V88, P3137, DOI 10.1210/jc.2002-021881; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Oh JY, 2002, METABOLISM, V51, P356, DOI 10.1053/meta.2002.29969; Ojuka EO, 2004, P NUTR SOC, V63, P275, DOI 10.1079/PNS2004339; Ortlepp JR, 2003, DIABETIC MED, V20, P451, DOI 10.1046/j.1464-5491.2003.00971.x; Pani MA, 2000, DIABETES, V49, P504, DOI 10.2337/diabetes.49.3.504; Payne JF, 2012, ENDOCR PRACT, V18, P185, DOI 10.4158/EP11147.OR; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Precoma DB, 2021, ARQ BRAS CARDIOL, V116, P855; Precoma DB, 2019, ARQ BRAS CARDIOL, V113, P787, DOI 10.5935/abc.20190204; Rosendorff C, 2015, HYPERTENSION, V65, P1372, DOI 10.1161/HYP.0000000000000018; Salinero-Fort MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076417; Shaat N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232297; Song N, 2019, GENET TEST MOL BIOMA, V23, P533, DOI 10.1089/gtmb.2019.0037; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vedralova M, 2012, KIDNEY BLOOD PRESS R, V36, P1, DOI 10.1159/000339021; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wong TY, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.12; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111320; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zhang H, 2012, GENE, V495, P183, DOI 10.1016/j.gene.2011.12.049; Zhang J, 2017, CAN J OPHTHALMOL, V52, pS39, DOI 10.1016/j.jcjo.2017.09.026; Zhang Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5305282; Zhong X, 2015, GENE, V566, P212, DOI 10.1016/j.gene.2015.04.045	58	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263346	10.1371/journal.pone.0263346	http://dx.doi.org/10.1371/journal.pone.0263346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213542	gold, Green Published			2022-12-26	WOS:000787811000021
J	De Jong, KA; Berisha, F; Naderpoor, N; Appelbe, A; Kotowicz, MA; Cukier, K; McGee, SL; Nikolaev, VO				De Jong, Kirstie A.; Berisha, Filip; Naderpoor, Negar; Appelbe, Alan; Kotowicz, Mark A.; Cukier, Kimberly; McGee, Sean L.; Nikolaev, Viacheslav O.			Polycystic ovarian syndrome increases prevalence of concentric hypertrophy in normotensive obese women	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; GEOMETRY; ECHOCARDIOGRAPHY; RECOMMENDATIONS; MORTALITY; UPDATE; RISK	Background It remains unclear as to whether polycystic ovary syndrome (PCOS) is an additional risk factor in the development of left ventricular (LV) hypertrophy in obese women. In the current study, we provide clarity on this issue by rigorously analysing patient LV geometry beyond the basic clinical measures currently used. Importantly, the cohort contained only normotensive patients that would normally be deemed low risk with no further intervention required. Methods The study comprised 24 obese women with PCOS and 29 obese Control women. Transthoracic echocardiography was used to evaluate LV structure/function. Basic clinical and metabolic data were collected for each participant consisting of age, BMI, blood pressure, fasting glucose, LDL-C, HLD-C, cholesterol and triglyceride levels. Exclusion criteria; BMI < 30 g/m(2), type 2 diabetes, hypertension. Results Both groups exhibited concentric remodelling of the LV posterior wall at a prevalence of similar to 20%, this associated with grade 1 diastolic dysfunction. Estimated LV mass/height(2.7) was increased patients with PCOS (45 +/- 2.2 vs 37 +/- 1.6) with 33% exhibiting LV mass/height(2.7) above ASE guidelines, compared to 7% in Controls. Furthermore, 25% of patients with PCOS were characterised with concentric hypertrophy, an alteration in LV geometry that was not observed in the Control group. Conclusions To our knowledge, this is the first study to assess LV geometric patterns in obese women with PCOS. The results suggest that obese women with PCOS are at greater risk of concentric hypertrophy than obese only women and provide justification for additional cardiovascular risk assessment in normotensive obese/PCOS women.	[De Jong, Kirstie A.; Berisha, Filip; Nikolaev, Viacheslav O.] Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany; [De Jong, Kirstie A.; Berisha, Filip; Nikolaev, Viacheslav O.] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany; [De Jong, Kirstie A.; McGee, Sean L.] Deakin Univ, Sch Med, Inst Mental & Phys Hlth & Clin Translat IMPACT, Metab Res Unit,Metab Reprogramming Lab, Waurn Ponds, Vic, Australia; [Berisha, Filip] Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany; [Naderpoor, Negar; Cukier, Kimberly] Geelong Endocrinol & Diabet Ctr, Geelong, Vic, Australia; [Naderpoor, Negar] Monash Univ, Monash Ctr Hlth Res & Implementat, Clayton, Vic, Australia; [Appelbe, Alan] Univ Hosp Geelong, Barwon Hlth, Cardiol Dept, Geelong, Vic, Australia; [Kotowicz, Mark A.] Univ Hosp, Endocrinol Dept, Barwon Hlth, Geelong, Vic, Australia; [Kotowicz, Mark A.] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Kotowicz, Mark A.] Univ Melbourne, Melbourne Med Sch, Dept Med Western Hlth, Melbourne, Vic, Australia	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Deakin University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Monash University; Geelong Hospital; Geelong Hospital; Deakin University; University of Melbourne	De Jong, KA (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany.; De Jong, KA (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany.; De Jong, KA (corresponding author), Deakin Univ, Sch Med, Inst Mental & Phys Hlth & Clin Translat IMPACT, Metab Res Unit,Metab Reprogramming Lab, Waurn Ponds, Vic, Australia.	k.de-jong@uke.de						Alexander CJ, 2009, REV CARDIOVASC MED, V10, P83; Aune E, 2015, JACC-CARDIOVASC IMAG, V8, P656, DOI 10.1016/j.jcmg.2015.02.014; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; De Jong KA, 2017, CAN J CARDIOL, V33, P860, DOI 10.1016/j.cjca.2017.03.009; De Jong KA, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0504-z; Ikeda Y, 2012, J ENDOCRINOL, V214, P1, DOI 10.1530/JOE-12-0126; Jovic JJ, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/8862878; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lavie CJ, 2007, AM J CARDIOL, V100, P1460, DOI 10.1016/j.amjcard.2007.06.040; Muiesan ML, 2004, HYPERTENSION, V43, P731, DOI 10.1161/01.HYP.0000121223.44837.de; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Norman RJ, 2001, HUM REPROD, V16, P1995, DOI 10.1093/humrep/16.9.1995; Tsao CW, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002188; Wang ET, 2012, J CLIN ENDOCR METAB, V97, P4656, DOI 10.1210/jc.2012-1597	15	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263312	10.1371/journal.pone.0263312	http://dx.doi.org/10.1371/journal.pone.0263312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213570	Green Published, gold			2022-12-26	WOS:000787811000020
J	Natalia, YA; Faes, C; Neyens, T; Molenberghs, G				Natalia, Yessika Adelwin; Faes, Christel; Neyens, Thomas; Molenberghs, Geert			The COVID-19 wave in Belgium during the Fall of 2020 and its association with higher education	PLOS ONE			English	Article							UNITED-STATES	Soon after SARS-CoV-2 emerged in late 2019, Belgium was confronted with a first COVID-19 wave in March-April 2020. SARS-CoV-2 circulation declined in the summer months (late May to early July 2020). Following a successfully trumped late July-August peak, COVID-19 incidence fell slightly, to then enter two successive phases of rapid incline: in the first half of September, and then again in October 2020. The first of these coincided with the peak period of returning summer travelers; the second one coincided with the start of higher education's academic year. The largest observed COVID-19 incidence occurred in the period 16-31 October, particularly in the Walloon Region, the southern, French-speaking part of Belgium. We examine the potential association of the higher education population with spatio-temporal spread of COVID-19, using Bayesian spatial Poisson models for confirmed test cases, accounting for socio-demographic heterogeneity in the population. We find a significant association between the number of COVID-19 cases in the age groups 18-29 years and 30-39 years and the size of the higher education student population at the municipality level. These results can be useful towards COVID-19 mitigation strategies, particularly in areas where virus transmission from higher education students into the broader community could exacerbate morbidity and mortality of COVID-19 among populations with prevalent underlying conditions associated with more severe outcomes following infection.	[Natalia, Yessika Adelwin; Faes, Christel; Neyens, Thomas; Molenberghs, Geert] Hasselt Univ, Data Sci Inst, I BioStat, Hasselt, Belgium; [Neyens, Thomas; Molenberghs, Geert] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Fac Med, L BioStat, Leuven, Belgium	Hasselt University; KU Leuven	Natalia, YA (corresponding author), Hasselt Univ, Data Sci Inst, I BioStat, Hasselt, Belgium.	yessikaadelwin.natalia@uhasselt.be	FAES, Christel/E-1384-2017	FAES, Christel/0000-0002-1878-9869; Natalia, Yessika Adelwin/0000-0002-4622-2616; Neyens, Thomas/0000-0003-2364-7555	European Union's Horizon 2020 research and innovation programme - project EpiPose [101003688]	European Union's Horizon 2020 research and innovation programme - project EpiPose	C. F. acknowledges funding from the European Union's Horizon 2020 research and innovation programme - project EpiPose (No. 101003688; https://ec.europa.eu/programmes/ horizon2020/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsan M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12403; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bae S, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e288; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Bhadra A, 2021, MODEL EARTH SYST ENV, V7, P623, DOI 10.1007/s40808-020-00984-7; Bjornsson AH, 2020, LAEKNABLADID, V106, P247, DOI 10.17992/lbl.2020.05.581; Boehmer TK, 2020, MMWR-MORBID MORTAL W, V69, P1404, DOI 10.15585/mmwr.mm6939e1; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Garland P., 2020, COVID 19 PANDEMIC EX; Gausman J, 2020, J WOMENS HEALTH, V29, P465, DOI 10.1089/jwh.2020.8472; Hawkins RB, 2020, PUBLIC HEALTH, V189, P129, DOI 10.1016/j.puhe.2020.09.016; Hodcroft EB, 2021, NATURE, V595, P707, DOI [10.1038/s41586-021-03677-y, 10.1101/2020.10.25.20219063]; Holmager TLF, 2021, SCAND J PUBLIC HEALT, V49, P88, DOI 10.1177/1403494820975607; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Jefferies S, 2020, LANCET PUBLIC HEALTH, V5, pE612, DOI 10.1016/S2468-2667(20)30225-5; Kadi Nadjat, 2020, Bull Natl Res Cent, V44, P138, DOI 10.1186/s42269-020-00393-x; Lampl BMJ, 2020, GMS HYG INFECT CONTR, V15, DOI 10.3205/dgkh000362; Larosa E, 2020, EUROSURVEILLANCE, V25, DOI 10.2807/1560-7917.ES.2020.25.49.2001911; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Leeb RT, 2020, MMWR-MORBID MORTAL W, V69, P1410, DOI 10.15585/mmwr.mm6939e2; Leidner AJ, 2021, MMWR-MORBID MORTAL W, V70, P14, DOI 10.15585/mmwr.mm7001a4; Mallon PW., 2021, MEDRXIV; Martino S., 2009, IMPLEMENTING APPROXI; Matusiak L, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13909; Miron VD, 2020, GERMS, V10, P294, DOI 10.18683/germs.2020.1220; Nagata JM, 2020, J ADOLESCENT HEALTH, V67, P297, DOI 10.1016/j.jadohealth.2020.04.020; Pedersen MJ, 2020, PUBLIC ADMIN REV, V80, P805, DOI 10.1111/puar.13240; Pouwels KB, 2021, LANCET PUBLIC HEALTH, V6, pE30, DOI 10.1016/S2468-2667(20)30282-6; R Core Team, 2020, R LANG ENV STAT COMP; Robert Koch Institute, 2021, INFORM DESIGNATION I; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sciensano, 2021, BELGIUM COVID 19 EPI; Sciensano, 2020, TESTING STRATEGY PRI; Sciensano, 2020, COVID 19 EPIDEMIOLOG; Sciensano, 2020, SCIENSANO; Sciensano, 2020, BELGIUM COVID 19 EPI; Sciensano, 2021, BELG MORT STAT; Seemann T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18314-x; Siu JYM, 2021, HEALTH SOC CARE COMM, V29, P1522, DOI 10.1111/hsc.13214; Statbel, 2020, STRUCTURE POPULATION; Statbel, 2021, MONTHLY FIGURES LABO; Statbel, 2020, FOC SECT; Vang KE, 2021, MMWR-MORBID MORTAL W, V70, P20, DOI 10.15585/mmwr.mm7001a5; Venkatesan P, 2020, LANCET RESP MED, V8, pE95, DOI 10.1016/S2213-2600(20)30461-6; Veto, 2020, MONDMASKER DRAGEN ZO; Wilder-Smith A, 2021, TROP DIS TRAVEL MED, V7, DOI 10.1186/s40794-020-00129-9; Wilson E, 2020, MMWR-MORBID MORTAL W, V69, P1416, DOI 10.15585/mmwr.mm6939e3; World Health Organization, 2021, NOV COR 2019 NCOV SI; Worldometers info, AGE SEX EXISTING CON; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yasri S, 2020, INT J PREVENTIVE MED, V11, DOI 10.4103/ijpvm.IJPVM_121_20	51	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264516	10.1371/journal.pone.0264516	http://dx.doi.org/10.1371/journal.pone.0264516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213651	Green Published, gold			2022-12-26	WOS:000787811000113
J	AbuRuz, S; Al-Azayzih, A; ZainAlAbdin, S; Beiram, R; Al Hajjar, M				AbuRuz, Salah; Al-Azayzih, Ahmad; ZainAlAbdin, Sham; Beiram, Rami; Al Hajjar, Mohammed			Clinical characteristics and risk factors for mortality among COVID-19 hospitalized patients in UAE: Does ethnic origin have an impact	PLOS ONE			English	Article								BackgroundThe relationship between COVID-19 patient's clinical characteristics and disease manifestation remains incompletely understood. The impact of ethnicity on mortality of patients with COVID-19 infection is poorly addressed in the literature. Emerging evidence suggests that many risk factors are related to symptoms severity and mortality risk, emphasizing the necessity of fulfilling this knowledge gap that may help reducing mortality from COVID-19 infections through tackling the risk factors. AimsTo explore epidemiological and demographic characteristics of hospitalized COVID-19 patients from different ethnic origins living in the UAE, compare them to findings reported across the globe and determine the impact of these characteristics and ethnicity on mortality during hospitalization. MethodsA single center, retrospective chart review study of hospitalized COVID-19 patients was conducted in a large COVID-19 referral hospital in UAE. The following outcomes were assessed: patients' clinical characteristics, disease symptoms and severity, and association of ethnicity and other risk factors on 30-day in hospital mortality. ResultsA total of 3296 patients were recruited in this study with an average age of 44.3 +/- 13.4 years old. Preliminary data analysis indicated that 78.3% (n = 2582) of cases were considered mild. Average duration of hospital stay was 6.0 +/- 7.3 days and 4.3% (n = 143) were admitted to ICU. The most frequently reported symptoms were cough (32.6%, n = 1075) and fever (22.2%, n = 731). The 30-day mortality rate during hospitalization was 2.7% (n = 90). Many risk factors were associated with mortality during hospitalization including: age, respiratory rate (RR), creatinine, and C-reactive protein, oxygen saturation (SaO(2)), hemoglobin, hematocrit, ferritin, creatinine, C-reactive protein, anemia, COPD, Chronic kidney disease, dyslipidemia, Vitamin-D Deficiency, and ethnic origin (p <0.05). Multiple logistic regression analysis showed that higher mortality rates during hospitalization was associated with anemia, chronic obstructive pulmonary disease (COPD), chronic kidney disease, and Middle Eastern origin (p<0.05). ConclusionThe results indicated that most COVID-19 cases were mild and morality rate was low compared to worldwide reported mortality. Mortality rate during hospitalization was higher in patients from Middle East origin with preexisting comorbidities especially anemia, COPD, and chronic kidney disease. Due to the relatively small number of mortality cases, other identified risk factors from univariate analysis such as age, respiratory rate, and Vitamin-D (VitD) deficiency should also be taken into consideration. It is crucial to stratify patients on admission based on these risk factors to help decide intensity and type of treatment which, possibly, will reduce the risk of death.	[AbuRuz, Salah; ZainAlAbdin, Sham; Beiram, Rami] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates; [AbuRuz, Salah] Univ Jordan, Fac Pharm, Dept Clin Pharm, Amman, Jordan; [Al-Azayzih, Ahmad] Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan; [Al Hajjar, Mohammed] Al Ain Hosp, Dept Pharm, Al Ain, U Arab Emirates	United Arab Emirates University; University of Jordan; Jordan University of Science & Technology	AbuRuz, S (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates.; AbuRuz, S (corresponding author), Univ Jordan, Fac Pharm, Dept Clin Pharm, Amman, Jordan.	saburuz@uaeu.edu.ac.ae	aburuz, salah/P-4293-2018	aburuz, salah/0000-0002-2478-3914				Adams JG, 2020, JAMA-J AM MED ASSOC, V323, P1439, DOI 10.1001/jama.2020.3972; Al Heialy S, 2021, SAUDI J BIOL SCI, V28, P1445, DOI 10.1016/j.sjbs.2020.11.081; [Anonymous], 2021, PRIM GOV EFF CONT CO; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Aruru M, 2021, RES SOC ADMIN PHARM, V17, P1967, DOI 10.1016/j.sapharm.2020.04.002; Banach M, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104891; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Chung Tom Wai-Hin, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa199; Feingold KR, 2020, ENDOTEXT INTERNET; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; He YZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.927212; Hemauer SJ, 2017, CRIT CARE MED, V45, pE479, DOI 10.1097/CCM.0000000000002288; Hernandez-Garduno E, 2020, OBES RES CLIN PRACT, V14, P375, DOI 10.1016/j.orcp.2020.06.001; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jelinek HF, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000427; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Li Y, 2021, CLIN CHIM ACTA, V517, P66, DOI 10.1016/j.cca.2021.02.011; Luo MQ, 2020, J CLIN ANESTH, V67, DOI 10.1016/j.jclinane.2020.110039; Marin BG, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2146; Mullol J, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-00961-1; Novelli A, 2020, HLA, V96, P610, DOI 10.1111/tan.14047; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Palmieri L, 2020, J GERONTOL A-BIOL, V75, P1796, DOI 10.1093/gerona/glaa146; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Radujkovic A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092757; Rozanska J, 2017, UAE A HUB CULTURAL D; Saadati Mojtaba, 2020, Iran J Public Health, V49, P2433, DOI 10.18502/ijph.v49i12.4837; Salimi H, 2020, J BIOL CHEM, V295, P348, DOI 10.1074/jbc.RA119.009481; Taneri PE, 2020, EUR J EPIDEMIOL, V35, P763, DOI 10.1007/s10654-020-00678-5; Tang QP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050438; Vouga M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92357-y; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Weir EK, 2020, CLIN MED, V20, pE107, DOI 10.7861/clinmed.2020-0301; Yu N, 2020, LANCET INFECT DIS, V20, P559, DOI 10.1016/S1473-3099(20)30176-6; Zhang AJ, 2021, CLIN INFECT DIS, V73, pE503, DOI 10.1093/cid/ciaa995; Zhang JJY, 2020, CLIN INFECT DIS, V71, P2199, DOI 10.1093/cid/ciaa576; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021	42	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264547	10.1371/journal.pone.0264547	http://dx.doi.org/10.1371/journal.pone.0264547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235580	gold, Green Published			2022-12-26	WOS:000787073100035
J	Ortiz-Paredes, D; Varsaneux, O; Worthington, J; Park, H; MacDonald, SE; Basta, NE; Lebouche, B; Cox, J; Ismail, SJ; Kronfli, N				Ortiz-Paredes, David; Varsaneux, Olivia; Worthington, James; Park, Hyejin; MacDonald, Shannon E.; Basta, Nicole E.; Lebouche, Bertrand; Cox, Joseph; Ismail, Shainoor J.; Kronfli, Nadine			Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons	PLOS ONE			English	Article							INCENTIVES; PARTICIPATION; IMMUNIZATION; HESITANCY	BackgroundVaccine uptake rates have been historically low in correctional settings. To better understand vaccine hesitancy in these high-risk settings, we explored reasons for COVID-19 vaccine refusal among people in federal prisons. MethodsThree maximum security all-male federal prisons in British Columbia, Alberta, and Ontario (Canada) were chosen, representing prisons with the highest proportions of COVID-19 vaccine refusal. Using a qualitative descriptive design and purposive sampling, individual semi-structured interviews were conducted with incarcerated people who had previously refused at least one COVID-19 vaccine until data saturation was achieved. An inductive-deductive thematic analysis of audio-recorded interview transcripts was conducted using the Conceptual Model of Vaccine Hesitancy. ResultsBetween May 19-July 8, 2021, 14 participants were interviewed (median age: 30 years; n = 7 Indigenous, n = 4 visible minority, n = 3 White). Individual-, interpersonal-, and system-level factors were identified. Three were particularly relevant to the correctional setting: 1) Risk perception: participants perceived that they were at lower risk of COVID-19 due to restricted visits and interactions; 2) Health care services in prison: participants reported feeling "punished" and stigmatized due to strict COVID-19 restrictions, and failed to identify personal benefits of vaccination due to the lack of incentives; 3) Universal distrust: participants expressed distrust in prison employees, including health care providers. InterpretationReasons for vaccine refusal among people in prison are multifaceted. Educational interventions could seek to address COVID-19 risk misconceptions in prison settings. However, impact may be limited if trust is not fostered and if incentives are not considered in vaccine promotion.	[Ortiz-Paredes, David; Park, Hyejin; Lebouche, Bertrand; Cox, Joseph; Kronfli, Nadine] McGill Univ Hlth Ctr, Ctr Outcomes Res & Evaluat, Res Inst, Montreal, PQ, Canada; [Varsaneux, Olivia; Worthington, James] Correct Serv Canada CSC, Ottawa, ON, Canada; [MacDonald, Shannon E.] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [MacDonald, Shannon E.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Basta, Nicole E.; Cox, Joseph; Kronfli, Nadine] McGill Univ, Sch Populat & Global Hlth, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Lebouche, Bertrand] McGill Univ, Fac Med & Hlth Sci, Dept Family Med, Montreal, PQ, Canada; [Lebouche, Bertrand; Cox, Joseph; Kronfli, Nadine] McGill Univ Hlth Ctr, Dept Med, Div Infect Dis & Chron Viral Illness Serv, Montreal, PQ, Canada; [Ismail, Shainoor J.] Publ Hlth Agcy Canada, Div Immunizat Programs & Pandem Preparedness, Ctr Immunizat & Resp Infect Dis, Ottawa, ON, Canada; [Ismail, Shainoor J.] Metro City Med Clin, Edmonton, AB, Canada	McGill University; University of Alberta; University of Alberta; McGill University; McGill University; McGill University; Public Health Agency of Canada	Kronfli, N (corresponding author), McGill Univ Hlth Ctr, Ctr Outcomes Res & Evaluat, Res Inst, Montreal, PQ, Canada.; Kronfli, N (corresponding author), McGill Univ, Sch Populat & Global Hlth, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Kronfli, N (corresponding author), McGill Univ Hlth Ctr, Dept Med, Div Infect Dis & Chron Viral Illness Serv, Montreal, PQ, Canada.	nadine.kronfli@mcgill.ca	Park, Hyejin/GLT-6311-2022; LEBOUCHE, Bertrand/GZL-8127-2022	Park, Hyejin/0000-0002-5355-5187; LEBOUCHE, Bertrand/0000-0002-1273-9393; varsaneux, olivia/0000-0003-3249-0721; Cox, Joseph/0000-0002-7041-1556; Ortiz-Paredes, David/0000-0002-0431-4889				[Anonymous], 2019, ACT AMEND CORRECTION; Bagnall AM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1584-x; Barnes MD, 2020, INQUIRY-J HEALTH CAR, V57, DOI 10.1177/0046958020923537; Beaudry G, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003201; Benin AL, 2006, PEDIATRICS, V117, P1532, DOI 10.1542/peds.2005-1728; Blair A., 2020, MEDRXIV, DOI [10.1101/2020.05.02.20086314, DOI 10.1101/2020.05.02.20086314]; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019381; Burton-Jeangros C, 2005, REV EPIDEMIOL SANTE, V53, P341, DOI 10.1016/S0398-7620(05)84616-4; Cholodofsky R., 2021, WESTMORELAND COUNTY; Clark M., 2021, TOWN HALL Q A PENNSY; Cloyes KG, 2016, AM J HOSP PALLIAT ME, V33, P390, DOI 10.1177/1049909115574491; Correctional Service Canada, 2021, VACC ADM INM FED COR; Correctional Service Canada, 2022, TEST INM FED CORR I; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Driftmier P., 2021, J CORRECT HEALTH CAR, DOI [10.11575/prism/38635, DOI 10.11575/PRISM/38635]; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; European Centre for Disease Prevention and Control, 2017, CAT INT ADDR VACC HE; Gagnon D., 2019, LIT REV EFFECTIVE ST; Geana MV, 2021, PUBLIC HEALTH NURS, V38, P892, DOI 10.1111/phn.12922; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Government of Canada, 2019, VIS MIN PERS; Griffith J, 2021, J MED INTERNET RES, V23, DOI 10.2196/26874; Gust D, 2005, AM J HEALTH BEHAV, V29, P81, DOI 10.5993/AJHB.29.1.7; Higgins ST, 2021, PREV MED, V145, DOI 10.1016/j.ypmed.2021.106421; Hu Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5070-0; Kronfli N, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100659; Kronfli N, 2019, CAN LIVER J, V2, P171, DOI 10.3138/canlivj.2019-0007; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lewis N., 2021, WE ASKED PEOPLE BARS; Liebling A., 2008, J SCAND STUD CRIMINO, V9, P25, DOI [10.1080/14043850802450773, DOI 10.1080/14043850802450773>;]; Madeddu G, 2019, VACCINE, V37, P4906, DOI 10.1016/j.vaccine.2019.07.014; Malakieh J., 2020, AD YOUTH CORR STAT C; Matheson FI, 2012, AM J PUBLIC HEALTH, V102, P1438, DOI 10.2105/AJPH.2012.300685; Muhajarine N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259513; National Advisory Committee on Immunization, 2020, PREL GUID KEY POP EA; Nowotny KM, 2018, SOCIOL COMPASS, V12, DOI 10.1111/soc4.12566; Paul E, 2021, LANCET REG HEALTH-EU, V1, DOI 10.1016/j.lanepe.2020.100012; Perry AE, 2021, ECLINICALMEDICINE, V32, DOI 10.1016/j.eclinm.2020.100702; Piedimonte S, 2018, J OBSTET GYNAECOL CA, V40, P440, DOI 10.1016/j.jogc.2017.07.028; Pont J, 2012, AM J PUBLIC HEALTH, V102, P475, DOI 10.2105/AJPH.2011.300374; Purnell JQ, 2014, J ACAD NUTR DIET, V114, P1023, DOI 10.1016/j.jand.2014.03.011; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Seddon T, 2005, ADDICT RES THEORY, V13, P101, DOI 10.1080/16066350512331328122; Shepherd SM, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4603-2; Singer E, 2006, AM J PREV MED, V31, P411, DOI 10.1016/j.amepre.2006.07.013; Singh D, 2019, CAN MED ASSOC J, V191, pE487, DOI 10.1503/cmaj.181437; State Correctional Institution Huntingdon, 2021, SPEC FIR CHAT 4 5 21; Vicente-Alcalde N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207589; Vlaev I, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7407-8; Volpp KG, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMp2107719; Wang EA, 2020, JAMA-J AM MED ASSOC, V324, P1031, DOI 10.1001/jama.2020.15589; White MC, 2002, ARCH INTERN MED, V162, P1044, DOI 10.1001/archinte.162.9.1044; Winter RJ, 2016, AUST NZ J PUBL HEAL, V40, P592, DOI 10.1111/1753-6405.12578	56	3	3	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264145	10.1371/journal.pone.0264145	http://dx.doi.org/10.1371/journal.pone.0264145			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263350	Green Published, gold			2022-12-26	WOS:000804638700033
J	Puangmalai, N; Sengupta, U; Bhatt, N; Gaikwad, S; Montalbano, M; Bhuyan, A; Garcia, S; McAllen, S; Sonawane, M; Jerez, C; Zhao, YX; Kayed, R				Puangmalai, Nicha; Sengupta, Urmi; Bhatt, Nemil; Gaikwad, Sagar; Montalbano, Mauro; Bhuyan, Arijit; Garcia, Stephanie; McAllen, Salome; Sonawane, Minal; Jerez, Cynthia; Zhao, Yingxin; Kayed, Rakez			<p>Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer's disease & nbsp;</p>	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; A-BETA; DISEASE; PROTEIN; AUTOPHAGY; STRESS; NEURONS; NEURODEGENERATION; IDENTIFICATION	Ubiquitin-modified tau aggregates are abundantly found in human brains diagnosed with Alzheimer's disease (AD) and other tauopathies. Soluble tau oligomers (TauO) are the most neurotoxic tau species that propagate pathology and elicit cognitive deficits, but whether ubiquitination contributes to tau formation and spreading is not fully understood. Here, we observed that K63-linked, but not K48-linked, ubiquitinated TauO accumulated at higher levels in AD brains compared with age-matched controls. Using mass spectrometry analyses, we identified 11 ubiquitinated sites on AD brain-derived TauO (AD TauO). We found that K63-linked TauO are associated with enhanced seeding activity and propagation in human tau expressing primary neuronal and tau biosensor cells. Additionally, exposure of tau-inducible HEK cells to AD TauO with different ubiquitin linkages (wild type, K48, and K63) resulted in enhanced formation and secretion of K63-linked TauO, which was associated with impaired proteasome and lysosome functions. Multipathway analysis also revealed the involvement of K63-linked TauO in cell survival pathways, which are impaired in AD. Collectively, our study highlights the significance of selective TauO ubiquitination, which could influence tau aggregation, accumulation, and subsequent pathological propagation. The insights gained from this study hold great promise for targeted therapeutic intervention in AD and related tauopathies.& nbsp;	[Puangmalai, Nicha; Sengupta, Urmi; Bhatt, Nemil; Gaikwad, Sagar; Montalbano, Mauro; Sonawane, Minal; Jerez, Cynthia; Kayed, Rakez] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Puangmalai, Nicha; Sengupta, Urmi; Bhatt, Nemil; Gaikwad, Sagar; Montalbano, Mauro; Sonawane, Minal; Jerez, Cynthia; Kayed, Rakez] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Puangmalai, Nicha; Sengupta, Urmi; Bhatt, Nemil; Gaikwad, Sagar; Montalbano, Mauro; Sonawane, Minal; Jerez, Cynthia; Kayed, Rakez] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Bhuyan, Arijit] Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA; [Garcia, Stephanie] Univ Texas Hlth Sci Ctr, Sch Dent, Houston, TX USA; [McAllen, Salome] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Zhao, Yingxin] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Zhao, Yingxin] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kayed, R (corresponding author), Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA.; Kayed, R (corresponding author), Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA.; Kayed, R (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	rakayed@utmb.edu	GAIKWAD, SAGAR/AAO-6607-2021	GAIKWAD, SAGAR/0000-0003-2040-1357; Bhuyan, Arijit/0000-0002-6774-4456	Mitchell Center for Neurodegenerative Diseases; Gillson Longenbaugh Foundation; National Institute of Health [R01AG054025, R01NS094557, RFA1AG055771, R01AG060718]; American Heart Association [17CSA33620007];  [T32 AG058522]	Mitchell Center for Neurodegenerative Diseases; Gillson Longenbaugh Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); 	Funding and additional information-This research work was supported by Mitchell Center for Neurodegenerative Diseases, the Gillson Longenbaugh Foundation and National Institute of Health grants: R01AG054025, R01NS094557, RFA1AG055771, R01AG060718, and the American Heart Association collaborative grant 17CSA33620007 (R. K.); U.S. supported by T32 AG058522.	Abisambra JF, 2013, J NEUROSCI, V33, P9498, DOI 10.1523/JNEUROSCI.5397-12.2013; Abreha MH, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800108; Abskharon R, 2020, J BIOL CHEM, V295, P10662, DOI 10.1074/jbc.RA120.013638; Albert M., 2019, Prevention of tau seeding and propagation by immunotherapy with a central tau; Alquezar C, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.595532; Arakhamia T, 2020, CELL, V180, P633, DOI 10.1016/j.cell.2020.01.027; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Baig S, 2009, NEUROSCIENCE, V163, P561, DOI 10.1016/j.neuroscience.2009.06.045; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Blom ES, 2009, DEMENT GERIATR COGN, V27, P458, DOI 10.1159/000216841; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Castillo-Carranza DL, 2014, J ALZHEIMERS DIS, V40, pS97, DOI 10.3233/JAD-132477; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P158, DOI 10.1097/nen.0b013e3180303b93; Chen XH, 2018, MED SCI MONITOR, V24, P5035, DOI 10.12659/MSM.907809; Chen X, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-019-0354-0; Chen XQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00659; Chu DD, 2019, ACS CHEM NEUROSCI, V10, P931, DOI 10.1021/acschemneuro.8b00457; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; de Calignon A, 2009, J NEUROPATH EXP NEUR, V68, P757, DOI 10.1097/NEN.0b013e3181a9fc66; De La-Rocque S, 2021, J NEUROCHEM, V156, P563, DOI 10.1111/jnc.15144; Dujardin S, 2020, NAT MED, V26, P1256, DOI 10.1038/s41591-020-0938-9; Farmer KM, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01012-6; Ferreon JC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051360; Galasko D, 1997, NEUROLOGY, V48, P632, DOI 10.1212/WNL.48.3.632; Galves M, 2019, TRENDS BIOCHEM SCI, V44, P872, DOI 10.1016/j.tibs.2019.04.007; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Harris LD, 2020, ADV EXP MED BIOL, V1233, P195, DOI 10.1007/978-3-030-38266-7_8; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Holmes BB, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024026; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Horie K., 2020, BRAIN, V144, P515, DOI [DOI 10.1093/brain/awaa373, 10.1093/brain/awaa373]; Ihara Y., 2012, Cold Spring Harb Perspect. Med., V2; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kocaturk NM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00128; Kontaxi C, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00056; Koss DJ, 2016, ACTA NEUROPATHOL, V132, P875, DOI 10.1007/s00401-016-1632-3; Kudo W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.43; Lasagna-Reeves C. A., 2011, J BIOL CHEMCURR NEUR, V20, P158; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee MJ, 2013, PROG NEUROBIOL, V105, P49, DOI 10.1016/j.pneurobio.2013.03.001; Liu J, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00203; Lo Cascio F, 2020, J BIOL CHEM, V295, P14807, DOI 10.1074/jbc.RA120.014630; Maher P., 2014, BIOPROTOC, V4, P1028; Manavalan A, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.76; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Martinisi Alfonso, 2021, Brain, V144, P963, DOI 10.1093/brain/awaa445; Mielcarek M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00042; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; MORISHIMAKAWASHIMA M, 1993, NEURON, V10, P1151, DOI 10.1016/0896-6273(93)90063-W; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Nilson AN, 2017, J ALZHEIMERS DIS, V55, P1083, DOI 10.3233/JAD-160912; Paine S, 2009, NEUROSCI LETT, V460, P205, DOI 10.1016/j.neulet.2009.05.074; Petrucelli L., 2004, Hum; Poling HM, 2018, NAT BIOMED ENG, V2, P429, DOI 10.1038/s41551-018-0243-9; Puangmalai N, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2503-3; Reese LC, 2011, CURR NEUROPHARMACOL, V9, P685, DOI 10.2174/157015911798376316; Roberts M, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0884-2; Sengupta U, 2017, ANN CLIN TRANSL NEUR, V4, P226, DOI 10.1002/acn3.382; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Shaw L. M., 2009, Cerebrospinal fluid biomarker signature in Alzheimer; Siddiqui WA, 2015, ARCH TOXICOL, V89, P289, DOI 10.1007/s00204-014-1448-7; Silva MC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16984-1; Sprenkle NT, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0183-y; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; Thibaudeau TA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03509-0; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Trzeciakiewicz H, 2017, SCI REP-UK, V7, DOI 10.1038/srep44102; Usenovic M, 2015, J NEUROSCI, V35, P14234, DOI 10.1523/JNEUROSCI.1523-15.2015; Wang L, 2012, P NATL ACAD SCI USA, V109, P16743, DOI 10.1073/pnas.1208011109; Wang Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0143-y; Wegmann S, 2021, CURR OPIN NEUROBIOL, V69, P131, DOI 10.1016/j.conb.2021.03.003; Wu XL, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02399-2; Wu YL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00114; Xu J., 2019, Commun; Yadikar H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205213; Zhang PF, 2014, CELL SIGNAL, V26, P556, DOI 10.1016/j.cellsig.2013.11.026; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0; Zhao YX, 2013, METHODS, V61, P313, DOI 10.1016/j.ymeth.2013.02.001; Zheng J, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00896-8; Zhou L., 2017, Tau association with synaptic vesicles	90	3	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101766	10.1016/j.jbc.2022.101766	http://dx.doi.org/10.1016/j.jbc.2022.101766			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35202653	Green Published, gold			2022-12-26	WOS:000793502000006
J	Zhou, L; Li, HR; Sun, SW; Zhang, TQ; Yu, YM; Xu, L; Wang, MH				Zhou, Lei; Li, Haoran; Sun, Shiwei; Zhang, Tieqi; Yu, Yueming; Xu, Liang; Wang, Minghai			Thrap3 promotes osteogenesis by inhibiting the degradation of Runx2	FASEB JOURNAL			English	Article						osteogenesis; Runx2; Sox9; Thrap3	CHONDROCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; NUCLEAR RECEPTORS; CBFA1; INTERACTS; COMPONENT; COMPLEX; TRAP; SOX9	The dysfunction of osteogenesis is a key character in the pathogenesis of osteoporosis, but the network of signaling mechanisms in controlling the differentiation of osteoblast remain unclear. Thrap3 has been proved participating in various biological process, especially in the differentiation of stem cells. Here, we demonstrate that Thrap3 could promote osteogenesis through the inhibition of the degradation of Runx2, which is a key molecular structure in early osteoblast differentiation. Furthermore, we found that the osteogenesis enhancing capacity of Thrap3 was caused by physically binding with Sox9, inhibiting the transcriptional activity of Sox9, and then decreasing the decomposition-promoted effect of Sox9 on Runx2. Our data shows that Thrap3 promotes osteoblast differentiation through the Thrap3-Sox9-Runx2 axis. What we found may help for further clarifying the molecular mechanism of osteogenic differentiation and give a new potential therapeutic target for osteoporosis.	[Zhou, Lei; Li, Haoran; Sun, Shiwei; Zhang, Tieqi; Yu, Yueming; Xu, Liang; Wang, Minghai] Fudan Univ, Shanghai Peoples Hosp 5, Dept Orthoped, 801 Heqing Rd, Shanghai, Peoples R China; [Zhou, Lei] Fudan Univ, Zhongshan Hosp, Dept Orthoped Surg, Shanghai, Peoples R China	Fudan University; Fudan University	Zhang, TQ; Wang, MH (corresponding author), Fudan Univ, Shanghai Peoples Hosp 5, Dept Orthoped, 801 Heqing Rd, Shanghai, Peoples R China.	13681914915@163.com; wangminghai@5thhospital.com			Key Department of Minhang District [2020MWTZB03]; Key Deparment of the Fifth People's Hospital of Shanghai [2020WYZDZK03]; Fifth People's Hosptal of Shanghai, Fudan University [2018WYZT01, N123E5]; Natural Science Foundation of Minhang District of Shanghai [2019MHZ013]; Minhang District Leading Talent Development Funds	Key Department of Minhang District; Key Deparment of the Fifth People's Hospital of Shanghai; Fifth People's Hosptal of Shanghai, Fudan University; Natural Science Foundation of Minhang District of Shanghai; Minhang District Leading Talent Development Funds	The Key Department of Minhang District, Grant/Award Number: 2020MWTZB03; The Key Deparment of the Fifth People's Hospital of Shanghai, Grant/Award Number: 2020WYZDZK03; The Fifth People's Hosptal of Shanghai, Fudan University, Grant/Award Number: 2018WYZT01 and N123E5; The Natural Science Foundation of Minhang District of Shanghai, Grant/Award Number: 2019MHZ013; The Minhang District Leading Talent Development Funds	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Cairns DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039642; Cheng AX, 2010, J BONE MINER RES, V25, P2404, DOI 10.1002/jbmr.174; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Delitala AP, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041034; ERIKSEN EF, 1985, BONE, V6, P421, DOI 10.1016/8756-3282(85)90218-2; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Guerit D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062582; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Ino Y, 2016, PROTEOMICS, V16, P1069, DOI 10.1002/pmic.201500365; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2002, EMBO J, V21, P3464, DOI 10.1093/emboj/cdf348; Katano-Toki A, 2013, MOL ENDOCRINOL, V27, P769, DOI 10.1210/me.2012-1332; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lee WC, 2017, ENDOCR REV, V38, P255, DOI 10.1210/er.2017-00064; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Sanghani-Kerai A, 2018, CURR STEM CELL RES T, V13, P369, DOI 10.2174/1574888X13666180410160511; Sono T, 2018, J BONE MINER METAB, V36, P410, DOI 10.1007/s00774-017-0855-2; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zaidi Mone, 2009, Curr Osteoporos Rep, V7, P47	24	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22231	10.1096/fj.202101706R	http://dx.doi.org/10.1096/fj.202101706R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35230719				2022-12-26	WOS:000772957100009
J	Hsu, P; Ready, EA; Grahn, JA				Hsu, Prisca; Ready, Emily A.; Grahn, Jessica A.			The effects of Parkinson's disease, music training, and dance training on beat perception and production abilities	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; STREET DANCERS; MOTOR; RHYTHM; TIME; GAIT	Humans naturally perceive and move to a musical beat, entraining body movements to auditory rhythms through clapping, tapping, and dancing. Yet the accuracy of this seemingly effortless behavior varies widely across individuals. Beat perception and production abilities can be improved by experience, such as music and dance training, and impaired by progressive neurological changes, such as in Parkinson's disease. In this study, we assessed the effects of music and dance experience on beat processing in young and older adults, as well as individuals with early-stage Parkinson's disease. We used the Beat Alignment Test (BAT) to assess beat perception and production in a convenience sample of 458 participants (278 healthy young adults, 139 healthy older adults, and 41 people with early-stage Parkinson's disease), with varying levels of music and dance training. In general, we found that participants with over three years of music training had more accurate beat perception than those with less training (p < .001). Interestingly, Parkinson's disease patients with music training had beat production abilities comparable to healthy adults while Parkinson's disease patients with minimal to no music training performed significantly worse. No effects were found in healthy adults for dance training, and too few Parkinson's disease patients had dance training to reliably assess its effects. The finding that musically trained Parkinson's disease patients performed similarly to healthy adults during a beat production task, while untrained patients did not, suggests music training may preserve certain rhythmic motor timing abilities in early-stage Parkinson's disease.	[Hsu, Prisca] Western Univ, Schulich Sch Med & Dent, London, ON, Canada; [Ready, Emily A.; Grahn, Jessica A.] Western Univ, Dept Psychol, London, ON, Canada; [Ready, Emily A.; Grahn, Jessica A.] Western Univ, Brain & Mind Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Hsu, P (corresponding author), Western Univ, Schulich Sch Med & Dent, London, ON, Canada.	phsu26@uwo.ca		Hsu, Prisca/0000-0003-1137-8394	Natural Science and Engineering Research Council of Canada [RGPIN-2016-05834]; James S. McDonnell Foundation	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); James S. McDonnell Foundation	The project is supported by the Natural Science and Engineering Research Council of Canada (JAG) (RGPIN-2016-05834) and the James S. McDonnell Foundation (JAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begel V, 2017, NEUROPSYCHOLOGIA, V94, P129, DOI 10.1016/j.neuropsychologia.2016.11.022; Bella SD, 2017, BEHAV RES METHODS, V49, P1128, DOI 10.3758/s13428-016-0773-6; Benoit CE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00494; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Cameron DJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00019; Cameron DJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01003; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; De Cock VC, 2020, ANN CLIN TRANSL NEUR, V7, P280, DOI 10.1002/acn3.50982; Dauvergne C, 2018, ANN PHYS REHABIL MED, V61, P380, DOI 10.1016/j.rehab.2018.08.002; De Cock VC, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0043-7; Fujii S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00771; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Iversen J.R., 2008, P 10 INT C MUSIC PER, P465, DOI DOI 10.1016/J.HEARES.2007.10.007; Jola C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033343; Jones CRG, 2014, ADV EXP MED BIOL, V829, P265, DOI 10.1007/978-1-4939-1782-2_14; Keysers C, 2020, NAT NEUROSCI, V23, P788, DOI 10.1038/s41593-020-0660-4; Lee KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134725; Miura A, 2013, MOTOR CONTROL, V17, P18, DOI 10.1123/mcj.17.1.18; Miura A, 2011, HUM MOVEMENT SCI, V30, P1260, DOI 10.1016/j.humov.2010.08.006; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Muller T, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-10; Nguyen T., MUSIC PERCEPT; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; Palmer C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0405; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Ready EA, 2019, GAIT POSTURE, V68, P555, DOI 10.1016/j.gaitpost.2018.12.038; Repp BH, 2007, MUSIC PERCEPT, V24, P367, DOI 10.1525/MP.2007.24.4.367; Repp BH, 2010, HUM MOVEMENT SCI, V29, P200, DOI 10.1016/j.humov.2009.08.002; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Skoe E, 2021, PERCEPT MOTOR SKILL, V128, P1337, DOI 10.1177/00315125211021210; Su YH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1678390; Thaut MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002312; Thompson EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128839; Tranchant P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160178; van Doorn J, 2021, PSYCHON B REV, V28, P813, DOI 10.3758/s13423-020-01798-5; Washburn A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00800; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	41	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264587	10.1371/journal.pone.0264587	http://dx.doi.org/10.1371/journal.pone.0264587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259161	Green Submitted, gold, Green Published			2022-12-26	WOS:000835141200018
J	Vigl, J; Strauss, H; Talamini, F; Zentner, M				Vigl, Julia; Strauss, Hannah; Talamini, Francesca; Zentner, Marcel			Relationship satisfaction in the early stages of the COVID-19 pandemic: A cross-national examination of situational, dispositional, and relationship factors	PLOS ONE			English	Article							MARITAL QUALITY; PERSONALITY	The outbreak of the COVID-19 pandemic has had a large impact on various aspects of life, but questions about its effects on close relationships remain largely unanswered. In the present study, we examined perceived changes in relationship satisfaction at the beginning of the COVID-19 pandemic by using an international sample of 3,243 individuals from 67 different countries, mostly from Italy, the United States, the United Kingdom, Germany, Austria, and Switzerland. In April and May 2020, participants responded to an online survey that included questions about relationship satisfaction, their satisfaction before the pandemic, other relationship aspects (e.g., shared time), special circumstances (e.g., mobility restrictions), and enduring dispositions (e.g., insecure attachment). A decline in time shared with one's partner was most strongly associated with perceived decreases in relationship satisfaction, resulting in a different pattern of findings for cohabiting and non-cohabiting individuals. Among the most influential moderators were anxious and avoidant attachment. The findings offer insights into both aggravating and protecting factors in couples' responses to pandemic-related stressors.	[Vigl, Julia; Strauss, Hannah; Talamini, Francesca; Zentner, Marcel] Univ Innsbruck, Dept Psychol, Innsbruck, Austria	University of Innsbruck	Vigl, J (corresponding author), Univ Innsbruck, Dept Psychol, Innsbruck, Austria.	julia.vigl@uibk.ac.at	Vigl, Julia/GNW-6371-2022; Talamini, Francesca/AFP-2094-2022	Vigl, Julia/0000-0003-2152-7584; Strauss, Hannah/0000-0002-6235-4010	Publishing Fund of the University of Innsbruck; Faculty of Psychology and Sport Science	Publishing Fund of the University of Innsbruck; Faculty of Psychology and Sport Science	This article was supported by the Publishing Fund of the University of Innsbruck in cooperation with the Faculty of Psychology and Sport Science. The funders had no role in study design, data collection and analysis.	Amato P. R., 2007, ALONE TOGETHER MARRI; [Anonymous], 2020, COVID 19 1 VACCINE G; [Anonymous], 2020, SCHENGENVISAINF 0722; Aron A, 2000, J PERS SOC PSYCHOL, V78, P273, DOI 10.1037/0022-3514.78.2.273; Barkley Jacob E, 2020, Int J Exerc Sci, V13, P1326; Bodenmann G., 2000, STRESS COPING PAAREN, DOI [10.1007/s003910070063 10923374, DOI 10.1007/S00391007006310923374]; Brennan K.AC.C.L., 1998, ATTACHMENT THEORY CL, P46, DOI DOI 10.1037/T03763-000; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Campbell L, 2005, J PERS SOC PSYCHOL, V88, P510, DOI 10.1037/0022-3514.88.3.510; Carlson DL., 2020, SCIENCEOPEN, DOI [10.31235/osf.io/jy8fn, DOI 10.31235/OSF.IO/JY8FN]; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Claxton A, 2008, J MARRIAGE FAM, V70, P28, DOI 10.1111/j.1741-3737.2007.00459.x; Dainton M., 2001, COMMUN Q, V49, P172, DOI [10.1080/01463370109385624, DOI 10.1080/01463370109385624]; Dargie E, 2015, J SEX MARITAL THER, V41, P181, DOI 10.1080/0092623X.2013.864367; Desson Z, 2020, HEALTH POLICY TECHN, V9, P405, DOI 10.1016/j.hlpt.2020.09.003; Dewitte M, 2020, NAT REV UROL, V17, P547, DOI 10.1038/s41585-020-0365-1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fodor E, 2021, EUR SOC, V23, pS95, DOI 10.1080/14616696.2020.1817522; Gerlach TM., 2020, ENCY PERSONALITY IND, P3688; Hale T., 2020, OXFORD COVID 19 GOVT; HASSEBRAUCK M, 1991, Z SOZIALPSYCHOL, V22, P256; Hatch LR, 2004, J FAM ISSUES, V25, P465, DOI 10.1177/0192513X03257766; Hazan C., 1994, PSYCHOL INQ, V5, P1, DOI [10.1207/s15327965pli0501_1, DOI 10.1207/S15327965PLI05011, DOI 10.1207/S15327965PLI0501_]; HENDRICK SS, 1988, J MARRIAGE FAM, V50, P93, DOI 10.2307/352430; KARNEY BR, 1995, PSYCHOL BULL, V118, P3, DOI 10.1037/0033-2909.118.1.3; Karney BR, 2002, J PERS SOC PSYCHOL, V82, P222, DOI 10.1037//0022-3514.82.2.222; Lafontaine M.F., 2016, EUR J PSYCHOL ASSESS, V32, P140, DOI [10.1027/1015-5759/a000243, DOI 10.1027/1015-5759/a000243, 10.1037/t51913-000]; Mark KP, 2014, J SEX RES, V51, P159, DOI 10.1080/00224499.2013.816261; Mikulincer M, 2003, PERS SOC PSYCHOL REV, V7, P20, DOI 10.1207/S15327957PSPR0701_2; Mikulincer M., 2004, HDB EXPT EXISTENTIAL, P287; Milam J, 2005, TRAUMATOLOGY, V11, P233, DOI [10.1177/153476560501100404, DOI 10.1177/153476560501100404]; Morgan SL, 2007, ANAL METHOD SOC RES, P1, DOI 10.1017/CBO9780511804564; Mund M, 2021, J HAPPINESS STUD, V22, P575, DOI 10.1007/s10902-020-00241-9; Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008; Overall NC, 2022, SOC PSYCHOL PERS SCI, V13, P285, DOI 10.1177/1948550621992973; Pietromonaco PR, 2021, AM PSYCHOL, V76, P438, DOI 10.1037/amp0000714; Rammstedt B, 2020, EUR J PSYCHOL ASSESS, V36, P149, DOI 10.1027/1015-5759/a000481; Randall AK, 2017, CURR OPIN PSYCHOL, V13, P96, DOI 10.1016/j.copsyc.2016.05.010; Ritchie Hannah, 2020, CORONAVIRUS PANDEMIC; Rudolph CW, 2021, IND ORGAN PSYCHOL-US, V14, P1, DOI 10.1017/iop.2020.48; Schmid L, 2021, EUR SOC, V23, pS743, DOI 10.1080/14616696.2020.1836385; Shaver P.R., 2007, HDB EMOTION REGULATI, P446; SHAVER PR, 1992, PERS SOC PSYCHOL B, V18, P536, DOI 10.1177/0146167292185003; Smith A, 2011, J SEX MARITAL THER, V37, P104, DOI 10.1080/0092623X.2011.560531; Soto CJ, 2017, J RES PERS, V68, P69, DOI 10.1016/j.jrp.2017.02.004; Turliuc MN, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.635148; Twisk J, 2004, J CLIN EPIDEMIOL, V57, P223, DOI 10.1016/j.jclinepi.2003.07.009; Urbasik F., 2021, LOVE IS NOT TOURISM, DOI [10.1096/fj.202001962R 33811381, DOI 10.1096/FJ.202001962R33811381]; Williamson HC, 2020, PSYCHOL SCI, V31, P1479, DOI 10.1177/0956797620972688; Zygar-Hoffmann C, 2020, COLLABRA-PSYCHOL, V6, DOI 10.1525/collabra.278	50	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264511	10.1371/journal.pone.0264511	http://dx.doi.org/10.1371/journal.pone.0264511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239691	Green Published, gold, Green Submitted			2022-12-26	WOS:000776002200039
J	Zdrazilova, L; Hansikova, H; Gnaiger, E				Zdrazilova, Lucie; Hansikova, Hana; Gnaiger, Erich			Comparable respiratory activity in attached and suspended human fibroblasts	PLOS ONE			English	Article							MESSENGER-RNA; OXIDATIVE-PHOSPHORYLATION; MACROPHAGES; METABOLISM; GROWTH; OXYGEN; CELLS	Measurement of oxygen consumption of cultured cells is widely used for diagnosis of mitochondrial diseases, drug testing, biotechnology, and toxicology. Fibroblasts are cultured in monolayers, but physiological measurements are carried out in suspended or attached cells. We address the question whether respiration differs in attached versus suspended cells using multiwell respirometry (Agilent Seahorse XF24) and high-resolution respirometry (Oroboros O2k), respectively. Respiration of human dermal fibroblasts measured in culture medium was baseline-corrected for residual oxygen consumption and expressed as oxygen flow per cell. No differences were observed between attached and suspended cells in ROUTINE respiration of living cells and LEAK respiration obtained after inhibition of ATP synthase by oligomycin. The electron transfer capacity was higher in the O2k than in the XF24. This could be explained by a limitation to two uncoupler titrations in the XF24 which led to an underestimation compared to multiple titration steps in the O2k. A quantitative evaluation of respiration measured via different platforms revealed that short-term suspension of fibroblasts did not affect respiratory activity and coupling control. Evaluation of results obtained by different platforms provides a test for reproducibility beyond repeatability. Repeatability and reproducibility are required for building a validated respirometric database.	[Zdrazilova, Lucie; Hansikova, Hana] Charles Univ Prague, Fac Med 1, Dept Pediat & Inherited Metab Disorders, Prague, Czech Republic; [Zdrazilova, Lucie; Hansikova, Hana] Gen Hosp Prague, Prague, Czech Republic; [Gnaiger, Erich] Oroboros Instruments, Innsbruck, Austria	Charles University Prague; General University Hospital Prague	Zdrazilova, L (corresponding author), Charles Univ Prague, Fac Med 1, Dept Pediat & Inherited Metab Disorders, Prague, Czech Republic.; Zdrazilova, L (corresponding author), Gen Hosp Prague, Prague, Czech Republic.; Gnaiger, E (corresponding author), Oroboros Instruments, Innsbruck, Austria.	Lucie.Zdrazilova@lf1.cuni.cz; erich.gnaiger@oroboros.at	Hansikova, Hana/E-9350-2017	Hansikova, Hana/0000-0002-2734-225X; Gnaiger, Erich/0000-0003-3647-5895	European Union [859770]; Institutional projects of Charles University [GAUK110119, SVV-UK 260367]; Ministry of Health of the Czech Republic [NV19-07-00149]; COST Action [CA15203 MitoEAGLE]	European Union(European Commission); Institutional projects of Charles University; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); COST Action(European Cooperation in Science and Technology (COST))	This work was partially funded by the European Union's Horizon 2020 research and innovation program under grant agreement No. 859770, NextGen-O2k project (EG), Institutional projects of Charles University GAUK110119 and SVV-UK 260367 (LZ) and by the Ministry of Health of the Czech Republic NV19-07-00149 (HH). Contribution to COST Action CA15203 MitoEAGLE with financial support of Short-Term Scientific missions (LZ).	ABELSON HT, 1974, CELL, V1, P161, DOI 10.1016/0092-8674(74)90107-X; Agilent Technologies, 2019, GLYC STRESS TEST KIT; BENECKE BJ, 1978, CELL, V14, P931, DOI 10.1016/0092-8674(78)90347-1; BENECKE BJ, 1980, J CELL PHYSIOL, V103, P247, DOI 10.1002/jcp.1041030209; BENZEEV A, 1990, CELL REGUL, V1, P621, DOI 10.1091/mbc.1.9.621; Burska D, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166147; Danhelovska T, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-1912-x; Doerrier C, 2018, METHODS MOL BIOL, V1782, P31, DOI 10.1007/978-1-4939-7831-1_3; FARMER SR, 1978, CELL, V15, P627, DOI 10.1016/0092-8674(78)90031-4; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Gnaiger E., 2019, MITOFIT PREPRINT ARC, V1, P1, DOI [10.26124/mitofit:190001.v6, DOI 10.26124/MITOFIT:190001.V6]; Gnaiger E., 2020, BIOEN ERG COMMUN, V2020, P1, DOI 10.26124/bec:2020-0001.v1; Gnaiger E., 2021, MITOFIT PREPRINTS, P8, DOI [10.26124/mitofit:2021-0008, DOI 10.26124/MITOFIT:2021-0008]; Gnaiger E., 2020, BIOENERG COMMUN, V5th, P2, DOI [DOI 10.26124/BEC:2020-0002, 10.26124/bec:2020-0002]; Gnaiger E., 2008, MITOCHONDRIAL DYSFUN, P327; Gnaiger E, ELEMENTARY UNIT CANO, V9th, DOI [10.26124/mitofit:200004.v2, DOI 10.26124/MITOFIT:200004.V2]; HARRISON CJ, 1979, DIFFERENTIATION, V15, P61, DOI 10.1111/j.1432-0436.1979.tb01035.x; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Komlodi T., 2021, BIOENERG COMMUN, V4, DOI [10.26124/bec:2020-0004, DOI 10.26124/BEC:2020]; LAZDINS JK, 1980, J CELL PHYSIOL, V105, P191, DOI 10.1002/jcp.1041050202; Park JY, 2018, ONCOTARGET, V9, P622, DOI 10.18632/oncotarget.23079; POFIT JF, 1977, J CELL PHYSIOL, V92, P249, DOI 10.1002/jcp.1040920213; Scandurra FM, 2010, ADV EXP MED BIOL, V662, P7, DOI 10.1007/978-1-4419-1241-1_2; Shen CF, 2019, VACCINE, V37, P6996, DOI 10.1016/j.vaccine.2019.07.003; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Ye F, 2013, ANAL BIOCHEM, V437, P52, DOI 10.1016/j.ab.2013.02.010; Yepez VA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199938; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264496	10.1371/journal.pone.0264496	http://dx.doi.org/10.1371/journal.pone.0264496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239701	Green Published, gold			2022-12-26	WOS:000776002200037
J	Mebus-Antunes, NC; Ferreira, WS; Barbosa, GM; Neves-Martins, TC; Weissmuller, G; Almeida, FCL; Da Poian, AT				Mebus-Antunes, Nathane C.; Ferreira, Wellington S.; Barbosa, Glauce M.; Neves-Martins, Thais C.; Weissmuller, Gilberto; Almeida, Fabio C. L.; Da Poian, Andrea T.			The interaction of dengue virus capsid protein with negatively charged interfaces drives the in vitro assembly of nucleocapsid-like particles	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CORE-LIKE PARTICLES; FLAVIVIRUS; ORGANIZATION; MATURATION; IMMATURE	Dengue virus (DENV) causes a major arthropod-borne viral disease, with 2.5 billion people living in risk areas. DENV consists in a 50 nm-diameter enveloped particle in which the surface proteins are arranged with icosahedral symmetry, while information about nucleocapsid (NC) structural organization is lacking. DENV NC is composed of the viral genome, a positive-sense single-stranded RNA, packaged by the capsid (C) protein. Here, we established the conditions for a reproducible in vitro assembly of DENV nucleocapsid-like particles (NCLPs) using recombinant DENVC. We analyzed NCLP formation in the absence or presence of oligonucleotides in solution using small angle X-ray scattering, Rayleigh light scattering as well as fluorescence anisotropy, and characterized particle structural properties using atomic force and transmission electron microscopy imaging. The experiments in solution comparing 2-, 5- and 25-mer oligonucleotides established that 2-mer is too small and 5-mer is sufficient for the formation of NCLPs. The assembly process was concentration-dependent and showed a saturation profile, with a stoichiometry of 1:1 (DENVC:oligonucleotide) molar ratio, suggesting an equilibrium involving DENVC dimer and an organized structure compatible with NCLPs. Imaging methods proved that the decrease in concentration to sub-nanomolar concentrations of DENVC allows the formation of regular spherical NCLPs after protein deposition on mica or carbon surfaces, in the presence as well as in the absence of oligonucleotides, in this latter case being surface driven. Altogether, the results suggest that in vitro assembly of DENV NCLPs depends on DENVC charge neutralization, which must be a very coordinated process to avoid unspecific aggregation. Our hypothesis is that a specific highly positive spot in DENVC alpha 4-alpha 4' is the main DENVC-RNA binding site, which is required to be firstly neutralized to allow NC formation.	[Mebus-Antunes, Nathane C.; Barbosa, Glauce M.; Neves-Martins, Thais C.; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, RJ, Brazil; [Ferreira, Wellington S.; Weissmuller, Gilberto] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil; [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Almeida, FCL; Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.; Almeida, FCL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Rio De Janeiro, RJ, Brazil.	falmeida@bioqmed.ufrj.br; dapoian@bioqmed.ufrj.br		Cunha Mebus Antunes, Nathane/0000-0002-8973-3635; Cristtina Neves-Martins, Thais/0000-0002-8393-3142	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil [E-26/202.945/2017, E-26/201.316/2016, 204.432/2014, 239.229/2018]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [439306/2018-3, 309028/2017-5]; Caixa Bank Foundation, Spain [LCF/PR/HR17/52150011]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Caixa Bank Foundation, Spain	ATDP was supported by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil (http://www.faperj.br/) [grant numbers E-26/202.945/2017, E-26/201.316/2016], Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil (https://www.gov.br/cnpq/pt-br)[grant numbers: 309028/2017-5] and la Caixa Bank Foundation, Spain (https://fundacionlacaixa.org/en/home) [grant number: LCF/PR/HR17/52150011]. FCLA was supported by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil (http://www.faperj.br/) [grant numbers 204.432/2014 and 239.229/2018] and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil (https://www.gov.br/cnpq/pt-br) [grant numbers: 439306/2018-3]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rivero N, 2005, BIOCHEM BIOPH RES CO, V334, P901, DOI 10.1016/j.bbrc.2005.06.185; Bruinsma RF, 2021, NAT REV PHYS, V3, P76, DOI 10.1038/s42254-020-00267-1; Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334; Canale C, 2011, METHODS MOL BIOL, V736, P31, DOI 10.1007/978-1-61779-105-5_3; CHENG RH, 1995, CELL, V80, P621; Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004; de Pablo PJ, 2018, SEMIN CELL DEV BIOL, V73, P199, DOI 10.1016/j.semcdb.2017.08.039; de Souza TLF, 2016, PEERJ, V4, DOI 10.7717/peerj.2670; Faustino AF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10592; Fournet G., 1955, SMALL ANGLE SCATTERI, V24; Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003; Kaufman F, 2020, FEBS LETT, V594, P1989, DOI 10.1002/1873-3468.13857; Keller A, 2020, APPL SURF SCI, V506, DOI 10.1016/j.apsusc.2019.144991; Kiermayr S, 2004, J VIROL, V78, P8078, DOI 10.1128/JVI.78.15.8078-8084.2004; Kondylis P, 2019, ANAL CHEM, V91, P622, DOI 10.1021/acs.analchem.8b04824; Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13; Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kunkel M, 2001, J VIROL, V75, P2119, DOI 10.1128/JVI.75.5.2119-2129.2001; Kuznetsov YG, 2011, MICROBIOL MOL BIOL R, V75, P268, DOI 10.1128/MMBR.00041-10; Lopez C, 2009, ARCH VIROL, V154, P695, DOI 10.1007/s00705-009-0350-8; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Maassen SJ, 2018, CHEM-EUR J, V24, P7456, DOI 10.1002/chem.201800285; Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219; Mendes A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030138; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Mukhopadhyay S, 2002, J VIROL, V76, P11128, DOI 10.1128/JVI.76.21.11128-11132.2002; Murugesapillai D, 2017, NANOSCALE, V9, P11327, DOI 10.1039/c7nr04231k; Neves-Martins TC, 2021, CURR OPIN VIROL, V47, P106, DOI 10.1016/j.coviro.2021.02.005; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352; Ruggeri FS, 2019, ARCH BIOCHEM BIOPHYS, V664, P134, DOI 10.1016/j.abb.2019.02.001; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Sotcheff S, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9010042; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Tan TY, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008542; Tellinghuisen TL, 2000, J VIROL, V74, P4302, DOI 10.1128/JVI.74.9.4302-4309.2000; Tellinghuisen TL, 1999, J VIROL, V73, P5309, DOI 10.1128/JVI.73.7.5309-5319.1999; Teoh PG, 2014, J VIROL, V88, P7998, DOI 10.1128/JVI.00940-14; Therkelsen MD, 2018, P NATL ACAD SCI USA, V115, P11608, DOI 10.1073/pnas.1809304115; Valbuena A, 2017, BIOPHYS J, V112, P663, DOI 10.1016/j.bpj.2016.11.3209; Valbuena A, 2015, NANOSCALE, V7, P14953, DOI 10.1039/c5nr04023j; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; WENGLER G, 1984, VIROLOGY, V132, P401, DOI 10.1016/0042-6822(84)90045-X; Whitehouse C, 2005, ANGEW CHEM INT EDIT, V44, P1965, DOI 10.1002/anie.200462160; Xie XP, 2019, CELL HOST MICROBE, V26, P606, DOI 10.1016/j.chom.2019.09.015; Yong XE, 2021, RNA BIOL, V18, P718, DOI 10.1080/15476286.2020.1860581; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463	50	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264643	10.1371/journal.pone.0264643	http://dx.doi.org/10.1371/journal.pone.0264643			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231063	Green Published, gold			2022-12-26	WOS:000849744700032
J	Xu, LB; Lin, XY; Li, XL; Hu, ZY; Hou, QL; Wang, Y; Wang, ZH				Xu, Lianbin; Lin, Xueyan; Li, Xiuli; Hu, Zhiyong; Hou, Qiuling; Wang, Yun; Wang, Zhonghua			Integration of transcriptomics and metabolomics provides metabolic and functional insights into reduced insulin secretion in MIN6 beta-cells exposed to deficient and excessive arginine	FASEB JOURNAL			English	Article						arginine availability; functional integrity; glucose-stimulated insulin secretion; insulin release; metabolomics; MIN6 beta-cell; transcriptomics	NITRIC-OXIDE PATHWAY; CATIONIC AMINO-ACID; NUTRIENT REGULATION; FATTY-ACIDS; GLUCOSE; PROLIFERATION; ALANINE	Previous work demonstrated that arginine is one of the strongest insulin secretagogues. However, knowledge of the mechanisms linking chronic arginine metabolism with beta-cell function and insulin secretion is relatively limited. After preliminary selection of concentration according to the cell proliferation, the MIN6 pancreatic beta-cells were randomly assigned to culture in 0.04 mM (low-arginine, LA), 0.4 mM (standard-arginine, SA), or 8 mM arginine (high-arginine, HA) for 24 h. Following the treatment, a combination of transcriptomics and metabolomics, together with a series of molecular biological tests were performed to investigate the responses of beta-cells to varied arginine availability. Our results showed that HA treatment reduced the chronic insulin releases, and LA and HA treatments decreased the glucose-stimulated insulin secretions (GSIS) of beta-cells relative to the SA group (p < .05). Transcriptomics analysis indicated that LA administration significantly inhibited oxidative phosphorylation and ATP metabolic process but promoted DNA repair and mRNA processing in beta-cells, while HA administration affected ammonium ion metabolic process and mRNA export (p < .05). Both LA and HA regulated the expressions of genes involved in DNA replication, cell-cycle phase transition, and response to oxidative stress (p < .05). Protein-protein interaction and transcription factor analyses suggested that Trp53 and Nr4a2 genes may play key roles during arginine stimulation. On the contrary, metabolomics analysis demonstrated that the differentially expressed metabolites (DEM) of MIN6 beta-cells induced by LA were mainly enriched in glycerophospholipid metabolism, linoleic acid metabolism, and purine metabolism, while most DEMs between LA vs. SA comparison belonged to amino acid metabolism. When combined the three groups, co-expression analysis suggested that insulin secretions had strong associations with L-pyroglutamic acid, L-glutamate, and creatine concentrations, while intracellular insulin contents were mainly correlated to L-arginine, argininosuccinic acid, and phosphorylcholine. At last, integrated analysis of transcriptomics and metabolomics showed that glycerophospholipid metabolism, biosynthesis of unsaturated fatty acids, and amino acid metabolism were the most relevant pathways in beta-cells exposed to abnormal arginine supply. This descriptive bioinformatics analysis suggested that the disturbed carbohydrate, lipid, and amino acid metabolisms, as well as the increased apoptosis and elevated oxidative stress, contributed to the reduced insulin secretion and lower GSIS in beta-cells induced by LA or HA treatments, while some underlying mechanisms need to be further explored.	[Xu, Lianbin; Lin, Xueyan; Hu, Zhiyong; Hou, Qiuling; Wang, Yun; Wang, Zhonghua] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China; [Li, Xiuli] Jiangsu Acad Agr Sci, Inst Anim Immune Engn, Nanjing, Peoples R China	Shandong Agricultural University; Jiangsu Academy of Agricultural Sciences	Wang, ZH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China.	zhwang@sdau.edu.cn		Xu, Lianbin/0000-0003-1286-3527	Natural Science Foundation of China [31772623]; Modern Agro-industry Technology Research System of China [CARS-36]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research System of China	Natural Science Foundation of China, Grant/Award Number: 31772623; Modern Agro-industry Technology Research System of China, Grant/Award Number: CARS-36	Bode-Boger SM, 1999, J INVEST MED, V47, P43; Brennan L, 2002, DIABETES, V51, P1714, DOI 10.2337/diabetes.51.6.1714; Caballano-Infantes E, 2017, WORLD J STEM CELLS, V9, P26, DOI 10.4252/wjsc.v9.i2.26; Calbet JAL, 2002, J NUTR, V132, P2174, DOI 10.1093/jn/132.8.2174; Cho J, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01226-3; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Crow J P, 1995, Curr Top Microbiol Immunol, V196, P57; Diaz-Vivancos P, 2015, FREE RADICAL BIO MED, V89, P1154, DOI 10.1016/j.freeradbiomed.2015.09.023; Dobbins RL, 1998, DIABETES, V47, P1613, DOI 10.2337/diabetes.47.10.1613; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fujiwara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092168; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; Greene JM, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-15; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Hubbi ME, 2015, AM J PHYSIOL-CELL PH, V309, pC775, DOI 10.1152/ajpcell.00279.2015; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kiely A, 2007, J ENDOCRINOL, V195, P113, DOI 10.1677/JOE-07-0306; Krause MS, 2011, J ENDOCRINOL, V211, P87, DOI 10.1530/JOE-11-0236; Li J, 2004, AM J PHYSIOL-ENDOC M, V287, pE834, DOI 10.1152/ajpendo.00234.2004; Mandl J, 2009, TRENDS ENDOCRIN MET, V20, P194, DOI 10.1016/j.tem.2009.01.003; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mullooly N, 2014, EXP PHYSIOL, V99, P538, DOI 10.1113/expphysiol.2013.077495; Murakami S, 2015, FREE RADICAL BIO MED, V88, P168, DOI 10.1016/j.freeradbiomed.2015.06.030; Newsholme P, 2007, BIOCHEM SOC T, V35, P1180, DOI 10.1042/BST0351180; Newsholme P, 2014, J ENDOCRINOL, V221, pR105, DOI 10.1530/JOE-13-0616; Newsholme P, 2010, ADV EXP MED BIOL, V654, P91, DOI 10.1007/978-90-481-3271-3_6; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Ramirez-Zamora S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066823; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Salvucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052611; Sener A, 2000, ENDOCRINE, V13, P329, DOI 10.1385/ENDO:13:3:329; Spinas GA, 1999, NEWS PHYSIOL SCI, V14, P49, DOI 10.1152/physiologyonline.1999.14.2.49; Stanley CA, 2009, AM J CLIN NUTR, V90, p862S, DOI 10.3945/ajcn.2009.27462AA; Stefano GB, 2015, ANN TRANSPL, V20, DOI 10.12659/AOT.894289; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vassiliou EK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-25; Werner A, 2016, EUR J IMMUNOL, V46, P92, DOI 10.1002/eji.201546047	39	1	1	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22206	10.1096/fj.202101723R	http://dx.doi.org/10.1096/fj.202101723R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199385				2022-12-26	WOS:000761250800047
J	Zhang, P; Su, L; Ji, XY; Ma, FF; Yue, QL; Zhao, C; Zhang, S; Sun, X; Li, KL; Zhao, L				Zhang, Ping; Su, Le; Ji, Xiuyu; Ma, Feifan; Yue, Qiulin; Zhao, Chen; Zhang, Song; Sun, Xin; Li, Kunlun; Zhao, Lin			Cistanche promotes the adipogenesis of 3T3-L1 preadipocytes	PLOS ONE			English	Article							LIPID-METABOLISM; BIOENERGETICS; MODULATION; PATHWAY; INSULIN; BNIP3	Cistanche deserticola Ma (cistanche) is a traditional herb with a wide range of therapeutic properties. However, no evidence of cistanche's effect on adipogenesis has been found. The effect of cistanche that promotes the adipogenesis of 3T3-L1 preadipocytes was proved by using MTT spectrophotometry, Nile Red staining, Oil Red O staining and transcriptome sequencing technology. The mRNA level of key transcription factors for adipogenesis such as PPAR, AP2 and LPL were examined by RT-PCR. The results showed that the intracellular lipid content in cistanche treated cells were notably increased when compared with the non-treated cells. Between the differentiation and cistanche treated groups, the expression of adipogenesis related genes such as grow hormone releasing hormone (Ghrp), BCL2/adenovirus E1B interacting protein 3 (Bnip3) and Gastric inhibitory polypeptide receptor (Gipr) were significantly increased. Our findings also verified that cistanche promoted adipogenesis, which was accompanied by up-regulated level of Bnip3 and PPAR. This study could uncover new signaling pathways involved in adipogenesis regulation.	[Zhang, Ping; Su, Le; Ji, Xiuyu; Ma, Feifan; Yue, Qiulin; Zhang, Song; Sun, Xin; Zhao, Lin] Qilu Univ Technol, Shandong Acad Sci, Sch Bioengn, State Key Lab Biobased Mat & Green Papermaking, Jinan, Peoples R China; [Zhao, Chen] Qilu Univ Technol, Shandong Acad Sci, Shandong Food Ferment Ind Res & Design Inst, Shandong Prov Key Lab Food & Fermentat Engn, Jinan, Peoples R China; [Li, Kunlun; Zhao, Lin] Jinan Hang Chen Biotechnol Co Ltd, Jinan, Peoples R China	Qilu University of Technology; Qilu University of Technology	Zhao, L (corresponding author), Qilu Univ Technol, Shandong Acad Sci, Sch Bioengn, State Key Lab Biobased Mat & Green Papermaking, Jinan, Peoples R China.; Zhao, L (corresponding author), Jinan Hang Chen Biotechnol Co Ltd, Jinan, Peoples R China.	iahb205@163.com			Spring Industry Leader Talent Support Plan [2017035, 2019042]; Shandong Tai shan leading talent project [LJNY202015]; Key R&D Program of Shandong Province [2019YYSP019, 2019QYTPY024]; Science, education and industry integration and innovation pilot project of Qilu University of Technology (Shandong Academy of Sciences) [2020KJCGH10, 2020KJC-YJ01]; National key plan "science and Technology to help the economy" special project and University, government, industry, research Collaborative innovation Fund project [2020CXY45]; Yantai Development Zone Science and Technology Leading Talents Project [2020CXRC4]	Spring Industry Leader Talent Support Plan; Shandong Tai shan leading talent project; Key R&D Program of Shandong Province; Science, education and industry integration and innovation pilot project of Qilu University of Technology (Shandong Academy of Sciences); National key plan "science and Technology to help the economy" special project and University, government, industry, research Collaborative innovation Fund project; Yantai Development Zone Science and Technology Leading Talents Project	This work was supported by Spring Industry Leader Talent Support Plan (grant number 2017035 and 2019042), Shandong Tai shan leading talent project (grant number LJNY202015), Key R&D Program of Shandong Province (grant number 2019YYSP019 and2019QYTPY024); Science, education and industry integration and innovation pilot project of Qilu University of Technology (Shandong Academy of Sciences) (grant number2020KJC-YJ01 and 2020KJCGH10), National key plan "science and Technology to help the economy" special project and University, government, industry, research Collaborative innovation Fund project (2020CXY45). Yantai Development Zone Science and Technology Leading Talents Project (grant number 2020CXRC4).	Billert M, 2018, BBA-MOL CELL BIOL L, V1863, P1449, DOI 10.1016/j.bbalip.2018.09.006; Blumer RME, 2008, METABOLISM, V57, P1655, DOI 10.1016/j.metabol.2008.07.020; Bu S, 2019, MOLECULES, V24, DOI 10.3390/molecules24193503; Cai R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050477; Chiang HC, 2017, CELL BIOL TOXICOL, V33, P511, DOI 10.1007/s10565-016-9380-7; Choi JW, 2016, DIABETOLOGIA, V59, P571, DOI 10.1007/s00125-015-3836-9; Forbes-Hernandez TY, 2020, FOOD FUNCT, V11, P297, DOI [10.1039/c9fo02285f, 10.1039/C9FO02285F]; Germain A, 2017, MOL BIOSYST, V13, P371, DOI 10.1039/c6mb00600k; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Hoffman JM, 2020, AGING-US, V12, P3473, DOI 10.18632/aging.102822; Hu YB, 2020, J CELL MOL MED, V24, P4023, DOI 10.1111/jcmm.15038; Kong ZL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101562; Lee JH, 2017, J PHARM PHARMACOL, V69, P325, DOI 10.1111/jphp.12684; Li RB, 2018, REDOX BIOL, V18, P229, DOI 10.1016/j.redox.2018.07.011; Li Z, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01269-w; Morikawa T, 2010, BIOORGAN MED CHEM, V18, P1882, DOI 10.1016/j.bmc.2010.01.047; Song DZ, 2018, J CELL PHYSIOL, V233, P9674, DOI 10.1002/jcp.26882; Tol MJ, 2016, DIABETES, V65, P2591, DOI 10.2337/db16-0243; Wang XM, 2017, MOLECULES, V22, DOI 10.3390/molecules22112011; Wu CJ, 2019, MOLECULES, V24, DOI 10.3390/molecules24040720; Xie YB, 2019, MOL MED REP, V19, P783, DOI 10.3892/mmr.2018.9713; Xiong WT, 2013, J ETHNOPHARMACOL, V150, P935, DOI 10.1016/j.jep.2013.09.027; Yang JY, 2008, OBESITY, V16, P16, DOI 10.1038/oby.2007.24; Yun JY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061760; Zeng Jian-chun, 2010, Zhongguo Gu Shang, V23, P606; Zhang T, 2019, J PROTEOME RES, V18, P1133, DOI 10.1021/acs.jproteome.8b00797; Zhang YN, 2019, J CELL BIOCHEM, V120, P8021, DOI 10.1002/jcb.28080; Zhu Z, 2016, IUBMB LIFE, V68, P557, DOI 10.1002/iub.1512	28	0	0	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264772	10.1371/journal.pone.0264772	http://dx.doi.org/10.1371/journal.pone.0264772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231074	gold, Green Published			2022-12-26	WOS:000849744700044
J	Saglam, O; Cao, BW; Wang, XF; Toruner, GA; Conejo-Garcia, JR				Saglam, Ozlen; Cao, Biwei; Wang, Xuefeng; Toruner, Gokce A.; Conejo-Garcia, Jose R.			Expression of epigenetic pathway related genes in association with PD-L1, ER/PgR and MLH1 in endometrial carcinoma	PLOS ONE			English	Article							CANCER; INHIBITION; RECEPTOR; MYC; METHYLATION; GROWTH; 3B	The distribution of Endometrial Cancer (EC)-related deaths is uneven among the morphologic subtypes of EC. Serous Cancer (SC) makes 10% of all EC and accounts for 40% of EC-related deaths. We investigated expression of selected genes involved in epigenetic pathways by immunohistochemistry in a cohort of 106 EC patients and analyzed mRNA-based expression levels for the same set of genes in EC samples from The Cancer Genome Atlas (TCGA) dataset. A tissue microarray was constructed using low-grade (n = 30) and high-grade (n = 28) endometrioid, serous (n = 31) and clear cell carcinoma (n = 17) samples. Epigenetic marker levels were associated with PD-L1, ER/PgR, and MLH1 expression. Epigenetic markers were evaluated by H-score and PD-L1 expression was recorded by using Combined Positive Score. Results were correlated with disease stage and survival outcome. BRD4, KAT6a and HDAC9 levels were higher in SC compared to other histologic subtypes (p<0.001-0.038). After adjusting for multiple comparisons, DNMT3b expression was higher in SC compared to endometrioid-type but not between SC and CCC. The expression levels of BRD4 (p = 0.021) and KAT6a (p = 0.0027) were positively associated with PD-L abundance, while PgR (p = 0.029) and PD-L1 expression were negatively associated. In addition, BRD4 expression was low in specimens with loss of MLH1 expression (p = 0.02). More importantly, BRD4 abundance had a negative impact on disease outcome (p = 0.02). Transcriptionally, BRD4, KAT6a and DNMT3b expression levels were higher in SC in TCGA dataset. The median PD-L1 expression was marginally associated with BRD4, a transcriptional activator of CD274/PD-L1 (p = 0.069) and positively with KAT6a (p = 0.0095). In conclusion, the protein expression levels of epigenetic markers involved in cancer pathogenesis are increased by immunohistochemistry in SC. PD-L1 levels are associated with BRD4 and KAT6a in EC samples. A combination therapy with BRD4/PD-L1 or KAT6a/PD-L1 inhibitors might have a potential use in EC, in particular serous-type carcinoma.	[Saglam, Ozlen] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA; [Cao, Biwei; Wang, Xuefeng] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [Toruner, Gokce A.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Conejo-Garcia, Jose R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Texas System; UTMD Anderson Cancer Center; H Lee Moffitt Cancer Center & Research Institute	Saglam, O (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA.	osaglam@hotmail.com						Andrews FH, 2017, P NATL ACAD SCI USA, V114, pE1072, DOI 10.1073/pnas.1613091114; Bradner JE., 2017, TRANSCRIPTIONAL ADDI, V168, P629; Cao Yuan, 2020, Nan Fang Yi Ke Da Xue Xue Bao, V40, P1295, DOI 10.12122/j.issn.1673-4254.2020.09.11; Dunn J, 2017, MOL IMMUNOL, V87, P227, DOI 10.1016/j.molimm.2017.04.012; Fader AN, 2018, J CLIN ONCOL, V36, P2044, DOI 10.1200/JCO.2017.76.5966; Fader AN, 2010, CURR OPIN OBSTET GYN, V22, P21, DOI 10.1097/GCO.0b013e328334d8a3; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Girault I, 2003, CLIN CANCER RES, V9, P4415; Hogg SJ, 2017, CELL REP, V18, P2162, DOI 10.1016/j.celrep.2017.02.011; Huan F, 2016, MOL CELL BIOL, V36, P1900, DOI 10.1128/MCB.00055-16; Iurlaro M, 2017, CURR OPIN GENET DEV, V43, P101, DOI 10.1016/j.gde.2017.02.003; Jin F, 2005, GYNECOL ONCOL, V96, P531, DOI 10.1016/j.ygyno.2004.10.039; Linares A, 2019, MOL ONCOL, V13, P1534, DOI 10.1002/1878-0261.12505; Lu KH, 2020, NEW ENGL J MED, V383, P2053, DOI 10.1056/NEJMra1514010; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Murali R, 2019, INT J GYNECOL PATHOL, V38, pS40, DOI 10.1097/PGP.0000000000000491; Nagarajan S, 2014, CELL REP, V8, P459, DOI 10.1016/j.celrep.2014.06.016; Ning YL, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000529; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Ren J, 2014, CURR PHARM DESIGN, V20, P1847, DOI 10.2174/13816128113199990528; Ren Y, 2007, CANCER GENET CYTOGEN, V175, P107, DOI 10.1016/j.cancergencyto.2007.02.002; Roberti A, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0675-4; Rokudai S, 2013, P NATL ACAD SCI USA, V110, P3895, DOI 10.1073/pnas.1300490110; Romero Y, 2020, CANCER IMMUNOL IMMUN, V69, P43, DOI 10.1007/s00262-019-02437-2; Saglam O, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238477; Sahin IH, 2019, BRIT J CANCER, V121, P809, DOI 10.1038/s41416-019-0599-y; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; So JY, 2020, CANCER RES, V80, P2612, DOI 10.1158/0008-5472.CAN-19-3339; Ueda SM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.075; Xiong YN, 2005, GYNECOL ONCOL, V96, P601, DOI 10.1016/j.ygyno.2004.11.047; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yu B, 2021, ADV SCI, V8, DOI 10.1002/advs.202100014; Yu L, 2017, ONCOGENE, V36, P2910, DOI 10.1038/onc.2016.433; Zelic R, 2019, PROSTATE CANCER P D, V22, P284, DOI 10.1038/s41391-018-0102-5; Zhu HR, 2016, CELL REP, V16, P2829, DOI 10.1016/j.celrep.2016.08.032; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	37	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264014	10.1371/journal.pone.0264014	http://dx.doi.org/10.1371/journal.pone.0264014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226658	gold, Green Published			2022-12-26	WOS:000793394000005
J	Sandor, J; Vincze, F; Shrikant, ML; Korosi, L; Ulicska, L; Kosa, K; Adany, R				Sandor, Janos; Vincze, Ferenc; Shrikant, Maya Liza; Korosi, Laszlo; Ulicska, Laszlo; Kosa, Karolina; Adany, Roza			COVID-19 vaccination coverage in deprived populations living in segregated colonies: A nationwide cross-sectional study in Hungary	PLOS ONE			English	Article							BLACK; ETHNICITY; DISPARITIES; HESITANCY; BARRIERS; LESSONS; PEOPLE; RACE	The segregated colonies (SCs) in Hungary are populated mainly but not exclusively by Roma. Their health care use is restricted in many respects. It has not been studied yet, whether fair COVID-19 vaccination coverage achieved in Hungary is accompanied with fair effectiveness in SCs. Using census data, the vaccination coverage in SCs and the complementary areas (CAs) in the same settlements of the country was determined. To describe the settlement level differences, the vaccination coverage (until June 30, 2021) in SCs were compared to those in CAs by age, sex, and eligibility for exemption certificate standardized measures. Aggregating settlement level data, the level of geographic discrimination in Hungary was also determined. According to nationwide aggregates, crude vaccination coverage was significantly lower in SCs (40.05%, 95% CI 39.87%-40.23%) than in CAs (65.42%, 95% CI 65.37%-65.46%). The relative standardized vaccination coverage was 0.643 (95% CI 0.639-0.647) in SCs. A total of 437 of the 938 investigated settlements showed significant local vaccination disparities. Hungarian citizens living in SCs, mainly of Roma ethnicity, are a distinct high-risk group. Special intervention adapted to SCs is needed to mitigate inequality in vaccination coverage and further consequences of the pandemic.	[Sandor, Janos; Vincze, Ferenc; Shrikant, Maya Liza; Adany, Roza] Univ Debrecen, Fac Med, Dept Publ Hlth & Epidemiol, Debrecen, Hungary; [Shrikant, Maya Liza] Arizona State Univ, Tempe, AZ USA; [Korosi, Laszlo] Natl Hlth Insurance Fund, Budapest, Hungary; [Ulicska, Laszlo] Minist Interior, Deputy State Secretariat Social Inclus, Budapest, Hungary; [Kosa, Karolina] Univ Debrecen, Fac Med, Dept Behav Sci, Debrecen, Hungary; [Adany, Roza] Univ Debrecen, Fac Med, Dept Publ Hlth & Epidemiol, MTA DE Publ Hlth Res Grp, Debrecen, Hungary	University of Debrecen; Arizona State University; Arizona State University-Tempe; University of Debrecen; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); University of Debrecen	Sandor, J (corresponding author), Univ Debrecen, Fac Med, Dept Publ Hlth & Epidemiol, Debrecen, Hungary.	janos.sandor@med.unideb.hu		Vincze, Ferenc/0000-0003-3595-7737; Sandor, Janos/0000-0001-8486-5666				A Union of Equality, COM2020620; Abdul-Mutakabbir JC, 2021, LANCET GLOB HEALTH, V9, pE749, DOI 10.1016/S2214-109X(21)00099-1; Adany R, 2014, EUR J PUBLIC HEALTH, V24, P702, DOI 10.1093/eurpub/cku143; Ala A, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100862; [Anonymous], WHO FEATURE STORIES; Ayers CK, 2021, J GEN INTERN MED, V36, P1734, DOI 10.1007/s11606-021-06715-7; Barry Vaughn, 2021, MMWR Morb Mortal Wkly Rep, V70, P818, DOI 10.15585/mmwr.mm7022e1; Braden CR, 2013, EMERG INFECT DIS, V19, P864, DOI 10.3201/eid1906.130192; Brown CC, 2021, VACCINE, V39, P4245, DOI 10.1016/j.vaccine.2021.06.038; Chu HR, 2021, SOC SCI MED, V286, DOI 10.1016/j.socscimed.2021.114315; Crawford R, 2016, PUBLIC HEALTH, V141, P186, DOI 10.1016/j.puhe.2016.09.018; Cromer KJ, 2019, J COMMUN HEALTH NURS, V36, P165, DOI 10.1080/07370016.2019.1665320; Curtice K, 2020, LANCET, V395, P1753, DOI 10.1016/S0140-6736(20)31242-3; Darko J, 2021, BRIT J GEN PRACT, V71, P170, DOI [10.3399/bjgp21X715433, 10.3399/bjgp21X15433]; Duchen Raquel, 2021, Healthc Q, V24, P7, DOI 10.12927/hcq.2021.26553; European Centre for Disease Prevention and Control, DOWNL COVID 19 DAT; Evans MK, 2020, NEW ENGL J MED, V383, P408, DOI 10.1056/NEJMp2019445; Fay R, COVID 19 IRISH TRAVE; Fiscella K, 2016, ANNU REV PUBL HEALTH, V37, P375, DOI 10.1146/annurev-publhealth-032315-021439; Glance LG, 2021, MED CARE, V59, P470, DOI 10.1097/MLR.0000000000001522; Griffin S, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n505; Hughes MM, 2021, MMWR-MORBID MORTAL W, V70, P431, DOI 10.15585/mmwr.mm7012e1; Indian Health Service, TRENDS IND HEALTH201; Kadambari S, 2021, LANCET INFECT DIS, V21, P1204, DOI 10.1016/S1473-3099(21)00404-7; Kosa K, 2011, EUR J PUBLIC HEALTH, V21, P463, DOI 10.1093/eurpub/ckp097; Krieger N, 2020, LANCET, V396, pE81, DOI 10.1016/S0140-6736(20)32220-0; Lee SQ, 2018, J MANAG CARE SPEC PH, V24, P778, DOI 10.18553/jmcp.2018.24.8.778; Lo CH, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101029; Morton CE, 2021, TRENDS REGIONAL VARI, DOI [10.1101/2021.01.25.21250356, DOI 10.1101/2021.01.25.21250356]; Muhsen K, 2021, LANCET REG HEALTH-EU, V7, DOI 10.1016/j.lanepe.2021.100130; Ndugga N., LATEST DATA COVID 19; Nguyen LH., 2021, PREPRINT, DOI [10.1101/2021.02.25.21252402, DOI 10.1101/2021.02.25.21252402V1]; O'Dowd A, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n357; Opel DJ, 2021, ANN INTERN MED, V174, P698, DOI 10.7326/M21-0055; Oroszi B, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006427; Parpia AS, 2021, ECLINICALMEDICINE, V33, DOI 10.1016/j.eclinm.2021.100761; Pasztor I.Z., 2016, FOLIA GEOGR, V58, P5; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Razai MS, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4921; Razieh C, 2021, EUR J PUBLIC HEALTH, V31, P639, DOI 10.1093/eurpub/ckab041; Rostila M, 2021, AM J EPIDEMIOL, V190, P1510, DOI 10.1093/aje/kwab057; Sandor J, 2017, INT J PUBLIC HEALTH, V62, P803, DOI 10.1007/s00038-017-0954-9; Sandor J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091835; Seligman B, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003490; Sze S, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100630; Tam T, 2018, Can Commun Dis Rep, V44, P98; Villani J, 2021, GLOB HEALTH PROMOT, V28, P46, DOI 10.1177/1757975921994075; Williams DR, 2000, HEALTH CARE FINANC R, V21, P75; Wong CA, 2021, MMWR-MORBID MORTAL W, V70, DOI 10.15585/mmwr.mm7028a2; World Health Organization, 2021, NOV COR 2019 NCOV SI; Zalla LC, 2021, AM J EPIDEMIOL, V190, P1439, DOI 10.1093/aje/kwab059	51	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264363	10.1371/journal.pone.0264363	http://dx.doi.org/10.1371/journal.pone.0264363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226687	gold, Green Published			2022-12-26	WOS:000793394000019
J	Ji, XY; Chen, XP; Zhang, BX; Xie, M; Zhang, TY; Luo, XY; Liu, DF; Feng, YY; Wang, YJ; Sun, MY; Li, CX; Huang, WJ; Xia, LM				Ji, Xiaoyu; Chen, Xiaoping; Zhang, Bixiang; Xie, Meng; Zhang, Tongyue; Luo, Xiangyuan; Liu, Danfei; Feng, Yangyang; Wang, Yijun; Sun, Mengyu; Li, Congxin; Huang, Wenjie; Xia, Limin			T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1	ONCOGENE			English	Article							PREDICTS POOR-PROGNOSIS; THERAPEUTIC TARGET; CELL-MIGRATION; CANCER; GENE; EXPRESSION; TBX3; DOWNSTREAM; INHIBITION; RESISTANCE	The effect of targeted therapy for metastatic hepatocellular carcinoma (HCC) is still unsatisfactory. Exploring the underlying mechanism of HCC metastasis is favorable to provide new therapeutic strategies. T-box (TBX) transcription factor family genes, which are crucial regulators in embryo and organ development, are vital for regulating tumor initiation, growth and metastasis. Here we explored the role of TBX19 in HCC metastasis, which is one of the most upregulated TBX family genes in human HCC tissues. TBX19 expression was markedly upregulated in HCC tissues and elevated TBX19 expression predicted poor prognosis. Overexpression of TBX19 enhanced HCC metastasis through upregulating epidermal growth factor receptor (EGFR) and Rac family small GTPase 1 (RAC1) expression. Downregulation of EGFR and RAC1 inhibited TBX19-mediated HCC metastasis, while upregulation of EGFR and RAC1 restored inhibition of HCC metastasis mediated by TBX19 knockdown. Furthermore, epidermal growth factor (EGF)/EGFR signaling upregulated TBX19 expression via the extracellular signal-regulated kinase (ERK)/nuclear factor (NF)-kB axis. Besides, the combined application of EGFR inhibitor Erlotinib and RAC1 inhibitor NSC23766 markedly inhibited TBX19-mediated HCC metastasis. In HCC cohorts, TBX19 expression was positively associated with EGFR and RAC1 expression. Patients with positive coexpression of TBX19/EGFR or TBX19/RAC1 displayed the poorest prognosis. In conclusion, EGF/EGFR signaling upregulated TBX19 expression via ERK/NF-kB pathway and TBX19 fostered HCC metastasis by enhancing EGFR and RAC1 expression, which formed an EGF-TBX19-EGFR positive feedback loop. Targeting this signaling pathway may offer a potential therapeutic strategy to efficiently restrain TBX19-mediated HCC metastasis.	[Ji, Xiaoyu; Xie, Meng; Zhang, Tongyue; Luo, Xiangyuan; Liu, Danfei; Feng, Yangyang; Wang, Yijun; Sun, Mengyu; Li, Congxin; Xia, Limin] Huazhong Univ Sci & Technol, Inst Liver & Gastrointestinal Dis, Tongji Hosp,Tongji Med Coll, Dept Gastroenterol,Hubei Key Lab HepatoPancreato, Wuhan 430030, Hubei, Peoples R China; [Chen, Xiaoping; Zhang, Bixiang; Huang, Wenjie] Huazhong Univ Sci & Technol, Hepat Surg Ctr,Hubei Key Lab HepatoPancreatobilia, Tongji Med Coll,Clin Med Res Ctr Hepat Surg Hubei, Tongji Hosp,Key Lab Organ Transplantat,Minist Edu, Wuhan 430030, Hubei, Peoples R China; [Chen, Xiaoping; Zhang, Bixiang; Huang, Wenjie] Huazhong Univ Sci & Technol, Hepat Surg Ctr,Hubei Key Lab HepatoPancreatobilia, Tongji Med Coll,Clin Med Res Ctr Hepat Surg Hubei, Tongji Hosp,Key Lab Organ Transplantat,Minist Pub, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xia, LM (corresponding author), Huazhong Univ Sci & Technol, Inst Liver & Gastrointestinal Dis, Tongji Hosp,Tongji Med Coll, Dept Gastroenterol,Hubei Key Lab HepatoPancreato, Wuhan 430030, Hubei, Peoples R China.; Huang, WJ (corresponding author), Huazhong Univ Sci & Technol, Hepat Surg Ctr,Hubei Key Lab HepatoPancreatobilia, Tongji Med Coll,Clin Med Res Ctr Hepat Surg Hubei, Tongji Hosp,Key Lab Organ Transplantat,Minist Edu, Wuhan 430030, Hubei, Peoples R China.; Huang, WJ (corresponding author), Huazhong Univ Sci & Technol, Hepat Surg Ctr,Hubei Key Lab HepatoPancreatobilia, Tongji Med Coll,Clin Med Res Ctr Hepat Surg Hubei, Tongji Hosp,Key Lab Organ Transplantat,Minist Pub, Wuhan 430030, Hubei, Peoples R China.	huangwenjie@tjh.tjmu.edu.cn; xialimin@tjh.tjmu.edu.cn	Wang, Yijun/GXW-1763-2022	Huang, Wenjie/0000-0003-3182-8516; Danfei, Liu/0000-0002-2298-5520; Zhang, Bixiang/0000-0002-1609-7260	National Natural Science Foundation of China [81871911, 81972237, 81772623]; National Key Research and Development Program of China [2018YFC1312103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	Research was supported by grants from the National Natural Science Foundation of China No. 81871911 (WH), No. 81972237 (LX), No. 81772623 (LX), and National Key Research and Development Program of China 2018YFC1312103 (LX).	Abrahams A, 2010, IUBMB LIFE, V62, P92, DOI 10.1002/iub.275; Ando J, 2017, FUKUSHIMA J MED SCI, V63, P141, DOI 10.5387/fms.2017-08; Bayo J, 2021, GUT, V70, P1362, DOI 10.1136/gutjnl-2020-321454; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Buckley AF, 2008, AM J CLIN PATHOL, V129, P245, DOI 10.1309/WF10QAAED3PP93BH; Cannon AC, 2020, TRENDS CANCER, V6, P478, DOI 10.1016/j.trecan.2020.02.021; Cao XB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-42; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang FY, 2016, ONCOL LETT, V12, P4305, DOI 10.3892/ol.2016.5296; Chen J, 2020, HEPATOLOGY, V71, P1712, DOI 10.1002/hep.30951; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Conlon FL, 2002, GENOME BIOL, V3; Cui J, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.616173; Dong L, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0025-6; Dong XB, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.590898; Feng XG, 2018, ONCOL RES, V26, P959, DOI 10.3727/096504017X15145624664031; Finn RS, 2021, HEPATOLOGY, V73, P150, DOI 10.1002/hep.31306; Furuse J, 2008, CRIT REV ONCOL HEMAT, V67, P8, DOI 10.1016/j.critrevonc.2008.02.009; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gastonguay AJ, 2012, CANCER BIOL THER, V13, P647, DOI 10.4161/cbt.20082; Gordan JD, 2020, J CLIN ONCOL, V38, P4317, DOI 10.1200/JCO.20.02672; Gudino V, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22531-3; He Q, 2021, HEPATOLOGY, V74, P3174, DOI 10.1002/hep.32062; He Q, 2020, ONCOGENE, V39, P7279, DOI 10.1038/s41388-020-01500-y; Hu WW, 2021, HEPATOLOGY, V73, P674, DOI 10.1002/hep.31293; Huang PX, 2014, J CELL MOL MED, V18, P218, DOI 10.1111/jcmm.12153; Kaneto N, 2014, CANCER SCI, V105, P788, DOI 10.1111/cas.12425; Kang L, 2020, AM J TRANSL RES, V12, P7870; Karachaliou N, 2019, EXPERT REV RESP MED, V13, P1019, DOI 10.1080/17476348.2019.1656068; Koinis F, 2020, CANCERS, V12, DOI 10.3390/cancers12010244; Komposch K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010030; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Li DX, 2020, THERANOSTICS, V10, P3749, DOI 10.7150/thno.42596; Liang BY, 2021, J HEPATOL, V75, P120, DOI 10.1016/j.jhep.2021.01.044; Liang JX, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.674426; Liu JX, 2001, P NATL ACAD SCI USA, V98, P8674, DOI 10.1073/pnas.141234898; Liu SJ, 2008, HEPATOLOGY, V47, P1964, DOI 10.1002/hep.22240; Liu XY, 2019, EXP THER MED, V17, P723, DOI 10.3892/etm.2018.7028; Liu ZY, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1412-8; Liu ZC, 2018, J CELL BIOCHEM, V119, P4170, DOI 10.1002/jcb.26625; London M, 2020, CELL BIOL INT, V44, P1267, DOI 10.1002/cbin.11340; Lowery FJ, 2012, CANCER METAST REV, V31, P479, DOI 10.1007/s10555-012-9380-x; Papaioannou VE, 2014, DEVELOPMENT, V141, P3819, DOI 10.1242/dev.104471; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Roselli M, 2012, CLIN CANCER RES, V18, P3868, DOI 10.1158/1078-0432.CCR-11-3211; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; Tang ML, 2021, CANCER RES, V81, P3835, DOI 10.1158/0008-5472.CAN-21-0436; Thomas MB, 2007, CANCER-AM CANCER SOC, V110, P1059, DOI 10.1002/cncr.22886; Wang N, 2019, THYROID, V29, P378, DOI 10.1089/thy.2018.0312; Wansleben S, 2014, BBA-REV CANCER, V1846, P380, DOI 10.1016/j.bbcan.2014.08.004; Xu MJ, 2017, CANCER METAST REV, V36, P463, DOI 10.1007/s10555-017-9687-8; Yoneda N, 2011, LAB INVEST, V91, P262, DOI 10.1038/labinvest.2010.161; Yu J, 2010, ONCOGENE, V29, P6464, DOI 10.1038/onc.2010.370; Zhang J, 2016, SAUDI MED J, V37, P1184, DOI 10.15537/smj.2016.11.16267; Zhangyuan GY, 2020, ONCOGENE, V39, P1213, DOI 10.1038/s41388-019-1052-7; Zhao ST, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0820-6; Zhou K, 2018, LAB INVEST, V98, P989, DOI 10.1038/s41374-018-0071-2; Zhou QQ, 2020, ONCOGENE, V39, P2140, DOI 10.1038/s41388-019-1131-9; Zhu G, 2015, ONCOGENE, V34, P5971, DOI 10.1038/onc.2015.45; Zhu YJ, 2017, ACTA PHARMACOL SIN, V38, P614, DOI 10.1038/aps.2017.5; Zong MJ, 2011, INT J MOL SCI, V12, P4953, DOI 10.3390/ijms12084953	61	3	3	4	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2022	41	15					2225	2238		10.1038/s41388-022-02249-2	http://dx.doi.org/10.1038/s41388-022-02249-2		FEB 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J8DX	35217793				2022-12-26	WOS:000761868000001
J	Ellins, EA; Harris, DE; Lacey, A; Akbari, A; Torabi, F; Smith, D; Jenkins, G; Obaid, D; Chase, A; John, A; Gravenor, MB; Halcox, JP				Ellins, Elizabeth A.; Harris, Daniel E.; Lacey, Arron; Akbari, Ashley; Torabi, Fatemeh; Smith, Dave; Jenkins, Geraint; Obaid, Daniel; Chase, Alex; John, Ann; Gravenor, Michael B.; Halcox, Julian P.			Achievement of European Society of Cardiology/European Atherosclerosis Society lipid targets in very high-risk patients: Influence of depression and sex	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; ANXIETY; EVENTS; CHOLESTEROL; PREDICTS; PEOPLE	Aims To explore differences in the use of lipid lowering therapy and/or achievement of lipid guideline targets in patients with and without prior depression and influence of sex in very high-risk coronary patients. Methods & findings A retrospective observational cohort study was conducted using individual-level linked electronic health record data in patients who underwent percutaneous coronary intervention (2012-2017) in Wales. The cohort comprised of 13,781 patients (27.4% female), with 26.1% having prior depression. Lipid levels were recorded in 10,050 patients of whom 25% had depression. History of depression was independently associated with not having lipids checked (OR 0.79 95%CI 0.72-0.87 p<0.001). Patients with prior depression were less likely to achieve targets for low density lipoprotein cholesterol (LDL-C <1.8mmol/l), non-high density lipoprotein cholesterol (non-HDL-C <2.6mmol/l) and triglycerides (<2.3mmol/l) than patients without depression (OR 0.86 95%CI 0.78-0.96 p = 0.007, OR 0.80 95%CI 0.69-0.92 p = 0.003 & OR 0.69 95CI% 0.61-0.79 p<0.001 respectively). Females were less likely to achieve targets for LDL-C and non-HDL-C than males (OR 0.55 95%CI 0.50-0.61 p<0.001 & OR 0.63 95%CI 0.55-0.73 p<0.001). There was an additive effect of depression and sex; females with depression were not only least likely to be tested (OR 0.74 95%CI 0.65-0.84 p<0.001) but also (where levels were known) less likely to achieve LDL-C (OR 0.47 95%CI 0.41-0.55 p<0.001) and non-HDL-C targets (OR 0.50 95%CI 0.41-0.60 p<0.001). It was not possible to look at the influence of medication adherence on achievement of lipid targets due to limitations of the use of anonymised routinely-held clinical care data. Conclusion Patients with prior depression were less likely to have their lipids monitored and achieve guideline targets within 1-year. Females with depression are the least likely to be tested and achieve lipid targets, suggesting not only a greater risk of future events, but also an opportunity to improve care.	[Ellins, Elizabeth A.; Harris, Daniel E.; Lacey, Arron; Akbari, Ashley; Torabi, Fatemeh; Obaid, Daniel; John, Ann; Gravenor, Michael B.; Halcox, Julian P.] Swansea Univ, Med Sch, Swansea, W Glam, Wales; [Harris, Daniel E.; Smith, Dave; Jenkins, Geraint; Obaid, Daniel; Chase, Alex; Halcox, Julian P.] Swansea Bay Univ Hlth Board, Port Talbot, Wales; [Harris, Daniel E.; Akbari, Ashley; Torabi, Fatemeh; John, Ann; Halcox, Julian P.] Swansea Univ, Med Sch, Hlth Data Res UK, Populat Data Sci, Swansea, W Glam, Wales; [John, Ann] Publ Hlth Wales NHS Trust, Cardiff, Wales	Swansea University; Swansea University	Ellins, EA (corresponding author), Swansea Univ, Med Sch, Swansea, W Glam, Wales.	E.A.Ellins@swansea.ac.uk		Akbari, Ashley/0000-0003-0814-0801; Jenkins, Geraint/0000-0002-3685-242X; Harris, Daniel/0000-0003-4885-637X; Ellins, Elizabeth/0000-0001-5164-6416; Smith, Dave/0000-0001-6648-7577; Lacey, Arron/0000-0001-7983-8073; Torabi, Fatemeh/0000-0002-5853-4625; John, Ann/0000-0002-5657-6995	Health Data Research UK from Health Data Research United Kingdom Ltd - UK Medical Research Council [HDR-9006]; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation (BHF); Wellcome Trust; Swansea Bay University Health Board Research and Development Department	Health Data Research UK from Health Data Research United Kingdom Ltd - UK Medical Research Council; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation (BHF)(British Heart Foundation); Wellcome Trust(Wellcome Trust); Swansea Bay University Health Board Research and Development Department	This work was supported by Health Data Research UK (www.hdruk.ac.uk), which receives its funding from Health Data Research United Kingdom Ltd (HDR-9006) funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation (BHF), and the Wellcome Trust (AA, JH, FT & AL). DH was also supported by Swansea Bay University Health Board Research and Development Department (https://sbuhb.nhs. wales/hospitals/a-z-hospital-services/researchand-development/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atherosclerosis.2004.08.035; British Heart Foundation, 2020, BRIT HEART FDN UK FA; Broadley AJM, 2006, J AM COLL CARDIOL, V48, P170, DOI 10.1016/j.jacc.2005.12.078; Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Dortland AKBV, 2010, ACTA PSYCHIAT SCAND, V122, P30, DOI 10.1111/j.1600-0447.2010.01565.x; Dortland AKBV, 2010, J CLIN PSYCHIAT, V71, P729, DOI 10.4088/JCP.08m04865blu; Excellence NIfHaC, 2016, TECHNOLOGY APPRAISAL; Excellence NIfHaC, 2016, TECHNOLOGY APPRAISAL, DOI [10.1007/s40273-016-0472-2, DOI 10.1007/S40273-016-0472-2]; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Guo YY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011644; Harris DE, 2021, EUR J PREV CARDIOL, V28, P854, DOI 10.1177/2047487320914115; John A, 2016, PSYCHOL MED, V46, P3315, DOI 10.1017/S0033291716002099; John A, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0274-7; Katzmann JL, 2019, PATIENT PREFER ADHER, V13, P9, DOI 10.2147/PPA.S182765; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; Kirchner JE, 2007, J GEN INTERN MED, V22, P92, DOI 10.1007/s11606-006-0017-z; Kivimaki M, 2018, NAT REV CARDIOL, V15, P215, DOI 10.1038/nrcardio.2017.189; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.15829/1560-4071-2020-3826, 10.1093/eurheartj/ehz455]; National Institute for Health and Care Excellence, 2020, IMPL VAG NERV STIM T; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Osborn DPJ, 2011, SCHIZOPHR RES, V129, P104, DOI 10.1016/j.schres.2011.04.003; Pajak A, 2013, EUR J PREV CARDIOL, V20, P331, DOI 10.1177/2047487312441724; Pelletier R, 2016, J AM COLL CARDIOL, V67, P127, DOI 10.1016/j.jacc.2015.10.067; Perez-Pinar M, 2016, EUR PSYCHIAT, V35, P8, DOI 10.1016/j.eurpsy.2016.02.004; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Persons JE, 2016, J AFFECT DISORDERS, V206, P55, DOI 10.1016/j.jad.2016.07.033; Peterson KA, 2022, CARDIOVASC DRUG THER, V36, P1197, DOI 10.1007/s10557-021-07273-0; Pizzi C, 2008, EUR HEART J, V29, P1110, DOI 10.1093/eurheartj/ehn137; Smith DJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-263; Song XQ, 2020, J AFFECT DISORDERS, V266, P158, DOI 10.1016/j.jad.2020.01.136; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Zhao M, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014742	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264529	10.1371/journal.pone.0264529	http://dx.doi.org/10.1371/journal.pone.0264529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213664	gold, Green Published			2022-12-26	WOS:000787811000115
J	Nasimi, F; Yazdchi, M				Nasimi, Fahimeh; Yazdchi, Mohammadreza			LDIAED: A lightweight deep learning algorithm implementable on automated external defibrillators	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; CARDIAC-ARREST	Differentiating between shockable and non-shockable Electrocardiogram (ECG) signals would increase the success of resuscitation by the Automated External Defibrillators (AED). In this study, a Deep Neural Network (DNN) algorithm is used to distinguish 1.4-second segment shockable signals from non-shockable signals promptly. The proposed technique is frequency-independent and is trained with signals from diverse patients extracted from MIT-BIH, MIT-BIH Malignant Ventricular Ectopy Database (VFDB), and a database for ventricular tachyarrhythmia signals from Creighton University (CUDB) resulting, in an accuracy of 99.1%. Finally, the raspberry pi minicomputer is used to load the optimized version of the model on it. Testing the implemented model on the processor by unseen ECG signals resulted in an average latency of 0.845 seconds meeting the IEC 60601-2-4 requirements. According to the evaluated results, the proposed technique could be used by AED's.	[Nasimi, Fahimeh; Yazdchi, Mohammadreza] Univ Isfahan, Fac Engn, Dept Biomed Engn, Esfahan, Iran	University of Isfahan	Yazdchi, M (corresponding author), Univ Isfahan, Fac Engn, Dept Biomed Engn, Esfahan, Iran.	yazdchi@eng.ui.ac.ir		nasimi, fahimeh/0000-0003-2019-7640; Yazdchi, Mohammadreza/0000-0001-8015-2124				Abadi M., 2016, TENSORFLOW LARGE SCA; Acharya UR, 2018, FUTURE GENER COMP SY, V79, P952, DOI 10.1016/j.future.2017.08.039; [Anonymous], 2010, TC 62SC 62D ELECTROM; Beed M., 2014, BENNETTS CARDIAC ARR; Brownlee J, 2016, MACHINE LEARNING MAS; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; Figuera C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159654; FLETCHER GF, 1977, JAMA-J AM MED ASSOC, V238, P2627, DOI 10.1001/jama.238.24.2627; Gaisendrees C, 2021, EXPERT REV MED DEVIC, V18, P179, DOI 10.1080/17434440.2021.1886076; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Greenwald S. D, 1986, DEV ANAL VENTRICULAR; Hai DT, 2021, ARXIV PREPRINT ARXIV; Hajeb-M S, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019065; Hammad M, 2021, INFORM SCIENCES, V571, P580, DOI 10.1016/j.ins.2021.05.035; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7; Josephson M, 2004, CIRCULATION, V109, P2685, DOI 10.1161/01.CIR.0000129322.97266.F3; Khadar SA, 2019, BIOMED SIGNAL PROCES, V51, P277, DOI 10.1016/j.bspc.2019.02.030; Lai D., 2020, IEEE SENS J; Lennox C, 2020, IEEE ENG MED BIO, P288, DOI 10.1109/EMBC44109.2020.9175213; Nguyen MT, 2018, BIOMED SIGNAL PROCES, V44, P258, DOI 10.1016/j.bspc.2018.03.014; Mohammed MA, 2021, IEEE INT SYMP CIRC S, DOI 10.1109/ISCAS51556.2021.9401697; Montavon G, 2012, NEURAL NETWORKS TRIC, V7700; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Moura V., 2020, MOBILE DEVICE ECG CL; Nannes B, 2020, LECT NOTES COMPUT SC, V12140, P334, DOI 10.1007/978-3-030-50423-6_25; Nazarian A., 2018, OPTIMIZING DEPLOYMEN; Nichol G, 2017, J AM COLL CARDIOL, V70, P1496, DOI 10.1016/j.jacc.2017.07.778; Nolle F.M., 1986, COMPUT CARDIOL, V13, P515; Okai T., 2020, J APPL LIFE SCI INT, P40; Panda R, 2020, COMPUT BIOL MED, V124, DOI 10.1016/j.compbiomed.2020.103939; Sabut S, 2021, PHYS ENG SCI MED, V44, P135, DOI 10.1007/s13246-020-00964-2; Seong KW, 2017, COMPUT ASSIST SURG, V22, P86, DOI 10.1080/24699322.2017.1379224; Sharma M, 2019, COMPUT BIOL MED, V115, DOI 10.1016/j.compbiomed.2019.103446; Temple A, 2012, BJA EDUC, V12, P283, DOI 10.1093/bjaceaccp/mks029; Thomas JL, 2014, AM J CARDIOL, V114, P968, DOI 10.1016/j.amjcard.2014.07.006; Tripathy RK, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00722; Ukil A, 2021, IEEE ENG MED BIO, P886, DOI 10.1109/EMBC46164.2021.9630348	39	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264405	10.1371/journal.pone.0264405	http://dx.doi.org/10.1371/journal.pone.0264405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213628	Green Published, gold			2022-12-26	WOS:000787811000091
J	Vonk, JMJ; Gross, AL; Zammit, AR; Bertola, L; Avila, JF; Jutten, RJ; Gaynor, LS; Suemoto, CK; Kobayashi, LC; O'Connell, ME; Elugbadebo, O; Amofa, PA; Staffaroni, AM; Renteria, MA; Turney, IC; Jones, RN; Manly, JJ; Lee, J; Zahodne, LB				Vonk, Jet M. J.; Gross, Alden L.; Zammit, Andrea R.; Bertola, Laiss; Avila, Justina F.; Jutten, Roos J.; Gaynor, Leslie S.; Suemoto, Claudia K.; Kobayashi, Lindsay C.; O'Connell, Megan E.; Elugbadebo, Olufisayo; Amofa, Priscilla A.; Staffaroni, Adam M.; Renteria, Miguel Arce; Turney, Indira C.; Jones, Richard N.; Manly, Jennifer J.; Lee, Jinkook; Zahodne, Laura B.			Cross-national harmonization of cognitive measures across HRS HCAP (USA) and LASI-DAD (India)	PLOS ONE			English	Article							HEALTH; DISPARITIES; RETIREMENT; ISSUES	Background As global populations age, cross-national comparisons of cognitive health and dementia risk are increasingly valuable. It remains unclear, however, whether country-level differences in cognitive function are attributable to population differences or bias due to incommensurate measurement. To demonstrate an effective method for cross-national comparison studies, we aimed to statistically harmonize measures of episodic memory and language function across two population-based cohorts of older adults in the United States (HRS HCAP) and India (LASI-DAD). Methods Data for 3,496 HRS HCAP (>= 65 years) and 3,152 LASI-DAD (>= 60 years) participants were statistically harmonized for episodic memory and language performance using confirmatory factor analysis (CFA) methods. Episodic memory and language factor variables were investigated for differential item functioning (DIF) and precision. Results CFA models estimating episodic memory and language domains based on a priori adjudication of comparable items fit the data well. DIF analyses revealed that four out of ten episodic memory items and five out of twelve language items measured the underlying construct comparably across samples. DIF-modified episodic memory and language factor scores showed comparable patterns of precision across the range of the latent trait for each sample. Conclusions Harmonization of cognitive measures will facilitate future investigation of cross-national differences in cognitive performance and differential effects of risk factors, policies, and treatments, reducing study-level measurement and administrative influences. As international aging studies become more widely available, advanced statistical methods such as those described in this study will become increasingly central to making universal generalizations and drawing valid conclusions about cognitive aging of the global population.	[Vonk, Jet M. J.; Avila, Justina F.; Renteria, Miguel Arce; Turney, Indira C.; Manly, Jennifer J.] Columbia Univ, Vagelos Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, Dept Neurol, New York, NY 10027 USA; [Vonk, Jet M. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Vonk, Jet M. J.] Univ Utrecht, Utrecht, Netherlands; [Gross, Alden L.] Johns Hopkins Univ, Ctr Aging & Hlth, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Zammit, Andrea R.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL USA; [Zammit, Andrea R.] Rush Univ, Dept Psychiat & Behav Sci, Med Ctr, Chicago, IL USA; [Bertola, Laiss] Univ Sao Paulo, Med Sch, Sao Paulo, SP, Brazil; [Jutten, Roos J.] Vrije Univ Amsterdam, Amsterdam Neurosci, Amsterdam UMC, Alzheimer Ctr, Amsterdam, Netherlands; [Jutten, Roos J.] Vrije Univ Amsterdam, Dept Neurol, Amsterdam Neurosci, Amsterdam UMC, Amsterdam, Netherlands; [Gaynor, Leslie S.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Suemoto, Claudia K.] Univ Sao Paulo, Div Geriatr, Med Sch, Sao Paulo, SP, Brazil; [Kobayashi, Lindsay C.] Univ Michigan, Ctr Social Epidemiol & Populat Hlth, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI USA; [O'Connell, Megan E.] Univ Saskatchewan, Dept Psychol, Saskatoon, SK, Canada; [Elugbadebo, Olufisayo] Univ Ibadan, Dept Psychiat, Ibadan, Nigeria; [Amofa, Priscilla A.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Staffaroni, Adam M.] Univ Calif San Francisco UCSF, Memory & Aging Ctr, Weill Inst Neurosci, Dept Neurol, San Francisco, CA USA; [Jones, Richard N.] Brown Univ, Warren Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI USA; [Lee, Jinkook] Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Ctr Econ & Social Res, Los Angeles, CA USA; [Lee, Jinkook] Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Econ, Los Angeles, CA USA; [Lee, Jinkook] RAND Corp, Santa Monica, CA USA; [Zahodne, Laura B.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	Columbia University; Utrecht University; Utrecht University Medical Center; Utrecht University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rush University; Rush University; Universidade de Sao Paulo; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; State University System of Florida; University of Florida; Universidade de Sao Paulo; University of Michigan System; University of Michigan; University of Saskatchewan; University of Ibadan; State University System of Florida; University of Florida; University of California System; University of California San Francisco; Brown University; University of Southern California; University of Southern California; RAND Corporation; University of Michigan System; University of Michigan	Vonk, JMJ (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, Dept Neurol, New York, NY 10027 USA.	jv2528@cumc.columbia.edu	Jones, Richard Norman/J-3488-2013; Suemoto, Claudia Kimie/AAC-7238-2019	Jones, Richard Norman/0000-0002-1049-218X; 	National Institute on Aging (NIA) of the National Institutes of Health (NIH) [R13 AG030995]; NIH NIA [U01 AG009740, U01 AG058499, R01AG051125, RF1AG055273, U01AG064948, K99AG066934, K01AG050699, R01AG070953, K01AG054700, K99AG066932, R01AG054520, P30AG059300]; NWO/ZonMw [09150161810017]; Alzheimer Nederland [WE.15-2018-05]; Sylvia and Leonard Foundation	National Institute on Aging (NIA) of the National Institutes of Health (NIH); NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NWO/ZonMw(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Alzheimer Nederland; Sylvia and Leonard Foundation	This work occurred as part of the 2019 Advanced Psychometric Methods in Cognitive Aging Research conference funded by the National Institute on Aging (NIA) of the National Institutes of Health (NIH) (R13 AG030995, PI: Dan M. Mungas). HRS HCAP is funded by the NIH NIA under awards U01 AG009740 and U01 AG058499. LASI-DAD is funded by the NIH NIA under awards R01AG051125, RF1AG055273, and U01AG064948. Dr. Jet M. J. Vonk is supported by the NIH NIA under award K99AG066934, NWO/ZonMw under Veni Grant project number 09150161810017, and by Alzheimer Nederland under Fellowship WE.15-2018-05. Dr. Alden Gross is supported by the NIH NIA under award K01AG050699, and Dr. Alden Gross and Dr. Lindsay Kobayashi are supported by the NIH NIA under award R01AG070953. Dr. Andrea R. Zammit is supported by the NIH NIA under award K01AG054700 and by the Sylvia and Leonard Foundation. Dr. Miguel Arce Renteri ' a is supported by the NIH NIA under award K99AG066932. Dr. Laura B. Zahodne is supported by the NIH NIA under awards R01AG054520 and P30AG059300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no salary directly from the funders for this work.	Auer S, 2000, INT PSYCHOGERIATR, V12, P391, DOI 10.1017/S104161020000733X; Avila JF, 2019, ALZHEIMERS DEMENT, V15, P1516, DOI 10.1016/j.jalz.2019.04.006; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Burkhauser R.V., 2005, J COMP POLICY ANAL, V7, P313; Chan KS, 2015, J AGING HEALTH, V27, P1392, DOI 10.1177/0898264315583054; Choi SW, 2011, J STAT SOFTW, V39, P1; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Fortuny LAI, 1997, J CLIN EXP NEUROPSYC, V19, P615, DOI 10.1080/01688639708403747; Gfeller JD, 1996, J CLIN PSYCHOL, V52, P191, DOI 10.1002/(SICI)1097-4679(199603)52:2<191::AID-JCLP10>3.0.CO;2-F; Goel A, 2019, INT PSYCHOGERIATR, V31, P1331, DOI 10.1017/S1041610218001746; Griffith L, 2013, HARMONIZATION COGNIT; Gross AL, 2020, J AM GERIATR SOC, V68, pS11, DOI 10.1111/jgs.16738; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Karp A, 2004, AM J EPIDEMIOL, V159, P175, DOI 10.1093/aje/kwh018; Langa K.M, 2018, HLTH RETIREMENT STUD; Langa KM, 2020, NEUROEPIDEMIOLOGY, V54, P64, DOI 10.1159/000503004; Lee J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030300; Lee J, 2014, J ECON AGEING, V4, P26, DOI 10.1016/j.jeoa.2014.02.002; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Mungas D, 2011, NEUROPSYCHOLOGY, V25, P260, DOI 10.1037/a0021090; Pedraza O, 2008, NEUROPSYCHOL REV, V18, P184, DOI 10.1007/s11065-008-9067-9; Ramirez M, 2005, HEALTH SERV RES, V40, P1640, DOI 10.1111/j.1475-6773.2005.00450.x; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Vonk JMJ, 2019, ALZHEIMERS DEMENT, V15, P1576, DOI 10.1016/j.jalz.2019.06.4944; Wechsler D, 1987, WMS R WECHSLER MEMOR; Weir DR., 2016, HARMONIZED COGNITIVE; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Weuve J, 2015, ALZHEIMERS DEMENT, V11, P1098, DOI 10.1016/j.jalz.2015.06.1885; Yang Frances M, 2011, Psychol Test Assess Model, V53, P440	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264166	10.1371/journal.pone.0264166	http://dx.doi.org/10.1371/journal.pone.0264166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213581	gold, Green Published			2022-12-26	WOS:000787811000056
J	Rahman, IU; Hart, RE; Ijaz, F; Afzal, A; Iqbal, Z; Calixto, ES; Abd-Allah, EF; Alqarawi, AA; Hashem, A; Al-Arjani, ABF; Kausar, R; Haq, SM				Rahman, Inayat Ur; Hart, Robbie E.; Ijaz, Farhana; Afzal, Aftab; Iqbal, Zafar; Calixto, Eduardo S.; Abd-Allah, Elsayed Fathi; Alqarawi, Abdulaziz A.; Hashem, Abeer; Al-Arjani, Al-Bandari Fahad; Kausar, Rukhsana; Haq, Shiekh Marifatul			Environmental variables drive plant species composition and distribution in the moist temperate forests of Northwestern Himalaya, Pakistan	PLOS ONE			English	Article							CLIMATE-CHANGE; MANOOR VALLEY; VEGETATION STRUCTURE; DIVERSITY; COMMUNITIES; RICHNESS; GRADIENTS; RESPONSES; BIODIVERSITY; DISTRICT	By assessing plant species composition and distribution in biodiversity hotspots influenced by environmental gradients, we greatly advance our understanding of the local plant community and how environmental factors are affecting these communities. This is a proxy for determining how climate change influences plant communities in mountainous regions ("space-for-time" substitution). We evaluated plant species composition and distribution, and how and which environmental variables drive the plant communities in moist temperate zone of Manoor valley of Northwestern Himalaya, Pakistan. During four consecutive years (2015-2018), we sampled 30 sampling sites, measuring 21 environmental variables, and recording all plant species present in an altitudinal variable range of 1932-3168 m.a.s.l. We used different multivariate analyses to identify potential plant communities, and to evaluate the relative importance of each environmental variable in the species composition and distribution. Finally, we also evaluated diversity patterns, by comparing diversity indices and beta diversity processes. We found that (i) the moist temperate zone in this region can be divided in four different major plant communities; (ii) each plant community has a specific set of environmental drivers; (iii) there is a significant variation in plant species composition between communities, in which six species contributed most to the plant composition dissimilarity; (iv) there is a significant difference of the four diversity indices between communities; and (v) community structure is twice more influenced by the spatial turnover of species than by the species loss. Overall, we showed that altitudinal gradients offer an important range of different environmental variables, highlighting the existence of micro-climates that drive the structure and composition of plant species in each micro-region. Each plant community along the altitudinal gradient is influenced by a set of environmental variables, which lead to the presence of indicator species in each micro-region.	[Rahman, Inayat Ur; Ijaz, Farhana; Afzal, Aftab; Iqbal, Zafar] Hazara Univ, Dept Bot, Mansehra, Khyber Pakhtunk, Pakistan; [Rahman, Inayat Ur; Hart, Robbie E.] Missouri Bot Garden, William L Brown Ctr, St Louis, MO 63110 USA; [Calixto, Eduardo S.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Calixto, Eduardo S.] Univ Missouri St Louis UMSL, Dept Biol, St Louis, MO USA; [Abd-Allah, Elsayed Fathi; Alqarawi, Abdulaziz A.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Prod, Riyadh, Saudi Arabia; [Hashem, Abeer; Al-Arjani, Al-Bandari Fahad] King Saud Univ, Coll Sci, Bot & Microbiol Dept, Riyadh, Saudi Arabia; [Kausar, Rukhsana] Int Islamic Univ, Dept Environm Sci, Islamabad, Pakistan; [Haq, Shiekh Marifatul] Univ Kashmir, Dept Bot, Srinagar, Jammu & Kashmir, India	Hazara University; Missouri Botanical Gardens; State University System of Florida; University of Florida; King Saud University; King Saud University; International Islamic University, Pakistan; University of Kashmir	Rahman, IU (corresponding author), Hazara Univ, Dept Bot, Mansehra, Khyber Pakhtunk, Pakistan.; Rahman, IU; Hart, RE (corresponding author), Missouri Bot Garden, William L Brown Ctr, St Louis, MO 63110 USA.	hajibotanist@outlook.com; robbie.hart@mobot.org	Marifatul Haq, shiekh/HHM-1960-2022; Afzal, Aftab/GQB-0908-2022; Iqbal, Zafar/S-9011-2018; Rahman, Inayat Ur/D-5420-2015; Abd_Allah, Elsayed Fathi/N-6846-2017	Abd_Allah, Elsayed Fathi/0000-0002-8509-8953; Ur Rahman, Inayat/0000-0003-3312-7975; Afzal, Aftab/0000-0002-8388-1709	Higher Education Commission (HEC), Pakistan; King Saud University, Riyadh, Saudi Arabia [RSP-2021/134]	Higher Education Commission (HEC), Pakistan(Higher Education Commission of Pakistan); King Saud University, Riyadh, Saudi Arabia(King Saud University)	This study was supported by the Higher Education Commission (HEC), Pakistan, through a scholarship awarded to IUR as an IRSIP research fellow to conduct research work at the Missouri Botanical Garden, Saint Louis, MO, USA. The authors would like to extend their sincere appreciation to the researchers supporting (Project Number RSP-2021/134), King Saud University, Riyadh, Saudi Arabia.	Adair KL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39033-4; Ali S.M., 1995, FLORA PAKISTAN; Ali SI., 1989, FLORA PAKISTAN; Amjad MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171896; [Anonymous], 2015, PC ORD MULTIVARIATE; Anslan S, 2020, BIOGEOSCIENCES, V17, P1261, DOI 10.5194/bg-17-1261-2020; Audorff V, 2011, J LIMNOL, V70, P9, DOI 10.4081/jlimnol.2011.s1.9; Baldwin AH, 2014, GLOBAL CHANGE BIOL, V20, P835, DOI 10.1111/gcb.12378; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Baselga MA., 2013, PACKAGE BETAPART; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Biodiversity IjazF., 2014, THESIS HAZARA U MANE; Bisbing SM, 2021, DIVERS DISTRIB, V27, P296, DOI 10.1111/ddi.13191; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Buckland ST, 2007, STAT SCI, V22, P44, DOI 10.1214/088342306000000673; Burrows MT, 2020, GLOBAL CHANGE BIOL, V26, P2093, DOI 10.1111/gcb.14968; Canadas EM, 2014, BIOL CONSERV, V170, P282, DOI 10.1016/j.biocon.2013.12.007; Cantonati M, 2006, HYDROBIOLOGIA, V562, P59, DOI 10.1007/s10750-005-1806-9; 송정호, 2015, [Journal of Korean Society of Forest Science, 한국산림과학회지], V104, P193, DOI 10.14578/jkfs.2015.104.2.193; Cleland EE, 2013, ECOLOGY, V94, P1687, DOI 10.1890/12-1006.1; Conti L, 2017, J VEG SCI, V28, P762, DOI 10.1111/jvs.12533; CURTIS JT, 1950, ECOLOGY, V31, P434, DOI 10.2307/1931497; Filgueiras BKC, 2021, TRENDS ECOL EVOL, V36, P545, DOI 10.1016/j.tree.2021.02.006; FRAHM JP, 1991, J BIOGEOGR, V18, P669, DOI 10.2307/2845548; Gauthray-Guyenet V, 2018, PLANT SOIL, V433, P111, DOI 10.1007/s11104-018-3819-y; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; Hansen AJ, 2001, BIOSCIENCE, V51, P765, DOI 10.1641/0006-3568(2001)051[0765:GCIFRO]2.0.CO;2; Haq F, 2017, ECOL INDIC, V80, P232, DOI 10.1016/j.ecolind.2017.05.047; Haq F, 2015, PAK J BOT, V47, P1399; Haq SM, 2021, J SUSTAIN FOREST, V40, P675, DOI 10.1080/10549811.2020.1803918; Hegazy AK, 1998, J ARID ENVIRON, V38, P3, DOI 10.1006/jare.1997.0311; Herve M, 2020, RVAIDEMEMOIRE TESTIN; Hill M.O., 1979, TWINSPAN FORTRAN PRO; Hu A, 2020, ISME J, V14, P931, DOI 10.1038/s41396-019-0574-x; Ijaz F., 2018, PLANT HUMAN HLTH, V1st ed, P675, DOI [10.1007/978-3-319-93997-1_19, DOI 10.1007/978-3-319-93997-1_19]; Iqbal Z, 2018, APPL ECOL ENV RES, V16, P5611, DOI 10.15666/aeer/1605_56115631; Jabis MD., 2018, CLIMATE CHANGE IMPAC; JAYASURIYA AHM, 1983, J ECOL, V71, P571, DOI 10.2307/2259735; Kang S, 2020, GLOB ECOL CONSERV, V24, DOI 10.1016/j.gecco.2020.e01246; Khan AM, 2019, ECOL INDIC, V104, P723, DOI 10.1016/j.ecolind.2019.05.048; Khan SM., 2012, THESIS U LEICESTER U; Kidane YO, 2019, GLOB ECOL CONSERV, V19, DOI 10.1016/j.gecco.2019.e00670; Kluge J, 2017, J BIOGEOGR, V44, P1711, DOI 10.1111/jbi.12955; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Kullman L, 2010, NORD J BOT, V28, P398, DOI 10.1111/j.1756-1051.2010.00812.x; Le Moullec M, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00299; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Lenth RV., 2021, EMMEANS ESTIMATED MA; Lou YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153972; Luo ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035514; Malanson GP, 2020, ARCT ANTARCT ALP RES, V52, P41, DOI 10.1080/15230430.2019.1698894; Malanson GP, 2019, PROG PHYS GEOG, V43, P521, DOI 10.1177/0309133319843873; Marini L, 2007, AGR ECOSYST ENVIRON, V119, P281, DOI 10.1016/j.agee.2006.07.015; Matthews TJ, 2014, ECOL EVOL, V4, P2263, DOI 10.1002/ece3.1092; Mayor JR, 2017, NATURE, V542, P91, DOI 10.1038/nature21027; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McCune B., 1986, ABSTR BOT, P221; McLean E. O., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P199; Motiekaityte V., 2006, EKOLOGIJA, V2, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nasir E., 1971, FLORA W PAKISTAN; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Niu YJ, 2019, SCI TOTAL ENVIRON, V650, P505, DOI 10.1016/j.scitotenv.2018.08.390; Noroozi J, 2019, BIOL CONSERV, V237, P299, DOI 10.1016/j.biocon.2019.07.005; Noroozi J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28504-9; Oduor CO, 2018, BMC ECOL, V18, DOI 10.1186/s12898-018-0202-z; Oksanen Jari, 2020, CRAN; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; R Core Team, 2020, R LANG ENV STAT COMP; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahman IU, 2019, APPL ECOL ENV RES, V17, P331, DOI 10.15666/aeer/1701_331341; Rahman IU, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10112372; Rahman IU, 2020, ECOL INFORM, V60, DOI 10.1016/j.ecoinf.2020.101162; Rahman IU, 2020, SCI TOTAL ENVIRON, V706, DOI 10.1016/j.scitotenv.2019.135714; Rahman IU, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8120581; Rahman IU, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8100378; Rahman IU, 2018, PAK J BOT, V50, P1113; Rahman IU, 2018, CLIN DERMATOL, V36, P310, DOI 10.1016/j.clindermatol.2018.03.016; Rahman IU, 2017, BANGL J BOT, V46, P111; Rahman IU, 2016, J ETHNOPHARMACOL, V194, P877, DOI 10.1016/j.jep.2016.10.068; Rahman IU, 2016, J ETHNOPHARMACOL, V192, P30, DOI 10.1016/j.jep.2016.06.049; Rahman IU, 2015, BANGL J BOT, V44, P613; Rahman IU, 2021, PAK J BOT, V53, P655, DOI 10.30848/PJB2021-2(35); Rahman IU., 2020, ECOPHYSIOLOGICAL PLA; Ravindranath N.H., 2007, CARBON INVENTORY MET; Rawat M, 2020, CATENA, V194, DOI 10.1016/j.catena.2020.104671; Ricklefs RE, 2006, ECOLOGY, V87, pS3, DOI 10.1890/0012-9658(2006)87[3:EDATOO]2.0.CO;2; Rudgers JA, 2014, ECOLOGY, V95, P1918, DOI 10.1890/13-1454.1; Schuur EAG, 2007, ECOSYSTEMS, V10, P280, DOI 10.1007/s10021-007-9024-0; SHIPLEY B, 1987, VEGETATIO, V69, P47, DOI 10.1007/BF00038686; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Smilauer P., 2014, MULTIVARIATE ANAL EC, V5; Soltanpour P. N., 1991, Advances in Soil Science, V16, P165; Son HJ, 2019, FOR SCI TECHNOL, V15, P33, DOI 10.1080/21580103.2018.1530153; Sprent P., 1994, JSTOR; Strohbach M, 2009, J LIMNOL, V68, P375, DOI 10.4081/jlimnol.2009.375; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tian ZQ, 2018, BOT SCI, V96, P157, DOI 10.17129/botsci.1531; Trigas P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059425; Tyler T, 2016, FLORA, V223, P74, DOI 10.1016/j.flora.2016.05.006; Vicherova E, 2015, PERSPECT PLANT ECOL, V17, P347, DOI 10.1016/j.ppees.2015.06.005; Vleminckx J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47595-6; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Weltzin JF, 2003, GLOBAL CHANGE BIOL, V9, P141, DOI 10.1046/j.1365-2486.2003.00571.x; Wilson MJ, 2012, ECOL INDIC, V20, P187, DOI 10.1016/j.ecolind.2012.02.009; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Yang YS, 2018, J MT SCI-ENGL, V15, P1006, DOI 10.1007/s11629-017-4637-z; Yang ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep15723	113	5	5	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0260687	10.1371/journal.pone.0260687	http://dx.doi.org/10.1371/journal.pone.0260687			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202409	gold, Green Published			2022-12-26	WOS:000773224600005
J	Mallik, A; Russo, FA				Mallik, Adiel; Russo, Frank A.			The effects of music & auditory beat stimulation on anxiety: A randomized clinical trial	PLOS ONE			English	Article							STATE-TRAIT INVENTORY; SALIVARY CORTISOL LEVEL; NEGATIVE AFFECT; RELAXING MUSIC; BINAURAL BEATS; PSYCHOMETRIC PROPERTIES; PREOPERATIVE ANXIETY; THERAPY; DISORDERS; REDUCTION	Background and objectivesMusic and auditory beat stimulation (ABS) in the theta frequency range (4-7 Hz) are sound-based anxiety treatments that have been independently investigated in prior studies. Here, the anxiety-reducing potential of calm music combined with theta ABS was examined in a large sample of participants. MethodsAn open-label randomized controlled trial was conducted with participants taking anxiolytics (n = 163). Participants were randomly assigned using the Qualtrics randomizer algorithm, to a single session of sound-based treatment in one of four parallel arms: combined (music & ABS; n = 39), music-alone (n = 36), ABS-alone (n = 41), or pink noise (control; n = 47). Pre- and post-intervention somatic and cognitive state anxiety measures were collected along with trait anxiety, personality measures and musical preferences. The study was completed online using a custom application. ResultsBased on trait anxiety scores participants were separated into moderate and high trait anxiety sub-groups. Among participants with moderate trait anxiety, we observed reductions in somatic anxiety that were greater in combined and music-alone conditions than in the pink noise condition; and reductions in cognitive state anxiety that were greater in the combined condition than in the music-alone, ABS-alone, and pink noise conditions. While we also observed reductions in somatic and cognitive state anxiety in participants with high trait anxiety, the conditions were not well differentiated. ConclusionsSound-based treatments are effective in reducing somatic and cognitive state anxiety. For participants with moderate trait anxiety, combined conditions were most efficacious.	[Mallik, Adiel; Russo, Frank A.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada	Toronto Metropolitan University	Mallik, A (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	adiel.mallik@ryerson.ca		Russo, Frank/0000-0002-2939-6358; Mallik, Adiel/0000-0002-6792-1061	Mitacs Accelerate [IT16618]; Mitacs Industrial Accelerate [IT17123]	Mitacs Accelerate; Mitacs Industrial Accelerate	Funding: Dr. Adiel Mallik would like to acknowledge the support of the Mitacs Accelerate (IT16618) and Mitacs Industrial Accelerate (IT17123) grants. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala TS, 2018, BIOMED SIGNAL PROCES, V42, P242, DOI 10.1016/j.bspc.2018.01.022; Altshuler IM., 1948, PSYCHIATRISTS EXPERI; Bachhuber MA, 2016, AM J PUBLIC HEALTH, V106, P686, DOI 10.2105/AJPH.2016.303061; Bados A, 2010, J PERS ASSESS, V92, P560, DOI 10.1080/00223891.2010.513295; Baldwin D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1199; Baldwin DS, 2010, CURR TOP BEHAV NEURO, V2, P453, DOI 10.1007/7854_2009_2; Bernardi L, 2009, CIRCULATION, V119, P3171, DOI 10.1161/CIRCULATIONAHA.108.806174; Brett J, 2015, AUST PRESCR, V38, P152, DOI 10.18773/austprescr.2015.055; Bringman H, 2009, ACTA ANAESTH SCAND, V53, P759, DOI 10.1111/j.1399-6576.2009.01969.x; Buffum MD, 2006, J VASC NURS, V24, P68, DOI 10.1016/j.jvn.2006.04.001; Bulfone T, 2009, HOLIST NURS PRACT, V23, P238, DOI 10.1097/HNP.0b013e3181aeceee; Camargo A, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-15; Chaieb L., 2017, BINAURAL BEAT STIMUL, P167; Chaieb L, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00070; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Chapados C, 2008, COGNITION, V108, P639, DOI 10.1016/j.cognition.2008.05.008; Coan J. A., 2007, HDB EMOTION ELICITAT; Crespo A, 2013, ARCH ACOUST, V38, P517, DOI 10.2478/aoa-2013-0061; DAVIS WB, 1989, J MUSIC THER, V26, P168, DOI 10.1093/jmt/26.4.168; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; DuPont RL, 1996, ANXIETY, V2, P167, DOI 10.1002/(SICI)1522-7154(1996)2:4<167::AID-ANXI2>3.0.CO;2-L; Fredenburg HA, 2014, ART PSYCHOTHER, V41, P174, DOI 10.1016/j.aip.2014.01.007; Frossard J., 2019, PERMUCO PERMUTATION; Garcia-Argibay M, 2019, PSYCHOL RES-PSYCH FO, V83, P357, DOI 10.1007/s00426-018-1066-8; Garza-Villarreal EA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01051; Garza-Villarreal EA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00090; Goldbeck L, 2012, J MUSIC THER, V49, P395, DOI 10.1093/jmt/49.4.395; Good P, 1994, PERMUTATION TESTS PR; Greaves-Lord K, 2007, ACTA PSYCHIAT SCAND, V116, P137, DOI 10.1111/j.1600-0447.2007.01001.x; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Gros DF, 2007, PSYCHOL ASSESSMENT, V19, P369, DOI 10.1037/1040-3590.19.4.369; Gunter RW, 2010, CLIN PSYCHOL REV, V30, P194, DOI 10.1016/j.cpr.2009.11.001; HANSER SB, 1985, J MUSIC THER, V22, P193, DOI 10.1093/jmt/22.4.193; Heiderscheit A, 2015, MUSIC THER PERSPECT, V33, P45, DOI 10.1093/mtp/miu042; Helsing M., 2016, MUSIC MED, V8, P187, DOI [10.47513/mmd.v8i4.442, DOI 10.47513/MMD.V8I4.442]; Isik BK, 2017, BRIT J ORAL MAX SURG, V55, P571, DOI 10.1016/j.bjoms.2017.02.014; Joormann J, 2005, COGNITIVE THER RES, V29, P569, DOI 10.1007/s10608-005-3340-5; Juruena MF, 2020, ADV EXP MED BIOL, V1191, P141, DOI 10.1007/978-981-32-9705-0_9; Kendall PC, 2001, J AM ACAD CHILD PSY, V40, P787, DOI 10.1097/00004583-200107000-00013; Kennel S, 2010, J PEDIATR NURS, V25, P3, DOI 10.1016/j.pedn.2008.06.010; Khalfa S, 2003, ANN NY ACAD SCI, V999, P374, DOI 10.1196/annals.1284.045; Kuehl R, 2000, DESIGN EXPT STAT PRI; Lane JD, 1998, PHYSIOL BEHAV, V63, P249, DOI 10.1016/S0031-9384(97)00436-8; Le Scouarnec RP, 2001, ALTERN THER HEALTH M, V7, P58; Lenze EJ, 2001, DEPRESS ANXIETY, V14, P86, DOI 10.1002/da.1050; Longo LP, 2000, AM FAM PHYSICIAN, V61, P2121; Lopez-Caballero F, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00557; Mallik A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41952; Martin LJ, 2015, CURR BIOL, V25, P326, DOI 10.1016/j.cub.2014.11.028; McConnell PA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01248; Merry M, 2021, ART PSYCHOTHER, V72, DOI 10.1016/j.aip.2020.101739; Miranda D., 2012, MUSIC HLTH WELLBEING, P513, DOI [10.1093/acprof:oso/9780199586974.003.0034, DOI 10.1093/ACPROF:OSO/9780199586974.003.0034]; Moore BC, 2012, INTRO PSYCHOL HEARIN; Onder H, 2007, J APPL ANIM RES, V32, P69; On FR, 2013, 2013 IEEE 9TH INTERNATIONAL COLLOQUIUM ON SIGNAL PROCESSING AND ITS APPLICATIONS (CSPA), P339, DOI 10.1109/CSPA.2013.6530068; Opbroek A, 2002, INT J NEUROPSYCHOPH, V5, P147, DOI 10.1017/S1461145702002870; Otte Christian, 2011, Dialogues Clin Neurosci, V13, P413; Padmanabhan R, 2005, ANAESTHESIA, V60, P874, DOI 10.1111/j.1365-2044.2005.04287.x; Panteleeva Y, 2018, PSYCHOL MUSIC, V46, P473, DOI 10.1177/0305735617712424; Parodi A, 2021, J PSYCHOSOM OBST GYN, V42, P147, DOI 10.1080/0167482X.2020.1751607; Pastor MA, 2002, J NEUROSCI, V22, P10501; Phillips SP, 2021, J AFFECT DISORDERS, V282, P141, DOI 10.1016/j.jad.2020.12.178; Pluck G., 2019, PSYCHOL NEUROSCIENCE, V12, P53, DOI [10.1037/pne0000166, DOI 10.1037/PNE0000166]; RAMMSAYER T, 1993, PERS INDIV DIFFER, V14, P701, DOI 10.1016/0191-8869(93)90118-M; Ree MJ, 2008, BEHAV COGN PSYCHOTH, V36, P313, DOI 10.1017/S1352465808004232; Reedijk SA, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00082; Reedijk SA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00786; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; RIDER MS, 1985, J MUSIC THER, V22, P183, DOI 10.1093/jmt/22.4.183; Ridley M, 2020, SCIENCE, V370, P1289, DOI 10.1126/science.aay0214; Roberts KE, 2016, PSYCHOL ASSESSMENT, V28, P134, DOI 10.1037/pas0000155; ROCKLIN T, 1981, BRIT J SOC PSYCHOL, V20, P279, DOI 10.1111/j.2044-8309.1981.tb00498.x; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Sandstrom G.M., 2010, MUSIC MED, V2, P137, DOI [10.1177/1943862110371486, DOI 10.1177/1943862110371486]; Schwarz DWF, 2005, CLIN NEUROPHYSIOL, V116, P658, DOI 10.1016/j.clinph.2004.09.014; Solca M, 2016, HEARING RES, V332, P233, DOI 10.1016/j.heares.2015.09.011; South African Department of Science and Technology, 2019, WHITE PAPER SCI TECH; Stewart RE, 2009, J CONSULT CLIN PSYCH, V77, P595, DOI 10.1037/a0016032; SUZUKI S, 1991, J SOUND VIB, V151, P407, DOI 10.1016/0022-460X(91)90537-T; Thanh NN, 2010, J PEDIATR ONCOL NURS, V27, P146, DOI 10.1177/1043454209355983; Twenge JM, 2020, DEPRESS ANXIETY, V37, P954, DOI 10.1002/da.23077; Uedo N, 2004, HEPATO-GASTROENTEROL, V51, P451; Vernon D, 2014, INT J PSYCHOPHYSIOL, V93, P134, DOI 10.1016/j.ijpsycho.2012.10.008; Vreeburg SA, 2010, PSYCHOSOM MED, V72, P340, DOI 10.1097/PSY.0b013e3181d2f0c8; Wahbeh H, 2007, J ALTERN COMPLEM MED, V13, P199, DOI 10.1089/acm.2006.6201; Wahbeh H, 2007, J ALTERN COMPLEM MED, V13, P25, DOI 10.1089/acm.2006.6196; Wang SM, 2002, ANESTH ANALG, V94, P1489, DOI 10.1097/00000539-200206000-00021; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Will U, 2007, NEUROSCI LETT, V424, P55, DOI 10.1016/j.neulet.2007.07.036; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wiwatwongwana D, 2016, EYE, V30, P1407, DOI 10.1038/eye.2016.160; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Wu PY, 2017, COMPLEMENT THER MED, V32, P56, DOI 10.1016/j.ctim.2017.03.007; Yusim A, 2020, J NERV MENT DIS, V208, P155, DOI 10.1097/NMD.0000000000001070; Zhou JH, 2012, J THEOR BIOL, V306, P68, DOI 10.1016/j.jtbi.2012.04.006; Zoteyeva V, 2016, PSYCHOL MUSIC, V44, P307, DOI 10.1177/0305735614566841	98	0	0	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0259312	10.1371/journal.pone.0259312	http://dx.doi.org/10.1371/journal.pone.0259312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263341	Green Submitted, Green Published, gold			2022-12-26	WOS:000804638700038
J	Milanini, J; Magdeleine, M; Fuggetta, N; Ikhlef, S; Brau, F; Abelanet, S; Alpy, F; Tomasetto, C; Drin, G				Milanini, Julie; Magdeleine, Maud; Fuggetta, Nicolas; Ikhlef, Souade; Brau, Frederic; Abelanet, Sophie; Alpy, Fabien; Tomasetto, Catherine; Drin, Guillaume			In situ artificial contact sites (ISACS) between synthetic and endogenous organelle membranes allow for quantification of protein-tethering activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; FFAT MOTIF; GOLGI-APPARATUS; BINDING PROTEIN; LIPID TRANSFER; VAP; ER; REQUIRES; STARD3	Membrane contact sites are specialized areas where the membranes of two distinct organelles are physically connected and allow for the exchange of molecules and for signaling processes. Understanding the mechanisms whereby proteins localize to and function in these structures is of special interest; however, methods allowing for reconstitution of these contact sites are few and only based on synthetic membranes and recombinant proteins. Here, we devised a strategy to create in situ artificial contact sites between synthetic and endogenous organelle membranes. Liposomes functionalized with a peptide containing a two phenylalanines in an acidic tract (FFAT) motif were added to adherent cells whose plasma membrane was perforated. Confocal and super-resolution microscopy revealed that these liposomes associated with the endoplasmic reticulum via the specific interaction of the FFAT motif with endoplasmic reticulum-resident vesicle-associated membrane protein-associated proteins. This approach allowed for quantification of the attachment properties of peptides corresponding to FFAT motifs derived from distinct proteins and of a protein construct derived from steroidogenic acute regulatory protein-related lipid transfer domain-3. Collectively, these data indicate that the creation of in situ artificial contact sites represents an efficient approach for studying the membranet-ethering activity of proteins and for designing membrane contact site reconstitution assays in cellular contexts.	[Milanini, Julie; Magdeleine, Maud; Fuggetta, Nicolas; Ikhlef, Souade; Brau, Frederic; Abelanet, Sophie; Drin, Guillaume] Univ Cote Azur, CNRS, Inst Pharmacol Mol & Cellulaire IPMC, Valbonne, France; [Alpy, Fabien; Tomasetto, Catherine] Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire IGBMC, U1258,INSERM,UMR7104, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Drin, G (corresponding author), Univ Cote Azur, CNRS, Inst Pharmacol Mol & Cellulaire IPMC, Valbonne, France.	drin@ipmc.cnrs.fr	Tomasetto, Catherine Laure/J-2783-2014	Tomasetto, Catherine Laure/0000-0002-1811-5848; FUGGETTA, Nicolas/0000-0002-8508-3188	CNRS, France; Universite Cote d'Azur, France; Agence Nationale de la Recherche, France [ANR-19-CE44-0003]	CNRS, France(Centre National de la Recherche Scientifique (CNRS)); Universite Cote d'Azur, France; Agence Nationale de la Recherche, France(French National Research Agency (ANR))	We acknowledge the flow cytometry and microscopy facility from the Institut de Pharmacologie Moleculaire et Cellulaire, which is part of the GIS IBiSA platform MICA (Microscopie Imagerie Cote d'Azur). We thank P. Eberling (IGBMC [Institut de Genetique et de Biologie Moleculaire et Cellulaire] peptide synthesis facility) for the peptide syntheses. This work was supported by the CNRS, France; Universite Cote d'Azur, France; and by a grant from the Agence Nationale de la Recherche, France (grant no.: ANR-19-CE44-0003).	Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Bian X, 2019, NAT CHEM BIOL, V15, P830, DOI 10.1038/s41589-019-0325-3; Cabukusta B, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108475; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Delfosse V., 2020, CONTACT, V3, DOI DOI 10.1177/2515256420946627; Di Mattia T, 2020, EMBO J, V39, DOI 10.15252/embj.2019104369; Di Mattia T, 2018, EMBO REP, V19, DOI 10.15252/embr.201745453; Eden ER, 2016, DEV CELL, V37, P473, DOI 10.1016/j.devcel.2016.05.005; James C, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071780; Janikiewicz J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0105-5; Johnson B, 2019, CHANNELS, V13, P88, DOI 10.1080/19336950.2019.1568824; Kabashi E, 2013, HUM MOL GENET, V22, P2350, DOI 10.1093/hmg/ddt080; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kamemura K, 2019, J BIOCHEM, V165, P391, DOI 10.1093/jb/mvz011; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; KOBAYASHI T, 1988, CELL, V55, P797, DOI 10.1016/0092-8674(88)90135-3; Li CL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.627700; Lipp NF, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00663; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maeda S, 2019, ELIFE, V8, DOI 10.7554/eLife.45777; Magdeleine M, 2016, ELIFE, V5, DOI 10.7554/eLife.16988; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Osawa T, 2019, NAT STRUCT MOL BIOL, V26, P281, DOI 10.1038/s41594-019-0203-4; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Petkovic M, 2021, GENE DEV, V35, P449, DOI 10.1101/gad.346759.120; Petkovic M, 2014, NAT CELL BIOL, V16, P434, DOI 10.1038/ncb2937; Prinz WA, 2020, NAT REV MOL CELL BIO, V21, P7, DOI 10.1038/s41580-019-0180-9; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scorrano L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09253-3; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; SIMONS K, 1987, EMBO J, V6, P2241, DOI 10.1002/j.1460-2075.1987.tb02496.x; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Valverde DP, 2019, J CELL BIOL, V218, P1787, DOI 10.1083/jcb.201811139; Wilhelm LP, 2017, EMBO J, V36, P1412, DOI 10.15252/embj.201695917; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yadav S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207985	42	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101780	10.1016/j.jbc.2022.101780	http://dx.doi.org/10.1016/j.jbc.2022.101780			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35231443	Green Published, gold			2022-12-26	WOS:000860390500002
J	Saragovi, A; Zilberman, T; Yasur, G; Turjeman, K; Abramovich, I; Kuchersky, M; Gottlieb, E; Barenholz, Y; Berger, M				Saragovi, A.; Zilberman, T.; Yasur, G.; Turjeman, K.; Abramovich, I.; Kuchersky, M.; Gottlieb, E.; Barenholz, Y.; Berger, M.			Analysis of cellular water content in T cells reveals a switch from slow metabolic water gain to rapid water influx prior to cell division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR WATER; VOLUME; TEMPERATURE; MECHANISM; MASS	Cell growth is driven by the acquisition and synthesis of both dry biomass and water mass. In this study, we examine the increase of water mass in T cell during cell growth. We found that T-cell growth is characterized by an initial phase of slow increase in cellular water, followed by a second phase of rapid increase in water content. To study the origin of the water gain, we developed a novel methodology we call cold aqua trap isotope ratio mass spectrometry, which allows analysis of the isotope composition of intracellular water. Applying cold aqua trap-isotope ratio mass spectrometry, we discovered that glycolysis-coupled metabolism of water accounts on average for 11 fl out of the 20 fl of water gained per cell during the initial slow phase. In addition, we show that at the end of the rapid phase before initiation of cell division, a water influx occurs, increasing the cellular water mass by threefold. Thus, we conclude that activated T cells switch from metabolizing water to rapidly taking up water from the extracellular medium prior to cell division. Our work provides a method to analyze cell water content as well as insights into the ways cells regulate their water mass.	[Saragovi, A.; Kuchersky, M.; Berger, M.] Hebrew Univ Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Med Sch, Jerusalem, Israel; [Zilberman, T.; Yasur, G.] Geol Survey Israel, Dept Geochem, Jerusalem IL-9692100, Israel; [Turjeman, K.; Barenholz, Y.] Hebrew Univ Jerusalem, Inst Med Res Israel Canada IMR, Hadassah Med Sch, Dept Biochem & Mol Biol,Lab Membrane & Liposome Re, Jerusalem, Israel; [Abramovich, I.; Gottlieb, E.] Techn Israel Inst Technol, Fac Med, Ruth & Bruce Rappaport, Haifa, Israel	Geological Survey Israel; Hebrew University of Jerusalem; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Saragovi, A; Berger, M (corresponding author), Hebrew Univ Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Med Sch, Jerusalem, Israel.	amijaisar@gmail.com; michaelb@ekmd.huji.ac.il	Gottlieb, Eyal/G-6450-2010	Gottlieb, Eyal/0000-0002-9770-0956; Turjeman, Keren/0000-0002-2062-2662	Israel Science Foundation [1596/17]; German-Israeli Foundation [I-224-414.11-2017]	Israel Science Foundation(Israel Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	Acknowledgments-This work was supported by grants from the Israel Science Foundation (grant no.: 1596/17) and the German-Israeli Foundation (grant no.: I-224-414.11-2017) .	Abir-Awan M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071589; Alberti S, 2017, CURR BIOL, V27, pR1097, DOI 10.1016/j.cub.2017.08.069; Aponte-Santamaria C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04180-z; Ayalon A, 1998, J HYDROL, V207, P18, DOI 10.1016/S0022-1694(98)00119-X; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chapman NM, 2018, CANCER IMMUNOL RES, V6, P502, DOI 10.1158/2326-6066.CIR-17-0605; Cohen R, 2012, J CONTROL RELEASE, V160, P346, DOI 10.1016/j.jconrel.2011.12.030; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004; Delgado FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067590; EASTEAL AJ, 1984, J PHYS CHEM-US, V88, P6060, DOI 10.1021/j150668a065; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Ginzberg MB, 2015, SCIENCE, V348, DOI 10.1126/science.1245075; Goldsmith Y, 2017, EARTH PLANET SC LETT, V457, P302, DOI 10.1016/j.epsl.2016.10.017; Ho SN, 2006, J CELL PHYSIOL, V206, P9, DOI 10.1002/jcp.20445; Hoffmann EK, 2011, ACTA PHYSIOL, V202, P465, DOI 10.1111/j.1748-1716.2010.02190.x; Ibata K, 2011, BIOPHYS J, V101, P2277, DOI 10.1016/j.bpj.2011.08.045; Ionenko IF, 2010, BIOL PLANTARUM, V54, P488, DOI 10.1007/s10535-010-0086-z; Koch AL, 1996, J MICROBIOL METH, V27, P49, DOI 10.1016/0167-7012(96)00928-1; Koivusalo M, 2009, J BIOL CHEM, V284, P6595, DOI 10.1074/jbc.R800049200; Kreuzer-Martin HW, 2005, P NATL ACAD SCI USA, V102, P17337, DOI 10.1073/pnas.0506531102; Lea NC, 2003, MOL CELL BIOL, V23, P2351, DOI 10.1128/MCB.23.7.2351-2361.2003; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Mackay GM, 2015, METHOD ENZYMOL, V561, P171, DOI 10.1016/bs.mie.2015.05.016; Martinez-Martin D, 2017, NATURE, V550, P500, DOI 10.1038/nature24288; Nelson SD, 2003, DRUG METAB DISPOS, V31, P1481, DOI 10.1124/dmd.31.12.1481; Nicchia GP, 2000, GLIA, V31, P29, DOI 10.1002/(SICI)1098-1136(200007)31:1<29::AID-GLIA30>3.0.CO;2-3; Olgun A, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-9; PIVARNIK JM, 1984, J APPL PHYSIOL, V56, P613, DOI 10.1152/jappl.1984.56.3.613; Platonova A, 2015, BBA-BIOMEMBRANES, V1848, P2337, DOI 10.1016/j.bbamem.2015.07.005; Sachs F, 2015, J GEN PHYSIOL, V145, P373, DOI 10.1085/jgp.201411297; Schmoller KM, 2015, TRENDS CELL BIOL, V25, P793, DOI 10.1016/j.tcb.2015.10.006; SCHOELLER DA, 1982, J APPL PHYSIOL, V53, P955, DOI 10.1152/jappl.1982.53.4.955; Soveral G, 2006, MICROBIOL-SGM, V152, P1515, DOI 10.1099/mic.0.28679-0; Tasnim H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01571; TEAGUE TK, 1993, CYTOMETRY, V14, P772, DOI 10.1002/cyto.990140710; Walker G, 2001, CURR PLANT SCI BIOT, V40, P57	37	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101795	10.1016/j.jbc.2022.101795	http://dx.doi.org/10.1016/j.jbc.2022.101795			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35248530	gold, Green Published			2022-12-26	WOS:000797895000004
J	Sarker, A; Rathore, AS; Khalid, MF; Gupta, RD				Sarker, Animesh; Rathore, Abhishek Singh; Khalid, Md Fahim; Gupta, Rinkoo Devi			Structure-guided affinity maturation of a single-chain variable fragment antibody against the Fu-bc epitope of the dengue virus envelope protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; DEPENDENT ENHANCEMENT; CONSERVED RESIDUES; FUSION-LOOP; IN-VITRO; INFECTION; GLYCOPROTEIN; EFFICACY	Dengue is one of the most dominant arthropod-borne viral diseases, infecting at least 390 million people every year throughout the world. Despite this, there is no effective treatment against dengue, and the only available vaccine has already been withdrawn owing to the significant adverse effects. Therefore, passive immunotherapy using monoclonal antibodies is now being sought as a therapeutic option. To date, many dengue monoclonal antibodies have been identified, most of which are serotype-specific, and only a few of which are cross-reactive. Furthermore, antibodies that cross-react within serotypes are weakly neutralizing and frequently induce antibody-dependent enhancement, which promotes viral entry and replication. Therefore, broadly neutralizing antibodies with no risk of antibody-dependent enhancement are required for the treatment of dengue. Here, we developed a single-chain variable fragment (scFv) antibody from an anti-fusion loop E53 antibody (PDB: 2IGF). We introduced previously predicted favorable complementarity-determining region (CDR) mutations into the gene encoding the scFv antibody for affinity maturation, and the resultant variants were tested in vitro against the highly conserved fusion and bc epitope of the dengue virus envelope protein. We show some of these scFv variants with two to three substitution mutations in three different CDRs possess affinity constants (K-D) ranging from 20 to 200 nM. The scFv-mutant15, containing D31L, Y105W, and S227W substitutions, showed the lowest affinity constant, (K-D = 24 +/- 7 nM), approximately 100-fold lower than its parental construct. We propose that the scFv-derivative antibody may be a good candidate for the development of an effective and safe immunotherapy.	[Sarker, Animesh; Rathore, Abhishek Singh; Khalid, Md Fahim; Gupta, Rinkoo Devi] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	South Asian University (SAU)	Gupta, RD (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	dgupta@sau.ac.in			SERB [EMR/2016/007246]; South Asian University	SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); South Asian University	R. D. G. thanks SERB for funding (Project Number: EMR/2016/007246). A. S., A. S. R., and M. F. K. are thankful to South Asian University for PhD fellowships.	Bhatt S., 2013, GLOBAL DISTRIBUTION; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; BRANDT WE, 1982, INFECT IMMUN, V36, P1036, DOI 10.1128/IAI.36.3.1036-1041.1982; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Caskey M., 2015, VIRAEMIA; Castao-Osorio J. C., 2018, DENGUE FEVER A RESIL, DOI [10.5772/intechopen.80820, DOI 10.5772/INTECHOPEN.80820]; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Deb Paroma, 2021, Biosaf Health, V3, P87, DOI 10.1016/j.bsheal.2021.02.001; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Nandi S, 2016, MABS-AUSTIN, V8, P1456, DOI 10.1080/19420862.2016.1227901; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Oliphant T., 2006, ANTIBODY RECOGNITION; Ramadhany R, 2015, ANTIVIR RES, V124, P61, DOI 10.1016/j.antiviral.2015.10.012; Ramos EL, 2015, J INFECT DIS, V211, P1038, DOI 10.1093/infdis/jiu539; Rathore AS, 2020, APPL MICROBIOL BIOT, V104, P4333, DOI 10.1007/s00253-020-10541-y; Rathore AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209576; Sarker A, 2019, MICROB CELL FACT, V18, DOI 10.1186/s12934-019-1053-9; Taylor PC, 2021, NAT REV IMMUNOL, V21, P382, DOI 10.1038/s41577-021-00542-x; Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Wang M, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00157; Winkler AM, 2015, CURR OPIN HEMATOL, V22, P521, DOI 10.1097/MOH.0000000000000191; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	34	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101772	10.1016/j.jbc.2022.101772	http://dx.doi.org/10.1016/j.jbc.2022.101772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35218775	gold, Green Published			2022-12-26	WOS:000793560400009
J	Kirichenko, AD; Poroshina, AA; Sherbakov, DY; Sadovsky, MG; Krutovsky, KV				Kirichenko, Anastasiya D.; Poroshina, Anastasiya A.; Sherbakov, Dmitry Yu; Sadovsky, Michael G.; Krutovsky, Konstantin, V			Comparative analysis of alignment-free genome clustering and whole genome alignment-based phylogenomic relationship of coronaviruses	PLOS ONE			English	Article							RECOMBINATION; PNEUMONIA; EVOLUTION	The SARS-CoV-2 is the third coronavirus in addition to SARS-CoV and MERS-CoV that causes severe respiratory syndrome in humans. All of them likely crossed the interspecific barrier between animals and humans and are of zoonotic origin, respectively. The origin and evolution of viruses and their phylogenetic relationships are of great importance for study of their pathogenicity and development of antiviral drugs and vaccines. The main objective of the presented study was to compare two methods for identifying relationships between coronavirus genomes: phylogenetic one based on the whole genome alignment followed by molecular phylogenetic tree inference and alignment-free clustering of triplet frequencies, respectively, using 69 coronavirus genomes selected from two public databases. Both approaches resulted in well-resolved robust classifications. In general, the clusters identified by the first approach were in good agreement with the classes identified by the second using K-means and the elastic map method, but not always, which still needs to be explained. Both approaches demonstrated also a significant divergence of genomes on a taxonomic level, but there was less correspondence between genomes regarding the types of diseases they caused, which may be due to the individual characteristics of the host. This research showed that alignment-free methods are efficient in combination with alignment-based methods. They have a significant advantage in computational complexity and provide valuable additional alternative information on the genomes relationships.	[Kirichenko, Anastasiya D.; Krutovsky, Konstantin, V] Siberian Fed Univ, Inst Fundamental Biol & Biotechnol, Dept Genom & Bioinformat, Krasnoyarsk, Russia; [Poroshina, Anastasiya A.; Sherbakov, Dmitry Yu] Russian Acad Sci, Limnol Inst, Lab Mol Systemat, Siberian Branch, Irkutsk, Russia; [Sherbakov, Dmitry Yu] Irkutsk State Univ, Fac Biol & Soil Studies, Irkutsk, Russia; [Sherbakov, Dmitry Yu] Novosibirsk State Univ, Fac Nat Sci, Novosibirsk, Russia; [Sadovsky, Michael G.] Russian Acad Sci, Inst Computat Modelling, Siberian Branch, Krasnoyarsk, Russia; [Sadovsky, Michael G.] VF Voino Yasenetsky Krasnoyarsk State Med Univ, Krasnoyarsk, Russia; [Sadovsky, Michael G.] Fed Med Biol Agcy, Fed Res & Clin Ctr, Krasnoyarsk, Russia; [Krutovsky, Konstantin, V] Georg August Univ Gottingen, Dept Forest Genet & Forest Tree Breeding, Gottingen, Germany; [Krutovsky, Konstantin, V] Georg August Univ Gottingen, Ctr Integrated Breeding Res, Gottingen, Germany; [Krutovsky, Konstantin, V] Siberian Fed Univ, Inst Fundamental Biol & Biotechnol, Genome Res & Educ Ctr, Lab Forest Genom, Krasnoyarsk, Russia; [Krutovsky, Konstantin, V] Russian Acad Sci, NI Vavilov Inst Gen Genet, Lab Populat Genet, Moscow, Russia; [Krutovsky, Konstantin, V] GF Morozov Voronezh State Univ Forestry & Technol, Sci & Methodol Ctr, Voronezh, Russia	Siberian Federal University; Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Irkutsk State University; Novosibirsk State University; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Institute of Computational Modelling of the Siberian Branch of the Russian Academy of Sciences; Krasnoyarsk State Medical University; University of Gottingen; University of Gottingen; Siberian Federal University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Voronezh State University of Forestry & Technologies named after G.F. Morozov	Krutovsky, KV (corresponding author), Siberian Fed Univ, Inst Fundamental Biol & Biotechnol, Dept Genom & Bioinformat, Krasnoyarsk, Russia.; Krutovsky, KV (corresponding author), Georg August Univ Gottingen, Dept Forest Genet & Forest Tree Breeding, Gottingen, Germany.; Krutovsky, KV (corresponding author), Georg August Univ Gottingen, Ctr Integrated Breeding Res, Gottingen, Germany.; Krutovsky, KV (corresponding author), Siberian Fed Univ, Inst Fundamental Biol & Biotechnol, Genome Res & Educ Ctr, Lab Forest Genom, Krasnoyarsk, Russia.; Krutovsky, KV (corresponding author), Russian Acad Sci, NI Vavilov Inst Gen Genet, Lab Populat Genet, Moscow, Russia.; Krutovsky, KV (corresponding author), GF Morozov Voronezh State Univ Forestry & Technol, Sci & Methodol Ctr, Voronezh, Russia.	konstantin.krutovsky@forst.uni-goettingen.de	Krutovsky, Konstantin V./A-5419-2012	Krutovsky, Konstantin V./0000-0002-8819-7084; Kirichenko, Anastasiia/0000-0002-9659-5189; Sadovsky, Michael/0000-0002-1807-0715; Sherbakov, Dmitry/0000-0002-1410-392X	Ministry of Science and Higher Education of the Russian Federation [0279-2021-002]	Ministry of Science and Higher Education of the Russian Federation	D.Y.S. and A.A.P. were supported by the basic project. 0279-2021-002 funded by the Ministry of Science and Higher Education of the Russian Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard G, 2019, BRIEF BIOINFORM, V20, P426, DOI 10.1093/bib/bbx067; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Bugaenko N. N., 1998, Open Systems & Information Dynamics, V5, P265, DOI 10.1023/A:1009637019316; Cheng ZKJ, 2020, INFECTION, V48, P155, DOI 10.1007/s15010-020-01401-y; do Vale B, 2021, VET RES COMMUN, V45, P1, DOI 10.1007/s11259-021-09787-2; Fedotovskaya Victory, 2020, Bioinformatics and Biomedical Engineering. 8th International Work-Conference, IWBBIO 2020. Proceedings. Lecture Notes in Bioinformatics. Subseries of Lecture Notes in Computer Science (LNBI 12108), P438, DOI 10.1007/978-3-030-45385-5_39; Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001; Gorban A, 2005, COMPUTING, V75, P359, DOI 10.1007/s00607-005-0122-6; Gorban A, 2014, PREPRINT; Gorban AN, 2003, IEEE IJCNN, P1826; Gorban AN, 2001, PREPRINT; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682; Jombart T, 2017, MOL ECOL RESOUR, V17, P1385, DOI 10.1111/1755-0998.12676; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lin CM, 2016, VIRUS RES, V226, P20, DOI 10.1016/j.virusres.2016.05.023; Liu P, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008421; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Maddison W.P., MESQUITE MODULAR SYS; Makarenkov V, 2021, BMC ECOL EVOL, V21, DOI 10.1186/s12862-020-01732-2; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Python Core Team, PYTHON DYNAMIC OPEN; R Core Team, R LANG ENV STAT COMP; Sadovsky MG, 2002, OPEN SYST INF DYN, V9, P37, DOI 10.1023/A:1014230928565; Sadovsky MG, 2002, OPEN SYST INF DYN, V9, P19, DOI 10.1023/A:1014278811727; Sadovsky MG., 2020, BIORXIV, DOI [https%3A//doi.org/10.1101/2020.12.18.423570, DOI 10.1101/2020.12.18.423570]; Sadovsky M, 2019, LECT N BIOINFORMAT, V11465, P335, DOI 10.1007/978-3-030-17938-0_30; Sadovsky M, 2015, LECT N BIOINFORMAT, V9043, P481, DOI 10.1007/978-3-319-16483-0_47; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD94, DOI 10.1093/nar/gky989; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Vlasova AN, 2022, CLIN INFECT DIS, V74, P446, DOI 10.1093/cid/ciab456; Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Yang D, 2015, VIRUS RES, V206, P120, DOI 10.1016/j.virusres.2015.02.025; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9; Zielezinski A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1319-7	47	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264640	10.1371/journal.pone.0264640	http://dx.doi.org/10.1371/journal.pone.0264640			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259178	Green Published, gold			2022-12-26	WOS:000835141200019
J	Malkin, JD; Baid, D; Alsukait, RF; Alghaith, T; Alluhidan, M; Alabdulkarim, H; Altowaijri, A; Almalki, ZS; Herbst, CH; Finkelstein, EA; El-Saharty, S; Alazemi, N				Malkin, Jesse D.; Baid, Drishti; Alsukait, Reem F.; Alghaith, Taghred; Alluhidan, Mohammed; Alabdulkarim, Hana; Altowaijri, Abdulaziz; Almalki, Ziyad S.; Herbst, Christopher H.; Finkelstein, Eric Andrew; El-Saharty, Sameh; Alazemi, Nahar			The economic burden of overweight and obesity in Saudi Arabia	PLOS ONE			English	Article							MEDICAL COST; GERMANY	Context The prevalence of overweight and obesity in Saudi Arabia has been rising. Although the health burden of excess weight is well established, little is known about the economic burden. Aims To assess the economic burden-both direct medical costs and the value of absenteeism and presenteeism-resulting from overweight and obesity in Saudi Arabia. Settings and design The cost of overweight and obesity in Saudi Arabia was estimated from a societal perspective using an epidemiologic approach. Methods and materials Data were obtained from previously published studies and secondary databases. Statistical analysis used Overweight/obesity-attributable costs were calculated for six major noncommunicable diseases; sensitivity analyses were conducted for key model parameters. Results The impact of overweight and obesity for these diseases is found to directly cost a total of $3.8 billion, equal to 4.3 percent of total health expenditures in Saudi Arabia in 2019. Estimated overweight and obesity-attributable absenteeism and presenteeism costs a total of $15.5 billion, equal to 0.9 percent of GDP in 2019. Conclusions Even when limited to six diseases and a subset of total indirect costs, results indicate that overweight and obesity are a significant economic burden in Saudi Arabia. Future studies should identify strategies to reduce the health and economic burden resulting from excess weight in Saudi Arabia.	[Baid, Drishti] Univ Southern Calif, Sol Price Sch Publ Policy, Los Angeles, CA 90007 USA; [Alsukait, Reem F.] King Saud Univ, Coll Appl Med Sci, Community Hlth Sci, Riyadh, Saudi Arabia; [Alsukait, Reem F.; Herbst, Christopher H.] World Bank, Hlth Nutr & Populat Global Practice, Riyadh, Saudi Arabia; [Alghaith, Taghred; Alluhidan, Mohammed; Alazemi, Nahar] Saudi Hlth Council, Riyadh, Saudi Arabia; [Alluhidan, Mohammed] Univ Lancaster, Lancaster, England; [Alabdulkarim, Hana] Minist Natl Guards Hlth Affairs, Drug Policy & Econ Ctr, Riyadh, Saudi Arabia; [Altowaijri, Abdulaziz] Minist Hlth, Program Hlth Assurance & Purchasing, Riyadh, Saudi Arabia; [Almalki, Ziyad S.] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Al Kharj, Saudi Arabia; [Finkelstein, Eric Andrew] Duke NUS Med Sch, Singapore, Singapore; [El-Saharty, Sameh] World Bank, Hlth Nutr & Populat Global Practice, Kuwait, Kuwait	University of Southern California; King Saud University; Lancaster University; Ministry of Health - Saudi Arabia; Prince Sattam Bin Abdulaziz University; National University of Singapore		jesse.malkin@gmail.com		Alluhidan, Mohammed/0000-0003-3824-2059	World Bank [P172148]; Saudi Health Council	World Bank(The World Bank India); Saudi Health Council	Funding for this research was provided by the World Bank under its advisory services program (P172148) to the Saudi Health Council, Saudi Arabia. The sponsors-the Saudi Health Council and the World Bank-participated in the preparation of this paper. However, the findings, interpretations, and conclusions expressed in this work are those of the authors and do not necessarily reflect the views of the Saudi Health Council or the World Bank, their Boards of Directors, or the governments they represent.	Almutairi N, 2013, APPL HEALTH ECON HEA, V11, P671, DOI 10.1007/s40258-013-0065-6; Alsukait R, 2020, ECON HUM BIOL, V38, DOI 10.1016/j.ehb.2020.100868; Anis AH, 2010, OBES REV, V11, P31, DOI 10.1111/j.1467-789X.2009.00579.x; [Anonymous], 2008, GROWING COST OBESITY, DOI DOI 10.1097/SAP.0B013-31816FCAC418434822; Benzaquem DC, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0121160, 10.1371/journal.pone.0112217]; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Effertz T, 2016, EUR J HEALTH ECON, V17, P1141, DOI 10.1007/s10198-015-0751-4; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Finkelstein EA, 2021, J MED ECON, V24, P828, DOI 10.1080/13696998.2021.1945242; Global Burden of Disease Collaborative Network, 2020, GLOBAL BURDEN DIS ST; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Lehnert T, 2015, EUR J HEALTH ECON, V16, P957, DOI 10.1007/s10198-014-0645-x; Lette M, 2016, EUR J HEALTH ECON, V17, P61, DOI 10.1007/s10198-014-0655-8; Ministere de l'Economie et des Finances, 2016, TRES EC, V179; Ministry of Health, 2020, KINGDOM SAUDI ARABIA; Mokdad AH, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000575; Odegaard K, 2008, INT J PEDIATR OBES, V3, P51, DOI 10.1080/17477160801897067; Organisation for Economic Co-operation and Development, 2019, The heavy burden of obesity. The economics of prevention, DOI 10.1787/67450d67-en; Qin XZ, 2016, HEALTH ECON, V25, P1291, DOI 10.1002/hec.3217; Schneider H., 2014, COST OBESITY SWITZER; World Bank, 2021, DATABANK; World Health Organisation, 2021, BANGLADESH	23	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264993	10.1371/journal.pone.0264993	http://dx.doi.org/10.1371/journal.pone.0264993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259190	Green Published, gold, Green Accepted			2022-12-26	WOS:000835141200036
J	Moitra, P; Madan, J				Moitra, Panchali; Madan, Jagmeet			Impact of screen time during COVID-19 on eating habits, physical activity, sleep, and depression symptoms: A cross-sectional study in Indian adolescents	PLOS ONE			English	Article							MAJOR DEPRESSION; YOUNG-ADULTS; MEDIA; CHILDREN; DIET; BEHAVIORS; PHQ-2	Objective This study attempted to address the limited knowledge regarding the impact of screen time (ST) on lifestyle behaviors in Indian adolescents during the ongoing COVID-19 pandemic. The objectives were to 1) evaluate frequency and duration of using screens, and screen addiction behaviors in 10-15 years old adolescents in Mumbai during the COVID-19 pandemic and 2) examine the association of ST with lifestyle behaviors-eating habits, snacking patterns, physical activity (PA) levels, sleep quality and depression symptoms. Methods An online survey was completed between January and March 2021. Eating habits, snacking patterns, time spent in different screen-based activities, and screen addiction behaviors were reported. The PA levels, sleep quality, and depression symptoms were evaluated using the Physical Activity Questionnaire for Children/Adolescents (PAQ C/A), Pittsburg Sleep Quality Index (PSQI), and Patient Health Questionnaire-2 (PHQ-2) respectively. Multiple linear regression analyses were performed to determine the impact of ST on lifestyle behaviors. Results Adolescents (n = 1298, M-age 13.2(1.1), 53.3% boys) reported the mean weekday and weekend ST as 442.3 (201.5) minutes/d and 379.9 (178.2) minutes/d respectively. Overall, 33.4% spent > 6hours/d for studying or doing homework, 65.4% used social networking sites for at least 2-3 hours/d, and 70.7% agreed that ST had taken up the majority of their leisure time. Only 12% engaged in moderate to vigorous PA (PAQ C/A scores < 2). More than half (52.5%) reported PSQI > 5 indicating poor sleep quality and 8.6% scored >= 3 on PHQ-2 to suggest a risk of depression. A higher ST was associated with lower PA and increased sleep problems and a greater screen addiction was inversely associated with the eating habit, PA, and sleep-related variables. Conclusion The study draws attention to a high prevalence of excess ST and its impact on eating habits, PA levels, and sleep quality in Indian adolescents during the COVID-19 pandemic. Targeted health promotion interventions that encourage judicious use of screens for education and entertainment and emphasize the adverse health effects of excess ST are required.	[Moitra, Panchali; Madan, Jagmeet] SNDT Womens Univ, Dept Food Nutr & Dietet, Sir Vithaldas Thackersey Coll Home Sci Autonomous, Mumbai, Maharashtra, India		Moitra, P (corresponding author), SNDT Womens Univ, Dept Food Nutr & Dietet, Sir Vithaldas Thackersey Coll Home Sci Autonomous, Mumbai, Maharashtra, India.	panchali2511@yahoo.co.in	Moitra, Panchali/AAH-3673-2021	Moitra, Panchali/0000-0002-3630-2794				Allafi A, 2014, PUBLIC HEALTH NUTR, V17, P2045, DOI 10.1017/S1368980013002218; Ashton JJ, 2019, LANCET CHILD ADOLESC, V3, P292, DOI 10.1016/S2352-4642(19)30062-8; Barnett TA, 2018, CIRCULATION, V138, pE142, DOI 10.1161/CIR.0000000000000591; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Dubey M, 2019, INDIAN J COMMUN MED, V44, P271, DOI 10.4103/ijcm.IJCM_87_19; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Falbe J, 2015, PEDIATRICS, V135, pE367, DOI 10.1542/peds.2014-2306; Genta FD, 2021, J CLIN SLEEP MED, V17, P1371, DOI 10.5664/jcsm.9196; Ghosh Aritra, 2020, Sens Int, V1, P100021, DOI 10.1016/j.sintl.2020.100021; Granic I, 2014, AM PSYCHOL, V69, P66, DOI 10.1037/a0034857; Guo YF, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88071-4; Hale L, 2018, CHILD ADOL PSYCH CL, V27, P229, DOI 10.1016/j.chc.2017.11.014; Hale L, 2015, SLEEP MED REV, V21, P50, DOI 10.1016/j.smrv.2014.07.007; Harris JL, 2009, HEALTH COMMUN, V24, P660, DOI 10.1080/10410230903242267; Kowalski KC, 2004, PHYS ACTIVITY QUESTI; Lang UE, 2015, CELL PHYSIOL BIOCHEM, V37, P1029, DOI 10.1159/000430229; Leech RM, 2015, INT J OBESITY, V39, P1079, DOI 10.1038/ijo.2015.66; Levis B, 2020, JAMA-J AM MED ASSOC, V323, P2290, DOI 10.1001/jama.2020.6504; Ma L, 2021, J AFFECT DISORDERS, V293, P78, DOI 10.1016/j.jad.2021.06.021; Manzar MD, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0915-x; Martin A, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009728.pub3, 10.1002/14651858.CD009728.pub4]; Moitra Panchali, 2021, Nutrition and Health (Bicester), V27, p0260106020982356, DOI 10.1177/0260106020982356; Moitra P, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.12998; Nagata JM, 2020, J ADOLESCENT HEALTH, V67, P297, DOI 10.1016/j.jadohealth.2020.04.020; Nagata JM., 2020, OBES, V28, DOI [10.1002/oby.22815, DOI 10.1002/OBY.22815]; Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013574.pub2, 10.1002/14651858.CD013574]; Orben A, 2019, PSYCHOL SCI, V30, P682, DOI 10.1177/0956797619830329; Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696; Patel A, 2021, EMERG INFECT DIS, V27, P2349, DOI 10.3201/eid2709.210934; Quirk SE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-175; Raniti MB, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy066; Richardson LP, 2010, PEDIATRICS, V125, pE1097, DOI 10.1542/peds.2009-2712; Rose T, 2017, J ADOLESCENT HEALTH, V61, P669, DOI 10.1016/j.jadohealth.2017.05.024; Rosen LD, 2014, COMPUT HUM BEHAV, V35, P364, DOI 10.1016/j.chb.2014.01.036; Sanchez-Villegas A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-3; Saxena S., 2016, INT J CONT MED RES, V3; Schmidt SCE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78438-4; Stiglic N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023191; Van den Bulck J, 2006, J HUM NUTR DIET, V19, P91, DOI 10.1111/j.1365-277X.2006.00683.x; Vardoulakis S, 2020, AUST NZ J PUBL HEAL, V44, P333, DOI 10.1111/1753-6405.13033; Whiting S, 2021, OBESITY FACTS, V14, P32, DOI 10.1159/000511263; Wu Xiaoyan, 2016, BMJ Open, V6, pe011533, DOI 10.1136/bmjopen-2016-011533; Xiang M, 2020, PROG CARDIOVASC DIS, V63, P531, DOI 10.1016/j.pcad.2020.04.013; Xiao SH, 2021, J PSYCHOSOC NURS MEN, V59, P14, DOI 10.3928/02793695-20201104-04	45	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264951	10.1371/journal.pone.0264951	http://dx.doi.org/10.1371/journal.pone.0264951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259203	gold, Green Published			2022-12-26	WOS:000835141200032
J	Immurana, M; Kisseih, KG; Yusif, HM; Yakubu, ZM				Immurana, Mustapha; Kisseih, Kwame Godsway; Yusif, Hadrat Mohammed; Yakubu, Ziblilla Mbanba			The effect of financial inclusion on open defecation and sharing of toilet facilities among households in Ghana	PLOS ONE			English	Article							SANITATION; ACCESS; WATER	Globally, and in Ghana, a lot of people do practice open defecation as well as share toilet facilities with other households. Meanwhile, open defecation in particular, is associated with numerous negative health and economic effects. To this end, a number of empirical studies have been conducted on the determinants of access to sanitation facilities among households in Ghana. Nonetheless, while financial inclusion (sustainable ways of ensuring easier accessibility to cheap and useful financial products and services among individuals/firms) can enhance the ability of households or individuals to afford toilet facilities, hence, could help in curbing open defecation and sharing of toilet facilities among households, the previous studies on Ghana did not pay attention to it. This study therefore uses data from the 7th round of the Ghana Living Standards Survey (GLSS7) to examine the association of financial inclusion with open defecation and sharing of toilet facilities among households in Ghana. The binary logit regression is used as the empirical estimation technique. The results show that, financial inclusion in general is associated with lesser likelihood of open defecation and sharing of toilet facilities among households in Ghana after controlling for welfare quintile, urban or rural residence and other covariates. Moreover, while informal financial inclusion is statistically insignificant, formal financial inclusion is found to be associated with reduced open defecation and sharing of toilet facilities among households. Thus, in the attempt to eliminate open defecation as well as reduce the sharing of toilet facilities among households in Ghana, conscious efforts should be devoted towards enhancing formal financial inclusion.	[Immurana, Mustapha] Univ Hlth & Allied Sci, Inst Hlth Res, Ho, Ghana; [Kisseih, Kwame Godsway] Christian Hlth Assoc Ghana Secretariat, Accra, Ghana; [Yusif, Hadrat Mohammed] Kwame Nkrumah Univ Sci & Technol, Dept Econ, Kumasi, Ghana; [Yakubu, Ziblilla Mbanba] Univ Dev Studies, Dept Appl Econ, Tamale, Ghana	Kwame Nkrumah University Science & Technology; University for Development Studies	Immurana, M (corresponding author), Univ Hlth & Allied Sci, Inst Hlth Res, Ho, Ghana.	mimmurana@uhas.edu.gh	Immurana, Mustapha/AEU-4908-2022	Immurana, Mustapha/0000-0001-5711-7566				Adams EA, 2016, SOC INDIC RES, V126, P673, DOI 10.1007/s11205-015-0912-y; Adjibolosoo SV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239491; Adzawla W, 2020, J ENVIRON PUBLIC HEA, V2020, DOI 10.1155/2020/4036045; Akpakli David Etsey, 2018, BMC Res Notes, V11, P473, DOI 10.1186/s13104-018-3572-6; Angoua ELE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202928; [Anonymous], SAN; Armah FA, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00931; Azage M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03828; Barenberg A., 2009, C CONTRIBUTION; Bhandarkar V., 2021, FINANCIAL INCLUSION; Bhatt N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219246; Biswas R, 2020, APPL WATER SCI, V10, DOI 10.1007/s13201-020-1169-4; Cameron C., 2005, MICROECONOMETRICS US, P1056; Ezenwaji EE, 2013, C CONTRIBUTION; Foggitt E, 2019, J WATER SANIT HYG DE, V9, P581, DOI 10.2166/washdev.2019.025; Ghana Statistical Service, 2015, GHAN POV MAPP REP; Ghana Statistical Service (GSS), 2019, GHAN LIV STAND SURV; Ghana Statistical Services ICF, 2020, GHAN MAL IND SURV 20; GREEN MS, 1992, INT J EPIDEMIOL, V21, P136, DOI 10.1093/ije/21.1.136; Grossman M, 2000, HANDB ECON, V17, P347; Immurana M., 2017, INT J MED MUSHROOMS, V5, P158, DOI [DOI 10.14419/IJM.V5I2.7830, 10.14419/ijm.v5i2.7830]; Immurana M., 2018, A DA T P DERGISI, V8, P87; Immurana M., 2016, J BEHAV HLTH, V4, P154, DOI [DOI 10.5455/JBH.20160809081632, 10.5455/jbh.20160809081632]; Immurana M., 2018, AM J PREV MED, V2, P18, DOI [10.5455/ajpmph.20171129072443, DOI 10.5455/AJPMPH.20171129072443]; Immurana M, 2022, J PUBLIC AFF, V22, DOI 10.1002/pa.2636; Mosimane A. W., 2020, African Journal of Food, Agriculture, Nutrition and Development, V20, P15919, DOI 10.18697/ajfand.91.18850; Mulenga J.N., 2017, INT J DEV SUSTAIN, V6, P746; Osumanu IK, 2019, J ENVIRON PUBLIC HEA, V2019, DOI 10.1155/2019/3075840; Pories L, 2016, AQUAT PR, V6, P74, DOI 10.1016/j.aqpro.2016.06.009; Simon SD, 2001, J ANDROL, V22, P533; The World Bank, FINANCIAL INCLUSION; United Nations Capital Development Fund, FINANCIAL INCLUSION; United Nations Children Fund (UNICEF), 2007, WAT ENV SAN CHILDR W; United Nations International Children Emergency Fund, SAN WORK CLEAN GHAN; Waste, 2020, FINANCIAL INCLUSION; Water and sanitation program (WSP), 2012, EC IMP POOR SAN AFR; World Health Organization, WATER SANITATION HYG; World Health Organization (WHO) and the United Nations Children's Fund (UNICEF), 2021, PROGR HOUS DRINK WAT	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264187	10.1371/journal.pone.0264187	http://dx.doi.org/10.1371/journal.pone.0264187			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245300	Green Published, gold			2022-12-26	WOS:000799799100011
J	Lopez-Jimenez, T; Duarte-Salles, T; Plana-Ripoll, O; Recalde, M; Xavier-Cos, F; Puente, D				Lopez-Jimenez, Tomas; Duarte-Salles, Talita; Plana-Ripoll, Oleguer; Recalde, Martina; Xavier-Cos, Francesc; Puente, Diana			Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study	PLOS ONE			English	Article							PRIMARY-CARE; DEFINITION; RISK; METAANALYSIS; INFORMATION; PREVALENCE; RECORDS; HEALTH; SIDIAP; SPAIN	Background Metabolic syndrome (MS) is the simultaneous occurrence of a cluster of predefined cardiovascular risk factors. Although individual MS components are associated with increased risk of cancer, it is still unclear whether the association between MS and cancer differs from the association between individual MS components and cancer. The aim of this matched case-control study was to estimate the association of 13 types of cancer with (1) MS and (2) the diagnosis of 0, 1 or 2 individual MS components. Methods Cases included 183,248 patients >= 40 years from the SIDIAP database with incident cancer diagnosed between January 2008-December 2017. Each case was matched to four controls by inclusion date, sex and age. Adjusted conditional logistic regression models were used to evaluate the association between MS and cancer risk, comparing the effect of global MS versus having one or two individual components of MS. Results MS was associated with an increased risk of the following cancers: colorectal (OR: 1.28, 95%CI: 1.23-1.32), liver (OR: 1.93, 95%CI: 1.74-2.14), pancreas (OR: 1.79, 95%CI: 1.63-1.98), post-menopausal breast (OR: 1.10, 95%CI: 1.06-1.15), pre-menopausal endometrial (OR: 2.14, 95%CI: 1.74-2.65), post-menopausal endometrial (OR: 2.46, 95%CI: 2.20-2.74), bladder (OR: 1.41, 95%CI: 1.34-1.48), kidney (OR: 1.84, 95%CI: 1.69-2.00), non-Hodgkin lymphoma (OR: 1.23, 95%CI: 1.10-1.38), leukaemia (OR: 1.42, 95%CI: 1.31-1.54), lung (OR: 1.11, 95%CI: 1.05-1.16) and thyroid (OR: 1.71, 95%CI: 1.50-1.95). Except for prostate, pre-menopause breast cancer and Hodgkin and non-Hodgkin lymphoma, MS is associated with a higher risk of cancer than 1 or 2 individual MS components. Estimates were significantly higher in men than in women for colorectal and lung cancer, and in smokers than in non-smokers for lung cancer. Conclusion MS is associated with a higher risk of developing 11 types of common cancer, with a positive correlation between number of MS components and risk of cancer.	[Lopez-Jimenez, Tomas; Duarte-Salles, Talita; Recalde, Martina; Xavier-Cos, Francesc; Puente, Diana] Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain; [Lopez-Jimenez, Tomas; Recalde, Martina; Puente, Diana] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Plana-Ripoll, Oleguer] Aarhus Univ, Natl Ctr Register Based Res, Dept Econ & Business Econ, Aarhus, Denmark; [Xavier-Cos, Francesc] Innovacio Inst Catala Salut, Barcelona, Spain; [Xavier-Cos, Francesc] Chairman Primary Care Diabet Europe, Ekerem, Belgium; [Xavier-Cos, Francesc] Fdn Network Study Grp Diabet Primary Care redGDPS, Sabadell, Spain; [Xavier-Cos, Francesc] Primary Care Management, Primary Care Ctr St Marti Provencals, Barcelona, Spain	Autonomous University of Barcelona; Aarhus University	Puente, D (corresponding author), Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain.; Puente, D (corresponding author), Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain.	dpuente@idiapjgol.org	Plana-Ripoll, Oleguer/E-1448-2015; Puente, Diana/N-9108-2018	Plana-Ripoll, Oleguer/0000-0002-6470-7465; Lopez-Jimenez, Tomas/0000-0001-8255-4936; Puente, Diana/0000-0003-4725-537X	Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain) [PI17/00914]; European Union ERDF funds (European Regional Development Fund); Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant program [2017/1630]	Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain)(Spanish Government); European Union ERDF funds (European Regional Development Fund); Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant program	The project received a research grant from the Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain), awarded on the 2017 call under the Health Strategy Action 2013-2016 of the National Research Program oriented to Societal Challenges, within the Technical, Scientific and Innovation Research National Plan 2013-2016 (reference PI17/00914), co-funded with European Union ERDF funds (European Regional Development Fund). MR is funded by Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant program (grant number:2017/1630).	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Almquist M, 2011, CANCER CAUSE CONTROL, V22, P743, DOI 10.1007/s10552-011-9747-2; Bartella V, 2012, CELL SIGNAL, V24, P1515, DOI 10.1016/j.cellsig.2012.03.012; Blanc-Lapierre A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2260-x; Bolibar B, 2012, MED CLIN-BARCELONA, V138, P617, DOI 10.1016/j.medcli.2012.01.020; Chen HY, 2021, GUT, V70, P1147, DOI 10.1136/gutjnl-2020-321661; Chen Y, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0176-4; Esposito K, 2013, MENOPAUSE, V20, P1301, DOI [10.1097/GME.0b013e31828ce95d, 10.1097/gme.0b013e31828ce95d]; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Fernandez-Berges D, 2012, REV ESP CARDIOL, V65, P241, DOI [10.1016/j.rec.2011.10.017, 10.1016/j.recesp.2011.10.015]; Fiori E, 2015, ANTICANCER RES, V35, P2211; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Galceran J, 2017, CANC INCIDENCE TARRA; Gomez-Gomez E, 2019, J CELL MOL MED, V23, P934, DOI 10.1111/jcmm.13994; Graham JW., 2012, MISSING DATA; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guallar-Castillon P, 2014, REV ESP CARDIOL, V67, P367, DOI [10.1016/j.rec.2013.08.014, 10.1016/j.recesp.2013.08.014]; Hammarsten J, 2018, NAT REV UROL, V15, P321, DOI 10.1038/nrurol.2018.8; Hennessy S, 1999, AM J EPIDEMIOL, V149, P195; Hwang KT, 2020, CANCER EPIDEM BIOMAR, V29, P2038, DOI 10.1158/1055-9965.EPI-20-0300; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; Li CY, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0422-9; Li ZB, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0478-y; Madley-Dowd P, 2019, J CLIN EPIDEMIOL, V110, P63, DOI 10.1016/j.jclinepi.2019.02.016; Monroy-Iglesias MJ, 2021, INT J CANCER, V148, P825, DOI 10.1002/ijc.33255; Montella M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1769-9; Navarro C, 2010, ANN ONCOL, V21, piii3, DOI 10.1093/annonc/mdq094; Nicolucci A, 2010, ACTA DIABETOL, V47, P87, DOI 10.1007/s00592-010-0187-3; Oh TR, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091329; Park JH, 2020, THYROID, V30, P1496, DOI 10.1089/thy.2019.0699; Peng XF, 2018, CANCER MANAG RES, V10, P6263, DOI 10.2147/CMAR.S181178; Puente D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025365; Qiao L, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00598-0; Recalde  M, 2019, CLIN EPIDEMIOL, V11, P1015, DOI 10.2147/CLEP.S225568; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rosato V, 2011, METABOLISM, V60, P1372, DOI 10.1016/j.metabol.2011.03.005; Rubin DB, 2004, MULTIPLE IMPUTATION; Sin S, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa596; Tan YF, 2019, CANCER EPIDEM BIOMAR, V28, P2038, DOI 10.1158/1055-9965.EPI-19-0303; Unitat dEpidemiologia i Registre de Cncer de Girona, 2016, CNCER GIRONA 201012; Wang L, 2020, AGING-US, V12, P9825, DOI 10.18632/aging.103247; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Xia B, 2020, INT J CANCER, V147, P3384, DOI 10.1002/ijc.33172; Xiang YJ, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00905; Zhang XE, 2018, J INVEST MED, V66, P22, DOI 10.1136/jim-2017-000434	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264634	10.1371/journal.pone.0264634	http://dx.doi.org/10.1371/journal.pone.0264634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245317	Green Published, gold			2022-12-26	WOS:000799799100029
J	Muller, P; Lapao, LV				Muller, Pia; Lapao, Luis Velez			Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid-Preventive therapies for people living with HIV	PLOS ONE			English	Review							INFECTED ADULTS; POSITIVE PATIENTS; PREGNANT-WOMEN; SOUTH-AFRICA; TUBERCULOSIS; PROPHYLAXIS; COMPLETION; ADHERENCE; CHALLENGES; UGANDA	Background Cotrimoxazole and isoniazid preventive therapy (CPT, IPT) have been shown to be efficacious therapies for the prevention of opportunistic infections and tuberculosis (TB) among people living with human immunodeficiency virus (HIV). Despite governments' efforts to translate World Health Organization recommendations into practice, implementation remains challenging. This review aimed to explore and compare CPT and IPT with respect to similarities and differences of barriers identified across high TB/HIV burden countries. A secondary objective was to identify facilitators for implementing both preventive therapies. Methods We searched MEDLINE, Web of Science and SCOPUS databases for peer-reviewed literature published before September 2020. We extracted and synthesized our findings using Maxqda software. We applied framework synthesis in conjunction with metasummary to compare both therapies with respect to similarities and differences of barriers identified across seven health system components (in line with the modified WHO's Framework for action). Protocol registration: PROSPERO (CRD42019137778). Findings We identified four hundred and eighty-two papers, of which we included forty for review. Although most barrier themes were identical for both preventive therapies, we identified seven intervention-specific themes. Like for CPT, barriers identified for IPT were most frequently classified as 'service delivery-related barriers' and 'patient & community-related barriers'. 'Health provider-related barriers' played an important role for implementing IPT. Most facilitators identified referred to health system strengthening activities. Conclusions For researchers with limited working experience in high TB/HIV burden countries, this review can provide valuable insights about barriers that may arise at different levels of the health system. For policymakers in high TB/HIV burden countries, this review offers strategies for improving the delivery of IPT (or any newer therapy regimen) for the prevention of TB. Based on our findings, we suggest initial and continuous stakeholder involvement, focusing on the efficient use and reinforcement of existing resources for health.	[Muller, Pia; Lapao, Luis Velez] Univ Nova Lisboa UNL, Inst Higiene & Med Trop IHMT, Global Hlth & Trop Med, Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Muller, P (corresponding author), Univ Nova Lisboa UNL, Inst Higiene & Med Trop IHMT, Global Hlth & Trop Med, Lisbon, Portugal.	pia.muller@ihmt.unl.pt	Velez Lapao, Luis Miguel/E-8465-2011	Velez Lapao, Luis Miguel/0000-0003-0506-1294; Muller, Pia/0000-0003-0231-5017	HansBockler Foundation (HBS); Portuguese Foundation for Science and Technology (FCT); HBS [385759]; FCT [UID/Multi/04413/2013, UID/Multi/04413/2020]	HansBockler Foundation (HBS); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); HBS; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was funded by the HansBockler Foundation (HBS -https://www.boeckler.de) and the Portuguese Foundation for Science and Technology (FCT -www.fct.pt).PM received a Research Scholarship from the HBS (Scholarship ID: 385759). LVL was funded by the FCT grants (UID/Multi/04413/2013 and UID/Multi/04413/2020).	Adepoju AV, 2020, J GLOB INFECT DIS, V12, P105, DOI 10.4103/jgid.jgid_138_18; AISU T, 1995, AIDS, V9, P267, DOI 10.1097/00002030-199509030-00008; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2022, FLEMING FUND; Ansa GA, 2014, T ROY SOC TROP MED H, V108, P560, DOI 10.1093/trstmh/tru110; Asonganyi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072712; Assefa Y, 2020, INT J INFECT DIS, V100, P273, DOI 10.1016/j.ijid.2020.09.011; Badje A, 2017, LANCET GLOB HEALTH, V5, pE1080, DOI 10.1016/S2214-109X(17)30372-8; Booth A, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0694-5; Butler A, 2016, WORLDV EVID-BASED NU, V13, P241, DOI 10.1111/wvn.12134; Catalani C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103205; Chan AK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-352; Chang LW, 2015, AIDS BEHAV, V19, P1742, DOI 10.1007/s10461-015-1159-y; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Cumpston M, 2019, CHAPTER 4 UPDATING R; Date AA, 2010, B WORLD HEALTH ORGAN, V88, P253, DOI 10.2471/BLT.09.066522; Durovni B, 2010, AIDS, V24, pS49, DOI 10.1097/01.aids.0000391022.95412.a6; Eholie SP, 2017, TROP MED INT HEALTH, V22, P1186, DOI 10.1111/tmi.12919; Ersoy SC, 2017, EBIOMEDICINE, V20, P173, DOI 10.1016/j.ebiom.2017.05.026; Faust L, 2020, HEALTH SCI REP-US, V3, DOI 10.1002/hsr2.158; Geremew D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4031-2; Getahun H, 2010, AIDS, V24, pS57, DOI 10.1097/01.aids.0000391023.03037.1f; Gust DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018435; Hannes K, 2011, CRITICAL APPRAISAL Q; Hauck K, 2019, SOC SCI MED, V220, P141, DOI 10.1016/j.socscimed.2018.10.030; Hong QN, 2018, EDUC INFORM, V34, P285, DOI 10.3233/EFI-180221; Horwood C, 2010, TROP MED INT HEALTH, V15, P992, DOI 10.1111/j.1365-3156.2010.02576.x; Huerga H, 2016, JAIDS-J ACQ IMM DEF, V71, pe89, DOI 10.1097/QAI.0000000000000895; Jacobson KB, 2017, AIDS CARE, V29, P936, DOI 10.1080/09540121.2017.1283390; Jarrett BA, 2020, AIDS BEHAV, V24, P1106, DOI 10.1007/s10461-019-02675-6; Joanna Briggs Institute, 2017, JBI REVIEWERS MANUAL; Kafu C, 2021, GLOB PUBLIC HEALTH, V16, P1645, DOI 10.1080/17441692.2020.1830296; Kamuhabwa AAR, 2016, DRUG HEALTHC PATIENT, V8, P91, DOI 10.2147/DHPS.S119073; Kamuhabwa AAR, 2015, DRUG HEALTHC PATIENT, V7, P147, DOI 10.2147/DHPS.S89115; Kates J, DONOR GOVT FUNDING H; Kenny T, 1998, FAM PRACT, V15, P471, DOI 10.1093/fampra/15.5.471; Khan FA, 2014, AIDS, V28, P1463, DOI 10.1097/QAD.0000000000000278; Kunkel A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0306; Lai J, 2019, INT J TUBERC LUNG D, V23, P371, DOI 10.5588/ijtld.18.0378; Lester R, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000391021.18284.12; Little KM, 2018, INT J TUBERC LUNG D, V22, P371, DOI 10.5588/ijtld.16.0836; Louwagie G, 2012, INT J TUBERC LUNG D, V16, P1052, DOI 10.5588/ijtld.11.0753; Luboga SA, 2016, HEALTH POLICY PLANN, V31, P897, DOI 10.1093/heapol/czw009; Luyirika E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069548; Mansoor L, 2007, HEALTH EDUC RES, V22, P37, DOI 10.1093/her/cyl039; McRobie E, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0574-z; Meribe SC, 2020, PUBLIC HEALTH ACTION, V10, P60, DOI 10.5588/pha.20.0003; Mindachew M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-916; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mugomeri E, 2019, SOUTH AFR J INFECT D, V34, DOI 10.4102/sajid.v34i1.10; Mugomeri E, 2018, HIV AIDS REV, V17, P299, DOI 10.5114/hivar.2018.80263; Munseri PJ, 2008, INT J TUBERC LUNG D, V12, P1037; Mwambete KD., 2013, CLIN MICROBIOLOGY OP; Naikoba S, 2017, JAIDS-J ACQ IMM DEF, V75, pE120, DOI 10.1097/qai.0000000000001378; Ngamvithayapong J, 1997, AIDS, V11, P107, DOI 10.1097/00002030-199701000-00016; Noyes J, 2018, J CLIN EPIDEMIOL, V97, P49, DOI 10.1016/j.jclinepi.2017.06.020; Okot-Chono R, 2009, INT J TUBERC LUNG D, V13, P955; Okwera A, 2015, AFR HEALTH SCI, V15, P49, DOI 10.4314/ahs.v15i1.7; Petticrew M, 2008, J EPIDEMIOL COMMUN H, V62, P552, DOI 10.1136/jech.2006.059394; Petticrew M, 2013, J CLIN EPIDEMIOL, V66, P1230, DOI 10.1016/j.jclinepi.2013.06.005; Reddy MM, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2019.1704540; Rowe KA, 2005, INT J TUBERC LUNG D, V9, P263; Rwabukwisi FC, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2662-9; Sandelowski M, 2007, RES NURS HEALTH, V30, P99, DOI 10.1002/nur.20176; Selehelo K, 2019, AFR J NURS MIDWIFERY, V21, DOI 10.25159/2520-5293/6221; Sibanda EL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2136-0; Steurs L., 2018, Development Studies Research, V5, pS1, DOI 10.1080/21665095.2018.1511378; Suthar AB, 2015, LANCET HIV, V2, pE137, DOI 10.1016/S2352-3018(15)00005-3; Szakacs TA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-97; Thabane L, 2009, CAN J ANAESTH, V56, P71, DOI 10.1007/s12630-008-9007-4; The World Bank, WORLD BANK COUNTRY L; Tram KH, 2020, AIDS CARE, V32, P119, DOI 10.1080/09540121.2019.1619661; UNAIDS, 2021, GLOB HIV AIDS STAT F; USAID, 2014, ADS CHAPTER 220 USE; USAID, 2021, USAIDS VISION HLTH S; Van Ginderdeuren E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212035; Wambiya EOA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-024286; WHO, 2010, MON BUILD BLOCKS HLT, DOI DOI 10.1146/ANNUREV.ECOLSYS.35.021103.105711; WHO/ UNAIDS, 1998, POLICY STATEMENT PRE; World Health Organization, 2001, Afr Health Sci, V1, P30; World Health Organization, 2018, HLTH SYSTEMS UNIVERS; World Health Organization, WHO CONSOLIDATED GUI; World Health Organization, 2021, TUBERCULOSIS KEY FAC; World Health Organization, 2016, CONS GUID US ANT DRU; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Zachariah R, 2006, TROP DOCT, V36, P79, DOI 10.1258/004947506776593314	86	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0251612	10.1371/journal.pone.0251612	http://dx.doi.org/10.1371/journal.pone.0251612			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231047	Green Submitted, Green Published, gold			2022-12-26	WOS:000849744700002
J	Bjorklund, J; Wiberg-Itzel, E; Wallstrom, T				Bjorklund, Jenny; Wiberg-Itzel, Eva; Wallstrom, Tove			Is there an increased risk of cesarean section in obese women after induction of labor? A retrospective cohort study	PLOS ONE			English	Article								Background Obesity is increasing in Sweden and is also of huge global concern. Obesity increases the risk of complications during pregnancy and the need for the induction of labor. Induction of labor increases the number of complications during delivery, leading to women with more negative birth experience. This study investigated how maternal body mass index (BMI) during antenatal care enrollment affects labor outcomes (proportion of cesarean section at induction of labor). Method This was a retrospective cohort study of 3772 women with mixed parity and induction of labor at Soderhospital, Stockholm, in 2009-2010 and 2012-2013. The inclusion criteria were simplex, >= 34 gestational weeks, cephalic presentation and no previous cesarean section. The women were grouped according to BMI, and statistical analyzes were performed to compare the proportion of cesarean sections after induction of labor. The primary outcome was the proportion of cesarean section after induction of labor divided by group of maternal BMI. The secondary outcomes were postpartum hemorrhage >1000 ml, time of labor, fetal outcome data, and indication for emergency cesarean section. Result The induction of labor in women with a high BMI resulted in a significantly increased risk of cesarean section, with 18.4-24.1% of deliveries, depending on the BMI group. This outcome persisted after adjustment in women with BMI 25-29.9 (aOR 1.4; 95% CI; 1.1-1.7) and BMI 30-34.9 (aOR 1.5; 95% CI; 1.1-2.1). There was also a significantly higher risk for CS among primiparous women (aOR 3.6; 95% CI; 2.9-45) and if the newborn weighted >= four kilos (aOR 1.6; 95% CI; 1.3-2.0). Conclusion Our findings show that a higher BMI increased the risk of cesarean section after induction of labor in the groups with BMI 25-34.9. Parity seems to be the strongest risk factor for CS regardless other variables.	[Bjorklund, Jenny; Wiberg-Itzel, Eva; Wallstrom, Tove] Karolinska Inst, Soderhosp, Dept Clin Sci & Educ, Stockholm, Sweden; [Bjorklund, Jenny; Wiberg-Itzel, Eva; Wallstrom, Tove] Soderhospital, Womens Clin, Stockholm, Sweden	Karolinska Institutet	Wallstrom, T (corresponding author), Karolinska Inst, Soderhosp, Dept Clin Sci & Educ, Stockholm, Sweden.; Wallstrom, T (corresponding author), Soderhospital, Womens Clin, Stockholm, Sweden.	tove.wallstrom@sll.se						Arrowsmith S, 2011, BJOG-INT J OBSTET GY, V118, P578, DOI 10.1111/j.1471-0528.2010.02889.x; Athukorala C, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-56; Bjermo H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1624-6; Carpenter JR, 2016, CLIN OBSTET GYNECOL, V59, P172, DOI 10.1097/GRF.0000000000000174; Dammer U, 2018, J OBSTET GYNAECOL RE, V44, P697, DOI 10.1111/jog.13561; Ellis JA, 2019, J MIDWIFERY WOM HEAL, V64, P55, DOI 10.1111/jmwh.12935; Harper LM, 2012, OBSTET GYNECOL, V119, P1113, DOI 10.1097/AOG.0b013e318253d7aa; Kim SS, 2016, OBSTET GYNECOL, V128, P104, DOI 10.1097/AOG.0000000000001465; Kobayashi N, 2015, BEST PRACT RES CL OB, V29, P394, DOI 10.1016/j.bpobgyn.2014.07.024; Lassiter JR, 2016, J MATERN-FETAL NEO M, V29, P3000, DOI 10.3109/14767058.2015.1112371; Rogers AJG, 2018, AM J OBSTET GYNECOL, V219, P356, DOI 10.1016/j.ajog.2018.06.006; Stephansson O PK., 2017, ACTA OBSTET GYN SCAN; Tolcher MC, 2015, OBSTET GYNECOL, V126, P1059, DOI 10.1097/AOG.0000000000001083; Vinturache A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0422-y; WHO Guidelines Approved by the Guidelines Review Committee, 2018, WHO REC INTR CAR POS, V2018; Wolfe KB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.051	16	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263685	10.1371/journal.pone.0263685	http://dx.doi.org/10.1371/journal.pone.0263685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213544	Green Published, gold			2022-12-26	WOS:000787811000031
J	Minor, S; Mitrofanova, N; Ramchand, G				Minor, Serge; Mitrofanova, Natalia; Ramchand, Gillian			Fine-grained time course of verb aspect processing	PLOS ONE			English	Article							SPOKEN WORD RECOGNITION; LANGUAGE COMPREHENSION; AMBIGUITY RESOLUTION; GRAMMATICAL ASPECT; LEXICAL SELECTION; YOUNG-CHILDREN; PRE-ACTIVATION; EYE-MOVEMENTS; INTEGRATION; INFORMATION	Sentence processing is known to be highly incremental. Speakers make incremental commitments as the sentence unfolds, dynamically updating their representations based on the smallest pieces of information from the incoming speech stream. Less is known about linguistic processing on the sub-word level, especially with regard to abstract grammatical information. This study employs the Visual World Paradigm to investigate the processing of grammatical aspect by Russian-speaking adults (n = 124). Aspectual information is encoded relatively early within the Russian verb which makes this an ideal testing ground to investigate the incrementality of grammatical processing on the sub-word level. Participants showed preference for pictures of ongoing events when they heard sentences involving Imperfective verbs, and for pictures of completed events when they heard sentences involving Perfective verbs. Crucially, the analysis of the participants' eye-movements showed that they exhibited preference for the target picture already before they heard the end of the verb. Moreover, the latency of this effect depended on where the aspectual information was encoded within the verb. These results indicate that the processing and integration of grammatical aspect information can happen rapidly and incrementally on a fine-grained word-internal level. Methodologically, the study draws together a set of analytical techniques which can be fruitfully applied to the analysis of effect latencies in a wide range of studies within the Visual World eye-tracking paradigm.	[Minor, Serge; Mitrofanova, Natalia; Ramchand, Gillian] UiT Arctic Univ Norway, Dept Language & Culture, Tromso, Norway	UiT The Arctic University of Tromso	Minor, S (corresponding author), UiT Arctic Univ Norway, Dept Language & Culture, Tromso, Norway.	serge.minor@uit.no			Norwegian Research Council [275490, 250857]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	GR and SM were funded by the the Norwegian Research Council (grant number 275490, "Modal Concepts and Compositionality" project). GM is the Principal Investigator on this grant. NM was funded by the Norwegian Research Council (grant number 250857, "Micro-variation in Multilingual Acquisition & Attrition Situations" project, awarded to Marit Westergaard) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Anderson SE, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00337; Becker RB, 2013, COGNITION, V129, P212, DOI 10.1016/j.cognition.2013.06.014; Bergen B, 2010, BRAIN LANG, V112, P150, DOI 10.1016/j.bandl.2009.07.002; Bondarko A. V., 1983, PRINCIPY FUNKCIONALN; Borovsky A, 2012, J EXP CHILD PSYCHOL, V112, P417, DOI 10.1016/j.jecp.2012.01.005; Bott O., 2014, MEANING UNDERSTANDIN; Bott O., 2013, SUBATOMIC SEMANTICS; Bott O., 2010, PROCESSING EVENTS; Bott O, 2015, LANG COGN NEUROSCI, V30, P877, DOI 10.1080/23273798.2015.1029499; Carpenter RHS, 1988, MOVEMENTS EYES; Carreiras M, 1997, MEM COGNITION, V25, P438, DOI 10.3758/BF03201120; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; DOWTY D, 1979, SEMANTICS VERBS TIME, DOI 10.1007/978-94-009-5800-5; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ferretti TR, 2007, J EXP PSYCHOL LEARN, V33, P182, DOI 10.1037/0278-7393.33.1.182; Forsyth J., 1970, GRAMMAR ASPECT USAGE; Good P., 2015, PERMUTATION PARAMETR; Gronn A., 2004, THESIS U OSLO; Guillelmon D, 2001, MEM COGNITION, V29, P503, DOI 10.3758/BF03196401; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; Hagoort P, 2007, PHILOS T R SOC B, V362, P801, DOI 10.1098/rstb.2007.2089; Hahn N, 2015, AUTISM RES, V8, P717, DOI 10.1002/aur.1487; Hopp H, 2016, SECOND LANG RES, V32, P277, DOI 10.1177/0267658315624960; Hopp H, 2013, SECOND LANG RES, V29, P33, DOI 10.1177/0267658312461803; Huang YJ, 2020, COGNITION, V200, DOI 10.1016/j.cognition.2020.104251; Huette S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00410; Huettig F, 2015, BRAIN RES, V1626, P118, DOI 10.1016/j.brainres.2015.02.014; Isacenko AV, 1960, GRAMMATICESKIJ STROJ; Ito A, 2018, J MEM LANG, V98, P1, DOI 10.1016/j.jml.2017.09.002; Janda L, 2007, STUD LANG, V31, P607, DOI 10.1075/sl.31.3.04jan; Janda LA, 2011, RUSS LINGUIST, V35, P147, DOI 10.1007/s11185-011-9076-9; Janda LA, 2011, COGN LINGUIST, V22, P719, DOI 10.1515/COGL.2011.027; Kamide Y, 2003, J PSYCHOLINGUIST RES, V32, P37, DOI 10.1023/A:1021933015362; Kamide Y, 2008, LANG LINGUIST COMPAS, V2, DOI 10.1111/j.1749-818x.2008.00072.x; Kazanina N, 2007, COGNITION, V105, P65, DOI 10.1016/j.cognition.2006.09.006; Klein Wolfgang., 1994, TIME LANGUAGE; Kuperberg GR, 2016, LANG COGN NEUROSCI, V31, P32, DOI 10.1080/23273798.2015.1102299; Lew-Williams C, 2007, PSYCHOL SCI, V18, P193, DOI 10.1111/j.1467-9280.2007.01871.x; Lew-Williams C, 2010, J MEM LANG, V63, P447, DOI 10.1016/j.jml.2010.07.003; Lyashevskaya O, 2009, CHASTOTNYJ SLOVARSOV; Madden CJ, 2009, Q J EXP PSYCHOL, V62, P1294, DOI 10.1080/17470210802696088; Madden CJ, 2003, MEM COGNITION, V31, P663, DOI 10.3758/BF03196106; Magliano JP, 2000, DISCOURSE PROCESS, V29, P83, DOI 10.1207/S15326950dp2902_1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martin MA, 2007, COMPUT STAT DATA AN, V51, P6321, DOI 10.1016/j.csda.2007.01.020; Maslov Jurij, 1948, IZVESTIJA AKADEMII N, V8, P303; Mirman D., 2014, GROWTH CURVE ANAL VI; Mozuraitis M, 2013, DISCOURSE PROCESS, V50, P1, DOI 10.1080/0163853X.2012.726184; Oakes LM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00697; Pickering MJ, 2000, J MEM LANG, V43, P447, DOI 10.1006/jmla.2000.2708; Reingold EM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01432; Roll M, 2017, NEUROSCI LETT, V658, P57, DOI 10.1016/j.neulet.2017.08.030; Sassenhagen J, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13335; Seedorff M, 2018, J MEM LANG, V102, P55, DOI 10.1016/j.jml.2018.05.004; Sheridan H, 2012, VIS COGN, V20, P733, DOI 10.1080/13506285.2012.693548; Snedeker J, 2004, COGNITIVE PSYCHOL, V49, P238, DOI 10.1016/j.cogpsych.2004.03.001; Staub A, 2006, J EXP PSYCHOL LEARN, V32, P425, DOI 10.1037/0278-7393.32.2.425; Stoll Sabine, 1998, FIRST LANG, V18, P351, DOI [10.1177/014272379801805405, DOI 10.1177/014272379801805405]; Stone K, 2021, BILING-LANG COGN, V24, P833, DOI 10.1017/S1366728920000607; Svedova N.Ju., 1980, RUSSKAJA GRAMMATIKA; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Tatevosov S., 2002, LINGUIST TYPOL, V6, P317, DOI 10.1515/lity.2003.003; Tatevosov S, 2016, GLAGOLNYJE KLASSY TI; Trueswell JC, 2008, DEVELOPMENTAL PSYCHOLINGUISTICS: ON-LINE METHODS IN CHILDREN'S LANGUAGE PROCESSING, P73; Truitt TP, 1997, 38 ANN M PSYCHONOMIC; van den Brink D, 2006, J EXP PSYCHOL LEARN, V32, P364, DOI 10.1037/0278-7393.32.3.364; van den Brink D, 2004, J COGNITIVE NEUROSCI, V16, P1068, DOI 10.1162/0898929041502670; van Hout Angeliek, 2005, ASPECTUAL INQUIRIES, P317, DOI DOI 10.1007/1-4020-3033-9_14; Van Petten C, 1999, J EXP PSYCHOL LEARN, V25, P394, DOI 10.1037/0278-7393.25.2.394; Vinnitskaya Inna, 2001, FIRST LANG, V21, P143, DOI [10.1177/014272370102106202, DOI 10.1177/014272370102106202]; WEIST RM, 1983, J CHILD LANG, V10, P85, DOI 10.1017/S0305000900005158; WEIST RM, 1991, J CHILD LANG, V18, P67, DOI 10.1017/S0305000900013301; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; Yang WC, 2020, COGNITION, V196, DOI 10.1016/j.cognition.2019.104103; Zaliznjak Anna A., 2000, VVEDENIE RUSSKUJU AS; Zhou P, 2014, COGNITION, V133, P262, DOI 10.1016/j.cognition.2014.06.018	77	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264132	10.1371/journal.pone.0264132	http://dx.doi.org/10.1371/journal.pone.0264132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213616	Green Published, gold			2022-12-26	WOS:000787811000052
J	Reese, CF; Chinnakkannu, P; Tourkina, E; Hoffman, S; Kuppuswamy, D				Reese, Charles F.; Chinnakkannu, Panneerselvam; Tourkina, Elena; Hoffman, Stanley; Kuppuswamy, Dhandapani			Multiple subregions within the caveolin-1 scaffolding domain inhibit fibrosis, microvascular leakage, and monocyte migration	PLOS ONE			English	Article							PROTEIN-KINASE-C; PULMONARY-FIBROSIS; SYSTEMIC-SCLEROSIS; OSMOTIC MINIPUMP; EXPRESSION; PERMEABILITY; PATHOGENESIS; SCLERODERMA; FIBROCYTES; REGULATOR	The caveolin-1 scaffolding domain (CSD, amino acids 82-101 of caveolin-1) has been shown to suppress bleomycin-induced lung and skin fibrosis and angiotensin II (AngII)-induced myocardial fibrosis. To identify active subregions within CSD, we split its sequence into three slightly overlapping 8-amino acid subregions (82-89, 88-95, and 94-101). Interestingly, all three peptides showed activity. In bleomycin-treated mice, all three subregions suppressed the pathological effects on lung and skin tissue morphology. In addition, while bone marrow monocytes isolated from bleomycin-treated mice showed greatly enhanced migration in vitro toward CXCL12, treatment in vivo with CSD and its subregions almost completely suppressed this enhanced migration. In AngII-induced heart failure, both 82-89 and 88-95 significantly suppressed fibrosis (both Col I and HSP47 levels), microvascular leakage, and heart weight/ body weight ratio (HW/BW) while improving ventricular function. In contrast, while 94-101 suppressed the increase in Col I, it did not improve the other parameters. The idea that all three subregions can be active depending on the assay was further supported by experiments studying the in vitro migration of human monocytes in which all three subregions were extremely active. These studies are very novel in that it has been suggested that there is only one active region within CSD that is centered on amino acids 90-92. In contrast, we demonstrate here the presence of other active regions within CSD.	[Reese, Charles F.; Tourkina, Elena; Hoffman, Stanley] Med Univ South Carolina, Dept Med, Div Rheumatol, Charleston, SC 29425 USA; [Chinnakkannu, Panneerselvam; Kuppuswamy, Dhandapani] Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Kuppuswamy, D (corresponding author), Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA.	kuppusd@musc.edu			Lung Therapeutics, Inc.; NIH [T32 HL007260, TL1 TR001451, T32 HL144470]; Lung Therapeutics	Lung Therapeutics, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung Therapeutics	This work was funded by a Sponsored Research Agreement from Lung Therapeutics, Inc., to SH; predoctoral fellowships from NIH (T32 HL007260 and TL1 TR001451) and from Lung Therapeutics to CFR; and a postdoctoral fellowship from NIH to CFR (T32 HL144470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140273; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Bernatchez P, 2011, J CLIN INVEST, V121, P3747, DOI 10.1172/JCI44778; Bernatchez PN, 2005, P NATL ACAD SCI USA, V102, P761, DOI 10.1073/pnas.0407224102; Bhandary YP, 2012, AM J PHYSIOL-LUNG C, V302, pL463, DOI 10.1152/ajplung.00099.2011; Blakaj A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S6; Bruni C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02045; Bruno BJ, 2013, THER DELIV, V4, P1443, DOI [10.4155/TDE.13.104, 10.4155/tde.13.104]; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Cai AX, 2021, NEPHRON, V145, P297, DOI 10.1159/000514314; Cepinskas G, 2008, J CLIN BIOCHEM NUTR, V42, P175, DOI 10.3164/jcbn.2008026; Chen F, 2014, FREE RADICAL BIO MED, V73, P201, DOI 10.1016/j.freeradbiomed.2014.04.029; Chidlow JH, 2009, GASTROENTEROLOGY, V136, P575, DOI 10.1053/j.gastro.2008.10.085; Chinnakkannu P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207844; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; D'Amario D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01347; Del Gaido F, 2008, ARTHRITIS RHEUM-US, V58, P2854, DOI 10.1002/art.23791; FLEISCHMAJER R, 1971, SCIENCE, V171, P1019, DOI 10.1126/science.171.3975.1019; Frech TM, 2012, J RHEUMATOL, V39, P1385, DOI 10.3899/jrheum.111380; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; George PM, 2020, LANCET RESP MED, V8, P807, DOI 10.1016/S2213-2600(20)30225-3; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Haggag Y.A., 2018, BIOMEDICAL J SCI TEC, P1, DOI DOI 10.26717/BJSTR.2018.08.001694; Janelidze S, 2017, NEUROBIOL AGING, V51, P104, DOI 10.1016/j.neurobiolaging.2016.11.017; Kasper M, 1998, HISTOCHEM CELL BIOL, V109, P41; Kronstein R, 2012, CARDIOVASC RES, V93, P130, DOI 10.1093/cvr/cvr256; Kuppuswamy D, 2021, J PHARMACOL EXP THER, V378, P1, DOI 10.1124/jpet.120.000424; Le Saux CJ, 2008, J BIOL CHEM, V283, P5760, DOI 10.1074/jbc.M701572200; Lee J, 2011, METHODS MOL BIOL, V763, P417, DOI 10.1007/978-1-61779-191-8_28; Lee R, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0028-7; Lee R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00140; Lee R, 2014, AM J PHYSIOL-LUNG C, V306, pL736, DOI 10.1152/ajplung.00210.2013; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Makihara N, 2015, EXP NEUROL, V264, P127, DOI 10.1016/j.expneurol.2014.12.007; Marudamuthu AS, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2848; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Oakley R, 2014, AGING DIS, V5, P114, DOI 10.14336/AD.2014.0500114; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Pleasant-Jenkins D, 2017, LAB INVEST, V97, P370, DOI 10.1038/labinvest.2016.153; Probst CK, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00100-2019; Ravanetti F, 2020, AM J PHYSIOL-LUNG C, V318, pL376, DOI 10.1152/ajplung.00311.2019; Razani B, 2001, J BIOL CHEM, V276, P38121; Reese C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00141; Reese C, 2014, ARTHRITIS RHEUMATOL, V66, P1909, DOI 10.1002/art.38572; Rybin VO, 1999, CIRC RES, V84, P980, DOI 10.1161/01.RES.84.9.980; Sarelius IH, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.985954; Satoh M, 2008, NEPHROL DIAL TRANSPL, V23, P3806, DOI 10.1093/ndt/gfn357; Schlegel A, 2000, J BIOL CHEM, V275, P21605, DOI 10.1074/jbc.M002558200; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Spagnolo P, 2020, LANCET RESP MED, V8, P750, DOI 10.1016/S2213-2600(20)30222-8; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Tahir AA, 2009, CANCER BIOL THER, V8, P2286; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Tourkina E, 2005, J BIOL CHEM, V280, P13879, DOI 10.1074/jbc.M412551200; Tourkina E, 2008, AM J PHYSIOL-LUNG C, V294, pL843, DOI 10.1152/ajplung.00295.2007; Tourkina E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-15; Tourkina E, 2010, ANN RHEUM DIS, V69, P1220, DOI 10.1136/ard.2009.117580; Wang CH, 2008, AM J RESP CRIT CARE, V178, P583, DOI 10.1164/rccm.200710-1557OC; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Weis SM, 2008, CURR OPIN HEMATOL, V15, P243, DOI 10.1097/MOH.0b013e3282f97d86; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Woodman SE, 2003, AM J PATHOL, V162, P2059, DOI 10.1016/S0002-9440(10)64337-4; Yamazaki Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091965; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Zanini A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-132	65	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264413	10.1371/journal.pone.0264413	http://dx.doi.org/10.1371/journal.pone.0264413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213624	Green Published, gold			2022-12-26	WOS:000787811000094
J	Zhang, ZC; Tao, MQ; Shan, X; Pan, YF; Sun, CQ; Song, LX; Pei, XL; Jing, ZG; Dai, ZL				Zhang, Zhenchao; Tao, Meiqi; Shan, Xi; Pan, Yongfei; Sun, Chunqing; Song, Lixiao; Pei, Xuli; Jing, Zange; Dai, Zhongliang			Characterization of the complete chloroplast genome of Brassica oleracea var. italica and phylogenetic relationships in Brassicaceae	PLOS ONE			English	Article							SEQUENCE; INVERSION; TOOLS	Broccoli (Brassica oleracea var. italica) is an important B. oleracea cultivar, with high economic and agronomic value. However, comparative genome analyses are still needed to clarify variation among cultivars and phylogenetic relationships within the family Brassicaceae. Herein, the complete chloroplast (cp) genome of broccoli was generated by Illumina sequencing platform to provide basic information for genetic studies and to establish phylogenetic relationships within Brassicaceae. The whole genome was 153,364 bp, including two inverted repeat (IR) regions of 26,197 bp each, separated by a small single copy (SSC) region of 17,834 bp and a large single copy (LSC) region of 83,136 bp. The total GC content of the entire chloroplast genome accounts for 36%, while the GC content in each region of SSC,LSC, and IR accounts for 29.1%, 34.15% and 42.35%, respectively. The genome harbored 133 genes, including 88 protein-coding genes, 37 tRNAs, and 8 rRNAs, with 17 duplicates in IRs. The most abundant amino acid was leucine and the least abundant was cysteine. Codon usage analyses revealed a bias for A/T-ending codons. A total of 35 repeat sequences and 92 simple sequence repeats were detected, and the SC-IR boundary regions were variable between the seven cp genomes. A phylogenetic analysis suggested that broccoli is closely related to Brassica oleracea var. italica MH388764.1, Brassica oleracea var. italica MH388765.1, and Brassica oleracea NC_0441167.1. Our results are expected to be useful for further species identification, population genetics analyses, and biological research on broccoli.	[Zhang, Zhenchao; Tao, Meiqi; Shan, Xi; Pan, Yongfei; Sun, Chunqing; Dai, Zhongliang] Zhenjiang Inst Agr Sci, Dept Vegetables & Flowers, Jurong, Peoples R China; [Song, Lixiao] Jiangsu Acad Agr Sci, Dept Vegetables, Nanjing, Peoples R China; [Pei, Xuli; Jing, Zange] Kunming Univ, Coll Agr & Life Sci, Kunming, Yunnan, Peoples R China	Jiangsu Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences; Kunming University	Dai, ZL (corresponding author), Zhenjiang Inst Agr Sci, Dept Vegetables & Flowers, Jurong, Peoples R China.	zzc1981zzc@163.com			National Natural Science Foundation of China (NSFC) [31401871]; Jiangsu Agriculture Science and Technology Innovation Fund [CX (18)3068]; Project for Nature Sciences in Zhejiang [LY18C150006]; Project for Fundamental Research of Local Undergraduate Universities (Partial) in Yunnan Province [2018FH001-044]; Jurong Science and Technology Innovation Fund Project [NY2019001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Agriculture Science and Technology Innovation Fund; Project for Nature Sciences in Zhejiang; Project for Fundamental Research of Local Undergraduate Universities (Partial) in Yunnan Province; Jurong Science and Technology Innovation Fund Project	The new statement below is suitable for my publication:This study was funded by the National Natural Science Foundation of China (NSFC) in the form of a grant to ZCZ [31401871], the Jiangsu Agriculture Science and Technology Innovation Fund in the form of funds to LXS [CX (18)3068], the Project for Nature Sciences in Zhejiang in the form of funds to ZGJ [LY18C150006], the Project for Fundamental Research of Local Undergraduate Universities (Partial) in Yunnan Province in the form of funds to ZGJ [2018FH001-044], and the Jurong Science and Technology Innovation Fund Project in the form of funds to ZCZ [NY2019001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bobik K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00781; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Chung HY, 2019, PLANT BIOTECHNOL REP, V13, P51, DOI 10.1007/s11816-018-00513-0; Doyle JJ, 1996, MOL PHYLOGENET EVOL, V5, P429, DOI 10.1006/mpev.1996.0038; Du XY, 2020, GENE, V731, DOI 10.1016/j.gene.2020.144340; Finley JW, 2001, J AGR FOOD CHEM, V49, P2679, DOI 10.1021/jf0014821; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gomez-Campo C., 1991, BOT CHRONIKA, V10, P429; Gu CH, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1870-3; Guo S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020246; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; He SL, 2012, INT J MOL SCI, V13, P12608, DOI 10.3390/ijms131012608; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Jang MW., 2012, J FOOD HYGIENE SAFET, V27, DOI [10.13103/JFHS.2012.27.4.461, DOI 10.13103/JFHS.2012.27.4.461]; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latte KP, 2011, FOOD CHEM TOXICOL, V49, P3287, DOI 10.1016/j.fct.2011.08.019; Li B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10409-8; Li XQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051045; Li X, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082443; Li YF, 2019, MOLECULES, V24, DOI 10.3390/molecules24020261; [李志超 Li Zhichao], 2019, [中国科学数据, China Scientific Data], V4, P1; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Mudunuri SB, 2007, BIOINFORMATICS, V23, P1181, DOI 10.1093/bioinformatics/btm097; Niu DK, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-24; Nuez F, 1999, COLLECCION SEMILLAS, P120; Peden JF., 2000, THESIS U NOTTINGHAM, V90, P73; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Redwan RM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0587-1; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shen XF, 2017, MOLECULES, V22, DOI 10.3390/molecules22081330; 이재준, 2009, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V38, P309; Spetea C, 2004, P NATL ACAD SCI USA, V101, P1409, DOI 10.1073/pnas.0308164100; Sun SS, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00493; Walker JF, 2014, AM J BOT, V101, P722, DOI 10.3732/ajb.1400049; Wang WB, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112288; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xue JH, 2012, AM J BOT, V99, pE240, DOI 10.3732/ajb.1100547; Yang K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194356	46	1	1	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0263310	10.1371/journal.pone.0263310	http://dx.doi.org/10.1371/journal.pone.0263310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202392	gold, Green Published			2022-12-26	WOS:000773224600010
J	Nielsen, KJ; Carstensen, O; Kaergaard, A; Vestergaard, JM; Biering, K				Nielsen, Kent J.; Carstensen, Ole; Kaergaard, Anette; Vestergaard, Jesper Medom; Biering, Karin			Neurological symptoms and disorders following electrical injury: A register-based matched cohort study	PLOS ONE			English	Article							LONG-TERM SEQUELAE; LOW-VOLTAGE; RISK; EPILEPSY; SHOCKS	IntroductionElectric shocks may have neurological consequences for the victims. Although the literature on the neurological consequences of electric shocks is limited by retrospective designs, case studies and studies of selected patient groups, previous research provides some evidence of a link between electric shocks, and diseases and symptoms of the central nervous system (CNS)(e.g. epilepsy, migraine and vertigo) and the peripheral nervous system (PNS)(e.g. loss of sensation, neuropathy and muscle weakness). This study aims to employ a register-based, matched cohort study, to investigate whether individuals demonstrate a greater risk of neurological diseases and symptoms of the CNS or PNS in the years following an electrical injury. Materials and methodsWe identified 14,112 electrical injuries over a period of 19 years in two Danish registries, and matched these with three different groups of persons in a prospective matched cohort study: (1) patients with dislocation/sprain injuries, (2) patients with eye injuries and (3) persons employed in the same occupation. Year of injury, sex and age were used as matching variables. The outcomes we identified comprised neurological disorders and central or peripheral nervous system symptoms that covered a range of diagnoses in the Danish National Patient Register. The associations were analysed using conditional logistic regression for a range of time periods (six months to five years) and conditional Cox regression for analyses of the complete follow-up period (up to 20 years). ResultsFor victims of electric shock, the CNS sequelae we identified included an increased risk of epilepsy, convulsions, abnormal involuntary movements, headache, migraine and vertigo. We also identified an uncertain, increased risk of spinal muscular atrophy and dystonia, whereas we identified no increased risk of Parkinson's disease, essential tremor, multiple sclerosis or other degenerative diseases of the nervous system. For victims of electric shock, the PNS sequelae we identified included an increased risk of disturbances of skin sensation, mononeuropathy in the arm or leg and nerve root and plexus disorders. We also identified an uncertain, increased risk of facial nerve disorders, other mononeuropathy, and polyneuropathy. ConclusionOur results confirm that electrical injuries increase the risk of several neurological diseases and symptoms of the CNS or PNS in the years following the injury. Most often the diseases and symptoms are diagnosed within the first six months of the injury, but delayed onset of up to 5 years cannot be ruled out for some symptoms and diagnoses. Some of the conditions were rare in our population, which limited our ability to identify associations, and this warrants cautious interpretation. Therefore, further studies are needed to confirm our findings, as are studies that examine the mechanisms underlying these associations.	[Nielsen, Kent J.; Carstensen, Ole; Kaergaard, Anette; Vestergaard, Jesper Medom; Biering, Karin] Univ Res Clin, Goedstrup Hosp, Danish Ramazzini Ctr, Dept Occupat Med, Herning, Denmark		Nielsen, KJ (corresponding author), Univ Res Clin, Goedstrup Hosp, Danish Ramazzini Ctr, Dept Occupat Med, Herning, Denmark.	kennie@rm.dk	Nielsen, Kent/CAG-3066-2022	Nielsen, Kent/0000-0002-4643-5697; Vestergaard, Jesper Medom/0000-0002-7435-6566	Danish Working Environment [22-2017-09]	Danish Working Environment	KN, OC, AK, JMV and KB received funding from the Danish Working Environment, grant number 22-2017-09, www.amff.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews CJ, 2017, NEURAL REGEN RES, V12, P677, DOI 10.4103/1673-5374.206636; [Anonymous], OSH SYSTEM NATL LEVE; [Anonymous], REGISTER BASED LABOU; [Anonymous], POPULATION; Arnoldo BD, 2004, J BURN CARE REHABIL, V25, P479, DOI 10.1097/01.BCR.0000144536.22284.5C; Asadi-Pooya AA, 2012, SEIZURE-EUR J EPILEP, V21, P165, DOI 10.1016/j.seizure.2011.10.009; Bailey B, 2008, AM J EMERG MED, V26, P413, DOI 10.1016/j.ajem.2007.06.021; Biering K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247317; Biering K, 2021, OCCUP ENVIRON MED, V78, P54, DOI 10.1136/oemed-2020-106858; Chudasama S, 2010, ANN PLAS SURG, V64, P522, DOI 10.1097/SAP.0b013e3181c1ff31; D. H. a. M. Authority, 1993, HOSP STAT, V57; Eurostat, ACC WORK STAT; Ferguson JS, 2010, J BURN CARE RES, V31, P458, DOI 10.1097/BCR.0b013e3181db5183; Grell K, 2012, BIOELECTROMAGNETICS, V33, P459, DOI 10.1002/bem.21705; Gunnarsson LG, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112371; Hansen SM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015967; Jalilian H, 2021, REV ENVIRON HEALTH, V36, P129, DOI 10.1515/reveh-2020-0041; Li XJ, 2008, SEIZURE-EUR J EPILEP, V17, P254, DOI 10.1016/j.seizure.2007.07.011; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Morse JS, 2005, J PSYCHOSOM RES, V58, P51, DOI 10.1016/j.jpsychores.2004.06.001; Morse MS, 2009, IEEE ENG MED BIO, P6522, DOI 10.1109/IEMBS.2009.5333144; Piotrowski A, 2014, BURNS, V40, P480, DOI 10.1016/j.burns.2013.08.008; Pliskin NH, 1998, J TRAUMA, V44, P709, DOI 10.1097/00005373-199804000-00027; Radulovic N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025990; S. Denmark, MIGRATION DENMARK; S. Denmark, DEATHS LIFE EXPECTAN; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shih JG, 2017, J BURN CARE RES, V38, pE293, DOI 10.1097/BCR.0000000000000373; Singerman J, 2008, J BURN CARE RES, V29, P773, DOI 10.1097/BCR.0b013e318184815d; Theman K, 2008, J BURN CARE RES, V29, P959, DOI 10.1097/BCR.0b013e31818b9eb6; van der Mark M, 2015, INT ARCH OCC ENV HEA, V88, P227, DOI 10.1007/s00420-014-0949-2; Wang MD, 2017, NEUROTOXICOLOGY, V61, P101, DOI 10.1016/j.neuro.2016.06.015; Wesner ML, 2013, CAN FAM PHYSICIAN, V59, P935; Yiannopoulou KG, 2021, NEUROL NEUROCHIR POL, V55, P12, DOI [10.5603/PJNNS.a2020.0076, 10.5603/JNNS.a2020.0076]	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264857	10.1371/journal.pone.0264857	http://dx.doi.org/10.1371/journal.pone.0264857			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235596	gold, Green Published			2022-12-26	WOS:000787073100043
J	Liu, YT; Lee, AG; Nguyen, AW; Maynard, JA				Liu, Yutong; Lee, Alison G.; Nguyen, Annalee W.; Maynard, Jennifer A.			An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC ANTIBODIES; GAMMA RECEPTORS; HUMAN IGG1; IN-VIVO; EXPRESSION; BINDING; AFFINITY; SPECIFICITY; VARIANTS; PROTEIN	Despite the exquisite specificity and high affinity of antibody based cancer therapies, treatment side effects can occur since the tumor-associated antigens targeted are also present on healthy cells. However, the low pH of the tumor microenvironment provides an opportunity to develop conditionally active antibodies with enhanced tumor specificity. Here, we engineered the human IgG1 Fc domain to enhance pH-selective binding to the receptor Fc gamma RIIIa and subsequent antibody-dependent cellular cytotoxicity (ADCC). We displayed the Fc domain on the surface of mammalian cells and generated a site-directed library by altering Fc residues at the Fc-Fc gamma RIIIa interface to support interactions with positively charged histidine residues. We then used a competitive staining and flow cytometric selection strategy to isolate Fc variants exhibiting reduced Fc gamma RIIIa affinities at neutral pH, but physiological affinities at the tumor-typical pH 6.5. We demonstrate that antibodies composed of Fab arms binding the breast cell epithelial marker Her2 and the lead Fc variant, termed acid-Fc, exhibited an ,~& nbsp;2-fold pH-selectivity for Fc gamma RIIIa binding based on the ratio of equilibrium dissociation constants K-d,K-7.4/K-d,K-6.5, due to a faster dissociation rate at pH 7.4. Finally, in vitro ADCC assays with human Fc gamma RIIIa-positive natural killer and Her2-positive target cells demonstrated similar activities for anti-Her2 antibodies bearing the wild-type or acid-Fc at pH 6.5, but nearly 20-fold reduced ADCC for acidFc at pH 7.4, based on EC50 ratios. This work shows the promise of mammalian cell display for Fc engineering and the feasibility of pH-selective Fc activation to provide a second dimension of selective tumor cell targeting.	[Liu, Yutong; Nguyen, Annalee W.; Maynard, Jennifer A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Lee, Alison G.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Nguyen, AW; Maynard, JA (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	annalee@utexas.edu; maynard@che.utexas.edu		Lee, Alison/0000-0001-8305-3332; Liu, Yutong/0000-0003-0626-8094	Cancer Prevention and Research Institute of Texas grant [RP180690]; Welch Foundation [F-1767]	Cancer Prevention and Research Institute of Texas grant; Welch Foundation(The Welch Foundation)	This work was supported by the Cancer Prevention and Research Institute of Texas grant RP180690 to A. W. N and J. A. M. and Welch Foundation grant F-1767 to J. A. M.	Ackerman M. E., 2011, J IMMU; Ahmed AA, 2016, J STRUCT BIOL, V194, P78, DOI 10.1016/j.jsb.2016.02.001; Andreev OA, 2010, MOL MEMBR BIOL, V27, P341, DOI 10.3109/09687688.2010.509285; Avery LB, 2016, MABS-AUSTIN, V8, P1064, DOI 10.1080/19420862.2016.1193660; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Brinkhaus M, 2020, J IMMUNOL, V205, P3456, DOI 10.4049/jimmunol.2000961; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Castelli DD, 2014, MAGN RESON MED, V71, P326, DOI 10.1002/mrm.24664; Challa DK, 2014, CURR TOP MICROBIOL, V382, P249, DOI 10.1007/978-3-319-07911-0_12; Chen D, 2021, THERANOSTICS, V11, P1901, DOI 10.7150/thno.51299; Corbet C, 2017, NAT REV CANCER, V17, P577, DOI 10.1038/nrc.2017.77; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; Dempsey N, 2021, BREAST CANCER RES TR, V188, P21, DOI 10.1007/s10549-021-06280-x; Desnoyers LR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006682; EAGLE H, 1971, SCIENCE, V174, P500, DOI 10.1126/science.174.4008.500; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; FLEIT HB, 1991, J LEUKOCYTE BIOL, V49, P556, DOI 10.1002/jlb.49.6.556; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; Hatjiharissi E., 2007, AUGMENTED; Holcmann M, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1004969; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Johnston RJ, 2019, NATURE, V574, P565, DOI 10.1038/s41586-019-1674-5; Jung ST, 2013, ACS CHEM BIOL, V8, P368, DOI 10.1021/cb300455f; Kamat V, 2017, ANAL BIOCHEM, V536, P16, DOI 10.1016/j.ab.2017.08.002; Kamata-Sakurai M, 2021, CANCER DISCOV, V11, P158, DOI 10.1158/2159-8290.CD-20-0328; Kang TH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00562; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; Kroetsch A, 2019, MABS-AUSTIN, V11, P411, DOI 10.1080/19420862.2018.1545510; Kunaparaju R, 2005, BIOTECHNOL BIOENG, V91, P670, DOI 10.1002/bit.20534; Lazar G. A., 2006, PROC NATL ACAD; Lee C.-H., 2017, IGG FC DOMAINS BIND; Lee CH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13108-2; Liu RN, 2020, ANTIBODIES, V9, DOI 10.3390/antib9040064; Lo M, 2017, J BIOL CHEM, V292, P3900, DOI 10.1074/jbc.M116.767749; Mimoto F, 2013, MABS-AUSTIN, V5, P229, DOI 10.4161/mabs.23452; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; Nguyen AW, 2018, PROTEIN ENG DES SEL, V31, P91, DOI 10.1093/protein/gzy004; Nimmerjahn Falk, 2012, Cancer Immun, V12, P13; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Overdijk MB, 2012, J IMMUNOL, V189, P3430, DOI 10.4049/jimmunol.1200356; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Robinson JI, 2018, P NATL ACAD SCI USA, V115, pE72, DOI 10.1073/pnas.1707856115; Romain G, 2014, BLOOD, V124, P3241, DOI 10.1182/blood-2014-04-569061; Rugo H. S., 2021, EFFICACY; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Sazinsky SL, 2008, P NATL ACAD SCI USA, V105, P20167, DOI 10.1073/pnas.0809257105; Scott Andrew M, 2012, Cancer Immun, V12, P14; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Sulea T, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1682866; Tobias R., 2019, FORTEBIO APPL NOTE, P12; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; Wagner EK, 2019, J BIOL CHEM, V294, P5790, DOI 10.1074/jbc.RA118.007187; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Webb AH, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3418-y; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wei D, 2019, MOL IMAGING BIOL, V21, P1020, DOI 10.1007/s11307-019-01335-4; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8	67	0	0	7	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101798	10.1016/j.jbc.2022.101798	http://dx.doi.org/10.1016/j.jbc.2022.101798			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35248534	gold, Green Published			2022-12-26	WOS:000793694800005
J	Deng, TM; Wu, YJ				Deng, Tianmin; Wu, Yongjun			Simultaneous vehicle and lane detection via MobileNetV3 in car following scene	PLOS ONE			English	Article								Aiming at vehicle and lane detections on road scene, this paper proposes a vehicle and lane line joint detection method suitable for car following scenes. This method uses the codec structure and multi-task ideas, shares the feature extraction network and feature enhancement and fusion module. Both ASPP (Atrous Spatial Pyramid Pooling) and FPN (Feature Pyramid Networks) are employed to improve the feature extraction ability and real-time of MobileNetV3, the attention mechanism CBAM (Convolutional Block Attention Module) is introduced into YOLOv4, an asymmetric network architecture of "more encoding-less decoding" is designed for semantic pixel-wise segmentation network. The proposed model employed improved MobileNetV3 as feature ex-traction block, and the YOLOv4-CBAM and Asymmetric SegNet as branches to detect vehicles and lane lines, respectively. The model is trained and tested on the BDD100K data set, and is also tested on the KITTI data set and Chongqing road images, and focuses on the detection effect in the car following scene. The experimental results show that the proposed model surpasses the YOLOv4 by a large margin of +1.1 AP50, +0.9 Recall, +0.7 F1 and +0.3 Precision, and surpasses the SegNet by a large margin of +1.2 IoU on BDD100k. At the same time, the detection speed is 1.7 times and 3.2 times of YOLOv4 and SegNet, respectively. It fully proves the feasibility and effectiveness of the improved method.	[Deng, Tianmin] Chongqing Univ, Sch Automat, Chongqing, Peoples R China; [Deng, Tianmin; Wu, Yongjun] Chongqing Jiaotong Univ, Sch Traff & Transportat, Chongqing, Peoples R China	Chongqing University; Chongqing Jiaotong University	Deng, TM (corresponding author), Chongqing Univ, Sch Automat, Chongqing, Peoples R China.; Deng, TM (corresponding author), Chongqing Jiaotong Univ, Sch Traff & Transportat, Chongqing, Peoples R China.	dtianmin@cqjtu.edu.cn			National Key Research and Development Program of China [SQ2020YFF0418521]; Chongqing Science and Technology Development Foundation [cstc2020jscx-dxwtBX0019]; Joint Key Research & De-velopment Program of Sichuan and Chongqing(CN) [cstc2020jscx-cylhX0007, cstc2020jscxcylhX0005]	National Key Research and Development Program of China; Chongqing Science and Technology Development Foundation; Joint Key Research & De-velopment Program of Sichuan and Chongqing(CN)	This work was supported by the National Key Research and Development Program of China (Grant number: SQ2020YFF0418521), Chongqing Science and Technology Development Foundation (Grant number: cstc2020jscx-dxwtBX0019), the Joint Key Research & De-velopment Program of Sichuan and Chongqing(CN) (Grant number: cstc2020jscx-cylhX0007 and cstc2020jscxcylhX0005).	Al Mamun A., 2021, INT J ELECT COMPUT E, V11, P3032, DOI DOI 10.11591/IJECE.V11I4.PP3032-3039; [曹磊 Cao Lei], 2021, [东南大学学报. 自然科学版, Journal of Southeast University. Natural Science Edition], V51, P87; [曹莹 Cao Ying], 2013, [自动化学报, Acta Automatica Sinica], V39, P745; Chang C.-C., 2011, ACM T INTEL SYST TEC, V2, P1, DOI [10.1145/1961189.1961199, DOI 10.1145/1961189.1961199]; Chen G, 2021, IEEE T INTELL TRANSP, V22, P7699, DOI 10.1109/TITS.2020.3007631; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Dai X.G., 2018, RES DETECTION CLASSI; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Deusch H, 2012, IEEE INT C INTELL TR, P270, DOI 10.1109/ITSC.2012.6338772; Ghosh R, 2021, MULTIMED TOOLS APPL, V80, P25985, DOI 10.1007/s11042-021-10954-5; He KM, 2014, LECT NOTES COMPUT SC, V8691, P346, DOI 10.1007/978-3-319-10578-9_23; Hou YN, 2019, IEEE I CONF COMP VIS, P1013, DOI 10.1109/ICCV.2019.00110; Howard A G., ARXIV PREPRINT ARXIV, P2017; Howard A, 2019, IEEE I CONF COMP VIS, P1314, DOI 10.1109/ICCV.2019.00140; Iandola F. N., 2016, CORR ABS160207360, DOI DOI 10.48550/ARXIV.1602.07360; Li J, 2017, IEEE T NEUR NET LEAR, V28, P690, DOI 10.1109/TNNLS.2016.2522428; Li Y, 2020, IEEE SIGNAL PROC MAG, V37, P50, DOI 10.1109/MSP.2020.2973615; Lin CY, 2021, IEEE SENS J, V21, P10029, DOI 10.1109/JSEN.2021.3057999; Lin TY, 2017, IEEE I CONF COMP VIS, P2999, DOI 10.1109/ICCV.2017.324; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Ma N.N., ARXIV PREPRINT ARXIV, P2018; Neven D, 2018, IEEE INT VEH SYM, P286; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Pan XG, 2018, AAAI CONF ARTIF INTE, P7276; Qian YQ, 2020, IEEE T INTELL TRANSP, V21, P4670, DOI 10.1109/TITS.2019.2943777; Ren SQ, 2017, IEEE T PATTERN ANAL, V39, P1137, DOI 10.1109/TPAMI.2016.2577031; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Teichmann M, 2018, IEEE INT VEH SYM, P1013; Ngoc TN, 2014, 2014 SEVENTH IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE FOR SECURITY AND DEFENSE APPLICATIONS (CISDA), P130; Wang BF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173424; Wang H, 2019, IEEE INTEL TRANSP SY, V11, P82, DOI 10.1109/MITS.2019.2903518; Woo SH, 2018, LECT NOTES COMPUT SC, V11211, P3, DOI 10.1007/978-3-030-01234-2_1; Wu JQ, 2020, IEEE INTEL TRANSP SY, V12, P25, DOI 10.1109/MITS.2018.2876559; Xu Q., 2021, SENSORS-BASEL, V21, DOI DOI 10.3390/s21010027; Yang W, 2018, PROC SPIE, V10670, DOI 10.1117/12.2309844; Zhang X, 2018, PROC CVPR IEEE, P6848, DOI 10.1109/CVPR.2018.00716; Zhang Y, 2022, IEEE T KNOWL DATA EN, V34, P5586, DOI 10.1109/TKDE.2021.3070203	37	4	5	25	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264551	10.1371/journal.pone.0264551	http://dx.doi.org/10.1371/journal.pone.0264551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245342	gold, Green Published			2022-12-26	WOS:000799799100025
J	Ansari, P; Flatt, PR; Harriott, P; Abdel-Wahab, YHA				Ansari, Prawej; Flatt, Peter R.; Harriott, Patrick; Abdel-Wahab, Yasser H. A.			Insulin secretory and antidiabetic actions of Heritiera fomes bark together with isolation of active phytomolecules	PLOS ONE			English	Article							FLAVONOL GLYCOSIDES; IN-VITRO; SKELETAL-MUSCLE; DPP-IV; ANTIOXIDANT; IDENTIFICATION; LANGERHANS; GLYCATION; PROTEIN; ISLETS	In folklore, Heritiera fomes (H. fomes) has been extensively used in treatment of various ailments such as diabetes, cardiac and hepatic disorders. The present study aimed to elucidate the antidiabetic actions of hot water extract of H. fomes (HWHF), including effects on insulin release from BRIN BD11 cells and isolated mouse islets as well as glucose homeostasis in high-fat-fed rats. Molecular mechanisms underlying anti-diabetic activity along with isolation of active compounds were also evaluated. Non-toxic concentrations of HWHF stimulated concentration-dependent insulin release from isolated mouse islets and clonal pancreatic beta -cells. The stimulatory effect was potentiated by glucose and isobutyl methylxanthine (IBMX), persisted in presence of tolbutamide or a depolarizing concentration of KCl but was attenuated by established inhibitors of insulin release such as diazoxide, verapamil, and Ca2+ chelation. HWHF caused depolarization of the beta -cell membrane and increased intracellular Ca2+. The extract also enhanced glucose uptake and insulin action in 3T3-L1 differentiated adipocytes cells and significantly inhibited in a dose-dependent manner starch digestion, protein glycation, DPP-IV enzyme activity, and glucose diffusion in vitro. Oral administration of HWHF (250 mg/5ml/kg b.w.) to high-fat fed rats significantly improved glucose tolerance and plasma insulin responses and it inhibited plasma DPP-IV activity. HWHF also decreased in vivo glucose absorption and intestinal disaccharidase activity while increasing gastrointestinal motility and unabsorbed sucrose transit. Compounds were isolated from HWHF with similar molecular weights to quercitrin (C-21 H-20 O-11) ranging from 447.9 to 449.9 Da which stimulated the insulin release in vitro and improved both glucose tolerance and plasma insulin responses in mice. In conclusion, H. fomes and its water-soluble phytochemicals such as quercitrin may exert antidiabetic actions mediated through a variety of mechanisms which might be useful as dietary adjunct in the management of type 2 diabetes.	[Ansari, Prawej; Flatt, Peter R.; Harriott, Patrick; Abdel-Wahab, Yasser H. A.] Ulster Univ, Sch Biomed Sci, Coleraine, Londonderry, North Ireland; [Ansari, Prawej] Independent Univ, Sch Pharm & Publ Hlth, Dept Pharm, Dhaka, Bangladesh	Ulster University; Independent University Bangladesh (IUB)	Abdel-Wahab, YHA (corresponding author), Ulster Univ, Sch Biomed Sci, Coleraine, Londonderry, North Ireland.	y.abdel-wahab@ulster.ac.uk		Abdel-Wahab, Yasser/0000-0002-3991-3419	Ulster University Strategic Research support	Ulster University Strategic Research support	Ulster University Strategic Research support and Vice Chancellor's research fellowship to P.A are gratefully acknowledged.	AbdelWahab YHA, 1996, DIABETES, V45, P1489, DOI 10.2337/diabetes.45.11.1489; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Ansari P, 2021, J PHARM PHARMACOL, V73, P1049, DOI 10.1093/jpp/rgab030; Ansari P, 2021, BIOSCIENCE REP, V41, DOI 10.1042/BSR20203824; Ansari P, 2021, BRIT J NUTR, V126, P1149, DOI 10.1017/S0007114520005085; Ansari P, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9101348; Ansari P, 2020, J ETHNOPHARMACOL, V253, DOI 10.1016/j.jep.2020.112647; Ansari P, 2017, J PEDIATR ENDOCR MET, V30, P37, DOI 10.1515/jpem-2016-0160; Aryaeian Naheed, 2017, Med J Islam Repub Iran, V31, P134, DOI 10.14196/mjiri.31.134; Asgharpour F, 2013, INT J MOL CELL MED, V2, P169; Aye MM, 2019, MOLECULES, V24, DOI 10.3390/molecules24020293; Balkhi B, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029280; Cagliero E., 2016, ENDOCRINOLOGY ADULT, VSeventh, P898; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Chen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045693; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Duffy NA, 2007, EUR J PHARMACOL, V568, P278, DOI 10.1016/j.ejphar.2007.05.010; EDWARDS CA, 1987, AM J CLIN NUTR, V46, P72, DOI 10.1093/ajcn/46.1.72; Gallagher AM, 2003, NUTR RES, V23, P413, DOI 10.1016/S0271-5317(02)00533-X; Godinho R, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/806979; Grace MH, 2014, FOOD CHEM, V158, P229, DOI 10.1016/j.foodchem.2014.02.117; Hannan JMA, 2020, BRIT J NUTR, V124, P1021, DOI 10.1017/S0007114520002111; Hardiyanti R., 2019, RAS YAN J CHEM, V12, P1822, DOI [10.31788/RJC.2019.1235353, DOI 10.31788/RJC.2019.1235353]; Harmon AW, 2003, BIOCHEM BIOPH RES CO, V305, P229, DOI 10.1016/S0006-291X(03)00720-4; Hossain M.A., 2013, J PHARMACOGNOSY PHYT, V2, P95; Hunter SJ, 2003, DIABETES, V52, P492, DOI 10.2337/diabetes.52.2.492; Islam ME, 2020, ADV TRADIT MED, V20, P189, DOI 10.1007/s13596-019-00401-0; Jovanovic JA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00793; Kim BR, 2018, MOLECULES, V23, DOI 10.3390/molecules23081998; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Mahmud Imran, 2014, Int Sch Res Notices, V2014, P938543, DOI 10.1155/2014/938543; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McClenaghan NH, 1996, J ENDOCRINOL, V151, P349, DOI 10.1677/joe.0.1510349; Moharram FA, 2006, NAT PROD RES, V20, P927, DOI 10.1080/14786410500378494; Mollik M. A. H., 2010, Ethnobotany Research and Applications, V8, P195; OHarte FPM, 1996, PEPTIDES, V17, P1323, DOI 10.1016/S0196-9781(96)00231-8; Patra JK, 2011, ACTA PHYSIOL PLANT, V33, P1051, DOI 10.1007/s11738-010-0667-7; Rahmatullah M., 2011, ADV NATURAL APPL SCI, V5, P116; Rathmann W, 2013, DTSCH ARZTEBL INT, V110, P331, DOI 10.3238/arztebl.2013.0331; Rubanza CDK, 2007, ARCH ANIM NUTR, V61, P151, DOI 10.1080/17450390701203907; Shah Muhammad Ajmal, 2018, Pharmacogn Mag, V13, pS817, DOI 10.4103/pm.pm_236_17; SHARP GWG, 1979, DIABETOLOGIA, V16, P287, DOI 10.1007/BF01223617; Shin JA, 2013, J DIABETES INVEST, V4, P334, DOI 10.1111/jdi.12075; Singh Awadhesh Kumar, 2014, Indian J Endocrinol Metab, V18, P753, DOI 10.4103/2230-8210.141319; SWINTOSKY JV, 1982, PHARM INT, V3, P163; Tremblay F, 2001, DIABETES, V50, P1901, DOI 10.2337/diabetes.50.8.1901; Wang Y, 2015, CELL TRANSPLANT, V24, P25, DOI 10.3727/096368913X673441; Wangensteen H, 2009, ADV PHYTOTHERAPY RES, P59; Wangensteen H, 2009, NAT PROD COMMUN, V4, P371; Yin Z, 2014, FOOD SCI HUM WELL, V3, P136, DOI DOI 10.1016/J.FSHW.2014.11.003; Zhang SW, 2019, FREE RADICAL BIO MED, V131, P332, DOI 10.1016/j.freeradbiomed.2018.12.023; Zhong XN, 1997, PHYTOCHEMISTRY, V46, P943, DOI 10.1016/S0031-9422(97)00366-X; Zochodne Douglas W, 2014, Handb Clin Neurol, V126, P379, DOI 10.1016/B978-0-444-53480-4.00028-X	53	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264632	10.1371/journal.pone.0264632	http://dx.doi.org/10.1371/journal.pone.0264632			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239729	Green Published, gold			2022-12-26	WOS:000776002200054
J	White, S; Heath, T; Ibrahim, WK; Ihsan, D; Blanchet, K; Curtis, V; Dreibelbis, R				White, Sian; Heath, Thomas; Ibrahim, Waleed Khalid; Ihsan, Dilveen; Blanchet, Karl; Curtis, Val; Dreibelbis, Robert			How is hygiene behaviour affected by conflict and displacement? A qualitative case study in Northern Iraq	PLOS ONE			English	Article							HAND HYGIENE; HEALTH; HOMEMAKING; DISGUST; HOME	This research aimed to qualitatively explore whether the determinants of handwashing behaviour change according to the duration of displacement or the type of setting that people are displaced to. We conducted an exploratory qualitative study in three different post-conflict settings in Northern Iraq-a long-term displacement camp, a short-term displacement camp, and villages where people were returning to post the conflict. We identified 33 determinants of handwashing in these settings and, of these, 21 appeared to be altered by the conflict and displacement. Determinants of handwashing behaviour in the post-conflict period were predominantly explained by disruptions to the physical, psychological, social and economic circumstances of displaced populations. Future hygiene programmes in post-conflict displacement settings should adopt a holistic way of assessing determinants and design programmes which promote agency, build on adaptive norms, create an enabling environment and which are integrated with other aspects of humanitarian response.	[White, Sian; Curtis, Val; Dreibelbis, Robert] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Heath, Thomas] Act Faim, Operat Dept, Paris, France; [Ibrahim, Waleed Khalid] Cihan Univ, Coll Med Technol, Nutr & Dietet Dept, Erbil, Kurdistan Regio, Iraq; [Blanchet, Karl] Univ Geneva, Geneva Ctr Humanitarian Studies, Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; Cihan University-Erbil; University of Geneva	White, S (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.	sina.white@Ishtm.ac.uk			United States Agency for international development's Bureau of Humanitarian Assistance [AID-OFDA-G-16-00270]	United States Agency for international development's Bureau of Humanitarian Assistance	Funding for this research was provided by United States Agency for international development's Bureau of Humanitarian Assistance via grant number AID-OFDA-G-16-00270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This grant contributed to the salaries of Sian White, Thomas Heath, Waleed Khalid Ibrahum and Dilveen Ihsan, but did not fully fund these.	Abbas AM, 2021, J OBSTET GYNAECOL, V41, P331, DOI 10.1080/01443615.2020.1819214; Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Al-Khatib Issam A., 2011, Eastern Mediterranean Health Journal, V17, P323; Aunger R., 2016, HEALTH PSYCHOL REV; Aunger R., 2017, BEHAV CENTRED DESIGN, DOI [10.1371/journal.pone.0171610, DOI 10.1371/JOURNAL.PONE.0171610]; Biran A, 2012, TROP MED INT HEALTH, V17, P1133, DOI 10.1111/j.1365-3156.2012.03045.x; Blum LS, 2019, CONFL HEALTH, V13, DOI 10.1186/s13031-019-0225-x; Bradt D., 2009, NETWORK PAPER EVIDEN; Braun V, 2021, QUAL RES PSYCHOL, V18, P328, DOI 10.1080/14780887.2020.1769238; Brewis A, 2019, SOC SCI MED, V220, P12, DOI 10.1016/j.socscimed.2018.10.020; Brun C, 2015, SOC ANAL, V59, P19, DOI 10.3167/sa.2015.590102; Brun C, 2015, REFUGE, V31, P5; Cavill S., 2020, WH2O J GENDER WATER, V7; Checchi F., 2007, PUBLIC HLTH CRISIS A; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Contzen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136445; Contzen N, 2015, AM J INFECT CONTROL, V43, P826, DOI 10.1016/j.ajic.2015.04.186; Coombes Y, 2010, INTRO FOAM FRAMEWORK; Curtis V, 2019, SOC SCI MED, V235, DOI 10.1016/j.socscimed.2019.112398; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; Curtis VA, 2009, HEALTH EDUC RES, V24, P655, DOI 10.1093/her/cyp002; D'Mello-Guyett L, 2018, CONFL HEALTH, V12, DOI 10.1186/s13031-018-0159-8; De Buck E., 2017, CAMPBELL COLLABORATI, V7; Dijkzeul D, 2013, DISASTERS, V37, pS1, DOI 10.1111/disa.12009; Dreibelbis R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1015; Flachenberg F., 2017, 40 WEDC INT C; Fontenelle LF, 2012, J ANXIETY DISORD, V26, P377, DOI 10.1016/j.janxdis.2011.12.001; Gaskell GD, 2000, PUBLIC OPIN QUART, V64, P77, DOI 10.1086/316761; Hart J, 2018, HUM ORGAN, V77, P371, DOI 10.17730/0018-7259.77.4.371; HORNSVELD RHJ, 1979, BEHAV RES THER, V17, P223, DOI 10.1016/0005-7967(79)90037-8; Husain F, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0053-6; Kibreab Gaim, 2000, CAN J AFR STUDIES, V34, P249; Kjellsson G, 2014, J HEALTH ECON, V35, P34, DOI 10.1016/j.jhealeco.2014.01.007; La Valle M.H., 2019, LIFE EVENTS CHANGES, P176; Morgan D.J., 1997, FOCUS GROUPS QUALITA, P8; Mosler HJ, 2012, INT J ENVIRON HEAL R, V22, P431, DOI 10.1080/09603123.2011.650156; Mubarak MY, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1789-3; Nahimana MR, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.54.12265; Neumark D, 2013, HOUS THEORY SOC, V30, P237, DOI 10.1080/14036096.2013.789071; Peterson EA, 1998, INT J EPIDEMIOL, V27, P520, DOI 10.1093/ije/27.3.520; Phillips RM, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0065-2; Porzig-Drummond R, 2009, SOC SCI MED, V68, P1006, DOI 10.1016/j.socscimed.2009.01.013; Ram P., 2010, GLOB SCAL HANDW PROJ; Ramesh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124688; Ramos M., 2016, HANDWASHING EMERGENC; Ranasinghe S, 2016, J INFECT PUBLIC HEAL, V9, P429, DOI 10.1016/j.jiph.2015.11.007; Reuven-Magril O, 2008, J ABNORM PSYCHOL, V117, P334, DOI 10.1037/0021-843X.117.2.334; ROGGE JR, 1989, INT MIGR REV, V23, P184, DOI 10.2307/2546257; Sagan S., 2019, Waterlines, V38, P20, DOI 10.3362/1756-3488.17-00; Sanyal R, 2014, INT J URBAN REGIONAL, V38, P558, DOI 10.1111/1468-2427.12020; Schatzman L., 1973, FIELD RES STRATEGIES; Slekiene J, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4638-4; Sphere Association, 2018, SPHER HDB HUM CHART; Stefanovic D, 2015, J REFUG STUD, V28, P276, DOI 10.1093/jrs/feu029; Thorpe SJ, 2011, BEHAV COGN PSYCHOTH, V39, P175, DOI 10.1017/S1352465810000676; Turner S, 2016, J REFUG STUD, V29, P139, DOI 10.1093/jrs/fev024; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; Vandevoordt R, 2017, J REFUG STUD, V30, P605, DOI 10.1093/jrs/fex017; Verplanken B., 2018, PSYCHOL HABIT THEORY, DOI [10.1007/978-3-319-97529-0_11, DOI 10.1007/978-3-319-97529-0_11]; Watson J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228482; White S, 2020, INT J HYG ENVIR HEAL, V227, DOI 10.1016/j.ijheh.2020.113512; White S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216237; Wolf J, 2019, INT J EPIDEMIOL, V48, P1204, DOI 10.1093/ije/dyy253; Wolf J, 2018, TROP MED INT HEALTH, V23, P508, DOI 10.1111/tmi.13051; Woodruff B., 2009, USE EPIDEMIOLOGICAL; Yates T., 2018, Waterlines, V37, P31, DOI 10.3362/1756-3488.17-00016; Zangana A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231694	67	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264434	10.1371/journal.pone.0264434	http://dx.doi.org/10.1371/journal.pone.0264434			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239702	gold, Green Published, Green Accepted			2022-12-26	WOS:000776002200033
J	Hur, MS; Lee, S; Jung, HS; Schneider, RA				Hur, Mi-Sun; Lee, Seunggyu; Jung, Han-Sung; Schneider, Richard A.			Anatomical connections among the depressor supercilii, levator labii superioris alaeque nasi, and inferior fibers of orbicularis oculi: Implications for variation in human facial expressions	PLOS ONE			English	Article							NEURAL CREST CELLS; CRANIAL PARAXIAL MESODERM; CRANIOFACIAL DEVELOPMENT; TISSUE ORIGINS; MUSCLES; SKULL; DIFFERENTIATION; EVOLUTIONARY; SKELETAL; MORPHOGENESIS	The aim of this study was to determine how the depressor supercilii (DS) connects to the levator labii superioris alaeque nasi (LLSAN) and inferior fibers of the orbicularis oculi (OOc INF) in the human midface. While grimacing, contraction of the DS with fibers connecting to the LLSAN and OOc INF can assist in pulling the medial eyebrow downward more than when these connecting fibers are not present. Contraction of these distinct connecting fibers between the DS and the LLSAN can also slightly elevate the nasal ala and upper lip. The DS was examined in 44 specimens of embalmed adult Korean cadavers. We found that the DS connected to the LLSAN or the OOc INF by muscle fibers or thin aponeuroses in 33 (75.0%) of the 44 specimens. The DS was connected to both the LLSAN and OOc INF by muscle fibers or aponeuroses and had no connection to either in 5 (11.4%) and 11 (25.0%) specimens, respectively. The DS was connected to the LLSAN by the muscle fibers and thin aponeuroses in 6 (13.6%) and 4 (9.1%) specimens, respectively. The DS was connected to the OOc INF by the muscle fibers and thin aponeuroses in 5 (11.4%) and 23 (52.3%) specimens, respectively. Our findings regarding the anatomical connections of the glabellar region DS to the midface LLSAN and OOc INF provide insights on the dynamic balance between the brow depressors such as the DS and brow-elevating muscle and contribute to understanding the anatomical origins of individual variation in facial expressions. These results can also improve the safety, predictability, and aesthetics of treatments for the glabellar region with botulinum toxin type A and can be helpful when performing electromyography.	[Hur, Mi-Sun] Daegu Catholic Univ, Sch Med, Dept Anat, Daegu, South Korea; [Lee, Seunggyu] Korea Univ, Div Appl Math Sci, Sejong, South Korea; [Jung, Han-Sung] Yonsei Univ, Coll Dent, Taste Res Ctr, Oral Sci Res Ctr,Dept Oral Biol,BK21 FOUR Project, Seoul, South Korea; [Schneider, Richard A.] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA	Catholic University of Daegu; Korea University; Yonsei University; Yonsei University Health System; University of California System; University of California San Francisco	Jung, HS (corresponding author), Yonsei Univ, Coll Dent, Taste Res Ctr, Oral Sci Res Ctr,Dept Oral Biol,BK21 FOUR Project, Seoul, South Korea.; Schneider, RA (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA.	HSJUNG@yuhs.ac; rich.schneider@ucsf.edu		Lee, Seunggyu/0000-0003-3141-6968; Schneider, Richard/0000-0002-2626-3111; Jung, Han-Sung/0000-0003-2795-531X; Hur, Mi-Sun/0000-0002-1482-1657	National Research Foundation of Korea (NRF) - Korean government (MSIT) [2020R1C1C1003237]; National Institute for Dental and Craniofacial Research (NIDCR) [R01 DE025668, R01 DE016402]; Korea University; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2020R1A2C1A01100114, NRF-2016R1A5A2008630]	National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); National Institute for Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Korea University; National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No.2020R1C1C1003237). RAS was supported in part by grants (R01 DE025668 and R01 DE016402) from the National Institute for Dental and Craniofacial Research (NIDCR). SL was supported by Korea University Grant and a National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2020R1A2C1A01100114). This research was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea Government (MSIP) (NRF-2016R1A5A2008630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMO AC, 1995, PLAST RECONSTR SURG, V95, P1170, DOI 10.1097/00006534-199506000-00005; Bell Charles, 1824, ESSAYS ANATOMY PHILO; Benedetto A. V., 2018, BOTULINUM TOXINS CLI, V3; Bruintjes TD, 1996, EUR ARCH OTO-RHINO-L, V253, P464, DOI 10.1007/BF00179951; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Burrows AM, 2008, BIOESSAYS, V30, P212, DOI 10.1002/bies.20719; Burrows AM, 2011, ANAT REC, V294, P645, DOI 10.1002/ar.21355; Burrows AM, 2009, J ANAT, V215, P320, DOI 10.1111/j.1469-7580.2009.01113.x; Cook BE, 2001, OPHTHAL PLAST RECONS, V17, P404, DOI 10.1097/00002341-200111000-00004; COULY GF, 1992, DEVELOPMENT, V114, P1; COULY GF, 1993, DEVELOPMENT, V117, P409; Daniel R K, 1997, Aesthet Surg J, V17, P97; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; de Maio M., 2007, RZANY B BOTULINUM TO; Dupin E, 2010, CELL CYCLE, V9, P238, DOI 10.4161/cc.9.2.10491; Evans DJR, 2006, DEV DYNAM, V235, P1310, DOI 10.1002/dvdy.20663; Flowers R S, 1998, Aesthet Surg J, V18, P463, DOI 10.1016/S1090-820X(98)70082-2; Flynn TC, 2003, CLIN DERMATOL, V21, P498, DOI 10.1016/j.clindermatol.2003.11.015; GRAMMER K, 1988, ETHOLOGY, V77, P279; Grenier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004381; HAPPAK W, 1988, J NEUROL SCI, V83, P25, DOI 10.1016/0022-510X(88)90017-2; Hollinshead WH., 1982, ANATOMY SURGEONS, V1; Huber E, 1931, EVOLUTION FACIAL MUS; Hur MS, 2017, SURG RADIOL ANAT, V39, P865, DOI 10.1007/s00276-017-1817-z; Jheon AH, 2009, J DENT RES, V88, P12, DOI 10.1177/0022034508327757; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kaminski J, 2019, P NATL ACAD SCI USA, V116, P14677, DOI 10.1073/pnas.1820653116; Kardon G, 1998, DEVELOPMENT, V125, P4019; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kim H. J., 2016, CLIN ANATOMY FACE FI; Knize DM, 2000, PLAST RECONSTR SURG, V105, P350, DOI 10.1097/00006534-200001000-00058; Kontges G, 1996, DEVELOPMENT, V122, P3229; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; LELIEVRE CS, 1978, J EMBRYOL EXP MORPH, V47, P17; Lorenc ZP, 2013, AESTHET PLAST SURG, V37, P975, DOI 10.1007/s00266-013-0178-1; Marcucio RS, 1999, DEV DYNAM, V214, P178; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; Morris H., 1947, MORRIS HUMAN ANATOMY, V10th; Morriss-Kay GM, 2001, J ANAT, V199, P143; Noden DM, 1999, DEV DYNAM, V216, P96, DOI 10.1002/(SICI)1097-0177(199910)216:2<96::AID-DVDY2>3.3.CO;2-Y; NODEN DM, 1986, DEV BIOL, V116, P347, DOI 10.1016/0012-1606(86)90138-7; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; Noden DM, 2006, ADV EXP MED BIOL, V589, P1; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Pinar Y, 2016, SURG RADIOL ANAT, V38, P1045, DOI 10.1007/s00276-016-1666-1; Rinon A, 2007, DEVELOPMENT, V134, P3065, DOI 10.1242/dev.002501; Sambasivan R, 2011, DEVELOPMENT, V138, P2401, DOI 10.1242/dev.040972; Schmidt KL, 2001, YEARB PHYS ANTHROPOL, V44, P3, DOI 10.1002/ajpa.20001; Schneider RA, 2018, GENESIS, V56, DOI 10.1002/dvg.23219; Seo, 2017, BOTULINUM TOXIN ASIA, P59; Solem RC, 2011, DEV BIOL, V356, P28, DOI 10.1016/j.ydbio.2011.05.003; Standring S., 2020, GRAYS ANATOMY ANATOM, V42th; Steinsapir KD, 2015, OPHTHAL PLAST RECONS, V31, P263, DOI 10.1097/IOP.0000000000000282; Tokita M, 2009, DEV BIOL, V331, P311, DOI 10.1016/j.ydbio.2009.05.548; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397; TRAINOR PA, 1995, DEVELOPMENT, V121, P2569; Tzahor E, 2009, DEV BIOL, V327, P273, DOI 10.1016/j.ydbio.2008.12.035; VITTI M, 1974, Electromyography and Clinical Neurophysiology, V14, P37; Waller BM, 2006, EMOTION, V6, P367, DOI 10.1037/1528-3542.6.3.367; Woodburne RT., 1994, ESSENTIALS HUMAN ANA, V246; Woronowicz KC, 2019, EVODEVO, V10, DOI 10.1186/s13227-019-0131-8; Woronowicz KC, 2018, DEV BIOL, V444, pS219, DOI 10.1016/j.ydbio.2018.05.002; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	67	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264148	10.1371/journal.pone.0264148	http://dx.doi.org/10.1371/journal.pone.0264148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231048	Green Published, gold			2022-12-26	WOS:000849744700014
J	Jin, XD; Kuang, YB; Li, LY; Li, HB; Zhao, T; He, YF; Di, CX; Kang, J; Yuan, LY; Yu, BY; Li, Q				Jin, Xiaodong; Kuang, Yanbei; Li, Linying; Li, Hongbin; Zhao, Ting; He, Yufang; Di, Cuixia; Kang, Jian; Yuan, Lingyan; Yu, Boyi; Li, Qiang			A positive feedback circuit comprising p21 and HIF-1 alpha aggravates hypoxia-induced radioresistance of glioblastoma by promoting Glut1/LDHA-mediated glycolysis	FASEB JOURNAL			English	Article						glioblastoma; glycolysis; HIF-1 alpha; hypoxia; p21; radioresistance	FUNCTIONAL INTERACTION; RECIPROCAL REGULATION; INDUCIBLE FACTOR; DNA-DAMAGE; CELL-DEATH; CANCER; GLIOMA; RESISTANCE; INHIBITOR; RADIOSENSITIZATION	The radioresistance induced by hypoxia is the major obstacle in the successful treatment of cancer radiotherapy. p21 was initially identified as a widespread inhibitor of cyclin-dependent kinases, through which mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. In this study, we discovered a novel function of p21, which participated in the regulation of metabolic pathways under hypoxia. We found that p21 was upregulated in glioblastoma (GBM) cells under hypoxic conditions, which enhanced the radioresistance of GBM cells. In principle, HIF-1 alpha is bound directly to the hypoxia response elements (HREs) of the p21 promoter to enhance its transcription activity, in turn, p21 also promoted the transcription of HIF-1 alpha at the mRNA level and maintained HIF-1 alpha function under oxygen deficiency. The positive correlation between p21 and HIF-1 alpha augmented Glut1/LDHA-mediated glycolysis and aggravated the radioresistance of GBM cells. Thus, our results constructed a positive feedback circuit comprising p21/HIF-1 alpha that might play a key role in enhancing the radioresistance of GBM under hypoxia.	[Jin, Xiaodong; Kuang, Yanbei; Li, Linying; Zhao, Ting; Di, Cuixia; Yuan, Lingyan; Yu, Boyi; Li, Qiang] Chinese Acad Sci, Inst Modern Phys, 509 Nanchang Rd, Lanzhou 730000, Gansu, Peoples R China; [Jin, Xiaodong; Kuang, Yanbei; Li, Linying; Zhao, Ting; Di, Cuixia; Yu, Boyi; Li, Qiang] Chinese Acad Sci, Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Peoples R China; [Jin, Xiaodong; Kuang, Yanbei; Li, Linying; Zhao, Ting; Di, Cuixia; Yu, Boyi; Li, Qiang] Key Lab Basic Res Heavy Ion Radiat Applicat Med, Lanzhou, Gansu, Peoples R China; [Jin, Xiaodong; Kuang, Yanbei; Li, Linying; Zhao, Ting; Di, Cuixia; Yu, Boyi; Li, Qiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Jin, Xiaodong; Di, Cuixia; Li, Qiang] Lanhai Nucl Med Res Ctr, Putian, Peoples R China; [Li, Hongbin] Lanzhou Univ Technol, Sch Life Sci & Engn, Lanzhou, Peoples R China; [He, Yufang] Third Hosp Gansu Prov, Lanzhou, Peoples R China; [Kang, Jian] Lanzhou Univ Technol, Coll Energy & Power Engn, Lanzhou, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University of Technology; Lanzhou University of Technology	Li, Q (corresponding author), Chinese Acad Sci, Inst Modern Phys, 509 Nanchang Rd, Lanzhou 730000, Gansu, Peoples R China.	liqiang@impcas.ac.cn			National Natural Science Foundation of China [11875299, U1532264]; National Key Research Program of China [2018YFC0115700, 2018YFC0115702]; Key Deployment Project of Chinese Academy of Sciences [KFZD-SW-222]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research Program of China; Key Deployment Project of Chinese Academy of Sciences	National Natural Science Foundation of China, Grant/Award Number: 11875299 and U1532264; National Key Research Program of China, Grant/Award Number: 2018YFC0115700 and 2018YFC0115702; Key Deployment Project of Chinese Academy of Sciences, Grant/Award Number: KFZD-SW-222	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bao YY, 2015, ONCOL REP, V34, P1805, DOI 10.3892/or.2015.4158; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Bhatt AN, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1368-9; Cohen AL, 2015, CANCER TREAT RES, V163, P15, DOI 10.1007/978-3-319-12048-5_2; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Faramarz-Allandini, 2010, WORLD NEUROSURG, V73, P128, DOI 10.1016/j.wneu.2009.06.001; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Grossman SA, 2004, SEMIN ONCOL, V31, P635, DOI 10.1053/j.seminoncol.2004.07.005; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jakob B, 2002, INT J RADIAT BIOL, V78, P75, DOI 10.1080/09553000110090007; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; Koike M, 2011, BIOCHEM BIOPH RES CO, V412, P39, DOI 10.1016/j.bbrc.2011.07.032; Kokunai T, 1999, JPN J CANCER RES, V90, P638, DOI 10.1111/j.1349-7006.1999.tb00795.x; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Koukourakis MI, 2014, BRIT J CANCER, V110, P2217, DOI 10.1038/bjc.2014.158; Koukourakis M, 2017, BIOCHEM BIOPH RES CO, V491, P932, DOI 10.1016/j.bbrc.2017.07.138; Li HB, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6017-2; Li XG, 2016, MOL MED REP, V13, P3661, DOI 10.3892/mmr.2016.4974; Luczak MW, 2017, TOXICOL APPL PHARM, V331, P94, DOI 10.1016/j.taap.2017.05.029; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; Ostrom QT, 2018, NEURO-ONCOLOGY, V20, P1, DOI 10.1093/neuonc/noy131; Pena-Rico MA, 2011, RADIOTHER ONCOL, V101, P132, DOI 10.1016/j.radonc.2011.07.002; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shimura T, 2014, RADIOTHER ONCOL, V112, P302, DOI 10.1016/j.radonc.2014.07.015; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Stubbs M, 2010, ADV ENZYME REGUL, V50, P44, DOI 10.1016/j.advenzreg.2009.10.027; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sunada S, 2016, CANCER SCI, V107, P1250, DOI 10.1111/cas.12998; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Vogelbaum Michael A, 2012, Clin Neurosurg, V59, P79; Wanka C, 2012, J BIOL CHEM, V287, P33436, DOI 10.1074/jbc.M112.384578; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yan SX, 2013, INT J MED SCI, V10, P1375, DOI 10.7150/ijms.6855; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Zhao F, 2016, CANCER CHEMOTH PHARM, V77, P963, DOI 10.1007/s00280-016-3007-9; Zhong JT, 2019, ONCOTARGETS THER, V12, P9129, DOI 10.2147/OTT.S221423; Zhu P, 2017, ONCOTARGET, V8, P44015, DOI 10.18632/oncotarget.17054	45	4	4	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22229	10.1096/fj.202101736R	http://dx.doi.org/10.1096/fj.202101736R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199870				2022-12-26	WOS:000761250800015
J	Maghradze, N; Jugheli, L; Borrell, S; Tukvadze, N; Kempker, RR; Blumberg, HM; Gagneux, S				Maghradze, Nino; Jugheli, Levan; Borrell, Sonia; Tukvadze, Nestani; Kempker, Russell R.; Blumberg, Henry M.; Gagneux, Sebastien			Developing customized stepwise MIRU-VNTR typing for tuberculosis surveillance in Georgia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DIVERSITY; STRAINS	Introduction Mycobacterial Interspersed Repetitive Units-Variable Tandem Repeats (MIRU-VNTR) typing has been widely used for molecular epidemiological studies of tuberculosis (TB). However, genotyping tools for Mycobacterium tuberculosis (Mtb) may be limiting in some settings due to high cost and workload. In this study developed a customized stepwise MIRU-VNTR typing that prioritizes high discriminatory loci and validated this method using penitentiary system cohort in the country of Georgia. Methods We used a previously generated MIRU-VNTR dataset from recurrent TB cases (32 cases) in Georgia and a new dataset of TB cases from the penitentiary system (102 cases) recruited from 2014 to 2015. A Hunter-Gaston Discriminatory Index (HGDI) was calculated utilizing a 24 standard loci panel, to select high discriminatory power loci, subsequently defined as the customized Georgia-specific set of loci for initial typing. The remaining loci were scored and hierarchically grouped for second and third step typing of the cohort. We then compared the processing time and costs of the customized stepwise method to the standard 24-loci method. Results For the customized Georgia-specific set that was used for initial typing, 10 loci were selected with a minimum value of 0.32 to the highest HGDI score locus. Customized 10 loci (step 1) typing of 102 Mtb patient isolates revealed 35.7% clustered cases. This proportion was reduced to 19.5% after hierarchical application of 2nd and 3rd step typing with the corresponding groups of loci. Our customized stepwise MIRU-VNTR genotyping approach reduced the quantity of samples to be typed and therefore overall processing time and costs by 42.6% each. Conclusion Our study shows that our customized stepwise MIRU-VNTR typing approach is a valid alternative of standard MIRI-VNTR typing panels for molecular epidemiological investigation in Georgia that saves time, workload and costs. Similar approaches could be developed for other settings.	[Maghradze, Nino; Jugheli, Levan; Borrell, Sonia; Tukvadze, Nestani; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Maghradze, Nino; Jugheli, Levan; Borrell, Sonia; Tukvadze, Nestani; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Maghradze, Nino; Jugheli, Levan; Tukvadze, Nestani] Natl Ctr TB & Lung Dis NCTLD, Tbilisi, Georgia; [Kempker, Russell R.; Blumberg, Henry M.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Gagneux, S (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Gagneux, S (corresponding author), Univ Basel, Basel, Switzerland.	sebastien.gagneux@unibas.ch		Gagneux, Sebastien/0000-0001-7783-9048; Maghradze, Nino/0000-0003-1227-1900	Swiss National Science Foundation [CRSII5_177163, 310030_188888]; European Research Council [ECOEVODRTB_883582]; U.S. National Institute of Health (NIH) Fogarty International Center [D43TW007124]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); U.S. National Institute of Health (NIH) Fogarty International Center	This work was supported by the Swiss National Science Foundation (grant numbers CRSII5_177163 and 310030_188888) -Sebastien Gagneux, the European Research Council (ECOEVODRTB_883582) -Sebastien Gagneux, and from the U.S. National Institute of Health (NIH) Fogarty International Center (D43TW007124) Russell R Kempker, Henry M. Blumberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante-Poku A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092675; Brites D., 2017, STRAIN VARIATION MYC, P117, DOI [10.1007/978-3-319-64371-7, DOI 10.1007/978-3-319-64371-7]; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; De Viedma DG, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.MTBP-0002-2016; Devi KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145860; Droznin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174373; Esen N, 2010, MIKROBIYOL BUL, V44, P375; Gegia M, 2011, HEALTH HUM RIGHTS, V13, P73; Gygli SM., 2021, NAT MED; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Maghradze N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223610; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Meehan CJ, 2019, NAT REV MICROBIOL, V17, P533, DOI 10.1038/s41579-019-0214-5; Meehan CJ, 2018, EBIOMEDICINE, V37, P410, DOI 10.1016/j.ebiom.2018.10.013; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Ngabonziza JCS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16626-6; Rasoahanitralisoa R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186088; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Sun LL, 2018, INT J INFECT DIS, V76, P109, DOI 10.1016/j.ijid.2018.06.009; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Weerasekera D, 2019, INFECT DIS-NOR, V51, P206, DOI 10.1080/23744235.2018.1551619; Wyllie DH, 2018, EBIOMEDICINE, V34, P122, DOI 10.1016/j.ebiom.2018.07.019	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264472	10.1371/journal.pone.0264472	http://dx.doi.org/10.1371/journal.pone.0264472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231041	Green Published, gold			2022-12-26	WOS:000849744700024
J	Valenzuela, JFB; Legara, EFT; Monterola, CP				Valenzuela, Jesus Felix Bayta; Legara, Erika Fille Tupas; Monterola, Christopher Pineda			Typology, network features and damage response in worldwide urban road systems	PLOS ONE			English	Article							GRAPH-THEORY; RESILIENCE	We survey the network properties and response to damage sustained of road networks of cities worldwide, using OpenStreetMap (OSM) data. We find that our primary damage response variable (t(1:0)) over bar, which is the average shortest time needed to reach all nodes in a road network (which stand in for locations within a metropolitan area) from an initial node (which stands in for the location of a center for disaster relief operations), is strongly linearly-correlated with p(d), the fraction of the road network segments damaged. We find that this result, previously reported for a city's road network as opposed to grid and scale-free idealizations, is widely present across the road networks we have examined regardless of location. Furthermore, we identify three families of road networks according to their damage response, forming a typology by which we can classify city road networks. Using this typology, we identify the family of road networks which may be of most concern from a humanitarian standpoint. We also find that, of the properties of the road networks we examined, the average shortest path length, < l(min)> and the average node degree, < k >, proxies for city road network size and complexity respectively, are very significantly-correlated with damage susceptibility. In addition to forming a damage response typology by which city road networks could be classified, we consider five cities in detail, looking at risks and previous disaster events. Our results offer a generalizable framework in evaluating the feasibility of coursing relief efforts within disaster-affected areas using land-based transportation methods. They also provide, albeit in retrospect, a glimpse of the time difficulties which occurred, and the stakes of life involved in the humanitarian crisis which developed in the Kathmandu area due to the earthquakes of April and May 2015.	[Valenzuela, Jesus Felix Bayta; Legara, Erika Fille Tupas; Monterola, Christopher Pineda] Asian Inst Management, Aboitiz Sch Innovat Technol & Entrepreneurship, Makati, Philippines	Asian Institute of Management	Valenzuela, JFB (corresponding author), Asian Inst Management, Aboitiz Sch Innovat Technol & Entrepreneurship, Makati, Philippines.	jvalenzuela@aim.edu			Philippine Council for Industry, Energy and Emerging Technology Research and Development (DOST-PCIEERD) [08501]	Philippine Council for Industry, Energy and Emerging Technology Research and Development (DOST-PCIEERD)(Department of Science & Technology (DOST), Philippines)	This work is primarily funded by the Philippine Council for Industry, Energy and Emerging Technology Research and Development (DOST-PCIEERD) under the grant project PATURO: Platform for Assessment and Tracking of Urbanization-Related Opportunities, project #08501, 2020.	[Anonymous], MAPZEN METROEXTRACTS; [Anonymous], 2013, UN OFF COORD HUM AFF; [Anonymous], LICENSED LICENSE; [Anonymous], 2015, DEMOGRAPHIA WORLD UR; [Anonymous], KEYHIGHWAY; [Anonymous], 2015, DEMOGRAPHIA WORLD UR; [Anonymous], NEXTZEN METROEXTRACT; [Anonymous], OPENSTREETMAP CONTRI; Aydin NY, 2018, INT J DISAST RISK RE, V31, P832, DOI 10.1016/j.ijdrr.2018.07.022; Aydin NY, 2018, NAT HAZARDS, V91, P37, DOI 10.1007/s11069-017-3112-z; Bell MGH, 2017, TRANSPORT RES B-METH, V99, P251, DOI 10.1016/j.trb.2017.03.002; Boeing G, 2019, APPL NETW SCI, V4, DOI 10.1007/s41109-019-0189-1; Bouchet M., 2018, GLOBAL METROMONITOR; Centre for Research on the Epidemiology of Disasters, 2019, NATURAL DISASTERS; Chen AY, 2016, TRANSPORT RES B-METH, V91, P408, DOI 10.1016/j.trb.2016.06.004; Chen XH, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/3464693; Faturechi R, 2014, TRANSPORT RES B-METH, V70, P47, DOI 10.1016/j.trb.2014.08.007; Federal Emergency Management Agency, 2014, BROCHURE; Galli P, 2019, TECTONICS, V38, P687, DOI 10.1029/2018TC005326; Jiang B, 2007, PHYSICA A, V384, P647, DOI 10.1016/j.physa.2007.05.064; Jordahl K, GEOPANDAS V081 2020; Lammer S, 2006, PHYSICA A, V363, P89, DOI 10.1016/j.physa.2006.01.051; Louf R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0924; Mapzen, MAPZEN SHUTDOWN; Ozdamar L, 2018, J IND MANAG OPTIM, V14, P1367, DOI 10.3934/jimo.2018011; Parilla J., 2015, GLOBAL METROMONITOR; Park M., 2015, CRITICAL 72 HOURS NE; Redzuan A.A., 2019, IOP C SERIES MAT SCI, VVol. 615, P012002; Rupi F, 2015, NETW SPAT ECON, V15, P397, DOI 10.1007/s11067-014-9260-8; Schintler LA, 2007, NETW SPAT ECON, V7, P301, DOI 10.1007/s11067-007-9029-4; Social AffairsPD United Nations DoE, 2018, WORLD URBANIZATION P; Sun CS, 2018, TRANSPORT RES B-METH, V117, P101, DOI 10.1016/j.trb.2018.08.013; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Valenzuela JF, 2015, COMPLEXITY, V21, P283, DOI 10.1002/cplx.21564; Valenzuela JF, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114500478; Viljoen NM, 2018, NETW SPAT ECON, V18, P85, DOI 10.1007/s11067-017-9370-1; Zanini MA, 2017, STRUCT INFRASTRUCT E, V13, P1117, DOI 10.1080/15732479.2016.1244211; Zio E, 2008, INT J RELIAB QUAL SA, V15, P67, DOI 10.1142/S0218539308002939	38	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264546	10.1371/journal.pone.0264546	http://dx.doi.org/10.1371/journal.pone.0264546			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231031	Green Published, gold			2022-12-26	WOS:000849744700027
J	Fleming, MB; Miller, T; Fu, WF; Li, ZG; Gasic, K; Saski, C				Fleming, Margaret B.; Miller, Texanna; Fu, Wanfang; Li, Zhigang; Gasic, Ksenija; Saski, Christopher			Ppe.XapF: High throughput KASP assays to identify fruit response to Xanthomonas arboricola pv. pruni (Xap) in peach	PLOS ONE			English	Article							ANTIOXIDANT CAPACITY; STONE FRUIT; BACTERIAL; SUSCEPTIBILITY; APPLE	Bacterial spot, caused by Xanthomonas arboricola pv. pruni (Xap), is a serious peach disease with symptoms that traverse severe defoliation and black surface pitting, cracking or blemishes on peach fruit with global economic impacts. A management option for control and meeting consumer demand for chemical-free, environmentally friendly fruit production is the development of resistant or tolerant cultivars. We developed simple, accurate, and efficient DNA assays (Ppe.XapF) based on SNP genotyping with KASP technology to quickly test for bacterial spot resistance alleles in peach fruit that allows breeders to cull seedlings at the greenhouse stage. The objective of this research was to validate newly developed DNA tests that target the two major QTLs for fruit resistance in peach with diagnostic utility in predicting fruit response to bacterial spot infection. Our study confirms that with only two Ppe.XapF DNA tests, Ppe.XapF1-1 and Ppe.XapF6-2, individuals carrying susceptible alleles can be identified. Use of these efficient and accurate Ppe.XapF KASP tests resulted in 44% reduction in seedling planting rate in the Clemson University peach breeding program.	[Fleming, Margaret B.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Fleming, Margaret B.; Miller, Texanna; Fu, Wanfang; Li, Zhigang; Gasic, Ksenija; Saski, Christopher] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA	Michigan State University; Clemson University	Gasic, K; Saski, C (corresponding author), Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA.	kgasic@clemson.edu; saski@clemson.edu			USDA's National Institute of Food and Agriculture for the Specialty Crop Research Initiative [2014-51181-22378]; NIFA/USDA [SC1700530, SC-1700568]	USDA's National Institute of Food and Agriculture for the Specialty Crop Research Initiative; NIFA/USDA(United States Department of Agriculture (USDA))	This work was supported by USDA's National Institute of Food and Agriculture for the Specialty Crop Research Initiative through the competitive project "RosBREED: Combining disease resistance with horticultural quality in new rosaceous cultivars" (2014-51181-22378) (KG and CS) and by NIFA/USDA, under project number SC1700530 (KG), and SC-1700568 (KG). Technical Contribution No. 6976 of the Clemson University Experiment Station. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri A, 2010, PLANT DIS, V94, P737, DOI 10.1094/PDIS-94-6-0737; Aranzana MJ, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0140-8; Bassi D., 2008, The peach: botany, production and uses, P1, DOI 10.1079/9781845933869.0001; Byrne DH, 2005, HORTTECHNOLOGY, V15, P494, DOI 10.21273/HORTTECH.15.3.0494; Cantin CM, 2009, J AGR FOOD CHEM, V57, P4586, DOI 10.1021/jf900385a; Edge-Garza DA, 2014, MOL BREEDING, V34, P2225, DOI 10.1007/s11032-014-0160-x; FAOSTAT, 2019, CROPS DAT; Gasic K, 2015, ACTA HORTIC, V1084, P69; Gasic K, 2019, HORTSCIENCE, V54, pS188; Ghafar AA, 2018, J AM POMOL SOC, V72, P40; He CL, 2014, METHODS MOL BIOL, V1145, P75, DOI 10.1007/978-1-4939-0446-4_7; Iezzoni A., 2017, Acta Horticulturae, P115, DOI [10.17660/actahortic.2017.1172.20, 10.17660/ActaHortic.2017.1172.20]; Iezzoni AF, 2020, HORTIC RES-ENGLAND, V7, DOI 10.1038/s41438-020-00398-7; Jung S., 2018, NAR, P1, DOI [10.1093/nar/gkx1156, DOI 10.1093/NAR/GKX1156]; Lalancette N, 2007, PLANT DIS, V91, P1122, DOI 10.1094/PDIS-91-9-1122; Lamichhane JR, 2014, PLANT DIS, V98, P1600, DOI 10.1094/PDIS-08-14-0831-FE; Layne D. R., 2008, PEACH BOT PRODUCTION; Noh YH, 2017, J BERRY RES, V7, P23, DOI [10.3233/jbr-160145, 10.3233/JBR-160145]; Okie W. R., 2008, The peach: botany, production and uses, P139, DOI 10.1079/9781845933869.0139; Okie W.R., 1998, HDB PEACH NECTARINE; Patterson EL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00752; Peace CP, 2014, TREE GENET GENOMES, V10, P1679, DOI 10.1007/s11295-014-0788-z; Peace CP, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.6; Preece JE, 2013, ACTA HORTIC, V985, P47; Ritchie D., 1995, COMPENDIUM STONE FRU, P50; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; SHERMAN WB, 1981, FRUIT VARIETIES J, V35, P74; Stefani E, 2010, J PLANT PATHOL, V92, pS99; Vanderzande S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210928; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; WERNER DJ, 1986, HORTSCIENCE, V21, P127; Yang NN, 2013, TREE GENET GENOMES, V9, P573, DOI 10.1007/s11295-012-0580-x	32	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264543	10.1371/journal.pone.0264543	http://dx.doi.org/10.1371/journal.pone.0264543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213640	Green Submitted, Green Published, gold			2022-12-26	WOS:000787811000119
J	Tiruneh, GT; Demissie, M; Worku, A; Berhane, Y				Tiruneh, Gizachew Tadele; Demissie, Meaza; Worku, Alemayehu; Berhane, Yemane			Predictors of maternal and newborn health service utilization across the continuum of care in Ethiopia: A multilevel analysis	PLOS ONE			English	Article							POSTNATAL CARE; WAITING HOMES; COVERAGE; ACCESS; INTERVENTIONS	Background The continuum of care for maternal and newborn health is a systematic approach for delivery of an integrated effective package of life-saving interventions throughout pregnancy, childbirth, and postpartum as well as across levels of service delivery to women and newborns. Nonetheless, in low-income countries, coverage of these interventions across the life cycle continuum is low. This study examined the predictors of utilization of maternal and newborn health care services along the continuum of care in Ethiopia. Methods This was a cross-sectional population-based study. We measured maternal and newborn health care utilization practices among women who had live births in the last 12 months preceding the survey in Amhara, Oromia, SNNP, and Tigray regions of Ethiopia. We fitted multilevel random-effects logistic regression models to examine the predictors of the continuum of care accounting for the survey design, and individual, and contextual characteristics of the respondents. Results Our analysis revealed that only one-fifth of women utilized maternal and newborn health services across the antepartum, intrapartum, and postpartum continuum; most women discontinued at the postpartum stage. Continued use of services varied significantly across wealth, model family, prenatal stay at maternity waiting homes, antenatal care in the first trimester, complete antenatal care service, and the administrative region at all antepartum, intrapartum, and postpartum stages. Moreover, family conversation during pregnancy [AOR: 2.12; 95% CI: 1.56-2.88], delivery by cesarean [AOR: 2.70; 95% CI: 1.82-4.02] and birth notified to health extension workers [AOR: 1.95; 95% CI: 1.56-2.43] were found to be predictors of the continuum of care at the postpartum stage. Conclusion In Ethiopia, despite good access to antepartum care, compliance with continuity of care across the pathway decreased with significant inequitable distributions, the poorest segment of the population being at most disadvantage. The main modifiable program factors connected to the continued uptake of maternal health services include family conversation, pregnant women conference, complete antenatal care, antenatal care in the first trimester, and birth notification.	[Tiruneh, Gizachew Tadele] JSI Res & Training Inst Inc, Last Ten Kilometers L10K Project, Addis Ababa, Ethiopia; [Demissie, Meaza; Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Continental Institute of Public Health; Addis Ababa University	Tiruneh, GT (corresponding author), JSI Res & Training Inst Inc, Last Ten Kilometers L10K Project, Addis Ababa, Ethiopia.	gizt121@gmail.com	Tiruneh, Gizachew Tadele/AAV-6638-2020	Tiruneh, Gizachew Tadele/0000-0002-5842-9518; Berhane, Yemane/0000-0002-2527-1339				Akinyemi JO, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1083-9; Alemayehu M, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03031-6; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Beake S, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-70; Berhe A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221161; Cameron A. C., 2010, MICROECONOMETRICS US; Central Statistical Agency-CSA/Ethiopia ICF, 2017, ETH DEM HLTH SURV 20; Chaka EE, 2019, ETHIOP J HEALTH SCI, V29, P935, DOI 10.4314/ejhs.v29i1.16; Chalise B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215613; Emiru AA, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-02953-5; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; FMoH, 2015, NATL STRATEGY NEWBOR; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Iqbal S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2111-9; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Karim AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065160; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kerber KJ, 2007, CONTINUUM CARE MATER; Kikuchi K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198829; Kikuchi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164965; Kikuchi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139288; Lori JR, 2013, MIDWIFERY, V29, P1095, DOI 10.1016/j.midw.2013.07.020; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Mekonnen Y, 2012, IN DEPTH ANAL EDHS 2; MoH, 2018, IMPLEMENTATION GUIDE; MOH, 2013, HSDP 4 ANN PERFORMAN; MOH, 2015, ETHIOPIA HLTH SECTOR; Mohan D, 2017, HEALTH POLICY PLANN, V32, P791, DOI 10.1093/heapol/czx005; Muluneh AG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234741; Mwangi W, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1803-4; Oh J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036516; Owili PO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3075-0; Sakuma S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215635; Shibanuma A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000786; Singh K, 2016, MATERN CHILD HLTH J, V20, P281, DOI 10.1007/s10995-015-1827-6; Tesfaye S, 2014, J MIDWIFERY WOM HEAL, V59, pS55, DOI 10.1111/jmwh.12168; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; Tiruneh GT, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03254-7; Tiruneh GT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228137; Tiruneh GT, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2356-x; Tiruneh GT, 2016, ETHIOP J HEALTH DEV, V30, P19; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; Wang WJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0497-0; WHO, 2016, WHO TECH REP SER, V997, P1; WHO, 2014, WHO REC POSTN CAR MO; WHO, MATERNITY WAITING HO; WHO, 2015, TRENDS MATERNAL MORT; WHO (World Health Organization), 2015, STRAT END PREV MAT M; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; Yeji F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142849	50	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264612	10.1371/journal.pone.0264612	http://dx.doi.org/10.1371/journal.pone.0264612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213657	gold, Green Published			2022-12-26	WOS:000787811000129
J	Wibisono, E; Mous, P; Firmana, E; Humphries, A				Wibisono, Elle; Mous, Peter; Firmana, Edwison; Humphries, Austin			A crew-operated data recording system for length-based stock assessment of Indonesia's deep demersal fisheries	PLOS ONE			English	Article							INDO-PACIFIC; SMALL-SCALE; CATCH; FISH; AGE; GROWTH; COMANAGEMENT; POPULATIONS; MANAGEMENT; MORTALITY	Deep demersal fisheries in Indonesia yielded close to 90,000 metric tons of snapper and grouper in 2019, landed by a fleet of approximately 10,000 fishing boats. Prior to the present study, information on these multi-species, dispersed, small- to medium-scale fisheries was scarce, while reliable species-specific data on catch and effort were non-existent. This data-deficiency made stock assessments and design of harvest control rules impossible. We developed a new data collection method, the Crew Operated Data Recording System (CODRS), to collect verifiable species- and length-composition data from catches across all segments of the fleet. CODRS engaged crews of 579 fishing vessels to take pictures of each fish in their catch, in combination with the deployment of a tracking device on their boats. Furthermore, we also conducted a frame survey to map the fleet across the entire Indonesian archipelago. Using more than 2 million CODRS images, we aimed to understand the basic characteristics and challenges within the fishery. We updated life-history parameters for the top 50 species in the fishery based on the maximum observed length-frequency distribution of the catch (i.e., asymptotic length, size at maturity, optimum fishing length, total mortality, and spawning potential ratio). Length-based stock assessments using the updated life-history parameters showed high risks of overfishing for most of the major target species, especially for snapper species with large maximum sizes. Our results indicated that effective management and harvest strategies are urgently needed across Indonesia's eleven Fishery Management Areas to prevent the collapse of these important fisheries.	[Wibisono, Elle; Humphries, Austin] Univ Rhode Isl, Dept Fisheries Anim & Vet Sci, Kingston, RI 02881 USA; [Mous, Peter] Yayasan Konservasi Alam Nusantara YKAN Fisheries, Bali, Indonesia; [Firmana, Edwison] Indonesia Minist Marine Affairs & Fisheries, Directorate Gen Capture Fisheries, Jakarta, Indonesia; [Humphries, Austin] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island; University of Rhode Island	Humphries, A (corresponding author), Univ Rhode Isl, Dept Fisheries Anim & Vet Sci, Kingston, RI 02881 USA.; Humphries, A (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	humphries@uri.edu		Wibisono, Elle/0000-0002-4671-1997	Walton Family Foundation [2015-1737, 2016-2141]; David and Lucile Packard Foundation [2016-64121, 2019-68508]; USAID SNAPPER [AID-497-A-16-00011]; Ocean Conservancy, Inc.; RJ Kose Grant	Walton Family Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); USAID SNAPPER; Ocean Conservancy, Inc.; RJ Kose Grant	This research was supported by The Walton Family Foundation (Grant #2015-1737), The David and Lucile Packard Foundation (Grant #2016-64121), USAID SNAPPER (AID-497-A-16-00011), The Walton Family Foundation (Grant #2016-2141), The Ocean Conservancy, Inc., The David and Lucile Packard Foundation (Grant #2019-68508), and The RJ Kose Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR., 1985, SNAPPERS WORLD ANNOT, V6; Andrews KR, 2016, MOL PHYLOGENET EVOL, V100, P361, DOI 10.1016/j.ympev.2016.04.004; [Anonymous], 2017, ESTIMASI POTENSI JUM, P8; Bell RJ, 2017, N AM J FISH MANAGE, V37, P1130, DOI 10.1080/02755947.2017.1350219; Berkes F, 2009, J ENVIRON MANAGE, V90, P1692, DOI 10.1016/j.jenvman.2008.12.001; Bradley D, 2019, FISH FISH, V20, P564, DOI 10.1111/faf.12361; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Chen Y, 2003, AQUAT SCI, V65, P92, DOI 10.1007/s000270300008; Cope JM, 2009, MAR COAST FISH, V1, P169, DOI 10.1577/C08-025.1; DUDLEY R G, 1987, Aquaculture and Fisheries Management, V18, P365, DOI 10.1111/j.1365-2109.1987.tb00325.x; Ehrhardt NM., 1992, T AM FISH SOC; Evans R., 2011, W AUSTR; Froese R, 2004, FISH FISH, V5, P86, DOI 10.1111/j.1467-2979.2004.00144.x; Froese R, 2000, J FISH BIOL, V56, P758, DOI 10.1111/j.1095-8649.2000.tb00870.x; Froese R., 2000, FISHBASE 2000 CONCEP, P344; Froese R, 2016, FISH FISH, V17, P785, DOI 10.1111/faf.12146; Fry GC, 2009, FISHERIES SCI, V75, P1219, DOI 10.1007/s12562-009-0157-2; Fujita R., 2012, GUIDE USE FROESE SUS; Gomez C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127395; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hirschhorn G., 1974, P192; Hordyk A, 2015, ICES J MAR SCI, V72, P217, DOI 10.1093/icesjms/fsu004; Kroodsma DA, 2018, SCIENCE, V359, P904, DOI 10.1126/science.aao5646; MacCall AD., 2009, J AM STAT ASSOC, V96, P781, DOI [10.1177/0269881108089819, DOI 10.1177/0269881108089819]; Martinez-Andrade F., 2003, COMP LIFE HIST ECOLO; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; McPherson G.R., 1992, Asian Fisheries Science, V5, P15; MEES CC, 1993, J FISH BIOL, V43, P695, DOI 10.1111/j.1095-8649.1993.tb01147.x; Meester GA, 2001, SARSIA, V86, P543, DOI 10.1080/00364827.2001.10420492; Morris L, 2006, ICES J MAR SCI, V63, P1590, DOI 10.1016/j.icesjms.2006.06.008; Nadon MO, 2016, CAN J FISH AQUAT SCI, V73, P1874, DOI 10.1139/cjfas-2015-0303; Nelson GA, 2022, FISHMETHODS FISHERY; Newman SJ, 2002, ESTUAR COAST SHELF S, V55, P67, DOI 10.1006/ecss.2001.0887; Newman SJ., 2001, FINAL REPORT FISHERI; Newman SJ, 2016, REV FISH BIOL FISHER, V26, P537, DOI 10.1007/s11160-016-9442-1; Nielsen JR, 2004, MAR POLICY, V28, P151, DOI 10.1016/S0308-597X(03)00083-6; Parra I, 2014, EVOL ECOL, V28, P707, DOI 10.1007/s10682-014-9702-2; Pelletier D, 2000, CAN J FISH AQUAT SCI, V57, P51, DOI 10.1139/cjfas-57-1-51; Pet JS, 1997, FISH RES, V31, P121, DOI 10.1016/S0165-7836(97)00007-6; Prescott J, 2016, REV FISH BIOL FISHER, V26, P679, DOI 10.1007/s11160-015-9417-7; Prince J, 2015, FISH RES, V171, P42, DOI 10.1016/j.fishres.2015.06.008; Quinn T.J., 1999, BIOL RES MANAG SER; RALSTON S, 1983, FISH B-NOAA, V81, P523; Ruiz J, 2015, ICES J MAR SCI, V72, P1201, DOI 10.1093/icesjms/fsu224; Russo T, 2011, FISH RES, V108, P184, DOI 10.1016/j.fishres.2010.12.020; Stamatopoulos C., 2002, SAMPLE BASED FISHERY, P132; Stephenson P., 1993, ADAPTIVE MANAGEMENT; Stevenson DE, 2018, FISH RES, V201, P26, DOI 10.1016/j.fishres.2018.01.004; Taylor NG, 2011, CAN J FISH AQUAT SCI, V68, P1507, DOI 10.1139/F2011-100; Thorson JT, 2009, FISH RES, V98, P75, DOI 10.1016/j.fishres.2009.03.016; Ticheler H. J., 1998, Fisheries Management and Ecology, V5, P81; Tillett BJ, 2012, FISH RES, V127, P109, DOI 10.1016/j.fishres.2012.04.007; Tirtadanu Wagiyo K, 2018, J PENELIT PERIKAN IN, V24, P1; Uehara M, 2018, REG STUD MAR SCI, V17, P112, DOI 10.1016/j.rsma.2017.12.002; van Helmond ATM, 2015, ICES J MAR SCI, V72, P1192, DOI 10.1093/icesjms/fsu200; Vasilakopoulos P, 2011, ICES J MAR SCI, V68, P1525, DOI 10.1093/icesjms/fsr075; Wahyuningsih P., 2013, BAWAL, V5, P175; Wallace RK, 1996, FIDHERIES MANAGEMENT; Walsh WA, 2005, FISH RES, V75, P175, DOI 10.1016/j.fishres.2004.11.007; White DJ, 2006, FISH RES, V80, P203, DOI 10.1016/j.fishres.2006.04.009; Yamamoto T., 1980, REPORT PREPARED FISH; Yuniarta S, 2017, FISH RES, V193, P173, DOI 10.1016/j.fishres.2017.04.009; Zhang CI, 2009, FISH RES, V100, P26, DOI 10.1016/j.fishres.2008.12.002	63	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263646	10.1371/journal.pone.0263646	http://dx.doi.org/10.1371/journal.pone.0263646			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213567	gold, Green Published			2022-12-26	WOS:000787811000026
J	Yamaguchi, S; Hamano, T; Oka, T; Doi, Y; Kajimoto, S; Sakaguchi, Y; Suzuki, A; Isaka, Y				Yamaguchi, Satoshi; Hamano, Takayuki; Oka, Tatsufumi; Doi, Yohei; Kajimoto, Sachio; Sakaguchi, Yusuke; Suzuki, Akira; Isaka, Yoshitaka			Low-grade proteinuria and atherosclerotic cardiovascular disease: A transition study of patients with diabetic kidney disease	PLOS ONE			English	Article							GLUCOSE CONTROL; RENAL-FUNCTION; COMPLICATIONS; ALBUMINURIA; EVENTS; HYPERTENSION; PROGRESSION; OUTCOMES; ADULTS; DEATH	Diabetic kidney disease (DKD) is heterogeneous in terms of proteinuria. Patients with DKD who present with low-grade proteinuria are more likely to have nephrosclerosis rather than traditional diabetic nephropathy. The amount of proteinuria might reflect the underlying pathology of renal failure and influence the prognosis after dialysis initiation. Clinical implications of proteinuria at the start of dialysis have not been confirmed, while greater proteinuria is associated with higher risk of cardiovascular disease (CVD) in the predialysis stages of chronic kidney disease. We performed a retrospective multicenter cohort study enrolling incident hemodialysis patients with diabetes. Patients were stratified using proteinuria quartiles. We examined the association of proteinuria quartiles with types of subsequent CVD. Among the enrolled 361 patients, the estimated mean glomerular filtration rate and proteinuria was 5.4 mUmin/1.73 m(2) and 6.3 g/gCr, respectively. Lower quartile of proteinuria (cutoffs: 3.0, 5.4, and 8.8 g/gCr) was significantly associated with male, older age, and history of atherosclerotic CVD including coronary artery disease, peripheral arterial disease, and cerebral infarction (P-trend<0.05). Kidney size was smaller in patients with lower levels of proteinuria. Patients with higher levels of proteinuria were more likely to have proliferative diabetic retinopathy (P-trend<0.05). Multivariate competing risk analysis revealed that the first quartile of proteinuria was associated with a greater risk of atherosclerotic CVD than the third quartile (subhazard ratio [95% confidence interval]: 2.04 [1.00-4.14]). This association was attenuated after additional adjustments for history of atherosclerotic CVD. Furthermore, patients with lower quartiles of proteinuria were more likely to die of atherosclerotic CVD than those with non-atherosclerotic CVD (P-trend = 0.01). Diabetic patients with lower proteinuria at dialysis initiation were characterized by severer macroangiopathy, as shown by a more atrophic kidney and higher prevalence of past atherosclerotic CVD. Hence, they are at a high risk of developing atherosclerotic CVD.	[Yamaguchi, Satoshi; Hamano, Takayuki; Oka, Tatsufumi; Doi, Yohei; Kajimoto, Sachio; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Nephrol, Suita, Osaka, Japan; [Yamaguchi, Satoshi; Suzuki, Akira] Japan Community Hlth Care Org Osaka Hosp, Dept Internal Med, Osaka, Osaka, Japan; [Hamano, Takayuki] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrol, Nagoya, Aichi, Japan; [Sakaguchi, Yusuke] Osaka Univ, Grad Sch Med, Dept Interorgan Commun Res Kidney Dis, Suita, Osaka, Japan	Osaka University; Nagoya City University; Osaka University	Hamano, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Nephrol, Suita, Osaka, Japan.; Hamano, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Nephrol, Nagoya, Aichi, Japan.	hamatea@med.nagoya-cu.ac.jp		Doi, Yohei/0000-0002-5165-291X				Abe M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5374746; Afkarian M, 2016, JAMA-J AM MED ASSOC, V316, P602, DOI 10.1001/jama.2016.10924; ALEXANDER RW, 1995, HYPERTENSION, V25, P155, DOI 10.1161/01.HYP.25.2.155; Bax L, 2003, EUR J CLIN INVEST, V33, P34, DOI 10.1046/j.1365-2362.2003.01091.x; FREEDMAN BI, 1995, AM J KIDNEY DIS, V25, P207, DOI 10.1016/0272-6386(95)90001-2; Gedebjerg A, 2018, J DIABETES COMPLICAT, V32, P34, DOI 10.1016/j.jdiacomp.2017.09.010; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hishida M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226866; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Kovesdy CP, 2013, J AM COLL CARDIOL, V61, P1626, DOI 10.1016/j.jacc.2012.11.071; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Man JHJ, 2020, CIRC RES, V126, P1297, DOI 10.1161/CIRCRESAHA.120.315930; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Molitch ME, 2010, DIABETES CARE, V33, P1536, DOI 10.2337/dc09-1098; Nakamura M, 1995, DIABETES RES CLIN PR, V30, P89, DOI 10.1016/0168-8227(95)01155-2; Nakayama H, 2015, INTERNAL MED, V54, P1971, DOI 10.2169/internalmedicine.54.4351; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; PARVING HH, 1983, METABOLISM, V32, P943, DOI 10.1016/0026-0495(83)90210-X; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Porrini E, 2015, LANCET DIABETES ENDO, V3, P382, DOI 10.1016/S2213-8587(15)00094-7; Pugliese G, 2014, ACTA DIABETOL, V51, P905, DOI 10.1007/s00592-014-0650-7; Shimizu M, 2013, DIABETES CARE, V36, P3655, DOI 10.2337/dc13-0298; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Thomas MC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.18; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Umanath K, 2018, AM J KIDNEY DIS, V71, P884, DOI 10.1053/j.ajkd.2017.10.026; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Yoo HJ, 2014, WORLD J DIABETES, V5, P357, DOI 10.4239/wjd.v5.i3.357	32	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264568	10.1371/journal.pone.0264568	http://dx.doi.org/10.1371/journal.pone.0264568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213636	gold, Green Published			2022-12-26	WOS:000787811000124
J	Guo, ZZ; Yu, SQ; Fu, JZ; Ma, K; Zhang, R				Guo, Zhongzhong; Yu, Shangqi; Fu, Jiazhi; Ma, Kai; Zhang, Rui			Screening and functional prediction of differentially expressed genes in walnut endocarp during hardening period based on deep neural network under agricultural internet of things	PLOS ONE			English	Article								The deep neural network is used to establish a neural network model to solve the problems of low accuracy and poor accuracy of traditional algorithms in screening differentially expressed genes and function prediction during the walnut endocarp hardening stage. The paper walnut is used as the research object to analyze the biological information of paper walnut. The changes of lignin deposition during endocarp hardening from 50 days to 90 days are observed by microscope. Then, the Convolutional Neural Network (CNN) and Long and Short-term Memory (LSTM) network model are adopted to construct an expression gene screening and function prediction model. Then, the transcriptome and proteome sequencing and biological information of walnut endocarp samples at 50, 57, 78, and 90 days after flowering are analyzed and taken as the training data set of the CNN + LSTM model. The experimental results demonstrate that the endocarp of paper walnut began to harden at 57 days, and the endocarp tissue on the hardened inner side also began to stain. This indicates that the endocarp hardened laterally from outside to inside. The screening and prediction results show that the CNN + LSTM model's highest accuracy can reach 0.9264. The Accuracy, Precision, Recall, and F1-score of the CNN + LSTM model are better than the traditional machine learning algorithm. Moreover, the Receiver Operating Curve (ROC) area enclosed by the CNN + LSTM model and coordinate axis is the largest, and the Area Under Curve (AUC) value is 0.9796. The comparison of ROC and AUC proves that the CNN + LSTM model is better than the traditional algorithm for screening differentially expressed genes and function prediction in the walnut endocarp hardening stage. Using deep learning to predict expressed genes' function accurately can reduce the breeding cost and significantly improve the yield and quality of crops. This research provides scientific guidance for the scientific breeding of paper walnut.	[Guo, Zhongzhong; Yu, Shangqi] Tarim Univ, Coll Life Sci, Alar, Xinjiang, Peoples R China; [Guo, Zhongzhong; Yu, Shangqi; Fu, Jiazhi; Zhang, Rui] Tarim Basin Xinjiang Prod & Construct Grp, Key Lab Biol Resource Protect & Utilizat, Alar, Xinjiang, Peoples R China; [Guo, Zhongzhong; Yu, Shangqi; Fu, Jiazhi; Zhang, Rui] Natl & Local Joint Engn Lab High Efficiency & Sup, Alar, Xinjiang, Peoples R China; [Fu, Jiazhi; Zhang, Rui] Tarim Univ, Coll Hort & Forestry Sci, Alar, Xinjiang, Peoples R China; [Ma, Kai] Xinjiang Acad Agr Sci, Res Inst Hort Crops, Urumqi, Peoples R China	Tarim University; Tarim University	Zhang, R (corresponding author), Tarim Basin Xinjiang Prod & Construct Grp, Key Lab Biol Resource Protect & Utilizat, Alar, Xinjiang, Peoples R China.; Zhang, R (corresponding author), Natl & Local Joint Engn Lab High Efficiency & Sup, Alar, Xinjiang, Peoples R China.; Zhang, R (corresponding author), Tarim Univ, Coll Hort & Forestry Sci, Alar, Xinjiang, Peoples R China.	zhrgsh@163.com			National Natural Science Foundation of China [32160698, 31260469]; Xinjiang Production and Construction Corps Southern Xinjiang Key Industry Innovation and Development Support Program Project: Evaluation of genetic resources and functional gene mining for the main traits of Xinjiang pear, walnut, and jujube [2017DB006]; research and innovation project of doctoral students of Tarim University: Based on the functional analysis of JrCOMT on the lignin biosynthesis and metabolism of the endocarp lignin of Luren walnut [TDBSCX201904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinjiang Production and Construction Corps Southern Xinjiang Key Industry Innovation and Development Support Program Project: Evaluation of genetic resources and functional gene mining for the main traits of Xinjiang pear, walnut, and jujube; research and innovation project of doctoral students of Tarim University: Based on the functional analysis of JrCOMT on the lignin biosynthesis and metabolism of the endocarp lignin of Luren walnut	1. National Natural Science Foundation of China: Study on the mechanism of unbalanced lignin synthesis in the walnut endocarp, which leads to the mechanism of the kernels, project approval number: 32160698; 2. National Natural Science Foundation of China: The cloning and functional verification of genes related to traits of rare walnut kernels in Xinjiang, project approval number: 31260469; 3. Xinjiang Production and Construction Corps Southern Xinjiang Key Industry Innovation and Development Support Program Project: Evaluation of genetic resources and functional gene mining for the main traits of Xinjiang pear, walnut, and jujube, project number: 2017DB006; 4. The research and innovation project of doctoral students of Tarim University: Based on the functional analysis of JrCOMT on the lignin biosynthesis and metabolism of the endocarp lignin of Luren walnut, project number: TDBSCX201904.	Bagwan WA, 2021, MODEL EARTH SYST ENV, V7, P2113, DOI 10.1007/s40808-020-00965-w; Bin Y, 2019, IEEE T CYBERNETICS, V49, P2631, DOI 10.1109/TCYB.2018.2831447; Chandra BS, 2019, IEEE T BIO-MED ENG, V66, P710, DOI 10.1109/TBME.2018.2854899; Chen SSC, 2019, FRONT INFORM TECH EL, V20, P1632, DOI 10.1631/FITEE.1900399; Cheng J, 2020, J ANIM SCI, V98, P10, DOI 10.1093/jas/skaa278.020; Christopher SF, 2021, J ENVIRON QUAL, V50, P667, DOI 10.1002/jeq2.20217; Dibs H, 2020, WATER AIR SOIL POLL, V231, DOI 10.1007/s11270-020-04846-x; Ermis E, 2020, RADIAT ONCOL, V15, DOI 10.1186/s13014-020-01553-z; Gorban AN, 2020, COGN COMPUT, V12, P388, DOI 10.1007/s12559-019-09667-7; Hasnain M., 2020, IEEE ACCESS, V8, P1; He X, 2019, RSC ADV, V9, P30809, DOI 10.1039/c9ra05858c; Jin XL, 2020, CROP J, V8, P87, DOI 10.1016/j.cj.2019.06.005; Khadivi A, 2019, SCI HORTIC-AMSTERDAM, V253, P147, DOI 10.1016/j.scienta.2019.04.041; Li G B., 2020, J YANCHENG I TECHNOL, V33, P5; Liu AN, 2019, MULTIMED TOOLS APPL, V78, P26851, DOI 10.1007/s11042-016-4251-z; Liu BH, 2020, SCI HORTIC-AMSTERDAM, V265, DOI 10.1016/j.scienta.2020.109212; Liu MZ, 2021, FOOD ENG REV, V13, P822, DOI 10.1007/s12393-020-09273-6; Liu Y., 2020, IEEE ACCESS, V33, P1; Luque A, 2019, PATTERN RECOGN, V91, P216, DOI 10.1016/j.patcog.2019.02.023; Matthew F, 2019, APPL STOCH MODEL BUS, V35, P788; Mortier E, 2020, AGRON SUSTAIN DEV, V40, DOI 10.1007/s13593-020-00647-y; Peeken JC, 2019, RADIOTHER ONCOL, V138, P166, DOI 10.1016/j.radonc.2019.06.031; Prabhakar SK, 2020, IEEE ACCESS, V23, P1; Sadeghi-Kiakhani M, 2019, J CLEAN PROD, V231, P1463, DOI 10.1016/j.jclepro.2019.05.283; Setiawan B, 2019, PROCEDIA COMPUT SCI, V161, P665, DOI 10.1016/j.procs.2019.11.170; Walters K, 2022, J RELIG HEALTH, V61, P4450, DOI 10.1007/s10943-020-01178-2; Wang BQ, 2021, PHYSIOL PLANTARUM, V172, P176, DOI 10.1111/ppl.13316; Wang Haiquan, 2019, JBI Database System Rev Implement Rep, V17, P1290, DOI 10.11124/JBISRIR-2017-003865; Wang ZY, 2021, APPL ACOUST, V172, DOI 10.1016/j.apacoust.2020.107647; Wang Z, 2020, J STAT PLAN INFER, V209, P174, DOI 10.1016/j.jspi.2020.03.008; Wilson B, 2019, ORYX, V53, P415, DOI 10.1017/S0030605318001230; Xie CH, 2019, PATTERN RECOGN LETT, V119, P148, DOI 10.1016/j.patrec.2017.12.001; Xiuliang J, 2020, CROP J, V8, P91; Yang W, 2021, SCI CHINA LIFE SCI, V64, P1025, DOI 10.1007/s11427-020-1798-4; Zhang S., 2020, FOOD HYDROCOLLOID, V31, P106; Zhao R, 2019, MECH SYST SIGNAL PR, V115, P213, DOI 10.1016/j.ymssp.2018.05.050; Zhou Y, 2019, NEURAL COMPUT APPL, V31, P1855, DOI 10.1007/s00521-017-3162-x	37	0	0	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0263755	10.1371/journal.pone.0263755	http://dx.doi.org/10.1371/journal.pone.0263755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202404	gold, Green Published			2022-12-26	WOS:000773224600017
J	Al-Maslamani, M; Elmagboul, EBI; Puthiyottil, A; Chemaitelly, H; Varghese, MK; Al Romaihi, HE; Al-Thani, MH; Al Khal, A; Unemo, M; Abu-Raddad, LJ				Al-Maslamani, Muna; Elmagboul, Emad Bashier Ibrahim; Puthiyottil, Aslam; Chemaitelly, Hiam; Varghese, Manoj Kizhakkepeedikayil; Al Romaihi, Hamad Eid; Al-Thani, Mohamed H.; Al Khal, Abdullatif; Unemo, Magnus; Abu-Raddad, Laith J.			First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020	PLOS ONE			English	Article							INFECTION; POPULATION; PREVALENCE; CHLAMYDIA; RISK	Limited data are available regarding antimicrobial resistance in Neisseria gonorrhoeae strains circulating in WHO Eastern Mediterranean Region (EMR). We investigated the antimicrobial susceptibility/resistance of N. gonorrhoeae isolates to five antimicrobials (ceftriaxone, azithromycin, ciprofloxacin, tetracycline, and benzylpenicillin) currently or previously used for gonorrhoea treatment in Qatar, 2017-2020. Minimum inhibitory concentrations (MICs; mg/L) of antimicrobials were determined using Etest on gonococcal isolates collected during January 1, 2017-August 30, 2020 at Hamad Medical Corporation, a national public healthcare provider. During 2017-2020, resistance in isolates from urogenital sites of 433 patients was 64.7% (95% CI: 59.5-69.6%; range: 43.9-78.7%) for ciprofloxacin, 50.7% (95% CI: 45.3-56.1%; range: 41.3-70.4%) for tetracycline, and 30.8% (95% CI: 26.3-35.6%; range: 26.7-35.8%) for benzylpenicillin. Percentage of isolates non-susceptible to azithromycin was 4.1% (95% CI: 2.0-7.4%; range: 2.7-4.8%) and all (100%) isolates were susceptible to ceftriaxone. Two (1.6%) isolates from 2019 and one (2.2%) isolate from 2020 had high-level resistance to azithromycin (MIC >= 256 mg/L). Overall, 1.0% (4/418) of isolates had a ceftriaxone MIC of 0.25 mg/L, which is at the ceftriaxone susceptibility breakpoint (MIC <= 0.25 mg/L). Treatment with ceftriaxone 250 mg plus azithromycin 1 g can continuously be recommended for gonorrhoea therapy in Qatar. Continued quality-assured gonococcal AMR surveillance is warranted in EMR.	[Al-Maslamani, Muna; Elmagboul, Emad Bashier Ibrahim; Puthiyottil, Aslam; Varghese, Manoj Kizhakkepeedikayil; Al Khal, Abdullatif] Hamad Med Corp, Doha, Qatar; [Elmagboul, Emad Bashier Ibrahim] Qatar Univ, Biomed Res Ctr, Doha, Qatar; [Chemaitelly, Hiam; Abu-Raddad, Laith J.] Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar; [Chemaitelly, Hiam; Abu-Raddad, Laith J.] Cornell Univ, Qatar Fdn Educ City, World Hlth Org Collaborating Ctr Dis Epidemiol An, Weill Cornell Med Qatar, Doha, Qatar; [Al Romaihi, Hamad Eid; Al-Thani, Mohamed H.] Minist Publ Hlth, Doha, Qatar; [Unemo, Magnus] Orebro Univ, Fac Med & Hlth,Dept Lab Med, WHO Collaborating Ctr Gonorrhoea & Other Sexually, Natl Reference Lab Sexually Transmitted Infect De, Orebro, Sweden; [Unemo, Magnus] UCL, Inst Global Hlth, London, England; [Abu-Raddad, Laith J.] Cornell Univ, Dept Populat Hlth Sci, Weill Cornell Med, New York, NY 10021 USA; [Abu-Raddad, Laith J.] Qatar Univ, Coll Hlth Sci, Dept Publ Hlth, QU Hlth, Doha, Qatar	Hamad Medical Corporation; Qatar University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Orebro University; University of London; University College London; Cornell University; Qatar University	Abu-Raddad, LJ (corresponding author), Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar.; Abu-Raddad, LJ (corresponding author), Cornell Univ, Qatar Fdn Educ City, World Hlth Org Collaborating Ctr Dis Epidemiol An, Weill Cornell Med Qatar, Doha, Qatar.; Unemo, M (corresponding author), Orebro Univ, Fac Med & Hlth,Dept Lab Med, WHO Collaborating Ctr Gonorrhoea & Other Sexually, Natl Reference Lab Sexually Transmitted Infect De, Orebro, Sweden.; Unemo, M (corresponding author), UCL, Inst Global Hlth, London, England.; Abu-Raddad, LJ (corresponding author), Cornell Univ, Dept Populat Hlth Sci, Weill Cornell Med, New York, NY 10021 USA.; Abu-Raddad, LJ (corresponding author), Qatar Univ, Coll Hlth Sci, Dept Publ Hlth, QU Hlth, Doha, Qatar.	magnus.unemo@regionorebrolan.se; lja2002@qatar-med.cornell.edu		Abu-Raddad, Laith/0000-0003-0790-0506	Biomedical Research Program	Biomedical Research Program	The authors are grateful for the support provided by the Biomedical Research Program and infrastructure support provided by the Biostatistics, Epidemiology, and Biomathematics Research Core, both at Weill Cornell Medicine - Qatar. The statements made herein are solely the responsibility of the authors.	Centers for Disease Control and Prevention, 2017, GONORRHEACDC FACT SH; Clinical Laboratory and Standards Institute, 2021, GLOB LAB STAND HLTH; Hook EW., 2007, GONOCOCCAL INFECT AD, V4, P627; Joint United Nations Programme on HIV/AIDS (UNAIDS)/World health Organization (WHO), 2021, SEXUALLY TRANSMITTED; Lewis DA, 2014, CURR OPIN INFECT DIS, V27, P62, DOI 10.1097/QCO.0000000000000025; Ness RB, 1997, FERTIL STERIL, V68, P205, DOI 10.1016/S0015-0282(97)81502-6; Ochsendorf FR, 2008, ANDROLOGIA, V40, P72, DOI 10.1111/j.1439-0272.2007.00825.x; Planning and Statistics Authority-State of Qatar, 2021, LAB FORC SAMPL SURV; Planning and Statistics Authority-State of Qatar, 2021, QAT MONTHL STAT 2021; Planning and Statistics Authority-State of Qatar, 2021, SIMPL CENS POP HOUS; Priya Dsouza Communications, POPULATION QATAR NAT; Reekie J, 2018, CLIN INFECT DIS, V66, P437, DOI 10.1093/cid/cix769; Rowley J, 2019, B WORLD HEALTH ORGAN, V97, P548, DOI 10.2471/BLT.18.228486; St Cyr S, 2020, MMWR-MORBID MORTAL W, V69, P1911, DOI 10.15585/mmwr.mm6950a6; Unemo M, 2020, INT J STD AIDS, DOI 10.1177/0956462420949126; Unemo M, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0136-6, 10.1038/s41572-019-0128-6]; Unemo M, 2019, SEX HEALTH, V16, P412, DOI 10.1071/SH19023; Unemo M, 2016, J ANTIMICROB CHEMOTH, V71, P3096, DOI 10.1093/jac/dkw288; Unemo M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1029-2; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; United Nations Department of Economic and Social Affairs-Population Dynamics, 2021, 2019 REV WORLD POP P; Walker CK, 2011, INT J WOMENS HEALTH, V3, P197, DOI 10.2147/IJWH.S13427; Wang YC, 2017, EUR J CLIN MICROBIOL, V36, P813, DOI 10.1007/s10096-016-2866-7; WHO, 2021, GLOB PRIOR LIST ANT; Wi T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002344; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization (WHO), GLOB HLTH SECT STRAT; World Health Organization WHO, 1990, WHOVDT90452	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264737	10.1371/journal.pone.0264737	http://dx.doi.org/10.1371/journal.pone.0264737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235608	Green Submitted, Green Published, gold			2022-12-26	WOS:000787073100042
J	O'Laughlin, K; Espinosa, CC; Smith-Jeffcoat, SE; Koh, M; Khalil, GM; Hoffman, A; Rebolledo, PA; Schechter, MC; Stewart, RJ; da Silva, J; Biedron, C; Bankamp, B; Folster, J; Gargis, AS; Bowen, MD; Paulick, A; Wang, YF; Tate, JE; Kirking, HL				O'Laughlin, Kevin; Espinosa, Catherine C.; Smith-Jeffcoat, Sarah E.; Koh, Mitsuki; Khalil, George M.; Hoffman, Adam; Rebolledo, Paulina A.; Schechter, Marcos C.; Stewart, Rebekah J.; da Silva, Juliana; Biedron, Caitlin; Bankamp, Bettina; Folster, Jennifer; Gargis, Amy S.; Bowen, Michael D.; Paulick, Ashley; Wang, Yun F.; Tate, Jacqueline E.; Kirking, Hannah L.		CDC Surge Diagnost Testing Lab; CDC COVID-19 Emergency Response GA	Specimen self-collection for SARS-CoV-2 testing: Patient performance and preferences-Atlanta, Georgia, August-October 2020	PLOS ONE			English	Article								Self-collected specimens can expand access to SARS-CoV-2 testing. At a large inner-city hospital 1,082 participants self-collected saliva and anterior nasal swab (ANS) samples before healthcare workers collected nasopharyngeal swab (NPS) samples on the same day. To characterize patient preferences for self-collection, this investigation explored ability, comfort, and ease of ANS and saliva self-collection for SARS-CoV-2 testing along with associated patient characteristics, including medical history and symptoms of COVID-19. With nearly all participants successfully submitting a specimen, favorable ratings from most participants (at least >79% in ease and comfort), and equivocal preference between saliva and ANS, self-collection is a viable SARS-CoV-2 testing option.	[O'Laughlin, Kevin; Espinosa, Catherine C.; Smith-Jeffcoat, Sarah E.; Koh, Mitsuki; Khalil, George M.; Stewart, Rebekah J.; da Silva, Juliana; Biedron, Caitlin; Bankamp, Bettina; Folster, Jennifer; Gargis, Amy S.; Bowen, Michael D.; Paulick, Ashley; Tate, Jacqueline E.; Kirking, Hannah L.] Ctr Dis Control & Prevent, COVID 19 Emergency Response, Atlanta, GA 30333 USA; [O'Laughlin, Kevin] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Hoffman, Adam; Schechter, Marcos C.; Wang, Yun F.] Grady Mem Hosp, Atlanta, GA USA; [Hoffman, Adam; Rebolledo, Paulina A.; Schechter, Marcos C.; Wang, Yun F.] Emory Univ, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University	O'Laughlin, K (corresponding author), Ctr Dis Control & Prevent, COVID 19 Emergency Response, Atlanta, GA 30333 USA.; O'Laughlin, K (corresponding author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	pgv6@cdc.gov		Espinosa, Catherine/0000-0003-3883-0635; Khalil, George/0000-0002-0996-0310; Hoffman, Adam/0000-0002-0885-3900; Miller, Halie/0000-0001-5004-0789; O'Laughlin, Kevin/0000-0001-9484-683X; Paulick, Ashley/0000-0001-6796-4355	Centers for Disease Control and Prevention; CDC Foundation	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by Centers for Disease Control and Prevention, and CDC Foundation. The funders had no role in study design, data collection and analysis, decision publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], TESTING SCREENING OU; [Anonymous], ORDER REQUIREMENT PR; [Anonymous], CDC SELF TESTING; [Anonymous], UNDERLYING MED CONDI; [Anonymous], RISK COVID 19 INFECT; CDC, 2019, NOV COR 2019 NCOV RE; Ferenczi BA, 2021, INT BRAZ J UROL, V47, P631, DOI [10.1590/S1677-5538.IBJU.2020.0516, 10.1590/s1677-5538.ibju.2020.0516]; Grady Health System, GRAD FAST FACTS; Hanson KE, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01824-20; Hwang SY., J INFECT DIS EPIDEMI, V6, P173; Ku CW, 2021, INT J INFECT DIS, V104, P255, DOI 10.1016/j.ijid.2020.12.080; Larremore DB, 2021, SCI ADV, V7, DOI [10.1101/2020.06.22.20136309, 10.1126/sciadv.abd5393]; Paltiel AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16818; Patel R, 2020, MBIO, V11, DOI 10.1128/mBio.00722-20; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Sharfstein JM, 2020, JAMA-J AM MED ASSOC, V323, P1437, DOI 10.1001/jama.2020.3864; Siegler AJ, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa269; Smith-Jeffcoat SE, 2021, EMERG INFECT DIS, V27, P2081, DOI 10.3201/eid2708.210667; Tu YP, 2020, CRIT CARE MED, V48, P1680, DOI 10.1097/CCM.0000000000004594; Yokota I, 2021, CLIN INFECT DIS, V73, pE559, DOI 10.1093/cid/ciaa1388	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264085	10.1371/journal.pone.0264085	http://dx.doi.org/10.1371/journal.pone.0264085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263342	Green Published, gold			2022-12-26	WOS:000804638700007
J	Safdar, B; Wang, M; Guo, XJ; Cha, C; Chun, HJ; Deng, YH; Dziura, J; El-Khoury, JM; Gorelick, F; Ko, AI; Lee, AI; Safirstein, R; Simonov, M; Zhou, B; Desir, GV				Safdar, Basmah; Wang, Melinda; Guo, Xiaojia; Cha, Charles; Chun, Hyung J.; Deng, Yanhong; Dziura, James; El-Khoury, Joe M.; Gorelick, Fred; Ko, Albert, I; Lee, Alfred, I; Safirstein, Robert; Simonov, Michael; Zhou, Bin; Desir, Gary, V			Association of renalase with clinical outcomes in hospitalized patients with COVID-19	PLOS ONE			English	Article							PLASMA RENALASE; OXIDASE; FORMS	Renalase is a secreted flavoprotein with anti-inflammatory and pro-cell survival properties. COVID-19 is associated with disordered inflammation and apoptosis. We hypothesized that blood renalase levels would correspond to severe COVID-19 and survival. In this retrospective cohort study, clinicopathologic data and blood samples were collected from hospitalized COVID-19 subjects (March-June 2020) at a single institution tertiary hospital. Plasma renalase and cytokine levels were measured and clinical data abstracted from health records. Of 3,450 COVID-19 patients, 458 patients were enrolled. Patients were excluded if < 18 years, or opted out of research. The primary composite outcome was intubation or death within 180 days. Secondary outcomes included mortality alone, intensive care unit admission, use of vasopressors, and CPR. Enrolled patients had mean age 64 years (SD +/- 17), were 53% males, and 48% non-whites. Mean renalase levels was 14,108.4 ng/ml (SD +/- 8,137 ng/ml). Compared to patients with high renalase, those with low renalase (< 8,922 ng/ml) were more likely to present with hypoxia, increased ICU admission (54% vs. 33%, p < 0.001), and cardiopulmonary resuscitation (10% vs. 4%, p = 0.023). In Cox proportional hazard model, every 1000 ng/ml increase in renalase decreased the risk of death or intubation by 5% (HR 0.95; 95% CI 0.91-0.98) and increased survival alone by 6% (HR 0.95; CI 0.90-0.98), after adjusting for socio-demographics, initial disease severity, comorbidities and inflammation. Patients with high renalase-low IL-6 levels had the best survival compared to other groups (p = 0.04). Renalase was independently associated with reduced intubation and mortality in hospitalized COVID-19 patients. Future studies should assess the pathophysiological relevance of renalase in COVID-19 disease.	[Safdar, Basmah; Dziura, James] Yale Sch Med, Dept Emergency Med, New Haven, CT 06510 USA; [Wang, Melinda; Guo, Xiaojia; Chun, Hyung J.; Gorelick, Fred; Lee, Alfred, I; Safirstein, Robert; Desir, Gary, V] Yale Sch Med, Dept Med, New Haven, CT USA; [Wang, Melinda; Gorelick, Fred] Yale Sch Med, Dept Cell Biol, New Haven, CT USA; [Guo, Xiaojia; Safirstein, Robert; Desir, Gary, V] VA CT HealthCare, West Haven, CT USA; [Cha, Charles] Hartford HealthCare, Dept Surg, Hartford, CT USA; [Deng, Yanhong; Dziura, James; Gorelick, Fred; Simonov, Michael; Zhou, Bin] Yale Ctr Analyt Sci, New Haven, CT USA; [El-Khoury, Joe M.] Yale Sch Med, Dept Lab Med, New Haven, CT USA; [Ko, Albert, I] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Safdar, B (corresponding author), Yale Sch Med, Dept Emergency Med, New Haven, CT 06510 USA.	basmah.safdar@yale.edu	Ko, Albert/P-2343-2015; Cha, Charles/AAD-1314-2019	Ko, Albert/0000-0001-9023-2339; Cha, Charles/0000-0001-7443-1258	National Institute of Health [DK098108, R44 DK111251, DK007017]; Department of Defense Cancer Award [CA180514]; Department of Medicine, the George M. O'Brien Kidney Center at Yale [P30DK079310]; VA Merit Award [BX003250]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Cancer Award(United States Department of Defense); Department of Medicine, the George M. O'Brien Kidney Center at Yale; VA Merit Award(US Department of Veterans Affairs)	This work was supported in part by the National Institute of Health grants DK098108 (F Gorelick), R44 DK111251 (G V Desir, F Gorelick), and DK007017 (M Wang); VA Merit Award BX003250 (F Gorelick); Department of Defense Cancer Award CA180514 (F Gorelick, G V Desir) an endowment from H. J. Binder and JoanWBinder (F Gorelick). Assistance from the Yale Department of Medicine COVID Explorer data repository was made possible by funding from the Department of Medicine, the George M. O'Brien Kidney Center at Yale (P30DK079310). G V Desir is a named inventor on several issued patents related to the discovery and therapeutic use of renalase. Renalase is licensed to Bessor Pharma, and G V Desir holds an equity position in Bessor and its subsidiary Personal Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora T., 2021, MEDRXIV; Beaupre BA, 2015, BIOCHEMISTRY-US, V54, P795, DOI 10.1021/bi5013436; Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575; Cai EP, 2020, NAT METAB, V2, P934, DOI 10.1038/s42255-020-0254-1; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Chang J, 2020, KIDNEY INT REP, V5, P362, DOI 10.1016/j.ekir.2019.12.002; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen XX, 2020, INFLAMM RES, V69, P883, DOI 10.1007/s00011-020-01378-2; Desir GV, 2009, KIDNEY INT, V76, P366, DOI 10.1038/ki.2009.169; Evans PC, 2020, CARDIOVASC RES, V116, P2177, DOI 10.1093/cvr/cvaa230; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Feng XD, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00301; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Gharanei S, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.621016; Gomez-Pastora J, 2020, CLIN CHIM ACTA, V509, P249, DOI 10.1016/j.cca.2020.06.033; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hollander L, 2016, CANCER RES, V76, P3884, DOI 10.1158/0008-5472.CAN-15-1524; Huang ZM, 2019, LIFE SCI, V222, P78, DOI 10.1016/j.lfs.2019.02.042; Ibrahim I., 2016, EGYPTIAN J INTERNAL, V28, P91, DOI [10.4103/1110-7782.200966, DOI 10.4103/1110-7782.200966]; Kappert K, 2020, BIOMARKERS, V25, P616, DOI 10.1080/1354750X.2020.1797880; Kar S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92146-7; Kolodecik TR, 2017, J BIOL CHEM, V292, P21047, DOI 10.1074/jbc.M117.789776; Leisman DE, 2020, LANCET RESP MED, V8, P1233, DOI 10.1016/S2213-2600(20)30404-5; Nicolai L, 2020, CIRCULATION, V142, P1176, DOI 10.1161/CIRCULATIONAHA.120.048488; Organization WH, COR DIS COVID 19 WHO; Pandita A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252411; Qi CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139627; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rossi PG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238281; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Sinha P, 2020, JAMA INTERN MED, V180, P1152, DOI 10.1001/jamainternmed.2020.3313; Sizova D, 2013, AM J PHYSIOL-RENAL, V305, pF839, DOI 10.1152/ajprenal.00616.2012; Stojanovic D, 2015, ANN TRANSPL, V20, P186, DOI 10.12659/AOT.892632; Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Wang Y, 2017, J CELL MOL MED, V21, P1260, DOI 10.1111/jcmm.13062; Wybraniec MT, 2018, KARDIOL POL, V76, P1232, DOI 10.5603/KP.a2018.0108; Wybraniec MT, 2018, NEPHROLOGY, V23, P133, DOI 10.1111/nep.12954; Wybraniec MT, 2014, J AM SOC HYPERTENS, V8, P464, DOI 10.1016/j.jash.2014.04.009; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Yang L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00243-2; You NN, 2020, EXP BIOL MED, V245, P576, DOI 10.1177/1535370220909311; Zhou MX, 2015, J CARDIOVASC PHARM T, V20, P509, DOI 10.1177/1074248415575967	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264178	10.1371/journal.pone.0264178	http://dx.doi.org/10.1371/journal.pone.0264178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259186	gold, Green Published			2022-12-26	WOS:000835141200010
J	Admasu, FT; Melese, BD; Amare, TJ; Zewude, EA; Denku, CY; Dejenie, TA				Admasu, Fitalew Tadele; Melese, Biruk Demssie; Amare, Tadeg Jemere; Zewude, Edget Abebe; Denku, Chalachew Yenew; Dejenie, Tadesse Asmamaw			The magnitude of neonatal asphyxia and its associated factors among newborns in public hospitals of North Gondar Zone, Northwest Ethiopia: A cross-sectional study	PLOS ONE			English	Article							RISK-FACTORS	Introduction Birth asphyxia is a prominent and avoidable cause of infant illness and death worldwide, particularly in underdeveloped countries such as Ethiopia. Early identification and control of the underlying contributory factors would help to alleviate the situation. As a result, the goal of this study was to assess the magnitude and determinants of neonatal asphyxia among live newborns at the northern Gondar public Hospitals in northwest Ethiopia. Materials and methods From April 1 to May 2, 2020, 357 newborns were studied in an institution-based cross-sectional study. The sample size was proportionally distributed among three public hospitals, namely Gondar referral teaching hospital, Debark general hospital, and Kola-Diba District Hospital, which was chosen at random. The number of deliveries given at each hospital six months prior to the data collecting period was used to allocate the hospitals. To get all participants, a systematic random sampling approach was adopted based on hospital delivery registration. The physicians' evaluation of an APGAR score of 7 in the first and fifth minutes of birth was used as the confirmation of birth asphyxia. Data was collected using a standardized and pretested questionnaire. Variables having p-values less than 0.25 were entered into a multivariable logistic regression analysis in the bivariable analysis. At a p-value of 0.05, a statistically significant level was reported. Results As per the study, the total prevalence of neonatal asphyxia was found to be 27.1 (95% CI: 21.4, 32.7). In a multivariable logistic regression analysis, neonates born to rural mothers (AOR = 2.441, 95% CI: 1.137, 5.241), primiparity (AOR = 5.521 95%CI: 1.691, 8.026), premature rupture of membrane, (AOR = 3.202, 95% CI: 1.484, 6.909) and low birth weight (< 2.5kg) (AOR = 3.706, 95%CI: 3.307, 4.152) were all found to be independent predictors of birth asphyxia. Conclusion This study identified that rural residence, primiparity, premature rupture of membrane, and birth weight were found to be the independent predictors of birth asphyxia. The majority of variables that cause birth asphyxia can be controlled.	[Admasu, Fitalew Tadele] Debre Tabor Univ, Coll Hlth Sci, Dept Med Biochem, Debre Tabor, Ethiopia; [Melese, Biruk Demssie] Debre Tabor Univ, Coll Hlth Sci, Dept Environm Hlth, Debre Tabor, Ethiopia; [Amare, Tadeg Jemere; Zewude, Edget Abebe] Debre Tabor Univ, Coll Hlth Sci, Dept Med, Physiol, Debre Tabor, Ethiopia; [Denku, Chalachew Yenew] Debre Tabor Univ, Coll Hlth Sci, Dept Social & Publ Hlth Environm Hlth, Debre Tabor, Ethiopia; [Dejenie, Tadesse Asmamaw] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Biochem, Gondar, Ethiopia	University of Gondar	Dejenie, TA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Biochem, Gondar, Ethiopia.	as24tadesse@gmail.com		Asmamaw Dejenie, Tadesse/0000-0002-2033-6113				Alemu A., 2017, MED THERAPEUTICS; American Academy of Pediatrics CoFaNACoOaGaCoOP, 2006, APG SCOR, P117; [Anonymous], 2019, MORBIDITIES RATE TIM; Bahubali Gane, 2013, Current Pediatric Research, V17, P119; Chiabi A, 2013, IRAN J CHILD NEUROL, V7, P46; Eshete A., 2013, BIRTH OUTCOMES LABOR; Gebremedhin M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0658-1; Getachew, 2012, ETHIOPIA J HLTH SCI; Herrera MI., 2017, COULD PERINATAL ASPH; Hibstu D. T., 2014, DETERMINANTS NEONATA, DOI [10.4236/oalib.1100880, DOI 10.4236/OALIB.1100880]; IGME, 2017, LEV TRENDS CHILD MOR; Jagkaew B., 2014, FACTORS ASS BIRTH AS; Kahsay Zenebe, 2014, Indo Global Journal of Pharmaceutical Sciences, V4, P74; Kaye D, 2003, East Afr Med J, V80, P140; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lee A., 2007, MPH BALTIMORE CAPSTO; Lee ACC, 2008, PEDIATRICS, V121, pE1381, DOI 10.1542/peds.2007-1966; Lincetto O, 2007, BIRTH ASPHYXIA SUMMA; Maternal and Child Epidemiology Estimation Group (MCEE) Organization WH, 2018, EST CHILD CAUS DEATH; Maternal and newborn health/safe motherhood unit, 1997, DIV REPR HLTH TECHN; Nayeri F, 2012, IRAN J REPROD MED, V10, P137; Onyearugha C., 2010, CONTINENTAL J TROP M, V4, P11; Organization WH, 2012, GUID BAS NEWB RES; Sahib HS., 2015, RISK, V2, P50; Tabassum F., 2014, INT J CLIN MED, V5, P1430, DOI [10.4236/ijcm.2014.521181, DOI 10.4236/IJCM.2014.521181]; UNICEF, 2022, DEM WSPOLCZ DZIETN; Uzel H., 2012, J CLIN EXPT; Wayessa Z.J., 2018, J MIDWIF REPROD HLTH, V6, P1289; World Health Organization, 2015, WORLD HLTH ORG; World Health Organization, 2022, GLOB HLTH OBS; Wosenu L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203763	32	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264816	10.1371/journal.pone.0264816	http://dx.doi.org/10.1371/journal.pone.0264816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245309	Green Published, gold			2022-12-26	WOS:000799799100035
J	Hahm, C; Chung, HS; Lee, M				Hahm, Chorong; Chung, Hae-Sun; Lee, Miae			Whole-genome sequencing for the characterization of resistance mechanisms and epidemiology of colistin-resistant Acinetobacter baumannii	PLOS ONE			English	Article							SPREAD	Background Multidrug-resistant Acinetobacter baumannii is an important causal pathogen of healthcare-associated infections, and colistin-resistant strains have recently emerged owing to the increased use of colistin. Using next-generation sequencing (NGS), a single whole-genome sequencing (WGS) protocol can identify and type pathogens, analyze genetic relationships among different pathogens, predict pathogenic transmissions, and detect antibiotic resistance genes. However, only a few studies have applied NGS in studying the resistance mechanism and epidemiology of colistin-resistant A. baumannii. This study aimed to elucidate the resistance mechanism of colistin-resistant A. baumannii and analyze its molecular epidemiology through WGS. Materials and methods The subjects in this study were patients who visited a university hospital between 2014 and 2018. Thirty colistin-resistant strains with high minimum inhibitory concentrations were selected from various patient samples, and WGS was performed. Comparative genomic analysis was performed for the 27 colistin-resistant A. baumannii strains using a colistin-susceptible strain as the reference genome. Results The WGS analysis found no mutation for lpxA, lpxC, lpx D, pmrA, pmrB, and mcr1, the genes known to be associated with colistin resistance. Fifty-seven coding sequences (CDS) showed differences; they included 13 CDS with known names and functions that contained 21 genes. From the whole-genome multi-locus sequence typing (wgMLST) and single nucleotide polymorphism (SNP) analyses, two major clusters were found for the colistin-resistant A. baumannii strains. However, no differences were observed by the time of detection for each cluster, the samples, the pattern of antibiotic resistance, or the patient characteristics. In the conventional MLST following the Oxford scheme, the typing result showed ST1809, ST451, ST191, ST1837, and ST369 in the global clone 2 (GC2), without any relation with the results of wgMLST and SNP analyses. Conclusion Based on the findings of the resistance gene analysis through WGS and comparative genomic analysis, the potential genes associated with colistin-resistance or CDS were examined. Furthermore, the analysis of molecular epidemiology through WGS regarding colistin-resistant A. baumannii may prove helpful in preventing infection by multidrug-resistant bacteria and controlling healthcare-associated infections.	[Hahm, Chorong; Chung, Hae-Sun; Lee, Miae] Ewha Womans Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Hahm, Chorong] Eone Labs, Dept Lab Med, Incheon, South Korea; [Chung, Hae-Sun; Lee, Miae] Ewha Womans Univ, Coll Med, EWHA Educ & Res Ctr Infect, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Lee, M (corresponding author), Ewha Womans Univ, Coll Med, Dept Lab Med, Seoul, South Korea.; Lee, M (corresponding author), Ewha Womans Univ, Coll Med, EWHA Educ & Res Ctr Infect, Seoul, South Korea.	miae@ewha.ac.kr		Chung, Hae-Sun/0000-0001-6382-4099; Hahm, Chorong/0000-0002-5880-8972	EWHA Education and Research Center for Infection Research Fund	EWHA Education and Research Center for Infection Research Fund	This work supported by grant from EWHA Education and Research Center for Infection Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Berlana D, 2005, AM J HEALTH-SYST PH, V62, P39, DOI 10.1093/ajhp/62.1.39; Blanc DS, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01729; Blin K, 2017, NUCLEIC ACIDS RES, V45, pW36, DOI 10.1093/nar/gkx319; Caniaux I, 2017, EUR J CLIN MICROBIOL, V36, P415, DOI 10.1007/s10096-016-2846-y; Choi HH, 2013, ANN CLIN LAB SCI, V43, P145; Chun J, 2018, INT J SYST EVOL MICR, V68, P461, DOI [10.1099/ijsem.0.002532, 10.1099/ijsem.0.002516]; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Fitzpatrick MA, 2016, J CLIN MICROBIOL, V54, P593, DOI 10.1128/JCM.01818-15; Gurung M, 2013, INFECT GENET EVOL, V19, P219, DOI 10.1016/j.meegid.2013.07.016; Ha SM, 2019, ANN LAB MED, V39, P530, DOI 10.3343/alm.2019.39.6.530; Rodriguez CH, 2019, INT J ANTIMICROB AG, V54, P587, DOI 10.1016/j.ijantimicag.2019.08.010; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jeon H, 2018, INFECT GENET EVOL, V58, P232, DOI 10.1016/j.meegid.2018.01.003; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Kim DH, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01972-16; Korea National Institute of Health, 2017, NAT ANT RES SURV KOR; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Lin MF, 2017, J MICROBIOL, V55, P130, DOI 10.1007/s12275-017-6408-5; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Mustapha MM, 2018, J ANTIMICROB CHEMOTH, V73, P2952, DOI 10.1093/jac/dky290; Na IY, 2016, J MICROBIOL BIOTECHN, V26, P171, DOI 10.4014/jmb.1507.07076; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Pormohammad A, 2020, MICROB PATHOGENESIS, V139, DOI 10.1016/j.micpath.2019.103887; Selasi GN, 2015, INFECT GENET EVOL, V36, P1, DOI 10.1016/j.meegid.2015.09.001; Sepahvand S, 2017, INFECT DRUG RESIST, V10, P455, DOI 10.2147/IDR.S141196; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Ward N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101850; World Health Organization, 2019, ANTIBACTERIAL AGENTS; Yamada KD, 2016, BIOINFORMATICS, V32, P3246, DOI 10.1093/bioinformatics/btw412; Yoon EJ, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00233	36	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264335	10.1371/journal.pone.0264335	http://dx.doi.org/10.1371/journal.pone.0264335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245298	gold, Green Published			2022-12-26	WOS:000799799100013
J	Gao, YF; Yu, Y; Qin, W; Fan, N; Qi, YL; Chen, H; Duan, WG				Gao, Yinfang; Yu, Yun; Qin, Wan; Fan, Nan; Qi, Yalin; Chen, Huan; Duan, Weigang			Uricase-deficient rats with similarly stable serum uric acid to human's are sensitive model animals for studying hyperuricemia	PLOS ONE			English	Article							UROLITHIASIS; ACTIVATION; INHIBITORS	The aim of this study was to provide a sensitive model animal for studying hyperuricemia. Male uricase-deficient rats, named Kunming-DY rats, were raised for 130 days, or orally administered with purines and other chemicals. Serum uric acid (SUA) in the animals was assayed, and the UA level in their organs and their 24-h excretion was determined. Genes in the jejunum, ileum, kidney and liver related to UA synthesis and transportation were detected by quantitative RNA sequencing. Uricase-deficient rats have a high level of SUA and are sensitive to xanthine, adenosine, inosine, allopurinol, and alcohol. Besides, the high level of SUA in male uricase-deficient rats was stable, much higher than that in wild-type rats but similar to that in men. The distribution pattern of UA in uricase-deficient rats' organs was different from that in wild-type rats. The kidney, liver, and small intestine were the top three organs where UA distributed, but the UA in the small intestine, colon, lung, thymus, and brain was less affected by uricase deficiency, indicating that these organs are constitutive distribution organs in UA. The 24-h UA excreted by a uricase-deficient rat was about five times higher than that excreted by a wild-type rat. However, the 24-h UA excreted through feces was not significantly changed. Both the urine volume and UA in uricase-deficient rats significantly increased, and more than 90% of UA was excreted via urine. The expression of xanthine dehydrogenase was not upregulated. Some genes of transporter associated with uric acid excretion in the kidney were significantly regulated, though not sufficient to explain the increase in SUA. In conclusion, male uricase-deficient rats' UA metabolism is similar to that of men. The elevation of SUA in uricase-deficient rats is caused by uricase deficiency, and uricase-deficient rats are a sensitive model for studying hyperuricemia.	[Gao, Yinfang; Yu, Yun; Fan, Nan; Qi, Yalin; Chen, Huan; Duan, Weigang] Kunming Med Univ, Sch Basic Med, Dept Pharmacol, Kunming, Yunnan, Peoples R China; [Qin, Wan] Yunnan Univ Tradit Chinese Med, Sch Basic Med, Dept Pathol, Kunming, Yunnan, Peoples R China	Kunming Medical University; Yunnan University of Chinese Medicine	Duan, WG (corresponding author), Kunming Med Univ, Sch Basic Med, Dept Pharmacol, Kunming, Yunnan, Peoples R China.	deardwg@126.com		Duan, Weigang/0000-0002-9006-861X	National Natural Science Foundation of China [81860162]; Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Kunming Medical University [202101AY070001-007]; Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Yunnan University of Traditional Chinese Medicine [202101AZ070001-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Kunming Medical University; Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Yunnan University of Traditional Chinese Medicine	The work was financially supported by the National Natural Science Foundation of China (No. 81860162), Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Kunming Medical University (202101AY070001-007), and Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Yunnan University of Traditional Chinese Medicine (202101AZ070001-010).	Bardin T, 2014, CURR OPIN RHEUMATOL, V26, P186, DOI 10.1097/BOR.0000000000000028; Ceballos-Picot I, 2014, NUCLEOS NUCLEOT NUCL, V33, P241, DOI 10.1080/15257770.2013.853780; Chen CY, 2016, MED SCI MONITOR, V22, P2501, DOI 10.12659/MSM.899852; Chen L, 2017, CHEM-BIOL INTERACT, V273, P56, DOI 10.1016/j.cbi.2017.05.025; Dalbeth N, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0115-y, 10.1038/s41572-019-0124-x]; Fan N., 2020, J YUNNAN U TRADITION, V43, P12, DOI [10.19288/j.cnki.issn.1000-2723.2020.06.003, DOI 10.19288/J.CNKI.ISSN.1000-2723.2020.06.003]; Fan N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256594; Fountoulakis M, 2002, TOXICOL APPL PHARM, V183, P71, DOI 10.1006/taap.2002.9460; Gabison L, 2006, FEBS LETT, V580, P2087, DOI 10.1016/j.febslet.2006.03.007; Garay RP, 2012, JOINT BONE SPINE, V79, P237, DOI 10.1016/j.jbspin.2012.01.004; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Li LJ, 2020, AM J TRANSL RES, V12, P3167; Lin YQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182602; Liu DQ, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/4081962; Lu J, 2018, KIDNEY INT, V93, P69, DOI 10.1016/j.kint.2017.04.031; Lv QL, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.524236; Mallat SG, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0684-z; Narimatsu T, 2019, ONCOL LETT, V17, P4429, DOI 10.3892/ol.2019.10086; Oyabambi AO, 2020, ENVIRON TOXICOL PHAR, V80, DOI 10.1016/j.etap.2020.103452; Prezioso D, 2013, ARCH ITAL UROL ANDRO, V85, P180, DOI 10.4081/aiua.2013.4.180; PUIG JG, 1984, J CLIN INVEST, V74, P936, DOI 10.1172/JCI111512; Rafey MA, 2003, CURR OPIN NEPHROL HY, V12, P511, DOI 10.1097/00041552-200309000-00005; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Singh JA, 2011, CURR OPIN RHEUMATOL, V23, P192, DOI 10.1097/BOR.0b013e3283438e13; Stockelman MG, 1998, AM J PHYSIOL-RENAL, V275, pF154, DOI 10.1152/ajprenal.1998.275.1.F154; Sumpter NA, 2020, CURR OPIN RHEUMATOL, V32, P126, DOI 10.1097/BOR.0000000000000691; Szczurek P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179195; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Unger S, 2007, Z RHEUMATOL, V66, P556, DOI 10.1007/s00393-007-0208-y; Watanabe T, 2014, NUCLEOS NUCLEOT NUCL, V33, P192, DOI 10.1080/15257770.2013.865742; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Xu LQ, 2017, ONCOTARGET, V8, P100852, DOI 10.18632/oncotarget.20135; Xu T, 2020, CLIN CHIM ACTA, V504, P168, DOI 10.1016/j.cca.2020.02.012; Yin H, 2015, CELL BIOL INT, V39, P563, DOI 10.1002/cbin.10423; Yu Y, 2020, PEERJ, V8, DOI 10.7717/peerj.8971; Yun Y., 2016, THESCIENTIFICWORLDJO, V2016, DOI [10.1155/2016/2695718, DOI 10.1155/2016/2695718]; Yun Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190194; Zhang N., 2019, J KUNMING MED U, V40; Zhang SS, 2019, CURR PHARM DESIGN, V25, P700, DOI 10.2174/1381612825666190408122557	39	0	0	10	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264696	10.1371/journal.pone.0264696	http://dx.doi.org/10.1371/journal.pone.0264696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239728	Green Published, gold			2022-12-26	WOS:000776002200064
J	Kokas, Z; Sandi, D; Fricska-Nagy, Z; Fuvesi, J; Biernacki, T; Koves, A; Fazekas, F; Birkas, AJ; Katona, G; Kovacs, K; Milanovich, D; Dobos, E; Kapas, I; Jakab, G; Csepany, T; Bense, E; Matyas, K; Rum, G; Szolnoki, Z; Deme, I; Jobbagy, Z; Kriston, D; Gerocs, Z; Dioszeghy, P; Bors, L; Varga, A; Kerenyi, L; Molnar, G; Kristof, P; Nagy, ZA; Satori, M; Imre, P; Pentek, S; Klivenyi, P; Kincses, ZT; Vecsei, L; Bencsik, K				Kokas, Zsofia; Sandi, Daniel; Fricska-Nagy, Zsanett; Fuvesi, Judit; Biernacki, Tamas; Koves, Agnes; Fazekas, Ferenc; Birkas, Adrienne Jori; Katona, Gabriella; Kovacs, Krisztina; Milanovich, Daniel; Dobos, Eniko; Kapas, Istvan; Jakab, Gabor; Csepany, Tunde; Bense, Erzsebet; Matyas, Klotild; Rum, Gabor; Szolnoki, Zoltan; Deme, Istvan; Jobbagy, Zita; Kriston, David; Gerocs, Zsuzsanna; Dioszeghy, Peter; Bors, Laszlo; Varga, Adrian; Kerenyi, Levente; Molnar, Gabriella; Kristof, Piroska; Nagy, Zsuzsanna Agnes; Satori, Maria; Imre, Piroska; Pentek, Szilvia; Klivenyi, Peter; Kincses, Zsigmond Tamas; Vecsei, Laszlo; Bencsik, Krisztina			Do Hungarian multiple sclerosis care units fulfil international criteria?	PLOS ONE			English	Article							PHARMACOLOGICAL-TREATMENT; ECTRIMS/EAN GUIDELINE; DIAGNOSTIC-CRITERIA; REGISTRY; REVISIONS; THERAPY; PEOPLE; MRI; MS	A patients Because of the past 3 decades' extensive research, several disease modifying therapies became available, thus a paradigm change is multiple sclerosis care was necessary. In 2018 a therapeutic guideline was created recommending that treatment of persons with multiple sclerosis should take place in specified care units where the entire spectrum of disease modifying therapies is available, patient monitoring is ensured, and therapy side effects are detected and treated promptly. In 2019 multiple sclerosis care unit criteria were developed, emphasizing personnel and instrumental requirements to provide most professional care. However, no survey was conducted assessing the real-world adaptation of these criteria. Objective To assess whether Hungarian care units fulfil international criteria. Methods A self-report questionnaire was assembled based on international guidelines and sent to Hungarian care units focusing on 3 main aspects: personnel and instrumental background, disease-modifying therapy use, number of people living with multiple sclerosis receiving care in care units. Data on number of persons with multiple sclerosis were compared to Hungarian prevalence estimates. Descriptive statistics were used to analyse data. Results Out of 27 respondent care units, 3 fulfilled minimum requirements and 7 fulfilled minimum and recommended requirements. The least prevalent neighbouring specialties were spasticity and pain specialist, and neuro-ophthalmologist and oto-neurologist. Only 15 centres used all available disease modifying therapies. A total number of 7213 people with multiple sclerosis received care in 27 respondent centres. Compared to prevalence estimates, 2500 persons with multiple sclerosis did not receive multiple sclerosis specific care in Hungary. Conclusion Less than half of Hungarian care units provided sufficient care for people living with multiple sclerosis. Care units employing fewer neighbouring specialties, might have difficulties diagnosing and providing appropriate care for persons with multiple sclerosis, especially for people with progressive disease course, contributing to the reported low number of persons living with multiple sclerosis.	[Kokas, Zsofia; Sandi, Daniel; Fricska-Nagy, Zsanett; Fuvesi, Judit; Biernacki, Tamas; Klivenyi, Peter; Kincses, Zsigmond Tamas; Vecsei, Laszlo; Bencsik, Krisztina] Univ Szeged, Fac Gen Med, Albert Szent Gyorgyi Clin Ctr, Dept Neurol, Szeged, Hungary; [Koves, Agnes] Bajcsy Zsilinszky Hosp, Dept Neurol, Budapest, Hungary; [Fazekas, Ferenc] Gyula Nyir Hosp, Dept Neurol, Budapest, Hungary; [Fazekas, Ferenc] Natl Inst Psychiat & Addict, Budapest, Hungary; [Birkas, Adrienne Jori] Natl Inst Clin Nerosci, Dept Neurol, Budapest, Hungary; [Katona, Gabriella] Natl Inst Rheumatism & Physiotherapy, Dept Neurol, Budapest, Hungary; [Kovacs, Krisztina] Peterfy Hosp, Dept Neurol, Budapest, Hungary; [Milanovich, Daniel] Semmelweis Univ, Dept Neurol, Budapest, Hungary; [Dobos, Eniko] St Imre Hosp, Dept Neurol, Budapest, Hungary; [Dobos, Eniko] Univ Teaching Hosp, Budapest, Hungary; [Kapas, Istvan] St Janos Hosp, Dept Neurol, Budapest, Hungary; [Jakab, Gabor] Uzsoki Hosp, Dept Neurol, Budapest, Hungary; [Csepany, Tunde] Univ Debrecen Clin Ctr, Div Neurol, Debrecen, Hungary; [Bense, Erzsebet] Univ Debrecen, Dept Neurol, Fac Med, Debrecen, Hungary; [Matyas, Klotild] Ferenc Markhot Teaching Hosp, Dept Neurol, Eger, Hungary; [Rum, Gabor] Aladar Petz Univ Teaching Hosp, Dept Neurol, Gyor, Hungary; [Szolnoki, Zoltan] Kalman Pandy Cty Hosp, Dept Neurol, Gyula, Hungary; [Deme, Istvan] Mor Kaposi Teaching Hosp, Dept Neuol, Kaposvar, Hungary; [Jobbagy, Zita] Kecskemet Cty Hosp, Dept Neurol, Kecskemet, Hungary; [Kriston, David] Borsod Abauj Zemplen Cty Cent Hosp, Dept Neurol, Miskolc, Hungary; [Kriston, David] Univ Teaching Hosp, Miskolc, Hungary; [Gerocs, Zsuzsanna] Dorottya Kanizsai Hosp, Dept Neurol, Nagykanizsa, Hungary; [Dioszeghy, Peter] Aladar Josa Teaching Hosp, Dept Neurol, Nyiregyhaza, Hungary; [Bors, Laszlo] Univ Pecs Clin Ctr Pecs, Dept Neurol, Pecs, Hungary; [Varga, Adrian] St Lazar Cty Hosp, Dept Neurol, Salgotarjan, Hungary; [Kerenyi, Levente] Fejer Cty St Gyorgy Univ Teaching Hosp, Dept Neurol, Szekesfehervar, Hungary; [Molnar, Gabriella] Janos Balassa Hosp, Dept Neurol, Szekszard, Hungary; [Kristof, Piroska] Jasz Nagykun Szolnok Cty Geza Hetenyi Hosp, Dept Neurol, Szolnok, Hungary; [Nagy, Zsuzsanna Agnes] Markusovszky Univ Teaching Hosp, Dept Neurol, Szombathely, Hungary; [Satori, Maria] St Borbala Hosp, Dept Neurol, Tatabanya, Hungary; [Imre, Piroska] Ferenc Csolnoky Hosp, Dept Neurol, Veszprem, Hungary; [Pentek, Szilvia] Zala Cty St Rafael Hosp, Dept Neurol, Zalaegerszeg, Hungary; [Kincses, Zsigmond Tamas] Univ Szeged, Fac Gen Med, Albert Szent Gyorgyi Clin Ctr, Dept Radiol, Szeged, Hungary; [Vecsei, Laszlo] MTA SZTE Neurosci Res Grp, Szeged, Hungary	Szeged University; National Institute Rheumatology & Physiotherapy; Semmelweis University; University of Debrecen; Szeged University; Neuroscience Research Group, HAS	Bencsik, K (corresponding author), Univ Szeged, Fac Gen Med, Albert Szent Gyorgyi Clin Ctr, Dept Neurol, Szeged, Hungary.	bencsik.krisztina@med.u-szeged.hu			University of Szeged [5535/EFOP 3.6.3-VEKOP-16-2017-00009, GINOP 2.3.2-15-2016-00034/TUDFO/47138-1/2019-ITM]	University of Szeged(European Commission)	This study was funded via the University of Szeged in the form of independent grants to ZsK (5535/EFOP 3.6.3-VEKOP-16-2017-00009) and LV (GINOP 2.3.2-15-2016-00034/TUDFO/47138-1/2019-ITM). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bencsik K, 2017, IDEGGYOGY SZEMLE, V70, P301, DOI 10.18071/isz.70.0301; Berger JR, 2006, ANN RHEUM DIS, V65, P48, DOI 10.1136/ard.2006.058404; Berger T, 2020, THER ADV NEUROL DISO, V13, DOI 10.1177/1756286420975223; Berger T, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418759189; Biernacki T, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1598; Brola W, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0662-8; Claflin SB, 2022, MULT SCLER J, V28, P831, DOI 10.1177/13524585211035948; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Cottrell DA, 1999, BRAIN, V122, P625, DOI 10.1093/brain/122.4.625; Cristiano E, 2021, J NEUROL SCI, V429, DOI 10.1016/j.jns.2021.118072; Flachenecker P, 2008, DTSCH ARZTEBL INT, V105, P113, DOI 10.3238/arztebl.2008.0113; He A, 2020, LANCET NEUROL, V19, P307, DOI 10.1016/S1474-4422(20)30067-3; Hillert J, 2015, ACTA NEUROL SCAND, V132, P11, DOI 10.1111/ane.12425; Hobart J, 2019, MULT SCLER J, V25, P1809, DOI 10.1177/1352458518809326; Iljicsov A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236432; KNOBLER RL, 1993, J INTERFERON RES, V13, P333, DOI 10.1089/jir.1993.13.333; Laakso SM, 2019, ACTA NEUROL SCAND, V140, P303, DOI 10.1111/ane.13145; Lad SP, 2010, NEUROEPIDEMIOLOGY, V35, P93, DOI 10.1159/000310301; Lorscheider J, 2016, BRAIN, V139, P2395, DOI 10.1093/brain/aww173; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Magyari M, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.1921; Marrie RA, 2015, MULT SCLER J, V21, P305, DOI 10.1177/1352458514564487; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Montalban X, 2018, EUR J NEUROL, V25, P215, DOI 10.1111/ene.13536; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; Montalban X, 2018, MULT SCLER J, V24, P96, DOI 10.1177/1352458517751049; Moradi N, 2021, CNS DRUGS, V35, P1097, DOI 10.1007/s40263-021-00833-w; Nicholas RS, 2020, MULT SCLER J-EXP TRA, V6, DOI 10.1177/2055217320901727; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Ntranos A, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0688-8; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rae-Grant A, 2018, NEUROLOGY, V90, P789, DOI 10.1212/WNL.0000000000005345; Rovira A, 2015, NAT REV NEUROL, V11, P471, DOI 10.1038/nrneurol.2015.106; Solomon AJ, 2022, MULT SCLER J, V28, P1248, DOI 10.1177/13524585211048401; Solomon AJ, 2021, MULT SCLER J, V27, P250, DOI 10.1177/1352458520910496; Sorensen PS, 2019, MULT SCLER J, V25, P627, DOI 10.1177/1352458518807082; Steinemann N, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1118-0; Thompson AJ, 2018, LANCET, V391, P1622, DOI 10.1016/S0140-6736(18)30481-1; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Trojano M, 2019, NEUROL SCI, V40, P155, DOI 10.1007/s10072-018-3610-0; Wallin MT, 2019, NEUROLOGY, V92, pE1029, DOI 10.1212/WNL.0000000000007035; Walton C, 2020, MULT SCLER J, V26, P1816, DOI 10.1177/1352458520970841; Wattjes MP, 2021, LANCET NEUROL, V20, P653, DOI 10.1016/S1474-4422(21)00095-8	44	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264328	10.1371/journal.pone.0264328	http://dx.doi.org/10.1371/journal.pone.0264328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239686	Green Accepted, Green Published, gold			2022-12-26	WOS:000776002200027
J	Li, CL; Guan, X; Jing, HG; Xiao, X; Jin, H; Xiong, JS; Ai, SQ; Wang, YJ; Su, TQ; Sun, GY; Fu, TJ; Wang, YJ; Guo, SL; Liang, P				Li, Chenlong; Guan, Xue; Jing, Hanguang; Xiao, Xu; Jin, Hua; Xiong, Jinsheng; Ai, Siqi; Wang, Yingjie; Su, Tianqi; Sun, Guiyin; Fu, Tianjiao; Wang, Yujie; Guo, Shouli; Liang, Peng			Circular RNA circBFAR promotes glioblastoma progression by regulating a miR-548b/FoxM1 axis	FASEB JOURNAL			English	Article						circBFAR; FoxM1; glioma; miR-548b; proliferation	CELL-PROLIFERATION; GASTRIC-CANCER; IN-VITRO; EXPRESSION; DIAGNOSIS; MIRNA; GLYCOLYSIS; DISCOVERY; APOPTOSIS; BIOMARKER	Glioblastoma multiforme (GBM) is the most common and aggressive type of tumor of the primary nervous system. Treatment options for GBM include surgery, chemotherapy, and radiation therapy; however, the clinical outcomes are poor, with a high rate of recurrence. An increasing number of studies have shown that circular RNAs (circRNAs) serve important roles in several types of cancer. Gene Expression Omnibus (GEO) database was utilized to identify the differentially expressed circRNAs and their biological functions. Then, we detected the circular RNA bifunctional apoptosis regulator (circBFAR) was significantly increased in three GEO datasets. However, the role of circBFAR has not been reported in GBM. In this study, the expression of circBFAR was significantly increased both in GBM tissues or cell lines and was negatively correlated with overall survival in patients with GBM. Knockdown of circBFAR inhibited proliferation and invasion both in vitro and in vivo. Increased expression of circBFAR resulted in a reduction of miR-548b expression in glioma cells. A luciferase reporter and RIP assay indicated that miR-548b was a direct target of circBFAR, and miR-548b may negatively regulate the expression of FoxM1. Rescue experiments showed that overexpression of FoxM1 could counter the effect of circBFAR silencing on the proliferation and invasion of glioma cell lines. Moreover, we identified that circBFAR regulates FoxM1 by interacting with miR-548b in glioma cells. In conclusion, the present study demonstrated that a circBFAR/miR-548b/FoxM1 axis regulates the development of GBM and highlights potentially novel therapeutic targets for the treatment of GBM.	[Li, Chenlong; Xiao, Xu; Jin, Hua; Xiong, Jinsheng; Ai, Siqi; Wang, Yingjie; Su, Tianqi; Sun, Guiyin; Fu, Tianjiao; Wang, Yujie; Liang, Peng] Harbin Med Univ, Dept Neurosurg, Canc Hosp, 150 Haping Rd, Harbin 150086, Heilongjiang, Peoples R China; [Guan, Xue] Harbin Med Univ, Anim Lab Ctr, Affiliated Hosp 2, Harbin, Peoples R China; [Jing, Hanguang] Guangdong Prov Hosp Tradit Chinese Med, Lin Yi Famous Doctor Studio, Breast Surg, Guangzhou, Peoples R China; [Guo, Shouli] Harbin Med Univ, Anim Expt Ctr, Affiliated Hosp 2, 256 Xuefu Rd, Harbin 150086, Lleilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Guangzhou University of Chinese Medicine; Harbin Medical University	Liang, P (corresponding author), Harbin Med Univ, Dept Neurosurg, Canc Hosp, 150 Haping Rd, Harbin 150086, Heilongjiang, Peoples R China.; Guo, SL (corresponding author), Harbin Med Univ, Anim Expt Ctr, Affiliated Hosp 2, 256 Xuefu Rd, Harbin 150086, Lleilongjiang, Peoples R China.	gsljkjy@126.com; liangpengd@yahoo.com		li, chenlong/0000-0002-1822-928X	Haiyan Fund Project of Harbin Medical University Cancer Hospital [JJMS2021-08]; Heilongjiang Provincial Postdoctoral Science Foundation (Heilongjiang Postdoctoral Science Foundation) [LBH-Z20073]; Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation) [2021M693819]; Top Young Talents Program of Harbin Medical University Cancer Hospital [BJQN2021-05]; Natural Science Foundation of Heilongjiang Province [JJ2021LH1458]	Haiyan Fund Project of Harbin Medical University Cancer Hospital; Heilongjiang Provincial Postdoctoral Science Foundation (Heilongjiang Postdoctoral Science Foundation); Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation); Top Young Talents Program of Harbin Medical University Cancer Hospital; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	Haiyan Fund Project of Harbin Medical University Cancer Hospital, Grant/Award Number: JJMS2021-08; Heilongjiang Provincial Postdoctoral Science Foundation (Heilongjiang Postdoctoral Science Foundation), Grant/Award Number: LBH-Z20073; Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation), Grant/Award Number: 2021M693819; The Top Young Talents Program of Harbin Medical University Cancer Hospital, Grant/Award Number: BJQN2021-05; Natural Science Foundation of Heilongjiang Province, Grant/Award Number: JJ2021LH1458	Barbagallo I, 2015, ACTA HISTOCHEM, V117, P705, DOI 10.1016/j.acthis.2015.09.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchini M, 2006, INT J ONCOL, V29, P83; Burri SH, 2018, AM J CLIN ONCOL-CANC, V41, P191, DOI 10.1097/COC.0000000000000395; Castaneda CA, 2011, EXPERT REV ANTICANC, V11, P1265, DOI [10.1586/era.11.40, 10.1586/ERA.11.40]; Chen HW, 2019, ONCOL LETT, V17, P5343, DOI 10.3892/ol.2019.10235; Chen X, 2018, CLIN CANCER RES, V24, P6319, DOI 10.1158/1078-0432.CCR-18-1270; Deng Z, 2019, J NEURORESTORATOLOGY, V7, P143, DOI 10.26599/JNR.2019.9040015; Di Fruscia P, 2015, CHEMMEDCHEM, V10, P69, DOI 10.1002/cmdc.201402431; Dong SQ, 2019, FEBS OPEN BIO, V9, P519, DOI 10.1002/2211-5463.12592; Fanale D, 2018, ADV EXP MED BIOL, V1087, P109, DOI 10.1007/978-981-13-1426-1_9; Guo XF, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01196-4; Han W, 2020, ONCOTARGETS THER, V13, P6937, DOI 10.2147/OTT.S260376; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hawkins SFC, 2017, METHODS MOL BIOL, V1546, P125, DOI 10.1007/978-1-4939-6730-8_8; Hou NY, 2018, CLIN EXP PHARMACOL P, V45, P729, DOI 10.1111/1440-1681.12931; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jia Y, 2020, PATHOL ONCOL RES, V26, P753, DOI 10.1007/s12253-019-00622-3; Kaminski A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32491-2; Kim H, 2020, NEUROPATH APPL NEURO, V46, P125, DOI 10.1111/nan.12571; Kwok CTD, 2016, STEM CELL RES, V16, P651, DOI 10.1016/j.scr.2016.03.007; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lee B, 2007, CANCER LETT, V247, P110, DOI 10.1016/j.canlet.2006.03.033; Li F, 2015, ONCOTARGET, V6, P6001, DOI 10.18632/oncotarget.3469; Li J, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0822-3; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Liang YJ, 2020, J GENE MED, V22, DOI 10.1002/jgm.3237; Lim YP, 2004, CLIN CANCER RES, V10, P3980, DOI 10.1158/1078-0432.CCR-03-0663; Liu LY, 2018, AGING-US, V10, P4120, DOI 10.18632/aging.101706; Lu S, 2018, LUNG CANCER, V123, P44, DOI 10.1016/j.lungcan.2018.06.027; Meganck RM, 2018, MOL THER-NUCL ACIDS, V13, P89, DOI 10.1016/j.omtn.2018.08.008; Min LY, 2019, FRONT BIOSCI-LANDMRK, V24, P819, DOI 10.2741/4753; Nishikawa M, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5387041; Panda AC, 2018, ADV EXP MED BIOL, V1087, P67, DOI 10.1007/978-981-13-1426-1_6; Park JK, 2010, J CLIN ONCOL, V28, P3838, DOI 10.1200/JCO.2010.30.0582; Peng P, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118039; Qiao YW, 2019, BIOENGINEERED, V10, P593, DOI 10.1080/21655979.2019.1679698; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Tachon G, 2019, MODERN PATHOL, V32, P774, DOI 10.1038/s41379-018-0192-6; Tan YL, 2019, INT J ONCOL, V54, P87, DOI 10.3892/ijo.2018.4598; Wang L, 2016, FRONT MED-PRC, V10, P41, DOI 10.1007/s11684-016-0429-z; Wang LJ, 2018, ADV EXP MED BIOL, V1087, P191, DOI 10.1007/978-981-13-1426-1_15; Wang L, 2012, SCI WORLD J, DOI 10.1100/2012/428979; Wang RL, 2017, NEUROPSYCH DIS TREAT, V13, P1805, DOI 10.2147/NDT.S137171; Wang YH, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01217; Wang YN, 2021, BIOCHEM BIOPH RES CO, V560, P80, DOI 10.1016/j.bbrc.2021.04.131; Waseem A, 2010, ORAL ONCOL, V46, P536, DOI 10.1016/j.oraloncology.2010.03.022; Weng WH, 2017, CLIN CANCER RES, V23, P3918, DOI 10.1158/1078-0432.CCR-16-2541; Wesselhoeft RA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05096-6; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xiao BX, 2017, INT J CLIN EXP PATHO, V10, P7661; Xiu GH, 2018, EUR J PHARMACOL, V833, P79, DOI 10.1016/j.ejphar.2018.04.021; Yang HJ, 2010, CANCER INVEST, V28, P127, DOI 10.3109/07357900903147184; Yao S, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0641-1; Yu CY, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0523-z; Yu X, 2016, J CELL MOL MED, V20, P10, DOI 10.1111/jcmm.12650; Zealy RW, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1414; Zhang CL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0482-4; Zhang L, 2019, INT J BIOL SCI, V15, P1091, DOI 10.7150/ijbs.31533	60	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22183	10.1096/fj.202101307R	http://dx.doi.org/10.1096/fj.202101307R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35202487	hybrid			2022-12-26	WOS:000761250800017
J	Shao, GY				Shao, Guangyao			Integrated RNA gene expression analysis identified potential immune-related biomarkers and RNA regulatory pathways of acute myocardial infarction	PLOS ONE			English	Article							FALSE DISCOVERY RATE; COMPLEX DISEASES; INTERLEUKIN-1; CERNA	Background Acute lesions are among the most important causes of death due to vascular lesions worldwide. However, there are no accurate genetic markers for Acute myocardial infarction (AMI). This project will use microarray integration analysis in bioinformatics analysis to find and validate relevant AMI gene markers. Methods Five microarray gene expression datasets were downloaded through the GEO database. We identified 50 significant DEGs by comparing and analyzing gene expression between 92 AMI and 57 standard samples. The BioGPS database screened differentially expressed genes specific to the immune system. DEGs were mainly involved in immune-related biological processes based on Enrichment analysis. Eight hub genes and three-gene cluster modules were subsequently screened using Cytoscape and validated using Box plot's grouping comparison and ROC curves. Combined group comparison results and ROC curves analysis concluded that AQP9, IL1B, and IL1RN might be potential gene markers for the AMI process. We used the StarBase database to predict target miRNAs for eight essential genes. The expected results were used to screen and obtain target lncRNAs. Then Cytoscape was used to create CeRNA networks. By searching the literature in PubMed, we concluded that AQP9, IL1B, and IL1RN could be used as gene markers for AMI, while FSTL3-miR3303pIL1B/IL1RN and ACSL4-miR5905p-IL1B could be used as RNA regulatory pathways affecting AMI disease progression. Conclusions Our study identified three genes that may be potential genetic markers for AMI's early diagnosis and treatment. In addition, we suggest that FSTL3-miR-330-3p-IL1B/IL1RN and ACSL4-miR590-5p-IL1B may be possible RNA regulatory pathways to control AMI disease progression.	[Shao, Guangyao] Qingdao Univ, Ri Zhao, Shandong, Peoples R China	Qingdao University	Shao, GY (corresponding author), Qingdao Univ, Ri Zhao, Shandong, Peoples R China.	s2669475603@163.com						Abbate A, 2020, CIRC RES, V126, P1260, DOI 10.1161/CIRCRESAHA.120.315937; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bai YT, 2018, BIOCHEM BIOPH RES CO, V499, P44, DOI 10.1016/j.bbrc.2018.03.113; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chan MY, 2020, CIRCULATION, V142, P1408, DOI 10.1161/CIRCULATIONAHA.119.045158; Chen DQ, 2019, CARDIOVASC THER, V2019, DOI 10.1155/2019/8490707; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2017, BRIEF BIOINFORM, V18, P558, DOI 10.1093/bib/bbw060; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Fan P, 2021, J MOL HISTOL, V52, P955, DOI 10.1007/s10735-021-10009-x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gao RF, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.04.022; Gladka MM, 2018, CIRCULATION, V138, P166, DOI 10.1161/CIRCULATIONAHA.117.030742; Huang SB, 2018, BRIT J PHARMACOL, V175, P1377, DOI 10.1111/bph.14155; Huang XM, 2019, HEART VESSELS, V34, P2041, DOI 10.1007/s00380-019-01452-8; Kumar R, 2011, INDIAN PEDIATR, V48, P277, DOI 10.1007/s13312-011-0055-4; Li JN, 2021, GENOMICS, V113, P1, DOI 10.1016/j.ygeno.2020.11.019; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li ZW, 2019, EUR HEART J, V40, P2507, DOI 10.1093/eurheartj/ehz305; Liu HS, 2020, KNOWL-BASED SYST, V191, DOI 10.1016/j.knosys.2019.105261; Liu W, 2022, INTERDISCIP SCI, V14, P168, DOI 10.1007/s12539-021-00478-9; Liu ZH, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0625-6; Luan H, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/8825997; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Spagnoli LG, 2002, J AM COLL CARDIOL, V40, P1579, DOI 10.1016/S0735-1097(02)02376-8; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Minkelen R, 2009, ATHEROSCLEROSIS, V203, P201, DOI 10.1016/j.atherosclerosis.2008.06.029; Van Tassell BW, 2013, CIRCULATION, V128, P1910, DOI 10.1161/CIRCULATIONAHA.113.003199; Varghese GP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003031; Wang CC, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab286; Wang H, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00104; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu TZ, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100141; Yang X, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/8957245; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang L, 2021, INTERDISCIP SCI, V13, P535, DOI 10.1007/s12539-021-00458-z; Zhang L, 2021, GENOMICS, V113, P874, DOI 10.1016/j.ygeno.2021.02.002; Zhuo LA, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1142-0	43	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264362	10.1371/journal.pone.0264362	http://dx.doi.org/10.1371/journal.pone.0264362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231061	Green Published, gold			2022-12-26	WOS:000849744700018
J	Kim, KS; Kim, BK; Chung, MJ; Cho, HB; Cho, BH; Jung, YG				Kim, Kyung-Su; Kim, Byung Kil; Chung, Myung Jin; Cho, Hyun Bin; Cho, Beak Hwan; Jung, Yong Gi			Detection of maxillary sinus fungal ball via 3-D CNN-based artificial intelligence: Fully automated system and clinical validation	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; CLASSIFICATION	Background This study aims to develop artificial intelligence (AI) system to automatically classify patients with maxillary sinus fungal ball (MFB), chronic rhinosinusitis (CRS), and healthy controls (HCs). Methods We collected 512 coronal image sets from ostiomeatal unit computed tomography (OMU CT) performed on subjects who visited a single tertiary hospital. These data included 254 MFB, 128 CRS, and 130 HC subjects and were used for training the proposed AI system. The AI system takes these 1024 sets of half CT images as input and classifies these as MFB, CRS, or HC. To optimize the classification performance, we adopted a 3-D convolutional neural network of ResNet 18. We also collected 64 coronal OMU CT image sets for external validation, including 26 MFB, 18 CRS, and 20 HCs from subjects from another referral hospital. Finally, the performance of the developed AI system was compared with that of the otolaryngology resident physicians. Results Classification performance was evaluated using internal 5-fold cross-validation (818 training and 206 internal validation data) and external validation (128 data). The area under the receiver operating characteristic over the internal 5-fold cross-validation and the external validation was 0.96 +/- 0.006 and 0.97 +/- 0.006, respectively. The accuracy of the internal 5-fold cross-validation and the external validation was 87.5 +/- 2.3% and 88.4 +/- 3.1%, respectively. As a result of performing a classification test on external validation data from six otolaryngology resident physicians, the accuracy was obtained as 84.6 +/- 11.3%. Conclusions This AI system is the first study to classify MFB, CRS, and HC using deep neural networks to the best of our knowledge. The proposed system is fully automatic but performs similarly to or better than otolaryngology resident physicians. Therefore, we believe that in regions where otolaryngology specialists are scarce, the proposed AI will perform sufficiently effective diagnosis on behalf of doctors.	[Kim, Kyung-Su; Chung, Myung Jin; Cho, Hyun Bin; Cho, Beak Hwan; Jung, Yong Gi] Samsung Med Ctr, Med AI Res Ctr, Seoul, South Korea; [Kim, Byung Kil; Jung, Yong Gi] Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea; [Chung, Myung Jin] Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea; [Cho, Beak Hwan] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med Device Management & Res, SAIHST,Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Cho, BH; Jung, YG (corresponding author), Samsung Med Ctr, Med AI Res Ctr, Seoul, South Korea.; Jung, YG (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea.; Cho, BH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Med Device Management & Res, SAIHST,Sch Med, Seoul, South Korea.	baekhwan.cho@samsung.com; ent.jyg@gmail.com		Jung, Yong gi/0000-0001-7456-849X; Kim, Kyung Su/0000-0001-6622-6545; Cho, Baek Hwan/0000-0001-7722-5660	Future Medicine 20*30 Project of the Samsung Medical Center [SMX1210791]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIT [NRF2017M3A9E1064784]	Future Medicine 20*30 Project of the Samsung Medical Center; Bio & Medical Technology Development Program of the NRF - Korean government, MSIT(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This research was supported by the Future Medicine 20*30 Project of the Samsung Medical Center [SMX1210791]. This research was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIT (NRF2017M3A9E1064784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Abduwani J, 2016, AM J OTOLARYNG, V37, P59, DOI 10.1016/j.amjoto.2015.08.002; Alakwaa W, 2017, INT J ADV COMPUT SC, V8, P409; Braun JJ, 2000, J RADIOL, V81, P227; Cha H, 2020, CLIN EXP OTORHINOLAR, V13, P157, DOI 10.21053/ceo.2019.00836; Chowdhury NI, 2019, INT FORUM ALLERGY RH, V9, P46, DOI 10.1002/alr.22196; deShazo RD, 1997, J ALLERGY CLIN IMMUN, V99, P475, DOI 10.1016/S0091-6749(97)70073-3; Dhong HJ, 2000, AM J RHINOL, V14, P227, DOI 10.2500/105065800779954446; Dufour X, 2006, MED MYCOL, V44, P61, DOI 10.1080/13693780500235728; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Fujima N, 2019, CANCERS, V11, DOI 10.3390/cancers11060800; Gao XHW, 2017, COMPUT METH PROG BIO, V138, P49, DOI 10.1016/j.cmpb.2016.10.007; Huang J, 2020, J LARYNGOL OTOL, V134, P52, DOI 10.1017/S0022215119002536; Huang WK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219369; Huang XJ, 2017, I S BIOMED IMAGING, P379, DOI 10.1109/ISBI.2017.7950542; Jeon Y, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11020250; Kay Will, 2017, ARXIV170506950; Kim HG, 2019, QUANT IMAG MED SURG, V9, P942, DOI 10.21037/qims.2019.05.15; Kim Y, 2019, INVEST RADIOL, V54, P7, DOI 10.1097/RLI.0000000000000503; Klossek JM, 1997, LARYNGOSCOPE, V107, P112, DOI 10.1097/00005537-199701000-00021; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Nomura Kazuhiro, 2013, Int J Otolaryngol, V2013, P731640, DOI 10.1155/2013/731640; Parmar P, 2020, J LARYNGOL OTOL, V134, P328, DOI 10.1017/S0022215120000444; Peng HX, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244406; Ramkumar S, 2017, AM J NEURORADIOL, V38, P1019, DOI 10.3174/ajnr.A5106; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Seo YJ, 2011, ACTA RADIOL, V52, P790, DOI 10.1258/ar.2011.110021; STAMMBERGER H, 1984, ANN OTO RHINOL LARYN, V93, P251, DOI 10.1177/000348948409300313; Tan MX, 2019, PR MACH LEARN RES, V97; Uemura T, 2020, PROC SPIE, V11314, DOI 10.1117/12.2549103; Ying X, 2018, CHINA PERSPECT-SER, P1, DOI 10.1088/1742-6596/1168/2/022022; Zhou T, 2021, APPL SOFT COMPUT, V98, DOI 10.1016/j.asoc.2020.106885	31	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263125	10.1371/journal.pone.0263125	http://dx.doi.org/10.1371/journal.pone.0263125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213545	Green Published, gold			2022-12-26	WOS:000787811000015
J	Lee, HJ; Kim, HK; Lee, SC; Ommen, SR; Kim, J; Park, JB; Choi, YJ; Lee, SP; Chang, SA; Kim, YJ				Lee, Hyun-Jung; Kim, Hyung-Kwan; Lee, Sang Chol; Ommen, Steve R.; Kim, Jihoon; Park, Jun-Bean; Choi, You-Jung; Lee, Seung-Pyo; Chang, Sung-A; Kim, Yong-Jin			Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy	PLOS ONE			English	Article							MOUSE MODEL; PULMONARY-HYPERTENSION; SYMPTOMATIC PATIENTS; EUROPEAN-SOCIETY; DISEASE; GENDER; PERFORMANCE; GUIDELINES	Background We aimed to clarify the sex differences in various cardiovascular and non-cardiovascular outcomes, and to investigate whether sex differences in outcomes are affected by age in hypertrophic cardiomyopathy (HCM). Methods A cohort of 835 patients with HCM initially evaluated during 2007-2019 were followed for a median of 6.4 years. Study outcomes were all-cause death, cardiovascular and non-cardiovascular death, sudden cardiac death (SCD)/SCD equivalent events, heart failure (HF) events, and the composite cardiovascular outcome including cardiovascular death, SCD/SCD equivalent events, admission for HF, and heart transplantation. Results Women were 5 years older (women 59.9 +/- 13.5 vs. men 54.9 +/- 11.4 years), had worse dyspnea, and greater left ventricular (LV) diastolic dysfunction and obstructive physiology at presentation. Women compared to men had higher all-cause mortality and cardiovascular event rates, driven by more cardiovascular deaths and heart failure (HF) events. Conversely, non-cardiovascular mortality was not different between the sexes. Female sex was independently associated with all-cause death (HR 1.88, 95% CI 1.11-3.20) and composite cardiovascular events (HR 3.60, 95% CI 2.00-6.49), independent of age, body mass index, New York Heart Association class, SCD risk score, and LV ejection fraction. When stratified by the age of 60, sex differences were not significant at <60 years; however, at >= 60 years, women had worse LV diastolic function, greater obstructive physiology, as well as worse survival and composite cardiovascular outcomes. Sex differences in outcomes remained consistent after propensity score matching for age and other clinical characteristics. Conclusions Women with HCM have worse cardiovascular prognosis than men, driven by higher cardiovascular mortality and HF events. The negative impact of female sex on cardiac function and cardiovascular outcome became prominent at age >= 60 years, suggesting age-related sex differences in the prognosis of HCM.	[Lee, Hyun-Jung; Kim, Hyung-Kwan; Park, Jun-Bean; Choi, You-Jung; Lee, Seung-Pyo; Kim, Yong-Jin] Seoul Natl Univ, Seoul Natl Univ Hosp, Cardiovasc Ctr, Sch Med, Seoul, South Korea; [Lee, Sang Chol; Kim, Jihoon; Chang, Sung-A] Sungkyunkwan Univ, Cardiovasc Imaging Ctr, Samsung Med Ctr, Heart Vasc Stroke Inst,Sch Med, Seoul, South Korea; [Ommen, Steve R.] Mayo Clin, Div Cardiovasc Dis, Coll Med, Rochester, MN USA	Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Mayo Clinic	Kim, HK (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Cardiovasc Ctr, Sch Med, Seoul, South Korea.; Lee, SC (corresponding author), Sungkyunkwan Univ, Cardiovasc Imaging Ctr, Samsung Med Ctr, Heart Vasc Stroke Inst,Sch Med, Seoul, South Korea.	cardiman73@gmail.com; chrislee.echo@gmail.com		Lee, Sang-Chol/0000-0003-2176-0482; Lee, Hyun-Jung/0000-0002-7498-0705; Kim, Hyung-Kwan/0000-0001-7950-2131				Batzner A, 2021, INT J CARDIOL, V328, P117, DOI 10.1016/j.ijcard.2020.12.039; Canepa M, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007230; Chen YZ, 2015, J STEROID BIOCHEM, V147, P92, DOI 10.1016/j.jsbmb.2014.12.011; Cheng S, 2013, CIRC-CARDIOVASC IMAG, V6, P692, DOI 10.1161/CIRCIMAGING.112.000627; Cheng S, 2010, CIRCULATION, V122, P570, DOI 10.1161/CIRCULATIONAHA.110.937821; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Geske JB, 2017, EUR HEART J, V38, P3434, DOI 10.1093/eurheartj/ehx527; Ghiselli L, 2020, EUR J PREV CARDIOL, V27, P1821, DOI 10.1177/2047487319886961; Gokce Mustafa, 2003, Am J Ther, V10, P104; Ho CY, 2018, CIRCULATION, V138, P1387, DOI 10.1161/CIRCULATIONAHA.117.033200; Jones KMD, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14396; Kim M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84335-1; Kitaoka H, 2013, EUR HEART J-CARD IMG, V14, P544, DOI 10.1093/ehjci/jes200; KRUMHOLZ HM, 1993, AM J CARDIOL, V72, P310, DOI 10.1016/0002-9149(93)90678-6; Lakdawala NK, 2021, CIRC-GENOM PRECIS ME, V14, DOI 10.1161/CIRCGEN.120.003062; Light KC, 2001, J HYPERTENS, V19, P269, DOI 10.1097/00004872-200102000-00014; Lu DY, 2020, AM HEART J, V219, P58, DOI 10.1016/j.ahj.2019.10.004; Maron BJ, 2016, JAMA CARDIOL, V1, P98, DOI 10.1001/jamacardio.2015.0354; Maron BJ, 2013, CIRCULATION, V127, P585, DOI 10.1161/CIRCULATIONAHA.112.136085; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Merz AA, 2016, HEART, V102, P825, DOI 10.1136/heartjnl-2015-308769; Moon I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227012; Mosca L, 2004, CIRCULATION, V109, P573, DOI 10.1161/01.CIR.0000115222.69428.C9; Musumeci MB, 2017, INT J CARDIOL, V248, P326, DOI 10.1016/j.ijcard.2017.07.010; Nijenkamp LLAM, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004133; O'Mahony C, 2018, CIRCULATION, V137, P1015, DOI 10.1161/CIRCULATIONAHA.117.030437; O'Neil A, 2018, CIRCULATION, V137, P854, DOI 10.1161/CIRCULATIONAHA.117.028595; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Olsson MC, 2001, AM J PHYSIOL-HEART C, V280, pH1136, DOI 10.1152/ajpheart.2001.280.3.H1136; Ong KC, 2016, EUR HEART J-CARD IMG, V17, P604, DOI 10.1093/ehjci/jew024; Palmer BM, 2008, AM J PHYSIOL-HEART C, V294, pH1939, DOI 10.1152/ajpheart.00644.2007; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Rowin EJ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012041; Sabbatini AR, 2020, J AM COLL CARDIOL, V75, P1074, DOI 10.1016/j.jacc.2019.12.049; van Driel B, 2019, CURR OPIN CARDIOL, V34, DOI 10.1097/HCO.0000000000000612; Wang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102969	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264580	10.1371/journal.pone.0264580	http://dx.doi.org/10.1371/journal.pone.0264580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213653	Green Published, gold			2022-12-26	WOS:000787811000126
J	Rubina, K; Shmakova, A; Shabanov, A; Andreev, Y; Borovkova, N; Kulabukhov, V; Evseev, A; Popugaev, K; Petrikov, S; Semina, E				Rubina, Kseniya; Shmakova, Anna; Shabanov, Aslan; Andreev, Yulii; Borovkova, Natalia; Kulabukhov, Vladimir; Evseev, Anatoliy; Popugaev, Konstantin; Petrikov, Sergey; Semina, Ekaterina			Novel prognostic determinants of COVID-19-related mortality: A pilot study on severely-ill patients in Russia	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; CORONAVIRUS DISEASE 2019; NEUTROPHIL-LYMPHOCYTE; D-DIMER; CYTOKINE	COVID-19 pandemic has posed a severe healthcare challenge calling for an integrated approach in determining the clues for early non-invasive diagnostics of the potentially severe cases and efficient patient stratification. Here we analyze the clinical, laboratory and CT scan characteristics associated with high risk of COVID-19-related death outcome in the cohort of severely-ill patients in Russia. The data obtained reveal that elevated dead lymphocyte counts, decreased early apoptotic lymphocytes, decreased CD14+/HLA-Dr+ monocytes, increased expression of JNK in PBMCs, elevated IL-17 and decreased PAI-1 serum levels are associated with a high risk of COVID-19-related mortality thus suggesting them to be new prognostic factors. This set of determinants could be used as early predictors of potentially severe course of COVID-19 for trials of prevention or timely treatment.	[Rubina, Kseniya] Lomonosov Moscow State Univ, Fac Med, Lab Morphogenesis & Tissue Reparat, Moscow, Russia; [Shmakova, Anna; Semina, Ekaterina] Fed State Budgetary Org Natl Cardiol Res Ctr Mini, Inst Expt Cardiol, Lab Mol Endocrinol, Moscow, Russia; [Shabanov, Aslan; Andreev, Yulii; Borovkova, Natalia; Kulabukhov, Vladimir; Evseev, Anatoliy; Popugaev, Konstantin; Petrikov, Sergey] Moscow Healthcare Dept, Dept Intens Care, Sklifosovsky Res Inst Emergency Med, Moscow, Russia; [Semina, Ekaterina] Lomonosov Moscow State Univ, Fac Med, Dept Biochem & Mol Med, Moscow, Russia	Lomonosov Moscow State University; National Medical Research Center of Cardiology; Lomonosov Moscow State University	Rubina, K (corresponding author), Lomonosov Moscow State Univ, Fac Med, Lab Morphogenesis & Tissue Reparat, Moscow, Russia.	kseniiarubina1971@gmail.com	Shmakova, Anna/AAC-4735-2019; Rubina, Kseniya/A-8208-2014	Semina, Ekaterina/0000-0002-3927-9286; Rubina, Kseniya/0000-0002-7166-7406	Russian Foundation for Basic Research [20-24-60029]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The reported study was funded by Russian Foundation for Basic Research (https:// www.rfbr.ru/rffi/eng) according to the research project 20-24-60029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld SC, 2020, CRIT CARE MED, V48, pE799, DOI 10.1097/CCM.0000000000004457; Cabrera-Garcia D., 2021, HIGH LEVELS PLASMINO, DOI [10.1101/2020.12.29.20248869, DOI 10.1101/2020.12.29.20248869]; Celikbilek M, 2013, J CLIN LAB ANAL, V27, P72, DOI 10.1002/jcla.21564; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Cheng AY, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106110; Coleman JJ, 2020, POSTGRAD MED J, V96, P392, DOI 10.1136/postgradmedj-2020-137979; Cron RQ, 2021, LANCET RHEUMATOL, V3, pE236, DOI 10.1016/S2665-9913(21)00011-4; Cugno M, 2021, J AUTOIMMUN, V116, DOI 10.1016/j.jaut.2020.102560; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]; Dempsey LA, 2020, NAT IMMUNOL, V21, P596, DOI 10.1038/s41590-020-0702-9; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; Fathi N, 2020, CELL BIOL INT, V44, P1792, DOI 10.1002/cbin.11403; Fruchter O, 2015, AM J MED SCI, V349, P29, DOI 10.1097/MAJ.0000000000000332; Ge YL, 2019, CLIN LAB, V65, P131, DOI 10.7754/Clin.Lab.2018.180720; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gong J, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05681-5; Hemmat N, 2021, ARCH VIROL, V166, P675, DOI 10.1007/s00705-021-04958-7; Hu YQ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237302; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang HC, 2019, CANCER MANAG RES, V11, P5157, DOI 10.2147/CMAR.S192532; Huang YS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242045; Ioannou GN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22310; Izcovich A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241955; Ji HL, 2020, PHYSIOL REV, V100, P1065, DOI 10.1152/physrev.00013.2020; Kang SJ, 2020, P NATL ACAD SCI USA, V117, P22351, DOI 10.1073/pnas.2010229117; Kearns SM, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.14843; Kilercik M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254073; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Lei Q, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79183-4; Leija-Martinez JJ, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109935; Li K., 2020, RADIOGRAPHIC FINDING, V236, P1067, DOI 10.1101/2020.03.23.20041673; Li M, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00545; Mahallawi WH, 2018, CYTOKINE, V104, P8, DOI 10.1016/j.cyto.2018.01.025; Martins PR, 2020, EUR J INTERN MED, V76, P97, DOI 10.1016/j.ejim.2020.04.043; Matsuyama T, 2020, CELL DEATH DIFFER, V27, P3209, DOI 10.1038/s41418-020-00633-7; Mery G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01714; Mesas AE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241742; Mikami T, 2021, J GEN INTERN MED, V36, P17, DOI 10.1007/s11606-020-05983-z; Mortaz E, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.592727; Oliveira E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249038; Pacha O, 2020, NAT REV IMMUNOL, V20, P345, DOI 10.1038/s41577-020-0328-z; Parrino J, 2007, EMERG INFECT DIS, V13, P191, DOI 10.3201/eid1302.060963; Patel Urvish, 2020, SN Compr Clin Med, V2, P1740, DOI 10.1007/s42399-020-00476-w; Rizo-Tellez SA, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8101560; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Shirato K, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06187; Solimani F, 2021, EUR J IMMUNOL, V51, P1071, DOI 10.1002/eji.202149173; Somova LM, 2014, INFEKTSIYA IMMUN, V4, P303, DOI 10.15789/2220-7619-2014-4-303-318; Tabatabaei SMH, 2020, EUR J RADIOL, V132, DOI 10.1016/j.ejrad.2020.109298; Taghiloo S, 2021, J MED VIROL, V93, P1589, DOI 10.1002/jmv.26505; Umemura Y, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092875; Wang HW, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0148-0; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; Wang Y, 2020, AM J RESP CRIT CARE, V201, P1430, DOI 10.1164/rccm.202003-0736LE; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; World Health Organization, 2021, COR DIS COVID 19 SIT; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xie MM, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181987; Ye WJ, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01428-7; Zhang SY, 2020, NAT REV IMMUNOL, V20, P455, DOI 10.1038/s41577-020-0373-7; Zhang XB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246030; Zhang Y, 2003, INFECT IMMUN, V71, P1513, DOI 10.1128/IAI.71.3.1513-1519.2003; Zhao Y, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00723-1; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zuo Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80010-z	66	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264072	10.1371/journal.pone.0264072	http://dx.doi.org/10.1371/journal.pone.0264072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213582	Green Published, gold, Green Submitted			2022-12-26	WOS:000787811000046
J	Zhu, LY; Lansink, AO				Zhu, Liyun; Lansink, Alfons Oude			Dynamic sustainable productivity growth of Dutch dairy farming	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; ANIMAL-WELFARE; ENVIRONMENTAL-IMPACT; TECHNICAL EFFICIENCY; DECISION-MAKING; SUBSIDIES; PERFORMANCE; HEALTH; CATTLE; MODEL	The economic, environmental and social sustainability of Dutch dairy farms have attracted increasing societal concern in the past decades. In this paper, we propose a recently developed dynamic Luenberger indicator based on the by-production model to measure dynamic productivity growth in the economic, environmental and social dimensions of sustainability of Dutch dairy farms. Subsequently, we investigate the statistical associations between productivity growth and socio-economic factors using the OLS bootstrap regression model. We find that dairy farms have suffered a decline in dynamic sustainable productivity growth, especially in the environmental dimension where it is more pronounced than in the economic and social dimensions. Furthermore, we find that both technical and scale inefficiency change contribute to the decline of environmental productivity growth. Specialization and government support are associated with a higher economic and environmental sustainability productivity growth, and with, a decreased growth of social sustainable productivity. We found no significant association between the age of the oldest entrepreneur, financial structure, farm size or cost of advisory service and dynamic productivity growth in the three sustainability dimensions. The results provide insights into potential pathways towards improving the three pillars of sustainability.	[Zhu, Liyun] Hebei Agr Univ, Baoding, Hebei, Peoples R China; [Lansink, Alfons Oude] Wageningen Univ, Wageningen, Netherlands	Hebei Agricultural University; Wageningen University & Research	Lansink, AO (corresponding author), Wageningen Univ, Wageningen, Netherlands.	alfons.oudelansink@wur.nl	Oude Lansink, Alfons GJM/H-8840-2012	Oude Lansink, Alfons GJM/0000-0002-9273-6044	Hebei Province Science and Technology Plan Soft Science Research Special Fund [205576173D]	Hebei Province Science and Technology Plan Soft Science Research Special Fund	The authors also would like to thank the financial support provided by Hebei Province Science and Technology Plan Soft Science Research Special Fund (205576173D).	Acosta-Alba I, 2012, RENEW AGR FOOD SYST, V27, P217, DOI 10.1017/S1742170511000329; Allendorf JJ, 2015, J DAIRY SCI, V98, P7730, DOI 10.3168/jds.2015-9390; Armagan G, 2012, QUAL QUANT, V46, P351, DOI 10.1007/s11135-010-9360-6; Armbrecht L., 2015, P ANIMAL HUSBANDRY T, V10, P70; Bailey J. S., 2016, STEP SUSTAINABLE LIV; Barnes AP, 2011, J DAIRY SCI, V94, P5449, DOI 10.3168/jds.2011-4262; Barry J, 2019, ANIM WELFARE, V28, P331, DOI 10.7120/09627286.28.3.331; Berger AN, 2006, J BANK FINANC, V30, P1065, DOI 10.1016/j.jbankfin.2005.05.015; Briec W, 2009, ECON MODEL, V26, P597, DOI 10.1016/j.econmod.2009.01.007; Burow E, 2013, ANIMAL, V7, P834, DOI 10.1017/S1751731112002297; Buys L, 2014, J ENVIRON MANAGE, V133, P184, DOI 10.1016/j.jenvman.2013.12.013; Chen WH, 2017, INT J LIFE CYCLE ASS, V22, P1459, DOI 10.1007/s11367-016-1250-2; Chung YH, 1997, J ENVIRON MANAGE, V51, P229, DOI 10.1006/jema.1997.0146; Dakpo K. H., 2015, EAAE PHD WORKSHOP; Dakpo KH, 2019, EUR J OPER RES, V276, P202, DOI 10.1016/j.ejor.2018.12.040; de Vries M, 2013, J DAIRY SCI, V96, P6264, DOI 10.3168/jds.2012-6129; ESWARAN M, 1986, ECON J, V96, P482, DOI 10.2307/2233128; European Commission, 2015, ATTITUDES EUROPEANS; Featherstone AM, 2005, AGRIC FINANCE REV, V65, P97, DOI 10.1108/00214660580001163; Forgacs C., 2017, OECONOMIA, V16, P13; Foster A.D., 2017, NBER WORKING PAPER N; Gazola MG, 2018, SEMIN-CIENC AGRAR, V39, P2685, DOI 10.5433/1679-0359.2018v39n6p2685; Giordano JO, 2011, J DAIRY SCI, V94, P6216, DOI 10.3168/jds.2011-4376; Guan ZF, 2006, AM J AGR ECON, V88, P644, DOI 10.1111/j.1467-8276.2006.00885.x; Guerci M, 2013, J CLEAN PROD, V54, P133, DOI 10.1016/j.jclepro.2013.04.035; Guyomard H., 2006, 96 EAAE SEMINAR; Hou Y, 2016, AGR ECOSYST ENVIRON, V218, P232, DOI 10.1016/j.agee.2015.11.025; Ingenbleek PTM, 2011, ANIM WELFARE, V20, P11; Ingvartsen KL, 2003, LIVEST PROD SCI, V83, P277, DOI 10.1016/S0301-6226(03)00110-6; Kapelko M, 2017, AGR ECON-BLACKWELL, V48, P561, DOI 10.1111/agec.12357; Kapelko M, 2017, J AGR ECON, V68, P579, DOI 10.1111/1477-9552.12188; Kapelko M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128217; Kapelko M, 2015, OMEGA-INT J MANAGE S, V54, P116, DOI 10.1016/j.omega.2015.01.010; Kazukauskas A., 2011, TRINITY EC PAPERS, V0411; Khan M. I., 2018, Pakistan Journal of Science, V70, P131; Kimura S., 2015, OECD FOOD AGR FISHER, V87, P1; Kleinhanss W, 2015, LANDBAUFORSCHUNG-GER, V65, P217, DOI 10.3220/LBF1446717620000; Kumbhakar SC, 2010, STUD PRODUCT EFFIC, V7, P109, DOI 10.1007/978-1-4419-6385-7_6; Lansink AO, 2015, J PROD ANAL, V44, P189, DOI 10.1007/s11123-014-0423-x; Lansink AO, 2015, EUR J OPER RES, V241, P555, DOI 10.1016/j.ejor.2014.09.027; Lapple D, 2019, J AGR ECON, V70, P178, DOI 10.1111/1477-9552.12282; Latruffe L, 2005, AGR ECON-BLACKWELL, V32, P281, DOI 10.1111/j.1574-0862.2005.00322.x; Latruffe L., 2016, Review of Agricultural, Food and Environmental Studies, V97, P15, DOI 10.1007/s41130-016-0007-4; Latruffe L, 2012, ECON SYST, V36, P264, DOI 10.1016/j.ecosys.2011.07.002; Lovarelli D, 2019, ITAL J ANIM SCI, V18, P1035, DOI 10.1080/1828051X.2019.1611389; Madau F. A., 2017, Agricultural and Food Economics, V5, DOI 10.1186/s40100-017-0085-x; Mary S, 2013, J AGR ECON, V64, P133, DOI 10.1111/j.1477-9552.2012.00365.x; Mas K., 2016, ADV ANIMAL BIOSCIENC, V7, P259; Matthews A, 2013, IMPACT CAP SUBSIDIES; McCloud N, 2008, ADV ECONOMETRICS, V23, P245, DOI 10.1016/S0731-9053(08)23008-2; McGlone JJ, 2001, LIVEST PROD SCI, V72, P75, DOI 10.1016/S0301-6226(01)00268-8; McLellan EL, 2018, BIOSCIENCE, V68, P194, DOI 10.1093/biosci/bix164; Melhim A, 2011, APPL ECON, V43, P3849, DOI 10.1080/00036841003724478; Montabon F, 2016, J SUPPLY CHAIN MANAG, V52, P11, DOI 10.1111/jscm.12103; Moreira VH, 2016, J DAIRY SCI, V99, P8356, DOI 10.3168/jds.2016-11055; Murty S, 2012, J ENVIRON ECON MANAG, V64, P117, DOI 10.1016/j.jeem.2012.02.005; Nahed J, 2019, AGROECOL SUST FOOD, V43, P605, DOI 10.1080/21683565.2018.1534302; Noordhuizen JPTM, 2005, LIVEST PROD SCI, V94, P51, DOI 10.1016/j.livprodsci.2004.11.031; O'Brien D, 2012, AGR SYST, V107, P33, DOI 10.1016/j.agsy.2011.11.004; Olmos G, 2009, ANIM WELFARE, V18, P467; Oltenacu PA, 2010, ANIM WELFARE, V19, P39; Rahman S, 2009, FOOD POLICY, V34, P340, DOI 10.1016/j.foodpol.2009.02.004; Rizov M, 2013, J AGR ECON, V64, P537, DOI 10.1111/1477-9552.12030; Schulte HD, 2018, LAND USE POLICY, V79, P375, DOI 10.1016/j.landusepol.2018.07.005; Segerkvist KA, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145502; SEN Amartya Kumar., 1962, Economic Weekly, V14, P243; Shaik S, 2015, EUR J OPER RES, V245, P463, DOI 10.1016/j.ejor.2015.03.018; Sheng Y, 2019, FOOD POLICY, V84, P196, DOI 10.1016/j.foodpol.2018.03.012; Silva E, 2015, INT J PROD ECON, V168, P245, DOI 10.1016/j.ijpe.2015.06.027; Simar L, 2007, J ECONOMETRICS, V136, P31, DOI 10.1016/j.jeconom.2005.07.009; Skevas I, 2018, EUR J OPER RES, V271, P250, DOI 10.1016/j.ejor.2018.04.050; Thomassen MA, 2005, AGR ECOSYST ENVIRON, V111, P185, DOI 10.1016/j.agee.2005.06.013; Tremetsberger L, 2019, ANIM WELFARE, V28, P345, DOI 10.7120/09627286.28.3.345; van Asselt ED, 2015, INT DAIRY J, V47, P19, DOI 10.1016/j.idairyj.2015.02.007; Wagner K, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8010001; Weiss CR, 1999, AM J AGR ECON, V81, P103, DOI 10.2307/1244454; Yan MJ, 2011, J ENVIRON MANAGE, V92, P372, DOI 10.1016/j.jenvman.2010.10.025; Zhou HB, 2018, EUR J OPER RES, V264, P1, DOI [10.1016/j.ejor.2017.06.023, 10.1016/j.ejor2017.06.023]	78	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264410	10.1371/journal.pone.0264410	http://dx.doi.org/10.1371/journal.pone.0264410			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213644	gold, Green Published			2022-12-26	WOS:000787811000093
J	Adedeji-Adenola, H; Olugbake, OA; Adeosun, SA				Adedeji-Adenola, Halimat; Olugbake, Olubusola A.; Adeosun, Shakirat A.			Factors influencing COVID-19 vaccine uptake among adults in Nigeria	PLOS ONE			English	Article							WILLINGNESS; AWARENESS	Background Emerging variants of Coronavirus disease 2019 (COVID-19) has claimed over 3000 lives in Nigeria and vaccination remains a means of reducing the death toll. Despite ongoing efforts by the government to ensure COVID-19 vaccination of most residents to attain herd immunity, myths and beliefs have adversely shaped the perception of most Nigerians, challenging the uptake of COVID-19 vaccine. This study aimed to assess the factors influencing the awareness, perception, and willingness to receive COVID-19 vaccine among Nigerian adults. Methods A cross-sectional online nationwide study was conducted from April to June 2021 among Nigerian adult population using the snowballing method. Descriptive analysis was used to summarise the data. Univariate and multivariate analysis was used to identify the predictors of COVID-19 uptake among the respondents. A p value <0.05 was considered significant. Results A total of 1058 completed forms were analysed and 63.9% were females. The mean age was 40.8 years12.2 years. Most of the respondents (740; 69.5%) had satisfactory awareness of the vaccination exercise. The media was the main source of information. Health workers reported higher level of awareness (aOR = 1.822, 95% CI: 1.388-2.524, p<0.001). Respondents that are Christians and Muslims had better awareness compared to the unaffiliated (aOR = 6.398, 95% CI: 1.918-21.338, P = 0.003) and (aOR = 7.595, 95% CI: 2.280-25.301, p<0.001) respectively. There is average score for perception statements (566; 53.2%) towards COVID-19 vaccination. Close to half of the respondents (44.2%) found the short period of COVID-19 production worrisome. Majority of the respondents were willing to get the vaccine (856; 80.9%). Those without a prior diagnosis of COVID-19 had a lower willingness to get vaccinated (aOR = 0.210 (95% CI: 0.082-0.536) P = 0.001). Conclusion The study revealed a high level of awareness, willingness to receive the vaccine and moderate perception towards the vaccination activities. Influencing factors that significantly affects awareness were religion, occupation, education and prior diagnosis of COVID-19; for perception and willingness-occupation, and prior diagnosis of the COVID-19 were influencing factors.	[Adedeji-Adenola, Halimat] Univ KwaZulu Natal, Discipline Pharmaceut Sci, Durban, South Africa; [Adedeji-Adenola, Halimat; Adeosun, Shakirat A.] Lagos State Primary Healthcare Board, Directorate Pharmaceut Serv, Lagos, Lagos State, Nigeria; [Olugbake, Olubusola A.; Adeosun, Shakirat A.] Univ Lagos, Fac Pharm, Lagos, Lagos State, Nigeria	University of Kwazulu Natal; University of Lagos	Adedeji-Adenola, H (corresponding author), Univ KwaZulu Natal, Discipline Pharmaceut Sci, Durban, South Africa.; Adedeji-Adenola, H (corresponding author), Lagos State Primary Healthcare Board, Directorate Pharmaceut Serv, Lagos, Lagos State, Nigeria.	yembol2011@yahoo.com	Adedeji-Adenola, Halimat/AHD-2044-2022	Adedeji-Adenola, Halimat/0000-0003-0522-0742				Adams SH, 2021, J ADOLESCENT HEALTH, V69, P511, DOI 10.1016/j.jadohealth.2021.06.003; Adejumo Oluseyi Ademola, 2021, Osong Public Health Res Perspect, V12, P236, DOI 10.24171/j.phrp.2021.0023; Alhassan RK, 2021, TROP MED HEALTH, V49, DOI 10.1186/s41182-021-00357-5; Angelo AT, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257109; Bari MS, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9121449; Bitar AN, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248325; Daly M, 2021, AM J PREV MED, V60, P766, DOI 10.1016/j.amepre.2021.01.008; Dean AG, 2013, OPENEPI OPEN SOURCE; El-Elimat T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250555; Emergencies SAGf, 2020, FACTORS INFLUENCING; Enitan SS., 2020, INT J VACCINE IMMUNI, V4, P1, DOI [10.16966/2470-9948.123, DOI 10.16966/2470-9948.123]; Gan L, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041993; GAVI, 2021, COVAX UPD PART DEL D; Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918; Handout-Feb SC., 2021, HEALTH-LONDON; Islam MS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11880-9; Karlsson LC, 2021, PERS INDIV DIFFER, V172, DOI 10.1016/j.paid.2020.110590; Lamptey E, 2021, CLIN EXP VACCINE RES, V10, P183, DOI 10.7774/cevr.2021.10.2.183; Latkin CA, 2021, SOC SCI MED, V270, DOI 10.1016/j.socscimed.2021.113684; Malik AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100495; Mannan DK, 2020, INT RES J BUSINESS S, V6; Mesesle M, 2021, INFECT DRUG RESIST, V14, P2193, DOI 10.2147/IDR.S316461; Mohamed NA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256110; Motta M., 2021, FRONTIERS POLITICAL, V3, P1, DOI [10.3389/fpos.2021.630133, DOI 10.3389/FPOS.2021.630133]; NigeriaHealthWatch, 2021, CONSPIRACY THEORIES; PremiumTimes, 2021, PREMIUMTIMES; Qattan AMN, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.644300; Rzymski P, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040382; Schwitzer G, 2005, PLOS MED, V2, P576, DOI 10.1371/journal.pmed.0020215; Seale H, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05833-1; Stanton NA, 2001, SAFETY SCI, V39, P189, DOI 10.1016/S0925-7535(01)00010-8; UNICEF, 2021, COMM LEAD TAK LEAD T; Vanguard, 2021, FAC LAUNCH COVID 19; Verger P, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.3.2002047; Wang M-W., 2021, COVID 19 VACCINATION; World Population Review, 2021, NIG 2021	36	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264371	10.1371/journal.pone.0264371	http://dx.doi.org/10.1371/journal.pone.0264371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202444	Green Published, gold			2022-12-26	WOS:000773224600036
J	Prestes, L; Barthem, R; Mello, A; Anderson, E; Correa, SB; Couto, TBD; Venticinque, E; Forsberg, B; Canas, C; Bentes, B; Goulding, M				Prestes, Luiza; Barthem, Ronaldo; Mello-Filho, Adauto; Anderson, Elizabeth; Correa, Sandra B.; D'Araujo Couto, Thiago Belisario; Venticinque, Eduardo; Forsberg, Bruce; Canas, Carlos; Bentes, Bianca; Goulding, Michael			Proactively averting the collapse of Amazon fisheries based on three migratory flagship species	PLOS ONE			English	Article							TAMBAQUI COLOSSOMA-MACROPOMUM; CATFISH BRACHYPLATYSTOMA-ROUSSEAUXII; FLOODPLAIN LAKES; TOCANTINS RIVER; MIDDLE SOLIMOES; SEED DISPERSAL; FISH; MANAGEMENT; ABUNDANCE; BASIN	Migratory species are the most important commercial fishes in the Amazon. They are also now the most threatened directly by some combination of overfishing, floodplain deforestation, and dam construction. Limited governmental monitoring and implemented regulations impede adequate management of the fisheries at adequate scale. We summarize the current stock status of the three most heavily exploited long-distance migratory species, which are two goliath catfishes (Brachyplatystoma rousseauxii and B. vaillantii) and the characiform Colossoma macropomum. In addition, we analyze impacts beyond overfishing on these species. Our results indicate: (i) the overfishing trends for these important species are either ominous or indicate the verge of collapse of the commercial fisheries based on them, and (ii) a dangerous synergy between overfishing, hydroelectric dams, and floodplain deforestation further challenge fisheries management of migratory species in the Amazon. We propose eight direct governmental actions as a proactive approach that addresses the main impacts on the fisheries. We consider that the most practical way to assess and manage overfishing of migratory species in the short run in an area as large as the main commercial fishing area in the Amazon is at market sites where enforced regulations can control fish catch. The management of the three species considered here has implications beyond just their sustainability. Their management would represent a paradigm shift where the governments assume their legal responsibilities in fishery management. These responsibilities include regulation enforcement, data collecting, inter-jurisdictional cooperation to protect migratory species at realistic life history scales, mitigation of the Madeira dams to assure goliath catfish passage to the largest western headwater region, and recognition of monitoring and managing wetland deforestation for the protection of fish and other aquatic and terrestrial biodiversity.	[Prestes, Luiza] Univ Estado Amapa, Programa Grad Engn Pesca, Macapa, Amapa, Brazil; [Barthem, Ronaldo] Museu Paraense Emilio Goeldi, Coordenacao Ciencias Terra & Ecol, Campus Pesquisa, Belem, Para, Brazil; [Mello-Filho, Adauto] Univ Fed Para, Programa Posgrad Ecol Aquat & Pesca, Belem, Para, Brazil; [Anderson, Elizabeth; D'Araujo Couto, Thiago Belisario] Florida Int Univ, Inst Environm, Miami, FL 33199 USA; [Correa, Sandra B.] Mississippi State Univ, Aquat Ecol, Dept Wildlife Fisheries & Aquaculture, Starville, MS USA; [Venticinque, Eduardo] Univ Fed Rio Grande do Norte UFRN, Natal, RN, Brazil; [Forsberg, Bruce] Vermont Dept Environm Conservat, Montpelier, VT USA; [Canas, Carlos] Battelle Mem Inst, Natl Ecol Observ Network, Gainesville, FL USA; [Bentes, Bianca] Univ Fed Para, Lab Biol Pesqueira & Manejo Recursos Aquat, Nucleo Ecol Aquat & Pesca, Belem, Para, Brazil; [Goulding, Michael] Wildlife Conservat Soc WCS, New York, NY USA	Museu Paraense Emilio Goeldi; Universidade Federal do Para; State University System of Florida; Florida International University; Mississippi State University; Universidade Federal do Rio Grande do Norte; Universidade Federal do Para	Prestes, L (corresponding author), Univ Estado Amapa, Programa Grad Engn Pesca, Macapa, Amapa, Brazil.	luliprestes@gmail.com	; Barthem, Ronaldo/K-1875-2015	forsberg, bruce/0000-0001-7606-0585; Prestes, Luiza/0000-0002-4942-5777; Barthem, Ronaldo/0000-0002-9919-0478; Canas, Carlos/0000-0001-9076-6525; Correa, Sandra Bibiana/0000-0003-4466-6923	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88881.188790/2018-01]; Wildlife Conservation Society (WCS); Gordon Betty Moore Foundation	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Wildlife Conservation Society (WCS); Gordon Betty Moore Foundation(Gordon and Betty Moore Foundation)	& nbsp;LP was supported by a doctoral fellowship (grant 88881.188790/2018-01) provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The authors thank the financial support from Wildlife Conservation Society (WCS), and the Gordon Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho CS, 2007, NEOTROP ICHTHYOL, V5, P205, DOI 10.1590/S1679-62252007000200015; Cordoba EA, 2013, NEOTROP ICHTHYOL, V11, P637, DOI 10.1590/S1679-62252013000300017; Agudelo-Cordoba E., 2000, BAGRES AMAZONIA COLO; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Allen MS, 2013, FISHERIES MANAG ECOL, V20, P247, DOI 10.1111/j.1365-2400.2012.00871.x; Almeida OTd., 2006, IND PESQUEIRA AMAZON; Almeida RM, 2020, FRONT ENV SCI-SWITZ, V8, DOI 10.3389/fenvs.2020.00120; Anderson EP, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1642; Anderson JT, 2011, P ROY SOC B-BIOL SCI, V278, P3329, DOI 10.1098/rspb.2011.0155; Anderson JT, 2009, OECOLOGIA, V161, P279, DOI 10.1007/s00442-009-1371-4; Arantes CC, 2018, J APPL ECOL, V55, P386, DOI 10.1111/1365-2664.12967; Arantes ML, 2016, FISHERIES MANAG ECOL, V23, P133, DOI 10.1111/fme.12164; Araujo JM, 2021, J APPL ECOL, V58, P1499, DOI 10.1111/1365-2664.13891; Araujo-Lima C., 1997, SO FRUITFUL FISH ECO, V12; Araujo-Lima CARM, 1998, J FISH BIOL, V53, P297, DOI 10.1006/jfbi.1998.0815; Araujo-Lima CARM, 1984, THESIS U FEDERAL DO; Barthem R., 1997, CATFISH CONNECTION E; Barthem RB., 1995, DIAGNOSTICO RECURSOS; Barthem RB, 2017, SCI REP-UK, V7, DOI 10.1038/srep41784; Barthem Ronaldo Borges, 1995, P329; Barthem RB, 2015, BOL INST PESCA, V41, P249; Batista JS, 2006, GENET MOL RES, V5, P723; Batista VdS., 1998, THESIS FUNDACAO U AM; Batista VdS., 2012, PEIXES PESCA NO SOLI; Bayley PB, 1989, CAN SPEC PUBL FISH A, V106, P385; Bayley PB., 1996, STATUS FISHERIES FIS; Campos CP, 2015, FISHERIES MANAG ECOL, V22, P400, DOI 10.1111/fme.12139; Campos-Silva JV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34745; Canas C., 1999, EVALUACION RECURSOS, P1; Canas CM, 2011, RIVER RES APPL, V27, P602, DOI 10.1002/rra.1377; Capitani L, 2021, REG ENVIRON CHANGE, V21, DOI 10.1007/s10113-021-01777-z; Carvajal-Vallejos FM, 2014, GENETICA, V142, P323, DOI 10.1007/s10709-014-9777-2; Castello L., 2017, FISH FISH, P1; Castello L, 2019, REV FISH BIOL FISHER, V29, P487, DOI 10.1007/s11160-019-09559-x; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Castello L, 2011, FISH RES, V110, P356, DOI 10.1016/j.fishres.2011.05.002; Klautau AGCD, 2016, BOL INST PESCA, V42, P102, DOI 10.5007/1678-2305.2016v42n1p102; Chapman BB, 2012, J FISH BIOL, V81, P479, DOI 10.1111/j.1095-8649.2012.03349.x; Correa SB, 2007, BIOSCIENCE, V57, P748, DOI 10.1641/B570907; Correa SB, 2015, BIOL CONSERV, V191, P159, DOI 10.1016/j.biocon.2015.06.019; Correa SB, 2015, BIOL REV, V90, P1263, DOI 10.1111/brv.12153; Costa LRF, 2013, BRAZ J BIOL, V73, P397, DOI 10.1590/S1519-69842013000200021; Costa LRFd., 1999, MANEJO PESCA TAMBAQU, P142; Couto TBA, 2021, NAT SUSTAIN, V4, P409, DOI 10.1038/s41893-020-00665-4; Damme PAV., 2019, NEOTROP ICHTH, V17; Correa MAD, 2014, ECOL ECON, V106, P186, DOI 10.1016/j.ecolecon.2014.07.023; DECARVALHO JL, 1986, AMAZONIANA, V9, P595; Do Prado FD, 2018, J FISH BIOL, V92, P55, DOI 10.1111/jfb.13486; Duponchelle F, 2021, AQUAT CONSERV, V31, P1087, DOI 10.1002/aqc.3550; Ebner BC, 2016, FISH FISH, V17, P1134, DOI 10.1111/faf.12161; FabrU N.N., 2005, MANEJO PESCA GRANDES; FAO, 1997, FISH MANAGE; Feng DM, 2020, HYDROL PROCESS, V34, P5402, DOI 10.1002/hyp.13952; Flecker AS, 2010, AM FISH S S, V73, P559; Formiga KM, 2021, NEOTROP ICHTHYOL, V19, DOI [10.1590/1982-0224-2020-0082, DOI 10.1590/1982-0224-2020-0082]; Santos MDF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00263; Funge-Smith SJ., 2018, C942 FAO, DOI [10.1073/pnas.1721097115, DOI 10.1073/PNAS.1721097115]; Gaertner D, 2001, AQUAT LIVING RESOUR, V14, P1, DOI 10.1016/S0990-7440(00)01104-9; Sousa RGC, 2011, J APPL ICHTHYOL, V27, P118, DOI 10.1111/j.1439-0426.2010.01521.x; Vasquez AG, 2009, J FISH BIOL, V75, P2527, DOI 10.1111/j.1095-8649.2009.02444.x; Goulding M., 1982, Revista Brasileira de Zoologia, V1, P107; Goulding M., 1981, MAN FISHERIES AMAZON, DOI 10.1007/978-94-017-2161-5; Goulding M., 1980, FISHES FOREST EXPLOR; Goulding M., 1996, FLOODS FORTUNE; Goulding M., 2003, SMITHSONIAN ATLAS AM; Goulding M, 2019, FISH FISH, V20, P138, DOI 10.1111/faf.12328; Hahn L, 2022, HYDROBIOLOGIA, V849, P323, DOI 10.1007/s10750-020-04438-0; Hauser M., 2019, AQUAT CONSERV; Hauser M, 2020, FRESHWATER BIOL, V65, P325, DOI 10.1111/fwb.13427; Hermann TW, 2021, ICHTHYOL HERPETOL, V109, P978, DOI 10.1643/i2020019; Hess LL, 2015, LBA ECO LC 07 WETLAN; Hilborn R, 2014, ICES J MAR SCI, V71, P1040, DOI 10.1093/icesjms/fsu034; Isaac V. J., 1996, Fisheries Management and Ecology, V3, P315, DOI 10.1046/j.1365-2400.1996.d01-154.x; Isaac VJ., 2000, MEDIO AMAZONAS BIOL, P65; Isaac VJ., 2000, IBAMA COLECAO MEIO A, V22, P201; Jimenez EA, 2013, BRAZ J OCEANOGR, V61, P129, DOI 10.1590/S1679-87592013000200005; Latrubesse EM, 2005, GEOMORPHOLOGY, V70, P187, DOI 10.1016/j.geomorph.2005.02.005; Leite Rosseval Galdino, 2006, Acta Amaz., V36, P557, DOI 10.1590/S0044-59672006000400018; Loubens G., 1997, ICHTHYOL EXPLOR FRES, V8, P1; Lundberg JG, 2005, COPEIA, P492; Marini C, 2022, MUS MANAGE CURATOR, V37, P598, DOI 10.1080/09647775.2021.1969677; Matsunaga AMF., 2017, BOL TEC-CIENT CEPNOR, V17, P9; McGrath D., 2008, NCN NOVOS CADERNOS N, V1; MCGRATH DG, 1993, HUM ECOL, V21, P167, DOI 10.1007/BF00889358; Melack JM, 2021, AQUAT CONSERV, V31, P1029, DOI 10.1002/aqc.3558; Melnychuk MC, 2021, NAT SUSTAIN, V4, P440, DOI 10.1038/s41893-020-00668-1; Merona Bd., 1988, MEM FUND LA SALLE CI, V48, P433; Miranda-Chumacero G, 2020, GLOB ECOL CONSERV, V24, DOI 10.1016/j.gecco.2020.e01309; Mounic-Silva CE, 2013, J APPL ICHTHYOL, V29, P118, DOI 10.1111/j.1439-0426.2012.02047.x; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; Oliveira ACB, 2006, FISHERIES MANAG ECOL, V13, P135, DOI 10.1111/j.1365-2400.2006.00481.x; Oliveira CM, 2020, BIOTA AMAZONIA, V10, P1; Pauly D., 2019, VANISHING FISH SHIFT; Pauly D., 1983, FISHBYTE WORLD FISH, V1, p9?13; Penna M. A. H, 2005, Braz. J. Biol., V65, P129, DOI 10.1590/S1519-69842005000100017; Petersen TA, 2016, J FISH BIOL, V89, P241, DOI 10.1111/jfb.12968; PETRERE M, 1986, AMAZONIANA, V9, P527; Petrere M, 2004, REV FISH BIOL FISHER, V14, P403, DOI 10.1007/s11160-004-8362-7; PETRERE M, 1983, J FISH BIOL, V22, P133, DOI 10.1111/j.1095-8649.1983.tb04733.x; PETRERE M JR, 1985, Ciencia e Cultura (Sao Paulo), V37, P1987; Petrere M. Jr, 1978, Acta Amazonica, V8, P1; Pons M, 2017, FISH FISH, V18, P1, DOI 10.1111/faf.12163; R Core Team, 2021, R LANG ENV STAT; Reinert TR, 2002, CONSERV BIOL, V16, P1344, DOI 10.1046/j.1523-1739.2002.01078.x; Reno VF, 2011, REMOTE SENS ENVIRON, V115, P3446, DOI 10.1016/j.rse.2011.08.008; Ribeiro MCLD, 1995, REGUL RIVER, V11, P325, DOI 10.1002/rrr.3450110308; Ruffino M. L., 2016, REPENSANDO GESTAO AM; Russo T, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00153; Sanchez-Botero JI., 2008, UAKARI, V2, P27; Schwamborn R, 2019, ECOL MODEL, V393, P37, DOI 10.1016/j.ecolmodel.2018.12.001; Serrao EdM, 2019, SOC NATUR, V31; Silva ULd., 2017, PERSPECTIVAS QUANTIT; Sorribas MV, 2016, CLIMATIC CHANGE, V136, P555, DOI 10.1007/s10584-016-1640-2; Sumaila UR, 2016, MAR POLICY, V69, P189, DOI 10.1016/j.marpol.2015.12.026; Tregidgo DJ, 2017, P NATL ACAD SCI USA, V114, P8655, DOI 10.1073/pnas.1614499114; Valbo-Jorgensen J, 2008, NATO SCI PEACE SECUR, P61, DOI 10.1007/978-1-4020-8924-4_5; Van-Damme P. A., 2011, PECES DELFINES AMAZO, P247; Verissimo J, 1970, PESCA AMAZONIA; WoynuYrovich A., 2019, FAO FISHERIES AQUACU, V624, P1; Zacardi Diego Maia, 2020, Pan-American Journal of Aquatic Sciences, V15, P258; Zagaglia CR, 2009, AN 14 S BRAS SENS RE, P4535	121	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264490	10.1371/journal.pone.0264490	http://dx.doi.org/10.1371/journal.pone.0264490			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T6JP	35235610	Green Published, gold			2022-12-26	WOS:000787073100051
J	Higuchi, K; Sugiyama, K; Tomabechi, R; Kishimoto, H; Inoue, K				Higuchi, Kei; Sugiyama, Koki; Tomabechi, Ryuto; Kishimoto, Hisanao; Inoue, Katsuhisa			Mammalian monocarboxylate transporter 7 (MCT7/Slc16a6) is a novel facilitative taurine transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL COMPONENT; PROTEIN; IDENTIFICATION; LOCALIZATION; MEMBRANE; LACTATE; HEALTH; RAT; CL	Monocarboxylate transporter 7 (MCT7) is an orphan transporter expressed in the liver, brain, and in several types of cancer cells. It has also been reported to be a survival factor in melanoma and breast cancers. However, this survival mechanism is not yet fully understood due to MCT7's unidentified substrate(s) and characterize the transport mechanisms by analyzing amino acid transport in HEK293T cells and polarized Caco-2 cells. Analysis of amino acids revealed significant rapid reduction in taurine from cells transfected with enhanced green fluorescent protein-tagged MCT7. We found that taurine uptake and efflux by MCT7 was pH-independent and that the uptake was not saturated in the presence of taurine excess of 200 mM. Furthermore, we found that monocarboxylates and acidic amino acids inhibited MCT7-mediated taurine uptake. These results imply that MCT7 may be a low-affinity facilitative taurine transporter. We also found that MCT7 was localized at the basolateral membrane in polarized Caco-2 cells and that the induction of MCT7 expression in polarized Caco2 cells enhanced taurine permeation. Finally, we demonstrated that interactions of MCT7 with ancillary proteins basigin/ CD147 and embigin/GP70 enhanced MCT7-mediated taurine transport. In summary, these findings reveal that taurine is a novel substrate of MCT7 and that MCT7-mediated taurine transport might contribute to the efflux of taurine from cells.	[Higuchi, Kei; Sugiyama, Koki; Tomabechi, Ryuto; Kishimoto, Hisanao; Inoue, Katsuhisa] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biopharmaceut, Hachioji, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences	Inoue, K (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biopharmaceut, Hachioji, Tokyo, Japan.	kinoue@toyaku.ac.jp		Higuchi, Kei/0000-0001-8440-8078				Abplanalp J, 2013, HUM MOL GENET, V22, P3218, DOI 10.1093/hmg/ddt175; Anderson CMH, 2009, J PHYSIOL-LONDON, V587, P731, DOI 10.1113/jphysiol.2008.164228; Busslinger GA, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108819; Cedernaes J, 2011, BIOCHEM BIOPH RES CO, V411, P702, DOI 10.1016/j.bbrc.2011.07.005; Dai W, 2020, MOL CARCINOGEN, V59, P640, DOI 10.1002/mc.23191; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Draoui N, 2011, DIS MODEL MECH, V4, P727, DOI 10.1242/dmm.007724; Felmlee MA, 2020, PHARMACOL REV, V72, P466, DOI 10.1124/pr.119.018762; Gaitan-Penas H, 2016, BIOPHYS J, V111, P1429, DOI 10.1016/j.bpj.2016.08.030; Gillen CM, 1999, AM J PHYSIOL-CELL PH, V276, pC328, DOI 10.1152/ajpcell.1999.276.2.C328; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hammes TO, 2012, DIGEST DIS SCI, V57, P675, DOI 10.1007/s10620-011-1931-4; Hugo SE, 2012, GENE DEV, V26, P282, DOI 10.1101/gad.180968.111; Jones RS, 2016, CLIN PHARMACOL THER, V100, P454, DOI 10.1002/cpt.418; Kim K. S., 1983, ARCH PHARM RES, V6, P109; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kuo KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039641; Lobo MVT, 2000, HISTOCHEM J, V32, P53, DOI 10.1023/A:1003910429346; Murakami S, 2018, AMINO ACIDS, V50, P1279, DOI 10.1007/s00726-018-2605-8; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nielsen CU, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13467; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Pasantes-Morales H., 1989, CRC HDB FREE REDICAL, P105; PORTMAN OW, 1955, J BIOL CHEM, V213, P733; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Ramadan T, 2006, J CELL PHYSIOL, V206, P771, DOI 10.1002/jcp.20531; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Takahashi M, 2020, DRUG METAB PHARMACOK, V35, P281, DOI 10.1016/j.dmpk.2020.01.008; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wang N, 2021, CELL, V184, P370, DOI 10.1016/j.cell.2020.11.043; Yanagita T, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-38; Yu Yang, 2016, Metab Eng Commun, V3, P64, DOI 10.1016/j.meteno.2016.03.001; Zhang B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16334-1	35	2	2	7	8	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101800	10.1016/j.jbc.2022.101800	http://dx.doi.org/10.1016/j.jbc.2022.101800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35257743	gold, Green Published			2022-12-26	WOS:000797895000003
J	Wischhof, L; Adhikari, A; Mondal, M; Marsal-Cots, A; Biernat, J; Mandelkow, EM; Mandelkow, E; Ehninger, D; Nicotera, P; Bano, D				Wischhof, Lena; Adhikari, Aasha; Mondal, Mrityunjoy; Marsal-Cots, Anaies; Biernat, Jacek; Mandelkow, Eva Maria; Mandelkow, Eckhard; Ehninger, Dan; Nicotera, Pierluigi; Bano, Daniele			Unbiased proteomic profiling reveals the IP3R modulator AHCYL1/IRBIT as a novel interactor of microtubule-associated protein tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; DENDRITIC SPINES; BINDING-PROTEIN; AUTOPHAGY; PHOSPHORYLATION; EXPRESSION; IRBIT; BETA; TAUOPATHY	Microtubule-associated protein tau is a naturally unfolded protein that can modulate a vast array of physiological processes through direct or indirect binding with molecular partners. Aberrant tau homeostasis has been implicated in the pathogenesis of several neurodegenerative disorders, including Alzheimer's disease. In this study, we performed an unbiased high-content protein profiling assay by incubating recombinant human tau on microarrays containing thousands of human polypeptides. Among the putative tau-binding partners, we identify SAH hydrolase-like protein 1/inositol 1,4,5-trisphosphate receptor (IP3R)-binding protein (AHCYL1/IRBIT), a member of the SAH hydrolase family and a previously described modulator of IP3R activity. Using coimmunoprecipitation assays, we show that endogenous as well as overexpressed tau can physically interact with AHCYL1/IRBIT in brain tissues and cultured cells. Proximity ligation assay experiments demonstrate that tau overexpression may modify the close localization of AHCYL1/IRBIT to IP3R at the endoplasmic reticulum. Together, our experimental evidence indicates that tau interacts with AHCYL1/IRBIT and potentially modulates AHCYL1/IRBIT function.	[Wischhof, Lena; Adhikari, Aasha; Mondal, Mrityunjoy; Marsal-Cots, Anaies; Biernat, Jacek; Mandelkow, Eva Maria; Mandelkow, Eckhard; Ehninger, Dan; Nicotera, Pierluigi; Bano, Daniele] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Biernat, Jacek; Mandelkow, Eva Maria; Mandelkow, Eckhard] CAESAR Res Ctr, Bonn, Germany; [Mandelkow, Eckhard] Univ Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR); University of Bonn	Bano, D (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.	daniele.bano@dzne.de		Biernat, Jacek/0000-0003-4237-3975; Mondal, Mrityunjoy/0000-0003-2973-4633; Bano, Daniele/0000-0002-9617-5504	Deutsche Forschungsgemeinschaft (German Research Foundation) [EXC2151-390873048]; Innovative Medicines Initiative (European Union) 2 joint undertaking [821522]; European Union; European Federation of Pharmaceutical Industries and Associations; Katharina-Hardt-Stiftung; Cure Alzheimer's Fund	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Innovative Medicines Initiative (European Union) 2 joint undertaking; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations; Katharina-Hardt-Stiftung; Cure Alzheimer's Fund	L. W., P. N., and D. B. are members of the Deutsche Forschungsgemeinschaft Cluster of Excellence ImmunoSensation funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy (EXC2151-390873048). D. B. is a member of the Mitochondrial Dysfunction in Parkinson's Consortium (PD-MitoQUANT). PD-MitoQUANT has received funding from the Innovative Medicines Initiative (European Union) 2 joint undertaking under grant agreement no. 821522. This joint undertaking receives support from the European Union's Horizon 2020 research and innovation program and European Federation of Pharmaceutical Industries and Associations. E. M. and E. M. M. were supported by Katharina-Hardt-Stiftung and Cure Alzheimer's Fund.	Abisambra JF, 2012, J MOL BIOL, V421, P653, DOI 10.1016/j.jmb.2012.02.003; Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Ando H, 2014, BBA-MOL CELL RES, V1843, P2195, DOI 10.1016/j.bbamcr.2014.01.031; Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Arendt T, 2013, AM J PHYSIOL-REG I, V305, pR478, DOI 10.1152/ajpregu.00117.2013; Bailey CH, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021758; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; BAUDIER J, 1988, J BIOL CHEM, V263, P5876; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bertan F., 2021, CELL REP METHODS, V1; Bonneau B, 2016, ELIFE, V5, DOI 10.7554/eLife.19896; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; BRANDT R, 1993, J BIOL CHEM, V268, P3414; Caballero B, 2018, AGING CELL, V17, DOI 10.1111/acel.12692; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Cieri D., 2018, BIOCH BIOPHYS ACTA M; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Goedert M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006254; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Houck AL, 2016, J EXP NEUROSCI, V10, P31, DOI 10.4137/JEN.S25100; Huang W., 2021, AUTOPHAGY, V16, P1; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iovino M, 2015, BRAIN, V138, DOI 10.1093/brain/awv222; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Ittner A, 2018, NEURON, V99, P13, DOI 10.1016/j.neuron.2018.06.003; Ittner L. M., 2010, DENDRITIC FUNCTION T; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaniyappan S, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00389-1; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Lee G, 1998, J CELL SCI, V111, P3167; LEE G, 1992, J CELL SCI, V102, P227; Leidal AM, 2018, NAT CELL BIOL, V20, P1338, DOI 10.1038/s41556-018-0235-8; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Marciniak E, 2017, J EXP MED, V214, P2257, DOI 10.1084/jem.20161731; Mertens J, 2013, AM J PATHOL, V182, P1769, DOI 10.1016/j.ajpath.2013.01.043; Mok SA, 2018, NAT STRUCT MOL BIOL, V25, P384, DOI 10.1038/s41594-018-0057-1; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Qiang L, 2018, CURR BIOL, V28, P2181, DOI 10.1016/j.cub.2018.05.045; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Rossi G, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00192; Sallaberry CA, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.725241; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tracy T. E., CELL; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	68	0	0	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101774	10.1016/j.jbc.2022.101774	http://dx.doi.org/10.1016/j.jbc.2022.101774			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35218773	Green Published, gold			2022-12-26	WOS:000793692600004
J	Yoon, H; You, M; Shon, C				Yoon, Hyejung; You, Myoungsoon; Shon, Changwoo			An application of the extended parallel process model to protective behaviors against COVID-19 in South Korea	PLOS ONE			English	Article							FEAR APPEALS; MOTIVATION THEORY	This study applied the extended parallel process model (EPPM) to investigate the factors affecting people's preventive behaviors against COVID-19, and thereby, draw relevant policy implications for current and future other epidemics. The EPPM was used to examine the danger control and fear control responses, along with the separate effects of their sub-factors (perceived susceptibility, perceived severity, response efficacy, and self-efficacy) on personal hygiene behaviors, social distancing measures, and fatalism. In total, data from an online survey of 813 adults were analyzed. The results of multiple regression analysis showed a strong effect of self-efficacy on danger control (beta = 0.23 for personal hygiene behaviors, beta = 0.26 for social distancing) and fear control responses (beta = -0.13 for fatalism). However, based on the type of control response, the effect of perceived susceptibility and perceived severity, which were the main factors in threat appraisal, was insignificant or marginally significant. Further, a higher perceived severity was associated with higher fatalism in the fear control response (beta = 0.09). Those who were currently employed performed fewer social distancing measures compared to those who did not (beta = -0.11), whereas there was no difference in personal hygiene behaviors. These results suggest that risk communication in emerging infectious disease crises should provide customized information on people who are hard to comply with social distancing. Besides delivering the message of self-efficacy, policies should be implemented to create a social environment in which individuals can practice social distancing without constraints.	[Yoon, Hyejung] Seoul Inst, Dept Urban Soc Res, Seoul, South Korea; [You, Myoungsoon] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea; [Shon, Changwoo] Inje Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Busan, South Korea	Seoul National University (SNU); Inje University	Shon, C (corresponding author), Inje Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Busan, South Korea.	cwshon21c@gmail.com		Yoonm, Hyejung/0000-0002-9604-2963				Ahorsu DK, 2020, GERONTOL GERIATR MED, V6, DOI 10.1177/2333721420966081; Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Akesson J., 2020, 08982937 NAT BUR EC; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Barnett DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006365; Bashirian S, 2020, J HOSP INFECT, V105, P430, DOI 10.1016/j.jhin.2020.04.035; Camacho-Rivera M, 2020, HEALTH EQUITY, V4, P336, DOI 10.1089/heq.2020.0031; Centers for Disease Control and Prevention, 2021, UND MED COND ASS HIG; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hayes J, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.560092; Heymann J, 2020, GLOB PUBLIC HEALTH, V15, P925, DOI 10.1080/17441692.2020.1764076; Jahangiry L, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09681-7; Jorgensen F, 2021, BRIT J HEALTH PSYCH, V26, P679, DOI 10.1111/bjhp.12519; Ju Y, 2022, RISK ANAL, V42, P56, DOI 10.1111/risa.13801; Kim EA, 2020, SAF HEALTH WORK-KR, V11, P275, DOI 10.1016/j.shaw.2020.07.006; Kim J, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045845; 김수진, 2019, [Korea Social Policy Review, 한국사회정책], V26, P3; Kim S-j., 2020, RES BRIEF, V63, P1; Kim S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228666; Kim T, 2020, EMERG INFECT DIS, V26, P2533, DOI 10.3201/eid2610.202647; Lee D, 2020, WORLD DEV, V135, DOI 10.1016/j.worlddev.2020.105057; Lee K, 2009, GLOB INST, P1; Lee M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092977; Lim S, 2020, J HOSP INFECT, V106, P206, DOI 10.1016/j.jhin.2020.06.017; Lin HC, 2021, PSYCHOL RES BEHAV MA, V14, P123, DOI 10.2147/PRBM.S291300; Lithopoulos A., 2021, CANADIAN PSYCHOLOGYP; Malecki KMC, 2021, CLIN INFECT DIS, V72, P697, DOI 10.1093/cid/ciaa758; Moussaoui LS, 2021, HEALTH PSYCHOL BEHAV, V9, P600, DOI 10.1080/21642850.2021.1947290; Nayak M.S.D.P., 2019, TECHNOLOGY, V31, P34, DOI [DOI 10.9790/0837-2405053138, 10.9790/0837-2405053138]; Noar SM, 2020, HEALTH COMMUN, V35, P1735, DOI 10.1080/10410236.2020.1838093; Ozdil K, 2021, PUBLIC HEALTH NURS, V38, P770, DOI 10.1111/phn.12898; Popova L, 2012, HEALTH EDUC BEHAV, V39, P455, DOI 10.1177/1090198111418108; Ranjit YS, 2021, J RISK RES, V24, P449, DOI 10.1080/13669877.2021.1887328; Rimal RN, 2006, HEALTH COMMUN, V20, P209, DOI 10.1207/s15327027hc2003_1; RIPPETOE PA, 1987, J PERS SOC PSYCHOL, V52, P596, DOI 10.1037/0022-3514.52.3.596; Roberto AJ., 2021, J HEALTH COMMUN, P1, DOI [10.1080/10810730.2020.1865486, DOI 10.1080/10810730.2020.1865486]; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Rui JR, 2021, JMIR HUM FACTORS, V8, DOI 10.2196/23232; Sandman P., 1989, EFFECTIVE RISK COMMU, P45, DOI 10.1007/978-1-4613-1569-8_6; Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090; Thompson D., 2020, ATLANTIC, V5; Travaglino GA, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.565845; Prasetyo YT, 2020, INT J INFECT DIS, V99, P312, DOI 10.1016/j.ijid.2020.07.074; Wang YB, 2020, J HEALTH PSYCHOL, V25, P733, DOI 10.1177/1359105320919177; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; Witte K, 1996, J Health Commun, V1, P317, DOI 10.1080/108107396127988; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328; World Health Organization, 2020, TECHNICAL SPECIFICAT; Wu J, 2020, CHINA CDC WEEKLY, V2, P249; Zhang XA, 2021, J RISK RES, V24, P432, DOI 10.1080/13669877.2021.1887326; Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271	54	2	2	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0261132	10.1371/journal.pone.0261132	http://dx.doi.org/10.1371/journal.pone.0261132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259157	Green Published, gold			2022-12-26	WOS:000835141200004
J	Yao, SZ; Lix, L; Teare, G; Evans, C; Blackburn, D				Yao, Shenzhen; Lix, Lisa; Teare, Gary; Evans, Charity; Blackburn, David			An integrated continuity of care measure improves performance in models predicting medication adherence using population-based administrative data	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; PERSISTENCE; PATIENT; HEALTH; NONADHERENCE; TERMINOLOGY; ASSOCIATION; THERAPY	Objectives Continuity of care (COC) is considered an important determinant of medication adherence based on measures such as the usual provider continuity index (UPCI) that are derived exclusively from physician visit claims. This study aimed to: a) determine if high UPCI values predict physicians who deliver different clinical services; and b) compare UPCI with an integrated COC measure capturing physician visits, prescribing, and a complete medical examination in a multivariable model of patients receiving statin medications. Methods This was a retrospective cohort study of new statin users between 2012 and 2017 in Saskatchewan, Canada. We calculated sensitivity/specificity of a high UPCI value for predicting physicians who were prescribers of statins and/or providers of complete medical examinations. Next, we used logistic regression models to test two measures of COC (high UPCI value or an integrated COC measure) on the outcome of optimal statin adherence (proportion of days covered >= 80%). The DeLong test was used to compare predictive performance of the two models. Results Among 55,144 new statin users, a high UPCI was neither a sensitive or specific marker of physicians who prescribed statins or performed a complete medical examination. The integrated COC measure had a stronger association with optimal adherence [adjusted odds ratio (OR) = 1.56, 95% confidence interval (CI) 1.50 to 1.63] than UPCI (adjusted OR = 1.23, 95% CI 1.19 to 1.28), and improved predictive performance of the adherence model. Conclusion The number of physician visits alone appears to be insufficient to represent COC. An integrated measure improves predictive performance for optimal medication adherence in patients initiating statins.	[Yao, Shenzhen; Evans, Charity; Blackburn, David] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada; [Lix, Lisa] Univ Manitoba, Rady Fac Hlth Sci, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Teare, Gary] Alberta Hlth Serv, Prov Populat & Publ Hlth, Program Knowledge Evidence & Innovat, Calgary, AB, Canada	University of Saskatchewan; University of Manitoba; Alberta Health Services (AHS); University of Calgary	Blackburn, D (corresponding author), Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada.	d.blackbum@usask.ca			University of Saskatchewan Chair in Patient Adherence to Drug Therapy	University of Saskatchewan Chair in Patient Adherence to Drug Therapy	This study was funded by the University of Saskatchewan Chair in Patient Adherence to Drug Therapy to DB.	Allison P.D., 2012, LOGISTIC REGRESSION, VSecond edition; Alsabbagh MHDW, 2014, VALUE HEALTH, V17, P288, DOI 10.1016/j.jval.2013.11.011; Alsabbagh MW, 2016, MED CARE, V54, P195, DOI 10.1097/MLR.0000000000000468; [Anonymous], 2018, CANADIAN CODING STAN; [Anonymous], 2015, CONTINUITY CARE FAMI; [Anonymous], DEFINITIONS GUIDELIN; [Anonymous], CHRONIC DIS DEFINED; [Anonymous], 2020, PAYMENT SCHEDULE INS; [Anonymous], 2015, CONCEPT MEASURING CO; [Anonymous], 1978, INT CLASSIFICATION D; [Anonymous], 2018, MEASURING HLTH INEQU; Bartlett LE, 2017, BRIT J CLIN PHARMACO, V83, P202, DOI 10.1111/bcp.13088; Bauer AM, 2014, J GEN INTERN MED, V29, P1139, DOI 10.1007/s11606-014-2845-6; BECKER MH, 1975, MED CARE, V13, P10, DOI 10.1097/00005650-197501000-00002; Chen CC, 2016, AM J MANAG CARE, V22, P136; Chen CC, 2013, MED CARE, V51, P231, DOI 10.1097/MLR.0b013e31827da5b9; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Culpepper WJ, 2019, NEUROLOGY, V92, pE1016, DOI 10.1212/WNL.0000000000007043; David G, 2018, HEALTH ECON, V27, P1805, DOI 10.1002/hec.3804; De Geest S, 2003, ADHERENCE LONG TERM; De Vera MA, 2014, BRIT J CLIN PHARMACO, V78, P684, DOI 10.1111/bcp.12339; Deaton A, 2016, JAMA-J AM MED ASSOC, V315, P1703, DOI 10.1001/jama.2016.4072; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dossa Anara Richi, 2017, CMAJ Open, V5, pE359, DOI 10.9778/cmajo.20160063; Gosden T, 2001, J Health Serv Res Policy, V6, P44, DOI 10.1258/1355819011927198; Gosden T, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002215; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hall JA, 2014, PATIENT EDUC COUNS, V95, P313, DOI 10.1016/j.pec.2014.03.015; Hanley GE, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-79; Hansen RA, 2015, ANN PHARMACOTHER, V49, P293, DOI 10.1177/1060028014563266; Lauffenburger JC, 2017, ANN INTERN MED, V166, P81, DOI 10.7326/M15-2659; Martin-Ruiz E, 2018, J CARDIOVASC PHARM T, V23, P200, DOI 10.1177/1074248417745357; Masson W, 2019, HIGH BLOOD PRESS CAR, V26, P263, DOI 10.1007/s40292-019-00330-8; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Piette JD, 2006, J CLIN EPIDEMIOL, V59, P739, DOI 10.1016/j.jclinepi.2005.11.023; Provost Sylvie, 2015, Int J Family Med, V2015, P967230, DOI 10.1155/2015/967230; Raebel MA, 2013, MED CARE, V51, pS11, DOI 10.1097/MLR.0b013e31829b1d2a; Rodriguez F, 2019, JAMA CARDIOL, V4, P206, DOI 10.1001/jamacardio.2018.4936; SACKETT DL, 1979, CAN MED ASSOC J, V121, P259; SAS Institute INC, 2011, SAS WINDOWS VERSION; Shalev V, 2014, PHARMACOTHERAPY, V34, P1, DOI 10.1002/phar.1326; Simon ST, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1493; Sox CH, 1997, ARCH FAM MED, V6, P223, DOI 10.1001/archfami.6.3.223; Stolpe Samuel, 2016, J Manag Care Spec Pharm, V22, P1224; Strom BL, 2013, TXB PHARMACOEPIDEMIO; Warren JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140008; Wong ES, 2012, MED CARE, V50, P591, DOI 10.1097/MLR.0b013e318249cb74	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264170	10.1371/journal.pone.0264170	http://dx.doi.org/10.1371/journal.pone.0264170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239713	Green Published, gold			2022-12-26	WOS:000776002200021
J	Chavez-Camarillo, GM; Lopez-Nunez, PV; Jimenez-Nava, RA; Aranda-Garcia, E; Cristiani-Urbina, E				Chavez-Camarillo, Griselda Ma; Vianey Lopez-Nunez, Perla; Arturo Jimenez-Nava, Raziel; Aranda-Garcia, Erick; Cristiani-Urbina, Eliseo			Production of extracellular alpha-amylase by single-stage steady-state continuous cultures of Candida wangnamkhiaoensis in an airlift bioreactor	PLOS ONE			English	Article							SACCHAROMYCOPSIS-FIBULIGERA; SCHWANNIOMYCES-CASTELLII; CONTINUOUS FERMENTATION; LIPOMYCES; YEASTS; STARCH; BIOSYNTHESIS; CASSAVA; GROWTH	The kinetics of growth and alpha-amylase production of a novel Candida wangnamkhiaoensis yeast strain were studied in single-stage steady-state continuous cultures. This was performed in a split-cylinder internal-loop airlift bioreactor, using a variety of carbon sources as fermentation substrates. Results showed that the steady-state yields of cell mass from carbohydrates were practically constant for the range of dilution rates assayed, equaling 0.535 +/- 0.030, 0.456 +/- 0.033, and 0.491 +/- 0.035 g biomass/g carbohydrate, when glucose, maltose, and starch, respectively were used as carbon sources. No alpha-amylase activity was detected when glucose was used as the carbon source in the influent medium, indicating that alpha-amylase synthesis of C. wangnamkhiaoensis is catabolically repressed by glucose. Contrastingly, maltose and starch induce synthesis of alpha-amylase in C. wangnamkhiaoensis, with starch being the best alpha-amylase inducer. The highest alpha-amylase volumetric and specific activities (58400 +/- 800 U/L and 16900 +/- 200 U/g biomass, respectively), and productivities (14000 +/- 200 U/L.h and 4050 +/- 60 U/g biomass.h, respectively) were achieved at a dilution rate of 0.24 h(-1) using starch as the carbon source. In conclusion, single-stage steady-state continuous culture in an airlift bioreactor represents a powerful tool, both for studying the regulatory mechanisms of alpha-amylase synthesis by C. wangnamkhiaoensis and for alpha-amylase production. Furthermore, results showed that C. wangnamkhiaoensis represents a potential yeast species for the biotechnological production of alpha-amylase, which can be used for the saccharification of starch. This offers an attractive renewable resource for the production of biofuels (particularly bioethanol), representing an alternative to fossil fuels with reduced cost of substrates.	[Chavez-Camarillo, Griselda Ma; Vianey Lopez-Nunez, Perla; Arturo Jimenez-Nava, Raziel] Inst Politecn Nacl, Dept Microbiol, Escuela Nacl Ciencias Biol, Prolongac Carpio & Plan Ayala S-N, Ciudad De Mexico, Mexico; [Vianey Lopez-Nunez, Perla; Arturo Jimenez-Nava, Raziel; Aranda-Garcia, Erick; Cristiani-Urbina, Eliseo] Inst Politecn Nacl, Dept Ingn Bioquim, Escuela Nacl Ciencias Biol, Unidad Profes Adolfo Lopez Mateos, Ciudad De Mexico, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Chavez-Camarillo, GM (corresponding author), Inst Politecn Nacl, Dept Microbiol, Escuela Nacl Ciencias Biol, Prolongac Carpio & Plan Ayala S-N, Ciudad De Mexico, Mexico.; Cristiani-Urbina, E (corresponding author), Inst Politecn Nacl, Dept Ingn Bioquim, Escuela Nacl Ciencias Biol, Unidad Profes Adolfo Lopez Mateos, Ciudad De Mexico, Mexico.	gchsepi@gmail.com; ecristianiu@yahoo.com.mx	Aranda-García, Erick/AAB-9048-2021	Aranda-García, Erick/0000-0002-4435-0577	Secretaria de Investigacion y Posgrado, IPN [SIP20201439, SIP20210590, SIP20201843, SIP20210584]	Secretaria de Investigacion y Posgrado, IPN	E.C.-U. - Secretaria de Investigacion y Posgrado, IPN. (SIP20201439 and SIP20210590). G.M.C.-C. -Secretaria de Investigacion y Posgrado, IPN (SIP20201843 and SIP20210584). The funders of our research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADMASSU W, 1984, BIOTECHNOL BIOENG, V26, P1511, DOI 10.1002/bit.260261218; ADMASSU W, 1983, BIOTECHNOL BIOENG, V25, P2641, DOI 10.1002/bit.260251112; ADMASSU W, 1981, BIOTECHNOL BIOENG, V23, P2361, DOI 10.1002/bit.260231016; AZOULAY E, 1980, APPL ENVIRON MICROB, V39, P41, DOI 10.1128/AEM.39.1.41-47.1980; Bayrock DP, 2005, WORLD J MICROB BIOT, V21, P83, DOI 10.1007/s11274-004-2781-4; Brethauer S, 2010, BIORESOURCE TECHNOL, V101, P4862, DOI 10.1016/j.biortech.2009.11.009; CALLEJA GB, 1986, J FERMENT BIOENG, V64, P71, DOI 10.1016/0385-6380(86)90060-9; Carrasco M, 2016, BMC MICROBIOL, V16, DOI [10.1186/s12866-016-0640-8, 10.1186/s12888-016-0753-5]; Carvalho Jessyca Ketterine, 2021, Biotechnology Reports, V30, pe00630, DOI 10.1016/j.btre.2021.e00630; CASTANEDAAGULLO M, 1956, J GEN PHYSIOL, V39, P369, DOI 10.1085/jgp.39.3.369; Chisti Y., 1998, APPL MECH REV, V51, P33, DOI [10.1115/1.3098989, DOI 10.1115/1.3098989]; Christiansen T, 2002, J BIOTECHNOL, V97, P265, DOI 10.1016/S0168-1656(02)00109-8; Clark D., 1997, BIOCH ENG, V2nd; CLEMENTI F, 1980, A VAN LEEUW J MICROB, V46, P399, DOI 10.1007/BF00421986; DEAN ACR, 1972, J APPL CHEM BIOTECHN, V22, P245, DOI 10.1002/jctb.5020220207; DEMOT R, 1984, FEMS MICROBIOL LETT, V25, P169, DOI 10.1016/0378-1097(84)90111-3; DJEKRIF DS, 2016, INT J LIFE SCI SCI R, V2, P339; Farooq MA, 2021, ARCH MICROBIOL, V203, P1281, DOI 10.1007/s00203-020-02128-y; Fossi BT, 2005, AFR J BIOTECHNOL, V4, P14; Gen Q, 2014, RENEW ENERG, V62, P522, DOI 10.1016/j.renene.2013.08.016; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gupta R, 2003, PROCESS BIOCHEM, V38, P1599, DOI 10.1016/S0032-9592(03)00053-0; Hashim SA., 2014, TRENDS LIFE SCI, V3, P30; Hernandez-Montanez Z, 2012, APPL BIOCHEM BIOTECH, V167, P2117, DOI 10.1007/s12010-012-9736-2; HORN CH, 1988, SYST APPL MICROBIOL, V10, P106, DOI 10.1016/S0723-2020(88)80022-5; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Kayikci O, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov068; KELLY CT, 1985, APPL MICROBIOL BIOT, V22, P352, DOI 10.1007/BF00582419; Klaic R., 1991, OVERVIEW REGARDING B, P183, DOI [10.1002/9781118958308.ch14, DOI 10.1002/9781118958308.CH14]; LEMMEL SA, 1980, APPL ENVIRON MICROB, V39, P387, DOI 10.1128/AEM.39.2.387-393.1980; LEMMEL SA, 1979, APPL ENVIRON MICROB, V37, P227, DOI 10.1128/AEM.37.2.227-232.1979; Li Haifeng, 2007, Journal of Ocean University of China, V6, P60, DOI 10.1007/s11802-007-0060-3; Limtong S, 2012, ANTON LEEUW INT J G, V102, P23, DOI 10.1007/s10482-012-9709-z; Chavez-Camarillo GM, 2018, ANN MICROBIOL, V68, P625, DOI 10.1007/s13213-018-1369-4; Martin GJO, 2006, J IND MICROBIOL BIOT, V33, P834, DOI 10.1007/s10295-006-0129-9; Matin A., 1981, CONTINUOUS CULTURES, P69; MOULIN G, 1978, FOLIA MICROBIOL, V23, P423, DOI 10.1007/BF02885569; MOULIN G, 1978, Z ALLG MIKROBIOL, V18, P269, DOI 10.1002/jobm.3630180405; MOULIN GJ, 1979, AGR BIOL CHEM TOKYO, V43, P1165, DOI 10.1080/00021369.1979.10863599; Paul JS, 2021, APPL BIOCHEM BIOTECH, V193, P2649, DOI 10.1007/s12010-021-03546-4; Salah HA, 2021, J PURE APPL MICROBIO, V15, P452, DOI 10.22207/JPAM.15.1.43; SILLS AM, 1984, APPL MICROBIOL BIOT, V20, P124; Simpson-Lavy K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43032-w; TODA K, 1976, BIOTECHNOL BIOENG, V18, P1117, DOI 10.1002/bit.260180808; Visvanathan R, 2020, J SCI FOOD AGR, V100, P2836, DOI 10.1002/jsfa.10315; Wang DIC., 1979, FERMENTATION ENZYME; Yalcin HT, 2013, TURK J BIOCHEM, V38, P101, DOI 10.5505/tjb.2013.95866	47	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264734	10.1371/journal.pone.0264734	http://dx.doi.org/10.1371/journal.pone.0264734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231077	gold, Green Published			2022-12-26	WOS:000849744700039
J	Pavic, Z; Suljok, A				Pavic, Zeljko; Suljok, Adrijana			Vaccination conspiracy beliefs among social science & humanities and STEM educated people-An analysis of the mediation paths	PLOS ONE			English	Article							CHILDHOOD VACCINATION; PARENTAL ATTITUDES; SUBJECT-MATTER; KNOWLEDGE; CONFIDENCE; TRUST; MMR; COMPLEMENTARY; GOVERNMENT; BEHAVIORS	Understanding vaccine hesitancy is becoming increasingly important, especially after the global outbreak of COVID-19. The main goal of this study was to explore the differences in vaccination conspiracy beliefs between people with a university degree coming from different scientific fields-Social Sciences & Humanities (SH) and Science, Technology, Engineering and Mathematics (STEM). The study was conducted on an online convenience sample of respondents with college and university degrees in Croatia (N = 577). The results revealed that respondents educated in SH proved to be more prone to vaccination conspiracy beliefs. The indirect effect through science literacy was confirmed, while this was not the case for the indirect effects through health beliefs (natural immunity beliefs) and trust in the healthcare system. However, all three variables were important direct predictors of vaccination conspiracy beliefs. Female gender and religiosity were positively correlated with vaccination conspiracy beliefs, while age was not a statistically significant predictor. The authors concluded by emphasizing the necessity of the more theoretically elaborated approaches to the study of the educational and other socio-demographic differences in vaccine hesitancy.	[Pavic, Zeljko] Josip Juraj Strossmayer Univ Osijek, Fac Humanities & Social Sci, Osijek, Croatia; [Suljok, Adrijana] Inst Social Res Zagreb, Zagreb, Croatia	University of JJ Strossmayer Osijek; Institute for Social Research Zagreb	Suljok, A (corresponding author), Inst Social Res Zagreb, Zagreb, Croatia.	adrijana@idi.hr	Pavić, Željko/AAD-1976-2020	Suljok, Adrijana/0000-0003-1762-2191	Croatian Science Foundation [HRZZ IP-2019-04-7902]	Croatian Science Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This work was funded by Croatian Science Foundation (grant number: HRZZ IP-2019-04-7902). Z. eljko Pavic is principal investigator, AdrijanaS. uljok is a member of the research group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://hrzz.hr/en/.	Albert M, 2008, SOC SCI MED, V66, P2520, DOI 10.1016/j.socscimed.2008.01.052; Allum N, 2008, PUBLIC UNDERST SCI, V17, P35, DOI 10.1177/0963662506070159; Allum N, 2014, PUBLIC UNDERST SCI, V23, P833, DOI 10.1177/0963662513492485; [Anonymous], 2005, SPECIAL EUROBAROMETE; [Anonymous], PRAVILNIK ZNANSTVENI; Attwell K, 2018, SOC SCI MED, V196, P106, DOI 10.1016/j.socscimed.2017.11.022; Becker T, 1989, ACAD TRIBES TERRITOR; BIGLAN A, 1973, J APPL PSYCHOL, V57, P204, DOI 10.1037/h0034699; BIGLAN A, 1973, J APPL PSYCHOL, V57, P195, DOI 10.1037/h0034701; Bleser WK, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4664; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Borjesson M, 2014, SCAND J PUBLIC HEALT, V42, P215, DOI 10.1177/1403494813510790; BOURDIEU P, 1975, SOC SCI INFORM, V14, P19, DOI 10.1177/053901847501400602; Brownlie J, 2005, SOCIOLOGY, V39, P221, DOI 10.1177/0038038505050536; Cant S., 2012, PALGRAVE HDB GEND HE, VSecond Ed; Casiday R, 2006, VACCINE, V24, P177, DOI 10.1016/j.vaccine.2005.07.063; Chow MYK, 2017, AUST FAM PHYSICIAN, V46, P145; Craciun C, 2012, VACCINE, V30, P6789, DOI 10.1016/j.vaccine.2012.09.016; Cvjetkovic SJ, 2017, J INFECT PUBLIC HEAL, V10, P649, DOI 10.1016/j.jiph.2017.05.008; DURANT JR, 1989, NATURE, V340, P11, DOI 10.1038/340011a0; European Commission, 2017, SPECIAL EUROBAROMETE; Frawley Jane E, 2018, BMC Res Notes, V11, P217, DOI 10.1186/s13104-018-3323-8; Fuchs Stephan, 1997, SCI STUD, V11, P4; Hadjipanayis A, 2020, VACCINE, V38, P1505, DOI 10.1016/j.vaccine.2019.11.068; Hobson-West P, 2007, SOCIOL HEALTH ILL, V29, P198, DOI 10.1111/j.1467-9566.2007.00544.x; Hornsey MJ, 2020, SOC SCI MED, V255, DOI 10.1016/j.socscimed.2020.113019; Jamison AM, 2019, SOC SCI MED, V221, P87, DOI 10.1016/j.socscimed.2018.12.020; Knorr-Cetina K., 1999, EPISTEMIC CULTURES S; Krishnamoorthy Y, 2019, J FAM MED PRIM CARE, V8, P3962, DOI 10.4103/jfmpc.jfmpc_790_19; Kuhn M, 2016, SOCIAL SCI THINK WOR; Lewis J, 2003, NAT REV IMMUNOL, V3, P913, DOI 10.1038/nri1228; Lorini C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017812; Luyten J, 2019, VACCINE, V37, P2494, DOI 10.1016/j.vaccine.2019.03.041; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Martin LR, 2017, ANN BEHAV MED, V51, P652, DOI 10.1007/s12160-017-9888-y; Mesch GS, 2015, HEALTH PROMOT INT, V30, P213, DOI 10.1093/heapro/dau094; Miller JD, 1998, PUBLIC UNDERST SCI, V7, P203, DOI 10.1088/0963-6625/7/3/001; Mora T, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5810-1; Orr D, 2016, ISR J HEALTH POLICY, V5, DOI 10.1186/s13584-016-0093-4; Pavic Z, 2014, SOC EKOL, V23, P95; Peretti-Watel P, 2013, EUROSURVEILLANCE, V18, P15, DOI 10.2807/1560-7917.ES2013.18.44.20623; Peretti-Watel Patrick, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289; Pew Research Center, PUBL SCI VIEWS SCI S; Pontifical Academy for Life, 2006, Natl Cathol Bioeth Q, V6, P541; Prpic K., MYTHS NATURAL SOCIAL, P275; Quinn F., 2016, INT J SCI SOC, V8, P31, DOI [10.18848/1836-6236/cgp/v08i03/31-50, DOI 10.18848/1836-6236/CGP/V08I03/31-50]; Quinn Sandra, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.3e4a5ea39d8620494e2a2c874a3c4201; Ren J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209117; Repalust A, 2017, PSYCHOL HEALTH MED, V22, P1045, DOI 10.1080/13548506.2016.1263756; Ritvo Paul, 2003, J Immune Based Ther Vaccines, V1, P3, DOI 10.1186/1476-8518-1-3; Roberts MR, 2013, PUBLIC UNDERST SCI, V22, P624, DOI 10.1177/0963662511420511; Salek J, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8010136; Sallam M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144915; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Shapiro GK, 2016, PAPILLOMAVIRUS RES, V2, P167, DOI 10.1016/j.pvr.2016.09.001; Shea JA, 2008, J GEN INTERN MED, V23, P727, DOI 10.1007/s11606-008-0575-3; Shui IM, 2006, AM J PREV MED, V31, P244, DOI 10.1016/j.amepre.2006.04.006; Sointu E, 2012, THEORIZING COMPLEMENTARY AND ALTERNATIVE MEDICINES: WELLBEING, SELF, GENDER, CLASS, P1, DOI 10.1057/9781137003737; Soveri A, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10643-w; Steens A, 2020, VACCINE, V38, P4536, DOI 10.1016/j.vaccine.2020.05.011; Suljok A., 2020, SOC PR, V58, P85, DOI [10.5673/sip.58.1.4, DOI 10.5673/SIP.58.1.4]; Wombwell E, 2015, J COMMUN HEALTH, V40, P597, DOI 10.1007/s10900-014-9956-1; Yang YT, 2016, AM J PUBLIC HEALTH, V106, P172, DOI 10.2105/AJPH.2015.302926	63	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264722	10.1371/journal.pone.0264722	http://dx.doi.org/10.1371/journal.pone.0264722			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231050	gold, Green Published, Green Accepted			2022-12-26	WOS:000849744700037
J	Yan, B; Xu, Y				Yan, Bing; Xu, Yi			Quantifying interaction uncertainty between subwatersheds and base-flow partitions on hydrological processes	PLOS ONE			English	Article							WATERSHED SUBDIVISION LEVEL; RECURSIVE DIGITAL-FILTERS; SEPARATION METHODS; RIVER-BASIN; PERFORMANCE; RECESSION; SEDIMENT; RUNOFF; IMPACT; IDENTIFICATION	Base flow, as an important component of runoff, is the main recharge source of runoff during the dry period, especially in the Yellow River Basin located in a semiarid area. However, the process of obtaining base flow has great uncertainty when considering hydrological simulations. Thus, in this study, a three-step framework is proposed, i.e., the particle swarm optimization (PSO) algorithm is used to calibrate model parameters under different subbasin partitioning schemes; then, the hydrograph separation (HYSEP), Improved United Kingdom Institute of Hydrology (IUKIH) and Lyne and Hollick filter (Lyne-Hollick) methods are used to separate the baseflow from the total runoff process, thereby exploring the uncertainty impacts of baseflow segmentation methods on the hydrological simulation process. The subsample-variance-decomposition method is used to quantify the independent and interactive uncertainty in the hydrological simulation process. The results show that the Topmodel model can be better applied to the source area of the Yellow River (the KGE values in the Sub5, Sub13, Sub21, Sub29, Sub37 and Sub13 scenarios were 0.91 and 0.65, 0.94 and 0.86, 0.94 and 0.88, 0.92 and 0.82, 0.95 and 0.89, and 0.92 and 0.83, respectively). The subbasin division uncertainty had less impact on simulated streamflow during the dry season and had a significant impact in the wet season, such as, the subbasin division uncertainty caused the difference between the median of the simulated streamflow to be as high as 213.09 m(3)/s in August but only 107.19 m(3)/s in January; Meanwhile, the baseflow segmentation method uncertainty has a significant impact on the annual mean streamflow values under different subbasin segmentation schemes. In addition, the baseflow values estimated by the Lyne-Hollick and HYSEP methods were obviously higher than those estimated by the IUKIH method during the wet season. The uncertainty influence of subbasin partitioning schemes and baseflow segmentation methods had significant differences on hydrological processes in different periods. The uncertainty influence of subbasin partitioning schemes was dominant in the dry season, accounting for 86%, and the baseflow segmentation methods took second place, accounting for approximately 12%. In the wet season, the uncertainty influence of the baseflow segmentation methods was gradually weakened, which may have been due to the uncertainty influence of the hydrological model. These results provide a reference for the calibration and validation of hydrological model parameters using baseflow components.	[Yan, Bing; Xu, Yi] Nanjing Hydraul Res Inst, Hydrol & Water Resources Dept, Nanjing, Peoples R China; [Yan, Bing] Hohai Univ, Coll Hydrol & Water Resources, Nanjing, Peoples R China; [Yan, Bing; Xu, Yi] State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Peoples R China	Nanjing Hydraulic Research Institute; Hohai University	Xu, Y (corresponding author), Nanjing Hydraul Res Inst, Hydrol & Water Resources Dept, Nanjing, Peoples R China.; Xu, Y (corresponding author), State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Peoples R China.	xuyi@nhri.cn		Yan, Bing/0000-0002-1607-4245	National Key Research and Development Program of China [2018YFC0406506, 2018YFC0406505, 2016YFC0401305]	National Key Research and Development Program of China	This work was financially supported by the National Key Research and Development Program of China [Grant number: 2018YFC0406506, 2018YFC0406505, 2016YFC0401305]	Aksoy H, 2015, CLEAN-SOIL AIR WATER, V43, P857, DOI 10.1002/clen.201400199; Arabi M, 2006, J AM WATER RESOUR AS, V42, P513, DOI 10.1111/j.1752-1688.2006.tb03854.x; BEVEN K, 1979, WATER RESOUR RES, V15, P1238, DOI 10.1029/WR015i005p01238; BEVEN K, 1992, HYDROL PROCESS, V6, P279, DOI 10.1002/hyp.3360060305; Bingner RL, 1997, T ASAE, V40, P1329, DOI 10.13031/2013.21391; Bosshard T, 2013, WATER RESOUR RES, V49, P1523, DOI 10.1029/2011WR011533; BRUTSAERT W, 1977, WATER RESOUR RES, V13, P637, DOI 10.1029/WR013i003p00637; Camacho RA, 2015, J AM WATER RESOUR AS, V51, P1372, DOI 10.1111/1752-1688.12319; Casey MJ., 2015, J HYDROL, P1943; Chang CL, 2009, ENVIRON MONIT ASSESS, V148, P159, DOI 10.1007/s10661-007-0147-8; Chang JX, 2015, QUATERN INT, V380, P169, DOI 10.1016/j.quaint.2014.03.048; Chapman T, 1999, HYDROL PROCESS, V13, P701, DOI 10.1002/(SICI)1099-1085(19990415)13:5&lt;701::AID-HYP774&gt;3.0.CO;2-2; Chen Y, 2020, ECOL INDIC, V118, DOI 10.1016/j.ecolind.2020.106771; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Eckhardt K, 2005, HYDROL PROCESS, V19, P507, DOI 10.1002/hyp.5675; Engeland K, 2005, HYDROLOG SCI J, V50, P45, DOI 10.1623/hysj.50.1.45.56334; Ferket BVA, 2010, J HYDROL, V381, P158, DOI 10.1016/j.jhydrol.2009.11.038; Gao ZL, 2016, HYDROL PROCESS, V30, P1315, DOI 10.1002/hyp.10704; Gupta HV, 2009, J HYDROL, V377, P80, DOI 10.1016/j.jhydrol.2009.08.003; Han JC, 2014, HYDROLOG SCI J, V59, P108, DOI 10.1080/02626667.2013.854368; Huang SZ, 2014, J HYDROL, V511, P764, DOI 10.1016/j.jhydrol.2014.01.062; Jha M, 2004, J AM WATER RESOUR AS, V40, P811, DOI 10.1111/j.1752-1688.2004.tb04460.x; Joseph JF, 2013, ENVIRON MODELL SOFTW, V46, P292, DOI 10.1016/j.envsoft.2013.03.012; Kim HS, 2015, J HYDROL, V521, P543, DOI 10.1016/j.jhydrol.2014.12.030; Kim JG, 2009, J AM WATER RESOUR AS, V45, P963, DOI 10.1111/j.1752-1688.2009.00339.x; Koskelo AI, 2012, J HYDROL, V450, P267, DOI 10.1016/j.jhydrol.2012.04.055; Larose M, 2007, J ENVIRON QUAL, V36, P521, DOI 10.2134/jeq2006.0154; Lee S, 2021, J HYDROL, V600, DOI 10.1016/j.jhydrol.2021.126564; Li BQ, 2017, STOCH ENV RES RISK A, V31, P1045, DOI 10.1007/s00477-016-1319-2; Li L, 2013, ENVIRON MODELL SOFTW, V41, P163, DOI 10.1016/j.envsoft.2012.11.009; Li L, 2014, ENVIRON MODELL SOFTW, V54, P39, DOI 10.1016/j.envsoft.2013.12.011; Lin BQ, 2020, ECOL INDIC, V111, DOI 10.1016/j.ecolind.2019.106040; Lott DA, 2016, J HYDROL, V535, P525, DOI 10.1016/j.jhydrol.2016.01.063; Ma YF, 2021, J HYDROL, V598, DOI 10.1016/j.jhydrol.2021.126444; Meng FC, 2016, J HYDROL-REG STUD, V6, P66, DOI 10.1016/j.ejrh.2016.03.003; NATHAN RJ, 1990, WATER RESOUR RES, V26, P1465, DOI 10.1029/WR026i007p01465; Niu WJ, 2020, J HYDROL, V590, DOI 10.1016/j.jhydrol.2020.125477; Partington D, 2012, J HYDROL, V458, P28, DOI 10.1016/j.jhydrol.2012.06.029; Rajat PA., 2021, ENVIRON MODELL SOFTW, V144; Rouhani H, 2007, HYDROL PROCESS, V21, P2998, DOI 10.1002/hyp.6527; Shamshirband S, 2020, ENG APPL COMP FLUID, V14, P339, DOI 10.1080/19942060.2020.1715844; Shao GW., 2020, WATER-SUI, V12, P1; Sharafati A, 2020, J HYDROL, V591, DOI 10.1016/j.jhydrol.2020.125468; Sharafati A, 2020, J HYDRO-ENVIRON RES, V29, P20, DOI 10.1016/j.jher.2019.11.002; Sharafati A, 2020, THEOR APPL CLIMATOL, V139, P389, DOI 10.1007/s00704-019-02979-6; Sharafati A, 2018, J PIPELINE SYST ENG, V9, DOI 10.1061/(ASCE)PS.1949-1204.0000347; Shi HY, 2015, HYDROL PROCESS, V29, P3236, DOI 10.1002/hyp.10439; Taormina R, 2015, J HYDROL, V529, P1788, DOI 10.1016/j.jhydrol.2015.08.008; Tongal H, 2018, J HYDROL, V564, P266, DOI 10.1016/j.jhydrol.2018.07.004; Wang GB, 2016, ECOL ENG, V87, P110, DOI 10.1016/j.ecoleng.2015.11.041; Wang TH, 2018, J HYDROL, V558, P301, DOI 10.1016/j.jhydrol.2018.01.050; Yang H, 2021, J HYDROL, V597, DOI 10.1016/j.jhydrol.2021.126311; Zhang JL, 2017, J HYDROL, V549, P252, DOI 10.1016/j.jhydrol.2017.04.004; Zhu YX, 2019, J HYDROL, V574, P915, DOI 10.1016/j.jhydrol.2019.05.010	54	0	0	9	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0261859	10.1371/journal.pone.0261859	http://dx.doi.org/10.1371/journal.pone.0261859			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231036	Green Published, gold			2022-12-26	WOS:000849744700004
J	Alazwari, A; Abdollahian, M; Tafakori, L; Johnstone, A; Alshumrani, RA; Alhelal, MT; Alsaheel, AY; Almoosa, ES; Alkhaldi, AR				Alazwari, Ahood; Abdollahian, Mali; Tafakori, Laleh; Johnstone, Alice; Alshumrani, Rahma A.; Alhelal, Manal T.; Alsaheel, Abdulhameed Y.; Almoosa, Eman S.; Alkhaldi, Aseel R.			Predicting age at onset of type 1 diabetes in children using regression, artificial neural network and Random Forest: A case study in Saudi Arabia	PLOS ONE			English	Article							PERINATAL RISK-FACTORS; ACCELERATOR HYPOTHESIS; EARLIER ONSET; BODY-WEIGHT; CHILDHOOD; MELLITUS; INSULIN; ANN; AUTOANTIBODIES; PREVENTION	The rising incidence of type 1 diabetes (T1D) among children is an increasing concern globally. A reliable estimate of the age at onset of T1D in children would facilitate intervention plans for medical practitioners to reduce the problems with delayed diagnosis of T1D. This paper has utilised Multiple Linear Regression (MLR), Artificial Neural Network (ANN) and Random Forest (RF) to model and predict the age at onset of T1D in children in Saudi Arabia (S.A.) which is ranked as the 7th for the highest number of T1D and 5th in the world for the incidence rate of T1D. De-identified data between (2010-2020) from three cities in S.A. were used to model and predict the age at onset of T1D. The best subset model selection criteria, coefficient of determination, and diagnostic tests were deployed to select the most significant variables. The efficacy of models for predicting the age at onset was assessed using multi-prediction accuracy measures. The average age at onset of T1D is 6.2 years and the most common age group for onset is (5-9) years. Most of the children in the sample (68%) are from urban areas of S.A., 75% were delivered after a full term pregnancy length and 31% were delivered through a cesarean section. The models of best fit were the MLR and RF models with R-2 = (0.85 and 0.95), the root mean square error = (0.25 and 0.15) and mean absolute error = (0.19 and 0.11) respectively for logarithm of age at onset. This study for the first time has utilised MLR, ANN and RF models to predict the age at onset of T1D in children in S.A. These models can effectively aid health care providers to monitor and create intervention strategies to reduce the impact of T1D in children in S.A.	[Alazwari, Ahood; Abdollahian, Mali; Tafakori, Laleh; Johnstone, Alice] RMIT Univ, Sch Sci, Melbourne, Vic, Australia; [Alazwari, Ahood] Al Baha Univ, Sch Sci, Moundq, Saudi Arabia; [Alshumrani, Rahma A.] Al Aziziyah Maternal & Children Hosp, Pediat Endocrine Dept, Jeddah, Saudi Arabia; [Alhelal, Manal T.; Almoosa, Eman S.] Maternal & Children Hosp, Pediat Endocrine Dept, Al Hasa, Saudi Arabia; [Alsaheel, Abdulhameed Y.; Alkhaldi, Aseel R.] King Fahad Med City KFMC, Pediat Endocrine Dept, Riyadh, Saudi Arabia	Royal Melbourne Institute of Technology (RMIT); Al Baha University; King Fahad Medical City	Alazwari, A (corresponding author), RMIT Univ, Sch Sci, Melbourne, Vic, Australia.; Alazwari, A (corresponding author), Al Baha Univ, Sch Sci, Moundq, Saudi Arabia.	S3677238@student.rmit.edu.au	; Johnstone, Alice/B-5383-2008	Alsaheel, Abdulhameed/0000-0002-2656-5267; Alazwari, Ahood/0000-0002-3791-2340; Johnstone, Alice/0000-0003-0736-9751				Abduljabbar MA, 2010, SAUDI MED J, V31, P413; Abrougui K, 2019, SOIL TILL RES, V190, P202, DOI 10.1016/j.still.2019.01.011; Adar A, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3318; Adua E., 2021, TRANSL MED COMMUN, V6; Ahmad MW, 2017, ENERG BUILDINGS, V147, P77, DOI 10.1016/j.enbuild.2017.04.038; Al-Daghri NM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-153; Al-Ghamdi AH., 2017, IOSR J PHARM BIOL SC, V12, P5; Al-Rubeaan K, 2015, J EPIDEMIOL COMMUN H, V69, P1045, DOI 10.1136/jech-2015-205710; Algert CS, 2009, DIABETIC MED, V26, P1193, DOI 10.1111/j.1464-5491.2009.02878.x; Alotaibi M, 2016, DIABETES RES CLIN PR, V120, P235, DOI 10.1016/j.diabres.2016.08.015; Altobelli E, 1998, ACTA DIABETOL, V35, P57, DOI 10.1007/s005920050102; Altobelli E, 2016, PEDIATR DIABETES, V17, P559, DOI 10.1111/pedi.12345; [Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a; Antonopoulos VZ, 2019, COMPUT ELECTRON AGR, V160, P160, DOI 10.1016/j.compag.2019.03.022; Betts P, 2005, DIABETIC MED, V22, P144, DOI 10.1111/j.1464-5491.2004.01368.x; Beyerlein A, 2019, J MED GENET, V56, P602, DOI 10.1136/jmedgenet-2018-105532; Beyerlein A, 2013, JAMA PEDIATR, V167, P800, DOI 10.1001/jamapediatrics.2013.158; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bonifacio E, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002548; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Butalia S, 2016, CAN J DIABETES, V40, P586, DOI 10.1016/j.jcjd.2016.05.002; Carel JC, 2008, BRIT MED J, V336, P677, DOI 10.1136/bmj.39517.508241.80; Carvalho NB, 2013, FOOD SCI TECH-BRAZIL, V33, P722, DOI 10.1590/S0101-20612013000400018; Cerci KN, 2020, INT COMMUN HEAT MASS, V116, DOI 10.1016/j.icheatmasstransfer.2020.104713; Chowdhury Subhankar, 2015, Indian J Endocrinol Metab, V19, pS51, DOI 10.4103/2230-8210.155402; Dayan CM, 2021, SCIENCE, V373, P506, DOI 10.1126/science.abi4742; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; Demirbilek H, 2013, J CLIN RES PEDIATR E, V5, P98, DOI 10.4274/Jcrpe.954; Duda RO., 1973, NEURAL COMPUT APPL; Egro FM, 2013, J MOL ENDOCRINOL, V51, pR1, DOI 10.1530/JME-13-0067; Eisenbarth GS, 2010, DIABETES, V59, P759, DOI 10.2337/db09-1855; El-Ziny MA, 2014, J CLIN RES PEDIATR E, V6, P9, DOI 10.4274/Jcrpe.1171; Evertsen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006873; Fallatah AM, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.13454; Ferrat LA, 2020, NAT MED, V26, P1247, DOI 10.1038/s41591-020-0930-4; Fissa MR, 2019, J MOL GRAPH MODEL, V87, P109, DOI 10.1016/j.jmgm.2018.11.013; Fojnica A, 2016, MEDD C EMBED COMPUT, P290, DOI 10.1109/MECO.2016.7525763; Garske T., 2018, THESIS U COLORADO DE; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Grulich-Henn J, 2018, J INHERIT METAB DIS, V41, P19, DOI 10.1007/s10545-017-0120-9; Hippich M, 2019, DIABETES, V68, P847, DOI 10.2337/db18-0882; International Diabetes Federation, 2019, IDF DIABETES ATLAS, V9th ed.; Jhee JH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221202; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Kaushik AC, 2018, NEURAL COMPUT APPL, V29, P985, DOI 10.1007/s00521-016-2502-6; Knerr I, 2005, DIABETOLOGIA, V48, P2501, DOI 10.1007/s00125-005-0033-2; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Kopitar L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68771-z; Kuchlbauer V, 2014, PEDIATR DIABETES, V15, P428, DOI 10.1111/pedi.12107; LaGasse JM, 2002, DIABETES CARE, V25, P505, DOI 10.2337/diacare.25.3.505; Laing SP, 1999, DIABETIC MED, V16, P466, DOI 10.1046/j.1464-5491.1999.00076.x; Lariviere B, 2005, EXPERT SYST APPL, V29, P472, DOI 10.1016/j.eswa.2005.04.043; Lee HY, 2015, EUR J PUBLIC HEALTH, V25, P1024, DOI 10.1093/eurpub/ckv059; Li Q, 2009, ENERG CONVERS MANAGE, V50, P90, DOI 10.1016/j.enconman.2008.08.033; Lindell N, 2018, DIABETOLOGIA, V61, P130, DOI 10.1007/s00125-017-4481-2; Liu X, 2020, DIABETES CARE, V43, P556, DOI 10.2337/dc19-1670; Liu Y., 2014, COMPUT MODEL NEW TEC, V18, P147; Lombardo Fortunato, 2021, J Diabetes Sci Technol, V15, P1377, DOI 10.1177/1932296820947072; Malachowska Beata, 2012, Pediatr Endocrinol Diabetes Metab, V18, P130; Moore PJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211558; Olden JD, 2004, ECOL MODEL, V178, P389, DOI 10.1016/j.ecolmodel.2004.03.013; Parveen N, 2017, PROCESS SAF ENVIRON, V107, P428, DOI 10.1016/j.psep.2017.03.007; Parviainen A, 2020, DIABETES CARE, V43, P2953, DOI 10.2337/dc20-0604; R Core Team, 2021, R LANG ENV STAT; Rajula HSR, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56090455; Redondo MJ, 2018, DIABETES CARE, V41, P1887, DOI 10.2337/dc18-0087; Robert AA, 2018, INT J PEDIAT, V2018, DOI 10.1155/2018/9408370; Robertson CC, 2018, CURR OPIN GENET DEV, V50, P7, DOI 10.1016/j.gde.2018.01.006; Rubio-Cabezas O, 2009, J CLIN ENDOCR METAB, V94, P4162, DOI 10.1210/jc.2009-1137; Shaikhina T, 2019, BIOMED SIGNAL PROCES, V52, P456, DOI 10.1016/j.bspc.2017.01.012; Sisodia D, 2018, P COMPUT SCI, V132, P1578; Sosenko JM, 2008, DIABETES CARE, V31, P2188, DOI 10.2337/dc08-0935; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; Tuomilehto J, 2013, CURR DIABETES REP, V13, P795, DOI 10.1007/s11892-013-0433-5; Vaarala O, 2012, ARCH PEDIAT ADOL MED, V166, P608, DOI 10.1001/archpediatrics.2011.1559; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; Wadsworth EJK, 1997, DIABETIC MED, V14, P390, DOI 10.1002/(SICI)1096-9136(199705)14:5<390::AID-DIA364>3.0.CO;2-E; Waldhoer T, 2008, PEDIATR DIABETES, V9, P178, DOI 10.1111/j.1399-5448.2008.00378.x; Wasserfall C, 2011, DIABETOLOGIA, V54, P2232, DOI 10.1007/s00125-011-2244-z; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; World Health Organization, WHO FACT SHEET PRET; Xia Y, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3075; Zhang XA, 2010, LINK MINING: MODELS, ALGORITHMS, AND APPLICATIONS, P505, DOI 10.1007/978-1-4419-6515-8_19; Ziegler AG, 2016, MOL METAB, V5, P255, DOI 10.1016/j.molmet.2016.02.003; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	85	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264118	10.1371/journal.pone.0264118	http://dx.doi.org/10.1371/journal.pone.0264118			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226685	gold, Green Published			2022-12-26	WOS:000793394000009
J	Johannesen, A; Patursson, O; Kristmundsson, J; Dam, SP; Mulelid, M; Klebert, P				Johannesen, Asa; Patursson, Oystein; Kristmundsson, Johannus; Dam, Signar Paetursonur; Mulelid, Mats; Klebert, Pascal			Waves and currents decrease the available space in a salmon cage	PLOS ONE			English	Article							FARMED ATLANTIC SALMON; SWIMMING BEHAVIOR; WELFARE INDICATORS; SEA-CAGE; GROWTH; LIGHT; LICE; MODEL	Due to increasing demand for salmon and environmental barriers preventing expansion in established sites, salmon farmers seek to move or expand their production to more exposed sites. In this study we investigate the effects of strong currents and waves on the behaviour of salmon and how they choose to use the space available to them. Observations are carried out in a site with strong tidal currents and well mixed water. Using video cameras and echo sounders, we show that salmon prefer to use the entire water column, narrowing their range only as a response to cage deformation, waves, or daylight. Conversely, salmon show strong horizontal preference, mostly occupying the portions of the cage exposed to currents. Additionally, waves cause salmon to disperse from the exposed side of the cage to the more sheltered side. Even when strong currents decrease the amount of available space, salmon choose to occupy the more exposed part of the cage. This indicates that at least with good water exchange, the high density caused by limited vertical space is not so aversive that salmon choose to move to less desirable areas of the cage. However, the dispersal throughout the entire available water column indicates that ensuring enough vertical space, even in strong currents, would be beneficial to salmon welfare.	[Johannesen, Asa] Fiskaaling, Vistfrodi, Hvalvik, Faroe Islands, Denmark; [Patursson, Oystein] RAO, Kirkjubo, Faroe Islands, Denmark; [Kristmundsson, Johannus] Fiskaaling, Fjardaelvi, Hvalvik, Faroe Islands, Denmark; [Dam, Signar Paetursonur] Hiddenfjord, Sorvagur, Faroe Islands, Denmark; [Mulelid, Mats; Klebert, Pascal] Sintef OCEAN, Trondheim, Norway	SINTEF	Johannesen, A (corresponding author), Fiskaaling, Vistfrodi, Hvalvik, Faroe Islands, Denmark.	asajoh@fiskaaling.fo	Kristmundsson, Jóhannus/AFR-1687-2022; klebert, pascal/DSX-4164-2022	Kristmundsson, Jóhannus/0000-0003-4757-2965; Johannesen, Asa/0000-0002-8877-4013	Norwegian Research Council [267800/E40]; Centre for Research-Based Innovation on exposed aquaculture operations (SFI EXPOSED)) [237790/O30]; Fiskaaling	Norwegian Research Council(Research Council of NorwayEuropean Commission); Centre for Research-Based Innovation on exposed aquaculture operations (SFI EXPOSED)); Fiskaaling	The Norwegian Research Council: 267800/E40 (FUTUREWELFARE) and Centre for Research-Based Innovation on exposed aquaculture operations (SFI EXPOSED):237790/ O30 supported this work in grants to Pascal Klebert and Asa Johannesen respectively. Fiskaaling also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C, 2017, R PACKAGE TEXTTTCIRC; [Anonymous], 2019, LTD ISPY; Arechavala-Lopez P, 2022, REV AQUACULT, V14, P704, DOI 10.1111/raq.12620; ASC, 2021, VIETN 1 ASC CLAM FAR; Assured R, 2021, EAT LESS EAT BETTER; Bates D.M., 2010, LME4 MIXED EFFECTS M; Brizzi G, 2021, OCEAN ENG, V224, DOI 10.1016/j.oceaneng.2021.108751; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Dam SP., 2015, STUDY ATLANTIC SALMO; FAO, 2020, STAT WORLD FISH AQ 2, DOI [10.4060/ca9229-n, 10.4060/ca9229en]; Franks B, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg0677; Freitas RHA, 2014, ZOOLOGY, V117, P179, DOI 10.1016/j.zool.2013.09.005; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Gansel LC, 2014, J OFFSHORE MECH ARCT, V136, DOI 10.1115/1.4027746; Hansen TJ, 2017, AQUACULT ENV INTERAC, V9, P193, DOI 10.3354/aei00224; Hedger RD, 2017, MAR ECOL PROG SER, V574, P127, DOI 10.3354/meps12180; Hemmingsen W, 2020, AQUACULTURE, V522, DOI 10.1016/j.aquaculture.2020.735160; Hvas M, 2021, AQUACULT ENV INTERAC, V13, P189, DOI 10.3354/aei00401; Hvas M, 2021, REV AQUACULT, V13, P836, DOI 10.1111/raq.12501; Hvas M, 2018, BIOL OPEN, V7, DOI 10.1242/bio.036079; Hvas M, 2017, AQUACULTURE, V473, P423, DOI 10.1016/j.aquaculture.2017.03.013; Johannesen A, 2021, WAVES CURRENTS DECRE; Johannesen A, 2020, PEERJ, V8, DOI 10.7717/peerj.9313; Johansson D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097635; Johnson SC, 2004, ZOOL STUD, V43, P229; Jonsdottir KE, 2019, AQUACULT ENV INTERAC, V11, P249, DOI 10.3354/aei00310; Kelley D, 2021, **DATA OBJECT**; Klebert P, 2015, OCEAN ENG, V104, P511, DOI 10.1016/j.oceaneng.2015.04.045; Kragesteen TJ, 2018, AQUACULT ENV INTERAC, V10, P49, DOI 10.3354/aei00252; Kristiansen D, 2015, CHINA OCEAN ENG, V29, P325, DOI 10.1007/s13344-015-0023-1; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lader P, 2008, AQUACULT ENG, V38, P52, DOI 10.1016/j.aquaeng.2007.11.001; Lekang OI, 2016, AQUACULT INT, V24, P757, DOI 10.1007/s10499-016-9994-z; Ludecke D, 2021, JOSS, V6, P3139, DOI [10.21105/joss.03139, DOI 10.21105/JOSS.03139]; Mederi, 2018, TIME VLC EXTENSION; Moltumyr L, 2021, AQUACULTURE, V532, DOI 10.1016/j.aquaculture.2020.736048; Oldham T, 2017, AQUACULT ENV INTERAC, V9, P145, DOI 10.3354/aei00219; Oppedal F, 2001, J FISH BIOL, V58, P1570, DOI 10.1006/jfbi.2001.1562; Oppedal F, 2007, AQUACULTURE, V265, P70, DOI 10.1016/j.aquaculture.2007.01.050; Oppedal F, 2011, AQUACULTURE, V315, P361, DOI 10.1016/j.aquaculture.2011.02.037; Oppedal F, 2011, AQUACULTURE, V311, P1, DOI 10.1016/j.aquaculture.2010.11.020; Overton K, 2019, REV AQUACULT, V11, P1398, DOI 10.1111/raq.12299; Patursson EJ, 2017, AQUACULT ENV INTERAC, V9, P33, DOI 10.3354/aei00209; Pettersen JM, 2014, REV AQUACULT, V6, P162, DOI 10.1111/raq.12039; RCore Team, 2020, R LANG ENV STAT COMP; Remen M, 2016, AQUACULTURE, V464, P582, DOI 10.1016/j.aquaculture.2016.07.037; ROTTINGEN I, 1976, Fiskeridirektoratets Skrifter Serie Havundersokelser, V16, P301; Sanchez-Suarez W, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10091585; Sievers M, 2018, AQUACULT ENV INTERAC, V10, P501, DOI 10.3354/aei00289; Solstorm D, 2018, AQUACULTURE, V486, P122, DOI 10.1016/j.aquaculture.2017.12.008; Solstorm F, 2016, AQUACULT ENV INTERAC, V8, P339, DOI 10.3354/aei00178; Stehfest KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04806-2; Stien LH, 2013, REV AQUACULT, V5, P33, DOI 10.1111/j.1753-5131.2012.01083.x; Van Rossum G, 2009, PYTHON 3 REFERENCE M, DOI DOI 10.5555/1593511; VideoLAN, 2019, VLC MEDIA PLAYER; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Williams TD, 2009, LAB ANIM-UK, V43, P107, DOI 10.1258/la.2007.007023; Wright DW, 2015, AQUACULT ENV INTERAC, V7, P61, DOI 10.3354/aei00136; Zeileis A, 2020, J STAT SOFTW, V96, P1, DOI 10.18637/jss.v096.i01	61	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263850	10.1371/journal.pone.0263850	http://dx.doi.org/10.1371/journal.pone.0263850			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213608	gold, Green Submitted, Green Published			2022-12-26	WOS:000787811000035
J	Nishida, S; Nakamura, M; Kiyono, R; Sato, S; Yasaka, K; Yoshida, R; Nosaka, K				Nishida, Satoru; Nakamura, Masatoshi; Kiyono, Ryosuke; Sato, Shigeru; Yasaka, Koki; Yoshida, Riku; Nosaka, Kazunori			Relationship between Nordic hamstring strength and maximal voluntary eccentric, concentric and isometric knee flexion torque	PLOS ONE			English	Article							MALE SOCCER PLAYERS; INJURY; RELIABILITY; MUSCLES; STRAIN; HIP; FOOTBALL; EXERCISE; VALIDITY; RISK	Nordic hamstring exercise is performed to prevent knee flexor muscle strain injuries and used to assess their injury risks. However, what exactly Nordic hamstring strength indicates is not clear. We investigated the relationship between Nordic hamstring strength and maximal voluntary contraction (MVC) torque of the knee flexors measured by an isokinetic dynamometer. Sixteen healthy young men who had not experienced hamstring strain injuries participated in the study. In Nordic hamstring, each participant was instructed to lean forward as far as possible in 3 s (approximately 307s), and force at the ankle joint of the dominant leg was measured during the movement. The force was multiplied by lower leg length and converted into torque. MVC torque of the knee flexors was measured isometrically at 30 degrees, 45 degrees, 60 degrees, and 90 degrees knee flexion joint angles, and concentrically and eccentrically at 307s and 607s in 10 degrees -90 degrees knee flexion for the dominant leg in a prone position. Correlations among the dependent variables were assessed using Pearson's correlation coefficients. Peak Nordic hamstring torque ranged 96.8-163.5 Nm, and peak MVC eccentric torque ranged 50.7-109.4 Nm at 30 degrees/s and 59.2-121.2 Nm at 60 degrees/s. No significant correlations were evident between the peak Nordic hamstring torque and peak eccentric knee flexion torque (r = 0.24-0.3, p = 0.26-0.4). This was also the case for the Nordic hamstring torque and MVC torque of isometric (r = -0.03-0.1, p = 0.71-0.92) and concentric contractions (r = 0.28-0.49, p = 0.053-0.29). These results show that Nordic hamstring strength is not associated with the knee flexor torque measured by an isokinetic dynamometer. It may be that other factors than static and dynamic hamstring strengths affect Nordic hamstring strength.	[Nishida, Satoru] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka, Japan; [Nakamura, Masatoshi; Kiyono, Ryosuke; Sato, Shigeru] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Nakamura, Masatoshi; Kiyono, Ryosuke; Sato, Shigeru; Yasaka, Koki; Yoshida, Riku] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata, Japan; [Nosaka, Kazunori] Edith Cowan Univ, Ctr Exercise & Sports Sci Res, Sch Med & Hlth Sci, Joondalup, WA, Australia	Fukuoka University; Niigata University; Niigata University; Edith Cowan University	Nishida, S (corresponding author), Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka, Japan.	satoru.nishida5521@gmail.com			JSPS KAKENHI [JP19K24299]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI (Grant Number JP19K24299), but the findings of the study are independent from the funding organisation. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ayala F, 2013, CLIN PHYSIOL FUNCT I, V33, P45, DOI 10.1111/j.1475-097X.2012.01162.x; Bautista IJ, 2021, J SCI MED SPORT, V24, P931, DOI 10.1016/j.jsams.2021.03.009; Bourne MN, 2017, BRIT J SPORT MED, V51, P469, DOI 10.1136/bjsports-2016-096130; Brockett CL, 2001, MED SCI SPORT EXER, V33, P783; Buckthorpe M, 2019, BRIT J SPORT MED, V53, P449, DOI 10.1136/bjsports-2018-099616; Chumanov ES, 2012, BRIT J SPORT MED, V46, P90, DOI 10.1136/bjsports-2011-090176; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P131, DOI 10.1123/ijspp.3.2.131; Alvares JBDR, 2015, PHYS THER SPORT, V16, P59, DOI 10.1016/j.ptsp.2014.04.004; Ekstrand J, 2016, BRIT J SPORT MED, V50, P731, DOI 10.1136/bjsports-2015-095359; Findley BW, 2006, J SPORT SCI MED, V5, P400; Green B, 2020, BRIT J SPORT MED, V54, P1081, DOI 10.1136/bjsports-2019-100983; Green B, 2018, BRIT J SPORT MED, V52, P329, DOI 10.1136/bjsports-2017-098101; Lee JWY, 2018, INT J SPORT PHYSIOL, V13, P620, DOI 10.1123/ijspp.2017-0336; Lee JWY, 2017, J EXERC SCI FIT, V15, P18, DOI 10.1016/j.jesf.2017.04.001; Mjolsnes R, 2004, SCAND J MED SCI SPOR, V14, P311, DOI 10.1046/j.1600-0838.2003.367.x; Moreno-Perez V, 2020, PHYS THER SPORT, V46, P97, DOI 10.1016/j.ptsp.2020.08.009; Narouei S, 2018, J EXERC REHABIL, V14, P231, DOI 10.12965//jer.1835200.600; Opar DA, 2015, MED SCI SPORT EXER, V47, P857, DOI 10.1249/MSS.0000000000000465; Opar DA, 2013, J ORTHOP SPORT PHYS, V43, P636, DOI 10.2519/jospt.2013.4837; Opar DA, 2012, SPORTS MED, V42, P209, DOI 10.2165/11594800-000000000-00000; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Roe M, 2018, BRIT J SPORT MED, V52, P982, DOI 10.1136/bjsports-2016-096401; Sarabon N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223437; Schache AG, 2012, MED SCI SPORT EXER, V44, P647, DOI 10.1249/MSS.0b013e318236a3d2; Schuermans J, 2017, GAIT POSTURE, V57, P270, DOI 10.1016/j.gaitpost.2017.06.268; Schuermans J, 2017, AM J SPORT MED, V45, P1315, DOI 10.1177/0363546516687750; Struzik A, 2015, ACTA BIOENG BIOMECH, V17, P131, DOI 10.5277/ABB-00290-2015-02; Sugiura Y, 2008, J ORTHOP SPORT PHYS, V38, P457, DOI 10.2519/jospt.2008.2575; Timmins RG, 2021, SCAND J MED SCI SPOR, V31, P1276, DOI 10.1111/sms.13941; Tyler TF, 2017, J SPORT REHABIL, V26, P131, DOI 10.1123/jsr.2015-0099; van den Tillaar R, 2017, INT J SPORTS PHYS TH, V12, P718, DOI 10.16603/ijspt20170718; van Dyk N, 2018, SCAND J MED SCI SPOR, V28, P1878, DOI 10.1111/sms.13201; van Dyk N, 2019, BRIT J SPORT MED, V53, P1362, DOI 10.1136/bjsports-2018-100045; Vercelli S, 2020, INT J REHABIL RES, V43, P272, DOI 10.1097/MRR.0000000000000415; Vincent W.J., 2005, STAT KINESIOLOGY, V3rd ed.; Wiesinger HP, 2020, SCAND J MED SCI SPOR, V30, P217, DOI 10.1111/sms.13569	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264465	10.1371/journal.pone.0264465	http://dx.doi.org/10.1371/journal.pone.0264465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213652	Green Published, gold			2022-12-26	WOS:000787811000105
J	Peeters, ETHM; Gerritsen, AAM; Seelen, LMS; Begheyn, M; Rienks, F; Teurlincx, S				Peeters, Edwin T. H. M.; Gerritsen, Anton A. M.; Seelen, Laura M. S.; Begheyn, Matthijs; Rienks, Froukje; Teurlincx, Sven			Monitoring biological water quality by volunteers complements professional assessments	PLOS ONE			English	Article							CITIZEN SCIENCE DATA; PUBLIC-PARTICIPATION; BIOTIC INTEGRITY; SHALLOW LAKES; INDEX; BIODIVERSITY; SYSTEM; MANAGEMENT; ACCURACY; HISTORY	Progressively more community initiatives have been undertaken over last decades to monitor water quality. Biological data collected by volunteers has been used for biodiversity and water quality studies. Despite the many citizen science projects collecting and using macroinvertebrates, the number of scientific peer-reviewed publications that use this data, remains limited. In 2018, a citizen science project on biological water quality assessment was launched in the Netherlands. In this project, volunteers collect macroinvertebrates from a nearby waterbody, identify and count the number of specimens, and register the catch through a web portal to instantaneously receive a water quality score based on their data. Water quality monitoring in the Netherlands is traditionally the field of professionals working at water authorities. Here, we compare the data from the citizen science project with the data gathered by professionals. We evaluate information regarding type and distribution of sampled waterbodies and sampling period, and compare general patterns in both datasets with respect to collected animals and calculated water quality scores. The results show that volunteers and professionals seldomly sample the same waterbody, that there is some overlap in sampling period, and that volunteers more frequently sampled urban waters and smaller waterbodies. The citizen science project is thus yielding data about understudied waters and this spatial and temporal complementarity is useful. The character and thoroughness of the assessments by volunteers and professionals are likely to differentiate. Volunteers collected significantly lower numbers of animals per sample and fewer animals from soft sediments like worms and more mobile individuals from the open water column such as boatsmen and beetles. Due to the lack of simultaneous observations at various locations by volunteers and professionals, a direct comparison of water quality scores is impossible. However, the obtained patterns from both datasets show that the water quality scores between volunteers and professionals are dissimilar for the different water types. To bridge these differences, new tools and processes need to be further developed to increase the value of monitoring biological water quality by volunteers for professionals.	[Peeters, Edwin T. H. M.] Wageningen Univ, Chairgrp Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Gerritsen, Anton A. M.] De Waterspin Advies, Arnhem, Netherlands; [Seelen, Laura M. S.] Reg Water Author Brabantse Delta, Dept Planning & Monitoring, Breda, Netherlands; [Begheyn, Matthijs] Global Learning & Observat Benefit Environm GLOBE, Utrecht, Netherlands; [Rienks, Froukje] Netherlands Inst Ecol NIOO KNAW, Sect Publ Relat & Sci Commun, Wageningen, Netherlands; [Teurlincx, Sven] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Peeters, ETHM (corresponding author), Wageningen Univ, Chairgrp Aquat Ecol & Water Qual Management, Wageningen, Netherlands.	edwin.peeters@wur.nl	Seelen, Laura/B-2253-2014	Seelen, Laura/0000-0003-0933-1642; Peeters, Edwin T.H.M./0000-0003-2541-1829				Abbott BW, 2018, SCI TOTAL ENVIRON, V624, P845, DOI 10.1016/j.scitotenv.2017.12.176; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Balazs B, 2021, SCI CITIZEN SCI, P139, DOI DOI 10.1007/978-3-030-58278-4_8; Barbour M.T., 1999, EPA 841 B 99 002; Barbour Michael T., 2006, Limnetica, V25, P839; Barnard P, 2017, BIOL CONSERV, V208, P183, DOI 10.1016/j.biocon.2016.09.011; Barrows APW, 2018, WATER RES, V147, P382, DOI 10.1016/j.watres.2018.10.013; Basile M, 2021, BIOL CONSERV, V256, DOI 10.1016/j.biocon.2021.109079; Bishop IJ, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su122410271; Bodilis P, 2014, ENVIRON MANAGE, V53, P172, DOI 10.1007/s00267-013-0171-0; Capdevila AS, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.137843; Chandler M., 2017, HDB DEV GLOBAL EARTH, P211; Chandler M, 2017, BIOL CONSERV, V213, P280, DOI 10.1016/j.biocon.2016.09.004; DEPAUW N, 1983, HYDROBIOLOGIA, V100, P153, DOI 10.1007/BF00027428; Dickens C. W. S., 2002, African Journal of Aquatic Science, V27, P1, DOI 10.2989/16085914.2002.9626569; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Domis LND, 2020, CURR OPIN ENV SUST, V46, P32, DOI 10.1016/j.cosust.2020.10.008; EC, 2003, COMMON IMPLEMENTATIO; Everall NC, 2017, ECOL INDIC, V78, P437, DOI 10.1016/j.ecolind.2017.03.040; Farnham DJ, 2017, SCI TOTAL ENVIRON, V580, P168, DOI 10.1016/j.scitotenv.2016.11.116; Feldman RE, 2018, INT J BIOMETEOROL, V62, P1421, DOI 10.1007/s00484-018-1540-4; Field A.P., 2020, DISCOVERING STAT USI, V4th; FIREHOCK K, 1995, J N AM BENTHOL SOC, V14, P197, DOI 10.2307/1467734; Florisson JH, 2018, FISH RES, V206, P296, DOI 10.1016/j.fishres.2018.05.006; Fore LS, 2001, FRESHWATER BIOL, V46, P109, DOI 10.1046/j.1365-2427.2001.00640.x; Forrester G, 2015, J NAT CONSERV, V24, P1, DOI 10.1016/j.jnc.2015.01.002; Fraisl D, 2020, SUSTAIN SCI, V15, P1735, DOI 10.1007/s11625-020-00833-7; Frigerio D, 2018, ETHOLOGY, V124, P365, DOI 10.1111/eth.12746; Fritz S, 2019, NAT SUSTAIN, V2, P922, DOI 10.1038/s41893-019-0390-3; Fuccillo KK, 2015, INT J BIOMETEOROL, V59, P917, DOI 10.1007/s00484-014-0892-7; Garaba SP, 2015, INT J ENV RES PUB HE, V12, P16096, DOI 10.3390/ijerph121215044; Gollan J, 2012, ENVIRON MANAGE, V50, P969, DOI 10.1007/s00267-012-9924-4; Hadj-Hammou J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188507; Hawkes HA, 1998, WATER RES, V32, P964, DOI 10.1016/S0043-1354(97)00275-3; Hellawell JM, 1986, BIOL INDICATORS FRES; Herbst DB, 2001, CARLIFORNIA STREAMSI; Hidalgo E.S., 2021, SCI CITIZEN SCI, P199, DOI [10.1007/978-3-030-58278-4, DOI 10.1007/978-3-030-58278-4_11]; HILSENHOFF W L, 1988, Journal of the North American Benthological Society, V7, P65, DOI 10.2307/1467832; Hoyer MV, 2021, LAKE RESERV MANAGE, V37, P235, DOI 10.1080/10402381.2021.1876190; Hunter J, 2013, CONCURR COMP-PRACT E, V25, P454, DOI 10.1002/cpe.2923; Jollymore A, 2017, J ENVIRON MANAGE, V200, P456, DOI 10.1016/j.jenvman.2017.05.083; Kishimoto K, 2021, BIOL CONSERV, V255, DOI 10.1016/j.biocon.2021.109001; Klemm DJ, 2003, ENVIRON MANAGE, V31, P656, DOI 10.1007/s00267-002-2945-7; Kolkwitz R, 1908, BERICHTE DTSCH BOTAN, V26, P505, DOI DOI 10.1111/J.1438-8677.1908.TBO6722.X; Kolkwitz R., 1909, INT REV GES HYDROBIO, V2, P126, DOI DOI 10.1002/IROH.19090020108; Kosmala M, 2016, FRONT ECOL ENVIRON, V14, P551, DOI 10.1002/fee.1436; Lehtiniemi M, 2020, J ENVIRON MANAGE, V267, DOI 10.1016/j.jenvman.2020.110608; Leopold M, 2009, BIODIVERS CONSERV, V18, P3367, DOI 10.1007/s10531-009-9646-y; Loperfido JV, 2010, ENVIRON SCI TECHNOL, V44, P7193, DOI 10.1021/es100164c; McGoff E, 2017, SCI TOTAL ENVIRON, V581, P105, DOI 10.1016/j.scitotenv.2016.11.215; McKinley DC, 2017, BIOL CONSERV, V208, P15, DOI 10.1016/j.biocon.2016.05.015; Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278; Moffett ER, 2015, NEW ZEAL J MAR FRESH, V49, P366, DOI 10.1080/00288330.2015.1018913; Moolna A, 2020, ECOSCIENCE, V27, P303, DOI 10.1080/11956860.2020.1812922; Moss B, 2003, AQUAT CONSERV, V13, P507, DOI 10.1002/aqc.592; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Orton R., 1996, FRESHWATER NAME TRAI; PEETERS ETHM, 1994, PROC INT ASSOC THEOR, V25, P1914; Pernat N, 2021, J APPL ECOL, V58, P214, DOI 10.1111/1365-2664.13767; Pinto P, 2020, WATER-SUI, V12, DOI 10.3390/w12030654; QBWat Pot R., VERSIE, V7; Rae M, 2019, ECOL INDIC, V98, P1, DOI 10.1016/j.ecolind.2018.10.053; Raitsos DE, 2010, LIMNOL OCEANOGR, V55, P1478, DOI 10.4319/lo.2010.55.4.1478; Ratnieks FLW, 2016, METHODS ECOL EVOL, V7, P1226, DOI 10.1111/2041-210X.12581; Rose S, 2020, OSTRICH, V91, P188, DOI 10.2989/00306525.2020.1783589; Rosenberg David M., 1993, P1; Safford H, 2018, ENVIRON ENG SCI, V35, P362, DOI 10.1089/ees.2017.0218; Sakai N, 2018, ECOL INDIC, V91, P38, DOI 10.1016/j.ecolind.2018.03.079; Scheffer M, 2006, OIKOS, V112, P227, DOI 10.1111/j.0030-1299.2006.14145.x; Seelen LMS, 2019, J ENVIRON MANAGE, V242, P246, DOI 10.1016/j.jenvman.2019.04.047; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Shupe SM, 2017, SCI TOTAL ENVIRON, V603, P745, DOI 10.1016/j.scitotenv.2017.02.195; Stepenuck KF, 2018, ENVIRON MANAGE, V61, P46, DOI 10.1007/s00267-017-0956-7; Swanson A, 2016, CONSERV BIOL, V30, P520, DOI 10.1111/cobi.12695; Teurlincx S, 2019, CURR OPIN ENV SUST, V36, P49, DOI 10.1016/j.cosust.2018.10.011; Thornhill I, 2018, WATER-SUI, V10, DOI 10.3390/w10070839; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; Usseglio-Polatera P, 2000, FRESHWATER BIOL, V43, P175, DOI 10.1046/j.1365-2427.2000.00535.x; Valois A, 2019, WATER SUPPLY, V19, P671, DOI 10.2166/ws.2018.116; van der Heijden J, 2012, ENVIRON POLICY GOV, V22, P177, DOI 10.1002/eet.1583; van der Velde T, 2017, BIOL CONSERV, V208, P127, DOI 10.1016/j.biocon.2016.05.025; Verdonschot P. F. M., 1990, ECOLOGICAL CHARACTER; Weeser B, 2018, SCI TOTAL ENVIRON, V631-632, P1590, DOI 10.1016/j.scitotenv.2018.03.130; Weigel BM, 2002, J N AM BENTHOL SOC, V21, P686, DOI 10.2307/1468439; WOODIWISS FS, 1964, CHEM IND-LONDON, P443	85	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263899	10.1371/journal.pone.0263899	http://dx.doi.org/10.1371/journal.pone.0263899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213583	Green Published, gold			2022-12-26	WOS:000787811000038
J	Saptana; Sayekti, AL; Perwita, AD; Sayaka, B; Gunawan, E; Sukmaya, SG; Hayati, NQ; Yusuf; Sumaryanto; Yufdy, MP; Mardianto, S; Pitaloka, AD				Saptana; Sayekti, Apri Laila; Perwita, Atika Dyah; Sayaka, Bambang; Gunawan, Endro; Sukmaya, Syahrul Ganda; Hayati, Nur Qomariah; Yusuf; Sumaryanto; Yufdy, Muhammad Prama; Mardianto, Sudi; Pitaloka, Atika Dian			Analysis of competitive and comparative advantages of potato production in Indonesia	PLOS ONE			English	Article							DAIRY FARMS; DETERMINANTS; PERFORMANCE; CHAINS; IMPACT	Fundamental issues in sustainable development of competitive potato production in Indonesia are production and distribution inefficiencies. This study aims to examine the potato production competitiveness through competitive and comparative analyses as well as evaluating the impacts of government policy on potato production. This study employs Policy Analysis Matrix (PAM) to analyse the cross-section data collected from six regencies in Indonesia. Potato production in Indonesia was profitable privately and socially. The highest value of competitive advantage was indicated by PCR value in the dry season in Wonosobo Regency, Central Java Province. The lowest values were found in Bandung Regency. Highest comparative advantage was revealed in Tanah Karo Regency, North Sumatra Province, during the rainy season. Highest comparative advantage was found in Bandung Regency, West Java Province, in the dry season. However, the social profit was lower than the private profit indicating the potato farmers dealt with disincentives due to imperfect market. It implies that increasing domestic potato production will be more profitable rather than import. The policy makers need to evaluate the recent policies on input and output markets as well as the supply chain of potato to cope with imperfect markets in order to increase farmers' income.	[Saptana; Sayaka, Bambang; Gunawan, Endro; Sumaryanto; Mardianto, Sudi] Indonesian Ctr Agr Socio Econ & Policy Studies, Bogor, Indonesia; [Sayekti, Apri Laila; Hayati, Nur Qomariah; Yusuf; Yufdy, Muhammad Prama] Indonesian Ctr Hort Res & Dev, Bogor, Indonesia; [Perwita, Atika Dyah] Walisongo State Islamic Univ, Fac Educ & Teacher Training, Semarang, Indonesia; [Sukmaya, Syahrul Ganda] Univ Jenderal Soedirman, Fac Agr, Purwokerto, Indonesia; [Pitaloka, Atika Dian] IPB Univ, Sch Business, Bogor, Indonesia	Universitas Jenderal Soedirman; Bogor Agricultural University	Gunawan, E (corresponding author), Indonesian Ctr Agr Socio Econ & Policy Studies, Bogor, Indonesia.	endrogun007@gmail.com	Perwita, Atika Dyah/ABC-9023-2021; , Prof. Dr. Saptana, M.Si./AAC-9657-2022; ganda, Syahrul/AAN-2289-2021; Sayekti, Apri/K-7067-2017	Perwita, Atika Dyah/0000-0002-5499-5205; , Prof. Dr. Saptana, M.Si./0000-0001-8882-0596; ganda, Syahrul/0000-0003-4892-9663; Yufdy, Muhammad Prama/0000-0002-6079-9489; gunawan, endro/0000-0002-4257-4905; Sayekti, Apri/0000-0003-3579-6742; Sayaka, Bambang/0000-0001-6184-0335				Abdullahi NM, 2022, COMPET REV, V32, P1025, DOI 10.1108/CR-03-2021-0036; Ahmed MEM, 2019, J APPL SCI RES, P3632; Alfalluji SJI, 2019, PLANT ARCH, V19, P1645; Athukorala PC, 2006, B INDONES ECON STUD, V42, P177, DOI 10.1080/00074910600873658; Bahri Pearson PS., 2005, IS RICE PROBABILITY; Balassa B., 1965, THEORY EC INTEGRATIO; Chowdhury SMZI, 2020, TURKISH RES J ACAD S, V3, P11; Cieslik K, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105366; Daryanto A., 2009, MAKALAH DISAMPAIKAN; David Gaytan FranciscoBenita., 2014, EP, V2, P307; Economist The., 2019, ECONOMIST; Esterhuizen DirkJV., 2008, ADV COMPETITIVENESS, V16, P31; Fauziah DS., 2019, ANALISIS DAYA SAING; Felice G, 2021, STRUCT CHANGE ECON D, V59, P228, DOI 10.1016/j.strueco.2021.08.013; Ferto I, 2003, WORLD ECON, V26, P247, DOI 10.1111/1467-9701.00520; FIRMANSYAH F., 2017, J EKON KEBIJAK, V10, P289, DOI [10.1002/aur.1651, DOI 10.15294/JEJAK.V10I2.11294]; Friyatno S, 2017, J MANAJ AGRIBISNIS, V14, P250, DOI [10.17358/jma.14.3.250, DOI 10.17358/JMA.14.3.250]; Gal T, 2013, ACTA POLYTECH HUNG, V10, P231; Gereffi G., 2016, GLOBAL VALUE CHAIN A, V2nd; Gitari HI, 2020, FIELD CROP RES, V258, DOI 10.1016/j.fcr.2020.107957; Gittinger JP., 1986, ANALISIS EKONOMI PRO; Grupe C., 2010, J EC RES INT, V2010, P14, DOI 10.1155/2010/860425; Gultom D., 2020, REGIONAL COMPREHENSI; Hailu Gebru, 2017, Agriculture and Food Security, V6, DOI 10.1186/s40066-017-0106-8; Halterman D, 2016, AM J POTATO RES, V93, P1, DOI 10.1007/s12230-015-9485-1; Hameed TS., 2017, INT J CURRENT RES 20, V9, P49729; Hassan SZ, 2021, MANAGE DECIS, V59, P829, DOI 10.1108/MD-12-2018-1392; Heckscher E.F., 1919, EKON TIDSKR, V21, P497, DOI DOI 10.2307/3437610; Hoang VV, 2020, J ECON STUD, V47, P307, DOI 10.1108/JES-10-2018-0366; Hodjo M, 2021, AFR J ECON MANAG STU, V12, P357, DOI 10.1108/AJEMS-09-2020-0427; Huo D, 2014, COMPET REV, V24, P393, DOI 10.1108/CR-01-2012-0002; Ingot SR., 2019, ADV EC MANAG RES, V98, P159, DOI [DOI 10.2991/ICOT-19.2019.34, 10.2991/icot-19.2019.34]; Kaplinsky R, 2000, J DEV STUD, V37, P117, DOI 10.1080/713600071; Kart MCO, 2017, SCI PAP-SER MANAG EC, V17, P239; Kempenaar C, 2017, POTATO RES, V60, P295, DOI 10.1007/s11540-018-9357-4; Kiloes AM., 2015, J HORT, V25, P88; Kozar L., 2021, EUROPEAN RES STUDIES, V24, P1260; Krugman PR., 1994, EKONOMI INT TEORI KE; Kumar NR., 2007, AGR EC RES REV, V20, P551; Kusuma RL., 2015, J MANAJ AGRIBISNIS, V12, P226, DOI [10.17358/jma.12.3.226, DOI 10.17358/JMA.12.3.226]; Kyomugisha H, 2017, J AGRIBUS DEV EMERG, V7, P52, DOI 10.1108/JADEE-06-2015-0031; Laursen K, 1998, REVEALED COMP ADVANT; Laursen K, 2015, EURASIAN BUS REV, V5, P99, DOI 10.1007/s40821-015-0017-1; Lindert P H, 1993, PENERBIT ERLANGGA JA; Manalu DST, 2014, JURNAL SAINS TERAPAN, V1, P1; McFadden JR, 2017, FOOD POLICY, V69, P82, DOI 10.1016/j.foodpol.2017.03.002; Michalickova M, 2014, AGR ECON-CZECH, V60, P82, DOI 10.17221/76/2013-AGRICECON; Monke E., 1989, POLICY ANAL MATRIX A; Monke Eric A, 1995, PEARSON POLICY ANAL; Moon W, 2022, CHINA AGR ECON REV, V14, P32, DOI 10.1108/CAER-02-2021-0030; Neszmelyi G. I, 2017, EC LOCAL ASPECTS RUR, P31; Newbert SL, 2008, STRATEGIC MANAGE J, V29, P745, DOI 10.1002/smj.686; Ningsih E.A., 2016, J APPL QUANT EC, V9, P117; Noland M., 1989, J INT EC INTEGRATION, V4, P8, DOI DOI 10.11130/JEI.1989.4.2.8; Ohlin B., 1933, INTERREGIONAL INT TR; Oliinyk O, 2021, MONTENEGRIN J ECON, V17, P7, DOI 10.14254/1800-5845/2021.17-3.1; Parzonko A, 2020, AGR ECON-CZECH, V66, P168, DOI 10.17221/254/2019-AGRICECON; Porter M.E., 1990, COMPETITIVE ADVANTAG; Purnamawati Astuti., 2013, YOGYAKARTA; Rambe P, 2022, EUR J INNOV MANAG, V25, P741, DOI 10.1108/EJIM-05-2020-0180; Sachitra V, 2018, COMPET REV, V28, P478, DOI 10.1108/CR-01-2017-0004; Saini I, 2021, SAUDI J BIOL SCI, V28, P2641, DOI 10.1016/j.sjbs.2021.02.070; Salam A., 2016, J INT AGR TRADE DEV, V10, P81; Salvatore D., 1994, EKONOMI INT; Saptana, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256832; Saptana, 2010, JURNAL FORUM PENELIT, V28, P1; Savitri PDL., 2015, E JURNAL EP UNUD, V4, P763; Selvia M., 2018, AGRICORE, V3, P548; Siudek T., 2014, ACTA SCI POLONORUM O, V13; Smith M, 2013, ISSUES COMPETITIVENE; Statistics Indonesia, 2021, STAT HORT 2020; Tufail S., 2014, THESIS FEDERAL URDU; [UNIDO] United Nations Industrial Development Organization, 2015, GLOBAL VALUE CHAINS; Vasa L., 2002, Journal of Central European Agriculture, V3, P313; World Bank, 2020, TRAD DEV AGE GLOB VA, DOI [10.1016/j.gaceta.2020.05.010, DOI 10.1016/J.GACETA.2020.05.010]; WTO, 2017, GLOB VAL CHAIN DEV R; WTO] World Trade Organization, 2019, GLOB VAL CHAIN DEV R	77	0	0	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0263633	10.1371/journal.pone.0263633	http://dx.doi.org/10.1371/journal.pone.0263633			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ4EP	35202433	gold, Green Published			2022-12-26	WOS:000773224600015
J	Sipahi, I				Sipahi, Ilke			Risk of cancer with angiotensin-receptor blockers increases with increasing cumulative exposure: Meta-regression analysis of randomized trials	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; MYOCARDIAL-INFARCTION; HEART-FAILURE; VALSARTAN; HYPERTENSION; TELMISARTAN; CANDESARTAN; IRBESARTAN; MORTALITY; METAANALYSIS	Angiotensin-receptor blockers (ARBs) are a class of drugs approved for the treatment of several common conditions, such as hypertension and heart failure. Recently, regulatory agencies have started to identify possibly carcinogenic nitrosamines and azido compounds in a multitude of formulations of several ARBs, resulting in progressive recalls. Furthermore, data from several randomized controlled trials suggested that there is also a clinically increased risk of cancer and specifically lung cancer with ARBs; whereas other trials suggested no increased risk. The purpose of this analysis was to provide additional insight into the ARB-cancer link by examining whether there is a relationship between degree of cumulative exposure to ARBs and risk of cancer in randomized trials. Trial-level data from ARB Trialists Collaboration including 15 randomized controlled trials was extracted and entered into meta-regression analyses. The two co-primary outcomes were the relationship between cumulative exposure to ARBs and risk of all cancers combined and the relationship between cumulative exposure and risk of lung cancer. A total of 74,021 patients were randomized to an ARB resulting in a total cumulative exposure of 172,389 person-years of exposure to daily high dose (or equivalent). 61,197 patients were randomized to control. There was a highly significant correlation between the degree of cumulative exposure to ARBs and risk of all cancers combined (slope = 0.07 [95% CI 0.03 to 0.11], p<0.001), and also lung cancer (slope = 0.16 [95% CI 0.05 to 0.27], p = 0.003). Accordingly, in trials where the cumulative exposure was greater than 3 years of exposure to daily high dose, there was a statistically significant increase in risk of all cancers combined (I-2 = 31.4%, RR 1.11 [95% CI 1.03 to 1.19], p = 0.006). There was a statistically significant increase in risk of lung cancers in trials where the cumulative exposure was greater than 2.5 years (I-2 = 0%, RR 1.21 [95% CI 1.02 to 1.44], p = 0.03). In trials with lower cumulative exposure to ARBs, there was no increased risk of all cancers combined or lung cancer. Cumulative exposure-risk relationship with ARBs was independent of background angiotensin-converting enzyme inhibitor treatment or the type of control (i.e. placebo or non-placebo control). Since this is a trial-level analysis. the effects of patient characteristics such as age and smoking status could not be examined due to lack of patient-level data. In conclusion, this analysis, for the first time, reveals that risk of cancer with ARBs (and specifically lung cancer) increases with increasing cumulative exposure to these drugs. The excess risk of cancer with long-term ARB use has public health implications.	[Sipahi, Ilke] Acibadem Univ, Dept Cardiol, Med Sch, Istanbul, Turkey	Acibadem University	Sipahi, I (corresponding author), Acibadem Univ, Dept Cardiol, Med Sch, Istanbul, Turkey.	ilkesipahi@gmail.com	SIPAHI, ILKE/K-9745-2013	SIPAHI, ILKE/0000-0001-8581-9557				Altman Douglas G, 2002, BMC Med Res Methodol, V2, P3, DOI 10.1186/1471-2288-2-3; [Anonymous], RECALLS SAFETY ALERT, P2021; [Anonymous], 2015, CTR DRUG EVALUATION; [Anonymous], 2018, STATEMENT FDA COMMIS; [Anonymous], 2008, TABULATED TRIAL REPO; [Anonymous], 2018, FDA UPDATES VALSARTA; [Anonymous], 2011, ASSESSMENT REPORT AR; [Anonymous], 2018, FDA ANNOUNCES VOLUNT; AurobindoPharma USA Inc., 2019, IN VOL NAT CONS LEV; Azoulay L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050893; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Bhaskaran K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2697; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Burton TM, 2013, DISPUTE FLARES INSID; Carey RM, 2018, ANN INTERN MED, V168, P351, DOI 10.7326/M17-3203; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; Clinical Review Khin Maung U MD, 2005, N20838SE1022 CLIN RE; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Copland E, 2021, LANCET ONCOL, V22, P558, DOI 10.1016/S1470-2045(21)00033-4; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Deshayes F, 2005, TRENDS ENDOCRIN MET, V16, P293, DOI 10.1016/j.tem.2005.07.009; FDA Drug Safety Communication, 2011, NO INCR RISK CANC CE; Hall AS, 2007, HEART, V93, P1011, DOI 10.1136/hrt.2006.107185; Hicks BM, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4209; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Micardis, 2009, TELM CARD REN DRUGS; Nissen SE, 2010, LANCET ONCOL, V11, P605, DOI 10.1016/S1470-2045(10)70142-X; Noone AM, 2018, SEER CANC STAT REV 1; Opelz G, 2011, AM J TRANSPLANT, V11, P2483, DOI 10.1111/j.1600-6143.2011.03681.x; Pasternak B, 2011, CIRCULATION, V123, P1729, DOI 10.1161/CIRCULATIONAHA.110.007336; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Rao GA, 2013, J HYPERTENS, V31, P1669, DOI 10.1097/HJH.0b013e3283621ea3; Sandoz Inc, 2018, ISS VOL NAT REC ON L; Sciegen Pharmaceuticals Inc, 2018, ISS VOL NAT REC IRB; Singh A, 2012, CURR OPIN CARDIOL, V27, P381, DOI 10.1097/HCO.0b013e328353bc68; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Sipahi I, 2011, AM J CARDIOL, V108, P294, DOI 10.1016/j.amjcard.2011.03.038; Smeeth L, 1999, BMJ-BRIT MED J, V318, P1548, DOI 10.1136/bmj.318.7197.1548; Soto-Pantoja DR, 2009, MOL CANCER THER, V8, P1676, DOI 10.1158/1535-7163.MCT-09-0161; Strauss MH, 2006, CIRCULATION, V114, P838, DOI 10.1161/CIRCULATIONAHA.105.594986; Strauss MH, 2018, CAN J DIABETES, V42, P124, DOI 10.1016/j.jcjd.2017.09.011; Strauss MH, 2017, CIRCULATION, V135, P2088, DOI 10.1161/CIRCULATIONAHA.117.026112; Sugiura R, 2012, AM J CARDIOL, V109, P576, DOI 10.1016/j.amjcard.2011.09.050; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Updated, 2019, TORR PHARM LTD ISS V; van Vark LC, 2012, EUR HEART J, V33, P2088, DOI 10.1093/eurheartj/ehs075; Volpe M, 2011, EUR HEART J, V32, P19, DOI 10.1093/eurheartj/ehq382; Walther T, 2003, FASEB J, V17, P2061, DOI 10.1096/fj.03-0129com; Yancy CW, 2016, CIRCULATION, V134, pE282, DOI 10.1161/CIR.0000000000000435; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Yusuf S, 2011, NEW ENGL J MED, V364, P928, DOI 10.1056/NEJMoa1008816; Zhao YT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003600	61	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263461	10.1371/journal.pone.0263461	http://dx.doi.org/10.1371/journal.pone.0263461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235571	gold, Green Published			2022-12-26	WOS:000787073100017
J	Espinoza-Corral, R; Lundquist, PK				Espinoza-Corral, Roberto; Lundquist, Peter K.			The plastoglobule-localized protein AtABC1K6 is a Mn2+-dependent kinase necessary for timely transition to reproductive growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JASMONIC ACID; LEAF SENESCENCE; ARABIDOPSIS; CHLOROPLAST; GENE; QUANTIFICATION; METABOLISM; EXPRESSION; GENOMICS; REVEALS	The Absence of bc(1) Complex (ABC1) is an ancient, atypical protein kinase family that emerged prior to the archaeal-eubacterial divergence. Loss-of-function mutants in ABC1 genes are linked to respiratory defects in microbes and humans and to compromised photosynthetic performance and stress tolerance in plants. However, demonstration of protein kinase activity remains elusive, hampering their study. Here, we investigate a homolog from Arabidopsis thaliana, AtABC1K6, and demonstrate in vitro autophosphorylation activity, which we replicate with a human ABC1 ortholog. We also show that AtABC1K6 protein kinase activity requires an atypical buffer composition, including Mn2+ as a divalent cation cofactor and a low salt concentration. AtABC1K6 associates with plastoglobule lipid droplets of A. thaliana chloroplasts, along with five paralogs. We show that the protein kinase activity associated with isolated A. thaliana plastoglobules was inhibited at higher salt concentrations, but could accommodate Mg2+ as well as Mn2+, indicating salt sensitivity, but not the requirement for Mn2+, may be a general characteristic of ABC1 proteins. Finally, loss of functional AtABC1K6 impairs the developmental transition from vegetative to reproductive growth. This phenotype was complemented by the wild-type sequence of AtABC1K6, but not by a kinase-dead point mutant in the unique Ala-triad of the ATP-binding pocket, demonstrating the physiological relevance of the protein's kinase activity. We suggest that ABC1s are bona fide protein kinases with a unique regulatory mechanism. Our results open the door to detailed functional and mechanistic studies of ABC1 proteins and plastoglobules.	[Espinoza-Corral, Roberto; Lundquist, Peter K.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Espinoza-Corral, Roberto; Lundquist, Peter K.] Michigan State Univ, Plant Resilience Inst, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Espinoza-Corral, R; Lundquist, PK (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.; Espinoza-Corral, R; Lundquist, PK (corresponding author), Michigan State Univ, Plant Resilience Inst, E Lansing, MI 48824 USA.	espino95@msu.edu; pklundqu@msu.edu		Espinoza-Corral, Roberto/0000-0002-5895-7978; Lundquist, Peter/0000-0001-8390-8089	USDA Umbrella Program [MICL02633]; AgBioResearch startup funds; Michigan State University	USDA Umbrella Program; AgBioResearch startup funds; Michigan State University	Funding and additional information-This work was supported by the USDA Umbrella Program (MICL02633), AgBioResearch startup funds, and Michigan State University startup funds to P. K. L.	Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Aubry S, 2020, PLANT PHYSIOL, V182, P776, DOI 10.1104/pp.19.01115; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOUSQUET I, 1991, EMBO J, V10, P2023, DOI 10.1002/j.1460-2075.1991.tb07732.x; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Bruschweiler R, 2003, PROTEINS, V50, P26, DOI 10.1002/prot.10250; Cardazzo B, 1998, GENE, V221, P117, DOI 10.1016/S0378-1119(98)00417-X; CHEN CG, 1995, BIOCHEMISTRY-US, V34, P13511, DOI 10.1021/bi00041a031; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eisenhut M, 2018, MOL PLANT, V11, P955, DOI 10.1016/j.molp.2018.04.008; Espinoza-Corral R, 2021, PLANT J, V106, P1571, DOI 10.1111/tpj.15253; Espinoza-Corral R, 2019, J EXP BOT, V70, P3981, DOI 10.1093/jxb/erz177; Evans IM, 2010, PLANT BIOLOGY, V12, P1, DOI 10.1111/j.1438-8677.2009.00206.x; Fang HX, 2020, FOOD CHEM, V309, DOI 10.1016/j.foodchem.2019.125737; Guiamet JJ, 1999, PLANT CELL PHYSIOL, V40, P986, DOI 10.1093/oxfordjournals.pcp.a029632; Hanson KG, 2002, MICROBIOL-SGM, V148, P1805, DOI 10.1099/00221287-148-6-1805; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Hu YR, 2017, J EXP BOT, V68, P1361, DOI 10.1093/jxb/erx004; Humphrey SJ, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0014-9; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kanev GK, 2019, TRENDS PHARMACOL SCI, V40, P818, DOI 10.1016/j.tips.2019.09.002; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kravanja M, 1999, MOL MICROBIOL, V31, P59, DOI 10.1046/j.1365-2958.1999.01146.x; Kunz HH, 2014, P NATL ACAD SCI USA, V111, P7480, DOI 10.1073/pnas.1323899111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; Liu L, 2016, MICRON, V80, P135, DOI 10.1016/j.micron.2015.10.007; Lundquist PK, 2013, PLANT CELL, V25, P1818, DOI 10.1105/tpc.113.111120; Lundquist PK, 2012, TRENDS PLANT SCI, V17, P546, DOI 10.1016/j.tplants.2012.05.010; Lundquist PK, 2012, PLANT PHYSIOL, V158, P1172, DOI 10.1104/pp.111.193144; Martinis J, 2014, PLANT J, V77, P269, DOI 10.1111/tpj.12385; Martinis J, 2013, PLANT PHYSIOL, V162, P652, DOI 10.1104/pp.113.218644; Modi V, 2019, P NATL ACAD SCI USA, V116, P6818, DOI 10.1073/pnas.1814279116; Ono K, 2019, J PLANT PHYSIOL, V238, P53, DOI 10.1016/j.jplph.2019.05.004; PALMER DA, 1995, MOL PLANT MICROBE IN, V8, P683, DOI 10.1094/MPMI-8-0683; Pralon T, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00337; Pralon T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0477-4; Puthiyaveetil S, 2008, P NATL ACAD SCI USA, V105, P10061, DOI 10.1073/pnas.0803928105; Puthiyaveetil S, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.20; Reidenbach AG, 2018, CELL CHEM BIOL, V25, P154, DOI 10.1016/j.chembiol.2017.11.001; Reinbothe C, 2009, FEBS J, V276, P4666, DOI 10.1111/j.1742-4658.2009.07193.x; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Seltmann MA, 2010, PLANT PHYSIOL, V152, P1940, DOI 10.1104/pp.110.153114; Shan XY, 2011, PLANT PHYSIOL, V155, P751, DOI 10.1104/pp.110.166595; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Springer A, 2016, P NATL ACAD SCI USA, V113, P3383, DOI 10.1073/pnas.1525747113; Stefely JA, 2016, MOL CELL, V63, P608, DOI 10.1016/j.molcel.2016.06.030; Stefely JA, 2015, MOL CELL, V57, P83, DOI 10.1016/j.molcel.2014.11.002; Tamary E, 2019, PLANT DIRECT, V3, DOI 10.1002/pld3.127; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Taylor SS, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100746; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; TUQUET C, 1980, CYTOBIOS, V29, P43; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Ullah A, 2019, SENESCENCE SIGNALLING AND CONTROL IN PLANTS, P111, DOI 10.1016/B978-0-12-813187-9.00007-X; Ung PMU, 2018, CELL CHEM BIOL, V25, P916, DOI 10.1016/j.chembiol.2018.05.002; van Wijk KJ, 2017, ANNU REV PLANT BIOL, V68, P253, DOI 10.1146/annurev-arplant-043015-111737; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Wang S, 2014, CHEM COMMUN, V50, P14117, DOI 10.1039/c4cc05375c; WU WH, 1992, PLANT PHYSIOL, V98, P666, DOI 10.1104/pp.98.2.666; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zhang XY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45704-z; Zhu XY, 2015, PLANT J, V84, P597, DOI 10.1111/tpj.13030	72	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101762	10.1101/2021.10.28.466314	http://dx.doi.org/10.1101/2021.10.28.466314			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35202657	Green Submitted			2022-12-26	WOS:000793502000014
J	Zhang, Q; Fang, YL; Lv, CJ; Zhu, YR; Xia, YF; Wei, ZF; Dai, Y				Zhang, Qin; Fang, Yulai; Lv, Changjun; Zhu, Yanrong; Xia, Yufeng; Wei, Zhifeng; Dai, Yue			Norisoboldine induces the development of Treg cells by promoting fatty acid oxidation-mediated H3K27 acetylation of Foxp3	FASEB JOURNAL			English	Article						collagen-induced arthritis; fatty acid oxidation; norisoboldine; regulatory T cells	REGULATORY T-CELLS; MACROPHAGE METABOLISM	Norisoboldine (NOR), an alkaloid isolated from Radix Lindera, was previously reported to promote the differentiation of regulatory T cells (Treg cells), an important subtype of lymphocytes capable of controlling autoimmune diseases. The present study was performed to explore the mechanism of NOR in the view of cellular metabolism. A global metabolomic analysis indicated that NOR preferentially altered the fatty acid oxidation (FAO) pathway and elevated the content of related metabolites during Treg cell differentiation. The detection of oxygen consumption rate (OCR) and mRNA expression of FAO-related enzymes demonstrated that NOR promoted FAO in the early stage of Treg cell differentiation. Consistently, pharmacological or genetic inhibition of FAO markedly diminished the induction of NOR on Treg cell differentiation. Furthermore, NOR was shown to elevate the level of acetyl-CoA derived from FAO and acetylation of lysine 27 on histone 3 (H3K27) at the Foxp3 promoter and CNS2 regions. A knockdown of CPT1, the rate-limiting enzyme of FAO, weakened the promotion of NOR on the development, acetyl-CoA level, and acetylation of H3K27 of Treg cells in vitro and in the mice with collagen-induced arthritis, and attenuated the anti-arthritic effect of NOR. These findings demonstrate that NOR induces the development of Treg cells through promoting FAO, therefore, facilitating gene transcription of Foxp3 via acetyl-CoA-mediated H3K27 acetylation modification, and FAO might serve as a novel target to induce Treg cell development.	[Zhang, Qin; Fang, Yulai; Lv, Changjun; Zhu, Yanrong; Xia, Yufeng; Wei, Zhifeng; Dai, Yue] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat Med, Nanjing 210009, Peoples R China	China Pharmaceutical University	Wei, ZF; Dai, Y (corresponding author), China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat Med, Nanjing 210009, Peoples R China.	1020132346@cpu.edu.cn; yuedaicpu@cpu.edu.cn			National Natural Science Foundation of China (NSFC) [81872881]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81872881	Almeida L, 2016, SEMIN IMMUNOL, V28, P514, DOI 10.1016/j.smim.2016.10.009; Baeten P, 2022, CLIN REV ALLERG IMMU, V62, P363, DOI 10.1007/s12016-021-08866-1; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Bradshaw PC, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10040572; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Chang L, 2021, BIOORG MED CHEM LETT, V37, DOI 10.1016/j.bmcl.2021.127844; Chen XL, 2021, CELL IMMUNOL, V365, DOI 10.1016/j.cellimm.2021.104378; Chwojnicki K, 2021, BIODRUGS, V35, P47, DOI 10.1007/s40259-020-00462-7; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Eleftheriadis T, 2016, INT J MOL MED, V38, P1605, DOI 10.3892/ijmm.2016.2750; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Georgiev P, 2019, J CLIN IMMUNOL, V39, P623, DOI 10.1007/s10875-019-00684-7; Guo Q, 2021, J BONE MINER RES, V36, P2065, DOI 10.1002/jbmr.4399; Hague M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00209; Hawse WF, 2019, J IMMUNOL, V203, P2771, DOI 10.4049/jimmunol.1900749; Iizuka-Koga M, 2017, J AUTOIMMUN, V83, P113, DOI 10.1016/j.jaut.2017.07.002; Lauterbach MA, 2019, IMMUNITY, V51, P997, DOI 10.1016/j.immuni.2019.11.009; Li XH, 2021, NEURON, V109, DOI 10.1016/j.neuron.2021.01.005; Liu RT, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1095-7; Lv Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0297-3; Metzler B, 2016, J IMMUNOL, V196, P3618, DOI 10.4049/jimmunol.1501756; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Miyara M, 2014, NAT REV RHEUMATOL, V10, P543, DOI 10.1038/nrrheum.2014.105; Ohkura N, 2020, CELL RES, V30, P465, DOI 10.1038/s41422-020-0324-7; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Pompura SL, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI138519; Saigusa R, 2020, NAT REV CARDIOL, V17, P387, DOI 10.1038/s41569-020-0352-5; Schroeder S, 2014, AUTOPHAGY, V10, P1335, DOI 10.4161/auto.28919; Song DY, 2020, FRONT MED-PRC, V14, P564, DOI 10.1007/s11684-019-0724-6; Spinner CA, 2021, IMMUNOL REV, V300, P65, DOI 10.1111/imr.12935; Takahashi D, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102913; Timblin GA, 2021, NAT METAB, V3, P618, DOI 10.1038/s42255-021-00392-w; Tong B, 2016, INT J BIOCHEM CELL B, V75, P63, DOI 10.1016/j.biocel.2016.03.014; von Knethen A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072356; Wang Y, 2020, EXP MOL MED, V52, P1959, DOI 10.1038/s12276-020-00534-2; Zhang Sheng-Xiao, 2021, Ther Adv Musculoskelet Dis, V13, p1759720X211011370, DOI 10.1177/1759720X211011370; Zhou L, 2021, CELL MOL IMMUNOL, V18, P698, DOI 10.1038/s41423-020-00623-2	39	0	0	5	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22230	10.1096/fj.202101643R	http://dx.doi.org/10.1096/fj.202101643R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CP	35233835				2022-12-26	WOS:000772945300001
J	Zhao, YH; Yue, SC; Zhou, X; Guo, J; Ma, SY; Chen, Q				Zhao, Yuhang; Yue, Shichao; Zhou, Xin; Guo, Jing; Ma, Shuyun; Chen, Qiang			O-GlcNAc transferase promotes the nuclear localization of the focal adhesion-associated protein Zyxin to regulate UV-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNACYLATION; PHOSPHORYLATION; MECHANISM; SENSOR; STABILITY; MEMBRANE; REVEALS; SITES; HIPPO; STATE	Zyxin is a zinc-binding phosphoprotein known to regulate cell migration, adhesion, and cell survival. Zyxin also plays a role in signal transduction between focal adhesions and the nuclear compartment. However, the mechanism of Zyxin shuttling to nucleus is still unclear. Here, we identify that the GlcNAc transferase (O-linked GlcNAc [O-GlcNAc] transferase) can O-GlcNAcylate Zyxin and regulate its nuclear localization. We show that O-GlcNAc transferase O-GlcNAcylates Zyxin at two residues, serine 169 (Ser-169) and Ser-246. In addition, O-GlcNAcylation of Ser-169, but not Ser-246, enhances its interaction with 14-3-3 gamma, which is a phosphoserine/threoninebinding protein and is reported to bind with phosphorylated Zyxin. Furthermore, we found that 14-3-3 gamma could promote the nuclear localization of Zyxin after Ser-169 O-GlcNAcylation by affecting the function of the N-terminal nuclear export signal sequence; functionally, UV treatment increases the O-GlcNAcylation of Zyxin, which may enhance the nuclear location of Zyxin. Finally, Zyxin in the nucleus maintains homeodomaininteracting protein kinase 2 stability and promotes UV-induced cell death. In conclusion, we uncover that the nuclear localization of Zyxin can be regulated by its O-GlcNAcylation, and that this protein may regulate UV-induced cell death.	[Zhao, Yuhang; Yue, Shichao; Zhou, Xin; Guo, Jing; Ma, Shuyun; Chen, Qiang] Wuhan Univ, Zhongnan Hosp, Med Res Inst, Dept Radiat & Med Oncol, Wuhan, Peoples R China; [Zhao, Yuhang; Yue, Shichao; Zhou, Xin; Guo, Jing; Ma, Shuyun; Chen, Qiang] Wuhan Univ, Med Res Inst, Frontier Sci Ctr Immunol & Metab, Wuhan, Peoples R China	Wuhan University; Wuhan University	Chen, Q (corresponding author), Wuhan Univ, Zhongnan Hosp, Med Res Inst, Dept Radiat & Med Oncol, Wuhan, Peoples R China.; Chen, Q (corresponding author), Wuhan Univ, Med Res Inst, Frontier Sci Ctr Immunol & Metab, Wuhan, Peoples R China.	C52616@hotmail.com			National Key Research and Development Program of China [2018YFC1003400]; National Natural Science Foundation of China [32170698, 31770868]; Wuhan University [2042018kf0215]; Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University [TFJC2018005]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan University; Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University	Q. C. is supported by grants from the National Key Research and Development Program of China (grant no.: 2018YFC1003400), the National Natural Science Foundation of China (grant nos.: 32170698 and 31770868), Wuhan University (grant no.: 2042018kf0215), and Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University (grant no.: TFJC2018005).	Babu SS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003173; Belgardt E, 2020, CELL SIGNAL, V72, DOI 10.1016/j.cellsig.2020.109662; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Chan CB, 2007, CELL DEATH DIFFER, V14, P1688, DOI 10.1038/sj.cdd.4402179; Copeland RJ, 2013, PROTEOM CLIN APPL, V7, P597, DOI 10.1002/prca.201300001; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; Crone J, 2011, CANCER RES, V71, P2350, DOI 10.1158/0008-5472.CAN-10-3486; Damayanti NP, 2017, ANALYST, V142, P2713, DOI 10.1039/c7an00471k; De Leon CA, 2017, BIOCHEMISTRY-US, V56, P3507, DOI 10.1021/acs.biochem.7b00268; Degenhardt YY, 2001, J VIROL, V75, P11791, DOI 10.1128/JVI.75.23.11791-11802.2001; DOrazi G., 2002, HOMEODOMAIN INTERACT; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Drees BE, 1999, J CELL BIOL, V147, P1549, DOI 10.1083/jcb.147.7.1549; Golsteyn RM, 1997, J CELL SCI, V110, P1893; Gorelik A, 2019, NAT STRUCT MOL BIOL, V26, P1071, DOI 10.1038/s41594-019-0325-8; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Huang X, 2013, J BIOL CHEM, V288, P36418, DOI 10.1074/jbc.M113.495713; Kiss A, 2015, INTEGR BIOL-UK, V7, P1171, DOI 10.1039/c4ib00291a; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Kwak TK, 2010, J BIOL CHEM, V285, P36021, DOI 10.1074/jbc.M110.129601; Li B, 2001, J BIOL CHEM, V276, P33328, DOI 10.1074/jbc.M100789200; Liebl MC, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900127; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Ma B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11123; Mason DE, 2019, J CELL BIOL, V218, P1369, DOI 10.1083/jcb.201806065; Niebuhr K., 1997, EMBO J; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; Parshina EA, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108396; Peng CM, 2017, MOL CELL, V68, P591, DOI 10.1016/j.molcel.2017.10.010; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; Roberts Gordon C. K., 2009, Biophysical Reviews, V1, P61, DOI 10.1007/s12551-009-0009-4; Sabino F, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02883-2; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Siddiqui MQ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052647; Singh JP, 2015, CANCER LETT, V356, P244, DOI 10.1016/j.canlet.2014.04.014; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Smith MA, 2014, TRENDS CELL BIOL, V24, P575, DOI [10.1016/J.tcb.2014.04.009, 10.1016/j.tcb.2014.04.009]; Sun XY, 2020, DEV CELL, V55, P468, DOI 10.1016/j.devcel.2020.09.022; Toleman CA, 2018, P NATL ACAD SCI USA, V115, P5956, DOI 10.1073/pnas.1722437115; Wang Y, 2003, BBA-MOL CELL RES, V1593, P115, DOI 10.1016/S0167-4889(02)00349-X; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wojtowicz A, 2010, CIRC RES, V107, P898, DOI 10.1161/CIRCRESAHA.110.227850; Wong KKL, 2020, P NATL ACAD SCI USA, V117, P2004, DOI 10.1073/pnas.1912894117; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036717; Xu ZW, 2019, J BIOL CHEM, V294, P3117, DOI 10.1074/jbc.RA118.005923; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Youn H, 2013, CANCER LETT, V331, P192, DOI 10.1016/j.canlet.2012.12.019; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhou J., 2018, P NATL ACAD SCI	55	1	1	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101776	10.1016/j.jbc.2022.101776	http://dx.doi.org/10.1016/j.jbc.2022.101776			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35227760	Green Published, gold			2022-12-26	WOS:000793692600009
J	Zheng, WW; Chang, RJ; Luo, Q; Liu, GL; Xu, TJ				Zheng, Weiwei; Chang, Renjie; Luo, Qiang; Liu, Guiliang; Xu, Tianjun			The long noncoding RNA MIR122HG is a precursor for miR-122-5p and negatively regulates the TAK1-induced innate immune response in teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; CELL VIABILITY; HOST; TAK1; PROLIFERATION; INVASION; CANCER; AXIS; EXPRESSION; INFECTION	Long noncoding RNAs (lncRNAs) are a diverse subset of RNA species of noncoding transcripts that are usually longer than 200 nt. However, the biological role and function of many lncRNAs have not been fully identified. It has been shown that one potential function of lncRNAs is to act as a precursor miRNA and promote the production of multiple miRNAs. However, the function of the miiuy croaker lncRNA MIR122HG has not been explored. In the present study, we show that this differentially expressed teleost fish lncRNA can act as the host gene of miR-122-5p, regulate its expression, and indirectly regulate the expression of potential inflammatory target protein transforming growth factor-beta-activated kinase 1. We show that MIR122HG can negatively regulate the transforming growth factor-beta-activated kinase 1-triggered NF-kappa B and interferon regulatory factor 3 signaling pathways and subsequently attenuate the innate immune response. In addition, MIR122HG can promote the replication of Siniperca chuatsi rhabdovirus and exacerbate the pathological effects caused by viral infection. We conclude that the study of lncRNA-miRNA-mRNA interaction through bioinformatics analysis or experimental-supported analysis can provide information for further elucidation of the functions of fish lncRNAs in innate immunity.	[Zheng, Weiwei; Chang, Renjie; Luo, Qiang; Liu, Guiliang; Xu, Tianjun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China; [Xu, Tianjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China	Shanghai Ocean University; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Shanghai Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China.	tianjunxu@163.com			National Natural Science Foundation of China [31822057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant no.: 31822057).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aoshi T, 2011, CURR OPIN VIROL, V1, P226, DOI 10.1016/j.coviro.2011.07.002; Bao SY, 2018, FISH SHELLFISH IMMUN, V74, P450, DOI 10.1016/j.fsi.2018.01.005; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Chu Q., 2020, MIICHTHYS MIIUY SCI, V64, P1; Chu Q, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008670; Chu Q, 2020, REV AQUACULT, V12, P2177, DOI 10.1111/raq.12428; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dhir A, 2015, NAT STRUCT MOL BIOL, V22, P319, DOI 10.1038/nsmb.2982; Ding FN, 2019, FEBS OPEN BIO, V9, P1869, DOI 10.1002/2211-5463.12730; Faghihi M. A., 2008, NAT MED; Hatinguais R, 2020, CURR TOP MICROBIOL, V425, P187, DOI 10.1007/82_2020_201; Huang B, 2019, FISH SHELLFISH IMMUN, V94, P373, DOI 10.1016/j.fsi.2019.09.037; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Jiang HJ, 2018, INT J BIOL MACROMOL, V111, P623, DOI 10.1016/j.ijbiomac.2018.01.022; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kang L, 2020, ACTA BIOCH BIOPH SIN, V52, P883, DOI 10.1093/abbs/gmaa061; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kim SY, 2014, MOL CELL BIOL, V34, P510, DOI 10.1128/MCB.01225-13; Levin RS, 2016, P NATL ACAD SCI USA, V113, pE4776, DOI 10.1073/pnas.1608355113; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li H, 2014, ONCOTARGET, V5, P2318, DOI 10.18632/oncotarget.1913; Liang M, 2019, ANIM CELLS SYST, V23, P128, DOI 10.1080/19768354.2019.1591506; Liu G, 2016, ONCOL RES, V23, P99, DOI 10.3727/096504015X14496932933575; Liu SB, 2019, FISH SHELLFISH IMMUN, V92, P224, DOI 10.1016/j.fsi.2019.06.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YY, 2017, NAT MED, V23, P1331, DOI 10.1038/nm.4424; Luo H, 2019, MOL IMMUNOL, V105, P46, DOI 10.1016/j.molimm.2018.11.011; Meng L, 2020, ACTA BIOCH BIOPH SIN, V52, P49, DOI 10.1093/abbs/gmz141; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Peng F, 2021, DEV COMP IMMUNOL, V121, DOI 10.1016/j.dci.2021.104073; Rao YL, 2019, FISH SHELLFISH IMMUN, V93, P492, DOI 10.1016/j.fsi.2019.08.005; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Taylor DH, 2015, MOL REPROD DEV, V82, P932, DOI 10.1002/mrd.22581; Truscott M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004493; Wang S, 2019, CANCER MANAG RES, V11, P9701, DOI 10.2147/CMAR.S225742; Wang Z, 2020, J CELL PHYSIOL, V235, P2825, DOI 10.1002/jcp.29188; Wu XC, 2017, NEURO-ONCOLOGY, V19, P1195, DOI 10.1093/neuonc/nox017; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yan XL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00606; Yu YP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01764; Zhang L, 2020, J IMMUNOL, V205, P1620, DOI 10.4049/jimmunol.2000341; Zheng WW, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009438; Zheng WW, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100304; Zhou YL, 2017, EUR J IMMUNOL, V47, P1414, DOI 10.1002/eji.201746959; Zou T, 2016, MOL CELL BIOL, V36, P1332, DOI 10.1128/MCB.01030-15	51	4	4	6	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101773	10.1016/j.jbc.2022.101773	http://dx.doi.org/10.1016/j.jbc.2022.101773			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35218771	Green Published, gold			2022-12-26	WOS:000793694800002
J	Ullah, I; Khan, A; Israr, M; Shah, M; Shams, S; Khan, W; Shah, M; Siraj, M; Akbar, K; Naz, T; Afridi, SG				Ullah, Ibrar; Khan, Asifullah; Israr, Muhammad; Shah, Mohibullah; Shams, Sulaiman; Khan, Waliullah; Shah, Muzafar; Siraj, Muhammad; Akbar, Kehkashan; Naz, Tahira; Afridi, Sahib Gul			Genomic miscellany and allelic frequencies of Plasmodium falciparum msp-1, msp-2 and glurp in parasite isolates	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; MEROZOITE SURFACE PROTEIN-1; GENETIC DIVERSITY; MALARIA; EPIDEMIOLOGY; AREA; POPULATIONS; CHILDREN	Introduction The genomic miscellany of malaria parasites can help inform the intensity of malaria transmission and identify potential deficiencies in malaria control programs. This study was aimed at investigating the genomic miscellany, allele frequencies, and MOI of P. falciparum infection. Methods A total of 85 P. falciparum confirmed isolates out of 100 were included in this study that were collected from P. falciparum patients aged 4 months to 60 years in nine districts of Khyber Pakhtunkhwa Province. Parasite DNA was extracted from 200 mu L whole blood samples using the Qiagen DNA extraction kit following the manufacturer's instructions. The polymorphic regions of msp-1, msp-2 and glurp loci were genotyped using nested PCR followed by gel electrophoresis for amplified fragments identification and subsequent data analysis. Results Out of 85 P. falciparum infections detected, 30 were msp-1 and 32 were msp-2 alleles specific. Successful amplification occurred in 88.23% (75/85) isolates for msp-1, 78.9% (67/85) for msp-2 and 70% (60/85) for glurp gene. In msp-1, the K1 allelic family was predominantly prevalent as 66.66% (50/75), followed by RO33 and MAD20. The frequency of samples with single infection having only K1, MAD20 and RO33 were 21.34% (16/75), 8% (6/75), and 10.67% (8/75), respectively. In msp-2, both the FC27 and 3D7 allelic families revealed almost the same frequencies as 70.14% (47/67) and 67.16% (45/67), respectively. Nine glurp RII region alleles were identified in 60 isolates. The overall mean multiplicity of infection for msp genes was 1.6 with 1.8 for msp-1 and 1.4 for msp-2, while for glurp the MOI was 1.03. There was no significant association between multiplicity of infection and age groups (Spearman's rank coefficient = 0.050; P = 0.6) while MOI and parasite density correlated for only msp-2 allelic marker. Conclusions The study showed high genetic diversity and allelic frequency with multiple clones of msp-1, msp-2 and glurp in P. falciparum isolates in Khyber Pakhtunkhwa, Pakistan. In the present study the genotype data may provide valuable information essential for monitoring the impact of malaria eradication efforts in this region.	[Ullah, Ibrar; Khan, Asifullah; Shams, Sulaiman; Naz, Tahira; Afridi, Sahib Gul] Abdul Wali Khan Univ Mardan, Dept Biochem, Mardan, Pakistan; [Israr, Muhammad] Univ Swat, Dept Forens Sci, Swat, Pakistan; [Shah, Mohibullah] Bahauddin Zakariya Univ Multan, Dept Biochem, Multan, Pakistan; [Khan, Waliullah] Abdul Wali Khan Univ Mardan, Dept Chem, Mardan, Pakistan; [Shah, Muzafar] Univ Swat, Ctr Anim Sci & Fisheries, Swat, Pakistan; [Siraj, Muhammad] Abbottabad Univ Sci & Technol, Dept Zool, Abbottabad, Pakistan; [Akbar, Kehkashan] Abbottabad Int Med Coll, Dept Biochem, Abbottabad, Pakistan	Bahauddin Zakariya University	Afridi, SG (corresponding author), Abdul Wali Khan Univ Mardan, Dept Biochem, Mardan, Pakistan.	drafridi@awkum.edu.pk	Afridi, Sahib Gul/AGH-9949-2022; Khan, Asifullah/AGU-9005-2022; Shams, Sulaiman/AEW-4594-2022; Shah, Muzafar/B-1964-2013; Shah, Mohibullah/B-2390-2015	Shams, Sulaiman/0000-0001-7792-1180; Shah, Muzafar/0000-0002-5069-0228; Shah, Mohibullah/0000-0001-6126-7102				Abd Razak MRM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152415; Adjah J, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3350-z; [Anonymous], 2019, PAK MAL ANN REP; Asif Sabina Aziz, 2008, J Ayub Med Coll Abbottabad, V20, P98; Atroosh Wahib M, 2011, Parasit Vectors, V4, P233, DOI 10.1186/1756-3305-4-233; Auburn S, 2017, INT J PARASITOL, V47, P77, DOI 10.1016/j.ijpara.2016.08.006; Bakhiet AMA, 2015, ACTA TROP, V148, P97, DOI 10.1016/j.actatropica.2015.04.013; Bonnefoy S, 2008, CELL, V134, P20, DOI 10.1016/j.cell.2008.06.040; BORRE MB, 1991, MOL BIOCHEM PARASIT, V49, P119, DOI 10.1016/0166-6851(91)90135-S; Chen JT, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2611-z; Chenet SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-93; Chitarra V, 1999, MOL CELL, V3, P457, DOI 10.1016/S1097-2765(00)80473-6; Congpuong Kanungnit, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P598, DOI 10.12980/APJTB.4.2014APJTB-2014-0156; Dolmazon V, 2008, ACTA TROP, V107, P37, DOI 10.1016/j.actatropica.2008.04.012; Duah NO, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1692-1; Escalante AA, 2015, AM J TROP MED HYG, V93, P79, DOI 10.4269/ajtmh.15-0005; Farnert A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-241; Farrar CT, 2015, J HEPATOL, V63, P689, DOI 10.1016/j.jhep.2015.04.029; Funwei RI, 2018, MALARIA J, V17, DOI 10.1186/s12936-017-2149-5; Gosi P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-403; Gueye NSG, 2018, ACTA TROP, V183, P78, DOI 10.1016/j.actatropica.2018.04.012; Gupta Purva, 2014, ScientificWorldJournal, V2014, P140867, DOI 10.1155/2014/140867; Hamid Muzamil M Abdel, 2013, N Am J Med Sci, V5, P95, DOI 10.4103/1947-2714.107524; Hamid MMA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1641-z; Karim AM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004399; Kiwuwa MS, 2013, PARASITOL RES, V112, P1691, DOI 10.1007/s00436-013-3325-3; Kumar D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-450; Mayengue PI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-276; Mita T, 2014, J INFECT DIS, V209, P130, DOI 10.1093/infdis/jit415; Mohammed H, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2540-x; Mohammed H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0604-8; Mustafa SO, 2017, F1000RES, V6, P1790, DOI [10.12688/F1000RESEARCH.12585.1, DOI 10.12688/F1000RESEARCH.12585.1]; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; Ngomo JMN, 2018, ACTA TROP, V178, P27, DOI 10.1016/j.actatropica.2017.09.026; Ntoumi F., 2001, Parassitologia (Rome), V42, P197; Ogouyemi-Hounto A, 2013, PARASITE, V20, DOI 10.1051/parasite/2013039; Ojurongbe O, 2011, W INDIAN MED J, V60, P19; Olasehinde GI, 2012, AFR HEALTH SCI, V12, P355, DOI 10.4314/ahs.v12i3.17; Ord R, 2005, MOL BIOCHEM PARASIT, V144, P86, DOI 10.1016/j.molbiopara.2005.08.005; Peyerl-Hoffmann G, 2001, TROP MED INT HEALTH, V6, P607, DOI 10.1046/j.1365-3156.2001.00761.x; Pratt-Riccio LR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-144; Salem MSOA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-26; Silue K D, 2006, Med Trop (Mars), V66, P149; SMYTHE JA, 1991, P NATL ACAD SCI USA, V88, P1751, DOI 10.1073/pnas.88.5.1751; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Soe TN, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2254-x; Sorontou Y., 2015, International Journal of Medical Science and Public Health, V4, P1584; Soulama I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-135; Takala S, 2002, MOL BIOCHEM PARASIT, V125, P163, DOI 10.1016/S0166-6851(02)00237-2; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; Vafa M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-17; Vardo-Zalik AM, 2013, AM J TROP MED HYG, V88, P29, DOI 10.4269/ajtmh.2012.12-0308; WEZAM A, 1994, ETHIOPIAN MED J, V32, P41; WHO, 2010, WHO LIB CAT IN PUBL; WHO-World Health Organization, 2011, TABL MAL VACC PROJ G; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; Yasinzai Mohammad Iqbal, 2008, Pak J Biol Sci, V11, P1620, DOI 10.3923/pjbs.2008.1620.1624; Yavo William, 2016, Journal of Parasitology Research, P3074803, DOI 10.1155/2016/3074803; Yuan LL, 2013, ACTA TROP, V125, P53, DOI 10.1016/j.actatropica.2012.09.008; Zakeri S, 2005, TROP MED INT HEALTH, V10, P1060, DOI 10.1111/j.1365-3156.2005.01477.x	61	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264654	10.1371/journal.pone.0264654	http://dx.doi.org/10.1371/journal.pone.0264654			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259187	Green Published, gold, Green Submitted			2022-12-26	WOS:000835141200020
J	Yu, HY; Yang, CC; Yu, P; Liu, K				Yu, Haiyan; Yang, Ching-Chi; Yu, Ping; Liu, Ke			Emotion diffusion effect: Negative sentiment COVID-19 tweets of public organizations attract more responses from followers	PLOS ONE			English	Article							SOCIAL MEDIA; LANGUAGE	Coronavirus disease 2019 (COVID-19) has triggered an enormous number of discussion topics on social media Twitter. It has an impact on the global health system and citizen responses to the pandemic. Multiple responses (replies, favorites, and retweets) reflect the followers' attitudes and emotions towards these tweets. Twitter data such as these have inspired substantial research interest in sentiment and social trend analyses. To date, studies on Twitter data have focused on the associational relationships between variables in a population. There is a need for further discovery of causality, such as the influence of sentiment polarity of tweet response on further discussion topics. These topics often reflect the human perception of COVID-19. This study addresses this exact topic. It aims to develop a new method to unveil the causal relationships between the sentiment polarity and responses in social media data. We employed sentiment polarity, i.e., positive or negative sentiment, as the treatment variable in this quasi-experimental study. The data is the tweets posted by nine authoritative public organizations in four countries and the World Health Organization from December 1, 2019, to May 10, 2020. Employing the inverse probability weighting model, we identified the treatment effect of sentiment polarity on the multiple responses of tweets. The topics with negative sentiment polarity on COVID-19 attracted significantly more replies (69 +/- 49) and favorites (688 +/- 677) than the positive tweets. However, no significant difference in the number of retweets was found between the negative and positive tweets. This study contributes a new method for social media analysis. It generates new insight into the influence of sentiment polarity of tweets about COVID-19 on tweet responses.	[Yu, Haiyan; Liu, Ke] Chongqing Univ Posts & Telecommun, Ctr Data & Decis Sci, Chongqing, Peoples R China; [Yang, Ching-Chi] Univ Memphis, Dept Math Sci, Memphis, TN 38152 USA; [Yu, Ping] Univ Wollongong, Sch Comp & Informat Technol, Wollongong, NSW, Australia	Chongqing University of Posts & Telecommunications; University of Memphis; University of Wollongong	Yang, CC (corresponding author), Univ Memphis, Dept Math Sci, Memphis, TN 38152 USA.	cyang3@memphis.edu	; Yu, Haiyan/K-2644-2014; Yu, Ping/B-1205-2008	Yang, Ching-Chi/0000-0003-2517-2709; Yu, Haiyan/0000-0002-6473-8552; Yu, Ping/0000-0002-7910-9396				[Anonymous], COVID 19 DASHBOARD C; [Anonymous], 2020, WIKIPEDIA; Araujo T., 2018, INTERNET RES; Bae Y, 2012, J AM SOC INF SCI TEC, V63, P2521, DOI 10.1002/asi.22768; Bail CA, 2016, P NATL ACAD SCI USA, V113, P11823, DOI 10.1073/pnas.1607151113; Balakrishnan V, 2020, COMPUT SECUR, V90, DOI 10.1016/j.cose.2019.101710; Bejan V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190571; Budak C, 2016, PUBLIC OPIN QUART, V80, P250, DOI 10.1093/poq/nfw007; Cheng J, 2009, J ROY STAT SOC B, V71, P881, DOI 10.1111/j.1467-9868.2009.00715.x; Comarela G, 2012, P 23 ACM C HYP SOC M; Eichstaedt JC, 2015, PSYCHOL SCI, V26, P159, DOI 10.1177/0956797614557867; Gjerstad P, 2021, DECIS SUPPORT SYST, V147, DOI 10.1016/j.dss.2021.113577; Gohil S, 2018, JMIR PUBLIC HLTH SUR, V4, P72, DOI 10.2196/publichealth.5789; Gruzd A, 2020, BIG DATA SOC, V7, DOI 10.1177/2053951720938405; Hortensius R, 2018, IEEE T COGN DEV SYST, V10, P852, DOI 10.1109/TCDS.2018.2826921; Hswen Y, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/12264; Imran AS, 2020, IEEE ACCESS, V8, P181074, DOI 10.1109/ACCESS.2020.3027350; Kiritchenko S, 2014, J ARTIF INTELL RES, V50, P723, DOI 10.1613/jair.4272; Korkontzelos I, 2016, J BIOMED INFORM, V62, P148, DOI 10.1016/j.jbi.2016.06.007; Li J, 2010, ELECTR J INF SYS DEV, V42; Liu B, 2011, DATA CENTRIC SYST AP, P459, DOI 10.1007/978-3-642-19460-3_11; McCabe M, 2019, TOP 30 MOST FOLLOWED; Monachesi P, 2021, TELEMAT INFORM, V58, DOI 10.1016/j.tele.2020.101531; Mousavi R., 2019, INFORM SYST RES, P1; Naveed N, 2011, P 3 INT WEB SCI C; Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; RStudioTeam, 2016, RSTUDIO INT DEV ENV; Secon H., 2020, COMPREHENSIVE TIMELI; Silge J., 2016, J OPEN SOURCE SOFTW, V1, P37, DOI [DOI 10.21105/JOSS.00037, 10.1007/s00216-016-9710-x]; Simon T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104136; Stilo G, 2016, DATA MIN KNOWL DISC, V30, P372, DOI 10.1007/s10618-015-0412-3; Tang L, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/26720; Terry M, 2009, TELEMED J E-HEALTH, V15, P507, DOI 10.1089/tmj.2009.9955; Teufel M, 2020, J PUBLIC HEALTH-UK, V42, P644, DOI 10.1093/pubmed/fdaa060; Wang JN, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.9082; Yu HY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132314; Yu HY, 2020, J MED INTERNET RES, V22, DOI 10.2196/18527	39	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264794	10.1371/journal.pone.0264794	http://dx.doi.org/10.1371/journal.pone.0264794			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259181	gold, Green Published			2022-12-26	WOS:000835141200027
J	Li, S; Xu, WY; Zhang, FF; Wu, H				Li, Shuai; Xu, Wenyuan; Zhang, Fengfa; Wu, He			A study on the rheological properties and modification mechanism of graphene oxide/polyurethane/SBS-modified asphalt	PLOS ONE			English	Article								To study the effect of graphene oxide (GO) on thermoplastic polyurethane (TPU)/styrenebutadiene-styrene (SBS)-modified asphalt and reveal the modification mechanism, GO/TPU/SBS-modified asphalt was prepared by high-speed shearing Hongjuan et al. (2020). The physical properties of the modified asphalt were measured via a basic index test, and the dynamic rheological behavior of the modified asphalt was characterized by a dynamic shear rheometer (DSR), a bending beam rheometer (BBR), and other technical means. Moreover, double-beam UV-visible (UV-Vis) spectrophotometry and Fourier-transform infrared spectroscopy (FTIR) were conducted to determine the mechanism of asphalt modification from the microscopic perspective. The experimental results reveal that the GO content can improve the basic mechanical properties, high-temperature stability, and low-temperature cracking resistance of TPU/SBS-modified asphalt. When the GO content is 0.5%, the ductility and softening point of the modified asphalt are found to be significantly increased, and the degree of penetration is slightly decreased. Moreover, with the increase of the GO content, the rutting resistance and crack resistance of the asphalt materials are improved. Via the joint action of physical modification and chemical reaction, GO can form a stable structure with asphalt molecules, enhance the stability between asphalt molecules, and increase the colloidal content of macromolecules in the modified asphalt components.	[Li, Shuai; Xu, Wenyuan] Northeast Forestry Univ, Coll Civil Engn, Harbin, Heilongjiang, Peoples R China; [Zhang, Fengfa; Wu, He] Heilongjiang Inst Technol, Coll Civil Engn, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China; Heilongjiang Institute of Technology	Xu, WY (corresponding author), Northeast Forestry Univ, Coll Civil Engn, Harbin, Heilongjiang, Peoples R China.	xuwenyuan@nefu.edu		Wenyuan, Xu/0000-0002-1397-9305	science and technology project of Heilongjiang Provincial Department of Transportation	science and technology project of Heilongjiang Provincial Department of Transportation	This study was supported by the science and technology project of Heilongjiang Provincial Department of Transportation "Research on Road Performance of High-performance Graphene Modified Asphalt Mixture in Cold Area".	Abe AA, 2021, MATERIALS, V14, DOI 10.3390/ma14071622; Alghrafy YM, 2021, CONSTR BUILD MATER, V273, DOI 10.1016/j.conbuildmat.2020.121771; [Anonymous], E202011 JTG; Fang CQ, 2013, J MATER SCI TECHNOL, V29, P589, DOI 10.1016/j.jmst.2013.04.008; Jamshidi A, 2015, CONSTR BUILD MATER, V98, P437, DOI 10.1016/j.conbuildmat.2015.08.069; JIANG Z X, 2019, HIGHWAY, V64, P272; Johnson TW, 2021, J TEST EVAL, V49, P1020, DOI 10.1520/JTE20190840; Li N, 2021, CONSTR BUILD MATER, V274, DOI 10.1016/j.conbuildmat.2020.121992; Li X, 2021, CONSTR BUILD MATER, V272, DOI 10.1016/j.conbuildmat.2020.121919; Li YY, 2018, CONSTR BUILD MATER, V165, P572, DOI 10.1016/j.conbuildmat.2018.01.068; [刘克非 Liu Kefei], 2020, [长安大学学报. 自然科学版, Journal of Chang'An University. Natural Science Edition], V40, P40; Liu Kefei, 2020, HIGHWAY, V65, P225; Liu S, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13060863; Nagabhushanarao SS, 2021, CONSTR BUILD MATER, V272, DOI 10.1016/j.conbuildmat.2020.121995; Steyn W, 2008, SATC; [武红娟 Wu Hongjuan], 2020, [长安大学学报. 自然科学版, Journal of Chang'An University. Natural Science Edition], V40, P97; Yagen Yang Shaofeng, 2000, J ANAL TEST, P41; Yang J, 2021, J CLEAN PROD, V289, DOI 10.1016/j.jclepro.2020.125135; Yu Rui, 2018, SCI TECHNOLOGY ENG, V18, P209; [袁东东 Yuan Dongdong], 2020, [长安大学学报. 自然科学版, Journal of Chang'An University. Natural Science Edition], V40, P135; Zeng Q, 2020, CONSTR BUILD MATER, V238, DOI 10.1016/j.conbuildmat.2019.117706; Zhou Huanyun, SCI TECHNOLOGY HIGHW, V201, P10; Zhou Zhigang, MAT REV, V201, P6093	23	0	0	33	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2022	17	3							e0262467	10.1371/journal.pone.0262467	http://dx.doi.org/10.1371/journal.pone.0262467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4X9QJ	35255086	Green Published, gold			2022-12-26	WOS:000861170400001
J	Niehues, RV; Wozniak, J; Wiersch, F; Lilienthal, E; Tacken, N; Schumertl, T; Garbers, C; Ludwig, A; Dusterhoft, S				Niehues, Rabea Victoria; Wozniak, Justyna; Wiersch, Florian; Lilienthal, Eva; Tacken, Nikola; Schumertl, Tim; Garbers, Christoph; Ludwig, Andreas; Duesterhoeft, Stefan			The collectrin-like part of the SARS-CoV-1 and-2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17	FASEB JOURNAL			English	Article						ADAM10; ADAM17; ectodomain shedding; SARS-CoV receptor; soluble ACE2	CONVERTING ENZYME 2; FACTOR-ALPHA; SUBSTRATE SELECTIVITY; SPIKE PROTEIN; SARS-COV; IRHOM2; DISINTEGRIN; ACTIVATION; CELLS; CLEAVAGE	The transmembrane protease angiotensin converting enzyme 2 (ACE2) is a protective regulator within the renin angiotensin system and additionally represents the cellular receptor for SARS-CoV. The release of soluble ACE2 (sACE2) from the cell surface is hence believed to be a crucial part of its (patho)physiological functions, as both, ACE2 protease activity and SARS-CoV binding ability, are transferred from the cell membrane to body fluids. Yet, the molecular sources of sACE2 are still not completely investigated. In this study, we show different sources and prerequisites for the release of sACE2 from the cell membrane. By using inhibitors as well as CRISPR/Cas9-derived cells, we demonstrated that, in addition to the metalloprotease ADAM17, also ADAM10 is an important novel shedding protease of ACE2. Moreover, we observed that ACE2 can also be released in extracellular vesicles. The degree of either ADAM10- or ADAM17-mediated ACE2 shedding is dependent on stimulatory conditions and on the expression level of the pro-inflammatory ADAM17 regulator iRhom2. Finally, by using structural analysis and in vitro verification, we determined for the first time that the susceptibility to ADAM10- and ADAM17-mediated shedding is mediated by the collectrin-like part of ACE2. Overall, our findings give novel insights into sACE2 release by several independent molecular mechanisms.	[Niehues, Rabea Victoria; Wozniak, Justyna; Wiersch, Florian; Lilienthal, Eva; Tacken, Nikola; Ludwig, Andreas; Duesterhoeft, Stefan] Rhein Westfal TH Aachen, Med Fac, Inst Mol Pharmacol, Aachen, Germany; [Schumertl, Tim; Garbers, Christoph] Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany	RWTH Aachen University; Otto von Guericke University	Ludwig, A; Dusterhoft, S (corresponding author), Rhein Westfal TH Aachen, Inst Mol Pharmacol, Wendlingweg 2, D-52074 Aachen, Germany.	aludwig@ukaachen.de; sduesterhoeft@ukaachen.de	Garbers, Christoph/D-9932-2015	Garbers, Christoph/0000-0003-4939-6950; Dusterhoft, Stefan/0000-0002-6926-136X	Deutsche Forschungsgemeinschaft (DFG) [DU 1582/1-1, LU 869/9-1]; RWTH Aachen \ Medizinische Fakultat, RWTH Aachen University (Medical Faculty, RWTH Aachen University) [691903-06/19]; Bundesministerium fur Bildung und Forschung (BMBF) [01KI20207]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); RWTH Aachen \ Medizinische Fakultat, RWTH Aachen University (Medical Faculty, RWTH Aachen University); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: DU 1582/1-1 and LU 869/9-1; RWTH Aachen | Medizinische Fakultat, RWTH Aachen University (Medical Faculty, RWTH Aachen University), Grant/Award Number: START #691903-06/19; Bundesministerium fur Bildung und Forschung (BMBF), Grant/Award Number: 01KI20207	Abd El-Aziz TM, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00374-6; Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Andring JT., 2020, AMINO ACID TRANSPORT, DOI [10.1101/2020.1110.1130.361873, DOI 10.1101/2020.1110.1130.361873]; Anguiano L, 2017, CURR MED CHEM, V24, P3231, DOI 10.2174/0929867324666170414162841; Arndt PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019938; Babendreyer A, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.610344; Bleibaum F, 2019, J MOL CELL BIOL, V11, P979, DOI 10.1093/jmcb/mjz008; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Caolo V, 2020, ELIFE, V9, DOI 10.7554/eLife.50684; Chan KK, 2020, SCIENCE, V369, P1261, DOI 10.1126/science.abc0870; Christova Y, 2013, EMBO REP, V14, P884, DOI 10.1038/embor.2013.128; Clarke NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034747; Cocozza F, 2020, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12050; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Dempsey PJ, 2017, BBA-MOL CELL RES, V1864, P2228, DOI 10.1016/j.bbamcr.2017.07.011; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Dreymueller D, 2014, J IMMUNOL, V192, P722, DOI 10.4049/jimmunol.1302496; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dusterhoft S, 2019, BBA-MOL CELL RES, V1866, P1567, DOI 10.1016/j.bbamcr.2019.06.017; Dusterhoft S, 2021, CELL MOL LIFE SCI, V78, P5015, DOI 10.1007/s00018-021-03845-3; Endres K, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00056; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Glowacka I, 2010, J VIROL, V84, P1198, DOI 10.1128/JVI.01248-09; Groth E, 2016, BBA-MOL CELL RES, V1863, P2795, DOI 10.1016/j.bbamcr.2016.09.002; Haga S, 2010, ANTIVIR RES, V85, P551, DOI 10.1016/j.antiviral.2009.12.001; Harper MT, 2011, J THROMB HAEMOST, V9, P1599, DOI 10.1111/j.1538-7836.2011.04393.x; Heurich A, 2014, J VIROL, V88, P1293, DOI 10.1128/JVI.02202-13; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; Inada M, 2016, INT J MOL MED, V37, P1521, DOI 10.3892/ijmm.2016.2568; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Iwata M., 2011, CURR ENZYME INHIBIT, V7, P42, DOI DOI 10.2174/157340811795713756; Iwata M, 2009, AM J PHYSIOL-CELL PH, V297, pC1318, DOI 10.1152/ajpcell.00036.2009; Jaimes JA, 2020, J MOL BIOL, V432, P3309, DOI 10.1016/j.jmb.2020.04.009; Jia HP, 2009, AM J PHYSIOL-LUNG C, V297, pL84, DOI 10.1152/ajplung.00071.2009; Jia HP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18880-0; Johnson N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07556-3; Kato T, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00153; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Koch L, 2021, FASEB J, V35, DOI 10.1096/fj.202002087R; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Kuba K, 2013, CIRC J, V77, P301, DOI 10.1253/circj.CJ-12-1544; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lambrecht BN, 2018, NAT REV IMMUNOL, V18, P745, DOI 10.1038/s41577-018-0068-5; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lorenzen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35067; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Palau V, 2020, NEPHROL DIAL TRANSPL, V35, P1071, DOI 10.1093/ndt/gfaa093; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Rahman MM, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2213; Riera M, 2016, AM J PHYSIOL-RENAL, V310, pF534, DOI 10.1152/ajprenal.00082.2015; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Seifert A, 2021, CELL MOL LIFE SCI, V78, P715, DOI 10.1007/s00018-020-03507-w; SHIVNAN E, 1995, J IMMUNOL, V154, P1146; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siggs OM, 2012, BLOOD, V119, P5769, DOI 10.1182/blood-2012-03-417949; Simossis VA, 2003, COMPUT BIOL CHEM, V27, P511, DOI 10.1016/j.compbiolchem.2003.09.002; Sommer A, 2016, CELL CYCLE, V15, P2995, DOI 10.1080/15384101.2016.1211449; Sommer A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11523; Stepanova G, 2021, BIOL FUTURA, V72, P291, DOI 10.1007/s42977-021-00092-2; Stevens BR., 2020, TMPRSS2 ADAM17 INTER, DOI [10.1101/2020.1110.1131.363473, DOI 10.1101/2020.1110.1131.363473]; Stevens BR, 2021, FUNCTION, V2, DOI 10.1093/function/zqab027; Vogel AB, 2021, NATURE, V592, P283, DOI 10.1038/s41586-021-03275-y; Wang JJ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4213541; Wang YL, 2020, INT J MED SCI, V17, P1522, DOI 10.7150/ijms.46695; Wozniak J, 2021, NAT REV NEPHROL, V17, P513, DOI 10.1038/s41581-021-00415-5; Wysocki J, 2021, J AM SOC NEPHROL, V32, P795, DOI 10.1681/ASN.2020101537; Xiao FX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085958; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yeung ML, 2021, CELL, V184, P2212, DOI 10.1016/j.cell.2021.02.053; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412; Zoufaly A, 2020, LANCET RESP MED, V8, P1154, DOI 10.1016/S2213-2600(20)30418-5; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	92	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22234	10.1096/fj.202101521R	http://dx.doi.org/10.1096/fj.202101521R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199397	hybrid, Green Published			2022-12-26	WOS:000761250800008
J	Yu, J; Zhang, XY; Chen, YX; Cheng, HB; Li, DM; Rao, HX				Yu, Juan; Zhang, Xiong-Ying; Chen, Yun-Xia; Cheng, Hong-Bing; Li, Dong-Mei; Rao, Hua-Xiang			Molecular detection and genetic characterization of small rodents associated Bartonella species in Zhongtiao Mountain, China	PLOS ONE			English	Article							CAT-SCRATCH DISEASE; SMALL MAMMALS; VERRUGA PERUANA; INFECTIONS; PREVALENCE; DIVERSITY; STRAINS; PATIENT; FEVER; DOGS	The prevalence and molecular characteristics of Bartonella infections in small rodents in the Zhongtiao Mountain, China have been explored. In this study, the liver, spleen and kidney tissues of captured rodents were used for Bartonella spp. detection and identification by combination of real-time PCR of transfer-mRNA (ssrA) gene and traditional PCR and sequencing of citrate synthase (gltA) gene. It was shown that 49.52% of the rodents (52/105) were positive for Bartonella spp.. The infection rate in different gender (chi(2) = 0.079, P = 0.778) and tissues (chi(2) = 0.233, P = 0.890) of small rodents did not have statistical difference, but that in different small rodents (Fisher's exact test, P < 0.001) and habitats (chi(2) = 5.483, P = 0.019) had statistical difference. And, the sequencing data suggests that Bartonella sequences (n = 31) were identified into three species, including 14 of B. grahamii, 3 of B. queenslandensis and 14 of unknown Bartonella species. Phylogenetic analysis showed that B. grahamii sequences were clustered with the isolates from South Korea and China, and B. queenslandensis sequences were mainly closely related to the isolates from China and Thailand. The genetic diversity analysis showed that B. grahamii and B. queenslandensis sequences exhibited noticeable intraspecies diversity. Taken together our data demonstrates the high prevalence and genetic diversity of Bartonella infections in small rodents in the Zhongtiao Mountain, especially a potential novel Bartonella specie was detected, which could benefit the prevention and control of rodent-Bartonella species in this area.	[Yu, Juan; Zhang, Xiong-Ying; Chen, Yun-Xia; Cheng, Hong-Bing] Changzhi Med Coll, Dept Basic Med Sci, Changzhi, Shanxi, Peoples R China; [Li, Dong-Mei] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Rao, Hua-Xiang] Changzhi Med Coll, Dept Publ Hlth & Prevent Med, Changzhi, Shanxi, Peoples R China	Changzhi Medical College; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Changzhi Medical College	Li, DM (corresponding author), Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Rao, HX (corresponding author), Changzhi Med Coll, Dept Publ Hlth & Prevent Med, Changzhi, Shanxi, Peoples R China.	lidongmei@icdc.cn; raohuaxiang2006006@163.com		Rao, Hua-xiang/0000-0002-6388-8276				Anstead GM, 2016, LANCET INFECT DIS, V16, pE164, DOI 10.1016/S1473-3099(16)30003-2; Arvand M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009765; Avidor B, 2004, J CLIN MICROBIOL, V42, P3462, DOI 10.1128/JCM.42.8.3462-3468.2004; Bai Y, 2008, MICROB ECOL, V56, P373, DOI 10.1007/s00248-007-9355-6; Bai Y, 2007, FEMS MICROBIOL ECOL, V61, P438, DOI 10.1111/j.1574-6941.2007.00364.x; Bai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080894; Bai Y, 2009, AM J TROP MED HYG, V81, P811, DOI 10.4269/ajtmh.2009.09-0294; BIRTLES RJ, 1994, ANN TROP MED PARASIT, V88, P317, DOI 10.1080/00034983.1994.11812872; Bitam I, 2009, CLIN MICROBIOL INFEC, V15, P102, DOI 10.1111/j.1469-0691.2008.02180.x; Breitschwerdt EB, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-29; Chaudhry R, 2018, INDIAN J MED RES, V147, P189, DOI 10.4103/ijmr.IJMR_1932_16; Chomel BB, 2006, EMERG INFECT DIS, V12, P389, DOI 10.3201/eid1203.050931; Chomel BB, 2003, ANN NY ACAD SCI, V990, P267, DOI 10.1111/j.1749-6632.2003.tb07376.x; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009010; Colton L, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-229; Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378; DALY JS, 1993, J CLIN MICROBIOL, V31, P872, DOI 10.1128/JCM.31.4.872-881.1993; Diaz MH, 2012, J CLIN MICROBIOL, V50, P1645, DOI 10.1128/JCM.06621-11; Fenollar F, 2005, J CLIN MICROBIOL, V43, P945, DOI 10.1128/JCM.43.2.945-947.2005; Gundi VAKB, 2009, INT J SYST EVOL MICR, V59, P2956, DOI 10.1099/ijs.0.002865-0; Holmberg M, 2003, EPIDEMIOL INFECT, V130, P149, DOI 10.1017/S0950268802008075; Hozakova L, 2017, EPIDEMIOL MIKROBI IM, V66, P99; Huang K, 2019, CAN J INFECT DIS MED, V2019, DOI 10.1155/2019/3209013; Huang RT, 2011, EMERG INFECT DIS, V17, P1707, DOI 10.3201/eid1709.110133; Hwang J, 2013, EMERG INFECT DIS, V19, P1167, DOI 10.3201/eid1907.130010; Iannino F, 2018, VET ITAL, V54, P63, DOI 10.12834/VetIt.398.1883.2; Kerkhoff FT, 1999, J CLIN MICROBIOL, V37, P4034, DOI 10.1128/JCM.37.12.4034-4038.1999; Kim KS, 2016, J WILDLIFE DIS, V52, P10, DOI 10.7589/2015-01-015; Kordick DL, 1997, J CLIN MICROBIOL, V35, P1813, DOI 10.1128/JCM.35.7.1813-1818.1997; Kosoy M, 2004, VECTOR-BORNE ZOONOT, V4, P296, DOI 10.1089/vbz.2004.4.296; Kosoy M, 2003, J CLIN MICROBIOL, V41, P645, DOI 10.1128/JCM.41.2.645-650.2003; Kosoy MY, 1997, AM J TROP MED HYG, V57, P578, DOI 10.4269/ajtmh.1997.57.578; Kraljik J, 2016, PARASITOLOGY, V143, P1437, DOI 10.1017/S0031182016000962; Ksiaa I, 2019, J CURR OPHTHALMOL, V31, P254, DOI 10.1016/j.joco.2019.03.005; Lamas C, 2008, MEM I OSWALDO CRUZ, V103, P221, DOI 10.1590/S0074-02762008000300001; Li Dong-mei, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P934; Li DM, 2015, APPL ENVIRON MICROB, V81, P7981, DOI 10.1128/AEM.02041-15; Liu QY, 2010, J WILDLIFE DIS, V46, P179, DOI 10.7589/0090-3558-46.1.179; Minnick MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002919; Mullins KE, 2017, EMERG INFECT DIS, V23, P430, DOI 10.3201/eid2303.161476; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; Oksi J, 2013, J CLIN MICROBIOL, V51, P2781, DOI 10.1128/JCM.00910-13; Rao HX, 2015, BIOMED ENVIRON SCI, V28, P674, DOI 10.3967/bes2015.094; Rao HX, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81508-w; SPACH DH, 1993, J CLIN MICROBIOL, V31, P692, DOI 10.1128/JCM.31.3.692-694.1993; Ye Xi, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P989; Ying B, 2002, AM J TROP MED HYG, V66, P622, DOI 10.4269/ajtmh.2002.66.622	47	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264591	10.1371/journal.pone.0264591	http://dx.doi.org/10.1371/journal.pone.0264591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226692	Green Published, gold			2022-12-26	WOS:000793394000035
J	Hirmondo, R; Horvath, A; Molnar, D; Torok, G; Nguyen, L; Toth, J				Hirmondo, Rita; Horvath, Armin; Molnar, Daniel; Torok, Gyorgy; Nguyen, Liem; Toth, Judit			The effects of mycobacterial RmlA perturbation on cellular dNTP pool, cell morphology, and replication stress in Mycobacterium smegmatis	PLOS ONE			English	Article							PROTEIN-KINASE-G; GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE; GENE; SHAPE; MICROARRAY; RESISTANCE; DIVISION; BACTERIA; GLUCOSE; GROWTH	The concerted action of DNA replication and cell division has been extensively investigated in eukaryotes. Well demarcated checkpoints have been identified in the cell cycle, which provides the correct DNA stoichiometry and appropriate growth in the progeny. In bacteria, which grow faster and less concerted than eukaryotes, the linkages between cell elongation and DNA synthesis are unclear. dTTP, one of the canonical nucleotide-building blocks of DNA, is also used for cell wall biosynthesis in mycobacteria. We hypothesize that the interconnection between DNA and cell wall biosynthesis through dTTP may require synchronization of these processes by regulating dTTP availability. We investigated growth, morphology, cellular dNTP pool, and possible signs of stress in Mycobacterium smegmatis upon perturbation of rhamnose biosynthesis by the overexpression of RmlA. RmlA is a cell wall synthetic enzyme that uses dTTP as the precursor for cross-linking the peptidoglycan with the arabinogalactan layers by a phosphodiester bond in the mycobacterial cell wall. We found that RmlA overexpression results in changes in cell morphology, causing cell elongation and disruption of the cylindrical cell shape. We also found that the cellular dTTP pool is reduced by half in RmlA overexpressing cells and that this reduced dTTP availability does not restrict cell growth. We observed 2-6-fold increases in the gene expression of replication and cell wall biosynthesis stress factors upon RmlA overexpression. Using super-resolution microscopy, we found that RmlA, acting to crosslink the nascent layers of the cell wall, localizes throughout the whole cell length in a helical pattern in addition to the cellular pole.	[Hirmondo, Rita; Horvath, Armin; Molnar, Daniel; Torok, Gyorgy; Toth, Judit] Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Molnar, Daniel] Eotvos Lorand Univ, Doctoral Sch Biol, Budapest, Hungary; [Molnar, Daniel] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary; [Torok, Gyorgy] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary; [Nguyen, Liem] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Toth, Judit] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Eotvos Lorand University; Semmelweis University; Case Western Reserve University; Budapest University of Technology & Economics	Hirmondo, R; Toth, J (corresponding author), Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.; Toth, J (corresponding author), Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Budapest, Hungary.	hirmondo.rita@ttk.hu; toth.judit@ttk.hu		Toth, Judit/0000-0002-0965-046X	National Research, Development and Innovation Office, Hungary [OTKA FK124527, PD128254]; National Institutes of Health [R01AI087903, R21AI119287, R21AI159770]	National Research, Development and Innovation Office, Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Research, Development and Innovation Office, Hungary, OTKA FK124527 to JT and PD128254 to RH. Work in L.N. laboratory was supported by National Institutes of Health grants R01AI087903, R21AI119287 and R21AI159770. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland D, 2000, J BACTERIOL, V182, P1802, DOI 10.1128/JB.182.7.1802-1811.2000; Alphey MS, ALLOSTERIC COMPETITI; Bischer AP, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00728-19; Blankenfeldt W, STRUCTURAL BASIS CAT; Brown HA, 2018, PROTEIN SCI, V27, P441, DOI 10.1002/pro.3333; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Deng JY, 2014, CELL REP, V9, P2317, DOI 10.1016/j.celrep.2014.11.023; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Ghosh S, 2016, J BACTERIOL, V198, P352, DOI 10.1128/JB.00669-15; Goossens SN, 2021, CLIN MICROBIOL REV, V34, DOI 10.1128/CMR.00141-20; Hardy GG, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00597-17; Hartmann R, 2020, MOL MICROBIOL, V114, P140, DOI 10.1111/mmi.14501; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Hsu CY, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00692-19; Jankute M, 2015, ANNU REV MICROBIOL, V69, P405, DOI 10.1146/annurev-micro-091014-104121; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kovacs CJ, 2019, MOL MICROBIOL, V112, P944, DOI 10.1111/mmi.14330; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; MELO A, 1965, J BIOL CHEM, V240, P398; Melzer ES, 2018, CYTOSKELETON, V75, P498, DOI 10.1002/cm.21490; Mizrahi V, 2019, SCIENCE, V363, P457, DOI 10.1126/science.aaw5224; Moretti R, 2007, J BIOL CHEM, V282, P16942, DOI 10.1074/jbc.M701951200; Plocinski P, 2013, TUBERCULOSIS, V93, pS21, DOI 10.1016/S1472-9792(13)70006-4; Plocinski P, 2012, J BACTERIOL, V194, P6398, DOI 10.1128/JB.01005-12; Qu DH, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.643951; Qu H, 2007, FEMS MICROBIOL LETT, V275, P237, DOI 10.1111/j.1574-6968.2007.00890.x; Rani C, 2016, EUR J PHARM SCI, V83, P62, DOI 10.1016/j.ejps.2015.12.013; Roberts G, 2003, FEMS MICROBIOL LETT, V221, P131, DOI 10.1016/S0378-1097(03)00177-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Srivastava V, 2007, MICROBIOL-SGM, V153, P659, DOI 10.1099/mic.0.2006/000547-0; Szabo JE, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkaa116; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Torres R, 2019, DNA REPAIR, V77, P45, DOI 10.1016/j.dnarep.2019.03.002; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wang H, 2016, J DRUG TARGET, V24, P392, DOI 10.3109/1061186X.2015.1095195; Williams E, 2007, EXTREMOPHILES, V11, P19, DOI 10.1007/s00792-006-0002-9; Williams KJ, 2010, PLASMID, V64, P69, DOI 10.1016/j.plasmid.2010.04.003; Wolff KA, 2009, ANTIMICROB AGENTS CH, V53, P3515, DOI 10.1128/AAC.00012-09	43	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0263975	10.1371/journal.pone.0263975	http://dx.doi.org/10.1371/journal.pone.0263975			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202428	gold, Green Published			2022-12-26	WOS:000773224600018
J	Ahmed, S; Manjunath, K; Chattopadhyay, G; Varadarajan, R				Ahmed, Shahbaz; Manjunath, Kavyashree; Chattopadhyay, Gopinath; Varadarajan, Raghavan			Identification of stabilizing point mutations through mutagenesis of destabilized protein libraries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SURFACE DISPLAY; DIRECTED EVOLUTION; IN-VIVO; SEQUENCE; ANTIBODIES; EXPRESSION; GENERATION; SECRETION; DESIGN; ASSAY	Although there have been recent transformative advances in the area of protein structure prediction, prediction of point mutations that improve protein stability remains challenging. It is possible to construct and screen large mutant libraries for improved activity or ligand binding. However, reliable screens for mutants that improve protein stability do not yet exist, especially for proteins that are well folded and relatively stable. Here, we demonstrate that incorporation of a single, specific, destabilizing mutation termed parent inactivating mutation into each member of a single-site saturation mutagenesis library, followed by screening for suppressors, allows for robust and accurate identification of stabilizing mutations. We carried out fluorescence-activated cell sorting of such a yeast surface display, saturation suppressor library of the bacterial toxin CcdB, followed by deep sequencing of sorted populations. We found that multiple stabilizing mutations could be identified after a single round of sorting. In addition, multiple libraries with different parent inactivating mutations could be pooled and simultaneously screened to further enhance the accuracy of identification of stabilizing mutations. Finally, we show that individual stabilizing mutations could be combined to result in a multi-mutant that demonstrated an increase in thermal melting temperature of about 20 degrees C, and that displayed enhanced tolerance to high temperature exposure. We conclude that as this method is robust and employs small library sizes, it can be readily extended to other display and screening formats to rapidly isolate stabilized protein mutants.	[Ahmed, Shahbaz; Chattopadhyay, Gopinath; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India; [Manjunath, Kavyashree] Inst Stem Cell Sci & Regenerat Med, Ctr Chem Biol & Therapeut, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India.	varadar@iisc.ac.in		Manjunath, Kavyashree/0000-0002-1838-5362; Chattopadhyay, Gopinath/0000-0002-6408-1968	Department of Science and Technology, Government of India [EMR/2017/004054]; Department of Biotechnology [BT/COE/34/SP15219/2015]; Ministry of Science and Technology, Government of India; Bill and Melinda Gates Foundation (USA) [INV-005948]; Council of Scientific & Industrial Research [SPM-07/079(0218)/2015EMR-I]; Department of Science and Technology (DST) Science and Engineering Research Board [PDF/2017/002641]	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology; Ministry of Science and Technology, Government of India(Ministry of Science and Technology, Government of India); Bill and Melinda Gates Foundation (USA)(Bill & Melinda Gates Foundation); Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST) Science and Engineering Research Board(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	Funding and additional information-This work was funded by grants to R. V. from the Department of Science and Technology, grant number-EMR/2017/004054, DT.15/12/2018), Government of India; Department of Biotechnology, grant no. BT/COE/34/SP15219/2015 DT, 20/11/2015, Ministry of Science and Technology, Government of India and Bill and Melinda Gates Foundation (USA) (INV-005948). S. A. acknowledges the Council of Scientific & Industrial Research for his fellowship (SPM-07/079(0218)/2015EMR-I). K. M. is thankful to the Department of Science and Technology (DST) Science and Engineering Research Board for financial support, sanction order no: PDF/2017/002641. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Adkar BV, 2012, STRUCTURE, V20, P371, DOI 10.1016/j.str.2011.11.021; Ahmed S, 2022, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.800819; Ahmed S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.765211; Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Bajaj K, 2004, BIOCHEM J, V380, P409, DOI 10.1042/BJ20031528; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BLACKLOW SC, 1991, BIOCHEMISTRY-US, V30, P8470, DOI 10.1021/bi00098a026; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Cao HL, 2019, J CHEM INF MODEL, V59, P1508, DOI 10.1021/acs.jcim.8b00697; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chattopadhyay G, 2019, PROTEIN SCI, V28, P1127, DOI 10.1002/pro.3622; Chen YT, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008543; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Esteban O, 2004, J MOL BIOL, V340, P81, DOI 10.1016/j.jmb.2004.04.054; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; G. Chattopadhyay, 2022, bioRxiv, DOI 10.1101/2021.11.18.469098; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Golinski AW, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026658118; Hagihara Y, 2002, P NATL ACAD SCI USA, V99, P6619, DOI 10.1073/pnas.102172099; HERMES JD, 1990, P NATL ACAD SCI USA, V87, P696, DOI 10.1073/pnas.87.2.696; Jain PC, 2014, ANAL BIOCHEM, V449, P90, DOI 10.1016/j.ab.2013.12.002; Kemble H, 2019, EVOL APPL, V12, P1721, DOI 10.1111/eva.12846; Kiss C, 2009, PROTEIN ENG DES SEL, V22, P313, DOI 10.1093/protein/gzp006; LEHTOVAARA PM, 1988, PROTEIN ENG, V2, P63, DOI 10.1093/protein/2.1.63; Maxwell KL, 1999, PROTEIN SCI, V8, P1908, DOI 10.1110/ps.8.9.1908; Mimmi S, 2019, TRENDS PHARMACOL SCI, V40, P87, DOI 10.1016/j.tips.2018.12.005; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nikolova PV, 2000, EMBO J, V19, P370, DOI 10.1093/emboj/19.3.370; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Park S, 2006, PROTEIN ENG DES SEL, V19, P211, DOI 10.1093/protein/gzl003; Pavoor TV, 2012, PROTEIN ENG DES SEL, V25, P625, DOI 10.1093/protein/gzs041; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Piatesi A, 2006, PROTEIN EXPRES PURIF, V48, P232, DOI 10.1016/j.pep.2006.01.026; Rocklin GJ, 2017, SCIENCE, V357, P168, DOI 10.1126/science.aan0693; Sahoo A, 2015, ELIFE, V4, DOI 10.7554/eLife.09532; Savojardo C, 2016, BIOINFORMATICS, V32, P2542, DOI 10.1093/bioinformatics/btw192; Schwimmer LJ, 2013, J IMMUNOL METHODS, V391, P60, DOI 10.1016/j.jim.2013.02.010; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Tao HY, 2002, CURR OPIN CHEM BIOL, V6, P858, DOI 10.1016/S1367-5931(02)00396-4; Traxlmayr MW, 2012, ARCH BIOCHEM BIOPHYS, V526, P174, DOI 10.1016/j.abb.2012.04.022; Tripathi A, 2016, MOL BIOL EVOL, V33, P2960, DOI 10.1093/molbev/msw182; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Wrenbeck EE, 2017, CURR OPIN STRUC BIOL, V45, P36, DOI 10.1016/j.sbi.2016.11.001; Wu CH, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0223-x; Zahradnik J, 2021, NAT MICROBIOL, V6, P1188, DOI 10.1038/s41564-021-00954-4; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zutz A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26337-1	54	3	3	7	12	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101785	10.1016/j.jbc.2022.101785	http://dx.doi.org/10.1016/j.jbc.2022.101785			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35247389	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000793502000012
J	Ishigami, I; Russi, S; Cohen, A; Yeh, SR; Rousseau, DL				Ishigami, Izumi; Russi, Silvia; Cohen, Aina; Yeh, Syun-Ru; Rousseau, Denis L.			Temperature-dependent structural transition following X-ray-induced metal center reduction in oxidized cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CRYORADIOLYTIC REDUCTION; PROTON TRANSLOCATION; RADIATION-DAMAGE; HEME-PROTEINS; ACTIVE-SITE; CRYSTALLOGRAPHY; RESOLUTION; MECHANISM; O-2	Cytochrome c oxidase (CcO) is the terminal enzyme in the electron transfer chain in the inner membrane of mitochondria. It contains four metal redox centers, two of which, Cu-B and heme alpha(3), form the binuclear center (BNC), where dioxygen is reduced to water. Crystal structures of CcO in various forms have been reported, from which ligand-binding states of the BNC and conformations of the protein matrix surrounding it have been deduced to elucidate the mechanism by which the oxygen reduction chemistry is coupled to proton translocation. However, metal centers in proteins can be susceptible to X-rayinduced radiation damage, raising questions about the reliability of conclusions drawn from these studies. Here, we used microspectroscopy-coupled X-ray crystallography to interrogate how the structural integrity of bovine CcO in the fully oxidized state (O) is modulated by synchrotron radiation. Spectroscopic data showed that, upon X-ray exposure, O was converted to a hybrid O* state where all the four metal centers were reduced, but the protein matrix was trapped in the genuine O conformation and the ligands in the BNC remained intact. Annealing the O* crystal above the glass transition temperature induced relaxation of the O* structure to a new R* structure, wherein the protein matrix converted to the fully reduced R conformation with the exception of helix X, which partly remained in the O conformation because of incomplete dissociation of the ligands from the BNC. We conclude from these data that reevaluation of reported CcO structures obtained with synchrotron light sources is merited.	[Ishigami, Izumi; Yeh, Syun-Ru; Rousseau, Denis L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Russi, Silvia; Cohen, Aina] Stanford Univ, SLAC Natl Accelerator Lab, Struct Mol Biol, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA	Yeshiva University; Albert Einstein College of Medicine; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Yeh, SR; Rousseau, DL (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	syun-ru.yeh@einsteinmed.edu; denis.rousseau@einsteinmed.edu		Cohen, Aina/0000-0003-2414-9427; Yeh, Syun-Ru/0000-0002-9858-386X; Ishigami, Izumi/0000-0001-6929-1908	National Institutes of Health National Institute of General Medical Sciences [R01 GM126297, R21 GM127944, R01 GM115773]	National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health National Institute of General Medical Sciences grants R01 GM126297 (to D. L. R. and S.-R. Y.), R21 GM127944 (to D. L. R.), and R01 GM115773 (to S.-R. Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Andersson R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04817-z; Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106; ARGADE PV, 1986, BIOPHYS J, V50, P613, DOI 10.1016/S0006-3495(86)83500-7; BABCOCK GT, 1993, J BIOENERG BIOMEMBR, V25, P71, DOI 10.1007/BF00762849; BAKER GM, 1987, J BIOL CHEM, V262, P595; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Belevich I, 2008, ANTIOXID REDOX SIGN, V10, P1, DOI 10.1089/ars.2007.1705; Denisov IG, 2007, RADIAT PHYS CHEM, V76, P714, DOI 10.1016/j.radphyschem.2006.03.002; Du WGH, 2020, INORG CHEM, V59, P8906, DOI 10.1021/acs.inorgchem.0c00724; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engler N, 2000, BIOPHYS J, V78, P2081, DOI 10.1016/S0006-3495(00)76755-5; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ferguson-Miller S, 2012, BBA-BIOENERGETICS, V1817, P489, DOI 10.1016/j.bbabio.2011.11.018; Garman EF, 2006, ACTA CRYSTALLOGR D, V62, P32, DOI 10.1107/S0907444905034207; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; Han S, 2000, J BIOL CHEM, V275, P1910, DOI 10.1074/jbc.275.3.1910; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/nmeth.2962, 10.1038/NMETH.2962]; Ishigami I, 2019, P NATL ACAD SCI USA, V116, P3572, DOI 10.1073/pnas.1814526116; Ishigami I, 2017, P NATL ACAD SCI USA, V114, P8011, DOI 10.1073/pnas.1705628114; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P769, DOI 10.1016/j.bbabio.2010.12.016; Kim E, 2004, CHEM REV, V104, P1077, DOI 10.1021/cr0206162; Kitagawa T, 1998, J BIOENERG BIOMEMBR, V30, P71, DOI 10.1023/A:1020511612194; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Liu B, 2009, BIOCHEMISTRY-US, V48, P820, DOI 10.1021/bi801759a; Liu JA, 2011, P NATL ACAD SCI USA, V108, P1284, DOI 10.1073/pnas.1012846108; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; MOODY AJ, 1991, BIOCHIM BIOPHYS ACTA, V1059, P189, DOI 10.1016/S0005-2728(05)80204-X; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Pfanzagl V, 2020, J BIOL CHEM, V295, P13488, DOI 10.1074/jbc.RA120.014087; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Rousseau DL, 1999, NATURE, V400, P412, DOI 10.1038/22664; Shimada A, 2020, J BIOL CHEM, V295, P5818, DOI 10.1074/jbc.RA119.009596; Sousa FL, 2012, BBA-BIOENERGETICS, V1817, P629, DOI 10.1016/j.bbabio.2011.09.020; Tiefenbrunn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022348; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Ueno G, 2019, J SYNCHROTRON RADIAT, V26, P912, DOI 10.1107/S1600577519006805; VANNESTE WH, 1966, BIOCHEMISTRY-US, V5, P838, DOI 10.1021/bi00867a005; VAROTSIS C, 1993, P NATL ACAD SCI USA, V90, P237, DOI 10.1073/pnas.90.1.237; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Wikstrom M, 2018, BBA-BIOENERGETICS, V1859, P692, DOI 10.1016/j.bbabio.2018.03.009; Wikstrom M, 2012, BBA-BIOENERGETICS, V1817, P468, DOI 10.1016/j.bbabio.2011.10.010; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yano N, 2016, J BIOL CHEM, V291, P23882, DOI 10.1074/jbc.M115.711770; Yi J, 2010, BIOCHEMISTRY-US, V49, P5969, DOI 10.1021/bi100801g; YOSHIKAWA S, 1977, J BIOL CHEM, V252, P5498; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yoshikawa S, 2015, CHEM REV, V115, P1936, DOI 10.1021/cr500266a	55	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101799	10.1016/j.jbc.2022.101799	http://dx.doi.org/10.1016/j.jbc.2022.101799			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35257742	gold, Green Published			2022-12-26	WOS:000823106100012
J	Ponzar, NL; Tajwar, R; Pozzi, N; Tavis, JE				Ponzar, Nathan L.; Tajwar, Razia; Pozzi, Nicola; Tavis, John E.			Alpha-hydroxytropolones are noncompetitive inhibitors of human RNase H1 that bind to the active site and modulate substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; B-VIRUS REPLICATION; RIBONUCLEASE-H; RNA/DNA HYBRID; METAL-IONS; DESTABILIZATION; MITOCHONDRIAL; SPECIFICITY; STABILITY; BLOCKING	The ribonucleases H (RNases H) of HIV and hepatitis B virus are type 1 RNases H that are promising drug targets because inhibiting their activity blocks viral replication. Eukaryotic ribonuclease H1 (RNase H1) is an essential protein and a probable off-target enzyme for viral RNase H inhibitors. alpha-hydroxytropolones (alpha HTs) are a class of anti-RNase H inhibitors that can inhibit the HIV, hepatitis B virus, and human RNases H1; however, it is unclear how these inhibitors could be developed to distinguish between these enzymes. To accelerate the development of selective RNase H inhibitors, we performed biochemical and kinetic studies on the human enzyme, which was recombinantly expressed in Escherichia coli. Size-exclusion chromatography showed that free RNase H1 is monomeric and forms a 2:1 complex with a substrate of 12 bp. FRET heteroduplex cleavage assays were used to test inhibition of RNase H1 in steady-state kinetics by two structurally diverse alpha HTs, 110 and 404. We determined that turnover rate was reduced, but inhibition was not competitive with substrate, despite inhibitor binding to the active site. Given the compounds' reversible binding to the active site, we concluded that traditional noncompetitive and mixed inhibition mechanisms are unlikely. Instead, we propose a model in which, by binding to the active site, alpha HTs stabilize an inactive enzyme-substrate-inhibitor complex. This new model clarifies the mechanism of action of alpha HTs against RNase H1 and will aid the development of RNase H inhibitors selective for the viral enzymes.	[Ponzar, Nathan L.; Tajwar, Razia; Tavis, John E.] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Ponzar, Nathan L.; Tajwar, Razia; Pozzi, Nicola; Tavis, John E.] St Louis Univ, Inst Drug & Biotherapeut Innovat, St Louis, MO 63103 USA; [Pozzi, Nicola] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63103 USA; [Tavis, John E.] Liver Ctr, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University; Saint Louis University	Tavis, JE (corresponding author), St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.; Tavis, JE (corresponding author), St Louis Univ, Inst Drug & Biotherapeut Innovat, St Louis, MO 63103 USA.; Tavis, JE (corresponding author), Liver Ctr, St Louis, MO 63103 USA.	john.tavis@health.slu.edu	Pozzi, Nicola/AAC-1771-2021	Pozzi, Nicola/0000-0003-2309-7100; Tavis, John/0000-0002-8711-4240	US Department of Defense grant [W81XWH-18-1-0307]	US Department of Defense grant(United States Department of Defense)	This work was funded by the US Department of Defense grant (grant no.: W81XWH-18-1-0307 [to J. E. T.]).	Cao LL, 2014, CURR MED CHEM, V21, P1956, DOI 10.2174/0929867321666140120121158; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; DABORA JM, 1994, PROTEIN SCI, V3, P1401, DOI 10.1002/pro.5560030906; Didierjean J, 2005, ANTIMICROB AGENTS CH, V49, P4884, DOI 10.1128/AAC.49.12.4884-4894.2005; Edwards T. C., 2017, INHIBITION HEPATITIS; Edwards TC, 2019, EXPERT OPIN THER TAR, V23, P559, DOI 10.1080/14728222.2019.1619697; Edwards TC, 2019, ANTIVIR RES, V164, P70, DOI 10.1016/j.antiviral.2019.02.005; Gaidamakov SA, 2005, NUCLEIC ACIDS RES, V33, P2166, DOI 10.1093/nar/gki510; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; HIRAI M, 1970, B CHEM SOC JPN, V43, P778, DOI 10.1246/bcsj.43.778; Holt IJ, 2019, DNA REPAIR, V84, DOI 10.1016/j.dnarep.2019.06.001; Hu Y, 2013, ANTIVIR RES, V99, P221, DOI 10.1016/j.antiviral.2013.06.007; Hyjek M, 2019, DNA REPAIR, V84, DOI 10.1016/j.dnarep.2019.102672; Jarmoskaite I, 2020, ELIFE, V9, DOI 10.7554/eLife.57264; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Kocyla A, 2017, J INORG BIOCHEM, V176, P53, DOI 10.1016/j.jinorgbio.2017.08.006; Kumar G, 2021, NUCLEIC ACIDS RES, V49, P1609, DOI 10.1093/nar/gkaa1294; Lee H, 2022, NUCLEIC ACIDS RES, V50, P1801, DOI 10.1093/nar/gkab1064; Li QL, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104777; Lima WF, 2016, NUCLEIC ACIDS RES, V44, P5299, DOI 10.1093/nar/gkw350; Lima WF, 2003, J BIOL CHEM, V278, P49860, DOI 10.1074/jbc.M306543200; Lu GF, 2015, ANTIMICROB AGENTS CH, V59, P1070, DOI 10.1128/AAC.04617-14; Michaelis L, 1913, BIOCHEM Z, V49, P333; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2008, EMBO J, V27, P1172, DOI 10.1038/emboj.2008.44; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Parajuli S, 2017, J BIOL CHEM, V292, P15216, DOI 10.1074/jbc.M117.787473; PAULING L, 1947, J AM CHEM SOC, V69, P542, DOI 10.1021/ja01195a024; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Samara NL, 2018, NAT STRUCT MOL BIOL, V25, P715, DOI 10.1038/s41594-018-0099-4; Spudich GM, 2004, J MOL BIOL, V335, P609, DOI 10.1016/j.jmb.2003.10.052; Strelow J., 2012, ASSAY GUIDANCE MANUA; Tavis JE, 2014, ANTIMICROB AGENTS CH, V58, P7451, DOI 10.1128/AAC.03875-14; Tian L, 2018, P NATL ACAD SCI USA, V115, P507, DOI 10.1073/pnas.1719746115; Tramontano E, 2019, ANTIVIR RES, V171, DOI 10.1016/j.antiviral.2019.104613; Yamasaki K, 1995, BIOCHEMISTRY-US, V34, P16552, DOI 10.1021/bi00051a003; Zhang Z, 2006, J BIOL CHEM, V281, P35794, DOI 10.1074/jbc.M608031200	40	0	0	7	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101790	10.1016/j.jbc.2022.101790	http://dx.doi.org/10.1016/j.jbc.2022.101790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35247386	gold, Green Published			2022-12-26	WOS:000793617400002
J	Tamura, T; Tanaka, Y; Watanabe, Y; Sato, K				Tamura, Toshiaki; Tanaka, Yasuhiro; Watanabe, Yoshihiro; Sato, Katsuro			Relationships between maximum tongue pressure and second formant transition in speakers with different types of dysarthria	PLOS ONE			English	Article							SPEECH-INTELLIGIBILITY; CONTACT PRESSURE; F2 SLOPE; STRENGTH; CONSEQUENCES; SEVERITY; WEAKNESS; FORCE; HAND	The effects of muscle weakness on speech are currently not fully known. We investigated the relationships between maximum tongue pressure and second formant transition in adults with different types of dysarthria. It focused on the slope in the second formant transition because it reflects the tongue velocity during articulation. Sixty-three Japanese speakers with dysarthria (median age, 68 years; interquartile range, 58-77 years; 44 men and 19 women) admitted to acute and convalescent hospitals were included. Thirty neurologically normal speakers aged 19-85 years (median age, 22 years; interquartile range, 21.0-23.8 years; 14 men and 16 women) were also included. The relationship between the maximum tongue pressure and speech function was evaluated using correlation analysis in the dysarthria group. Speech intelligibility, the oral diadochokinesis rate, and the second formant slope were based on the impaired speech index. More than half of the speakers had mild to moderate dysarthria. Speakers with dysarthria showed significantly lower maximum tongue pressure, speech intelligibility, oral diadochokinesis rate, and second formant slope than neurologically normal speakers. Only the second formant slope was significantly correlated with the maximum tongue pressure (r = 0.368, p = 0.003). The relationship between the second formant slope and maximum tongue pressure showed a similar correlation in the analysis of subgroups divided by sex. The oral diadochokinesis rate, which is related to the speed of articulation, is affected by voice on/off, mandibular opening/closing, and range of motion. In contrast, the second formant slope was less affected by these factors. These results suggest that the maximum isometric tongue strength is associated with tongue movement speed during articulation.	[Tamura, Toshiaki; Sato, Katsuro] Niigata Univ Hlth & Welf, Dept Speech Language & Hearing Sci, Niigata, Niigata, Japan; [Tamura, Toshiaki; Sato, Katsuro] Niigata Univ Hlth & Welf, Grad Sch, Hlth & Welf, Niigata, Niigata, Japan; [Tanaka, Yasuhiro] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Nisshin, Aichi, Japan; [Watanabe, Yoshihiro] Uonuma Kikan Hosp, Dept Rehabil, Uonuma City, Niigata, Japan	Niigata University; Niigata University; Aichi Gakuin University	Tamura, T (corresponding author), Niigata Univ Hlth & Welf, Dept Speech Language & Hearing Sci, Niigata, Niigata, Japan.; Tamura, T (corresponding author), Niigata Univ Hlth & Welf, Grad Sch, Hlth & Welf, Niigata, Niigata, Japan.	toshiaki-tamura@nuhw.ac.jp		Tamura, Toshiaki/0000-0002-0676-5173	Japan Society for the Promotion of Science [JP20K19324]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) (https://www.jsps.go.jp/j-grantsinaid/) under Grant number JP20K19324. The funders had no role in the study design, data collection and analysis, decision to publish, and prepared of the manuscript.	ACKERMANN H, 1991, J NEUROL NEUROSUR PS, V54, P1093, DOI 10.1136/jnnp.54.12.1093; Bunton Kate, 2008, Seminars in Speech and Language, V29, P267, DOI 10.1055/s-0028-1103390; De Bodt MS, 2002, J COMMUN DISORD, V35, P283, DOI 10.1016/S0021-9924(02)00065-5; Duffy J. R., 2020, MOTOR SPEECH DISORDE, V4th; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; DWORKIN JP, 1980, J SPEECH HEAR RES, V23, P828, DOI 10.1044/jshr.2304.828; Hayashi R, 2002, INT J PROSTHODONT, V15, P385; Itoh M., 1993, JPN J LOGOP PHONIATR, V34, P237, DOI [10.5112/jjlp.34.237, DOI 10.5112/JJLP.34.237]; Kent D. R., 1994, AM J SPEECH-LANG PAT, V3, P81, DOI [10.1044/1058-0360.0302.81, DOI 10.1044/1058-0360.0302.81]; KENT RD, 1989, CLIN LINGUIST PHONET, V3, P347, DOI 10.3109/02699208908985295; Kent RD, 1999, J COMMUN DISORD, V32, P141, DOI 10.1016/S0021-9924(99)00004-0; Kim Y, 2011, J SPEECH LANG HEAR R, V54, P417, DOI 10.1044/1092-4388(2010/10-0020); Kim Y, 2009, FOLIA PHONIATR LOGO, V61, P329, DOI 10.1159/000252849; Lansford KL, 2014, J SPEECH LANG HEAR R, V57, P68, DOI 10.1044/1092-4388(2013/12-0263); McCauley RJ, 2009, AM J SPEECH-LANG PAT, V18, P343, DOI 10.1044/1058-0360(2009/09-0006); MCHENRY MA, 1994, J SPEECH HEAR RES, V37, P1271, DOI 10.1044/jshr.3706.1271; Moon Jong Hoon, 2017, J Phys Ther Sci, V29, P1201, DOI 10.1589/jpts.29.1201; Neel AT, 2008, J SPEECH LANG HEAR R, V51, P574, DOI 10.1044/1092-4388(2008/041); Neel AT, 2015, J SPEECH LANG HEAR R, V58, P1, DOI 10.1044/2014_JSLHR-S-13-0172; Neel AT, 2012, J SPEECH LANG HEAR R, V55, P235, DOI 10.1044/1092-4388(2011/10-0258); Neel AT., 2008, J MED SPEECH-LANG PA, P235; Nishio M., 1998, JPN J LOGOP PHONIATR, V39, P410, DOI [10.5112/jjlp.39.410, DOI 10.5112/JJLP.39.410]; Nishio M., 2004, ASSESSMENT MOTOR SPE; Palmer MF, 1940, J SPEECH DISORD, V5, P133, DOI 10.1044/jshd.0502.133; Rong PY, 2012, CLIN LINGUIST PHONET, V26, P806, DOI 10.3109/02699206.2012.706686; Searl J, 2007, J MED SPEECH-LANG PA, V15, P279; Searl J, 2017, J SPEECH LANG HEAR R, V60, P810, DOI 10.1044/2016_JSLHR-S-16-0107; Solomon NP, 2017, AM J SPEECH-LANG PAT, V26, P951, DOI 10.1044/2017_AJSLP-16-0144; Solomon NP, 2000, J SPEECH LANG HEAR R, V43, P256, DOI 10.1044/jslhr.4301.256; STEVENS KN, 1989, J PHONETICS, V17, P3, DOI 10.1016/S0095-4470(19)31520-7; Taguchi T., 1966, TOKYO JAPANESE IGAKU, DOI [10.11501/1381781, DOI 10.11501/1381781]; Takeuchi K, 2012, JPN J DYSPHAGIA REHA, V16, P165, DOI [DOI 10.32136/JSDR.16.2_165, 10.32136/jsdr.16.2_165]; Tamura T., 2020, JAPANESE J SPEECH LA, V17, P130, DOI [10.11477/mf.6001200278, DOI 10.11477/MF.6001200278]; Tamura T., 2021, JPN J LOGOP PHONIATR, V62, P205, DOI [10.5112/jjlp.62.205, DOI 10.5112/JJLP.62.205]; Thompson A, 2019, J ACOUST SOC AM, V145, pEL323, DOI 10.1121/1.5099163; Tjaden K, 2013, FOLIA PHONIATR LOGO, V65, P214, DOI 10.1159/000355867; Tsuga K, 2011, J ORAL REHABIL, V38, P680, DOI 10.1111/j.1365-2842.2011.02202.x; Utanohara Y, 2008, DYSPHAGIA, V23, P286, DOI 10.1007/s00455-007-9142-z; Weismer G, 2006, CLIN LINGUIST PHONET, V20, P315, DOI 10.1080/02699200400024806; Westbury J.R., 1993, ANN B RES I LOGOP PH, V27, P13; Yoshikawa M, 2011, DYSPHAGIA, V26, P232, DOI 10.1007/s00455-010-9291-3; Yunusova Y, 2012, FOLIA PHONIATR LOGO, V64, P94, DOI 10.1159/000336890	42	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264995	10.1371/journal.pone.0264995	http://dx.doi.org/10.1371/journal.pone.0264995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259200	gold, Green Published			2022-12-26	WOS:000835141200037
J	Ejigu, S; Haile, D; Solomon, Y				Ejigu, Solomon; Haile, Diresbachew; Solomon, Yerukneh			Effect of malaria and HIV/AIDS co-infection on red blood cell indices and its relation with the CD4 level of patients on HAART in Bench Sheko Zone, Southwest Ethiopia	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; HEMATOLOGICAL ABNORMALITIES; ANEMIA; PREVALENCE; IMPACT	Background Malaria and HIV/AIDS are the two most common infections in sub Saharan Africa (SSA) and worldwide. HIV infected individuals in malaria endemic areas experience severe malaria episodes. The immunological basis of this clinical observation is unclear and the hematologic abnormalities such as anemia in malaria and HIV co infected patients were inconsistent from studies in the past. Ethiopia's three-fourth of the landmass is malarious and HIV prevalence is high that significantly affect RBC indices and other hematologic profiles. Objective This study aimed to compare RBC indices and anemia in HIV patients' co-infected with malaria and those HIV patients without malaria and correlates these with CD4 level. Methods A comparative cross-sectional study was employed on 103 malaria-HIV/AIDS co infected (MHC) and 103 HIV patients without malaria on HAART of the same ART centers in Bench Sheko Zone. Data was collected by structured questionnaire and blood samples were collected from both groups for malaria test and RBC indices measurement. Data was entered and checked in Epi-data and exported to IBM SPSS version 21 software packages for analysis. Results There were significant differences in MeanSD of RBC indices between the two groups (P<0.001). RBC, Hgb, HCT and MCV were lower in MHC patients. In total study participants, significant positive correlation was observed between CD4 count with MCV, CD4 count with MCH and CD4 count with anemia. In the group of malaria-HIV co-infected, CD4 count with RBC and CD4 count with Hgb and in HIV without malaria CD4 count with MCV, CD4 count with MCH and CD4 count with MCHC were positively correlated. Overall anemia prevalence was 45.1%. Anemia prevalence in MHC (Malaria-HIV co-infected) was 63.4%. Anemia prevalence distribution among sex showed that 61.3% in female sex and anemia prevalence distribution among CD4 group showed 55.9% in patients with CD4 count of <= 500 cells/mu l. Anemia in MHC patients was higher in those with CD4 count of <= 500 cells/mu l (59.3%) while in OH (Only HIV infected) anemia prevalence was similar in those with CD4 count of <= 500 and >= 500 cells/mu l (50%). There is significant difference in anemia in MHC and OH infected with different CD4 group (P<0.01). Conclusion There was a difference in RBC indices in both groups; RBC, Hgb, HCT and MCV were lower in MHC patients. There was positive correlation between CD4 counts with some RBC indices in combined both groups. However, there was positive correlation between CD4 counts with RBC and Hgb in malaria-HIV co-infected. The combined prevalence of anemia was higher and anemia in MHC was greater than OH infected patients.	[Ejigu, Solomon] Mizan Tepi Univ, Dept Biomed Sci, Coll Med & Hlth Sci, Mizan Aman, Ethiopia; [Haile, Diresbachew] Addis Ababa Univ, Sch Med, Dept Physiol, Coll Hlth Sci, Addis Ababa, Ethiopia; [Solomon, Yerukneh] Debre Berhan Univ, Dept Biomed Sci, Coll Med & Hlth Sci, Debre Berhan, Ethiopia	Addis Ababa University	Ejigu, S (corresponding author), Mizan Tepi Univ, Dept Biomed Sci, Coll Med & Hlth Sci, Mizan Aman, Ethiopia.	solomonejigu67@gmail.com	Solomon, Yerukneh/GQH-9871-2022	Solomon, Yerukneh/0000-0002-1426-386X	Addis Ababa University	Addis Ababa University	The authors acknowledge the Addis Ababa University and Bench Sheko Zone that permitted us to conduct the study and the participants who consented to participate in the study.	Addissie Adamu, 2007, Ethiop Med J, V45, P9; Adeoti OAH., 2015, AM J BIOMEDICAL RES, V3, P8; Agarwal DCJ., 2010, HIGH INCIDENCE ZIDOV; Ageru TA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221853; Akinbo F. O., 2016, Annals of Nigerian Medicine, V10, P11, DOI 10.4103/0331-3131.189802; Akinbo FO, 2012, J RES HEALTH SCI, V12, P15; Alem MKT., 2013, PATIENTS ANTIRETROVI, V2, P2; Alemayehu G, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1029-0; Alemu A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-18; Amitis Ramezani AA., 2008, IRANIAN J PATHOLOGY, V3, P4; Ashley EA, 2018, LANCET, V391, P1608, DOI 10.1016/S0140-6736(18)30324-6; Asmamaw T, 2013, INT J LIFE SCI BIOTE, V2, P1; Assefa Muluken, 2015, BMC Hematol, V15, P6, DOI 10.1186/s12878-015-0024-6; Ayele DG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-195; Barnabas Yulitha., 2019, CENTRAL TANZANIA TRE, V4; Bate A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1853-z; Bello BaI David, 2018, J ADV MICROBIOLOGY, V11, P6; Beyene HB, 2017, ACTA TROP, V169, P8, DOI 10.1016/j.actatropica.2017.01.007; Clark IA CG., 1988, BRIT J HAEMATOL, V70, P5, DOI [10.1111/j.1365-2141.1988.tb02426.x, DOI 10.1111/J.1365-2141.1988.TB02426.X]; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; Cuadros DF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023458; Curkendall SM, 2007, HIV MED, V8, P483, DOI 10.1111/j.1468-1293.2007.00500.x; De Santis GC, 2011, INT J INFECT DIS, V15, pE808, DOI 10.1016/j.ijid.2011.08.001; Denue BA, 2013, E MEDITERR HEALTH J, V19, P362, DOI 10.26719/2013.19.4.362; Denue BABHaAA., 2013, CHANGES BLOOD PROFIL, V5, P7; Desta Kassa BP., 2005, ETHIOP J HEALTH DEV, V19, P9; Erhabor AIMLS A., 2006, NIGERIAN J MED, V15, P5; Frischknecht F, 2016, FEBS LETT, V590, P2000, DOI 10.1002/1873-3468.12151; Gedefaw L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072202; Gosellea O., 2009, MALARIA INFECT HIVAI; Gurjeet Singh, 2014, International Journal of Current Microbiology and Applied Sciences, V3, P622; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Hochman Sarah, 2009, Interdiscip Perspect Infect Dis, V2009, P617954, DOI 10.1155/2009/617954; Jegede FE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174233; Kimbi HK., 2013, J BACTERIOL PARASITO, V4, P164, DOI DOI 10.4172/2155-9597.1000164; Kurtis JD, 2001, INFECT IMMUN, V69, P123, DOI 10.1128/IAI.69.1.123-128.2001; Kyeyune R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-496; Maher D, 2005, TROP MED INT HEALTH, V10, P734, DOI 10.1111/j.1365-3156.2005.01456.x; Meidani M, 2012, J RES MED SCI, V17, P138; Mouala C, 2008, JAIDS-J ACQ IMM DEF, V49, P55, DOI 10.1097/QAI.0b013e31817e635b; Mugisha JO, 2008, TROP MED INT HEALTH, V13, P788, DOI 10.1111/j.1365-3156.2008.02069.x; Naing C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003205; Obirikorang C, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-102; Ojurongbe O, 2014, J TROP MED-US, V2014, DOI 10.1155/2014/161284; Omoregie R., 2009, TANZAN J HLTH RES, P11, DOI [10.4314/thrb.v11i1.43244, DOI 10.4314/THRB.V11I1.43244]; Omoti CE, 2013, ASIAN PAC J TROP MED, V6, P126, DOI 10.1016/S1995-7645(13)60007-3; Onifade EOAaOOM A.K, 2007, MIDDLE-EAST J SCI RE, V2, P6; Organization RBMPWH, EV ADV MAL 2015 UPD; Ouedraogo SM SI., 2015, AFR J INT MED, V3, P7; Rattanapunya S, 2015, ACTA TROP, V145, P55, DOI 10.1016/j.actatropica.2015.02.001; Sahle Tsion, 2017, BMC Hematol, V17, P2, DOI 10.1186/s12878-017-0072-1; Subramaniam KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124412; Tagoe DNA, 2012, J INFECT DEV COUNTR, V6, P660, DOI 10.3855/jidc.2124; Tay SCK, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0064-6; Tchinda GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040553; UNAIDS, 2017, HIV AIDS JUNPO GENE; USAID, 2015, BURK FAS MAL OP PLAN, P45; WHO, 2011, WHO TECH REP SER, V959, P1; WHO, 2015, UPDATE ETHIOPIA HIV; Woldeamanuel Gashaw Garedew, 2018, BMC Hematol, V18, P7, DOI 10.1186/s12878-018-0099-y; World Health Organization, 2017, DEPRESSION; WYF G, 2013, BMC HEMATOLGY, P5; Yinzhong S., 2013, PLOS ONE, V8; Yitayih Wondimeneh GF, 2013, HIV MALARIA COINFECT, V3, P7	64	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0263865	10.1371/journal.pone.0263865	http://dx.doi.org/10.1371/journal.pone.0263865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245289	Green Published, gold			2022-12-26	WOS:000799799100008
J	Opio, M; Akello, F; Twongyeirwe, DK; Opio, D; Aceng, J; Namagga, JK; Kabakyenga, JK				Opio, Mark; Akello, Florence; Twongyeirwe, Doreen Kagina; Opio, David; Aceng, Juliet; Namagga, Jane Kasozi; Kabakyenga, Jerome Kahuma			Perspectives on linkage to care for patients diagnosed with HIV: A qualitative study at a rural health center in South Western Uganda	PLOS ONE			English	Article							INTEGRATING HIV; POSITIVE MEN; ENGAGEMENT; BARRIERS; STIGMA; FACILITATORS; SERVICES; CLIENTS; PEOPLE; SEX	Linkage to care for newly diagnosed human immunodeficiency virus (HIV) patients is important to ensure that patients have good access to care. However, there is little information about factors influencing linkage to care for HIV patients. We aimed to identify existing measures in place that promote linkage to care and to explore facilitators and barriers to linkage to care for clients diagnosed with HIV/acquired immune deficiency syndrome at a rural health center in Uganda. This descriptive qualitative study enrolled 33 purposively selected participants who included expert clients, linkage facilitators, heads of families with people living with HIV, and health workers. Data were collected using in-depth interviews that were audio-recorded, transcribed, and translated. The data were manually analyzed to generate themes. The following four themes were generated: 1) availability of services that include counseling, testing, treatment, follow-up, referral, outreach activities, and support systems. 2) Barriers to linkage to care were at the individual, health facility, and community levels. Individual-level barriers were socioeconomic status, high transport costs, fear of adverse drug effects, fear of broken relationships, and denial of positive results or treatment, while health facility barriers were reported to be long waiting time, negative staff attitude, and drug stock outs. Community barriers were mostly due to stigma experienced by HIV clients, resulting in discrimination by community members. 3) Facilitators to linkage to care were positive staff attitudes, access to information, fear of death, and support from others. 4) Suggestions for improving service delivery were shortening waiting time, integrating HIV services, increasing staff numbers, and intensifying outreaches. Our findings highlight the importance of stakeholder involvement in linkage to care. Access and linkage to care are positively and negatively influenced at the individual, community, and health facility levels. However, integration of HIV services and intensifying outreaches are key to improving linkage to care.	[Opio, Mark; Akello, Florence; Twongyeirwe, Doreen Kagina; Opio, David; Namagga, Jane Kasozi] Mbarara Univ Sci & Technol, Dept Nursing, Mbarara, Uganda; [Aceng, Juliet] Mbarara Univ Sci & Technol, Dept Med Lab Sci, Mbarara, Uganda; [Kabakyenga, Jerome Kahuma] Mbarara Univ Sci & Technol, Maternal Newborn & Child Hlth Inst, Mbarara, Uganda	Mbarara University of Science & Technology; Mbarara University of Science & Technology; Mbarara University of Science & Technology	Kabakyenga, JK (corresponding author), Mbarara Univ Sci & Technol, Maternal Newborn & Child Hlth Inst, Mbarara, Uganda.	jkabakyenga@must.ac.ug			Fogarty International Center (U.S. Department of State's Office of the U.S. Global AIDS Coordinator and Health Diplomacy [S/GAC]; President's Emergency Plan for AIDS Relief [PEPFAR]) of the National Institutes of Health [R25TW011210]	Fogarty International Center (U.S. Department of State's Office of the U.S. Global AIDS Coordinator and Health Diplomacy [S/GAC]; President's Emergency Plan for AIDS Relief [PEPFAR]) of the National Institutes of Health	MO, DKT, JA, DO, FA. Research reported in this publication was supported by the Fogarty International Center (U.S. Department of State's Office of the U.S. Global AIDS Coordinator and Health Diplomacy [S/GAC] and the President's Emergency Plan for AIDS Relief [PEPFAR]) of the National Institutes of Health under Award Number R25TW011210. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health".	Berger Miriam B, 2016, J Int Assoc Provid AIDS Care, V15, P486; Boeke CE, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3042-8; Bogart LM, 2016, AIDS BEHAV, V20, P2464, DOI 10.1007/s10461-016-1331-z; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Cloete A, 2008, AIDS CARE, V20, P1105, DOI 10.1080/09540120701842720; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; Finocchario-Kessler S, 2014, HEALTH CARE WOMEN IN, V35, P896, DOI 10.1080/07399332.2014.924520; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Giancomazzo A, 2019, THINK LINK PROGRAMMA; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Greeff M, 2010, INT J NURS STUD, V47, P475, DOI 10.1016/j.ijnurstu.2009.09.008; Gunda A, 2017, JAIDS-J ACQ IMM DEF, V75, pS132, DOI [10.1097/QAI.0000000000001367, 10.1097/qai.0000000000001367]; Hatcher AM, 2012, AIDS BEHAV, V16, P1295, DOI 10.1007/s10461-011-0065-1; Herce ME, 2019, AIDS BEHAV, V23, pS120, DOI 10.1007/s10461-019-02541-5; IntraHealth, 2017, REP ASS US CHW DIFF; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Karatzas N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216936; Kebaabetswe P, 2020, AIDS CARE, V32, P722, DOI 10.1080/09540121.2019.1640843; Kyakuwa M, 2012, MED ANTHROPOL, V31, P149, DOI 10.1080/01459740.2011.603399; Li HC, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2158-7; Liu Y, 2016, AIDS PATIENT CARE ST, V30, P70, DOI 10.1089/apc.2015.0296; MacPherson P, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.18020; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Ministry of Health, 2016, NAT HIV TEST SERV PO; Ministry of Health Uganda, 2000, HLTH SECT STRAT PLAN, P1; Montgomery S B, 1989, AIDS Educ Prev, V1, P303; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Nyato D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219032; Owusu KK, 2019, HIV AIDS-RES PALLIAT, V11, P321, DOI 10.2147/HIV.S216093; Ozolins U, 2020, EXPERT REV PHARM OUT, V20, P69, DOI 10.1080/14737167.2020.1734453; Philbin MM, 2014, AIDS BEHAV, V18, P1501, DOI 10.1007/s10461-013-0650-6; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Rachlis B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3462-6; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Sanga ES, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6691-7; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Shamu S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210826; Simmerlink AM., 2014, HIGH UPTAKE LOW RATE; Uebel KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054266; Uganda AIDS Commission, 2017, ANN PROGR REP 2015 2; Uganda Bureau of Statistics, 2020, POP CENS POP PROJ DI, P2015; UNAIDS, 2016, HIV CAR SUPP TAK ACC; UNAIDS, 2021, FACT SHEET 2021 END; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2021, HIV AIDS EST UG; Wachira J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0646-6; Wanyenze RK, 2011, AIDS BEHAV, V15, P751, DOI 10.1007/s10461-010-9704-1	48	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0263864	10.1371/journal.pone.0263864	http://dx.doi.org/10.1371/journal.pone.0263864			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239667	Green Published, gold			2022-12-26	WOS:000776002200016
J	Sabblah, GT; Seaneke, SK; Kushitor, M; van Hunsel, F; Taxis, K; Duwiejua, M; van Puijenbroek, E				Sabblah, George Tsey; Seaneke, Seth Kwaku; Kushitor, Mawuli; van Hunsel, Florence; Taxis, Katja; Duwiejua, Mahama; van Puijenbroek, Eugene			Evaluation of pharmacovigilance systems for reporting medication errors in Africa and the role of patients using a mixed-methods approach	PLOS ONE			English	Article							ADMINISTRATION ERRORS; BARRIERS; CHECKLIST; NURSES; SAFETY; UNIT	Background Reviewing the epidemiological profile of medication errors (MEs) reported by African countries and the systems put in place to report such errors is crucial because reporting plays an important role in improving patient safety. The objectives of this study were to characterize the profile of spontaneously reported MEs submitted by African countries to VigiBase; the World Health Organization (WHO) global database of individual case safety reports, describe systems in place for reporting these errors, and explore the challenges and facilitators for spontaneous reporting and understand the potential role of patients. Methods In the present study, we used, a mixed-methods sequential explanatory design involving a quantitative review of ME reports over a 21-year period (1997-2018) and qualitative interviews with employees from African countries that are members of the WHO Program for International Drug Monitoring (WHO PIDM). Descriptive statistics were used to summarize key variables of interest. Results A total of 4,205 ME reports were submitted by African countries to VigiBase representing 0.4% of all reports in the database. Only 15 countries out of the 37 WHO PIDM members from Africa contributed ME to reports, with 99% (3,874) of them reports originating from Egypt, Morocco, and South Africa. The reasons given for low reporting of MEs were weak healthcare and pharmacovigilance systems, lack of staff capacity at the national centers, illiteracy, language difficulties, and socio-cultural and religious beliefs. Some facilitators suggested by the participants to promote reporting included proactive engagement of patients regarding issues relating to MEs, leveraging on increased technology, benchmarking and mentoring by more experienced national centers. Sixteen of the twenty countries interviewed had systems for reporting MEs integrated into adverse drug reaction reporting with minimal patient involvement in seven of these countries. Patients were not involved in directly reporting MEs in the remaining 13 countries. Conclusions MEs are rarely reported through pharmacovigilance systems in African countries with limited patient involvement. The systems are influenced by multifactorial issues some of which are not directly related to healthcare.	[Sabblah, George Tsey; Seaneke, Seth Kwaku] Food & Drugs Author, Accra, Ghana; [Sabblah, George Tsey; Taxis, Katja; van Puijenbroek, Eugene] Univ Groningen, Groningen Res Inst Pharm, PharmacoTherapy Epidemiol & Econ, Groningen, Netherlands; [Kushitor, Mawuli] Univ Hlth & Allied Sci, Dept Hlth Policy Planning & Management, Ho, Volta Region, Ghana; [van Hunsel, Florence; van Puijenbroek, Eugene] Netherlands Pharmacovigilance Ctr Lareb, Shertogenbosch, Netherlands; [Duwiejua, Mahama] Univ Ghana, Coll Hlth Sci, Sch Pharm, Legon, Accra, Ghana	University of Groningen; University of Ghana	Sabblah, GT (corresponding author), Food & Drugs Author, Accra, Ghana.; Sabblah, GT (corresponding author), Univ Groningen, Groningen Res Inst Pharm, PharmacoTherapy Epidemiol & Econ, Groningen, Netherlands.	georgesabblah@gmail.com		van Puijenbroek, Eugene/0000-0002-2236-1398				Alj L, 2021, EUR J CLIN PHARMACOL, V17, P1; Alj L., 2007, INT J RISK SAF MED, V19, P187; Ampadu HH, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0431-0; Aseeri M, 2020, PHARMACY-BASEL, V8, DOI 10.3390/pharmacy8020069; Bahadori Mohammadkarim, 2013, ISRN Nurs, V2013, P876563, DOI 10.1155/2013/876563; Barry A, 2020, DRUG SAFETY, V43, P339, DOI 10.1007/s40264-019-00898-z; Bencheikh RS, 2009, BRIT J CLIN PHARMACO, V67, P687, DOI 10.1111/j.1365-2125.2009.03426.x; Benkirane R, 2015, DRUG SAFETY, V38, P383, DOI 10.1007/s40264-014-0257-5; Benn J, 2009, QUAL SAF HEALTH CARE, V18, P11, DOI 10.1136/qshc.2007.024166; Brabcova I, 2014, KONTAKT, V16, pe65, DOI DOI 10.1016/J.K0N-TAKT.2014.05.003; Britten N, 2009, BRIT J CLIN PHARMACO, V67, P646, DOI 10.1111/j.1365-2125.2009.03421.x; Chiang HY, 2010, NURS OUTLOOK, V58, P17, DOI 10.1016/j.outlook.2009.06.001; *COUNC EUR, 2006, CREAT BETT MED SAF C; Evans SM, 2006, QUAL SAF HEALTH CARE, V15, P39, DOI 10.1136/qshc.2004.012559; Feleke Y, 2010, TROP J PHARM RES, V9, P401; Gordon PC, 2004, SAJAA, V10, P7, DOI DOI 10.1080/22201173.2004.10872353; Hartnell N, 2012, BMJ QUAL SAF, V21, P361, DOI 10.1136/bmjqs-2011-000299; Hazell L, 2013, DRUG SAFETY, V36, P199, DOI 10.1007/s40264-013-0021-2; Holmstrom AR, 2012, J PATIENT SAF, V8, P165, DOI 10.1097/PTS.0b013e3182676cf3; Isah AO, 2012, THER ADV DRUG SAF, V3, P25, DOI 10.1177/2042098611425695; Ivankova NV, 2006, FIELD METHOD, V18, P3, DOI 10.1177/1525822X05282260; Kiguba Ronald, 2015, Drugs Real World Outcomes, V2, P273; Lee E, 2017, INT J QUAL HEALTH C, V29, P728, DOI 10.1093/intqhc/mzx096; Medical Dictionary for Regulatory Activities, 2018, MEDDR DISTR FIL FORM; Mekonnen Alemayehu B, 2018, Drugs Real World Outcomes, V5, P1, DOI 10.1007/s40801-017-0125-6; Negash G, 2013, ARCH PHARM PRACT, V4, P147, DOI 10.4103/2045-080X.123220; Noren GN, 2007, DATA MIN KNOWL DISC, V14, P305, DOI 10.1007/s10618-006-0052-8; Ogunleye OO, 2016, INT J RISK SAF MED, V28, P77, DOI 10.3233/JRS-160721; Okyerefo MPK, 2017, HEALTH SOCIOL REV, V26, P308, DOI 10.1080/14461242.2016.1257360; Olsson S, 2010, DRUG SAFETY, V33, P689, DOI 10.2165/11536390-000000000-00000; Onyigbuo CC, 2016, MENT HEALTH RELIG CU, V19, P255, DOI 10.1080/13674676.2016.1166357; Pal SN, 2015, DRUG SAFETY, V38, P319, DOI 10.1007/s40264-015-0283-y; Patrician PA, 2009, J NURS CARE QUAL, V24, P277, DOI 10.1097/NCQ.0b013e3181afa4cb; Poorolajal J, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.166680; Sabblah George Tsey, 2019, Ghana Med J, V53, P150, DOI 10.4314/gmj.v53i2.10; Shehata ZHA, 2016, J AM MED INFORM ASSN, V23, P366, DOI 10.1093/jamia/ocv096; Soydemir D, 2017, WESTERN J NURS RES, V39, P1348, DOI 10.1177/0193945916671934; Stewart D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204987; Stratton Karen M, 2004, J Pediatr Nurs, V19, P385; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tregunno PM, 2014, DRUG SAFETY, V37, P249, DOI 10.1007/s40264-014-0146-y; Truter A, 2017, S AFR J CHILD HEALTH, V11, P5, DOI [10.7196/SAJCH.2017.v11i1.1101, 10.7196/sajch.2017.v11i1.1101]; Von Bertalanffy L., 2015, GEN SYSTEMS THEORY F; World Alliance for patient Safety, 2005, WHO DRAFT GUID ADV E; World Health Organization, 2017, MED HARM WHO GLOB PA; World Health Organization (WHO), 2014, REP LEARN SYST MED E; World Health Organization (WHO), 2012, WHO LAUNCH GLOB EFF	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264699	10.1371/journal.pone.0264699	http://dx.doi.org/10.1371/journal.pone.0264699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239736	gold, Green Published			2022-12-26	WOS:000776002200065
J	Arnold, R; Hofer, E; Haas, J; Sanchez-Quintana, D; Plank, G				Arnold, Robert; Hofer, Ernst; Haas, Josef; Sanchez-Quintana, Damian; Plank, Gernot			Diversity and complexity of the cavotricuspid isthmus in rabbits: A novel scheme for classification and geometrical transformation of anatomical structures	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; CONDUCTION DISTURBANCES; PECTINATE MUSCLES; TRICUSPID-VALVE; CARDIAC ANATOMY; ATRIAL-FLUTTER; TISSUE; HETEROGENEITY; FIBRILLATION; ARCHITECTURE	The aim of this study was to describe the morphology of the cavotricuspid isthmus (CTI) in detail and introduce a comprehensive scheme to describe the topology of this region based on functional considerations. This may lead to a better understanding of isthmus-dependent flutter and fibrillation and to improved intervention strategies. We used images of the cavotricuspid isthmus from 52 rabbits of both sexes with a median weight of 3.40 +/- 0.93 kg. The area of the CTI was 124.25 +/- 42.14 mm(2) with 53.28 +/- 21.13 mm(2) covered by pectinate muscles connecting the terminal crest and the vestibule. Isthmus length decreased from inferolateral (13.09 +/- 2.14 mm) to central (9.85 +/- 2.14 mm) to paraseptal (4.88 +/- 1.96 mm) resembling the overall human geometry. Ramification sites of pectinate muscles were identified and six levels dividing the CTI from posterior to anterior were introduced. This allowed the classification of pectinate muscle segments based on the connected ramification level. To account for the high inter-individual variations in size and shape, the CTI was projected onto a normalized reference frame using bilinear transformation. Furthermore, two measures of complexity were introduced: (i) the ramification index, which reflects the total number of muscle segments connected to a ramification site and (ii) the complexity index, which reflects the type of ramification (branching or merging site). Topological analysis showed that the complexity of the pectinate muscle network decreases from inferolateral to paraseptal and that the number of electrically uncoupled parallel pathways increases in the central section between the terminal crest and the vestibule which introduces potential reentry pathways.	[Arnold, Robert; Hofer, Ernst; Plank, Gernot] Med Univ Graz, Gottfried Schatz Res Ctr, Div Biophys, Graz, Austria; [Haas, Josef] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Sanchez-Quintana, Damian] Univ Extremadura, Fac Med, Dept Anat & Cell Biol, Badajoz, Spain	Medical University of Graz; Medical University of Graz; Universidad de Extremadura	Arnold, R (corresponding author), Med Univ Graz, Gottfried Schatz Res Ctr, Div Biophys, Graz, Austria.	robert.arnold@medunigraz.at	; Plank, Gernot/C-9498-2011	Arnold, Robert/0000-0002-0524-9812; Plank, Gernot/0000-0002-7380-6908				Cabrera JA, 2013, HEART, V99, P417, DOI 10.1136/heartjnl-2011-301154; [Anonymous], 2009, J CARDIOVASC ELECTR, V20, P1108, DOI 10.1111/j.1540-8167.2009.01511.x; Arnold R, 2009, IFMBE PROC, V22, P1145; Arnold R, 2011, IEEE ENG MED BIO, P247, DOI 10.1109/IEMBS.2011.6090047; Arnold R, 2013, BEAT TO BEAT BEHAV A; Aslanidi OV, 2009, BIOPHYS J, V96, P798, DOI 10.1016/j.bpj.2008.09.057; Baccillieri MS, 2019, HEART RHYTHM, V16, P1611, DOI 10.1016/j.hrthm.2019.05.030; Berenfeld O, 2002, CIRC RES, V90, P1173, DOI 10.1161/01.RES.0000022854.95998.5C; Cabrera JA, 2005, J CARDIOVASC ELECTR, V16, P402, DOI 10.1046/j.1540-8167.2005.40709.x; Cabrera JA, 1998, J CARDIOVASC ELECTR, V9, P1186, DOI 10.1111/j.1540-8167.1998.tb00091.x; Calkins H, 2018, EUROPACE, V20, P157, DOI [10.1093/europace/eux275, 10.1016/j.hrthm.2017.05.012, 10.1093/europace/eux274]; Campos FO, 2013, IEEE T BIO-MED ENG, V60, P2339, DOI 10.1109/TBME.2013.2256359; Campos FO, 2010, IEEE ENG MED BIO, P2541, DOI 10.1109/IEMBS.2010.5626870; Caswell TA., 2020, **DATA OBJECT**, DOI 10.5281/ZENODO.4030140; Chaumont C, 2020, J CARDIOVASC ELECTR, V31, P2344, DOI 10.1111/jce.14627; Cherian T, 2020, J CARDIOVASC ELECTR, V31, P2352, DOI 10.1111/jce.14626; Christopoulos Georgios, 2020, HeartRhythm Case Rep, V6, P115, DOI 10.1016/j.hrcr.2019.09.004; COSIO FG, 1993, AM J CARDIOL, V71, P705, DOI 10.1016/0002-9149(93)91014-9; de Bakker JMT, 2010, CIRC-ARRHYTHMIA ELEC, V3, P204, DOI 10.1161/CIRCEP.109.904763; Farre J, 2010, PACE, V33, P497, DOI 10.1111/j.1540-8159.2009.02644.x; Glashan CA, 2018, EUR HEART J, V39, P2867, DOI 10.1093/eurheartj/ehy168; Hansen BJ, 2018, JACC-CLIN ELECTROPHY, V4, P1501, DOI 10.1016/j.jacep.2018.08.024; Hansen BJ, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004398; Hofer E, 2013, BIOMED ENG-BIOMED TE, V58, DOI 10.1515/bmt-2013-4421; Hofer E, 2009, IFMBE PROC, V22, P1184; Hofer E, 2009, IFMBE PROC, V25, P559, DOI 10.1007/978-3-642-03879-2_156; Klimek-Piotrowska W, 2017, EUROPACE, V19, P452, DOI 10.1093/europace/euw022; Klimek-Piotrowska W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163383; Kucera JP, 1998, CIRC RES, V83, P795, DOI 10.1161/01.RES.83.8.795; Lee KN, 2019, EUROPACE, V21, P598, DOI 10.1093/europace/euy313; Loukas M, 2008, ANN ANAT, V190, P81, DOI 10.1016/j.aanat.2007.05.002; Muszkiewicz A, 2016, PROG BIOPHYS MOL BIO, V120, P115, DOI 10.1016/j.pbiomolbio.2015.12.002; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Perez FJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P393, DOI 10.1161/CIRCEP.109.871665; Pogwizd Steven M, 2008, Drug Discov Today Dis Models, V5, P185, DOI 10.1016/j.ddmod.2009.02.001; Rastogi R., 2016, Journal of Morphological Sciences, V33, P142, DOI 10.4322/jms.092015; Redfearn DP, 2006, J CARDIOVASC ELECTR, V17, P832, DOI 10.1111/j.1540-8167.2006.00512.x; Regoli F, 2018, EUR HEART J-CARD IMG, V19, P84, DOI 10.1093/ehjci/jew336; Roney CH, 2019, MED IMAGE ANAL, V55, P65, DOI 10.1016/j.media.2019.04.004; Sanchez-Quintana D, 2002, HEART, V88, P406, DOI 10.1136/heart.88.4.406; Sanchez-Quintana D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/547364; Scaglione M, 2004, EUROPACE, V6, P407, DOI 10.1016/j.eupc.2004.05.008; Siddiqui Abu Ubaida, 2013, ISRN Anat, V2013, P803853, DOI 10.5402/2013/803853; Spach MS, 2007, HEART RHYTHM, V4, P175, DOI 10.1016/j.hrthm.2006.10.023; SPACH MS, 1982, CIRC RES, V50, P175, DOI 10.1161/01.RES.50.2.175; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Waskom M., 2020, ZENODO, DOI [10.5281/zenodo.592845, DOI 10.5281/ZENODO.592845]; Zhao JC, 2009, J CARDIOVASC ELECTR, V20, P675, DOI 10.1111/j.1540-8167.2008.01420.x	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264625	10.1371/journal.pone.0264625	http://dx.doi.org/10.1371/journal.pone.0264625			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231058	gold, Green Published			2022-12-26	WOS:000849744700030
J	Conrad, MS; Gardner, ML; Miguel, C; Freitas, MA; Rood, KM; Ma'ayeh, M				Conrad, Matthew S.; Gardner, Miranda L.; Miguel, Christine; Freitas, Michael A.; Rood, Kara M.; Ma'ayeh, Marwan			Proteomic analysis of the umbilical cord in fetal growth restriction and preeclampsia	PLOS ONE			English	Article							VESSELS; GLYCOSAMINOGLYCANS; FIBROCYTES; COLLAGEN; TANDEM	Fetal growth restriction (FGR) is associated with adverse perinatal outcomes. Pre-eclampsia (PreE) increases the associated perinatal morbidity and mortality. The structure of the umbilical cord in the setting of FGR and PreE is understudied. This study aimed to examine changes in the umbilical cord (UC) composition in pregnancies complicated by FGR and FGR with PreE. UC from gestational age-matched pregnancies with isolated FGR (n = 5), FGR+PreE (n = 5) and controls (n = 5) were collected, and a portion of the UC was processed for histologic and proteomic analysis. Manual segmentation analysis was performed to measure cross-section analysis of umbilical cord regions. Wharton's Jelly samples were analyzed on a tims-TOF Pro. Spectral count and ion abundance data were analyzed, creating an intersection dataset from multiple mass spectrometry search and inference engines. UCs from FGR and FGR with PreE had lower cross-sectional area and Wharton's Jelly area compared with control (p = 0.03). When comparing FGR to control, 28 proteins were significantly different in abundance analysis and 34 in spectral count analysis (p < 0.05). Differential expression analysis between PreE with FGR vs controls demonstrated that 48 proteins were significantly different in abundance and 5 in spectral count. The majority of changes occurred in proteins associated with extracellular matrix, cellular process, inflammatory, and angiogenesis pathways. The structure and composition of the UC is altered in pregnancies with FGR and FGR with PreE. Future work in validating these proteomic differences will enable identification of therapeutic targets for FGR and FGR with PreE.	[Conrad, Matthew S.; Miguel, Christine; Rood, Kara M.; Ma'ayeh, Marwan] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Gardner, Miranda L.; Freitas, Michael A.] Ohio State Univ, Coll Med, Campus Chem Instrument Ctr CCIC, Mass Spectrometry & Prote Facil, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Rood, KM (corresponding author), Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA.	kara.rood@osumc.edu		Gardner, Miranda/0000-0003-2821-0512	CCTS [UL1TR002733]; NIH [S10 OD026945]	CCTS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by by the CCTS and CTSA Grant number (UL1TR002733) to MSC. https://ccts.osu.edu/content/current-grantopportunities The tims-ToF Pro was purchased using funds from NIH award S10 OD026945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, OBSTET GYNECOL, P137; Backes CH, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/214365; Bankowski E, 1996, EUR J OBSTET GYN R B, V66, P109, DOI 10.1016/0301-2115(96)02390-1; Barbieri C, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-32; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Blanco MV, 2011, J CLIN HYPERTENS, V13, P30, DOI 10.1111/j.1751-7176.2010.00384.x; Bondarenko PV, 2002, ANAL CHEM, V74, P4741, DOI 10.1021/ac0256991; Bruch JF, 1997, HUM PATHOL, V28, P1139, DOI 10.1016/S0046-8177(97)90251-3; Byron A, 2013, INT J EXP PATHOL, V94, P75, DOI 10.1111/iep.12011; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dahabiyeh LA, 2018, BIOMARKERS, V23, P609, DOI 10.1080/1354750X.2018.1474257; Dutman AC, 2015, PEDIATR DEVEL PATHOL, V18, P10, DOI 10.2350/13-10-1390-OA.1; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Gardner ML., 2020, BIORXIV; Kim JS, 2008, J CELL MOL MED, V12, P1317, DOI 10.1111/j.1582-4934.2008.00284.x; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Kito K, 2008, CURR GENOMICS, V9, P263, DOI 10.2174/138920208784533647; Lau SY, 2013, AM J REPROD IMMUNOL, V70, P412, DOI 10.1111/aji.12138; Law KP, 2015, INT J MOL SCI, V16, P10952, DOI 10.3390/ijms160510952; Lever Rebecca, 2001, Inflammopharmacology, V9, P165, DOI 10.1163/156856001300248443; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Pettker CM, 2017, OBSTET GYNECOL, V129, pE150, DOI 10.1097/AOG.0000000000002046; Peyter AC, 2014, PLACENTA, V35, P891, DOI 10.1016/j.placenta.2014.08.090; Pfeuffer J, 2020, J PROTEOME RES, V19, P1060, DOI 10.1021/acs.jproteome.9b00566; Proctor LK, 2013, PLACENTA, V34, P62, DOI 10.1016/j.placenta.2012.10.015; Raio L, 2003, J ULTRAS MED, V22, P1341, DOI 10.7863/jum.2003.22.12.1341; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1049, DOI 10.1016/0002-9378(95)91325-4; Sharony R, 2016, EARLY HUM DEV, V92, P57, DOI 10.1016/j.earlhumdev.2015.11.006; Sobolewski K, 1997, BIOL NEONATE, V71, P11; Nguyen TPH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214671	32	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0262041	10.1371/journal.pone.0262041	http://dx.doi.org/10.1371/journal.pone.0262041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213550	Green Published, gold			2022-12-26	WOS:000787811000006
J	Kumar, P; Singh, AB; Singh, R				Kumar, Pradeep; Singh, A. B.; Singh, Rajeev			Comprehensive health risk assessment of microbial indoor air quality in microenvironments	PLOS ONE			English	Article							SIZE-SEGREGATED BIOAEROSOLS; CULTURABLE FUNGI; DIFFERENT SITES; OUTDOOR AIR; BACTERIAL; ENVIRONMENT; AEROSOL; QUANTIFICATION; POLLUTION; EXPOSURE	The higher airborne microbial concentration in indoor areas might be responsible for the adverse indoor air quality, which relates well with poor respiratory and general health effects in the form of Sick building syndromes. The current study aimed to isolate and characterize the seasonal (winter and spring) levels of culturable bio-aerosols from indoor air, implicating human health by using an epidemiological health survey. Microorganisms were identified by standard macro and microbiological methods, followed by biochemical testing and molecular techniques. Sampling results revealed the bacterial and fungal aerosol concentrations ranging between (300-3650 CFU/m(3)) and (300-4150 CFU/m(3)) respectively, in different microenvironments during the winter season (December-February). However, in spring (March-May), bacterial and fungal aerosol concentrations were monitored, ranging between (450-5150 CFU/m(3)) and (350-5070 CFU/m(3)) respectively. Interestingly, Aspergillus and Cladosporiurn were the majorly recorded fungi whereas, Staphylococcus, Streptobacillus, and Micrococcus found predominant bacterial genera among all the sites. Taken together, the elevated levels of bioaerosols are the foremost risk factor that can lead to various respiratory and general health issues in additional analysis, the questionnaire survey indicated the headache (28%) and allergy (20%) were significant indoor health concerns. This type of approach will serve as a foundation for assisting residents in taking preventative measures to avoid exposure to dangerous bioaerosols.	[Kumar, Pradeep; Singh, Rajeev] Univ Delhi, Satyawati Coll, Dept Environm Studies, Delhi, India; [Singh, A. B.] CSIR, Inst Genom & Integrat Biol IGIB, Delhi Univ Campus, Delhi, India	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Singh, R (corresponding author), Univ Delhi, Satyawati Coll, Dept Environm Studies, Delhi, India.	10rsingh@gmail.com	Kumar, Pradeep/ABA-6989-2021	Kumar, Pradeep/0000-0001-7245-8211; Singh, Rajeev/0000-0001-8804-155X	Science and Engineering Research Board,Department of Science and Technology (SERBDST), New Delhi, India [ECR/2017/ 000470]	Science and Engineering Research Board,Department of Science and Technology (SERBDST), New Delhi, India(Department of Science & Technology (India))	This work was financially supported by Science and Engineering Research Board,Department of Science and Technology (SERBDST), New Delhi, India (Grant No. ECR/2017/ 000470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2017, J AEROSOL SCI, V114, P209, DOI 10.1016/j.jaerosci.2017.09.019; Agarwal S, 2016, PROCEDIA ENVIRON SCI, V35, P400, DOI 10.1016/j.proenv.2016.07.021; Amarasekara RWK, 2021, AIR QUAL ATMOS HLTH, V14, P1103, DOI 10.1007/s11869-021-01001-1; Anderson K., 1993, MM QUESTIONNAIRES TO; Andualem Z, 2019, MULTIDISCIP RESP MED, V14, DOI 10.1186/s40248-018-0167-y; [Anonymous], 2009, BERGEYS MANUAL SYSTE, V3; Asif A, 2018, BUILD ENVIRON, V135, P68, DOI 10.1016/j.buildenv.2018.03.010; Aydogdu H, 2010, ENVIRON MONIT ASSESS, V164, P53, DOI 10.1007/s10661-009-0874-0; Balyan P., 2018, INT J HLTH SCI RES, V8, P273; Baquero F., 1996, CLIN MICROBIOL INFEC, V1, p2S10, DOI [10.1111/j.1469-0691.1996.tb00185.x, DOI 10.1111/J.1469-0691.1996.TB00185.X]; Baxi SN, 2016, J ALLER CL IMM-PRACT, V4, P396, DOI 10.1016/j.jaip.2016.01.008; Berglund B., 1992, INDOOR AIR, DOI 10.1111/j.1600-0668.1992.02-21.x.; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Bragoszewska E, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112604; Bragoszewska E, 2018, AEROBIOLOGIA, V34, P241, DOI 10.1007/s10453-018-9510-1; Bragoszewska E, 2018, AIR QUAL ATMOS HLTH, V11, P729, DOI 10.1007/s11869-018-0579-z; BURGE H, 1990, J ALLERGY CLIN IMMUN, V86, P687, DOI 10.1016/S0091-6749(05)80170-8; Chirca I, 2019, FUTURE MICROBIOL, V14, P1007, DOI 10.2217/fmb-2019-0140; Cho SY, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112560; Chuang CY, 2014, J DENT SCI, V9, P294, DOI 10.1016/j.jds.2014.06.002; Bezerra GFD, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0128-y; Dey D, 2019, AEROBIOLOGIA, V35, P15, DOI 10.1007/s10453-018-9534-6; Dutta S, 2014, ENVIRON URBAN ASIA, V5, P131, DOI 10.1177/0975425314521545; Eduard W, 2001, OCCUP ENVIRON MED, V58, P113, DOI 10.1136/oem.58.2.113; Fernstrom A, 2013, J PATHOG, V2013, DOI [10.1155/013/493960, 10.1155/2013/493960]; Ferone M, 2020, COMPR REV FOOD SCI F, V19, P3106, DOI 10.1111/1541-4337.12618; Franchitti E, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11050452; Frankel M, 2012, APPL ENVIRON MICROB, V78, P8289, DOI 10.1128/AEM.02069-12; Fung Frederick, 2003, Appl Occup Environ Hyg, V18, P535, DOI 10.1080/10473220301451; Ghanizadeh F, 2018, REV ENVIRON HEALTH, V33, P231, DOI 10.1515/reveh-2018-0011; Ghosh Bipasha, 2013, Sustainable Environment Research, V23, P199; Golofit-Szymczak M, 2010, INT J OCCUP SAF ERGO, V16, P465; Goyer N, 2001, AIHAJ, V62, P330, DOI 10.1202/0002-8894(2001)062<0330:EOCCAB>2.0.CO;2; GUPTA SK, 1993, ASIAN PAC J ALLERGY, V11, P19; Herr CEW, 2003, OCCUP ENVIRON MED, V60, P336, DOI 10.1136/oem.60.5.336; Heseltine E., 2009, WHO GUID IND AIR QUA; Heseltine E., 2009, WHO GUID IND AIR QUA; Humbal C, 2019, AIR QUAL ATMOS HLTH, V12, P693, DOI 10.1007/s11869-019-00689-6; Husman T, 1996, SCAND J WORK ENV HEA, V22, P5, DOI 10.5271/sjweh.103; Jensen P. A., 1998, NIOSH MAN ANAL METHO, V1, P82, DOI DOI 10.26616/nioshpub82100; Karmakar B, 2020, SN APPL SCI, V2, DOI 10.1007/s42452-020-2323-1; Kaur-Sidhu M, 2019, AIR SOIL WATER RES, V12, DOI 10.1177/1178622119874314; Keswani J, 2005, J ENVIRON MONITOR, V7, P311, DOI 10.1039/b415498c; Khan AAH, 2012, SAUDI J BIOL SCI, V19, P405, DOI 10.1016/j.sjbs.2012.06.002; King MD, 2020, AEROSOL SCI TECH, V54, P611, DOI 10.1080/02786826.2020.1723789; Kulmala M, 1999, ATMOS ENVIRON, V33, P2133, DOI 10.1016/S1352-2310(99)00070-9; Kumar B., 2013, INT J ENV ENG MANAG, V4, P219; Kumar P, 2021, AIR QUAL ATMOS HLTH, V14, P1723, DOI 10.1007/s11869-021-00978-z; Kumar P, 2021, AEROBIOLOGIA, V37, P719, DOI 10.1007/s10453-021-09718-3; Kumari P, 2016, SCI REP-UK, V6, DOI 10.1038/srep37929; Lal H, 2017, AEROSOL AIR QUAL RES, V17, P1570, DOI 10.4209/aaqr.2015.05.0331; Madamarandawala P, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-1306-6; Manisalidis I, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00014; Melody SM, 2016, INT J ENVIRON HEAL R, V26, P525, DOI 10.1080/09603123.2016.1194384; Mirhoseini SH, 2016, AEROSOL AIR QUAL RES, V16, P1903, DOI 10.4209/aaqr.2015.08.0528; Moldoveanu A M., 2003, CURRENT AIR QUALITY, V60, P336, DOI [10.5772/59727, DOI 10.5772/59727]; Nakamura K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22259; Norback D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147996; Park JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125251; Park J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35706; Priyamvada H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11727-7; Rautiainen P, 2019, INT J ENVIRON HEAL R, V29, P479, DOI 10.1080/09603123.2018.1550194; Reijula K, 2004, OCCUP ENVIRON MED, V61, P33; Reynolds S J, 2001, Appl Occup Environ Hyg, V16, P1065; Rumchev K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040429; Sharma G., 2010, J YEAST FUNGAL RES, V1, P157, DOI DOI 10.5897/JYFR.9000029; Sharma R, 2005, CURR SCI INDIA, V89, P72; Sharma R, 2011, ALLERGY RHINOL, V2, P21, DOI 10.2500/ar.2011.2.0005; Shin SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126960; Srikanth P, 2008, INDIAN J MED MICROBI, V26, P302, DOI 10.4103/0255-0857.43555; Srivastava A, 2012, NAT HAZARDS, V60, P485, DOI 10.1007/s11069-011-0022-3; Sutton DA., 1997, GUIDE CLINICALLY SIG; Svajlenka J, 2017, INT J ENVIRON HEAL R, V27, P427, DOI 10.1080/09603123.2017.1373276; TUAZON CU, 1979, JAMA-J AM MED ASSOC, V241, P1137, DOI 10.1001/jama.241.11.1137; Wang XY, 2016, BUILD ENVIRON, V102, P159, DOI 10.1016/j.buildenv.2016.03.010; Weikl F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154131; WHO, 1988, IND AIR QUAL BIOL CO, V31; Wu YP, 2018, INT J LOW-CARBON TEC, V13, P148, DOI 10.1093/ijlct/cty007	78	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264226	10.1371/journal.pone.0264226	http://dx.doi.org/10.1371/journal.pone.0264226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213573	gold, Green Published			2022-12-26	WOS:000787811000063
J	Ottesen, TD; Mercier, MR; Brand, J; Amick, M; Grauer, JN; Rubin, LE				Ottesen, Taylor D.; Mercier, Michael R.; Brand, Jordan; Amick, Michael; Grauer, Jonathan N.; Rubin, Lee E.			The case for decreased surgeon-reported complications due to surgical volume and fellowship status in the treatment of geriatric hip fracture: An analysis of the ABOS database	PLOS ONE			English	Article							HOSPITAL VOLUME; AMERICAN BOARD; ORTHOPEDIC SURGEONS; INTERNAL-FIXATION; FEMUR FRACTURES; MORTALITY; ARTHROPLASTY; OUTCOMES; EXPERIENCE; MORBIDITY	Introduction American orthopaedists are increasingly seeking fellowship sub-specialization. One proposed benefit of fellowship training is decrease in complications, however, few studies have investigated the rates of medical and surgical complications for hip fracture patients between orthopedists from different fellowship backgrounds. This study aims to investigate the effect of fellowship training and case volume on medical and surgical outcomes of patient following hip fracture surgical intervention. Methods 1999-2016 American Board of Orthopedic Surgery (ABOS) Part II Examination Case List data were used to assess patients treated by trauma or adult reconstruction fellowship-trained orthopedists versus all-other orthopaedists. Rates of surgeon-reported medical and surgical adverse events were compared between the three surgeon cohorts. Using binary multivariate logistic regression to control of demographic factors, independent factors were evaluated for their effect on surgical complications. Results Data from 73,427 patients were assessed. An increasing number of hip fractures are being treated by trauma fellowship trained surgeons (9.43% in 1999-2004 to 60.92% in 2011-2016). In multivariate analysis, there was no significant difference in type of fellowship, however, surgeons with increased case volume saw significantly decreased odds of complications (16-30 cases: OR = 0.91; 95% CI: 0.85-0.97; p = 0.003; 31+ cases: OR = 0.68; 95% CI: 0.61-0.76; p<0.001). Femoral neck hip fractures were associated with increased odds of surgical complications. Discussion Despite minor differences in incidence of surgical complications between different fellowship trained orthopaedists, there is no major difference in overall risk of surgical complications for hip fracture patients based on fellowship status of early orthopaedic surgeons. However, case volume does significantly decrease the risk of surgical complications among these patients and may stand as a proxy for fellowship training. Fellows required to take hip fracture call as part of their training regardless of fellowship status exhibited decreased complication risk for hip fracture patients, thus highlighting the importance of additional training.	[Ottesen, Taylor D.; Mercier, Michael R.; Brand, Jordan; Amick, Michael; Grauer, Jonathan N.; Rubin, Lee E.] Yale Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06510 USA; [Ottesen, Taylor D.] Harvard Combined Orthopaed Residency Program, Boston, MA USA	Yale University; Harvard University; Harvard Medical School	Grauer, JN (corresponding author), Yale Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06510 USA.	Jonathan.grauer@yale.edu		Ottesen, Taylor/0000-0002-3777-1955; Grauer, Jonathan/0000-0002-2626-7278				Almansoori KA, 2015, EDUC RES INT, V2015, DOI 10.1155/2015/191470; Ames James B, 2010, Am J Orthop (Belle Mead NJ), V39, pE84; [Anonymous], 2002, J BONE JOINT SURG AM, V84A, P670; Bateman L, 2012, OCHSNER J, V12, P101; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Browne JA, 2009, J TRAUMA, V66, P809, DOI 10.1097/TA.0b013e31816166bb; Butler BA, 2019, J SURG EDUC, V76, P1556, DOI 10.1016/j.jsurg.2019.05.014; Childs Sean, 2017, J Hand Surg Am, V42, pe91, DOI 10.1016/j.jhsa.2016.11.015; Clement RC, 2018, J ORTHOP TRAUMA, V32, P354, DOI 10.1097/BOT.0000000000001176; Coffield E, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-4896-1; Daniels Alan H, 2014, J Grad Med Educ, V6, P218, DOI 10.4300/JGME-D-14-00120.1; Duchman KR, 2017, CLIN ORTHOP RELAT R, V475, P221, DOI 10.1007/s11999-016-5023-9; Forte ML, 2010, J BONE JOINT SURG AM, V92A, P799, DOI 10.2106/JBJS.H.01204; Gottschalk MB, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.15.01049; Hammond JW, 2003, J BONE JOINT SURG AM, V85A, P2318, DOI 10.2106/00004623-200312000-00008; Henry PDG, 2018, J ORTHOP TRAUMA, V32, P134, DOI 10.1097/BOT.0000000000001048; Horst PK, 2015, J BONE JOINT SURG AM, V97A, P869, DOI 10.2106/JBJS.N.00995; Kristensen PK, 2014, MED CARE, V52, P1023, DOI 10.1097/MLR.0000000000000234; LAVERNIA CJ, 1995, J ARTHROPLASTY, V10, P133, DOI 10.1016/S0883-5403(05)80119-6; Mabry SE, 2019, J ARTHROPLASTY, V34, P1980, DOI 10.1016/j.arth.2019.04.038; Maruthappu M, 2015, ANN SURG, V261, P642, DOI 10.1097/SLA.0000000000000852; Nielsen E, 2019, SPINE, V44, pE1103, DOI 10.1097/BRS.0000000000003072; Nimptsch U, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016184; Okike K, 2017, J BONE JOINT SURG AM, V99, P1547, DOI 10.2106/JBJS.16.01133; Pour AE, 2016, INT ORTHOP, V40, P2061, DOI 10.1007/s00264-016-3137-z; Pour AE, 2016, J ARTHROPLASTY, V31, P1417, DOI 10.1016/j.arth.2015.12.045; Schmidt-Rohlfing B, 2013, J ORTHOP TRAUMA, V27, P312, DOI 10.1097/BOT.0b013e3182703730; Shah SN, 2005, J ARTHROPLASTY, V20, P503, DOI 10.1016/j.arth.2004.03.025; Shervin N, 2007, CLIN ORTHOP RELAT R, P35, DOI 10.1097/BLO.0b013e3180375514; Spaans EA, 2019, ARCH ORTHOP TRAUM SU, V139, P255, DOI 10.1007/s00402-018-3076-9; Veronese N, 2018, INJURY, V49, P1458, DOI 10.1016/j.injury.2018.04.015; Vitale MA, 2005, J BONE JOINT SURG AM, V87A, P2687, DOI 10.2106/JBJS.D.01825; Wera GD, 2018, JAAOS GLOB RES REV, V2, DOI 10.5435/JAAOSGlobal-D-18-00080; Wiegers EJA, 2019, ACTA ORTHOP, V90, P26, DOI 10.1080/17453674.2018.1545383; Yoo J, 2019, OSTEOPOROSIS INT, V30, P145, DOI 10.1007/s00198-018-4747-7; Yuan W, 2019, ARCH ORTHOP TRAUM SU, V139, P35, DOI 10.1007/s00402-018-3047-1; Zlowodzki M, 2006, J ORTHOP TRAUMA, V20, P366, DOI 10.1097/00005131-200605000-00013	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263475	10.1371/journal.pone.0263475	http://dx.doi.org/10.1371/journal.pone.0263475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213546	Green Published, gold			2022-12-26	WOS:000787811000023
J	Shahi, TB; Sitaula, C; Neupane, A; Guo, W				Shahi, Tej Bahadur; Sitaula, Chiranjibi; Neupane, Arjun; Guo, William			Fruit classification using attention-based MobileNetV2 for industrial applications	PLOS ONE			English	Article								Recent deep learning methods for fruits classification resulted in promising performance. However, these methods are with heavy-weight architectures in nature, and hence require a higher storage and expensive training operations due to feeding a large number of training parameters. There is a necessity to explore lightweight deep learning models without compromising the classification accuracy. In this paper, we propose a lightweight deep learning model using the pre-trained MobileNetV2 model and attention module. First, the convolution features are extracted to capture the high-level object-based information. Second, an attention module is used to capture the interesting semantic information. The convolution and attention modules are then combined together to fuse both the high-level object-based information and the interesting semantic information, which is followed by the fully connected layers and the softmax layer. Evaluation of our proposed method, which leverages transfer learning approach, on three public fruit-related benchmark datasets shows that our proposed method outperforms the four latest deep learning methods with a smaller number of trainable parameters and a superior classification accuracy. Our model has a great potential to be adopted by industries closely related to the fruit growing and retailing or processing chain for automatic fruit identification and classifications in the future.	[Shahi, Tej Bahadur; Neupane, Arjun; Guo, William] Cent Queensland Univ, Sch Engn & Technol, North Rockhampton, Qld, Australia; [Sitaula, Chiranjibi] Monash Univ, Dept Elect & Comp Syst Engn, Melbourne, Vic, Australia	Central Queensland University; Monash University	Shahi, TB (corresponding author), Cent Queensland Univ, Sch Engn & Technol, North Rockhampton, Qld, Australia.	t.shahi@cqu.edu.au	Sitaula, Chiranjibi/AAQ-8207-2021; Shahi, Tej Bahadur/AAG-2552-2020	Sitaula, Chiranjibi/0000-0002-4564-2985; Shahi, Tej Bahadur/0000-0002-0616-3180; Neupane, Arjun/0000-0002-1010-7552	Australian Government; CQUniversity	Australian Government(Australian GovernmentCGIAR); CQUniversity	Research Training Program (RTP) scholarship funded by the Australian Government and the support and resources provided by CQUniversity. There was no additional external funding received for this study.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Altaheri H, 2019, IEEE ACCESS, V7, P117115, DOI 10.1109/ACCESS.2019.2936536; Behera S. K., 2021, Information Processing in Agriculture, V8, P244, DOI 10.1016/j.inpa.2020.05.003; Behera SK., 2020, INFORM PROCESSING AG; Bhole Varsha, 2020, SIGITE '20: Proceedings of the 21st Annual Conference on Information Technology Education, P180, DOI 10.1145/3368308.3415370; Castro W, 2019, IEEE ACCESS, V7, P27389, DOI 10.1109/ACCESS.2019.2898223; Chakraborty Sovon, 2021, Proceedings of the 5th International Conference on Trends in Electronics and Informatics (ICOEI 2021), P1207, DOI 10.1109/ICOEI51242.2021.9453004; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; Chu J., 2021, IEEE T IND ELECTRON; Dosovitskiy A., 2020, ARXIV; Fan SX, 2020, J FOOD ENG, V286, DOI 10.1016/j.jfoodeng.2020.110102; Fekri-Ershad S, 2020, EXPERT SYST APPL, V158, DOI 10.1016/j.eswa.2020.113509; Femling F, 2018, 2018 14TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY & INTERNET BASED SYSTEMS (SITIS), P9, DOI 10.1109/SITIS.2018.00013; Gutierrez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143197; Herman Herman, 2021, 2021 International Conference on Information Management and Technology (ICIMTech), P116, DOI 10.1109/ICIMTech53080.2021.9534988; Hossain MS, 2019, IEEE T IND INFORM, V15, P1027, DOI 10.1109/TII.2018.2875149; Howard A.G., 2017, ARXIV; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Iandola FN, 2016, ARXIV; Joseph Jinu Lilly, 2021, Innovations in Electrical and Electronic Engineering. Proceedings of ICEEE 2021. Lecture Notes in Electrical Engineering (LNEE 756), P807, DOI 10.1007/978-981-16-0749-3_62; Khan Ejaz, 2021, 2021 International Conference on Applied and Engineering Mathematics (ICAEM), P67, DOI 10.1109/ICAEM53552.2021.9547133; Kheiralipour K, 2017, J FOOD PROCESS ENG, V40, DOI 10.1111/jfpe.12558; Koirala A, 2019, PRECIS AGRIC, V20, P1107, DOI 10.1007/s11119-019-09642-0; Krizhevsky Alex, 2017, Communications of the ACM, V60, P84, DOI 10.1145/3065386; Liu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087818; Liu L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219803; Rojas-Aranda JL, 2020, LECT NOTES COMPUT SC, V12088, P3, DOI 10.1007/978-3-030-49076-8_1; Meshram V., 2020, IEEE Dataport, DOI 10.21227/gzkn-f379; Mishra B, 2021, J APPL REMOTE SENS, V15, DOI 10.1117/1.JRS.15.034520; Muhammad G, 2015, ENG APPL ARTIF INTEL, V37, P361, DOI 10.1016/j.engappai.2014.10.001; Muresan H, 2018, ACTA U SAPIEN INFORM, V10, P26, DOI 10.2478/ausi-2018-0002; Piedad EJ, 2018, POSTHARVEST BIOL TEC, V145, P93, DOI 10.1016/j.postharvbio.2018.06.004; Raghu Maithra, 2021, ADV NEURAL INFORM PR; Rocha A, 2010, COMPUT ELECTRON AGR, V70, P96, DOI 10.1016/j.compag.2009.09.002; Rossum G., 1995, PYTHON REFERENCE MAN; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Saranya N, 2021, J AMB INTEL HUM COMP, DOI 10.1007/s12652-021-03267-w; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shahi TB, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8091441; Shook J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252402; Simonyan Karen, ICLR 2015; Sitaula C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-03287-8; Sitaula C, 2021, EXPERT SYST APPL, V182, DOI 10.1016/j.eswa.2021.115285; Sitaula C, 2021, HEALTH INF SCI SYST, V9, DOI 10.1007/s13755-021-00152-w; Sitaula C, 2021, APPL INTELL, V51, P2850, DOI 10.1007/s10489-020-02055-x; Sitaula C, 2019, LECT NOTES COMPUT SC, V11854, P404, DOI 10.1007/978-3-030-34879-3_31; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Waltner G, 2017, LECT NOTES COMPUT SC, V10590, P385, DOI 10.1007/978-3-319-70742-6_36; Wang F, 2017, PROC CVPR IEEE, P6450, DOI 10.1109/CVPR.2017.683; Woo SH, 2018, LECT NOTES COMPUT SC, V11211, P3, DOI 10.1007/978-3-030-01234-2_1; Xiang Q, 2019, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND APPLICATION ENGINEERING (CSAE2019), DOI 10.1145/3331453.3361658; Zawbaa HM, 2014, 2014 14TH INTERNATIONAL CONFERENCE ON HYBRID INTELLIGENT SYSTEMS (HIS), P164, DOI 10.1109/HIS.2014.7086191; Zhang YD, 2014, J FOOD ENG, V143, P167, DOI 10.1016/j.jfoodeng.2014.07.001; Zoph B, 2018, PROC CVPR IEEE, P8697, DOI 10.1109/CVPR.2018.00907	55	10	10	11	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264586	10.1371/journal.pone.0264586	http://dx.doi.org/10.1371/journal.pone.0264586			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213643	gold, Green Published			2022-12-26	WOS:000787811000127
J	Seifu, B; Fikru, C; Yilma, D; Tessema, F				Seifu, Benyam; Fikru, Chaltu; Yilma, Delelegn; Tessema, Fasil			Predictors of time to death among cervical cancer patients at Tikur Anbesa specialized hospital from 2014 to 2019: A survival analysis	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; POOR SURVIVAL; AGE	Background Cervical cancer (CC) is the 4(th) most prevalent cancer among females globally. In Ethiopia, around 7,095 new CC cases are diagnosed every year and it is the second common cause of cancer deaths in women. There is limited evidence on survival status as well as about predictors of time to death among CC patients in Ethiopia. Thus, this study investigated the five-year survival status and predictors of time to death among CC patients who had been admitted at Tikur Anbesa specialized Hospital (TASH) from 2014-2019. Methods Facility-based, retrospective-cohort study was conducted at Tikur Anbesa specialized Hospital among 348 patients from June 2014 to June 2019. A systematic random sampling method was employed to select the study participants. Data were extracted from the patient card, and through phone calls. The data was collected using the android version CS-Entry tool. Data was analyzed by SPSS version 23. Kaplan and Meier's method was used to estimate survival functions and Cox-proportional hazard regression analysis was carried out in order to identify the independent predictors of time to death. Results The overall incidence of death was 31 per 100 person-years of follow up. The median (IQR) follow-up time of the entire cohorts was 18.55 (8.96-49.65) months. The independent predictors for time to death included; age older than 50 years [AHR: 1.4; 95% CI: 1.1-1.9], late stage of CC at diagnosis [AHR: 2.2; 95% CI: 1.7-2.9], No CC treatment [AHR: 2.1; 95% CI: 1.5-3.1] and HIV positive [AHR: 2.3; 95% CI: 1.4-3.8]. Conclusion and recommendation The death rate of CC patients was high. The significant predictors associated with shorten time to death of CC patients were older age, advanced cancer stage at diagnosis, HIV infection and not receiving cancer treatment. Therefore, improving early detection and initiation of treatment for all CC patients is necessary in order to improve patient's survival status. The government needs to strengthen the routine CC screening programs to address high-risk women such as elderly and HIV positive women in Ethiopia.	[Seifu, Benyam] Ambo Univ, Collage Med & Hlth Sci, Ambo, Ethiopia; [Fikru, Chaltu; Tessema, Fasil] Jimma Univ, Fac Publ Hlth, Jimma, Ethiopia; [Yilma, Delelegn] Ambo Univ, Coll Med & Hlth Sci, Ambo, Ethiopia	Ambo University; Jimma University; Ambo University	Seifu, B (corresponding author), Ambo Univ, Collage Med & Hlth Sci, Ambo, Ethiopia.	benyamseifu77@gmail.com		seifu, benyam/0000-0003-3861-0878; Yilma, Delelegn/0000-0002-4961-2310				Abate S.M., 2016, CERV CANC, V1; Abera N., 2017, J GYNECOLOGY WOMENS, V5; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Aweke YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181415; Bouassa RSM, 2017, MED SANTE TROP, V27, P16, DOI [10.1684/mst.2017.0648, 10.1684/mst.2016.0648]; Bouassa RSM, 2017, EXPERT REV ANTI-INFE, V15, P613, DOI 10.1080/14787210.2017.1322902; Bruni L B.-R.L., 2017, 27HPV INF CTR; Chen TH, 2012, ACTA ONCOL, V51, P915, DOI 10.3109/0284186X.2012.708105; Cunningham F, 2014, WILLIAMS OBSTET, V24e; Denny L, 2012, CANCER EPIDEM BIOMAR, V21, P1434, DOI 10.1158/1055-9965.EPI-12-0334; Diaz A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196764; Dryden-Peterson S, 2016, J CLIN ONCOL, V34, P3749, DOI 10.1200/JCO.2016.67.9613; Federal Ministry of Health Ethiopia, 2015, NAT CANC CONTR PLAN; Federal ministry of health Ethiopia (FMOH) and ICF, 2016, ETH DEM HLTH SURV 20; Ferrandina G, 2002, J CLIN ONCOL, V20, P973, DOI 10.1200/JCO.20.4.973; Fink VI, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-018-0188-3; Gao Y, 2013, CLIN INTERV AGING, V8, P783, DOI 10.2147/CIA.S45613; Getinet M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0016-2; Gross AJ, 1975, SURVIVAL DISTRIBUTIO; Gurmu SE., 2018, ANN DATA SCI, V5, P513; Hammer A, 2019, ACTA OBSTET GYN SCAN, V98, P1063, DOI 10.1111/aogs.13608; Ioka A, 2005, JPN J CLIN ONCOL, V35, P464, DOI 10.1093/jjco/hyi125; Ioka A, 2009, ASIAN PAC J CANCER P, V10, P457; Kantelhardt EJ, 2014, ONCOLOGIST, V19, P727, DOI 10.1634/theoncologist.2013-0326; Kasturi Jayant., 2016, IMPROVED SURVIVAL CE, V17; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Madli F., 2019, BRUNEI INT MED J, V15, P125; Mejia A., 2012, CANC CONTROL LOW MID; Mitchell DG, 2006, J CLIN ONCOL, V24, P5687, DOI 10.1200/JCO.2006.07.4799; Ojamaa K, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5006-1; Quinn BA, 2019, BRACHYTHERAPY, V18, P29, DOI 10.1016/j.brachy.2018.08.016; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Tseng JH, 2018, INT J GYNECOL CANCER, V28, P1350, DOI 10.1097/IGC.0000000000001319; WHO, 2014, COMPR CERV CANC CONT; WHO, 2014, NONC DIS NCD COUNT; Wondim YT, 2015, ETHIOPIA MED J, V53; Yifru T, 2016, ABSTRACT B FEMALE CA, V1, P27	37	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264369	10.1371/journal.pone.0264369	http://dx.doi.org/10.1371/journal.pone.0264369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202442	gold, Green Published			2022-12-26	WOS:000773224600034
J	Tran, TTN; Tran, QH; Nguyen, QT; Le, MT; Trinh, DTT; Thai, KM				Thi-Thuy-Nga Tran; Que-Huong Tran; Quoc-Thai Nguyen; Minh-Tri Le; Dieu-Thuong Thi Trinh; Khac-Minh Thai			Identification of potential interleukin-8 inhibitors acting on the interactive site between chemokine and CXCR2 receptor: A computational approach	PLOS ONE			English	Article							PROTEIN-STRUCTURE; BINDING; PHARMACOPHORES; SOLUBILITY; DESIGN; TOOL	Interactions between interleukin (IL)-8 and its receptors, CXCR1, and CXCR2, serve crucial roles in inflammatory conditions and various types of cancers. Inhibition of this signaling pathway has been exploited as a promising strategy in treating these diseases. However, most studies only focused on the design of allosteric antagonists-bound receptors on the intracellular side of IL-8 receptors. Recently, the first cryo-EM structures of IL-8-CXCR2-Gi complexes have been solved, revealing the unique binding and activation modes of the endogenous chemokine IL-8. Hence, we set to identify small molecule inhibitors for IL-8 using critical protein-protein interaction between IL-8 and CXCR2 at the orthosteric binding site. The pharmacophore models and molecular docking screened compounds from DrugBank and NCI databases. The oral bioavailability of the top 23 ligands from the screening was then predicted by the SwissAMDE tool. Molecular dynamics simulation and free binding energy calculation were performed for the best compounds. The result indicated that DB14770, DB12121, and DB03916 could form strong interactions and stable protein-ligand complexes with IL-8. These three candidates are potential IL-8 inhibitors that can be further evaluated by in vitro experiments in the next stage.	[Thi-Thuy-Nga Tran; Que-Huong Tran; Quoc-Thai Nguyen; Minh-Tri Le; Khac-Minh Thai] Univ Med & Pharm Ho Chi Minh City, Fac Pharm, Ho Chi Minh City, Vietnam; [Thi-Thuy-Nga Tran; Que-Huong Tran] Da Nang Univ Med Technol & Pharm, Dept Pharmaceut Chem, Da Nang, Vietnam; [Minh-Tri Le] Vietnam Natl Univ Ho Chi Minh City, Sch Med, Ho Chi Minh City, Vietnam; [Dieu-Thuong Thi Trinh] Univ Med & Pharm Ho Chi Minh City, Fac Tradit Med, Ho Chi Minh City, Vietnam	Hochiminh City University of Medicine & Pharmacy; Danang University of Medical Technology & Pharmacy; Vietnam National University Hochiminh City; Hochiminh City University of Medicine & Pharmacy	Thai, KM (corresponding author), Univ Med & Pharm Ho Chi Minh City, Fac Pharm, Ho Chi Minh City, Vietnam.; Trinh, DTT (corresponding author), Univ Med & Pharm Ho Chi Minh City, Fac Tradit Med, Ho Chi Minh City, Vietnam.	thuong.ttd@ump.edu.vn; thaikhacminh@ump.edu.vn	Thai, Khac-Minh/E-8213-2010	Thai, Khac-Minh/0000-0002-5279-9614; Trinh, Dieu-Thuong Thi/0000-0002-3886-3210; Nguyen, Quoc-Thai/0000-0001-6315-2974	VietNam National Foundation for Science and Technology Development (NAFOSTED) [108.05-2018.15]	VietNam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED))	This work was supported by the VietNam National Foundation for Science and Technology Development (NAFOSTED) under the Grant Number 108.05-2018.15 (to Quoc-Thai Nguyen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham L, GROMACS. Version 2020.2 [software], DOI 10.5281/zenodo.3773801; Arooj M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063030; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Berkamp S, 2017, J BIOMOL NMR, V69, P111, DOI 10.1007/s10858-017-0128-3; BioSolveIT GmbH, BIOSOLVEIT LEADIT VE; Bizzarri Cinzia, 2003, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V2, P67, DOI 10.2174/1568014033355844; Chemical Computing Group ULC, MOL OP ENV MOE VERS; Chen IJ, 2008, J CHEM INF MODEL, V48, P1773, DOI 10.1021/ci800130k; Cheron N, 2017, J COMPUT CHEM, V38, P1941, DOI 10.1002/jcc.24839; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Delaney JS, 2004, J CHEM INF COMP SCI, V44, P1000, DOI 10.1021/ci034243x; Gaurav A, 2014, J RECEPT LIGAND CH R, V7, P27, DOI 10.2147/JRLCR.S46845; GAYLE RB, 1993, J BIOL CHEM, V268, P7283; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gustavsson M, 2020, J LEUKOCYTE BIOL, V107, P1115, DOI 10.1002/JLB.2MR1219-288R; Ha H, 2017, THERANOSTICS, V7, P1543, DOI 10.7150/thno.15625; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Le MT, 2020, SAR QSAR ENVIRON RES, V31, P883, DOI 10.1080/1062936X.2020.1837239; Liou JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094178; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu KW, 2020, NATURE, V585, P135, DOI 10.1038/s41586-020-2492-5; MATSUSHIMA K, 1992, CHEM IMMUNOL, V51, P236; Mukaida N., 1998, ENCY IMMUNOLOGY, V2nd, P1466; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Park SH, 2011, J MOL BIOL, V414, P194, DOI 10.1016/j.jmb.2011.08.025; Pirhadi S, 2013, CURR TOP MED CHEM, V13, P1036, DOI 10.2174/1568026611313090006; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; rcsb.org, 2000, PROT DAT BANK; Reddy TRK, 2012, CHEMMEDCHEM, V7, P1435, DOI 10.1002/cmdc.201200107; Reva BA, 1998, FOLD DES, V3, P141, DOI 10.1016/S1359-0278(98)00019-4; Roccatano D., 2018, MICRO NANOMANUFACTUR, P123; Rognan D, 2015, MEDCHEMCOMM, V6, P51, DOI 10.1039/c4md00328d; Rungrotmongkol T, 2010, J MOL GRAPH MODEL, V29, P347, DOI 10.1016/j.jmgm.2010.09.010; Sanders MPA, 2012, MEDCHEMCOMM, V3, P28, DOI 10.1039/c1md00210d; Shiri F, 2019, J BIOMOL STRUCT DYN, V37, P1800, DOI 10.1080/07391102.2018.1468281; Strieter R., 2006, ENCY RESP MED SCI DI, P395; Sundar S., 2019, INFORM MED UNLOCKED, V16, P100210, DOI [10.1016/j.imu.2019.100210, DOI 10.1016/J.IMU.2019.100210]; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; Voet A, 2013, CURR TOP MED CHEM, V13, P989, DOI 10.2174/1568026611313090003; Wang EC, 2019, CHEM REV, V119, P9478, DOI 10.1021/acs.chemrev.9b00055; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	49	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264385	10.1371/journal.pone.0264385	http://dx.doi.org/10.1371/journal.pone.0264385			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202450	Green Published, gold			2022-12-26	WOS:000773224600039
J	Eng, ME; Bloise, E; Matthews, SG				Eng, Margaret Elizabeth; Bloise, Enrrico; Matthews, Stephen G.			Fetal glucocorticoid exposure leads to sex-specific changes in drug-transporter function at the blood-brain barrier in juvenile guinea pigs	FASEB JOURNAL			English	Article						blood-brain barrier; breast cancer resistance protein (BCRP; Abcg2); drug transporters; fetal development; glucocorticoids (betamethasone); P-glycoprotein (P-gp; Abcb1)	ANTENATAL CORTICOSTEROIDS; MULTIDRUG-RESISTANCE; CORTISOL RESISTANCE; MULTIPLE COURSES; EXPRESSION; RECEPTOR; EFFLUX; BIRTH	Antenatal synthetic glucocorticoids (sGCs) are a life-saving treatment in managing pre-term birth. However, off-target effects of sGCs can impact blood-brain barrier (BBB) drug transporters essential for fetal brain protection, including P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (BCRP/Abcg2). We hypothesized that maternal antenatal sGC treatment modifies BBB function in juvenile offspring in a sex-dependent manner. Thus, the objective of this study was to determine the long-term impact of a single or multiple courses of betamethasone on P-gp/Abcb1 and BCRP/Abcg2 expression and function at the BBB. Pregnant guinea pigs (N = 42) received 3 courses (gestation days (GDs) 40, 50, and 60) or a single course (GD50) of betamethasone (1 mg/kg) or vehicle (saline). Cerebral microvessels and brain endothelial cells (BEC) were collected from the post-natal day (PND) 14 offspring to measure protein, gene expression, and function of the drug transporters P-gp/Abcb1 and BCRP/Abcg2. P-gp protein expression was decreased (p < .05) in microvessels from male offspring that had been exposed to multiple courses and a single course of sGC, in utero. Multiple courses of sGC resulted in a significant decrease in P-gp function in BECs from males (p < .05), but not females. There was a very strong trend for increased P-gp function in males compared to females (p = .055). Reduced P-gp expression and function at the BBB of young male offspring following multiple prenatal sGC exposures, is clinically relevant as many drugs administered postnatally are P-gp substrates. These novel sex differences in drug transporter function may underlie potential sexual dimorphism in drug sensitivity and toxicity in the newborn and juvenile brain.	[Eng, Margaret Elizabeth; Matthews, Stephen G.] Univ Toronto, Temerty Fac Med, Dept Physiol, Med Sci Bldg Room 3207,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Bloise, Enrrico] Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil; [Matthews, Stephen G.] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Temerty Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Temerty Fac Med, Dept Med, Toronto, ON, Canada	University of Toronto; Universidade Federal de Minas Gerais; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Matthews, SG (corresponding author), Univ Toronto, Temerty Fac Med, Dept Physiol, Med Sci Bldg Room 3207,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	stephen.matthews@utoronto.ca	Bloise, Enrrico/O-6710-2018	Bloise, Enrrico/0000-0003-0275-8686	Canadian Institutes of Health Research (CIHR) [FDN-148368]; Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST); Higher Education Personnel Improvement Coordination (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior [CAPES]) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [10578/2020-5]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST); Higher Education Personnel Improvement Coordination (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior [CAPES]); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by a Foundation grant from Canadian Institutes of Health Research (CIHR; FDN-148368) to S.G.M. M.E.E. was supported in part by a Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST). E.B. is supported by the Higher Education Personnel Improvement Coordination (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior [CAPES]; finance code 001, CAPES-Print fellowship) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 10578/2020-5)	Baello S, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12853; Baello S, 2016, GROWTH FACTORS, V34, P33, DOI 10.3109/08977194.2016.1162163; Bloise E, 2016, HUM REPROD UPDATE, V22, P164, DOI 10.1093/humupd/dmv049; Bloise E.., 2019, MULTIDRUG RESISTANCE, P228, DOI [10.1016/B978-0-12-813146-6.00020-5, DOI 10.1016/B978-0-12-813146-6.00020-5]; Brocklehurst P, 1999, BRIT J OBSTET GYNAEC, V106, P977, DOI 10.1111/j.1471-0528.1999.tb08440.x; Dagenais C, 2001, PHARMACEUT RES, V18, P957, DOI 10.1023/A:1010984110732; Daood M, 2008, NEUROPEDIATRICS, V39, P211, DOI 10.1055/s-0028-1103272; Dean F, 1999, BRAIN RES, V846, P253, DOI 10.1016/S0006-8993(99)02064-8; Dou L, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12040296; Eustaquio Do Imperio Guinever, 2021, Tissue Barriers, V9, P1860616, DOI 10.1080/21688370.2020.1860616; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Fu D, 2012, INT J BIOCHEM CELL B, V44, P461, DOI 10.1016/j.biocel.2011.12.009; Goralski KB, 2006, DRUG METAB DISPOS, V34, P288, DOI 10.1124/dmd.105.007427; Gottschalk S, 2011, NEUROTOXICOLOGY, V32, P50, DOI 10.1016/j.neuro.2010.10.006; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Iqbal M, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12360; Iqbal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043022; Iqbal M, 2012, ENDOCRINOLOGY, V153, P3295, DOI 10.1210/en.2012-1054; Iqbal M, 2011, ENDOCRINOLOGY, V152, P1067, DOI 10.1210/en.2010-1227; Jullienne A, 2014, J CEREBR BLOOD F MET, V34, P1637, DOI 10.1038/jcbfm.2014.124; Kaguelidou F, 2016, BRIT J CLIN PHARMACO, V82, P1058, DOI 10.1111/bcp.13034; Kanado Y, 2019, BIOCHEM BIOPH RES CO, V519, P613, DOI 10.1016/j.bbrc.2019.09.021; KEIGHTLEY MC, 1995, STEROIDS, V60, P87, DOI 10.1016/0039-128X(94)00014-4; Keightley MC, 1998, ENDOCRINOLOGY, V139, P2479, DOI 10.1210/en.139.5.2479; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Liu WH, 2010, J BIOL CHEM, V285, P6101, DOI 10.1074/jbc.M109.050229; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Mai Y, 2020, INT J PHARMACEUT, V587, DOI 10.1016/j.ijpharm.2020.119678; McGoldrick E, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub4; Mess A, 2007, PLACENTA, V28, P812, DOI 10.1016/j.placenta.2007.02.005; Moisiadis VG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11635-w; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Morrison JL, 2018, J PHYSIOL-LONDON, V596, P5535, DOI 10.1113/JP274948; Murphy KE, 2008, LANCET, V372, P2143, DOI 10.1016/S0140-6736(08)61929-7; Nierwinska K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211818; Obermeier B, 2016, HAND CLINIC, V133, P39, DOI 10.1016/B978-0-444-63432-0.00003-7; Owen D, 2003, ENDOCRINOLOGY, V144, P2775, DOI 10.1210/en.2002-0145; Pappas JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111135; Petropoulos S, 2011, BIOL REPROD, V84, P783, DOI 10.1095/biolreprod.110.088468; Petropoulos S, 2010, BRAIN RES, V1357, P9, DOI 10.1016/j.brainres.2010.08.016; Potschka H, 2002, NEUROSCI LETT, V327, P173, DOI 10.1016/S0304-3940(02)00423-8; RIGAUDIERE N, 1976, J REPROD FERTIL, V48, P291, DOI 10.1530/jrf.0.0480291; Sadowska GB, 2010, AM J PHYSIOL-HEART C, V298, pH179, DOI 10.1152/ajpheart.00828.2009; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Schumacher U, 1997, HISTOCHEM CELL BIOL, V108, P179, DOI 10.1007/s004180050159; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Seelbach MJ, 2007, J NEUROCHEM, V102, P1677, DOI 10.1111/j.1471-4159.2007.04644.x; Skoll A, 2018, J OBSTET GYNAECOL CA, V40, P1219, DOI 10.1016/j.jogc.2018.04.018; Slosky LM, 2013, MOL PHARMACOL, V84, P774, DOI 10.1124/mol.113.086298; Soares MJ, 2018, BIOL REPROD, V99, P196, DOI 10.1093/biolre/ioy049; Soldin OP, 2009, CLIN PHARMACOKINET, V48, P143, DOI 10.2165/00003088-200948030-00001; Stonestreet BS, 2000, AM J PHYSIOL-REG I, V279, pR468, DOI 10.1152/ajpregu.2000.279.2.R468; Strazielle N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00021; van Assema DME, 2012, MOL IMAGING BIOL, V14, P771, DOI 10.1007/s11307-012-0556-0; Wang XQ, 2010, MOL PHARMACOL, V78, P376, DOI 10.1124/mol.110.063685; Yang XB, 2017, NEUROSCI LETT, V645, P60, DOI 10.1016/j.neulet.2017.02.044; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967	60	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22245	10.1096/fj.202101552RR	http://dx.doi.org/10.1096/fj.202101552RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CE	35262963	Green Published			2022-12-26	WOS:000772944200001
J	Hoshino, Y; Okuno, T; Saigusa, D; Kano, K; Yamamoto, S; Shindou, H; Aoki, J; Uchida, K; Yokomizo, T; Ito, N				Hoshino, Yoko; Okuno, Toshiaki; Saigusa, Daisuke; Kano, Kuniyuki; Yamamoto, Shota; Shindou, Hideo; Aoki, Junken; Uchida, Kanji; Yokomizo, Takehiko; Ito, Nobuko			Lysophosphatidic acid receptor(1/3) antagonist inhibits the activation of satellite glial cells and reduces acute nociceptive responses	FASEB JOURNAL			English	Article						acute pain; lysophosphatidic acid; neuroglia; nociceptive pain; satellite glial cells	DORSAL-ROOT GANGLIA; TNF-ALPHA; LPA RECEPTORS; FORMALIN TEST; EDG-FAMILY; PAIN; AUTOTAXIN; INJURY; ROLES; EXCITABILITY	Lysophosphatidic acid (LPA) exerts various biological activities through six characterized G protein-coupled receptors (LPA(1-6)). While LPA-LPA(1) signaling contributes toward the demyelination and retraction of C-fiber and induces neuropathic pain, the effects of LPA-LPA(1) signaling on acute nociceptive pain is uncertain. This study investigated the role of LPA-LPA(1) signaling in acute nociceptive pain using the formalin test. The pharmacological inhibition of the LPA-LPA(1) axis significantly attenuated formalin-induced nociceptive behavior. The LPA(1) mRNA was expressed in satellite glial cells (SGCs) in dorsal root ganglion (DRG) and was particularly abundant in SGCs surrounding large DRG neurons, which express neurofilament 200. Treatment with LPA(1/3) receptor (LPA(1/3)) antagonist inhibited the upregulation of glial markers and inflammatory cytokines in DRG following formalin injection. The LPA(1/3) antagonist also attenuated phosphorylation of extracellular signal-regulated kinase, especially in SGCs and cyclic AMP response element-binding protein in the dorsal horn following formalin injection. LPA amounts after formalin injection to the footpad were quantified by liquid chromatography/tandem mass spectrometry, and LPA levels were found to be increased in the innervated DRGs. Our results indicate that LPA produced in the innervated DRGs promotes the activation of SGCs through LPA(1), increases the sensitivity of primary neurons, and modulates pain behavior. These results facilitate our understanding of the pathology of acute nociceptive pain and demonstrate the possibility of the LPA(1) on SGCs as a novel target for acute pain control.	[Hoshino, Yoko; Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Grad Sch Med, Dept Biochem, Tokyo, Japan; [Hoshino, Yoko; Uchida, Kanji; Ito, Nobuko] Univ Tokyo, Grad Sch Med, Dept Anesthesiol, Tokyo, Japan; [Saigusa, Daisuke] Teikyo Univ, Fac Pharma Sci, Lab Biomed & Analyt Sci, Tokyo, Japan; [Saigusa, Daisuke] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan; [Kano, Kuniyuki; Aoki, Junken] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo, Japan; [Yamamoto, Shota; Shindou, Hideo] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Med Sci, Tokyo, Japan	Juntendo University; University of Tokyo; Teikyo University; Tohoku University; University of Tokyo; National Center for Global Health & Medicine - Japan; University of Tokyo	Ito, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Anesthesiol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	nobuko.tky@gmail.com	; Yokomizo, Takehiko/P-5673-2016	Kano, Kuniyuki/0000-0002-4539-5750; Uchida, Kanji/0000-0001-9337-1916; Aoki, Junken/0000-0001-9435-1896; Yokomizo, Takehiko/0000-0002-5219-1553	MEXT | Japan Society for the Promotion of Science (JSPS) [20K09190, 19K07357, 18H02627]; Japan Agency for Medical Research and Development (AMED) [J200001087, 20km0105001]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 20K09190, 19K07357, 18H02627, 20K09190, 20K09190 and 20K09190; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: J200001087, 20km0105001, J200001087, J200001087 and J200001087	Aikawa S, 2015, J BIOCHEM, V157, P81, DOI 10.1093/jb/mvu077; Valdes-Rives SA, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9173090; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Asahara M, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0010-9; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; Salinas-Abarca AB, 2017, EUR J PHARMACOL, V797, P83, DOI 10.1016/j.ejphar.2017.01.018; Berta T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-18; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Dubovy P, 2006, CELL MOL NEUROBIOL, V26, P1205, DOI 10.1007/s10571-006-9006-3; de San Roman EG, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00223; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hanani M, 2020, NAT REV NEUROSCI, V21, P485, DOI 10.1038/s41583-020-0333-z; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jancalek R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-11; Ji RR, 1997, J NEUROSCI, V17, P1776; Jimenez-Andrade JM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-10; Kato K, 2016, NAT STRUCT MOL BIOL, V23, P395, DOI 10.1038/nsmb.3200; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Kritikou E, 2016, SCI REP-UK, V6, DOI 10.1038/srep37585; Kuwajima K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207310; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Ma L, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-29; Ma PC, 2020, PAIN, V161, P1584, DOI 10.1097/j.pain.0000000000001855; Nascimento DSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108152; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Miyabe C, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1973-0; Miyagi M, 2006, EUR SPINE J, V15, P953, DOI 10.1007/s00586-005-1031-2; Morita M, 2020, NEUROSCIENCE, V428, P217, DOI 10.1016/j.neuroscience.2019.12.029; Nieto-Posadas A, 2012, NAT CHEM BIOL, V8, P78, DOI 10.1038/nchembio.712; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Ohashi T, 2015, EXP DERMATOL, V24, P698, DOI 10.1111/exd.12752; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Lemes JBP, 2018, NEUROSCI LETT, V676, P8, DOI 10.1016/j.neulet.2018.04.003; Ray M, 2020, J LIPID RES, V61, P1244, DOI 10.1194/jlr.D120000880; Rimola V, 2020, J NEUROSCI, V40, P9519, DOI 10.1523/JNEUROSCI.1223-20.2020; Robering JW, 2019, GLIA, V67, P999, DOI 10.1002/glia.23585; Sahbaie P, 2012, ANESTHESIOLOGY, V117, P602, DOI 10.1097/ALN.0b013e3182655f9f; Sanchez-Maran L, 2018, NEUROPHARMACOLOGY, V133, P189, DOI 10.1016/j.neuropharm.2018.01.033; Sleigh James N, 2016, BMC Res Notes, V9, P82, DOI 10.1186/s13104-016-1915-8; Szepanowski F, 2018, NEUROSCI LETT, V662, P136, DOI 10.1016/j.neulet.2017.10.023; Tabbai S, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00146; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takeda M, 2007, PAIN, V129, P155, DOI 10.1016/j.pain.2006.10.007; Teo ST, 2009, IUBMB LIFE, V61, P791, DOI 10.1002/iub.220; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Uchida H, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-71; Uranbileg B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52999-5; Yano R, 2013, CELL MOL NEUROBIOL, V33, P1033, DOI 10.1007/s10571-013-9970-3; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	59	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22236	10.1096/fj.202101678R	http://dx.doi.org/10.1096/fj.202101678R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35218596				2022-12-26	WOS:000772957100012
J	Liu, R; Song, YR; Li, CX; Zhang, ZJ; Xue, ZY; Huang, QC; Yu, LCY; Zhu, DJ; Cao, ZW; Lu, AP; Lu, C; Liu, YY				Liu, Rui; Song, Yurong; Li, Chenxi; Zhang, Zhengjia; Xue, Zeyu; Huang, Qingcai; Yu, Liuchunyang; Zhu, Dongjie; Cao, Zhiwen; Lu, Aiping; Lu, Cheng; Liu, Yuanyan			The naturally occurring flavonoid nobiletin reverses methotrexate resistance via inhibition of P-glycoprotein synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; ABC TRANSPORTERS; CANCER; METABOLISM; TARGET; CELLS	Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA). However, after long-term treatment, some patients develop resistance. P-glycoprotein (P-gp), as an indispensable drug transporter, is essential for mediating this MTX resistance. In addition, nobiletin (NOB), a naturally occurring polymethoxylated flavonoid, has also been shown to reverse P-gp-mediated MTX resistance in RA groups; however, the precise role of NOB in this process is still unclear. Here, we administered MTX and NOB alone or in combination to collagen II-induced arthritic (CIA) mice and evaluated disease severity using the arthritis index, synovial histopathological changes, immunohistochemistry, and P-gp expression. In addition, we used conventional RNA-seq to identify targets and possible pathways through which NOB reverses MTX-induced drug resistance. We found that NOB in combination with MTX could enhance its performance in synovial tissue and decrease P-gp expression in CIA mice compared to MTX treatment alone. In vitro, in MTX-resistant fibroblast-like synoviocytes from CIA cells (CIA-FLS/MTX), we show that NOB treatment downregulated the PI3K/AKT/HIF-1 alpha pathway, thereby reducing the synthesis of the P-gp protein. In addition, NOB significantly inhibited glycolysis and metabolic activity of CIA-FLS/MTX cells, which could reduce the production of ATP and block P-gp, ultimately decreasing the efflux of MTX and maintaining its anti-RA effects. In conclusion, this study shows that NOB overcomes MTX resistance in CIA-FLS/MTX cells through the PI3K/AKT/HIF-1a pathway, simultaneously influencing metabolic processes and inhibiting P-gp-induced drug efflux.	[Liu, Rui; Song, Yurong; Li, Chenxi; Zhang, Zhengjia; Xue, Zeyu; Huang, Qingcai; Yu, Liuchunyang; Zhu, Dongjie; Cao, Zhiwen; Liu, Yuanyan] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China; [Lu, Aiping] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China; [Lu, Cheng] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China	Beijing University of Chinese Medicine; Hong Kong Baptist University; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS	Liu, YY (corresponding author), Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China.; Lu, AP (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China.; Lu, C (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China.	lap64067611@126.com; lv_cheng0816@163.com; yyliu_1980@163.com			Beijing Natural Science Foundation [7202111]; National Science and Technology Major Project [2018ZX10101001-005-003]; Fundamental Research Funds for the Central public welfare research institutes [Z0653/Z0656]; Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine [ZYYCXTD-D-202005]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Science and Technology Major Project; Fundamental Research Funds for the Central public welfare research institutes; Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine	This work was supported by Beijing Natural Science Foundation (7202111), National Science and Technology Major Project (2018ZX10101001-005-003), the Fundamental Research Funds for the Central public welfare research institutes (Z0653/Z0656), and Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (No: ZYYCXTD-D-202005). All special thanks for the longterm subsidy mechanism from the Ministry of Finance and the Ministry of Education of PRC for BUCM.	Alexa-Stratulat T, 2019, DRUG RESIST UPDATE, V46, DOI 10.1016/j.drup.2019.100643; Asgari Y, 2015, GENOMICS, V105, P275, DOI 10.1016/j.ygeno.2015.03.001; Ashrafizadeh M, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8050110; Briz O, 2019, EXPERT OPIN DRUG MET, V15, P577, DOI 10.1080/17425255.2019.1631285; Calabrese LH, 2016, ARTHRIT CARE RES, V68, P723, DOI 10.1002/acr.22865; Chen JH, 2021, ARTHRITIS RHEUMATOL, V73, P1810, DOI 10.1002/art.41748; de Oliveira PG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01743; Dong C, 2020, AM J CANCER RES, V10, P263; Feng SL, 2020, ACTA PHARMACOL SIN B, V10, P327, DOI 10.1016/j.apsb.2019.07.007; Fletcher JI, 2016, DRUG RESIST UPDATE, V26, P1, DOI 10.1016/j.drup.2016.03.001; Gifford AJ, 1998, INT J CANCER, V78, P176, DOI 10.1002/(SICI)1097-0215(19981005)78:2<176::AID-IJC10>3.3.CO;2-F; GROFF GD, 1983, SEMIN ARTHRITIS RHEU, V12, P333, DOI 10.1016/0049-0172(83)90014-8; He D, 2019, PHYTOTHER RES, V33, P1122, DOI 10.1002/ptr.6306; Hua SS, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00184; Huang H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2918796; Priya MJ, 2022, J BIOMOL STRUCT DYN, V40, P4273, DOI 10.1080/07391102.2020.1855249; Kaihara K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22083898; Lee JH, 2019, CANCERS, V11, DOI 10.3390/cancers11020254; Li GQ, 2013, MOL CELL BIOCHEM, V372, P221, DOI 10.1007/s11010-012-1463-z; Liu ZB, 2020, EUR J PHARMACOL, V875, DOI 10.1016/j.ejphar.2020.172939; Long QZ, 2013, ANTI-CANCER DRUG, V24, P810, DOI 10.1097/CAD.0b013e328363046d; Marki-Zay J, 2013, CLIN EXP RHEUMATOL, V31, P779; Masoumi M, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107064; McGarry T, 2018, ARTHRITIS RHEUMATOL, V70, P1959, DOI 10.1002/art.40569; Miyoshi M, 2018, METHODS MOL BIOL, V1868, P3, DOI 10.1007/978-1-4939-8802-0_1; Muhammad II, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010167; Norris MD, 1996, INT J CANCER, V65, P613; Storelli F, 2021, CLIN PHARMACOL THER, V110, P432, DOI 10.1002/cpt.2227; Takase-Minegishi K, 2018, RHEUMATOLOGY, V57, P49, DOI 10.1093/rheumatology/kex036; Tripathi SC, 2017, CANCER RES, V77, P4414, DOI 10.1158/0008-5472.CAN-16-2874; Tsujimura S, 2018, MOD RHEUMATOL, V28, P276, DOI 10.1080/14397595.2017.1341458; Wang TT, 2021, CLIN REV ALLERG IMMU, V60, P55, DOI 10.1007/s12016-020-08821-6; Xu SW, 2020, PHARMACOL RES, V153, DOI 10.1016/j.phrs.2020.104660; Zhang ZQ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03123-3	34	1	1	9	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101756	10.1016/j.jbc.2022.101756	http://dx.doi.org/10.1016/j.jbc.2022.101756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35202652	gold, Green Published			2022-12-26	WOS:000823106100005
J	Maier, T; Peirce, P; Baird, L; Whitehouse, SL; Slater, NKH; Beardsall, K				Maier, Theresa; Peirce, Paula; Baird, Laura; Whitehouse, Sophie L.; Slater, Nigel K. H.; Beardsall, Kathryn			Drug delivery from a solid formulation during breastfeeding-A feasibility study with mothers and infants	PLOS ONE			English	Article							VITAMIN-B-12; PARENTS; FOLATE; ANEMIA; REDUCE; HIV	Background Breastfeeding is critical to health outcomes, particularly in low-resource settings where there is little access to clean water. For infants in their first twelve months of life, the delivery of medications is challenging, and use of oral syringes to deliver liquid formulations can pose both practical and emotional challenges. Objective To explore the potential to deliver medicine to infants via a solid formulation during breastfeeding. Methods Single center feasibility study within a tertiary level neonatal unit in the UK, involving twenty-six breastfeeding mother-infant dyads. A solid formulation of Vitamin B12 was delivered to infants during breastfeeding. Outcomes included the quantitative change in serum vitamin B12 and assessment of maternal expectations and experiences. Results Delivery of Vitamin B12 through a solid formulation that dissolved in human milk did not impair breastfeeding, and Vitamin B12 levels rose in all infants from a mean baseline (range) 533 pg/mL (236-925 pg/mL) to 1871 pg/mL (610-4981 pg/mL) at 6-8 hours post-delivery. Mothers described the surprising ease of 'drug' delivery, with 85% reporting a preference over the use of syringes. Conclusions Solid drug formulations can be delivered during breastfeeding and were preferred by mothers over the delivery of liquid formulations via a syringe.	[Maier, Theresa; Slater, Nigel K. H.] Univ Cambridge, Dept Chem Engn & Biotechnol, West Cambridge Site, Cambridge, England; [Maier, Theresa; Beardsall, Kathryn] Univ Cambridge, Dept Paediat, Cambridge, England; [Peirce, Paula; Baird, Laura; Beardsall, Kathryn] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Whitehouse, Sophie L.] Univ Leicester, Coll Social Sci Arts & Humanities, Leicester, Leics, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Leicester	Beardsall, K (corresponding author), Univ Cambridge, Dept Paediat, Cambridge, England.; Beardsall, K (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England.	kb274@medschl.cam.ac.uk			University of Cambridge WD Armstrong Trust; University of Cambridge Kurt Hahn Trust; German Academic Scholarship Foundation	University of Cambridge WD Armstrong Trust; University of Cambridge Kurt Hahn Trust; German Academic Scholarship Foundation	University of Cambridge WD Armstrong Trust (no grant number [to TM]), https://www.tech.cam.ac.uk/wd-armstrong-trust-fund University of Cambridge Kurt Hahn Trust (no grant number [to TM]), https://www.iso.admin.cam.ac.uk/grants-and-scholarships/kurt-hahn-trust/awards-german-students German Academic Scholarship Foundation (no grant number [to TM]), https://www.studienstiftung.de/en/Applicable to all funders above: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2012, ADV NUTR, V3, P54, DOI 10.3945/an.111.001370; Arockiasamy V, 2008, PEDIATRICS, V121, pE215, DOI 10.1542/peds.2007-1005; Bennett SM, 2012, CHEMOSENS PERCEPT, V5, P231, DOI 10.1007/s12078-012-9128-6; Billingham SAM, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-104; Bravi F, 2016, AM J CLIN NUTR, V104, P646, DOI 10.3945/ajcn.115.120881; Carkeet C, 2006, P NATL ACAD SCI USA, V103, P5694, DOI 10.1073/pnas.0601251103; Cescutti-Butler L, 2003, J CLIN NURS, V12, P752, DOI 10.1046/j.1365-2702.2003.00783.x; Chertok IRA, 2009, J CLIN NURS, V18, P2949, DOI 10.1111/j.1365-2702.2009.02912.x; Chertok IR, 2006, JOGNN-J OBST GYN NEO, V35, P265, DOI [10.1111/j.1552-6909.2006.00028.x, 10.1111/J.1552-6909.2006.00028.x]; De Cosmi V, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020107; Dworkin SL, 2012, ARCH SEX BEHAV, V41, P1319, DOI 10.1007/s10508-012-0016-6; Gerrard SE, 2013, BIOTECHNOL BIOENG, V110, P2058, DOI 10.1002/bit.24867; Haiden N, 2006, PEDIATRICS, V118, P180, DOI 10.1542/peds.2005-2475; Hart CW, 2015, J HUM LACT, V31, P68, DOI 10.1177/0890334414559980; Helms RA, 2006, TXB THERAPEUTICS DRU, V8th; Jiang SY, 2014, EARLY HUM DEV, V90, P781, DOI 10.1016/j.earlhumdev.2014.08.019; Kennell J, 2005, ACTA PAEDIATR, V94, P775, DOI 10.1080/08035250510035634; Lewandowski L. A., 2003, FAMILY CENTERED CARE; Lopez FL, 2015, EXPERT OPIN DRUG DEL, V12, P1727, DOI 10.1517/17425247.2015.1060218; Maier T., 2020, J NEONATAL NURSING, V26, P152; Maier T, 2019, EUR J PHARM SCI, V131, P119, DOI 10.1016/j.ejps.2019.01.032; Maier T, 2018, INT J PHARMACEUT, V537, P290, DOI 10.1016/j.ijpharm.2017.12.042; Meier P P, 2000, J Hum Lact, V16, P106, DOI 10.1177/089033440001600205; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Richards L., 2014, HANDLING QUALITATIVE; Scheuerle RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171624; Strand TA, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1937-0; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; WORTHINGTONWHITE DA, 1994, AM J CLIN NUTR, V60, P930, DOI 10.1093/ajcn/60.6.930	30	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264747	10.1371/journal.pone.0264747	http://dx.doi.org/10.1371/journal.pone.0264747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245341	Green Submitted, gold, Green Published			2022-12-26	WOS:000799799100031
J	Moseson, H; Seymour, JW; Zuniga, C; Wollum, A; Katz, A; Thompson, TA; Gerdts, C				Moseson, Heidi; Seymour, Jane W.; Zuniga, Carmela; Wollum, Alexandra; Katz, Anna; Thompson, Terri-Ann; Gerdts, Caitlin			"It just seemed like a perfect storm": A multi-methods feasibility study on the use of Facebook, Google Ads, and Reddit to collect data on abortion-seeking experiences from people who considered but did not obtain abortion care in the United States	PLOS ONE			English	Article							RESTRICTIVE LAW; WOMEN; SERVICES; IMPACT	Most studies of abortion access have recruited participants from abortion clinics, thereby missing people for whom barriers to care were insurmountable. Consequently, research may underestimate the nature and scope of barriers that exist. We aimed to recruit participants who had considered, but failed to obtain, an abortion using three online platforms, and to evaluate the feasibility of collecting data on their abortion-seeking experiences in a multi-modal online study. In 2018, we recruited participants for this feasibility study from Facebook, Google Ads, and Reddit for an online survey about experiences seeking abortion care in the United States; we additionally conducted in-depth interviews among a subset of survey participants. We completed descriptive analyses of survey data, and thematic analyses of interview data. Recruitment results have been previously published. For the primary outcomes of this analysis, over one month, we succeeded in capturing data on abortion-seeking experiences from 66 individuals who were not currently pregnant and reported not having obtained an abortion, nor visited an abortion facility, despite feeling that abortion could have been the best option for a recent pregnancy. A subset of survey respondents (n = 14) completed in-depth interviews. Results highlighted multiple, reinforcing barriers to abortion care, including legal restrictions such as gestational limits and waiting periods that exacerbated financial and other burdens, logistical and informational barriers, as well as barriers to abortion care less frequently reported in the literature, such as a preference for medication abortion. These findings support the use of online recruitment to identify and survey an understudied population about their abortion-seeking experiences. Further, findings contribute to a more complete understanding of the full range of barriers to abortion care that people experience in the United States, and how these barriers intersect to not just delay, but to prevent people from obtaining abortion.	[Moseson, Heidi; Wollum, Alexandra; Katz, Anna; Gerdts, Caitlin] Ibis Reprod Hlth, Oakland, CA 94612 USA; [Seymour, Jane W.; Zuniga, Carmela; Thompson, Terri-Ann] Ibis Reprod Hlth, Cambridge, MA USA; [Seymour, Jane W.] Univ Wisconsin, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Moseson, H (corresponding author), Ibis Reprod Hlth, Oakland, CA 94612 USA.	hmoseson@ibisreproductivehealth.org		Wollum, Alexandra/0000-0002-5737-0112	Society of Family Planning [SFPRF11-11]	Society of Family Planning	HM, CG received a grant from the Society of Family Planning (grant#: SFPRF11-11) to fund this work (https://societyfp.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearak JM, 2017, LANCET PUBLIC HEALTH, V2, pE493, DOI 10.1016/S2468-2667(17)30158-5; Biggs MA, 2017, JAMA PSYCHIAT, V74, P169, DOI 10.1001/jamapsychiatry.2016.3478; Borgatta L, 2011, CONTRACEPTION, V84, P4, DOI 10.1016/j.contraception.2011.02.005; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Foster DG, 2015, PSYCHOL MED, V45, P2073, DOI 10.1017/S0033291714003213; Foster DG, 2018, AM J PUBLIC HEALTH, V108, P407, DOI [10.2105/AJPH.2017.304247, 10.2105/ajph.2017.304247]; Fuentes L, 2016, CONTRACEPTION, V93, P292, DOI 10.1016/j.contraception.2015.12.017; Gerdts C, 2016, AM J PUBLIC HEALTH, V106, P857, DOI 10.2105/AJPH.2016.303134; Harris LF, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-76; Jerman, 2016, TIME APPOINTMENT DEL; Jerman J., 2016, CHARACTERISTICS US A; Jerman J, 2017, PERSPECT SEX REPRO H, V49, P95, DOI 10.1363/psrh.12024; Jones RK, 2018, WOMEN HEALTH ISS, V28, P212, DOI 10.1016/j.whi.2017.12.003; Jones RK, 2013, WOMEN HEALTH ISS, V23, pE173, DOI 10.1016/j.whi.2013.03.001; Karasek D, 2016, WOMEN HEALTH ISS, V26, P60, DOI 10.1016/j.whi.2015.10.004; Kavanaugh ML, 2019, CONTRACEPTION, V100, P79, DOI 10.1016/j.contraception.2019.03.048; Moseson H, 2020, CONT CLIN TRIAL COMM, V19, DOI 10.1016/j.conctc.2020.100590; National Academies of Sciences E and Medicine, 2018, SAF QUAL AB CAR US; Newberry C, 2019, FACEBOOK TARGETING T; Ralph LJ, 2018, J ADOLESCENT HEALTH, V62, P281, DOI 10.1016/j.jadohealth.2017.09.031; Roberts SCM, 2019, SEX RES SOC POLICY, V16, P476, DOI 10.1007/s13178-018-0359-4; Roberts SCM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0144-z; Roberts SCM, 2014, WOMEN HEALTH ISS, V24, pE211, DOI 10.1016/j.whi.2014.01.003; Rocca CH, 2019, MATERN CHILD HLTH J, V23, P1547, DOI 10.1007/s10995-019-02782-9; Upadhyay UD, 2021, SOC SCI MED, V274, DOI 10.1016/j.socscimed.2021.113747; Upadhyay Ushma D, 2020, Contracept X, V2, P100017, DOI 10.1016/j.conx.2019.100017; Upadhyay UD, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0259-1; Upadhyay UD, 2014, AM J PUBLIC HEALTH, V104, P1687, DOI 10.2105/AJPH.2013.301378; White K, 2016, WOMEN HEALTH ISS, V26, P298, DOI 10.1016/j.whi.2016.01.003	29	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264748	10.1371/journal.pone.0264748	http://dx.doi.org/10.1371/journal.pone.0264748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239738	gold, Green Published			2022-12-26	WOS:000776002200070
J	Pasternak, Z; Chapnik, N; Yosef, R; Kopelman, NM; Jurkevitch, E; Segev, E				Pasternak, Zohar; Chapnik, Noam; Yosef, Roy; Kopelman, Naama M.; Jurkevitch, Edouard; Segev, Elad			Identifying protein function and functional links based on large-scale co-occurrence patterns	PLOS ONE			English	Article							IDENTIFICATION; NETWORKS	Objective The vast majority of known proteins have not been experimentally tested even at the level of measuring their expression, and the function of many proteins remains unknown. In order to decipher protein function and examine functional associations, we developed "Cliquely", a software tool based on the exploration of co-occurrence patterns. Computational model Using a set of more than 23 million proteins divided into 404,947 orthologous clusters, we explored the co-occurrence graph of 4,742 fully sequenced genomes from the three domains of life. Edge weights in this graph represent co-occurrence probabilities. We use the Bron-Kerbosch algorithm to detect maximal cliques in this graph, fully-connected subgraphs that represent meaningful biological networks from different functional categories. Main results We demonstrate that Cliquely can successfully identify known networks from various pathways, including nitrogen fixation, glycolysis, methanogenesis, mevalonate and ribosome proteins. Identifying the virulence-associated type III secretion system (T3SS) network, Cliquely also added 13 previously uncharacterized novel proteins to the T3SS network, demonstrating the strength of this approach. Cliquely is freely available and open source. Users can employ the tool to explore co-occurrence networks using a protein of interest and a customizable level of stringency, either for the entire dataset or for a one of the three domains-Archaea, Bacteria, or Eukarya.	[Pasternak, Zohar] Israel Police, Div Identificat & Forens Sci, Jerusalem, Israel; [Pasternak, Zohar; Chapnik, Noam; Yosef, Roy] Holon Inst Technol, Fac Management Technol, Holon, Israel; [Kopelman, Naama M.; Segev, Elad] Holon Inst Technol, Fac Sci, Holon, Israel; [Jurkevitch, Edouard] Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Jerusalem, Israel	Hebrew University of Jerusalem	Kopelman, NM (corresponding author), Holon Inst Technol, Fac Sci, Holon, Israel.	naamako@hit.ac.il		Segev, Elad/0000-0002-2786-324X				Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Brown SD, 2012, J BIOL CHEM, V287, P35, DOI 10.1074/jbc.R111.283408; Casimiro-Soriguer CS, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700071; Cheng YM, 2015, NUCLEIC ACIDS RES, V43, pW160, DOI 10.1093/nar/gkv455; Copp JN, 2019, METHOD ENZYMOL, V620, P315, DOI 10.1016/bs.mie.2019.03.015; Copp JN, 2018, BIOCHEMISTRY-US, V57, P4651, DOI 10.1021/acs.biochem.8b00473; Cromar GL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw013; Duncan MC, 2012, ANTIMICROB AGENTS CH, V56, P5433, DOI 10.1128/AAC.00975-12; Eblen JD, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S5; Foster SR, 2019, CELL, V179, P895, DOI 10.1016/j.cell.2019.10.010; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Grogan DW, 2001, P NATL ACAD SCI USA, V98, P7928, DOI 10.1073/pnas.141113098; Hou J, 2017, NEW APPROACHES OF PROTEIN FUNCTION PREDICTION FROM PROTEIN INTERACTION NETWORKS, P1; Hu YH, 2017, G3-GENES GENOM GENET, V7, P2855, DOI 10.1534/g3.117.043885; Kellner S, 2018, EMERG TOP LIFE SCI, V2, P595, DOI 10.1042/ETLS20180021; Kose F, 2001, BIOINFORMATICS, V17, P1198, DOI 10.1093/bioinformatics/17.12.1198; Koskinen P, 2015, BIOINFORMATICS, V31, P1544, DOI 10.1093/bioinformatics/btu851; Krause DJ, 2018, P NATL ACAD SCI USA, V115, P11030, DOI 10.1073/pnas.1806268115; Kulmanov M, 2020, BIOINFORMATICS, V36, P422, DOI 10.1093/bioinformatics/btz595; Lavezzo E, 2016, METHODS, V93, P15, DOI 10.1016/j.ymeth.2015.08.021; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; MARTIN YC, 1993, J COMPUT AID MOL DES, V7, P83, DOI 10.1007/BF00141577; Niu YL, 2017, PEERJ, V5, DOI 10.7717/peerj.3712; Pagel P, 2004, J MOL BIOL, V344, P1331, DOI 10.1016/j.jmb.2004.10.019; Pasternak Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142933; Peled S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13424; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Segev E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195537; Sherill-Rofe D, 2019, GENOME RES, V29, P439, DOI 10.1101/gr.241414.118; Skunca N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114701; Stone CB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-18; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Uchiyama I, 2015, NUCLEIC ACIDS RES, V43, pD270, DOI 10.1093/nar/gku1152; Vila J, 2020, CLIN MICROBIOL INFEC, V26, P596, DOI 10.1016/j.cmi.2019.09.015; Voggenreiter O, 2012, BMC BIOINFORMATICS, V13, pA10, DOI DOI 10.1186/1471-2105-13-S18-A10; Wang L, 2021, J BIOMOL STRUCT DYN, V39, P7080, DOI 10.1080/07391102.2020.1808531	41	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264765	10.1371/journal.pone.0264765	http://dx.doi.org/10.1371/journal.pone.0264765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239724	Green Published, gold			2022-12-26	WOS:000776002200074
J	Liu, R; Yang, GX; Bao, M; Zhou, ZM; Mao, XY; Liu, WJ; Jiang, XY; Zhu, D; Ren, XL; Huang, J; Chen, CS				Liu, Rong; Yang, Guangxi; Bao, Min; Zhou, Zhongmei; Mao, Xiaoyun; Liu, Wenjing; Jiang, Xiaoyan; Zhu, Di; Ren, Xinle; Huang, Jian; Chen, Ceshi			STAMBPL1 promotes breast cancer cell resistance to cisplatin partially by stabilizing MKP-1 expression	ONCOGENE			English	Article							PROTEIN-KINASE PHOSPHATASE-1; TUMORIGENESIS; ERK	Dual-specificity mitogen-activated protein kinase phosphatase-1 (MKP-1/DUSP1/CL-100) has been documented to promote breast cancer cell survival and chemoresistance. MKP-1 is an unstable protein that is ubiquitinated and degraded via the ubiquitin-proteasome system. However, it is not clear how MKP-1 protein stability is regulated in breast cancer. In this study, we performed a genome-wide siRNA library screen of deubiquitinases (DUBs) and identified STAMBPL1 as an MKP-1 DUB in breast cancer cells. STAMBPL1 interacts with MKP-1 and stabilizes MKP-1 via deubiquitination. Both STAMBPL1 and MKP-1 depletion sensitize breast cancer cells to cisplatin in vitro and in vivo, and ectopic overexpression of MKP-1 partially rescues STAMBPL1 depletion-induced cisplatin sensitivity. Furthermore, STAMBPL1 and MKP-1 depletion increased breast cancer sensitivity to cisplatin by increasing the phosphorylation and activation of c-Jun N-terminal protein kinase (JNK). Collectively, our findings not only identify STAMBPL1 as an MKP-1 DUB but also reveal a critical mechanism that regulates MKP-1 expression in breast cancer. Our findings indicate that the STAMBPL1/MKP-1 axis represents a potential therapeutic target in breast cancer.	[Liu, Rong; Yang, Guangxi; Bao, Min; Zhou, Zhongmei; Liu, Wenjing; Jiang, Xiaoyan; Chen, Ceshi] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Liu, Rong] Peking Univ First Hosp, Translat Canc Res Ctr, Beijing 100034, Peoples R China; [Bao, Min] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou 215000, Peoples R China; [Mao, Xiaoyun] China Med Univ, Dept Breast Surg, Affiliated Hosp 1, Shenyang 110000, Peoples R China; [Zhu, Di; Ren, Xinle; Huang, Jian] Guangdong Med Univ, Affiliated Hosp, Ctr Pathol Diag & Res, Dept Pathol, Zhanjiang 524000, Peoples R China; [Chen, Ceshi] Chinese Acad Sci, Kunming Inst Zool, KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming 650223, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Soochow University - China; China Medical University; Guangdong Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology	Liu, R; Chen, CS (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China.; Liu, R (corresponding author), Peking Univ First Hosp, Translat Canc Res Ctr, Beijing 100034, Peoples R China.; Huang, J (corresponding author), Guangdong Med Univ, Affiliated Hosp, Ctr Pathol Diag & Res, Dept Pathol, Zhanjiang 524000, Peoples R China.; Chen, CS (corresponding author), Chinese Acad Sci, Kunming Inst Zool, KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming 650223, Yunnan, Peoples R China.	liurong@pkufh.com; 18665763598@163.com; chenc@mail.kiz.ac.cn		Chen, Ceshi/0000-0001-6398-3516; Liu, Rong/0000-0001-6123-9152	National Key Research and Development Program of China [2020YFA0112300, 2018YFC2000400]; National Natural Science Foundation of China [81772847, 82073270, U1502222, 81572610, 81830087, U2102203]; Shortage of Talent of Project in Guangdong Province, China [4YF16002G]; Project of Innovative Research Team of Yunnan Province [2019HC005]; Yunnan Fundamental Research Projects [202001AW070018, 202101AS070050]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shortage of Talent of Project in Guangdong Province, China; Project of Innovative Research Team of Yunnan Province; Yunnan Fundamental Research Projects	This work was supported by the National Key Research and Development Program of China [2020YFA0112300 and 2018YFC2000400 to CC], National Natural Science Foundation of China [81772847, 82073270 and U1502222 to RL; 81572610 to JH; 81830087 and U2102203 to CC], a Shortage of Talent of Project in Guangdong Province, China [4YF16002G], Project of Innovative Research Team of Yunnan Province [2019HC005] and Yunnan Fundamental Research Projects (202001AW070018 and 202101AS070050).	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen X, 2019, CANCER LETT, V456, P49, DOI 10.1016/j.canlet.2019.04.020; D'Arcy P, 2015, PHARMACOL THERAPEUT, V147, P32, DOI 10.1016/j.pharmthera.2014.11.002; Deng L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0107-0; Eckstein N, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-91; Fang J, 2018, ONCOL LETT, V16, P1869, DOI 10.3892/ol.2018.8822; Guo F, 2020, CELL DEATH DIFFER, V27, P1938, DOI 10.1038/s41418-019-0473-8; Hill DP, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6278-9; Jamdade VS, 2015, BRIT J PHARMACOL, V172, P4228, DOI 10.1111/bph.13211; Kang YS, 2016, BIOCHEM BIOPH RES CO, V478, P403, DOI 10.1016/j.bbrc.2016.07.035; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim C, 2018, CELL, V173, P879, DOI 10.1016/j.cell.2018.03.041; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lavorgna A, 2012, J VIROL, V86, P3357, DOI 10.1128/JVI.06456-11; Liao Q, 2003, GASTROENTEROLOGY, V124, P1830, DOI 10.1016/S0016-5085(03)00398-6; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084982; Liu R, 2020, INT J BIOL SCI, V16, P611, DOI 10.7150/ijbs.39491; Liu R, 2016, THERANOSTICS, V6, P533, DOI 10.7150/thno.14315; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lornejad-Schafer MR, 2005, CELL PHYSIOL BIOCHEM, V16, P193, DOI 10.1159/000089845; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Petrelli F, 2016, BREAST CANCER RES TR, V160, P425, DOI 10.1007/s10549-016-4025-3; Qin JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9471; Rincon R, 2016, MOL CANCER THER, V15, P2780, DOI 10.1158/1535-7163.MCT-15-0920; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Shahriyar SA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103280; Shen JL, 2016, CANCER MED-US, V5, P2061, DOI 10.1002/cam4.772; Vicent S, 2004, CLIN CANCER RES, V10, P3639, DOI 10.1158/1078-0432.CCR-03-0771; Wang HY, 2003, CANCER LETT, V191, P229, DOI 10.1016/S0304-3835(02)00612-2; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Woo SM, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120838; Yu DJ, 2019, ONCOL LETT, V18, P4421, DOI 10.3892/ol.2019.10789; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	42	0	0	7	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2022	41	16					2265	2274		10.1038/s41388-022-02252-7	http://dx.doi.org/10.1038/s41388-022-02252-7		MAR 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0N1NW	35236965				2022-12-26	WOS:000763262700003
J	Grabarczyk, EE; Gill, SA; Vonhof, MJ; Alabady, MS; Wang, ZY; Schmidt, JM				Grabarczyk, Erin E.; Gill, Sharon A.; Vonhof, Maarten J.; Alabady, Magdy S.; Wang, Zengyan; Schmidt, Jason M.			Diet composition and diversity does not explain fewer, smaller urban nestlings	PLOS ONE			English	Article							CLUTCH-SIZE; GREAT TITS; BROOD SIZE; URBANIZATION; PREY; GROWTH; CONSEQUENCES; LANDSCAPES; ABUNDANCE; PATTERNS	The reproductive success of animals breeding in cities is often lower compared to counterparts that inhabit rural, suburban, and peri-urban areas. Urban dwelling may be especially costly for offspring development and survival. Diet composition and diversity may underlie factors that lead to lower fitness, particularly if prey abundance and quality decline in modified environments. Moreover, breeding success may change over the course of a season, an effect that may be augmented in urban areas. In this study, we tested the hypothesis that habitat and date affected nestling house wren (Troglodytes aedon) body condition and survival, and examined whether diet explained differences in nestling success. We monitored urban and rural populations of house wrens breeding in nest boxes, and tested whether clutch size, nestling survivorship, and nestling body condition varied by habitat or by date, and then characterized the diet of a subset of nestlings with DNA metabarcoding of fecal samples. Urbanization had clear impacts on house wren nestling fitness: urban broods contained fewer, smaller nestlings. Early nestling survival decreased as the breeding season progressed, and this effect was more pronounced in the urban population. However, the diets of urban and rural nestlings were similar and did not explain differences in body condition. Instead, across populations, diet changed with date, becoming less diverse, with fewer Lepidoptera and more Orthoptera. Regardless of habitat, adult house wrens provide nestlings with similar types of foods, but other factors, such as quantity or quality of prey delivered, may lead to fitness disparities between urban and rural nestlings.	[Grabarczyk, Erin E.; Gill, Sharon A.; Vonhof, Maarten J.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Vonhof, Maarten J.] Western Michigan Univ, Inst Environm & Sustainabil, Kalamazoo, MI 49008 USA; [Alabady, Magdy S.; Wang, Zengyan] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Schmidt, Jason M.] Univ Georgia, Entomol Dept, Tifton, GA 31793 USA; [Grabarczyk, Erin E.] USDA ARS, Southeast Watershed Res, Tifton, GA 31793 USA	Western Michigan University; Western Michigan University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Grabarczyk, EE (corresponding author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.; Schmidt, JM (corresponding author), Univ Georgia, Entomol Dept, Tifton, GA 31793 USA.; Grabarczyk, EE (corresponding author), USDA ARS, Southeast Watershed Res, Tifton, GA 31793 USA.	erin.grabarczyk@usda.gov; jschmid2@uga.edu		M. Schmidt, Jason/0000-0002-8119-856X; Alabady, Magdy/0000-0002-1601-682X	NSF [1257699]; University of Georgia faculty enhancement grant	NSF(National Science Foundation (NSF)); University of Georgia faculty enhancement grant	Funding was provided by NSF grant (1257699) to S. Gill, and a University of Georgia faculty enhancement grant to J. Schmidt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson MFJ, 2017, FRONT ECOL ENVIRON, V15, P189, DOI 10.1002/fee.1480; Baldan D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72951-2; Bowers EK, 2014, BEHAV ECOL, V25, P1485, DOI 10.1093/beheco/aru153; Burger C, 2012, J ANIM ECOL, V81, P926, DOI 10.1111/j.1365-2656.2012.01968.x; Buxton VL, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2517; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Daan S., 1988, P392; Deagle BE, 2019, MOL ECOL, V28, P391, DOI 10.1111/mec.14734; Dodson JC, 2016, ECOL EVOL, V6, P7462, DOI 10.1002/ece3.2400; DUNN EH, 1976, WILSON BULL, V88, P478; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Garcia K, 2020, J INTEGR PEST MANAG, V11, DOI 10.1093/jipm/pmaa009; Gordon A, 2010, FASTX TOOLKIT FASTQA; Grabarczyk EE, 2020, ETHOLOGY, V126, P1069, DOI 10.1111/eth.13085; Grade AM, 2021, ECOSPHERE, V12, DOI 10.1002/ecs2.3665; GREENEWALT CRAWFORD H., 1955, PROC AMER PHIL SOC, V99, P200; GUINAN DM, 1987, CAN J ZOOL, V65, P1587, DOI 10.1139/z87-248; Hajdasz AC, 2019, URBAN ECOSYST, V22, P1113, DOI 10.1007/s11252-019-00884-4; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hermans SM, 2018, MOL ECOL RESOUR, V18, P557, DOI 10.1111/1755-0998.12762; Klett-Mingo JI, 2016, ANIM BEHAV, V115, P29, DOI 10.1016/j.anbehav.2016.02.021; Injaian AS, 2018, BEHAV ECOL, V29, P1181, DOI 10.1093/beheco/ary097; Injaian AS, 2018, ANIM BEHAV, V136, P31, DOI 10.1016/j.anbehav.2017.12.003; Jarrett C, 2020, OECOLOGIA, V193, P377, DOI 10.1007/s00442-020-04678-w; Kitson JJN, 2019, MOL ECOL, V28, P471, DOI 10.1111/mec.14518; Lebbin DJ, 2007, WILSON J ORNITHOL, V119, P506, DOI 10.1676/06-139.1; Leonard ML, 2012, BIOL LETTERS, V8, P530, DOI 10.1098/rsbl.2012.0032; Lindell C, 2018, AGR ECOSYST ENVIRON, V257, P1, DOI 10.1016/j.agee.2018.01.028; McClenaghan B, 2019, AUK, V136, DOI 10.1093/auk/uky003; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; MELLOTT RS, 1993, J FIELD ORNITHOL, V64, P205; MILLER CK, 1995, J FIELD ORNITHOL, V66, P152; Moretto Lauren, 2017, Journal of Urban Ecology, V3, pjux016, DOI 10.1093/jue/jux016; Narango DL, 2018, P NATL ACAD SCI USA, V115, P11549, DOI 10.1073/pnas.1809259115; Ouyang JQ, 2018, INTEGR COMP BIOL, V58, P915, DOI 10.1093/icb/icy110; Pollock CJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04575-y; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Raap T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35626; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Razeng E, 2015, J AVIAN BIOL, V46, P89, DOI 10.1111/jav.00475; Rosenberg KV, 2019, SCIENCE, V366, P120, DOI 10.1126/science.aaw1313; Schmidt JM, 2019, AGR ECOSYST ENVIRON, V272, P86, DOI 10.1016/j.agee.2018.11.014; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Seress G, 2020, J ANIM ECOL, V89, P1570, DOI 10.1111/1365-2656.13211; Seress G, 2018, ECOL APPL, V28, P1143, DOI 10.1002/eap.1730; Seress G, 2012, J AVIAN BIOL, V43, P403, DOI 10.1111/j.1600-048X.2012.05527.x; Serrano-Davies E, 2017, BIRD STUDY, V64, P295, DOI 10.1080/00063657.2017.1357678; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shutt JD, 2020, MOL ECOL, V29, P1199, DOI 10.1111/mec.15394; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; Stolz C., 2019, NESTLING DIET SVALBA; Stracey CM, 2014, WILSON J ORNITHOL, V126, P366, DOI 10.1676/13-107.1; Stuart CJ, 2019, AUK, V136, DOI 10.1093/auk/ukz045; Styrsky JD, 1999, P ROY SOC B-BIOL SCI, V266, P1253, DOI 10.1098/rspb.1999.0771; Sullins DS, 2018, AUK, V135, P583, DOI 10.1642/AUK-17-199.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Townsend AK, 2019, CONDOR, V121, DOI 10.1093/condor/duz040; Valera F, 1997, CONDOR, V99, P765, DOI 10.2307/1370487; Vaugoyeau M, 2016, ECOL EVOL, V6, P5907, DOI 10.1002/ece3.2335; Wagner DL, 2020, ANNU REV ENTOMOL, V65, P457, DOI 10.1146/annurev-ento-011019-025151; Wilkin TA, 2009, J AVIAN BIOL, V40, P135, DOI 10.1111/j.1600-048X.2009.04362.x; YOUNG BE, 1994, AUK, V111, P545; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	67	0	0	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264381	10.1371/journal.pone.0264381	http://dx.doi.org/10.1371/journal.pone.0264381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231042	Green Published, gold			2022-12-26	WOS:000849744700020
J	Liu, L; Liu, XG; Du, C; Fang, HT; Zhang, JY; Li, WJ; Cao, LT; Gao, L				Liu, Li; Liu, Xiaoguang; Du, Chao; Fang, Haitao; Zhang, Jiyun; Li, Wenjing; Cao, Litong; Gao, Li			Spring diet and energy intake of whooper swans (Cygnus cygnus) at the Yellow River National Wetland in Baotou, China	PLOS ONE			English	Article							ANSER-ERYTHROPUS; HOME-RANGE; GEESE; LAKE; POPULATIONS; REACHES; MIDDLE; TIME	The energy supply of food available at stopover sites plays an important role in the life cycle of migratory birds. The Yellow River National Wetland in Baotou, China, is an essential migration station and a source of energy for migratory birds as it is located at an important intersection between East Asian/Australian and Central Asian flyways. From February to may 2020, we measured diet composition and energy content of whooper swans (Cygnus cygnus) by fecal micro-tissue analysis to understand their use of the stopover site and inform conservation. The following results were obtained: (1) whooper swans mainly fed on nine species of plants belonging to four families, including corn (Zea mays), reeds (Phragmites australis), and Suaeda (Suaeda glauca), which is related to the availability of local crops and abundance of plants. (2) The energy provided by crops to whooper swans was significantly higher than that of the most abundant plants in wetlands. Zea mays was the most consumed crop, and other abundant wetland plants played complementary roles. (3) The daily energy intake of whooper swans was 1393.11 kJ, which was considerably higher than their daily energy consumption. This suggested that the wetlands and the surrounding farmlands provide energy for the whooper swans to continue their migration. In order to protect migratory whooper swans, protection of important refuelling areas such as our study site should be implemented to provide sufficient energy supplies for continuing migration.	[Liu, Li; Liu, Xiaoguang; Du, Chao; Zhang, Jiyun; Li, Wenjing; Cao, Litong; Gao, Li] Baotou Teachers Coll, Fac Biol Sci & Technol, Baotou, Inner Mongolia, Peoples R China; [Fang, Haitao] Inner Mongolia Forestry Monitoring & Planning Ins, Hohhot, Inner Mongolia, Peoples R China	Baotou Teachers College	Gao, L (corresponding author), Baotou Teachers Coll, Fac Biol Sci & Technol, Baotou, Inner Mongolia, Peoples R China.	gaoli8905@163.com						Alerstam T., 1990, P331; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Brander LM, 2006, ENVIRON RESOUR ECON, V33, P223, DOI 10.1007/s10640-005-3104-4; Calder W.A., 1974, AVIAN BIOL, V4, P259; [曹垒 Cao Lei], 2021, [中国科学院院刊, Bulletin of the Chinese Academy of Sciences], V36, P436; Chen Y, 2019, AVIAN RES, V10, DOI 10.1186/s40657-019-0145-x; Clausen KK, 2013, J ORNITHOL, V154, P155, DOI 10.1007/s10336-012-0881-8; Darimont C.T., 2008, Wildlife Biology in Practice, V4, P73; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Fan YG, 2020, AVIAN RES, V11, DOI 10.1186/s40657-020-0189-y; Fox AD, 2017, AMBIO, V46, P188, DOI 10.1007/s13280-016-0879-1; Fox AD, 2011, AQUAT CONSERV, V21, P82, DOI 10.1002/aqc.1154; Jia R, 2019, ECOL RES, V34, P637, DOI 10.1111/1440-1703.12031; JOHNSON MK, 1983, J WILDLIFE MANAGE, V47, P877, DOI 10.2307/3808631; Kear J., 2005, DUCKS GEESE SWANS; King JR., 1974, AVIAN ENERGETICS, P4; Kolzsch A, 2016, OIKOS, V125, P1496, DOI 10.1111/oik.03121; Lameris TK, 2021, BEHAV ECOL, V32, P539, DOI 10.1093/beheco/araa152; LEFEBVRE EA, 1967, J WILDLIFE MANAGE, V31, P538, DOI 10.2307/3798137; Li L, 2020, NAT ECOL EVOL, V4, P772, DOI 10.1038/s41559-020-1161-2; Li Shu-hong, 2017, Shengtaixue Zazhi, V36, P1910, DOI 10.13292/j.1000-4890.201707.035; Li YB, 2020, EMERG INFECT DIS, V26, P2956, DOI 10.3201/eid2612.201201; Liang J, 2021, ECOL INDIC, V127, DOI 10.1016/j.ecolind.2021.107729; Liang J, 2021, SCI TOTAL ENVIRON, V768, DOI 10.1016/j.scitotenv.2020.144534; Liang J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18594-2; Liu L, 2020, ENVIRON SCI POLLUT R, V27, P6429, DOI 10.1007/s11356-019-07132-4; Liu L, 2019, B ENVIRON CONTAM TOX, V102, P778, DOI 10.1007/s00128-019-02596-z; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; OWEN M, 1975, J WILDLIFE MANAGE, V39, P271, DOI 10.2307/3799903; Prop J, 1998, NORSK POLARINST SKRI, P175; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Reynolds PS, 1996, AM NAT, V147, P735, DOI 10.1086/285877; Wang F, 2017, MAR POLLUT BULL, V119, P60, DOI 10.1016/j.marpolbul.2017.03.063; Wang X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09971-8; Wang X, 2013, J ORNITHOL, V154, P1095, DOI 10.1007/s10336-013-0979-7; Wang X, 2013, IBIS, V155, P576, DOI 10.1111/ibi.12039; Wang Y., 2016, J INNER MONGOLIA U N, V47, P328; Wood KA, 2019, ECOL MODEL, V409, DOI 10.1016/j.ecolmodel.2019.108762; Yu H, 2017, CURR BIOL, V27, pR376, DOI 10.1016/j.cub.2017.04.037	39	1	1	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264528	10.1371/journal.pone.0264528	http://dx.doi.org/10.1371/journal.pone.0264528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226691	gold, Green Published			2022-12-26	WOS:000793394000029
J	Baumer, N; Tiemann, J; Scheller, A; Meyer, T; Wittmann, L; Suburu, MEG; Greune, L; Peipp, M; Kellmann, N; Gumnior, A; Brand, C; Hartmann, W; Rossig, C; Muller-Tidow, C; Neri, D; Strassert, CA; Ruter, C; Dersch, P; Lenz, G; Koeffler, HP; Berdel, WE; Baumer, S				Baeumer, Nicole; Tiemann, Jessica; Scheller, Annika; Meyer, Theresa; Wittmann, Lisa; Suburu, Matias Ezequiel Gutierrez; Greune, Lilo; Peipp, Matthias; Kellmann, Neele; Gumnior, Annika; Brand, Caroline; Hartmann, Wolfgang; Rossig, Claudia; Muller-Tidow, Carsten; Neri, Dario; Strassert, Cristian A.; Rueter, Christian; Dersch, Petra; Lenz, Georg; Koeffler, H. Phillip; Berdel, Wolfgang E.; Baeumer, Sebastian			Targeted siRNA nanocarrier: a platform technology for cancer treatment	ONCOGENE			English	Article							SMALL INTERFERING RNAS; PROTAMINE; DELIVERY; AGGREGATION; RESISTANCE; DRUGS	The small arginine-rich protein protamine condenses complete genomic DNA into the sperm head. Here, we applied its high RNA binding capacity for spontaneous electrostatic assembly of therapeutic nanoparticles decorated with tumour-cell-specific antibodies for efficiently targeting siRNA. Fluorescence microscopy and DLS measurements of these nanocarriers revealed the formation of a vesicular architecture that requires presence of antibody-protamine, defined excess of free SMCC-protamine, and anionic siRNA to form. Only these complex nanoparticles were efficient in the treatment of non-small-cell lung cancer (NSCLC) xenograft models, when the oncogene KRAS was targeted via EGFR-mediated delivery. To show general applicability, we used the modular platform for IGF1R-positive Ewing sarcomas. Anti-IGR1R-antibodies were integrated into an antibody-protamine nanoparticle with an siRNA specifically against the oncogenic translocation product EWS/FLI1. Using these nanoparticles, EWS/FLI1 knockdown blocked in vitro and in vivo growth of Ewing sarcoma cells. We conclude that these antibody-protamine-siRNA nanocarriers provide a novel platform technology to specifically target different cell types and yet undruggable targets in cancer therapy by RNAi.	[Baeumer, Nicole; Tiemann, Jessica; Scheller, Annika; Wittmann, Lisa; Kellmann, Neele; Gumnior, Annika; Brand, Caroline; Lenz, Georg; Berdel, Wolfgang E.; Baeumer, Sebastian] Univ Munster, Dept Med A, Hematol Oncol, Munster, Germany; [Meyer, Theresa; Greune, Lilo; Rueter, Christian; Dersch, Petra] Univ Munster, Ctr Mol Biol Inflammat ZMBE, Inst Infectiol, Munster, Germany; [Suburu, Matias Ezequiel Gutierrez; Strassert, Cristian A.] Univ Munster, Inst Inorgan & Analyt Chem, Munster, Germany; [Peipp, Matthias] Univ Kiel, Div Stem Cell Transplantat & Immunotherapy, Kiel, Germany; [Hartmann, Wolfgang] Univ Munster, Gerhard Domagk Inst Pathol, Munster, Germany; [Rossig, Claudia] Univ Childrens Hosp Munster, Dept Pediat Hematol & Oncol, Munster, Germany; [Muller-Tidow, Carsten] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Neri, Dario] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	University of Munster; University of Munster; University of Munster; University of Kiel; University of Munster; University of Munster; Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Baumer, S (corresponding author), Univ Munster, Dept Med A, Hematol Oncol, Munster, Germany.	baumers@uni-muenster.de	Baeumer, Sebastian/GYU-0544-2022; Peipp, Matthias/A-8775-2013	Meyer, Theresa/0000-0001-7748-9084; Tiemann, Jessica/0000-0002-1804-0348; Gutierrez Suburu, Matias Ezequiel/0000-0002-9133-3614	Deutsche Krebshilfe [70112282]; Wilhelm Sander-Stiftung [2014.054.1, 2017.071.1]; Innovative Medical Research of the University of Munster Medical School [111418, 211502, 121314, 111501, 121802]; Cedars-Sinai Cancer (CSC) Developmental Funds; Deutsche Forschungsgemeinschaft [6103/3-1, DFG CRC1009B03, DFG EXC1003]; Interdisciplinary Centre for Clinical Research (IZKF Munster) [Bau2/009/19]; Sanford Burnham Prebys (SBP) Cancer Center	Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm Sander-Stiftung; Innovative Medical Research of the University of Munster Medical School; Cedars-Sinai Cancer (CSC) Developmental Funds; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research (IZKF Munster); Sanford Burnham Prebys (SBP) Cancer Center	We thank Annette Westermann and Mara Apel for excellent technical support. This study was funded by Deutsche Krebshilfe (No. 70112282, NB and SB), Wilhelm Sander-Stiftung (2014.054.1 and 2017.071.1, WEB and SB), Innovative Medical Research of the University of Munster Medical School (111418, SB; 211502, SB; 121314, NB; 111501 and 121802, SB and NB), Sanford Burnham Prebys (SBP) Cancer Center and Cedars-Sinai Cancer (CSC) Developmental Funds to HPK, and Deutsche Forschungsgemeinschaft (DFG EXC1003, WEB and GL; 6103/3-1, SB; DFG CRC1009B03, CR). SB and NB gratefully acknowledge the Interdisciplinary Centre for Clinical Research (IZKF Munster, Bau2/009/19).	Baumer N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200163; Baumer N, 2016, NAT PROTOC, V11, P22, DOI 10.1038/nprot.2015.137; Baumer S, 2015, CLIN CANCER RES, V21, P1383, DOI 10.1158/1078-0432.CCR-13-2017; Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Carr JA, 1999, J CARDIOVASC SURG, V40, P659; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Delgado D, 2011, EUR J PHARM BIOPHARM, V79, P495, DOI 10.1016/j.ejpb.2011.06.005; Dohjima T, 2003, MOL THER, V7, P811, DOI 10.1016/S1525-0016(03)00101-1; Dolgin E, 2020, NAT BIOTECHNOL, V38, P385, DOI 10.1038/s41587-020-0481-8; Doody JF, 2007, MOL CANCER THER, V6, P2642, DOI 10.1158/1535-7163.MCT-06-0506; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; HED J, 1987, J IMMUNOL METHODS, V101, P119, DOI 10.1016/0022-1759(87)90224-9; Ladenstein R, 2010, J CLIN ONCOL, V28, P3284, DOI 10.1200/JCO.2009.22.9864; Mochizuki T, 1998, ANESTH ANALG, V87, P781, DOI 10.1097/00000539-199810000-00008; Naing A, 2012, CLIN CANCER RES, V18, P2625, DOI 10.1158/1078-0432.CCR-12-0061; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; ROSSMANN P, 1982, VIRCHOWS ARCH B, V40, P81, DOI 10.1007/BF02932853; Rotow J, 2017, NAT REV CANCER, V17, P637, DOI 10.1038/nrc.2017.84; SMULL CE, 1962, J BACTERIOL, V84, P1035, DOI 10.1128/JB.84.5.1035-1040.1962; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Vasimalai N, 2013, J MATER CHEM B, V1, P5620, DOI 10.1039/c3tb20991a; Wang MN, 2021, NAT MED, V27, P1345, DOI 10.1038/s41591-021-01450-2; Yoo H, 2015, ARCH PHARM RES, V38, P129, DOI 10.1007/s12272-014-0359-8	23	1	1	8	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2022	41	15					2210	2224		10.1038/s41388-022-02241-w	http://dx.doi.org/10.1038/s41388-022-02241-w		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J8DX	35220407	Green Published, hybrid			2022-12-26	WOS:000761831800001
J	Liu, CJ; Wang, QP; Cao, Z				Liu, Changjiang; Wang, Qiuping; Cao, Zhen			An intelligent optimization method for highway route selection based on comprehensive weight and TOPSIS	PLOS ONE			English	Article								In order to accurately analyze and evaluate multi-index and multi-route traffic schemes for comparison and selection, we introduce herein a comprehensive weight and an intelligent selection algorithm for traffic scheme optimization to improve upon the shortcomings of common qualitative and quantitative analysis methods. Firstly, we establish an evaluation index system of transportation by traffic scheme considering the factors of technology, ecological environment, social environment, and economy, based on the whole life cycle. Secondly, the comprehensive weight based on subjective and objective factors is constructed. Finally, we establish an optimization method for transportation schemes by using the comprehensive weight and Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS) model. The results show that the evaluation index system based on the whole life cycle is more comprehensive and accurate. The comprehensive weight vector avoids the defects of single weight methods and makes full use of subjective data and expert opinions. The comprehensive weight vector is introduced into the decision-maker's preference coefficient, so that analysts can determine the scheme according to the subjective and objective information and to the required accuracy. This method uses a large number of evaluation groups to evaluate the scheme, and the evaluation results show greater objectivity and efficiency.	[Liu, Changjiang; Wang, Qiuping; Cao, Zhen] Xian Univ Architecture & Technol, Sch Civil Engn, Xian, Peoples R China; [Liu, Changjiang] Shaanxi Prov Transport Planning Design & Res Inst, Xian, Peoples R China	Xi'an University of Architecture & Technology	Liu, CJ (corresponding author), Xian Univ Architecture & Technol, Sch Civil Engn, Xian, Peoples R China.; Liu, CJ (corresponding author), Shaanxi Prov Transport Planning Design & Res Inst, Xian, Peoples R China.	lcj2012@foxmail.com	Liu, Changjiang/HDO-2166-2022	Liu, Changjiang/0000-0002-2780-9980				Blagojevic A., 2020, OPER RES ENG SCI, V3, P1, DOI [10.31181/oresta2003001b, DOI 10.31181/ORESTA2003001B]; [陈毕伍 CHEN Bi-wu], 2009, [中国公路学报, China Journal of Highway and Transport], V22, P111; Choi J, 2011, KSCE J CIV ENG, V15, P405, DOI 10.1007/s12205-011-1124-x; Deng Huanbin, 2010, 2010 International Conference on Mechanic Automation and Control Engineering (MACE), P760, DOI 10.1109/MACE.2010.5535824; Dhanalakshmi CS, 2022, BIOMASS CONVERS BIOR, V12, P5845, DOI 10.1007/s13399-020-01009-0; El Allaki F, 2019, PREV VET MED, V165, P36, DOI 10.1016/j.prevetmed.2019.02.006; Feng JT., 2019, LOGISTICS TECHNOLOGY, V2, P84, DOI [10.3969/j.issn.1005-152X.2019.02.016, DOI 10.3969/J.ISSN.1005-152X.2019.02.016]; Hui MU., 2009, J ZHENGZHOU U ENG SC, V3, DOI [10.1016/S1874-8651(10)60059-2, DOI 10.1016/S1874-8651(10)60059-2]; Jiang Y., 2019, B SURVEYING MAPPING, V1, P186, DOI [10.13474/j.cnki.11-2246.2019.0543, DOI 10.13474/J.CNKI.11-2246.2019.0543]; Jokic Z, 2021, OPER RES ENG SCI THE, V4, P115, DOI [10.31181/oresta20401156j, DOI 10.31181/ORESTA20401156J]; Kang MW, 2012, TRANSPORT RES C-EMER, V21, P257, DOI 10.1016/j.trc.2011.09.006; Kang Q., 2019, J U S CHINA SCI TECH, V33, DOI [10.19431/j.cnki.1673-0062.20190419.017, DOI 10.19431/J.CNKI.1673-0062.20190419.017]; Kasalica S., 2020, OPERATIONAL RES ENG, V3, P84, DOI [10.31181/oresta20303085k, DOI 10.31181/ORESTA20303085K]; Kazemi SF, 2013, PROCEEDINGS 27TH EUROPEAN CONFERENCE ON MODELLING AND SIMULATION ECMS 2013, P551, DOI 10.7148/2013-0551; Ki Y, 2019, IEEE ACCESS, V7, P121709, DOI 10.1109/ACCESS.2019.2937826; Liu CJ, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13073741; Liu F., 2018, DECIS MAK APPL MANAG, V1, P121, DOI [10.31181/dmame1802128l, DOI 10.31181/dmame1802128l]; Liu Q., 2005, J WUHAN U TECHNOLOGY, V18, P832, DOI [10.3963/j.issn.1671-6477.2005.06.009, DOI 10.3963/J.ISSN.1671-6477.2005.06.009]; Luiz F., 1989, J ADV TRANSPORT, V23, P43, DOI [DOI 10.1002/ATR.5670230104, 10.1002/atr.5670230104]; Luo Y., 2000, J XIAN HIGHWAY U, V20, P52; Ong MC, 2021, PROC INTEGR OPTIM, V5, P43, DOI 10.1007/s41660-020-00146-3; Pamucar D., 2018, DECIS MAK APPL MANAG, P13, DOI [DOI 10.31181/DMAME180113P, 10.31181/dmame180113p]; Rui H., 2013, APPL MECH MAT, V295, P2469, DOI [10.4028/www.scientific.net/AMM.295-298.2469, DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.295-298.2469]; Sari F, 2017, INT J ENG GEOSCI, V2, P1, DOI 10.26833/ijeg.285770; Shi F, 2014, TRANSPORT RES C-EMER, V39, P36, DOI 10.1016/j.trc.2013.11.015; SMITH PN, 1994, J ENVIRON MANAGE, V42, P365, DOI 10.1006/jema.1994.1078; Vilke S., 2020, BUSINESS LOGISTICS M, V20, P21; Wang SJ., 2017, COLD REG SCI TECHNOL, V138, DOI [10.1016/j.coldregions, DOI 10.1016/J.COLDREGIONS]; Ward M, 2021, WATER-SUI, V13, DOI 10.3390/w13030367; Xiao Li, 2021, IOP Conference Series: Earth and Environmental Science, V651, DOI 10.1088/1755-1315/651/3/032106; Xiuying Liu, 2013, Information Technology Journal, V12, P2587, DOI 10.3923/itj.2013.2587.2592; Yang Yan-gang, 2021, E3S Web of Conferences, V233, DOI 10.1051/e3sconf/202123301136; Yang Zhichao, 2014, Electric Power Automation Equipment, V34, P90, DOI 10.3969/j.issn.1006-6047.2014.04.016; Yao Wang, 2021, Journal of Physics: Conference Series, V1748, DOI 10.1088/1742-6596/1748/5/052058; Yi C, 2001, J RES TECHNICAL EC, V018, P112, DOI [10.3969/j.issn.1000-3894.2001.12.030, DOI 10.3969/J.ISSN.1000-3894.2001.12.030]; Ying Zhou, 2019, IOP Conference Series: Earth and Environmental Science, V304, DOI 10.1088/1755-1315/304/3/032112; Zhang C, 2017, SELECTIVE PREFERENCE, DOI [10.12783/dtmse/ictim2017/9947, DOI 10.12783/DTMSE/ICTIM2017/9947]; Zhang Chi, 2016, Journal of Traffic and Transportation Engineering, V16, P14; Zhu X., 2008, HIGHWAY ENG, V5, P85	39	1	1	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0262588	10.1371/journal.pone.0262588	http://dx.doi.org/10.1371/journal.pone.0262588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213560	gold, Green Published			2022-12-26	WOS:000787811000010
J	Nguyen, THP; Hokstad, I; Fagerland, MW; Mollnes, TE; Hollan, I; Feinberg, MW; Hjeltnes, G; Eilertsen, GO; Mikkelsen, K; Agewall, S				Nguyen, Thao H. P.; Hokstad, Ingrid; Fagerland, Morten Wang; Mollnes, Tom Eirik; Hollan, Ivana; Feinberg, Mark W.; Hjeltnes, Gunnbjorg; Eilertsen, Gro O.; Mikkelsen, Knut; Agewall, Stefan			Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HIGH-DENSITY-LIPOPROTEINS; ENDOTHELIAL FUNCTION; SYNOVIAL-FLUID; ATHEROSCLEROSIS; METHOTREXATE; SYSTEM; INFLAMMATION; COMBINATION; RESPONSES	Background The complement system plays an important role in pathophysiology of cardiovascular disease (CVD), and might be involved in accelerated atherogenesis in rheumatoid arthritis (RA). The role of complement activation in response to treatment, and in development of premature CVD in RA, is limited. Therefore, we examined the effects of methotrexate (MTX) and tumor necrosis factor inhibitors (TNFi) on complement activation using soluble terminal complement complex (TCC) levels in RA; and assessed associations between TCC and inflammatory and cardiovascular biomarkers. Methods We assessed 64 RA patients starting with MTX monotherapy (n = 34) or TNFi with or without MTX co-medication (TNFi +/- MTX, n = 30). ELISA was used to measure TCC in EDTA plasma. The patients were examined at baseline, after 6 weeks and 6 months of treatment. Results Median TCC was 1.10 CAU/mL, and 57 (89%) patients had TCC above the estimated upper reference limit (<0.70). Compared to baseline, TCC levels were significantly lower at 6-week visit (0.85 CAU/mL, p<0.0001), without significant differences between the two treatment regimens. Notably, sustained reduction in TCC was only achieved after 6 months on INFi +/- MTX (0.80 CAU/mL, p = 0.006). Reductions in TCC after treatment were related to decreased C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and interleukin 6, and increased levels of total, high and low-density lipoprotein cholesterol. Similarly, baseline TCC was significantly related to baseline CRP, ESR and interleukin 6. Patients with endothelial dysfunction had higher baseline TCC than those without (median 1.4 versus 1.0 CAU/mL, p = 0.023). Conclusions Patients with active RA had elevated TCC, indicating increased complement activation. TCC decreased with antirheumatic treatment already after 6 weeks. However, only treatment with TNFi +/- MTX led to sustained reduction in TCC during the 6-month follow-up period. RA patients with endothelial dysfunction had higher baseline TCC compared to those without, possibly reflecting involvement of complement in the atherosclerotic process in RA.	[Nguyen, Thao H. P.] Lillehammer Hosp Rheumat Dis, Lillehammer, Norway; [Nguyen, Thao H. P.; Agewall, Stefan] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Hokstad, Ingrid] Innlandet Hosp Trust, Dept Lab Med, Lillehammer, Norway; [Fagerland, Morten Wang] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Mollnes, Tom Eirik] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Mollnes, Tom Eirik] Nordland Hosp, Res Lab, Bodo, Norway; [Mollnes, Tom Eirik] Univ Tromso, Fac Hlth Sci, KG Jebsen TREC, Tromso, Norway; [Mollnes, Tom Eirik] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Trondheim, Norway; [Hollan, Ivana] Beitostolen Hlth & Sport Ctr, Beitostolen, Norway; [Hollan, Ivana] Norwegian Univ Sci & Technol, Gjovik, Norway; [Feinberg, Mark W.] Harvard Med Sch, Boston, MA 02115 USA; [Feinberg, Mark W.] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; [Hjeltnes, Gunnbjorg] Innlandet Hosp Trust, Dept Internal Med, Lillehammer, Norway; [Eilertsen, Gro O.] UIT Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Eilertsen, Gro O.] Univ Hosp North Norway, Dept Rheumatol, Tromso, Norway; [Mikkelsen, Knut] Volvat Med Ctr, Lillehammer, Norway; [Agewall, Stefan] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway	University of Oslo; Innlandet Hospital Trust; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Innlandet Hospital Trust; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo	Nguyen, THP (corresponding author), Lillehammer Hosp Rheumat Dis, Lillehammer, Norway.; Nguyen, THP (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	nhpthao00@gmail.com		Nguyen, Thao/0000-0003-2597-4031; Feinberg, Mark/0000-0001-9523-3859	Norwegian Women's Public Health Association [H2/2018]; Norwegian Council on Cardiovascular Disease; Odd Fellow Foundation; Simon Fougner Hartmann Family Fund; AbbVie	Norwegian Women's Public Health Association; Norwegian Council on Cardiovascular Disease; Odd Fellow Foundation; Simon Fougner Hartmann Family Fund; AbbVie(AbbVie)	The first author's scholarship is funded by The Norwegian Women's Public Health Association, Grant H2/2018, URL: https:// sanitetskvinnene.no/. Financial support to the complement analyses was kindly provided by The Norwegian Council on Cardiovascular Disease, The Odd Fellow Foundation and The Simon Fougner Hartmann Family Fund, URL: https://nasjonalforeningen.no/, https://www.oddfellow.no/, and no webpage, respectively. The establishment of PSARA biobank was sponsored by Abbott Laboratories Norway - now AbbVie, URL: https:// www.abbvie.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Back M, 2019, NAT REV CARDIOL, V16, P389, DOI 10.1038/s41569-019-0169-2; Ballanti E, 2011, AUTOIMMUN REV, V10, P617, DOI 10.1016/j.autrev.2011.04.012; Belinsky GS, 2007, TOXICOL SCI, V97, P582, DOI 10.1093/toxsci/kfm067; Bemis EA, 2019, MOL IMMUNOL, V112, P256, DOI 10.1016/j.molimm.2019.05.012; Bergseth G, 2013, MOL IMMUNOL, V56, P232, DOI 10.1016/j.molimm.2013.05.221; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1761, DOI 10.1016/S0735-1097(03)00329-2; Bordy R, 2018, NAT REV RHEUMATOL, V14, P404, DOI 10.1038/s41584-018-0022-8; BRODEUR JP, 1991, ARTHRITIS RHEUM, V34, P1531; Charles-Schoeman C, 2012, ANN RHEUM DIS, V71, P1157, DOI 10.1136/annrheumdis-2011-200493; Corallini F, 2009, RHEUMATOLOGY, V48, P293, DOI 10.1093/rheumatology/ken495; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Crowson CS, 2018, ANN RHEUM DIS, V77, P48, DOI 10.1136/annrheumdis-2017-211735; Cutolo M, 2002, CLIN EXP RHEUMATOL, V20, pS76; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; Del Bo' C., 2014, PharmaNutrition, V2, P1, DOI 10.1016/j.phanu.2013.07.001; Deyab G, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1439-1; Deyab G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169830; Di Muzio G, 2011, INT J IMMUNOPATH PH, V24, P357, DOI 10.1177/039463201102400209; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Eng GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162316; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; England BR, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1036; Familian A, 2005, ANN RHEUM DIS, V64, P1003, DOI 10.1136/ard.2004.029124; Galindo-Izquierdo M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010148; Geovanini GR, 2018, CLIN SCI, V132, P1243, DOI 10.1042/CS20180306; Gordon SM, 2017, ATHEROSCLEROSIS, V259, P104, DOI 10.1016/j.atherosclerosis.2016.11.015; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hertle E, 2014, INT J CARDIOL, V174, P400, DOI 10.1016/j.ijcard.2014.04.057; Hjeltnes G, 2013, CLIN EXP RHEUMATOL, V31, P415; Hjeltnes G, 2012, SCAND J RHEUMATOL, V41, P240, DOI 10.3109/03009742.2012.656698; Hokstad I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220079; Holers VM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01057; Hollan I, 2020, EUR HEART J-CARD PHA, V6, P104, DOI 10.1093/ehjcvp/pvz033; Hovland A, 2015, ATHEROSCLEROSIS, V241, P480, DOI 10.1016/j.atherosclerosis.2015.05.038; Konttinen YT, 1996, ANN RHEUM DIS, V55, P888, DOI 10.1136/ard.55.12.888; Lappegard KT, 2014, MOL IMMUNOL, V61, P126, DOI 10.1016/j.molimm.2014.06.036; Liao KP, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001588; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Martin EA, 2011, CELL BIOCHEM FUNCT, V29, P272, DOI 10.1002/cbf.1745; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Molenaar ETH., 2009, RHEUMATOL, V48, P293, DOI [10.1093/rheumatology/ken495, DOI 10.1093/RHEUMATOLOGY/KEN495]; MOLLNES TE, 1986, ARTHRITIS RHEUM, V29, P715, DOI 10.1002/art.1780290603; MOLLNES TE, 1986, ARTHRITIS RHEUM, V29, P1359, DOI 10.1002/art.1780291108; MORGAN BP, 1988, CLIN EXP IMMUNOL, V73, P473; Myasoedova E, 2017, CURR OPIN RHEUMATOL, V29, P277, DOI 10.1097/BOR.0000000000000378; Navarro-Millan I, 2013, ARTHRITIS RHEUM-US, V65, P1430, DOI 10.1002/art.37916; Neumann E, 2002, ARTHRITIS RHEUM, V46, P934, DOI 10.1002/art.10183; Nguyen THP, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253793; Niyonzima N, 2015, J IMMUNOL, V195, P257, DOI 10.4049/jimmunol.1403044; Nurmohamed MT, 2015, NAT REV RHEUMATOL, V11, P693, DOI 10.1038/nrrheum.2015.112; Pasqui AL, 2002, CLIN EXP MED, V2, P33, DOI 10.1007/s102380200004; PERISSUTTI S, 1994, INT J CLIN LAB RES, V24, P45, DOI 10.1007/BF02592409; PERLMUTTER DH, 1986, J CLIN INVEST, V78, P1349, DOI 10.1172/JCI112721; Pope JE, 2021, SEMIN ARTHRITIS RHEU, V51, P219, DOI 10.1016/j.semarthrit.2020.11.005; Qin XB, 2006, CELL MOL IMMUNOL, V3, P333; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ridker PM, 2009, CLIN CHEM, V55, P209, DOI 10.1373/clinchem.2008.119214; ROBBINS RA, 1991, AM J PHYSIOL, V260, pL254, DOI 10.1152/ajplung.1991.260.4.L254; Rozanski A, 2001, CIRCULATION, V103, P2084; Shields KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174577; Skeoch S, 2015, NAT REV RHEUMATOL, V11, P390, DOI 10.1038/nrrheum.2015.40; Smolen JS, 2020, ANN RHEUM DIS, V79, P685, DOI 10.1136/annrheumdis-2019-216655; Suresh R, 2016, J CELL SCI, V129, P1928, DOI 10.1242/jcs.179291; Tanaka A, 2018, HYPERTENSION, V72, P1060, DOI 10.1161/HYPERTENSIONAHA.118.11554; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Title LM, 2000, J AM COLL CARDIOL, V36, P2185, DOI 10.1016/S0735-1097(00)00980-3; Viedt C, 2000, FASEB J, V14, P2370; VOLANAKIS JE, 1982, ANN NY ACAD SCI, V389, P235, DOI 10.1111/j.1749-6632.1982.tb22140.x; Wang L, 2014, FREE RADICAL BIO MED, V70, P155, DOI 10.1016/j.freeradbiomed.2014.01.015; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yin W, 2008, THROMB RES, V122, P221, DOI 10.1016/j.thromres.2007.11.005; Zhou Z, 2016, CELL MOL IMMUNOL, V13, P301, DOI 10.1038/cmi.2015.97	76	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264628	10.1371/journal.pone.0264628	http://dx.doi.org/10.1371/journal.pone.0264628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213675	Green Published, gold			2022-12-26	WOS:000787811000132
J	Ott, BM; Litaker, RW; Holland, WC; Delwiche, CF				Ott, Brittany M.; Litaker, R. Wayne; Holland, William C.; Delwiche, Charles F.			Using RDNA sequences to define dinoflagellate species	PLOS ONE			English	Article							OSTREOPSIS CF. OVATA; TOXIC DINOFLAGELLATE; ALEXANDRIUM-TAMARENSE; SP-NOV; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; MITOCHONDRIAL COX1; GENETIC DIVERSITY; RIBOSOMAL-RNA; COB GENES	Dinoflagellate species are traditionally defined using morphological characters, but molecular evidence accumulated over the past several decades indicates many morphologically-based descriptions are inaccurate. This recognition led to an increasing reliance on DNA sequence data, particularly rDNA gene segments, in defining species. The validity of this approach assumes the divergence in rDNA or other selected genes parallels speciation events. Another concern is whether single gene rDNA phylogenies by themselves are adequate for delineating species or if multigene phylogenies are required instead. Currently, few studies have directly assessed the relative utility of multigene versus rDNA-based phylogenies for distinguishing species. To address this, the current study examined D1-D3 and ITS/5.8S rDNA gene regions, a multi-gene phylogeny, and morphological characters in Gambierdiscus and other related dinoflagellate genera to determine if they produce congruent phylogenies and identify the same species. Data for the analyses were obtained from previous sequencing efforts and publicly available dinoflagellate transcriptomic libraries as well from the additional nine well-characterized Gambierdiscus species transcriptomic libraries generated in this study. The D1-D3 and ITS/5.8S phylogenies successfully identified the described Gambierdiscus and Alexandrium species. Additionally, the data showed that the D1-D3 and multigene phylogenies were equally capable of identifying the same species. The multigene phylogenies, however, showed different relationships among species and are likely to prove more accurate at determining phylogenetic relationships above the species level. These data indicated that D1-D3 and ITS/5.8S rDNA region phylogenies are generally successful for identifying species of Gambierdiscus, and likely those of other dinoflagellates. To assess how broadly general this finding is likely to be, rDNA molecular phylogenies from over 473 manuscripts representing 232 genera and 863 described species of dinoflagellates were reviewed. Results showed the D1-D3 rDNA and ITS phylogenies in combination are capable of identifying 97% of dinoflagellate species including all the species belonging to the genera Alexandrium, Ostreopsis and Gambierdiscus, although it should be noted that multi-gene phylogenies are preferred for inferring relationships among these species. A protocol is presented for determining when D1-D3, confirmed by ITS/5.8S rDNA sequence data, would take precedence over morphological features when describing new dinoflagellate species. This protocol addresses situations such as: a) when a new species is both morphologically and molecularly distinct from other known species; b) when a new species and closely related species are morphologically indistinguishable, but genetically distinct; and c) how to handle potentially cryptic species and cases where morphotypes are clearly distinct but have the same rDNA sequence. The protocol also addresses other molecular, morphological, and genetic approaches required to resolve species boundaries in the small minority of species where the D1-D3/ITS region phylogenies fail.	[Ott, Brittany M.] Univ Maryland, Joint Inst Food Safety & Appl Nutr JIFSAN, College Pk, MD 20742 USA; [Ott, Brittany M.; Delwiche, Charles F.] Univ Maryland, Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Litaker, R. Wayne] NOAA, CSS Inc, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci,Beaufort Lab, Beaufort, NC 28516 USA; [Holland, William C.] NOAA, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Beaufort Lab, Beaufort, NC USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS)	Ott, BM (corresponding author), Univ Maryland, Joint Inst Food Safety & Appl Nutr JIFSAN, College Pk, MD 20742 USA.; Ott, BM (corresponding author), Univ Maryland, Cell Biol & Mol Genet, College Pk, MD 20742 USA.; Litaker, RW (corresponding author), NOAA, CSS Inc, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci,Beaufort Lab, Beaufort, NC 28516 USA.	bott1@umd.edu; wayne.r.litaker@noaa.gov	Litaker, Richard Wayne/AAH-2036-2021	Litaker, Richard Wayne/0000-0001-6293-8000; Ott, Brittany/0000-0003-1677-7431	National Science Foundation (NSF) [DEB1541529]; Maryland Agricultural Experiment Station (MAES); University of Maryland through Joint Institute for Food Safety and Applied Nutrition (JIFSAN); Food and Drug Administration through Joint Institute for Food Safety and Applied Nutrition (JIFSAN); National Oceanic and Atmospheric Administration (NOAA), National Ocean Service, National Centers for Coastal Ocean Science	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Maryland Agricultural Experiment Station (MAES); University of Maryland through Joint Institute for Food Safety and Applied Nutrition (JIFSAN); Food and Drug Administration through Joint Institute for Food Safety and Applied Nutrition (JIFSAN); National Oceanic and Atmospheric Administration (NOAA), National Ocean Service, National Centers for Coastal Ocean Science	This project was supported in part by the National Science Foundation (NSF) in the form of a grant to CFD and BMO [DEB1541529] and the Maryland Agricultural Experiment Station (MAES) in the form of funds to CFD. This project was also supported in part by the joint collaboration between the University of Maryland and the Food and Drug Administration through Joint Institute for Food Safety and Applied Nutrition (JIFSAN) in the form of support to BMO. This project was also supported by the National Oceanic and Atmospheric Administration (NOAA), National Ocean Service, National Centers for Coastal Ocean Science in the form of program funds to CH and WL. The NOAA provided support in the form of a salary to WL. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adolf JE, 2006, ESTUAR COAST SHELF S, V67, P108, DOI 10.1016/j.ecss.2005.11.030; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angles S, 2017, J PHYCOL, V53, P833, DOI 10.1111/jpy.12546; Annenkova NV, 2018, J PHYCOL, V54, P571, DOI 10.1111/jpy.12748; Annenkova NV, 2015, ISME J, V9, P1821, DOI 10.1038/ismej.2014.267; Baden DG., NATURAL TOXINS DRUGS, P141; BAGNIS R, 1980, TOXICON, V18, P199, DOI 10.1016/0041-0101(80)90074-4; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cai RB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59524-z; Calasan AZ, 2019, ENVIRON MICROBIOL, V21, P4125, DOI 10.1111/1462-2920.14766; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carnicer O, 2015, CRYPTOGAMIE ALGOL, V36, P101, DOI 10.7872/crya.v36.iss1.2015.101; Casabianca S, 2014, MAR POLLUT BULL, V88, P102, DOI 10.1016/j.marpolbul.2014.09.018; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; de Salas MF, 2003, J PHYCOL, V39, P1233, DOI 10.1111/j.0022-3646.2003.03-019.x; Duff RJ, 2008, J EUKARYOT MICROBIOL, V55, P306, DOI 10.1111/j.1550-7408.2008.00328.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Efimova K., 2014, JBES; Fensome RA, 1999, GRANA, V38, P66; Fraga S, 2016, HARMFUL ALGAE, V58, P93, DOI 10.1016/j.hal.2016.06.004; Fraga S, 2014, PROTIST, V165, P839, DOI 10.1016/j.protis.2014.09.003; Gomez F, 2017, REV BIOL TROP, V65, P1022, DOI 10.15517/rbt.v65i3.29436; Gomez F, 2012, SYST BIODIVERS, V10, P267, DOI 10.1080/14772000.2012.721021; Gomez F, 2011, HIDROBIOLOGICA, V21, P343; Gottschling M, 2005, ANN MO BOT GARD, V92, P425; Gottschling M, 2005, MOL PHYLOGENET EVOL, V36, P444, DOI 10.1016/j.ympev.2005.03.036; Gottschling M, 2004, NUCLEIC ACIDS RES, V32, P307, DOI 10.1093/nar/gkh168; Gottschling M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92107-0; Gottschling M, 2020, FRESHWATER BIOL, V65, P193, DOI 10.1111/fwb.13413; Guillou L, 2002, PROTIST, V153, P223, DOI 10.1078/1434-4610-00100; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hardison DR, 2012, J PHYCOL, V48, P844, DOI 10.1111/j.1529-8817.2012.01186.x; Hernandez-Rosas A, 2018, J APPL PHYCOL, V30, P1117, DOI 10.1007/s10811-017-1269-1; Hickerson MJ, 2006, EVOLUTION, V60, P2435; Higman WA, 2001, PHYCOLOGIA, V40, P256, DOI 10.2216/i0031-8884-40-3-256.1; Hoppenrath M, 2008, J PHYCOL, V44, P451, DOI 10.1111/j.1529-8817.2008.00483.x; Hoppenrath M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-116; Hoppenrath M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013220; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; Hume BCC, 2016, P NATL ACAD SCI USA, V113, P4416, DOI 10.1073/pnas.1601910113; Jang SH, 2017, J PHYCOL, V53, P131, DOI 10.1111/jpy.12486; Janouskovec J, 2017, P NATL ACAD SCI USA, V114, pE171, DOI 10.1073/pnas.1614842114; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; John U, 2014, PROTIST, V165, P779, DOI 10.1016/j.protis.2014.10.001; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Keller M.D., 1985, P113; Kim S, 2011, MOL BIOL EVOL, V28, P1469, DOI 10.1093/molbev/msq332; Kon NF, 2017, PHYCOL RES, V65, P291, DOI 10.1111/pre.12186; Kremp A, 2014, J PHYCOL, V50, P81, DOI 10.1111/jpy.12134; Kretzschmar AL, 2019, PROTIST, V170, DOI 10.1016/j.protis.2019.125699; Kretzschmar AL, 2017, J PHYCOL, V53, P283, DOI 10.1111/jpy.12496; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2007, MOL PHYLOGENET EVOL, V45, P417, DOI 10.1016/j.ympev.2007.06.017; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Leaw CP, 2016, HARMFUL ALGAE, V55, P137, DOI 10.1016/j.hal.2016.02.010; Leaw CP, 2005, PHYCOLOGIA, V44, P550, DOI 10.2216/0031-8884(2005)44[550:PAOASA]2.0.CO;2; Leliaert F, 2021, J PHYCOL, V57, P412, DOI 10.1111/jpy.13134; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; LEWIS RJ, 1993, COMP BIOCHEM PHYS C, V106, P615, DOI 10.1016/0742-8413(93)90217-9; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lilly EL, 2007, J PHYCOL, V43, P1329, DOI 10.1111/j.1529-8817.2007.00420.x; Lin S, 2009, APPL ENVIRON MICROB, V75, P1279, DOI 10.1128/AEM.01578-08; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Litaker RW, 2019, J PHYCOL, V55, P730, DOI 10.1111/jpy.12852; Litaker RW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185776; Litaker RW, 2009, PHYCOLOGIA, V48, P344, DOI 10.2216/07-15.1; Litaker RW, 2003, J PHYCOL, V39, P754, DOI 10.1046/j.1529-8817.2003.02112.x; Litaker RW, 2002, J PHYCOL, V38, P442, DOI 10.1046/j.1529-8817.2002.t01-1-01242.x; LOEBLICH AR, 1976, J PROTOZOOL, V23, P13, DOI 10.1111/j.1550-7408.1976.tb05241.x; Logares R, 2007, MOL PHYLOGENET EVOL, V45, P887, DOI 10.1016/j.ympev.2007.08.005; Lopez AI, 2018, EUR J PHYCOL, V53, P156, DOI 10.1080/09670262.2017.1397198; Luo ZH, 2017, HARMFUL ALGAE, V66, P88, DOI 10.1016/j.hal.2017.05.008; Mason PL, 2007, J PHYCOL, V43, P799, DOI 10.1111/j.1529-8817.2007.00370.x; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Medlin LK, 1998, EUR J PROTISTOL, V34, P329, DOI 10.1016/S0932-4739(98)80060-6; Mendez GS, 2015, J EUKARYOT MICROBIOL, V62, P679, DOI 10.1111/jeu.12230; Mertens KN, 2014, GEOLOGY, V42, P531, DOI 10.1130/G35456.1; Miranda LN, 2012, HARMFUL ALGAE, V16, P35, DOI 10.1016/j.hal.2012.01.002; Montresor M, 2003, POLAR BIOL, V26, P186, DOI 10.1007/s00300-002-0473-9; Montresor M, 2003, PHYCOLOGIA, V42, P56, DOI 10.2216/i0031-8884-42-1-56.1; Murray S, 2009, PROTIST, V160, P245, DOI 10.1016/j.protis.2008.12.004; Nascimento SM, 2015, PHYCOLOGIA, V54, P628, DOI 10.2216/15-61.1; Nishimura T, 2016, HARMFUL ALGAE, V52, P11, DOI 10.1016/j.hal.2015.11.018; Nylander, 2004, MRMODELTEST V2 PROGR; Orr RJS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050004; Park MG, 2011, AQUAT MICROB ECOL, V62, P279, DOI 10.3354/ame01474; Parkinson JE, 2015, J PHYCOL, V51, P850, DOI 10.1111/jpy.12340; Pochon X, 2014, PEERJ, V2, DOI 10.7717/peerj.394; Qiu DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029398; Raho N, 2013, HARMFUL ALGAE, V28, P64, DOI 10.1016/j.hal.2013.05.012; Rene A, 2019, HARMFUL ALGAE, V84, P161, DOI 10.1016/j.hal.2019.04.001; Renoux LP, 2017, J PARASITOL, V103, P366, DOI 10.1645/16-93; Rhodes L, 2017, HARMFUL ALGAE, V65, P61, DOI 10.1016/j.hal.2017.04.010; Rodriguez F, 2012, HARMFUL ALGAE, V13, P26, DOI 10.1016/j.hal.2011.09.012; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roth MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00422; Shi XG, 2020, J APPL PHYCOL, V32, P431, DOI 10.1007/s10811-019-01961-z; Smith KF, 2016, HARMFUL ALGAE, V60, P45, DOI 10.1016/j.hal.2016.10.006; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stern RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042780; Stoecker DK, 1999, J EUKARYOT MICROBIOL, V46, P397, DOI 10.1111/j.1550-7408.1999.tb04619.x; Takahashi K, 2021, PHYCOL RES, V69, P175, DOI 10.1111/pre.12455; Taylor F.J.R., 1979, P71; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; Taylor F.J.R., 1987, Botanical Monographs (Oxford), V21, P24; TAYLOR FJR, 1980, BIOSYSTEMS, V13, P65, DOI 10.1016/0303-2647(80)90006-4; Tester PA, 2020, HARMFUL ALGAE, V91, DOI 10.1016/j.hal.2019.101655; Van Nieuwenhove N, 2018, PALYNOLOGY, V42, P111, DOI 10.1080/01916122.2018.1465736; Vandersea MW, 2017, PHYCOLOGIA, V56, P303, DOI 10.2216/16-41.1; Vandersea MW, 2012, J PHYCOL, V48, P902, DOI 10.1111/j.1529-8817.2012.01146.x; Wang N, 2019, HARMFUL ALGAE, V88, DOI 10.1016/j.hal.2019.05.003; Wham DC, 2017, PHYCOLOGIA, V56, P396, DOI 10.2216/16-86.1; Wolf C, 2013, ANTARCT SCI, V25, P741, DOI 10.1017/S0954102013000229; Wolny JL, 2020, J PHYCOL, V56, P404, DOI 10.1111/jpy.12966; YASUMOTO T, 1977, B JPN SOC SCI FISH, V43, P1021, DOI 10.2331/suisan.43.1021; Zhang FL, 2012, WORLD J MICROB BIOT, V28, P3255, DOI 10.1007/s11274-012-1136-9; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099; Zinssmeister C, 2011, SYST BIODIVERS, V9, P145, DOI 10.1080/14772000.2011.586071	126	1	1	8	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264143	10.1371/journal.pone.0264143	http://dx.doi.org/10.1371/journal.pone.0264143			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213572	gold, Green Published			2022-12-26	WOS:000787811000053
J	Zhang, HW; Li, X; Liu, JT; Lin, X; Pei, LP; Boyce, BF; Xing, LP				Zhang, Hengwei; Li, Xing; Liu, Jiatong; Lin, Xi; Pei, Lingpeng; Boyce, Brendan F.; Xing, Lianping			Proteasome inhibition-enhanced fracture repair is associated with increased mesenchymal progenitor cells in mice	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; MORPHOGENETIC PROTEIN-2; PARATHYROID-HORMONE; LYMPHATIC VESSELS; UP-REGULATION; IN-VIVO; STEM; BORTEZOMIB; SMURF1	The ubiquitin/proteasome system controls the stability of Runx2 and JunB, proteins essential for differentiation of mesenchymal progenitor/stem cells (MPCs) to osteoblasts. Local administration of proteasome inhibitor enhances bone fracture healing by accelerating endochondral ossification. However, if a short-term administration of proteasome inhibitor enhances fracture repair and potential mechanisms involved have yet to be exploited. We hypothesize that injury activates the ubiquitin/proteasome system in callus, leading to elevated protein ubiquitination and degradation, decreased MPCs, and impaired fracture healing, which can be prevented by a short-term of proteasome inhibition. We used a tibial fracture model in Nestin-GFP reporter mice, in which a subgroup of MPCs are labeled by Nestin-GFP, to test our hypothesis. We found increased expression of ubiquitin E3 ligases and ubiquitinated proteins in callus tissues at the early phase of fracture repair. Proteasome inhibitor Bortezomib, given soon after fracture, enhanced fracture repair, which is accompanied by increased callus Nestin-GFP+ cells and their proliferation, and the expression of osteoblast-associated genes and Runx2 and JunB proteins. Thus, early treatment of fractures with Bortezomib could enhance the fracture repair by increasing the number and proliferation of MPCs.	[Zhang, Hengwei; Li, Xing; Liu, Jiatong; Lin, Xi; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Pei, Lingpeng] Minzu Univ China, Key Lab Ethnomed, Beijing, Peoples R China; [Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Ctr Musculoskeletal Res, Med Ctr, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Xing, LP (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA.; Xing, LP (corresponding author), Univ Rochester, Ctr Musculoskeletal Res, Med Ctr, Rochester, NY 14642 USA.	Lianping_xing@urmc.rochester.edu		Liu, Jiatong/0000-0003-0746-8127	National Institute of Health PHS awards [P30AR061307pilot, R01AG059775]; NYSTEM [N13G-084, C029548]; National Natural Science Foundation of China [81673769, 31771560]	National Institute of Health PHS awards; NYSTEM; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Institute of Health PHS awards (P30AR061307pilot to H.Z., R01AG059775 to L. X.), NYSTEM N13G-084 (C029548 to L.X.), and National Natural Science Foundation of China (No.81673769 to L.P., No.31771560 to H.Z.). H.Z. is responsible for conception and design, material collection, data collection, data analysis, data interpretation, manuscript writing and final approval of manuscript; L.P. is responsible for data interpretation and final approval of manuscript; L.X. is responsible for conception and design, financial support, manuscript writing, and final approval of manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2012, NAT CELL BIOL, V14, P656, DOI 10.1038/ncb2534; Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Brown ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099656; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Clark D, 2017, CURR OSTEOPOROS REP, V15, P601, DOI 10.1007/s11914-017-0413-9; Curtis EM, 2016, BONE, V87, P19, DOI 10.1016/j.bone.2016.03.006; Darzynkiewick, 2004, NEW DEV CYTOMETRY, V4th, P75; Deleu S, 2009, CANCER RES, V69, P5307, DOI 10.1158/0008-5472.CAN-08-4472; Dy GK, 2005, CLIN CANCER RES, V11, P3410, DOI 10.1158/1078-0432.CCR-04-2068; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Huang CL, 2015, J BONE MINER RES, V30, P1217, DOI 10.1002/jbmr.2460; Ito Y, 2011, BIOCHEM BIOPH RES CO, V407, P225, DOI 10.1016/j.bbrc.2011.03.003; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Karpov DS, 2013, FEBS LETT, V587, P3108, DOI 10.1016/j.febslet.2013.08.007; Khedgikar V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.294; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Kung MH, 2012, J CELL PHYSIOL, V227, P1062, DOI 10.1002/jcp.22819; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Morgan EF, 2008, BONE, V43, P1031, DOI 10.1016/j.bone.2008.07.251; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Naik AA, 2009, J BONE MINER RES, V24, P251, DOI 10.1359/JBMR.081002; Oyajobi BO, 2007, BRIT J HAEMATOL, V139, P434, DOI 10.1111/j.1365-2141.2007.06829.x; Pountos I, 2010, J ORTHOP TRAUMA, V24, P552, DOI 10.1097/BOT.0b013e3181efa8fe; Qiang YW, 2012, SEMIN HEMATOL, V49, P243, DOI 10.1053/j.seminhematol.2012.04.011; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi JX, 2013, BIOTECH HISTOCHEM, V88, P428, DOI 10.3109/10520295.2012.729864; Shi JX, 2014, ARTHRITIS RHEUMATOL, V66, P657, DOI 10.1002/art.38278; Shu L, 2013, J BONE MINER RES, V28, P1925, DOI 10.1002/jbmr.1938; Starr AJ, 2003, J BONE JOINT SURG AM, V85A, P2049, DOI 10.2106/00004623-200310000-00027; SUAREZ F, 1993, J BONE MINER RES, V8, P1201; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tournaire G, 2020, BONE, V133, DOI 10.1016/j.bone.2020.115259; Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x; Wang CC, 2016, J CLIN INVEST, V126, P1471, DOI 10.1172/JCI80672; Wang H, 2020, J BONE MINER RES, V35, P343, DOI 10.1002/jbmr.3889; Wislet-Gendebien S, 2012, CELL MOL LIFE SCI, V69, P2593, DOI 10.1007/s00018-012-0937-1; Xing LP, 2020, BONE, V138, DOI 10.1016/j.bone.2020.115492; Xing LP, 2010, J CELL BIOCHEM, V110, P554, DOI 10.1002/jcb.22586; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang CH, 2006, ANN ONCOL, V17, P813, DOI 10.1093/annonc/mdj131; Yoshii T, 2015, J ORTHOP RES, V33, P1197, DOI 10.1002/jor.22849; Zhang HW, 2013, STEM CELLS, V31, P1574, DOI 10.1002/stem.1395; Zhang HW, 2013, J BIOL CHEM, V288, P22359, DOI 10.1074/jbc.M112.442459; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zhao L, 2011, STEM CELLS, V29, P1601, DOI 10.1002/stem.703; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28	52	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263839	10.1371/journal.pone.0263839	http://dx.doi.org/10.1371/journal.pone.0263839			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213543	gold, Green Published			2022-12-26	WOS:000787811000034
J	Baysinger, MR; Wilson, RM; Hanson, PJ; Kostka, JE; Chanton, JP				Baysinger, Mackenzie R.; Wilson, Rachel M.; Hanson, Paul J.; Kostka, Joel E.; Chanton, Jeffrey P.			Compositional stability of peat in ecosystem-scale warming mesocosms	PLOS ONE			English	Article							MARCELL EXPERIMENTAL FOREST; ORGANIC-MATTER; DECOMPOSITION; LIMITATION; CO2; STOICHIOMETRY; DEGRADATION; TEMPERATURE; MINNESOTA; PEATLANDS	Peatlands historically have acted as a C sink because C-fixation rates exceeded the rate of heterotrophic decomposition. Under future warmer conditions predicted for higher latitudes, however, that balance may shift towards higher rates of heterotrophic respiration leading to the release of previously stored C as CO2 and CH4. The Spruce and Peatlands Response Under Changing Environments (SPRUCE) experiment is designed to test the response of peatlands to climate forcing using a series of warmed enclosures in combination with peat below-ground heating from 0 to +9 degrees C above ambient conditions. This experimental design allowed a test of chemical changes occurring within peatland soils following five years of warming. We analyzed samples in the uppermost 2m of peat using Fourier Transform Infrared Spectroscopy (FT-IR) to quantify the relative abundance of carbohydrate and aromatic compounds in the peat. The peat soils were subjected to deep peat heating (DPH) beginning in June of 2014 followed by whole ecosystem warming (WEW) in August of 2015. We found that the relative amounts of labile and recalcitrant chemical compound groups across the full peat depth interval did not significantly change after five years of exposure to warming. This appears the case even though previous studies have shown that net C losses and loss of bulk peat mass to be instability over that time period. Results suggest that the current store of carbon in peatlands are largely compositionally stable leading to no changes the in the ratio of chemical moieties on the initial four-year timescale of this experiment.	[Baysinger, Mackenzie R.; Wilson, Rachel M.; Chanton, Jeffrey P.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Hanson, Paul J.] Oak Ridge Natl Lab, Div Environm Sci, Climate Change Sci Inst, POB 2008, Oak Ridge, TN 37831 USA; [Kostka, Joel E.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Kostka, Joel E.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Baysinger, Mackenzie R.] Alfred Wegner Inst, Helmholtz Ctr Polar & Marine Res, Potsdam, Germany	State University System of Florida; Florida State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Chanton, JP (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.	jchanton@fsu.edu	Hanson, Paul James/D-8069-2011	Hanson, Paul James/0000-0001-7293-3561; Chanton, Jeffrey/0000-0002-3303-9708	Office of Biological and Environmental Research, Terrestrial Ecosystem Science Program, under United States DOE [DE-SC0007144, DE-SC0012088]; Oak Ridge National Laboratory [DE-SC0007144, DE-DESC0012088, DE-AC05-00OR22725]; U.S. Department of Energy [DE-AC0500OR22725]; UTBattelle, LLC	Office of Biological and Environmental Research, Terrestrial Ecosystem Science Program, under United States DOE; Oak Ridge National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); UTBattelle, LLC	JPC, RMW, JEK, & MRB were funded by DE-SC0007144, DE-SC0012088, Office of Biological and Environmental Research, Terrestrial Ecosystem Science Program, under United States DOE contracts DE-SC0007144 and DE-DESC0012088. https://ess.science.energy.gov/.PJH, DE-AC05-00OR22725, Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. https://www.ornl.gov/"Note: This manuscript has been co-authored by UTBattelle, LLC under Contract No. DE-AC0500OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-publicaccess-plan)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004; Biester H, 2014, BIOGEOSCIENCES, V11, P2691, DOI 10.5194/bg-11-2691-2014; Clymo R. S., 1987, Effects of atmospheric pollutants on forests, wetlands and agricultural ecosystems NATO ASI Series G: Ecological Sciences, Vol. 16., P513; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Crowther TW, 2016, NATURE, V540, P104, DOI 10.1038/nature20150; Grover SPP, 2012, EUR J SOIL SCI, V63, P129, DOI 10.1111/j.1365-2389.2011.01424.x; Grover SPP, 2010, EUR J SOIL SCI, V61, P217, DOI 10.1111/j.1365-2389.2009.01220.x; Hanson P.J., 2020, SPRUCE PLOT LEVEL WA, DOI 10.25581/spruce.079/1608615; Hanson PJ, 2020, AGU ADV, V1, DOI 10.1029/2020AV000163; Hanson PJ, 2017, BIOGEOSCIENCES, V14, P861, DOI 10.5194/bg-14-861-2017; Hanson PJ, 2011, GLOBAL CHANGE BIOL, V17, P1083, DOI 10.1111/j.1365-2486.2010.02221.x; Hill BH, 2018, WETL ECOL MANAG, V26, P425, DOI 10.1007/s11273-017-9584-5; Hill BH, 2014, BIOGEOCHEMISTRY, V120, P203, DOI 10.1007/s10533-014-9991-0; Hodgkins SB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06050-2; Hodgkins SB, 2014, P NATL ACAD SCI USA, V111, P5819, DOI 10.1073/pnas.1314641111; Hopple AM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16311-8; Hopple AM, 2019, GEODERMA, V349, P79, DOI 10.1016/j.geoderma.2019.04.040; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Keiluweit M, 2016, BIOGEOCHEMISTRY, V127, P157, DOI 10.1007/s10533-015-0180-6; Keiser AD, 2019, SOIL BIOL BIOCHEM, V137, DOI 10.1016/j.soilbio.2019.107561; LaRowe DE, 2011, GEOCHIM COSMOCHIM AC, V75, P2030, DOI 10.1016/j.gca.2011.01.020; Leifeld J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051856; Lin XJ, 2014, APPL ENVIRON MICROB, V80, P3518, DOI 10.1128/AEM.00205-14; Lin X, 2014, APPL ENVIRON MICROB, V80, P3531, DOI 10.1128/AEM.00206-14; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Malhotra A, 2020, P NATL ACAD SCI USA, V117, P17627, DOI 10.1073/pnas.2003361117; McFarlane KJ, 2018, RADIOCARBON, V60, P941, DOI 10.1017/RDC.2018.37; Myhre G, 2013, ATMOS CHEM PHYS, V13, P1853, DOI 10.5194/acp-13-1853-2013; Neubauer SC, 2015, ECOSYSTEMS, V18, P1000, DOI 10.1007/s10021-015-9879-4; Pracht LE, 2018, BIOGEOSCIENCES, V15, P1733, DOI 10.5194/bg-15-1733-2018; Ramaswamy V, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P349; Steinweg JM, 2018, SOIL BIOL BIOCHEM, V125, P244, DOI 10.1016/j.soilbio.2018.07.001; Tfaily MM, 2014, J GEOPHYS RES-BIOGEO, V119, P661, DOI 10.1002/2013JG002492; Treat CC, 2014, GLOBAL CHANGE BIOL, V20, P2674, DOI 10.1111/gcb.12572; Wilson RM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13723; Wilson RM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2004192118; Wilson RM, 2017, ORG GEOCHEM, V112, P22, DOI 10.1016/j.orggeochem.2017.06.011; Yu ZC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043584; Yu ZC, 2011, HOLOCENE, V21, P761, DOI 10.1177/0959683610386982	39	1	1	11	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263994	10.1371/journal.pone.0263994	http://dx.doi.org/10.1371/journal.pone.0263994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235578	gold, Green Published, Green Submitted			2022-12-26	WOS:000787073100009
J	Hojreh, A; Ba-Ssalamah, A; Lang, C; Poetter-Lang, S; Huber, WD; Tamandl, D				Hojreh, Azadeh; Ba-Ssalamah, Ahmed; Lang, Christian; Poetter-Lang, Sarah; Huber, Wolf-Dietrich; Tamandl, Dietmar			Influence of age on gadoxetic acid disodium-induced transient respiratory motion artifacts in pediatric liver MRI	PLOS ONE			English	Article							GD-EOB-DTPA; LESIONS; CIRRHOSIS; COMMON	PurposeGd-EOB-DTPA-enhanced liver MRI is frequently compromised by transient severe motion artifacts (TSM) in the arterial phase, which limits image interpretation for the detection and differentiation of focal liver lesions and for the recognition of the arterial vasculature before and after liver transplantation. The purpose of this study was to investigate which patient factors affect TSM in children who undergo Gd-EOB-DTPA-enhanced liver MRI and whether younger children are affected as much as adolescents. MethodsOne hundred and forty-eight patients (65 female, 83 male, 0.1-18.9 years old), who underwent 226 Gd-EOB-DTPA-enhanced MRIs were included retrospectively in this single-center study. The occurrence of TSM was assessed by three readers using a four-point Likert scale. The relation to age, gender, body mass index, indication for MRI, requirement for sedation, and MR repetition was investigated using uni- and multivariate logistic regression analysis. ResultsIn Gd-EOB-DTPA-enhanced MRIs, TSM occurred in 24 examinations (10.6%). Patients with TSM were significantly older than patients without TSM (median 14.3 years; range 10.1-18.1 vs. 12.4 years; range 0.1-18.9, p<0.001). TSM never appeared under sedation. Thirty of 50 scans in patients younger than 10 years were without sedation. TSM were not observed in non-sedated patients younger than 10 years of age (p = 0.028). In a logistic regression analysis, age remained the only cofactor independently associated with the occurrence of TSM (hazard ratio 9.152, p = 0.049). ConclusionTSM in Gd-EOB-DTPA-enhanced liver MRI do not appear in children under the age of 10 years.	[Hojreh, Azadeh; Ba-Ssalamah, Ahmed; Lang, Christian; Poetter-Lang, Sarah; Tamandl, Dietmar] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Lang, Christian] Gen Hosp Wiener Neustadt, Dept Anaesthesia Emergency Med & Intens Care, Wiener Neustadt, Austria; [Huber, Wolf-Dietrich] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Tamandl, D (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	dietmar.tamandl@meduniwen.ac.at		Lang, Christian/0000-0002-6207-043X; Hojreh, Azadeh/0000-0002-4556-1931				Ba-Ssalamah A, 2009, EUR RADIOL, V19, P342, DOI 10.1007/s00330-008-1172-x; Bartolozzi C, 2001, EUR RADIOL, V11, P1374, DOI 10.1007/s003300100845; Bartolozzi C, 2013, ABDOM IMAGING, V38, P290, DOI 10.1007/s00261-012-9952-9; Bashir MR, 2015, RADIOLOGY, V274, P141, DOI 10.1148/radiol.14140386; Bastati N, 2014, RADIOLOGY, V271, P739, DOI 10.1148/radiol.14131890; Burk KS, 2016, RADIOL CLIN N AM, V54, P185, DOI 10.1016/j.rcl.2015.09.010; Davenport MS, 2014, AM J ROENTGENOL, V203, P796, DOI 10.2214/AJR.13.11587; Davenport MS, 2014, RADIOLOGY, V272, P123, DOI 10.1148/radiol.14132269; Davenport MS, 2013, RADIOLOGY, V266, P452, DOI 10.1148/radiol.12120826; Gilligan LA, 2019, PEDIATR RADIOL, V49, P1171, DOI 10.1007/s00247-019-04437-x; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Haradome H, 2010, J MAGN RESON IMAGING, V32, P334, DOI 10.1002/jmri.22241; Hayashi T, 2015, RADIOLOGY, V276, P756, DOI 10.1148/radiol.2015141646; Hussain SM, 2009, RADIOGRAPHICS, V29, P1637, DOI 10.1148/rg.296095508; Ito K, 2000, AM J ROENTGENOL, V175, P1145, DOI 10.2214/ajr.175.4.1751145; Kim SY, 2015, AM J ROENTGENOL, V204, P1220, DOI 10.2214/AJR.14.13677; Lanier H, 2020, ABDOM RADIOL, V45, P101, DOI 10.1007/s00261-019-02296-6; Masand PM, 2018, PEDIATR RADIOL, V48, P1234, DOI 10.1007/s00247-018-4218-5; MCQUEEN DS, 1989, BRIT J PHARMACOL, V98, P413, DOI 10.1111/j.1476-5381.1989.tb12612.x; Merkle EM, 2016, EUR RADIOL, V26, P674, DOI 10.1007/s00330-015-3873-2; Meyers AB, 2012, PEDIATR RADIOL, V42, P859, DOI 10.1007/s00247-012-2366-6; Meyers AB, 2011, PEDIATR RADIOL, V41, P1183, DOI 10.1007/s00247-011-2148-6; Monti L, 2016, RADIOL MED, V121, P378, DOI 10.1007/s11547-016-0628-3; Morana G, 2011, INVEST RADIOL, V46, P225, DOI 10.1097/RLI.0b013e3181feee3a; Motosugi U, 2016, RADIOLOGY, V279, P93, DOI 10.1148/radiol.2015150642; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P849, DOI 10.1002/jmri.21913; Olsen OE, 2013, ACTA RADIOL, V54, P1030, DOI 10.1177/0284185113494038; Polanec SH, 2017, J MAGN RESON IMAGING, V46, P1107, DOI 10.1002/jmri.25657; SPRINGER C, 1988, RESP PHYSIOL, V74, P55, DOI 10.1016/0034-5687(88)90140-5; Vasanawala SS, 2010, PEDIATR RADIOL, V40, P431, DOI 10.1007/s00247-009-1522-0; Wybranski C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230024	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264069	10.1371/journal.pone.0264069	http://dx.doi.org/10.1371/journal.pone.0264069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235594	gold, Green Published			2022-12-26	WOS:000787073100037
J	Andrade, MLSD; Oliveira, JD; Cabral, PC; Cureau, FV; Leal, VS; de Lira, PIC				Siqueira de Souza Andrade, Maria Laura; Oliveira, Juliana de Souza; Cabral, Poliana Coelho; Cureau, Felipe Vogt; Leal, Vanessa Sa; Cabral de Lira, Pedro Israel			Associations between biological and behavioral factors in early life and food consumption in Brazilian adolescents: Results from the ERICA study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; FEEDING PRACTICES; FAT INTAKE; DIET; CARBOHYDRATE; EXPOSURE; PRETERM; FAMINE; FRUIT; RISK	The aim of the present study was to determine associations between biological and behavioral factors in early life and food consumption in Brazilian adolescents. The sample was composed of 36,956 adolescents (12-17 years of age) who participated in the "Study of Cardiovascular Risk in Adolescents". Sociodemographic, biological, and behavioral variables were collected using questionnaires self-administered by the adolescents. Early-life factors were assessed using a questionnaire administered to the parents/guardians of the adolescents. Dependent variables related to food consumption (total energy intake and percentages of macronutrient intake [carbohydrates, lipids and proteins]) were measured using the 24-hour recall method and compared to dietary reference intakes. Data analysis was performed with the aid of STATA 14.0, using multiple linear regression analysis with respective beta coefficients. The level of significance was set at 5% (p <= 0.05). Adolescents born with low weight had lower energy intake (-94.8 kcal, 95%CI: -177.2; -12.3, p = 0.024) and 1.25% higher carbohydrate intake (95%CI: 0.15; 2.34, p = 0.025) compared to those born with adequate weight. Those who received exclusive breast breastfeeding for three to six months ingested 1.32% more lipids than those who received exclusive breast breastfeeding for less than three months (95%CI: 0.37; 2.26, p = 0.006). In conclusion, low birth weight was associated with lower energy intake and a higher percentage of carbohydrate intake, whereas breastfeeding three to six months was associated with a higher percentage of lipid intake.	[Siqueira de Souza Andrade, Maria Laura; Oliveira, Juliana de Souza; Cabral, Poliana Coelho; Leal, Vanessa Sa; Cabral de Lira, Pedro Israel] Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil; [Oliveira, Juliana de Souza; Leal, Vanessa Sa] Univ Fed Pernambuco, Ctr Acad Vitoria, Nutr Ctr, Vitoria De Santo Antao, PE, Brazil; [Cureau, Felipe Vogt] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Siqueira de Souza Andrade, Maria Laura] Univ Fed Pernambuco, Postgrad Program Nutr, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal do Rio Grande do Sul; Universidade Federal de Pernambuco	Andrade, MLSD (corresponding author), Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil.; Andrade, MLSD (corresponding author), Univ Fed Pernambuco, Postgrad Program Nutr, Recife, PE, Brazil.	laurasiqueira89@hotmail.com	Cabral, Poliana Coelho/AAX-9405-2021; Cureau, Felipe/H-1021-2018	Cabral, Poliana Coelho/0000-0002-2709-4823; Cureau, Felipe/0000-0001-7255-9717; Siqueira de Souza Andrade, Maria Laura/0000-0002-0227-2494	Brazilian fostering agencies Financiadora de Estudos e Projetos (FINEP [Study and Project Funding Agency]) [01090421]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq [National Council of Scientific and Technological Research]) [565037/2010-2, 405.009/2012-7]	Brazilian fostering agencies Financiadora de Estudos e Projetos (FINEP [Study and Project Funding Agency]); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq [National Council of Scientific and Technological Research])	This work was supported by Brazilian fostering agencies Financiadora de Estudos e Projetos (FINEP [Study and Project Funding Agency]) (grant number: 01090421) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq [National Council of Scientific and Technological Research]) (grant numbers: 565037/2010-2, 405.009/2012-7).	Alves MD, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00153818, 10.1590/0102-311X00153818]; Ayres C, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/657379; Barbieri MA, 2009, PEDIATR RES, V65, P215, DOI 10.1203/PDR.0b013e31818d6850; Barufaldi Laura Augusta, 2016, Rev. bras. epidemiol., V19, P464, DOI 10.1590/1980-5497201600020020; Beauchamp GK, 2009, J PEDIATR GASTR NUTR, V48, pS25, DOI 10.1097/MPG.0b013e31819774a5; Bischoff AR, 2018, BRIT J NUTR, V119, P1295, DOI [10.1017/S0007114518000892, 10.1017/s0007114518000892]; Bloch KV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1442-x; Crozier SR, 2010, AM J CLIN NUTR, V91, P1745, DOI 10.3945/ajcn.2009.29128; Cureau F. V., 2016, REV SAUDE PUBL, V50, P4; de Farias JC, 2009, REV PANAM SALUD PUBL, V25, P344, DOI 10.1590/S1020-49892009000400009; de Lauzon-Guillain B, 2013, AM J CLIN NUTR, V98, P804, DOI 10.3945/ajcn.112.057026; Doornweerd S., 2015, CLIN NUTR, P1, DOI [10.1016/j.clnu.2014.07.011, DOI 10.1016/J.CLNU.2014.07.011]; Grote V, 2016, EUR J CLIN NUTR, V70, P250, DOI 10.1038/ejcn.2015.162; Ibge. Instituto Brasileiro de Geografia e Estatistica, 2011, PESQ ORC 2008 2009 T; Institute of Medicine, 2002, DIETARY REFERENCE IN; Kampmann FB, 2019, J DEV ORIG HLTH DIS, V10, P488, DOI 10.1017/S2040174418000910; Kaseva N, 2013, J PEDIATR-US, V163, P43, DOI 10.1016/j.jpeds.2012.12.076; Labayen I, 2015, MATERN CHILD NUTR, V11, P1036, DOI 10.1111/mcn.12130; de Vasconcellos MTL, 2015, CAD SAUDE PUBLICA, V31, P921, DOI 10.1590/0102-311X00043214; Little RJA, 2002, WILEY SERIES PROBABI, DOI 10.1002/9781119013563; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; Migraine A, 2013, AM J CLIN NUTR, V97, P1270, DOI 10.3945/ajcn.112.051151; Molle RD, 2015, BRAIN RES, V1618, P41, DOI 10.1016/j.brainres.2015.05.019; Movassagh EZ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090990; da Silva TLN, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S01518-8787.2016050006730; Okubo H, 2016, PUBLIC HEALTH NUTR, V19, P650, DOI 10.1017/S1368980015001779; Oliveira A, 2015, J PEDIATR-US, V166, P59, DOI 10.1016/j.jpeds.2014.09.031; Passanha Adriana, 2018, Rev. paul. pediatr., V36, P148, DOI 10.1590/1984-0462/;2018;36;2;00008; Perala MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046139; Perrine CG, 2014, PEDIATRICS, V134, pS50, DOI 10.1542/peds.2014-0646I; Puffer RR., 1987, PAHO SCI PUBLICATION; Ribeiro Adolfo Monteiro, 2015, Rev. paul. pediatr., V33, P340, DOI 10.1016/j.rpped.2014.09.007; Shultis WA, 2005, J EPIDEMIOL COMMUN H, V59, P955, DOI 10.1136/jech.2005.034413; Skinner JD, 2002, J NUTR EDUC BEHAV, V34, P310, DOI 10.1016/S1499-4046(06)60113-9; Soldateli B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148357; Souza Amanda de Moura, 2016, Rev. Saúde Pública, V50, p5s, DOI 10.1590/s01518-8787.2016050006698; Spaniol AM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8405-6; Stein AD, 2009, J NUTR, V139, P1555, DOI 10.3945/jn.109.105536; Tanner JM., 1991, GROWTH MATURATION PH; van Deutekom AW, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0335-4; WHO, 2006, CHILD GROWTH STAND L, DOI [10.1007/s00431-008-0796-9, DOI 10.1007/S00431-008-0796-9]; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x; Yuan WL, 2017, EUR J CLIN NUTR, V71, P219, DOI 10.1038/ejcn.2016.216	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264714	10.1371/journal.pone.0264714	http://dx.doi.org/10.1371/journal.pone.0264714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T6JP	35235605	gold, Green Published			2022-12-26	WOS:000787073100012
J	Baymiller, M; Nordick, B; Forsyth, CM; Martinis, SA				Baymiller, Max; Nordick, Benjamin; Forsyth, Connor M.; Martinis, Susan A.			Tissue-specific alternative splicing separates the catalytic and cell signaling functions of human leucyl-tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL FUNCTION; MTORC1; AMINOACYLATION; FRAGMENT; BINDING; DOMAIN; SRSF1	The aminoacyl-tRNA synthetases are an ancient and ubiq-uitous component of all life. Many eukaryotic synthetases balance their essential function, preparing aminoacyl-tRNA for use in mRNA translation, with diverse roles in cell signaling. Herein, we use long-read sequencing to discover a leukocyte-specific exon skipping event in human leucyl-tRNA synthetase (LARS). We show that this highly expressed splice variant, LSV3, is regulated by serine-arginine-rich splicing factor 1 (SRSF1) in a cell-type-specific manner. LSV3 has a 71 amino acid deletion in the catalytic domain and lacks any tRNA leucylation activity in vitro. However, we demonstrate that this LARS splice variant retains its role as a leucine sensor and signal transducer for the proliferation-promoting mTOR kinase. This is despite the exon deletion in LSV3 including a portion of the previously mapped Vps34-binding domain used for one of two distinct pathways from LARS to mTOR. In conclusion, alternative splicing of LARS has separated the ancient catalytic activity of this housekeeping enzyme from its more recent evolutionary role in cell signaling, providing an opportunity for functional specificity in human immune cells.	[Baymiller, Max; Nordick, Benjamin; Forsyth, Connor M.; Martinis, Susan A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Nordick, Benjamin] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA; [Forsyth, Connor M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Tennessee System; University of Tennessee Knoxville; Northwestern University; Feinberg School of Medicine	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	martinis@illinois.edu		Baymiller, Max/0000-0003-2438-243X; Nordick, Benjamin/0000-0001-6213-9137; Forsyth, Connor/0000-0002-2576-861X	W. M. Keck Foundation; National Institutes of Health [T32-GM136629]	W. M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This research was supported by a grant to S. A. M. from the W. M. Keck Foundation. M. B. was supported by National Institutes of Health #T32-GM136629. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; D'Hulst G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13889-6; Das S, 2012, CELL REP, V1, P110, DOI 10.1016/j.celrep.2011.12.001; Davis C. A., 2018, ENCYCLOPEDIA; Dong XC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0181-6; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Giudice G, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw035; Gonzalez-Garay ML, 2016, TRANSL BIOINFORM, V9, P141, DOI 10.1007/978-94-017-7450-5_6; Greenberg Y, 2008, FASEB J, V22, P1597, DOI 10.1096/fj.07-9973com; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Horn M, 2014, DEV CELL, V28, P697, DOI 10.1016/j.devcel.2014.01.028; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jobin PG, 2020, J BIOL CHEM, V295, P2186, DOI 10.1074/jbc.RA119.010486; Kaisers W, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061110; Katsuyama T, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109339; Kim S, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109031; Kono M, 2018, ARTHRITIS RHEUMATOL, V70, P2046, DOI 10.1002/art.40585; Lee EY, 2016, NAT IMMUNOL, V17, P1252, DOI 10.1038/ni.3542; Lee M., 2018, P NATL ACAD SCI, VU; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Liu JM, 2004, NUCLEIC ACIDS RES, V32, P719, DOI 10.1093/nar/gkh240; Liu RJ, 2020, NUCLEIC ACIDS RES, V48, P4946, DOI 10.1093/nar/gkaa189; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Mascarenhas A. P., 2009, V22, P155; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Ofir-Birin Y., 2013, MOL; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Pang YLJ, 2014, WIRES RNA, V5, P461, DOI 10.1002/wrna.1224; Pang YLJ, 2009, BIOCHEMISTRY-US, V48, P8958, DOI 10.1021/bi901111y; Park M. C., 2012, PROC NATL ACAD SCI S; Paz S, 2021, CYTOKINE GROWTH F R, V57, P19, DOI 10.1016/j.cytogfr.2020.10.008; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Van Nostrand EL, 2020, NATURE, V583, P711, DOI 10.1038/s41586-020-2077-3; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wei ZY, 2016, NUCLEIC ACIDS RES, V44, P1247, DOI 10.1093/nar/gkw002; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Yoon I., 2020, GLUCOSE DEPENDENT CO; Yoon MS, 2016, CELL REP, V16, P1510, DOI 10.1016/j.celrep.2016.07.008; Zhang W, 2020, CELL MOL IMMUNOL, V17, P1063, DOI 10.1038/s41423-019-0281-6; Zhang XY, 2020, NAT METAB, V2, P110, DOI 10.1038/s42255-019-0162-4; Zhenyukh O, 2017, FREE RADICAL BIO MED, V104, P165, DOI 10.1016/j.freeradbiomed.2017.01.009	52	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101757	10.1016/j.jbc.2022.101757	http://dx.doi.org/10.1016/j.jbc.2022.101757			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35202654	Green Published, gold			2022-12-26	WOS:000793502000009
J	Zhou, JM; Sun, CB; Yang, L; Wang, JH; Jn-Simon, N; Zhou, C; Bryant, A; Cao, Q; Li, CL; Petersen, B; Pi, LY				Zhou, Junmei; Sun, Chunbao; Yang, Lu; Wang, Jinhui; Jn-Simon, Natacha; Zhou, Chen; Bryant, Andrew; Cao, Qi; Li, Chenglong; Petersen, Bryon; Pi, Liya			Liver regeneration and ethanol detoxification: A new link in YAP regulation of ALDH1A1 during alcohol-related hepatocyte damage	FASEB JOURNAL			English	Article						Aldh1a1; carbon tetrachloride (CCl4); ethanol; liver regeneration; Yes-associated protein	TISSUE GROWTH-FACTOR; HIPPO PATHWAY; ALDEHYDE DEHYDROGENASES; CELLS; GENE; METABOLISM; INHIBITION; EXPRESSION; INDUCTION; MECHANISM	Yes-associated protein (YAP), a central effector in the Hippo pathway, is involved in the regulation of organ size, stem cell self-renewal, and tissue regeneration. In this study, we observed YAP activation in patients with alcoholic steatosis, hepatitis, and cirrhosis. Accumulation of this protein in the nucleus was also observed in murine livers that were damaged after chronic-plus-single binge or moderate ethanol ingestion combined with carbon tetrachloride intoxication (ethanol/CCl4). To understand the role of this transcriptional coactivator in alcohol-related liver injury, we knocked out the Yap1 gene in hepatocytes of floxed homozygotes through adeno-associated virus (AAV8)-mediated deletion utilizing Cre recombinase. Yap1 hepatocyte-specific knockouts (KO) exhibited hemorrhage, massive hepatic necrosis, enhanced oxidative stress, elevated hypoxia, and extensive infiltration of CD11b(+) inflammatory cells into hepatic microenvironments rich for connective tissue growth factor (Ctgf) during ethanol/CCl4-induced liver damage. Analysis of whole-genome transcriptomics indicated upregulation of genes involved in hypoxia and extracellular matrix (ECM) remodeling, whereas genes related to hepatocyte proliferation, progenitor cell activation, and ethanol detoxification were downregulated in the damaged livers of Yap1 KO. Acetaldehyde dehydrogenase (Aldh)1a1, a gene that encodes a detoxification enzyme for aldehyde substrates, was identified as a potential YAP target because this gene could be transcriptionally activated by a hyperactive YAP mutant. The ectopic expression of the human ALDH1A1 gene caused increase in hepatocyte proliferation and decrease in hepatic necrosis, oxidative stress, ECM remodeling, and inflammation during ethanol/CCl4-induced liver damage. Taken together, these observations indicated that YAP was crucial for liver repair during alcohol-associated injury. Its regulation of ALDH1A1 represents a new link in liver regeneration and detoxification.	[Zhou, Junmei] Guilin Med Univ, Guangxi Key Lab Mol Med Liver Injury & Repair, Affiliated Hosp, Guilin, Peoples R China; [Sun, Chunbao; Jn-Simon, Natacha; Pi, Liya] Tulane Univ, Dept Pathol, New Orleans, LA 70118 USA; [Yang, Lu] Beckman Res Inst City Hope, Dept Syst Biol, Duarte, CA USA; [Wang, Jinhui] Beckman Res Inst City Hope, Integrat Genom Core, Duarte, CA USA; [Zhou, Chen; Li, Chenglong] Univ Florida, Dept Med Chem, Gainesville, FL USA; [Bryant, Andrew] Univ Florida, Dept Med, Gainesville, FL USA; [Cao, Qi] Univ Maryland, Dept Diagnost Radiol & Nucl Med, Sch Med, Baltimore, MD USA; [Petersen, Bryon] Univ Florida, Dept Pediat, Gainesville, FL USA	Guilin Medical University; Tulane University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida	Pi, LY (corresponding author), Tulane Univ, Sch Med, Dept Pathol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	lpi@tulane.edu	Wang, Jin/GYA-2019-2022		National Institutes of Health NIAAA [KO1AA024174, RO1AA028035]; Children Miracle Research Foundation; National Natural Science Foundation	National Institutes of Health NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Children Miracle Research Foundation; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study is supported by National Institutes of Health NIAAA KO1AA024174 and RO1AA028035 grants as well as Children Miracle Research Foundation grant awarded to LP. This study is also partially supported by the National Natural Science Foundation	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Chen Y, 2013, PROG RETIN EYE RES, V33, P28, DOI 10.1016/j.preteyeres.2012.10.001; Chiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069114; Del Re DP, 2013, J BIOL CHEM, V288, P3977, DOI 10.1074/jbc.M112.436311; Deshpande KT, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010005; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Lai YS, 2019, J CELL MOL MED, V23, P1257, DOI 10.1111/jcmm.14027; LIEBER CS, 1968, SCIENCE, V162, P917, DOI 10.1126/science.162.3856.917; Liu HX, 2014, BIOCHEM PHARMACOL, V91, P256, DOI 10.1016/j.bcp.2014.07.003; Liu Y, 2019, J HEPATOL, V71, P719, DOI 10.1016/j.jhep.2019.05.029; Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205; Machado MV, 2015, J HEPATOL, V63, P962, DOI 10.1016/j.jhep.2015.05.031; Makia NL, 2011, CHEM-BIOL INTERACT, V191, P278, DOI 10.1016/j.cbi.2011.01.013; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Miyamura N, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms16017; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; Nielsen MC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051175; Pi LY, 2015, HEPATOLOGY, V61, P678, DOI 10.1002/hep.27425; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Rebollido-Rios R, 2020, ONCOGENE, V39, P2756, DOI 10.1038/s41388-020-1184-9; Roychowdhury S, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.61; Saleh MB, 2021, J HEPATOL, V75, P912, DOI 10.1016/j.jhep.2021.05.041; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Shabtai Y, 2018, BIOCHEM CELL BIOL, V96, P148, DOI 10.1139/bcb-2017-0132; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Su T, 2015, ELIFE, V4, DOI 10.7554/eLife.02948; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Suzuki E, 2012, HEPATOL RES, V42, P1100, DOI 10.1111/j.1872-034X.2012.01028.x; Svendsen P, 2017, MOL THER-METH CLIN D, V4, P50, DOI 10.1016/j.omtm.2016.11.004; Swiderska-Syn M, 2016, HEPATOLOGY, V64, P232, DOI 10.1002/hep.28542; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Vidal F, 1998, ALCOHOL, V15, P3, DOI 10.1016/S0741-8329(97)00073-6; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Wu HT, 2013, CELL REP, V3, P1663, DOI 10.1016/j.celrep.2013.04.020; Xiao Y, 2018, DEV CELL, V45, P153, DOI 10.1016/j.devcel.2018.03.019; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yu JH, 2017, ONCOTARGET, V8, P38426, DOI 10.18632/oncotarget.16430; Zhao AY, 2018, ONCOTARGETS THER, V11, P6657, DOI 10.2147/OTT.S170858; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou JM, 2020, FASEB J, V34, P4970, DOI 10.1096/fj.201902382R	54	2	2	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22224	10.1096/fj.202101686R	http://dx.doi.org/10.1096/fj.202101686R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CX	35218575	hybrid, Green Published			2022-12-26	WOS:000772946100001
J	Cortesi, PA; Antonazzo, IC; Gasperini, C; Nica, M; Ritrovato, D; Mantovani, LG				Cortesi, Paolo Angelo; Antonazzo, Ippazio Cosimo; Gasperini, Claudio; Nica, Mihaela; Ritrovato, Daniela; Mantovani, Lorenzo Giovanni			Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy	PLOS ONE			English	Article							BURDEN	Background Siponimod is an effective treatment for patients with secondary progressive multiple sclerosis (SPMS), with active disease evidenced by relapses or imaging features characteristic of multiple sclerosis inflammatory activity, however there is a need to evaluate its economic value and sustainability compared to other disease modifying-therapies (DMTs). Objective To estimate the siponimod cost-effectiveness profile and its relative budget impact compared with other DMTs, by using the Italian National Healthcare System perspective. Methods We performed: 1) a cost-effectiveness analysis (CEA) vs interferon beta-1b using an analytical Markov model and a life time-horizon, and 2) a budget impact analysis by using 3-years time-horizon. The results were reported as incremental cost-effectiveness ratio (ICER) and net-monetary benefit (NMB) for CEA, using a willingness to pay threshold of (sic) 40,000 per QALY gained, and as difference in the overall budget (Euro) between the scenario with and without siponimod for budget impact. Results In the base case scenario siponimod resulted cost-effective compared with interferon beta1b 28,891(sic) per QALY. Overall, the market access of siponimod was associated to an increased budget of about 3(sic) millions (+0.9%) in the next 3 years simulated. Conclusion Compared to interferon beta-1b, siponimod seems to be cost-effective in SPMS patients and sustainable, with less than 1% overall budget increased in the next 3 years. Future studies need to confirm our results in the real word setting and in other countries.	[Cortesi, Paolo Angelo; Antonazzo, Ippazio Cosimo; Mantovani, Lorenzo Giovanni] Univ Milano Bicocca, Res Ctr Publ Hlth CESP, Monza, Italy; [Cortesi, Paolo Angelo; Mantovani, Lorenzo Giovanni] IRCCS MultiMed, Value Based Healthcare Unit, Sesto San Giovanni, Italy; [Gasperini, Claudio] San Camillo Forlanini Hosp, Multiple Sclerosis Ctr, Dept Neurol, Rome, Italy; [Nica, Mihaela; Ritrovato, Daniela] Novartis Farma SpA, Origgio, Italy	University of Milano-Bicocca; IRCCS Multimedica; Azienda Ospedaliera San Camillo-Forlanini; Novartis	Antonazzo, IC (corresponding author), Univ Milano Bicocca, Res Ctr Publ Hlth CESP, Monza, Italy.	ippazio.antonazzo@unimib.it		Antonazzo, Ippazio Cosimo/0000-0001-8046-4574	Novartis SpA	Novartis SpA	The study was supported by Novartis SpA in the form of a grant. There are no grant numbers to declare. Novartis also provided support in the form of salaries for MN and DR. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman Gabriel, 2013, J Med Econ, V16, P639, DOI 10.3111/13696998.2013.778268; Agenzia Italiana del Farmaco (AIFA)- Italian Medicine Agency, LISTS CLASS CLASS H; [Anonymous], 2020, DRUG REIMBURSEMENT R; Associazione Italiana Sclerosi Multipla Onlus, 2019, BAROMETRO SCLEROSI M; Capra R, 2017, MULT SCLER J, V23, P1757, DOI 10.1177/1352458516687402; Cortesi PA, 2018, J VIRAL HEPATITIS, V25, P791, DOI 10.1111/jvh.12877; Cortesi PA., 2019, HLTH EC THERAPEUTIC, V20, P61; European Medicine Agency (EMA), SIPON ANN 1 SUMM PRO; Harding KE, 2013, J NEUROL NEUROSUR PS, V84, P141, DOI 10.1136/jnnp-2012-303996; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Istituto Nazionale di Statistica (ISTAT), DEM ISTAT POP IT RES; Kappos L, 2018, LANCET, V391, P1263, DOI 10.1016/S0140-6736(18)30475-6; Kobelt G, 2006, J NEUROL NEUROSUR PS, V77, P918, DOI 10.1136/jnnp.2006.090365; Kobelt G, 2017, MULT SCLER J, V23, P1123, DOI 10.1177/1352458517694432; Koch-Henriksen N, 1998, J NEUROL NEUROSUR PS, V65, P56, DOI 10.1136/jnnp.65.1.56; Mantovani LG, 2019, FARMECONOMIA, V20, P73, DOI 10.7175/fe.v20i1.1437; Mantovani LG, 2016, HEPATOLOGY, V64, P1331, DOI 10.1002/hep.28527; National Institute for Health and Care Excellence (NICE), 2007, NAT TREATM AD HIGHL; National Institute for Health and Care Excellence (NICE), 2020, SIP TREAT SEC PROGR; NICE, 2018, OCR TREAT REL REM MU; Panitch H, 2004, NEUROLOGY, V63, P1788; Phillippo DM., 2016, 18 NICE DSU; Samjoo IA, 2020, CURR MED RES OPIN, V36, P1157, DOI 10.1080/03007995.2020.1747999; Scott LJ, 2020, CNS DRUGS, V34, P1191, DOI 10.1007/s40263-020-00771-z; Synnott PG, 2020, J MANAG CARE SPEC PH, V26, P236, DOI 10.18553/jmcp.2020.26.3.236; Tong JY, 2021, NEUROL SCI, V42, P1687, DOI 10.1007/s10072-021-05049-w; Trojano M, 2019, NEUROL SCI, V40, P155, DOI 10.1007/s10072-018-3610-0; Tullman MJ, 2013, AM J MANAG CARE, V19, pS15; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Zuvich RL, 2009, SEMIN IMMUNOL, V21, P328, DOI 10.1016/j.smim.2009.08.003	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264123	10.1371/journal.pone.0264123	http://dx.doi.org/10.1371/journal.pone.0264123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259168	Green Published, gold			2022-12-26	WOS:000835141200008
J	Sung, HW; Choi, SE; Chu, CH; Ouyang, MX; Kalyan, S; Scott, N; Hur, SC				Sung, Hyun Woo; Choi, Sung-Eun; Chu, Chris H.; Ouyang, Mengxing; Kalyan, Srivathsan; Scott, Nathan; Hur, Soojung Claire			Sensitizing drug-resistant cancer cells from blood using microfluidic electroporator	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; METASTATIC BREAST-CANCER; LIQUID BIOPSY; MET; AMPLIFICATION; ESTABLISHMENT; CHEMOTHERAPY; PROGRESSION; LAPATINIB; SURVIVAL	Direct assessment of patient samples holds unprecedented potential in the treatment of cancer. Circulating tumor cells (CTCs) in liquid biopsies are a rapidly evolving source of primary cells in the clinic and are ideal candidates for functional assays to uncover real-time tumor information in real-time. However, a lack of routines allowing direct and active interrogation of CTCs directly from liquid biopsy samples represents a bottleneck for the translational use of liquid biopsies in clinical settings. To address this, we present a workflow for using a microfluidic vortex-assisted electroporation system designed for the functional assessment of CTCs purified from blood. Validation of this approach was assessed through drug response assays on wild-type (HCC827 wt) and gefitinib-resistant (HCC827 GR6) non-small cell lung cancer (NSCLC) cells. HCC827 cells trapped within microscale vortices were electroporated to sequentially deliver drug agents into the cytosol. Electroporation conditions facilitating multi-agent delivery were characterized for both cell lines using an automatic single-cell image fluorescence intensity algorithm. HCC827 GR6 cells spiked into the blood to emulate drug-resistant CTCs were able to be collected with high purity, demonstrating the ability of the device to minimize background cell impact for downstream sensitive cell assays. Using our proposed workflow, drug agent combinations to restore gefitinib sensitivity reflected the anticipated cytotoxic response. Taken together, these results represent a microfluidics multi-drug screening panel workflow that can enable functional interrogation of patient CTCs in situ, thereby accelerating the clinical standardization of liquid biopsies.	[Sung, Hyun Woo] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Choi, Sung-Eun; Kalyan, Srivathsan; Scott, Nathan; Hur, Soojung Claire] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Chu, Chris H.] Virginia Mason Med Ctr, Dept Internal Med, Washington, DC USA; [Ouyang, Mengxing] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Hur, Soojung Claire] Johns Hopkins Univ Hosp, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Hur, Soojung Claire] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Virginia Mason Medical Center; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Hur, SC (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.; Hur, SC (corresponding author), Johns Hopkins Univ Hosp, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA.; Hur, SC (corresponding author), Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA.	schur@jhu.edu		Sung, Hyun Woo/0000-0001-6498-6751	Rowland Fellowship; Harvard University; Vortex Biosciences, Inc.; Susan G. Komen Career Catalyst Award [CCR19609203]; NCI of National Institute of Health [R21CA229024]	Rowland Fellowship; Harvard University; Vortex Biosciences, Inc.; Susan G. Komen Career Catalyst Award(Susan G. Komen Breast Cancer Foundation); NCI of National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is gratefully supported by Rowland Fellowship (S.C.H), sponsored research agreement between Harvard University and Vortex Biosciences, Inc. (S.C.H), the Susan G. Komen Career Catalyst Award (S.C.H) under award number CCR19609203, and NCI of National Institute of Health (S.C.H) under award number R21CA229024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen KE, 2017, ONCOTARGET, V8, P45544, DOI 10.18632/oncotarget.17271; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Albain KS, 2008, J CLIN ONCOL, V26, P3950, DOI 10.1200/JCO.2007.11.9362; Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Cayrefourcq L, 2015, CANCER RES, V75, P892, DOI 10.1158/0008-5472.CAN-14-2613; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen CT, 2012, MOL CANCER THER, V11, P660, DOI 10.1158/1535-7163.MCT-11-0754; Cristofanilli M, 2006, SEMIN ONCOL, V33, pS9, DOI 10.1053/j.seminoncol.2006.03.016; Diez-Silva M, 2010, MRS BULL, V35, P382, DOI 10.1557/mrs2010.571; Doddapaneni R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15531-1; Duellman SJ, 2015, ASSAY DRUG DEV TECHN, V13, P456, DOI 10.1089/adt.2015.669; Eduati F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04919-w; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Grillet F, 2017, GUT, V66, P1802, DOI 10.1136/gutjnl-2016-311447; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; Imbeault Emilie, 2013, Methods Mol Biol, V1031, P51, DOI 10.1007/978-1-62703-481-4_6; Jaroszeski MJ, 2000, ANTI-CANCER DRUG, V11, P201, DOI 10.1097/00001813-200003000-00008; Jin C, 2014, LAB CHIP, V14, P32, DOI 10.1039/c3lc50625h; Jordan NV, 2016, NATURE, V537, P102, DOI 10.1038/nature19328; Khoo BL, 2019, BRIT J CANCER, V120, P407, DOI 10.1038/s41416-018-0301-9; Khoo BL, 2018, NAT PROTOC, V13, P34, DOI 10.1038/nprot.2017.125; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Leary M, 2018, CANCERS, V10, DOI 10.3390/cancers10120483; Lim CT, 2019, CURR OPIN PHARMACOL, V48, P155, DOI 10.1016/j.coph.2019.09.008; Lim SB, 2019, NPJ PRECIS ONCOL, V3, DOI 10.1038/s41698-019-0095-0; Mader S, 2017, ONCOL RES TREAT, V40, P404, DOI 10.1159/000478018; Mansoori B, 2017, ADV PHARM BULL, V7, P339, DOI 10.15171/apb.2017.041; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Meador CB, 2014, CLIN CANCER RES, V20, P2264, DOI 10.1158/1078-0432.CCR-13-1591; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Navin NE, 2014, CELL REP, V6, P417, DOI 10.1016/j.celrep.2014.01.035; Neumann MHD, 2018, COMPUT STRUCT BIOTEC, V16, P190, DOI 10.1016/j.csbj.2018.05.002; Niepel Mario, 2017, Curr Protoc Chem Biol, V9, P55, DOI 10.1002/cpch.21; Olmos D, 2009, ANN ONCOL, V20, P27, DOI 10.1093/annonc/mdn544; Onidani K, 2019, CANCER SCI, V110, P2590, DOI 10.1111/cas.14092; Ouyang MX, 2017, SCI REP-UK, V7, DOI 10.1038/srep44757; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; SCHMIDSCHONBEIN GW, 1980, BLOOD, V56, P866; Shevkoplyas SS, 2005, ANAL CHEM, V77, P933, DOI 10.1021/ac049037i; Siravegna G, 2017, NAT REV CLIN ONCOL, V14, P531, DOI 10.1038/nrclinonc.2017.14; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Sollier E, 2014, LAB CHIP, V14, P63, DOI 10.1039/c3lc50689d; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Tan CL, 2016, ONCOTARGET, V7, P23251, DOI 10.18632/oncotarget.8136; Tol J, 2010, ANN ONCOL, V21, P1006, DOI 10.1093/annonc/mdp463; Uggeri J, 2004, HISTOCHEM CELL BIOL, V122, P499, DOI 10.1007/s00418-004-0712-y; Vickers DAL, 2014, ANAL CHEM, V86, P10099, DOI 10.1021/ac501479g; Wicha MS, 2011, J CLIN ONCOL, V29, P1508, DOI 10.1200/JCO.2010.34.0026; Wilbaux M, 2015, CPT-PHARMACOMET SYST, V4, P277, DOI 10.1002/psp4.34; Wong AHH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08831-z; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Yun HY, 2013, LAB CHIP, V13, P2764, DOI 10.1039/c3lc50196e; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zhao P, 2019, J CANCER, V10, P6095, DOI 10.7150/jca.33157	60	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264907	10.1371/journal.pone.0264907	http://dx.doi.org/10.1371/journal.pone.0264907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259174	Green Published, gold			2022-12-26	WOS:000835141200030
J	Yang, YH; Dai, J; Zeng, Y; Liu, Y				Yang, Yaohong; Dai, Jing; Zeng, Yi; Liu, Ying			Analysis on the stochastic evolution process of low-carbon transformation for supplier groups in construction supply chain	PLOS ONE			English	Article							FIXATION TIMES; GAME	To achieve the goal of "emission peak and carbon neutrality", it is particularly important to accelerate the transformation of low-carbon production as the construction industry of China's major carbon emission. Considering the national industrial management system, this paper constructs a stochastic game model of supplier group's production strategy in construction supply chain based on Moran process, analyzes the conditions for low-carbon emission strategy to fixate in supplier populations and become an evolutionary stable strategy, then, carries out numerical analysis on fixation probability and fixation times, and the influence of various factors on the evolution process is discussed, such as the initial willingness of suppliers to choose low-carbon emission strategy, the cost subsidy coefficient of government to low carbon suppliers, the reward and punishment of government and the credibility of suppliers. The results show that on the basis of vigorously promoting environmental protection, the government should implement a differentiated treatment policy through the establishment of carbon emissions standards, cost subsidies, incentives and punishment measures, and information disclosure systems to guide supplier groups to transformation into low-carbon production.	[Yang, Yaohong; Dai, Jing; Zeng, Yi; Liu, Ying] North China Univ Water Resources & Elect Power, Sch Water Conservancy, Zhengzhou, Peoples R China; [Yang, Yaohong] Henan Key Lab Water Resources Conservat & Intens, Zhengzhou, Henan, Peoples R China	North China University of Water Resources & Electric Power	Yang, YH (corresponding author), North China Univ Water Resources & Elect Power, Sch Water Conservancy, Zhengzhou, Peoples R China.; Yang, YH (corresponding author), Henan Key Lab Water Resources Conservat & Intens, Zhengzhou, Henan, Peoples R China.	yangyaohong@ncwu.edu.cn		Yaohong, Yang/0000-0003-2004-7140	Humanities and Social Sciences funded projects of the Ministry of Education [17YJCZH257]; Support plan for scientific and technological innovation talents in Colleges and universities of Henan Province Humanities and Social Sciences): Mechanism and efficiency of carbon water cycle in regional system; Henan discipline innovation and talent introduction base [GXJD004]	Humanities and Social Sciences funded projects of the Ministry of Education; Support plan for scientific and technological innovation talents in Colleges and universities of Henan Province Humanities and Social Sciences): Mechanism and efficiency of carbon water cycle in regional system; Henan discipline innovation and talent introduction base	This work was supported by grants from the Humanities and Social Sciences funded projects of the Ministry of Education (17YJCZH257): Research on carbon quota allocation of enterprises based on comprehensive performance of carbon emission, the Support plan for scientific and technological innovation talents in Colleges and universities of Henan Province Humanities and Social Sciences): Mechanism and efficiency of carbon water cycle in regional system, the Project supported by Henan discipline innovation and talent introduction base(GXJD004): Intelligent water conservancy. There was no additional external funding received for this study.	Agency XN gov.cn, 11 JINPING DELIVERS; Altrock PM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011909; Altrock PM, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013012; Antal T, 2006, B MATH BIOL, V68, P1923, DOI 10.1007/s11538-006-9061-4; [柴彩春 Chai Caichun], 2015, [系统工程理论与实践, Systems Engineering-Theory & Practice], V35, P2262; Chen ZL, 2020, ENERG POLICY, V137, DOI 10.1016/j.enpol.2019.111095; Choi J, 2019, SCI TOTAL ENVIRON, V674, P580, DOI 10.1016/j.scitotenv.2019.04.152; Du SF, 2017, ANN OPER RES, V255, P569, DOI 10.1007/s10479-015-1988-0; Fang H., 2021, HIGHWAY ENG, V46; Federation CBM, 2021, CHINA BUILDING MAT, P21; Feng Z.F., 2021, CHIN TRADIT PAT MED, P1; Fu FF, 2018, J ENG MANAGEMENT, V32, P98; Gao Y., 2021, COMPUTER SIMULATION, V38; He QH., 2015, FORUM SCI TECHNOLOGY, P136; Hu S., 2020, BUILD SCI, V36, P288; Jialin Zheng, 2020, IOP Conference Series: Materials Science and Engineering, V790, DOI 10.1088/1757-899X/790/1/012126; Jiang JX, 2021, SYSTEMS ENG, P1; Jin HY, 2021, CHINA BUILDING MAT, P24; Jin HY., 2021, CARBON PEAK CARBON N, P26; Li J., 2015, J ENG MANAGEMENT, V29, P12; Liang W., 2017, J BEIJING JIAO TONG, V16, P137; [林欢 Lin Huan], 2021, [运筹与管理, Operations Research and Management Science], V30, P29; Liu XM., 2019, SYSTEMS ENG, V37, P31; Liu XS, 2015, J THEOR BIOL, V387, P214, DOI 10.1016/j.jtbi.2015.09.016; [刘铮 Liu Zheng], 2009, [土木工程学报, China Civil Engineering Journal], V42, P131; Jabbour ABLD, 2017, ENERG EFFIC, V10, P777, DOI 10.1007/s12053-016-9478-z; Lu J., 2019, J BEIJING I TECHNOL, V21, P17; Ma XM., 2014, CHINA LOW CARBON FIN; Monasterolo I, 2017, CLIMATIC CHANGE, V145, P495, DOI 10.1007/s10584-017-2095-9; Nishitani K., 2015, J MANAG CONTROL, V27, P33; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Perc M, 2016, PHYS LETT A, V380, P2803, DOI 10.1016/j.physleta.2016.06.017; Robati M, 2019, J CLEAN PROD, V225, P541, DOI 10.1016/j.jclepro.2019.03.339; Song Han, 2016, Computer Integrated Manufacturing Systems, V22, P2217, DOI 10.13196/j.cims.2016.09.018; [宋民雪 Song Minxue], 2020, [中国管理科学, Chinese Journal of Management Science], V28, P142; Sun JY, 2015, CONSTRUCTION SCI TEC, P64; Sun SYH, 2021, COMPUT ASSIST LANG L, V34, P1061, DOI 10.1080/09588221.2019.1657902; Taylor C, 2004, B MATH BIOL, V66, P1621, DOI 10.1016/j.bulm.2004.03.004; Taylor C, 2006, J THEOR BIOL, V243, P245, DOI 10.1016/j.jtbi.2006.06.016; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Traulsen A, 2008, B MATH BIOL, V70, P1410, DOI 10.1007/s11538-008-9305-6; Wang HC, 2010, CONSTRUCTION EC, P31; [王天华 Wang Tianhua], 2019, [系统工程理论与实践, Systems Engineering-Theory & Practice], V39, P3139; Wang TR., 2020, J TECHNOLOGY EC, V39, P168; [王先甲 Wang Xianjia], 2019, [系统科学与数学, Journal of Systems Science and Mathematical Sciences], V39, P1533; [王先甲 Wang Xianjia], 2017, [运筹与管理, Operations Research and Management Science], V26, P105; [王要武 Wang Yaowu], 2004, [土木工程学报, China Civil Engineering Journal], V37, P86; Wei SM, 2021, CLIN ORAL IMPLAN RES, V32, P383, DOI 10.1111/clr.13719; [武山松 Wu Shansong], 2020, [系统工程理论与实践, Systems Engineering-Theory & Practice], V40, P2885; Wu SF, 2021, COMMUN STAT-SIMUL C, DOI 10.1080/03610918.2021.1884716; Wu SJ., 2017, RESOURCES ENV, V27, P21; Xu L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03270-2; [杨丰梅 Yang Fengmei], 2017, [系统工程学报, Journal of Systems Engineering], V32, P596; Yang GS., 2018, SCI TECHNOLOGY MANAG, V38, P212; Yang T, 2020, MODERNIZATION MANAGE, V40, P16; Yang Y, 2020, CLIN ORAL INVEST, V24, P1465, DOI 10.1007/s00784-019-03179-2; Yin S, 2019, SCI TOTAL ENVIRON, V677, P19, DOI 10.1016/j.scitotenv.2019.04.317; Zeng ZX., 2022, CHINESE J SYSTEMS SC; [张克勇 Zhang Keyong], 2021, [运筹与管理, Operations Research and Management Science], V30, P108; Zhang KZ., 2020, J CHONGQING U SOCIAL, V26, P82; [张李浩 Zhang Lihao], 2020, [计算机集成制造系统, Computer Integrated Manufacturing Systems], V26, P3167; [张李浩 Zhang Lihao], 2018, [计算机集成制造系统, Computer Integrated Manufacturing Systems], V24, P763; [张李浩 Zhang Lihao], 2017, [计算机集成制造系统, Computer Integrated Manufacturing Systems], V23, P883; Zhang LK, 2022, J AM STAT ASSOC, V117, P1357, DOI 10.1080/01621459.2020.1858838; Zhang LH, 2021, J MECH SCI TECHNOL, V35, P3171, DOI 10.1007/s12206-021-0638-5; Zhang M., 2020, CONTROL DECISION, P1; [张维月 Zhang Weiyue], 2021, [中国管理科学, Chinese Journal of Management Science], V29, P90	67	1	1	18	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264579	10.1371/journal.pone.0264579	http://dx.doi.org/10.1371/journal.pone.0264579			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259163	Green Published, gold			2022-12-26	WOS:000835141200017
J	Pajusalu, M; Iakubivskyi, I; Schwarzkopf, GJ; Knuuttila, O; Vaisanen, T; Buhrer, M; Palos, MF; Teras, H; Le Bonhomme, G; Praks, J; Slavinskis, A				Pajusalu, Mihkel; Iakubivskyi, Iaroslav; Schwarzkopf, Gabriel Jorg; Knuuttila, Olli; Vaisanen, Timo; Buhrer, Maximilian; Palos, Mario F.; Teras, Hans; Le Bonhomme, Guillaume; Praks, Jaan; Slavinskis, Andris			SISPO: Space Imaging Simulator for Proximity Operations	PLOS ONE			English	Article							BIDIRECTIONAL REFLECTANCE SPECTROSCOPY; MODEL; DESIGN	This paper describes the architecture and demonstrates the capabilities of a newly developed, physically-based imaging simulator environment called SISPO, developed for small solar system body fly-by and terrestrial planet surface mission simulations. The image simulator utilises the open-source 3-D visualisation system Blender and its Cycles rendering engine, which supports physically based rendering capabilities and procedural micropolygon displacement texture generation. The simulator concentrates on realistic surface rendering and has supplementary models to produce realistic dust- and gas-environment optical models for comets and active asteroids. The framework also includes tools to simulate the most common image aberrations, such as tangential and sagittal astigmatism, internal and external comatic aberration, and simple geometric distortions. The model framework's primary objective is to support small-body space mission design by allowing better simulations for characterisation of imaging instrument performance, assisting mission planning, and developing computer-vision algorithms. SISPO allows the simulation of trajectories, light parameters and camera's intrinsic parameters.	[Pajusalu, Mihkel; Iakubivskyi, Iaroslav; Teras, Hans; Le Bonhomme, Guillaume; Slavinskis, Andris] Univ Tartu, Space Technol Dept, Tartu Observ, Toravere, Estonia; [Schwarzkopf, Gabriel Jorg; Knuuttila, Olli; Vaisanen, Timo; Buhrer, Maximilian; Palos, Mario F.; Praks, Jaan] Aalto Univ, Sch Elect Engn, Dept Elect & Nanoengn, Espoo, Finland; [Buhrer, Maximilian] Cranfield Univ, Sch Aerosp Transport & Mfg, Cranfield, Beds, England	University of Tartu; Tartu Observatory; Aalto University; Cranfield University	Iakubivskyi, I (corresponding author), Univ Tartu, Space Technol Dept, Tartu Observ, Toravere, Estonia.	iaroslav.iakubivskyi@ut.ee	Iakubivskyi, Iaroslav/AAI-2517-2021; Slavinskis, Andris/G-7798-2016; Praks, Jaan/M-4488-2016	Iakubivskyi, Iaroslav/0000-0003-0744-2357; Slavinskis, Andris/0000-0001-7310-7608; Praks, Jaan/0000-0001-7466-3569; Knuuttila, Olli/0000-0002-5767-5872	ESA Contract [4000131003/20/NL/IB/ig]; University of Tartu [4000131003/20/NL/IB/ig]; Archimedes Foundation [2014-2020.4.01.16-0029 KOMEET]; Eesti Teadusagentuur (EE) [MOBTP151, PUTJD601]; Tartu Observatory [74001073]	ESA Contract; University of Tartu; Archimedes Foundation; Eesti Teadusagentuur (EE); Tartu Observatory	This work was funded by the ESA Contract No. 4000131003/20/NL/IB/ig with the University of Tartu ("Comet Interceptor (EE-1): OPIC Engineering Model Development", PI is MP; the salary was paid to: MP, II, GLB, HT, and hardware acquisition), the Archimedes Foundation (https://archimedes.ee, UT ASTRA project 2014-2020.4.01.16-0029 KOMEET "Benefits for Estonian Society from Space Research and Application" in the form of travel supports), the Eesti Teadusagentuur (EE) (MOBTP151 and PUTJD601, awarded to MP), and the base funding of Tartu Observatory (registration number 74001073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton C, 2016, INT ARCH PHOTOGRAMM, V41, P357, DOI 10.5194/isprsarchives-XLI-B4-357-2016; AMICA imaging team, 2007, SHAP MOD 25143 IT TA; [Anonymous], 1998, SEMINAL GRAPHICS PIO, DOI DOI 10.1145/280811.280975; Bhrer M., 2020, THESIS LULE U TECHNO; Blender Online Community, 2020, BLEND 3D MOD REND PA; Bowles NE, 2018, ADV SPACE RES, V62, P1998, DOI 10.1016/j.asr.2017.10.021; Brochard R, 2018, 69 TH INT ASTRONAUTI, P111; BROWN DC, 1971, PHOTOGRAMM ENG, V37, P855; Cernea Dan, 2020, OPENMVS MULTIVIEW ST; Culjak I., 2012, 2012 35th International Convention on Information and Communication Technology, Electronics and Microelectronics, P1725; Cushing GE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030709; ESA, ANN OPP NEW SCI ID E; ESA, TECHNICAL REPORT 201, P81100; Ferri A, 2018, ADV SPACE RES, V62, P2163, DOI 10.1016/j.asr.2018.06.014; FINSON ML, 1968, ASTROPHYS J, V154, P327, DOI 10.1086/149761; Fitzsimmons A, 2019, ASTROPHYS J LETT, V885, DOI 10.3847/2041-8213/ab49fc; Fitzsimmons A, 2018, NAT ASTRON, V2, P133, DOI 10.1038/s41550-017-0361-4; Flavell L., 2011, BEGINNING BLENDER OP, P69; Garreta Piol B., 2020, THESIS U POLITCNICA; Gaskell RW, 2008, METEORIT PLANET SCI, V43, P1049, DOI 10.1111/j.1945-5100.2008.tb00692.x; Girardeau-Montaut D, 2011, OPEN SOURCE PROJECT, P588; HAPKE B, 1984, ICARUS, V59, P41, DOI 10.1016/0019-1035(84)90054-X; HAPKE B, 1981, J GEOPHYS RES, V86, P3039, DOI 10.1029/JB086iB04p03039; Hapke B, 2002, ICARUS, V157, P523, DOI 10.1006/icar.2002.6853; Hapke B., 2012, THEORY REFLECTANCE E; Iakubivskyi I, 2020, ADV SPACE RES; Jones GH, 2018, ADV SPACE RES, V62, P1921, DOI 10.1016/j.asr.2018.02.032; Kainz F, 2003, ACM SIGGRAPH TECHNIC; Kohout T, 2018, ADV SPACE RES, V62, P2239, DOI 10.1016/j.asr.2017.07.036; Kramer T, 2018, ADV PHYS-X, V3, DOI 10.1080/23746149.2017.1404436; Kramer T, 2017, MON NOT R ASTRON SOC, V469, pS20, DOI 10.1093/mnras/stx866; Lambert J.H., 1760, PHOTOMETRIA SIVE MEN; Levasseur-Regourd AC, 2019, ASTRON ASTROPHYS, V630, DOI 10.1051/0004-6361/201834894; Liu Z, 2012, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2012, DOI 10.5244/C.26.16; Maisonobe L., 2010, 4 INT C ASTR TOOLS T; Martin I, 2019, 2 RPI SPAC IM WORKSH; MCEWEN AS, 1991, ICARUS, V92, P298, DOI 10.1016/0019-1035(91)90053-V; Moulon P, 2013, P CVMP 2013; Moulon P, 2017, LECT NOTES COMPUT SC, V10214, P60, DOI 10.1007/978-3-319-56414-2_5; Nesnas IA, 2019, AEROSP CONF PROC; Oberst J, 2018, ADV SPACE RES, V62, P2220, DOI 10.1016/j.asr.2017.12.028; OREN M, 1995, INT J COMPUT VISION, V14, P227, DOI 10.1007/BF01679684; Pajusalu M, 2020, 71 INT ASTR C IAC 20, P18; Pajusalu M, 2019, AEROSP CONF PROC; Pernechele C, 2020, PROC SPIE, V11203, DOI 10.1117/12.2539239; Probst A, 2018, ADV SPACE RES, V62, P2125, DOI 10.1016/j.asr.2017.07.041; Robinson MS, 2012, PLANET SPACE SCI, V69, P18, DOI 10.1016/j.pss.2012.05.008; Sauro F, 2020, EARTH-SCI REV, V209, DOI 10.1016/j.earscirev.2020.103288; Schmitt MI, 2017, MON NOT R ASTRON SOC, V469, pS380, DOI 10.1093/mnras/stx1780; Schwarzkopf GJ, 2020, Space Imaging Simulator for Proximity Operations, DOI 10.5281/zenodo.3661054; Schwarzkopf GJ, 2020, THESIS LULE U TECHNO; Semenov B, 2018, 2018 SPACEOPS C MARS, P2366, DOI [10.2514/6.2018-2366, DOI 10.2514/6.2018-2366]; Slavinskis A, 2018, AEROSP CONF PROC, DOI 10.1109/AERO.2018.8396670; Snodgrass C, 2018, ADV SPACE RES, V62, P1947, DOI 10.1016/j.asr.2017.09.011; Snodgrass C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13470-1; SPUDIS PD, 1985, EOS T AGU, V66, P721, DOI DOI 10.1029/E0066I043P00721; Uckert K, 2020, ASTROBIOLOGY, V20, P1427, DOI 10.1089/ast.2019.2177; Walker R, 2018, ASTRON GEOPHYS, V59, P24, DOI 10.1093/astrogeo/aty232; WHITTED T, 1980, COMMUN ACM, V23, P343, DOI 10.1145/358876.358882	60	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0263882	10.1371/journal.pone.0263882	http://dx.doi.org/10.1371/journal.pone.0263882			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245306	Green Submitted, gold, Green Published			2022-12-26	WOS:000799799100009
J	Bush, KA; Kilts, CD				Bush, Keith A.; Kilts, Clinton D.			A test of affect processing bias in response to affect regulation	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; EMOTION; PICTURES; ATTENTION; AROUSAL	In this study we merged methods from machine learning and human neuroimaging to test the role of self-induced affect processing states in biasing the affect processing of subsequent image stimuli. To test this relationship we developed a novel paradigm in which (n = 40) healthy adult participants observed affective neural decodings of their real-time functional magnetic resonance image (rtfMRI) responses as feedback to guide explicit regulation of their brain (and corollary affect processing) state towards a positive valence goal state. By this method individual differences in affect regulation ability were controlled. Attaining this brain-affect goal state triggered the presentation of pseudo-randomly selected affectively congruent (positive valence) or incongruent (negative valence) image stimuli drawn from the International Affective Picture Set. Separately, subjects passively viewed randomly triggered positively and negatively valent image stimuli during fMRI acquisition. Multivariate neural decodings of the affect processing induced by these stimuli were modeled using the task trial type (state- versus randomly-triggered) as the fixed-effect of a general linear mixed-effects model. Random effects were modeled subject-wise. We found that self-induction of a positive valence brain state significantly positively biased valence processing of subsequent stimuli. As a manipulation check, we validated affect processing state induction achieved by the image stimuli using independent psychophysiological response measures of hedonic valence and autonomic arousal. We also validated the predictive fidelity of the trained neural decoding models using brain states induced by an out-of-sample set of image stimuli. Beyond its contribution to our understanding of the neural mechanisms that bias affect processing, this work demonstrated the viability of novel experimental paradigms triggered by pre-defined cognitive states. This line of individual differences research potentially provides neuroimaging scientists with a valuable tool for exploring the roles and identities of intrinsic cognitive processing mechanisms that shape our perceptual processing of sensory stimuli.	[Bush, Keith A.; Kilts, Clinton D.] Univ Arkansas Med Sci, Brain Imaging Res Ctr, Dept Psychiat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Bush, KA (corresponding author), Univ Arkansas Med Sci, Brain Imaging Res Ctr, Dept Psychiat, Little Rock, AR 72205 USA.	kabush@uams.edu			Brain and Behavior Research Foundation NARSAD Young Investigator Award - Families for Borderline Personality Disorder Research [26079]; National Science Foundation [BCS-1735820]; National Institute on Drug Abuse [1T32DA022981]; UAMS Translational Research Institute (TRI) through the National Center for Advancing Translational Sciences [1U54TR001629-01A1]	Brain and Behavior Research Foundation NARSAD Young Investigator Award - Families for Borderline Personality Disorder Research; National Science Foundation(National Science Foundation (NSF)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); UAMS Translational Research Institute (TRI) through the National Center for Advancing Translational Sciences	This study was funded by Brain and Behavior Research Foundation NARSAD Young Investigator Award #26079 sponsored by the Families for Borderline Personality Disorder Research (K.A.B). Elements of the real-time fMRI infrastructure deployed in this work were supported by National Science Foundation grant BCS-1735820 (K.A.B). Additional personnel support was provided by National Institute on Drug Abuse grant 1T32DA022981 (C.D.K). Subject recruitment for the project was supported by the UAMS Translational Research Institute (TRI) through the National Center for Advancing Translational Sciences (1U54TR001629-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baucom LB, 2012, NEUROIMAGE, V59, P718, DOI 10.1016/j.neuroimage.2011.07.037; Berking M, 2012, CURR OPIN PSYCHIATR, V25, P128, DOI 10.1097/YCO.0b013e3283503669; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Boden MT, 2013, COGNITION EMOTION, V27, P961, DOI 10.1080/02699931.2012.751899; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bush KA, 2018, P C COGN COMP NEUR P; Bush KA., 2020, ACTION VALUE MODEL E, V23; Bush KA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33621-6; Bush KA, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00262; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Czekoova K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00367; Esteban O, 2019, NAT METHODS, V16, P111, DOI 10.1038/s41592-018-0235-4; Flaisch T, 2008, PSYCHOPHYSIOLOGY, V45, P1, DOI 10.1111/j.1469-8986.2007.00600.x; Fujimura T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00212; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Halder S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053513; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Heller AS, 2011, NEUROIMAGE, V58, P930, DOI 10.1016/j.neuroimage.2011.06.057; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kober SE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00695; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 2008, INT AFFECTIVE PICTUR; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; MacNamara A, 2009, EMOTION, V9, P531, DOI 10.1037/a0016251; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Platt JC, 2000, ADV NEUR IN, P61; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; WEGNER DM, 1980, J PERS SOC PSYCHOL, V38, P719, DOI 10.1037/0022-3514.38.5.719; Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9; Wilson KA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66109-3; Witte M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00478; Wu LD, 2012, INT J PSYCHOPHYSIOL, V85, P224, DOI 10.1016/j.ijpsycho.2012.04.010	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264758	10.1371/journal.pone.0264758	http://dx.doi.org/10.1371/journal.pone.0264758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239737	Green Published, gold			2022-12-26	WOS:000776002200073
J	Nava-Santana, C; Rodriguez-Armida, M; Jimenez, JV; Vargas-Parra, N; Leon, DEA; Campos-Murguia, A; Macias-Rodriguez, R; Arteaga-Garrido, A; Hernandez-Villegas, AC; Dominguez-Cherit, G; Rivero-Sigarroa, E; Gamboa-Dominguez, A; Gullias-Herrero, A; Sifuentes-Osornio, J; Uribe-Uribe, NO; Morales-Buenrostro, LE				Nava-Santana, Carlos; Rodriguez-Armida, Maria; Victor Jimenez, Jose; Vargas-Parra, Nancy; Aguilar Leon, Diana E.; Campos-Murguia, Alejandro; Macias-Rodriguez, Ricardo; Arteaga-Garrido, Andres; Hernandez-Villegas, Antonio C.; Dominguez-Cherit, Guillermo; Rivero-Sigarroa, Eduardo; Gamboa-Dominguez, Armando; Gullias-Herrero, Alfonso; Sifuentes-Osornio, Jose; Ofelia Uribe-Uribe, Norma; Morales-Buenrostro, Luis E.			Clinicopathologic characteristics of severe COVID-19 patients in Mexico City: A post-mortem analysis using a minimally invasive autopsy approach	PLOS ONE			English	Article							NEUTROPHILS	Objective Describe the histological findings of minimally ultrasound-guided invasive autopsies in deceased patients with severe SARS-CoV-2 and compare the diagnostic yield with open autopsies. Design Observational post-mortem cohort study. Minimally invasive ultrasound-guided autopsies were performed in fourteen deceased patients with a confirmed diagnosis of SARS-CoV-2 pneumonia. Histological and clinical findings of lung, kidney, and liver tissue are described and contrasted with those previously reported in the literature. Setting Single-center COVID-19 reference center in Mexico City. Results Fourteen minimally invasive autopsies revealed a gross correlation with open autopsies reports: 1) Lung histology was characterized mainly by early diffuse alveolar damage (12/13). Despite low lung compliances and prolonged mechanical ventilation, the fibrotic phase was rarely observed (2/13). 2) Kidney histopathology demonstrated acute tubular injury (12/13), interstitial nephritis (11/13), and glomerulitis (11/13) as the predominant features 3) Liver histology was characterized by neutrophilic inflammation in all of the cases, as well as hepatic necrosis (8/14) despite minimal alterations in liver function testing. Hepatic steatosis was observed in most cases (12/14). SARS-CoV-2 positivity was widely observed throughout the immunohistochemical analysis. However, endothelitis and micro thrombosis, two of the hallmark features of the disease, were not observed. Conclusion Our data represents the largest minimally invasive, ultrasound-guided autopsy report. We demonstrate a gross histological correlation with large open autopsy cohorts. However, this approach might overlook major histologic features of the disease, such as endothelitis and micro-thrombosis. Whether this represents sampling bias is unclear.	[Nava-Santana, Carlos; Rodriguez-Armida, Maria; Morales-Buenrostro, Luis E.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol, Mexico City, DF, Mexico; [Victor Jimenez, Jose; Arteaga-Garrido, Andres; Gullias-Herrero, Alfonso; Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med, Mexico City, DF, Mexico; [Vargas-Parra, Nancy; Aguilar Leon, Diana E.; Gamboa-Dominguez, Armando; Ofelia Uribe-Uribe, Norma] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Pathol, Mexico City, DF, Mexico; [Campos-Murguia, Alejandro; Macias-Rodriguez, Ricardo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Mexico City, DF, Mexico; [Hernandez-Villegas, Antonio C.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Radiol, Mexico City, DF, Mexico; [Dominguez-Cherit, Guillermo; Rivero-Sigarroa, Eduardo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Crit Care Med, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Sifuentes-Osornio, J (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med, Mexico City, DF, Mexico.	jose.sifuenteso@incmnsz.mx		Jimenez, Jose Victor/0000-0002-9209-0327; Dominguez-Cherit, Guillermo/0000-0003-1403-4415				Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Bonaventura A, 2021, NAT REV IMMUNOL, V21, P319, DOI 10.1038/s41577-021-00536-9; Borczuk AC, 2020, MODERN PATHOL, V33, P2156, DOI 10.1038/s41379-020-00661-1; Brook OR, 2021, ABDOM RADIOL, V46, P1263, DOI 10.1007/s00261-020-02753-7; Bryce C, 2021, MODERN PATHOL, V34, P1456, DOI 10.1038/s41379-021-00793-y; Calabretta E, 2021, BRIT J HAEMATOL, V193, P43, DOI 10.1111/bjh.17240; Caramaschi S, 2021, MODERN PATHOL, V34, P1614, DOI 10.1038/s41379-021-00814-w; Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5; Castillo P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002171; Castillo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132057; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; D'Onofrio V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242300; De Michele S, 2020, AM J CLIN PATHOL, V154, P748, DOI 10.1093/ajcp/aqaa156; Duarte-Neto AN, 2020, HISTOPATHOLOGY, V77, P186, DOI 10.1111/his.14160; Duarte-Neto AN, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007625; Edler C, 2020, INT J LEGAL MED, V134, P1275, DOI 10.1007/s00414-020-02317-w; Fan ZY, 2020, CLIN GASTROENTEROL H, V18, P1561, DOI 10.1016/j.cgh.2020.04.002; Garcia-Basteiro AL, 2021, CHEST, V159, P103, DOI 10.1016/j.chest.2020.06.071; Golmai P, 2020, J AM SOC NEPHROL, V31, P1944, DOI 10.1681/ASN.2020050683; Gonzalez-Arnay E, 2020, J FORENSIC LEG MED, V76, DOI 10.1016/j.jflm.2020.102067; Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2; Grillo F, 2020, LANCET INFECT DIS, V21, pE72, DOI 10.1016/S1473-3099(20)30582-X; Hariri LP, 2021, CHEST, V159, P73, DOI 10.1016/j.chest.2020.09.259; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Keten D, 2020, J FORENSIC LEG MED, V73, DOI 10.1016/j.jflm.2020.102000; Kudose S, 2020, J AM SOC NEPHROL, V31, P1959, DOI 10.1681/ASN.2020060802; Lagana SM, 2020, MODERN PATHOL, V33, P2147, DOI 10.1038/s41379-020-00649-x; Levy JH, 2021, ARTERIOSCL THROM VAS, V41, P1774, DOI 10.1161/ATVBAHA.121.316101; Loupy A, 2017, AM J TRANSPLANT, V17, P28, DOI 10.1111/ajt.14107; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; Nascimbeni F, 2018, EXPERT REV GASTROENT, V12, P351, DOI 10.1080/17474124.2018.1415756; Polak SB, 2020, MODERN PATHOL, V33, P2128, DOI 10.1038/s41379-020-0603-3; Rakislova N, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10040412; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Santoriello D, 2020, J AM SOC NEPHROL, V31, P2158, DOI 10.1681/ASN.2020050744; Schurink B, 2020, LANCET MICROBE, V1, pE290, DOI 10.1016/S2666-5247(20)30144-0; Sharma P, 2020, J AM SOC NEPHROL, V31, P1948, DOI 10.1681/ASN.2020050699; Sonzogni A, 2020, LIVER INT, V40, P2110, DOI 10.1111/liv.14601; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Thille AW, 2013, AM J RESP CRIT CARE, V187, P761, DOI 10.1164/rccm.201211-1981OC; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wang XX, 2021, J CLIN PATHOL, V74, P522, DOI 10.1136/jclinpath-2020-206623; Wu J H, 2020, Zhonghua Bing Li Xue Za Zhi, V49, P568, DOI 10.3760/cma.j.cn112151-20200405-00291; Xu RN, 2014, CELL MOL IMMUNOL, V11, P224, DOI 10.1038/cmi.2014.2; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yao X H, 2020, Zhonghua Bing Li Xue Za Zhi, V49, P411, DOI 10.3760/cma.j.cn112151-20200312-00193; Yi ES, 2020, LANCET INFECT DIS, V20, P1102, DOI 10.1016/S1473-3099(20)30449-7; Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134	48	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0262783	10.1371/journal.pone.0262783	http://dx.doi.org/10.1371/journal.pone.0262783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239660	Green Published, gold			2022-12-26	WOS:000776002200007
J	Seneadza, NAH; Insaidoo, G; Boye, H; Ani-Amponsah, M; Leung, T; Meek, J; Enweronu-Laryea, C				Seneadza, Nana Ayegua Hagan; Insaidoo, Genevieve; Boye, Hilda; Ani-Amponsah, Mary; Leung, Terence; Meek, Judith; Enweronu-Laryea, Christabel			Neonatal jaundice in Ghanaian children: Assessing maternal knowledge, attitude, and perceptions	PLOS ONE			English	Article							OUTCOMES; ACCRA	Background Neonatal jaundice (NNJ) is a major cause of preventable childhood mortality and long-term impairment especially in countries with significant prevalence of the inherited condition, glucose-6-phosphate dehydrogenase (G6PD) defect. In Ghana, routine screening of pregnant women for G6PD defect is standard care. Prevention of poor health outcomes from NNJ is contingent on population health literacy and early diagnosis. As part of a project to evaluate a screening tool for NNJ, we assessed the knowledge, attitude, and perceptions of Ghanaian mothers on NNJ at baseline. Methods Using a cross-sectional design, mothers attending antenatal and postnatal clinics at 3 selected health facilities in 2 geographical regions of Ghana were interviewed. Data on mothers' understanding, perceptions, beliefs, and actions towards NNJ were evaluated. Chi-square test was used to determine the association between selected maternal characteristics and knowledge, attitude, and perception to NNJ. Results Of the 504 mothers interviewed, 428(85.4%) had heard about NNJ, 346 (68.7%) said the earliest signs are seen in the eyes, 384(76.2%) knew NNJ may be harmful and 467(92.7%) recommended seeking healthcare for the jaundiced newborn. None of the women knew about G6PD or their G6PD status following antenatal screening. Most did not know the signs/symptoms of severe NNJ. Of the 15 mothers who had had a jaundiced neonate, cost was the most perceived (8 out of 15) barrier to accessing health care. There were significant associations (p-value <= 0.05) between maternal age, educational level, and knowledge of NNJ. Conclusion Despite the high level of awareness of NNJ, gaps still exit in the knowledge, attitudes and perceptions of mothers concerning NNJ. Improving education of women about the causes, symptoms/signs, and the role of G6PD in severe NNJ is recommended. Addressing barriers to accessing healthcare for the jaundiced infant may enhance timely management of NNJ and reduce the associated complications and mortality.	[Seneadza, Nana Ayegua Hagan] Univ Ghana, Med Sch, Coll Hlth Sci, Dept Community Hlth, Accra, Ghana; [Insaidoo, Genevieve] Holy Family Hosp, Dept Child Hlth, Nkawkaw, Eastern Region, Ghana; [Boye, Hilda] Korle Bu Teaching Hosp, Dept Child Hlth, Accra, Ghana; [Ani-Amponsah, Mary] Univ Ghana, Coll Hlth Sci, Sch Nursing & Midwifery, Accra, Ghana; [Leung, Terence] UCL, Dept Med Phys & Biomed Engn, Malet Pl Engn Bldg, London, England; [Meek, Judith] Univ Coll London Hosp, Neonatal Care Unit, Ega Wing, London, England; [Enweronu-Laryea, Christabel] Univ Ghana, Med Sch, Coll Hlth Sci, Dept Child Hlth, Accra, Ghana	University of Ghana; University of Ghana; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Ghana	Enweronu-Laryea, C (corresponding author), Univ Ghana, Med Sch, Coll Hlth Sci, Dept Child Hlth, Accra, Ghana.	ccelaryea@ug.edu.gh		Ani-Amponsah, Mary/0000-0002-0480-612X; Enweronu-Laryea, Christabel/0000-0001-9346-5365	United States Agency for International Development (USAID) through its "Saving Lives at Birth (Round 7)" programme grant [RS 17-08196]	United States Agency for International Development (USAID) through its "Saving Lives at Birth (Round 7)" programme grant(United States Agency for International Development (USAID))	TL and CEL received funding support for the main study on evaluating a screening tool for neonatal jaundice from the United States Agency for International Development (USAID) through its "Saving Lives at Birth (Round 7)" programme grant (Grant ID: RS 17-08196) but not specifically for this baseline study which was conducted before the evaluation study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adei-Atiemo E, 2015, PEDIATRICS, V135, pS7, DOI 10.1542/peds.2014-3330K; Amegan-Aho Kokou H, 2019, Ghana Med J, V53, P267, DOI 10.4314/gmj.v53i4.3; [Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; Atay E, 2006, J TROP PEDIATRICS, V52, P56, DOI 10.1093/tropej/fmi042; Bee DT, 2016, ARCH DIS CHILDHOOD-E, V101, P210, DOI 10.1136/archdischild-2015-309450; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Boo N Y, 2011, Med J Malaysia, V66, P239; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Brethauer M, 2010, MCN-AM J MATERN-CHIL, V35, P8, DOI 10.1097/01.NMC.0000366803.88540.1d; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Ezeaka CV, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-192; Ghana Statistical Service-GSS Ghana Health Service-GHS and ICF, 2018, GHAN MAT HLTH SURV 2; Gilbert CJP., 1964, GHANA MED J, V3; Goodman Olayinka O, 2015, Niger Postgrad Med J, V22, P158, DOI 10.4103/1117-1936.170741; Gul S, 2014, INT J HEALTH SCI-IJH, V8, P167, DOI 10.12816/0006083; Hampshire K, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105257; Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries, 2001, NEUR PSYCH DEV DIS M; Isa Hasan M, 2017, Korean J Pediatr, V60, P106, DOI 10.3345/kjp.2017.60.4.106; IZUORA GI, 1985, CENT AFR J MED, V31, P13; Le LT, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-264; Leung TS, 2015, BIOMED OPT EXPRESS, V6, P4529, DOI 10.1364/BOE.6.004529; Magfouri H, 2019, J CLIN NEONATOL, V8, P116, DOI 10.4103/jcn.JCN_119_18; Manyeh Alfred Kwesi, 2017, BMC Res Notes, V10, P268, DOI 10.1186/s13104-017-2591-z; Maya-Enero S, 2020, EUR J PEDIATR, V179, P1403, DOI 10.1007/s00431-020-03623-6; Moawad EMI, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004804; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Ogunlesi TA, 2015, NIGER J CLIN PRACT, V18, P33, DOI 10.4103/1119-3077.146976; Onyearugha C, 2016, J HLTH SCI RES, V1, P42; Shrestha S, 2019, SRI LANKA J CHILD HE, V48, P215; Smitherman H, 2006, SEMIN FETAL NEONAT M, V11, P214, DOI 10.1016/j.siny.2006.02.002; Soghoian S, 2012, TROP MED INT HEALTH, V17, P135, DOI 10.1111/j.1365-3156.2011.02885.x; Sudakin Daniel L, 2011, Curr Top Toxicol, V7, P13; Taylor JA, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0312	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264694	10.1371/journal.pone.0264694	http://dx.doi.org/10.1371/journal.pone.0264694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239710	Green Published, gold			2022-12-26	WOS:000776002200063
J	Liang, YR; Liao, FC; Huang, TP				Liang, Ying-Ru; Liao, Fang-Chin; Huang, Tzu-Pi			Deciphering the influence of Bacillus subtilis strain Ydj3 colonization on the vitamin C contents and rhizosphere microbiomes of sweet peppers	PLOS ONE			English	Article							GROWTH-PROMOTING-RHIZOBACTERIA; FRUIT-QUALITY; RESPONSES; PGPR	Bacillus subtilis strain Ydj3 was applied to sweet peppers to understand the influence of this bacterium on the growth, fruit quality, and rhizosphere microbial composition of sweet pepper. The promotion of seed germination was observed for sweet pepper seeds treated with the Ydj3 strain, indicating that Ydj3 promoted seed germination and daily germination speed (131.5 +/- 10.8 seeds/day) compared with the control (73.8 +/- 2.5 seeds/day). Strain Ydj3 displayed chemotaxis toward root exudates from sweet pepper and could colonize the roots, which enhanced root hair growth. Following the one-per-month application of strain Ydj3 to sweet pepper grown in a commercial greenhouse, the yield, fruit weight, and vitamin C content significantly increased compared with those of the control. Additionally, the composition of the rhizosphere bacterial community of sweet pepper changed considerably, with the Bacillus genus becoming the most dominant bacterial genus in the treated group. These results suggested that B. subtilis Ydj3 promotes seed germination and enhances fruit quality, particularly the vitamin C content, of sweet pepper. These effects may be partly attributed to the B. subtilis Ydj3 colonization of sweet pepper roots due to Ydj3 chemotaxis toward root exudates, resulting in the modulation of the rhizosphere bacterial community.	[Liang, Ying-Ru; Huang, Tzu-Pi] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan; [Liang, Ying-Ru; Liao, Fang-Chin] Council Agr, Agr Chem & Tox Subst Res Inst, Execut Yuan, Taichung, Taiwan; [Huang, Tzu-Pi] Natl Chung Hsing Univ, Innovat & Dev Ctr Sustainable Agr, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University	Huang, TP (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan.; Huang, TP (corresponding author), Natl Chung Hsing Univ, Innovat & Dev Ctr Sustainable Agr, Taichung, Taiwan.	tphuang@nchu.edu.tw		Huang, Tzu-Pi/0000-0003-2904-3373				Abu-Zahra T R, 2011, Pak J Biol Sci, V14, P876, DOI 10.3923/pjbs.2011.876.881; Agarwal M, 2017, MICROBIOL RES, V205, P40, DOI 10.1016/j.micres.2017.08.012; Ali MB, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-84; Biswas T., 2017, OVERVIEW US BELL PEP; Calatayud A, 2018, PEPPER CROP CLIMATE, P129; Pinero MC, 2018, J SCI FOOD AGR, V98, P1071, DOI 10.1002/jsfa.8557; Cisternas-Jamet J, 2020, SCI HORTIC-AMSTERDAM, V263, DOI 10.1016/j.scienta.2019.109107; Flores-Felix JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122281; Djavanshir K., 1976, Silvae Genetica, V25, P79; Fan B, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02491; FAOSTAT Database, FOOD AGR ORG UN 2020; Gomez-Lopez MD, 2013, J SCI FOOD AGR, V93, P1062, DOI 10.1002/jsfa.5847; Grover M, 2021, FRONT SUSTAIN FOOD S, V4, DOI 10.3389/fsufs.2020.618230; Huang TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042124; Huang YY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9397619; Lamsal Kabir, 2012, Mycobiology, V40, P244, DOI 10.5941/MYCO.2012.40.4.244; Lee Y, 1999, J AGR FOOD CHEM, V47, P700, DOI 10.1021/jf980921h; Li YJ, 2020, OPEN LIFE SCI, V15, P553, DOI 10.1515/biol-2020-0062; Lopez-Bucio J, 2007, MOL PLANT MICROBE IN, V20, P207, DOI 10.1094/MPMI-20-2-0207; Mamphogoro TP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65587-9; Mashabela MN, 2015, J FOOD SCI, V80, pH2612, DOI 10.1111/1750-3841.13103; Mazumder R, 1999, J MICROBIOL METH, V37, P255, DOI 10.1016/S0167-7012(99)00072-X; Mena-Violante HG, 2007, SCI HORTIC-AMSTERDAM, V113, P103, DOI 10.1016/j.scienta.2007.01.031; Perez-Lopez AJ, 2007, J SCI FOOD AGR, V87, P2075, DOI 10.1002/jsfa.2966; Qiao JQ, 2017, BMC MICROBIOL, V17, P1, DOI 10.1186/s12866-017-1039-x; Rahman M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20235-1; Sun B, 2020, ENVIRON INT, V144, DOI 10.1016/j.envint.2020.105989; Tan SY, 2013, APPL SOIL ECOL, V64, P15, DOI 10.1016/j.apsoil.2012.10.011; Tu L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3251357; Vacheron J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00356; Yamada S, 1999, APPL ENVIRON MICROB, V65, P1483; Zhang N, 2014, PLANT SOIL, V374, P689, DOI 10.1007/s11104-013-1915-6	32	0	0	11	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264276	10.1371/journal.pone.0264276	http://dx.doi.org/10.1371/journal.pone.0264276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226695	Green Published, gold			2022-12-26	WOS:000793394000014
J	Horback, KM; Parsons, TD				Horback, Kristina M.; Parsons, Thomas D.			Judgement bias of group housed gestating sows predicted by behavioral traits, but not physical measures of welfare	PLOS ONE			English	Article							COGNITIVE BIAS; INDIVIDUAL-DIFFERENCES; COPING STYLES; PERSONALITY; ANIMALS; EXPRESSION; MOTIVATION; EMOTIONS; ABILITY; PIGS	Judgement bias testing has emerged as a potential tool for assessing affective states in animals. Researchers infer an animal's affective state based on an animal's response to an ambiguous stimulus that is intermediate to both the rewarded and punished conditioned stimuli. Animals can be classified as "optimistic" or having a positive affective state if the animal displays behaviors that suggest an increased expectation of reward in the face of ambiguous stimuli. Alternatively, animals can be classified "pessimistic" or having a negative affective state if the animal displays behaviors that suggest an increased expectation of punishment in the face of ambiguous stimuli. Recent reports in multiple species question what factors influence performance in judgement bias testing, and which may allow for erroneous conclusions regarding individual affective state. In order to better understand this concern, 25 female swine were subjected to behavioral assessments at critical rearing stages to determine response variability. These same individuals were then assessed for physical measures of welfare and judgement bias using the "go/no-go" task as breeding adults. Sows which were more aggressive approached the ambiguous, but not the positive, stimulus significantly faster than others. Both optimistic and pessimistic biases were observed despite all sows living in enriched housing, and, sows with more positive physical welfare measures (fewer skin lesions and healthy body condition) did not exhibit more optimistic judgement biases. Our data demonstrate that behavior traits, such as aggressiveness, can affect a sow's performance in a judgement bias test, while measures of physical health did not. We suggest that individual differences in behavior (e.g., bold-aggressive behavioral syndrome, or, proactive coping style) generate different emotional responses and can contribute to the animal's overall affective state more so than physical ailment. Our findings highlight the complexity of how different factors impact an animal's overall affective state and support the need for complementary measures in future JBT studies, including personality assessment.	[Horback, Kristina M.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Parsons, Thomas D.] Univ Penn, Swine Teaching & Res Ctr, Dept Clin Studies, Sch Vet Med, Kennett Sq, Philadelphia, PA 19104 USA	University of California System; University of California Davis; University of Pennsylvania	Horback, KM (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	kmhorback@ucdavis.edu		Horback, Kristina/0000-0003-1667-4280	Kraft Foods Oscar Mayer; Pig Improvement Company; Pennsylvania Pork Producers Council; Pennsylvania Soybean Board; Pennsylvania Department of Agriculture; American Society for the Prevention of Cruelty to Animals	Kraft Foods Oscar Mayer; Pig Improvement Company; Pennsylvania Pork Producers Council; Pennsylvania Soybean Board; Pennsylvania Department of Agriculture; American Society for the Prevention of Cruelty to Animals	This work was supported in part by Kraft Foods Oscar Mayer, Pig Improvement Company,Pennsylvania Pork Producers Council, Pennsylvania Soybean Board, Pennsylvania Department of Agriculture, and the American Society for the Prevention of Cruelty to Animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arey DS, 1998, LIVEST PROD SCI, V56, P61, DOI 10.1016/S0301-6226(98)00144-4; Asher L, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0402; Barnard S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25224-y; Barnett JL, 2001, AUST J AGR RES, V52, P1, DOI 10.1071/AR00057; Bates D, 2012, LME4 LINEAR MIXED EF; Capitanio JP, 1999, BRAIN BEHAV IMMUN, V13, P138, DOI 10.1006/brbi.1998.0540; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Clegg ILK, 2017, BEHAV BRAIN RES, V322, P115, DOI 10.1016/j.bbr.2017.01.026; Coffey RD, 1999, ASC158; Cussen VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126170; Cussen VA, 2014, ANIM BEHAV, V89, P123, DOI 10.1016/j.anbehav.2013.12.022; d'Ettorre P, 2017, BEHAV PROCESS, V134, P63, DOI 10.1016/j.beproc.2016.09.008; Desire L, 2002, BEHAV PROCESS, V60, P165, DOI 10.1016/S0376-6357(02)00081-5; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Dupjan S, 2013, J VET BEHAV, V8, P485, DOI 10.1016/j.jveb.2013.05.007; Faustino AI, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00104; Goursot C, 2021, APPL ANIM BEHAV SCI, V237, DOI 10.1016/j.applanim.2021.105279; Gygax L, 2014, ANIM BEHAV, V95, P59, DOI 10.1016/j.anbehav.2014.06.013; Hallion LS, 2011, PSYCHOL BULL, V137, P940, DOI 10.1037/a0024355; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Henry S, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-016-1429-1; Horback K., 2017, PERSONALITY NONHUMAN; Horback KM, 2019, BEHAV PROCESS, V159, P86, DOI 10.1016/j.beproc.2018.12.021; Horback KM, 2018, ANIMAL, V12, P2365, DOI 10.1017/S1751731118000149; Horback KM, 2016, ANIMAL, V10, P1351, DOI 10.1017/S1751731116000215; Ijichi C, 2014, APPL ANIM BEHAV SCI, V152, P38, DOI 10.1016/j.applanim.2013.12.007; Ijichi CL, 2013, ANIM BEHAV, V85, P1145, DOI 10.1016/j.anbehav.2013.03.033; Janczak AM, 2003, APPL ANIM BEHAV SCI, V82, P121, DOI 10.1016/S0168-1591(03)00055-8; Jardim V, 2021, BEHAV BRAIN RES, V407, DOI 10.1016/j.bbr.2021.113262; Keen HA, 2014, ANIM COGN, V17, P529, DOI 10.1007/s10071-013-0684-1; Kirkden RD, 2006, APPL ANIM BEHAV SCI, V100, P29, DOI 10.1016/j.applanim.2006.04.009; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lalot M, 2017, BEHAV PROCESS, V134, P70, DOI 10.1016/j.beproc.2016.09.012; Lecorps Benjamin, 2020, JDS Commun, V1, P45, DOI 10.3168/jdsc.2020-0023; Lecorps B, 2021, NEUROSCI BIOBEHAV R, V130, P240, DOI 10.1016/j.neubiorev.2021.08.025; Long J.S., 2006, REGRESSION MODELS CA, VSecond; Lovendahl P, 2005, LIVEST PROD SCI, V93, P73, DOI 10.1016/j.livprodsci.2004.11.008; Luo L, 2019, ANIM COGN, V22, P959, DOI 10.1007/s10071-019-01287-w; Marchant-Forde J.N., 2008, WELFARE PIGS, V7; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Matzel LD, 2003, J NEUROSCI, V23, P6423; MEESE GB, 1973, ANIM BEHAV, V21, P326, DOI 10.1016/S0003-3472(73)80074-0; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Neave HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080556; Patterson-Kane EG, 2011, J APPL ANIM WELF SCI, V14, P175, DOI 10.1080/10888705.2011.575739; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pierdon MK, 2018, J ANIM SCI, V96, P5024, DOI 10.1093/jas/sky380; Reimert I, 2013, PHYSIOL BEHAV, V109, P42, DOI 10.1016/j.physbeh.2012.11.002; SCHOUTEN WGP, 1991, BEHAV PROCESS, V25, P125, DOI 10.1016/0376-6357(91)90015-R; Schulz LL., 2015, CHOICES, V30, P1; Scollo A, 2014, APPL ANIM BEHAV SCI, V153, P26, DOI [10.1016/j.applanim.2014.01.006, 10.1016/j.appl]; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; Thodberg K, 2002, APPL ANIM BEHAV SCI, V77, P53, DOI 10.1016/S0168-1591(02)00023-0; Tonepohl B, 2013, APPL ANIM BEHAV SCI, V144, P108, DOI 10.1016/j.applanim.2013.01.004; Varley M.A., 1993, P BRIT SOC ANIM PROD, P14; Verjat A, 2021, ANIM COGN, V24, P53, DOI 10.1007/s10071-020-01414-y; Weaver SA, 2004, J AGR ENVIRON ETHIC, V17, P51, DOI 10.1023/B:JAGE.0000010844.52041.32; Zinpro, 2012, FEET 1 SWIN LOC SCOR	59	3	3	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264258	10.1371/journal.pone.0264258	http://dx.doi.org/10.1371/journal.pone.0264258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213574	Green Published, gold			2022-12-26	WOS:000787811000066
J	Darwish, AMG; Allam, MG; Shokery, ES; Ayad, EHE				Darwish, Amira M. G.; Allam, Marwa G.; Shokery, Enaam S.; Ayad, Eman H. E.			Functional products fortified with probiotic LAB isolated from Egyptian dairy sources showed hypolipidemic effects in Albino rats	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; STREPTOCOCCUS-THERMOPHILUS; MILK; COMBINATION; METABOLISM; CHEESE; STRAIN; COW	Biological food industry has increased economic importance of new Lactic Acid Bacteria (LAB) with functional aspects such as health promoting and enhanced sensorial traits. The objectives of the present study were the isolation and genotypic characterization (16S rRNA) of new LAB isolates from Egyptian Laban Rayeb, Zabady and mothers' breast milk as potential probiotics. Strains were in vitro and in vivo evaluated for their safety and probiotic health promoting traits in Albino rats then applied into two types of functional dairy products. Three strains Streptococcus thermophilus MH422542, Enterococcus faecium MH422543 and Lactococcus lactis subsp lactis MH422545, were selected from a pool of 82 strains. St. thermophilus showed proteolytic activity and production of Exopolysaccharides (EPS). When evaluated in animal models; the strains showed hypolipidemic effects especially E. faecium that reduced atherogenic indices up to 88%. The strains modulated the gut microbiota by reducing Staphylococcus sp. and coliforms with no adverse effects either on blood parameters, antioxidant enzymes, cancer markers or hepatocytes histological examination. Only E. faecium MH422543 showed an immune response by increased white blood cells (WBC) while lymph and platelets values were not affected. The probiotic strains approved their convenience as starter/ adjunct cultures and enhanced organoleptic properties of the fermented dairy products.	[Darwish, Amira M. G.] Arid Lands Cultivat Res Inst ALCRI, City Sci Res & Technol Applicat SRTA City, Alexandria, Egypt; [Allam, Marwa G.; Ayad, Eman H. E.] Alexandria Univ, Fac Agr, Food Sci Dept, Alexandria, Egypt; [Shokery, Enaam S.] Alexandria Univ, Fac Agr, Dairy Sci & Technol Dept, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City); Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Darwish, AMG (corresponding author), Arid Lands Cultivat Res Inst ALCRI, City Sci Res & Technol Applicat SRTA City, Alexandria, Egypt.	amiragdarwish@yahoo.com	Darwish, Amira M.G./I-9278-2016	Darwish, Amira M.G./0000-0003-3586-1575	Faculty of Agriculture Saba Basha, Alexandria University Culture Collection (FABA); Alexandria University (ALXREP)	Faculty of Agriculture Saba Basha, Alexandria University Culture Collection (FABA); Alexandria University (ALXREP)(Alexandria University)	Strains applied in this research are registered at Faculty of Agriculture Saba Basha, Alexandria University Culture Collection (FABA), which was established within the project funded by Alexandria University (ALXREP).	Allam MGM, 2017, LWT-FOOD SCI TECHNOL, V79, P625, DOI 10.1016/j.lwt.2016.11.032; Allam MGM., 2016, RES J MICROBIOL, V11, P169, DOI [10.3923/jm.2016.169.177, DOI 10.3923/JM.2016.169.177]; [Anonymous], 2009, 229353 ISO, VFirst edit; [Anonymous], 2020, RAD GUID 2020, P1; Ayad EHE, 2004, FOOD MICROBIOL, V21, P715, DOI 10.1016/j.fm.2004.02.009; Ayad EHE, 2002, INT DAIRY J, V12, P145, DOI 10.1016/S0958-6946(01)00133-9; Ayad EHE, 2006, LAIT, V86, P317, DOI 10.1051/lait:2006007; Baccigalupi L, 2005, RES MICROBIOL, V156, P830, DOI 10.1016/j.resmic.2005.05.001; Bennama R, 2012, EUR FOOD RES TECHNOL, V234, P119, DOI 10.1007/s00217-011-1620-8; Bintsis T, 2018, AIMS MICROBIOL, V4, P665, DOI 10.3934/microbiol.2018.4.665; Breidt F, 1996, J RAPID METH AUT MIC, V4, P219; Chen C, 2017, INT J FOOD PROP, V20, pS316, DOI 10.1080/10942912.2017.1295988; Dan T, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02183; Darwish AMG., 2010, EG C DAIR SCI TECHN, P565; Darwish AMG., 2018, MICROB BIOSYST, DOI [10.21608/mb.2018.4276.1001, DOI 10.21608/MB.2018.4276.1001]; Darwish AMG, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.654624; Dasen G, 1998, SYST APPL MICROBIOL, V21, P251, DOI 10.1016/S0723-2020(98)80030-1; Dave RI, 1998, J DAIRY SCI, V81, P2804, DOI 10.3168/jds.S0022-0302(98)75839-4; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; El-Kholy WM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222789; El-Soda M., 2003, Egyptian Journal of Dairy Science, V31, P23; Erejuwa OO, 2010, INT J MOL SCI, V11, P2056, DOI 10.3390/ijms11052056; Fenster K, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030083; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gordon GJ, 2000, AM J PATHOL, V156, P607, DOI 10.1016/S0002-9440(10)64765-7; Holmes DT, 2008, CLIN BIOCHEM, V41, P631, DOI 10.1016/j.clinbiochem.2008.01.023; Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001; Iyer R, 2010, INT DAIRY J, V20, P133, DOI 10.1016/j.idairyj.2009.10.005; Jantararussamee C, 2021, PROBIOTICS ANTIMICRO, V13, P40, DOI 10.1007/s12602-020-09663-6; Kapila Suman, 2006, Indian J Med Sci, V60, P361; Kumar V., 2010, ROBBINS PATHOLOGICAL, V7th, DOI [10.1097/NEN.0b013e3181cd8dbc, DOI 10.1097/NEN.0B013E3181CD8DBC]; Latimer G.W., 2016, OFFICIAL METHODS ANA, V20st; Lequin RM, 2005, CLIN CHEM, V51, P2415, DOI 10.1373/clinchem.2005.051532; Ling ER., 1945, TXB DAIRY CHEM, V2nd, DOI [10.1038/155709a0, DOI 10.1038/155709A0]; MacFaddin JF., 1976, BIOCH TESTS IDENTIFI, P643; Maniatis T., 1982, MOL CLONING; Mannucci C, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020261; Mostefaoui A., 2014, African Journal of Microbiology Research, V8, P2208; Navidghasemizad S, 2009, INT J DAIRY TECHNOL, V62, P260, DOI 10.1111/j.1471-0307.2009.00462.x; Ozturk B, 2015, FOOD CHEM, V187, P499, DOI 10.1016/j.foodchem.2015.04.065; Prasad Patil, 2015, Asian Journal of Dairy and Food Research, V34, P280; Riane K, 2020, BRAZ J MICROBIOL, V51, P1615, DOI 10.1007/s42770-020-00302-4; ROSEN JA, 1977, PLANT PHYSIOL, V59, P1085, DOI 10.1104/pp.59.6.1085; Sarao LK, 2017, CRIT REV FOOD SCI, V57, P344, DOI 10.1080/10408398.2014.887055; Scourboutakos MJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040400; Narayan KS, 2021, FERMENTATION-BASEL, V7, DOI 10.3390/fermentation7020047; Soni R, 2020, J FOOD SCI TECH MYS, V57, P2038, DOI 10.1007/s13197-020-04238-3; Surber G, 2019, FOODS, V8, DOI 10.3390/foods8050146; Tamime AY., 2007, TAMIME ROBENSONS YOG, V3rd ed; Terpou A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071591; THIBOUTOT H, 1995, MILCHWISSENSCHAFT, V50, P448; Tulini FL, 2016, J DAIRY RES, V83, P115, DOI 10.1017/S0022029915000606; Wa YC, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01312; Walzik D, 2021, EUR J APPL PHYSIOL, V121, P1803, DOI 10.1007/s00421-021-04668-7; Wei PL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28215-1; Xu ZP, 2015, FOOD SCI TECHNOL RES, V21, P263, DOI 10.3136/fstr.21.263; Xu ZY, 2021, INT J BIOL MACROMOL, V178, P263, DOI 10.1016/j.ijbiomac.2021.02.173; Zhong H, 2020, FOOD FUNCT, V11, P9192, DOI [10.1039/d0fo00334d, 10.1039/D0FO00334D]; Zommara M. A., 2006, Egyptian Journal of Dairy Science, V34, P47	62	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263241	10.1371/journal.pone.0263241	http://dx.doi.org/10.1371/journal.pone.0263241			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235577	Green Published, gold			2022-12-26	WOS:000787073100047
J	Fentie, D; Derese, T				Fentie, Dilnessa; Derese, Tariku			Prevalence and associated factors of overweight/obesity among severely ill psychiatric patients in Eastern Ethiopia: A comparative cross-sectional study	PLOS ONE			English	Article							OBESITY	BackgroundGlobally, the burden of overweight and obesity is a major cardiovascular disease risk factor and is even higher among patients with psychiatric disorders compared to the general population. This is mainly due to the deleterious lifestyles characterized by physical inactivity, excessive substance use, and unhealthy diets common among patients with psychiatric disorders, as well as the negative metabolic effects of psychotropic medications. Despite these conditions being a high burden among patients with psychiatric illness, little attention is given to them during routine reviews in psychiatric clinics in most African nations, including Ethiopia. Therefore, this study aimed to estimate and compare the prevalence of and associated risk factors for overweight and obesity among patients with psychiatric illnesses. MethodsA comparative cross-sectional study was conducted between severely ill psychiatric patients and non-psychiatric patients in Dire Dawa, Eastern Ethiopia. The study included 192 study participants (96 psychiatric patients and 96 non-psychiatric controls). Weight and height were measured for 192 study participants. Baseline demographic and clinical characteristics of psychiatric and non-psychiatric patients were described. The data were cleaned and analyzed using the Statistical Package for Social Sciences, Version 21. The intergroup comparisons were performed using an independent sample t-test and Chi-square tests. Logistic regression analysis was used to identify the association between overweight/obesity and the associated variables. ResultsThe magnitude of overweight/obesity was significantly higher in the severely ill psychiatric groups (43.8%) than in the non-exposed controls (20.80%). The prevalence of overweight/obesity was highest in major depressive disorders (40%), followed by schizophrenia (32%), and bipolar disorder (28%). ConclusionsThere was a high prevalence of obesity/overweight among psychiatric patients. Educational status, unemployment, and late stages of the disease were significant predictors of overweight/ obesity. Clinicians should be aware of the health consequences of overweight/obesity, and considering screening strategies as a part of routine psychiatric care is strongly recommended.	[Fentie, Dilnessa] Dire Dawa Univ, Coll Med & Hlth Sci, Sch Med, Dire Dawa, Ethiopia; [Derese, Tariku] Dire Dawa Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Dire Dawa, Ethiopia	University of Gondar; University of Gondar	Fentie, D (corresponding author), Dire Dawa Univ, Coll Med & Hlth Sci, Sch Med, Dire Dawa, Ethiopia.	fagitaabo@gmail.com						Ajayi IO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3789-z; Aldossari KK, 2021, SAUDI J BIOL SCI, V28, P2783, DOI 10.1016/j.sjbs.2021.02.008; AlQahtani AAA., 2015, SAUDI J OBESITY, V3, P48, DOI DOI 10.4103/2347-2618.171953; Annamalai A, 2017, WORLD J DIABETES, V8, P390, DOI 10.4239/wjd.v8.i8.390; Asaye S, 2018, DIABETES METAB SYND, V12, P753, DOI 10.1016/j.dsx.2018.04.037; Association AP, 2004, ENCY APPL PSYCHOL, P607; Care PH., 2017, PRIM HEAL CARE, V7, P1; Cerezo C, 2013, CURR HYPERTENS REP, V15, P196, DOI 10.1007/s11906-013-0337-4; Chao AM, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-0990-7; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chouinard VA, 2016, PSYCHIAT RES, V237, P304, DOI 10.1016/j.psychres.2016.01.024; Demographic E, 2017, ETH DEM HLTH SURV 20, P158; Getachew T, 2017, ETHIOP J HEALTH DEV, V31, P312; Hughes A, 2017, PREV MED, V97, P19, DOI 10.1016/j.ypmed.2016.12.045; Husky MM, 2017, J WOMENS HEAL, V00; Kamel A, 2016, EGYPT J PSYCHIAT, V37, P157; Marcus MD, 2014, J LIFE LONG LEARNING, V12, P476; Mekonnen T., 2019, BMC OBES, V6, P1; Prevention(CDC) CFDC, 2017, BURD OV OB AD POP, P125; Pringle Jan., 2019, U EDINBURGH, P6; Ryan H, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/918368; Tran A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/193719; Weiss F, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082344; Weschenfelder J., 2018, LICENS INTECHOPEN, P17; WHO, 2017, WORLD OB DAY UND SOC, V10; WHO, 2016, WHO REP WORLW IMP OB; WHO, 2010, TECHNICAL REPORT; Wilson Angela L, 2014, Evid Based Nurs, V17, P112, DOI 10.1136/eb-2013-101675; World Health Organization, 2020, DIG TOOLS COVID 19 C; Zukiewicz-Sobczak W, 2014, ANN AGR ENV MED, V21, P590, DOI 10.5604/12321966.1120608	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264461	10.1371/journal.pone.0264461	http://dx.doi.org/10.1371/journal.pone.0264461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T6JP	35235579	Green Published, gold			2022-12-26	WOS:000787073100030
J	Roloff, C; Berg, P				Roloff, Christoph; Berg, Philipp			Effect of flow diverter stent malposition on intracranial aneurysm hemodynamics-An experimental framework using stereoscopic particle image velocimetry	PLOS ONE			English	Article							ENDOVASCULAR TREATMENT; CEREBRAL ANEURYSMS; DIVERSION; COMPLICATIONS; COILING; SURVIVAL	BackgroundFlow-diverting stents are increasingly used for the minimally-invasive treatment of intracranial aneurysms. However, a correct positioning of such devices can be challenging due to varying vessel diameters as well as the complex anatomy of the neurovasculature. As a consequence, unsuccessful treatment outcomes are increasingly reported requiring an improvement of the understanding of stent-induced flow modification. MethodsTo evaluate the effect of different degrees of flow diverter stent malposition on intra-aneurysmal hemodynamic changes, a controlled hemodynamic configuration was created using an idealized intracranial aneurysms model. Afterwards, four different treatment scenarios were reproduced comprising of 1) the ideal treatment, 2) an insufficient wall apposition in the region of the ostium, 3) a distorted device migrating into the aneurysm sac and 4) an inaccurately deployed stent due to wrong release location. For the assessment of the individual flow modifications, high-resolution stereoscopic particle image velocimetry (PIV) measurements were carried out. ResultsThe analysis of the precise in-vitro PIV measurements reveals that in all cases a considerable reduction of the cycle-averaged and peak-systolic velocity was obtained. Compared to the untreated aneurysm configuration, the flow reduction ranged from 63% (scenario 4) up to 89% (scenario 3). The ideal treatment reached a reduction of 78%, which is known to be sufficient for a successful therapy. However, inaccurate device positioning leads to increased oscillating flow towards the lateral directions reducing the chances of sufficient thrombus formation. ConclusionsHigh-resolution in-vitro PIV measurements enable an accurate quantification of the treatment efficacy for flow-diverting devices. Furthermore, insufficient treatment outcomes can be reproduces allowing for an assessment of intra-aneurysmal hemodynamic changes.	[Roloff, Christoph; Berg, Philipp] Univ Magdeburg, Lab Fluid Dynam & Tech Flows, Magdeburg, Germany; [Berg, Philipp] Univ Magdeburg, Res Campus STIMULATE, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Berg, P (corresponding author), Univ Magdeburg, Lab Fluid Dynam & Tech Flows, Magdeburg, Germany.; Berg, P (corresponding author), Univ Magdeburg, Res Campus STIMULATE, Magdeburg, Germany.	berg@ovgu.de			Federal Ministry of Education and Research in Germany within the Forschungscampus STIMULATE [13GW0095A]; German Research Foundation [BE 6230/2-1]	Federal Ministry of Education and Research in Germany within the Forschungscampus STIMULATE; German Research Foundation(German Research Foundation (DFG))	This study was partly funded by the Federal Ministry of Education and Research in Germany within the Forschungscampus STIMULATE (grant number 13GW0095A) and the German Research Foundation (grant number BE 6230/2-1).	Amili O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188323; Anderson JR, 2015, IEEE ENG MED BIO, P7300, DOI 10.1109/EMBC.2015.7320077; Berg P, 2017, ELS MIC SOC BOOK SER, P371, DOI 10.1016/B978-0-12-811018-8.00014-X; Berg P, 2018, INT J ARTIF ORGANS, V41, P698, DOI 10.1177/0391398818775521; Berg P, 2016, J BIOMECH, V49, P4, DOI 10.1016/j.jbiomech.2015.10.047; Berg P, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031794; Bonney PA, 2020, NEUROSURGERY, V86, pS64, DOI 10.1093/neuros/nyz305; Briganti F, 2015, NEURORADIOL J, V28, P365, DOI 10.1177/1971400915602803; Brina O, 2019, AM J NEURORADIOL, V40, P2117, DOI 10.3174/ajnr.A6312; Brinjikji W, 2015, AM J NEURORADIOL, V36, P2308, DOI 10.3174/ajnr.A4443; Brinjikji W, 2015, AM J NEURORADIOL, V36, P1216, DOI 10.3174/ajnr.A4175; Brinjikji W, 2013, STROKE, V44, P442, DOI 10.1161/STROKEAHA.112.678151; Britz GW, 2004, STROKE, V35, P1399, DOI 10.1161/01.STR.0000128706.41021.01; Bruneau M, 2016, NEUROSURGERY, V78, P47, DOI 10.1227/NEU.0000000000000991; Cagnazzo F, 2018, AM J NEURORADIOL, V39, P1669, DOI 10.3174/ajnr.A5730; Chalouhi N, 2013, STROKE, V44, P2150, DOI 10.1161/STROKEAHA.113.001785; Chiu AHY, 2020, NEUROSURGERY, V86, pS106, DOI 10.1093/neuros/nyz343; Chodzynski KJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67218-9; Cohen JE, 2014, J CLIN NEUROSCI, V21, P1116, DOI 10.1016/j.jocn.2013.11.010; D'Urso PI, 2011, STROKE, V42, P2363, DOI 10.1161/STROKEAHA.111.620328; Gounis MJ, 2019, STROKE, V50, P218, DOI 10.1161/STROKEAHA.118.022315; Guedon A, 2016, J NEUROSURG, V125, P929, DOI 10.3171/2015.10.JNS15703; Janiga G, 2015, J BIOMECH, V48, P3846, DOI 10.1016/j.jbiomech.2015.09.039; Krebs JM., 2020, MED IMAGING 2020 BIO, P39; Kulcsar Z, 2011, AM J NEURORADIOL, V32, P20, DOI 10.3174/ajnr.A2370; Li YJ, 2021, TECHNOL HEALTH CARE, V29, P253, DOI 10.3233/THC-202252; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Muhl-Benninghaus Ruben, 2019, J Neurointerv Surg, V11, P196, DOI 10.1136/neurintsurg-2018-013975; Rajah G, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.3.FOCUS16427; Ravindran K, 2019, AM J NEURORADIOL, V40, P295, DOI 10.3174/ajnr.A5955; Ravindran K, 2020, NEUROSURGERY, V86, pS13, DOI 10.1093/neuros/nyz324; Rouchaud A, 2016, AM J NEURORADIOL, V37, P2087, DOI 10.3174/ajnr.A4848; Rouchaud A, 2016, NEURORADIOLOGY, V58, P171, DOI 10.1007/s00234-015-1615-4; Schneiders J J, 2013, AJNR Am J Neuroradiol, V34, pE1, DOI 10.3174/ajnr.A2613; Seibert Brad, 2011, Front Neurol, V2, P45, DOI 10.3389/fneur.2011.00045; Silva MA, 2019, J NEUROSURG, V130, P1505, DOI 10.3171/2018.1.JNS171774; Sindeev S, 2019, WORLD NEUROSURG, V122, pE577, DOI 10.1016/j.wneu.2018.10.107; Tanioka S, 2019, J NEUROINTERV SURG, V11, P614, DOI 10.1136/neurintsurg-2018-014489; Tupin S, 2020, EXP FLUIDS, V61, DOI 10.1007/s00348-020-02998-4; Zhang MZ, 2021, INT J NUMER METH BIO, V37, DOI 10.1002/cnm.3465; Zhao B, 2016, AM J NEURORADIOL, V37, P1700, DOI 10.3174/ajnr.A4834; Zhou G, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.3.FOCUS16450	42	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264688	10.1371/journal.pone.0264688	http://dx.doi.org/10.1371/journal.pone.0264688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235597	Green Published, gold			2022-12-26	WOS:000787073100005
J	Castiglioni, VG; Ramalho, JJ; Kroll, JR; Stucchi, R; van Beuzekom, H; Schmidt, R; Altelaar, M; Boxem, M				Castiglioni, Victoria G.; Ramalho, Joao J.; Kroll, Jason R.; Stucchi, Riccardo; van Beuzekom, Hanna; Schmidt, Ruben; Altelaar, Maarten; Boxem, Mike			Identification and characterization of Crumbs polarity complex proteins in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA STARDUST; TIGHT JUNCTIONS; CELL POLARITY; PHOTORECEPTOR MORPHOGENESIS; TRANSMEMBRANE PROTEIN; RETINITIS-PIGMENTOSA; MPZ-1 INTERACT; HOMOLOG; PATJ; PALS1	Crumbs proteins are evolutionarily conserved trans-membrane proteins with essential roles in promoting the formation of the apical domain in epithelial cells. The short intracellular tail of Crumbs proteins are known to interact with several proteins, including the scaffolding protein PALS1 (protein associated with LIN7, Stardust in Drosophila). PALS1 in turn binds to a second scaffolding protein PATJ (PALS1-associated tight junction protein) to form the core Crumbs/ PALS1/PATJ complex. While essential roles in epithelial organization have been shown for Crumbs proteins in Drosophila and mammalian systems, the three Caenorhabditis elegans crumbs genes are dispensable for epithelial polarization and development. Here, we investigated the presence and function of PALS1 and PATJ orthologs in C. elegans. We identified MAGU-2 as the C. elegans ortholog of PALS1 and show that MAGU-2 interacts with all three Crumbs proteins and localizes to the apical membrane domain of intestinal epithelial cells in a Crumbs-dependent fashion. Similar to crumbs mutants, magu-2 deletion showed no epithelial polarity defects. We also identified MPZ-1 as a candidate ortholog of PATJ based on the physical interaction with MAGU-2 and sequence similarity with PATJ proteins. However, MPZ-1 is not broadly expressed in epithelial tissues and, therefore, not likely a core component of the C. elegans Crumbs complex. Finally, we show over-expression of the Crumbs proteins EAT-20 or CRB-3 can lead to apical membrane expansion in the intestine. Our results shed light on the composition of the C. elegans Crumbs com-plex and indicate that the role of Crumbs proteins in promoting apical domain formation is conserved.	[Castiglioni, Victoria G.; Ramalho, Joao J.; Kroll, Jason R.; van Beuzekom, Hanna; Schmidt, Ruben; Boxem, Mike] Univ Utrecht, Div Dev Biol, Dept Biol, Fac Sci,Inst Biodynam & Biocomplex, Utrecht, Netherlands; [Stucchi, Riccardo] Univ Utrecht, Div Cell Biol Neurobiol & Biophys, Dept Biol, Fac Sci,Inst Biodynam & Biocomplex, Utrecht, Netherlands; [Stucchi, Riccardo; Altelaar, Maarten] Univ Utrecht, Div Biomol Mass Spectrometry & Prote, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Stucchi, Riccardo; Altelaar, Maarten] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Ramalho, Joao J.] Wageningen Univ & Res, Lab Biochem, Wageningen, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University; Wageningen University & Research	Boxem, M (corresponding author), Univ Utrecht, Div Dev Biol, Dept Biol, Fac Sci,Inst Biodynam & Biocomplex, Utrecht, Netherlands.	m.boxem@uu.nl	; Boxem, Mike/B-8857-2011	Kroll, Jason/0000-0002-8229-7412; Boxem, Mike/0000-0003-3966-4173; Ramalho, Joao/0000-0002-1367-6275; Castiglioni, Victoria G/0000-0001-9884-2537; Stucchi, Riccardo/0000-0003-3793-634X	Netherlands Organization for Scientific Research (NWO)-ALW Open Program [824.14.021, NWO-VICI 016.VICI.170.165]	Netherlands Organization for Scientific Research (NWO)-ALW Open Program(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO)-ALW Open Program 824.14.021 and NWO-VICI 016.VICI.170.165 grants to M. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves C. H., 2013, Loss of CRB2; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100; Berger S, 2007, GENETICS, V176, P2189, DOI 10.1534/genetics.107.071449; Bit-Avragim N, 2008, J CELL SCI, V121, P2503, DOI 10.1242/jcs.033167; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; BRENNER S, 1974, GENETICS, V77, P71; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chen J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000041; Cherra SJ, 2020, J NEUROGENET, V34, P298, DOI 10.1080/01677063.2020.1726915; Cho SH, 2012, HUM MOL GENET, V21, P2663, DOI 10.1093/hmg/dds091; de Almeida FN, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.175497; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2002, MECH DEVELOP, V110, P203, DOI 10.1016/S0925-4773(01)00568-8; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Dillon J, 2018, INVERTEBR NEUROSCI, V18, DOI 10.1007/s10158-018-0218-2; Ebarasi L, 2009, DEV BIOL, V334, P1, DOI 10.1016/j.ydbio.2009.04.017; Feng W, 2005, P NATL ACAD SCI USA, V102, P6861, DOI 10.1073/pnas.0409346102; Friedland A. E., 2013, Nat. Methods, V10, P741; Ghanta KS, 2020, GENETICS, V216, P643, DOI 10.1534/genetics.120.303564; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Harris T. W., 2020, Nucleic Acids Res; Hong Y, 2003, P NATL ACAD SCI USA, V100, P12712, DOI 10.1073/pnas.2135347100; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Kempkens O, 2006, EUR J CELL BIOL, V85, P753, DOI 10.1016/j.ejcb.2006.03.003; Koorman T, 2016, NAT CELL BIOL, V18, P337, DOI 10.1038/ncb3300; Kumichel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094038; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pW293, DOI 10.1093/nar/gkab301; Li YJ, 2014, P NATL ACAD SCI USA, V111, P17444, DOI 10.1073/pnas.1416515111; Lin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031499; Makarova O, 2003, GENE, V302, P21, DOI 10.1016/S0378111902010843; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Mellacheruvu D., 2013, The CRAPome; Michel D, 2005, J CELL SCI, V118, P4049, DOI 10.1242/jcs.02528; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Palmitessa A, 2010, J BIOL CHEM, V285, P15187, DOI 10.1074/jbc.M110.104612; Park B, 2011, J NEUROSCI, V31, P17230, DOI 10.1523/JNEUROSCI.4430-11.2011; Penalva C, 2012, DEVELOPMENT, V139, P4549, DOI 10.1242/dev.085449; Perez-Mockus G, 2017, J CELL BIOL, V216, P1405, DOI 10.1083/jcb.201611196; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Roh MH, 2002, J BIOL CHEM, V277, P27501, DOI 10.1074/jbc.M201177200; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Schwartz ML, 2016, GENETICS, V202, P1277, DOI 10.1534/genetics.115.184275; Segbert C, 2004, DEV BIOL, V266, P17, DOI 10.1016/j.ydbio.2003.10.019; Sen A, 2012, J CELL BIOL, V199, P685, DOI 10.1083/jcb.201206064; Shibata Y, 2000, GENETICS, V154, P635; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Tanoue A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-00159-z; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tilston-Lnel A. M., 2016, J. Mol; Ullmer C, 1998, FEBS LETT, V424, P63, DOI 10.1016/S0014-5793(98)00141-0; van de Pavert S. A., 2004, Crumbs homologue 1 is required for maintenance of photoreceptor cell polarization and adhesion during light exposure; van den Hurk JAJM, 2005, MOL VIS, V11, P263; van Rossum AGSH, 2006, HUM MOL GENET, V15, P2659, DOI 10.1093/hmg/ddl194; Waaijers S., 2016, A; Waaijers S, 2015, BIOL OPEN, V4, P276, DOI 10.1242/bio.201410744; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wang Q, 2007, MOL BIOL CELL, V18, P874, DOI 10.1091/mbc.E06-07-0651; Wen WY, 2018, J MOL BIOL, V430, P3504, DOI 10.1016/j.jmb.2017.09.013; Whiteman EL, 2014, MOL CELL BIOL, V34, P43, DOI 10.1128/MCB.00999-13; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WODARZ A, 1993, MECH DEVELOP, V44, P175, DOI 10.1016/0925-4773(93)90066-7; Xiao H, 2006, DEV BIOL, V298, P379, DOI 10.1016/j.ydbio.2006.06.044; Xiao ZJ, 2011, DEV DYNAM, V240, P2646, DOI 10.1002/dvdy.22778; Yin Y, 2014, REPROD DOMEST ANIM, V49, P824, DOI 10.1111/rda.12374; Zhou WK, 2012, DEVELOPMENT, V139, P2891, DOI 10.1242/dev.083162; Zou J, 2013, INT J DEV NEUROSCI, V31, P770, DOI 10.1016/j.ijdevneu.2013.09.005	89	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101786	10.1016/j.jbc.2022.101786	http://dx.doi.org/10.1016/j.jbc.2022.101786			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35247383	gold, Green Published			2022-12-26	WOS:000793692600002
J	Vega, M; Chen, Y; Shi, YJ; Gera, J; Lichtenstein, A				Vega, Mario; Chen, Yu; Shi, Yijiang; Gera, Joseph; Lichtenstein, Alan			Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CASCADE; BETA-TRCP; ACTIVATION; DEGRADATION; APOPTOSIS	DEPTOR is a 48 kDa protein upregulated in multiple myeloma (MM) cells. DEPTOR inhibits mTOR and, by repressing a negative feedback loop, promotes AKT activation. We previously identified a compound that binds to DEPTOR in MM cells and induces its proteasomal degradation. To identify the mechanism of degradation, here, we screened for drug-induced posttranslational modifications and identified reduced phosphorylation of DEPTOR on serine 235 (S235). We show that an S235 phosphomimetic DEPTOR mutant was resistant to degradation, confirming the importance of this posttranslational modification. In addition, a DEPTOR mutant with a serine-to-alanine substitution at S235 could only be expressed upon concurrent proteasome inhibition. Thus, S235 phosphorylation regulates DEPTOR stability. Screening the DEPTOR interactome identified that the association of USP-7 deubiquitinase with DEPTOR was dependent upon S235 phosphorylation. Inhibition of USP-7 activity resulted in DEPTOR polyubiquitination and degradation. A scansite search suggested that ERK1 may be responsible for S235 phosphorylation, which was confirmed through the use of inhibitors, ERK1 knockdown, and an in vitro kinase assay. Inhibition of ERK1 also downregulated AKT phosphorylation. To test if DEPTOR phosphorylation mediated this crosstalk, MM cells were transfected with WT or phosphomimetic DEPTOR and exposed to ERK inhibitors. Although WT DEPTOR had no effect on the inhibition of AKT phosphorylation, the phosphomimetic DEPTOR prevented inhibition. These results indicate that ERK1 maintains AKT activity in MM cells via phosphorylation of DEPTOR. We propose that DEPTOR-dependent crosstalk provides MM cells with a viability-promoting signal (through AKT) when proliferation is stimulated (through ERK).	[Vega, Mario; Shi, Yijiang; Gera, Joseph; Lichtenstein, Alan] Greater Los Angeles VA UCLA Healthcare Ctr, Hematol Oncol, Los Angeles, CA 90073 USA; [Chen, Yu] Univ Calif Los Angeles, Mol Instrumentat Ctr, Los Angeles, CA USA; [Chen, Yu] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Lichtenstein, A (corresponding author), Greater Los Angeles VA UCLA Healthcare Ctr, Hematol Oncol, Los Angeles, CA 90073 USA.	alan.lichtenstein@med.va.gov		Vega, Mario I/0000-0002-3932-2483; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [RO1CA217820, RO1CA21426, RO1CA211562]; Research funds of the Veteran's Administration	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research funds of the Veteran's Administration	Supported by the National Institutes of Health grants RO1CA217820 (to J. G.), RO1CA21426 (to A. L.), RO1CA211562 (to A. L.) and Research funds of the Veteran's Administration (to J. G. and A. L.). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.	Bruneau S, 2013, BLOOD, V122, P1833, DOI 10.1182/blood-2013-03-488486; Carbonneau M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12700; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; DAEIPOUR M, 1993, J IMMUNOL, V150, P4743; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Gonzalez-Teran B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10477; Hoang B, 2016, MOL CANCER RES, V14, P397, DOI 10.1158/1541-7786.MCR-15-0422; Hu LP, 2003, BLOOD, V101, P3126, DOI 10.1182/blood-2002-08-2640; KUMAR G, 1994, J IMMUNOL, V153, P4436; Le J, 2017, BIOORG MED CHEM LETT, V27, P4714, DOI 10.1016/j.bmcl.2017.09.002; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogata A, 1997, CLIN CANCER RES, V3, P1017; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Shi Y, 2016, ONCOGENE, V35, P1015, DOI 10.1038/onc.2015.156; Shi YJ, 2016, CANCER RES, V76, P5822, DOI 10.1158/0008-5472.CAN-16-1019; Vega MI, 2019, MOL CANCER THER, V18, P1822, DOI 10.1158/1535-7163.MCT-19-0115; Yang J, 2012, LEUKEMIA, V26, P2114, DOI 10.1038/leu.2012.71; Zhao LL, 2018, J BIOL CHEM, V293, P4883, DOI 10.1074/jbc.M117.809533; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029	20	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101750	10.1016/j.jbc.2022.101750	http://dx.doi.org/10.1016/j.jbc.2022.101750			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35216969	gold, Green Published			2022-12-26	WOS:000823106100004
J	Huang, XL; Han, CP; Ma, MK				Huang, Xulin; Han, Chenping; Ma, Mingkang			Visual preferences for outdoor space along commercial pedestrian streets under the influence of plant characteristics	PLOS ONE			English	Article							SCENIC BEAUTY; ENVIRONMENT; QUALITY; WALKING; SYSTEM; INFORMATION; LANDSCAPES; ATTRIBUTES; TREES	Chinese commercial pedestrian streets have developed rapidly in recent years. However, people's preferences were not sufficiently considered and reflected in the outdoor space and landscape design. With the outdoor landscapes along commercial pedestrian streets in the region south of the Five Ridges as the research objects, this study revealed the public's different preference evaluations of the landscapes under the reciprocal effects of street characteristics. The main results were as follows: (a) When arcade spaces were available, people prefer streets with taller trees and a lower planting density (50 plants/km or less). Conversely, they preferred streets with relatively low trees (3-6 m), a higher planting density (100-200 plants/km) and two or more vertical layers of plants. People did not like the way that plants are lined in the middle of a street. (b) When there were only one or two types of signage hanging, people preferred streets with a moderate planting density (50-100 plants/km); and there were three or more types of signage hanging, people preferred the plants with low linear density (50 plants/km or less) and that were arranged along one or two sides of the street. (c) When benches were available, people preferred streets with plants on one or both sides, fewer plant colours (one or two kind of colours) and better plant growth status. Specifically, the richer the vertical structure and the bigger number of colours were, the higher the preference score. This study provided design schemes to enhance the visual quality of landscapes by improving landscape characteristics in similar outdoor spaces.	[Huang, Xulin; Han, Chenping; Ma, Mingkang] China Univ Min & Technol, Sch Architecture & Design, Xuzhou, Jiangsu, Peoples R China	China University of Mining & Technology	Han, CP (corresponding author), China Univ Min & Technol, Sch Architecture & Design, Xuzhou, Jiangsu, Peoples R China.	hanchenping@cumt.edu.cn		Han, Chenping/0000-0003-3959-1760				Arriaza M, 2004, LANDSCAPE URBAN PLAN, V69, P115, DOI 10.1016/j.landurbplan.2003.10.029; Bircher, 2000, ENCY FRUIT TREES EDI; Borst HC, 2009, J ENVIRON PSYCHOL, V29, P477, DOI 10.1016/j.jenvp.2009.08.002; Bulthoff H.H., 2001, VISION ATTENTION, P233; Carmelinon G, 2019, FRONT ARCHIT RES, V8, P261, DOI 10.1016/j.foar.2019.01.003; Cheung PK, 2019, BUILD ENVIRON, V164, DOI 10.1016/j.buildenv.2019.106362; Dijkstra J, 2009, PEDESTRIAN BEHAVIOR: MODELS, DATA COLLECTION AND APPLICATIONS, P63; Elsadek M, 2019, URBAN FOR URBAN GREE, V42, P51, DOI 10.1016/j.ufug.2019.05.007; Ernawati J, 2016, PROCD SOC BEHV, V234, P461, DOI 10.1016/j.sbspro.2016.10.264; Fernandes ClaudiaOliveira., 2018, URBAN FOR URBAN GREE; Filova L, 2015, J ENVIRON PLANN MAN, V58, P2037, DOI 10.1080/09640568.2014.973481; Gandy R, 2007, LANDSCAPE URBAN PLAN, V82, P85, DOI 10.1016/j.landurbplan.2007.01.018; Geist J.F., 1983, ARCADES HIST BUILDIN; Gidlof-Gunnarsson A, 2007, LANDSCAPE URBAN PLAN, V83, P115, DOI 10.1016/j.landurbplan.2007.03.003; Giles-Corti B, 2005, AM J PREV MED, V28, P169, DOI 10.1016/j.amepre.2004.10.018; Gong Han., 2018, BUSINESS MANAGER, P84; Hami A, 2018, URBAN FOR URBAN GREE, V30, P1, DOI 10.1016/j.ufug.2017.12.019; Han Xili., 2016, LANDS DESIGN, P10; Hassan DM, 2019, AIN SHAMS ENG J, V10, P453, DOI 10.1016/j.asej.2018.12.006; Hengzhuan Fang., 2004, CHONGQING ARCHITECTU, V1, P10; Jiang B, 2018, NEURAL COMPUT APPL, V29, P1199, DOI 10.1007/s00521-016-2828-0; Jing Pan., 2019, CITY OBSERVATION, V4, P108; Kang CD, 2015, CITIES, V46, P94, DOI 10.1016/j.cities.2015.05.006; Kang Y, 2018, SUSTAIN CITIES SOC, V43, P21, DOI 10.1016/j.scs.2018.07.009; Kaplan R, 1989, EXPERIENCE NATURE PS; Kusumarini Y, 2012, PROCD SOC BEHV, V68, P515, DOI 10.1016/j.sbspro.2012.12.245; Lekagul A, 2002, THESIS VIRGINIA POLY; Limoges S, 2018, URBAN FOR URBAN GREE, V31, P15, DOI 10.1016/j.ufug.2018.01.019; Lin L, 2018, ENVIRON IMPACT ASSES, V70, P22, DOI 10.1016/j.eiar.2018.03.001; Lu X, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P457, DOI 10.1145/2647868.2654927; Ma XY, 2021, CITIES, V110, DOI 10.1016/j.cities.2020.103086; Ma Xiaoli., 2017, RES BUSINESS EC, P41; Maftei L, 2021, ARCHNET-IJAR, V15, P887, DOI 10.1108/ARCH-03-2021-0067; Mahmoudi M, 2015, CITIES, V43, P104, DOI 10.1016/j.cities.2014.11.016; Meitner MJ, 2004, LANDSCAPE URBAN PLAN, V68, P3, DOI 10.1016/S0169-2046(03)00115-4; Motamedi A, 2017, ADV ENG INFORM, V32, P248, DOI 10.1016/j.aei.2017.03.005; Ng WY, 2015, URBAN FOR URBAN GREE, V14, P30, DOI 10.1016/j.ufug.2014.11.002; Nielsen AB, 2012, J ENVIRON MANAGE, V113, P456, DOI 10.1016/j.jenvman.2012.10.014; Othman N, 2015, PROCD SOC BEHV, V170, P350, DOI 10.1016/j.sbspro.2015.01.045; Peng Changxin., 2004, J S CHINA U TECHNOLO, V6, P29; Qiao Hongyue., 2006, BEIJING FORESTRY U; Qiu GY., 2014, AGU FALL M ABSTRACTS; Qiu W., 2022, CITIES, P104037, DOI [10.1016/j.cities.2022.104037, DOI 10.1016/J.CITIES.2022.104037]; Rogge E, 2007, LANDSCAPE URBAN PLAN, V82, P159, DOI 10.1016/j.landurbplan.2007.02.006; Santosa Herry, 2018, IOP Conference Series: Earth and Environmental Science, V213, DOI 10.1088/1755-1315/213/1/012003; Schiffman HarveyRichard., 1990, SENSATION PERCEPTION; Seresinhe CI, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170170; Shamsuddin S, 2012, PROCD SOC BEHV, V50, P167, DOI 10.1016/j.sbspro.2012.08.025; Shi SL, 2014, SUSTAIN CITIES SOC, V13, P148, DOI 10.1016/j.scs.2014.04.011; Siostrom P, 2016, LANDSC ARCHIT FRONT, V4, P64; Stevens T, 1995, PREFERENCES VISUAL A; Suhardi M., 2006, THESIS VIRGINIA POLY; Sun L, 2020, INT J PATTERN RECOGN, V34, DOI 10.1142/S0218001420500044; Ulrich Roger S., 1983, BEHAV NATURAL ENV; van den Berg AE, 2003, J ENVIRON PSYCHOL, V23, P135, DOI 10.1016/S0272-4944(02)00111-1; Wang RG, 2017, SUSTAIN CITIES SOC, V28, P350, DOI 10.1016/j.scs.2016.10.010; Wolf Kathleen L., 2003, Journal of Arboriculture, V29, P117; Xie Xiaomeng., 2016, STUDY SHOP SIGNS GUA; Xu Leiqing., 2012, ARCHITECT, V2, P74; Yoshinobu Ashihara., 2006, TIANJING BAIHUA LIT; Zhang K, 2019, TOURISM MANAGE, V75, P595, DOI 10.1016/j.tourman.2019.07.002; Zhang Rong., 2009, STUDY PLANT COMBINAT; Zhao JW, 2017, URBAN FOR URBAN GREE, V25, P19, DOI 10.1016/j.ufug.2017.04.015	63	0	0	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264482	10.1371/journal.pone.0264482	http://dx.doi.org/10.1371/journal.pone.0264482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259182	Green Published, gold			2022-12-26	WOS:000835141200016
J	Schmidt, A; Leavell, D; Punches, J; Ibarra, MAR; Kagan, JS; Creutzburg, M; McCune, M; Salwasser, J; Walter, C; Berger, C				Schmidt, Andres; Leavell, Daniel; Punches, John; Ibarra, Marco A. Rocha; Kagan, James S.; Creutzburg, Megan; McCune, Myrica; Salwasser, Janine; Walter, Cara; Berger, Carrie			A quantitative wildfire risk assessment using a modular approach of geostatistical clustering and regionally distinct valuations of assets-A case study in Oregon	PLOS ONE			English	Article							CLIMATE-CHANGE; PACIFIC-NORTHWEST; WILDLAND FIRE; DROUGHT; RESTORATION; SUPPORT; TRADEOFFS; SEVERITY; DYNAMICS; WEATHER	The intensity and scale of wildfires has increased throughout the Pacific Northwest in recent decades, especially within the last decade, destroying vast amounts of valuable resources and assets. This trend is predicted to remain or even magnify due climate change, growing population, increased housing density. Furthermore, the associated stress of prolonged droughts and change in land cover/land use puts more population at risk. We present results of a multi-phase Extension Fire Program Initiative combining fire model results based on worst-case meteorological conditions recorded at 50 weather stations across Oregon with spatially distinct valuations of resources and assets based on regional ecological and socioeconomic conditions. Our study focuses on six different Fire Service Areas covering the state of Oregon. We used a geostatistical approach to find weather stations that provide worst-case meteorological input data on record for representative sub-domains. The results provide regionally distinct assessments of potential value loss by wildfire and show that, depending on the region, 12% to 52% of the highest relative risk areas are on private land. This underscores the need to unite strategies and efforts on the landscape scale by including different landowners, managers, and stakeholders of public land and private land efficiently address wildfire damage protection and mitigation. Our risk assessments closely agreed with risks identified during landscape-scale ground projects.	[Schmidt, Andres] Oregon State Univ, Dept Fisheries Wildlife & Conservat Sci, Corvallis, OR 97331 USA; [Leavell, Daniel; Punches, John] Oregon State Univ, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA; [Ibarra, Marco A. Rocha; Berger, Carrie] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Kagan, James S.; Creutzburg, Megan; McCune, Myrica; Salwasser, Janine] Oregon State Univ, Inst Nat Resources, Corvallis, OR 97331 USA; [Walter, Cara] Oregon State Univ, Dept Biol & Ecol Engn, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University; Oregon State University	Schmidt, A (corresponding author), Oregon State Univ, Dept Fisheries Wildlife & Conservat Sci, Corvallis, OR 97331 USA.	andres.schmidt@oregonstate.edu	Schmidt, Andres/E-6765-2019	Schmidt, Andres/0000-0001-7110-6652; Walter, Cara/0000-0001-5934-5482	Oregon legislature as part of the Public Service budget for Extension Services	Oregon legislature as part of the Public Service budget for Extension Services	This research was supported by the Oregon legislature as part of the Public Service budget for Extension Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatatzoglou JT, 2017, B AM METEOROL SOC, V98, P1815, DOI 10.1175/BAMS-D-16-0193.1; Abatzoglou JT, 2016, P NATL ACAD SCI USA, V113, P11770, DOI 10.1073/pnas.1607171113; Ager AA, 2016, J ENVIRON MANAGE, V176, P157, DOI 10.1016/j.jenvman.2016.01.033; Allen I, 2019, FIRE-BASEL, V2, DOI 10.3390/fire2020017; [Anonymous], 1995, BIOLOGICAL ASSESSMEN, DOI DOI 10.1371/journal.pone.0135454; Azuma DL, 2002, PNWRP560 USDA FOR SE, DOI [10.2737/PNW-RP-560, DOI 10.2737/PNW-RP-560]; Bayham J, 2020, FORESTS, V11, DOI 10.3390/f11020169; Boumans R, 2002, ECOL ECON, V41, P529, DOI 10.1016/S0921-8009(02)00098-8; Bradshaw L, 2000, RMRSGTR67 USDA FOR S, DOI [10.2737/RMRS-GTR-67, DOI 10.2737/RMRS-GTR-67]; Buechling A, 2011, WEST J APPL FOR, V26, P71, DOI 10.1093/wjaf/26.2.71; Calkin DE, 2010, GEN TECH REP US DEP, DOI [DOI 10.2737/RMRS-GTR-235, 10.2737/RMRS-GTR-235]; Cassell BA, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2934; Charnley S, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab639a; Creutzburg MK, 2015, ENVIRON MANAGE, V55, P43, DOI 10.1007/s00267-014-0362-3; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Dietz MS, 2020, BIOL CONSERV, V248, DOI 10.1016/j.biocon.2020.108646; Drury SA, 2016, FIRE ECOL, V12, P103, DOI 10.4996/fireecology.1201103; Duque JC, 2007, INT REGIONAL SCI REV, V30, P195, DOI 10.1177/0160017607301605; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Finney MA, 2006, P RMRS, V41, P213; Flannigan M, 2013, FOREST ECOL MANAG, V294, P54, DOI 10.1016/j.foreco.2012.10.022; Fleming RA, 2002, CLIMATIC CHANGE, V55, P251, DOI 10.1023/A:1020299422491; Foster D, 2016, INT J APPL GEOSPAT R, V7, P53, DOI 10.4018/IJAGR.2016100105; Gilbertson-Day JW, PACIFIC NW QUANTITAT; Grayson LM, 2017, FOREST ECOL MANAG, V399, P213, DOI 10.1016/j.foreco.2017.05.038; Halofsky JE, 2020, FIRE ECOL, V16, DOI 10.1186/s42408-019-0062-8; Hammer RB, 2007, INT J WILDLAND FIRE, V16, P255, DOI 10.1071/WF05077; Han WG, 2012, COMPUT ELECTRON AGR, V84, P111, DOI 10.1016/j.compag.2012.03.005; Haugo R, 2015, FOREST ECOL MANAG, V335, P37, DOI 10.1016/j.foreco.2014.09.014; Hendersen E, 2017, NEW VENTURE FUND PRO; Heris MP, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0542-3; Hessburg PF, 2005, FOREST ECOL MANAG, V211, P117, DOI 10.1016/j.foreco.2005.02.016; Hibbard M, 2019, COMMUNITY DEV, V50, P34, DOI 10.1080/15575330.2019.1567565; Higuera PE, 2021, GLOBAL CHANGE BIOL, V27, P1, DOI 10.1111/gcb.15388; Holden ZA, 2018, P NATL ACAD SCI USA, V115, pE8349, DOI 10.1073/pnas.1802316115; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Horel JD, 2010, J APPL METEOROL CLIM, V49, P1563, DOI 10.1175/2010JAMC2397.1; Jain P, 2017, INT J WILDLAND FIRE, V26, P1009, DOI [10.1071/WF17008, 10.1071/wf17008]; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Kagan JS, 2016, RARE THREATENED ENDA; Kolb TE, 2016, FOREST ECOL MANAG, V380, P321, DOI 10.1016/j.foreco.2016.04.051; Kolden CA, 2019, FIRE-BASEL, V2, DOI 10.3390/fire2020030; Krist FJ, 2015, FOREST HLTH MONITORI, P87; Leavell D, 2018, PLANNING IMPLEMENTIN; Linn R, 2007, INT J WILDLAND FIRE, V16, P183, DOI 10.1071/WF06078; Loehman RA, 2017, LANDSCAPE ECOL, V32, P1447, DOI 10.1007/s10980-016-0414-6; Madrigal J, 2012, ANN FOREST SCI, V69, P387, DOI 10.1007/s13595-011-0165-0; McCaskill GL, 2019, FORESTS, V10, DOI 10.3390/f10010015; McEvoy A, 2021, FORESTS, V12, DOI 10.3390/f12070934; Meeks WL, 2004, DECIS SUPPORT SYST, V38, P47, DOI 10.1016/S0167-9236(03)00076-9; Miller C, 2019, ATMOSPHERE-BASEL, V10, DOI 10.3390/atmos10090515; Mutch R.W., 1993, GEN TECHNICAL REPORT; Nolin AW, 2012, MT RES DEV, V32, pS35, DOI 10.1659/MRD-JOURNAL-D-11-00038.S1; Oregon Department of Agriculture, OR AGR STAT 2019; Oregon Department of Forestry, 2020, FIN ODF FIR REP 2020; Parks SA, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aab791; Picotte JJ, 2020, FIRE ECOL, V16, DOI 10.1186/s42408-020-00076-y; Picotte JJ, 2019, FIRE-BASEL, V2, DOI 10.3390/fire2020035; Radeloff VC, 2017, **DATA OBJECT**, DOI 10.2737/RDS-2015-0012-2; Radeloff VC, 2018, P NATL ACAD SCI USA, V115, P3314, DOI 10.1073/pnas.1718850115; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; Rupp DE, 2017, CLIM DYNAM, V49, P1783, DOI 10.1007/s00382-016-3418-7; Sanborn Map Inc, 2013, W WID WILDF RISK ASS; Scasta J. D., 2016, Rangelands, V38, P197; Schmidt A, 2018, NEURAL NETWORKS, V108, P97, DOI 10.1016/j.neunet.2018.08.004; Schwarz PA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002234; Scott JH, 2001, US FOR SERV RMRS-RP, P1; Scott JH, 2020, WILDFIRE RISK COMMUN, DOI [10.2737/RDS-2020-0016, DOI 10.2737/RDS-2020-0016, 10.2737/RDS-2020-016]; Scott JH, 2013, RMRSGTR315 USDA FOR, DOI [10.2737/rmrs-gtr-315, DOI 10.2737/RMRS-GTR-315]; Setterfield SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059144; Sharp J, 2004, WEATHER FORECAST, V19, P970, DOI 10.1175/826.1; Short K.C., 2016, **DATA OBJECT**, DOI 10.2737/RDS-2016-0034; Stehman SV, 2008, PHOTOGRAMM ENG REM S, V74, P1561, DOI 10.14358/PERS.74.12.1561; Stein B.A., 2002, STATES UNION RANKING; Stewart SI, 2007, J FOREST, V105, P201; Stutts M., 2014, NATL REGISTER HIST P; Theobald DM, 2007, LANDSCAPE URBAN PLAN, V83, P340, DOI 10.1016/j.landurbplan.2007.06.002; Thompson MP, 2017, FORESTS, V8, DOI 10.3390/f8120469; Thompson MP, 2015, ENVIRON MODELL SOFTW, V63, P61, DOI 10.1016/j.envsoft.2014.09.018; Thorson TD, 2002, ECOREGIONS OREGON; USDA National Agricultural Statistics Service (USDA-NASS), 2017, CROPL DAT LAYER 2017; Vogler KC, 2015, FORESTS, V6, P4403, DOI 10.3390/f6124375; Weise DR, 1996, CAN J FOREST RES, V26, P1849, DOI 10.1139/x26-210; Wells N, 2004, J CLIMATE, V17, P2335, DOI 10.1175/1520-0442(2004)017&lt;2335:ASPDSI&gt;2.0.CO;2; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wyse SV, 2018, ECOSYSTEMS, V21, P886, DOI 10.1007/s10021-017-0195-z; Xiao M, 2016, J HYDROMETEOROL, V17, P2391, DOI 10.1175/JHM-D-15-0142.1	91	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264826	10.1371/journal.pone.0264826	http://dx.doi.org/10.1371/journal.pone.0264826			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259177	gold, Green Published			2022-12-26	WOS:000835141200029
J	Sward, E; Wilcke, M				Sward, Elin; Wilcke, Maria			Effects of intra-articular Platelet-Rich Plasma (PRP) injections on osteoarthritis in the thumb basal joint and scaphoidtrapeziotrapezoidal joint	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; DOUBLE-BLIND; PAIN; PREVALENCE; DISABILITY; PLACEBO	Intra-articular injection of platelet rich plasma (PRP) has been reported to decrease pain and improve function in knee osteoarthritis. There are few reports on the effect of PRP in the treatment of osteoarthritis in the hand. Our aim was to evaluate the effect of PRP-injections on pain and functional outcome in the short-term for osteoarthritis in the thumb basal joint and scaphoidtrapeziotrapezoidal (STT) joint. A retrospective analysis was performed of 29 patients treated with intra-articular PRP injection for painful osteoarthritis in the thumb basal joint (21 patients) or STT joint (eight patients). The patients received two consecutive, radiologically guided PRP injections at an interval of 3-4 weeks. Pain at rest and on load (numerical rating scale (NRS) 0-10), Patient-rated Wrist and Hand Evaluation (PRWHE) score (0100), grip strength (Jamar) and key pinch were recorded pre-injection and 3 months after the second injection. Mean age was 63 (range 34-86) years and 17 patients were women. We used generalized estimating equations (GEE) to analyze the effect on the outcome variables. Possible predictors were included in the model (high pain level pre-injection, gender, age, manually demanding work, affected joint (thumb base or STT) and use of analgesic). The GEE analysis showed that PRP injections had no effect on reported pain, PRWHE score, grip strength or key pinch. 16/28 patients experience a positive effect according to a yes/no question. The short-term effect of PRP for osteoarthritis in the thumb base and STT-joint is doubtful and needs to be properly investigated in placebo-controlled studies.	[Sward, Elin; Wilcke, Maria] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Sward, Elin; Wilcke, Maria] Soder Sjukhuset, Dept Hand Surg, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Sodersjukhuset Hospital	Wilcke, M (corresponding author), Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden.; Wilcke, M (corresponding author), Soder Sjukhuset, Dept Hand Surg, Stockholm, Sweden.	maria.wilcke@sll.se	Wilcke, Maria/AAY-7916-2020	Wilcke, Maria/0000-0001-6805-6746				ARMSTRONG AL, 1994, J HAND SURG-BRIT EUR, V19B, P340, DOI 10.1016/0266-7681(94)90085-X; Ayub S, 2021, RHEUMATOLOGY, V60, P1629, DOI 10.1093/rheumatology/keaa808; Dahaghin S, 2005, ANN RHEUM DIS, V64, P682, DOI 10.1136/ard.2004.023564; Dai WL, 2017, ARTHROSCOPY, V33, P659, DOI 10.1016/j.arthro.2016.09.024; EATON RG, 1973, J BONE JOINT SURG AM, VA 55, P1655, DOI 10.2106/00004623-197355080-00010; Egloff N, 2017, J PAIN RES, V10, P259, DOI 10.2147/JPR.S116674; Loibl M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9262909; MacDermid JC, 1998, J ORTHOP TRAUMA, V12, P577, DOI 10.1097/00005131-199811000-00009; Malahias MA, 2021, CARTILAGE, V12, P51, DOI 10.1177/1947603518805230; McAlindon TE, 2017, JAMA-J AM MED ASSOC, V317, P1967, DOI 10.1001/jama.2017.5283; Mosegaard SB, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-3058-2; Patel S, 2013, AM J SPORT MED, V41, P356, DOI 10.1177/0363546512471299; Riley N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027507; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Smith PA, 2016, AM J SPORT MED, V44, P884, DOI 10.1177/0363546515624678; Wernecke C, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115581163; White L, 2010, J PLAST SURG HAND SU, V44, P112, DOI 10.3109/02844311003675388; Wilcke M, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-3045-7; Wilcke MT, 2009, SCAND J PLAST RECONS, V43, P94, DOI 10.1080/02844310902734598; Wolf JM, 2014, ARTHRIT CARE RES, V66, P961, DOI 10.1002/acr.22250; Xie XT, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4493; Xing D, 2017, INT J RHEUM DIS, V20, P1612, DOI 10.1111/1756-185X.13233; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Zhao K, 2020, J ORTHOP TRANSL, V22, P34, DOI 10.1016/j.jot.2019.10.002	24	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264203	10.1371/journal.pone.0264203	http://dx.doi.org/10.1371/journal.pone.0264203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259167	gold, Green Published			2022-12-26	WOS:000835141200012
J	Atuhaire, LK; Nansubuga, E; Nankinga, O; Nviiri, HN; Odur, B; Mossong, J				Atuhaire, Leonard K.; Nansubuga, Elizabeth; Nankinga, Olivia; Nviiri, Helen Namirembe; Odur, Benard; Mossong, Joel			Prevalence and determinants of death registration and certification uptake in Uganda	PLOS ONE			English	Article							CIVIL REGISTRATION; VITAL-STATISTICS; HEALTH; DISTANCE; SERVICES; STATE	Death registration in Uganda remains extremely low, yet mortality statistics are vital in health policy, planning, resource allocation and decision-making. According to NIRA, only 1% of deaths are registered annually, while Uganda Bureau of Statistics estimates death registration at 24% for the period 2011-2016. The wide variation between the administrative and survey statistics can be attributed to the restriction to only certified death registration by NIRA while survey statistics relate to all forms of death notification and registration at the different sub-national levels. Registration of deaths is of critical importance to individuals and a country's government. Legally, it grants administrative rights in management of a deceased's estate, and access to social (insurance and pension) benefits of a deceased person. It is also essential for official statistics and planning purposes. There is an urgent need for continuous and real-time collection of mortality data or statistics in Uganda. These statistics are of significance in public health for identifying the magnitude and distribution of major disease problems, and are essential for the design, implementation, monitoring, and assessment of health programmes and policies. Lack of such continuous and timely data has negative consequences for the achievement of both national and Sustainable Development Goals 3, 11, 16, and 17. This study assessed the determinants of death registration and certification, using a survey of 2018-2019 deaths in 2,100 households across four administrative regions of Uganda and Kampala district. Multivariate-binary logistic regression was used to model factors associated with the likelihood of a death being registered or certified. We find that around one-third of deaths were registered while death certificates were obtained for less than 5% of the total deaths. Death registration and certification varied notably within Uganda. Uptake of death registration and certification was associated with knowledge on death registration, region, access to mass media, age of the deceased, place of death, occupation of the deceased, relationship to household head and request for death certificate. There is need for decentralization of death registration services; massive sensitization of communities and creating demand for death registration.	[Atuhaire, Leonard K.] Makerere Univ, Sch Stat & Planning, Dept Planning & Appl Stat, Kampala, Uganda; [Nansubuga, Elizabeth; Nankinga, Olivia] Makerere Univ, Sch Stat & Planning, Dept Populat Studies, Kampala, Uganda; [Nviiri, Helen Namirembe] Uganda Bur Stat, Directorate Populat & Social Stat, Kampala, Uganda; [Odur, Benard] Makerere Univ, Sch Stat & Planning, Dept Stat Methods & Actuarial Sci, Kampala, Uganda	Makerere University; Makerere University; Makerere University	Atuhaire, LK (corresponding author), Makerere Univ, Sch Stat & Planning, Dept Planning & Appl Stat, Kampala, Uganda.	leonard.atuhaire@mak.ac.ug			Makerere University Research and Innovations Fund MakRIF	Makerere University Research and Innovations Fund MakRIF	LA obtained a grant from: Makerere University Research and Innovations Fund MakRIF URL https://rif.mak.ac.ug The funder provided support in the form of salaries for authors [LA, EN, HNN, ON and BO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AbouZahr C, 2015, LANCET, V386, P1373, DOI 10.1016/S0140-6736(15)60173-8; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Atama C., 2021, INT J SOCIOLOGY ANTH, V13, P1; Awoyemi T. T., 2011, Journal of Human Ecology, V35, P1; Bago JL, 2019, SEX REPROD HEALTHC, V21, P1, DOI 10.1016/j.srhc.2019.04.004; Baidoo S., 2012, CAN ICTS NEWSOCIAL M; Bhatia A, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0635-6; Brinkerhoff DW, 2018, GOVERNANCE, V31, P103, DOI 10.1111/gove.12271; Fall A, 2021, GENUS, V77, DOI 10.1186/s41118-021-00133-7; Garenne M, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.32795; Horton R, 2007, LANCET, V370, P1526, DOI 10.1016/S0140-6736(07)61418-4; Jackson D, 2018, B WORLD HEALTH ORGAN, V96, P861, DOI 10.2471/BLT.18.213090; Kasasa S, 2021, POPUL HEALTH METR, V19, DOI 10.1186/s12963-020-00231-2; Kim K, 2013, GERONTOLOGIST, V53, P1020, DOI 10.1093/geront/gns147; Kivinda JM, 2012, THESIS U NAIROBI; KwaZulu-Natal Tourism Authority, 2019, 20182019 TKZN KWAZ N; Lopez AD, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01526-9; Mathenge G., 2013, AFRICAN J HLTH SCI, V26, P272; Mills S, 2019, J HEALTH POPUL NUTR, V38, DOI 10.1186/s41043-019-0178-0; Rao C, 2004, SO AFR J DEMOGRAPHY, P81; Rao C, 2010, B WORLD HEALTH ORGAN, V88, P58, DOI 10.2471/BLT.08.061630; Redmond N, 2010, AM J PREV MED, V38, P620, DOI 10.1016/j.amepre.2010.03.001; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Sousa L., 2015, INT J AGEING LATER L, V9, P35, DOI https://doi.org/10.3384/ijal.1652-8670.15266; Sousa L, 2010, EUR J AGEING, V7, P5, DOI 10.1007/s10433-010-0139-3; Tobin EA., 2013, ANN NIGERIAN MED, V7, P3, DOI [10.4103/0331-3131.119979, DOI 10.4103/0331-3131.119979]; UBOS ICF, 2018, UGANDA DEMOGRAPHIC H; UN DESA, 2010, STAT CIV REG VIT STA; United Nation (UN), 2021, FUT FOOD AGR REP 202; United Nations, 1998, HDB CIV REG VIT STAT, V73; United Nations Economic Commission for Africa (UNECA), 2017, REP STAT CIV REG VIT; United Republic of Tanzania, 2015, HLTH SECT STRAT PLAN; Wakibi S, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/9963703; Williams A. O., 2014, African Population Studies, V27, P263; World Health Organization, 2014, GLOB CIV REG VIT STA	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264742	10.1371/journal.pone.0264742	http://dx.doi.org/10.1371/journal.pone.0264742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245336	gold, Green Published			2022-12-26	WOS:000799799100030
J	Geiger, F; Schnitzler, LG; Brugger, MS; Westerhausen, C; Engelke, H				Geiger, Florian; Schnitzler, Lukas G.; Brugger, Manuel S.; Westerhausen, Christoph; Engelke, Hanna			Directed invasion of cancer cell spheroids inside 3D collagen matrices oriented by microfluidic flow in experiment and simulation	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; ALIGNMENT; MIGRATION; DYNAMICS; FIBERS; IMAGE	Invasion is strongly influenced by the mechanical properties of the extracellular matrix. Here, we use microfluidics to align fibers of a collagen matrix and study the influence of fiber orientation on invasion from a cancer cell spheroid. The microfluidic setup allows for highly oriented collagen fibers of tangential and radial orientation with respect to the spheroid, which can be described by finite element simulations. In invasion experiments, we observe a strong bias of invasion towards radial as compared to tangential fiber orientation. Simulations of the invasive behavior with a Brownian diffusion model suggest complete blockage of migration perpendicularly to fibers allowing for migration exclusively along fibers. This slows invasion toward areas with tangentially oriented fibers down, but does not prevent it.	[Geiger, Florian; Engelke, Hanna] Ludwig Maximilians Univ Munchen, Dept Chem, Munich, Germany; [Schnitzler, Lukas G.; Brugger, Manuel S.; Westerhausen, Christoph] Univ Augsburg, Inst Phys, Expt Phys 1, Augsburg, Germany; [Brugger, Manuel S.] Stiftung Deutsch Wirtschaft Sdw gGmbH, Berlin, Germany; [Westerhausen, Christoph] Univ Augsburg, Inst Theoret Med, Physiol, Augsburg, Germany; [Westerhausen, Christoph; Engelke, Hanna] Ctr NanoSci CeNS, Munich, Germany; [Engelke, Hanna] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmaceut Chem, Graz, Austria	University of Munich; University of Augsburg; University of Augsburg; University of Graz	Engelke, H (corresponding author), Ludwig Maximilians Univ Munchen, Dept Chem, Munich, Germany.; Westerhausen, C (corresponding author), Univ Augsburg, Inst Phys, Expt Phys 1, Augsburg, Germany.; Westerhausen, C (corresponding author), Univ Augsburg, Inst Theoret Med, Physiol, Augsburg, Germany.; Westerhausen, C; Engelke, H (corresponding author), Ctr NanoSci CeNS, Munich, Germany.; Engelke, H (corresponding author), Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmaceut Chem, Graz, Austria.	christoph.westerhausen@gmail.com; hanna.engelke@uni-graz.at		Engelke, Hanna/0000-0001-9529-9436	Deutsche Forschungsgemeinschaft [201269156 -SFB 1032]; Center for NanoScience Munich; University of Graz; University of Augsburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for NanoScience Munich; University of Graz; University of Augsburg	Deutsche Forschungsgemeinschaft (Project ID 201269156 -SFB 1032, project B11, to H.E.), the Center for NanoScience Munich (to H.E. and C.W.), University of Graz (to H.E.) and the University of Augsburg (Medicine Department, Seed Funding, to C.W.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh H, 2017, P NATL ACAD SCI USA, V114, pE1617, DOI 10.1073/pnas.1617037114; Carey SP, 2016, INTEGR BIOL-UK, V8, P821, DOI 10.1039/c6ib00030d; Caswell PT, 2018, TRENDS CELL BIOL, V28, P823, DOI 10.1016/j.tcb.2018.06.003; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Dietrich M, 2018, SOFT MATTER, V14, P2816, DOI 10.1039/c8sm00018b; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Geiger F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225215; Han WJ, 2016, P NATL ACAD SCI USA, V113, P11208, DOI 10.1073/pnas.1610347113; Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598; Ilina O, 2020, NAT CELL BIOL, V22, P1103, DOI 10.1038/s41556-020-0552-6; Illes B, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102185; Kopanska KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156442; Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z; Licup AJ, 2015, P NATL ACAD SCI USA, V112, P9573, DOI 10.1073/pnas.1504258112; Oswald L, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa8e83; Palamidessi A, 2019, NAT MATER, V18, P1252, DOI 10.1038/s41563-019-0425-1; Park J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10729-5; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ray A, 2018, INTEGR BIOL-UK, V10, P100, DOI 10.1039/c7ib00152e; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Rubenstein BM, 2008, BIOPHYS J, V95, P5661, DOI 10.1529/biophysj.108.140624; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi QM, 2014, P NATL ACAD SCI USA, V111, P658, DOI 10.1073/pnas.1311312110; Thielicke W., 2014, FLAPPING FLIGHT BIRD; Thielicke W., 2014, J OPEN RES STW, V2, P30, DOI [10.5334/JORS.BL, DOI 10.5334/JORS.BL]; Wu PH, 2018, ANNU REV BIOPHYS, V47, P549, DOI 10.1146/annurev-biophys-070816-033854	27	2	2	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264571	10.1371/journal.pone.0264571	http://dx.doi.org/10.1371/journal.pone.0264571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231060	Green Published, gold			2022-12-26	WOS:000849744700028
J	Kebede, F; Kebede, T; Negese, B; Abera, A; Fentaw, G; Kasaw, A				Kebede, Fassikaw; Kebede, Tsehay; Negese, Belete; Abera, Atitegeb; Fentaw, Getahun; Kasaw, Ayalew			Incidence and predictors of severe acute malnutrition mortality in children aged 6-59 months admitted at Pawe general hospital, Northwest Ethiopia	PLOS ONE			English	Article								Background Severe acute malnutrition (SAM) is defined as a weight-for-height < -3z scores of the median WHO growth standards, or visible severe wasting or the presence of nutritional edema. SAM related mortality rates in under-five children are well documented in Ethiopia but data on their predictors are limited. We aimed to document factors associated with SAM related mortality to inform better inpatient management. Methods A facility-based retrospective cohort study was conducted among children admitted due to SAM at Pawe General Hospital, Northwest Ethiopia, from the 1st of January 2015 to the 31st of December 2019. Data from the records of SAM children were extracted using a standardized checklist. Epi-Data version 3.2 was used for data entry, and Stata version 14 was used for analysis. Bi-variable and multivariable Cox regression analyses were conducted to identify predictors of mortality. Variables with P<0.05 were considered significant predictors of mortality. Results Five-hundred sixty-eight SAM cases were identified of mean age was 27.4 (SD +/- 16.5) months. The crude death rate was 91/568 (16.02%) and the mean time to death was determined as 13 (+/- 8) days. Independent risk factors for death were: (i) vomiting AHR = 5.1 (1.35-21.1, p = 0.026), (ii) diarrhea AHR = 2.79 (1.46-5.4, p = 0.002), (iii) needing nasogastric therapy AHR = 3.22 (1.65-6.26, p = 0.001), (iv) anemia AHR = 1.89 (1.15-3.2, p = 0.012), and (v) being readmitted with SAM AHR = 1.7 (1.12-2.8, p = 0.037). Conclusion SAM mortality was high in under-five children in our setting. The identified risk factors should inform treatment and prevention strategies. Improved community health education should focus on healthy nutrition and seeking early treatment. Inpatient mortality may be reduced by stricter adherence to treatment guidelines and recognizing early the key risk factors for death.	[Kebede, Fassikaw; Abera, Atitegeb] Woldia Univ, Coll Hlth Sci, Dept Epidemiol & Biostat, Woldia, Ethiopia; [Kebede, Tsehay] Bahir Dare Univ, Fac Social Sci, Dept Geog & Environm Study, Bahir Dar, Ethiopia; [Negese, Belete] Debre Birhan Univ, Coll Med & Hlth Sci, Dept Nursing & Midwifery, Debre Birhan, Ethiopia; [Fentaw, Getahun] Woldia Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Nutr, Woldia, Ethiopia; [Kasaw, Ayalew] Gambela Coll Hlth Sci Southern Ethiopia, Dept Nursing & Midwifery, Gambela, Ethiopia	University of Gondar	Kebede, F (corresponding author), Woldia Univ, Coll Hlth Sci, Dept Epidemiol & Biostat, Woldia, Ethiopia.	fassikaw123@gmail.com	Kebede, Fassikaw/AAE-1866-2022	Kebede, Fassikaw/0000-0002-6117-5272; Fentaw Mulaw, Getahun/0000-0002-4173-3759; Kebede, Tsehay/0000-0002-6841-4686				Abraha Mulu W, 2009, Health Res Policy Syst, V7, P29, DOI 10.1186/1478-4505-7-29; [Anonymous], 2015, MANAGEMENT SEVERE AC; Banga D, 2020, INT J PEDIAT, V2020, DOI 10.1155/2020/7809412; Desyibelew HD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171020; Dwivedi D., 2017, Journal of Nepal Paediatric Society, V37, P250, DOI 10.3126/jnps.v37i3.18480; Ethiopian Federal Ministry of Health, 2007, PROTOCOL MANAGEMENT; Federal Democratic Republic Of Ethiopia, 2018, SEQOTA DECLARATION I; Fikrie A, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0642-x; Gavhi F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232838; Girum T, 2021, SURVIVAL STATUS PRED; Guesh Gebremicael, 2018, BMC Res Notes, V11, P832, DOI 10.1186/s13104-018-3937-x; Irena AH, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-110; Jarso H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0398-4; Kebede F, 2021, J TROP MED-US, V2021, DOI 10.1155/2021/9996953; Kebede F, 2021, INT J CHILD HEALTH N, V10, P34, DOI 10.6000/1929-4247.2021.10.01.5; Lambebo A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249232; Mamo WN, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0732-9; Mena MB, 2018, INT J PEDIAT, V2018, DOI 10.1155/2018/8686501; Munthali T, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0072-1; Tadele Girum, 2018, The Open Public Health Journal, V11, P209, DOI 10.2174/1874944501811010209; Tesfay W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238311; Teshome G, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1407-9; UNICEF, REPORT 2019; Wagnew F, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0309-x; World Health Organization(WHO), 2013, UPDATES MANAGEMENT S; World Health Organization (WHO), UPDATES MANAGEMENT S	27	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263236	10.1371/journal.pone.0263236	http://dx.doi.org/10.1371/journal.pone.0263236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213569	gold, Green Published			2022-12-26	WOS:000787811000016
J	Marseille, E; Mitchell, JM; Kahn, JG				Marseille, Elliot; Mitchell, Jennifer M.; Kahn, James G.			Updated cost-effectiveness of M DMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial	PLOS ONE			English	Article							LONG-TERM; PSYCHOTHERAPY; SYMPTOMS; PTSD	Background Severe posttraumatic stress disorder (PTSD) is a prevalent and debilitating condition in the United States. and globally. Using pooled efficacy data from six phase 2 trials, therapy using 3,4-methylenedioxymethamphetamine (MDMA) appeared cost-saving from a payer's perspective. This study updates the cost-effectiveness analysis of this novel therapy using data from a new phase 3 trial, including the incremental cost-effectiveness of the more intensive phase 3 regimen compared with the shorter phase 2 regimen. Methods We adapted a previously-published Markov model to portray the costs and health benefits of providing MDMA-assisted therapy (MDMA-AT) to patients with chronic, severe, or extreme PTSD in a recent phase 3 trial, compared with standard care. Inputs were based on trial results and published literature. The trial treated 90 patients with a clinician administered PTSD scale (CAPS-5) total severity score of 35 or greater at baseline, and duration of PTSD symptoms of 6 months or longer. The primary outcome was assessed 8 weeks after the final experimental session. Patients received three 90-minute preparatory psychotherapy sessions, three 8-hour active MDMA or placebo sessions, and nine 90-minute integrative psychotherapy sessions. Our model calculates the per-patient cost of MDMA-AT, net all-cause medical costs, mortality, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs). We reported results from the U.S. health care payer's perspective for multiple analytic time horizons, (base-case is 30 years), and conducted extensive sensitivity analyses. Costs and QALYs were discounted by 3% annually. Costs were adjusted to 2020 U.S. dollars according to the medical component of the U.S. Bureau of Labor Statistics' Consumer Price Index (CPI). Results MDMA AT as conducted in the phase 3 trial costs $11,537 per patient. Compared to standard of care for 1,000 patients, MDMA-AT generates discounted net health care savings of $132.9 million over 30 years, accruing 4,856 QALYs, and averting 61.4 premature deaths. MDMA-AT breaks even on cost at 3.8 years while delivering 887 QALYs. A third MDMA session generates additional medical savings and health benefits compared with a two-session regimen. Hypothetically assuming no savings in health care costs, MDMA-AT has an ICER of $2,384 per QALY gained. Conclusions MDMA-AT provided to patients with severe or extreme chronic PTSD is cost-saving from a payer's perspective, while delivering substantial clinical benefit.	[Marseille, Elliot] Univ Calif Berkeley, Global Initiat Psychedel Sci Econ, Berkeley, CA 94720 USA; [Mitchell, Jennifer M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Kahn, James G.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marseille, E (corresponding author), Univ Calif Berkeley, Global Initiat Psychedel Sci Econ, Berkeley, CA 94720 USA.	emarseille1@berkeley.edu						[Anonymous], 2020, CONS PRIC IND; Bisson JI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub4; Center for Medicare and Medicaid Services, 2020, PHYS FEE SCHED SEARC; Consumer Price Index, 2020, MEDICAL CARE US CITY; FAIR Health Consumer, SEARCH MEDICAL HOSP; Gutner CA, 2016, PSYCHOL TRAUMA-US, V8, P115, DOI 10.1037/tra0000062; Haviland MG, 2016, J NERV MENT DIS, V204, P78, DOI 10.1097/NMD.0000000000000432; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Marseille E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239997; Mitchell JM, 2021, NAT MED, V27, P1025, DOI 10.1038/s41591-021-01336-3; Mithoefer MC, 2019, PSYCHOPHARMACOLOGY, V236, P2735, DOI 10.1007/s00213-019-05249-5; Mithoefer MC, 2013, J PSYCHOPHARMACOL, V27, P28, DOI 10.1177/0269881112456611; Morina N, 2014, CLIN PSYCHOL REV, V34, P249, DOI 10.1016/j.cpr.2014.03.002; Oehen P, 2013, J PSYCHOPHARMACOL, V27, P40, DOI 10.1177/0269881112464827; Pickard AS, 2019, VALUE HEALTH, V22, P931, DOI 10.1016/j.jval.2019.02.009; Savoca Elizabeth, 2000, J Ment Health Policy Econ, V3, P199, DOI 10.1002/mhp.102; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Steinert C, 2015, NORD J PSYCHIAT, V69, P483, DOI 10.3109/08039488.2015.1005023; Walker EA, 2003, ARCH GEN PSYCHIAT, V60, P369, DOI 10.1001/archpsyc.60.4.369; Watkins LE, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00258; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486	21	2	2	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263252	10.1371/journal.pone.0263252	http://dx.doi.org/10.1371/journal.pone.0263252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213554	gold, Green Published			2022-12-26	WOS:000787811000017
J	Nelson, DR; Brown, J; Morikawa, A; Method, M				Nelson, David R.; Brown, Jacqueline; Morikawa, Aki; Method, Michael			Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics	PLOS ONE			English	Article							21-GENE RECURRENCE SCORE; CHEMOTHERAPY; TRIAL; GUIDELINES; TAMOXIFEN; SURVIVAL; THERAPY; UTILITY; ASSAY	Objectives To investigate breast cancer-specific mortality by early breast cancer (EBC; Stages I-IIIC) subtype; incidence of high-risk indicators for recurrence (defined in monarchE trial); and mortality risk difference by those who did/did not meet these criteria. Materials and methods Analyses included patients with initial EBC diagnosis between 2010-2015 from Surveillance, Epidemiology, and End Results (SEER) data (n = 342,149). Cox proportional hazards models and Kaplan-Meier estimates examined mortality among 228,031 patients, by subtype (hormone receptor [HR]-positive [+], human epidermal growth factor receptor-2 [HER2] negative [-]; triple negative [TNBC]; HR+, HER2+; HR-, HER2+). Incidence and mortality among patients who did/did not meet monarchE clinicopathological high-risk criteria were examined. Results Among patients with HR+, HER2- EBC, histologic Grade 3 (vs. Grade 1) was the most influential factor on mortality (hazard ratio, 3.61; 95%Cl, 3.27, 3.98). Among patients with TNBC, >= 4 ipsilateral axillary positive nodes (vs. node negative) was the most influential factor on mortality (hazard ratio, 3.46; 95%Cl, 2.87, 4.17). For patients with HR-, HER2+ or HR+, HER2+ EBC, tumor size >= 5 cm (vs. <1 cm) and >= 4 ipsilateral axillary positive nodes were the most influential factors on mortality. The 60-month mortality rate for the 12% of patients within the HR+, HER2- EBC group meeting monarchE clinicopathological high-risk criteria was 16.5%, versus 7.0% (Stage II-III and node positive) and 2.8% (Stage I or node negative) for those not meeting criteria. The 60-month mortality rate for patients with TNBC was 18.5%. Conclusion Mortality risk and the relative importance of risk factors varied by subtype. monarchE clinicopathological high-risk criteria were associated with increased mortality risk among patients with HR+, HER2- EBC. Patients with HR+, HER2- EBC, and monarchE clinicopathological high-risk criteria experienced risk of mortality similar to patients with early TNBC. These data highlight a high unmet need in this select patient population who may benefit most from therapy escalation.	[Nelson, David R.; Method, Michael] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Brown, Jacqueline] Eli Lilly & Co, Bracknell, Berks, England; [Morikawa, Aki] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA	Eli Lilly; Eli Lilly; University of Michigan System; University of Michigan	Nelson, DR (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	nelson_david_r@lilly.com		Nelson, David/0000-0002-3240-0725	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This study was funded by Eli Lilly and Company. Eli Lilly and Company contracted with Syneos Health for medical writing assistance. The funder provided support in the form of salaries for authors DRN, JB and MM, design of study, data analysis, decision to publish, and preparation of the manuscript. The funder did not have any role in data collection. The specific roles of these authors are articulated in the `author contributions' section.	American Society of Clinical Oncology, 2021, SEL OPT ADJ CHEM TAR, DOI [10.3816/CBC.2008.s.012, DOI 10.3816/CBC.2008.S.012]; Amin M.B., 2017, AJCC CANC STAGING MA, V8; [Anonymous], BREAST CANC VERS 1 2, P2021; Bergh D., 2014, PAC RIM OBJ MEAS S P; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burstein HJ, 2019, ANN ONCOL, V30, P1541, DOI 10.1093/annonc/mdz235; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Gluz O, 2016, J CLIN ONCOL, V34, P2341, DOI 10.1200/JCO.2015.63.5383; HALL WJ, 1980, BIOMETRIKA, V67, P133; Harbeck N, 2021, ANN ONCOL, V32, P1571, DOI 10.1016/j.annonc.2021.09.015; Harbeck N., 2020, SAN ANTONIO BREAST C; Howlader N, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju055; Jasem J, 2017, J NATL COMPR CANC NE, V15, P494, DOI 10.6004/jnccn.2017.0049; Johnston SRD, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.02514; Kalinsky K, 2020, SAN ANTONIO BREAST C, pGS3; Kontzoglou K, 2013, ONCOLOGY-BASEL, V84, P219, DOI 10.1159/000346475; Kwa M, 2017, NAT REV CLIN ONCOL, V14, P595, DOI 10.1038/nrclinonc.2017.74; Mamounas EP, 2018, BREAST CANCER RES TR, V168, P69, DOI 10.1007/s10549-017-4550-8; Marme F, 2016, EUR J CANCER, V53, P65, DOI 10.1016/j.ejca.2015.09.022; Millar EKA, 2020, CANCERS, V12, DOI 10.3390/cancers12123749; National Cancer Institute, 2019, SEER RES DAT REC DES; National Cancer Institute Surveillance Epidemiology and End Results Program, 2021, CANC STAT FACTS FEM; National Cancer Institute. Surveillance Epidemiology and End Results Program, ASCII TEXT VERS SEER; National Cancer Institute's, SURV EP END RES SEER; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Senkus E, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt284; Sopik V, 2019, BREAST CANCER RES TR, V173, P465, DOI 10.1007/s10549-018-5002-9; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; Telli ML, 2019, J NATL COMPR CANC NE, V17, P552, DOI 10.6004/jnccn.2019.5006; Vasconcelos I, 2016, BREAST, V29, P181, DOI 10.1016/j.breast.2016.07.016; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Wallgren A, 2003, J CLIN ONCOL, V21, P1205, DOI 10.1200/JCO.2003.03.130; Yanai H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245725; Zhai QL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223325	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264637	10.1371/journal.pone.0264637	http://dx.doi.org/10.1371/journal.pone.0264637			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213669	gold, Green Published			2022-12-26	WOS:000787811000133
J	Theisen, TC; Boothroyd, JC				Theisen, Terence C.; Boothroyd, John C.			Transcriptional signatures of clonally derived Toxoplasma tachyzoites reveal novel insights into the expression of a family of surface proteins	PLOS ONE			English	Article							RNA-SEQ; GONDII; ANTIGEN; IDENTIFICATION; SUPERFAMILY; CELLS; STAGE	Toxoplasma gondii has numerous, large, paralogous gene families that are likely critical for supporting its unparalleled host range: nearly any nucleated cell in almost any warm-blooded animal. The SRS (SAG1-related sequence) gene family encodes over 100 proteins, the most abundant of which are thought to be involved in parasite attachment and, based on their stage-specific expression, evading the host immune response. For most SRS proteins, however, little is understood about their function and expression profile. Single-parasite RNA-sequencing previously demonstrated that across an entire population of lab-grown tachyzoites, transcripts for over 70 SRS genes were detected in at least one parasite. In any one parasite, however, transcripts for an average of only 7 SRS genes were detected, two of which, SAG1 and SAG2A, were extremely abundant and detected in virtually all. These data do not address whether this pattern of sporadic SRS gene expression is consistently inherited among the progeny of a given parasite or arises independently of lineage. We hypothesized that if SRS expression signatures are stably inherited by progeny, subclones isolated from a cloned parent would be more alike in their expression signatures than they are to the offspring of another clone. In this report, we compare transcriptomes of clonally derived parasites to determine the degree to which expression of the SRS family is stably inherited in individual parasites. Our data indicate that in RH tachyzoites, SRS genes are variably expressed even between parasite samples subcloned from the same parent within approximately 10 parasite divisions (72 hours). This suggests that the pattern of sporadically expressed SRS genes is highly variable and not driven by inheritance mechanisms, at least under our conditions.	[Theisen, Terence C.; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Theisen, Terence C.] NanoString Technol Inc, Seattle, WA USA	Stanford University	Boothroyd, JC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu		Boothroyd, John C./0000-0001-9719-745X	National Institutes of Health [RO1 AI021423]; NIH [T32-AI007328]; Stanford University - Stanford Interdisciplinary Graduate Bio-X Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University - Stanford Interdisciplinary Graduate Bio-X Fellowship	This work was supported by the National Institutes of Health RO1 AI021423 (JCB), and fellowship support by NIH (T32-AI007328) and Stanford University - Stanford Interdisciplinary Graduate Bio-X Fellowship (TCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Azzouz N, 2013, GLYCOBIOLOGY, V23, P106, DOI 10.1093/glycob/cws134; Behnke MS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-350; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; COUVREUR G, 1988, PARASITOLOGY, V97, P1, DOI 10.1017/S0031182000066695; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUBEY JP, 1970, J EXP MED, V132, P636, DOI 10.1084/jem.132.4.636; Dzierszinski F, 2000, MOL MICROBIOL, V37, P574, DOI 10.1046/j.1365-2958.2000.02014.x; FRENKEL JK, 1972, J INFECT DIS, V126, P664, DOI 10.1093/infdis/126.6.664; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029998; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Garfoot AL, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6213-0; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; HAYNES BF, 1995, AIDS RES HUM RETROV, V11, P211, DOI 10.1089/aid.1995.11.211; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Hehl AB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1225-x; Hoff EF, 2002, TRENDS PARASITOL, V18, P251, DOI 10.1016/S1471-4922(02)02240-7; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jones EJ, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2016.1273865; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Kahn SJ, 1997, J IMMUNOL, V159, P4444; Kim SK, 2005, J IMMUNOL, V174, P8038, DOI 10.4049/jimmunol.174.12.8038; Leal-Sena JA, 2018, APPL MICROBIOL BIOT, V102, P2235, DOI 10.1007/s00253-018-8759-1; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; Lorenzi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10147; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manger ID, 1998, INFECT IMMUN, V66, P1632, DOI 10.1128/IAI.66.4.1632-1637.1998; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; MINEO JR, 1994, EXP PARASITOL, V79, P11, DOI 10.1006/expr.1994.1054; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pittman KJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-806; R Core Team, 2021, R LANGUAGE ENV STAT; Radke JR, 2004, MOL MICROBIOL, V52, P93, DOI 10.1111/j.1365-2958.2003.03967.x; Ramakrishnan C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37671-8; Rastogi S, 2020, MBIO, V11, DOI 10.1128/mBio.00182-20; Saadatnia G, 2012, SCAND J INFECT DIS, V44, P805, DOI 10.3109/00365548.2012.693197; Saeij JPJ, 2008, INFECT IMMUN, V76, P2402, DOI 10.1128/IAI.01494-07; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; TOMAVO S, 1991, INFECT IMMUN, V59, P3750, DOI 10.1128/IAI.59.10.3750-3753.1991; Tomita T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003823; Waldman BS, 2020, CELL, V180, P359, DOI 10.1016/j.cell.2019.12.013; Waskom M.L., 2021, JOSS, V6, P3021, DOI [DOI 10.21105/JOSS.03021, 10.21105/joss.03021, 10.5281/ZENODO.592845]; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; WEBSTER RG, 1966, J IMMUNOL, V97, P177; Xue Y, 2020, ELIFE, V9, DOI 10.7554/eLife.54129	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0262374	10.1371/journal.pone.0262374	http://dx.doi.org/10.1371/journal.pone.0262374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213559	Green Published, Green Submitted, gold			2022-12-26	WOS:000787811000008
J	van Dijken, BRJ; Ankrah, AO; Stormezand, GN; Dierckx, RAJO; van Laar, PJ; van der Hoorn, A				van Dijken, Bart R. J.; Ankrah, Alfred O.; Stormezand, Gilles N.; Dierckx, Rudi A. J. O.; van Laar, Peter Jan; van der Hoorn, Anouk			Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma	PLOS ONE			English	Article							C-11-METHIONINE PET; TUMOR VOLUME; BRAIN-TUMORS; SURVIVAL	Purpose C-11-Methionine (C-11-MET) PET prognostication of isocitrate dehydrogenase (IDH) wild type glioblastomas is inadequate as conventional parameters such as standardized uptake value (SUV) do not adequately reflect tumor heterogeneity. We retrospectively evaluated whether volume-based parameters such as metabolic tumor volume (MTV) and total lesion methionine metabolism (TLMM) outperformed SUV for survival correlation in patients with IDH wild type glioblastomas. Methods Thirteen IDH wild type glioblastoma patients underwent preoperative C-11-MET PET. Both SUV-based parameters and volume-based parameters were calculated for each lesion. Kaplan-Meier curves with log-rank testing and Cox regression analysis were used for correlation between PET parameters and overall survival. Results Median overall survival for the entire cohort was 393 days. MTV (HR 1.136, p = 0.007) and TLMM (HR 1.022, p = 0.030) were inversely correlated with overall survival. SUV-based C-11-MET PET parameters did not show a correlation with survival. In a paired analysis with other clinical parameters including age and radiotherapy dose, MTV and TLMM were found to be independent factors. Conclusions MTV and TLMM, and not SUV, significantly correlate with overall survival in patients with IDH wild type glioblastomas. The incorporation of volume-based C-11-MET PET parameters may lead to a better outcome prediction for this heterogeneous patient population.	[van Dijken, Bart R. J.; Dierckx, Rudi A. J. O.; van Laar, Peter Jan; van der Hoorn, Anouk] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Ankrah, Alfred O.; Stormezand, Gilles N.; Dierckx, Rudi A. J. O.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [van Laar, Peter Jan] Zorggrp Twente, Dept Radiol, Almelo, Netherlands; [van Laar, Peter Jan] Zorggrp Twente, Dept Radiol, Hengelo, Netherlands	University of Groningen; University of Groningen	van Dijken, BRJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands.	b.r.j.van.dijken@umcg.nl		van der Hoorn, Anouk/0000-0003-4649-327X; Stormezand, Gilles/0000-0002-1370-8791				Albert NL, 2016, NEURO-ONCOLOGY, V18, P1199, DOI 10.1093/neuonc/now058; Bauer EK, 2020, EUR J NUCL MED MOL I, V47, P1486, DOI 10.1007/s00259-020-04695-0; Borght TV, 2006, EUR J NUCL MED MOL I, V33, P1374, DOI 10.1007/s00259-006-0206-3; Carretta A, 2020, RADIOL ONCOL, V54, P278, DOI 10.2478/raon-2020-0034; Ceccon G, 2021, J NUCL MED, V62, P918, DOI 10.2967/jnumed.120.254243; Cegla P, 2019, CLIN NUCL MED, V44, P860, DOI 10.1097/RLU.0000000000002733; Ceyssens S, 2006, AM J NEURORADIOL, V27, P1432; Cicuendez M, 2015, CLIN NEUROL NEUROSUR, V139, P328, DOI 10.1016/j.clineuro.2015.10.035; Creff G, 2020, JAMA OTOLARYNGOL, V146, P471, DOI 10.1001/jamaoto.2020.0014; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Glaudemans AWJM, 2013, EUR J NUCL MED MOL I, V40, P615, DOI 10.1007/s00259-012-2295-5; Kobayashi K, 2015, EUR J NUCL MED MOL I, V42, P1071, DOI 10.1007/s00259-015-3046-1; Kolinger GD, 2019, EJNMMI RES, V9, DOI 10.1186/s13550-019-0481-1; LANGSTROM B, 1987, J NUCL MED, V28, P1037; Lopci E, 2017, EUR J NUCL MED MOL I, V44, P1155, DOI 10.1007/s00259-017-3618-3; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Morales-Lozano MI, 2020, CANCERS, V12, DOI 10.3390/cancers12041042; Ogawa T, 2020, EJNMMI RES, V10, DOI 10.1186/s13550-020-00633-1; Poetsch N, 2018, NEURO-ONCOLOGY, V20, P411, DOI 10.1093/neuonc/nox177; Suchorska B, 2015, NEUROLOGY, V84, P710, DOI 10.1212/WNL.0000000000001262; Takei H, 2020, J NEUROSURG, V133, P1010, DOI 10.3171/2019.5.JNS19780; van den Bent MJ, 2017, LANCET, V390, P1645, DOI 10.1016/S0140-6736(17)31442-3; Yoo MY, 2015, NUCL MED MOLEC IMAG, V49, P291, DOI 10.1007/s13139-015-0362-0	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264387	10.1371/journal.pone.0264387	http://dx.doi.org/10.1371/journal.pone.0264387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213602	Green Published, gold			2022-12-26	WOS:000787811000085
J	Yoshida, A; Phillips-Mason, P; Tarallo, V; Avril, S; Koivisto, C; Leone, G; Diehl, JA				Yoshida, Akihiro; Phillips-Mason, Polly; Tarallo, Vincenzo; Avril, Stefanie; Koivisto, Christopher; Leone, Gustavo; Diehl, J. Alan			Non-phosphorylatable cyclin D1 mutant potentiates endometrial hyperplasia and drives carcinoma with Pten loss	ONCOGENE			English	Article							KAPPA-B; PROTEOLYSIS; CANCER; PRMT5; EXPRESSION; SUBUNIT; MTOR	Cyclin D1 is a regulatory subunit of -Cyclin Dependent Kinases 4 and 6 (CDK4/6) and regulates progression from G1 to S phase of the cell cycle. Dysregulated cyclin D1-CDK4/6 contributes to abnormal cell proliferation and tumor development. Phosphorylation of threonine 286 of cyclin D1 is necessary for ubiquitin-dependent degradation. Non-phosphorylatable cyclin D1 mutants are stabilized and concentrated in the nucleus, contributing to genomic instability and tumor development. Studies investigating the tumor-promoting functions of cyclin D1 mutants have focused on the use of artificial promoters to drive the expression which unfortunately may not accurately reflect tumorigenic functions of mutant cyclin D1 in cancer development. We have generated a conditional knock-in mouse model where cyclin D1T286A is expressed under the control of its endogenous promoter following Cre-dependent excision of a lox-stop-lox sequence. Acute expression of cyclin D1T286A following tamoxifen-inducible Cre recombinase triggers inflammation, lymphocyte abnormality and ultimately mesenteric tumors in the intestine. Tissue-specific expression of cyclin D1T286A in the uterus and endometrium cooperates with Pten loss to drive endometrial hyperplasia and cancer. Mechanistically, cyclin D1T286A mutant activates NF-kappa B signaling, augments inflammation, and contributes to tumor development. These results indicate that mutation of cyclin D1 at threonine 286 has a critical role in regulating inflammation and tumor development.	[Yoshida, Akihiro] Univ Hosp Cleveland, Dept Dermatol, Med Ctr, Cleveland, OH 44106 USA; [Yoshida, Akihiro; Avril, Stefanie] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Yoshida, Akihiro; Phillips-Mason, Polly; Tarallo, Vincenzo; Diehl, J. Alan] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Yoshida, Akihiro; Avril, Stefanie; Diehl, J. Alan] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Avril, Stefanie] Univ Hosp Cleveland, Dept Pathol, Med Ctr, Cleveland, OH 44106 USA; [Koivisto, Christopher] Med Univ South Carolina, Dept Biochem, Charleston, SC 29425 USA; [Leone, Gustavo] Med Coll Wisconsin, Canc Ctr, Dept Biochem, Wauwatosa, WI 53226 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Medical University of South Carolina; Medical College of Wisconsin	Yoshida, A (corresponding author), Univ Hosp Cleveland, Dept Dermatol, Med Ctr, Cleveland, OH 44106 USA.; Yoshida, A (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.; Yoshida, A; Diehl, JA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.; Yoshida, A; Diehl, JA (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	axy234@case.edu; jad283@case.edu		Tarallo, Vincenzo/0000-0001-8158-1326; , J. Alan/0000-0001-9854-5049; Yoshida, Akihiro/0000-0002-9785-9035	National Cancer Institute [R01 CA093237, P01 CA098101, R01 CA121275]; Advancing a Healthier Wisconsin Endowment Award	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Advancing a Healthier Wisconsin Endowment Award	This work was supported by grants from National Cancer Institute: R01 CA093237 and P01 CA098101 (JAD); R01 CA121275 and Advancing a Healthier Wisconsin Endowment Award (GL).	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; ANDO K, 1993, P NATL ACAD SCI USA, V90, P9571, DOI 10.1073/pnas.90.20.9571; Caserta E, 2015, GENE DEV, V29, P1707, DOI 10.1101/gad.262568.115; Contreras CM, 2010, DIS MODEL MECH, V3, P181, DOI 10.1242/dmm.004440; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gladden AB, 2006, ONCOGENE, V25, P998, DOI 10.1038/sj.onc.1209147; GU L, 2004, BLOOD, V104, P4438, DOI DOI 10.1182/BLOOD.V104.11.4438.4438; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Kwon HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11686; Li Y, 2015, CANCER DISCOV, V5, P288, DOI 10.1158/2159-8290.CD-14-0625; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Masclef L, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00106; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Pontano LL, 2008, MOL CELL BIOL, V28, P7245, DOI 10.1128/MCB.01085-08; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Tian YQ, 2019, AGING CELL, V18, DOI 10.1111/acel.12858; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	30	1	1	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2022	41	15					2187	2195		10.1038/s41388-022-02243-8	http://dx.doi.org/10.1038/s41388-022-02243-8		FEB 2022	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J8DX	35210557				2022-12-26	WOS:000761270800001
J	Romero-Ibarguengoitia, ME; Rivera-Salinas, D; Hernandez-Ruiz, YG; Armendariz-Vazquez, AG; Gonzalez-Cantu, A; Barco-Flores, IA; Gonzalez-Facio, R; Montelongo-Cruz, LP; Del Rio-Parra, GF; Garza-Herrera, MR; Leal-Melendez, JA; Sanz-Sanchez, MA				Elena Romero-Ibarguengoitia, Maria; Rivera-Salinas, Diego; Guadalupe Hernandez-Ruiz, Yodira; Gabriela Armendariz-Vazquez, Ana; Gonzalez-Cantu, Arnulfo; Antonieta Barco-Flores, Irene; Gonzalez-Facio, Rosalinda; Patricia Montelongo-Cruz, Laura; Francisco Del Rio-Parra, Gerardo; Rene Garza-Herrera, Mauricio; Andrea Leal-Melendez, Jessica; Angel Sanz-Sanchez, Miguel			Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel	PLOS ONE			English	Article								BackgroundVaccination is our main strategy to control SARS-CoV-2 infection. Given the decrease in quantitative SARS-CoV-2 spike 1-2 IgG antibody titers three months after the second BNT162b2 dose, healthcare workers received a third booster six months after completing the original protocol. This study aimed to analyze the quantitative SARS-CoV-2 spike 1-2 IgG antibody titers and the safety of the third dose. Material and methodsA prospective longitudinal cohort study included healthcare workers who received a third booster six months after completing the BNT162b2 regimen. We assessed the quantitative SARS-CoV-2 spike 1-2 IgG antibody titers 21-28 days after the first and second dose, three months after the completed protocol, 1-7 days following the third dose, and 21-28 days after booster administration. ResultsThe cohort comprised 168 participants aged 41(10) years old, 67% of whom were female. The third dose was associated with an increase in quantitative antibody titers, regardless of previous SARS-CoV-2 history. In cases with a negative SARS-CoV-2 history, the median (IQR) antibody titer values increased from 379 (645.4) to 2960 (2010) AU/ml, whereas in cases with a positive SARS-CoV-2 history, from 590 (1262) to 3090 (2080) AU/ml (p<0.001). The third dose caused a lower number of total (local and systemic) adverse events following immunization (AEFI) compared with the first two vaccines. However, in terms of specific symptoms such as fatigue, myalgia, arthralgia, fever, and adenopathy, the proportion was higher in comparison with the first and second doses (p<0.05). The most common AEFI after the third BNT162b2 vaccine was pain at the injection site (n = 82, 84.5%), followed by fatigue (n = 45, 46.4%) of mild severity (n = 36, 37.1%). ConclusionThe third dose applied six months after the original BNT162b2 regimen increased the quantitative SARS-CoV-2 spike 1-2 IgG antibody titers. The booster dose was well tolerated and caused no severe AEFI.	[Elena Romero-Ibarguengoitia, Maria; Rivera-Salinas, Diego; Guadalupe Hernandez-Ruiz, Yodira; Gabriela Armendariz-Vazquez, Ana; Gonzalez-Cantu, Arnulfo; Antonieta Barco-Flores, Irene; Gonzalez-Facio, Rosalinda; Patricia Montelongo-Cruz, Laura; Francisco Del Rio-Parra, Gerardo; Rene Garza-Herrera, Mauricio; Andrea Leal-Melendez, Jessica; Angel Sanz-Sanchez, Miguel] Hosp Clin Nova Monterrey, Dept Invest, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Elena Romero-Ibarguengoitia, Maria; Rivera-Salinas, Diego; Guadalupe Hernandez-Ruiz, Yodira; Gabriela Armendariz-Vazquez, Ana; Gonzalez-Cantu, Arnulfo; Patricia Montelongo-Cruz, Laura; Francisco Del Rio-Parra, Gerardo; Rene Garza-Herrera, Mauricio; Andrea Leal-Melendez, Jessica; Angel Sanz-Sanchez, Miguel] Univ Monterrey, Acad Affairs Hlth Sci, Sch Med, San Pedro Garza Garcia, Nuevo Leon, Mexico; [Elena Romero-Ibarguengoitia, Maria] Ave Bosque 139, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Elena Romero-Ibarguengoitia, Maria] Ave Ignacio Morones Prieto, San Pedro Garza Garcia, Nuevo Leon, Mexico	Tecnologico de Monterrey; Universidad de Monterrey	Romero-Ibarguengoitia, ME (corresponding author), Hosp Clin Nova Monterrey, Dept Invest, San Nicolas De Los Garza, Nuevo Leon, Mexico.; Romero-Ibarguengoitia, ME (corresponding author), Univ Monterrey, Acad Affairs Hlth Sci, Sch Med, San Pedro Garza Garcia, Nuevo Leon, Mexico.; Romero-Ibarguengoitia, ME (corresponding author), Ave Bosque 139, San Nicolas De Los Garza, Nuevo Leon, Mexico.; Romero-Ibarguengoitia, ME (corresponding author), Ave Ignacio Morones Prieto, San Pedro Garza Garcia, Nuevo Leon, Mexico.	MROMEROI@novaservicios.com.mx	Gonzalez, Arnulfo/AAD-9873-2019	Romero-Ibarguengoitia, Maria Elena/0000-0002-2572-4043; Gonzalez-Cantu, Arnulfo/0000-0003-0103-0079				[Anonymous], DIASORIN; [Anonymous], 2021, FDA AUTH BOOST DOS P; Badiani A A, 2020, Public Health Pract (Oxf), V1, P100061, DOI 10.1016/j.puhip.2020.100061; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Bonelli F, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01224-20; CDC, 2020, COVID 19 VACC; Chen MS, 2021, INFECT DIS POVERTY, V10, DOI 10.1186/s40249-021-00878-5; Cuschieri S, 2019, SAUDI J ANAESTH, V13, P31, DOI 10.4103/sja.SJA_543_18; Economic Commission for Latin America Pan American Health Organization, 2021, PROL HLTH CRIS ITS I; Erice A, 2022, CLIN MICROBIOL INFEC, V28, DOI 10.1016/j.cmi.2021.08.023; Fan YJ, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9090989; Favresse J, 2021, EMERG MICROBES INFEC, V10, P1495, DOI 10.1080/22221751.2021.1953403; Food and Drug Administration, 2020, FDA TAK KEY ACT FIGH; Jagtap S, 2021, J VIROL METHODS, V296, DOI 10.1016/j.jviromet.2021.114222; Kontopoulou K., 2021, 3899094 SOC SCI RES; Lamb YN, 2021, DRUGS, V81, P495, DOI 10.1007/s40265-021-01480-7; Levi Riccardo, 2021, Commun Med (Lond), V1, P32, DOI 10.1038/s43856-021-00032-0; Levi R, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149154; Peled Y, 2022, J HEART LUNG TRANSPL, V41, P148, DOI 10.1016/j.healun.2021.08.010; Pellini R, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100928; Sadarangani M, 2021, NAT REV IMMUNOL, V21, P475, DOI 10.1038/s41577-021-00578-z; Salvagno GL., 2021, SSRN J INTERNET; Sandri MT., 2020, SARS COV 2 SEROLOGY, DOI [10.1101/2020.05.24.20111245v2, DOI 10.1101/2020.05.24.20111245V2]; Tre-Hardy M., 2021, J INFECT INTERNET; World Health Organization, 2020, DIR GEN OP REM MED B	25	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263942	10.1371/journal.pone.0263942	http://dx.doi.org/10.1371/journal.pone.0263942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235587	gold, Green Published			2022-12-26	WOS:000787073100023
J	Salahshour, M; Oberhauser, V; Smerlak, M				Salahshour, Mohammad; Oberhauser, Vincent; Smerlak, Matteo			The cost of noise: Stochastic punishment falls short of sustaining cooperation in social dilemma experiments	PLOS ONE			English	Article							PUBLIC-GOODS; ALTRUISTIC PUNISHMENT; STRONG RECIPROCITY; PROVISION; EVOLUTION; UNCERTAINTY; SANCTIONS; JUDGES; RISK; LAW	Identifying mechanisms able to sustain costly cooperation among self-interested agents is a central problem across social and biological sciences. One possible solution is peer punishment: when agents have an opportunity to sanction defectors, classical behavioral experiments suggest that cooperation can take root. Overlooked from standard experimental designs, however, is the fact that real-world human punishment-the administration of justice-is intrinsically noisy. Here we show that stochastic punishment falls short of sustaining cooperation in the repeated public good game. As punishment noise increases, we find that contributions decrease and punishment efforts intensify, resulting in a 45% drop in gains compared to a noiseless control. Moreover, we observe that uncertainty causes a rise in antisocial punishment, a mutually harmful behavior previously associated with societies with a weak rule of law. Our approach brings to light challenges to cooperation that cannot be explained by economic rationality and strengthens the case for further investigations of the effect of noise-and not just bias-on human behavior.	[Salahshour, Mohammad; Oberhauser, Vincent; Smerlak, Matteo] Max Planck Inst Math Sci, Leipzig, Germany	Max Planck Society	Smerlak, M (corresponding author), Max Planck Inst Math Sci, Leipzig, Germany.	smerlak@mis.mpg.de		Smerlak, Matteo/0000-0002-0844-8868; Salahshour Mehmandoust Olia, Mohammad/0000-0001-5354-9839; Oberhauser, Vincent/0000-0002-4512-6390	Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Funding for this work was provided by the Alexander von Humboldt Foundation in the framework of the Sofja Kovalevskaja Award endowed by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefin MR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72971-y; AUSTIN W, 1977, J CRIM LAW CRIM, V68, P306, DOI 10.2307/1142852; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baker T, 2004, IOWA LAW REV, V89, P443; Baumann F., 2017, SUPREME COURT EC REV, V25, P65, DOI [10.1086/692925, DOI 10.1086/692925]; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Carpenter JP, 2007, GAME ECON BEHAV, V60, P31, DOI 10.1016/j.geb.2006.08.011; Chaudhuri A, 2011, EXP ECON, V14, P47, DOI 10.1007/s10683-010-9257-1; CLANCY K, 1981, J CRIM LAW CRIM, V72, P524, DOI 10.2307/1143005; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; Dari-Mattiacci G, 2007, J INST THEOR ECON, V163, P627, DOI 10.1628/093245607783242990; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Duersch P., 2009, DISCUSSION PAPER SER; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Eren O, 2018, AM ECON J-APPL ECON, V10, P171, DOI 10.1257/app.20160390; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2014, SOC CHOICE WELFARE, V43, P195, DOI 10.1007/s00355-013-0763-x; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Grechenig K, 2010, J EMPIR LEGAL STUD, V7, P847, DOI 10.1111/j.1740-1461.2010.01197.x; Guala F, 2010, BUSINESS STAT WORKIN; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hsee CK, 1999, J BEHAV DECIS MAKING, V12, P165, DOI 10.1002/(SICI)1099-0771(199906)12:2<165::AID-BDM316>3.0.CO;2-N; ISAAC RM, 1988, Q J ECON, V103, P179, DOI 10.2307/1882648; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2021, LITTLE BROWN; Ledyard JO., 2020, 2 PUBLIC GOODS SURVE; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; Nikiforakis N, 2008, EXP ECON, V11, P358, DOI 10.1007/s10683-007-9171-3; Olson M., 1965, LOGIC COLLECT ACTION, P124; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Parks CD, 2010, J PERS SOC PSYCHOL, V99, P303, DOI 10.1037/a0018403; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Rizzolli M, 2012, J LAW ECON, V55, P311, DOI 10.1086/663346; Salahshour M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254860; Sarel R, 2018, JUDICIAL ERRORS CRIM; Shteynberg G., 2005, CULTURAL PSYCHOL REV; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Sylwester K, 2013, J NEUROSCI PSYCHOL E, V6, P167, DOI 10.1037/npe0000009; Szolnoki A, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.041027; Valenzuela A, 2010, J CONSUM RES, V36, P792, DOI 10.1086/605592; Walker JM, 2004, EXP ECON, V7, P235, DOI 10.1023/B:EXEC.0000040559.08652.51; Weber EU, 1998, MANAGE SCI, V44, P1205, DOI 10.1287/mnsc.44.9.1205; Wenseleers T, 2006, NATURE, V444, P50, DOI 10.1038/444050a; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110; Zourrig H, 2009, J BUS RES, V62, P995, DOI 10.1016/j.jbusres.2008.08.006	56	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263028	10.1371/journal.pone.0263028	http://dx.doi.org/10.1371/journal.pone.0263028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T6JP	35235586	gold, Green Published, Green Submitted			2022-12-26	WOS:000787073100020
J	Wongsuk, T; Boonsilp, S; Homkaew, A; Thananon, K; Oonanant, W				Wongsuk, Thanwa; Boonsilp, Siriphan; Homkaew, Anchalee; Thananon, Konrawee; Oonanant, Worrapoj			Whole genome sequence of pan drug-resistant clinical isolate of Acinetobacter baumannii ST1890	PLOS ONE			English	Article							RIBOSOMAL-RNA METHYLASE; FUNCTIONAL-CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; COMPARATIVE EFFICACY; COLISTIN RESISTANCE; EFFLUX PUMP; VIRULENCE; GENES; EVOLUTION; INFECTIONS	Acinetobacter baumannii is an opportunistic gram-negative bacteria typically attributed to hospital-associated infection. It could also become multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan drug-resistant (PDR) during a short period. Although A. baumannii has been documented extensively, complete knowledge on the antibiotic-resistant mechanisms and virulence factors responsible for pathogenesis has not been entirely elucidated. This study investigated the drug resistance pattern and characterized the genomic sequence by de novo assembly of PDR A. baumannii strain VJR422, which was isolated from a catheter-sputum specimen. The results showed that the VJR422 strain was resistant to any existing antibiotics. Based on de novo assembly, whole-genome sequences showed a total genome size of 3,924,675-bp. In silico and conventional MLST analysis of sequence type (ST) of this strain was new ST by Oxford MLST scheme and designated as ST1890. Moreover, we found 10,915 genes that could be classified into 45 categories by Gene Ontology (GO) analysis. There were 1,687 genes mapped to 34 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The statistics from Clusters of Orthologous Genes (COG) annotation identified 3,189 genes of the VJR422 strain. Regarding the existence of virulence factors, a total of 59 virulence factors were identified in the genome of the VJR422 strain by virulence factors of pathogenic bacteria databases (VFDB). The drug-resistant genes were investigated by searching in the Comprehensive Antibiotic Resistance Database (CARD). The strain harbored antibiotic-resistant genes responsible for aminoglycoside, beta-lactam-ring-containing drugs, erythromycin, and streptogramin resistance. We also identified resistance-nodulation-cell division (RND) and the major facilitator superfamily (MFS) associated with the antibiotic efflux pump. Overall, this study focused on A. baumannii strain VJR422 at the genomic level data, i.e., GO, COG, and KEGG. The antibiotic-resistant genotype and phenotype as well as the presence of potential virulence associated factors were investigated.	[Wongsuk, Thanwa; Boonsilp, Siriphan] Navamindradhiraj Univ, Vajira Hosp, Dept Clin Pathol, Fac Med, Bangkok, Thailand; [Homkaew, Anchalee] Navamindradhiraj Univ, Fac Med, Div Cent Lab & Blood Bank, Vajira Hosp, Bangkok, Thailand; [Thananon, Konrawee] Navamindradhiraj Univ, Fac Med, Res Facilitat Div, Vajira Hosp, Bangkok, Thailand; [Thananon, Konrawee] Chulalongkorn Univ, Fac Dent, Dept Microbiol, Res Unit Integrat Immunomicrobial Biochem & Biore, Bangkok, Thailand; [Oonanant, Worrapoj] Navamindradhiraj Univ, Fac Med, Dept Basic Med Sci, Vajira Hosp, Bangkok, Thailand	Chulalongkorn University	Oonanant, W (corresponding author), Navamindradhiraj Univ, Fac Med, Dept Basic Med Sci, Vajira Hosp, Bangkok, Thailand.	worrapoj@nmu.ac.th	; Wongsuk, Thanwa/I-7585-2016	Oonanant, Worrapoj/0000-0002-3925-5321; Wongsuk, Thanwa/0000-0001-9904-4334	Navamindradhiraj University Research Fund [29/2561]	Navamindradhiraj University Research Fund	We would like to thank the Faculty of Medicine Vajira Hospital for supporting professional English language editing by Enago and ProofRead4Sure. We thank Assoc. Prof. Sarawut Kumphune (Biomedical Engineering Institute, Chiang Mai University, Chiang Mai, Thailand) for carefully read our manuscript and gave detailed comments and suggestions.	Abdi SN, 2020, INFECT DRUG RESIST, V13, P423, DOI 10.2147/IDR.S228089; Abolghait SK, 2020, INT J FOOD MICROBIOL, V328, DOI 10.1016/j.ijfoodmicro.2020.108669; Algammal AM, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02287-y; Algammal AM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88861-w; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75914-9; Algammal AM, 2020, INFECT DRUG RESIST, V13, P3255, DOI 10.2147/IDR.S272733; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72264-4; Algammal AM, 2020, TOXINS, V12, DOI 10.3390/toxins12060383; Algammal AM, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01037-z; Algammal AM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050362; Ambrosi C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01977; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Bonnin RA, 2013, ANTIMICROB AGENTS CH, V57, P674, DOI 10.1128/AAC.01086-12; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Hernan RC, 2009, DIAGN MICR INFEC DIS, V65, P188, DOI 10.1016/j.diagmicrobio.2009.05.019; Caselli E, 2018, ACS INFECT DIS, V4, P337, DOI 10.1021/acsinfecdis.7b00153; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Cho YJ, 2009, DIAGN MICR INFEC DIS, V64, P185, DOI 10.1016/j.diagmicrobio.2009.02.010; Chung ES, 2017, J ANTIMICROB CHEMOTH, V72, P2133, DOI 10.1093/jac/dkx102; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Enany ME, 2018, PAK J PHARM SCI, V31, P1865; Evans BA, 2008, CLIN MICROBIOL INFEC, V14, P268, DOI 10.1111/j.1469-0691.2007.01919.x; Fang YH, 2016, GENOM DATA, V7, P269, DOI 10.1016/j.gdata.2015.12.002; Fernando D, 2012, J ANTIMICROB CHEMOTH, V67, P569, DOI 10.1093/jac/dkr519; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gentilini F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02872; Golebiewski M, 2007, ANTIMICROB AGENTS CH, V51, P3789, DOI 10.1128/AAC.00457-07; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Jalal D, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00725-21; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karakonstantis S, 2020, J HOSP INFECT, V106, P447, DOI 10.1016/j.jhin.2020.09.009; Karakonstantis S, 2020, J ANTIMICROB CHEMOTH, V75, P271, DOI 10.1093/jac/dkz401; Kengkla K, 2018, J ANTIMICROB CHEMOTH, V73, P22, DOI 10.1093/jac/dkx368; Kim DH, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01972-16; Kyriakidis I, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10030373; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lee CR, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00055; Lemee L, 2004, J CLIN MICROBIOL, V42, P2609, DOI 10.1128/JCM.42.6.2609-2617.2004; Leus IV, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00049-18; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu JT, 2021, J GLOB ANTIMICROB RE, V24, P136, DOI 10.1016/j.jgar.2020.08.021; Lopez-Rojas R, 2013, ANTIMICROB AGENTS CH, V57, P4587, DOI 10.1128/AAC.00543-13; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Makharita RR, 2020, INFECT DRUG RESIST, V13, P3991, DOI 10.2147/IDR.S276975; Mulani MS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00539; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Naha A, 2021, J CELL BIOCHEM, V122, P1946, DOI 10.1002/jcb.30156; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nguyen ST, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0250-9; Nie L, 2014, ACTA PHARM SIN B, V4, P295, DOI 10.1016/j.apsb.2014.06.004; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; O'Hara JA, 2013, ANTIMICROB AGENTS CH, V57, P2103, DOI 10.1128/AAC.02501-12; Papathanakos G, 2020, J ANTIMICROB CHEMOTH, V75, P3081, DOI 10.1093/jac/dkaa264; Pasqua M, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090285; Patel J.B., 2017, M100 CLSI; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perez CE, 2018, BIOCHEMISTRY-US, V57, P354, DOI 10.1021/acs.biochem.7b00863; Peterson LR, 2009, CLIN INFECT DIS, V49, P992, DOI 10.1086/605539; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P1919, DOI 10.1093/jac/dkq195; Saha S, 2008, NUCLEIC ACIDS RES, V36, P2284, DOI 10.1093/nar/gkn064; Salverda MLM, 2010, FEMS MICROBIOL REV, V34, P1015, DOI 10.1111/j.1574-6976.2010.00222.x; Sharma A, 2017, J ANTIMICROB CHEMOTH, V72, P68, DOI 10.1093/jac/dkw382; Srinivasan VB, 2009, ANTIMICROB AGENTS CH, V53, P5312, DOI 10.1128/AAC.00748-09; Tada T, 2014, ANTIMICROB AGENTS CH, V58, P2916, DOI 10.1128/AAC.01212-13; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thadtapong N, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10091054; Uechi K, 2018, J INFECT CHEMOTHER, V24, P68, DOI 10.1016/j.jiac.2017.09.006; Vijayakumar S, 2019, INDIAN J MED RES, V149, P240, DOI 10.4103/ijmr.IJMR_2085_17; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; Wang HL, 2017, INT J MOL MED, V39, P364, DOI 10.3892/ijmm.2016.2844; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wisplinghoff H, 2008, CLIN MICROBIOL INFEC, V14, P708, DOI 10.1111/j.1469-0691.2008.02010.x; Zhang YY, 2018, MICROB DRUG RESIST, V24, P1259, DOI 10.1089/mdr.2017.0246; Zhang YP, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06529-2	87	0	0	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264374	10.1371/journal.pone.0264374	http://dx.doi.org/10.1371/journal.pone.0264374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263355	Green Published, gold			2022-12-26	WOS:000804638700042
J	Cai, H; Wang, X; Zhang, ZX; Chen, J; Wang, FB; Wang, L; Liu, J				Cai, Hao; Wang, Xin; Zhang, Zhixin; Chen, Juan; Wang, Fangbin; Wang, Lu; Liu, Jian			Moderate L-lactate administration suppresses adipose tissue macrophage M1 polarization to alleviate obesity-associated insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACID; INFLAMMATION; AMPK; ACTIVATION; METABOLISM; MICE; KINASE; TARGET; MUSCLE	As a crucial metabolic intermediate, L-lactate is involved in redox balance, energy balance, and acid-base balance in organisms. Moderate exercise training transiently elevates plasma L-lactate levels and ameliorates obesity-associated type 2 diabetes. However, whether moderate L-lactate administration improves obesity-associated insulin resistance remains unclear. In this study, we defined 800 mg/kg/day as the dose of moderate L-lactate administration. In mice fed with a high-fat diet (HFD), moderate L-lactate administration for 12 weeks was shown to alleviate weight gain, fat accumulation, and insulin resistance. Along with the phenotype alterations, white adipose tissue thermogenesis was also found to be elevated in HFD-fed mice. Meanwhile, moderate L-lactate administration suppressed the infiltration and proinflammatory M1 polarization of adipose tissue macrophages (ATMs) in HFD-fed mice. Furthermore, L-lactate treatment suppressed the lipopolysaccharide-induced M1 polarization of bone marrowderived macrophages (BMDMs). L-lactate can bind to the surface receptor GPR132, which typically drives the downstream cAMP-PKA signaling. As a nutrient sensor, AMP-activated protein kinase (AMPK) critically controls macrophage inflammatory signaling and phenotype. Thus, utilizing inhibitors of the kinases PKA and AMPK as well as siRNA against GPR132, we demonstrated that GPR132-PKA-AMPKa1 signaling mediated the suppression caused by L-lactate treatment on BMDM M1 polarization. Finally, L-lactate addition remarkably resisted the impairment of lipopolysaccharide-treated BMDM conditional media on adipocyte insulin sensitivity. In summary, moderate L-lactate administration suppresses ATM proinflammatory M1 polarization through activation of the GPR132-PKA-AMPKa1 signaling pathway to improve insulin resistance in HFD-fed mice, suggesting a new therapeutic and interventional approach to obesity-associated type 2 diabetes.	[Cai, Hao; Wang, Xin; Zhang, Zhixin; Chen, Juan; Wang, Fangbin; Wang, Lu; Liu, Jian] Hefei Univ Technol, Sch Food & Biol Engn, Hefei, Anhui, Peoples R China; [Liu, Jian] Hefei Univ Technol, Engn Res Ctr Bioproc, Minist Educ, Hefei, Anhui, Peoples R China	Hefei University of Technology; Hefei University of Technology	Liu, J (corresponding author), Hefei Univ Technol, Sch Food & Biol Engn, Hefei, Anhui, Peoples R China.; Liu, J (corresponding author), Hefei Univ Technol, Engn Res Ctr Bioproc, Minist Educ, Hefei, Anhui, Peoples R China.	liujian509@hfut.edu.cn		Wang, Xin/0000-0002-8694-1172; Cai, Hao/0000-0002-3316-2271	National Natural Science Foundation of China [32070757, 31671485, 31801114]; Fundamental Research Funds for the Central Universities [JZ2018QTXM0553]; University Synergy Innovation Program of Anhui Province [GXXT-2019-026]; Natural Science Foundation of Anhui Province [1908085QC98]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); University Synergy Innovation Program of Anhui Province; Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This study was supported by the National Natural Science Foundation of China (grant nos.: 32070757 and 31671485 [to J. L.] and 31801114 [to J. C.]), the Fundamental Research Funds for the Central Universities (grant no.: JZ2018QTXM0553 [to J. L.]), the University Synergy Innovation Program of Anhui Province (grant no.: GXXT-2019-026; to J. L.), and the Natural Science Foundation of Anhui Province (grant no.: 1908085QC98; to J. C.).	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Bao B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084075; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bolick DT, 2009, CIRC RES, V104, P318, DOI 10.1161/CIRCRESAHA.108.181131; Brooks GA, 2020, REDOX BIOL, V35, DOI 10.1016/j.redox.2020.101454; Brooks GA, 2018, CELL METAB, V27, P757, DOI 10.1016/j.cmet.2018.03.008; Carbone S, 2019, PROG CARDIOVASC DIS, V62, P327, DOI 10.1016/j.pcad.2019.08.004; Carneiro L, 2017, MOL METAB, V6, P1625, DOI 10.1016/j.molmet.2017.10.005; Carriere A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885; Ceppo F, 2014, ENDOCRINOLOGY, V155, P951, DOI 10.1210/en.2013-1815; Chaurasia B, 2016, CELL METAB, V24, P820, DOI 10.1016/j.cmet.2016.10.002; Chen PW, 2017, P NATL ACAD SCI USA, V114, P580, DOI 10.1073/pnas.1614035114; Chiang CF, 2017, ONCOTARGET, V8, P20706, DOI 10.18632/oncotarget.14982; Choi CS, 2002, AM J PHYSIOL-ENDOC M, V283, pE233, DOI 10.1152/ajpendo.00557.2001; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786; Gellen B, 2018, LANCET HAEMATOL, V5, pE554, DOI 10.1016/S2352-3026(18)30163-7; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Heden TD, 2017, APPL PHYSIOL NUTR ME, V42, P732, DOI 10.1139/apnm-2016-0382; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang YJ, 2019, AGING-US, V11, P2217, DOI 10.18632/aging.101910; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Ippolito L, 2019, TRENDS BIOCHEM SCI, V44, P153, DOI 10.1016/j.tibs.2018.10.011; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kari S, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00769; Keiran N, 2019, NAT IMMUNOL, V20, P581, DOI 10.1038/s41590-019-0372-7; Kim N, 2017, SCI REP-UK, V7, DOI 10.1038/srep41066; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Lee YS, 2018, CELL, V172, P22, DOI 10.1016/j.cell.2017.12.025; Leiherer A, 2013, VASC PHARMACOL, V58, P3, DOI 10.1016/j.vph.2012.09.002; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; Nielsen OB, 2001, J PHYSIOL-LONDON, V536, P161, DOI 10.1111/j.1469-7793.2001.t01-1-00161.x; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Petridou A, 2019, METABOLISM, V92, P163, DOI 10.1016/j.metabol.2018.10.009; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Ren WK, 2019, ADV NUTR, V10, P321, DOI 10.1093/advances/nmy084; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sanchez-Lopez E, 2019, CELL METAB, V29, P1350, DOI 10.1016/j.cmet.2019.03.011; Takahashi H, 2019, NAT METAB, V1, P291, DOI 10.1038/s42255-018-0030-7; Tao SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26835; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; Wu LM, 2018, FREE RADICAL BIO MED, V121, P215, DOI 10.1016/j.freeradbiomed.2018.05.004; Ying W, 2013, JOVE-J VIS EXP, DOI 10.3791/50323; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang F, 2016, ONCOTARGET, V7, P52294, DOI 10.18632/oncotarget.10561; Zhang J, 2020, CELL METAB, V31, P1136, DOI 10.1016/j.cmet.2020.05.004; Zhang X, 2016, INT J OBESITY, V40, P1841, DOI 10.1038/ijo.2016.108; Zhou HF, 2014, ACS NANO, V8, P7305, DOI 10.1021/nn502372n	57	1	1	16	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101768	10.1016/j.jbc.2022.101768	http://dx.doi.org/10.1016/j.jbc.2022.101768			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35218776	gold, Green Published			2022-12-26	WOS:000823106100007
J	Raja, R; Wang, CY; Mishra, R; Das, A; Ali, A; Banerjea, AC				Raja, Rameez; Wang, Chenyao; Mishra, Ritu; Das, Arundhoti; Ali, Amjad; Banerjea, Akhil C.			Host AKT-mediated phosphorylation of HIV-1 accessory protein Vif potentiates infectivity via enhanced degradation of the restriction factor APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBF-BETA; UBIQUITINATION; VIRIONS; PATHWAY	HIV-1 encodes accessory proteins that neutralize antiviral restriction factors to ensure its successful replication. One accessory protein, the HIV-1 viral infectivity factor (Vif), is known to promote ubiquitination and proteasomal degradation of the antiviral restriction factor apolipoprotein B mRNAediting enzyme-catalytic polypeptide-like 3G (APOBEC3G), a cytosine deaminase that leads to hypermutations in the viral DNA and subsequent aberrant viral replication. We have previously demonstrated that the HIV-1 viral transcription mediator Tat activates the host progrowth PI-3-AKT pathway, which in turn promotes HIV-1 replication. Because the HIV-1 Vif protein contains the putative AKT phosphorylation motif RMRINT, here we investigated whether AKT directly phosphorylates HIV-1 Vif to regulate its function. Coimmunoprecipitation experiments showed that AKT and Vif interact with each other, supporting this hypothesis. Using in vitro kinase assays, we further showed that AKT phosphorylates Vif at threonine 20, which promotes its stability, as Vif becomes destabilized after this residue is mutated to alanine. Moreover, expression of dominant-negative kinase-deficient AKT as well as treatment with a chemical inhibitor of AKT increased K48ubiquitination and proteasomal degradation of HIV-1 Vif. In contrast, constitutively active AKT (Myr-AKT) reduced K48ubiquitination of Vif to promote its stability. Finally, inhibition of AKT function restored APOBEC3G levels, which subsequently reduced HIV-1 infectivity. Thus, our results establish a novel mechanism of HIV-1 Vif stabilization through AKTmediated phosphorylation at threonine 20, which reduces APOBEC3G levels and potentiates HIV-1 infectivity.	[Raja, Rameez; Wang, Chenyao] Cleveland Clin, Dept Inflammat & Immun, Cleveland, OH 44106 USA; [Raja, Rameez; Banerjea, Akhil C.] Natl Inst Immunol, Virol 2, New Delhi, India; [Mishra, Ritu] Amity Univ, Amity Inst Virol & Immunol, Noida, Uttar Pradesh, India; [Das, Arundhoti] NCI, Lab Genome Integr, Bethesda, MD 20892 USA; [Ali, Amjad] UMass Chan Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA USA	Cleveland Clinic Foundation; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Amity University Noida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Raja, R (corresponding author), Cleveland Clin, Dept Inflammat & Immun, Cleveland, OH 44106 USA.; Raja, R; Banerjea, AC (corresponding author), Natl Inst Immunol, Virol 2, New Delhi, India.	rajar@ccf.org; akhil@nii.ac.in		Raja, Rameez/0000-0001-6940-5880	Department of Science and Technology of Government of India; Department of Biotechnology of Government of India	Department of Science and Technology of Government of India(Department of Science & Technology (India)); Department of Biotechnology of Government of India(Department of Biotechnology (DBT) India)	Several reagents were obtained from AIDS Reference & Reagent Program of NIH, MD, USA. This work was supported by the Department of Biotechnology and Department of Science and Technology of Government of India. We thank Smriti Parashar and Sneh Lata for their technical help and sharing reagents.	Ali A, 2021, BIOCHEM BIOPH RES CO, V574, P27, DOI 10.1016/j.bbrc.2021.08.031; Ali A, 2017, BIOCHEM J, V474, P1653, DOI 10.1042/BCJ20160304; Antonucci JM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01541; Baldauf H. M., 2012, SAMHD1 RESTRICTS HIV; Borgatti P, 1997, EUR J IMMUNOL, V27, P2805, DOI 10.1002/eji.1830271110; Bres V., 2003, NAT; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Dang Y, 2008, J BIOL CHEM, V283, P13124, DOI 10.1074/jbc.M708728200; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Ganser-Pornillos BK, 2019, NAT REV MICROBIOL, V17, P546, DOI 10.1038/s41579-019-0225-2; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Izumi T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-1; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Lata S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8244; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Miyakawa K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7945; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Okada A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02027; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Raja R, 2022, CELL DEATH DIFFER, V29, P504, DOI 10.1038/s41418-021-00870-4; Raja R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32316-2; Raja R, 2017, BIOCHEM J, V474, P2449, DOI 10.1042/BCJ20160825; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Verma S, 2011, BLOOD, V117, P6600, DOI 10.1182/blood-2011-01-333427; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	27	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101805	10.1016/j.jbc.2022.101805	http://dx.doi.org/10.1016/j.jbc.2022.101805			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35259395	gold, Green Published			2022-12-26	WOS:000793692600007
J	Shivakumar, PG; Georgiou, P; Narayanan, S; Shahamiri, SR				Shivakumar, Prashanth Gurunath; Georgiou, Panayiotis; Narayanan, Shrikanth; Shahamiri, Seyed Reza			Confusion2Vec 2.0: Enriching ambiguous spoken language representations with subwords	PLOS ONE			English	Article							CONTEXT; MODELS	Word vector representations enable machines to encode human language for spoken language understanding and processing. Confusion2vec, motivated from human speech production and perception, is a word vector representation which encodes ambiguities present in human spoken language in addition to semantics and syntactic information. Confusion2vec provides a robust spoken language representation by considering inherent human language ambiguities. In this paper, we propose a novel word vector space estimation by unsupervised learning on lattices output by an automatic speech recognition (ASR) system. We encode each word in Confusion2vec vector space by its constituent subword character n-grams. We show that the subword encoding helps better represent the acoustic perceptual ambiguities in human spoken language via information modeled on lattice-structured ASR output. The usefulness of the proposed Confusion2vec representation is evaluated using analogy and word similarity tasks designed for assessing semantic, syntactic and acoustic word relations. We also show the benefits of subword modeling for acoustic ambiguity representation on the task of spoken language intent detection. The results significantly outperform existing word vector representations when evaluated on erroneous ASR outputs, providing improvements up-to 13.12% relative to previous state-of-the-art in intent detection on ATIS benchmark dataset. We demonstrate that Confusion2vec subword modeling eliminates the need for retraining/adapting the natural language understanding models on ASR transcripts.	[Shivakumar, Prashanth Gurunath; Georgiou, Panayiotis; Narayanan, Shrikanth] Univ Southern Calif, Dept Elect & Comp Engn, Los Angeles, CA 90007 USA	University of Southern California	Shivakumar, PG (corresponding author), Univ Southern Calif, Dept Elect & Comp Engn, Los Angeles, CA 90007 USA.	pgurunat@usc.edu	Georgiou, Panayiotis/E-8387-2018	Georgiou, Panayiotis/0000-0002-0790-7161; Gurunath Shivakumar, Prashanth/0000-0003-1632-3309	Simons Foundation [627148]	Simons Foundation	This work was supported by Simons Foundation under grant 627148 awarded to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams O, 2017, 15TH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (EACL 2017), VOL 1: LONG PAPERS, P937; AllenNLPELMo, ALLENNLPELMO; [Anonymous], FASTTEXT LIB FAST TE; [Anonymous], BERT PRETRAINING DEE; [Anonymous], WIKI WORD VECTORSFAS; [Anonymous], WORD2VEC TOOL COMPUT; Aydelott J, 2004, LANG COGNITIVE PROC, V19, P29, DOI 10.1080/01690960344000099; Bazzi I, 2002, THESIS MIT; Bengio Y, 2003, J MACH LEARN RES, V3, P1137, DOI 10.1162/153244303322533223; Bojanowski Piotr, 2017, T ASSOC COMPUT LING, V5, P135, DOI 10.1162/tacl_a_00051; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Chen Q., ARXIV PREPRINT ARXIV; Cieri C., 2004, L REC, V4, P69; Devlin J., 2018, ARXIV181004805; E HH, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P5467; Finkelstein L, 2002, ACM T INFORM SYST, V20, P116, DOI 10.1145/503104.503110; Goo Chih-Wen, 2018, P C N AM CH ASS COMP, P753; Gutmann MU, 2012, J MACH LEARN RES, V13, P307; Hakkani-Tur D, 2016, INTERSPEECH, P715, DOI 10.21437/Interspeech.2016-402; Hemphill Charles T, 1990, SPEECH NATURAL LANGU; Huang CW, 2020, INT CONF ACOUST SPEE, P8009, DOI 10.1109/ICASSP40776.2020.9054689; Kong YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095001; Ladhak F, 2016, INTERSPEECH, P695, DOI 10.21437/Interspeech.2016-1583; Li C, 2018, P 2018 C EMPIRICAL M; Liu B, 2016, ARXIV PREPRINT ARXIV; Liu B, 2016, INTERSPEECH, P685, DOI 10.21437/Interspeech.2016-1352; Mikolov T., 2013, ARXIV PREPRINT ARXIV; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Pennington J., 2014, P 2014 C EMPIRICAL M, P1532, DOI DOI 10.3115/V1/D14-1162; Pennington Jeffrey, GLOVE GLOBAL VECTORS; Peters M., 2018, PROC NAACL, P2227, DOI DOI 10.18653/V1/N18-1202; Phatak SA, 2007, J ACOUST SOC AM, V121, P2312, DOI 10.1121/1.2642397; Povey D., 2011, IEEE 2011 WORKSH AUT; Schnabel T., 2015, EMNLP; Schumann R, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P6059; Shivakumar PG, 2019, INTERSPEECH, P819, DOI 10.21437/Interspeech.2019-2226; Shivakumar PG, 2019, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.195; Sperber M, 2019, ARXIV PREPRINT ARXIV; Tai KS, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING, VOL 1, P1556; Tan ZX, 2018, NEUROCOMPUTING, V284, P138, DOI 10.1016/j.neucom.2018.01.010; Vaswani A, 2017, ADV NEUR IN, V30; Weide R.L., 1998, CMU PRONUNCIATION DI; Xiao FS, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P3090; Zhang XH, 2014, INT CONF ACOUST SPEE; Zoph B., 2016, P 2016 C EMP METH NA, P1568, DOI DOI 10.18653/V1/D16-1163	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264488	10.1371/journal.pone.0264488	http://dx.doi.org/10.1371/journal.pone.0264488			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245327	gold, Green Submitted, Green Published			2022-12-26	WOS:000799799100023
J	Simonsen, L; Lau, J; Kruse, T; Guo, TQ; McGuire, J; Jeppesen, JF; Niss, K; Sauerberg, P; Raun, K; de la Cour, CD				Simonsen, Lotte; Lau, Jesper; Kruse, Thomas; Guo, Tingqing; McGuire, Jim; Jeppesen, Jacob Fuglsbjerg; Niss, Kristoffer; Sauerberg, Per; Raun, Kirsten; de la Cour, Charlotta Dornonville			Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BROWN ADIPOSE-TISSUE; OBESITY; GLP-1; WEIGHT; OXYNTOMODULIN; OVERWEIGHT; MANAGEMENT; ANALOG	During recent years combining GLP-1 and glucagon receptor agonism with the purpose of achieving superior weight loss and metabolic control compared to GLP-1 alone has received much attention. The superior efficacy has been shown by several in preclinical models but has been difficult to reproduce in humans. In this paper, we present the pre-clinical evaluation of NN1177, a long-acting GLP-1/glucagon receptor co-agonist previously tested in clinical trials. To further investigate the contribution from the respective receptors, two other co-agonists (NN1151, NN1359) with different GLP-1-to-glucagon receptor ratios were evaluated in parallel. In the process of characterizing NN1177, species differences and pitfalls in traditional pre-clinical evaluation methods were identified, highlighting the translational challenges in predicting the optimal receptor balance in humans. In diet-induced obese (DIO) mice, NN1177 induced a dose-dependent body weight loss, primarily due to loss of fat mass, and improvement in glucose tolerance. In DIO rats, NN1177 induced a comparable total body weight reduction, which was in contrast mainly caused by loss of lean mass, and glucose tolerance was impaired. Furthermore, despite long half-lives of the three co-agonists, glucose control during steady state was seen to depend on compound exposure at time of evaluation. When evaluated at higher compound exposure, glucose tolerance was similarly improved for all three co-agonists, independent of receptor balance. However, at lower compound exposure, glucose tolerance was gradually impaired with higher glucagon receptor preference. In addition, glucose tolerance was found to depend on study duration where the effect of glucagon on glucose control became more evident with time. To conclude, the pharmacodynamic effects at a given GLP-1-to-glucagon ratio differs between species, depends on compound exposure and study length, complicating the identification of an optimally balanced clinical candidate. The present findings could partly explain the low number of clinical successes for this dual agonism.	[Simonsen, Lotte; Raun, Kirsten] Novo Nordisk AS, Global Obes & Liver Dis Res, Malov, Denmark; [Lau, Jesper; Kruse, Thomas] Novo Nordisk AS, Res Chem, Malov, Denmark; [Guo, Tingqing] Novo Nordisk Res Ctr, Discovery Biol, Beijing, Peoples R China; [McGuire, Jim] Novo Nordisk AS, Incretin Biol, Malov, Denmark; [Jeppesen, Jacob Fuglsbjerg; de la Cour, Charlotta Dornonville] Novo Nordisk AS, Global Diabet Cardio & Renal Res, Malov, Denmark; [Niss, Kristoffer] Novo Nordisk AS, Bioinformat & Data Min, Malov, Denmark; [Sauerberg, Per] Novo Nordisk AS, Project & Alliance Management, Malov, Denmark; [McGuire, Jim] Catalyst Biosci, Translat Res, San Francisco, CA USA	Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk	de la Cour, CD (corresponding author), Novo Nordisk AS, Global Diabet Cardio & Renal Res, Malov, Denmark.	cddc@novonordisk.com		Niss, Kristoffer/0000-0001-5910-1525	Novo Nordisk	Novo Nordisk(Novo Nordisk)	The work was funded by Novo Nordisk.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Barazzoni R, 1999, DIABETOLOGIA, V42, P326, DOI 10.1007/s001250051158; BILLINGTON CJ, 1987, AM J PHYSIOL, V252, pR160, DOI 10.1152/ajpregu.1987.252.1.R160; Clemmensen C, 2014, DIABETES, V63, P1422, DOI 10.2337/db13-1609; Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928; CRYER PE, 1981, DIABETES, V30, P261, DOI 10.2337/diab.30.3.261; Day JW, 2012, BIOPOLYMERS, V98, P443, DOI 10.1002/bip.22072; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Dicker A, 1998, AM J PHYSIOL-REG I, V275, pR1674, DOI 10.1152/ajpregu.1998.275.5.R1674; Dunphy JL, 1998, MOL CELL ENDOCRINOL, V141, P179, DOI 10.1016/S0303-7207(98)00096-3; Elvert R, 2018, ENDOCRINOLOGY, V159, P3105, DOI 10.1210/en.2018-00399; Evers A, 2018, J MED CHEM, V61, P5580, DOI 10.1021/acs.jmedchem.8b00292; Evers A, 2017, J MED CHEM, V60, P4293, DOI 10.1021/acs.jmedchem.7b00174; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; Gonzalez-Garcia I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143445; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; HANSEN LH, 1995, PEPTIDES, V16, P1163, DOI 10.1016/0196-9781(95)00078-X; Henderson SJ, 2016, DIABETES OBES METAB, V18, P1176, DOI 10.1111/dom.12735; Holst JJ, 2017, DIABETES, V66, P235, DOI 10.2337/db16-0994; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hope DCD, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.735019; Kerr BD, 2010, BIOCHEM PHARMACOL, V80, P1727, DOI 10.1016/j.bcp.2010.08.010; Kleinert M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215407; Knudsen LB, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00155; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kruse T, 2021, J MED CHEM, V64, P11183, DOI 10.1021/acs.jmedchem.1c00565; Lau J, 2015, J MED CHEM, V58, P7370, DOI 10.1021/acs.jmedchem.5b00726; Loh RKC, 2017, OBES REV, V18, P1227, DOI 10.1111/obr.12584; Naqvi S, 2019, SCIENCE, V365, P249, DOI 10.1126/science.aaw7317; Nauck MA, 2020, MOL METAB, V46, DOI 10.1016/j.molmet.2020.101102; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Roller M, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02260-y; Salem V, 2016, DIABETES OBES METAB, V18, P72, DOI 10.1111/dom.12585; Schlein M, 2017, AAPS J, V19, P397, DOI 10.1208/s12248-016-0028-6; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Sollner JF, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.185; Tan TM, 2013, DIABETES, V62, P1131, DOI 10.2337/db12-0797; Wermers RA, 1996, MEDICINE, V75, P53, DOI 10.1097/00005792-199603000-00002; Wynne K, 2006, INT J OBESITY, V30, P1729, DOI 10.1038/sj.ijo.0803344; Wynne K, 2005, DIABETES, V54, P2390, DOI 10.2337/diabetes.54.8.2390	40	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264974	10.1371/journal.pone.0264974	http://dx.doi.org/10.1371/journal.pone.0264974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245328	Green Published, gold			2022-12-26	WOS:000799799100045
J	Baek, I; Kim, SB				Baek, Insung; Kim, Seoung Bum			3-Dimensional convolutional neural networks for predicting StarCraft ? results and extracting key game situations	PLOS ONE			English	Article								In real-time strategy games, players collect resources, control various units, and create strategies to win. The creation of winning strategies requires accurately analyzing previous games; therefore, it is important to be able to identify the key situations that determined the outcomes of those games. However, previous studies have mainly focused on predicting game results. In this study, we propose a methodology to predict outcomes and to identify information about the turning points that determine outcomes in StarCraft ?, one of the most popular real-time strategy games. We used replay data from StarCraft ? that is similar to video data providing continuous multiple images. First, we trained a result prediction model using 3D-residual networks (3D-ResNet) and replay data to improve prediction performance by utilizing in-game spatiotemporal information. Second, we used gradient-weighted class activation mapping to extract information defining the key situations that significantly influenced the outcomes of the game. We then proved that the proposed method outperforms by comparing 2D-residual networks (2D-ResNet) using only one time-point information and 3D-ResNet with multiple time-point information. We verified the usefulness of our methodology on a 3D-ResNet with a gradient class activation map linked to a StarCraft ? replay dataset.	[Baek, Insung; Kim, Seoung Bum] Korea Univ, Sch Ind & Management Engn, Seoul, South Korea	Korea University	Kim, SB (corresponding author), Korea Univ, Sch Ind & Management Engn, Seoul, South Korea.	sbkim1@korea.ac.kr		Kim, Seoung Bum/0000-0002-2205-8516	National Research Foundation of Korea - MSIT [NRF-2019R1A4A1024732]; Brain Korea 21 FOUR, Ministry of Science and ICT in Korea under the ITRC support program [IITP-2020-0-01749]; Ministry of Culture, Sports and Tourism and Korea Creative Content Agency [R2019020067]	National Research Foundation of Korea - MSIT; Brain Korea 21 FOUR, Ministry of Science and ICT in Korea under the ITRC support program; Ministry of Culture, Sports and Tourism and Korea Creative Content Agency	SBK was supported by a National Research Foundation of Korea grant funded by the MSIT (NRF-2019R1A4A1024732). IB was supported by the Brain Korea 21 FOUR, Ministry of Science and ICT in Korea under the ITRC support program (IITP-2020-0-01749), and the Ministry of Culture, Sports and Tourism and Korea Creative Content Agency (R2019020067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Caballero A., 2017, IJCCI, P401, DOI [10.5220/0006587304010406, DOI 10.5220/0006587304010406]; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Certicky M, 2019, IEEE T GAMES, V11, P227, DOI 10.1109/TG.2018.2883499; Chen HY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245992; Chen L, 2020, IEEE WINT CONF APPL, P2783, DOI 10.1109/WACV45572.2020.9093461; Erickson G.K.S., 2014, P 10 ART INT INT DIG; Gheisari M, 2017, IEEE INT C COMPUT, P173, DOI 10.1109/CSE-EUC.2017.215; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Justesen N, 2020, IEEE T GAMES, V12, P1, DOI 10.1109/TG.2019.2896986; Kang SK, 2020, PROCEEDINGS OF THE 35TH ANNUAL ACM SYMPOSIUM ON APPLIED COMPUTING (SAC'20), P915, DOI 10.1145/3341105.3373894; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Leblanc D, 2013, 28 INT C COMP THEIR, P319; Lee ALF, 2021, PSYCHON B REV, V28, P1233, DOI 10.3758/s13423-020-01869-7; Lee D., 2018, P C ART INT INT DIG, P187; Lee D, 2021, EXPERT SYST APPL, V185, DOI 10.1016/j.eswa.2021.115592; Li BQ, 2018, IEEE ACCESS, V6, P18967, DOI 10.1109/ACCESS.2018.2814605; Liao XY, 2019, LECT NOTES COMPUT SC, V11366, P620, DOI 10.1007/978-3-030-20876-9_39; Lin M, 2019, IEEE ACCESS, V7, P101609, DOI 10.1109/ACCESS.2019.2930581; Liskowski P, 2018, IEEE T GAMES, V10, P354, DOI 10.1109/TG.2018.2799997; Nagorsky E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237584; Oh IS, 2017, EXPERT SYST APPL, V71, P192, DOI 10.1016/j.eswa.2016.11.026; Pang ZJ, 2019, AAAI CONF ARTIF INTE, P4691; Ravari YN, 2016, WS1621; Reitman JG, 2020, GAMES CULT, V15, P32, DOI 10.1177/1555412019840892; Sato R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221347; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Semenov A, 2017, COMM COM INF SC, V661, P26, DOI 10.1007/978-3-319-52920-2_3; Simonyan Karen, ICLR 2015; Thompson JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075129; Vinyals O, 2019, NATURE, V575, P350, DOI 10.1038/s41586-019-1724-z; Wang XL, 2018, PROC CVPR IEEE, P7794, DOI 10.1109/CVPR.2018.00813; Wu H., 2017, MSC DATASET MACROMAN; Xiong S, 2014, 2014 2ND INTERNATIONAL CONFERENCE ON SYSTEMS AND INFORMATICS (ICSAI), P271, DOI 10.1109/ICSAI.2014.7009298	33	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264550	10.1371/journal.pone.0264550	http://dx.doi.org/10.1371/journal.pone.0264550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239703	gold, Green Published			2022-12-26	WOS:000776002200044
J	Orel, E; Esra, R; Estill, J; Thiabaud, A; Marchand-Maillet, S; Merzouki, A; Keiser, O				Orel, Erol; Esra, Rachel; Estill, Janne; Thiabaud, Amaury; Marchand-Maillet, Stephane; Merzouki, Aziza; Keiser, Olivia			Prediction of HIV status based on socio-behavioural characteristics in East and Southern Africa	PLOS ONE			English	Article								Introduction High yield HIV testing strategies are critical to reach epidemic control in high prevalence and low-resource settings such as East and Southern Africa. In this study, we aimed to predict the HIV status of individuals living in Angola, Burundi, Ethiopia, Lesotho, Malawi, Mozambique, Namibia, Rwanda, Zambia and Zimbabwe with the highest precision and sensitivity for different policy targets and constraints based on a minimal set of socio-behavioural characteristics. Methods We analysed the most recent Demographic and Health Survey from these 10 countries to predict individual's HIV status using four different algorithms (a penalized logistic regression, a generalized additive model, a support vector machine, and a gradient boosting trees). The algorithms were trained and validated on 80% of the data, and tested on the remaining 20%. We compared the predictions based on the F1 score, the harmonic mean of sensitivity and positive predictive value (PPV), and we assessed the generalization of our models by testing them against an independent left-out country. The best performing algorithm was trained on a minimal subset of variables which were identified as the most predictive, and used to 1) identify 95% of people living with HIV (PLHIV) while maximising precision and 2) identify groups of individuals by adjusting the probability threshold of being HIV positive (90% in our scenario) for achieving specific testing strategies. Results Overall 55,151 males and 69,626 females were included in the analysis. The gradient boosting trees algorithm performed best in predicting HIV status with a mean F1 score of 76.8% [95% confidence interval (CI) 76.0%-77.6%] for males (vs [CI 67.8%-70.6%] for SVM) and 78.8% [CI 78.2%-79.4%] for females (vs [CI 73.4%-75.8%] for SVM). Among the ten most predictive variables for each sex, nine were identical: longitude, latitude and, altitude of place of residence, current age, age of most recent partner, total lifetime number of sexual partners, years lived in current place of residence, condom use during last intercourse and, wealth index. Only age at first sex for male (ranked 10th) and Rohrer's index for female (ranked 6th) were not similar for both sexes. Our large-scale scenario, which consisted in identifying 95% of all PLHIV, would have required testing 49.4% of males and 48.1% of females while achieving a precision of 15.4% for males and 22.7% for females. For the second scenario, only 4.6% of males and 6.0% of females would have had to be tested to find 55.7% of all males and 50.5% of all females living with HIV. Conclusions We trained a gradient boosting trees algorithm to find 95% of PLHIV with a precision twice higher than with general population testing by using only a limited number of socio-behavioural characteristics. We also successfully identified people at high risk of infection who may be offered pre-exposure prophylaxis or voluntary medical male circumcision. These findings can inform the implementation of new high-yield HIV tests and help develop very precise strategies based on low-resource settings constraints.	[Orel, Erol; Esra, Rachel; Estill, Janne; Thiabaud, Amaury; Merzouki, Aziza; Keiser, Olivia] Univ Geneva, Inst Global Hlth, Geneva, Switzerland; [Estill, Janne] Univ Bern, Inst Math Stat & Actuarial Sci, Bern, Switzerland; [Marchand-Maillet, Stephane] Univ Geneva, Dept Comp Sci, Viper Grp, Geneva, Switzerland	University of Geneva; University of Bern; University of Geneva	Orel, E (corresponding author), Univ Geneva, Inst Global Hlth, Geneva, Switzerland.	Erol.Orel@unige.ch		Thiabaud, Amaury/0000-0003-1544-415X; Orel, Erol/0000-0003-4652-4750	Swiss National Science Foundation (SNF) [163878, 202660]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	We acknowledge the support of the Swiss National Science Foundation (SNF professorship grant no 163878 and grant no 202660 to O Keiser) which funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom MG, 2019, ECLINICALMEDICINE, V17, DOI 10.1016/j.eclinm.2019.10.016; Ahmed S, 2016, TROP MED INT HEALTH, V21, P479, DOI 10.1111/tmi.12671; Akullian A, 2017, AIDS, V31, P1755, DOI [10.1097/QAD.0000000000001553, 10.1097/qad.0000000000001553]; Balzer LB, 2020, CLIN INFECT DIS, V71, P2326, DOI 10.1093/cid/ciz1096; Bisaso KR, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0659-x; BLAIR DC, 1979, J AM SOC INFORM SCI, V30, P374, DOI 10.1002/asi.4630300621; Bulstra CA, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003042; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cuadros DF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09464-y; De Cock KM, 2019, AIDS, V33, P349, DOI [10.1097/qad.0000000000002096, 10.1097/QAD.0000000000002096]; Dwyer-Lindgren L, 2019, NATURE, V570, P189, DOI 10.1038/s41586-019-1200-9; Feller DJ, 2018, JAIDS-J ACQ IMM DEF, V77, P160, DOI 10.1097/QAI.0000000000001580; Hastie T., 1986, STAT SCI, V1, P297; Huang G, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193597; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Koss CA, 2018, CLIN INFECT DIS, V67, P1853, DOI 10.1093/cid/ciy390; Krakower DS, 2019, LANCET HIV, V6, pE696, DOI 10.1016/S2352-3018(19)30139-0; Lundberg SM, 2017, ADV NEUR IN, V30; Marcus JL, 2019, LANCET HIV, V6, pE688, DOI 10.1016/S2352-3018(19)30137-7; Nguyen CD, 2017, EMERG THEMES EPIDEMI, V14, DOI 10.1186/s12982-017-0062-6; Palk L, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1006-x; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Sommer M, 2015, ENVIRON URBAN, V27, P105, DOI 10.1177/0956247814564528; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Temah CT., 2009, REV EC DEV, VVol. 17, P41; UNAIDS, 2015, UND FAST TRACK ACC A; UNAIDS, 2019, GLOB AIDS UPD 2019; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vapnik V.N., 1995, NATURE STAT LEARNING; Wray TB, 2019, PREV SCI, V20, P904, DOI 10.1007/s11121-019-01019-z; Young SD, 2017, JAIDS-J ACQ IMM DEF, V74, pS128, DOI 10.1097/qai.0000000000001240; Zheng WJ, 2018, STAT MED, V37, P261, DOI 10.1002/sim.7296; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zulu LC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-285	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264429	10.1371/journal.pone.0264429	http://dx.doi.org/10.1371/journal.pone.0264429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239697	Green Published, gold			2022-12-26	WOS:000776002200032
J	Donfrancesco, C; Profumo, E; Lo Noce, C; Minutoli, D; Di Lonardo, A; Buttari, B; Vespasiano, F; Vannucchi, S; Galletti, F; Onder, G; Colivicchi, F; Galeone, D; Bellisario, P; Palmieri, L				Donfrancesco, Chiara; Profumo, Elisabetta; Lo Noce, Cinzia; Minutoli, Daniela; Di Lonardo, Anna; Buttari, Brigitta; Vespasiano, Francesca; Vannucchi, Serena; Galletti, Ferruccio; Onder, Graziano; Colivicchi, Furio; Galeone, Daniela; Bellisario, Paolo; Palmieri, Luigi			Trends of overweight, obesity and anthropometric measurements among the adult population in Italy: The CUORE Project health examination surveys 1998, 2008, and 2018	PLOS ONE			English	Article							BODY-MASS INDEX; SELF-REPORTED WEIGHT; RISK; SURVEILLANCE; PREVALENCE; MORTALITY; VALIDITY; BIAS	Background/Objectives Obesity is associated with an increased risk of noncommunicable diseases, such as diabetes, coronary heart disease, stroke, cancers, and conditions, including obstructive sleep apnea and osteoarthritis. Obesity is largely preventable, and halting its rise is one of the World Health Organization Global Action Plan for the Prevention of Noncommunicable Diseases targets. This study aimed to assess trends of anthropometric measurements in Italy using the data collected within the CUORE Project health examination surveys (HESs) 1998, 2008, and 2018. Subjects/Methods Within the HESs 1998-2002, 2008-2012, and 2018-2019, anthropometric measurements were collected in random samples of the resident population aged 35-74 years, stratified by age and sex, from 10 Italian Regions in Northern, Central, and Southern Italy (2984 men and 2944 women, 2224 men and 2188 women, 1035 men and 1065 women, respectively). Weight, height, and waist and hip circumferences were measured using standardized methodologies. A standardized questionnaire was used to collect data on education. Indicators were age standardized. Results For both men and women, mean body mass index in 2018 was comparable with those in 1998 and 2008 (in 1998, 2008, and 2018-men: 26.7, 27.5, and 27.0 kg/m(2); women: 26.2, 26.6, and 26.3 kg/m(2)). In 1998, 2008, 2018 prevalence of overweight resulted 49%, 47%, 46% in men and 33%, 32%, 28% in women respectively; prevalence of obesity resulted 17%, 24% 20% in men and 19%, 23%, 23% in women respectively. All indicators of excess weight worsen with increasing age and are more severe in persons with a lower educational level. Conclusions Although the overall trend of excess weight over the past two decades appeared to be substantially stable in the Italian adult population, the continuous strengthening of undertaken initiatives should continue since there remains a high proportion of overweight or obesity and a gap between educational levels.	[Donfrancesco, Chiara; Profumo, Elisabetta; Lo Noce, Cinzia; Minutoli, Daniela; Di Lonardo, Anna; Buttari, Brigitta; Vespasiano, Francesca; Vannucchi, Serena; Onder, Graziano; Palmieri, Luigi] Ist Super Sanita, Rome, Italy; [Galletti, Ferruccio] Federico II Univ Naples, Med Sch, Naples, Italy; [Colivicchi, Furio] Natl Assoc Hosp Cardiologists, Hlth Care Fdn, Florence, Italy; [Colivicchi, Furio] Presidio Osped San Filippo Neri ASL Roma 1, UOC Cardiol Clin & Riabilitat, Rome, Italy; [Galeone, Daniela; Bellisario, Paolo] Italian Minist Hlth, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Naples Federico II	Donfrancesco, C (corresponding author), Ist Super Sanita, Rome, Italy.	chiara.donfrancesco@iss.it	Vespasiano, Francesca/G-5970-2015; Vespasiano, Francesca/AFO-2093-2022; Buttari, Brigitta/I-3030-2014; donfrancesco, chiara/K-1460-2016	Vespasiano, Francesca/0000-0002-3820-1508; Buttari, Brigitta/0000-0002-0575-4106; donfrancesco, chiara/0000-0002-8040-5571	Italian Ministry of Health (MoH); Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Fondazione per il Tuo cuore onlus (Heart Care Foundation - HCF); OEC/HES; Joint Action of the European Health Examination Survey; MoH - CCM; Italian National Institute of Health (Istituto Superiore di Sanita - ISS)	Italian Ministry of Health (MoH)(Ministry of Health, Italy); Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Fondazione per il Tuo cuore onlus (Heart Care Foundation - HCF); OEC/HES; Joint Action of the European Health Examination Survey; MoH - CCM; Italian National Institute of Health (Istituto Superiore di Sanita - ISS)	The Osservatorio Epidemiologico Cardiovascolare (OEC) 1998-2002 and the Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey (OEC/HES) 2008-2012 within the CUORE Project were funded by the Italian Ministry of Health (MoH), by the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), by the Fondazione per il Tuo cuore onlus (Heart Care Foundation -HCF) and OEC/HES 2008-2012 also by the Joint Action of the European Health Examination Survey. The Health Examination Survey (HES) 2018-2019 within the CUORE Project was promoted and funded by the MoH -CCM for activities related to the CCM 2017 project -Central Actions Area -entitled "Monitoring of the average daily consumption of sodium in the Italian population". The OEC 1998-2002, OEC/HES 2008-2012 and HES 2018-2019 were also funded by the Italian National Institute of Health (Istituto Superiore di Sanita -ISS) through permanent staff salary and some travels refund. Italian Ministry of Health defined the needs and use of data for evidence based policy making and collaborate in the interpretation of results for health promotion and prevention activities and planning health services. Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) and the Fondazione per il Tuo cuore onlus (Heart Care Foundation-HCF) had a role in data collection and in the interpretation of results.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; [Anonymous], REV EUROPEAN STANDAR; [Anonymous], NONC DIS COUNTR PROF; [Anonymous], 2018, REV SCI EV POL NUTR; [Anonymous], 2008, WAIST CIRCUMFERENCE; [Anonymous], PASSI SURVEILLANCE; [Anonymous], WHO OBESITY OVERWEIG; [Anonymous], EUROPEAN HLTH EXAMIN; [Anonymous], RAPPORTO OSSERVASALU; Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x; Devaux M., 2011, OECD J EC STUDIES, V1, P1, DOI [10.1787/eco_studies-2011-5kg5825v1k23, DOI 10.1787/ECO_STUDIES-2011-5KG5825V1K23]; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Donfrancesco C, 2021, NUTR METAB CARDIOVAS, V31, P814, DOI 10.1016/j.numecd.2020.11.015; Donfrancesco C, 2021, NUTR METAB CARDIOVAS, V31, P802, DOI 10.1016/j.numecd.2020.10.017; EUROSTAT, OV OB BMI STAT; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Gallus S, 2006, EUR J CLIN NUTR, V60, P1174, DOI 10.1038/sj.ejcn.1602433; Gallus S, 2013, EUR J NUTR, V52, P677, DOI 10.1007/s00394-012-0372-y; Gelius P, 2020, PREV MED REP, V18, DOI 10.1016/j.pmedr.2020.101095; Giampaoli S, 2015, EUR J PREV CARDIOL, V22, P9, DOI 10.1177/2047487315589011; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gorber SC, 2010, OBESITY, V18, P354, DOI 10.1038/oby.2009.206; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Italian National Institute of Statistics, 2017, POP ED LEV OCC RET M; John U, 2006, EUR J CLIN NUTR, V60, P372, DOI 10.1038/sj.ejcn.1602325; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Khan SS, 2018, JAMA CARDIOL, V3, P280, DOI 10.1001/jamacardio.2018.0022; Khaodhiar L, 1999, Clin Cornerstone, V2, P17, DOI 10.1016/S1098-3597(99)90002-9; KUSKOWSKAWOLK A, 1989, INT J OBESITY, V13, P441; Micciolo R, 2010, ANN EPIDEMIOL, V20, P258, DOI 10.1016/j.annepidem.2010.01.006; Mindell JS, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0072-4; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; National Institute of Statistics, RES POP 1991 2019; NCD Risk Factor Collaboration (NCD-RisC), BOD MASS IND URB RUR; Obesity and inequities, 2014, GUID ADDR IN OV OB; OECD, 2017, OB UPD, V13, P331; OECD, 2018, HLTH GLANC EUR 2016, DOI [10.1787/82129230-en, DOI 10.1787/82129230-EN]; OECD/European Union, 2018, HLTH GLANC EUR 2018, DOI [10.1787/health_glance_eur-2018-en, DOI 10.1787/HEALTH_GLANCE_EUR-2018-EN]; Organisation for Economic Co-operation and Development, 2019, The heavy burden of obesity. The economics of prevention, DOI 10.1787/67450d67-en; Panico S, 2008, PREV MED, V47, P53, DOI 10.1016/j.ypmed.2008.01.023; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Sun YQ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l1042; Tolonen H, 2014, EUR J PUBLIC HEALTH, V24, P941, DOI 10.1093/eurpub/cku074; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; World Bank Group Report, 2020, OB HLTH EC CONS IMP; World Health Organization, BOD MASS IND BMI; World Health Organization, 2013, GLOB ACT PLAN PREV C; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yun S, 2006, INT J OBESITY, V30, P164, DOI 10.1038/sj.ijo.0803125	51	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264778	10.1371/journal.pone.0264778	http://dx.doi.org/10.1371/journal.pone.0264778			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231070	Green Published, gold			2022-12-26	WOS:000849744700046
J	Kang, YM; Lee, YY; Lin, SC; Chang, FC; Hsu, SPC; Lin, CF; Liang, ML; Chen, HH; Wong, TT; Lan, KL; Chao, YE; Chen, YW				Kang, Yu-Mei; Lee, Yi-Yen; Lin, Shih-Chieh; Chang, Feng-Chi; Hsu, Sanford P. C.; Lin, Chun-Fu; Liang, Muh-Lii; Chen, Hsin-Hung; Wong, Tai-Tong; Lan, Keng-Li; Chao, Yee; Chen, Yi-Wei			Bifocal lesions have a poorer treatment outcome than a single lesion in adult patients with intracranial germinoma	PLOS ONE			English	Article							GERM-CELL TUMORS; QUALITY-OF-LIFE; RADIOTHERAPY; RADIATION; CHILDREN	Intracranial germinoma (IG) rarely occurs in adults. Its optimal treatment strategy is unclear. We evaluated the outcomes of radiotherapy in adults with intracranial germinoma. Data of 29 adult patients (age, 18-52 years; median age, 24.3 years) with IG treated with radiotherapy at Taipei Veterans General Hospital were retrospectively reviewed. They were followed up for a median time of 5.9 years (range, 1.0-12.8 years). We used the Kaplan-Meier method to estimate the progression-free survival (PFS) and overall survival (OS), and univariate and multivariate Cox proportional hazards regression models to identify the factors affecting PFS. PFS and OS were compared between adult and pediatric patients with IG. The 1-, 3-, and 5-year PFS rates were 96.6%, 85.8%, and 77.8%, respectively, in the adult patients, and the OS rate were all 100%. Seven patients (24.1%) experienced recurrence, and in six of them, salvage therapy successfully controlled the disease. Two patients (6.9%) died after 5 years of follow-up due to disease progression and central pontine myelinolysis. In the univariate and multivariate Cox analysis, bifocal lesions had a significantly lower PFS than those with single lesions (p = 0.008). Kaplan-Meier survival analysis showed that adult patients had a poorer PFS (p = 0.06) and OS (p = 0.025) than pediatric patients. Our study showed bifocal lesions were associated with lower PFS than a single lesion among adult IG patients, and adult IG patients tended to have poorer PFS and OS compared to pediatric IG patients. For adult patients with bifocal IG, we recommend treatment with craniospinal irradiation, whole ventricle irradiation (WVI) with chemotherapy, or frequent spine images follow-up for patients who received only WVI.	[Kang, Yu-Mei; Lan, Keng-Li; Chen, Yi-Wei] Taipei Vet Gen Hosp, Dept Oncol, Div Radiat Oncol, Taipei, Taiwan; [Kang, Yu-Mei; Lee, Yi-Yen; Lin, Shih-Chieh; Chang, Feng-Chi; Hsu, Sanford P. C.; Lin, Chun-Fu; Liang, Muh-Lii; Chen, Hsin-Hung; Wong, Tai-Tong; Chen, Yi-Wei] Natl Yang Ming Chiao Tung Univ, Fac Med, Taipei, Taiwan; [Kang, Yu-Mei] Natl Yang Ming Chiao Tung Univ, Sch Med, Inst Clin Med, Taipei, Taiwan; [Lee, Yi-Yen; Liang, Muh-Lii; Chen, Hsin-Hung; Wong, Tai-Tong] Taipei Vet Gen Hosp, Neurol Inst, Div Pediat Neurosurg, Taipei, Taiwan; [Lin, Shih-Chieh] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Chang, Feng-Chi] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Hsu, Sanford P. C.; Lin, Chun-Fu] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Lan, Keng-Li] Natl Yang Ming Chiao Tung Univ, Sch Med, Inst Tradit Med, Taipei, Taiwan; [Chao, Yee] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Chen, Yi-Wei] Yuanpei Univ Med Technol, Dept Med Imaging & Radiol Technol, Hsinchu, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chen, YW (corresponding author), Taipei Vet Gen Hosp, Dept Oncol, Div Radiat Oncol, Taipei, Taiwan.; Chen, YW (corresponding author), Natl Yang Ming Chiao Tung Univ, Fac Med, Taipei, Taiwan.; Chen, YW (corresponding author), Yuanpei Univ Med Technol, Dept Med Imaging & Radiol Technol, Hsinchu, Taiwan.	chenyw@vghtpe.gov.tw	Chen, Yi/HIR-2608-2022	Lin, Chun-Fu/0000-0001-5831-6620				Bossolo AG, 2018, CASE REP ENDOCRINOL, V2018, DOI 10.1155/2018/1746917; Boukobza Monique, 2019, eNeurologicalSci, V15, P100187, DOI 10.1016/j.ensci.2019.100187; Calaminus G, 2013, NEURO-ONCOLOGY, V15, P788, DOI 10.1093/neuonc/not019; Chen JT, 2019, J CHIN MED ASSOC, V82, P133, DOI 10.1097/JCMA.0000000000000015; Chen YW, 2012, CANCER-AM CANCER SOC, V118, P2752, DOI 10.1002/cncr.26564; Cheng S, 2016, J NEURO-ONCOL, V127, P173, DOI 10.1007/s11060-015-2029-1; Cuccia V, 2010, CHILD NERV SYST, V26, P1043, DOI 10.1007/s00381-010-1120-3; de Pemille CV, 2016, WORLD NEUROSURG, V92, DOI 10.1016/j.wneu.2016.05.041; Fetcko Kaleigh, 2018, Med Res Arch, V6; Foote M, 2010, J NEURO-ONCOL, V100, P459, DOI 10.1007/s11060-010-0206-9; Huang PI, 2008, CHILD NERV SYST, V24, P1315, DOI 10.1007/s00381-008-0648-y; Kang YM, 2020, CHILD NERV SYST, V36, P1745, DOI 10.1007/s00381-020-04543-4; Kreutz J, 2017, ANN ENDOCRINOL-PARIS, V78, P141, DOI 10.1016/j.ando.2016.10.005; Lafay-Cousin L, 2006, INT J RADIAT ONCOL, V65, P486, DOI 10.1016/j.ijrobp.2005.12.011; Lee DS, 2019, RADIOTHER ONCOL, V138, P180, DOI 10.1016/j.radonc.2019.06.002; Lian X, 2019, J CANCER RES CLIN, V145, P709, DOI 10.1007/s00432-018-2743-0; Liang SY, 2013, NEURO-ONCOLOGY, V15, P1543, DOI 10.1093/neuonc/not127; Lo AC, 2020, INT J RADIAT ONCOL, V106, P269, DOI 10.1016/j.ijrobp.2019.10.020; Lo AC, 2019, J NEURO-ONCOL, V143, P289, DOI 10.1007/s11060-019-03159-2; McCarthy BJ, 2012, NEURO-ONCOLOGY, V14, P1194, DOI 10.1093/neuonc/nos155; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Ogawa K, 2008, INT J RADIAT ONCOL, V72, P1347, DOI 10.1016/j.ijrobp.2008.03.055; Phi JH, 2013, J NEUROSURG-PEDIATR, V11, P107, DOI 10.3171/2012.10.PEDS11487; Rogers SJ, 2005, LANCET ONCOL, V6, P509, DOI 10.1016/S1470-2045(05)70245-X; Selek U, 2007, STRAHLENTHER ONKOL, V183, P236, DOI 10.1007/s00066-007-1563-y; Sutton LN, 1999, NEUROSURGERY, V45, P1292, DOI 10.1097/00006123-199912000-00002; Wang LH, 2014, NATURE, V511, P241, DOI 10.1038/nature13296; Wang WG, 2018, J NEURO-ONCOL, V137, P77, DOI 10.1007/s11060-017-2696-1; Weksberg DC, 2012, INT J RADIAT ONCOL, V82, P1341, DOI 10.1016/j.ijrobp.2011.04.033; Yen SH, 2010, INT J RADIAT ONCOL, V77, P980, DOI 10.1016/j.ijrobp.2009.06.035	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264641	10.1371/journal.pone.0264641	http://dx.doi.org/10.1371/journal.pone.0264641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231071	Green Published, gold			2022-12-26	WOS:000849744700031
J	Kumar, P; Liu, YS; Shen, Y; Maher, JJ; Cingolani, F; Czaja, MJ				Kumar, Pradeep; Liu, Yunshan; Shen, Yang; Maher, Jacquelyn J.; Cingolani, Francesca; Czaja, Mark J.			Mouse liver injury induces hepatic macrophage FGF23 production	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; DOMINANT HYPOPHOSPHATEMIC RICKETS; KIDNEY; EXPRESSION; ACTIVATION; MORTALITY; DISEASE; FGF-23; DEATH; FIBROBLAST-GROWTH-FACTOR-23	Fibroblast growth factor 23 (FGF23) is a bone marrow cell produced hormone that functions in the intestine and kidney to regulate phosphate homeostasis. Increased serum FGF23 is a well-established predictor of mortality in renal disease, but recent findings linking increased levels to hepatic and cardiac diseases have suggested that other organs are sources of FGF23 or targets of its effects. The potential ability of the liver to produce FGF23 in response to hepatocellular injury was therefore examined. Very low levels of Fgf23 mRNA and FGF23 protein were detected in normal mouse liver, but the amounts increased markedly during acute liver injury from the hepatotoxin carbon tetrachloride. Serum levels of intact FGF23 were elevated during liver injury from carbon tetrachloride. Chronic liver injury induced by a high fat diet or elevated bile acids also increased hepatic FGF23 levels. Stimulation of toll-like receptor (TLR) 4-driven inflammation by gut-derived lipopolysaccharide (LPS) underlies many forms of liver injury, and LPS induced Fgf23 in the liver as well as in other organs. The LPS-inducible cytokines IL-1 beta and TNF increased hepatic Fgf23 expression as did a TLR2 agonist Pam2CSK3. Analysis of Fgf23 expression and FGF23 secretion in different hepatic cell types involved in liver injury identified the resident liver macrophage or Kupffer cell as a source of hepatic FGF23. LPS and cytokines selectively induced the hormone in these cells but not in hepatocytes or hepatic stellate cells. FGF23 failed to exert any autocrine effect on the inflammatory state of Kupffer cells but did trigger proinflammatory activation of hepatocytes. During liver injury inflammatory factors induce Kupffer cell production of FGF23 that may have a paracrine proinflammatory effect on hepatocytes. Liver-produced FGF23 may have systemic hormonal effects as well that influence diseases in in other organs.	[Kumar, Pradeep; Liu, Yunshan; Shen, Yang; Cingolani, Francesca; Czaja, Mark J.] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Maher, Jacquelyn J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Maher, Jacquelyn J.] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	Emory University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Czaja, MJ (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	mark.j.czaja@emory.edu		Czaja, Mark/0000-0003-2306-7219; SHEN, YANG/0000-0002-2448-8405	NIH [R01DK044234, P30DK026743]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by NIH grants R01DK044234 (MJC) and P30DK026743 (JJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 1999, CLIN CHIM ACTA, V289, P177, DOI 10.1016/S0009-8981(99)00140-0; Bansal S, 2017, NEPHROL DIAL TRANSPL, V32, P960, DOI [10.1093/ndt/gfw376, 10.1093/ndt/gfx003]; Bayer J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251317; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Carpino G, 2020, HEPATOLOGY, V72, P470, DOI 10.1002/hep.31056; Cingolani F., 2021, REDUNDANT FUNCTIONS, DOI [10.1002/hep4.1867, DOI 10.1002/HEP4.1867]; CZAJA MJ, 1994, HEPATOLOGY, V19, P1282, DOI 10.1016/0270-9139(94)90878-8; David V, 2017, AM J PHYSIOL-RENAL, V312, pF1, DOI 10.1152/ajprenal.00359.2016; David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099; Gattineni J, 2011, AM J PHYSIOL-RENAL, V301, pF371, DOI 10.1152/ajprenal.00740.2010; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Gulati S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092292; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Han XB, 2016, FEBS LETT, V590, P53, DOI 10.1002/1873-3468.12040; Haring R, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003486; He XX, 2018, CLIN EXP PHARMACOL P, V45, P668, DOI 10.1111/1440-1681.12933; Hu X, 2020, DIABET METAB SYND OB, V13, P1171, DOI 10.2147/DMSO.S241348; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878; Kovesdy CP, 2016, AM J PHYSIOL-RENAL, V310, pF1168, DOI 10.1152/ajprenal.00606.2015; Krick S, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00236-2018; Lalazar G, 2016, AM J PHYSIOL-GASTR L, V311, pG377, DOI 10.1152/ajpgi.00124.2016; Liu K, 2015, AUTOPHAGY, V11, P271, DOI 10.1080/15548627.2015.1009787; Lutsey PL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000936; Masuda Y, 2015, BIOL PHARM BULL, V38, P687, DOI 10.1248/bpb.b14-00276; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; Prie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066182; Qin ZX, 2017, ATHEROSCLEROSIS, V261, P1, DOI 10.1016/j.atherosclerosis.2017.03.042; Schattenberg JM, 2004, HEPATOLOGY, V39, P444, DOI 10.1002/hep.20067; SCHMIEDEBERG P, 1993, J CELL PHYSIOL, V154, P294, DOI 10.1002/jcp.1041540212; Shen Y, 2021, HEPATOLOGY, V74, P2745, DOI 10.1002/hep.32010; Shen Y, 2020, HEPATOLOGY, V72, P595, DOI 10.1002/hep.31209; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Sugiura H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191706; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vervloet M, 2019, NAT REV NEPHROL, V15, P109, DOI 10.1038/s41581-018-0087-2; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Wijarnpreecha K, 2021, CLIN MOL HEPATOL, V27, P221, DOI 10.3350/cmh.2020.0239; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Zanchi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070775; Zannetti C, 2016, J IMMUNOL, V197, P356, DOI 10.4049/jimmunol.1502301; Zhu DX, 2013, MOL CELL ENDOCRINOL, V372, P1, DOI 10.1016/j.mce.2013.03.008; Zou BJ, 2018, CANCER MANAG RES, V10, P5303, DOI 10.2147/CMAR.S176152	49	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264743	10.1371/journal.pone.0264743	http://dx.doi.org/10.1371/journal.pone.0264743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231062	Green Published, gold			2022-12-26	WOS:000849744700041
J	Martinez-Campelo, L; Cruz, R; Blanco-Verea, A; Moscoso, I; Ramos-Luis, E; Lage, R; Alvarez-Barredo, M; Sabater-Molina, M; Penafiel-Verdu, P; Jimenez-Jaimez, J; Rodriguez-Manero, M; Brion, M				Martinez-Campelo, Laura; Cruz, Raquel; Blanco-Verea, Alejandro; Moscoso, Isabel; Ramos-Luis, Eva; Lage, Ricardo; Alvarez-Barredo, Maria; Sabater-Molina, Maria; Penafiel-Verdu, Pablo; Jimenez-Jaimez, Juan; Rodriguez-Manero, Moises; Brion, Maria			Searching for genetic modulators of the phenotypic heterogeneity in Brugada syndrome	PLOS ONE			English	Article							OXIDATIVE STRESS; SODIUM-CHANNEL; SCN5A; DISEASE; EXPRESSION; MUTATIONS; VARIANTS; FIBROSIS; GENOME; CLOCK	In Brugada syndrome, even within the same family where all affected individuals share the same mutation, phenotypic variation is prominent, with variable penetrance and expressivity, presenting different degrees of involvement. It is difficult to establish a direct correlation between genotype and phenotype to predict prognosis in complications and risk of sudden death. The factors that modulate this inter- and intra-familial phenotypic variability remain to be determined. With the intention of testing whether other genetic factors, in addition to the causal mutation in SCN5A, may have a modulating effect on the Brugada phenotype and the risk of sudden death, we have studied 8 families with a causal variant in SCN5A with at least two affected individuals, one of whom has suffered cardiac arrest or sudden death. Whole exome sequencing was performed looking for additional variants that modify the phenotype and allow us to predict a better or worse prognosis for the evolution of the disease. The results did not show any clear genetic modifier; nevertheless, highlight the possible implication of the cholesterol and fibrosis pathways, as well as the circadian rhythm, as possible modulators of Brugada syndrome phenotype.	[Martinez-Campelo, Laura; Blanco-Verea, Alejandro; Ramos-Luis, Eva; Alvarez-Barredo, Maria; Brion, Maria] Santiago de Compostela Hlth Res Inst, Cardiovasc Genet, Santiago De Compostela, Spain; [Martinez-Campelo, Laura; Cruz, Raquel; Blanco-Verea, Alejandro; Ramos-Luis, Eva; Brion, Maria] Univ Santiago de Compostela, Genom Med Grp, Santiago De Compostela, Spain; [Cruz, Raquel] Carlos III Hlth Inst, CIBER Rare Dis, Madrid, Spain; [Moscoso, Isabel; Lage, Ricardo; Alvarez-Barredo, Maria; Sabater-Molina, Maria; Penafiel-Verdu, Pablo; Jimenez-Jaimez, Juan; Rodriguez-Manero, Moises; Brion, Maria] Carlos III Hlth Inst, Cardiovasc CIBER, Madrid, Spain; [Moscoso, Isabel; Lage, Ricardo] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Cardiol Grp, Santiago De Compostela, Spain; [Sabater-Molina, Maria; Penafiel-Verdu, Pablo] Virgen de la Arrixaca Univ Clin Hosp, Murcian Inst Biosanit Res, Cardiol Serv, Cardiogenet Lab, Murcia, Spain; [Jimenez-Jaimez, Juan] Virgen de las Nieves Univ Hosp, Arrhythmia Unit, Granada, Spain; [Rodriguez-Manero, Moises] Santiago de Compostela Univ Hosp, Cardiol Serv, Santiago De Compostela, Spain; [Brion, Maria] Santiago de Compostela Univ Hosp, Cardiol Serv, Family Heart Dis Unit, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Universitario Virgen de las Nieves; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Brion, M (corresponding author), Santiago de Compostela Hlth Res Inst, Cardiovasc Genet, Santiago De Compostela, Spain.; Brion, M (corresponding author), Univ Santiago de Compostela, Genom Med Grp, Santiago De Compostela, Spain.; Brion, M (corresponding author), Carlos III Hlth Inst, Cardiovasc CIBER, Madrid, Spain.; Brion, M (corresponding author), Santiago de Compostela Univ Hosp, Cardiol Serv, Family Heart Dis Unit, Santiago De Compostela, Spain.	maria.brion@usc.es	Brion, Maria/J-8059-2014; Moscoso, Isabel/GXZ-9513-2022; Sabater-Molina, Maria/I-2722-2015	Brion, Maria/0000-0001-7463-2148; Moscoso, Isabel/0000-0002-6078-4666; Sabater-Molina, Maria/0000-0003-1352-1748; Lage Fernandez, Ricardo/0000-0002-8779-7723; CRUZ, RAQUEL/0000-0002-6964-8898; Ramos Luis, Eva/0000-0002-2212-7403; , Laura/0000-0001-7721-948X; Penafiel Verdu, Pablo/0000-0002-0641-5077	XIV Convocatoria de Ayudas a la Investigacion en Salud de la Fundacion Mutua Madrilena; Plan Estatal de I+D+i 2013-2020, Subdireccion General de Evaluacion y Fomento de la Investigacion (ISCIII-SGEFI) from Instituto de Salud Carlos III (ISCIII); Fondo Europeo de Desarrollo Regional (FEDER) [PI19/01283, CB16/11/00226, FI20/00191]; Instituto de Salud Carlos III (ISCIII)	XIV Convocatoria de Ayudas a la Investigacion en Salud de la Fundacion Mutua Madrilena; Plan Estatal de I+D+i 2013-2020, Subdireccion General de Evaluacion y Fomento de la Investigacion (ISCIII-SGEFI) from Instituto de Salud Carlos III (ISCIII); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission)	This research was funded by the XIV Convocatoria de Ayudas a la Investigacion en Salud de la Fundacion Mutua Madrilena and by the Plan Estatal de I+D+i 2013-2020, Subdireccion General de Evaluacion y Fomento de la Investigacion (ISCIII-SGEFI) from Instituto de Salud Carlos III (ISCIII) and Fondo Europeo de Desarrollo Regional (FEDER) (grant numbers PI19/01283, CB16/11/00226). The PhD work of M.C.L. was funded by PFIS scholarship from the Instituto de Salud Carlos III (ISCIII) and Fondo Europeo de Desarrollo Regional (FEDER)(grant number FI20/00191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Sayed ZR, 2021, CARDIOVASC RES, V117, P2092, DOI 10.1093/cvr/cvaa259; Beltran-Alvarez P, 2014, J MOL CELL CARDIOL, V76, P126, DOI 10.1016/j.yjmcc.2014.08.014; Bernardi J, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.611860; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Black N, 2019, HEART RHYTHM, V16, P298, DOI 10.1016/j.hrthm.2018.08.026; Boukens BJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041570; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Brugada J, 2018, J AM COLL CARDIOL, V72, P1046, DOI 10.1016/j.jacc.2018.06.037; Campuzano O, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197155; Cerrone M, 2019, CIRCULATION, V140, P595, DOI 10.1161/CIRCULATIONAHA.118.035954; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Daimi H, 2019, BIOMED J, V42, P252, DOI 10.1016/j.bj.2019.03.003; Daimi H, 2015, HEART RHYTHM, V12, P1333, DOI 10.1016/j.hrthm.2015.02.018; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Eastaugh LJ, 2011, J CARDIOVASC ELECTR, V22, P1073, DOI 10.1111/j.1540-8167.2010.02003.x; Frustaci A, 2005, CIRCULATION, V112, P3680, DOI 10.1161/CIRCULATIONAHA.105.520999; Juang JMJ, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102843; Kimura Yoshitaka, 2016, HeartRhythm Case Rep, V2, P465, DOI 10.1016/j.hrcr.2016.06.002; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Mademont-Soler I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163514; Marangoni S, 2011, CARDIOVASC RES, V91, P606, DOI 10.1093/cvr/cvr142; Martino T, 2004, J MOL MED, V82, P256, DOI 10.1007/s00109-003-0520-1; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Monasky MM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051687; Monasky MM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01088; Nademanee K, 2015, J AM COLL CARDIOL, V66, P1976, DOI 10.1016/j.jacc.2015.08.862; Perez-Agustin A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228556; Pollex RL, 2007, CIRCULATION, V115, P3130, DOI 10.1161/CIRCULATIONAHA.106.677591; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schroder EA, 2013, AM J PHYSIOL-CELL PH, V304, pC954, DOI 10.1152/ajpcell.00383.2012; Sonoda K, 2018, HEART RHYTHM, V15, P1179, DOI 10.1016/j.hrthm.2018.03.033; Tafti MF, 2018, CARDIOL J, V25, P113, DOI 10.5603/CJ.a2017.0104; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Tarradas A, 2017, J MOL CELL CARDIOL, V102, P74, DOI 10.1016/j.yjmcc.2016.10.013; Walsh R, 2019, J CARDIOVASC ELECTR, V30, P128, DOI 10.1111/jce.13774; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WU CC, 1995, J MOL CELL CARDIOL, V27, P1263, DOI 10.1016/S0022-2828(05)82388-0; Yagihara N, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003644; Yan Q, 2018, BIOINFORMATICS, V34, P2144, DOI 10.1093/bioinformatics/bty066; Zakany F, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158706; Zhang XM, 2018, J CLIN INVEST, V128, P1154, DOI 10.1172/JCI95710; Zhou R, 2011, CELL PHYSIOL BIOCHEM, V27, P299, DOI 10.1159/000327956	44	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0263469	10.1371/journal.pone.0263469	http://dx.doi.org/10.1371/journal.pone.0263469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231055	Green Published, gold			2022-12-26	WOS:000849744700011
J	Paulose, T; Nkosi, ZZ; Endriyas, M				Paulose, Tsegab; Nkosi, Zerish Zethu; Endriyas, Misganu			Prevalence of hypertension and its associated factors in Hawassa city administration, Southern Ethiopia: Community based cross-sectional study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIGH BLOOD-PRESSURE; PREVENTION; URGENT; BURDEN	Background In association with the epidemiological, nutritional and demographic transition, many research findings showed that the number of risk factors that leads to increased prevalence of hypertension in low and middle income countries like Ethiopia is increasing. Several urban specific studies conducted in Ethiopia showed varying prevalence of hypertension. The aim of this study was to determine prevalence of hypertension and to identify factors associated with hypertension in Hawassa city administration, Southern Ethiopia. Methods A community-based cross sectional study was carried out in Hawassa city administration in 2017. A multi-stage sampling technique was used to select 612 study participants. Descriptive statistics was used to describe socio-demographic, behavioral and anthropometric variables. The economic status of household, 'wealth index', was constructed by running principal component analysis. Binary logistic regression analysis was performed to assess factors associated with hypertension at 95%CI. Results The overall prevalence of hypertension was 21.2% (95% CI: 18.1-24.7), (24.5% for urban and 14.7% for peri-urban). About two fifths of hypertension cases (42.3%) were newly diagnosed with elevated blood pressure during data collection. Age, occupation, wealth status, consuming vegetables and animal fat, usual mode of transport, body mass index (BMI), family history of hypertension and existence of diabetes were associated with presence of hypertension at 95%CI. The average diastolic blood pressure for urban was 2.18mmHg higher than that of peri-urban groups (p-0.01). Conclusion More than one fifth of study participants had hypertension and about two fifths of hypertension cases were newly diagnosed. Health communication should be strengthened focusing on identified risk factors and attention should be given to early detect and tackle the effects of hypertension in resource limited setting.	[Paulose, Tsegab] Univ South Africa Ethiopia, Reg Learning Ctr, Hlth Studies Dept, Addis Ababa, Ethiopia; [Nkosi, Zerish Zethu] Univ South Africa, Hlth Studies Dept, Pretoria, South Africa; [Endriyas, Misganu] SNNPR Hlth Bur, Hawassa, Ethiopia	University of South Africa	Paulose, T (corresponding author), Univ South Africa Ethiopia, Reg Learning Ctr, Hlth Studies Dept, Addis Ababa, Ethiopia.	tsegabpaulose@gmail.com	Endriyas, Misganu/AGZ-6466-2022	Endriyas, Misganu/0000-0002-0026-9611				Abdissa SG, 2015, ETHIOP J HEALTH DEV, V29, P22; Abebe SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125210; Aounallah-Skhiri H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-98; Asresahegn Henok, 2017, BMC Res Notes, V10, P629, DOI 10.1186/s13104-017-2966-1; Ba HO, 2018, INT J HYPERTENS, V2018, DOI 10.1155/2018/6959165; Bawah AA, 1999, STUD FAMILY PLANN, V30, P54, DOI 10.1111/j.1728-4465.1999.00054.x; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Campbell NRC, 2015, J CLIN HYPERTENS, V17, P663, DOI 10.1111/jch.12599; Cappuccio FP, 2016, INTERN EMERG MED, V11, P299, DOI 10.1007/s11739-016-1423-9; Carey RM, 2018, J AM COLL CARDIOL, V72, P1278, DOI 10.1016/j.jacc.2018.07.008; Chen Y, 2018, PULSE, V6, P112, DOI 10.1159/000489855; Chowdhury MAB, 2021, J HUM HYPERTENS, V35, P912, DOI 10.1038/s41371-020-00435-x; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; Echouffo-Tcheugui JB, 2015, J CLIN HYPERTENS, V17, P751, DOI 10.1111/jch.12620; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; International Institute of Population Science, 2016, NATL FAMILY HLTH SUR; Kaler A, 2009, SOC SCI MED, V68, P1711, DOI 10.1016/j.socscimed.2009.01.038; Kibret KT, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0014-z; O'Brien E, 2017, J CLIN HYPERTENS, V19, P564, DOI 10.1111/jch.12998; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Olsen MH, 2015, LANCET, V386, P637, DOI 10.1016/S0140-6736(15)61178-3; Organization WH, 2019, HYP WHO; Ratovoson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137408; Roba HS, 2019, INT J HYPERTENS, V2019, DOI 10.1155/2019/9878437; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Shukuri A, 2019, INTEGR BLOOD PRESS C, V12, P23, DOI 10.2147/IBPC.S212821; Steven V., 2013, PAN AFR MED J, V16; Tiruneh SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244642; Wang W., 2019, PLOS ONE, V14; World Health Organization, 2019, HYP WHO; Wu F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1407-0	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264679	10.1371/journal.pone.0264679	http://dx.doi.org/10.1371/journal.pone.0264679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231073	Green Published, gold			2022-12-26	WOS:000849744700034
J	Kim, AS; Werlin, EC; Kagaya, H; Chen, MA; Wu, B; Mottola, G; Jan, M; Conte, MS				Kim, Alexander S.; Werlin, Evan C.; Kagaya, Hideo; Chen, Mian; Wu, Bian; Mottola, Giorgio; Jan, Masood; Conte, Michael S.			17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury	PLOS ONE			English	Article							PRORESOLVING LIPID MEDIATORS; PERIPHERAL ARTERIAL-DISEASE; INFLAMMATION; LIPOXIN; GUIDELINES; MANAGEMENT; RESOLUTION; DELIVERY; SIGNALS; A(4)	Background Persistent inflammation following vascular injury drives neointimal hyperplasia (NIH). Specialized lipid mediators (SPM) mediate resolution which attenuates inflammation and downstream NIH. We investigated the effects of a synthetic analogue of resolvin D1 (RvD1) on vascular cells and in a model of rat carotid angioplasty. Methods Human venous VSMC and endothelial cells (EC) were employed in migration, cell shape, toxicity, proliferation and p65 nuclear translocation assays. Murine RAW 264.7 cells were utilized to test the effect of pro-resolving compounds on phagocytic activity. A model of rat carotid angioplasty was used to evaluate the effects of 17R/S-benzo-RvD1 (benzo-RvD1) and 17R-RvD1 applied to the adventitia via 25% Pluronic gel. Immunostaining was utilized to examine Ki67 expression and leukocyte recruitment. Morphometric analysis was performed on arteries harvested 14 days after injury. Results Exposure to benzo-RvD1 attenuated PDGF- stimulated VSMC migration across a range of concentrations (0.1-100 nM), similar to that observed with 17R-RvD1. Pre-treatment with either Benzo-RvD1 or 17R-RvD1 (10, 100nM) attenuated PDGF-BB-induced VSMC cytoskeletal changes to nearly baseline dimensions. Benzo-RvD1 demonstrated modest anti-proliferative activity on VSMC and EC at various concentrations, without significant cytotoxicity. Benzo-RvD1 (10nM) inhibited p65 nuclear translocation in cytokine-stimulated EC by 21% (p<0.05), similar to 17R-RvD1. Consistent with pro-resolving activities of other SPM, both 17R-RvD1 and benzo-RvD1 increased the phagocytic activity of RAW 264.7 cells against S. Aureus and Zymosan particles. There were no significant differences in Ki-67 or CD45 staining observed on day 3 after angioplasty. Periadventitial treatment with benzo-RvD1 reduced carotid neointimal area at 14 days compared to control (0.08 mm(2) v. 0.18 mm(2); p<0.05), with similar efficacy to 17R-RvD1. Conclusions 17R/S-benzo-RvD1 and 17R-RvD1 exhibit similar pro-resolving and anti-migratory activity in cell-based assays, and both compounds attenuated NIH following acute arterial injury in rats. Further studies of the mechanisms of resolution following vascular injury, and the translational potential of SPM analogues, are indicated.	[Conte, Michael S.] UCSF, Dept Surg, San Francisco, CA 94143 USA; UCSF, Cardiovasc Res Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Conte, MS (corresponding author), UCSF, Dept Surg, San Francisco, CA 94143 USA.	michael.conte2@ucsf.edu		Kim, Alexander/0000-0002-5018-9361				AUTIERI MV, 1995, BIOCHEM BIOPH RES CO, V213, P827, DOI 10.1006/bbrc.1995.2204; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Chateigner-Boutin AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089620; Chiang N, 2019, J CLIN INVEST, V129, P5294, DOI 10.1172/JCI129448; Chiang N, 2017, MOL ASPECTS MED, V58, P114, DOI 10.1016/j.mam.2017.03.005; Cholkar K, 2016, INT J PHARMACEUT, V498, P326, DOI 10.1016/j.ijpharm.2015.12.037; CLOWES AW, 1985, CIRC RES, V56, P139, DOI 10.1161/01.RES.56.1.139; Conte MS, 2019, J VASC SURG, V69, p3S, DOI 10.1016/j.jvs.2019.02.016; Conte MS, 2018, J CLIN INVEST, V128, P3727, DOI 10.1172/JCI97947; Conte MS, 2015, J VASC SURG, V61, p1S, DOI 10.1016/j.jvs.2014.12.006; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; Criqui MH, 2001, VASC MED, V6, P3, DOI 10.1177/1358836X0100600i102; Dalli J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01400; Fu T, 2020, ACS PHARMACOL TRANSL, V3, P43, DOI 10.1021/acsptsci.9b00097; Hirsch AT, 2008, VASC MED, V13, P209, DOI 10.1177/1358863X08089277; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Katsanos K, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.011245; Kim AS, 2020, ADV DRUG DELIVER REV, V159, P170, DOI 10.1016/j.addr.2020.07.011; Lance KD, 2017, J BIOMED MATER RES A, V105, P31, DOI 10.1002/jbm.a.35861; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Mottola G, 2020, PROSTAG OTH LIPID M, V146, DOI 10.1016/j.prostaglandins.2019.106401; Mottola G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174936; Motwani MP, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94463; Orr SK, 2015, AM J PHYSIOL-LUNG C, V308, pL904, DOI 10.1152/ajplung.00370.2014; Petri MH, 2015, INT J CARDIOL, V179, P370, DOI 10.1016/j.ijcard.2014.11.010; Pirault J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01273; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Shah PK, 2003, CIRCULATION, V107, P2175, DOI 10.1161/01.CIR.0000069943.41206.BD; Shu J, 2018, ATHEROSCLEROSIS, V275, P379, DOI 10.1016/j.atherosclerosis.2018.05.033; Song PG, 2019, LANCET GLOB HEALTH, V7, pE1020, DOI 10.1016/S2214-109X(19)30255-4; Spite Matthew, 2014, Cell Metab, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Vavra AK, 2011, NITRIC OXIDE-BIOL CH, V25, P22, DOI 10.1016/j.niox.2011.04.013; Wang GJ, 2005, ARTERIOSCL THROM VAS, V25, P2081, DOI 10.1161/01.ATV.0000183885.66153.8a; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; Wu B, 2018, J VASC SURG, V68, p188S, DOI 10.1016/j.jvs.2018.05.206; Wu B, 2017, J VASC SURG, V65, P207, DOI 10.1016/j.jvs.2016.01.030	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264217	10.1371/journal.pone.0264217	http://dx.doi.org/10.1371/journal.pone.0264217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226675	gold, Green Published			2022-12-26	WOS:000793394000011
J	Kurkipuro, J; Mierau, I; Wirth, T; Samaranayake, H; Smith, W; Karkkainen, HR; Tikkanen, M; Yrjanheikki, J				Kurkipuro, Jere; Mierau, Igor; Wirth, Thomas; Samaranayake, Haritha; Smith, Wesley; Karkkainen, Hanna-Riikka; Tikkanen, Mirka; Yrjanheikki, Juha			Four in one-Combination therapy using live Lactococcus lactis expressing three therapeutic proteins for the treatment of chronic non-healing wounds	PLOS ONE			English	Article							DIABETIC FOOT ULCERS; COLONY-STIMULATING FACTOR; GROWTH-FACTOR; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; INTERLEUKIN-4; COMPLICATIONS; POLARIZATION; MULTICENTER; EFFICACY	Diabetes mellitus is one of the major concerns for health care systems, affecting 382 million people worldwide. Among the different complications of diabetes, lower limbs chronic ulceration is a common, severe and costly cause of morbidity. Diabetic foot ulcers are a leading cause of hospitalization in diabetic patients and its rate exceed the ones of congestive heart failure, depression or renal disease. Diabetic non-healing ulcers account for more than 60% of all non-traumatic lower limb amputations and the five-year mortality after amputation is higher than 50%, being equal to several types of advanced cancer. The primary management goals for an existing diabetic foot ulcer are to achieve primary healing as expeditiously as possible and to achieve a reduction of the amputation rate in the patients. Unfortunately, approximately a quarter of patients do not partially or fully respond to the standard of care. Advanced therapies for chronic wounds are existing, however, recent guidelines including the latest reviews and meta-analyses of the scientific and clinical evidence available from current treatment strategies and new therapeutic agents revealed that there is a lack of clinical data and persistent gap of evidence for many of the advanced therapeutic approaches. In addition, no pharmacological wound healing product has gained authority approval for more than 10 years in both US and EU, constituting a highly unmet medical need. In this publication we present data from a live biopharmaceutical product AUP1602-C designed as a single pharmaceutical entity based on the non-pathogenic, food-grade lactic acid bacterium Lactococcus lactis subsp. cremoris that has been genetically engineered to produce human fibroblast growth factor 2,interleukin4 and colony stimulating factor 1. Designed to address different aspects of wound healing (i.e. fibroblast proliferation, angiogenesis and immune cell activation) and currently in phase I clinical study, we show how the combination of the individual components on the wound micro-environment initiates and improves the wound healing in chronic wounds.	[Kurkipuro, Jere; Mierau, Igor; Wirth, Thomas; Samaranayake, Haritha; Smith, Wesley; Karkkainen, Hanna-Riikka; Tikkanen, Mirka; Yrjanheikki, Juha] Aurealis Therapeut, Kuopio, Finland		Kurkipuro, J (corresponding author), Aurealis Therapeut, Kuopio, Finland.	jere@aurealistherapeutics.com		Kurkipuro, Jere/0000-0002-5239-6532				Alvarsson A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-18; [Anonymous], 2017, FDA PERM MARK DEV TR; Armstrong DG, 2020, J FOOT ANKLE RES, V13, DOI 10.1186/s13047-020-00383-2; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Armstrong DG, 2005, LANCET, V366, P1704, DOI 10.1016/S0140-6736(05)67695-7; Barlow S, 2007, EFSA J, V5, DOI 10.2903/j.efsa.2007.587; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Blume PA, 2008, DIABETES CARE, V31, P631, DOI 10.2337/dc07-2196; Bron PA, 2002, APPL ENVIRON MICROB, V68, P5663, DOI 10.1128/AEM.68.11.5663-5670.2002; CERRETTI DP, 1988, MOL IMMUNOL, V25, P761, DOI 10.1016/0161-5890(88)90112-5; Chen L, 2015, WOUND REPAIR REGEN, V23, P874, DOI 10.1111/wrr.12338; Crawford F, 2007, QJM-INT J MED, V100, P65; Driver VR, 2015, WOUND REPAIR REGEN, V23, P891, DOI 10.1111/wrr.12357; EPoBH BIOHAZ), 2017, SCI OP UPD LIST QPS; Faglia E, 2009, DIABETES CARE, V32, P822, DOI 10.2337/dc08-1223; Federation ID, IDF DIABETES ATLAS; Fernandez-Montequin JI, 2009, INT WOUND J, V6, P67, DOI 10.1111/j.1742-481X.2008.00561.x; Fukushi J, 2000, J IMMUNOL, V165, P2818, DOI 10.4049/jimmunol.165.5.2818; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gershater MA, 2009, DIABETOLOGIA, V52, P398, DOI 10.1007/s00125-008-1226-2; Goldman RJ, 2009, PM&R, V1, P471, DOI 10.1016/j.pmrj.2009.03.012; Green M.R., 2012, MOL CLONING LAB MANU; Halldorsdottir HD, 2002, SCAND J INFECT DIS, V34, P205, DOI 10.1080/00365540110080377; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; Holo H, 1995, Methods Mol Biol, V47, P195; Hong JP, 2006, ANN PLAS SURG, V56, P394, DOI 10.1097/01.sap.0000198731.12407.0c; Hume DA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00370; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Jaiswal SS, 2010, INDIAN J SURG, V72, P31, DOI 10.1007/s12262-010-0005-8; Jneid J., 2017, HUM MICROBIOME J, V5, P1, DOI [10.1016/j.humic.2017.09.002, DOI 10.1016/J.HUMIC.2017.09.002]; KLAGSBRUN M, 1987, P NATL ACAD SCI USA, V84, P1839, DOI 10.1073/pnas.84.7.1839; Koebmann BJ, 2000, J BACTERIOL, V182, P4738, DOI 10.1128/JB.182.17.4738-4743.2000; Krzyszczyk P, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00419; LACRAZ S, 1992, J CLIN INVEST, V90, P382, DOI 10.1172/JCI115872; Lalau JD, 2002, DIABETES METAB, V28, P223; Lin KH, 2010, INFECTION, V38, P147, DOI 10.1007/s15010-010-9219-3; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701; Marti-Carvajal AJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008548.pub2; Martin P, 2015, BRIT J DERMATOL, V173, P370, DOI 10.1111/bjd.13954; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mattey DL, 1997, ANN RHEUM DIS, V56, P426, DOI 10.1136/ard.56.7.426; Medina Marcela, 2010, Bioeng Bugs, V1, P313, DOI 10.4161/bbug.1.5.12086; Michanek A, 1998, Lakartidningen, V95, P5755; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Mohan VK, 2007, DIABETES RES CLIN PR, V78, P405, DOI 10.1016/j.diabres.2007.06.004; Moura J, 2014, GENES-BASEL, V5, P926, DOI 10.3390/genes5040926; Pellizzer Giampietro, 1996, Clin Microbiol Infect, V2, P230; Pereira SG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01791; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POSTLETHWAITE AE, 1991, J CLIN INVEST, V87, P2147, DOI 10.1172/JCI115247; POSTLETHWAITE AE, 1992, J CLIN INVEST, V90, P1479, DOI 10.1172/JCI116015; Pouget C, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.747618; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Resch M, 2008, INT J CARDIOL, V126, pE8, DOI 10.1016/j.ijcard.2006.12.068; Sanders JW, 1997, APPL ENVIRON MICROB, V63, P4877, DOI 10.1128/AEM.63.12.4877-4882.1997; Sanders JW, 1998, MOL MICROBIOL, V27, P299, DOI 10.1046/j.1365-2958.1998.00676.x; Santema TB, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011255.pub2; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Skrepnek GH, 2017, DIABETES CARE, V40, P936, DOI 10.2337/dc16-2189; Speranza B., 2017, STARTER CULTURES FOO; Teuber M., 1995, GENERA LACTIC ACID B, P173, DOI DOI 10.1007/978-1-4615-5817-0_6; Thomas D R, 1999, Ostomy Wound Manage, V45, P22; VANASSELDONK M, 1993, MOL GEN GENET, V240, P428, DOI 10.1007/BF00280397; VANROOIJEN RJ, 1992, J BACTERIOL, V174, P2273, DOI 10.1128/JB.174.7.2273-2280.1992; Varney ML, 2005, J INTERF CYTOK RES, V25, P674, DOI 10.1089/jir.2005.25.674; Vas PRJ, 2020, FOOT DIABETIS, V5th ed; Veves A, 2001, DIABETES CARE, V24, P290, DOI 10.2337/diacare.24.2.290; vonWright A., 2019, LACTIC ACID BACTERIA, V5; Wieman TJ, 1998, AM J SURG, V176, p74S, DOI 10.1016/S0002-9610(98)00185-8; Yam KK, 2008, VACCINE, V26, P2689, DOI 10.1016/j.vaccine.2008.03.024; Yang Y, 1996, J INVEST DERMATOL, V107, P367, DOI 10.1111/1523-1747.ep12363346; Zhang GY, 2009, BIOTECHNOL PROGR, V25, P1587, DOI 10.1002/btpr.277; Zhao RL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122085; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	77	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264775	10.1371/journal.pone.0264775	http://dx.doi.org/10.1371/journal.pone.0264775			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226700	Green Published, gold			2022-12-26	WOS:000793394000043
J	Hut, PR; Kuiper, SEM; Nielen, M; Hulsen, JHJL; Stassen, EN; Hostens, MM				Hut, P. R.; Kuiper, S. E. M.; Nielen, M.; Hulsen, J. H. J. L.; Stassen, E. N.; Hostens, M. M.			Sensor based time budgets in commercial Dutch dairy herds vary over lactation cycles and within 24 hours	PLOS ONE			English	Article							BODY CONDITION SCORE; FEEDING-BEHAVIOR; HEALTH DISORDERS; LYING BEHAVIOR; SHORT-COMMUNICATION; PRIMIPAROUS COWS; STOCKING DENSITY; DRY PERIOD; RUMINATION; IDENTIFICATION	Cows from 8 commercial Dutch dairy farms were equipped with 2 sensors to study their complete time budgets of eating, rumination, lying, standing and walking times as derived from a neck and a leg sensor. Daily sensor data of 1074 cows with 3201 lactations was used from 1 month prepartum until 10 months postpartum. Farms provided data over a 5 year period. The final models (lactational time budget and 24h time budget) showed significant effects of parity, farm and calving season. When primiparous cows were introduced in the lactational herd, they showed a decrease in lying time of 215 min (95% CI: 187-242) and an increase in standing time of 159 min (95% CI: 138-179), walking time of 23 min (95% CI: 20-26) and rumination time of 69 min (95% CI: 57-82). Eating time in primiparous cows increased from 1 month prepartum until 9 months in lactation with 88 min (95% CI: 76-101) and then remained stable until the end of lactation. Parity 2 and parity 3+ cows decreased in eating time by 30 min (95% CI: 20-40) and 26 min (95% CI: 18-33), respectively, from 1 month before to 1 month after calving. Until month 6, eating time increased 11 min (95% CI: 1-22) for parity 2, and 24 min (95% CI: 16-32) for parity 3+. From 1 month before calving to 1 month after calving, they showed an increase in ruminating of 17 min (95% CI: 6-28) and 28 min (95% CI: 21-35), an increase in standing time of 117 min (95% CI: 100-135) and 133 min (95% CI: 121-146), while lying time decreased with 113 min (95% CI: 91-136) and 130 min (95% CI: 114-146), for parity 2 and 3+, respectively. After month 1 in milk to the end of lactation, lying time increased 67 min (95% CI: 49-85) for parity 2, and 77 min (95% CI: 53-100) for parity 3+. Lactational time budget patterns are comparable between all 8 farms, but cows on conventional milking system (CMS) farms with pasture access appear to show higher standing and walking time, and spent less time lying compared to cows on automatic milking system (AMS) farms without pasture access. Every behavioral parameter presented a 24h pattern. Cows eat, stand and walk during the day and lie down and ruminate during the night. Daily patterns in time budgets on all farms are comparable except for walking time. During the day, cows on CMS farms with pasture access spent more time walking than cows on AMS farms without pasture access. The average 24h pattern between parities is comparable, but primiparous cows spent more time walking during daytime compared to older cows. These results indicate a specific behavioral pattern per parameter from the last month prepartum until 10 months postpartum with different patterns between parities but comparable patterns across farms. Furthermore, cows appear to have a circadian rhythm with varying time budgets in the transition period and during lactation.	[Hut, P. R.; Kuiper, S. E. M.; Nielen, M.; Hostens, M. M.] Univ Utrecht, Fac Vet Med, Dept Populat Hlth Sci, Div Farm Anim Hlth, Utrecht, Netherlands; [Hulsen, J. H. J. L.] Vetvice Cowsignals, Bergen Op Zoom, Netherlands; [Stassen, E. N.] Wageningen Univ & Res, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands; [Hostens, M. M.] Univ Ghent, Dept Reprod Obstet & Herd Hlth, Merelbeke, Belgium	Utrecht University; Wageningen University & Research; Ghent University	Hut, PR (corresponding author), Univ Utrecht, Fac Vet Med, Dept Populat Hlth Sci, Div Farm Anim Hlth, Utrecht, Netherlands.	P.R.Hut@uu.nl						[Anonymous], 2019, TIDYR EASILY TIDY DA; Auguie B, 2017, **DATA OBJECT**; Azizi O, 2010, ARCH TIERZUCHT, V53, P130, DOI 10.5194/aab-53-130-2010; Bach A, 2006, J DAIRY SCI, V89, P337, DOI 10.3168/jds.S0022-0302(06)72099-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beauchemin KA, 2002, CAN J ANIM SCI, V82, P215, DOI 10.4141/A01-080; Belaid MA, 2021, J DAIRY SCI, V104, P4575, DOI 10.3168/jds.2020-18792; Boe KE, 2003, APPL ANIM BEHAV SCI, V80, P175, DOI 10.1016/S0168-1591(02)00217-4; Borchers MR, 2021, ANIMAL, V15, DOI 10.1016/j.animal.2020.100008; Borchers MR, 2017, J DAIRY SCI, V100, P5664, DOI 10.3168/jds.2016-11526; Daros RR, 2020, J DAIRY SCI, V103, P649, DOI 10.3168/jds.2019-16975; Dela Rue B, 2020, J DAIRY SCI, V103, P9488, DOI 10.3168/jds.2020-18173; Deming JA, 2013, J DAIRY SCI, V96, P344, DOI 10.3168/jds.2012-5985; DeVries TJ, 2003, J DAIRY SCI, V86, P4079, DOI 10.3168/jds.S0022-0302(03)74020-X; Foris B, 2021, J DAIRY SCI, V104, P3485, DOI 10.3168/jds.2020-18896; Fox J., 2019, R COMPANION APPL REG, V.; Fregonesi JA, 2007, J DAIRY SCI, V90, P5468, DOI 10.3168/jds.2007-0494; Fregonesi JA, 2007, J DAIRY SCI, V90, P3349, DOI 10.3168/jds.2006-794; Genz A, 2020, **DATA OBJECT**; Goff JP, 1997, J DAIRY SCI, V80, P1260, DOI 10.3168/jds.S0022-0302(97)76055-7; Goldhawk C, 2009, J DAIRY SCI, V92, P4971, DOI 10.3168/jds.2009-2242; Gomez A, 2010, J DAIRY SCI, V93, P5772, DOI 10.3168/jds.2010-3436; Gonzalez LA, 2008, J DAIRY SCI, V91, P1017, DOI 10.3168/jds.2007-0530; Graves S., 2019, MULTCOMPVIEW VISUALI; Hothorn T., 2019, **DATA OBJECT**; HOTHORN T, MULTCOMP SIMULTANEOU; Hut PR, 2021, J DAIRY SCI, V104, P4746, DOI 10.3168/jds.2020-19200; Hut PR, 2019, PREV VET MED, V169, DOI 10.1016/j.prevetmed.2019.104694; Huzzey JM, 2006, J DAIRY SCI, V89, P126, DOI 10.3168/jds.S0022-0302(06)72075-6; Huzzey JM, 2005, J DAIRY SCI, V88, P2454, DOI 10.3168/jds.S0022-0302(05)72923-4; Jensen MB, 2017, J DAIRY SCI, V100, P9759, DOI 10.3168/jds.2017-13035; Kok A, 2017, APPL ANIM BEHAV SCI, V186, P7, DOI 10.1016/j.applanim.2016.10.017; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lenth R., EMMEANS ESTIMATED MA; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lobeck-Luchterhand KM, 2015, J DAIRY SCI, V98, P240, DOI 10.3168/jds.2014-8492; Lovendahl P, 2016, J DAIRY SCI, V99, P408, DOI 10.3168/jds.2015-9838; Luchterhand KM, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00065; Maselyne J, 2017, RES VET SCI, V110, P1, DOI 10.1016/j.rvsc.2016.10.003; Molina FM, 2020, J DAIRY RES, V87, P28, DOI 10.1017/S002202992000045X; Neave HW, 2017, J DAIRY SCI, V100, P548, DOI 10.3168/jds.2016-10987; Neisen G, 2009, APPL ANIM BEHAV SCI, V119, P127, DOI 10.1016/j.applanim.2009.04.006; Nielsen PP, 2018, J DAIRY SCI, V101, P5449, DOI 10.3168/jds.2017-13784; Olmos G, 2009, LIVEST SCI, V125, P199, DOI 10.1016/j.livsci.2009.04.009; Ostergaard S, 2010, J DAIRY SCI, V93, P3533, DOI 10.3168/jds.2009-2865; Price B., 2019, CARDATA COMPANION AP; RCore Team, 2020, R LANG ENV STAT COMP; Roca-Fernandez AI, 2013, SPAN J AGRIC RES, V11, P120, DOI 10.5424/sjar/2013111-2682; Rojo-Gimeno C, 2019, NJAS-WAGEN J LIFE SC, V90-91, DOI 10.1016/j.njas.2019.100311; Saint-Dizier M, 2012, REPROD DOMEST ANIM, V47, P1056, DOI 10.1111/j.1439-0531.2011.01971.x; Schirmann K, 2012, J DAIRY SCI, V95, P3212, DOI 10.3168/jds.2011-4741; Shepley E, 2020, APPL ANIM BEHAV SCI, V224, DOI 10.1016/j.applanim.2019.104928; Stangaferro ML, 2016, J DAIRY SCI, V99, P7411, DOI 10.3168/jds.2016-10908; Stangaferro ML, 2016, J DAIRY SCI, V99, P7422, DOI 10.3168/jds.2016-11352; Stangaferro ML, 2016, J DAIRY SCI, V99, P7395, DOI 10.3168/jds.2016-10907; Stevenson JS, 2014, J DAIRY SCI, V97, P4296, DOI 10.3168/jds.2013-7873; Telezhenko E, 2017, J DAIRY SCI, V100, P6494, DOI 10.3168/jds.2016-12208; Veissier I, 2017, J DAIRY SCI, V100, P3969, DOI 10.3168/jds.2016-11853; Wagner N, 2021, METHODS, V186, P14, DOI 10.1016/j.ymeth.2020.09.003; Wagner-Storch AM, 2003, J DAIRY SCI, V86, P1494, DOI 10.3168/jds.S0022-0302(03)73735-7; Wathes DC, 2007, DOMEST ANIM ENDOCRIN, V33, P203, DOI 10.1016/j.domaniend.2006.05.004; Wickham H., 2019, DPLYR GRAMMAR DATA M, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Xu ZZ, 1998, J DAIRY SCI, V81, P2890, DOI 10.3168/jds.S0022-0302(98)75849-7	65	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264392	10.1371/journal.pone.0264392	http://dx.doi.org/10.1371/journal.pone.0264392			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213613	Green Published, gold			2022-12-26	WOS:000787811000086
J	Famie, S; Ammi, M; Bourdin, V; Amorim, MA				Famie, Sylvain; Ammi, Mehdi; Bourdin, Vincent; Amorim, Michel-Ange			Evidence for an internal model of friction when controlling kinetic energy at impact to slide an object along a surface toward a target	PLOS ONE			English	Article							MOTOR PRIMITIVES; SCHEMA THEORY; PREDICTION; ADJUSTMENTS; SHOULDER; MOTION; MEMORY; WRIST; NOISE; ELBOW	Although the role of an internal model of gravity for the predictive control of the upper limbs is quite well established, evidence is lacking regarding an internal model of friction. In this study, 33 male and female human participants performed a striking movement (with the index finger) to slide a plastic cube-like object to a given target distance. The surface material (aluminum or balsa wood) on which the object slides, the surface slope (-10 degrees, 0, or +10 degrees) and the target distance (25 cm or 50 cm) varied across conditions, with ten successive trials in each condition. Analysis of the object speed at impact and spatial error suggests that: 1) the participants chose to impart a similar speed to the object in the first trial regardless of the surface material to facilitate the estimation of the coefficient of friction; 2) the movement is parameterized across repetitions to reduce spatial error; 3) an internal model of friction can be generalized when the slope changes. Biomechanical analysis showed interindividual variability in the recruitment of the upper limb segments and in the adjustment of finger speed at impact in order to transmit the kinetic energy required to slide the object to the target distance. In short, we provide evidence that the brain builds an internal model of friction that makes it possible to parametrically control a striking movement in order to regulate the amount of kinetic energy required to impart the appropriate initial speed to the object.	[Famie, Sylvain; Amorim, Michel-Ange] Univ Paris Saclay, CIAMS, Orsay, France; [Famie, Sylvain; Amorim, Michel-Ange] Univ Orleans, CIAMS, Orleans, France; [Famie, Sylvain; Bourdin, Vincent] Univ Paris Saclay, LIMSI, CNRS, Orsay, France; [Famie, Sylvain; Ammi, Mehdi] Univ Paris 08, LIASD, St Denis, France	UDICE-French Research Universities; Universite Paris Saclay; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite Paris-VIII	Famie, S (corresponding author), Univ Paris Saclay, CIAMS, Orsay, France.; Famie, S (corresponding author), Univ Orleans, CIAMS, Orleans, France.; Famie, S (corresponding author), Univ Paris Saclay, LIMSI, CNRS, Orsay, France.; Famie, S (corresponding author), Univ Paris 08, LIASD, St Denis, France.	sylvain.famie@universite-paris-saclay.fr	Amorim, Michel-Ange/E-7209-2017	Amorim, Michel-Ange/0000-0002-8455-1437; Famie, Sylvain/0000-0003-2064-4033				Albert ST, 2020, ELIFE, V9, DOI 10.7554/eLife.52507; Amorim MA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00483; Babin-Ratte S, 1999, EXP BRAIN RES, V128, P81, DOI 10.1007/s002210050821; Baures R, 2007, VISION RES, V47, P2982, DOI 10.1016/j.visres.2007.07.024; Bernshtein NA, 1967, COORDINATION REGULAT; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; Bril B, 2012, PHILOS T R SOC B, V367, P59, DOI 10.1098/rstb.2011.0147; Bril B, 2010, J EXP PSYCHOL HUMAN, V36, P825, DOI 10.1037/a0018171; Craig CM, 2000, NATURE, V405, P295, DOI 10.1038/35012690; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Delis I, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00008; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; Gaveau J, 2016, ELIFE, V5, DOI 10.7554/eLife.16394; Gaveau J, 2014, J NEUROPHYSIOL, V111, P4, DOI 10.1152/jn.01029.2012; Giszter SF, 2015, CURR OPIN NEUROBIOL, V33, P156, DOI 10.1016/j.conb.2015.04.004; Hadjiosif AM, 2021, J NEUROSCI, V41, P2747, DOI 10.1523/JNEUROSCI.2125-20.2021; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hecht H.., 2014, OPEN MIND; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; Hubbard TL, 1998, CAN J EXP PSYCHOL, V52, P44, DOI 10.1037/h0087278; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Joh AS, 2007, J EXP PSYCHOL HUMAN, V33, P1145, DOI 10.1037/0096-1523.33.5.1145; Johnson R. A., 1988, APPL MULTIVARIATE ST; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kawato M.., 2009, ENCY NEUROSCIENCE, P757, DOI 10.1016/B978-008045046-9.01307-3; Klein LK, 2021, J NEUROPHYSIOL, V125, P1330, DOI 10.1152/jn.00021.2021; McIntyre J, 2003, I IEEE EMBS C NEUR E, P438, DOI 10.1109/CNE.2003.1196855; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; McNamee D, 2019, ANNU REV CONTR ROBOT, V2, P339, DOI 10.1146/annurev-control-060117-105206; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Michotte A.., 2017, PERCEPTION CAUSALITY; O'Shea H, 2021, NEUROSCI BIOBEHAV R, V123, P286, DOI 10.1016/j.neubiorev.2021.01.007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Opsomer L, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00938; Saels P, 1999, NEUROPSYCHOLOGIA, V37, P751, DOI 10.1016/S0028-3932(98)00113-4; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schmidt RA, 2003, RES Q EXERCISE SPORT, V74, P366, DOI 10.1080/02701367.2003.10609106; Schot WD, 2010, J NEUROSCI METH, V187, P147, DOI 10.1016/j.jneumeth.2010.01.004; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; Smeets JBJ, 2010, EXP BRAIN RES, V203, P339, DOI 10.1007/s00221-010-2236-0; Sternad D, 2018, CURR OPIN BEHAV SCI, V20, P183, DOI 10.1016/j.cobeha.2018.01.004; Takamuku S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49359-8; Ulloa A, 2003, NEURAL NETWORKS, V16, P521, DOI 10.1016/S0893-6080(03)00094-7; White O, 2018, FRONT NEUROROBOTICS, V12, DOI 10.3389/fnbot.2018.00031; Winter D. A, 2009, BIOMECHANICS MOTOR C; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Zago M, 2008, VISION RES, V48, P1532, DOI 10.1016/j.visres.2008.04.005; Zhang XD, 2003, J BIOMECH, V36, P1097, DOI 10.1016/S0021-9290(03)00112-X	52	0	0	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264370	10.1371/journal.pone.0264370	http://dx.doi.org/10.1371/journal.pone.0264370			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZZ4EP	35202414	gold, Green Submitted, Green Published			2022-12-26	WOS:000773224600035
J	Burgess-Hull, AJ; Smith, KE; Panlilio, LV; Schriefer, D; Preston, KL; Alter, A; Yeager, C; Chizmar, T; Delbridge, T; Zamore, K; Beeson, J; Epstein, DH				Burgess-Hull, Albert J.; Smith, Kirsten E.; Panlilio, Leigh, V; Schriefer, Destiny; Preston, Kenzie L.; Alter, Aliese; Yeager, Christopher; Chizmar, Timothy; Delbridge, Ted; Zamore, Kenan; Beeson, Jeff; Epstein, David H.			Nonfatal opioid overdoses before and after Covid-19: Regional variation in rates of change	PLOS ONE			English	Article							UNITED-STATES; MORTALITY; SPREAD	BackgroundThe Covid-19 pandemic and its accompanying public-health orders (PHOs) have led to (potentially countervailing) changes in various risk factors for overdose. To assess whether the net effects of these factors varied geographically, we examined regional variation in the impact of the PHOs on counts of nonfatal overdoses, which have received less attention than fatal overdoses, despite their public health significance. MethodsData were collected from the Overdose Detection Mapping Application Program (ODMAP), which recorded suspected overdoses between July 1, 2018 and October 25, 2020. We used segmented regression models to assess the impact of PHOs on nonfatal-overdose trends in Washington DC and the five geographical regions of Maryland, using a historical control time series to adjust for normative changes in overdoses that occurred around mid-March (when the PHOs were issued). ResultsThe mean level change in nonfatal opioid overdoses immediately after mid-March was not reliably different in the Covid-19 year versus the preceding control time series for any region. However, the rate of increase in nonfatal overdose was steeper after mid-March in the Covid-19 year versus the preceding year for Maryland as a whole (B = 2.36; 95% CI, 0.65 to 4.06; p = .007) and for certain subregions. No differences were observed for Washington DC. ConclusionsThe pandemic and its accompanying PHOs were associated with steeper increases in nonfatal opioid overdoses in most but not all of the regions we assessed, with a net effect that was deleterious for the Maryland region as a whole.	[Burgess-Hull, Albert J.; Smith, Kirsten E.; Panlilio, Leigh, V; Schriefer, Destiny; Preston, Kenzie L.; Epstein, David H.] NIDA, Intramural Res Program, Baltimore, MD 21224 USA; [Alter, Aliese; Yeager, Christopher; Beeson, Jeff] Off Natl Drug Control Policy, High Intens Drug Trafficking Area, Washington, DC USA; [Chizmar, Timothy; Delbridge, Ted] Maryland Inst Emergency Med Serv Syst MIEMSS, Baltimore, MD USA; [Zamore, Kenan] Dist Columbia Dept Hlth, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Burgess-Hull, AJ (corresponding author), NIDA, Intramural Res Program, Baltimore, MD 21224 USA.	albert.burgess-hull@nih.gov		Chizmar, Timothy/0000-0003-0067-880X; Schriefer, Destiny/0000-0003-3583-1659; Burgess-Hull, Albert/0000-0003-2494-5538; Smith, Kirsten/0000-0002-9278-1830	Intramural Research Program of the National Institutes of Health NIDA	Intramural Research Program of the National Institutes of Health NIDA	ABH, DHE, KES, LVP, DS, and KLP were supported in part by the Intramural Research Program of the National Institutes of Health NIDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported in part by the Intramural Research Program of the NIH NIDA.	AMA, ISS BRIEF REP INCR O; Bareket-Bojmel L, 2021, INT J COGN THER, V14, P566, DOI 10.1007/s41811-020-00078-3; Bergmann BG, 2021, ADDICT BEHAV, V113, DOI 10.1016/j.addbeh.2020.106661; Caudarella A, 2016, DRUG ALCOHOL DEPEN, V162, P51, DOI 10.1016/j.drugalcdep.2016.02.024; Centers for Disease Control, INCR FAT DRUG OV US; Centers for Disease Control and Prevention, 2020, 1 TRAV REL CAS 2019; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Dave D, 2021, ECON INQ, V59, P29, DOI 10.1111/ecin.12944; Del Boca D, 2020, REV ECON HOUSEHOLD, V18, P1001, DOI 10.1007/s11150-020-09502-1; del Pozo B, 2020, J SUBST ABUSE TREAT, V119, DOI 10.1016/j.jsat.2020.108139; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021; Forati AM, 2021, J URBAN HEALTH, V98, P551, DOI 10.1007/s11524-021-00554-x; Glober N, 2020, J URBAN HEALTH, V97, P802, DOI 10.1007/s11524-020-00484-0; Haffajee RL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6373; Hategeka C, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003567; Holland KM, 2021, JAMA PSYCHIAT, V78, P372, DOI 10.1001/jamapsychiatry.2020.4402; Hoots B, 2020, ADDICTION, V115, P946, DOI 10.1111/add.14878; Knell G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176268; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Lin L, 2020, JAMA PSYCHIAT, V77, P1209, DOI 10.1001/jamapsychiatry.2020.1698; Linas BP, 2021, J SUBST ABUSE TREAT, V120, DOI 10.1016/j.jsat.2020.108158; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740; Melamed OC, 2020, SUBST ABUS, V41, P286, DOI 10.1080/08897077.2020.1784363; Mellis AM, 2021, J SUBST ABUSE TREAT, V121, DOI 10.1016/j.jsat.2020.108180; Mervosh S., 2020, NEW YORK TIMES; Monnat SM, 2019, J RURAL STUD, V68, P319, DOI 10.1016/j.jrurstud.2018.12.004; NEWEY WK, 1994, REV ECON STUD, V61, P631, DOI 10.2307/2297912; Ochalek TA, 2020, JAMA-J AM MED ASSOC, V324, P1673, DOI 10.1001/jama.2020.17477; Olfson M, 2018, DRUG ALCOHOL DEPEN, V190, P112, DOI 10.1016/j.drugalcdep.2018.06.004; Ornell F, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113096; R Core Team, 2013, R LANG ENV STAT COMP; Rigg KK, 2018, INT J DRUG POLICY, V57, P119, DOI 10.1016/j.drugpo.2018.04.011; Rodda LN, 2020, J URBAN HEALTH, V97, P808, DOI 10.1007/s11524-020-00486-y; Schuchat A, 2020, MMWR-MORBID MORTAL W, V69, P551, DOI 10.15585/mmwr.mm6918e2; Slavova S, 2020, DRUG ALCOHOL DEPEN, V214, DOI 10.1016/j.drugalcdep.2020.108176; Soares WE, 2022, ANN EMERG MED, V79, P158, DOI 10.1016/j.annemergmed.2021.03.013; Spagnolo PA, 2020, AM J PSYCHIAT, V177, P805, DOI 10.1176/appi.ajp.2020.20040417; Stoove MA, 2009, DRUG ALCOHOL REV, V28, P347, DOI 10.1111/j.1465-3362.2009.00057.x; Substance Abuse and Mental Health Services Administration, OP TREATM PROGR GUID; Swift H., 2020, NEW YORK TIMES; Thylstrup B, 2020, DRUG ALCOHOL DEPEN, V206, DOI 10.1016/j.drugalcdep.2019.107714; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Vivolo-Kantor AM, 2020, MMWR-MORBID MORTAL W, V69, P371, DOI 10.15585/mmwr.mm6913a3; World Health Organization, 2015, ICD10CM WHO; Zibbell J., 2019, NONFATAL OPIOID OVER	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263893	10.1371/journal.pone.0263893	http://dx.doi.org/10.1371/journal.pone.0263893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263326	gold, Green Published			2022-12-26	WOS:000804638700034
J	Rubio-Cisneros, NT; Montero-Munoz, JL; Rubio-Cisneros, II; Morales-Ojeda, S; Pech, M; Ruiz-Ayma, G; Rueda-Flores, M; Baker, R; Jimenez, A; Fuentes, K; Gonzalez-Rojas, JI				Rubio-Cisneros, Nadia T.; Montero-Munoz, Jorge L.; Rubio-Cisneros, Igor I.; Morales-Ojeda, Sara; Pech, Monica; Ruiz-Ayma, Gabriel; Rueda-Flores, Marisol; Baker, Rachel; Jimenez, Armando; Fuentes, Karen; Gonzalez-Rojas, Jose, I			Tourists perceptions of Caribbean islands facing environmental threats before the COVID-19 health crisis: Holbox Island and Archipelago of Bocas del Toro	PLOS ONE			English	Article							ECOSYSTEM SERVICES; WATER-QUALITY; GLOBAL CHANGE; CABO PULMO; IMPACTS; SUSTAINABILITY; CONSERVATION; CYCLE	Knowledge gaps exist in the socio-ecological systems of small touristic islands in Latin America. Understanding tourists' perceptions of their environmental knowledge can help plan actions to prevent natural capital loss necessary for local economies. Tourists' perceptions of a touristic hotspot, Holbox Island, were documented. Surveys demonstrated that tourists are aware of their environmental impacts and are interested in minimizing these. Results were compared with results on Bocas del Toro, Panama. Tourists' perceptions had similarities among sites driven by similarities in tourists' populations with a common geographic origin. Tourists lack site-specific knowledge to steer them towards environmentally conscious decisions in both regions. Findings suggest the need to promote local actions to gain tourists' understanding about their destination and support education programs on island conservation. Addressing these needs can help build resilience to overcome the adverse socio-environmental effects of tourism, environmental disasters, and health crises as COVID-19 on small islands.	[Rubio-Cisneros, Nadia T.; Ruiz-Ayma, Gabriel; Jimenez, Armando; Gonzalez-Rojas, Jose, I] Univ Autonoma Nuevo Leon, Lab Biol Conservac & Desarrollo Sustentable, Fac Ciencias Biol, Monterrey, Mexico; [Rubio-Cisneros, Nadia T.] Univ Calif San Diego, Ctr Marine Biodivers & Conservat, Scripps Inst Oceanog, Fellow Coastal Ecosyst Serv, La Jolla, CA 92093 USA; [Rubio-Cisneros, Nadia T.; Rubio-Cisneros, Igor I.; Morales-Ojeda, Sara; Ruiz-Ayma, Gabriel; Rueda-Flores, Marisol; Baker, Rachel; Jimenez, Armando] Mar Sustentable Ciencia & Conservac AC, Merida, Yucatan, Mexico; [Montero-Munoz, Jorge L.; Morales-Ojeda, Sara; Pech, Monica] Inst Politecn Nacl, Unidad Merida, Ctr Invest & Estudios Avanzados, CINVESTAV, Merida, Yucatan, Mexico; [Rubio-Cisneros, Igor I.] Univ Autonoma Nuevo Leon, Secretaria Extens & Cultura, Colegio Civil Ctr Cultural Univ S-N, Monterrey, Nuevo Leon, Mexico; [Pech, Monica] No Arizona Univ, Sch Earth & Sustainabil, Flagstaff, AZ 86011 USA; [Rueda-Flores, Marisol] Hlth Reefs Hlth People, Washington, DC USA; [Baker, Rachel] Univ North Carolina NC Wilmington, Wilmington, NC USA; [Fuentes, Karen] Manta Mexico Caribe AC, Isla Mujeres, Mexico	Universidad Autonoma de Nuevo Leon; University of California System; University of California San Diego; Scripps Institution of Oceanography; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Nuevo Leon; Northern Arizona University	Rubio-Cisneros, NT; Gonzalez-Rojas, JI (corresponding author), Univ Autonoma Nuevo Leon, Lab Biol Conservac & Desarrollo Sustentable, Fac Ciencias Biol, Monterrey, Mexico.; Rubio-Cisneros, NT (corresponding author), Univ Calif San Diego, Ctr Marine Biodivers & Conservat, Scripps Inst Oceanog, Fellow Coastal Ecosyst Serv, La Jolla, CA 92093 USA.; Rubio-Cisneros, NT (corresponding author), Mar Sustentable Ciencia & Conservac AC, Merida, Yucatan, Mexico.	rubio.nadiat@gmail.com; jose.gonzalezrjs@uanl.edu.mx		Rubio-Cisneros, Nadia/0000-0001-7775-4132; Gonzalez-Rojas, Jose I./0000-0003-2740-7305				Abbas J., 2021, CURRENT RES BEHAV SC, V2; Alix-Garcia JM, 2018, P NATL ACAD SCI USA, V115, P7016, DOI 10.1073/pnas.1720873115; Almaras S, 2020, ENTRA HOLBOX LISTA C; Anderson R, 2015, J POLIT ECOL, V22, P239, DOI 10.2458/v22i1.21107; [Anonymous], 2020, EL EC; Antele FA, 2014, CARACTERIZACIN EVALU; Archer E., 1985, Caribbean Geography, V2, P45; Balzan Mario V., 2018, International Journal of Biodiversity Science Ecosystem Services & Management, V14, P71, DOI 10.1080/21513732.2018.1439103; Barbosa Cuervo A. P, 2020, ESTUDIO POSIBLES EFE; Bauza-Martorell FJ, 2020, TURISMO DESPUS PANDE, P270; Bennett NJ, 2017, CONSERV BIOL, V31, P56, DOI 10.1111/cobi.12788; Bourque OR, 2016, 19 IDCE; Brent Edwards Jr D., 2017, TRAJECTORY GLOBAL ED; Briassoulis H., 2000, TOURISM ENV ENVIRONM, V6; Brinklow L, 2021, COVID 19 ISLAND INSI, P3160; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; BUTLER RW, 1980, CAN GEOGR-GEOGR CAN, V24, P5, DOI 10.1111/j.1541-0064.1980.tb00970.x; Campos-Vazquez R., 2020, COVID EC, P218; Carte L, 2010, GEOFORUM, V41, P700, DOI 10.1016/j.geoforum.2010.03.002; Cesar Dachary A, 2020, TURISMO DESPUS PANDE, P1; Cisneros-Montemayor AM, 2013, ORYX, V47, P381, DOI 10.1017/S0030605312001718; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2015, PRIMER V7 USER MANUA; Coba H, 2016, PESCA ILEGAL ACABA C, P18; COBI, 2016, CAR PESQ TIB QUINT R; CONAFOR [Comisin Nacional Forestal]. visin de Mxico sobre REDD+, 2011, HAC ESTR NAC; CONANP, 2018, FICH SIMEC YUM BALAM; CONANP (Comisin Nacional de reas Naturales Protegidas), 2018, CONS HOLB PUBL PROGR; Cramer KL, 2013, B MAR SCI, V89, P955, DOI 10.5343/bms.2012.1028; Cullen-Unsworth LC, 2014, MAR POLLUT BULL, V83, P387, DOI 10.1016/j.marpolbul.2013.06.001; D'agata S, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0128; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Deutsche Welle, 2020, IMP TUR ARR EC EX; Dorsett C, 2019, TOURISM MANAGE, V74, P290, DOI 10.1016/j.tourman.2019.03.011; El Universal, 2020, EL UNIVERSAL 0324; Arias-Gonzalez JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174855; Esquivel G., 2020, ECONOMIAUNAM, V17, P28, DOI [10.22201/fe.24488143-.2020.51.543, DOI 10.22201/FE.24488143-.2020.51.543]; Etikan I., 2016, AM J THEORETICAL APP, V5, P1, DOI [10.11648/j.ajtas.20160501.11, DOI 10.11648/J.AJTAS.20160501.11]; Fabinyi M, 2010, HUM ECOL, V38, P415, DOI 10.1007/s10745-010-9329-z; Fjetland CA, 2000, NAT RESOUR J, V40, P47; Flores Z, 2020, EL FINANCIERO 0512; Fragments of Hope. Fragments of Hope and Belize Fisheries Department, 2016, SEA FOOD GUID BEL; Freedman L., 2020, DIGITAL COMMERCE 360; Friedlander AM, 2018, MAR POLLUT BULL, V135, P139, DOI 10.1016/j.marpolbul.2018.05.064; Gallardo-Torres A, 2014, CATLOGO PECES COSTA, VSegunda; Gonzlez-Daz M, 2020, BBC NEWS; Guerron-Montero C, 2005, HUM ORGAN, V64, P360, DOI 10.17730/humo.64.4.2mx2j6qd0xyg1rqv; Hakim L., 2020, J MARINE ISLAND CULT, V9, P130, DOI [10.21463/jmic.2020.09.1.08, DOI 10.21463/JMIC.2020.09.1.08]; Hernandez-Terrones LM, 2015, CONT SHELF RES, V102, P62, DOI 10.1016/j.csr.2015.04.015; Herrera-Silveira J., 2004, ENV ANAL GULF MEXICO, P512; Herrera-Silveira JA, 2020, PEERJ, V8, DOI 10.7717/peerj.8790; Ilescas R, 2020, SUBE 10 PERSONAS MUE; INE, 2020, AN MOV POBL DUR EST; Infobae, 2020, COR QUINT ROO DESV S, pB; Infobae, 2020, CANCN IN SEM CON SEM; Infobae, 2020, MAP COR MXIC 11 JUL; Infobae, 2020, QUINT ROO REGR SEMF; Jouault Samuel, 2021, Invest. Geog, pe60240, DOI 10.14350/rig.60240; Klepeis P, 2001, LAND USE POLICY, V18, P27, DOI 10.1016/S0264-8377(00)00043-0; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kuempel CD, 2017, SCI REP-UK, V7, DOI 10.1038/srep39670; Langle-Flores A, 2017, J COASTAL RES, P134, DOI 10.2112/SI77-014.1; Leal-Bautista R. M., 2013, Journal of Environmental Protection, V4, P1272, DOI 10.4236/jep.2013.411148; Leatherman TL, 2010, ECON HUM BIOL, V8, P153, DOI 10.1016/j.ehb.2010.05.008; Liu X, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072300; Lopez-Ercilla I, 2021, MAR POLICY, V131, DOI 10.1016/j.marpol.2021.104606; Lopez-Santillan AA., 2015, OTRA EC REV LATINOAM, V9; Lpez-Santilln A, 2010, METAMORFOSIS PARASO; Marn-Guardado G., 2012, TURISMO GLOBALIZACIN, P275; Marviva, 2012, GUIA ID FIL PESC MAR, P55; McAfee K, 2010, ANN ASSOC AM GEOGR, V100, P579, DOI 10.1080/00045601003794833; McCleery RA, 2020, SCIENCE, V369, P515, DOI 10.1126/science.abd2854; Mendez-Medina C, 2015, MARIT STUD, V14, DOI 10.1186/s40152-015-0026-9; Miranda F, 2020, MILENIO NEWSPAP 0602; Mndez E, 2020, EXCELSIOR NEWSP 0615; Morgan D., 2008, SAGE ENCY QUALITATIV, P816, DOI 10.4135/9781412963909; Mulder N, 2020, INT TRADE SERIES; Murray G, 2007, COAST MANAGE, V35, P339, DOI 10.1080/08920750601169600; Oreja Rodriguez JR, 2008, TOURISM MANAGE, V29, P53, DOI 10.1016/j.tourman.2007.04.007; Pablos-Mendez A, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2939; Palco Noticias, 2021, PALCOQUINTANARROENSE, P3; Panamerican Health Organization, 2020, US; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Puczko L., 2000, Journal of Sustainable Tourism, V8, P458, DOI 10.1080/09669580008667380; Reportur MX, 2020, CANCN MULTAN HOTELER, P20; Reportur MX, 2020, CANCN REBELIN HOLBOX; Restrepo I, 2014, PROBLEMAS HOLBOX NOT; Richter IGM, 2017, FOODS, V6, DOI 10.3390/foods6100086; Romero-Padilla Y, 2020, TURISMO DESPUS PANDE, P270; Rubio E, 2010, ARGUMENTOS, V23, P161; Rubio-Cisneros NT, 2018, REG STUD MAR SCI, V22, P112, DOI 10.1016/j.rsma.2018.06.006; Rubio-Cisneros NT, 2019, MAR POLICY, V100, P8, DOI 10.1016/j.marpol.2018.10.003; SAGARPA (Secretara de Agricultura G., 2010, DES RUR PESC AL ESTR; Sandbrook C, 2020, COVID CONSERVATION G, P17; Sandbrook C, 2022, ORYX, V56, P277, DOI 10.1017/S0030605320001039; Secretara de Turismo de Quintana Roo, 2020, CLIM PRINC PUEST CAR; Secretaria de Medio Ambiente y Recursos Naturales, 2010, DIARIO OFICIAL FEDER; SEDETUR, 2019, IND TURST; SEDETUR, 2018, IND TURST; SEDETUR, 2015, IND TURST; Seemann J, 2014, ENVIRON MONIT ASSESS, V186, P1747, DOI 10.1007/s10661-013-3490-y; Sheller M, 2021, J SUSTAIN TOUR, V29, P1436, DOI 10.1080/09669582.2020.1791141; Shepherd G., 2008, ECOSYSTEM APPROACH L; Suchley A, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12571; The Marine Stewardship Council, 2012, SIAN KAAN BANC CHINC; Theobald W.F, 2005, GLOBAL TOURISM, Vthird; Thornton TF, 2012, ECOL SOC, V17, DOI 10.5751/ES-04714-170308; Torres-Cruz I, 2020, BRIOAGROPECUARIO; Tran KC., 2005, WATER ENV SYST, V2, P255; UNESCO, 2010, SHAD BLUE UPGR COAST; United Nations, 2020, COVID 19 TRANSF TOUR; United Nations Development Programme. San Crisanto Foundation Mexico, 2012, EQ IN CAS STUD SER; Vargas Martinez E. E., 2013, International Journal of Humanities and Social Science, V3, P16; Vargas SA, 2020, TURISMO DESPUS PANDE, P270; Vzquez J, 2020, EL EC; Vzquez J, 2020, EL EC; World Bank, 2019, US; World Tourism Organization-UNWTO, 2022, UNWTO WORLD TOUR BAR, V17, P1, DOI [DOI 10.18111/WTOBAROMETERENG, 10.18111/wtobarometereng.2022.20.1.4, DOI 10.18111/WTOBAROMETERENG.2022.20.1.4]; World Travel & Tourism Council, 2017, TRAV TOUR EC IMP 201, P118; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yuum-Kaah, 2014, YUUM KAAH REGIONAL O; Ziegler J, 2012, TOURISM MANAGE, V33, P692, DOI 10.1016/j.tourman.2011.08.004	123	1	1	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0262014	10.1371/journal.pone.0262014	http://dx.doi.org/10.1371/journal.pone.0262014			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263328	Green Published, gold			2022-12-26	WOS:000804638700024
J	Nanut, MP; Zurga, S; Konjar, S; Prunk, M; Kos, J; Sabotic, J				Nanut, Milica Perisic; Zurga, Simon; Konjar, Spela; Prunk, Mateja; Kos, Janko; Sabotic, Jerica			The fungal Clitocybe nebularis lectin binds distinct cell surface glycoprotein receptors to induce cell death selectively in Jurkat cells	FASEB JOURNAL			English	Article						CD45; cytotoxicity; homotypic aggregation; lectin; T cell leukemia	GROUP BOX-1 PROTEIN; EDIBLE MUSHROOM; CROSS-LINKING; NEGATIVE REGULATION; ANTITUMOR LECTIN; DENDRITIC CELLS; APOPTOSIS; CD45; GLYCOSYLATION; ANTIGEN	Clitocybe nebularis lectin (CNL) is a GalNAc beta 1-4GlcNAc-binding lectin that exhibits an antiproliferative effect exclusively on the Jurkat leukemic T cell line by provoking homotypic aggregation and dose-dependent cell death. Cell death of Jurkat cells exhibited typical features of early apoptosis, but lacked the activation of initiating and executing caspases. None of the features of CNL-induced cell death were effectively blocked with the pan-caspase inhibitor or different cysteine peptidase inhibitors. Furthermore, CNL binding induced Jurkat cells to release the endogenous damage-associated molecular pattern molecule high-mobility group box 1 (HMGB1). A plant lectin with similar glycan-binding specificity, Wisteria floribunda agglutinin (WFA) showed less selective toxicity and induced cell death in Jurkat, Tall-104, and Hut-87 cell lines. HMGB1 release was also detected when Jurkat cells were treated with WFA. We identified the CD45 and CD43 cell surface glycoproteins on Jurkat cells as the main targets for CNL binding. However, the blockade of CD45 phosphatase activity failed to block either CNL-induced homotypic agglutination or cell death. Overall, our results indicate that CNL triggers atypical cell death selectively on Jurkat cells, suggesting the potential applicability of CNL in novel strategies for treating and/or detecting acute T cell leukemia.	[Nanut, Milica Perisic; Zurga, Simon; Konjar, Spela; Prunk, Mateja; Sabotic, Jerica] Jozef Stefan Inst, Dept Biotechnol, Jamova Testa 39, Ljubljana 1000, Slovenia; [Kos, Janko] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Sabotic, J (corresponding author), Jozef Stefan Inst, Dept Biotechnol, Jamova Testa 39, Ljubljana 1000, Slovenia.	jerica.sabotic@ijs.si	Konjar, Špela/AAU-6390-2020	Prunk, Mateja/0000-0002-9117-633X; Konjar, Spela/0000-0002-8969-0233; Perisic Nanut, Milica/0000-0003-2314-2733	Research Agency of the Republic of Slovenia [P4-0127]	Research Agency of the Republic of Slovenia(Slovenian Research Agency - Slovenia)	This research was funded by the Research Agency of the Republic of Slovenia, grant number P4-0127 to J.K.	Altin JG, 1997, IMMUNOL CELL BIOL, V75, P430, DOI 10.1038/icb.1997.68; Andersson U, 2018, SEMIN IMMUNOL, V38, P40, DOI 10.1016/j.smim.2018.02.011; Barrows BD, 2006, METHOD ENZYMOL, V417, P340, DOI 10.1016/S0076-6879(06)17021-4; BAZIL V, 1995, BLOOD, V86, P502, DOI 10.1182/blood.V86.2.502.bloodjournal862502; Bovi M, 2013, GLYCOBIOLOGY, V23, P578, DOI 10.1093/glycob/cws164; Brojatsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095032; Brown TJ, 1996, J BIOL CHEM, V271, P27686, DOI 10.1074/jbc.271.44.27686; Cermak L, 2002, J BIOL CHEM, V277, P7955, DOI 10.1074/jbc.M108048200; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; Cho JY, 2003, EXP CELL RES, V290, P155, DOI 10.1016/S0014-4827(03)00322-7; Dang AM, 1996, CELL IMMUNOL, V169, P196, DOI 10.1006/cimm.1996.0110; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Dumitriu IE, 2005, TRENDS IMMUNOL, V26, P381, DOI 10.1016/j.it.2005.04.009; Erbacher A, 2009, HUM IMMUNOL, V70, P308, DOI 10.1016/j.humimm.2009.02.005; Esko JD., 1999, ESSENTIALS GLYCOBIOL, P375; Fukushima K, 2010, GLYCOBIOLOGY, V20, P452, DOI 10.1093/glycob/cwp197; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; Haji-Ghassemi O, 2016, J BIOL CHEM, V291, P24085, DOI 10.1074/jbc.M116.750463; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hassan MAA, 2015, INT J MOL SCI, V16, P7802, DOI 10.3390/ijms16047802; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hirano K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981627; Huang J, 2007, MOL CANCER RES, V5, P543, DOI 10.1158/1541-7786.MCR-06-0431; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Irie-Sasaki J, 2003, CURR TOP MED CHEM, V3, P783, DOI 10.2174/1568026033452339; Jacobson LS, 2013, J BIOL CHEM, V288, P7481, DOI 10.1074/jbc.M112.400655; Karmakar S, 2008, GLYCOBIOLOGY, V18, P770, DOI 10.1093/glycob/cwn066; KAWAGISHI H, 1990, BIOCHIM BIOPHYS ACTA, V1034, P247, DOI 10.1016/0304-4165(90)90045-X; Kim HJ, 2006, EXP MOL MED, V38, P357, DOI 10.1038/emm.2006.42; Klaus SJ, 1996, J IMMUNOL, V156, P2743; Koyama Y, 2002, BIOSCI BIOTECH BIOCH, V66, P784, DOI 10.1271/bbb.66.784; Lesage S, 1997, J IMMUNOL, V159, P4762; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2298-2; LIN JY, 1984, J BIOCHEM, V96, P35, DOI 10.1093/oxfordjournals.jbchem.a134826; Liu J, 2020, CANCER GENE THER, V27, P267, DOI 10.1038/s41417-019-0134-6; Liu YD, 2017, J BIOL CHEM, V292, P3186, DOI 10.1074/jbc.M116.751685; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; MODY R, 1995, J PHARMACOL TOX MET, V33, P1, DOI 10.1016/1056-8719(94)00052-6; Muramatsu T, 2002, SCIENCE, V295, P53, DOI 10.1126/science.1068156; Park WS, 2004, TISSUE ANTIGENS, V63, P46, DOI 10.1111/j.1399-0039.2004.00151.x; Peracaula R, 2003, GLYCOBIOLOGY, V13, P227, DOI 10.1093/glycob/cwg019; Pereira MS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02754; Pericolini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012720; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perron M, 2018, MOL PHARMACOL, V93, P575, DOI 10.1124/mol.117.110908; Pohleven J, 2012, J BIOL CHEM, V287, P10602, DOI 10.1074/jbc.M111.317263; Pohleven J, 2009, BBA-GEN SUBJECTS, V1790, P173, DOI 10.1016/j.bbagen.2008.11.006; Sabotic J, 2019, MOLECULES, V24, DOI 10.3390/molecules24234204; Sato T, 2017, GLYCOBIOLOGY, V27, P743, DOI 10.1093/glycob/cwx038; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Schietinger A, 2008, SEMIN IMMUNOL, V20, P276, DOI 10.1016/j.smim.2008.07.001; SPERTINI F, 1994, J IMMUNOL, V153, P1593; Steff AM, 2003, CRIT REV IMMUNOL, V23, P421, DOI 10.1615/CritRevImmunol.v23.i56.40; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xu YF, 2005, IMMUNOL CELL BIOL, V83, P440, DOI 10.1111/j.1440-1711.2005.01347.x; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang N, 2009, J MOL BIOL, V387, P694, DOI 10.1016/j.jmb.2009.02.002; YU LG, 1993, CANCER RES, V53, P4627; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3; YUAN M, 1986, CANCER RES, V46, P4841; Zhao CG, 2003, BIOCHEM J, V374, P321, DOI 10.1042/BJ20030300; Zurga S, 2017, ONCOTARGET, V8, P26896, DOI 10.18632/oncotarget.15849	69	2	2	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22215	10.1096/fj.202101056RR	http://dx.doi.org/10.1096/fj.202101056RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0DF	35224765				2022-12-26	WOS:000772946900001
J	Zhang, BX; Munske, GR; Timokhin, VI; Ralph, J; Davydov, DR; Vermerris, W; Sattler, SE; Kang, C				Zhang, Bixia; Munske, Gerhard R.; Timokhin, Vitaliy, I; Ralph, John; Davydov, Dmitri R.; Vermerris, Wilfred; Sattler, Scott E.; Kang, ChulHee			Functional and structural insight into the flexibility of cytochrome P450 reductases from Sorghum bicolor and its for lignin composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P450 OXIDOREDUCTASE; ARABIDOPSIS-THALIANA; BIOCHEMICAL-CHARACTERIZATION; CATALYTIC MECHANISM; ELECTRON-TRANSFER; KINETIC-ANALYSIS; C REDUCTASE; PLANT; BIOSYNTHESIS; PROTEIN	Plant NADPH-dependent cytochrome P450 reductase (CPR) is a multidomain enzyme that donates electrons for hydroxylation reactions catalyzed by class II cytochrome P450 monooxygenases involved in the synthesis of many primary and secondary metabolites. These P450 enzymes include trans-cinnamate-4-hydroxylase, p-coumarate-30-hydroxylase, and ferulate-5-hydroxylase involved in monolignol biosynthesis. Because of its role in monolignol biosynthesis, alterations in CPR activity could change the composition and overall output of lignin. Therefore, to understand the structure and function of three CPR subunits from sorghum, recombinant subunits SbCPR2a, SbCPR2b, and SbCPR2c were subjected to X-ray crystallography and kinetic assays. Steady-state kinetic analyses demonstrated that all three CPR subunits supported the oxidation reactions catalyzed by SbC4H1 (CYP73A33) and structure with the well-investigated CPRs from mammals enabled us to identify critical residues of functional importance and suggested that the plant flavin mononucleotide-binding domain might be more flexible than mammalian homologs. In addition, the elucidated structure of SbCPR2b included the first observation of NADP+ in a native CPR. Overall, we conclude that the connecting domain of SbCPR2, especially its hinge region, could serve as a target to alter biomass composition in bioenergy and forage sorghums through protein engineering.	[Zhang, Bixia; Davydov, Dmitri R.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Munske, Gerhard R.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Timokhin, Vitaliy, I; Ralph, John] Univ Wisconsin, Dept Biochem, Great Lakes Bioenergy Res Ctr, 420 Henry Mall, Madison, WI 53705 USA; [Timokhin, Vitaliy, I; Ralph, John] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Vermerris, Wilfred] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Vermerris, Wilfred] Univ Florida, UF Genet Inst, Gainesville, FL 32611 USA; [Sattler, Scott E.] USDA ARS, Sorghum & Forage Res Unit, Lincoln, NE USA	Washington State University; Washington State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Kang, C (corresponding author), Washington State Univ, Dept Chem, Pullman, WA 99164 USA.	chkang@wsu.edu		Sattler, Scott/0000-0002-6814-4073; Zhang, Bixia/0000-0002-4907-3062	National Science Foundation [CHE-1804699, MCB-2043248]; Murdock Charitable Trust; US Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office; US DOE's International Affairs [DEPI0000031]; US Department of Agriculture-National Institute of Food and Agriculture Biomass Research and Development Initiative [2011-1006-30358]; US Department of Agriculture-Agriculture Research Service project [3042-21220-033-000-D]; DOE Great Lakes Bioenergy Research Center, DOE Biological and Environmental Research Office of Science [DE-SC0018409]	National Science Foundation(National Science Foundation (NSF)); Murdock Charitable Trust; US Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office(United States Department of Energy (DOE)); US DOE's International Affairs(United States Department of Energy (DOE)); US Department of Agriculture-National Institute of Food and Agriculture Biomass Research and Development Initiative; US Department of Agriculture-Agriculture Research Service project; DOE Great Lakes Bioenergy Research Center, DOE Biological and Environmental Research Office of Science(United States Department of Energy (DOE))	Funding and additional information-Original research was supported by grant from the National Science Foundation (grant numbers: CHE-1804699 and MCB-2043248) and Murdock Charitable Trust (to C. H. K.). W. V. acknowledges financial support from the US Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office and sponsored by the US DOE's International Affairs (grant no.: DEPI0000031) and the US Department of Agriculture-National Institute of Food and Agriculture Biomass Research and Development Initiative (grant no.: 2011-1006-30358). S. E. S. acknowledges support from US Department of Agriculture-Agriculture Research Service project (grant no.: 3042-21220-033-000-D). V. I. T. and J. R. were funded by the DOE Great Lakes Bioenergy Research Center, DOE Biological and Environmental Research Office of Science (grant no.: DE-SC0018409). And we thank Sebastien SantiniCNRS/Aix-Marseille University IGS UMR7256 for releasing the Phylogeny.fr for phylogenetic tree building.	Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ballard CR, 2019, BIOACTIVE COMPOUNDS: HEALTH BENEFITS AND POTENTIAL APPLICATIONS, P185, DOI 10.1016/B978-0-12-814774-0.00010-4; BENVENISTE I, 1986, BIOCHEM J, V235, P365, DOI 10.1042/bj2350365; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Campelo D, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00755; Casler MD, 2002, THEOR APPL GENET, V104, P127, DOI 10.1007/s001220200015; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cheynier V, 2013, PLANT PHYSIOL BIOCH, V72, P1, DOI 10.1016/j.plaphy.2013.05.009; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dixon RA, 2001, PHYTOCHEMISTRY, V57, P1069, DOI 10.1016/S0031-9422(01)00092-9; Ebrecht AC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56516-6; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feltus FA, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-80; Frances O, 2015, BIOPHYS J, V108, P1527, DOI 10.1016/j.bpj.2015.01.032; Freeman SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09840-8; Gou MY, 2019, PLANT CELL, V31, P1344, DOI 10.1105/tpc.18.00778; Green AR, 2014, PLANT PHYSIOL, V165, P1440, DOI 10.1104/pp.114.241729; Grinkova YV, 2013, BIOCHEM BIOPH RES CO, V430, P1223, DOI 10.1016/j.bbrc.2012.12.072; Guillaumie S, 2007, PLANTA, V226, P235, DOI 10.1007/s00425-006-0468-9; HALAKA FG, 1985, BIOPHYS J, V48, P209, DOI 10.1016/S0006-3495(85)83774-7; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HORECKER BL, 1949, J BIOL CHEM, V178, P683; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Humphreys JM, 1999, P NATL ACAD SCI USA, V96, P10045, DOI 10.1073/pnas.96.18.10045; IYANAGI T, 1973, BIOCHEMISTRY-US, V12, P2297, DOI 10.1021/bi00736a018; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jiao YP, 2016, PLANT CELL, V28, P1551, DOI 10.1105/tpc.16.00373; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jun SY, 2017, PLANT PHYSIOL, V174, P2128, DOI 10.1104/pp.17.00576; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Li YD, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau2968; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Linger J. G., 2014, P NATL ACAD SCI USA; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Mansfield SD, 2012, NEW PHYTOL, V194, P91, DOI 10.1111/j.1469-8137.2011.04031.x; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; Mizutani M, 1998, PLANT PHYSIOL, V116, P357, DOI 10.1104/pp.116.1.357; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Mothersole RG, 2016, ARCH BIOCHEM BIOPHYS, V606, P111, DOI 10.1016/j.abb.2016.07.018; Moural TW, 2017, PLANT PHYSIOL, V173, P417, DOI 10.1104/pp.16.01426; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Niu GQ, 2017, FEBS J, V284, P754, DOI 10.1111/febs.14017; OMURA T, 1962, J BIOL CHEM, V237, P1375; Padmakshan D, 2022, HOLZFORSCHUNG, V76, P133, DOI 10.1515/hf-2021-0149; Paquette SM, 2009, PHYTOCHEMISTRY, V70, P1940, DOI 10.1016/j.phytochem.2009.08.024; PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rastogi S, 2008, PLANT SCI, V174, P264, DOI 10.1016/j.plantsci.2007.11.014; RAW I, 1959, J BIOL CHEM, V234, P1867; Ro DK, 2002, PLANT PHYSIOL, V130, P1837, DOI 10.1104/pp.008011; RUSSELL DW, 1971, J BIOL CHEM, V246, P3870; Rwere F, 2016, J BIOL CHEM, V291, P14639, DOI 10.1074/jbc.M116.724625; Sarath G, 2008, J IND MICROBIOL BIOT, V35, P343, DOI 10.1007/s10295-007-0296-3; Sattler SE, 2014, G3-GENES GENOM GENET, V4, P2115, DOI 10.1534/g3.114.014001; Sattler SE, 2012, BIOENERG RES, V5, P855, DOI 10.1007/s12155-012-9197-z; Sattler SA, 2017, PLANT PHYSIOL, V173, P1031, DOI 10.1104/pp.16.01671; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Schreiner M, 2012, CRIT REV PLANT SCI, V31, P229, DOI 10.1080/07352689.2012.664979; Scully ED, 2018, NEW PHYTOL, V217, P82, DOI 10.1111/nph.14815; Scully ED, 2016, PLANT J, V85, P378, DOI 10.1111/tpj.13112; Sellner M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031023; Sevrioukova I, 1996, BIOCHEMISTRY-US, V35, P7058, DOI 10.1021/bi960060a; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Shahidi F, 2015, J FUNCT FOODS, V18, P820, DOI 10.1016/j.jff.2015.06.018; Shen AL, 2000, J BIOL CHEM, V275, P41087, DOI 10.1074/jbc.M008380200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shuai L, 2016, SCIENCE, V354, P329, DOI 10.1126/science.aaf7810; Simtchouk S, 2013, FEBS J, V280, P6627, DOI 10.1111/febs.12567; STANIER RY, 1954, J BIOL CHEM, V210, P799; Stone ML, 2018, ACS SUSTAIN CHEM ENG, V6, P11211, DOI 10.1021/acssuschemeng.8b02741; Sundermann A, 2013, PROTEIN SCI, V22, P1183, DOI 10.1002/pro.2307; Sugishima M, 2014, P NATL ACAD SCI USA, V111, P2524, DOI 10.1073/pnas.1322034111; Sundin L, 2014, PLANT PHYSIOL, V166, P1956, DOI 10.1104/pp.114.245548; Terrett OM, 2019, CURR OPIN BIOTECH, V56, P97, DOI 10.1016/j.copbio.2018.10.010; Tetreault HM, 2020, PLANT MOL BIOL, V103, P269, DOI 10.1007/s11103-020-00991-3; Tetreault HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204153; van der Weijde T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00107; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; Wadsater M, 2012, J BIOL CHEM, V287, P34596, DOI 10.1074/jbc.M112.400085; Walker AM, 2016, PLANT PHYSIOL, V172, P78, DOI 10.1104/pp.16.00845; Walker AM, 2013, PLANT PHYSIOL, V162, P640, DOI 10.1104/pp.113.217836; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Watson CJW, 2001, PLANT CELL PHYSIOL, V42, P873, DOI 10.1093/pcp/pce110; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Whitelaw DA, 2015, ARCH BIOCHEM BIOPHYS, V584, P107, DOI 10.1016/j.abb.2015.09.002; Xia CW, 2018, BIOCHEMISTRY-US, V57, P945, DOI 10.1021/acs.biochem.7b01102; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103; Zhang BX, 2020, PLANT PHYSIOL, V183, P957, DOI 10.1104/pp.20.00406	98	2	2	13	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101761	10.1016/j.jbc.2022.101761	http://dx.doi.org/10.1016/j.jbc.2022.101761			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35202651	Green Published, gold			2022-12-26	WOS:000793502000011
J	Davies, DJ; Hadis, M; Di Pietro, V; Lazzarino, G; Forcione, M; Harris, G; Stevens, AR; Soon, WC; Oppenheimer, PG; Milward, M; Belli, A; Palin, WM				Davies, David J.; Hadis, Mohammed; Di Pietro, Valentina; Lazzarino, Giuseppe; Forcione, Mario; Harris, Georgia; Stevens, Andrew R.; Soon, Wai Cheong; Oppenheimer, Pola Goldberg; Milward, Michael; Belli, Antonio; Palin, William M.			Photobiomodulation reduces hippocampal apoptotic cell death and produces a Raman spectroscopic "signature"	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LEVEL LASER THERAPY; SPINAL-CORD; IN-VITRO; LIGHT; TISSUE; MODEL; MECHANISMS; INDUCTION; PRESSURE	Apoptotic cell death within the brain represents a significant contributing factor to impaired post-traumatic tissue function and poor clinical outcome after traumatic brain injury. After irradiation with light in the wavelength range of 600-1200 nm (photobiomodulation), previous investigations have reported a reduction in apoptosis in various tissues. This study investigates the effect of 660 nm photobiomodulation on organotypic slice cultured hippocampal tissue of rats, examining the effect on apoptotic cell loss. Tissue optical Raman spectroscopic changes were evaluated. A significantly higher proportion of apoptotic cells 62.8 +/- 12.2% vs 48.6 +/- 13.7% (P<0.0001) per region were observed in the control group compared with the photobiomodulation group. After photobiomodulation, Raman spectroscopic observations demonstrated 1440/1660 cm(-1) spectral shift. Photobiomodulation has the potential for therapeutic utility, reducing cell loss to apoptosis in injured neurological tissue, as demonstrated in this in vitro model. A clear Raman spectroscopic signal was observed after apparent optimal irradiation, potentially integrable into therapeutic light delivery apparatus for real-time dose metering.	[Davies, David J.; Di Pietro, Valentina; Forcione, Mario; Stevens, Andrew R.; Soon, Wai Cheong; Belli, Antonio] Univ Birmingham, Inst Inflammat & Ageing, Dept Neurosci & Ophthalmol, Birmingham, W Midlands, England; [Davies, David J.; Forcione, Mario; Stevens, Andrew R.; Belli, Antonio] Univ Hosp Birmingham Edgbaston, Natl Inst Hlth Res Surg Reconstruct, Birmingham, W Midlands, England; [Davies, David J.; Forcione, Mario; Stevens, Andrew R.; Belli, Antonio] Univ Hosp Birmingham Edgbaston, Microbiol Res Ctr, Birmingham, W Midlands, England; [Hadis, Mohammed; Milward, Michael; Palin, William M.] Univ Birmingham, Coll Med & Dent Sci, Sch Dent, Inst Clin Sci,Photobiol Res Grp, Birmingham, W Midlands, England; [Lazzarino, Giuseppe] Univ Catania, Dept Chem Sci, Lab Biochem, Catania, Italy; [Harris, Georgia; Oppenheimer, Pola Goldberg] Univ Birmingham, Fac Chem & Biol Engn, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Catania; University of Birmingham	Davies, DJ (corresponding author), Univ Birmingham, Inst Inflammat & Ageing, Dept Neurosci & Ophthalmol, Birmingham, W Midlands, England.; Davies, DJ (corresponding author), Univ Hosp Birmingham Edgbaston, Natl Inst Hlth Res Surg Reconstruct, Birmingham, W Midlands, England.; Davies, DJ (corresponding author), Univ Hosp Birmingham Edgbaston, Microbiol Res Ctr, Birmingham, W Midlands, England.	daviesdj@doctors.org.uk	Stevens, Andrew/GXH-1543-2022	Stevens, Andrew/0000-0002-3222-133X; Harris, Georgia/0000-0001-8826-7057; Goldberg Oppenheimer, Pola/0000-0002-1014-4724	Midland Neuroscience Teaching and Research Fund (University of Birmingham) [1001177]	Midland Neuroscience Teaching and Research Fund (University of Birmingham)	DD received a grant from the Midland Neuroscience Teaching and Research Fund (University of Birmingham Grant Number 1001177) (https://mntrf.org.uk/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnaashari M, 2013, J LASERS MED SCI, V4, P57; BANBURY C, 2019, SCI REP-UK, V9, P1, DOI DOI 10.1038/S41598-018-37186-230626917; Banbury C, 2020, BIOMED OPT EXPRESS, V11, P6249, DOI 10.1364/BOE.399473; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Chu YH, 2018, LASER MED SCI, V33, P279, DOI 10.1007/s10103-017-2364-x; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Darlot F, 2016, ANN NEUROL, V79, P59, DOI 10.1002/ana.24542; de Medeiros ML, 2017, LASER MED SCI, V32, P35, DOI 10.1007/s10103-016-2080-y; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; El Gammal ZH, 2017, LASER MED SCI, V32, P1637, DOI 10.1007/s10103-017-2271-1; Ferland RJ, 2002, NEUROSCIENCE, V115, P669, DOI 10.1016/S0306-4522(02)00514-6; Fukuoka CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169443; Galli R, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01165; Giuliani A, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-8; Hadis MA, 2017, J BIOPHOTONICS, V10, P1514, DOI 10.1002/jbio.201600273; Hadis MA, 2016, LASER MED SCI, V31, P789, DOI 10.1007/s10103-016-1914-y; Hamblin MR, 2018, PHOTOCHEM PHOTOBIOL, V94, P199, DOI 10.1111/php.12864; Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Karu TI, 2010, IUBMB LIFE, V62, P607, DOI 10.1002/iub.359; Katoh K, 1996, NEUROSCI LETT, V216, P9; Kohler M, 2009, ANAL BIOANAL CHEM, V393, P1513, DOI 10.1007/s00216-008-2592-9; Kumar V, 2010, INDIAN J PURE AP PHY, V48, P85; Lalonde JW., 2019, MECH PHOTOBIOMODULAT, P18, DOI [10.1117/12.2508684.full, DOI 10.1117/12.2508684.FULL]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lanzafame RJ, 2007, LASER SURG MED, V39, P534, DOI 10.1002/lsm.20519; Liang JG, 2012, FREE RADICAL BIO MED, V53, P1459, DOI 10.1016/j.freeradbiomed.2012.08.003; Lim W, 2009, FREE RADICAL BIO MED, V47, P850, DOI 10.1016/j.freeradbiomed.2009.06.023; Lima PLV, 2019, J PHOTOCH PHOTOBIO B, V194, P71, DOI 10.1016/j.jphotobiol.2019.03.015; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Moro C, 2014, J NEUROSURG, V120, P670, DOI 10.3171/2013.9.JNS13423; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Mowbray M, 2021, ACS BIOMATER SCI ENG, V7, P1252, DOI 10.1021/acsbiomaterials.0c01156; Muthuselvi C., 2018, ASIAN J APPL SCI, V11, P83, DOI [DOI 10.3923/AJAPS.2018.83.91, 10.3923/ajaps.2018.83.91]; Pansani TN, 2014, INT J ORAL MAX SURG, V43, P1030, DOI 10.1016/j.ijom.2014.02.011; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reinhart F, 2016, J NEUROSURG, V124, P1829, DOI 10.3171/2015.5.JNS15735; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; Sacharz J, 2018, SPECTROCHIM ACTA A, V188, P581, DOI 10.1016/j.saa.2017.07.046; Salehpour F, 2018, MOL NEUROBIOL, V55, P6601, DOI 10.1007/s12035-017-0852-4; Shipp DW., 2017, SPECTROSCOPY RAMAN 1, DOI [10.1364/aop.XX.XXXXXX, DOI 10.1364/AOP.XX.XXXXXX]; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Sommer AP, 2012, PHOTOMED LASER SURG, V30, P54, DOI 10.1089/pho.2011.3073; Staniszewska-Slezak E, 2015, SPECTROCHIM ACTA A, V147, P245, DOI 10.1016/j.saa.2015.03.086; Sun Grace, 2004, Dent Clin North Am, V48, P1061, DOI 10.1016/j.cden.2004.05.004; Sussai DA, 2010, LASER MED SCI, V25, P115, DOI 10.1007/s10103-009-0697-9; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yoon SR, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071664	56	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264533	10.1371/journal.pone.0264533	http://dx.doi.org/10.1371/journal.pone.0264533			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239693	gold, Green Published			2022-12-26	WOS:000776002200042
J	Durisin, M; Kruger, C; Pich, A; Warnecke, A; Steffens, M; Zeilinger, C; Lenarz, T; Prenzler, N; Schmitt, H				Durisin, Martin; Krueger, Caroline; Pich, Andreas; Warnecke, Athanasia; Steffens, Melanie; Zeilinger, Carsten; Lenarz, Thomas; Prenzler, Nils; Schmitt, Heike			Proteome profile of patients with excellent and poor speech intelligibility after cochlear implantation: Can perilymph proteins predict performance?	PLOS ONE			English	Article							INDUCED HEARING-LOSS; ATTRACTIN; MYELOPEROXIDASE; KALLIKREIN; EBSELEN; RELEVANCE; CELLS	Modern proteomic analysis and reliable surgical access to gain liquid inner ear biopsies have enabled in depth molecular characterization of the cochlea microenvironment. In order to clarify whether the protein composition of the perilymph can provide new insights into individual hearing performance after cochlear implantation (CI), computational analysis in correlation to clinical performance after CI were performed based on the proteome profile derived from perilymph samples (liquid biopsies). Perilymph samples from cochlear implant recipients have been analyzed by mass spectrometry (MS). The proteins were identified using the shot-gun proteomics method and quantified and analyzed using Max Quant, Perseus and IPA software. A total of 75 perilymph samples from 68 (adults and children) patients were included in the analysis. Speech perception data one year after implantation were available for 45 patients and these were used for subsequent analysis. According to their hearing performance, patients with excellent (n = 22) and poor (n = 14) performance one year after CI were identified and used for further analysis. The protein composition and statistically significant differences in the two groups were detected by relative quantification of the perilymph proteins. With this procedure, a selection of 287 proteins were identified in at least eight samples in both groups. In the perilymph of the patients with excellent and poor performance, five and six significantly elevated proteins were identified respectively. These proteins seem to be involved in different immunological processes in excellent and poor performer. Further analysis on the role of specific proteins as predictors for poor or excellent performance among CI recipients are mandatory. Combinatory analysis of molecular inner ear profiles and clinical performance data using bioinformatics analysis may open up new possibilities for patient stratification. The impact of such prediction algorithms on diagnosis and treatment needs to be established in further studies.	[Durisin, Martin; Krueger, Caroline; Warnecke, Athanasia; Steffens, Melanie; Lenarz, Thomas; Prenzler, Nils; Schmitt, Heike] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Pich, Andreas] Hannover Med Sch, Core Facil Prote, Hannover, Germany; [Warnecke, Athanasia; Lenarz, Thomas; Schmitt, Heike] Hannover Med Sch, Cluster Excellence German Res Fdn DFG, Hannover, Germany; [Warnecke, Athanasia; Lenarz, Thomas; Schmitt, Heike] Hannover Med Sch, Deutsch Forsch Gemeinschaff Hearing4all, Hannover, Germany; [Zeilinger, Carsten] Gottfried Wilhelm Leibniz Univ, BMWZ Zentrum Biomol Wirkstoffe, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Leibniz University Hannover	Warnecke, A (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.; Warnecke, A (corresponding author), Hannover Med Sch, Cluster Excellence German Res Fdn DFG, Hannover, Germany.; Warnecke, A (corresponding author), Hannover Med Sch, Deutsch Forsch Gemeinschaff Hearing4all, Hannover, Germany.	warnecke.athanasia@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022	Steffens, Melanie/0000-0003-2266-2278	DFG Cluster of Excellence [EXC 2177/1]	DFG Cluster of Excellence(German Research Foundation (DFG))	This work was supported by the DFG Cluster of Excellence EXC 2177/1 "Hearing4all".	Alfadda AA, 2017, MOL CELLS, V40, P685, DOI 10.14348/molcells.2017.0073; Ansong E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127295; Avci E, 2014, J COMP NEUROL, V522, P3245, DOI 10.1002/cne.23594; Bellini S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122709; Bhattacharya K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19783-w; Blamey PJ, 2015, EAR HEARING, V36, P408, DOI 10.1097/AUD.0000000000000150; Bond BR, 1998, HEARING RES, V123, P1, DOI 10.1016/S0378-5955(98)00089-6; Burton DGA, 2018, BIOGERONTOLOGY, V19, P447, DOI 10.1007/s10522-018-9763-7; Cai H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57299-6; Carlson ML, 2020, NEW ENGL J MED, V382, P1531, DOI 10.1056/NEJMra1904407; Carlson ML, 2012, OTOLARYNG CLIN N AM, V45, P221, DOI 10.1016/j.otc.2011.09.002; de Vries I, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00214; Fang WF, 2010, CARCINOGENESIS, V31, P1360, DOI 10.1093/carcin/bgq114; Kil J, 2007, HEARING RES, V226, P44, DOI 10.1016/j.heares.2006.08.006; Kil J, 2017, LANCET, V390, P969, DOI 10.1016/S0140-6736(17)31791-9; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; Kranz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092157; Kuramoto T, 2001, P NATL ACAD SCI USA, V98, P559, DOI 10.1073/pnas.98.2.559; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Lenarz Thomas, 2017, Laryngorhinootologie, V96, pS123, DOI 10.1055/s-0043-101812; Liang Q, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01073; Lysaght AC, 2011, J PROTEOME RES, V10, P3845, DOI 10.1021/pr200346q; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mavel S, 2018, HEARING RES, V367, P129, DOI 10.1016/j.heares.2018.05.016; May LA, 2013, J CLIN INVEST, V123, P3577, DOI 10.1172/JCI68480; Meyer H, 2012, INT J NANOMED, V7, P2449, DOI 10.2147/IJN.S29712; Minami SB, 2004, J NEUROSCI RES, V78, P383, DOI 10.1002/jnr.20267; Muto Y, 2003, MOL BRAIN RES, V111, P111, DOI 10.1016/S0169-328X(02)00696-4; Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Nokkari A, 2018, PROG NEUROBIOL, V165, P26, DOI 10.1016/j.pneurobio.2018.01.003; Obermeier B, 2008, NAT MED, V14, P688, DOI 10.1038/nm1714; Paz J, 2007, NEUROBIOL AGING, V28, P1446, DOI 10.1016/j.neurobiolaging.2006.06.014; Pereira SVN, 2018, PEDIATR PULM, V53, P888, DOI 10.1002/ppul.24005; Rask-Andersen H, 2015, NEURAL REGEN RES, V10, P710, DOI 10.4103/1673-5374.156963; Rasmussen JE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198442; Scherer EQ, 2002, STROKE, V33, P2965, DOI 10.1161/01.STR.0000043673.22993.FD; Schmitt H, 2018, OTOL NEUROTOL, V39, P37, DOI 10.1097/MAO.0000000000001625; Schmitt HA, 2021, ACS OMEGA, V6, P21241, DOI 10.1021/acsomega.1c01136; Schmitt HA, 2017, J PROTEOME RES, V16, P1911, DOI 10.1021/acs.jproteome.6b00986; Serlidaki D, 2020, J BIOL CHEM, V295, P7301, DOI 10.1074/jbc.RA119.012449; Shew M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40192-7; Shew M, 2018, NEUROREPORT, V29, P894, DOI 10.1097/WNR.0000000000001049; Shivshankar P, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00418; Sotiropoulou G, 2012, TRENDS PHARMACOL SCI, V33, P623, DOI 10.1016/j.tips.2012.09.005; Taleb M, 2008, JARO-J ASSOC RES OTO, V9, P277, DOI 10.1007/s10162-008-0122-2; Taleb M, 2009, CELL STRESS CHAPERON, V14, P427, DOI 10.1007/s12192-008-0097-2; Tang W, 2000, P NATL ACAD SCI USA, V97, P6025, DOI 10.1073/pnas.110139897; Tang W, 2002, J NEUROPATH EXP NEUR, V61, P767, DOI 10.1093/jnen/61.9.767; Tang Y, 2009, CURR MED CHEM, V16, P4502, DOI 10.2174/092986709789760689; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; Volkman R, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00990; Warnecke A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00665; Watanabe K, 2001, EUR ARCH OTO-RHINO-L, V258, P164, DOI 10.1007/s004050100335; World Health Organization, 2021, GLOB DEAFN HEAR LOSS; Wurfel W, 2014, HEARING RES, V316, P65, DOI 10.1016/j.heares.2014.07.013; Yamane M, 2020, FASEB J, V34, P10778, DOI 10.1096/fj.201900218R; Yamasoba T, 2005, NEUROSCI LETT, V380, P234, DOI 10.1016/j.neulet.2005.01.047; Yanamadala V, 2010, TRENDS MOL MED, V16, P69, DOI 10.1016/j.molmed.2009.12.001; Yang T, 2018, HEARING RES, V364, P48, DOI 10.1016/j.heares.2018.04.001	59	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0263765	10.1371/journal.pone.0263765	http://dx.doi.org/10.1371/journal.pone.0263765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239655	Green Published, gold			2022-12-26	WOS:000776002200013
J	Garcia, E; Ladak, Z; Landry, T; Wollin, M; Persad, ARL; Sergi, CM; Huynh, HQ; Persad, R; Persad, S				Garcia, Elizabeth; Ladak, Zeenat; Landry, Takaaki; Wollin, Michael; Persad, Amit R. L.; Sergi, Consolato M.; Huynh, Hien Q.; Persad, Rabindranath; Persad, Sujata			Epithelial-mesenchymal transition, regulated by beta-catenin and Twist, leads to esophageal wall remodeling in pediatric eosinophilic esophagitis	PLOS ONE			English	Article							DILATED INTERCELLULAR SPACES; MECHANISMS; MANAGEMENT; REVERSES; ADHESION; FEATURES; CELLS	Eosinophilic Esophagitis (EoE) is an antigen-triggered inflammatory condition of the esophageal lining characterized by eosinophilic infiltration. EoE is associated with significant remodeling, and although this remodeling is reversed by current treatment regimens, symptoms of EoE and associated remodeling reappear upon cessation of therapies. We hypothesized that structural remodeling of cell-cell adhesion is a key factor in the pathogenesis of EoE and that epithelial to mesenchymal transition (EMT) was a viable molecular process to lead to this remodeling. Endoscopically obtained biopsy samples from 18 EoE and 18 control pediatric patients were evaluated by transmission electron microscopy to measure intercellular spaces (IS) between cells. Biopsy samples from all groups were analyzed for cellular levels of cell-cell adhesion proteins: E-cadherin, zonula occludens associated protein-1 (ZO-1), and N-cadherin. We also analyzed for cellular levels and localization two of transcription factors, Twist1 and beta -catenin, that are associated with promoting EMT. The IS was significantly increased in the EoE group compared to the control. We observed a significant decrease in E-cadherin and ZO-1 levels and a concomitant increase in N-cadherin levels in EoE samples compared to control. Further, while there was no significant change in cellular levels of beta -catenin, we observed an altered localization of the protein from the cell membrane in control tissue to a nuclear/perinuclear localization in EoE. We observed higher levels of the transcription factor Twist1 in the EoE group compared to normal which was localized mainly at the nucleus. Our results suggest that the integrity of normally sealed esophageal epithelia is compromised in the EoE patients compared to control subjects, and this is due to alterations in the expression of cell adhesion molecules at the esophageal epithelium. Our data also suggest that EMT, potentially regulated by transcription factors beta -catenin and Twist1, may be responsible for the molecular alteration which leads to the remodeling of esophageal epithelia in EoE.	[Garcia, Elizabeth; Ladak, Zeenat; Landry, Takaaki; Wollin, Michael; Persad, Amit R. L.; Sergi, Consolato M.; Huynh, Hien Q.; Persad, Rabindranath; Persad, Sujata] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Alberta	Persad, S (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	sujata.persad@med.ualberta.ca		Ladak, Zeenat/0000-0001-8904-3186; Sergi, Consolato/0000-0002-2779-7879	Stollery Children's Hospital Research Foundation; Women & Children's Health Research Institute (WCHRI)	Stollery Children's Hospital Research Foundation; Women & Children's Health Research Institute (WCHRI)	The research presented in this manuscript was supported by funds from the Stollery Children's Hospital Research Foundation and by a grant from the Women & Children's Health Research Institute (WCHRI) to Sujata Persad.	ALBELDA SM, 1991, AM J RESP CELL MOL, V4, P195, DOI 10.1165/ajrcmb/4.3.195; Alberts B., 1994, MOL BIOL CELL, V3, P950; Arias A, 2019, EXPERT REV GASTROENT, V13, P99, DOI 10.1080/17474124.2019.1546120; ATTWOOD SEA, 1993, DIGEST DIS SCI, V38, P109, DOI 10.1007/BF01296781; Brown-Whitehorn T, 2007, CURR OPIN PEDIATR, V19, P575, DOI 10.1097/MOP.0b013e3282bf6ebf; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Dellon ES, 2018, GASTROENTEROLOGY, V155, P1022, DOI 10.1053/j.gastro.2018.07.009; Dong WL, 2017, ONCOL REP, V37, P1873, DOI 10.3892/or.2017.5369; Egan M, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0798-2; Furuta GT, 2006, ALIMENT PHARM THER, V24, P173, DOI 10.1111/j.1365-2036.2006.02984.x; Furuta Glenn T, 2002, Curr Allergy Asthma Rep, V2, P67, DOI 10.1007/s11882-002-0042-x; Gann PH, 2020, J ALLERGY CLIN IMMUN, V146, P367, DOI 10.1016/j.jaci.2020.03.045; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Ha JR, 2014, EXP CELL RES, V321, P153, DOI 10.1016/j.yexcr.2013.11.021; Hirano I, 2013, GUT, V62, P489, DOI 10.1136/gutjnl-2011-301817; Hu W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44048-y; Kagalwalla AF, 2012, J ALLERGY CLIN IMMUN, V129, P1387, DOI 10.1016/j.jaci.2012.03.005; Kottyan LC, 2020, J ALLERGY CLIN IMMUN, V145, P9, DOI 10.1016/j.jaci.2019.11.013; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Lucendo AJ, 2017, UNITED EUR GASTROENT, V5, P335, DOI 10.1177/2050640616689525; Mahmood MQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11375-x; Mishra A, 2001, J CLIN INVEST, V107, P83, DOI 10.1172/JCI10224; Molina-Infante J, 2018, J ALLERGY CLIN IMMUN, V142, P41, DOI 10.1016/j.jaci.2018.02.028; MONTEFORT S, 1993, EUR RESPIR J, V6, P1257; MONTEFORT S, 1992, CLIN EXP ALLERGY, V22, P511, DOI 10.1111/j.1365-2222.1992.tb00159.x; Muir AB, 2019, J GASTROENTEROL, V54, P10, DOI 10.1007/s00535-018-1498-3; Muir AB, 2015, EXP CELL RES, V330, P102, DOI 10.1016/j.yexcr.2014.08.026; Muir AB, 2013, EXP CELL RES, V319, P850, DOI 10.1016/j.yexcr.2012.12.002; Orenstein SR, 2000, AM J GASTROENTEROL, V95, P1422; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Persad R, 2012, J PEDIATR GASTR NUTR, V55, P251, DOI 10.1097/MPG.0b013e31824b6391; PERSSON CGA, 1995, CLIN EXP ALLERGY, V25, P807, DOI 10.1111/j.1365-2222.1995.tb00022.x; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Ravelli A, 2014, J PEDIATR GASTR NUTR, V59, P589, DOI 10.1097/MPG.0000000000000491; Ravelli AM, 2006, J PEDIATR GASTR NUTR, V42, P510, DOI 10.1097/01.mpg.0000215312.78664.b9; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Whelan KA, 2018, CELL MOL GASTROENTER, V5, P461, DOI 10.1016/j.jcmgh.2018.01.011; Yu L, 2014, ONCOL REP, V31, P321, DOI 10.3892/or.2013.2841	41	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264622	10.1371/journal.pone.0264622	http://dx.doi.org/10.1371/journal.pone.0264622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239721	gold, Green Published			2022-12-26	WOS:000776002200051
J	Troughton, LD; O'Loughlin, DA; Zech, T; Hamill, KJ				Troughton, Lee D.; O'Loughlin, Danielle A.; Zech, Tobias; Hamill, Kevin J.			Laminin N-terminus alpha 31 is upregulated in invasive ductal breast cancer and changes the mode of tumour invasion	PLOS ONE			English	Article							DOWN-REGULATION; EPITHELIAL-CELLS; EXPRESSION; MIGRATION; MATRIX; ADHESION; COMPLEX; TRANSITION; FRAGMENT; NETRIN-4	Laminin N-terminus alpha 31 (LaNt alpha 31) is an alternative splice isoform derived from the laminin alpha 3 gene. The LaNt alpha 31 protein is enriched around the terminal duct lobular units in normal breast tissue. In the skin and cornea the protein influences epithelial cell migration and tissue remodelling. However, LaNt alpha 31 has never been investigated in a tumour environment. Here we analysed LaNt alpha 31 in invasive ductal carcinoma and determined its contribution to breast carcinoma invasion. LaNt alpha 31 expression and distribution were analysed by immunohistochemistry in human breast tissue biopsy sections and tissue microarrays covering 232 breast cancer samples. This analysis revealed LaNt alpha 31 to be upregulated in 56% of invasive ductal carcinoma specimens compared with matched normal tissue, and further increased in nodal metastasis compared with the tumour mass in 45% of samples. 65.8% of triple negative cases displayed medium to high LaNt alpha 31 expression. To study LaNt alpha 31 function, an adenoviral system was used to induce expression in MCF-7 and MDA-MB-231 cells. 2D cell migration and invasion into collagen hydrogels were not significantly different between LaNt alpha 31 overexpressing cells and control treated cells. However, LaNt alpha 31 overexpression reduced the proliferation rate of MCF-7 and MDA-MB-231 cells. Moreover, LaNt alpha 31 overexpressing MDA-MB-231 cells displayed a striking change in their mode of invasion into laminin-containing Matrigel; changing from multicellular streaming to individual cellular-invasion. In agreement with these results, 66.7% of the tumours with the highest LaNt alpha 31 expression were non-cohesive. Together these findings indicate that breast cancer-associated changes in LaNt alpha 31 expression could contribute to the processes involved in tumour invasion and may represent a new therapeutic target.	[Troughton, Lee D.] Loyola Univ Chicago, Cell & Mol Physiol, Chicago, IL 60660 USA; [Troughton, Lee D.; O'Loughlin, Danielle A.; Hamill, Kevin J.] Univ Liverpool, Inst Life Course & Med Sci, Liverpool, Merseyside, England; [Zech, Tobias] Univ Liverpool, Inst Syst Mol & Integrat Biol, Liverpool, Merseyside, England	Loyola University Chicago; University of Liverpool; University of Liverpool	Troughton, LD (corresponding author), Loyola Univ Chicago, Cell & Mol Physiol, Chicago, IL 60660 USA.; Troughton, LD (corresponding author), Univ Liverpool, Inst Life Course & Med Sci, Liverpool, Merseyside, England.	ltroughton@loyola.luc.edu		Hamill, Kevin/0000-0002-7852-1944	Biotechnology and Biological Sciences Research Council [BB/L020513/1, BB/P0257731]; North West Cancer Research [DBhDyARIsADt6sGZhIHHYWcv86EXoJE6fN0 1f2Ju1jRgMgpOJ7jTmFJFfe3Ixc-YqBV4aAm15EALw_wcB]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); North West Cancer Research	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/L020513/1 and BB/P0257731, and by North West Cancer Research, all grants awarded to KJH. These funding sources supported the purchase of consumables and equipment access and paid salaries of LDT. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://bbsrc.ukri.org/https://www.nwcr.org/?gclid=Cj0KCQjw9YW DBhDyARIsADt6sGZhIHHYWcv86EXoJE6fN0 1f2Ju1jRgMgpOJ7jTmFJFfe3Ixc-YqBV4aAm15EALw_wcB.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Balduyck M, 2000, CLIN EXP METASTAS, V18, P171, DOI 10.1023/A:1006762425323; Barrera V, 2018, INVEST OPHTH VIS SCI, V59, P4082, DOI 10.1167/iovs.18-24037; BERGSTRAESSER LM, 1995, AM J PATHOL, V147, P1823; Brassart-Pasco S, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00397; C. J.Sugden, 2020, bioRxiv, DOI 10.1101/617597; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Carpenter PM, 2008, AM J SURG PATHOL, V32, P345, DOI 10.1097/PAS.0b013e3181592201; Carpenter PM, 2017, CANCER MED-US, V6, P220, DOI 10.1002/cam4.957; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Farina KL, 1998, CANCER RES, V58, P2528; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; Garcia E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23590; GERDES J, 1984, J IMMUNOL, V133, P1710; Giussani M, 2018, J CELL PHYSIOL, V233, P6280, DOI 10.1002/jcp.26513; Hamill KJ, 2015, J INVEST DERMATOL, V135, P1043, DOI 10.1038/jid.2014.505; Hamill KJ, 2012, J INVEST DERMATOL, V132, P448, DOI 10.1038/jid.2011.297; Hamill KJ, 2009, J BIOL CHEM, V284, P35588, DOI 10.1074/jbc.M109.052811; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Henning K, 1999, HISTOPATHOLOGY, V34, P305; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Holler E, 2005, BREAST CANCER RES, V7, P166, DOI 10.1186/bcr1270; Horejs CM, 2014, P NATL ACAD SCI USA, V111, P5908, DOI 10.1073/pnas.1403139111; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Kariya Y, 2004, J BIOL CHEM, V279, P24774, DOI 10.1074/jbc.M400670200; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kligys K, 2013, AM J RESP CELL MOL, V49, P731, DOI 10.1165/rcmb.2012-0509OC; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; MacDonald E, 2018, J CELL BIOL, V217, P2549, DOI 10.1083/jcb.201710051; Martin KJ, 1998, MOL MED, V4, P602, DOI 10.1007/BF03401760; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Mori T, 2011, CANCER SCI, V102, P1095, DOI 10.1111/j.1349-7006.2011.01892.x; Moriggi M, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800278; Oppelt A, 2014, BIOCHEM J, V461, P383, DOI 10.1042/BJ20140132; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Pinner S, 2008, J MICROSC-OXFORD, V231, P441, DOI 10.1111/j.1365-2818.2008.02056.x; Plopper GE, 1998, BREAST CANCER RES TR, V51, P57, DOI 10.1023/A:1006086218174; Reuten R, 2021, NAT MATER, V20, P892, DOI 10.1038/s41563-020-00894-0; Reuten R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13515; Rousselle P, 2020, SEMIN CANCER BIOL, V62, P149, DOI 10.1016/j.semcancer.2019.09.026; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Schneiders FI, 2007, J BIOL CHEM, V282, P23750, DOI 10.1074/jbc.M703137200; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Sidhom G, 1999, INT J CLIN LAB RES, V29, P26, DOI 10.1007/s005990050058; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Troughton LD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239889; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Xu XP, 2017, ONCOL REP, V37, P449, DOI 10.3892/or.2016.5239; Yu XZ, 2012, J CELL BIOL, V199, P527, DOI 10.1083/jcb.201203025; YURCHENCO PD, 1994, CONTRIB NEPHROL, V107, P47	55	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264430	10.1371/journal.pone.0264430	http://dx.doi.org/10.1371/journal.pone.0264430			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231053	Green Published, gold, Green Submitted			2022-12-26	WOS:000849744700022
J	Atoloye, IA; Adesina, IS; Sharma, H; Subedi, K; Liang, CL; Shahbazi, A; Bhowmik, A				Atoloye, Idowu A.; Adesina, Ifeoluwa S.; Sharma, Harmandeep; Subedi, Kiran; Liang, Chyi-Lyi (Kathleen); Shahbazi, Abolghasem; Bhowmik, Arnab			Hemp biochar impacts on selected biological soil health indicators across different soil types and moisture cycles	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; 2 AGRICULTURAL SOILS; ENZYME-ACTIVITIES; ORGANIC-MATTER; WATER-RETENTION; SANDY SOIL; CARBON; RESPONSES; MINERALIZATION; PHOSPHORUS	Application of crop residues and biochar have been demonstrated to improve soil biological and chemical properties in agroecosystems. However, the integrated effect of organic amendments and hydrological cycles on soil health indicators are not well understood. In this study, we quantified the impact of hemp residue (HR), hemp biochar (HB), and hardwood biochar (HA) on five hydrolytic enzymes, soil microbial phospholipid (PLFA) community structure, pH, permanganate oxidizable carbon (POXC) soil organic carbon (SOC), and total nitrogen (TN). We compared two soil types, Piedmont and Coastal Plain soils of North Carolina, under (i) a 30-d moisture cycle maintained at 60% water-filled pore space (WFPS) (D-W1), followed by (ii) a 7-day alternate dry-wet cycle for 42 days (D-W2), or (iii) maintained at 60% WFPS for 42 days (D-W3) during an aerobic laboratory incubation. Results showed that HR and HB significantly increased the geometric mean enzyme activity by 1-2-fold in the Piedmont soil under the three moisture cycles and about 1.5-fold under D-W in the Coastal soil. In the presence of HA, the measured soil enzyme activities were significantly lower than control under the moisture cycles in both soil types. The shift in microbial community structure was distinct in the Coastal soil but not in the Piedmont soil. Under D-W2, HR and HB significantly increased POXC (600-700 mg POXC kg(-1) soil) in the Coastal soil but not in the Piedmont soil while HA increased nitrate (8 mg kg(-1)) retention in the Coastal soil. The differences in amendment effect on pH SOC, TN, POXC, and nitrate were less distinct in the fine-textured Piedmont soil than the coarse-textured Coastal soil. Overall, the results indicate that, unlike HA, HR and HB will have beneficial effects on soil health and productivity, therefore potentially improving soil's resilience to changing climate.	[Atoloye, Idowu A.; Adesina, Ifeoluwa S.; Sharma, Harmandeep; Shahbazi, Abolghasem; Bhowmik, Arnab] North Carolina A&T State Univ, Dept Nat Resources & Environm Design, Greensboro, NC 27411 USA; [Subedi, Kiran] North Carolina A&T State Univ, Coll Agr & Environm Sci, Analyt Serv Lab, Greensboro, NC USA; [Liang, Chyi-Lyi (Kathleen)] North Carolina A&T State Univ, Ctr Environm Farming Syst, Greensboro, NC USA	University of North Carolina; North Carolina A&T State University; University of North Carolina; North Carolina A&T State University; University of North Carolina; North Carolina A&T State University	Bhowmik, A (corresponding author), North Carolina A&T State Univ, Dept Nat Resources & Environm Design, Greensboro, NC 27411 USA.	abhowmik@ncat.edu	ATOLOYE, IDOWU A/GQB-5011-2022; Atoloye, Idowu Ademola/AAG-3359-2021	ATOLOYE, IDOWU A/0000-0002-9853-1576; 				Acosta-Martinez V, 2011, SSSA BOOK S, V9, P161, DOI 10.2136/sssabookser9.c8; Adesina I, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10040129; Al Marzooqi F, 2017, APPL SOIL ECOL, V114, P9, DOI 10.1016/j.apsoil.2017.02.012; Azadi N, 2021, BIOCHAR, V3, P485, DOI 10.1007/s42773-021-00123-0; Bansal OP., 2018, METALS SOIL CONTAMIN, DOI DOI 10.5772/INTECHOPEN.81348; Benbi DK, 2021, CARBON MANAG, V12, P385, DOI 10.1080/17583004.2021.1962409; Bhowmik A, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11143908; Bhowmik A, 2017, SOIL BIOL BIOCHEM, V112, P204, DOI 10.1016/j.soilbio.2017.04.015; BOBBIE RJ, 1980, APPL ENVIRON MICROB, V39, P1212, DOI 10.1128/AEM.39.6.1212-1222.1980; Bonnett S., 2014, GEOPHYSIC RES ABSTRA, V16, P1; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Brtnicky M, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11061174; Caldwell BA, 2005, PEDOBIOLOGIA, V49, P637, DOI 10.1016/j.pedobi.2005.06.003; Chen H, 2021, SOIL BIOL BIOCHEM, V153, DOI 10.1016/j.soilbio.2020.108079; Cooper JM, 1997, CAN J SOIL SCI, V77, P281, DOI 10.4141/S96-023; DICK RP, 1994, SSSA SPEC PUBL, P107; Dingha B, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11092691; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; EIVAZI F, 1988, SOIL BIOL BIOCHEM, V20, P601, DOI 10.1016/0038-0717(88)90141-1; Elzobair KA, 2016, CHEMOSPHERE, V142, P114, DOI 10.1016/j.chemosphere.2015.03.018; FINDLAY RH, 1989, APPL ENVIRON MICROB, V55, P2888, DOI 10.1128/AEM.55.11.2888-2893.1989; Frene JP., 2020, AGROSYS GEOSCI ENV, V3, DOI [10.1002/agg2.20094, DOI 10.1002/AGG2.20094]; Ghezzehei TA, 2019, BIOGEOSCIENCES, V16, P1187, DOI 10.5194/bg-16-1187-2019; Gul S, 2015, AGR ECOSYST ENVIRON, V206, P46, DOI 10.1016/j.agee.2015.03.015; Gunal E, 2018, ARCH AGRON SOIL SCI, V64, P1963, DOI 10.1080/03650340.2018.1471205; Hale SE, 2012, ENVIRON SCI TECHNOL, V46, P2830, DOI 10.1021/es203984k; Harrison-Kirk T, 2014, SOIL BIOL BIOCHEM, V74, P50, DOI 10.1016/j.soilbio.2014.02.021; Ippolito JA, 2020, BIOCHAR, V2, P421, DOI 10.1007/s42773-020-00067-x; Jabborova D, 2021, SCI HORTIC-AMSTERDAM, V290, DOI 10.1016/j.scienta.2021.110518; Jing YL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65796-2; Khadem A, 2017, GEODERMA, V308, P149, DOI 10.1016/j.geoderma.2017.08.004; Li H, 2021, SCI TOTAL ENVIRON, V787, DOI 10.1016/j.scitotenv.2021.147591; Li WT, 2018, PEDOSPHERE, V28, P323, DOI [10.1016/S1002-0160(18)60010-4, 10.1016/s1002-0160(18)60010-4]; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267, DOI 10.2136/sssaj1984.03615995004800060013x; Liu ZL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179079; Luo Y, 2013, SOIL BIOL BIOCHEM, V57, P513, DOI 10.1016/j.soilbio.2012.10.033; Cayuela ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep01732; Manzoni S, 2012, ECOLOGY, V93, P930, DOI 10.1890/11-0026.1; Mark T., 2020, EC VIABILITY IND HEM; Mitchell PJ, 2015, SOIL BIOL BIOCHEM, V81, P244, DOI 10.1016/j.soilbio.2014.11.017; Orwin KH, 2005, PLANT SOIL, V278, P205, DOI 10.1007/s11104-005-8424-1; Parham JA, 2000, SOIL BIOL BIOCHEM, V32, P1183, DOI 10.1016/S0038-0717(00)00034-1; Pennanen T, 1998, APPL ENVIRON MICROB, V64, P2173; Perez-Guzman L., 2020, Agrosystems, Geosciences & Environment, V3, DOI 10.1002/agg2.20082; Pezzolla D, 2019, J PLANT NUTR SOIL SC, V182, P217, DOI 10.1002/jpln.201800082; Rahman MT, 2018, SOIL TILL RES, V175, P28, DOI 10.1016/j.still.2017.08.007; Rajkovich S, 2012, BIOL FERT SOILS, V48, P271, DOI 10.1007/s00374-011-0624-7; Sandhu S, 2019, BIOCHAR, V1, P271, DOI 10.1007/s42773-019-00025-2; Sekaran U, 2020, LAND DEGRAD DEV, V31, P894, DOI 10.1002/ldr.3508; Siebielec S, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10091429; Singh S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90359-4; Sun Y, 2020, CATENA, V193, DOI 10.1016/j.catena.2020.104607; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Tian J, 2016, SCI TOTAL ENVIRON, V556, P89, DOI 10.1016/j.scitotenv.2016.03.010; VANGESTEL M, 1993, SOIL BIOL BIOCHEM, V25, P109, DOI 10.1016/0038-0717(93)90249-B; Wang DY, 2020, APPL SOIL ECOL, V152, DOI 10.1016/j.apsoil.2020.103570; Wang DY, 2019, GEODERMA, V340, P185, DOI 10.1016/j.geoderma.2019.01.012; Wang DY, 2017, GEODERMA, V303, P110, DOI 10.1016/j.geoderma.2017.05.027; Watts DB, 2007, COMMUN SOIL SCI PLAN, V38, P2103, DOI 10.1080/00103620701548860; Weil R. R., 2003, American Journal of Alternative Agriculture, V18, P3, DOI 10.1079/AJAA2003003; Willers C, 2015, J APPL MICROBIOL, V119, P1207, DOI 10.1111/jam.12902; Wu D, 2018, APPL SOIL ECOL, V129, P121, DOI 10.1016/j.apsoil.2018.05.009; Xiang SR, 2008, SOIL BIOL BIOCHEM, V40, P2281, DOI 10.1016/j.soilbio.2008.05.004; Xu G, 2019, BIORESOURCES, V14, P9957, DOI 10.15376/biores.14.4.9957-9967; Yang M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190959; Yarwood SA, 2021, PRINCIPLES APPL SOIL, P239, DOI [10.1016/B978-0-12-820202-9.00010-1, DOI 10.1016/B978-0-12-820202-9.00010-1, DOI 10.1016/B978-0-12-820202-9.00010]; Zhang MY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01321; Zomer RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15794-8	68	1	1	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264620	10.1371/journal.pone.0264620	http://dx.doi.org/10.1371/journal.pone.0264620			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226702	gold, Green Published			2022-12-26	WOS:000793394000036
J	Chen, Y; Lease, NK; Gin, JW; Ogorzalek, TL; Adams, PD; Hillson, NJ; Petzold, CJ				Chen, Yan; Lease, Nurgul Kaplan; Gin, Jennifer W.; Ogorzalek, Tadeusz L.; Adams, Paul D.; Hillson, Nathan J.; Petzold, Christopher J.			Modular automated bottom-up proteomic sample preparation for high-throughput applications	PLOS ONE			English	Article							WORKFLOW	Manual proteomic sample preparation methods limit sample throughput and often lead to poor data quality when thousands of samples must be analyzed. Automated liquid handler systems are increasingly used to overcome these issues for many of the sample preparation steps. Here, we detail a step-by-step protocol to prepare samples for bottom-up proteomic analysis for Gram-negative bacterial and fungal cells. The full modular protocol consists of three optimized protocols to: (A) lyse Gram-negative bacteria and fungal cells; (B) quantify the amount of protein extracted; and (C) normalize the amount of protein and set up tryptic digestion. These protocols have been developed to facilitate rapid, low variance sample preparation of hundreds of samples, be easily implemented on widely-available Beckman-Coulter Biomek automated liquid handlers, and allow flexibility for future protocol development. By using this workflow 50 micrograms of protein from 96 samples can be prepared for tryptic digestion in under an hour. We validate these protocols by analyzing 47 Pseudomonas putida and Rhodosporidium toruloides samples and show that this modular workflow provides robust, reproducible proteomic samples for high-throughput applications. The expected results from these protocols are 94 peptide samples from Gram-negative bacterial and fungal cells prepared for bottom-up quantitative proteomic analysis without the need for desalting column cleanup and with protein relative quantity variance (CV%) below 15%.	[Chen, Yan; Lease, Nurgul Kaplan; Gin, Jennifer W.; Ogorzalek, Tadeusz L.; Adams, Paul D.; Hillson, Nathan J.; Petzold, Christopher J.] Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Chen, Yan; Lease, Nurgul Kaplan; Gin, Jennifer W.; Ogorzalek, Tadeusz L.; Hillson, Nathan J.; Petzold, Christopher J.] Lawrence Berkeley Natl Lab, Agile BioFoundry, Emeryville, CA 94608 USA; [Chen, Yan; Lease, Nurgul Kaplan; Gin, Jennifer W.; Ogorzalek, Tadeusz L.; Hillson, Nathan J.; Petzold, Christopher J.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA USA; [Adams, Paul D.] Lawrence Berkeley Natl Lab, Mol Biophys & Bioimaging Div, Berkeley, CA USA; [Lease, Nurgul Kaplan] Myriad Womens Hlth Inc, San Francisco, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Petzold, CJ (corresponding author), Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Emeryville, CA 94608 USA.; Petzold, CJ (corresponding author), Lawrence Berkeley Natl Lab, Agile BioFoundry, Emeryville, CA 94608 USA.; Petzold, CJ (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.	cjpetzold@lbl.gov	Adams, Paul David/A-1977-2013	Adams, Paul David/0000-0001-9333-8219	Lawrence Berkeley National Laboratory [AC0205CH11231]; U. S. Department of Energy [AC0205CH11231]	Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); U. S. Department of Energy(United States Department of Energy (DOE))	The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The views and opinions of the authors expressed herein do not necessarily state or reflect those of the United States Government or any agency thereof. Neither the United States Government nor any agency thereof, nor any of their employees, makes any warranty, expressed or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. The proof-of-concept work and resources were part of the Joint BioEnergy Institute (JBEI; http://www.jbei. org) and extension of the procedure and identification of the sources of error were part of the Agile BioFoundry (ABF; http://agilebiofoundry. org) supported through contract DE-AC0205CH11231 between Lawrence Berkeley National Laboratory and the U. S. Department of Energy.	Arul AB, 2015, B KOREAN CHEM SOC, V36, P1791, DOI 10.1002/bkcs.10338; Chen Y., 2021, PROTOCOLSIO, DOI [10.17504/protocols.io.buthnwj6, DOI 10.17504/PROTOCOLS.IO.BUTHNWJ6]; Chen Y, 2019, J PROTEOME RES, V18, P3752, DOI 10.1021/acs.jproteome.9b00455; Dayon L, 2014, J PROTEOME RES, V13, P3837, DOI 10.1021/pr500635f; Fu Q, 2020, JOVE-J VIS EXP, DOI 10.3791/59842; Fu Q, 2018, J PROTEOME RES, V17, P420, DOI 10.1021/acs.jproteome.7b00623; Lee J, 2019, J PROTEOME RES, V18, P2337, DOI 10.1021/acs.jproteome.9b00023; Liang YR, 2021, ANAL CHEM, V93, P1658, DOI 10.1021/acs.analchem.0c04240; Lopez-Ferrer D, 2005, J PROTEOME RES, V4, P1569, DOI 10.1021/pr050112v; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu X, 2020, ANAL CHEM, V92, P8893, DOI 10.1021/acs.analchem.0c00752; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Muller T, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20199111; Potriquet J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175967; Specht H., 2018, AUTOMATED SAMPLE PRE, DOI [10.1101/399774, DOI 10.1101/399774]; Switzar L, 2013, PROTEOMICS, V13, P2980, DOI 10.1002/pmic.201300080; Zheng YZ, 2017, CLIN MASS SPECTROM, V6, P1, DOI 10.1016/j.clinms.2017.10.001	17	0	0	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264467	10.1371/journal.pone.0264467	http://dx.doi.org/10.1371/journal.pone.0264467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213656	Green Published, gold			2022-12-26	WOS:000787811000106
J	Martianez-Ramirez, NL; Pineda-Galan, C; Rodriguez-Bailon, M; Romero-Galisteo, RP				Lola Martianez-Ramirez, Noa; Pineda-Galan, Consolacion; Rodriguez-Bailon, Maria; Romero-Galisteo, Rita-Pilar			Competence assessment rubric in the Physiotherapy Practicum	PLOS ONE			English	Article							HIGHER-EDUCATION; PROFESSIONAL COMPETENCE; PRACTICE APP; STUDENTS	Introduction Competence-based learning must be integrated into the practical development of Physiotherapy. Teamwork, interpersonal relations, analytical skills or critical/clinical thinking are some examples of internationally recommended competences in this kind of university studies. Therefore, there is a need to evaluate this learning in Physiotherapy through valid tools that facilitate this task. Objective To analyze the psychometric properties according to competences in Clinical Practices (RECOPC-FIS II) in order to assess 14 transversal or universal competences of under-graduate students in the Physiotherapy degree. Methods A validation study was conducted with 197 students in the 3rd and 4th year of the Physiotherapy degree and 202 clinical tutors who assessed these students using the RECOPC-FIS II. Different psychometric properties were analyzed: factor structure, internal consistency and sensitivity to change. Results The RECOPC-FIS II has a high internal consistency. Its 14 items saturate in a single factor. Regarding the sensitivity to change, the rubric showed higher scores in the Practicum of the 4th year with respect to that of the 3rd year, reaching significant differences in all of them. Conclusion The RECOPC-FIS II is a valid and reliable instrument to assess the transversal competencies of undergraduate students of Physiotherapy during their clinical practice. Therefore, it is intended to facilitate the acquisition of essential skills for the development of their professional career. The flexibility of this tool would allow its adaptation to other health science courses.	[Lola Martianez-Ramirez, Noa] Autonomous Univ Madrid, La Salle Higher Educ Ctr, Dept Physiotherapy, Madrid, Spain; [Pineda-Galan, Consolacion; Rodriguez-Bailon, Maria; Romero-Galisteo, Rita-Pilar] Univ Malaga, Fac Hlth Sci, Dept Physiotherapy, Malaga, Spain	Autonomous University of Madrid; Universidad de Malaga	Rodriguez-Bailon, M (corresponding author), Univ Malaga, Fac Hlth Sci, Dept Physiotherapy, Malaga, Spain.	mariabailon@uma.es	Pineda Galan, Consolacion C/GNW-6464-2022; Romero Galisteo, Rita Pilar/Z-1976-2018	Pineda Gaan, Consolacion/0000-0003-2997-0396; Rodriguez-Bailon, Maria/0000-0001-6658-7658; Romero Galisteo, Rita Pilar/0000-0003-4669-0679	University of Malaga from an Educational Innovation Project with title: Evaluation rubric for competency-based interventions and training program for clinical tutors in the Physiotherapy and Occupational Therapy Practicum [PIE17-008]; University of Malaga	University of Malaga from an Educational Innovation Project with title: Evaluation rubric for competency-based interventions and training program for clinical tutors in the Physiotherapy and Occupational Therapy Practicum; University of Malaga	CPG,RPRG,MRB,NMR. This work was supported by the University of Malaga from an Educational Innovation Project with title: Evaluation rubric for competency-based interventions and training program for clinical tutors in the Physiotherapy and Occupational Therapy Practicum. Code: PIE17-008. This work also received financial support from University of Malaga.	Allison H., 2004, AUSTR OCCUPATIONAL T, V51, P125, DOI [10.1111/j.1440-1630.2004.00414.x, DOI 10.1111/J.1440-1630.2004.00414.X]; [Anonymous], 2004, LIBRO BLANCO T TULO; Bergsmann E, 2018, ASSESS EVAL HIGH EDU, V43, P537, DOI 10.1080/02602938.2017.1378617; Bergsmann E, 2015, EVAL PROGRAM PLANN, V52, P1, DOI 10.1016/j.evalprogplan.2015.03.001; Blomeke S, 2015, Z PSYCHOL, V223, P3, DOI 10.1027/2151-2604/a000194; Cebrian-de-la-Serna M, 2014, COMUNICAR, V22, P153, DOI 10.3916/C43-2014-15; Chan A, 2016, MED EDUC, V50, P898, DOI 10.1111/medu.13117; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Copley J, 2012, BRIT J OCCUP THER, V75, P456, DOI 10.4276/030802212X13496921049662; Dalton M, 2012, J PHYSIOTHER, V58, P49, DOI 10.1016/S1836-9553(12)70072-3; Dalton M, 2011, J PHYSIOTHER, V57, P239, DOI 10.1016/S1836-9553(11)70054-6; Diaz-Mohedo E., DELPHI APPROACH, V4, P1, DOI [10.1186/s12909-021-02904-4, DOI 10.1186/S12909-021-02904-4]; Dogan CD., 2015, TURKIYE KLIN J SPORT, V7, P9; Durante E., 2012, REV DOCENCIA U, V10, P149, DOI 10.4995/redu.2012.6101; European Association for Quality Assurance in Higher Education (ENQA), 2015, QUAL PROC EUR HIGH E; Fahy A, 2011, Nurs Stand, V25, P42; Gantt LT, 2010, NURS EDUC PERSPECT, V31, P101; Gonzalez J., 2006, CONTRIBUCION U PROCE; Hartig J., 2008, ASSESSMENT COMPETENC; Jimenez Galan YI., 2011, CPU E REV INVESTIG E, V13, P1; Marin-Garcia JA, 2015, INTANG CAP, V11, P118, DOI 10.3926/ic.538; Martianez N.L., 2016, HERNANDO COMPETENCIA; Martianez NL., 2015, FISIOTERAPIA, V37, P83; Martianez Ramirez NL., 2016, RUBRICA COMO INSTRUM; Miller L., 2001, OCCUPATIONAL THERAPY, V8, P244, DOI DOI 10.1002/OTI.149; MostafaKhan HSE., 2013, IRAN REHABIL J, V11, P46; Noble C, 2020, ADV HEALTH SCI EDUC, V25, P55, DOI 10.1007/s10459-019-09905-5; Nunez-Cortes JM., 2014, GUIA EVALUACION PRAC; O'Connor A, 2018, PHYSIOTHERAPY, V104, P46, DOI 10.1016/j.physio.2017.01.005; Osana H.P., 2004, EDUC RES EVAL, V10, P473, DOI [10.1080/13803610512331383529, DOI 10.1080/13803610512331383529]; Ossenberg C, 2016, NURS EDUC TODAY, V36, P23, DOI 10.1016/j.nedt.2015.07.012; Panadero E, 2013, EDUC RES REV-NETH, V9, P129, DOI 10.1016/j.edurev.2013.01.002; Pozo Florez JA del, 2015, COMPETENCIAS PROFESI, V3a; Rodriguez de Castro F, 2015, ED MED S1, V16, P50; Iglesias-Parra MR, 2015, J NURS SCHOLARSHIP, V47, P371, DOI 10.1111/jnu.12140; Shavelson R.J., 2010, EMPIRICAL RES VOCATI, V2, P41, DOI 10.1007/BF03546488; Shipman D, 2012, NURS EDUC TODAY, V32, P246, DOI 10.1016/j.nedt.2011.04.007; T Campos Garcia CRB y ARR, 2011, GUIA TUT FORM PRACT; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tamayo-Caballero RL., 2018, ATLANTE CUAD ED DESA; Tejada Fernandez J, 2005, REDIE REV ELECT INVE, V7, P10; Fernandez JT, 2016, EDUC XX1, V19, P17, DOI 10.5944/educXX1.12175; Terron-Lopez MJ., 2012, VERTICE; The Chartered Society of Physiotherapy, 2013, PHYS FRAM PUTT PHYS; Tilson JK, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-78; Torres-Narvaez MR, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1377-x; Tractenberg RE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225256; Turpin M, 2011, AUST OCCUP THER J, V58, P67, DOI 10.1111/j.1440-1630.2010.00890.x; World Confederation for Physical Therapy (WCPT), 2018, ADV PRACT PHYS EUR R; World Confederation for Physical Therapy (WCPT), 2017, WCPT GUID CLIN ED CO; Beraza MAZ, 2011, REV EDUC-MADRID, P21	51	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264120	10.1371/journal.pone.0264120	http://dx.doi.org/10.1371/journal.pone.0264120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213586	Green Published, gold			2022-12-26	WOS:000787811000049
J	Manno, C; Tammineni, E; Figueroa, L; Marty, I; Rios, E				Manno, Carlo; Tammineni, Eshwar; Figueroa, Lourdes; Marty, Isabelle; Rios, Eduardo			Quantification of the calcium signaling deficit in muscles devoid of triadin	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; CALSEQUESTRIN; RELEASE; EXCITATION; PROTEIN; STORE; ORGANIZATION	Triadin, a protein of the sarcoplasmic reticulum (SR) of striated muscles, anchors the calcium-storing protein calsequestrin to calcium release RyR channels at the junction with t-tubules, and modulates these channels by conformational effects. Triadin ablation induces structural SR changes and alters the expression of other proteins. Here we quantify alterations of calcium signaling in single skeletal myofibers of constitutive triadin-null mice. We find higher resting cytosolic and lower SR-luminal [Ca2+], 40% lower calsequestrin expression, and more Ca(v)1.1, RyR1 and SERCA1. Despite the increased Ca(v)1.1, the mobile intra-membrane charge was reduced by similar to 20% in Triadin-null fibers. The initial peak of calcium release flux by pulse depolarization was minimally altered in the null fibers (revealing an increase in peak calcium permeability). The "hump" phase that followed, attributable to calcium detaching from calsequestrin, was 25% lower, a smaller change than expected from the reduced calsequestrin content and calcium saturation. The exponential decay rate of calcium transients was 25% higher, consistent with the higher SERCA1 content. Recovery of calcium flux after a depleting depolarization was faster in triadin-null myofibers, consistent with the increased uptake rate and lower SR calsequestrin content. In sum, the triadin knockout determines an increased RyR1 channel openness, which depletes the SR, a substantial loss of calsequestrin and gains in other couplon proteins. Powerful functional compensations ensue: activation of SOCE that increases [Ca2+](cyto); increased SERCA1 activity, which limits the decrease in [Ca2+](SR) and a restoration of SR calcium storage of unknown substrate. Together, they effectively limit the functional loss in skeletal muscles.	[Manno, Carlo; Tammineni, Eshwar; Figueroa, Lourdes; Rios, Eduardo] Rush Univ, Med Ctr, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Marty, Isabelle] Grenoble Inst Neurosci, INSERM U1216, La Tronche, France	Rush University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Manno, C (corresponding author), Rush Univ, Med Ctr, Dept Physiol & Biophys, Chicago, IL 60612 USA.	carlos_manno@rush.edu	Tammineni, Eshwar Reddy/GLU-4484-2022	Manno, Carlo/0000-0002-1120-9606; Figueroa, Lourdes Carolina/0000-0002-4323-4507; Tammineni, Eshwar Reddy/0000-0001-7290-9326	NIAMS; NIGMS institutes of the National Institutes of Health, USA [AR072602, AR071381, GM111254]; Association Francaise contre les Myopathies (AFM-Telethon)	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS institutes of the National Institutes of Health, USA; Association Francaise contre les Myopathies (AFM-Telethon)	Supported by the following grants from the NIAMS and NIGMS institutes of the National Institutes of Health, USA: AR072602 to S. Hamilton, F. Horrigan, SY Jung and E Rios, AR071381 to S. Riazi, M. Fill and E. Rios, and GM111254 to CH Kang and E. Rios. Supported by grants from Association Francaise contre les Myopathies (AFM-Telethon) to I. Marty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PD, 2009, J PHYSIOL-LONDON, V587, P3123, DOI 10.1113/jphysiol.2009.172015; Altmann HM, 2015, CIRCULATION, V131, P2051, DOI 10.1161/CIRCULATIONAHA.115.015397; Barone V, 2015, J MUSCLE RES CELL M, V36, P501, DOI 10.1007/s10974-015-9421-5; Beedle AM, 2016, JOVE-J VIS EXP, DOI 10.3791/55058; Boncompagni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039962; BRUM G, 1988, J PHYSIOL-LONDON, V398, P441, DOI 10.1113/jphysiol.1988.sp017052; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; Clemens DJ, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.118.002419; DiFranco M, 2006, PROTEIN EXPRES PURIF, V47, P281, DOI 10.1016/j.pep.2005.10.018; Edwards JN, 2010, CELL CALCIUM, V47, P458, DOI 10.1016/j.ceca.2010.04.001; Eltit JM, 2011, CELL CALCIUM, V49, P128, DOI 10.1016/j.ceca.2011.01.005; Eltit JM, 2010, J BIOL CHEM, V285, P38453, DOI 10.1074/jbc.M110.164525; Engel AG, 2017, NEUROLOGY, V88, P1153, DOI 10.1212/WNL.0000000000003745; Escobar AL, 1997, PFLUG ARCH EUR J PHY, V434, P615, DOI 10.1007/s004240050444; Fourest-Lieuvin A, 2012, J CELL SCI, V125, P3443, DOI 10.1242/jcs.100958; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; GONZALEZ A, 1993, J GEN PHYSIOL, V102, P373, DOI 10.1085/jgp.102.3.373; Goonasekera SA, 2007, J GEN PHYSIOL, V130, P365, DOI 10.1085/jgp.200709790; Groh S, 1999, J BIOL CHEM, V274, P12278, DOI 10.1074/jbc.274.18.12278; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; KIM KC, 1990, BIOCHEMISTRY-US, V29, P9281, DOI 10.1021/bi00491a025; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Launikonis BS, 2005, J PHYSIOL-LONDON, V567, P523, DOI 10.1113/jphysiol.2005.087973; Lazic SE, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005282; LIU GH, 1994, J BIOL CHEM, V269, P33028; MACLENNAN DH, 1973, COLD SPRING HARB SYM, V37, P469, DOI 10.1101/SQB.1973.037.01.058; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; Manno C, 2017, P NATL ACAD SCI USA, V114, pE638, DOI 10.1073/pnas.1620265114; Manno C, 2013, J PHYSIOL-LONDON, V591, P423, DOI 10.1113/jphysiol.2012.243444; Marty I, 2015, J PHYSIOL-LONDON, V593, P3261, DOI 10.1113/jphysiol.2014.281147; Marty I, 2009, J PHYSIOL-LONDON, V587, P3117, DOI 10.1113/jphysiol.2009.171892; MELZER W, 1984, BIOPHYS J, V45, P637, DOI 10.1016/S0006-3495(84)84203-4; MELZER W, 1987, BIOPHYS J, V51, P849, DOI 10.1016/S0006-3495(87)83413-6; Oddoux S, 2009, J BIOL CHEM, V284, P34918, DOI 10.1074/jbc.M109.022442; Ohkura M, 1998, BIOCHEMISTRY-US, V37, P12987, DOI 10.1021/bi972803d; Osseni A, 2016, J CELL SCI, V129, P3744, DOI 10.1242/jcs.188862; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Pape PC, 2007, J PHYSIOL-LONDON, V581, P319, DOI 10.1113/jphysiol.2006.126474; Perni S, 2017, P NATL ACAD SCI USA, V114, P13822, DOI 10.1073/pnas.1716461115; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Qin J, 2008, J GEN PHYSIOL, V131, P325, DOI 10.1085/jgp.200709907; Rios E, 2019, J GEN PHYSIOL, V151, P593, DOI 10.1085/jgp.201812268; Rios E, 2015, J GEN PHYSIOL, V145, P459, DOI 10.1085/jgp.201411321; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Roux-Buisson N, 2012, HUM MOL GENET, V21, P2759, DOI 10.1093/hmg/dds104; Royer L, 2008, J PHYSIOL-LONDON, V586, P4609, DOI 10.1113/jphysiol.2008.157990; Royer L, 2010, J GEN PHYSIOL, V136, P325, DOI 10.1085/jgp.201010454; Schuhmeier RP, 2004, J GEN PHYSIOL, V123, P33, DOI 10.1085/jgp.200308908; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Shin DW, 2003, J BIOL CHEM, V278, P3286, DOI 10.1074/jbc.M209045200; Shin DW, 2000, FEBS LETT, V486, P178, DOI 10.1016/S0014-5793(00)02246-8; Sigg D, 1997, J GEN PHYSIOL, V109, P27, DOI 10.1085/jgp.109.1.27; Sikkel MB, 2017, CARDIOVASC RES, V113, P1743, DOI 10.1093/cvr/cvx151; Stern MD, 1997, J GEN PHYSIOL, V110, P415, DOI 10.1085/jgp.110.4.415; Sztretye M, 2011, J GEN PHYSIOL, V138, P231, DOI 10.1085/jgp.201010592; Sztretye M, 2011, J GEN PHYSIOL, V138, P211, DOI 10.1085/jgp.201010591; Tammineni ER, 2020, ELIFE, V9, DOI 10.7554/eLife.53999; Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100; Tijskens P, 2003, J MOL CELL CARDIOL, V35, P961, DOI 10.1016/S0022-2828(03)00181-0; Ursu D, 2005, J PHYSIOL-LONDON, V562, P347, DOI 10.1113/jphysiol.2004.073882; Valle G, 2008, BIOCHEM J, V413, P291, DOI 10.1042/BJ20080163; Wang LM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11349; Wu YC, 1996, BIOPHYS J, V71, P2256, DOI 10.1016/S0006-3495(96)79429-8	68	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264146	10.1371/journal.pone.0264146	http://dx.doi.org/10.1371/journal.pone.0264146			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213584	Green Published, gold			2022-12-26	WOS:000787811000054
J	Yoshida, S; Miyagawa, S; Matsuzaki, T; Ishii, Y; Fukuda-Kawaguchi, E; Kawamura, T; Kawamura, A; Nakamura, Y; Toda, K; Sawa, Y				Yoshida, Shohei; Miyagawa, Shigeru; Matsuzaki, Takashi; Ishii, Yasuyuki; Fukuda-Kawaguchi, Emi; Kawamura, Takuji; Kawamura, Ai; Nakamura, Yuki; Toda, Koichi; Sawa, Yoshiki			Chimerism through the activation of invariant natural killer T cells prolongs graft survival after transplantation of induced pluripotent stem cell-derived allogeneic cardiomyocytes	PLOS ONE			English	Article							HEART; EXPANSION; FAILURE; SHEETS	The loss of functional cells through immunological rejection after transplantation reduces the efficacy of regenerative therapies for cardiac failure that use allogeneic induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). Recently, mixed-chimera mice with donor-specific immunotolerance have been established using the RGI-2001 (liposomal formulation of alpha-galactosyl ceramide) ligand, which activates invariant natural killer T (iNKT) cells. The present study aimed to investigate whether mixed chimerism, established using RGI-2001, prolongs graft survival in allogeneic iPSC-CM transplantation. Mixed-chimera mice were established via combinatorial treatment with RGI-2001 and anti-CD154 antibodies in an irradiated murine bone marrow transplant model. Luciferase-expressing allogeneic iPSC-CMs were transplanted into mixed-chimera and untreated mice, followed by in vivo imaging. RGI-2001 enhanced iNKT cell activation in mice, and mixed chimerism was successfully established. In vivo imaging revealed that while the allografts were completely obliterated within 2 weeks when transplanted to untreated mice, their survivals were not affected in the mixed-chimera mice. Furthermore, numerous CD3+ cells infiltrated allografts in untreated mice, but fewer CD3+ cells were present in mixed-chimera mice. We conclude that mixed-chimera mice established using RGI-2001 showed prolonged graft survival after allogeneic iPSC-CM transplantation. This donor-specific immunotolerance might increase the efficacy of regenerative therapies for heart failure with allogeneic iPSC-CMs.	[Yoshida, Shohei; Miyagawa, Shigeru; Kawamura, Takuji; Kawamura, Ai; Nakamura, Yuki; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan; [Matsuzaki, Takashi] Osaka Univ, Grad Sch Med, Dept DDS Pharmaceut Dev, Osaka, Japan; [Ishii, Yasuyuki; Fukuda-Kawaguchi, Emi] REGIMMUNE Corp, Tokyo, Japan; [Ishii, Yasuyuki] Juntendo Univ, Grad Sch Med, Dept Immunol Diag, Bunkyo City, Japan	Osaka University; Osaka University; Juntendo University	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp		Miyagawa, Shigeru/0000-0003-0015-6569				Chang DH, 2014, IMMUNOTHERAPY-UK, V6, P181, DOI [10.2217/IMT.13.163, 10.2217/imt.13.163]; Duramad O, 2011, BIOL BLOOD MARROW TR, V17, P1154, DOI 10.1016/j.bbmt.2010.11.022; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Fujii S, 2010, SEMIN IMMUNOL, V22, P97, DOI 10.1016/j.smim.2009.10.002; Hirai T, 2016, AM J TRANSPLANT, V16, P426, DOI 10.1111/ajt.13493; Hirai T, 2014, AM J TRANSPLANT, V14, P554, DOI 10.1111/ajt.12606; Ikemiyagi M, 2017, THER APHER DIAL, V21, P139, DOI 10.1111/1744-9987.12508; Ishii R, 2018, AM J TRANSPLANT, V18, P328, DOI 10.1111/ajt.14453; Ishii Y, 2008, FRONT BIOSCI, V13, P6214, DOI 10.2471/3149; Jessup M, 2017, J AM COLL CARDIOL, V69, P2977, DOI 10.1016/j.jacc.2017.03.001; Kashiyama N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217076; Kashiyama N, 2019, TRANSPLANTATION, V103, P1582, DOI 10.1097/TP.0000000000002765; Kashiyama N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165748; Katsumata H, 2019, TRANSPL INT, V32, P443, DOI 10.1111/tri.13390; Katsumata H, 2019, IMMUNOL LETT, V206, P41, DOI 10.1016/j.imlet.2018.11.013; Kawamura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19464; Kawamura M, 2013, CIRCULATION, V128, pS87, DOI 10.1161/CIRCULATIONAHA.112.000366; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kawamura T, 2016, STEM CELL REP, V6, P312, DOI 10.1016/j.stemcr.2016.01.012; Kawamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111064; Kojo S, 2005, J IMMUNOL, V175, P3648, DOI 10.4049/jimmunol.175.6.3648; Lund LH, 2017, J HEART LUNG TRANSPL, V36, P1037, DOI 10.1016/j.healun.2017.07.019; Miyagawa S, 2016, CURR GENE THER, V16, P5, DOI 10.2174/1566523216666160119094143; Miyairi S, 2017, EUR J IMMUNOL, V47, P734, DOI 10.1002/eji.201646670; Nakamura Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47134-3; Potena L, 2018, CURR CARDIOL REP, V20, DOI 10.1007/s11886-018-1018-3; Shah Kevin S, 2019, Curr Heart Fail Rep, V16, P150, DOI 10.1007/s11897-019-00432-3; Sougawa N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21923-8; Yoshida S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58126-z; Yoshida S, 2018, MOL THER, V26, P2681, DOI 10.1016/j.ymthe.2018.08.012; Youn JC, 2018, J AM COLL CARDIOL, V71, P40, DOI 10.1016/j.jacc.2017.10.077	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264317	10.1371/journal.pone.0264317	http://dx.doi.org/10.1371/journal.pone.0264317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235568	Green Published, gold			2022-12-26	WOS:000787073100021
J	Zhai, XY; Yi, PS; Wang, XT; Wang, HF; Yang, XJ; Mei, ZB; Ge, MY				Zhai, Xinyu; Yi, Pengsheng; Wang, Xitao; Wang, Haifeng; Yang, Xuejun; Mei, Zubing; Ge, Minyao			Effect of statins on risk and mortality of urologic malignancies: Protocol of an umbrella review	PLOS ONE			English	Review							METAANALYSIS; CANCER; WORLDWIDE; EXCESS; BIAS	Introduction Urologic malignancies are the major causes of morbidity and mortality in men over 40 years old, accounting for more than 20% of all malignant tumors. Several meta-analyses are shown that statin exposure can reduce the morbidity and mortality of various urologic cancers. The adjuvant roles of statin in tumor prevention and anti-tumor activity are now being gradually recognized and have gained attention. Nevertheless, to date, multiple clinical studies and meta-analyses found inconsistent results of their anti-cancer effects. This study aims to evaluate the credibility of the published systematic reviews and meta-analyses that assessed the effects of statin exposure for the incidence and mortality of urologic cancers through an umbrella review. Methods and analysis The guidance of overviews of systematic reviews reported in the Cochrane Handbook for Systematic Reviews of interventions will be followed while performing and reporting this umbrella review. This project was registered in PROSPERO with the registration number of CRD42020208854. PubMed, Embase and Cochrane Library will be searched for systematic reviews to identify and appraise systematic reviews or meta-analyses of interventional and observational studies examining statin use and the risks of urologic cancer incidence and mortality without language restriction. The search will be carried out on 10 February 2022. Systematic reviews based on qualitative, quantitative or mixed-methods studies will be involved and critically evaluated by two authors using the Assessment of Multiple Systematic Reviews 2 (AMSTAR2, an updated version of AMSTAR) tool. We will determine the level of evidence using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) tool. The summary effect estimates will be calculated using random-effects models. Between- study heterogeneity will be assessed using the I-2 statistic. Furthermore, we will also assess the evidence of excess significance bias and evidence of small study effects. Ethics and dissemination Ethics approval is not required as we will search and gather data based on the published systematic reviews and meta-analyses. We plan to publish the results of this umbrella review in a peer-reviewed journal and will be presented at a urological disease conference. All the relevant additional data will also be uploaded to the online open access databases.	[Zhai, Xinyu; Ge, Minyao] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Urol, Shanghai, Peoples R China; [Yi, Pengsheng] Affiliated Hosp North Sichuan Med Coll, Dept HepatoBiliary Pancrease, Nanchong, Sichuan, Peoples R China; [Wang, Xitao] Binhai New Area Hosp Tradit Chinese Med, Dept Surg, Tianjin, Peoples R China; [Wang, Haifeng] Tongji Univ, Shanghai East Hosp, Dept Urol, Sch Med, Shanghai, Peoples R China; [Yang, Xuejun] Shanghai Univ Tradit Chinese Med, Inst Nephrol, Shuguang Hosp, Shanghai, Peoples R China; [Mei, Zubing] Anorectal Dis Inst Shuguang Hosp, Shanghai, Peoples R China; [Mei, Zubing] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Anorectal Surg, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; North Sichuan Medical University; Tongji University; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Ge, MY (corresponding author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Urol, Shanghai, Peoples R China.; Yang, XJ (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Nephrol, Shuguang Hosp, Shanghai, Peoples R China.; Mei, ZB (corresponding author), Anorectal Dis Inst Shuguang Hosp, Shanghai, Peoples R China.; Mei, ZB (corresponding author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Anorectal Surg, Shanghai, Peoples R China.	yangxuejun@shutcm.edu.cn; herrmayor@126.com; billgmy@shutcm.edu.cn			National Natural Science Foundation of China [81774112]; Project of Sichuan Provincial Science and Technology Department [2018JY0501]; Siming Scholars from Shuguang Hospital [SGXZ-201913]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Sichuan Provincial Science and Technology Department; Siming Scholars from Shuguang Hospital	This work was supported by the National Natural Science Foundation of China (grant no. 81774112), the Project of Sichuan Provincial Science and Technology Department (grant no. 2018JY0501) and a grant from Siming Scholars from Shuguang Hospital (grant no. SGXZ-201913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi M, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165968; Bartlomiejczyk MA, 2019, CURR CARDIOVASC RISK, V13, DOI 10.1007/s12170-019-0597-x; Bertuccio P, 2021, EUR UROL ONCOL, V4, P677, DOI 10.1016/j.euo.2021.05.005; Biondi-Zoccai G., 2016, UMBRELLA REV EVIDENC; Blais JE, 2021, ATHEROSCLEROSIS, V328, P44, DOI 10.1016/j.atherosclerosis.2021.05.016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dy GW, 2017, EUR UROL, V71, P437, DOI 10.1016/j.eururo.2016.10.008; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Grimm MO, 2019, EUR UROL, V76, P368, DOI 10.1016/j.eururo.2019.05.041; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Hassanabad AF, 2019, AM J CLIN ONCOL-CANC, V42, P732, DOI 10.1097/COC.0000000000000579; He YZ, 2018, ANN INTERN MED, V169, P543, DOI 10.7326/M18-0808; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Jeong IG, 2021, CLIN CANCER RES, V27, P5004, DOI 10.1158/1078-0432.CCR-21-0480; Khan SU, 2019, ANN INTERN MED, V171, P190, DOI 10.7326/M19-0341; Kockelbergh R, 2017, J CLIN UROL, V10, P3, DOI 10.1177/2051415816674103; Kyrgiou M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j477; Li X, 2018, BRIT J CLIN PHARMACO, V84, P1109, DOI 10.1111/bcp.13559; Li Y, 2019, CANCER MED-US, V8, P3305, DOI 10.1002/cam4.2151; Liu B., 2017, RELATIONSHIP STATINS; Markozannes G., 2017, BMC PSYCHOL, V5, P1, DOI [10.1186/s40359-016-0170-z, DOI 10.1186/S40359-016-0170-Z]; Mei ZB, 2017, INT J CANCER, V140, P1068, DOI 10.1002/ijc.30526; Miyazawa Y., 2021, AACR; Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI 10.14306/renhyd.20.2.223; Mulchandani R, 2020, EXPERT OPIN DRUG SAF, V19, P1011, DOI 10.1080/14740338.2020.1796966; Pose E, 2019, J HEPATOL, V70, P194, DOI 10.1016/j.jhep.2018.07.019; Richters A, 2020, WORLD J UROL, V38, P1895, DOI 10.1007/s00345-019-02984-4; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Xu WH, 2021, ARCH GYNECOL OBSTET, V304, P1315, DOI 10.1007/s00404-021-06065-z; Yang H, 2020, J CLIN PHARM THER, V45, P488, DOI 10.1111/jcpt.13092; Yang PR, 2020, CANCERS, V12, DOI 10.3390/cancers12082055	37	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264076	10.1371/journal.pone.0264076	http://dx.doi.org/10.1371/journal.pone.0264076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235590	gold, Green Published			2022-12-26	WOS:000787073100016
J	Buurstede, JC; Paul, SN; De Bosscher, K; Meijer, OC; Kroon, J				Buurstede, Jacobus C.; Paul, Susana N.; De Bosscher, Karolien; Meijer, Onno C.; Kroon, Jan			Hepatic glucocorticoid-induced transcriptional regulation is androgen-dependent after chronic but not acute glucocorticoid exposure	FASEB JOURNAL			English	Article						androgen receptor; androgens; glucocorticoid receptor; glucocorticoids; liver	HEPATOCELLULAR-CARCINOMA; TARGET GENES; FATTY LIVER; RECEPTOR; GR; INHIBITION; RESISTANCE; STEATOSIS; HEALTH; ALPHA	Glucocorticoids exert their pleiotropic effects by activating the glucocorticoid receptor (GR), which is expressed throughout the body. GR-mediated transcription is regulated by a multitude of tissue- and cell type-specific mechanisms, including interactions with other transcription factors such as the androgen receptor (AR). We previously showed that the transcription of canonical glucocorticoid-responsive genes is dependent on active androgen signaling, but the extent of this glucocorticoid-androgen crosstalk warrants further investigation. In this study, we investigated the overall glucocorticoid-androgen crosstalk in the hepatic transcriptome. Male mice were exposed to GR agonist corticosterone and AR antagonist enzalutamide in order to determine the extent of androgen-dependency after acute and chronic exposure. We found that a substantial proportion of the hepatic transcriptome is androgen-dependent after chronic exposure, while after acute exposure the transcriptomic effects of glucocorticoids are largely androgen-independent. We propose that prolonged glucocorticoid exposure triggers a gradual upregulation of AR expression, instating a situation of androgen dependence which is likely not driven by direct AR-GR interactions. This indirect mode of glucocorticoid-androgen interaction is in accordance with the absence of enriched AR DNA-binding near AR-dependent corticosterone-regulated genes after chronic exposure. In conclusion, we demonstrate that glucocorticoid effects and their interaction with androgen signaling are dependent on the duration of exposure and believe that our findings contribute to a better understanding of hepatic glucocorticoid biology in health and disease.	[Buurstede, Jacobus C.; Paul, Susana N.; Meijer, Onno C.; Kroon, Jan] Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [De Bosscher, Karolien] UGent, VIB Ctr Med Biotechnol, Translat Nucl Receptor Res, Dept Biomol Med, Ghent, Belgium	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Flanders Institute for Biotechnology (VIB); Ghent University	Buurstede, JC; Kroon, J (corresponding author), Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	j.c.buurstede@lumc.nl; j.kroon@lumc.nl	Buurstede, Jacobus/G-6237-2019	Buurstede, Jacobus/0000-0002-3620-9311	Board of Directors of Leiden University Medical Center	Board of Directors of Leiden University Medical Center	JCB was funded with a PhD grant by the Board of Directors of Leiden University Medical Center	Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Atkinson HC, 2006, J NEUROENDOCRINOL, V18, P526, DOI 10.1111/j.1365-2826.2006.01444.x; Balakrishnan M, 2021, CLIN GASTROENTEROL H, V19, P61, DOI 10.1016/j.cgh.2020.04.067; Bebermeier JH, 2006, J MOL MED, V84, P919, DOI 10.1007/s00109-006-0081-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Bose SK, 2016, ENDOCRINOLOGY, V157, P4943, DOI 10.1210/en.2016-1615; Chen TY, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.141024; Claessens F, 2017, CELL MOL LIFE SCI, V74, P2217, DOI 10.1007/s00018-017-2467-3; Cohen DM, 2017, TRENDS ENDOCRIN MET, V28, P531, DOI 10.1016/j.tem.2017.04.001; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; De Bosscher K, 2020, NAT REV ENDOCRINOL, V16, P363, DOI 10.1038/s41574-020-0349-5; de Quervain D, 2017, NAT REV NEUROSCI, V18, P7, DOI 10.1038/nrn.2016.155; Della Torre S, 2018, J ENDOCRINOL, V238, P165, DOI 10.1530/JOE-18-0003; Della Torre S, 2018, CELL METAB, V28, P256, DOI 10.1016/j.cmet.2018.05.021; Donahue J L, 2000, Am J Ther, V7, P365, DOI 10.1097/00045391-200007060-00005; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Duma D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001077; Gasparini SJ, 2019, DIABETOLOGIA, V62, P1463, DOI 10.1007/s00125-019-4887-0; Hartig SM, 2012, CHEM BIOL, V19, P1126, DOI 10.1016/j.chembiol.2012.07.020; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helms TH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82252-x; Hemmer MC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08196-5; Hunt HJ, 2017, J MED CHEM, V60, P3405, DOI 10.1021/acs.jmedchem.7b00162; Jin HJ, 2013, TRANSL ANDROL UROL, V2, P158, DOI 10.3978/j.issn.2223-4683.2013.09.01; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kaikaew K, 2019, ENDOCRINOLOGY, V160, P2367, DOI 10.1210/en.2019-00194; Kroon J, 2021, MOL METAB, V47, DOI 10.1016/j.molmet.2021.101179; Kulik M, 2021, NUCLEIC ACIDS RES, V49, P3856, DOI 10.1093/nar/gkab185; Lee I, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000507; Lempiainen JK, 2017, MOL CELL PROTEOMICS, V16, P1462, DOI 10.1074/mcp.M117.067488; Li HK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46378-3; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma WL, 2014, ENDOCR-RELAT CANCER, V21, pR165, DOI 10.1530/ERC-13-0283; Ma WL, 2012, HEPATOLOGY, V56, P176, DOI 10.1002/hep.25644; Nixon M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9074; Pihlajamaa P, 2014, EMBO J, V33, P312, DOI 10.1002/embj.201385895; Presman DM, 2016, P NATL ACAD SCI USA, V113, P8236, DOI 10.1073/pnas.1606774113; Quatrini L, 2021, CELL MOL IMMUNOL, V18, P269, DOI 10.1038/s41423-020-00526-2; Quinn MA, 2018, CELL REP, V22, P2690, DOI 10.1016/j.celrep.2018.02.041; Quinn MA, 2016, FASEB J, V30, P971, DOI 10.1096/fj.15-278309; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Spaanderman DCE, 2019, J ENDOCRINOL, V240, P51, DOI 10.1530/JOE-18-0503; Spiga F, 2014, COMPR PHYSIOL, V4, P1273, DOI 10.1002/cphy.c140003; Timmermans S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01545; Wang YM, 2015, BIOCHEM PHARMACOL, V96, P357, DOI 10.1016/j.bcp.2015.06.018; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Whirledge S, 2018, ENDOCRINOLOGY, V159, P46, DOI 10.1210/en.2017-00728; Wilson S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32611; Woods CP, 2015, J STEROID BIOCHEM, V154, P94, DOI 10.1016/j.jsbmb.2015.07.020; Yang F, 2017, MOL CELL, V66, P321, DOI 10.1016/j.molcel.2017.03.019; Zheng DS, 2018, MOL CELL ENDOCRINOL, V471, P33, DOI 10.1016/j.mce.2017.05.025	55	1	1	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22251	10.1096/fj.202101313R	http://dx.doi.org/10.1096/fj.202101313R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35262955	Green Published			2022-12-26	WOS:000772957100008
J	Cooper, SL; Wragg, ES; Pannucci, P; Soave, M; Hill, SJ; Woolard, J				Cooper, Samantha L.; Wragg, Edward S.; Pannucci, Patrizia; Soave, Mark; Hill, Stephen J.; Woolard, Jeanette			Regionally selective cardiovascular responses to adenosine A(2A) and A(2B) receptor activation	FASEB JOURNAL			English	Article						A(2) receptor activation; adenosine; Doppler flow; hemodynamics	K-ATP CHANNEL; CUTTING EDGE; MICE LACKING; AGONIST; CELLS; RELAXATION; MECHANISM; BINDING; KIDNEY	Adenosine is a local mediator that regulates changes in the cardiovascular system via activation of four G protein-coupled receptors (A(1), A(2A), A(2B), A(3)). Here, we have investigated the effect of A(2A) and A(2B)-selective agonists on vasodilatation in three distinct vascular beds of the rat cardiovascular system. NanoBRET ligand binding studies were used to confirm receptor selectivity. The regional hemodynamic effects of adenosine A(2A) and A(2B) selective agonists were investigated in conscious rats. Male Sprague-Dawley rats (350-450 g) were chronically implanted with pulsed Doppler flow probes on the renal artery, mesenteric artery, and the descending abdominal aorta. Cardiovascular responses were measured following intravenous infusion (3 min for each dose) of the A(2A)-selective agonist CGS 21680 (0.1, 0.3, 1 mu g kg(-1) min(-1)) or the A(2B)-selective agonist BAY 60-6583 (4,13.3, 40 mu g kg(-1) min(-1)) following predosing with the A(2A)-selective antagonist SCH 58261 (0.1 or 1 mg kg(-1) min(-1)), the A(2B)/A(2A) antagonist PSB 1115 (10 mg kg(-1) min(-1)) or vehicle. The A(2A)-selective agonist CGS 21680 produced a striking increase in heart rate (HR) and hindquarters vascular conductance (VC) that was accompanied by a significant decrease in mean arterial pressure (MAP) in conscious rats. In marked contrast, the A(2B)-selective agonist BAY 60-6583 significantly increased HR and VC in the renal and mesenteric vascular beds, but not in the hindquarters. Taken together, these data indicate that A(2A) and A(2B) receptors are regionally selective in their regulation of vascular tone. These results suggest that the development of A(2B) receptor agonists to induce vasodilatation in the kidney may provide a good therapeutic approach for the treatment of acute kidney injury.	[Cooper, Samantha L.; Wragg, Edward S.; Pannucci, Patrizia; Soave, Mark; Hill, Stephen J.; Woolard, Jeanette] Univ Nottingham, Sch Life Sci, Div Physiol, Nottingham, England; [Cooper, Samantha L.; Wragg, Edward S.; Pannucci, Patrizia; Soave, Mark; Hill, Stephen J.; Woolard, Jeanette] Univ Birmingham, Ctr Membrane Prot & Receptors, Birmingham, W Midlands, England; [Cooper, Samantha L.; Wragg, Edward S.; Pannucci, Patrizia; Soave, Mark; Hill, Stephen J.; Woolard, Jeanette] Univ Nottingham, Midlands, England	University of Nottingham; University of Birmingham; University of Nottingham	Woolard, J (corresponding author), Univ Nottingham, Sch Life Sci, Div Physiol Pharmacol & Neurosci, Nottingham NG7 2UH, England.	jeanette.woolard@nottingham.ac.uk	Hill, Stephen/N-6753-2013	Hill, Stephen/0000-0002-4424-239X; Cooper, Samantha/0000-0002-9062-5893; Soave, Mark/0000-0002-9199-1772; Woolard, Jeanette/0000-0001-5406-6847	British Heart Foundation (BHF) [PG/14/95/31248]; RCUK | Medical Research Council (MRC) [MR/N020081/1]; European Union [858070]	British Heart Foundation (BHF)(British Heart Foundation); RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission)	British Heart Foundation (BHF), Grant/Award Number: PG/14/95/31248; RCUK | Medical Research Council (MRC), Grant/Award Number: MR/N020081/1; European Union's Horizon 2020 Research and Innovation Program (H2020--MSCA--ITN Program), Grant/Award Number: 858070	Alberti C, 1997, J CARDIOVASC PHARM, V30, P320, DOI 10.1097/00005344-199709000-00008; AREND LJ, 1985, CIRC RES, V56, P242, DOI 10.1161/01.RES.56.2.242; Borea PA, 2018, PHYSIOL REV, V98, P1591, DOI 10.1152/physrev.00049.2017; Carter JJ, 2017, FASEB J, V31, P1193, DOI 10.1096/fj.201600749R; CHURCHILL PC, 1987, AM J PHYSIOL, V252, pF299, DOI 10.1152/ajprenal.1987.252.2.F299; Cooper SL, 2020, BRIT J PHARMACOL, V177, P346, DOI 10.1111/bph.14870; Cooper SL, 2019, BRIT J PHARMACOL, V176, P864, DOI 10.1111/bph.14575; Corriden R, 2014, FASEB J, V28, P4211, DOI 10.1096/fj.13-247270; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; Dionisotti S, 1997, BRIT J PHARMACOL, V121, P353, DOI 10.1038/sj.bjp.0701119; El-Mas MM, 2011, TOXICOL APPL PHARM, V254, P229, DOI 10.1016/j.taap.2011.04.014; EVONIUK G, 1987, J PHARMACOL EXP THER, V240, P428; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Feng MG, 2010, AM J PHYSIOL-RENAL, V299, pF310, DOI 10.1152/ajprenal.00149.2010; Franco R, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10112831; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Goulding J, 2018, BIOCHEM PHARMACOL, V147, P55, DOI 10.1016/j.bcp.2017.10.013; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Headrick JP, 2013, PHARMACOL THERAPEUT, V140, P92, DOI 10.1016/j.pharmthera.2013.06.002; Hinz S, 2014, J PHARMACOL EXP THER, V349, P427, DOI 10.1124/jpet.113.210849; HOLZ FG, 1987, RENAL PHYSIOL BIOCH, V10, P272; HUTCHISON AJ, 1989, J PHARMACOL EXP THER, V251, P47; Ichinose TK, 2009, AM J PHYSIOL-HEART C, V296, pH1058, DOI 10.1152/ajpheart.00906.2008; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jamwal S, 2019, CURR PHARM DESIGN, V25, P2892, DOI 10.2174/1381612825666190716112319; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Lai EY, 2006, KIDNEY INT, V70, P690, DOI 10.1038/sj.ki.5001650; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Lee TK, 2009, J CARDIOVASC PHARM, V53, P167, DOI 10.1097/FJC.0b013e318198ca6b; Linden J, 1999, MOL PHARMACOL, V56, P705; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P2097, DOI 10.1161/ATVBAHA.111.226837; MATHOT RAA, 1995, BRIT J PHARMACOL, V114, P761, DOI 10.1111/j.1476-5381.1995.tb13270.x; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Ponnoth DS, 2009, AM J PHYSIOL-HEART C, V297, pH1655, DOI 10.1152/ajpheart.00192.2009; Prentice DJ, 2002, N-S ARCH PHARMACOL, V366, P127, DOI 10.1007/s00210-002-0581-7; Rabadi MM, 2015, ACTA PHYSIOL, V213, P222, DOI 10.1111/apha.12402; Sanjani MS, 2011, AM J PHYSIOL-HEART C, V301, pH2322, DOI 10.1152/ajpheart.00052.2011; Sitkovsky MV, 2014, CANCER IMMUNOL RES, V2, P598, DOI 10.1158/2326-6066.CIR-14-0075; Soave M, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.250; SPIELMAN WS, 1991, HYPERTENSION, V17, P117, DOI 10.1161/01.HYP.17.2.117; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/NMETH.3398, 10.1038/nmeth.3398]; Sun BF, 2017, P NATL ACAD SCI USA, V114, P2066, DOI 10.1073/pnas.1621423114; Tang LL, 1999, AM J PHYSIOL-RENAL, V277, pF926, DOI 10.1152/ajprenal.1999.277.6.F926	46	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22214	10.1096/fj.202101945R	http://dx.doi.org/10.1096/fj.202101945R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CW	35230706	hybrid, Green Published			2022-12-26	WOS:000772946000001
J	Du, Y; Cao, ML; Liu, YW; He, YQ; Yang, CX; Zhang, GL; Fan, YB; Gao, F				Du, Yan; Cao, Manlin; Liu, Yiwen; He, Yiqing; Yang, Cuixia; Zhang, Guoliang; Fan, Youben; Gao, Feng			Tumor microenvironment remodeling modulates macrophage phenotype in breast cancer lymphangiogenesis	FASEB JOURNAL			English	Article						bone marrow-derived macrophages; hyaluronan remodeling; LMW-HA; lymphangiogenesis; tumor microenvironment	MOLECULAR-WEIGHT HYALURONAN; ANGIOGENESIS; CELLS; OLIGOSACCHARIDES; INDUCTION; MONOCYTES; NODE	Hyaluronan (HA) is dynamically remodeled in tumor microenvironment (TME) and is reported to be closely related to tumor lymphatic metastasis by inducing lymphangiogenesis. Macrophages are known to be involved in neo-lymphatic vessels formation. However, few studies have investigated the role of HA-mediated TME remodeling on macrophages-dependent lymphangiogenesis. We previously showed that HA could drive macrophages to acquire the M2 phenotype. In this study, we attempt to study the crosstalk between HA in TME and macrophages dependent lymphangiogenesis. First, we found that the abundant assembly of HA in breast cancer tissue was accompanied by increased infiltration of macrophages featured by expressing lymphatic endothelial markers. Then, to further identify the remodeling of HA in regulating macrophage phenotype, we used HA fragments which are usually enriched in TME for this purpose. Our results showed that the reconstructed HA could induce bone marrow-derived macrophages (BMDMs) to express markers of lymphatic endothelium and form tube-like structures, suggesting a novel function of HA from TME on macrophages-dependent lymphangiogenesis. Finally, we found that inhibition of the HA-TLR4 pathway could reduce the ability of BMDMs to exhibit lymphatic endothelial phenotype. Our results provide new insight into tumor microenvironment remodeling and macrophages in breast cancer lymphangiogenesis.	[Du, Yan; Liu, Yiwen; He, Yiqing; Yang, Cuixia; Zhang, Guoliang; Gao, Feng] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Mol Biol, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Du, Yan; Yang, Cuixia; Gao, Feng] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Clin Lab, Shanghai, Peoples R China; [Cao, Manlin] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Rehabil Med, Shanghai, Peoples R China; [Fan, Youben] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Gen Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, F (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Mol Biol, 600 Yishan Rd, Shanghai 200233, Peoples R China.; Fan, YB (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Gen Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China.	ybfan@sjtu.edu.cn; gaofengly@sjtu.edu.cn	liu, yi/GXE-9662-2022		National Natural Science Foundation of China (NSFC) [81872357, 81974446, 81502490, 81974445, 82073199, 81572821, 81672843, 81702852]; Shanghai Pujiang Program [2019PJD037]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20171924]; Shanghai Young Talents in Clinical Medical Technology [2017]; Sailing Program of Shanghai Committee of Science and Technology [14YF1412200]; Shanghai Shen-Kang Hospital Development Center [SHDC22014004]; Shanghai 'Rising Stars of Medical Talent' Youth Development Program Clinical Laboratory Practitioners Program [2021, 2020]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; Shanghai Young Talents in Clinical Medical Technology; Sailing Program of Shanghai Committee of Science and Technology; Shanghai Shen-Kang Hospital Development Center; Shanghai 'Rising Stars of Medical Talent' Youth Development Program Clinical Laboratory Practitioners Program	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81872357, 81974446, 81502490, 81974445, 82073199, 81572821, 81672843 and 81702852; Shanghai Pujiang Program, Grant/Award Number: 2019PJD037; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support, Grant/Award Number: 20171924; Shanghai Young Talents in Clinical Medical Technology, Grant/Award Number: 2017; the Sailing Program of Shanghai Committee of Science and Technology, Grant/Award Number: 14YF1412200; the Shanghai Shen-Kang Hospital Development Center, Grant/Award Number: SHDC22014004; Shanghai 'Rising Stars of Medical Talent' Youth Development Program Clinical Laboratory Practitioners Program, Grant/Award Number: 2020; Shanghai 'Rising Stars of Medical Talent' Youth Development Program Clinical Laboratory Practitioners Program, Grant/Award Number: 2021	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Arneth B, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56010015; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Bauer J, 2018, J MOL MED, V96, P199, DOI 10.1007/s00109-017-1615-4; Bieniasz-Krzywiec P, 2019, CELL METAB, V30, P917, DOI 10.1016/j.cmet.2019.07.015; Bron S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1073882; Caon I, 2020, SEMIN CANCER BIOL, V62, P9, DOI 10.1016/j.semcancer.2019.07.007; Changming W, 2011, LYMPHOLOGY, V44, P48; Chanmee T, 2016, CANCER LETT, V375, P20, DOI 10.1016/j.canlet.2016.02.031; Corliss BA, 2016, MICROCIRCULATION, V23, P95, DOI 10.1111/micc.12259; Da W, 2019, INT J IMMUNOPATH PH, V33, DOI 10.1177/2058738419861600; Danussi C, 2008, MOL CELL BIOL, V28, P4026, DOI 10.1128/MCB.02062-07; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; Du Y, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232235; Gomes FG, 2013, LIFE SCI, V92, P101, DOI 10.1016/j.lfs.2012.10.008; Guo QJ, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9720912; Hall KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031794; Hinshaw DC, 2019, CANCER RES, V79, P4557, DOI 10.1158/0008-5472.CAN-18-3962; Horton MR, 1999, J IMMUNOL, V162, P4171; Hu XT, 2018, CANCER SCI, V109, P3005, DOI 10.1111/cas.13738; Huang CY, 2017, SAUDI MED J, V38, P237, DOI 10.15537/smj.2017.3.16245; Hwang I, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02618-z; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Jung YJ, 2015, BIOCHEM BIOPH RES CO, V466, P339, DOI 10.1016/j.bbrc.2015.09.023; Karousou E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/606458; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Lee JY, 2010, CIRCULATION, V122, P1413, DOI 10.1161/CIRCULATIONAHA.110.941468; Li ZY, 2018, J IMMUNOL, V200, P2826, DOI 10.4049/jimmunol.1701471; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Pereira ER, 2018, SCIENCE, V359, P1403, DOI 10.1126/science.aal3622; Poltavets V, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00431; Rayahin JE, 2015, ACS BIOMATER SCI ENG, V1, P481, DOI 10.1021/acsbiomaterials.5b00181; Ren B, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0858-1; Riabov V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00075; Schmaus A, 2014, BRIT J CANCER, V111, P559, DOI 10.1038/bjc.2014.332; Schmieder A, 2011, INT J CANCER, V129, P122, DOI 10.1002/ijc.25657; Sokolowska M, 2014, J BIOL CHEM, V289, P4470, DOI 10.1074/jbc.M113.515106; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; van't Hull EF, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29080; Volk-Draper L, 2019, AM J PATHOL, V189, P2269, DOI 10.1016/j.ajpath.2019.07.006; Wu H, 2012, J SURG ONCOL, V106, P462, DOI 10.1002/jso.23110; Wu M, 2015, FASEB J, V29, P1290, DOI 10.1096/fj.14-259978; Yan SS, 2020, CANCER LETT, V488, P18, DOI 10.1016/j.canlet.2020.04.021; Yu MS, 2015, EXP CELL RES, V336, P150, DOI 10.1016/j.yexcr.2015.06.014; Zhang BK, 2019, CANCER IMMUNOL IMMUN, V68, P189, DOI 10.1007/s00262-018-2261-6; Zhang GL, 2019, FEBS J, V286, P3148, DOI 10.1111/febs.14859; Zhang GL, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1172154; Zhang Y, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03385-x	49	1	1	6	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22248	10.1096/fj.202101230R	http://dx.doi.org/10.1096/fj.202101230R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0DC	35239213				2022-12-26	WOS:000772946600001
J	Clark, NM; Janaka, SK; Hartman, W; Stramer, S; Goodhue, E; Weiss, J; Evans, DT; Connor, JP				Clark, Natasha M.; Janaka, Sanath Kumar; Hartman, William; Stramer, Susan; Goodhue, Erin; Weiss, John; Evans, David T.; Connor, Joseph P.			Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection	PLOS ONE			English	Article							DEPENDENT ENHANCEMENT; VIRUS-INFECTION; CORONAVIRUS	The novel coronavirus, SARS-CoV-2 that causes COVID-19 has resulted in the death of nearly 4 million people within the last 18 months. While preventive vaccination, and monoclonal antibody therapies have been rapidly developed and deployed, early in the pandemic the use of COVID-19 convalescent plasma (CCP) was a common means of passive immunization with a theoretical risk of antibody-dependent enhancement (ADE) of viral infection. Though vaccines elicit a strong and protective immune response and transfusion of CCP with high titers of neutralization activity are correlated with better clinical outcomes, the question of whether antibodies in CCP can enhance infection of SARS-CoV-2 has not been directly addressed. In this study, we analyzed for and observed passive transfer of neutralization activity with CCP transfusion. Furthermore, to specifically understand if antibodies against the spike protein (S) enhance infection, we measured the anti-S IgG, IgA, and IgM responses and adapted retroviral-pseudotypes to measure virus neutralization with target cells expressing the ACE2 virus receptor and the Fc alpha receptor (Fc alpha R) or Fc gamma receptor IIA (Fc gamma RIIA). Whereas neutralizing activity of CCP correlated best with higher titers of anti-S IgG antibodies, the neutralizing titer was not affected when Fc receptors were present on target cells. These observations support the absence of antibody-dependent enhancement of infection (ADE) by IgG and IgA isotypes found in CCP. The results presented, therefore, not only supports the therapeutic use of currently available antibody-based treatment, including the continuation of CCP transfusion strategies, but also the use of various vaccine platforms in a prophylactic approach.	[Clark, Natasha M.; Janaka, Sanath Kumar; Hartman, William; Evans, David T.; Connor, Joseph P.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Stramer, Susan; Goodhue, Erin; Weiss, John] Amer Red Cross, Washington, DC USA; [Evans, David T.] Wisconsin Natl Primate Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; American Red Cross	Connor, JP (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.	jconnor@UWHealth.org		Connor, Joseph/0000-0002-1799-8335; Clark, Natasha/0000-0002-3152-892X	University of Wisconsin Department of Pathology and Laboratory Medicine; NIH/NCI [P30 CA014520]; Research and Development funds	University of Wisconsin Department of Pathology and Laboratory Medicine; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research and Development funds	This study was funded by Research and Development funds provided to Joseph Connor, MD by the University of Wisconsin Department of Pathology and Laboratory Medicine (no grant number assigned) and was supported in part by NIH/NCI P30 CA014520-UW Comprehensive Cancer Center through the use of its shared services support. The funders listed had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AS, 2016, HUM VACC IMMUNOTHER, V12, P2351, DOI 10.1080/21645515.2016.1177688; Arvin AM, 2020, NATURE, V584, P353, DOI 10.1038/s41586-020-2538-8; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Cele S, 2021, NATURE, V593, P142, DOI 10.1038/s41586-021-03471-w; Chen PL, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.584956; Crooks CM, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009641; Dong YJ, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.10003; Earle KA, 2021, VACCINE, V39, P4423, DOI 10.1016/j.vaccine.2021.05.063; Franchini Massimo, 2021, Mayo Clin Proc Innov Qual Outcomes, V5, P403, DOI 10.1016/j.mayocpiqo.2021.01.010; Gasser R, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108790; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hohdatsu T, 1998, J VET MED SCI, V60, P49, DOI 10.1292/jvms.60.49; Indenbaum V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241164; Janaka S. K., 2021, MEDRXIV, DOI [10.1101/2021.03.08.21253135, DOI 10.1101/2021.03.08.21253135]; Janaka SK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253551; Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11; Joyner M.J., 2020, MEDRXIV, DOI [10.1101/2020.08.12.20169359, DOI 10.1101/2020.08.12.20169359]; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Katz LM, 2021, NEW ENGL J MED, V384, P666, DOI 10.1056/NEJMe2035678; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Klassen SA, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.684151; Klassen SA, 2021, MAYO CLIN PROC, V96, P1262, DOI 10.1016/j.mayocp.2021.02.008; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Liu ZZ, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00402-5; Lo Sasso B, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11071135; Min L, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.671633; Moore JP, 2021, JAMA-J AM MED ASSOC, V325, P1251, DOI 10.1001/jama.2021.3465; Moore JP, 2020, J VIROL, V94, DOI 10.1128/JVI.01083-20; Murin CD, 2019, NAT MICROBIOL, V4, P734, DOI 10.1038/s41564-019-0392-y; Narayan R, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.580096; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Polack FP, 2003, NAT MED, V9, P1209, DOI 10.1038/nm918; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Rejeki MS, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100931; Ricke DO, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.640093; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rodriguez-Guerra Miguel, 2021, Drugs Context, V10, DOI 10.7573/dic.2020-10-3; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Starr TN, 2021, NATURE, V597, P97, DOI 10.1038/s41586-021-03807-6; Takano T, 2008, J VET MED SCI, V70, P1315, DOI 10.1292/jvms.70.1315; Welte T, 2021, EUR RESPIR REV, V30, DOI 10.1183/16000617.0384-2020; Wu F, 2020, JAMA INTERN MED, V180, P1356, DOI 10.1001/jamainternmed.2020.4616; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yip MS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-82; Zang JK, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00199-1; Zhang B-z HuY-f., 2020, BIORXIV, DOI [10.1101/2020.04.23.056853, DOI 10.1101/2020.04.23.056853]; Zhu MS, 2004, CELL MOL IMMUNOL, V1, P193; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	53	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0257930	10.1371/journal.pone.0257930	http://dx.doi.org/10.1371/journal.pone.0257930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259162	gold, Green Published			2022-12-26	WOS:000835141200003
J	Maeder, M; Guo, XD; Neff, F; Mathis, DS; Gossner, MM				Maeder, Marcus; Guo, Xianda; Neff, Felix; Mathis, Doris Schneider; Gossner, Martin M.			Temporal and spatial dynamics in soil acoustics and their relation to soil animal diversity	PLOS ONE			English	Article							DIURNAL ACTIVITY; FOREST; DECOMPOSITION; MICROCLIMATE; ECOLOGY; INDEXES; LITTER; FAUNA	The observation and assessment of animal biodiversity using acoustic technology has developed considerably in recent years. Current eco-acoustic research focuses on automatic audio recorder arrays and acoustic indices, which may be used to study the spatial and temporal dynamics of local animal communities in high resolution. While such soundscapes have often been studied above ground, their applicability in soils has rarely been tested. For the first time, we applied acoustic and statistical methods to explore the spatial, diurnal, and seasonal dynamics of the soundscape in soils. We studied the dynamics of acoustic complexity in forest soils in the alpine Pfynwald forest in the Swiss canton of Valais and related them to meteorological and microclimatic data. To increase microclimatic variability, we used a long-term irrigation experiment. We also took soil samples close to the sensors on 6 days in different seasons. Daily and seasonal patterns of acoustic complexity were predicted to be associated with abiotic parameters-that is, meteorological and microclimatic conditions-and mediated by the dynamics of the diversity and activity of the soil fauna. Seasonal patterns in acoustic complexity showed the highest acoustic complexity values in spring and summer, decreasing in fall and winter. Diurnal acoustic complexity values were highest in the afternoon and lowest during the night. The measurement of acoustic diversity at the sampling site was significantly associated with soil communities, with relationships between taxa richness or community composition and acoustic complexity being strongest shortly before taking the soil samples. Our results suggest that the temporal and spatial dynamics of the diversity and community composition of soil organisms can be predicted by the acoustic complexity of soil soundscapes. This opens up the possibility of using soil soundscape analysis as a noninvasive and easy-to-use method for soil biodiversity monitoring programs.	[Maeder, Marcus; Guo, Xianda] Swiss Fed Inst Technol, USYS TdLab, Zurich, Switzerland; [Maeder, Marcus] Zurich Univ Arts ZHdK, Inst Comp Mus & Sound Technol, Zurich, Switzerland; [Maeder, Marcus; Gossner, Martin M.] Swiss Fed Inst Technol, Inst Terr Ecosyst, Zurich, Switzerland; [Neff, Felix; Mathis, Doris Schneider; Gossner, Martin M.] Swiss Fed Inst Forest Snow & Landscape Res WSL, Forest Hlth & Biot Interact, Birmensdorf, Switzerland; [Neff, Felix] Agroscope, Agroecol & Environm, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Research Station Agroscope	Maeder, M (corresponding author), Swiss Fed Inst Technol, USYS TdLab, Zurich, Switzerland.; Maeder, M (corresponding author), Zurich Univ Arts ZHdK, Inst Comp Mus & Sound Technol, Zurich, Switzerland.; Maeder, M; Gossner, MM (corresponding author), Swiss Fed Inst Technol, Inst Terr Ecosyst, Zurich, Switzerland.; Gossner, MM (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Forest Hlth & Biot Interact, Birmensdorf, Switzerland.	marcus.maeder@zhdk.ch; martin.gossner@wsl.ch	Maeder, Marcus/P-4878-2017	Maeder, Marcus/0000-0002-3469-0172; Neff, Felix/0000-0001-7266-2589	MM - 20'000 CHF - Biovision Foundation	MM - 20'000 CHF - Biovision Foundation	MM - 20'000 CHF - Biovision Foundation - www.biovision.ch - NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay L, 2020, FRESHW SCI, V39, P356, DOI 10.1086/709130; BARONIURBANI C, 1988, INSECT SOC, V35, P241, DOI 10.1007/BF02224057; BLUMBERG AY, 1988, AGR ECOSYST ENVIRON, V20, P159, DOI 10.1016/0167-8809(88)90107-7; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Bo Tan, 2010, Acta Ecologica Sinica, V30, P93; Bose AK, 2022, ECOL MONOGR, V92, DOI 10.1002/ecm.1507; Campos-Cerqueira M, 2020, REMOTE SENS ECOL CON, V6, P274, DOI 10.1002/rse2.120; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Depraetere M, 2012, ECOL INDIC, V13, P46, DOI 10.1016/j.ecolind.2011.05.006; Dervash M., 2018, INT J ADV RES SCI EN, V7; DiCarlo DA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017811; Dombos M, 2017, METHODS ECOL EVOL, V8, P313, DOI 10.1111/2041-210X.12662; Dunger W, 1983, TIERE IM BODEN; Farina A, 2019, BIOSYSTEMS, V183, DOI 10.1016/j.biosystems.2019.103986; Flammer I, 2001, J APPL GEOPHYS, V46, P115, DOI 10.1016/S0926-9851(01)00032-5; Fox J., 2019, R COMPANION APPL REG, V.; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Gagliano M, 2012, TRENDS PLANT SCI, V17, P323, DOI 10.1016/j.tplants.2012.03.002; Gasc A, 2013, ECOL INDIC, V25, P279, DOI 10.1016/j.ecolind.2012.10.009; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Gorres CM., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Grapsas N, 2014, INT J MULTIPHAS FLOW, V62, P30, DOI 10.1016/j.ijmultiphaseflow.2014.01.011; Harte J, 1996, SOIL BIOL BIOCHEM, V28, P313, DOI 10.1016/0038-0717(95)00139-5; Heiniger C, 2015, SOIL BIOL BIOCHEM, V86, P181, DOI 10.1016/j.soilbio.2015.04.003; Herrera-Montes MI, 2011, URBAN ECOSYST, V14, P415, DOI 10.1007/s11252-011-0158-7; Herzog C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096321; Inyang EI, 2019, INSECTS, V10, DOI 10.3390/insects10090267; Joo W, 2011, LANDSCAPE URBAN PLAN, V103, P259, DOI 10.1016/j.landurbplan.2011.08.001; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Karyanto A., 2008, HDB TROPICAL SOIL BI, P85; Koerner RM., 1981, ACOUSTIC EMISSIONS G; Kohler G., 2014, MULLER BAHRMANN BEST; Kramer K., 2021, COUNTING COST 2021 Y; Krause B, 2008, J AUDIO ENG SOC, V56, P73; Krause B, 2016, BIOL CONSERV, V195, P245, DOI 10.1016/j.biocon.2016.01.013; Lacoste M., 2018, SCI REP-UK, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Linke S, 2020, FRESHWATER BIOL, V65, P86, DOI 10.1111/fwb.13227; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Maeder M., 2019, SOUNDSCAPE J, V18, P005; Mankin RW, 2007, J ECON ENTOMOL, V100, P790, DOI 10.1603/0022-0493(2007)100[790:AIFMIP]2.0.CO;2; Mennill DJ, 2012, METHODS ECOL EVOL, V3, P704, DOI 10.1111/j.2041-210X.2012.00209.x; Merchant ND, 2015, METHODS ECOL EVOL, V6, P257, DOI 10.1111/2041-210X.12330; Moebius F., 2013, 21584 ETH; Muller S, 2022, AGR ECOSYST ENVIRON, V328, DOI 10.1016/j.agee.2021.107845; Obrist Martin K., 2010, Abc Taxa, V8, P68; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pieretti N, 2011, ECOL INDIC, V11, P868, DOI 10.1016/j.ecolind.2010.11.005; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2020, R LANG ENV STAT COMP; Rillig MC, 2019, SOIL SYST, V3, DOI 10.3390/soilsystems3030045; Seeber J, 2005, PEDOBIOLOGIA, V49, P221, DOI 10.1016/j.pedobi.2004.10.003; SETALA H, 1988, BIOL FERT SOILS, V5, P282, DOI 10.1007/BF00262132; sjPlot, 2021, DATA VISUALIZATION S, DOI 10.5281/ZENODO.1308157; Stan Development Team, 2016, RSTAN R INT STAN; Stowell D, 2020, REMOTE SENS ECOL CON, V6, P217, DOI 10.1002/rse2.174; Sueur J, 2014, ACTA ACUST UNITED AC, V100, P772, DOI 10.3813/AAA.918757; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; Sulkava P, 1996, PEDOBIOLOGIA, V40, P505; Sulkava P., 2001, JYVASKYLA STUDIES BI; Thakur MP, 2014, OECOLOGIA, V175, P713, DOI 10.1007/s00442-014-2927-5; Verboom WC, 2005, SPECTRAL ANAL KNOCK; Villanueva-Rivera LJ., 2018, **DATA OBJECT**; WILLIAMS G, 1959, J ANIM ECOL, V28, P1, DOI 10.2307/2010; Zettel J., 1999, ILLUSTRIERTER BESTIM, V110; Zhang ML, 2003, J ECON ENTOMOL, V96, P1770, DOI 10.1603/0022-0493-96.6.1770	65	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0263618	10.1371/journal.pone.0263618	http://dx.doi.org/10.1371/journal.pone.0263618			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259175	Green Published, gold			2022-12-26	WOS:000835141200007
J	Mas-Ubillus, G; Ortiz, PJ; Huaringa-Marcelo, J; Sarzo-Miranda, P; Munoz-Aguirre, P; Diaz-Ramos, A; Arribasplata-Purizaca, K; Mendoza, D; Rojas-Poma, J; Marcelo-Ruiz, C; Ayala-Diaz, P; Hidalgo-Arroyo, E; Tupia-Cespedes, L				Mas-Ubillus, Guiliana; Ortiz, Pedro J.; Huaringa-Marcelo, Jorge; Sarzo-Miranda, Paola; Munoz-Aguirre, Patricia; Diaz-Ramos, Alejandra; Arribasplata-Purizaca, Kattia; Mendoza, Doris; Rojas-Poma, Juan; Marcelo-Ruiz, Cristian; Ayala-Diaz, Pedro; Hidalgo-Arroyo, Edwin; Tupia-Cespedes, Lourdes			High mortality among hospitalized adult patients with COVID-19 pneumonia in Peru: A single centre retrospective cohort study	PLOS ONE			English	Article								Background Peru is the country with the world's highest COVID-19 death rate per capita. Characteristics associated with increased mortality among adult patients with COVID-19 pneumonia in this setting are not well described. Methods Retrospective, single-center cohort study including 1537 adult patients hospitalized with a diagnosis of SARS-CoV-2 pneumonia between May 2020 and August 2020 at a national hospital in Lima, Peru. The primary outcome measure was in-hospital mortality. Results In-hospital mortality was 49.71%. The mean age was 60 +/- 14.25 years, and 68.38% were males. We found an association between mortality and inflammatory markers, mainly leukocytes, D-dimer, lactate dehydrogenase, C-reactive protein and ferritin. A multivariate model adjusted for age, hypertension, diabetes mellitus, and corticosteroid use demonstrated that in-hospital mortality was associated with greater age (RR: 2.01, 95%CI: 1.59-2.52) and a higher level of oxygen requirement (RR: 2.77, 95%CI: 2.13-3.62). Conclusions: In-hospital mortality among COVID-19 patients in Peru is high and is associated with greater age and higher oxygen requirements.	[Mas-Ubillus, Guiliana; Ortiz, Pedro J.; Huaringa-Marcelo, Jorge; Sarzo-Miranda, Paola; Munoz-Aguirre, Patricia; Diaz-Ramos, Alejandra; Arribasplata-Purizaca, Kattia; Mendoza, Doris; Rojas-Poma, Juan; Marcelo-Ruiz, Cristian; Ayala-Diaz, Pedro; Hidalgo-Arroyo, Edwin; Tupia-Cespedes, Lourdes] Hosp Nacl Arzobispo Loayza, Dept Emergency, Lima, Peru; [Mas-Ubillus, Guiliana; Ortiz, Pedro J.; Munoz-Aguirre, Patricia; Diaz-Ramos, Alejandra; Ayala-Diaz, Pedro; Hidalgo-Arroyo, Edwin; Tupia-Cespedes, Lourdes] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru; [Huaringa-Marcelo, Jorge] Univ Cient Sur Carr, Fac Med, Lima, Peru	Universidad Peruana Cayetano Heredia	Ortiz, PJ (corresponding author), Hosp Nacl Arzobispo Loayza, Dept Emergency, Lima, Peru.; Ortiz, PJ (corresponding author), Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru.	pedro.ortiz@upch.pe	Mendoza, Doris/HHT-0772-2022	Ayala Diaz, Pedro/0000-0002-9108-0901; Ortiz, Pedro J/0000-0001-8071-8650				Abate SM, 2021, ANN MED SURG, V64, DOI 10.1016/j.amsu.2021.102204; Agencia Peruana de Noticias, 2021, HLTH MIN PER IS PREP; [Anonymous], 2021, COVID 19 DASHBOARD C; [Anonymous], 2021, MINISTERIO SALUD; [Anonymous], 2021, HOSP NACL ARZOBISPO; Baskaran V, 2021, J MED MICROBIOL, V70, DOI 10.1099/jmm.0.001350; Bellan M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77698-4; Booth A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247461; Brown SM, 2016, CHEST, V150, P307, DOI 10.1016/j.chest.2016.01.003; Chatterjee NA, 2021, INFLUENZA OTHER RESP, V15, P569, DOI 10.1111/irv.12869; Chaudhary AH, 2021, INT J CONSUM STUD, V45, P478, DOI 10.1111/ijcs.12638; Chedid M, 2021, J INFECT PUBLIC HEAL, V14, P570, DOI 10.1016/j.jiph.2021.02.001; Chemical and Engineering News (CEN), 2020, DEV COUNTR FAC DIAGN; Chong WH, 2021, INFECTION, V49, P591, DOI 10.1007/s15010-021-01602-z; Chua F, 2021, THORAX, V76, P696, DOI 10.1136/thoraxjnl-2020-216425; Fabre V, 2022, INFECT CONT HOSP EP, V43, P570, DOI 10.1017/ice.2021.175; Feng Y, 2020, AM J RESP CRIT CARE, V201, P1380, DOI 10.1164/rccm.202002-0445OC; FOPH, 2020, SCARC MED OX WORLDW, P2020; Quispe-Canari JF, 2021, SAUDI PHARM J, V29, P1, DOI 10.1016/j.jsps.2020.12.001; Garcia PJ, 2019, LANCET, V394, P2119, DOI 10.1016/S0140-6736(19)32527-9; Gras M, 2021, ANN PHARM FR, V79, P522, DOI 10.1016/j.pharma.2021.02.003; Gue YX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78505-w; HelpPeru, 2021, OX CRIS PER; Herrera-Anazco P, 2021, INT J HEALTH PLAN M, V36, P995, DOI 10.1002/hpm.3135; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Instituto de Evaluacion de Tecnologias en Salud e Investigacion, 2021, GUIA PRACT CLIN MAN; Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414; Kamran SM, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.11368; Khan MMA, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020503; Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9; Lopez-Pais J, 2021, PREV MED REP, V21, DOI 10.1016/j.pmedr.2020.101298; Martinez-Valle A, 2021, J PUBLIC HEALTH POL, V42, P27, DOI 10.1057/s41271-020-00269-4; Mejia F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244171; Miller MJ, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008265; Ministerio de Salud, 2021, US; Ministerio de Salud. Lima-Peru. MINSA, 2020, DOC TECN MAN AMB PER; Montenegro-Idrogo Juan José, 2020, Rev. perú. med. exp. salud publica, V37, P781, DOI 10.17843/rpmesp.2020.374.5786; National Health Commission of the People's Republic of China, 2021, UPD NOV COR PNEUM OU; Noor FM, 2020, J COMMUN HEALTH, V45, P1270, DOI 10.1007/s10900-020-00920-x; opencovid, 2021, OPEN COVID PERU; Melo JRR, 2021, CAD SAUDE PUBLICA, V37, DOI [10.1590/0102-311X00053221, 10.1590/0102-311x00053221]; Rees GH, 2021, INT J HEALTH PLAN M, V36, P190, DOI 10.1002/hpm.3127; Rocha R, 2021, LANCET GLOB HEALTH, V9, pE782, DOI 10.1016/S2214-109X(21)00081-4; Ryu S, 2021, J INFECT DIS, V224, P949, DOI [10.1093/infdis/jiab708, 10.1093/infdis/jiab208]; Sanz F, 2015, RESPIROLOGY, V20, P813, DOI 10.1111/resp.12560; Schwalb A, 2021, AM J TROP MED HYG, V104, P1176, DOI 10.4269/ajtmh.20-1323; Staub MB, 2021, INFECT CONT HOSP EP, V42, P810, DOI 10.1017/ice.2020.1291; Tandon T, 2021, J EDUC HEALTH PROMOT, V10, DOI 10.4103/jehp.jehp_481_20; Taylor L, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n611; Vidal-Anzardo Margot, 2020, Rev. perú. med. exp. salud publica, V37, P203, DOI 10.17843/rpmesp.2020.372.5534; Videnza Consultores, 2021, PER HLTH SYST, DOI [10.6084/m9.figshare.14977839.v1, DOI 10.6084/M9.FIGSHARE.14977839.V1]; World Health Organization, 2021, PUBL HLTH EM INT CON; Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016; Zhang AR, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10030232	54	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0265089	10.1371/journal.pone.0265089	http://dx.doi.org/10.1371/journal.pone.0265089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259196	gold, Green Published			2022-12-26	WOS:000835141200044
J	Xue, JS; Jiang, YJ; Zheng, YB; Xiong, SH				Xue, Jinshun; Jiang, Yingjun; Zheng, Yuanbiao; Xiong, Shaohui			Laboratory evaluation of the effect of compaction method and compaction work on the performance of SMA-13 mixture	PLOS ONE			English	Article							ASPHALT MIXTURE	The influence of compaction methods such as the Marshall compaction method (MCM), vibration compaction method (VCM) and gyration compaction method (GCM), on the performance of stone mastic asphalt (SMA-13) mixture has yet to be explored. Therefore, to compare the influences of compaction methods and work on the physical and mechanical properties of SMA-13 mixture, the volume parameters, mechanical properties, and gradation changes of SMA-13 mixture specimens prepared under different vibration compaction times, Marshall double-compaction numbers, and gyration compaction numbers were studied. The compaction method for SMA-13 mixture design was also proposed under the principle of optimum properties. Results demonstrate that the asphalt aggregate ratio and compaction work directly affect the volumetric properties (VV, VFA, and VMA) of asphalt mixture specimens while the raw material and mineral aggregate gradation were fixed. The influence of compaction work on physical properties is greater than that of asphalt aggregate ratio. The mechanical strength of VCM and GCM specimens is higher than that of MCM specimens under the same compaction work and the optimum asphalt aggregate ratio. With the increase in compaction work, the mechanical properties of SMA-13 mixture are improved at the same compaction method and the optimum asphalt aggregate ratio. The aggregate gradation of the SMA-13 mixture before and after compacted using VCM and GCM changes minimally compared with that of the SMA-13 mixture compacted by MCM. Thus, the compaction methods of VCM65 and GCM130 were recommended for SMA-13 mixture design.	[Xue, Jinshun] Hubei Univ Arts & Sci, Hubei Key Lab Power Syst Design & Test Elect Vehi, Xiangyang, Hubei, Peoples R China; [Xue, Jinshun] Hubei Univ Arts & Sci, Sch Civil Engn & Architecture, Xiangyang, Hubei, Peoples R China; [Jiang, Yingjun] Changan Univ, Key Lab Special Area Highway Engn Minist Educ, Xian, Shaanxi, Peoples R China; [Zheng, Yuanbiao; Xiong, Shaohui] Ningbo Commun Planning Inst Co Ltd, Ningbo, Zhejiang, Peoples R China	Hubei University of Arts & Science; Hubei University of Arts & Science; Chang'an University	Xue, JS (corresponding author), Hubei Univ Arts & Sci, Hubei Key Lab Power Syst Design & Test Elect Vehi, Xiangyang, Hubei, Peoples R China.; Xue, JS (corresponding author), Hubei Univ Arts & Sci, Sch Civil Engn & Architecture, Xiangyang, Hubei, Peoples R China.; Jiang, YJ (corresponding author), Changan Univ, Key Lab Special Area Highway Engn Minist Educ, Xian, Shaanxi, Peoples R China.	jinshunx@163.com; jyj@chd.edu.cn			Ningbo Transportation Bureau; Ningbo Communications Planning institute Co., Ltd.; Hubei Provincial Natural Science Foundation of China [2020CFB330]; Hubei Superior and Distinctive Discipline Group of "Mechatronics and Automobiles" [XKQ2021025]; Ningbo transportation technology project [202006]	Ningbo Transportation Bureau; Ningbo Communications Planning institute Co., Ltd.; Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Superior and Distinctive Discipline Group of "Mechatronics and Automobiles"; Ningbo transportation technology project	The project was funded by the Ningbo Transportation Bureau, the Ningbo Communications Planning institute Co., Ltd., and Hubei Provincial Natural Science Foundation of China under grant 2020CFB330, Hubei Superior and Distinctive Discipline Group of "Mechatronics and Automobiles" under grant XKQ2021025. YJ, YZ, and SX cooperated with one another to complete the Ningbo transportation technology project (No.202006) application, which also helped fund the project. YZ and SX receive salary support from Ningbo Communications Planning institute Co., Ltd. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, E20 JTG; Cheng YW, 2013, ADV MATER RES-SWITZ, V671-674, P1208, DOI 10.4028/www.scientific.net/AMR.671-674.1208; Cui WP, 2014, KEY ENG MATER, V599, P159, DOI 10.4028/www.scientific.net/KEM.599.159; Gallego J, 2020, MATERIALS, V13, DOI 10.3390/ma13020265; Georgiou P, 2016, MATER STRUCT, V49, P665, DOI 10.1617/s11527-015-0528-3; Goetz WilliamH., 1989, ASPHALT CONCRETE MIX, P5, DOI [10.1520/STP20066S, DOI 10.1520/STP20066S]; Huang QB, 2020, MATERIALS, V13, DOI 10.3390/ma13132964; Hunter A.E., 2004, 8 C ASPHALT PAVEMENT, P125; Jiang YJ, 2015, CONSTR BUILD MATER, V91, P111, DOI 10.1016/j.conbuildmat.2015.05.054; Jiang YJ, 2020, ROAD MATER PAVEMENT, V21, P1454, DOI 10.1080/14680629.2018.1553730; Jiang YJ, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002488; Jiang YJ, 2017, CONSTR BUILD MATER, V135, P612, DOI 10.1016/j.conbuildmat.2016.12.159; Li Y, 2018, TRANSPORT RES REC, V2672, P12, DOI 10.1177/0361198118790373; Ling JM, 2020, J TRANSP ENG B-PAVE, V146, DOI 10.1061/JPEODX.0000157; Luo YF, 2019, CONSTR BUILD MATER, V225, P214, DOI 10.1016/j.conbuildmat.2019.07.119; Ministry of Transport of the People's Republic of China, 2004, F402004 JTG; Ministry of Transport of the People's Republic of China, 2005, E422005 JTG; [沙爱民 SHA Aimin], 2008, [长安大学学报. 自然科学版, Journal of Chang'An University. Natural Science Edition], V28, P1; Song S, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13074002; Tapkin S, 2013, MATER RES-IBERO-AM J, V16, P546, DOI [10.1590/S1516-14392013000200033, 10.1590/S1516-14392013005000016]; Wang WS, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11061006; Wang XW, 2021, CONSTR BUILD MATER, V276, DOI 10.1016/j.conbuildmat.2021.122255; Wu BW, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11115145; Xie Xiaoguang., 2001, CHINA J HIGHWAY TRAN, V14, P9; Xu B, 2016, CONSTR BUILD MATER, V124, P846, DOI 10.1016/j.conbuildmat.2016.08.005; You QL, 2020, CONSTR BUILD MATER, V258, DOI 10.1016/j.conbuildmat.2020.120317	26	1	1	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0265097	10.1371/journal.pone.0265097	http://dx.doi.org/10.1371/journal.pone.0265097			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259197	Green Published, gold			2022-12-26	WOS:000835141200046
J	Ziauddeen, N; Gurdasani, D; O'Hara, ME; Hastie, C; Roderick, P; Yao, GQ; Alwan, NA				Ziauddeen, Nida; Gurdasani, Deepti; O'Hara, Margaret E.; Hastie, Claire; Roderick, Paul; Yao, Guiqing; Alwan, Nisreen A.			Characteristics and impact of Long Covid: Findings from an online survey	PLOS ONE			English	Article							FATIGUE SEVERITY SCALE	Background Long Covid is a public health concern that needs defining, quantifying, and describing. We aimed to explore the initial and ongoing symptoms of Long Covid following SARS-CoV-2 infection and describe its impact on daily life. Methods We collected self-reported data through an online survey using convenience non-probability sampling. The survey enrolled adults who reported lab-confirmed (PCR or antibody) or suspected COVID-19 who were not hospitalised in the first two weeks of illness. This analysis was restricted to those with self-reported Long Covid. Univariate comparisons between those with and without confirmed COVID-19 infection were carried out and agglomerative hierarchical clustering was used to identify specific symptom clusters, and their demographic and functional correlates. Results We analysed data from 2550 participants with a median duration of illness of 7.6 months (interquartile range (IQR) 7.1-7.9). 26.5% reported lab-confirmation of infection. The mean age was 46.5 years (standard deviation 11 years) with 82.8% females and 79.9% of participants based in the UK. 89.5% described their health as good, very good or excellent before COVID-19. The most common initial symptoms that persisted were exhaustion, chest pressure/tightness, shortness of breath and headache. Cognitive dysfunction and palpitations became more prevalent later in the illness. Most participants described fluctuating (57.7%) or relapsing symptoms (17.6%). Physical activity, stress, and sleep disturbance commonly triggered symptoms. A third (32%) reported they were unable to live alone without any assistance at six weeks from start of illness. 16.9% reported being unable to work solely due to COVID-19 illness. 37.0% reported loss of income due to illness, and 64.4% said they were unable to perform usual activities/duties. Acute systems clustered broadly into two groups: a majority cluster (n = 2235, 88%) with cardiopulmonary predominant symptoms, and a minority cluster (n = 305, 12%) with multisystem symptoms. Similarly, ongoing symptoms broadly clustered in two groups; a majority cluster (n = 2243, 88.8%) exhibiting mainly cardiopulmonary, cognitive symptoms and exhaustion, and a minority cluster (n = 283, 11.2%) exhibiting more multisystem symptoms. Belonging to the more severe multisystem cluster was associated with more severe functional impact, lower income, younger age, being female, worse baseline health, and inadequate rest in the first two weeks of the illness, with no major differences in the cluster patterns when restricting analysis to the lab-confirmed subgroup. Conclusion This is an exploratory survey of Long Covid characteristics. Whilst this is a non-representative population sample, it highlights the heterogeneity of persistent symptoms, and the significant functional impact of prolonged illness following confirmed or suspected SARS-CoV2 infection. To study prevalence, predictors and prognosis, research is needed in a representative population sample using standardised case definitions.	[Ziauddeen, Nida; Roderick, Paul; Alwan, Nisreen A.] Univ Southampton, Sch Primary Care Populat Sci & Med Educ, Fac Med, Southampton, Hants, England; [Ziauddeen, Nida; Alwan, Nisreen A.] NIHR Appl Res Collaborat Wessex, Southampton, Hants, England; [Gurdasani, Deepti] Queen Mary Univ London, William Harvey Res Inst, London, England; [O'Hara, Margaret E.; Hastie, Claire] Long Covid Support Www Longcovid Org, London, England; [Yao, Guiqing] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Alwan, Nisreen A.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Alwan, Nisreen A.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	University of Southampton; University of London; Queen Mary University London; University of Leicester; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Ziauddeen, N; Alwan, NA (corresponding author), Univ Southampton, Sch Primary Care Populat Sci & Med Educ, Fac Med, Southampton, Hants, England.; Ziauddeen, N; Alwan, NA (corresponding author), NIHR Appl Res Collaborat Wessex, Southampton, Hants, England.; Alwan, NA (corresponding author), Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.; Alwan, NA (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.	Nida.Ziauddeen@soton.ac.uk; N.A.Alwan@soton.ac.uk	Alwan, Nisreen A./AFP-0662-2022	Alwan, Nisreen A./0000-0002-4134-8463; Ziauddeen, Nida/0000-0002-8964-5029				Altmann DM, 2020, BMJ; Alwan N.A., 2020, WELLCOME OPEN RES, V39, P73, DOI [10.12688/wellcomeopenres.16307.1, DOI 10.12688/WELLCOMEOPENRES.16307.1]; Alwan Nisreen A, 2021, Commun Med (Lond), V1, P15, DOI 10.1038/s43856-021-00016-0; Alwan NA, 2021, SCIENCE, V373, P491, DOI 10.1126/science.abg7113; Alwan NA, 2021, MED-CAMBRIDGE, V2, P501, DOI 10.1016/j.medj.2021.03.003; Alwan NA, 2020, NATURE, V584, P170, DOI 10.1038/d41586-020-02335-z; [Anonymous], UPDATED ESTIMATES PR; [Anonymous], COR COVID 19 INF SUR; [Anonymous], ENERGY ENVELOPE PREV; Bergamaschi L., 2021, MEDRXIV, DOI [10.1101/2021.01.11.20248765, DOI 10.1101/2021.01.11.20248765]; Bliddal S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92045-x; Callard F, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113426; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Davis HE, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101019; del Rio C, 2020, JAMA-J AM MED ASSOC, V324, P1723, DOI 10.1001/jama.2020.19719; Dennis A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-048391; Garcia-Abellan J, 2021, J CLIN IMMUNOL, V41, P1490, DOI 10.1007/s10875-021-01083-7; Goertz YMJ, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00542-2020; Hellewell J, 2021, BMC MED, V19, DOI 10.1186/s12916-021-01982-x; Iacobucci G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1845; Kingstone Tom, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101143; Klok FA., 2020, EUR RESPIR J, DOI [10.1183/13993003.01494-2020, DOI 10.1183/13993003.01494]; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Ladds E, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-06001-y; Lu YP, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100484; Michelen M., 2020, MEDRXIV, DOI [10.1101/2020.12.08.20246025, DOI 10.1101/2020.12.08.20246025]; Miller TE, 2020, FASEB J, V34, P13877, DOI 10.1096/fj.202001700RR; Nabavi N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3489; National Institute for Health and Care Excellence, COVID 19 RAP GUID MA; Nehme M, 2021, ANN INTERN MED, V174, P723, DOI 10.7326/M20-5926; Office for National Statistics, TECHN ART UPD EST PR; Office of National Statistics, PREV ONG SYMPT FOLL; Petersen Maria Skaalum, 2021, Clin Infect Dis, V73, pe4058, DOI 10.1093/cid/ciaa1792; Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557; Soriano JB, 2022, LANCET INFECT DIS, V22, pE102, DOI 10.1016/S1473-3099(21)00703-9; Vaes AW, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092946; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; Ward H, 2021, LANCET REG HEALTH-EU, V4, DOI 10.1016/j.lanepe.2021.100098; Wong AW, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.03276-2020; Y. Huang, 2021, medRxiv, DOI 10.1101/2021.03.03.21252086	40	18	18	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264331	10.1371/journal.pone.0264331	http://dx.doi.org/10.1371/journal.pone.0264331			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259179	Green Accepted, gold, Green Published			2022-12-26	WOS:000835141200013
J	Fenny, AP; Otieku, E; Labi, KAK; Asante, FA; Enemark, U				Fenny, Ama Pokuaa; Otieku, Evans; Labi, Kwaku Appiah-Korang; Asante, Felix Ankomah; Enemark, Ulrika			Cost-effectiveness analysis of alcohol handrub for the prevention of neonatal bloodstream infections: Evidence from HAI-Ghana study	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; HYGIENE; WORKERS; SEPSIS; UNIT	Published evidence of the cost-effectiveness of alcohol-based handrub (ABH) for the prevention of neonatal bloodstream infections (BSI) is limited in sub-Saharan Africa. Therefore, this study evaluates the cost-effectiveness of a multimodal hand hygiene involving alcohol-based hand rub (ABH) for the prevention of neonatal BSI in a neonatal intensive care unit (NICU) setting in Ghana using data from HAI-Ghana study. Design was a before and after intervention study using economic evaluation model to assess the cost-effectiveness of a multimodal hand hygiene strategy involving alcohol-based hand rub plus soap and water compared to existing practice of using only soap and water. We measured effect and cost by subtracting outcomes without the intervention from outcomes with the intervention. The primary outcome measure is the number of neonatal BSI episode averted with the intervention and the consequent cost savings from patient and provider perspectives. The before and after intervention studies lasted four months each, spanning October 2017 to January 2018 and December 2018 to March 2019, respectively. The analysis shows that the ABH program was effective in reducing patient cost of neonatal BSI by 41.7% and BSI-attributable hospital cost by 48.5%. Further, neonatal BSI-attributable deaths and extra length of hospital stay (LOS) decreased by 73% and 50% respectively. Also, the post-intervention assessment revealed the ABH program contributed to 16% decline in the incidence of neonatal BSI at the NICU. The intervention is a simple and adaptable strategy with cost-saving potential when carefully scaled up across the country. Though the cost of the intervention may be more relative to using just soap and water for hand hygiene, the outcome is a good reason for investment into the intervention to reduce the incidence of neonatal BSI and the associated costs from patient and providers' perspectives.	[Fenny, Ama Pokuaa; Otieku, Evans; Asante, Felix Ankomah] Univ Ghana, Inst Stat Social & Econ Res ISSER, Econ Div, Legon, Accra, Ghana; [Otieku, Evans; Enemark, Ulrika] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Labi, Kwaku Appiah-Korang] Univ Ghana, Med Sch, Dept Med Microbiol, Accra, Ghana	University of Ghana; Aarhus University; University of Ghana	Fenny, AP (corresponding author), Univ Ghana, Inst Stat Social & Econ Res ISSER, Econ Div, Legon, Accra, Ghana.	amafenny@yahoo.co.uk		Otieku, Evans/0000-0002-6809-5160	Danish Ministry of Foreign Affairs as part of the HAI-Ghana [16PO1-GHA]	Danish Ministry of Foreign Affairs as part of the HAI-Ghana	Financial support was provided by the Danish Ministry of Foreign Affairs as part of the HAI-Ghana project/DANIDA grant number 16PO1-GHA.	Ahmed QA, 2006, LANCET, V367, P1025, DOI 10.1016/S0140-6736(06)68431-6; Allegranzi B, 2013, LANCET INFECT DIS, V13, P843, DOI 10.1016/S1473-3099(13)70163-4; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Asare A, 2009, J INFECT DEV COUNTR, V3, P352; Dodor EA., 2019, POSTGRADUATE MED J G, V8, P79; Ellingson K, 2014, INFECT CONT HOSP EP, V35, P937, DOI [10.1086/677145, 10.1017/S0899823X00193900]; Fenny AP, 2021, PHARMACOECON-OPEN, V5, P111, DOI 10.1007/s41669-020-00230-x; Fleischmann-Struzek C, 2018, LANCET RESP MED, V6, P223, DOI 10.1016/S2213-2600(18)30063-8; Graves N, 2018, J HOSP INFECT, V100, P123, DOI 10.1016/j.jhin.2018.07.008; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Kac G, 2005, J HOSP INFECT, V60, P32, DOI 10.1016/j.jhin.2004.10.014; Labi AK, 2019, J HOSP INFECT, V101, P60, DOI 10.1016/j.jhin.2018.04.019; Thu LTA, 2015, AM J INFECT CONTROL, V43, pE93, DOI 10.1016/j.ajic.2015.08.006; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; McFarland Agi, 2014, Nurs Stand, V29, P49, DOI 10.7748/ns.29.10.49.e9315; McNeil SA, 2001, CLIN INFECT DIS, V32, P367, DOI 10.1086/318488; Memirie ST, 2019, HEALTH POLICY PLANN, V34, P289, DOI 10.1093/heapol/czz034; National Health Insurance Scheme, 2020, NHIS US, V2021; Owusu BA, 2018, AFR HEALTH SCI, V18, P369, DOI 10.4314/ahs.v18i2.22; Polin RA, 2012, PEDIATRICS, V129, pE1085, DOI 10.1542/peds.2012-0145; Ranjeva SL, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000347; Salzo Angelo, 2021, Hosp Top, V99, P140, DOI 10.1080/00185868.2021.1902758; Shane AL, 2014, J INFECTION, V68, pS24, DOI 10.1016/j.jinf.2013.09.011; Shemilt I, 2010, EVID POLICY, V6, P51, DOI 10.1332/174426410X482999; Simoens S, 2009, INT J ENV RES PUB HE, V6, P2950, DOI 10.3390/ijerph6122950; Tette EMA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232406; Trick WE, 2003, CLIN INFECT DIS, V36, P1383, DOI 10.1086/374852; WHO, 2003, WHO GUIDE COST EFFEC; World Health Organization, 2009, WHO GUID HAND HYG HL	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264905	10.1371/journal.pone.0264905	http://dx.doi.org/10.1371/journal.pone.0264905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245332	gold, Green Published			2022-12-26	WOS:000799799100042
J	Rani, J; Das De, T; Chauhan, C; Kumari, S; Sharma, P; Tevatiya, S; Chakraborti, S; Pandey, KC; Singh, N; Dixit, R				Rani, Jyoti; Das De, Tanwee; Chauhan, Charu; Kumari, Seena; Sharma, Punita; Tevatiya, Sanjay; Chakraborti, Soumyananda; Pandey, Kailash C.; Singh, Namita; Dixit, Rajnikant			Functional disruption of transferrin expression alters reproductive physiology in Anopheles culicifacies	PLOS ONE			English	Article							IRON HOMEOSTASIS; MOSQUITO; PROTEIN; FAMILY; ABSORPTION; EVOLUTION; TRANSPORT; FERRITIN; INSIGHTS; INSECTS	Background Iron metabolism is crucial to maintain optimal physiological homeostasis of every organism and any alteration of the iron concentration (i.e. deficit or excess) can have adverse consequences. Transferrins are glycoproteins that play important role in iron transportation and have been widely characterized in vertebrates and insects, but poorly studied in blood-feeding mosquitoes. Results We characterized a 2102 bp long transcript AcTrf1a with complete CDS of 1872bp, and 226bp UTR region, encoding putative transferrin homolog protein from mosquito An. culicifacies. A detailed in silico analysis predicts AcTrf1a encodes 624 amino acid (aa) long polypeptide that carries transferrin domain. AcTrf1a also showed a putative N-linked glycosylation site, a characteristic feature of most of the mammalian transferrins and certain non-blood feeding insects. Structure modelling prediction confirms the presence of an iron-binding site at the N-terminal lobe of the transferrin. Our spatial and temporal expression analysis under altered pathophysiological conditions showed that AcTrf1a is abundantly expressed in the fat-body, ovary, and its response is significantly altered (enhanced) after blood meal uptake, and exogenous bacterial challenge. Additionally, non-heme iron supplementation of FeCl3 at 1 mM concentration not only augmented the AcTrf1a transcript expression in fat-body but also enhanced the reproductive fecundity of gravid adult female mosquitoes. RNAi-mediated knockdown of AcTrf1a causes a significant reduction in fecundity, confirming the important role of transferrin in oocyte maturation. Conclusion All together our results advocate that detailed characterization of newly identified AcTrf1a transcript may help to select it as a unique target to impair the mosquito reproductive outcome.	[Rani, Jyoti; Das De, Tanwee; Chauhan, Charu; Kumari, Seena; Sharma, Punita; Tevatiya, Sanjay; Chakraborti, Soumyananda; Pandey, Kailash C.; Dixit, Rajnikant] ICMR Natl Inst Malaria Res, Lab Host Parasite Interact Studies, New Delhi, India; [Rani, Jyoti; Singh, Namita] Guru Jambheshwar Univ Sci & Technol, Dept Biotechnol, Hisar, Haryana, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Guru Jambheshwar University of Science & Technology	Dixit, R (corresponding author), ICMR Natl Inst Malaria Res, Lab Host Parasite Interact Studies, New Delhi, India.	dixitrk@mrcindia.com		DIXIT, RAJNIKANT/0000-0002-3536-8329	Science and Engineering Research Board, India (SERB) [CRG/2020/001397]; Department of Biotechnology (DBT), Government of India [BT/BT/RLF/Re-entry/09/2019]; Council of Scientific & Industrial Research (CSIR), Govt. India [SRF/09/752(0062)/2016-EMR-1]	Science and Engineering Research Board, India (SERB); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific & Industrial Research (CSIR), Govt. India	This study was funded by the following funding awards: (i) Science and Engineering Research Board, India (SERB, File No. CRG/2020/001397); Recipient: Rajnikant Dixit (ii) Department of Biotechnology (DBT), Government of India (BT/BT/RLF/Re-entry/09/2019); Recipient: Soumyananda Chakraborti (iii) Council of Scientific & Industrial Research (CSIR), Govt. India ((SRF/09/752(0062)/2016-EMR-1); Recipient: Jyoti Rani The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LN, 2016, COMP BIOCHEM PHYS D, V17, P1, DOI 10.1016/j.cbd.2015.11.002; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Benoit JB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003874; Brummett LM, 2017, INSECT BIOCHEM MOLEC, V81, P1, DOI 10.1016/j.ibmb.2016.12.006; Clemens A., 2011, BIOL MOSQUITOES; Das De T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00148; Dev V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P239, DOI 10.5772/55215; Dunkov B, 2006, INSECT BIOCHEM MOLEC, V36, P300, DOI 10.1016/j.ibmb.2006.01.007; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Farkas R, 2018, DEV GROWTH DIFFER, V60, P411, DOI 10.1111/dgd.12562; Geiser DL, 2019, J INSECT SCI, V19, DOI 10.1093/jisesa/iez089; Geiser DL, 2012, BBA-GEN SUBJECTS, V1820, P437, DOI 10.1016/j.bbagen.2011.07.011; Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013; Harizanova N, 2005, INSECT MOL BIOL, V14, P79, DOI 10.1111/j.1365-2583.2004.00533.x; Harizanova N., 2004, BIOTECHNOL BIOTEC EQ, V18, P118, DOI [10.1080/13102818.2004.10817097, DOI 10.1080/13102818.2004.10817097]; Hernandez-Gallardo AK, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008503; Hirai M, 2000, ARCH INSECT BIOCHEM, V44, P17, DOI 10.1002/(SICI)1520-6327(200005)44:1&lt;17::AID-ARCH3&gt;3.0.CO;2-O; Iatsenko I, 2020, P NATL ACAD SCI USA, V117, P7317, DOI 10.1073/pnas.1914830117; Kawabata H, 2019, FREE RADICAL BIO MED, V133, P46, DOI 10.1016/j.freeradbiomed.2018.06.037; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Kucharski R, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.27; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumari Seena, 2021, Curr Res Immunol, V2, P12, DOI 10.1016/j.crimmu.2021.02.002; KURAMA T, 1995, EUR J BIOCHEM, V228, P229, DOI 10.1111/j.1432-1033.1995.tb20254.x; Lambert LA, 2005, COMP BIOCHEM PHYS B, V142, P129, DOI 10.1016/j.cbpb.2005.07.007; Lambert LA, 2005, COMP BIOCHEM PHYS B, V140, P11, DOI 10.1016/j.cbpc.2004.09.012; Law JH, 2002, BIOCHEM BIOPH RES CO, V292, P1191, DOI 10.1006/bbrc.2001.2015; Lee KS, 2006, FREE RADICAL BIO MED, V41, P1151, DOI 10.1016/j.freeradbiomed.2006.07.001; Legrand D, 2016, J PEDIATR-US, V173, pS10, DOI 10.1016/j.jpeds.2016.02.071; Ling L, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023470118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Mandilaras K, 2013, NUTRIENTS, V5, P1622, DOI 10.3390/nu5051622; Marques J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35886-3; Mizutani K, 2012, BBA-GEN SUBJECTS, V1820, P203, DOI 10.1016/j.bbagen.2011.08.003; Mohd-Padil H, 2013, MOL BIOL EVOL, V30, P894, DOI 10.1093/molbev/mss325; Munoz M, 2009, WORLD J GASTROENTERO, V15, P4617, DOI 10.3748/wjg.15.4617; Najera DG, 2021, INSECT SCI, V28, P495, DOI 10.1111/1744-7917.12783; Paily KP, 2007, PARASITOL RES, V101, P325, DOI 10.1007/s00436-007-0474-2; Pitts RJ, 2014, J INSECT PHYSIOL, V64, P1, DOI 10.1016/j.jinsphys.2014.02.012; Rani J, 2021, GENE, V798, DOI 10.1016/j.gene.2021.145810; Recalcati S, 2017, IUBMB LIFE, V69, P389, DOI 10.1002/iub.1628; Rivera-Perez C, 2017, CURR OPIN INSECT SCI, V23, P112, DOI 10.1016/j.cois.2017.07.002; Rodriguez-Garcia C, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009270; Sangokoya C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003408; Sun HZ, 1999, CHEM REV, V99, P2817, DOI 10.1021/cr980430w; Tan WB, 2012, PARASITOL RES, V110, P939, DOI 10.1007/s00436-011-2580-4; Tang XN, 2013, IUBMB LIFE, V65, P863, DOI 10.1002/iub.1211; Tang XN, 2013, FASEB J, V27, P288, DOI 10.1096/fj.12-213595; Weber JJ, 2021, PROTEIN SCI, V30, P408, DOI 10.1002/pro.3999; Weber JJ, 2020, INSECT BIOCHEM MOLEC, V125, DOI 10.1016/j.ibmb.2020.103438; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Whiten SR, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01134; Xiao GR, 2019, CELL REP, V26, P748, DOI 10.1016/j.celrep.2018.12.053; Yoshiga T, 1997, P NATL ACAD SCI USA, V94, P12337, DOI 10.1073/pnas.94.23.12337; YOUNG SP, 1981, HEPATOLOGY, V1, P114, DOI 10.1002/hep.1840010205; Yun EY, 2009, DEV COMP IMMUNOL, V33, P1064, DOI 10.1016/j.dci.2009.05.008; Zhou GL, 2009, INSECT BIOCHEM MOLEC, V39, P234, DOI 10.1016/j.ibmb.2008.12.004	58	1	1	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264523	10.1371/journal.pone.0264523	http://dx.doi.org/10.1371/journal.pone.0264523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245324	Green Published, gold, Green Submitted			2022-12-26	WOS:000799799100024
J	Penning, Y; El Asmar, A; Moreau, M; Raspe, J; Dal Lago, L; Pepersack, T; Donckier, V; Liberale, G				Penning, Yoon; El Asmar, Antoine; Moreau, Michel; Raspe, Julie; Dal Lago, Lissandra; Pepersack, Thierry; Donckier, Vincent; Liberale, Gabriel			Evaluation of the Comprehensive Geriatric Assessment (CGA) tool as a predictor of postoperative complications following major oncological abdominal surgery in geriatric patients	PLOS ONE			English	Article							CANCER-PATIENTS; ELDERLY-PATIENTS; OLDER PATIENTS; VALIDATION; OUTCOMES; FRAILTY; G8; SCALE; INDEX	Introduction The concept of frailty extends beyond chronological age. Identifying frailty using a two-step approach, starting with the use of a screening tool (G8) followed by comprehensive geriatric assessment (CGA), may be useful in guiding treatment decisions and follow-up. This study evaluated the association between G8 and CGA, and the risk of 90-day postoperative complications risk, in oncogeriatric patients. Methods Data on geriatric patients with major oncological abdominal surgery was retrospectively collected from our hospital records between 2016 and 2019. Patients with an impaired G8 screening score, who subsequently underwent CGA geriatric screening, were included. Postoperative complications were classified using the Clavien-Dindo classification (CD), and the Comprehensive Complication Index (CCI). The association between the individual components of the geriatric assessment tools and the 90-day postoperative complications risk was analyzed. Results One hundred and twelve patients, aged >= 70 years, operated for an intra-abdominal tumor with curative intent, were included. Seventy-six patients (67.9%) presented with an impaired G8, out of whom sixty-six (58.9%) had a CGA performed. On univariate analysis, altered nutritional status assessed by the Mini-Nutritional Assessment-Short Form was the only variable associated with higher postoperative total complication rate (p = 0.01). Patients with an impaired G8 had significantly more postoperative complications and higher 1-year mortality rates than patients with normal G8. Fifteen patients (13.4%) had grade III-IVb complications. A CCI > 50 was recorded in 16 patients (14.3%). All-cause 90-day postoperative mortality was 10.7%. Conclusion Identifying an altered preoperative nutritional status, as part of the CGA, in patients screening positive for frailty, is a potentially modifiable risk factor that can enhance preoperative management and optimize treatment decision making. G8 may be a predictive factor for postoperative complications in oncogeriatric patients.	[Penning, Yoon; El Asmar, Antoine; Raspe, Julie; Donckier, Vincent; Liberale, Gabriel] Univ Libre Bruxelles ULB, Inst Jules Bordet, Dept Surg Oncol, Brussels, Belgium; [Moreau, Michel] Univ Libre Bruxelles ULB, Data Ctr & Stat Dept, Inst Jules Bordet, Brussels, Belgium; [Dal Lago, Lissandra; Pepersack, Thierry] Univ Libre Bruxelles ULB, Inst Jules Bordet, Dept Med, Brussels, Belgium	Institut Jules Bordet; Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles	El Asmar, A (corresponding author), Univ Libre Bruxelles ULB, Inst Jules Bordet, Dept Surg Oncol, Brussels, Belgium.	antoine.el.asmar@gmail.com		Liberale, Gabriel/0000-0001-8051-1588				Anisimov VN, 2009, BIOGERONTOLOGY, V10, P323, DOI 10.1007/s10522-008-9209-8; Badgwell B, 2013, J SURG ONCOL, V108, P182, DOI 10.1002/jso.23369; Bellera CA, 2012, ANN ONCOL, V23, P2166, DOI 10.1093/annonc/mdr587; Bessems SAM., 2020, J GERIATR ONCOL; Bruijnen CP, 2021, J GERIATR ONCOL, V12, P793, DOI 10.1016/j.jgo.2020.10.017; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; de Vries J, 2020, EJSO-EUR J SURG ONC, V46, P123, DOI 10.1016/j.ejso.2019.08.008; Dent E, 2019, LANCET, V394, P1376, DOI 10.1016/S0140-6736(19)31785-4; Fagard K, 2017, J GERIATR ONCOL, V8, P320, DOI 10.1016/j.jgo.2017.07.008; Feng MA, 2015, J SURG RES, V193, P265, DOI 10.1016/j.jss.2014.07.004; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Huisman MG, 2017, EJSO-EUR J SURG ONC, V43, P1, DOI 10.1016/j.ejso.2016.06.003; Kaibori M, 2016, LANGENBECK ARCH SURG, V401, P205, DOI 10.1007/s00423-016-1388-1; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Kanda M, 2020, SURG TODAY, V50, P3, DOI 10.1007/s00595-019-01877-8; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kenig J, 2015, ARCH GERONTOL GERIAT, V61, P437, DOI 10.1016/j.archger.2015.06.018; Kothari P, 2019, UPDATES SURG, V71, P89, DOI 10.1007/s13304-018-0531-7; Lee DU, 2021, SURG ONCOL, V38, DOI 10.1016/j.suronc.2021.101587; Mokutani Y, 2016, DIGEST SURG, V33, P470, DOI 10.1159/000446709; Nishijima TF, 2021, EJSO-EUR J SURG ONC, V47, P896, DOI 10.1016/j.ejso.2020.09.031; Plas M, 2019, EJSO-EUR J SURG ONC, V45, P1403, DOI 10.1016/j.ejso.2019.04.024; Ray S, 2019, J SURG RES, V244, P417, DOI 10.1016/j.jss.2019.06.093; Repetto L, 2003, EUR J CANCER, V39, P870, DOI 10.1016/S0959-8049(03)00062-5; Richards SJG, 2018, INT J COLORECTAL DIS, V33, P1657, DOI 10.1007/s00384-018-3163-y; Souwer ETD, 2018, J GERIATR ONCOL, V9, P110, DOI 10.1016/j.jgo.2017.09.003; Stulberg JJ, 2020, JAMA SURG, V155, P960, DOI 10.1001/jamasurg.2020.3007; United Nations Department of Economic and Social Affairs Population Division, 2020, WORLD POP AG 2019 HI; van Walree IC, 2019, J GERIATR ONCOL, V10, P847, DOI 10.1016/j.jgo.2019.04.016; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264790	10.1371/journal.pone.0264790	http://dx.doi.org/10.1371/journal.pone.0264790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239731	Green Published, gold			2022-12-26	WOS:000776002200076
J	Miller, JK; Elenberg, K; Dubrawski, A				Miller, James Kyle; Elenberg, Kimberly; Dubrawski, Artur			Forecasting emergence of COVID-19 variants of concern	PLOS ONE			English	Article							EVOLUTIONARY DYNAMICS	We consider whether one can forecast the emergence of variants of concern in the SARS-CoV-2 outbreak and similar pandemics. We explore methods of population genetics and identify key relevant principles in both deterministic and stochastic models of spread of infectious disease. Finally, we demonstrate that fitness variation, defined as a trait for which an increase in its value is associated with an increase in net Darwinian fitness if the value of other traits are held constant, is a strong indicator of imminent transition in the viral population.	[Miller, James Kyle; Dubrawski, Artur] Auton Syst LLC, Pittsburgh, PA 15217 USA; [Elenberg, Kimberly] US Dept Def Covid Task Force, Washington, DC USA		Miller, JK (corresponding author), Auton Syst LLC, Pittsburgh, PA 15217 USA.	kyle.miller@autonsys.com			Auton Systems LLC	Auton Systems LLC	Auton Systems LLC provided support in the form of salaries for authors KM and AD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971; Castro LA, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007683; Day T, 2020, CURR BIOL, V30, pR849, DOI 10.1016/j.cub.2020.06.031; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Eigen M, 2002, P NATL ACAD SCI USA, V99, P13374, DOI 10.1073/pnas.212514799; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Fudolig M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243408; Gandon S, 2016, TRENDS ECOL EVOL, V31, P776, DOI 10.1016/j.tree.2016.07.010; Ganyani T, 2021, ANNU REV STAT APPL, V8, P69, DOI 10.1146/annurev-statistics-061120-034438; Gerrish PJ, 2012, J R SOC INTERFACE, V9, P2268, DOI 10.1098/rsif.2012.0119; Gordo I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004876; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Koelle K, 2015, ELIFE, V4, DOI 10.7554/eLife.07361; Li QQ, 2021, CELL, V184, P2362, DOI 10.1016/j.cell.2021.02.042; Martin G, 2016, GENETICS, V204, P1541, DOI 10.1534/genetics.116.187385; Mayr E., 1988, NEW PHILOS BIOL OBSE, V211; Mousavizadeh L, 2021, J MICROBIOL IMMUNOL, V54, P159, DOI 10.1016/j.jmii.2020.03.022; Roche B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-87; Sniegowski PD, 2010, PHILOS T R SOC B, V365, P1255, DOI 10.1098/rstb.2009.0290; TAJIMA F, 1989, GENETICS, V123, P597; Tang L, 2020, INT STAT REV, V88, P462, DOI 10.1111/insr.12402; Vilar S, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10020091; Yan L, 2019, ELIFE, V8, DOI 10.7554/eLife.44205	24	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264198	10.1371/journal.pone.0264198	http://dx.doi.org/10.1371/journal.pone.0264198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202422	gold, Green Published			2022-12-26	WOS:000773224600026
J	Dutta, S; Selvam, B; Das, A; Shukla, D				Dutta, Soumajit; Selvam, Balaji; Das, Aditi; Shukla, Diwakar			Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC COMMUNICATION PIPELINES; RESOLUTION CRYSTAL-STRUCTURE; TRANSITION PATH THEORY; MOLECULAR-DYNAMICS; STRUCTURAL INSIGHTS; INVERSE AGONISM; CB1; DISTANCE; PHARMACOLOGY; ACTIVATION	Cannabinoid receptor 1 (CB1) is a therapeutically relevant drug target for controlling pain, obesity, and other central nervous system disorders. However, full agonists and antagonists of CB1 have been reported to cause serious side effects in patients. Therefore, partial agonists have emerged as a viable alternative as they can mitigate overstimulation and side effects. One of the key bottlenecks in the design of partial agonists, however, is the lack of understanding of the molecular mechanism of partial agonism itself. In this study, we examine two mechanistic hypotheses for the origin of partial agonism in cannabinoid receptors and predict the mechanistic basis of partial agonism particular, we inspect whether partial agonism emerges from the ability of THC to bind in both agonist and antagonist-binding poses or from its ability to only partially activate the receptor. We used extensive molecular dynamics simulations and Markov state modeling to capture the THC binding in both antagonist and agonist-binding poses in the CB1 receptor. Furthermore, we predict that binding of THC in the agonist-binding pose leads to rotation of toggle switch residues and causes partial outward movement of intracellular transmembrane helix 6 (TM6). Our simulations also suggest that the alkyl side chain of THC plays a crucial role in determining partial agonism by stabilizing the ligand in the agonist and antagonist-like poses within the pocket. Taken together, this study provides important insights into the mechanistic origin of the partial agonism of THC.	[Dutta, Soumajit; Selvam, Balaji; Shukla, Diwakar] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Das, Aditi] Univ Illinois, Dept Comparat Biosci, Urbana, IL USA; [Das, Aditi] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Das, Aditi] Univ Illinois, Dept Biochem, Urbana, IL USA; [Das, Aditi; Shukla, Diwakar] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Das, Aditi; Shukla, Diwakar] Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA; [Shukla, Diwakar] Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA; [Shukla, Diwakar] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Shukla, Diwakar] Univ Illinois, NIH Ctr Macromol Modeling & Bioinformat, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Shukla, D (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, NIH Ctr Macromol Modeling & Bioinformat, Urbana, IL 61801 USA.	diwakar@illinois.edu	Shukla, Diwakar/GRY-2518-2022	Shukla, Diwakar/0000-0003-4079-5381; Dutta, Soumajit/0000-0003-3951-8088	NSF Early CAREER Award [MCB-1845606]	NSF Early CAREER Award(National Science Foundation (NSF))	Funding and additional information-D. S. acknowledges support from NSF Early CAREER Award (MCB-1845606) .	A.White, 2020, bioRxiv, DOI 10.1101/2020.07.28.225722; Adams AJ, 2017, NEW ENGL J MED, V376, P235, DOI 10.1056/NEJMoa1610300; Aldukhi F, 2020, J PHYS CHEM B, V124, P355, DOI 10.1021/acs.jpcb.9b09377; Badowski ME, 2018, THER CLIN RISK MANAG, V14, P643, DOI 10.2147/TCRM.S126849; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bhattacharya S, 2014, BIOPHYS J, V107, P422, DOI 10.1016/j.bpj.2014.06.015; Bow EW, 2016, PERSPECT MED CHEM, V8, DOI 10.4137/PMC.S32171; Bowman GR, 2014, ADV EXP MED BIOL, V797, P1, DOI 10.1007/978-94-007-7606-7; Case D. A., 2018, AMBER 2019; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dohm S, 2020, J CHEM THEORY COMPUT, V16, P2002, DOI 10.1021/acs.jctc.9b01266; Dutta S, 2022, ACS CHEM NEUROSCI, V13, P379, DOI 10.1021/acschemneuro.1c00760; E W, 2006, J STAT PHYS, V123, P503, DOI 10.1007/s10955-005-9003-9; Eddy MT, 2021, STRUCTURE, V29, P170, DOI 10.1016/j.str.2020.11.005; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fay JF, 2013, BIOCHEMISTRY-US, V52, P8286, DOI 10.1021/bi400842k; Fleetwood O, 2021, ELIFE, V10, DOI 10.7554/eLife.60715; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hernandez C. X., 2017, J OPEN SOURCE SOFTW, V2, P427, DOI [DOI 10.21105/JOSS.00427, 10.21105/joss.00427]; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hua T, 2020, CELL, V180, P655, DOI 10.1016/j.cell.2020.01.008; Hua T, 2017, NATURE, V547, P468, DOI 10.1038/nature23272; Hua T, 2016, CELL, V167, P750, DOI 10.1016/j.cell.2016.10.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibsen MS, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00350; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kapoor A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11483-8; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kohlhoff KJ, 2014, NAT CHEM, V6, P15, DOI [10.1038/NCHEM.1821, 10.1038/nchem.1821]; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Kumar KK, 2019, CELL, V176, P448, DOI 10.1016/j.cell.2018.11.040; Lawrenz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07918; Li XT, 2020, TRENDS PHARMACOL SCI, V41, P665, DOI 10.1016/j.tips.2020.06.010; Li XT, 2019, CELL, V176, P459, DOI 10.1016/j.cell.2018.12.011; MacLennan SJ, 1998, BRIT J PHARMACOL, V124, P619, DOI 10.1038/sj.bjp.0701915; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Masureel M, 2018, NAT CHEM BIOL, V14, P1059, DOI 10.1038/s41589-018-0145-x; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Meng Y, 2016, P NATL ACAD SCI USA, V113, P9193, DOI 10.1073/pnas.1602790113; Metzner P, 2009, MULTISCALE MODEL SIM, V7, P1192, DOI 10.1137/070699500; Mey Antonia S J S, 2020, Living J Comput Mol Sci, V2, DOI 10.33011/livecoms.2.1.18378; Mittal S, 2018, J PHYS CHEM B, V122, P10793, DOI 10.1021/acs.jpcb.8b07076; Mittal S, 2018, MOL SIMULAT, V44, P891, DOI 10.1080/08927022.2018.1448976; Nivedha AK, 2018, MOL PHARMACOL, V93, P288, DOI 10.1124/mol.117.110395; Noe F, 2015, J CHEM THEORY COMPUT, V11, P5002, DOI 10.1021/acs.jctc.5b00553; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Pandy-Szekeres G, 2018, NUCLEIC ACIDS RES, V46, pD440, DOI 10.1093/nar/gkx1109; Perez-Hernandez G, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811489; Pertwee RG, 2006, BRIT J PHARMACOL, V147, pS163, DOI 10.1038/sj.bjp.0706406; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Saleh N, 2018, ANGEW CHEM INT EDIT, V57, P2580, DOI 10.1002/anie.201708764; Sam AH, 2011, J OBES, V2011, DOI 10.1155/2011/432607; Selvam B, 2018, ACS CENTRAL SCI, V4, P1146, DOI 10.1021/acscentsci.8b00330; Selvam B, 2018, ANGEW CHEM INT EDIT, V57, P3048, DOI 10.1002/anie.201708889; Selvana B, 2019, ACS CENTRAL SCI, V5, P1085, DOI 10.1021/acscentsci.9b00252; Shao ZH, 2019, NAT CHEM BIOL, V15, P1199, DOI 10.1038/s41589-019-0387-2; Shao ZH, 2016, NATURE, V540, P602, DOI 10.1038/nature20613; Shim JY, 2011, J BIOL CHEM, V286, P33422, DOI 10.1074/jbc.M111.261651; Shukla D, 2015, ACCOUNTS CHEM RES, V48, P414, DOI 10.1021/ar5002999; Shukla S, 2019, STRUCTURE, V27, P692, DOI 10.1016/j.str.2018.12.005; Song LF, 2019, J CHEM INF MODEL, V59, P3128, DOI 10.1021/acs.jcim.9b00105; Sultan MM, 2018, NAT CHEM, V10, P903, DOI 10.1038/s41557-018-0077-9; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vaidehi N, 2016, CURR OPIN PHARMACOL, V30, P76, DOI 10.1016/j.coph.2016.07.010; Walther S, 2010, PHARMACEUTICALS-BASE, V3, P2689, DOI 10.3390/ph3082689; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wehmeyer C., 2018, LIVECOMS, V1, P1; Zou SL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030833	78	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101764	10.1016/j.jbc.2022.101764	http://dx.doi.org/10.1016/j.jbc.2022.101764			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35227761	gold, Green Published			2022-12-26	WOS:000797895000009
J	Mezzasoma, L; Bellezza, I; Orvietani, P; Manni, G; Gargaro, M; Sagini, K; Llorente, A; Scarpelli, P; Pascucci, L; Cellini, B; Talesa, VN; Fallarino, F; Romani, R				Mezzasoma, Letizia; Bellezza, Ilaria; Orvietani, Pierluigi; Manni, Giorgia; Gargaro, Marco; Sagini, Krizia; Llorente, Alicia; Scarpelli, Paolo; Pascucci, Luisa; Cellini, Barbara; Talesa, Vincenzo Nicola; Fallarino, Francesca; Romani, Rita			Amniotic fluid stem cell-derived extracellular vesicles are independent metabolic units capable of modulating inflammasome activation in THP-1 cells	FASEB JOURNAL			English	Article						ATP production; immunoregulation; inflammasomes; stem cell-derived extracellular vesicles	A(2A) ADENOSINE RECEPTOR; NLRP3 INFLAMMASOME; IMMUNE-RESPONSES; EXOSOMES; PROSTASOMES; REGULATORS; AGONISTS; INJURY; CD39; CD73	An immunoregulatory role of stem cells, often mediated by their secretome, has been claimed by several studies. Stem cell-derived extracellular vesicles (EVs) are crucial components of the secretome. EVs, a heterogeneous group of membranous vesicles released by many cell types into the extracellular space, are now considered as an additional mechanism for intercellular communication. In this study, we aimed at investigating whether human amniotic stem cell-derived extracellular vesicles (HASC-EVs) were able to interfere with inflammasome activation in the THP-1 cell line. Two subsets of HASC-EVs were collected by sequential centrifugation, namely HASC-P10 and HASC-P100. We demonstrated that HASC-EVs were neither internalized into nor undertake a direct interaction with THP-1 cells. We showed that HASC-P10 and P100 were able to intrinsically produce ATP, which was further converted to adenosine by 5'-nucleotidase (CD73) and ectonucleoside triphosphate diphosphohydrolase-1 (CD39). We found that THP-1 cells conditioned with both types of HASC-EVs failed to activate the NLRP3/caspase-1/inflammasome platform in response to LPS and ATP treatment by a mechanism involving A2a adenosine receptor activation. These results support a role for HASC-EVs as independent metabolic units capable of modifying the cellular functions, leading to anti-inflammatory effects in monocytic cells.	[Mezzasoma, Letizia; Bellezza, Ilaria; Orvietani, Pierluigi; Manni, Giorgia; Gargaro, Marco; Scarpelli, Paolo; Cellini, Barbara; Talesa, Vincenzo Nicola; Fallarino, Francesca; Romani, Rita] Univ Perugia, Dept Med & Surg, Polo Unico St Andrea Fratte, Pe Lucio Severi 1, I-06132 Perugia, Italy; [Sagini, Krizia; Llorente, Alicia] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway; [Pascucci, Luisa] Dept Vet Med, Perugia, Italy	University of Perugia; University of Oslo	Romani, R (corresponding author), Univ Perugia, Dept Med & Surg, Polo Unico St Andrea Fratte, Pe Lucio Severi 1, I-06132 Perugia, Italy.	rita.romani@unipg.it	SAGINI, Krizia/Z-1629-2019; Cellini, Barbara/AAC-6401-2019; Fallarino, Francesca/O-3358-2013; Gargaro, Marco/K-7077-2016	SAGINI, Krizia/0000-0003-3357-2171; Cellini, Barbara/0000-0002-5221-9288; Llorente, Alicia/0000-0002-0045-071X; Pascucci, Luisa/0000-0002-2562-1140; Fallarino, Francesca/0000-0002-8501-2136; Gargaro, Marco/0000-0003-0645-9800; Scarpelli, Paolo/0000-0001-6583-3693; BELLEZZA, ILARIA/0000-0002-8106-1600	Department of Medicine and Surgery, Perugia University	Department of Medicine and Surgery, Perugia University	Department of Medicine and Surgery, Perugia University	Angioni R, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1757900; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Balbi C, 2017, STEM CELL TRANSL MED, V6, P1340, DOI 10.1002/sctm.16-0297; Bebelman MP, 2018, PHARMACOL THERAPEUT, V188, P1, DOI 10.1016/j.pharmthera.2018.02.013; Biasizzo M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.591803; Bjorge IM, 2017, BIOMATER SCI-UK, V6, P60, DOI 10.1039/c7bm00479f; Campden RI, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101459; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen BY, 2019, CLIN CHIM ACTA, V493, P14, DOI 10.1016/j.cca.2019.02.021; Chiasserini D, 2017, J PROTEOMICS, V152, P329, DOI 10.1016/j.jprot.2016.11.013; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Faas MM, 2017, MOL ASPECTS MED, V55, P9, DOI 10.1016/j.mam.2017.01.002; Fonseka P, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2020.166747; Garcia NA, 2016, CARDIOVASC RES, V109, P397, DOI 10.1093/cvr/cvv260; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Goran-Ronquist K, 2013, BBA-GEN SUBJECTS, V1830, P4604, DOI 10.1016/j.bbagen.2013.05.019; Harrell CR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121605; Harrell CR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050467; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 1998, EUR J PHARMACOL, V358, P261, DOI 10.1016/S0014-2999(98)00619-0; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Iraci N, 2017, NAT CHEM BIOL, V13, P951, DOI [10.1038/nchembio.2422, 10.1038/NCHEMBIO.2422]; Jiang LR, 2019, BIOCHEM BIOPH RES CO, V508, P735, DOI 10.1016/j.bbrc.2018.11.189; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Keshtkar S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0791-7; Lappas CM, 2005, EXPERT OPIN INV DRUG, V14, P797, DOI 10.1517/13543784.14.7.797; Lin LY, 2018, CELL IMMUNOL, V326, P24, DOI 10.1016/j.cellimm.2017.07.010; Liu YN, 2018, EBIOMEDICINE, V36, P140, DOI 10.1016/j.ebiom.2018.08.054; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McKelvey Kelly J, 2015, J Circ Biomark, V4, P7, DOI 10.5772/61186; Mezzasoma L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010024; Mezzasoma L, 2019, CANCERS, V11, DOI 10.3390/cancers11091276; Mezzasoma L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5858315; Mezzasoma L, 2016, IMMUNOL RES, V64, P303, DOI 10.1007/s12026-015-8751-0; Morello S, 2009, J RECEPT LIGAND CH R, V2, P11, DOI 10.2147/JRLCR.S4710; Nojehdehi S, 2018, J CELL BIOCHEM, V119, P9433, DOI 10.1002/jcb.27260; O'Connell JS, 2021, PEDIATR SURG INT, V37, P301, DOI 10.1007/s00383-020-04826-6; Okusa MD, 2000, AM J PHYSIOL-RENAL, V279, pF809, DOI 10.1152/ajprenal.2000.279.5.F809; Palmer TM, 2008, BRIT J PHARMACOL, V153, pS27, DOI 10.1038/sj.bjp.0707524; Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575; Poli G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165758; Rajan TS, 2017, INT J IMMUNOPATH PH, V30, P238, DOI 10.1177/0394632017722332; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ratajczak MZ, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.603942; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Romani R, 2015, J CELL MOL MED, V19, P1593, DOI 10.1111/jcmm.12534; Ronquist KG, 2013, AM J PHYSIOL-ENDOC M, V304, pE576, DOI 10.1152/ajpendo.00511.2012; Ronquist KG, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29877; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shigemoto-Kuroda T, 2017, STEM CELL REP, V8, P1214, DOI 10.1016/j.stemcr.2017.04.008; Sitkovsky MV, 2003, BIOCHEM PHARMACOL, V65, P493, DOI 10.1016/S0006-2952(02)01548-4; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Song N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02305; Takov K, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0785-3; Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Veerman RE, 2019, TRENDS MOL MED, V25, P382, DOI 10.1016/j.molmed.2019.02.003; Zeng Q, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00182; Zhang SP, 2019, BIOMATERIALS, V200, P35, DOI 10.1016/j.biomaterials.2019.02.006; Zhang W, 2019, INVEST OPHTH VIS SCI, V60, P294, DOI 10.1167/iovs.18-25617; Zhang X, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0181-x; Zhu Y, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0510-9	66	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22218	10.1096/fj.202101657R	http://dx.doi.org/10.1096/fj.202101657R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CK	35218567	hybrid			2022-12-26	WOS:000772944800001
J	Salinas-Estrella, E; Ueti, MW; Lobanov, VA; Castillo-Payro, E; Lizcano-Mata, A; Badilla, C; Martinez-Ibanez, F; Mosqueda, J				Salinas-Estrella, Elizabeth; Ueti, Massaro W.; Lobanov, Vladislav A.; Castillo-Payro, Evelio; Lizcano-Mata, Amelia; Badilla, Cesar; Martinez-Ibanez, Francisco; Mosqueda, Juan			Serological and molecular detection of Babesia caballi and Theileria equi in Mexico: A prospective study	PLOS ONE			English	Article							INFECTED HORSES; PCR; BLOOD; TRANSMISSION; PREVALENCE; ANTIBODIES; LAVERAN	Equine piroplasmosis is a disease of horses, mules and donkeys, caused by the hemoprotozoans Babesia caballi and Theileria equi and transmitted by ticks of tropical and subtropical regions. Because the clinical signs are not specific, the diagnosis of equine piroplasmosis is difficult. In Mexico, where the environmental factors are conducive to the persistence of these pathogens, there is a lack of molecular studies to evaluate the occurrence of both parasites in horses. In the present study, matching serum and whole blood samples were obtained from 269 horses residing in 24 locations with tropical or subtropical climate and the presence of ticks. Testing of serum samples by ELISA demonstrated 55.7% seroprevalence of B. caballi and 68.4% prevalence of antibodies to T. equi. Blood samples analyzed with nPCR test were 7.8% positive to B. caballi and 78.8% positive to T. equi, while a duplex qPCR showed 15.24% positive samples to B. caballi and 59.11% to T. equi. From these results, 27 samples were sequenced for T. equi and 13 for B. caballi, confirming the presence of both horse parasites that cause equine piroplasmosis and suggesting that they are widespread in Mexico. This is the first study confirming the presence of B. caballi and T. equi in Mexico using both serological and molecular diagnostic methods. This study shows a high incidence of exposure to the etiological agents of equine piroplasmosis in horses in the studied areas.	[Salinas-Estrella, Elizabeth; Mosqueda, Juan] Autonomous Univ Queretaro, Nat Sci Coll, Immunol & Vaccines Lab, Queretaro, Qro, Mexico; [Salinas-Estrella, Elizabeth] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Programa Maestria & Doctorado Ciencias La Prod &, Ciudad De Mexico, Mexico; [Ueti, Massaro W.] Washington State Univ, Dept Vet Microbiol & Pathol, USDA Anim Dis Res Unit, Pullman, WA 99164 USA; [Lobanov, Vladislav A.] Canadian Food Inspect Agcy, Ctr Food Borne & Anim Parasitol, Saskatoon, SK, Canada; [Lizcano-Mata, Amelia] Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, Dept Clin Grandes Especies, Merida, Yucatan, Mexico; [Badilla, Cesar] Univ Politecn Mar & Sierra UPMyS, Ingn Produce & Anim, Elota, Sinaloa, Mexico; [Martinez-Ibanez, Francisco] Secretaria Agr Ganaderia Desarrollo Rural Pesca &, Ctr Nacl Serv Constatac Sanidad Anim, Lab Taxon, Serv Nacl Sanidad Inocuidad & Calidad Agroaliment, Jiutepec, Morelos, Mexico; [Salinas-Estrella, Elizabeth] Inst Nacl Invest Forestales Agr & Pecuarias, Ctr Nacl Invest Disciplinaria Salud Anim & Inocui, Unidad Anaplasmosis, Jiutepec, Morelos, Mexico	Universidad Autonoma de Queretaro; Universidad Nacional Autonoma de Mexico; United States Department of Agriculture (USDA); Washington State University; Canadian Food Inspection Agency; Universidad Autonoma de Yucatan	Mosqueda, J (corresponding author), Autonomous Univ Queretaro, Nat Sci Coll, Immunol & Vaccines Lab, Queretaro, Qro, Mexico.	joel.mosqueda@uaq.mx		Salinas Estrella, Elizabeth/0000-0002-0503-6577; Mosqueda, Juan/0000-0001-8892-6390	CONACyT-Problemas Nacionales [PN2017-7256]; Universidad Autonoma de Queretaro. FONDEC [FNV-2020-05]; USDA-ARS Offshore project [2090-32000-039-18-A]; CONACyT Beca Nacional program; CONACyT Beca Mixta program	CONACyT-Problemas Nacionales; Universidad Autonoma de Queretaro. FONDEC; USDA-ARS Offshore project; CONACyT Beca Nacional program; CONACyT Beca Mixta program	This work was supported by CONACyT-Problemas Nacionales PN2017-7256 (JM), Universidad Autonoma de Queretaro. FONDEC, FNV-2020-05 (JM), and USDA-ARS Offshore project 2090-32000-039-18-A (MWU). Elizabeth Salinas received a fellowship from CONACyT Beca Nacional and Beca Mixta programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhassan A, 2007, TROP ANIM HEALTH PRO, V39, P369, DOI 10.1007/s11250-007-9025-1; Alhassan A, 2005, VET PARASITOL, V129, P43, DOI 10.1016/j.vetpar.2004.12.018; Ayala-Valdovinos MA, 2017, PARASITOL INT, V66, P821, DOI 10.1016/j.parint.2016.09.011; Bashiruddin JB, 1999, VET PARASITOL, V84, P75, DOI 10.1016/S0304-4017(99)00049-7; Cantu-Martinez MA, 2012, J PARASITOL, V98, P869, DOI 10.1645/GE-3064.1; DEWAAL DT, 1992, BRIT VET J, V148, P6, DOI 10.1016/0007-1935(92)90061-5; FAO, FOOD AGR DAT; Garcia-Bocanegra I, 2013, VET J, V195, P172, DOI 10.1016/j.tvjl.2012.06.012; Grause JF, 2013, VET J, V196, P541, DOI 10.1016/j.tvjl.2012.10.025; inegi (Instituto Nacional de Estadistica y Geografia), 2019, AN EST; Jaramillo-Arango CJ., 2010, EL MANUAL MODERNO, P112; Kappmeyer LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-603; Kappmeyer LS, 1999, J CLIN MICROBIOL, V37, P2285, DOI 10.1128/JCM.37.7.2285-2290.1999; Kim C, 2008, VET PARASITOL, V151, P158, DOI 10.1016/j.vetpar.2007.10.023; KNOWLES DP, 1991, INFECT IMMUN, V59, P2412, DOI 10.1128/IAI.59.7.2412-2417.1991; Lobanov VA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2751-6; Mahmoud MS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1539-9; Mehlhorn H, 1998, PARASITOL RES, V84, P467, DOI 10.1007/s004360050431; Mosqueda J, 2012, CURR MED CHEM, V19, P1504, DOI 10.2174/092986712799828355; Nicolaiewsky TB, 2001, VET PARASITOL, V101, P9, DOI 10.1016/S0304-4017(01)00471-X; NUTTALL G. H. F., 1912, Parasitology, V5, P65, DOI 10.1017/S003118200000010X; OIE, TERR AN HLTH COD; Rampersad J, 2003, VET PARASITOL, V114, P81, DOI 10.1016/S0304-4017(03)00129-8; Rapoport A, 2014, INFECT GENET EVOL, V23, P115, DOI 10.1016/j.meegid.2014.01.033; Rodriguez-Vivas RI., 2000, REV BIOMED, V11, P277; Romero-Salas D, 2021, TICKS TICK-BORNE DIS, V12, DOI 10.1016/j.ttbdis.2021.101671; Rosales R, 2013, VET PARASITOL, V196, P37, DOI 10.1016/j.vetpar.2013.02.004; Rothschild CM., 2007, EQUINE INFECT DIS, P465; Rovid A, 2010, EMERGING EXOTIC DIS, VFirst, P256; SAGARPA, 2018, AC MED CUAL SE ENL E; Sahagun-Ruiz A., 1995, INT INFORM SYSTEM AG; Schwint ON, 2008, J MED ENTOMOL, V45, P1152, DOI 10.1603/0022-2585(2008)45[1152:TOBCBD]2.0.CO;2; Schwint ON, 2009, ANTIMICROB AGENTS CH, V53, P4327, DOI 10.1128/AAC.00404-09; Scoles GA, 2015, ANNU REV ENTOMOL, V60, P561, DOI 10.1146/annurev-ento-010814-021110; Ueti MW, 2008, INFECT IMMUN, V76, P3525, DOI 10.1128/IAI.00251-08; Ueti MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044713; Ueti MW, 2005, J CLIN MICROBIOL, V43, P3755, DOI 10.1128/JCM.43.8.3755-3759.2005; Ueti MW, 2003, J CLIN MICROBIOL, V41, P5803, DOI 10.1128/JCM.41.12.5803-5809.2003; Vargas D., 2004, Parasitologia Latinoamericana, V59, P179; Wise LN, 2014, VET CLIN N AM-EQUINE, V30, P677, DOI 10.1016/j.cveq.2014.08.008	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264998	10.1371/journal.pone.0264998	http://dx.doi.org/10.1371/journal.pone.0264998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259206	gold, Green Published			2022-12-26	WOS:000835141200038
J	He, WH; Zhang, WD; Cheng, CC; Lu, J; Liu, L; Chen, ZH; Wang, WH				He, Wan-hong; Zhang, Wang-dong; Cheng, Cui-cui; Lu, Jia; Liu, Lei; Chen, Zhi-hua; Wang, Wen-hui			Expression characteristics of polymeric immunoglobulin receptor in Bactrian camel (Camelus bactrianus) lungs	PLOS ONE			English	Article							FREE SECRETORY COMPONENT; EPITHELIAL-CELL LINE; IG RECEPTOR; IMMUNE-SYSTEM; AIRWAY EPITHELIUM; GENE-TRANSFER; CUTTING EDGE; TRANSPORT; INNATE; RESPONSES	Polymeric immunoglobulin receptor (pIgR), the transmembrane transporter of polymeric immunoglobulin A and M, has multiple immune functions. To explore the characteristics of pIgR expression in Bactrian camel lungs, twelve healthy adult (2-7 years old) Bactrian camels were systematically studied. The results showed that pIgR was mainly expressed in the cytoplasm and membrane of ciliated cells, as well as in the cytoplasm and membrane of basal cells, serous cells of bronchial glands, club cells and alveolar type 2 cells in Bactrian camel lungs. Specially, as the bronchial branches extended, the pIgR expression level in ciliated cells significantly declined (p<0.05), and the corresponding bronchial luminal areas obviously decreased (p<0.05). However, pIgR was not expressed in goblet cells, endocrine cells, alveolar type 1 cells and mucous cells of bronchial glands. The results demonstrated that ciliated cells continuously distributed throughout the whole bronchial tree mucosa were the major expression sites of pIgR, and pIgR was also expressed in basal cells, serous cells of bronchial glands, club cells and alveolar type 2 cells, which would facilitate secretory immunoglobulin A (SIgA) transmembrane transport by pIgR and form an intact protective barrier. Moreover, the pIgR expression level in ciliated cells was positively correlated with the bronchial luminal areas; but negatively correlated with the cleanliness of airflow through the bronchial cross-sections, showing that the pIgR expression level in the bronchial epithelium was inhomogeneous. Our study provided a foundation for further exploring the regulatory functions of immunoglobulins (i.e., SIgA) after transport across the membrane by pIgR in Bactrian camel lungs.	[He, Wan-hong; Zhang, Wang-dong; Cheng, Cui-cui; Lu, Jia; Liu, Lei; Chen, Zhi-hua; Wang, Wen-hui] Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Wang, WH (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China.	wwh777@126.com			National Natural Science Foundation of China [31960693, 31760723, 31260595]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No.31960693, 31760723 and 31260595) to W.H. W, and the URL is http://www.nsfc.gov.cn.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI148517; Arodaki F, 2017, ANAT HISTOL EMBRYOL, V46, P405, DOI 10.1111/ahe.12272; Blanch VJ, 1999, J IMMUNOL, V162, P1232; Brandtzaeg P, 2006, ADV EXP MED BIOL, V579, P149; Bruno MEC, 2005, J IMMUNOL, V174, P7278, DOI 10.4049/jimmunol.174.11.7278; Chen YX., 2020, ANIMAL ANATOMY HISTO; Cheng LZ, 2003, CONT HISTOLOGY; de Oliveira IR, 2001, FEMS MICROBIOL LETT, V203, P29, DOI 10.1016/S0378-1097(01)00332-9; Du RH, 2015, VIRCHOWS ARCH, V467, P657, DOI 10.1007/s00428-015-1854-0; EIFFERT H, 1984, H-S Z PHYSIOL CHEM, V365, P1489, DOI 10.1515/bchm2.1984.365.2.1489; FERKOL T, 1993, J CLIN INVEST, V92, P2394, DOI 10.1172/JCI116845; FERKOL T, 1995, J CLIN INVEST, V95, P493, DOI 10.1172/JCI117690; Ganesan S, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24997; Griggs TF, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0567-0; Guzman-Bautista ER, 2015, DEV COMP IMMUNOL, V53, P271, DOI 10.1016/j.dci.2015.07.010; He WH, 2019, PEERJ, V7, DOI 10.7717/peerj.6571; Hempen PM, 2002, J IMMUNOL, V169, P1912, DOI 10.4049/jimmunol.169.4.1912; Hinojosa E, 2009, J INFECT DIS, V200, P546, DOI 10.1086/600870; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Huang YT, 2005, J IMMUNOL, V174, P4828, DOI 10.4049/jimmunol.174.8.4828; HULING S, 1992, P NATL ACAD SCI USA, V89, P4260, DOI 10.1073/pnas.89.10.4260; IOVANNITTI B, 1985, RES VET SCI, V38, P80, DOI 10.1016/S0034-5288(18)31852-6; ISAACSON P, 1982, J CLIN PATHOL, V35, P14, DOI 10.1136/jcp.35.1.14; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Jenkins SL, 2003, AM J PHYSIOL-GASTR L, V285, pG714, DOI 10.1152/ajpgi.00130.2003; Jia S., 2017, GENE CLONING BIOINFO; Johansen FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/mi.2011.37; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Kaetzel CS, 2001, CURR BIOL, V11, pR35, DOI 10.1016/S0960-9822(00)00041-5; Kuek LE, 2020, AM J PHYSIOL-LUNG C, V319, pL603, DOI 10.1152/ajplung.00283.2020; KVALE D, 1995, GUT, V36, P737, DOI 10.1136/gut.36.5.737; Li D, 2017, ZOOL RES, V38, P44, DOI 10.13918/j.issn.2095-8137.2017.007; Liu DY, 2013, J CLIN IMMUNOL, V33, P1009, DOI 10.1007/s10875-013-9891-4; Martin MG, 1998, AM J PHYSIOL-GASTR L, V275, pG778, DOI 10.1152/ajpgi.1998.275.4.G778; MESTECKY J, 1974, J IMMUNOL, V113, P404; MOSTOV KE, 1984, NATURE, V308, P37, DOI 10.1038/308037a0; Ocak S, 2012, EUR RESPIR J, V39, P1171, DOI 10.1183/09031936.00184410; Pausder A, 2022, LUNG, V200, P119, DOI 10.1007/s00408-021-00498-8; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Pilette C, 2001, EUR RESPIR J, V18, P571, DOI 10.1183/09031936.01.00228801; Pilette C, 2001, AM J RESP CRIT CARE, V163, P185, DOI 10.1164/ajrccm.163.1.9912137; Raji AR, 2006, J APPL ANIM RES, V30, P37, DOI 10.1080/09712119.2006.9706821; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Robinson JK, 2001, J IMMUNOL, V166, P3688, DOI 10.4049/jimmunol.166.6.3688; Rokicki W, 2016, KARDIOCHIR TORAKOCHI, V13, P26, DOI 10.5114/kitp.2016.58961; ROSSEL M, 1993, AM J RESP CELL MOL, V9, P341, DOI 10.1165/ajrcmb/9.3.341; Schjerven H, 2001, J IMMUNOL, V167, P6412, DOI 10.4049/jimmunol.167.11.6412; Schneeman TA, 2005, J IMMUNOL, V175, P376, DOI 10.4049/jimmunol.175.1.376; Trevisi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081473; UNDERDOWN BJ, 1992, J IMMUNOL, V149, P487; Weitnauer M, 2016, MUCOSAL IMMUNOL, V9, P287, DOI 10.1038/mi.2015.126; Widdicombe JH, 2015, PHYSIOL REV, V95, P1241, DOI 10.1152/physrev.00039.2014; Wieland WH, 2004, BIOCHEM J, V380, P669, DOI [10.1042/BJ20040200, 10.1042/bj20040200]; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Yang B, 2010, ANAT HISTOL EMBRYOL, V39, P138, DOI 10.1111/j.1439-0264.2009.00988.x; Yang X, 2012, STUDY BINDING SITES; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; Zhao XX., 1995, ECOPHYSIOLOGY REPROD	59	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264815	10.1371/journal.pone.0264815	http://dx.doi.org/10.1371/journal.pone.0264815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245335	Green Published, gold			2022-12-26	WOS:000799799100034
J	Ahonkhai, AA; Rebeiro, PF; Jenkins, CA; Rickles, M; Cook, M; Conserve, DF; Pierce, LJ; Shepherd, BE; Brantley, M; Wester, C				Ahonkhai, Aima A.; Rebeiro, Peter F.; Jenkins, Cathy A.; Rickles, Michael; Cook, Mekeila; Conserve, Donaldson F.; Pierce, Leslie J.; Shepherd, Bryan E.; Brantley, Meredith; Wester, Carolyn			Individual, community, and structural factors associated with linkage to HIV care among people diagnosed with HIV in Tennessee	PLOS ONE			English	Article							RACIAL/ETHNIC DISPARITIES; HEALTH; INITIATION; OUTCOMES; STRESS	Objective We assessed trends and identified individual- and county-level factors associated with individual linkage to HIV care in Tennessee (TN). Methods TN residents diagnosed with HIV from 2012-2016 were included in the analysis (n = 3,751). Individuals were assigned county-level factors based on county of residence at the time of diagnosis. Linkage was defined by the first CD4 or HIV RNA test date after HIV diagnosis. We used modified Poisson regression to estimate probability of 30-day linkage to care at the individual-level and the contribution of individual and county-level factors to this outcome. Results Both MSM (aRR 1.23, 95%CI 0.98-1.55) and women who reported heterosexual sex risk factors (aRR 1.39, 95%CI 1.18-1.65) were more likely to link to care within 30-days than heterosexual males. Non-Hispanic Black individuals had poorer linkage than White individuals (aRR 0.77, 95%CI 0.71-0.83). County-level mentally unhealthy days were negatively associated with linkage (aRR 0.63, 95%CI: 0.40-0.99). Conclusions Racial disparities in linkage to care persist at both individual and county levels, even when adjusting for county-level social determinants of health. These findings suggest a need for structural interventions to address both structural racism and mental health needs to improve linkage to care and minimize racial disparities in HIV outcomes.	[Ahonkhai, Aima A.; Rebeiro, Peter F.] Vanderbilt Univ, Med Ctr, Dept Med, Infect Dis, Nashville, TN 37232 USA; [Ahonkhai, Aima A.; Pierce, Leslie J.] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Med Ctr, Nashville, TN 37232 USA; [Rebeiro, Peter F.; Jenkins, Cathy A.; Shepherd, Bryan E.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Rebeiro, Peter F.] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med, Nashville, TN 37212 USA; [Rickles, Michael; Brantley, Meredith; Wester, Carolyn] Tennessee Dept Hlth, Nashville, TN USA; [Cook, Mekeila] Meharry Med Coll, Div Publ Hlth Practice, Nashville, TN 37208 USA; [Conserve, Donaldson F.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Tennessee Department Health; Meharry Medical College; University of South Carolina System; University of South Carolina Columbia	Ahonkhai, AA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Infect Dis, Nashville, TN 37232 USA.; Ahonkhai, AA (corresponding author), Vanderbilt Univ, Vanderbilt Inst Global Hlth, Med Ctr, Nashville, TN 37232 USA.	aimalohi.a.ahonkhai@vumc.org		Ahonkhai, Aimalohi/0000-0003-0666-4767; Rebeiro, Peter/0000-0003-1951-9104	National Institute of Allergy and Infectious Diseases [P30-AI110527]; National Institute of Mental Health [R25MH080665]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The data in this manuscript have been supported by the National Institute of Allergy and Infectious Diseases (P30-AI110527, AAA) and the National Institute of Mental Health (R25MH080665, AAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA, RAC PUBL HLTH CRIS; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Berger M, 2015, STRESS, V18, P1, DOI 10.3109/10253890.2014.989204; Bradley H, 2016, CLIN INFECT DIS, V62, P90, DOI 10.1093/cid/civ708; CDC, 2019, UND HIV CAR CONT; CDC,, 2020, BEHAV RISK FACT SURV; CDC, 2021, PROT RICHM AFR AM CE; CDC, 2019, HIV SO US, P4; Centers for Disease Control and Prevention, 2020, CDC COVID DAT TRACK; Craw J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-246; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Gray SC, 2016, AIDS CARE, V28, P266, DOI 10.1080/09540121.2015.1080793; Groos M., 2018, J HLTH DISPARITIES R, P11; Harrison TP, 2018, PUBLIC HEALTH REP, V133, p10S, DOI 10.1177/0033354918801583; Howe CJ, 2018, AM J EPIDEMIOL, V187, P316, DOI 10.1093/aje/kwx247; Jones CP, 2018, ETHNIC DIS, V28, P231, DOI 10.18865/ed.28.S1.231; Kirby JB, 2005, J HEALTH SOC BEHAV, V46, P15, DOI 10.1177/002214650504600103; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482; McGoy SL, 2018, PUBLIC HEALTH REP, V133, p43S, DOI 10.1177/0033354918801893; Pilcher CD, 2017, JAIDS-J ACQ IMM DEF, V74, P44, DOI 10.1097/QAI.0000000000001134; Ray R., 2020, REDUCE RACIAL GAP CO; Rebeiro PF, 2018, AIDS CARE, V30, P1426, DOI 10.1080/09540121.2018.1465526; Rickles M, 2018, CLIN INFECT DIS, V66, P1722, DOI 10.1093/cid/cix1079; Senn TE, 2014, ANN BEHAV MED, V48, P215, DOI 10.1007/s12160-014-9591-1; Surratt HL, 2015, AM J PUBLIC HEALTH, V105, P1660, DOI 10.2105/AJPH.2015.302612; Sutton MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170714; TDH, 2020, TENN HIV EPID PROF 2; TDH, RYAN WHIT PROGR; TDH, 2010, 2010 HIV CONT CAR TE; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; Trepka MJ, 2018, J HEALTH CARE POOR U, V29, P1153, DOI 10.1353/hpu.2018.0085; US Census Bureau, ACS; US Census Bureau, DEC CENS DATA; US Census Bureau. American Community Survey (ACS), AM COMM SURV ACS; Van Handel MM, 2016, JAIDS-J ACQ IMM DEF, V73, P323, DOI 10.1097/QAI.0000000000001098; WBUR, IS SYST RAC PUBL HLT; Weiser J, 2015, JAMA INTERN MED, V175, P1650, DOI 10.1001/jamainternmed.2015.4095	37	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264508	10.1371/journal.pone.0264508	http://dx.doi.org/10.1371/journal.pone.0264508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239705	gold, Green Published, Green Submitted			2022-12-26	WOS:000776002200038
J	Compagni, RD; Cheng, Z; Russo, S; Van Boeckel, TP				Compagni, Riccardo Delli; Cheng, Zhao; Russo, Stefania; Van Boeckel, Thomas P.			A hybrid Neural Network-SEIR model for forecasting intensive care occupancy in Switzerland during COVID-19 epidemics	PLOS ONE			English	Article							SELECTION	Anticipating intensive care unit (ICU) occupancy is critical in supporting decision makers to impose (or relax) measures that mitigate COVID-19 transmission. Mechanistic approaches such as Susceptible-Infected-Recovered (SIR) models have traditionally been used to achieve this objective. However, formulating such models is challenged by the necessity to formulate equations for plausible causal mechanisms between the intensity of COVID-19 transmission and external epidemic drivers such as temperature, and the stringency of non-pharmaceutical interventions. Here, we combined a neural network model (NN) with a Susceptible-Exposed-Infected-Recovered model (SEIR) in a hybrid model and attempted to increase the prediction accuracy of existing models used to forecast ICU occupancy. Between 1(st) of October, 2020 - 1(st) of July, 2021, the hybrid model improved performances of the SEIR model at different geographical levels. At a national level, the hybrid model improved, prediction accuracy (i.e., mean absolute error) by 74%. At the cantonal and hospital levels, the reduction on the forecast's mean absolute error were 46% and 50%, respectively. Our findings illustrate those predictions from hybrid model can be used to anticipate occupancy in ICU, and support the decision-making for lifesaving actions such as the transfer of patients and dispatching of medical personnel and ventilators.	[Compagni, Riccardo Delli; Cheng, Zhao; Van Boeckel, Thomas P.] Swiss Fed Inst Technol, Hlth Geog & Policy Grp, Zurich, Switzerland; [Russo, Stefania] Swiss Fed Inst Technol, Ecovis Lab, Photogrammetry & Remote Sensing, Zurich, Switzerland; [Van Boeckel, Thomas P.] Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Van Boeckel, TP (corresponding author), Swiss Fed Inst Technol, Hlth Geog & Policy Grp, Zurich, Switzerland.; Van Boeckel, TP (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA.	thomas.vanboeckel@env.ethz.ch		Zhao, Cheng/0000-0002-3176-0593	Swiss National Science Foundation [NRP78 4078P0_198428]; Swiss National Science Foundation Eccellenza Professorial Fellowship [PCEFP3_181248]; Branco Weiss Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation Eccellenza Professorial Fellowship(Swiss National Science Foundation (SNSF)); Branco Weiss Foundation	RDC was supported by the Swiss National Science Foundation (NRP78 4078P0_198428). TPVB was supported by Swiss National Science Foundation Eccellenza Professorial Fellowship (PCEFP3_181248). TPVB and CZ were supported by the Branco Weiss Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala'raj M, 2021, INFECT DIS MODEL, V6, P98, DOI 10.1016/j.idm.2020.11.007; Aleta A, 2020, NAT HUM BEHAV, V4, P964, DOI 10.1038/s41562-020-0931-9; Althaus CL., 2020, REAL TIME MODELING P; [Anonymous], 2021, COVID 19 INDIA WHY 2; Baker RE, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0660; Balabdaoui F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77420-4; BELUE LM, 1995, NEUROCOMPUTING, V7, P111, DOI 10.1016/0925-2312(94)E0053-T; Berger J, 2014, PHILOS PSYCHOL, V27, P829, DOI 10.1080/09515089.2013.771241; Bishop C.M., 1995, NEURAL NETWORKS PATT; Chen Chaoran, 2021, Epidemics, V37, P100480, DOI 10.1016/j.epidem.2021.100480; Cheng Z, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20277; Chu F, 2014, NEURAL COMPUT APPL, V24, P1259, DOI 10.1007/s00521-013-1347-5; Cibas T, 1996, NEUROCOMPUTING, V12, P223, DOI 10.1016/0925-2312(95)00121-2; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Deng XL, 2019, MULTIMED TOOLS APPL, V78, P3797, DOI 10.1007/s11042-018-6083-5; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dunner RP., COVID MEASURES CH; Fagiuoli S, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2011599; Federal Office of Public Health FOPH, VACC PEOPL; Fisher A, 2019, J MACH LEARN RES, V20; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Gitto S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247726; Gunther F, 2010, R J, V2, P30; Hale T, 2021, NAT HUM BEHAV, V5, P529, DOI 10.1038/s41562-021-01079-8; Harris S, 2018, INTENS CARE MED, V44, P606, DOI 10.1007/s00134-018-5148-2; Hauser A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003189; HORNIK K, 1990, NEURAL NETWORKS, V3, P551, DOI 10.1016/0893-6080(90)90005-6; Karpatne A, 2017, IEEE T KNOWL DATA EN, V29, P2318, DOI 10.1109/TKDE.2017.2720168; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lee DS, 2005, J BIOTECHNOL, V115, P317, DOI 10.1016/j.jbiotec.2004.09.001; Marini M., 2020, MEDRXIV, p2020; 2020.03.30.20047472, DOI 10.1101/2020.03.30.20047472; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Metzler B, 2020, EUR HEART J, V41, P1852, DOI 10.1093/eurheartj/ehaa314; Neil M Ferguson DanielLaydon., 2020, IMPACT NONPHARMACEUT; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; OpenDataZH, SARS COV 2 OP GOV DA; Phua J, 2020, INTENS CARE MED, V46, P1600, DOI 10.1007/s00134-020-06162-8; Poirier C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74089-7; Rahmadani F, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10238539; Raschka S., 2020, ARXIV181112808CSST; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Richard AN, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20224; Rohrer M, 2020, EARTH SYST ENVIRON, V4, P789, DOI 10.1007/s41748-020-00184-4; San O., NEURAL NETWORK CLOSU, P34; Shattock AJ., 2021, MEDRXIV, DOI [10.1101/2021.04.14.21255503, DOI 10.1101/2021.04.14.21255503]; Supino M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09913-w; THOMPSON ML, 1994, AICHE J, V40, P1328, DOI 10.1002/aic.690400806; Vollmer MAC, 2021, BMC EMERG MED, V21, DOI 10.1186/s12873-020-00395-y; Watson GL, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008837; Willard J., 2020, PHYS STAT; Yildirim A, 2009, KYBERNETES, V38, P1566, DOI 10.1108/03684920910991540	54	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0263789	10.1371/journal.pone.0263789	http://dx.doi.org/10.1371/journal.pone.0263789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239662	gold, Green Published			2022-12-26	WOS:000776002200014
J	Fei, XJ; Jin, ML; Wang, YQ; Li, TT; Lu, ZK; Yuan, ZH; Wang, HH; Lu, J; Quan, K; Di, R; Wei, CH				Fei, Xiaojuan; Jin, Meilin; Wang, Yuqin; Li, Taotao; Lu, Zengkui; Yuan, Zehu; Wang, Huihua; Lu, Jian; Quan, Kai; Di, Ran; Wei, Caihong			Transcriptome reveals key microRNAs involved in fat deposition between different tail sheep breeds	PLOS ONE			English	Article							ADIPOGENIC DIFFERENTIATION; LIVER-DISEASE; AMPK; EXPRESSION; SIGNATURE; PROMOTES; HEALTH; TOOL	MicroRNA (miRNA) is a kind of noncoding RNA whose function involved in various biological processes in neuronal maturation and adipocyte cells, such as differentiation, proliferation, development, apoptosis, and metabolism. Herein, miRNA-Seq was used to identify miRNAs in the tail fat tissue of Hu sheep (short-fat-tailed) and Tibetan sheep (short-thin-tailed). In this study, 155 differentially expression miRNAs (DE miRNAs) were identified, including 78 up-regulated and 77 down-regulated. Among these DE miRNAs, 17 miRNAs were reported and related with lipid metabolism. MiRanda and RNAhybrid software were used to predict the target genes of DE miRNAs, obtaining the number of targeting relationships is 38553. Target genes were enriched by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). 742 terms and 302 single pathways are enriched, including lipid metabolic process, response to lipid, cellular lipid catabolic process, lipid catabolic process, cellular lipid metabolic process, inositol lipid-mediated signaling, calcium channel activity, PI3K-Akt signaling pathway, MAPK signaling pathway, ECM-receptor interaction, AMPK signaling pathway, Wnt signaling pathway and TGF-beta signaling pathway. Notably, miR-379-5p was associated with tail fat deposition of sheep. Dual-Luciferase reporter assays showed miR-379-5p and HOXC9 had targeted relationship. The result of RT-qPCR showed that the expression trend of miR-379-5p and HOXC9 was opposite. miR-379-5p was down-regulated and highly expressed in tail adipose tissue of Tibetan sheep. HOXC9 was highly expressed in adipose tissue of Hu sheep. These results could provide a meaningful theoretical basis for studying the molecular mechanisms of sheep tail adipogenesis.	[Fei, Xiaojuan; Jin, Meilin; Li, Taotao; Wang, Huihua; Di, Ran; Wei, Caihong] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Wang, Yuqin] Henan Univ Sci & Technol, Luoyang, Henan, Peoples R China; [Lu, Zengkui] Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Gansu, Peoples R China; [Yuan, Zehu] Yangzhou Univ, Joint Int Res Lab Agr & Agriprod Safety, Minist Educ, Yangzhou, Jiangsu, Peoples R China; [Lu, Jian] Natl Anim Husb Serv, Beijing, Peoples R China; [Quan, Kai] Henan Univ Anim Husb & Econ, Zhengzhou, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Henan University of Science & Technology; Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; Yangzhou University; Henan University of Animal Husbandry & Economy	Di, R; Wei, CH (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China.	dirangirl@163.com; weicaihong@caas.cn			China Agriculture Research System of MOF and MARA [CARS-38]	China Agriculture Research System of MOF and MARA(Ministry of Oceans & Fisheries (MOF), Republic of Korea)	This research was supported by the China Agriculture Research System of MOF and MARA (No. CARS-38).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ziki MD, 2019, NUTR RES, V70, P18, DOI 10.1016/j.nutres.2018.06.009; Bakhtiarizadeh MR, 2019, G3-GENES GENOM GENET, V9, P1263, DOI 10.1534/g3.118.201014; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bork S, 2011, J CELL PHYSIOL, V226, P2226, DOI 10.1002/jcp.22557; Brune JE, 2016, OBESITY, V24, P51, DOI 10.1002/oby.21317; Cao DD, 2019, J CELL PHYSIOL, V234, P9475, DOI 10.1002/jcp.27634; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Chen X, 2018, DIABETES, V67, P554, DOI 10.2337/db17-0318; Chen XY, 2019, WORLD J GASTROENTERO, V25, P6607, DOI 10.3748/wjg.v25.i45.6607; Cheng FE, 2019, J AGR FOOD CHEM, V67, P5957, DOI 10.1021/acs.jafc.9b01253; Cheng J, 2020, J FOOD SCI, V85, P3998, DOI 10.1111/1750-3841.15475; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Choi EO, 2015, MOL MED REP, V12, P1314, DOI 10.3892/mmr.2015.3463; Culwick MD, 2020, CURR OPIN ANESTHESIO, V33, P808, DOI 10.1097/ACO.0000000000000926; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Deng W, 2020, INT J STEM CELLS, V13, P142, DOI 10.15283/ijsc19073; Dong LQ, 2017, ACS APPL MATER INTER, V9, P15274, DOI 10.1021/acsami.7b02411; Du JJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020501; Farkhondeh T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124258; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gonzalez A, 2020, CELL METAB, V31, P472, DOI 10.1016/j.cmet.2020.01.015; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lee HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066267; Li CX, 2019, WORLD J GASTROENTERO, V25, P5120, DOI 10.3748/wjg.v25.i34.5120; Li N, 2019, INT J MOL MED, V44, P1619, DOI 10.3892/ijmm.2019.4325; Li Q, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10010089; Liu Y, 2019, FOOD FUNCT, V10, P2538, DOI [10.1039/C9FO00095J, 10.1039/c9fo00095j]; Long JK, 2019, MOL MED, V25, DOI 10.1186/s10020-019-0085-2; Lopez S, 2018, J NUTR BIOCHEM, V57, P45, DOI 10.1016/j.jnutbio.2018.03.010; Lu ZK, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10040739; Ma H, 2019, J ENDOCRINOL, V243, P97, DOI 10.1530/JOE-18-0693; Ma LA, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0262-0; Machal J, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0488-9; Mantilla-Escalante DC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061326; Obianom ON, 2019, J MED CHEM, V62, P727, DOI 10.1021/acs.jmedchem.8b01408; Ojima K, 2016, FEBS OPEN BIO, V6, P816, DOI 10.1002/2211-5463.12091; Pflug FG, 2018, BIOINFORMATICS, V34, P3137, DOI 10.1093/bioinformatics/bty283; Qian SW, 2019, J MOL CELL BIOL, V11, P14, DOI 10.1093/jmcb/mjy011; Qin GH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124126; Ristl R, 2020, STAT METHODS MED RES, V29, P1746, DOI 10.1177/0962280219873005; San JS, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2021.101135; Song TX, 2019, CLIN SCI, V133, P2107, DOI 10.1042/CS20190128; Sun JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102142; Tian LL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.455; Torres LF, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4168380; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Wang XY, 2021, GENE, V781, DOI 10.1016/j.gene.2021.145492; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei CH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1384-9; Wu WJ, 2021, ADIPOCYTE, V10, P264, DOI 10.1080/21623945.2021.1917811; Wu WJ, 2017, J AGR FOOD CHEM, V65, P5512, DOI 10.1021/acs.jafc.7b00594; Xie T, 2019, CLIN SCI, V133, P2029, DOI 10.1042/CS20190093; Xu HY, 2020, BIOCHEMISTRY-MOSCOW+, V85, P749, DOI 10.1134/S0006297920070032; Xu HY, 2021, HORM METAB RES, V53, P63, DOI 10.1055/a-1276-1602; Xu JJ, 2019, BIOCHEM BIOPH RES CO, V514, P1251, DOI 10.1016/j.bbrc.2019.04.179; Xu SS, 2017, ANIM GENET, V48, P560, DOI 10.1111/age.12572; Xu Y, 2020, THERANOSTICS, V10, P11302, DOI 10.7150/thno.47746; Yuan Z, 2017, ANIM GENET, V48, P55, DOI 10.1111/age.12477; Zhang JX, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/3413186; Zhang TY, 2019, J ANIM BREED GENET, V136, P362, DOI 10.1111/jbg.12402; Zhang XM, 2016, OBESITY, V24, P1097, DOI 10.1002/oby.21467; Zhang XR, 2016, EUR J PHARMACOL, V779, P46, DOI 10.1016/j.ejphar.2016.03.011; Zhao FP, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10050773; Zhu CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep27822	66	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264804	10.1371/journal.pone.0264804	http://dx.doi.org/10.1371/journal.pone.0264804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231067	Green Published, gold			2022-12-26	WOS:000849744700048
J	Hadley, E; Rhea, S; Jones, K; Li, L; Stoner, M; Bobashev, G				Hadley, Emily; Rhea, Sarah; Jones, Kasey; Li, Lei; Stoner, Marie; Bobashev, Georgiy			Enhancing the prediction of hospitalization from a COVID-19 agent-based model: A Bayesian method for model parameter estimation	PLOS ONE			English	Article								Agent-based models (ABMs) have become a common tool for estimating demand for hospital beds during the COVID-19 pandemic. A key parameter in these ABMs is the probability of hospitalization for agents with COVID-19. Many published COVID-19 ABMs use either single point or age-specific estimates of the probability of hospitalization for agents with COVID-19, omitting key factors: comorbidities and testing status (i.e., received vs. did not receive COVID-19 test). These omissions can inhibit interpretability, particularly by stakeholders seeking to use an ABM for transparent decision-making. We introduce a straightforward yet novel application of Bayes' theorem with inputs from aggregated hospital data to better incorporate these factors in an ABM. We update input parameters for a North Carolina COVID-19 ABM using this approach, demonstrate sensitivity to input data selections, and highlight the enhanced interpretability and accuracy of the method and the predictions. We propose that even in tumultuous scenarios with limited information like the early months of the COVID-19 pandemic, straightforward approaches like this one with discrete, attainable inputs can improve ABMs to better support stakeholders.	[Hadley, Emily; Rhea, Sarah; Jones, Kasey; Li, Lei; Stoner, Marie; Bobashev, Georgiy] RTI Int, Durham, NC 27709 USA; [Rhea, Sarah] North Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC USA	Research Triangle Institute; University of North Carolina; North Carolina State University	Hadley, E (corresponding author), RTI Int, Durham, NC 27709 USA.	ehadley@rti.org		li, lei/0000-0002-3993-2193; Rhea, Sarah/0000-0002-6183-1620; Jones, K/0000-0002-9154-9079; Stoner, Marie/0000-0002-7189-8669; Hadley, Emily/0000-0003-0074-4344	RTI International; North Carolina Department of Health and Human Services [2020-DHHS-COVPS 010]; Centers for Disease Control and Prevention (CDC) [75D30120P07909]; CDC MInD Healthcare Network Contract [U01CK00527]	RTI International; North Carolina Department of Health and Human Services; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC MInD Healthcare Network Contract	This work was supported by RTI International; North Carolina Department of Health and Human Services Contract #2020-DHHS-COVPS 010; Centers for Disease Control and Prevention (CDC) Contract #75D30120P07909; and CDC MInD Healthcare Network Contract #U01CK00527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2020, NATURE, V580, P316, DOI 10.1038/d41586-020-01003-6; Begley S., 2020, STAT-US; C. C. Kerr, 2021, medRxiv, DOI 10.1101/2020.05.10.20097469; Cavallo Joseph J, 2020, JAMA Health Forum, V1, pe200345, DOI 10.1001/jamahealthforum.2020.0345; CDC, 2020, CONS REST BAR OP; Centers for Disease Control and Prevention, 2020, ACCESSED FEBRUARY, V12, P2021; Centers for Disease Control and Prevention, 2020, MANAGEMENT PATIENTS; de Sire A, 2020, EUR J PHYS REHAB MED, V56, P839, DOI 10.23736/S1973-9087.20.06614-9; Donker T, 2021, INFECT CONT HOSP EP, V42, P653, DOI 10.1017/ice.2020.464; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Fari G, 2022, J MED VIROL, V94, P110, DOI 10.1002/jmv.27272; Fort D, 2020, OCHSNER J, V20, P285, DOI 10.31486/toj.20.0073; Gao X, 2020, JAMIA OPEN, V3, P628, DOI 10.1093/jamiaopen/ooaa062; Gao X, 2021, J AM MED INFORM ASSN, V28, P472, DOI 10.1093/jamia/ocaa246; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Hoertel N., 2020, MEDRXIV, DOI [10.1101/2020.04.23.20076885, DOI 10.1101/2020.04.23.20076885]; Jones K, 2021, Arxiv, DOI arXiv:2106.04461; Kashyap S, 2020, J AM MED INFORM ASSN, V27, P1026, DOI 10.1093/jamia/ocaa076; Kerschbaum S. L., 2017, NEGOTIATING DISABILI; Killerby ME, 2020, MMWR-MORBID MORTAL W, V69, P790, DOI 10.15585/mmwr.mm6925e1; Pekkanen J., 2020, MEDRXIV, DOI [10.1101/2020.04.09.20047498, DOI 10.1101/2020.04.09.20047498]; Rhea S, 2019, HEALTH SECUR, V17, P276, DOI 10.1089/hs.2019.0021; Silva PCL, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110088; Soria A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246170; Truszkowska A, 2021, ADV THEOR SIMUL, V4, DOI [10.1002/adts.202170005, 10.1002/adts.202000277]; Verity R, 2020, MEDRXIV, DOI [10.1016/S1473-3099(20)30243-7, DOI 10.1016/S1473-3099(20)30243-7]; Weissman GE, 2020, ANN INTERN MED, V173, P21, DOI 10.7326/M20-1260	29	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264704	10.1371/journal.pone.0264704	http://dx.doi.org/10.1371/journal.pone.0264704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231066	Green Published, gold			2022-12-26	WOS:000849744700036
J	Lu, CL; Li, BW; Yang, M; Wang, XQ				Lu, Cai-Lian; Li, Bo-Wen; Yang, Mi; Wang, Xiao-Qin			Relationship between alveolar-bone morphology at the mandibular incisors and their inclination in adults with low-angle, skeletal class III malocclusion-A retrospective CBCT study	PLOS ONE			English	Article							THICKNESS; MAXILLARY; ACCURACY; PROCLINATION	Objective To quantitatively study the effect of the labial inclination of the mandibular central incisors on the surrounding cortical and cancellous-bone morphology among patients with low-angle, skeletal class III malocclusion, by using cone-beam computed-tomography (CBCT) imaging. Materials and methods The CBCT images of 60 patients with low-angle, skeletal class III malocclusion were divided into lingual-inclination, upright, and labial-inclination groups. The height of the alveolar bone and the thickness and area of the cortical, cancellous, and total alveolar bone were measured separately on each side of the mandibular central incisors. Results The thickness of the labial cortical bone from 6 mm below the cementoenamel junction (CEJ) to the root apex; the thickness of the labial cancellous bone at the root apex; the total thickness of the alveolar bone at the root apex; the area of labial cortical bone; the total area of labial alveolar bone; and the height of the labial alveolar bone were highest in the labial-inclination group (all P<0.05). All these variables were positively correlated with the labial inclination of the mandibular central incisors (all P<0.05). There were no statistical differences between the groups for any of the measurements on the lingual side of the teeth (P>0.05). Conclusion The morphology of the alveolar bone on the labial but not the lingual side of the mandibular central incisors was statistically significantly correlated with the labial inclination of those teeth in patients with low-angle, skeletal class III malocclusion.	[Lu, Cai-Lian; Li, Bo-Wen; Yang, Mi; Wang, Xiao-Qin] Shanxi Med Univ, Dept Stomatol, Hosp 1, Taiyuan, Peoples R China; [Lu, Cai-Lian; Li, Bo-Wen; Yang, Mi; Wang, Xiao-Qin] Shanxi Med Univ, Sch & Hosp Stomatol, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi Medical University	Wang, XQ (corresponding author), Shanxi Med Univ, Dept Stomatol, Hosp 1, Taiyuan, Peoples R China.; Wang, XQ (corresponding author), Shanxi Med Univ, Sch & Hosp Stomatol, Taiyuan, Peoples R China.	wangxiaoqing2009@yeah.net			Shanxi Provincial Science and Technology Development (Social Development) Key Project [201803D31065]	Shanxi Provincial Science and Technology Development (Social Development) Key Project	This research is funded by the Shanxi Provincial Science and Technology Development (Social Development) Key Project [no. 201803D31065]. The funder has no role in research design, data collection and analysis, publication decision or manuscript preparation.	Casanova-Sarmiento JA, 2020, INT ORTHOD, V18, P79, DOI 10.1016/j.ortho.2019.10.001; Choi YJ, 2015, ANGLE ORTHOD, V85, P427, DOI 10.2319/021414-110.1; Cook VC, 2015, ORTHOD CRANIOFAC RES, V18, P127, DOI 10.1111/ocr.12072; Filipova D, 2019, BRATISL MED J, V120, P155, DOI 10.4149/BLL_2019_025; FUHRMANN RAW, 1995, DENTOMAXILLOFAC RAD, V24, P50, DOI 10.1259/dmfr.24.1.8593909; Gallichan N, 2020, EUR ARCH PAEDIATR DE, V21, P537, DOI 10.1007/s40368-020-00526-w; Lee S, 2018, KOREAN J ORTHOD, V48, P349, DOI 10.4041/kjod.2018.48.6.349; Ma J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210461; Mao HM, 2020, HEAD FACE MED, V16, DOI 10.1186/s13005-020-00242-2; Min HY., 2018, EVALUATION BONE MORP; Morais JF, 2018, ANGLE ORTHOD, V88, P748, DOI 10.2319/101117-686.1; Morris JW, 2017, AM J ORTHOD DENTOFAC, V151, P851, DOI 10.1016/j.ajodo.2016.09.027; Padala S, 2018, ANGLE ORTHOD, V88, P227, DOI 10.2319/060617-379.1; Rossi M, 2017, INT ORTHOD, V15, P610, DOI 10.1016/j.ortho.2017.09.003; Sheng Y, 2020, J OROFAC ORTHOP, V81, P1, DOI 10.1007/s00056-019-00196-4; Srebrzynska-Witek A, 2018, CLIN ORAL INVEST, V22, P1567, DOI 10.1007/s00784-017-2255-3; Sun BY, 2015, INT J CLIN EXP MED, V8, P12866; Tian YL, 2015, KOREAN J ORTHOD, V45, P245, DOI 10.4041/kjod.2015.45.5.245; Vardimon AD, 1998, AM J ORTHOD DENTOFAC, V114, P520, DOI 10.1016/S0889-5406(98)70172-6; Weissheimer A, 2012, AM J ORTHOD DENTOFAC, V142, P801, DOI 10.1016/j.ajodo.2012.07.015; Wood R, 2013, AM J ORTHOD DENTOFAC, V143, P353, DOI 10.1016/j.ajodo.2012.10.019; Yamada C, 2007, ANGLE ORTHOD, V77, P766, DOI 10.2319/072906-309; Yao CCJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71126-3; Yu QA, 2009, INT J ORAL SCI, V1, P217, DOI 10.4248/IJOS09047	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264788	10.1371/journal.pone.0264788	http://dx.doi.org/10.1371/journal.pone.0264788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231080	Green Published, gold			2022-12-26	WOS:000849744700047
J	Shih, CW; Chen, YH; Chen, WL				Shih, Chi-Wei; Chen, Yu-Hsin; Chen, Wei-Liang			Percentage of body fat is associated with increased risk of diverticulosis: A cross sectional study	PLOS ONE			English	Article							COLONIC DIVERTICULOSIS; DISEASE; OBESITY; CONSTIPATION; FIBER; DIET	Background Obesity has been indicated to be a risk factor of diverticulosis. However, plausible relationship remained controversial. This cross-sectional study elucidated the association between percentage of body fat and the risk of diverticulosis. Methods The study was conducted at a single medical center in Taiwan from 2000-2016 which enrolled 5557 adults with age above 20 years old receiving a health examination including self-reported questionnaires, measurement of percentage of body fat (PBF), blood test and colonoscopy at the Tri-Service General Hospital (TSGH). Logistic regressions were used to analyze the association between PBF and diverticulosis. Further stratification of participants was based on age and gender and three extended models were established for multivariable adjustment. Results 243 of 3141 males and 103 of 2416 females were diagnosed with having diverticulosis. After covariates adjustment, only participants in the highest quartile of PBF (Q4.33.8%) showed significantly positive association with the risk diverticulosis (OR 2.089, p < 0.001). In subgroup analysis, the odds ratio for having diverticulosis in females was significantly higher than in males. In addition, We found that the odds ratio of having diverticulosis was higher in the group older than 60 years old compared to the younger group (OR 1.052; p<0.001; OR 1.043; p<0.001). Conclusions In conclusion, PBF was a potential risk factor of diverticulosis. Individuals with higher PBF exhibits increased risk of diverticulosis, especially in females. Furthermore, bioelectrical impedance analysis may create a simple, available and radiation-free way to assess the risk of diverticulosis.	[Shih, Chi-Wei] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Internal Med, Taipei, Taiwan; [Chen, Yu-Hsin] Triserv Gen Hosp, Hualien Armed Forces Gen Hosp, Natl Def Med Ctr, Dept Emergency Med, Taipei, Taiwan; [Chen, Yu-Hsin] Taichung Vet Gen Hosp, Dept Emergency Med, Taichung, Taiwan; [Chen, Wei-Liang] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Div Family Med,Dept Family & Community Med, Taipei, Taiwan; [Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chen, Wei-Liang] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Taichung Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Chen, WL (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Div Family Med,Dept Family & Community Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	weiliang0508@gmail.com						ALDOORI WH, 1994, AM J CLIN NUTR, V60, P757, DOI 10.1093/ajcn/60.5.757; ALDOORI WH, 1995, GUT, V36, P276, DOI 10.1136/gut.36.2.276; Braunschmid T, 2015, INT J SURG, V19, P42, DOI 10.1016/j.ijsu.2015.04.045; Coppini LZ, 2005, CURR OPIN CLIN NUTR, V8, P329, DOI 10.1097/01.mco.0000165013.54696.64; Crowe FL, 2014, GUT, V63, P1450, DOI 10.1136/gutjnl-2013-304644; Crowe FL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4131; De Cecco C, 2016, EUR RADIOL, V26, P639, DOI 10.1007/s00330-015-3866-1; Dobbins C, 2006, COLORECTAL DIS, V8, P37, DOI 10.1111/j.1463-1318.2005.00847.x; Halligan S, 2002, BEST PRACT RES CL GA, V16, P595, DOI 10.1053/bega.2002.0323; Lee SP, 2014, TURK J GASTROENTEROL, V25, P192, DOI 10.5152/tjg.2014.4581; Loffeld R. J. L. F, 2002, Colorectal Dis, V4, P189, DOI 10.1046/j.1463-1318.2002.00328.x; Nagata N, 2015, J CLIN GASTROENTEROL, V49, P816, DOI 10.1097/MCG.0000000000000267; Nagata N, 2014, INT J COLORECTAL DIS, V29, P379, DOI 10.1007/s00384-013-1808-4; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; Seidell JC, 1997, BRIT MED BULL, V53, P238, DOI 10.1093/oxfordjournals.bmb.a011611; Sharara AI, 2013, J CLIN GASTROENTEROL, V47, P420, DOI 10.1097/MCG.0b013e31826be847; Song Jung Hoon, 2010, Korean Journal of Internal Medicine, V25, P140, DOI 10.3904/kjim.2010.25.2.140; Stollman N, 2004, LANCET, V363, P631, DOI 10.1016/S0140-6736(04)15597-9; Stollman NH, 1999, AM J GASTROENTEROL, V94, P3110, DOI 10.1111/j.1572-0241.1999.01501.x; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Wang FW, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0267-5; Wijarnpreecha K, 2018, DIS COLON RECTUM, V61, P476, DOI 10.1097/DCR.0000000000000999; Yamada E, 2015, NEUROGASTROENT MOTIL, V27, P333, DOI 10.1111/nmo.12478; Yamamichi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123688; Yeo LX, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819855734	25	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264746	10.1371/journal.pone.0264746	http://dx.doi.org/10.1371/journal.pone.0264746			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231075	Green Published, gold			2022-12-26	WOS:000849744700042
J	Park, S; Lee, JP; Kim, DK; Kim, YS; Lim, CS				Park, Seokwoo; Lee, Jung Pyo; Kim, Dong Ki; Kim, Yon Su; Lim, Chun Soo			Superior effect of allopurinol compared to febuxostat on the retardation of chronic kidney disease progression	PLOS ONE			English	Article							URIC-ACID; RENAL-DISEASE; GFR DECLINE; HYPERURICEMIA; CKD; GENERATION; RISK	Background Although hyperuricemia is associated with chronic kidney disease, whether and how it should be managed for renoprotection remains debatable. Thus, we investigated whether allopurinol and febuxostat, the most frequently used urate-lowering treatments, have differential renoprotective effects on chronic kidney disease. Methods Incident users of allopurinol and febuxostat were identified from two tertiary referral centers. One-to-one propensity score matching between the allopurinol and febuxostat groups was performed. Participants were followed up until the occurrence of clinical outcomes, urate-lowering agent discontinuation, mortality, or the end of the study period, whichever occurred first. The primary outcomes were a 30% decline in estimated glomerular filtration rate (eGFR) and end-stage renal disease. Differential trends of eGFR decline were estimated using a linear mixed-effects model. Results Each group included 654 participants. Baseline eGFRs were 40.1 [26.6-57.3] and 39.1 [27.9-58.3] mL/min/1.73 m(2) in the allopurinol and febuxostat group, respectively. Adjusted least square mean change in serum urate was -1.58 mg/dL [95% confidence interval (CI), -1.78 to -1.38] and -2.69 mg/dL (95% CI, -2.89 to -2.49) in the allopurinol and febuxostat groups, respectively. Despite lower serum urate levels, febuxostat was significantly more associated with a 30% decline in eGFR (hazard ratio 1.26; 95% CI 1.03-1.54) and end-stage renal disease (hazard ratio 1.91, 95% CI 1.42-2.58) than allopurinol. Annual eGFR decline in febuxostat users was estimated to be more rapid than in allopurinol users by 2.14 (standard error 0.71) mL/min/1.73 m(2) per year. Conclusions Allopurinol demonstrated attenuation of chronic kidney disease progression and prevention of hypouricemia, compared to febuxostat. Because the treatment can be renoprotective, further studies on its effects on chronic kidney disease are required.	[Park, Seokwoo; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Seokwoo; Lee, Jung Pyo; Kim, Dong Ki; Kim, Yon Su; Lim, Chun Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Park, Seokwoo] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Dong Ki; Kim, Yon Su] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Lim, CS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Lim, CS (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	cslimjy@snu.ac.kr	Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852; Lim, Chun Soo/0000-0001-9123-6542				Badve SV, 2020, NEW ENGL J MED, V382, P2504, DOI 10.1056/NEJMoa1915833; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Boucquemont J, 2017, NEPHROL DIAL TRANSPL, V32, P185, DOI 10.1093/ndt/gfw380; Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Chen Q, 2020, CLIN J AM SOC NEPHRO, V15, P1576, DOI 10.2215/CJN.05190420; Chou HW, 2018, NEPHROL DIAL TRANSPL, V33, P1620, DOI 10.1093/ndt/gfx313; Doria A, 2020, NEW ENGL J MED, V382, P2493, DOI 10.1056/NEJMoa1916624; Eleftheriadis T, 2018, INT UROL NEPHROL, V50, P179, DOI 10.1007/s11255-017-1733-5; Feig DI, 2020, NEW ENGL J MED, V382, P2567, DOI 10.1056/NEJMe2015886; Feig DI, 2013, J PEDIATR-US, V162, P896, DOI 10.1016/j.jpeds.2012.12.078; GIBSON T, 1982, ANN RHEUM DIS, V41, P59, DOI 10.1136/ard.41.1.59; Goicoechea M, 2015, AM J KIDNEY DIS, V65, P543, DOI 10.1053/j.ajkd.2014.11.016; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hirsch GA, 2012, J AM COLL CARDIOL, V59, P802, DOI 10.1016/j.jacc.2011.10.895; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hsu YSO, 2020, CLIN PHARMACOL THER, V107, P1159, DOI 10.1002/cpt.1697; Jalal DI, 2010, NEPHROL DIAL TRANSPL, V25, P1865, DOI 10.1093/ndt/gfp740; Kanda E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118031; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kim S, 2017, KIDNEY RES CLIN PRAC, V36, P274, DOI 10.23876/j.krcp.2017.36.3.274; Kimura K, 2018, AM J KIDNEY DIS, V72, P798, DOI 10.1053/j.ajkd.2018.06.028; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Lee JW, 2019, INT UROL NEPHROL, V51, P467, DOI 10.1007/s11255-018-2051-2; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin TC, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016311; Pilemann-Lyberg S, 2019, DIABETES CARE, V42, P1088, DOI 10.2337/dc18-2173; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Sato Y, 2019, NAT REV NEPHROL, V15, P767, DOI 10.1038/s41581-019-0174-z; Singh JA, 2017, ANN RHEUM DIS, V76, P1669, DOI 10.1136/annrheumdis-2017-211210; Sircar D, 2015, AM J KIDNEY DIS, V66, P945, DOI 10.1053/j.ajkd.2015.05.017; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Vargas-Santos AB, 2018, JAMA INTERN MED, V178, P1526, DOI 10.1001/jamainternmed.2018.4463; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; White WB, 2018, NEW ENGL J MED, V378, P1200, DOI 10.1056/NEJMoa1710895; Yang CY, 2015, JAMA INTERN MED, V175, P1550, DOI 10.1001/jamainternmed.2015.3536; Zeng XX, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010161; Zhang X, 2019, INT UROL NEPHROL, V51, P2273, DOI 10.1007/s11255-019-02318-8	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264627	10.1371/journal.pone.0264627	http://dx.doi.org/10.1371/journal.pone.0264627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226683	gold, Green Published			2022-12-26	WOS:000793394000037
J	Wabinski, J; Smiechowska-Petrovskij, E; Moscicka, A				Wabinski, Jakub; Smiechowska-Petrovskij, Emilia; Moscicka, Albina			Applying height differentiation of tactile symbols to reduce the minimum horizontal distances between them on tactile maps	PLOS ONE			English	Article							DESIGN	In this paper, we wanted to verify the hypothesis that extruding cartographic symbols on tactile maps to different heights might allow reducing the minimum (suggested in the literature) horizontal distances between them, without impacting the overall map's legibility. This approach might allow preparing tactile maps in smaller scales and thus, reducing production cost, or putting additional spatial information on the same map sheet that would not fit otherwise. To verify the hypothesis we have prepared 6 different stimuli variants with or without height differentiation applied and different horizontal distances between tactile symbols adopted (1 mm, 2 mm and 3 mm). In the controlled study sessions with 30 participants with visual impairments we have measured the times required for solving 3 different spatial tasks on 3D printed tactile stimuli. We have also performed qualitative analysis to learn participants' opinions about the proposed design and materials used. It turns out that applying height differentiation not only results in shorter times required for solving spatial tasks but is also considered by blind individuals as a convenient improvement in terms of use comfort and allows reduction of recommended minimum horizontal distances between symbols on tactile maps.	[Wabinski, Jakub; Moscicka, Albina] Mil Univ Technol, Fac Civil Engn & Geodesy, Inst Geodesy, Warsaw, Poland; [Smiechowska-Petrovskij, Emilia] Cardinal Stefan Wyszynski Univ, Fac Educ Sci, Dept Special Educ, Warsaw, Poland	Institute of Geodesy & Cartography; Military University of Technology in Warsaw; Cardinal Stefan Wyszynski University in Warsaw	Wabinski, J (corresponding author), Mil Univ Technol, Fac Civil Engn & Geodesy, Inst Geodesy, Warsaw, Poland.	Jakub.wabinski@wat.edu.pl	Mościcka, Albina/F-5045-2019; Wabiński, Jakub/AAB-4249-2019	Mościcka, Albina/0000-0003-4673-3720; Wabiński, Jakub/0000-0002-9995-1329	Military University of Technology, Faculty of Civil Engineering and Geodesy [5314000-22-871/UGB/2021]	Military University of Technology, Faculty of Civil Engineering and Geodesy	This research was funded by Military University of Technology, Faculty of Civil Engineering and Geodesy, grant number 5314000-22-871/UGB/2021.	BANA and the CBA, 2010, GUIDELINES STANDARDS; Barvir R, 2021, ISPRS INT J GEO-INF, V10, DOI 10.3390/ijgi10080505; Bertin J., 2010, SEMIOLOGY GRAPHICS D; Blades M, 1999, PROF GEOGR, V51, P539, DOI 10.1111/0033-0124.00191; Cervenka P, 2016, 15 INT C COMPUTERS H, P1; Dacen Nagel D.L., 1990, CARTOGRAPHICA, V27, P47; Danish Association of the Blind, 2018, BRAIL TEACH LIT REP; Edman P. K., 1992, TACTILE GRAPHICS; Gill JM., 1982, TACTUAL PERCEPTION S, P405; Gual J, 2014, BRIT J VISUAL IMPA, V32, P263, DOI 10.1177/0264619614540291; Holloway L, 2018, PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2018), DOI 10.1145/3173574.3173772; Jafri R, 2015, INT C HLTH INFORMATI, P55; James G.A., 2009, TACTUAL PERCEPTION S, P334; Khochen-Bagshaw M., 2012, PROCEEDING WORLD C B; Klatzky R.L., 2003, HDB PSYCHOL VOLUME 4, P151; Koch WG., 2012, LECT NOTES GEOINFORM, P137, DOI [10.1007/978-3-642-12272-9_9, DOI 10.1007/978-3-642-12272-9_9]; Lawrence MM, 2011, J VISUAL IMPAIR BLIN, V105, P681, DOI 10.1177/0145482X1110501014; LEONARD JA, 1967, NATURE, V215, P1413, DOI 10.1038/2151413a0; Lobben A, 2012, PROF GEOGR, V64, P95, DOI 10.1080/00330124.2011.595619; McCallum D, 2005, J ENG DESIGN, V16, P525, DOI 10.1080/09544820500273946; Morash VS, 2016, IEEE T HAPTICS, V9, P100, DOI 10.1109/TOH.2015.2508021; National Federation of the Blind, 2009, BRAILLE LITERACY CRI; Nolan C, 1971, FINAL REPORT; Orti JG., 2013, CARTOGR J, P1; Pike E., 1992, CARTOGRAPHICA, V29, P83, DOI DOI 10.3138/RQ41-Q433-8411-7G40; Potelarska-Walczynska L., 1979, PR I GEOD KARTOGR, V3; Ratajski L., 1989, METODYKA KARTOGRAFII; Rowell J, 2005, P 22 INT CARTOGRAPHI; Rowell J, 2003, PROC 21 INT CARTOGR, P651; Salistchev KA., 2002, KARTOGRAFIA OG LNA, VThird; smiechowska-Petrovskij E., 2015, FORUM PEDAGOG, V1, P195; Taylor B, 2016, ASSETS'16: PROCEEDINGS OF THE 18TH INTERNATIONAL ACM SIGACCESS CONFERENCE ON COMPUTERS AND ACCESSIBILITY, P71, DOI 10.1145/2982142.2982167; Touya G, 2019, INT J CARTOGRAPHY, V5, P67, DOI 10.1080/23729333.2018.1486784; Towarzystwo Opieki nad Ociemnialymi w Laskach, 2010, ATLAS PRZYRODY DLA O; Ungar S., 1997, CARTOGR PERSPECT, V28, P4, DOI [10.14714/CP28.686, DOI 10.14714/CP28.686]; Vozenilek V, 2009, P 24 INT CARTOGRAPHI, P1; Vozenilek V, 2014, SABIED INTEGR IZGL, P193; Wabinski J., 2017, ANN GEOMATICS, V15, P391; Wabinski J, 2021, CARTOGR J, V58, P123, DOI 10.1080/00087041.2020.1721765; Wabinski J, 2019, ISPRS INT GEO-INF, V8, DOI 10.3390/ijgi8070293; Wieckowska E., 2012, STANDARDY TWORZENIA; Wiedel J.W., 1969, RD2557S DEP HLTH ED; Zebehazy KT, 2014, J VISUAL IMPAIR BLIN, V108, P275	43	3	3	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264564	10.1371/journal.pone.0264564	http://dx.doi.org/10.1371/journal.pone.0264564			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213662	Green Published, gold			2022-12-26	WOS:000787811000123
J	Xue, ZH; Li, L				Xue, Zhehua; Li, Lei			Rapid and green detection of manganese in electrolytes by ultraviolet-visible spectrometry to control pollutant discharge	PLOS ONE			English	Article							SPECTROSCOPY; PERFORMANCE	Controlling the manganese (Mn2+) concentration is important to product quality in the electrolytic manganese industry. Conventional methods for detecting Mn2+ are complex and reagent-consuming, which makes them slow and polluting. It is of great significance to develop a new fast and environmentally friendly method to quantify Mn2+ in electrolyte. The characteristic ultraviolet-visible (UV-vis) absorbance at 401 nm of Mn2+ will vary linearly with the Mn2+ concentration after data correction. Adjusting the pH, calibrating the spectral bandwidth (SBW) and optical path length (OPL), and subtracting the interference from coexisting substances by linear interpolation improve the measuring accuracy. Mn2+ concentration can be determined by direct fast UV-vis absorbance measurement at characteristic peaks without using harmful reagents which facilitates such measurement to be applicated as on-line detection method for electrolytic manganese industry. The method developed in this study will help achieve the goal of improving the detection speed while cutting back on pollutant discharge from concentration analysis process in electrolytic manganese industry.	[Xue, Zhehua; Li, Lei] Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Shanghai, Peoples R China; [Xue, Zhehua; Li, Lei] Shanghai Inst Pollut Control & Ecol Secur, Shanghai, Peoples R China	Tongji University	Li, L (corresponding author), Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Shanghai, Peoples R China.; Li, L (corresponding author), Shanghai Inst Pollut Control & Ecol Secur, Shanghai, Peoples R China.	lileitongji@126.com	li, li/HII-4157-2022; LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022	Li, Lei/0000-0002-3986-3933	Fundamental Research Funds for the Central Universities	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities (No grant number, received by Lei Li, URL: www.moe.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blarney FPC, 2019, METALLOMICS, V11, P2097, DOI 10.1039/c9mt00219g; Clark RW, 1998, J CHEM EDUC, V75, P1182, DOI 10.1021/ed075p1182; Dai Z, 2009, SUPRAMOL CHEM, V21, P296, DOI 10.1080/10610270802438853; Davutluoglu OI, 2011, J ENVIRON MANAGE, V92, P2250, DOI 10.1016/j.jenvman.2011.04.013; Du Pasquier A, 1999, J ELECTROCHEM SOC, V146, P428, DOI 10.1149/1.1391625; GILBERT DD, 1991, J CHEM EDUC, V68, pA278, DOI 10.1021/ed068pA278; Hatat-Fraile MM, 2019, TALANTA, V194, P786, DOI 10.1016/j.talanta.2018.11.003; Jankovic J, 2005, NEUROLOGY, V64, P2021, DOI 10.1212/01.WNL.0000166916.40902.63; Jensen PS, 2002, APPL SPECTROSC, V56, P1600, DOI 10.1366/000370202321115878; Jiang YY, 2021, ELECTROCHEM COMMUN, V123, DOI 10.1016/j.elecom.2020.106912; La Colla NS, 2015, J ENVIRON MANAGE, V151, P44, DOI 10.1016/j.jenvman.2014.11.030; Mack HS, 1987, U.S. pat. patent, Patent No. [4.699,081, 4699081]; Martin CJ, 2006, NEUROTOXICOLOGY, V27, P347, DOI 10.1016/j.neuro.2005.11.002; MCKENZIE RM, 1971, MINERAL MAG, V38, P493, DOI 10.1180/minmag.1971.038.296.12; MOHC, 2012, GB 29208 2012; Oulhote Y, 2014, ENVIRON HEALTH PERSP, V122, P1343, DOI 10.1289/ehp.1307918; SAC, 2006, GBT 2774 2006; Sahani MK, 2015, MAT SCI ENG C-MATER, V50, P124, DOI 10.1016/j.msec.2015.01.091; SAMRC, 1995, GBT 15899 1995; Sanchez-Hachair A, 2018, CR CHIM, V21, P890, DOI 10.1016/j.crci.2018.05.002; Singh M, 2016, J MOL SPECTROSC, V329, P20, DOI 10.1016/j.jms.2016.10.001; Tan Z., 2004, METALLURGY MANGANESE; Terada Y, 2001, J POWER SOURCES, V97-8, P420, DOI 10.1016/S0378-7753(01)00741-8; Wang LF, 2003, J ELECTROCHEM SOC, V150, pA905, DOI 10.1149/1.1577543; Wen YZ, 2018, MEASUREMENT, V130, P39, DOI 10.1016/j.measurement.2018.07.081; Yang L, 2017, ANAL CHEM, V89, P2191, DOI 10.1021/acs.analchem.6b04760; Zhao LC, 2017, ANAL CHEM, V89, P13429, DOI 10.1021/acs.analchem.7b03722	27	0	0	17	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264532	10.1371/journal.pone.0264532	http://dx.doi.org/10.1371/journal.pone.0264532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213674	gold, Green Published			2022-12-26	WOS:000787811000116
J	Teuscher, F				Teuscher, Friedrich			The quantification of Simpson's paradox and other contributions to contingency table theory	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; HYPOTHESIS	The analysis of contingency tables is a powerful statistical tool used in experiments with categorical variables. This study improves parts of the theory underlying the use of contingency tables. Specifically, the linkage disequilibrium parameter as a measure of two-way interactions applied to three-way tables makes it possible to quantify Simpson's paradox by a simple formula. With tests on three-way interactions, there is only one that determines whether the partial interactions of all variables agree or whether there is at least one variable whose partial interactions disagree. To date, there has been no test available that determines whether the partial interactions of a certain variable agree or disagree, and the presented work closes this gap. This work reveals the relation of the multiplicative and the additive measure of a three-way interaction. Another contribution addresses the question of which cells in a contingency table are fixed when the first- and second-order marginal totals are given. The proposed procedure not only detects fixed zero counts but also fixed positive counts. This impacts the determination of the degrees of freedom. Furthermore, limitations of methods that simulate contingency tables with given pairwise associations are addressed.	[Teuscher, Friedrich] Res Inst Farm Anim Biol FBN, Inst Genet & Biometry, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN)	Teuscher, F (corresponding author), Res Inst Farm Anim Biol FBN, Inst Genet & Biometry, Dummerstorf, Germany.	teuscher@fbn-dummerstorf.de		Teuscher, Friedrich/0000-0002-9198-2382				Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Alin A, 2010, WIRES COMPUT STAT, V2, P247, DOI 10.1002/wics.72; [Anonymous], 1958, BIOMETRICS, V14, P560; Appleton DR, 1996, AM STAT, V50, P340, DOI 10.2307/2684931; Bartlett MS., 1935, J ROYAL STAT SOC S, V2, P248; BENNETT JH, 1954, ANN EUGENIC, V18, P311; BICKEL PJ, 1975, SCIENCE, V187, P398, DOI 10.1126/science.187.4175.398; BLYTH CR, 1972, J AM STAT ASSOC, V67, P364, DOI 10.2307/2284382; Cheng PE., 2006, J DATA SCI, V4, P387; Demirtas H, 2006, J STAT COMPUT SIM, V76, P1017, DOI 10.1080/10629360600569246; Feller W., 1970, INTRO PROBABILITY TH, V3; Fienberg SE, 2012, MAXIMUM LIKELIHOOD E; Fienberg SE, 2007, J STAT PLAN INFER, V137, P3430, DOI 10.1016/j.jspi.2007.03.022; Fienberg SE, 2012, ANN STAT, V40, P996, DOI 10.1214/12-AOS986; GANGE SJ, 1995, AM STAT, V49, P134, DOI 10.2307/2684626; GOOD IJ, 1963, ANN MATH STAT, V34, P911, DOI 10.1214/aoms/1177704014; Gorelick R, 2004, GENETICS, V166, P1581, DOI 10.1534/genetics.166.3.1581; HAUNSPERGER DB, 1991, AM STAT, V45, P252, DOI 10.2307/2684305; Hill W.G., 1976, P339; Ibrahim NA, 2011, COMPUT METH PROG BIO, V104, pE122, DOI 10.1016/j.cmpb.2011.06.003; Kaiser S, 2011, 94 U MUN DEP STAT; Khinchin AI., 1957, MATH FDN INFORM THEO; Kim Y, 2008, GENET EPIDEMIOL, V32, P301, DOI 10.1002/gepi.20305; Lancaster H. O., 1969, CHI SQUARED DISTRIBU; LANCASTER HO, 1951, J ROY STAT SOC B, V13, P242; Lee AJ, 1997, COMPUT STAT DATA AN, V26, P133, DOI 10.1016/S0167-9473(97)00030-3; Mood Alexander McFarlane, 1950, INTRO THEORY STAT, P1; Nielsen DM, 2004, GENETICS, V168, P1029, DOI 10.1534/genetics.103.022335; NIJENHUIS LE, 1985, TISSUE ANTIGENS, V26, P215, DOI 10.1111/j.1399-0039.1985.tb00963.x; Pavlides MG, 2009, AM STAT, V63, P226, DOI 10.1198/tast.2009.09007; Rojanaworarit Chanapong, 2020, J Med Life, V13, P37, DOI 10.25122/jml-2019-0120; ROY SN, 1956, ANN MATH STAT, V27, P749, DOI 10.1214/aoms/1177728181; Selvitella A., 2017, J STAT DISTRIBUTIONS, V4, P1, DOI [10.1186/s40488-017-0056-5, DOI 10.1186/S40488-017-0056-5]; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHAPIRO SH, 1982, AM STAT, V36, P43, DOI 10.2307/2684092; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; SLATKIN M, 1972, GENETICS, V72, P157; Streitberg B, 1999, ANN STAT, V27, P405, DOI 10.1214/aos/1018031118; STREITBERG B, 1990, ANN STAT, V18, P1878, DOI 10.1214/aos/1176347885; TOWE J, 1985, BIOMETRICAL J, V27, P17, DOI 10.1002/bimj.4710270103; Upton G., 2014, DICT STAT; WAGNER CH, 1982, AM STAT, V36, P46, DOI 10.2307/2684093; Wang Bokai, 2018, Shanghai Arch Psychiatry, V30, P139, DOI 10.11919/j.issn.1002-0829.218026; Wolfram S., 2003, MATH BOOK; Zeidler E., 2004, OXFORD USERS GUIDE M	45	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0262502	10.1371/journal.pone.0262502	http://dx.doi.org/10.1371/journal.pone.0262502			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202396	gold, Green Published, Green Submitted			2022-12-26	WOS:000773224600006
J	Liu, BB; Zhang, J; Shao, L; Yao, JM				Liu, Binbin; Zhang, Jie; Shao, Lu; Yao, Jiaming			Network pharmacology analysis and molecular docking to unveil the potential mechanisms of San-Huang-Chai-Zhu formula treating cholestasis	PLOS ONE			English	Article							SCORING FUNCTION; INJURY; TISSUE	Objective Chinese medicine formulae possess the potential for cholestasis treatment. This study aimed to explore the underlying mechanisms of San-Huang-Chai-Zhu formula (SHCZF) against cholestasis. Methods The major chemical compounds of SHCZF were identified by high-performance liquid chromatography. The bioactive compounds and targets of SHCZF, and cholestasis-related targets were obtained from public databases. Intersected targets of SHCZF and cholestasis were visualized by Venn diagram. The protein-protein interaction and compound-target networks were established by Cytoscape according to the STRING database. The biological functions and pathways of potential targets were characterized by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis. The biological processtarget-pathway network was constructed by Cytoscape. Finally, the interactions between biological compounds and hub target proteins were validated via molecular docking. Results There 7 major chemical compounds in SHCZF. A total of 141 bioactive compounds and 83 potential targets were screened for SHCZF against cholestasis. The process of SHCZF against cholestasis was mainly involved in AGE-RAGE signaling pathway in diabetic complications, fluid shear stress and atherosclerosis, and drug metabolism-cytochrome P450. ALB, IL6, AKT1, TP53, TNF, MAPK3, APOE, IL1B, PPARG, and PPARA were the top 10 hub targets. Molecular docking showed that bioactive compounds of SHCZF had a good binding affinity with hub targets. Conclusions This study predicted that the mechanisms of SHCZF against cholestasis mainly involved in AGE-RAGE signaling pathway in diabetic complications, fluid shear stress and atherosclerosis, and drug metabolism-cytochrome P450. Moreover, APOE, AKT1, and TP53 were the critical hub targets for bioactive compounds of SHCZF.	[Liu, Binbin; Zhang, Jie; Shao, Lu; Yao, Jiaming] Zhejiang Chinese Med Univ, Dept Digest, Hangzhou TCM Hosp, Hangzhou Hosp Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University	Yao, JM (corresponding author), Zhejiang Chinese Med Univ, Dept Digest, Hangzhou TCM Hosp, Hangzhou Hosp Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China.	turtle82@126.com		Yao, Jiaming/0000-0002-9059-5989	Zhejiang science and technology research fund [2014C33238]; Zhejiang science and technology research fund of traditional Chinese medicine [2020ZB158]	Zhejiang science and technology research fund; Zhejiang science and technology research fund of traditional Chinese medicine	This work was supported by Zhejiang science and technology research fund [No. 2014C33238] and Zhejiang science and technology research fund of traditional Chinese medicine [No.2020ZB158], funder play the role of conception and design of the research, analysis and interpretation of data and revision of manuscript.	Amberger Joanna S, 2017, Curr Protoc Bioinformatics, V58, DOI 10.1002/cpbi.27; Amirneni S, 2020, WORLD J GASTROENTERO, V26, P7470, DOI 10.3748/wjg.v26.i47.7470; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Burley SK, 2017, METHODS MOL BIOL, V1606, P627, DOI 10.1007/978-1-4939-7000-1_26; Cai D., 2014, CHINESE ARCH TRADITI, V3, P2428; Cao YJ, 2017, CHIN MED-UK, V12, DOI 10.1186/s13020-017-0158-5; Cao ZB, 2021, J ETHNOPHARMACOL, V264, DOI 10.1016/j.jep.2020.113289; Chen CC, 2020, J ETHNOPHARMACOL, V249, DOI 10.1016/j.jep.2019.112432; Chen L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184129; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Dkhil MA, 2015, SAUDI J BIOL SCI, V22, P551, DOI 10.1016/j.sjbs.2014.11.023; Dong R, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.705498; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Guan LF, 2019, MEDCHEMCOMM, V10, P148, DOI 10.1039/c8md00472b; Guo W, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01185; Hasegawa S, 2021, DRUGS, V81, P1181, DOI 10.1007/s40265-021-01545-7; Hu NH, 2020, EUR J PHARMACOL, V882, DOI 10.1016/j.ejphar.2020.173269; Hu QC, 2020, BIODATA MIN, V13, DOI 10.1186/s13040-020-00224-9; Huang L, 2018, NUCLEIC ACIDS RES, V46, pD1117, DOI 10.1093/nar/gkx1028; Jungst C, 2013, EUR J CLIN INVEST, V43, P1069, DOI 10.1111/eci.12128; Kancherla V, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00002; Kassouf T, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10091256; Li YY, 2021, J PHARMACEUT BIOMED, V198, DOI 10.1016/j.jpba.2021.113986; Liang XJ, 2014, MOL BIOSYST, V10, P1014, DOI 10.1039/c3mb70507b; Luo TT, 2020, CHIN J INTEGR MED, V26, P72, DOI 10.1007/s11655-019-3064-0; Ma J, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00109; Nabih ES, 2019, N-S ARCH PHARMACOL, V392, P37, DOI 10.1007/s00210-018-1560-y; Pan LL, 2020, J ETHNOPHARMACOL, V258, DOI 10.1016/j.jep.2020.112842; Pinero J, 2020, NUCLEIC ACIDS RES, V48, pD845, DOI 10.1093/nar/gkz1021; Prateeksha, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9020068; Rappaport N, 2017, NUCLEIC ACIDS RES, V45, pD877, DOI 10.1093/nar/gkw1012; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Schmidt S, 2010, J PHARM SCI-US, V99, P1107, DOI 10.1002/jps.21916; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Silveira MG, 2014, EXPERT OPIN PHARMACO, V15, P365, DOI 10.1517/14656566.2014.873404; Stelzer G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2722-2; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Su GY, 2019, CURR DRUG METAB, V20, P292, DOI 10.2174/1389200220666181231124439; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wammers M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18305-x; Wang Qiu-Hong, 2016, Zhongguo Zhong Yao Za Zhi, V41, P898, DOI 10.4268/cjcmm20160523; Wei Fu-Xiao, 2021, Zhongguo Zhong Yao Za Zhi, V46, P4230, DOI 10.19540/j.cnki.cjcmm.20210520.702; Xia Qing, 2019, Zhongguo Zhong Yao Za Zhi, V44, P2662, DOI 10.19540/j.cnki.cjcmm.20190520.205; Xian Z, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8827955; Xiao LL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75141-2; Xue HY, 2021, J ETHNOPHARMACOL, V269, DOI 10.1016/j.jep.2020.113706; Yang M, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/4050714; Yang X, 2021, PHYTOMEDICINE, V87, DOI 10.1016/j.phymed.2021.153575; Yao YL, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.573074; Ye H, 2011, NUCLEIC ACIDS RES, V39, pD1055, DOI 10.1093/nar/gkq1165; [张海燕 Zhang Haiyan], 2011, [中国中药杂志, China Journal of Chinese Materia Medica], V36, P2610; Zhang RZ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00123; Zhou Y, 2021, J ETHNOPHARMACOL, V264, DOI 10.1016/j.jep.2020.113021	55	0	0	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264398	10.1371/journal.pone.0264398	http://dx.doi.org/10.1371/journal.pone.0264398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196362	gold, Green Published			2022-12-26	WOS:000835161600045
J	Al Ahad, MA; Demsar, U; Sullivan, F; Kulu, H				Al Ahad, Mary Abed; Demsar, Urska; Sullivan, Frank; Kulu, Hill			Air pollution and individuals' mental well-being in the adult population in United Kingdom: A spatial-temporal longitudinal study and the moderating effect of ethnicity	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; HEALTH; EXPOSURE; DEPRESSION; RISK; GHQ-12; ASSOCIATIONS; MINORITIES; IMMIGRANTS; ANNOYANCE	BackgroundRecent studies suggest an association between ambient air pollution and mental well-being, though evidence is mostly fragmented and inconclusive. Research also suffers from methodological limitations related to study design and moderating effect of key demographics (e.g., ethnicity). This study examines the effect of air pollution on reported mental well-being in United Kingdom (UK) using spatial-temporal (between-within) longitudinal design and assesses the moderating effect of ethnicity. MethodsData for 60,146 adult individuals (age:16+) with 349,748 repeated responses across 10-data collection waves (2009-2019) from "Understanding-Society: The-UK-Household-Longitudinal-Study" were linked to annual concentrations of NO2, SO2, PM10, and PM2.5 pollutants using the individuals' place of residence, given at the local-authority and at the finer Lower-Super-Output-Areas (LSOAs) levels; allowing for analysis at two geographical scales across time. The association between air pollution and mental well-being (assessed through general-health-questionnaire-GHQ12) and its modification by ethnicity and being non-UK born was assessed using multilevel mixed-effect logit models. ResultsHigher odds of poor mental well-being was observed with every 10 mu g/m(3) increase in NO2, SO2, PM10 and PM2.5 pollutants at both LSOAs and local-authority levels. Decomposing air pollution into spatial-temporal (between-within) effects showed significant between, but not within effects; thus, residing in more polluted local-authorities/LSOAs have higher impact on poor mental well-being than the air pollution variation across time within each geographical area. Analysis by ethnicity revealed higher odds of poor mental well-being with increasing concentrations of SO2, PM10, and PM2.5 only for Pakistani/Bangladeshi, other-ethnicities and non-UK born individuals compared to British-white and natives, but not for other ethnic groups. ConclusionUsing longitudinal individual-level and contextual-linked data, this study highlights the negative effect of air pollution on individuals' mental well-being. Environmental policies to reduce air pollution emissions can eventually improve the mental well-being of people in UK. However, there is inconclusive evidence on the moderating effect of ethnicity.	[Al Ahad, Mary Abed; Demsar, Urska; Kulu, Hill] Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland; [Sullivan, Frank] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland	University of St Andrews; University of St Andrews	Al Ahad, MA (corresponding author), Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland.	maaa1@st-andrews.ac.uk	Sullivan, Frank/L-8286-2019; Abed Al Ahad, Mary/GYJ-3209-2022	Sullivan, Frank/0000-0002-6623-4964; Abed Al Ahad, Mary/0000-0002-9006-730X; Demsar, Urska/0000-0001-7791-2807	St Leonard's PhD scholarship, University of St Andrews, Scotland, United Kingdom	St Leonard's PhD scholarship, University of St Andrews, Scotland, United Kingdom	This paper is part of a PhD project that is funded by the St Leonard's PhD scholarship, University of St Andrews, Scotland, United Kingdom.	Ab Manan N, 2018, ANN GLOB HEALTH, V84, P670, DOI 10.29024/aogh.2376; Al Ahad MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241415; AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Bakolis I, 2021, SOC PSYCH PSYCH EPID, V56, P1587, DOI 10.1007/s00127-020-01966-x; Berglund E, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0309-2; Braithwaite I, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4595; Brown G, 2014, INT J METH PSYCH RES, V23, P36, DOI 10.1002/mpr.1434; Calderon-Garciduenas L, 2015, PRIM HEALTH CARE RES, V16, P329, DOI 10.1017/S146342361400036X; Cezard G, 2022, POPUL SPACE PLACE, V28, DOI 10.1002/psp.2403; Claeson AS, 2013, INT ARCH OCC ENV HEA, V86, P367, DOI 10.1007/s00420-012-0770-8; defra, 2020, MODELLED BACKGROUND; Dieleman JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110257; Dzhambov A, 2018, ENVIRON RES, V160, P47, DOI 10.1016/j.envres.2017.09.015; Dzhambov AM, 2018, ENVIRON RES, V166, P458, DOI 10.1016/j.envres.2018.06.031; Egede LE, 2006, J GEN INTERN MED, V21, P667, DOI 10.1111/j.1525-1497.2006.0512.x; Gater R, 2009, SOC PSYCH PSYCH EPID, V44, P198, DOI 10.1007/s00127-008-0426-x; Genc S, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/782462; Gilliver SC, 2014, EUR J PUBLIC HEALTH, V24, P72, DOI 10.1093/eurpub/cku101; Godinho EL, 2011, MED ORAL PATOL ORAL, V16, pE857, DOI 10.4317/medoral.17173; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Grazuleviciene R, 2004, SCAND J WORK ENV HEA, V30, P293, DOI 10.5271/sjweh.797; Holi MM, 2003, NORD J PSYCHIAT, V57, P233, DOI 10.1080/08039480310001418; Hori D, 2016, ENVIRON HEALTH PREV, V21, P410, DOI 10.1007/s12199-016-0541-3; Jerrett M, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-49; Jyethi D.S., 2016, PLANT RESPONSES AIR, P5; Kilian J, 2018, BIOMED J, V41, P141, DOI 10.1016/j.bj.2018.06.001; Klaeboe R, 2008, ATMOS ENVIRON, V42, P7689, DOI 10.1016/j.atmosenv.2008.04.049; Klompmaker JO, 2019, ENVIRON INT, V129, P525, DOI 10.1016/j.envint.2019.05.040; Lajos GJ, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-54; Lehtomaki H, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11050467; Lim YH, 2012, ENVIRON HEALTH PERSP, V120, P1023, DOI 10.1289/ehp.1104100; Liu H, 2021, J CLEAN PROD, V281, DOI 10.1016/j.jclepro.2020.125364; Local Authority Districts, 2017, FULL CLIPP BOUND UK; Lu JG, 2020, CURR OPIN PSYCHOL, V32, P52, DOI 10.1016/j.copsyc.2019.06.024; Lu JG, 2018, PSYCHOL SCI, V29, P340, DOI 10.1177/0956797617735807; Lucas K., 2019, INEQUALITIES MOBILIT; Lynn P., 2009, SAMPLE DESIGN UNDERS; Lynn P, 2018, DEMOGR RES, V38, P513, DOI 10.4054/DemRes.2018.38.21; Maheswaran H, 2015, SOC SCI MED, V136, P135, DOI 10.1016/j.socscimed.2015.05.026; Manisalidis I, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00014; McNeish D, 2019, PSYCHOL METHODS, V24, P20, DOI 10.1037/met0000182; Min JY, 2018, SCI TOTAL ENVIRON, V628-629, P573, DOI 10.1016/j.scitotenv.2018.02.011; Morris RH, 2021, BIOESSAYS, V43, DOI 10.1002/bies.202000288; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nerdrum P., 2006, J EDUC RES, V50, P95, DOI [10.1080/00313830500372075, DOI 10.1080/00313830500372075]; Newbury JB, 2019, JAMA PSYCHIAT, V76, P614, DOI 10.1001/jamapsychiatry.2019.0056; Oudin A, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-017-0348-8; Pedersen CB, 2004, SCHIZOPHR RES, V66, P83, DOI 10.1016/S0920-9964(03)00062-8; Power MC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1111; Puustinen PJ, 2011, SCAND J PUBLIC HEALT, V39, P577, DOI 10.1177/1403494811414244; Roberts S, 2019, PSYCHIAT RES, V272, P8, DOI 10.1016/j.psychres.2018.12.050; Santiago JL, 2022, SCI TOTAL ENVIRON, V819, DOI 10.1016/j.scitotenv.2021.152062; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Shin J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195607; Smith NR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1459-1; Su JG, 2011, ENVIRON RES, V111, P319, DOI 10.1016/j.envres.2011.01.002; Sui GY, 2018, ENVIRON SCI POLLUT R, V25, P28517, DOI 10.1007/s11356-018-2881-6; Szyszkowicz M, 2016, ENVIRON HEALTH INSIG, V10, P155, DOI [10.4137/EHI.S40493, 10.4137/ehi.s40493]; Szyszkowicz M, 2011, AIR QUAL ATMOS HLTH, V4, P259, DOI 10.1007/s11869-010-0081-8; Szyszkowicz Mieczyslaw, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P241, DOI 10.2478/v10001-007-0024-2; ukdataservice, 2011, 2011 CENSUS GEOGRAPH; University of Essex IfSaER NatCen Social Research Kantar Public, UND SOC WAV 110 2009, V13th; van Ham M, 2009, J HOUS BUILT ENVIRON, V24, P407, DOI 10.1007/s10901-009-9158-9; Ventriglio A, 2021, CNS SPECTRUMS, V26, P51, DOI 10.1017/S1092852920001303; Vestreng V, 2007, ATMOS CHEM PHYS, V7, P3663, DOI 10.5194/acp-7-3663-2007; Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2; Volk HE, 2013, JAMA PSYCHIAT, V70, P71, DOI 10.1001/jamapsychiatry.2013.266; von Lindern E, 2016, HEALTH PLACE, V39, P92, DOI 10.1016/j.healthplace.2015.12.003; Wrede O, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10284-z; Xue T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10196-y; Yang ZM, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/abe88f; Yuchi W, 2020, ENVIRON HEALTH-GLOB, V19, DOI 10.1186/s12940-020-0565-4; Zhang X, 2017, J ENVIRON ECON MANAG, V85, P81, DOI 10.1016/j.jeem.2017.04.001; Zu DQ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186734; Zulkefly N. S., 2010, GLOBAL J HLTH SCI, V2, P73	75	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264394	10.1371/journal.pone.0264394	http://dx.doi.org/10.1371/journal.pone.0264394			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263348	Green Published, gold			2022-12-26	WOS:000804638700015
J	Bonaldo, RD; Steiner, TM; Amaral, ACZ				Bonaldo, Rafael de Oliveira; Steiner, Tatiana Menchini; Zacagnini Amaral, Antonia Cecilia			Revision of Meiodorvillea Jumars, 1974 (Annelida: Dorvilleidae) including descriptions of three new species from the Southwestern Atlantic Ocean	PLOS ONE			English	Article							POLYCHAETA; GENUS	Meiodorvillea Jumars, 1974 is a little-known genus of Dorvilleidae Chamberlin, 1919, characterized by its small size and reduced appendages and jaw apparatus. A revision of the genus is presented, including analysis of the type material of M. minuta (Hartman, 1965) and M. apalpata Jumars, 1974, as well as specimens collected from shelf and slope continental areas in Brazil. A neotype was designated for M. minuta and its distribution was extended to Brazil. The identity of M. chilensis (Hartmann-Schroder, 1965) is questioned and three new species from 21 to 1,300.7 meters depth are also described. Meiodorvillea penhae sp. nov. has furcate chaeta only in the first anterior chaetigers. In contrast, Meiodorvillea hartmanae sp. nov. has very small palps and asymmetrical thin furcate chaeta and Meiodorvillea jumarsi sp. nov. has dorsal cirri and geniculate chaeta only in the first anterior chaetigers.	[Bonaldo, Rafael de Oliveira; Zacagnini Amaral, Antonia Cecilia] Univ Estadual Campinas, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil; [Bonaldo, Rafael de Oliveira; Steiner, Tatiana Menchini; Zacagnini Amaral, Antonia Cecilia] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Biodiversidade Bent Marinha, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Bonaldo, RD (corresponding author), Univ Estadual Campinas, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil.; Bonaldo, RD (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Biodiversidade Bent Marinha, Campinas, SP, Brazil.	rafaeldeoliveirabonaldo@gmail.com		MENCHINI STEINER, TATIANA/0000-0003-4710-8927	Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior -Brasil (CAPES) [001]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); FAEPEX (Fund for Support to Teaching, Research and Outreach Activities) [2692/19]; CNPq (Conselho Nacional de Desenvolvimento CientiPRIME) [301551/2019-7]; Programa Biota/FAPESP [2018/10313-0]; CENPES/PETROBRAS	Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAEPEX (Fund for Support to Teaching, Research and Outreach Activities); CNPq (Conselho Nacional de Desenvolvimento CientiPRIME)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Programa Biota/FAPESP; CENPES/PETROBRAS	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior -Brasil (CAPES) -Finance Code 001 to ROB https://www.gov.br/capes/pt-br ROB received a MsC. fellowship from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) (proc. 2018/13244-9) https://fapesp.br/ROB received a grant from FAEPEX (Fund for Support to Teaching, Research and Outreach Activities) (proc. 2692/19) https://www.prp.unicamp.br/pt-br/faepex ACZA received a productivity grant from CNPq (Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo gico) (proc. 301551/2019-7) https://www.cnpq.br/Part of the material from MDBio used for this study is part of a project funded by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), Programa Biota/FAPESP (proc. 2018/10313-0) https://fapesp.br/We thank CENPES/PETROBRAS for sampling and providing part of the material analyzed in this study. https://tecnologia.petrobras.com.br/index.html.	Amaral A. C. Z., 2013, CATALOGO ESPECIES AN; BLAKE JA, 1994, DEEP-SEA RES PT II, V41, P919, DOI 10.1016/0967-0645(94)90054-X; Chamberlin RV., 1919, MEM MUS COMP ZOOL, V48, P1, DOI [10.5962/bhl.title.49195, DOI 10.5962/BHL.TITLE.49195]; Claparede E, 1869, Z WISS ZOOL, V16, P163; DAY J. H., 1963, BULL BRIT MUS [NAT HIST] ZOOL, V10, P381; Delle Chiaje S, 1828, STAMPERIA SOC TIPOGR, V1, P1, DOI 10.5962/bhl.title.10021; Ehlers E., 1901, FESTSCHRIFT FEIER HU, P1; EIBYEJACOBSEN D, 1994, ZOOL SCR, V23, P107, DOI 10.1111/j.1463-6409.1994.tb00379.x; Hartman O., 1965, Occasional Papers of the Allan Hancock Foundation, VNo. 28, P1; Hartmann-Schroder G., 1965, P59; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL; JUMARS PA, 1974, ZOOL J LINN SOC-LOND, V54, P101, DOI 10.1111/j.1096-3642.1974.tb00794.x; Lavrado HP., 2010, BIODIVERSIDADE REGI, V1; M'INTOSH W. C., 1869, Transactions of the Royal Society of Edinburgh, Vvol. xxv, P305; Moore J. Percy, 1909, Proceedings of the Academy of Natural Sciences of Philadelphia, V61; Moore John Percy, 1906, Proceedings of the Academy of Natural Sciences of Philadelphia, V58; Nunez J, 1998, B MAR SCI, V62, P115; ORENSANZ J M, 1973, Physis Seccion A los Oceanos y sus Organismos, V32, P325; OUG E, 1978, SARSIA, V63, P285, DOI 10.1080/00364827.1978.10411350; Parfitt E., 1866, ZOOL, V1, P113; PETTIBONE MARIAN H., 1961, PROC BIOL SOC WASHINGTON, V74, P167; PURSCHKE G, 1987, ACTA ZOOL-STOCKHOLM, V68, P83, DOI 10.1111/j.1463-6395.1987.tb00880.x; Ravara A, 2021, EUR J TAXON, V736, P44, DOI 10.5852/ejt.2021.736.1251; Read G., 1919, WORLD POLYCHAETA DAT; SCHAFF TR, 1994, DEEP-SEA RES PT II, V41, P901, DOI 10.1016/0967-0645(94)90053-1; Steiner Tatiana Menchini, 2004, Beaufortia, V54, P39; Tempestini A, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-07176-8; WAINRIGHT S C, 1982, Proceedings of the Biological Society of Washington, V95, P694; Webster HE, 1879, T ALBANY I, V9, P202, DOI DOI 10.5962/BHL.TITLE.11296; Wolf G., 1980, MORPHOLOGISCHE UNTER; WOLF PS, 1986, P BIOL SOC WASH, V99, P616; Wolf PS., 1984, TAXONOMIC GUIDE POLY, V6; Zanol J, 2021, DIVERSITY-BASEL, V13, DOI 10.3390/d13020074	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264081	10.1371/journal.pone.0264081	http://dx.doi.org/10.1371/journal.pone.0264081			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235589	Green Published, gold			2022-12-26	WOS:000787073100014
J	Haynes, AC; Lywood, A; Crowe, EM; Fielding, JL; Rossiter, JM; Kent, C				Haynes, Alice C.; Lywood, Annie; Crowe, Emily M.; Fielding, Jessica L.; Rossiter, Jonathan M.; Kent, Christopher			A calming hug: Design and validation of a tactile aid to ease anxiety	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; LOWER BLOOD-PRESSURE; HEALTHY-VOLUNTEERS; ABDOMINAL-WALL; STRESS; TOUCH; OXYTOCIN; CORTISOL; RESPIRATION; RESPONSES	Anxiety disorders affect approximately one third of people during their lifetimes and are the ninth leading cause of global disability. Current treatments focus on therapy and pharmacological interventions. However, therapy is costly and pharmacological interventions often have undesirable side-effects. Healthy people also regularly suffer periods of anxiety. Therefore, a non-pharmacological, intuitive, home intervention would be complementary to other treatments and beneficial for non-clinical groups. Existing at-home anxiety aids, such as guided meditations, typically employ visual and/or audio stimuli to guide the user into a calmer state. However, the tactile sense has the potential to be a more natural modality to target in an anxiety-calming device. The tactile domain is relatively under-explored, but we suggest that there are manifold physiological and affective qualities of touch that lend it to the task. In this study we demonstrate that haptic technology can offer an enjoyable, effective and widely accessible alternative for easing state anxiety. We describe a novel huggable haptic interface that pneumatically simulates slow breathing. We discuss the development of this interface through a focus group evaluating five prototypes with embedded behaviours ('breathing', 'purring', 'heartbeat' and 'illumination'). Ratings indicated that the 'breathing' prototype was most pleasant to interact with and participants described this prototype as 'calming' and 'soothing', reminding them of a person breathing. This prototype was developed into an ergonomic huggable cushion containing a pneumatic chamber powered by an external pump allowing the cushion to 'breathe'. A mixed-design experiment (n = 129) inducing anxiety through a group mathematics test found that the device was effective at reducing pre-test anxiety compared to a control (no intervention) condition and that this reduction in anxiety was indistinguishable from that of a guided meditation. Our findings highlight the efficacy of this interface, demonstrating that haptic technologies can be effective at easing anxiety. We suggest that the field should be explored in more depth to capture the nuances of different modalities in relation to specific situations and trait characteristics.	[Haynes, Alice C.; Rossiter, Jonathan M.] Univ Bristol, Engn Math Dept, Bristol, Avon, England; [Haynes, Alice C.; Rossiter, Jonathan M.] Bristol Robot Lab, Soft Robot Grp, Bristol, Avon, England; [Lywood, Annie] Bonnie Binary Ltd, Bristol, Avon, England; [Crowe, Emily M.] Vrije Univ, Fac Behav & Movement Sci, Amsterdam, Netherlands; [Fielding, Jessica L.; Kent, Christopher] Univ Bristol, Sch Psychol Sci, Bristol, Avon, England	University of Bristol; University of Bristol; University of West England; Vrije Universiteit Amsterdam; University of Bristol	Haynes, AC (corresponding author), Univ Bristol, Engn Math Dept, Bristol, Avon, England.; Haynes, AC (corresponding author), Bristol Robot Lab, Soft Robot Grp, Bristol, Avon, England.	alice.haynes@bristol.ac.uk		Haynes, Alice/0000-0003-2146-6902; Crowe, Emily/0000-0001-8265-7791; Fielding, Jess/0000-0002-0950-4788	Brigstow Institute, University of Bristol, UK; EPSRC [EP/M020460/1, EP/R02961X/1, EP/S026096/1, EP/T020792/1]; Royal Academy of Engineering as a Chair in Emerging Technologies	Brigstow Institute, University of Bristol, UK; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Academy of Engineering as a Chair in Emerging Technologies	The proto type development was funded by a seed corngrant from the Brigstow Institute, University of Bristol, UK which also supported author A.L. in the form of consultation fees. A.H is supported through the EPSRC Doctoral Training Partnership (EP/N509619/1).J.R. is supported by the Royal Academyof Engineering as a Chair in Emerging Technologies and by the EPSRC (grants EP/M020460/1, EP/R02961X/1, EP/S026096/1 and EP/T020792/1). A.L. received a salary from Bonnie Binary during the time frame of this project. The specific role of the author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	[Anonymous], 2017, MEDITATION 4 BREATH; Aslan I, 2016, PROCEEDINGS OF THE NORDICHI '16: THE 9TH NORDIC CONFERENCE ON HUMAN-COMPUTER INTERACTION - GAME CHANGING DESIGN, DOI 10.1145/2971485.2996727; Azevedo RT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02274-2; Ban Y, 2018, SA'18: SIGGRAPH ASIA 2018 EMERGING TECHNOLOGIES, DOI 10.1145/3275476.3275492; Bandelow B, 2015, DIALOGUES CLIN NEURO, V17, P327; Barrett K.E., 2019, GANONGS REV MEDICAL, V26th ed., P961; Bumatay AL, 2015, COMM COM INF SC, V529, P451, DOI 10.1007/978-3-319-21383-5_75; Chapell MS, 2005, J EDUC PSYCHOL, V97, P268, DOI 10.1037/0022-0663.97.2.268; Chen W, 2015, IEEE J BIOMED HEALTH, V19, P979, DOI 10.1109/JBHI.2014.2349153; Chen YF, 2017, PERSPECT PSYCHIATR C, V53, P329, DOI 10.1111/ppc.12184; Cheng KS, 2019, MINDFULNESS, V10, P2082, DOI 10.1007/s12671-019-01178-8; Chinareva S, 2020, CHI'20: EXTENDED ABSTRACTS OF THE 2020 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3334480.3382938; Cho H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164822; Choi KY, 2020, TEI'20: PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON TANGIBLE, EMBEDDED, AND EMBODIED INTERACTION, P17, DOI 10.1145/3374920.3374938; Costa J, 2016, UBICOMP'16: PROCEEDINGS OF THE 2016 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P758, DOI 10.1145/2971648.2971752; Dijk E.O., 2010, EUROHAPTICS 2010, P47; Dijkstra E, 2018, VET J, V234, P96, DOI 10.1016/j.tvjl.2018.02.014; Dimitriev DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146131; Driscoll R., 2007, WESTSIDE TEST ANXIET; Eckstein M, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.555058; Ellingsen DM, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01986; Field T, 2005, INT J NEUROSCI, V115, P1397, DOI 10.1080/00207450590956459; Field T., 2001, TOUCH; Field T, 2014, COMPLEMENT THER CLIN, V20, P224, DOI 10.1016/j.ctcp.2014.07.002; Grewen KM, 2005, PSYCHOSOM MED, V67, P531, DOI 10.1097/01.psy.0000170341.88395.47; Grewen KM, 2003, BEHAV MED, V29, P123, DOI 10.1080/08964280309596065; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gustafsson C, 2015, J GERONTOL NURS, V41, P46, DOI 10.3928/00989134-20150806-44; Hahn H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171220; Hall III JP., EXPT MODEL EXPLORING, P8; Handlin L, 2012, ANTHROZOOS, V25, P215, DOI 10.2752/175303712X13316289505468; Henry EM., 2016, THERAPY DOGS COLL CL; Holt-Lunstad J, 2008, PSYCHOSOM MED, V70, P976, DOI 10.1097/PSY.0b013e318187aef7; INGERSOLL EW, 1994, PHYSIOL BEHAV, V56, P855, DOI 10.1016/0031-9384(94)90315-8; Jerath R, 2006, MED HYPOTHESES, V67, P566, DOI 10.1016/j.mehy.2006.02.042; Kaneko H, 2012, RESP CARE, V57, P1442, DOI 10.4187/respcare.01655; Kaya N., 2004, COLL STUD J, V38, P396; Keshmiri S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01192; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kolisko P, 2004, ACTA U PALACKI OLOMU, V34; Light KC, 2005, BIOL PSYCHOL, V69, P5, DOI 10.1016/j.biopsycho.2004.11.002; Lindgren L, 2010, AUTON NEUROSCI-BASIC, V158, P105, DOI 10.1016/j.autneu.2010.06.011; Lu WA, 2011, ALTERN THER HEALTH M, V17, P8; Ma X, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00874; Macher D, 2013, BRIT J EDUC PSYCHOL, V83, P535, DOI 10.1111/j.2044-8279.2012.02081.x; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Martos-Montes R., 2019, HUM ANIM INTERACT B, V8, P36; Mason H, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/743504; McDaniel T, 2020, HAPTIC INTERFACES FOR ACCESSIBILITY, HEALTH, AND ENHANCED QUALITY OF LIFE, P149, DOI 10.1007/978-3-030-34230-2_6; Miri P., 2021, CHALLENGES EVALUATIN; Miri P, 2020, P 2020 CHI C HUMAN F, P1; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Morrison I, 2016, ADAPT HUM BEHAV PHYS, V2, P344, DOI 10.1007/s40750-016-0052-x; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Pal GK, 2004, INDIAN J MED RES, V120, P115; Paredes Pablo E., 2018, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, V2, DOI 10.1145/3191760; Paredes Pablo, 2011, CHI 11 EXTENDED ABST, P1699; Pawling R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173457; Petersen S, 2017, J ALZHEIMERS DIS, V55, P569, DOI 10.3233/JAD-160703; Regehr C, 2013, J AFFECT DISORDERS, V148, P1, DOI 10.1016/j.jad.2012.11.026; Robinson H, 2015, AUSTRALAS J AGEING, V34, P27, DOI 10.1111/ajag.12099; Roquet CD, 2018, CHI 2018: EXTENDED ABSTRACTS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3170427.3188616; Russo MA, 2017, BREATHE, V13, P298, DOI 10.1183/20734735.009817; SAMMON MP, 1994, J APPL PHYSIOL, V77, P1548, DOI 10.1152/jappl.1994.77.3.1548; Sato TG, 2015, IEEE T HAPTICS, V8, P119, DOI 10.1109/TOH.2015.2396896; Sefidgar YS, 2016, IEEE T AFFECT COMPUT, V7, P108, DOI 10.1109/TAFFC.2015.2457893; Seignourel PJ, 2008, CLIN PSYCHOL REV, V28, P1071, DOI 10.1016/j.cpr.2008.02.008; Sensirion, 2020, US; Serin A., 2018, J BIOTECHNOL BIOMED, V1, P42, DOI [10.14302/issn.2576-6694.jbbs-18-1887, DOI 10.14302/ISSN.2576-6694.JBBS-18-1887]; SHEA SA, 1987, RESP PHYSIOL, V68, P331, DOI 10.1016/S0034-5687(87)80018-X; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Sonne T, 2016, PROCEEDINGS OF THE TENTH ANNIVERSARY CONFERENCE ON TANGIBLE EMBEDDED AND EMBODIED INTERACTION (TEI16), P271, DOI 10.1145/2839462.2839480; Spielberger CD., 2010, CORSINI ENCY PSYCHOL, P11; Stepanova ER, 2020, PROCEEDINGS OF THE 2020 ACM DESIGNING INTERACTIVE SYSTEMS CONFERENCE (DIS 2020), P641, DOI 10.1145/3357236.3395532; Streeter CC, 2012, MED HYPOTHESES, V78, P571, DOI 10.1016/j.mehy.2012.01.021; Streeter CC, 2010, J ALTERN COMPLEM MED, V16, P1145, DOI 10.1089/acm.2010.0007; Suga A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56204-5; Sugawara A, 2012, ANTHROZOOS, V25, P25, DOI 10.2752/175303712X13240472427311; Sumioka H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03034; Taneja P, 2021, PSYCHOL RES-PSYCH FO, V85, P20, DOI 10.1007/s00426-019-01253-8; Terzimehic N, 2019, CHI 2019: PROCEEDINGS OF THE 2019 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3290605.3300687; Tran D, 2016, J MECH BEHAV BIOMED, V60, P451, DOI 10.1016/j.jmbbm.2016.03.001; Treadaway C., 2019, DESIGN HLTH, V3, P27, DOI [10.1080/24735132.2019.1593295, DOI 10.1080/24735132.2019.1593295]; Triscoli C, 2017, BIOL PSYCHOL, V128, P71, DOI 10.1016/j.biopsycho.2017.07.007; Triscoli C, 2017, PHYSIOL BEHAV, V177, P169, DOI 10.1016/j.physbeh.2017.05.006; Van Puyvelde M, 2015, BIOL PSYCHOL, V108, P132, DOI 10.1016/j.biopsycho.2015.04.001; van Rooij Marieke, 2016, P 2016 CHI C EXT ABS, P1989, DOI [10.1145/2851581.2892452, DOI 10.1145/2851581.2892452]; von Muggenthaler E., 2001, J ACOUST SOC AM, V110, P2666, DOI [10.1121/1.4777098, DOI 10.1121/1.4777098]; Walach H, 2006, PERS INDIV DIFFER, V40, P1543, DOI 10.1016/j.paid.2005.11.025; Weekes N, 2006, STRESS, V9, P199, DOI 10.1080/10253890601029751; Williams M., 2011, MINDFULNESS 8 WEEK P; World Health Organization, 2017, DEPRESSION OTHER COM; Yamazaki R, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00537; Yanaka S, 2017, LECT NOTES COMPUT SC, V10280, P478, DOI 10.1007/978-3-319-57987-0_39; Yoshida S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100996; Zaccaro A, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00353; Zhang XC, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/3281040; Zhang YG, 2020, IEEE ENG MED BIO, P2999, DOI 10.1109/EMBC44109.2020.9175900; Zhang ZH, 2011, CLIN EXP HYPERTENS, V33, P281, DOI 10.3109/10641963.2010.531850	99	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0259838	10.1371/journal.pone.0259838	http://dx.doi.org/10.1371/journal.pone.0259838			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263344	gold, Green Published			2022-12-26	WOS:000804638700035
J	Nobre, JNP; Morais, RLD; Fernandes, AC; Viegas, AA; Figueiredo, PHS; Costa, HS; Camargos, ACR; Dias-Peixoto, MF; Mendonca, VA; Lacerda, ACR				Pontes Nobre, Juliana Nogueira; De Souza Morais, Rosane Luzia; Fernandes, Amanda Cristina; Viegas, Angela Alves; Scheidt Figueiredo, Pedro Henrique; Costa, Henrique Silveira; Resende Camargos, Ana Cristina; Dias-Peixoto, Marco Fabricio; Mendonca, Vanessa Amaral; Rodrigues Lacerda, Ana Cristina			Is body fat mass associated with worse gross motor skills in preschoolers? An exploratory study	PLOS ONE			English	Article							FUNDAMENTAL MOVEMENT SKILLS; PHYSICAL-ACTIVITY; SCHOOL-CHILDREN; EARLY-CHILDHOOD; HEALTH; COORDINATION; COMPETENCE; OVERWEIGHT; FITNESS; OBESITY	We compared the motor competence between overweight/obese and eutrophic preschoolers with similar physical activity levels, age, socioeconomic status, maternal education, quality of the home environment and quality of the school environment. We also investigated to what extent excess body fat mass explains gross motor skills in preschoolers. A cross-sectional quantitative and exploratory study was conducted with 48 preschoolers assigned into eutrophic and overweight/obese groups. Overweight/obese preschoolers had worse Locomotor subtest standard scores than the eutrophic ones (p = 0.01), but similar Object Control subtest and Gross Motor Quotient scores (p > 0.05). Excess body fat mass explained 12% of the low Locomotor subtest standard scores in preschoolers (R-2 = 0.12; p = 0.007). Excess body fat mass was associated with worse locomotor skills when the model was adjusted for physical activity levels, age, socioeconomic status, maternal education, quality of the home environment and quality of the school environment. Thus, excess body fat mass partly explains lower locomotor skills in preschoolers.	[Pontes Nobre, Juliana Nogueira; De Souza Morais, Rosane Luzia; Fernandes, Amanda Cristina; Viegas, Angela Alves; Dias-Peixoto, Marco Fabricio] Univ Fed Vales Jequitinhonha & Mucuri UFVJM, Ctr Integrad Posgrad & Pesquisa Saude CIPq Saude, Diamantina, MG, Brazil; [Scheidt Figueiredo, Pedro Henrique; Costa, Henrique Silveira; Mendonca, Vanessa Amaral; Rodrigues Lacerda, Ana Cristina] Univ Fed Vales Jequitinhonha & Mucuri UFVJM, Fac Fisioterapia, Diamantina, MG, Brazil; [Resende Camargos, Ana Cristina] Univ Fed Minas Gerais UFMG, Fac Fisioterapia, Belo Horizonte, MG, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais	Nobre, JNP (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri UFVJM, Ctr Integrad Posgrad & Pesquisa Saude CIPq Saude, Diamantina, MG, Brazil.	junobre2007@yahoo.com.br	Costa, Henrique Silveira/H-8286-2014; Dias Peixoto, Marco Fabrício/AAI-9408-2020; Mendonça, Vanessa Amaral/T-7958-2019; Dias Peixoto, Marco Fabricio/AGC-4901-2022; Camargos, Ana Cristina/O-5993-2016; Morais, Rosane/GLU-8302-2022	Costa, Henrique Silveira/0000-0002-1426-7246; Dias Peixoto, Marco Fabrício/0000-0003-3324-3634; Mendonça, Vanessa Amaral/0000-0002-1696-6091; Camargos, Ana Cristina/0000-0003-2719-4231; Morais, Rosane/0000-0002-8236-4531; Nogueira Pontes Nobre, Juliana/0000-0002-9876-1136	Fundacao de Amparo a Pesquisa de Minas Gerais [FAPEMIG APQ-01898-18]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM)	Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM)	This study was financed (financial support and scholarships) in part by the Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG APQ-01898-18), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001, and the Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEP (Associacao Brasileira de Empresas de pesquisa). Brazilian Associations of Research Companies, 2019, EC CLASS CRIT BRAZ; Abreu-Lima I., 2008, ESCALA AVALIACAO AMB; Armstrong MEG, 2011, PERCEPT MOTOR SKILL, V113, P999, DOI 10.2466/06.10.13.PMS.113.6.999-1016; Barnett LM, 2022, SPORTS MED, V52, P875, DOI 10.1007/s40279-021-01516-8; Barnett LM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3742-1; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Bradley RH, 2003, EARLY CHILD RES Q, V18, P294, DOI 10.1016/S0885-2006(03)00041-3; Bradley RH, 2015, J FAM THEOR REV, V7, P381, DOI 10.1111/jftr.12108; Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551; Butte NF, 2014, MED SCI SPORT EXER, V46, P1216, DOI 10.1249/MSS.0000000000000209; Cattuzzo MT, 2016, J SCI MED SPORT, V19, P123, DOI 10.1016/j.jsams.2014.12.004; Cheng J, 2016, CHILD CARE HLTH DEV, V42, P343, DOI 10.1111/cch.12336; Coppens E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01273; D'Hondt E, 2013, INT J OBESITY, V37, P61, DOI 10.1038/ijo.2012.55; D'hondt E, 2011, INT J PEDIATR OBES, V6, pE556, DOI 10.3109/17477166.2010.500388; Daelmans B, 2017, LANCET, V389, P9, DOI 10.1016/S0140-6736(16)31659-2; Dias Natália Martins, 2017, Trends Psychol., V25, P1897, DOI 10.9788/tp2017.4-19; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Flores FS, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8080705; Flores FS, 2019, PERCEPT MOTOR SKILL, V126, P366, DOI 10.1177/0031512519829271; Gallahue DL., 2012, UNDERSTANDING MOTOR; Geserick M, 2018, NEW ENGL J MED, V379, P1303, DOI 10.1056/NEJMoa1803527; Ghosh S, 2016, DEV PSYCHOBIOL, V58, P734, DOI 10.1002/dev.21413; Madrona PG, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030427; Graziele Bento Gisele, 2016, Rev. salud pública, V18, P630, DOI 10.15446/rsap.v18n4.42351; Hall Charlotte J S, 2018, J Funct Morphol Kinesiol, V3, DOI 10.3390/jfmk3040057; Harms T., 2006, ESCALA AVALIACAO AMB; Harms T., 2009, ESCALA AVALIACAO AMB; Harms Thelma, 2013, Cad. Pesqui., V43, P76, DOI 10.1590/S0100-15742013000100005; Henrique RS, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23364; Hulteen RM, 2018, SPORTS MED, V48, P1533, DOI 10.1007/s40279-018-0892-6; Jones PC, 2017, J SCHOOL PSYCHOL, V64, P109, DOI 10.1016/j.jsp.2017.06.001; Kakebeeke TH, 2017, OBESITY FACTS, V10, P420, DOI 10.1159/000477406; Lima RA, 2021, SCAND J MED SCI SPOR, V31, P15, DOI 10.1111/sms.13787; Lima RA, 2019, J PEDIAT-BRAZIL, V95, P482, DOI 10.1016/j.jped.2018.02.010; Lobstein T, 2016, PEDIATR OBES, V11, P321, DOI 10.1111/ijpo.12185; Lopes VP, 2014, CHILD CARE HLTH DEV, V40, P891, DOI 10.1111/cch.12127; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; Mariano M, 2019, EARLY EDUC DEV, V30, P511, DOI 10.1080/10409289.2018.1554388; Matarma T, 2018, SCAND J MED SCI SPOR, V28, P2668, DOI 10.1111/sms.13264; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Ministrio da Sade, 2021, OBESIDADE INFANTIL A; Morais RLD, 2021, INFANT BEHAV DEV, V64, DOI 10.1016/j.infbeh.2021.101619; Niemisto D, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16111989; Okely AD, 2004, RES Q EXERCISE SPORT, V75, P238, DOI 10.1080/02701367.2004.10609157; Penpraze V, 2006, PEDIATR EXERC SCI, V18, P483, DOI 10.1123/pes.18.4.483; Prskalo Ivan, 2015, Coll Antropol, V39 Suppl 1, P21; Camargos ACR, 2016, RES DEV DISABIL, V59, P410, DOI 10.1016/j.ridd.2016.10.001; Rey E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236070; Silva-Santos S, 2019, J MOTOR LEARN DEV, V7, P273, DOI 10.1123/jmld.2017-0056; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Tompuri TT, 2015, CLIN PHYSIOL FUNCT I, V35, P21, DOI 10.1111/cpf.12118; Ulrich D. A., 2019, TEST GROSS MOTOR DEV; Valentini NC, 2012, J MOTOR BEHAV, V44, P275, DOI 10.1080/00222895.2012.700967; Verbecque E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18157878; WHO, 2020, GUID PHYS ACT SED BE; WHO, 2022, DIFF SIMPL PREEXP PR; Wood AP, 2022, CHILD OBES, V18, P50, DOI 10.1089/chi.2021.0026	58	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264182	10.1371/journal.pone.0264182	http://dx.doi.org/10.1371/journal.pone.0264182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263353	Green Published, gold			2022-12-26	WOS:000804638700029
J	Rosendahl, AH; Monnius, M; Laitala, A; Railo, A; Miinalainen, I; Heljasvaara, R; Maki, JM; Myllyharju, J				Rosendahl, Ann-Helen; Monnius, Mia; Laitala, Anu; Railo, Antti; Miinalainen, Ilkka; Heljasvaara, Ritva; Maki, Joni M.; Myllyharju, Johanna			Deletion of hypoxia-inducible factor prolyl 4-hydroxylase 2 in FoxD1-lineage mesenchymal cells leads to congenital truncal alopecia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE; INTRACELLULAR DOMAIN; EPITHELIAL-CELLS; BNIP3 PLAYS; STEM-CELLS; HIF-ALPHA; NOTCH; SKIN; DIFFERENTIATION; BIOLOGY	Hypoxia-inducible factors (HIFs) induce numerous genes regulating oxygen homeostasis. As oxygen sensors of the cells, the HIF prolyl 4-hydroxylases (HIF-P4Hs) regulate the stability of HIFs in an oxygen-dependent manner. During hair follicle (HF) morphogenesis and cycling, the location of dermal papilla (DP) alternates between the dermis and hypodermis and results in varying oxygen levels for the DP cells. These cells are known to express hypoxia-inducible genes, but the role of the hypoxia response pathway in HF development and homeostasis has not been studied. Using conditional gene targeting and analysis of hair morphogenesis, we show here that lack of Hif-p4h-2 in Forkhead box D1 (FoxD1)-lineage mesodermal cells interferes with the normal HF development in mice. FoxD1-lineage cells were found to be mainly mesenchymal cells located in the dermis of truncal skin, including those cells composing the DP of HFs. We found that upon Hif-p4h-2 inactivation, HF development was disturbed during the first catagen leading to formation of epithelial-lined HF cysts filled by unorganized keratins, which eventually manifested as truncal alopecia. Furthermore, the depletion of Hif-p4h-2 led to HIF stabilization and dysregulation of multiple genes involved in keratin formation, HF differentiation, and HIF, transforming growth factor beta (TGF-beta), and Notch signaling. We hypothesize that the failure of HF cycling is likely to be mechanistically caused by disruption of the interplay of the HIF, TGF-beta, and Notch pathways. In summary, we show here for the first time that HIF-P4H-2 function in FoxD1-lineage cells is essential for the normal development and homeostasis of HFs.	[Rosendahl, Ann-Helen; Monnius, Mia; Laitala, Anu; Railo, Antti; Heljasvaara, Ritva; Maki, Joni M.; Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, Electron Microscope Core Facil, Oulu, Finland; [Rosendahl, Ann-Helen; Monnius, Mia; Laitala, Anu; Railo, Antti; Miinalainen, Ilkka; Heljasvaara, Ritva; Maki, Joni M.; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, Electron Microscope Core Facil, Oulu, Finland; [Rosendahl, Ann-Helen; Monnius, Mia; Laitala, Anu; Railo, Antti; Heljasvaara, Ritva; Maki, Joni M.; Myllyharju, Johanna] Univ Oulu, Fac Biochem & Mol Med, Electron Microscope Core Facil, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Maki, JM; Myllyharju, J (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Electron Microscope Core Facil, Oulu, Finland.; Maki, JM; Myllyharju, J (corresponding author), Univ Oulu, Bioctr Oulu, Electron Microscope Core Facil, Oulu, Finland.; Maki, JM; Myllyharju, J (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Electron Microscope Core Facil, Oulu, Finland.	joni.maki@oulu.fi; johanna.myllyharju@oulu.fi		Miinalainen, Ilkka/0000-0002-3922-3442; Laitala, Anu/0000-0002-9587-2025; Rosendahl, Ann-Helen Sigrid/0000-0001-7968-0990	Academy of Finland Center of Excellence 2012 to 2017 grant [251314]; S. Juselius Foundation; Jane and Aatos Erkko Foundation; FibroGen, Inc; Finnish Cultural Foundation; Instrumentarium Science Foundation;  [296498]	Academy of Finland Center of Excellence 2012 to 2017 grant(Academy of Finland); S. Juselius Foundation; Jane and Aatos Erkko Foundation; FibroGen, Inc; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Instrumentarium Science Foundation; 	This study was supported by the Academy of Finland Center of Excellence 2012 to 2017 grant (grant no.: 251314) (to J. M.) and Academy Project Grant (grant no.: 296498) (to J. M.), S. Juselius Foundation (to J. M.), Jane and Aatos Erkko Foundation (to J. M.), FibroGen, Inc (to J. M.), The Finnish Cultural Foundation (to A.-H. R.), and the Instrumentarium Science Foundation (to A.-H. R.).	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alibardi L, 2013, ACTA HISTOCHEM, V115, P519, DOI 10.1016/j.acthis.2012.11.011; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Bose A, 2013, INT J MOL SCI, V14, P19385, DOI 10.3390/ijms141019385; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Cockman M. E., 2019, LACK ACTIVITY RECOMB; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COULY G, 1988, DEVELOPMENT, V103, P101; Cowburn AS, 2014, J INVEST DERMATOL, V134, P801, DOI 10.1038/jid.2013.395; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erber L, 2019, MOL CELL PROTEOMICS, V18, P1772, DOI 10.1074/mcp.RA119.001535; Evans SM, 2006, J INVEST DERMATOL, V126, P2596, DOI 10.1038/sj.jid.5700451; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hashimoto T, 2001, J INVEST DERM SYMP P, V6, P38, DOI 10.1046/j.0022-202x.2001.00003.x; Higgins CA, 2009, J INVEST DERMATOL, V129, P2100, DOI 10.1038/jid.2009.66; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hu YY, 2014, CANCER LETT, V349, P67, DOI 10.1016/j.canlet.2014.03.035; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Imamura Y, 2014, FASEB J, V28, P2517, DOI 10.1096/fj.13-244079; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Ivan M., 2002, PROC NATL; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jamora C, 2005, PLOS BIOL, V3, P131, DOI 10.1371/journal.pbio.0030011; Joshi Rajiv S, 2011, Int J Trichology, V3, P57, DOI 10.4103/0974-7753.82119; Kobayashi H, 2016, J CLIN INVEST, V126, P1926, DOI 10.1172/JCI83551; KOPAN R, 1993, J CELL BIOL, V121, P631, DOI 10.1083/jcb.121.3.631; Kothari S, 2003, ONCOGENE, V22, P4734, DOI 10.1038/sj.onc.1206666; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Kutchuk L, 2015, DEVELOPMENT, V142, P983, DOI 10.1242/dev.113449; Magerl M, 2001, J INVEST DERMATOL, V116, P947, DOI 10.1046/j.0022-202x.2001.01368.x; Mesa KR, 2015, NATURE, V522, P94, DOI 10.1038/nature14306; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Moriyama M, 2014, J INVEST DERMATOL, V134, P1627, DOI 10.1038/jid.2014.11; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Myllyharju J, 2013, ACTA PHYSIOL, V208, P148, DOI 10.1111/apha.12096; Nowell C, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a017772; Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P93, DOI 10.1387/ijdb.15272374; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Rathman-Josserand M, 2013, J INVEST DERMATOL, V133, P2094, DOI 10.1038/jid.2013.113; Rezvani HR, 2011, J INVEST DERMATOL, V131, P1793, DOI 10.1038/jid.2011.141; Rezza A, 2016, CELL REP, V14, P3001, DOI 10.1016/j.celrep.2016.02.078; Rosenberger C, 2007, J INVEST DERMATOL, V127, P2445, DOI 10.1038/sj.jid.5700874; Roth KJ, 2015, CELL MOL GASTROENTER, V1, P589, DOI 10.1016/j.jcmgh.2015.09.005; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Rundle CW, 2017, CLIN DERMATOL, V35, P367, DOI 10.1016/j.clindermatol.2017.03.009; Schlake T, 2007, SEMIN CELL DEV BIOL, V18, P267, DOI 10.1016/j.semcdb.2007.01.005; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sennett R, 2015, DEV CELL, V34, P577, DOI 10.1016/j.devcel.2015.06.023; Soma T, 2002, J INVEST DERMATOL, V118, P993, DOI 10.1046/j.1523-1747.2002.01746.x; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Ueno M., 2011, AM J PHYSIOL-LUNG C; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Wang S, 2016, ONCOTARGET, V7, P58848, DOI 10.18632/oncotarget.11585; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Zhao B, 2017, INT J MOL MED, V39, P153, DOI 10.3892/ijmm.2016.2816; Zheng XF, 2017, EXP CELL RES, V358, P129, DOI 10.1016/j.yexcr.2017.06.006	76	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101787	10.1016/j.jbc.2022.101787	http://dx.doi.org/10.1016/j.jbc.2022.101787			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35247391	Green Submitted, gold, Green Published			2022-12-26	WOS:000793617400006
J	Shapira, G; Abu Hamad, R; Weiner, C; Rainy, N; Sorek-Abramovich, R; Benveniste-Levkovitz, P; Rock, R; Avnat, E; Levtzion-Korach, O; Bar Chaim, A; Shomron, N				Shapira, Guy; Abu Hamad, Ramzia; Weiner, Chen; Rainy, Nir; Sorek-Abramovich, Reut; Benveniste-Levkovitz, Patricia; Rock, Rachel; Avnat, Eden; Levtzion-Korach, Osnat; Bar Chaim, Adina; Shomron, Noam			Population differences in antibody response to SARS-CoV-2 infection and BNT162b2 vaccination	FASEB JOURNAL			English	Article						antibodies; COVID-19; SARS-CoV-2; severity; vaccination; vaccine	PROTECTION; AGE	The concentration of SARS-CoV-2-specific serum antibodies, elicited by vaccination or infection, is a primary determinant of anti-viral immunity, which correlates with protection against infection and COVID-19. Serum samples were obtained from 25 897 participants and assayed for anti-SARS-CoV-2 spike protein RBD IgG antibodies. The cohort was composed of newly vaccinated BNT162b2 recipients, in the first month or 6 months after vaccination, COVID-19 patients and a general sample of the Israeli population. Antibody levels of BNT162b2 vaccine recipients were negatively correlated with age, with a prominent decrease in recipients over 55 years old, which was most significant in males. This trend was observable within the first month and 6 months after vaccination, while younger participants were more likely to maintain stable levels of serum antibodies. The antibody concentration of participants previously infected with SARS-CoV-2 was lower than the vaccinated and had a more complex, non-linear relation to age, sex and COVID-19 symptoms. Taken together, our data supports age and sex as primary determining factors for both the magnitude and durability of humoral response to SARS-CoV-2 infection and the COVID-19 vaccine. Our results could inform vaccination policies, prioritizing the most susceptible populations for repeated vaccination.	[Shapira, Guy; Weiner, Chen; Avnat, Eden; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, Tel Aviv, Israel; [Shapira, Guy; Shomron, Noam] Tel Aviv Univ, Edmond J Safra Ctr Bioinformat, Tel Aviv, Israel; [Abu Hamad, Ramzia; Weiner, Chen; Rainy, Nir; Sorek-Abramovich, Reut; Benveniste-Levkovitz, Patricia; Rock, Rachel; Levtzion-Korach, Osnat; Bar Chaim, Adina] Shamir Med Ctr, Beer Yaagov, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Shamir Medical Center (Assaf Harofeh)	Bar Chaim, A (corresponding author), Shamir Med Ctr, Beer Yaagov, Israel.; Shomron, N (corresponding author), Tel Aviv Univ, Fac Med, Haim Levanon 1, IL-6997801 Tel Aviv, Israel.	adinab@shamir.gov.il; nshomron@tauex.tau.ac.il		Shapira, Guy/0000-0001-9376-4955; Avnat, Eden/0000-0002-5455-0994	Israel Science Foundation (ISF) [1852/16]; Horizon 2020-Research and Innovation Framework Programme, PSY-PGx; Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness; Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Koret-UC Berkeley-Tel Aviv University Initiative in Computational Biology and Bioinformatics; QBI/UCSF-Tel Aviv University joint Initiative in Computational Biology and Drug Discovery; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University	Israel Science Foundation (ISF)(Israel Science Foundation); Horizon 2020-Research and Innovation Framework Programme, PSY-PGx; Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness(European Commission); Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Koret-UC Berkeley-Tel Aviv University Initiative in Computational Biology and Bioinformatics; QBI/UCSF-Tel Aviv University joint Initiative in Computational Biology and Drug Discovery; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University	The Shomron Laboratory is supported by the Israel Science Foundation (ISF; 1852/16); Horizon 2020-Research and Innovation Framework Programme, PSY-PGx; Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness; The Edmond J. Safra Center for Bioinformatics at Tel Aviv University; The Koret-UC Berkeley-Tel Aviv University Initiative in Computational Biology and Bioinformatics; The QBI/UCSF-Tel Aviv University joint Initiative in Computational Biology and Drug Discovery; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University	Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Al-kuraishy HM, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.649128; Apostolidis SA, 2021, NAT MED, V27, P1990, DOI 10.1038/s41591-021-01507-2; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Blomberg BB, 2011, J CLIN INVEST, V121, P2981, DOI 10.1172/JCI58406; Cayan S, 2020, AGING MALE, V23, P1493, DOI 10.1080/13685538.2020.1807930; Costeira R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257051; Cylus J, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00453-1; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Fathi A, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.601170; Fujimoto AB, 2021, VACCINE, V39, P5055, DOI 10.1016/j.vaccine.2021.06.067; Furman D, 2015, EXPERT REV VACCINES, V14, P461, DOI 10.1586/14760584.2015.966694; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Garcia-Beltran WF, 2021, CELL, V184, P476, DOI 10.1016/j.cell.2020.12.015; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Hoepel W, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf8654; Hoffmann M, 2022, CELL, V185, P447, DOI 10.1016/j.cell.2021.12.032; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; Jonsdottir HR, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020284; Kelsey TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109346; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Leung K, 2022, LANCET, V399, P2, DOI 10.1016/S0140-6736(21)02841-5; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Mishra S, 2021, ECLINICALMEDICINE, V39, DOI 10.1016/j.eclinm.2021.101064; Muller L, 2021, CLIN INFECT DIS, V73, P2065, DOI 10.1093/cid/ciab381; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Parazzini F, 2007, MATURITAS, V56, P280, DOI 10.1016/j.maturitas.2006.09.003; Pellini R, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100928; Penna C, 2020, BRIT J PHARMACOL, V177, P4375, DOI 10.1111/bph.15207; Perkmann T, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00247-21; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Salonia A, 2021, ANDROLOGY-US, V9, P1043, DOI 10.1111/andr.12993; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; Shapiro JR, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00412-6; Tregoning JS, 2021, NAT REV IMMUNOL, V21, P626, DOI 10.1038/s41577-021-00592-1; Vogl T, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100191; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Weisberg SP, 2021, NAT IMMUNOL, V22, P25, DOI 10.1038/s41590-020-00826-9; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	41	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22223	10.1096/fj.202101492R	http://dx.doi.org/10.1096/fj.202101492R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CA	35239233	Green Published, hybrid			2022-12-26	WOS:000772943800001
J	Kanjanapruthipong, T; Ampawong, S; Thaenkham, U; Tuentam, K; Watthanakulpanich, D				Kanjanapruthipong, Tapanee; Ampawong, Sumate; Thaenkham, Urusa; Tuentam, Khwanchanok; Watthanakulpanich, Dorn			Survival of immature pre-adult Gnathostoma spinigerum in humans after treatment with albendazole	PLOS ONE			English	Article							IMMUNODIAGNOSIS; STAGE	Human gnathostomiasis is a food-borne zoonotic helminthic infection widely reported in Latin America, Asia and Southeast Asia, particularly in Thailand. There are increasing reports of the parasite in countries where it is not endemic. A study of the survival drug-treated immature stage (STIM) of Gnathostoma spinigerum recovered from infected patients focused on their integument surface using scanning electron microscopy (SEM). STIM displayed a specific, characteristic head bulb, with a pair of large thick equal-sized trilobulated lips in the centre. Cephalic spines had eight transverse rows on the head bulb with single-ended tips curved posteriorly. Body cuticular spines on the anterior half of the STIM were not sharp-pointed but distributed more densely, with multi-dentated-cuticular spines, irregularly arranged in a lining pattern of velvety cuticular folds. The length of cuticular spines increased caudally. The size of spines became gradually smaller, and numbers decreased towards the posterior end. Spines were still widely dispersed posteriorly as their density dropped. The morphology of STIM of G. spinigerum are described in detail for the first time. These specimens showed structural adaptation based on changes on integument surfaces, probably to protect against damage induced by the toxic effects of albendazole.	[Kanjanapruthipong, Tapanee; Ampawong, Sumate; Tuentam, Khwanchanok] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand; [Thaenkham, Urusa; Watthanakulpanich, Dorn] Mahidol Univ, Fac Trop Med, Dept Helminthol, Bangkok, Thailand	Mahidol University; Mahidol University	Watthanakulpanich, D (corresponding author), Mahidol Univ, Fac Trop Med, Dept Helminthol, Bangkok, Thailand.	dorn.wat@mahidol.edu			Faculty of Tropical Medicine, Mahidol University	Faculty of Tropical Medicine, Mahidol University	This study was additional supported for journal publication by the Faculty of Tropical Medicine, Mahidol University. The authors would like to thank Dr. Paron Dekumyoy, Dr. Wallop Pakdee, Dr. Tippayarat Yoonuan for labour-intensive data support. Appreciated thanks are extended to the ENAGO for editing English grammar in the manuscript.	AKAHANE H, 1986, Japanese Journal of Parasitology, V35, P465; ANANTAPHRUTI M, 1982, Southeast Asian Journal of Tropical Medicine and Public Health, V13, P531; ANDO K, 1990, Japanese Journal of Parasitology, V39, P482; Mosqueda-Cabrera MA, 2009, PARASITOL RES, V105, P1637, DOI 10.1007/s00436-009-1604-9; Arunyanart C, 2009, SE ASIAN J TROP MED, V40, P1199; Camacho SPD, 1998, AM J TROP MED HYG, V59, P908, DOI 10.4269/ajtmh.1998.59.908; Camacho SPD, 2002, PARASITOL RES, V88, P639, DOI 10.1007/s00436-002-0636-1; Cruz-Reyes A, 2012, PARASITOL RES, V110, P557, DOI 10.1007/s00436-011-2522-1; Daengsvang S., 1986, The 25th anniversary of the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 1960-1985., P124; Daengsvang S., 1980, MONOGRAPH GENUS GNAT; Dekumyoy P., 2013, HELMINTH NEMATODE GN, P94; HIRA PR, 1989, AM J TROP MED HYG, V41, P91, DOI 10.4269/ajtmh.1989.41.91; KRAIVICHIAN P, 1992, T ROY SOC TROP MED H, V86, P418, DOI 10.1016/0035-9203(92)90248-B; LACEY E, 1990, PARASITOL TODAY, V6, P112, DOI 10.1016/0169-4758(90)90227-U; MALEEWONG W, 1992, J PARASITOL, V78, P125, DOI 10.2307/3283698; MARRINER SE, 1986, EUR J CLIN PHARMACOL, V30, P705, DOI 10.1007/BF00608219; Miyazaki I., 1991, An illustrated book of helminthic zoonoses.; Nontasut Ponganant, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P650; Nontasut Ponganant, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P374; NOPPARATANA C, 1991, INT J PARASITOL, V21, P677, DOI 10.1016/0020-7519(91)90079-M; RADOMYOS P, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P215; RATANARAPEE S, 1982, J MED ASSOC THAILAND, V65, P642; RATANARAPEE S, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P376; Riganti M., 1990, ATLAS TROPICAL HISTO; RUSNAK JM, 1993, CLIN INFECT DIS, V16, P33, DOI 10.1093/clinids/16.1.33; Ryan ET, 2019, HUNTERS TROPICAL MED; Sakamoto Mitsuo, 2004, Kansenshogaku Zasshi, V78, P442; Sharma C, 2017, AM J TROP MED HYG, V97, P1611, DOI 10.4269/ajtmh.17-0239; Sirikulchayanonta Vorachai, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P302; Sivakorn C, 2020, AM J TROP MED HYG, V103, P1129, DOI 10.4269/ajtmh.20-0236; Sohn Woon-Mok, 1993, Korean Journal of Parasitology, V31, P347, DOI 10.3347/kjp.1993.31.4.347; Strady C, 2009, AM J TROP MED HYG, V80, P33, DOI 10.4269/ajtmh.2009.80.33; Sukontason Kom, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P379; Sukontason Kom, 2000, Journal of the Medical Association of Thailand, V83, P426; Suntharasamai P., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P716; WILLIAMS HC, 1989, CLIN EXP DERMATOL, V14, P355, DOI 10.1111/j.1365-2230.1989.tb02583.x	36	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264766	10.1371/journal.pone.0264766	http://dx.doi.org/10.1371/journal.pone.0264766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259176	gold, Green Published			2022-12-26	WOS:000835141200026
J	Wang, CH; Zhang, SS; Ma, BY; Fu, Y; Luo, YZ				Wang, Caihong; Zhang, Shaosen; Ma, Boyuan; Fu, Yan; Luo, Yongzhang			TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression	ONCOGENE			English	Article							RAB-COUPLING PROTEIN; MUTANT P53; CELL; GAIN; INVASION; GENE; ACTIVATION; INTEGRIN	Mutant p53 (mtp53) can exert cancer-promoting activities via "gain-of-function", which has become a popular research target. Although lots of researchers focus on the tumor-suppressor role for p53, the regulation of mutant p53 remains unknown. Here, we report a mechanism by which mtp53 regulate the transcription of Rab coupling protein (RCP) to influence lung cancer behavior. First, we show that RCP is specifically expressed at high levels in lung cancer tissues and cells, and RCP knockout suppresses tumor growth and metastasis. Further mass spectrometry and functional analysis identify that Sp1, Sp3 and Stat3 are the transcriptional activators of RCP. Moreover, p53 is involved in modulating RCP expression in an Sp1/3 dependent manner. Mechanistically, in contrast to wild-type p53 suppression of RCP transcription by decreasing Sp1/3 proteins, TP53 mutations have changed on Sp1/3 expression via "loss-of-function". Surprisingly, the DNA contact mutants of p53 further robustly enhance their binding ability with Sp1/3 to drive RCP expression through the "gain-of-function" activity. Collectively, we reveal a mechanism by which p53 regulating the transcription of RCP to influence lung cancer progression, which provides new insights for treating p53 mutant lung cancer.	[Wang, Caihong] Capital Med Univ, Beijing Friendship Hosp, Beijing Inst Trop Med, Beijing 100050, Peoples R China; [Wang, Caihong; Zhang, Shaosen; Ma, Boyuan; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Caihong; Zhang, Shaosen; Ma, Boyuan; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Natl Engn Res Ctr Prot Technol, Beijing 100084, Peoples R China; [Wang, Caihong; Zhang, Shaosen; Ma, Boyuan; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China; [Zhang, Shaosen] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Etiol & Carcinogenesis, Beijing 100021, Peoples R China	Capital Medical University; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Luo, YZ (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Luo, YZ (corresponding author), Tsinghua Univ, Natl Engn Res Ctr Prot Technol, Beijing 100084, Peoples R China.; Luo, YZ (corresponding author), Tsinghua Univ, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China.	yluo@tsinghua.edu.cn		Zhang, Shaosen/0000-0003-0010-1445	National Natural Science Foundation of China [82103071]; National Major Scientific and Technological Special Project for "Significant New Drugs Development" [20181821569]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Special Project for "Significant New Drugs Development"	This work was supported by the National Natural Science Foundation of China (No. 82103071 to CW) and the National Major Scientific and Technological Special Project for "Significant New Drugs Development" (No. 20181821569 to YL).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Balsara BR, 1997, CANCER RES, V57, P2116; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Cho KH, 2019, ARCH PHARM RES, V42, P101, DOI 10.1007/s12272-019-01129-w; Choe SR, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0078-1; Dai YZ, 2012, ONCOL LETT, V3, P1231, DOI 10.3892/ol.2012.652; Donehower LA, 2019, CELL REP, V28, P1370, DOI 10.1016/j.celrep.2019.07.001; Escoll M, 2017, ONCOGENE, V36, P3515, DOI 10.1038/onc.2016.518; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gettinger SN, 2012, J CLIN ONCOL, V30; Ghosh M, 2021, CANCER CELL, V39, P494, DOI 10.1016/j.ccell.2021.01.003; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gundry C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14646; Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Hwang MH, 2017, ONCOGENE, V36, P1102, DOI 10.1038/onc.2016.277; Jacquemet G, 2013, J CELL BIOL, V202, P917, DOI 10.1083/jcb.201302041; Kim JY, 2020, EXP MOL MED, V52, P1152, DOI 10.1038/s12276-020-0474-1; Kim MP, 2018, CELL DEATH DIFFER, V25, P161, DOI 10.1038/cdd.2017.185; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Kurppa KJ, 2020, CANCER CELL, V37, P104, DOI 10.1016/j.ccell.2019.12.006; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lindsay AJ, 2002, J BIOL CHEM, V277, P12190, DOI 10.1074/jbc.M108665200; Lindsay AJ, 2017, ONCOTARGET, V8, P104717, DOI 10.18632/oncotarget.10513; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; Mills GB, 2009, J CLIN INVEST, V119, P2123, DOI 10.1172/JCI40256; Mollaoglu G, 2017, CANCER CELL, V31, P270, DOI 10.1016/j.ccell.2016.12.005; Monteleone E, 2019, CANCERS, V11, DOI 10.3390/cancers11010101; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Novo D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07339-y; Oduah EI, 2020, CANCER BIOL THER, V21, P293, DOI 10.1080/15384047.2019.1702403; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Phatak V, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03497-y; Prekeris R, 2000, MOL CELL, V6, P1437, DOI 10.1016/S1097-2765(00)00140-4; Schuette W, 2005, J CLIN ONCOL, V23, P8389, DOI 10.1200/JCO.2005.02.3739; Su HW, 2009, AM J PHYSIOL-CELL PH, V296, pC13, DOI 10.1152/ajpcell.00263.2008; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tang QS, 2021, EMBO REP, V22, DOI 10.15252/embr.201948351; Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Xu SR, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1442-3; Zhang J, 2019, P NATL ACAD SCI USA, V116, P24259, DOI 10.1073/pnas.1913919116; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622; Zhang L, 2010, J BIOL CHEM, V285, P38463, DOI 10.1074/jbc.M110.153999; Zhang SS, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107879; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	54	1	1	3	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2022	41	16					2357	2371		10.1038/s41388-022-02260-7	http://dx.doi.org/10.1038/s41388-022-02260-7		MAR 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0N1NW	35256783				2022-12-26	WOS:000765674100001
J	Shelat, S; van de Wiel, T; Molin, E; van Lint, JWC; Cats, O				Shelat, Sanmay; van de Wiel, Thijs; Molin, Eric; van Lint, J. W. C.; Cats, Oded			Analysing the impact of COVID-19 risk perceptions on route choice behaviour in train networks	PLOS ONE			English	Article							HIERARCHICAL INFORMATION INTEGRATION; WILLINGNESS-TO-PAY; TRAVEL BEHAVIOR; TRANSPORT	Introduction Unlike previous pandemics, COVID-19 has sustained over a relatively longer period with cyclical infection waves and numerous variants. Public transport ridership has been hit particularly hard. To restore travellers' confidence it is critical to assess their risk determinants and trade-offs. Methods To this end, we survey train travellers in the Netherlands in order to: (i) quantify the impact of trip-specific, policy-based, and pandemic-related attributes on travellers' COVID-19 risk perceptions; and (ii) evaluate the trade-off between this risk perception and other travel attributes. Adopting the hierarchical information integration approach, in a two-stage stated preference experiment, respondents are asked to first rate how risky they perceive different travel situations to be, and then to choose between different travel options that include their own perceived risk rating as an attribute. Perceived risk ratings and choices between travel options are modelled using a linear regression and a mixed multinomial logit model, respectively. Results We find that on-board crowding and infection rates are the most important factors for risk perception. Amongst personal characteristics, the vulnerability of family and friends has the largest impact-nearly twice that of personal health risk. The bridging choice experiment reveals that while values of time have remained similar to pre-pandemic estimates, travellers are significantly more likely to choose routes with less COVID-19 risk (e.g., due to lower crowding). Respondents making longer trips by train value risk four times as much as their shorter trip counterparts. By combining the two models, we also report willingness to pay for mitigating factors: reduced crowding, mask mandates, and increased sanitization. Conclusion Since we evaluate the impact of a large number of variables on route choice behaviour, we can use the estimated models to predict behaviour under detailed pandemic scenarios. Moreover, in addition to highlighting the importance of COVID-19 risk perceptions in public transport route choices, the results from this study provide valuable information regarding the mitigating impacts of various policies on perceived risk.	[Shelat, Sanmay; van de Wiel, Thijs; van Lint, J. W. C.; Cats, Oded] Delft Univ Technol, Dept Transport & Planning, Delft, Netherlands; [Molin, Eric] Delft Univ Technol, Transport & Logist Grp, Delft, Netherlands	Delft University of Technology; Delft University of Technology	Shelat, S (corresponding author), Delft Univ Technol, Dept Transport & Planning, Delft, Netherlands.	s.shelat@tudelft.nl		van Lint, Hans/0000-0003-1493-6750; Shelat, Sanmay/0000-0002-5412-3933	My-TRAC [777640]; Amsterdam Institute for Advanced Metropolitan Solutions	My-TRAC; Amsterdam Institute for Advanced Metropolitan Solutions	SS was funded by the My-TRAC (H2020 Grant No. 777640) project and the Amsterdam Institute for Advanced Metropolitan Solutions. The Transport Institute of TU Delft provided funding for the survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaditya B, 2021, TRANSPORT POLICY, V108, P47, DOI 10.1016/j.tranpol.2021.05.003; [Anonymous], 2021, DUTCHNEWS NL 1002; Awad-Nunez S, 2021, EUR TRANSP RES REV, V13, DOI 10.1186/s12544-021-00476-4; Beck MJ, 2020, TRANSPORT POLICY, V99, P95, DOI 10.1016/j.tranpol.2020.08.004; Bos IDM, 2004, ENVIRON PLANN A, V36, P1673, DOI 10.1068/a36138; Bucsky Peter, 2020, Transp Res Interdiscip Perspect, V8, P100141, DOI 10.1016/j.trip.2020.100141; Centraal Bureau voor de Statistiek, 2015, OND VERPL NED 2014; Cho SH, 2021, TRANSP LETT, V13, P367, DOI 10.1080/19427867.2021.1897937; ChoiceMetrics, 2012, NGENE 111 USER MANUA; City Mapper, 2021, CIT MOB IND; de Haas Mathijs, 2020, Transp Res Interdiscip Perspect, V6, P100150, DOI 10.1016/j.trip.2020.100150; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Elias W, 2013, TRANSPORT POLICY, V28, P114, DOI 10.1016/j.tranpol.2012.08.005; Engle S., 2020, STAYING HOME MOBILIT; Gerhold L., 2020, COVID 19 RISK PERCEP, DOI [10.31234/osf.io/xmpk4, DOI 10.31234/OSF.IO/XMPK4]; Gkiotsalitis K, 2021, TRANSPORT REV, V41, P374, DOI 10.1080/01441647.2020.1857886; Goldbaum Christina, 2020, NEW YORK TIMES; Goldman E, 2020, LANCET INFECT DIS, V20, P892, DOI 10.1016/S1473-3099(20)30561-2; Google, 2020, COVID 19 COMM MOB RE; Groeniger JO, 2021, SOC SCI MED, V275, DOI 10.1016/j.socscimed.2021.113819; Hess S, 2019, J CHOICE MODEL, V32, DOI 10.1016/j.jocm.2019.100170; Holguin-Veras J., 2003, IMPACTS EXTREME EVEN, P373; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Hu MG, 2021, CLIN INFECT DIS, V72, P604, DOI 10.1093/cid/ciaa1057; Kim C, 2017, KSCE J CIV ENG, V21, P2888, DOI 10.1007/s12205-017-0821-5; Kouwenhoven M, 2014, RES TRANSP ECON, V47, P37, DOI 10.1016/j.retrec.2014.09.017; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Li Z, 2011, TRANSPORT POLICY, V18, P880, DOI 10.1016/j.tranpol.2011.06.003; LOUVIERE J, 1990, GEOGR ANAL, V22, P127; LOUVIERE JJ, 1984, ADV CONSUM RES, V11, P148; McGovern P., 2021, OCCUPATIONAL HLTH WE; Mertens G, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102258; Molin E, 2017, J AIR TRANSP MANAG, V62, P165, DOI 10.1016/j.jairtraman.2017.04.002; Molin EJE, 2009, TRANSPORT REV, V29, P635, DOI 10.1080/01441640902829470; Moreno T, 2021, ENVIRON INT, V147, DOI 10.1016/j.envint.2020.106326; Nederlandse Spoorwegen, 2021, 2020 YEAR DOM COVID; Nordgren LF, 2007, J BEHAV DECIS MAKING, V20, P533, DOI 10.1002/bdm.565; Pawar Digvijay S, 2020, Transp Res Interdiscip Perspect, V7, P100203, DOI 10.1016/j.trip.2020.100203; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; Rijksoverheid, 2021, NUMB INF PERS; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Shelat S., 2021, AVOIDING CROWD TRAVE; Teixeira Joao Filipe, 2020, Transp Res Interdiscip Perspect, V6, P100166, DOI 10.1016/j.trip.2020.100166; Thompson Derek, 2020, ATLANTIC; Translink, 2021, IMP COR; UITP, 2020, PUBL TRANSP IS COVID; ul Haq S, 2020, J INFECT DEV COUNTR, V14, P823, DOI 10.3855/jidc.12851; Wang KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089405; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Yildirim M, 2021, PSYCHOL HEALTH MED, V26, P35, DOI 10.1080/13548506.2020.1776891	50	4	4	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264805	10.1371/journal.pone.0264805	http://dx.doi.org/10.1371/journal.pone.0264805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239712	Green Published, gold			2022-12-26	WOS:000776002200079
J	Amdemariam, LK; Watumo, AM; Sibamo, EL; Agide, FD				Amdemariam, Lemlem Kifleyesus; Watumo, Aregash Mecha; Sibamo, Epfrem Lejore; Agide, Feleke Doyore			Perception towards cardiovascular diseases preventive practices among bank workers in Hossana town using the health belief model	PLOS ONE			English	Article							MORTALITY; KNOWLEDGE; BURDEN	Background Cardiovascular diseases (CVD) are becoming a public health problem in Ethiopia, especially among those who have limited physical activity. Although bank workers are at an increased risk of contracting CVD, their participation in CVD preventive activities is not studied in Ethiopia. Therefore, this study aimed to assess the perception of bank workers towards CVD preventive behaviors and associated factors in Hossana town. Methods A cross-sectional study was conducted on a sample of 258 participants from February 11 to 30/2020. A simple random sampling method was used to select study participants from the enumerated list of staff. Data was collected using a self-administered structured questionnaire and the collected data was entered and analyzed using SPSS version 20 software. Descriptive statistics and logistic regression analysis were done. A p-value less than 0.05 with 95% CI was considered to declare an association between independent and dependent variables. Results A total of 253 respondents with response rate of 98.0% were participated. The study revealed that the likelihood of performing CVD preventive behaviors is 62.0%. Moreover, the study found that bank workers' exposure to passive smoking [AOR = 0.5; 95% CI: 0.23-0.98], level of alcohol consumed [AOR = 0.5; 95% CI: 0.01-0.54], regularly consuming fruit and vegetable in daily meal [AOR = 0.16; 95% CI: 0.03-0.80], perceived severity[AOR = 0.1;95% CI: 0.01-0.68], and cues to take action [AOR = 0.12;95% CI: 0.02-0.73] were identified as predictors of perception to engage in CVD preventive behaviors. Conclusion The level of bank workers' perception of engaging in CVD preventive behavior was in a considerable state to design and implement intervention strategies. Behavior change communication should be strengthened to improve their knowledge and perception of the severity of CVD and barriers so as to improve the likelihood of taking action.	[Amdemariam, Lemlem Kifleyesus; Watumo, Aregash Mecha; Agide, Feleke Doyore] Wachemo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hossana, Ethiopia; [Sibamo, Epfrem Lejore] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia	Hawassa University	Agide, FD (corresponding author), Wachemo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hossana, Ethiopia.	feledoag@yahoo.com		Agide, Feleke/0000-0002-9311-9275; Lejore, Ephrem/0000-0003-0090-4184				Albugami S., 2020, CUREUS J MED SCIENCE, V12; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Dadi AF, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8293-9; EPHI F. WHO, 2016, ETH STEPS REP RISK F; Fikriana R., SELF BELIEF SOCIAL S; Glanz K, 2008, HLTH BEHAV HLTH ED T, V4th; Harold JG, 2013, J AM COLL CARDIOL, V62, P357, DOI 10.1016/j.jacc.2013.05.002; Hausmann-Muela S, 2003, HLTH SEEKING BEHAV H; Hobbs FDR, 2004, HEART, V90, P1217, DOI 10.1136/hrt.2003.027680; Homko J, 2008, J CARDIOVASC NURS, V23, P332, DOI 10.1097/01.JCN.0000317432.44586.aa; Jorvand R., 2018, J ED COMMUNITY HLTH, V5, P4; Jorvand R, 2018, IRAN RED CRESCENT ME, V20, DOI 10.5812/ircmj.62027; Kahnooji Z., 2021, COMMUNITY HLTH J, V14, P1; Kamran A, 2014, ANN MED HEALTH SCI R, V4, P922, DOI 10.4103/2141-9248.144914; Lynch EB, 2006, AM J EPIDEMIOL, V164, P1171, DOI 10.1093/aje/kwj334; Massaquoi H, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-020-03521-7; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mehrmal S, 2021, J AM ACAD DERMATOL, V84, P46, DOI 10.1016/j.jaad.2020.04.139; Mensah GA, 2015, CARDIOVASC J AFR, V26, pS6, DOI 10.5830/CVJA-2015-036; Mohammad H., 2013, J HLTH SYSTEM RES, V8, P1151; Mohammadi N., 2018, SCI J HAMADAN NURSIN, V2008, P2819; Moshki M., 2015, J HEALTH, V6, P367; Nur KRM, 2018, Int J Nurs Sci, V5, P174, DOI 10.1016/j.ijnss.2018.04.007; Organization WH, 2018, NONCOMMUNICABLE DIS; Ozlu MO., 2015, ETHIOPIA URBANIZATIO; Rahmati-Najarkolaei F, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.18879; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Sharifirad G, 2009, J RES MED SCI, V14, P1; Sharifzadeh G, 2017, J HLTH SCI TECH, V1, P64; Tan MY, 2004, DIABETES RES CLIN PR, V66, P71, DOI 10.1016/j.diabres.2004.02.021; Tesfaye F., THESIS EPIDEMIOLOGI; World Health Organization, 2017, CARDIOVASCULAR DIS; World Health Organization. Prevention of Cardiovascular Disease, 2007, POCK GUID ASS MAN CA, P17; Zhu S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15024-1	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264112	10.1371/journal.pone.0264112	http://dx.doi.org/10.1371/journal.pone.0264112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226671	gold, Green Published			2022-12-26	WOS:000793394000008
J	Musskopf, ML; Stadler, AF; Wikesjo, UM; Susin, C				Musskopf, Marta Liliana; Stadler, Amanda Finger; Wikesjo, Ulf Me; Susin, Cristiano			The minipig intraoral dental implant model: A systematic review and meta-analysis	PLOS ONE			English	Review							SURFACE-MODIFIED ZIRCONIA; ENHANCED BONE APPOSITION; TITANIUM IMPLANTS; ANIMAL-MODELS; CHONDROITIN SULFATE; MINIATURE PIG; OSSEOINTEGRATION; COLLAGEN; IMMEDIATE; STABILITY	Objectives The objective of this report was to provide a review of the minipig intraoral dental implant model including a meta-analysis to estimate osseointegration and crestal bone remodeling. Methods A systematic review including PubMed and EMBASE databases through June 2021 was conducted. Two independent examiners screened titles/abstracts and selected full-text articles. Studies evaluating titanium dental implant osseointegration in native alveolar bone were included. A quality assessment of reporting was performed. Random-effects meta-analyses and meta-regressions were produced for bone-implant contact (BIC), first BIC, and crestal bone level. Results 125 out of 249 full-text articles were reviewed, 55 original studies were included. Quality of reporting was generally low, omissions included animal characteristics, examiner masking/calibration, and sample size calculation. The typical minipig model protocol included surgical extraction of the mandibular premolars and first molar, 124 wks post-extraction healing, placement of three narrow regular length dental implants per jaw quadrant, submerged implant healing and 8 wks of osseointegration. Approximately 90% of studies reported undecalcified incandescent light microscopy histometrics. Overall, mean BIC was 59.88% (95%CI: 57.43-62.33). BIC increased significantly over time (p<0.001): 40.93 (95%CI: 34.95-46.90) at 2 wks, 58.37% (95%CI: 54.38-62.36) at 4 wks, and 66.33% (95%CI: 63.45-69.21) beyond 4 wks. Variability among studies was mainly explained by differences in observation interval post-extraction and post-implant placement, and implant surface. Heterogeneity was high for all studies (I-2 > 90%, p<0.001). Conclusions The minipig intraoral dental implant model appears to effectively demonstrate osseointegration and alveolar bone remodeling similar to that observed in humans and canine models.	[Musskopf, Marta Liliana; Stadler, Amanda Finger; Wikesjo, Ulf Me; Susin, Cristiano] Univ N Carolina, Adams Sch Dent, Lab Appl Periodontal & Craniofacial Res, Div Comprehens Oral Hlth Periodontol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Musskopf, ML; Susin, C (corresponding author), Univ N Carolina, Adams Sch Dent, Lab Appl Periodontal & Craniofacial Res, Div Comprehens Oral Hlth Periodontol, Chapel Hill, NC 27515 USA.	mlmusskopf@unc.edu; csusin@unc.edu						Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x; Amari Y, 2019, INT J IMPLANT DENT, V5, DOI 10.1186/s40729-019-0194-2; [Anonymous], 2005, DENT PRECLINICAL EVA; Assenza B, 2010, CLIN ORAL INVEST, V14, P285, DOI 10.1007/s00784-009-0289-x; BASQUILL PJ, 1994, J PERIODONTOL, V65, P872, DOI 10.1902/jop.1994.65.9.872; Boticelli D LN., 2017, CLIN ORAL IMPLAN RES, V28, P742, DOI [10.1111/clr.12872, DOI 10.1111/CLR.12872]; Botzenhart U, 2015, ANN ANAT, V199, P16, DOI 10.1016/j.aanat.2014.02.011; Bousdras VA, 2007, CLIN IMPLANT DENT R, V9, P197, DOI 10.1111/j.1708-8208.2007.00038.x; Brockmeyer P, 2016, J CRANIO MAXILL SURG, V44, P1095, DOI 10.1016/j.jcms.2016.05.025; Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704; Buser D, 2017, PERIODONTOL 2000, V73, P7, DOI 10.1111/prd.12185; Cecchinato D, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02293.x; Chiang HJ, 2016, J BIOMED MATER RES A, V104, P397, DOI 10.1002/jbm.a.35577; Cochran D, 2016, INT J ORAL MAX IMPL, V31, P1341, DOI 10.11607/jomi.4712; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Donati M, 2013, CLIN ORAL IMPLAN RES, V24, P738, DOI 10.1111/j.1600-0501.2012.02479.x; Dostalova T, 2001, J BIOMED OPT, V6, P239, DOI 10.1117/1.1357191; Duyck J, 2010, CLIN ORAL IMPLAN RES, V21, P877, DOI 10.1111/j.1600-0501.2010.01895.x; Elian N, 2011, J PERIODONTOL, V82, P1749, DOI 10.1902/jop.2011.100661; Eom TG, 2016, INT J ORAL MAX IMPL, V31, P997, DOI 10.11607/jomi.4165; Eom TG, 2012, OR SURG OR MED OR PA, V114, P411, DOI 10.1016/j.oooo.2011.10.036; Gahlert M, 2012, CLIN ORAL IMPLAN RES, V23, P281, DOI 10.1111/j.1600-0501.2011.02157.x; Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x; Gottlow J, 2012, CLIN IMPLANT DENT R, V14, P538, DOI 10.1111/j.1708-8208.2010.00289.x; GOULD TRL, 1992, J PERIODONTOL, V63, P593, DOI 10.1902/jop.1992.63.7.593; Gredes T, 2014, IMPLANT DENT, V23, P502, DOI 10.1097/ID.0000000000000110; Hao CP, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93307-4; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; Herrero-Climent M, 2018, CLIN ORAL INVEST, V22, P1423, DOI 10.1007/s00784-017-2223-y; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Hoornaert A, 2020, CLIN ORAL IMPLAN RES, V31, P526, DOI 10.1111/clr.13589; Hou PJ, 2018, J MECH BEHAV BIOMED, V79, P173, DOI 10.1016/j.jmbbm.2017.11.042; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Huang MS, 2015, IMPLANT DENT, V24, P441, DOI 10.1097/ID.0000000000000258; Ivanoff CJ, 2001, CLIN ORAL IMPLAN RES, V12, P128, DOI 10.1034/j.1600-0501.2001.012002128.x; Kammerer T, 2021, EUR SURG RES, V61, P177, DOI 10.1159/000513846; Kantarci A, 2015, PERIODONTOL 2000, V68, P66, DOI 10.1111/prd.12052; Karl M, 2020, INT J ORAL MAX IMPL, V35, P313, DOI 10.11607/jomi.7694; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Korn P, 2014, J BIOMED MATER RES A, V102, P2334, DOI 10.1002/jbm.a.34913; Kuo TF, 2017, J MED BIOL ENG, V37, P313, DOI 10.1007/s40846-017-0230-8; Lang NP, 2011, CLIN ORAL IMPLAN RES, V22, P349, DOI 10.1111/j.1600-0501.2011.02172.x; Lee J, 2012, J CLIN PERIODONTOL, V39, P781, DOI 10.1111/j.1600-051X.2012.01905.x; Linares A, 2011, CLIN ORAL IMPLAN RES, V22, P38, DOI 10.1111/j.1600-0501.2010.01988.x; Linares A, 2013, J CLIN PERIODONTOL, V40, P412, DOI 10.1111/jcpe.12068; Lopez-Garcia M G-CA., 2015, INT J STOMATOL OCCLU, V8, P41; Mardas N, 2014, J INVEST SURG, V27, P32, DOI 10.3109/08941939.2013.817628; Mehl C, 2018, J ZHEJIANG UNIV-SC B, V19, P525, DOI 10.1631/jzus.B1600505; Mehl C, 2016, INT J ORAL MAX IMPL, V31, P1264, DOI 10.11607/jomi.5321; Nakajima Y, 2018, IMPLANT DENT, V27, P193, DOI 10.1097/ID.0000000000000723; Nkenke E, 2005, INT J ORAL MAX IMPL, V20, P540; Nkenke E, 2003, CLIN ORAL IMPLAN RES, V14, P312, DOI 10.1034/j.1600-0501.2003.120906.x; Omori Y, 2018, IMPLANT DENT, V27, P415, DOI 10.1097/ID.0000000000000772; Ou KL, 2016, CLIN ORAL INVEST, V20, P1515, DOI 10.1007/s00784-015-1629-7; Ou KL, 2016, IMPLANT DENT, V25, P63, DOI 10.1097/ID.0000000000000337; Page MJ, 2021, J CLIN EPIDEMIOL, V134, P178, DOI 10.1016/j.jclinepi.2021.03.001; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Pellegrini G, 2009, J DENT RES, V88, P1065, DOI 10.1177/0022034509349748; Martinez CPA, 2016, CLIN ORAL IMPLAN RES, V27, P964, DOI 10.1111/clr.12665; Pilawski I, 2021, JDR CLIN TRANSL RES, V6, P352, DOI 10.1177/2380084420936979; Rimondini Lia, 2005, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V100, pe43, DOI 10.1016/j.tripleo.2005.05.058; Rios-Santos JV, 2018, J MATER SCI-MATER M, V29, DOI 10.1007/s10856-018-6101-1; Roehling S, 2018, CLIN ORAL IMPLAN RES, V29, P135, DOI 10.1111/clr.13352; Romero-Ruiz MM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092307; Ruehe B, 2011, J ORAL IMPLANTOL, V37, P3, DOI 10.1563/AAID-JOI-D-09-00090; Ruehe B, 2009, ORAL SURG ORAL MED O, V108, P699, DOI 10.1016/j.tripleo.2009.06.037; Russell WMS., 1959, MED J AUSTRALIA; Saulacic N, 2012, EUR CELLS MATER, V23, P273, DOI 10.22203/eCM.v023a21; Schliephake H, 2010, J CLIN PERIODONTOL, V37, P818, DOI 10.1111/j.1600-051X.2010.01549.x; Schulz MC, 2014, J MATER SCI-MATER M, V25, P247, DOI 10.1007/s10856-013-5066-3; Sennerby L, 1993, Clin Oral Implants Res, V4, P65; Sivan-Gildor A, 2014, J PERIODONTOL, V85, P1458, DOI 10.1902/jop.2014.140042; Stadlinger B, 2008, INT J ORAL MAX SURG, V37, P54, DOI 10.1016/j.ijom.2007.05.024; Stadlinger B, 2010, INT J ORAL MAX SURG, V39, P585, DOI 10.1016/j.ijom.2010.01.015; Stadlinger B, 2008, J BIOMED MATER RES B, V87B, P516, DOI 10.1002/jbm.b.31138; Stadlinger B, 2012, J BIOMED MATER RES B, V100B, P331, DOI 10.1002/jbm.b.31953; Stadlinger B, 2009, J CLIN PERIODONTOL, V36, P882, DOI 10.1111/j.1600-051X.2009.01466.x; Stadlinger B, 2009, J CLIN PERIODONTOL, V36, P698, DOI 10.1111/j.1600-051X.2009.01435.x; Stavropoulos A, 2016, Adv Dent Res, V28, P34, DOI 10.1177/0022034515624446; Stembirek J, 2012, LAB ANIM-UK, V46, P269, DOI 10.1258/la.2012.012062; Stramandinoli-Zanicotti RT, 2014, IMPLANT DENT, V23, P560, DOI 10.1097/ID.0000000000000150; Susin C, 2019, CLIN IMPLANT DENT R, V21, P44, DOI 10.1111/cid.12754; Susin C, 2019, CLIN IMPLANT DENT R, V21, P34, DOI 10.1111/cid.12755; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Taguchi T, 2021, J ORTHOP RES, V39, P7, DOI 10.1002/jor.24852; Thome G, 2021, CLIN ORAL INVEST, V25, P603, DOI 10.1007/s00784-020-03513-z; Traini T, 2009, CLIN IMPLANT DENT R, V11, P41, DOI 10.1111/j.1708-8208.2008.00086.x; Vasak C, 2014, CLIN ORAL IMPLAN RES, V25, P1378, DOI 10.1111/clr.12277; Verket A, 2014, CLIN ORAL IMPLAN RES, V25, pE100, DOI 10.1111/clr.12070; Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x; Wennerberg A, 2018, EUR J ORAL IMPLANTOL, V11, pS123; Wikesjo UME, 2006, J CLIN PERIODONTOL, V33, P846, DOI 10.1111/j.1600-051X.2006.00985.x; Wikesjo UME, 2008, J CLIN PERIODONTOL, V35, P1001, DOI 10.1111/j.1600-051X.2008.01321.x; Yonezawa D, 2018, INT J ORAL MAX IMPL, V33, P181, DOI 10.11607/jomi.5928; Zechner W, 2003, CLIN ORAL IMPLAN RES, V14, P150, DOI 10.1034/j.1600-0501.2003.140203.x	96	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264475	10.1371/journal.pone.0264475	http://dx.doi.org/10.1371/journal.pone.0264475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226690	Green Published, gold			2022-12-26	WOS:000793394000024
J	Abdullahi, A; Nzou, SM; Kikuvi, G; Mwau, M				Abdullahi, Amina; Nzou, Samson Muuo; Kikuvi, Gideon; Mwau, Matilu			Neisseria gonorrhoeae infection in female sex workers in an STI clinic in Nairobi, Kenya	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE	Background Gonorrhea caused by Neisseria gonorrhoeae is the second most prevalent curable sexually transmitted infection worldwide. Female Sex Workers (FSWs) are at a higher risk of contracting gonorrhea due to their risky sexual behaviors like inconsistent condom use and multiple sexual partners. We determined the prevalence and risk factors associated with gonorrhea and its antimicrobial susceptibility pattern among symptomatic FSWs attending Sexual Workers Outreach Program (SWOP) city clinic in Nairobi, Kenya. Methods Using convenience sampling, we recruited 379 female sex workers from SWOP City clinic in Nairobi County. We administered a semi-structured questionnaire to collect data on socio-demographics and behavioral risk factors associated with gonorrhea. We also conducted three focus groups. Two endocervical swabs were collected from each participant by the attending physician for the laboratory identification of Neisseria gonorrhoeae. An antimicrobial susceptibility test was performed using the disc diffusion method. Results Twenty-four out of 379 (6.3%) participants tested positive for gonorrhea by PCR. The significant risk factors associated with gonorrhea were having multiple sexual partners in the previous two weeks, primary education, and being in the age group of 38-49 years (p < 0.05). From the qualitative data, sex work disclosure, and difficulty in engaging protected sex with their partner, and unprotected sex with their clients due to more money from the client, PREP, and alcohol use made the female sex workers vulnerable to gonorrhea exposure and or risky sexual behavior. The culture-positive sample result yielded complete (100%) resistance to all the antimicrobials used. Conclusion Neisseria gonorrhoeae infection is prevalent among symptomatic FSWs in Nairobi. Multiple sexual partners, being in age group 38-49 years and having primary education were the factors associated with gonorrhea among the study participants. Based on our identification of a highly resistant isolate, we strongly recommend increasing capacity for culture-based diagnosis and susceptibility testing.	[Abdullahi, Amina; Mwau, Matilu] Kenya Med Res Inst KEMRI, Ctr Infect & Parasit Dis Control Res, Busia, Kenya; [Nzou, Samson Muuo] Kenya Med Res Inst KEMRI, Ctr Microbiol Res, Nairobi, Kenya; [Kikuvi, Gideon] Jomo Kenyatta Univ Agr & Technol JKUAT, Sch Publ Hlth, Nairobi, Kenya	Kenya Medical Research Institute; Kenya Medical Research Institute; Jomo Kenyatta University of Agriculture & Technology	Abdullahi, A (corresponding author), Kenya Med Res Inst KEMRI, Ctr Infect & Parasit Dis Control Res, Busia, Kenya.	amina02.abdalla@gmail.com						Chow EPF, 2019, SEX TRANSM INFECT, V95, P398, DOI 10.1136/sextrans-2018-053957; Das A, 2011, PREVALENCE ASSESSMEN, V2011; Dela H, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4035-y; Duncan S, 2011, SEX TRANSM INFECT, V87, P231, DOI 10.1136/sti.2010.048777; Fonck K, 2000, SEX TRANSM DIS, V27, P417, DOI 10.1097/00007435-200008000-00007; Hawken MP, 2002, SEX TRANSM INFECT, V78, P271, DOI 10.1136/sti.78.4.271; Hook EW, 2012, AM J MED SCI, V343, P10, DOI 10.1097/MAJ.0b013e31823ea276; Lagace-Wiens PRS, 2012, SEX TRANSM DIS, V39, P332, DOI 10.1097/OLQ.0b013e318248a85f; Luo L, 2015, INT J INFECT DIS, V38, P115, DOI 10.1016/j.ijid.2015.07.025; Maina AN, 2016, BMC RES NOTES, V9, P1; Musyoki H., 2015, PREVALENCE HIV SEXUA, V19, P46; Nasirian Maryam, 2017, J Int Assoc Provid AIDS Care, V16, P608, DOI 10.1177/2325957417732836; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Ohnishi M, 2011, EMERG INFECT DIS, V17, P148, DOI 10.3201/eid1701.100397; Organization W.H., 2012, GLOB INC PREV SEL CU; Organization W.H, 2016, WHO GUIDELINES TREAT, V2016; Organization W.H., 2018, REP GLOB SEX TRANSM; Sopheab H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-167; Souza RP, 2013, AM J TROP MED HYG, V89, P1199, DOI 10.4269/ajtmh.13-0315; Tadele A., 2019, PREVALENCE ASS FACTO, V19, P1; Whiley DM, 2012, J ANTIMICROB CHEMOTH, V67, P2059, DOI 10.1093/jac/dks188; Willers DM, 2008, SEX TRANSM DIS, V35, P68, DOI 10.1097/OLQ.0b013e318154bdb2; Yokoi S, 2007, EMERG INFECT DIS, V13, P1275	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263531	10.1371/journal.pone.0263531	http://dx.doi.org/10.1371/journal.pone.0263531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213551	gold, Green Published			2022-12-26	WOS:000787811000024
J	Ali, AA; Usman, AM; Badebo, FB; Tilahun, SH				Ali, Abraham A.; Usman, Akmel M.; Badebo, Fekadeselassie B.; Tilahun, Solomon H.			Exploring the patterns of multisectoral approach in fighting COVID-19 Pandemic in SNNPR, Ethiopia: A qualitative case study approach	PLOS ONE			English	Article							ACCOUNTABILITY	Background Since COVID-19 has been declared as a global pandemic, South Nations, Nationalities People's Region, Ethiopia, has been responding by establishing strong structure. The response against the disease requires consolidated efforts, However, there is paucity of information about the patterns of multisectoral collaboration actions in the region. Therefore, this study was conducted with the aim of exploring the patterns of multisectoral collaboration against the COVID-19 using a qualitative case study design. Data were collected by key informant interview and document review and analyzed using a content analysis framework focused on case study data analysis. Result The study has indicated a unique perspective in establishing functional multisectoral approach with strong courage and motivation of most involved stakeholder. Almost all stakeholders have shown clear understanding about the multidimensional burdens the disease could cause and the necessities for joint efforts to tackle the multidimensional problems. The study further elucidated that despite the encouraging beginning, the eventual slowdown undertakings in the joint actions. This included failure to meet regularly to monitor and evaluate as stated earlier and societies' reluctances despite consistent information dissemination. Conclusion A firm understanding about multidimensional impacts of COVID-19 by all stakeholders was revealed in the region. Remarkable achievements were observed at the early stage of disease prevention and control responses with encouraging multisectoral approach as guided by the convergence model. However, several setbacks were observed in the process of multisectoral approach intervention as indicated by the conceptual framework. Hence, to ensure sustainable MSA, revitalization of the initial commitment of all stakeholders and strengthening MSA considering end-to end approach of the convergence frame is crucial; subsequent quantitative study recommended to establish wider determinants on success of MSA.	[Ali, Abraham A.; Usman, Akmel M.; Badebo, Fekadeselassie B.; Tilahun, Solomon H.] SNNPR, Policy Study & Res Inst, Hawassa, Ethiopia		Ali, AA (corresponding author), SNNPR, Policy Study & Res Inst, Hawassa, Ethiopia.	alanoabraham@yahoo.com			bureau of finance; bureau of health; policy study and research institute	bureau of finance; bureau of health; policy study and research institute	The study was funded by three bureaus namely: bureau of finance, bureau of health, policy study and research institute. The fund from the three bureaus covered the fieldwork, write-up, and related expenses; in the form of perdiem and transportation costs but there was no fund allocated for the communication and dissemination of the finding including publication. The study was initiated by the researchers whose names was stated as authors of this manuscript." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeleye OA, 2010, J ENVIRON PUBLIC HEA, V2010, DOI 10.1155/2010/272896; Allen P, 2000, BRIT MED J, V321, P608, DOI 10.1136/bmj.321.7261.608; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2013, OFFICIAL J EUROPEAN, V91, P12, DOI DOI 10.2903/J.EFSA.2011.2481; Bennett S, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000880; Bureau of Finance (BoF), ANN PERFORMANCE REPO; Camp W. G., 2001, J VOCAT EDUC TRAIN, V26, P27; Central Statistical Agency, 2007, CENTRAL STAT AGENCY; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen Z, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00150-7; Cumming DHM, 2015, ONE HEALTH: THE THEORY AND PRACTICE OF INTEGRATED HEALTH APPROACHES, P38, DOI [10.1079/9781780643410.0000, 10.1079/9781780643410.0038]; Getaneh Y., 2020, MED RXIV PREPRINT, DOI 10.11o1/2020; Giovanetti M., 2020, SUSTAINABLE DEV SOLU; Grant C., 2014, J CONNECTING ED PRAC, V4, P12, DOI [10.5929/2014.4.2.9, DOI 10.5929/2014.4.2.9]; Harris J, IFPRI DISCUSSION PAP, V1200; Health policy project, 2014, CAPACITY DEV RESOURC; Himmelman AT, 2002, COLLABORATION CHANGE; Himmelman AT., 1996, CREATING COLLABORATI, p18f; Hollweck T, 2015, CAN J PROGRAM EVAL, V30, P108, DOI 10.3138/cjpe.30.1.108; Ishak NM., 2014, WORLD J ED, V4; Kang Eunjeong, 2011, J Prev Med Public Health, V44, P201, DOI 10.3961/jpmph.2011.44.5.201; Kebede WS., 2020, FRONTIER INSIGHT; Kitaw Y., 2018, ETHIOP J HEALTH DEV, V32; Koplan JP, 2013, EMERG INFECT DIS, V19, P861, DOI 10.3201/eid1906.121426; Kuruvilla S, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4771; Markman KD, 2000, BRIT J SOC PSYCHOL, V39, P313, DOI 10.1348/014466600164499; Melis AP, 2013, ANN NY ACAD SCI, V1299, P68, DOI 10.1111/nyas.12263; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; National Disaster Risk Management Commission (NDRMC) and OCHA, 2020, ETHIOPIA COVID 19 HU; NRC: National Research Council, 2014, CONV FAC TRANSD INT, DOI 10.17226/18722; Ouedraogo O, 2020, INT J HEALTH PLAN M, V35, P120, DOI 10.1002/hpm.2823; Peake S., 2008, HLTH EQUITY INTERSEC; Qian X, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00650-1; Regional Health Bureau (BoH), 2020, COMPREHENSIVE ACTION; Ritchie J, 2014, QUALITATIVE RES PRAC; Salinka S., 2017, INDIAN J PUBLIC HLTH, V61, P163, DOI [10.4103/ijph.IJPH_220_17, DOI 10.4103/IJPH.IJPH_220_17]; Schwartz J, 2017, J MICROBIOL IMMUNOL, V50, P125, DOI 10.1016/j.jmii.2016.08.010; Setyawan FEB, 2020, KESMAS, V15, P37, DOI 10.21109/kesmas.v15i2.3937; Sutton Jane, 2015, Can J Hosp Pharm, V68, P226; United Nations Children's Fund (UNICEF) World Health Organization International Bank for Reconstruction and Development & The World Bank, 2020, RISK COMMUNICATION E; USAID, 2014, MULTISECTORAL NUTR S; Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689; WHO, 2009, WHO GUIDELINES HAND; WHO, 2018, FINAL REPORT; WHO OIE (World organization for animal health) & FAO, 2019, TAKING MULTISECTORAL; WHO. World Health Organization, 1978, P INT C PRIMARY HLTH; World Bank, 2020, GLOB EC OUTL COVID 1; World Health Organization, 2013, GUIDELINES MANAGEMEN; Yasobant S, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0398-6	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263667	10.1371/journal.pone.0263667	http://dx.doi.org/10.1371/journal.pone.0263667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213548	Green Published, gold, Green Submitted			2022-12-26	WOS:000787811000028
J	Chen, JI; He, TS; Liao, HY				Chen, Josie, I; He, Tai-Sen; Liao, Hsin-Ya			Does speech rate influence intertemporal decisions? an experimental investigation	PLOS ONE			English	Article							PREFERENCE; PITCH	This paper experimentally examines the effect of speech rate on intertemporal decisions. In a delay-discounting task, subjects made a series of intertemporal choices between smaller-sooner and larger-delayed rewards and were asked to listen to a voice recording verbalizing the information for payoff options. We manipulated the speech rate of the voice recordings and administered two treatment conditions: Slow and Fast. We did not find an overall treatment effect in the acoustic manipulation.	[Chen, Josie, I; Liao, Hsin-Ya] Natl Taiwan Univ, Dept Econ, Taipei, Taiwan; [He, Tai-Sen] Nanyang Technol Univ, Sch Social Sci, Econ Programme, Singapore, Singapore	National Taiwan University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	He, TS (corresponding author), Nanyang Technol Univ, Sch Social Sci, Econ Programme, Singapore, Singapore.	ts.he@ntu.edu.sg	Chen, Josie I/AHA-3570-2022	Chen, Josie I/0000-0002-7276-5817; He, Tai-Sen/0000-0003-2780-6082	Ministry of Science and Technology of Taiwan [MOST 110-2628-H-002-009-, MOST 110-2634-F-002-045-]; Ministry of Education of Taiwan [MOE 111L900203]; Ministry of Education of Singapore (MOE Academic Research Fund Tier 1) [RG141/19]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education of Taiwan(Ministry of Education, Taiwan); Ministry of Education of Singapore (MOE Academic Research Fund Tier 1)	Chen acknowledges financial support from the Ministry of Science and Technology of Taiwan (MOST 110-2628-H-002-009- and MOST 110-2634-F-002-045-) and the Ministry of Education of Taiwan (MOE 111L900203). He acknowledges financial support from the Ministry of Education of Singapore (MOE Academic Research Fund Tier 1 RG141/19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLE W, 1979, J PERS SOC PSYCHOL, V37, P715, DOI 10.1037/0022-3514.37.5.715; Benjamin DJ, 2013, J EUR ECON ASSOC, V11, P1231, DOI 10.1111/jeea.12055; Breitenstein C, 2001, COGNITION EMOTION, V15, P57, DOI 10.1080/0269993004200114; Buelow MT, 2020, CURR PSYCHOL, V39, P2129, DOI 10.1007/s12144-018-9899-2; Chen JI, 2021, J ECON PSYCHOL, V87, DOI 10.1016/j.joep.2021.102454; Chen JI, 2019, EUR ECON REV, V120, DOI 10.1016/j.euroecorev.2019.103307; Franco-Watkins AM, 2010, EXP PSYCHOL, V57, P193, DOI 10.1027/1618-3169/a000024; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Guyer JJ, 2019, PERS SOC PSYCHOL B, V45, P389, DOI 10.1177/0146167218787805; Hall JA, 2008, PERS SOC PSYCHOL B, V34, P144, DOI 10.1177/0146167207309192; He T.S., 2021, SUBTLE PRONOUN SHIFT; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; Hupp JM, 2013, J EXP CHILD PSYCHOL, V115, P536, DOI 10.1016/j.jecp.2012.12.012; Hupp JM, 2009, BRIT J DEV PSYCHOL, V27, P495, DOI 10.1348/026151008X345988; Jungers MK, 2016, MUSIC PERCEPT, V34, P33, DOI 10.1525/MP.2016.34.1.33; Kahneman D., 2011, THINKING FAST SLOW; Lindner F, 2017, J ECON PSYCHOL, V60, P53, DOI 10.1016/j.joep.2016.12.004; Loewenstein G., 2015, DECISION, P55, DOI [DOI 10.1037/DEC0000029, 10.1037/dec0000029]; Olschewski S, 2018, J EXP PSYCHOL GEN, V147, P462, DOI 10.1037/xge0000403; Rhodes M, 2019, PSYCHOL SCI, V30, P455, DOI 10.1177/0956797618823670; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; SMITH BL, 1975, LANG SPEECH, V18, P145, DOI 10.1177/002383097501800203; Zuckerman M., 1981, ADV EXP SOC PSYCHOL, V14, P1, DOI DOI 10.1016/S0065-2601(08)60369-X	24	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264356	10.1371/journal.pone.0264356	http://dx.doi.org/10.1371/journal.pone.0264356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213622	Green Published, gold			2022-12-26	WOS:000787811000081
J	Espada-Hinojosa, S; Drexel, J; Kesting, J; Kniha, E; Pifeas, I; Schuster, L; Volland, JM; Zambalos, HC; Bright, M				Espada-Hinojosa, Salvador; Drexel, Judith; Kesting, Julia; Kniha, Edwin; Pifeas, Iason; Schuster, Lukas; Volland, Jean-Marie; Zambalos, Helena C.; Bright, Monika			Host-symbiont stress response to lack-of-sulfide in the giant ciliate mutualism	PLOS ONE			English	Article							ZOOTHAMNIUM NIVEUM HEMPRICH; 1838 OLIGOHYMENOPHORA; PERITRICH CILIATE; HYDROGEN-SULFIDE; CELLS; ADAPTATIONS; LUCINIDAE; EHRENBERG; BIVALVIA; GROWTH	The mutualism between the thioautotrophic bacterial ectosymbiont Candidatus Thiobius zoothamnicola and the giant ciliate Zoothamnium niveum thrives in a variety of shallow-water marine environments with highly fluctuating sulfide emissions. To persist over time,both partners must reproduce and ensure the transmission of symbionts before the sulfide stops, which enables carbon fixation of the symbiont and nourishment of the host. We experimentally investigated the response of this mutualism to depletion of sulfide. We found that colonies released some initially present but also newly produced macrozooids until death, but in fewer numbers than when exposed to sulfide. The symbionts on the colonies proliferated less without sulfide, and became larger and more rod-shaped than symbionts from freshly collected colonies that were exposed to sulfide and oxygen. The symbiotic monolayer was severely disturbed by growth of other microbes and loss of symbionts. We conclude that the response of both partners to the termination of sulfide emission was remarkably quick. The development and the release of swarmers continued until host died and thus this behavior contributed to the continuation of the association.	[Espada-Hinojosa, Salvador; Drexel, Judith; Kesting, Julia; Kniha, Edwin; Pifeas, Iason; Schuster, Lukas; Volland, Jean-Marie; Zambalos, Helena C.; Bright, Monika] Univ Vienna, Dept Funct & Evolutionary Ecol, Vienna, Austria; [Kniha, Edwin] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Schuster, Lukas] Monash Univ, Ctr Geometr Biol, Sch Biol Sci, Melbourne, Vic, Australia; [Volland, Jean-Marie] DOE JGI LRC Syst, Menlo Pk, CA USA	University of Vienna; Medical University of Vienna; Monash University	Espada-Hinojosa, S (corresponding author), Univ Vienna, Dept Funct & Evolutionary Ecol, Vienna, Austria.	salvador.espada@univie.ac.at		Volland, Jean-Marie/0000-0002-8716-2728; Espada-Hinojosa, Salvador/0000-0001-9569-409X	Austrian Science Fund projects [FWF P24565 B22, FWF 32197]	Austrian Science Fund projects(Austrian Science Fund (FWF))	Funding came from two Austrian Science Fund projects FWF P24565 B22 and FWF 32197 granted to MB. (https://www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; BauerNebelsick M, 1996, EUR J PROTISTOL, V32, P18, DOI 10.1016/S0932-4739(96)80036-8; BauerNebelsick M, 1996, EUR J PROTISTOL, V32, P202, DOI 10.1016/S0932-4739(96)80020-4; Bright M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51511-3; Bright M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00145; Bright M, 2010, OCEANOGR MAR BIOL, V48, P213; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Brissac T, 2009, FEMS MICROBIOL ECOL, V67, P261, DOI 10.1111/j.1574-6941.2008.00626.x; Bronstein JL, 2015, MUTUALISM, P1, DOI 10.1093/acprof:oso/9780199675654.001.0001; Caro A, 2009, APPL ENVIRON MICROB, V75, P3304, DOI 10.1128/AEM.02659-08; Cavanaugh CM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P475, DOI 10.1007/0-387-30741-9_18; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Douglas AE., 2010, SYMBIOTIC HABIT; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Elisabeth NH, 2012, MICROSC RES TECHNIQ, V75, P1136, DOI 10.1002/jemt.22041; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Grimonprez A, 2018, EUR J PROTISTOL, V62, P43, DOI 10.1016/j.ejop.2017.11.002; HAGSTROM A, 1979, APPL ENVIRON MICROB, V37, P805; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jorgensen B. B, 2006, MARINE GEOCHEMISTRY, P271, DOI DOI 10.1007/3-540-32144-6_8; Kadar E, 2005, J EXP MAR BIOL ECOL, V318, P99, DOI 10.1016/j.jembe.2004.12.025; Klose Julia, 2015, Proc Natl Acad Sci U S A, V112, P11300, DOI 10.1073/pnas.1501160112; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; MILLERO FJ, 1988, LIMNOL OCEANOGR, V33, P269, DOI 10.4319/lo.1988.33.2.0269; Oren Aharon, 2017, Int J Syst Evol Microbiol, V67, P1085, DOI 10.1099/ijsem.0.001715; Ott J, 2004, OCEANOGR MAR BIOL, V42, P95; Ott J., 2004, ATOLL RES BULL, V516, P1, DOI [10.5479/si.00775630.516.1, DOI 10.5479/SI.00775630.516.1]; Ott JA, 1998, MAR ECOL-P S Z N I, V19, P229, DOI 10.1111/j.1439-0485.1998.tb00464.x; Paredes GF, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.01186-20; Rinke C, 2006, APPL ENVIRON MICROB, V72, P2014, DOI 10.1128/AEM.72.3.2014-2021.2006; Rinke C, 2007, P ROY SOC B-BIOL SCI, V274, P2259, DOI 10.1098/rspb.2007.0631; Roy H, 2009, MAR BIOL, V156, P669, DOI 10.1007/s00227-008-1117-6; Schuster L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162834; Stewart FJ, 2005, TRENDS MICROBIOL, V13, P439, DOI 10.1016/j.tim.2005.07.007; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; TRUMP BF, 1966, LAB INVEST, V15, P368; Van Dover CL., 2000, ECOLOGY DEEP SEA HYD, P397, DOI [10.1038/35025044, DOI 10.1038/35025044]; VANVEEN JA, 1979, APPL ENVIRON MICROB, V37, P686, DOI 10.1128/AEM.37.4.686-692.1979; Volland JM, 2018, ISME J, V12, P714, DOI 10.1038/s41396-018-0069-1; Vopel K, 2002, AQUAT MICROB ECOL, V29, P19, DOI 10.3354/ame029019; Vopel K, 2005, LIMNOL OCEANOGR, V50, P128, DOI 10.4319/lo.2005.50.1.0128; Vopel K, 2001, MAR ECOL PROG SER, V210, P93, DOI 10.3354/meps210093; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205	45	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0254910	10.1371/journal.pone.0254910	http://dx.doi.org/10.1371/journal.pone.0254910			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213532	Green Published, Green Submitted, gold			2022-12-26	WOS:000787811000002
J	Jariyapan, N; Tippawangkosol, P; Sor-Suwan, S; Mano, C; Yasanga, T; Somboon, P; Depaquit, J; Siriyasatien, P				Jariyapan, Narissara; Tippawangkosol, Pongsri; Sor-Suwan, Sriwatapron; Mano, Chonlada; Yasanga, Thippawan; Somboon, Pradya; Depaquit, Jerome; Siriyasatien, Padet			Significance of eggshell morphology as an additional tool to distinguish species of sand flies (Diptera: Psychodidae: Phlebotominae)	PLOS ONE			English	Article							LUTZOMYIA NYSSOMYIA INTERMEDIA; IMMATURE STAGES; VECTORS; SANDFLIES; DIPTERAPSYCHODIDAE; ULTRASTRUCTURE; IDENTIFICATION; CRUCIATA; PATTERNS; SPP.	Morphological characteristics of eggshells are important in sand fly ootaxonomy. In this study, eggshells from Phlebotomus stantoni Newstead, Sergentomyia khawi (Raynal), and Grassomyia indica (Theodor) sand flies collected in Chiang Mai province, Thailand were examined and characterized using light microscopy (LM) and scanning electron microscopy (SEM). Then, eggshell morphology of these three species was described for the first time. Each gravid female was forced to lay eggs by decapitation and the eggs were collected for SEM analysis. Egg laying females were identified by morphological examination and molecular typing using cytochrome b (CA) as a molecular marker. The chorionic sculpturing of Ph. stantoni eggs combines two patterns on the same egg: unconnected parallel ridges and reticular patterns. Sergentomyia khawi and Gr. indica have similar chorionic polygonal patterns, but their exochorionic morphology and aeropylar area are different. Results indicate that eggshell morphological characteristics such as chorionic pattern, exochorionic morphology, inter-ridge/boundary area, aeropylar area (including the number of aeropyles) and basal layer, can be useful to develop morphological identification keys of eggs. These can serve as an additional tool to distinguish species of sand flies. In addition, the chorionic sculpturing of the eggs of the three species of sand flies observed by LM is useful for species identification in gravid females with spermathecae obscured by eggs.	[Jariyapan, Narissara; Sor-Suwan, Sriwatapron; Siriyasatien, Padet] Chulalongkorn Univ, Fac Med, Dept Parasitol, Bangkok, Thailand; [Jariyapan, Narissara; Sor-Suwan, Sriwatapron; Siriyasatien, Padet] Chulalongkorn Univ, Fac Med, Dept Parasitol, Vector Biol & Vector Borne Dis Res Unit, Bangkok, Thailand; [Tippawangkosol, Pongsri; Mano, Chonlada; Somboon, Pradya] Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai, Thailand; [Yasanga, Thippawan] Chiang Mai Univ, Fac Med, Med Sci Res Equipment Ctr, Chiang Mai, Thailand; [Depaquit, Jerome] Univ Reims, Fac Pharm, EA7510 ESCAPE USC ANSES VECPAR, SFR Cap Sante, Reims, France	Chulalongkorn University; Chulalongkorn University; Chiang Mai University; Chiang Mai University; Universite de Reims Champagne-Ardenne	Jariyapan, N (corresponding author), Chulalongkorn Univ, Fac Med, Dept Parasitol, Bangkok, Thailand.; Jariyapan, N (corresponding author), Chulalongkorn Univ, Fac Med, Dept Parasitol, Vector Biol & Vector Borne Dis Res Unit, Bangkok, Thailand.; Somboon, P (corresponding author), Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai, Thailand.	narissara.j@chula.ac.th; pradya.somboon@cmu.ac.th		Siriyasatien, Padet/0000-0002-9248-1678; Depaquit, Jerome/0000-0001-6995-0088	Program Management Unit for Human Resources & Institutional Development, Research and Innovation - Chulalongkorn University [B16F630071]; Thailand Science Research and Innovation (TSRI) Fund [CU_FRB640001_01_30_1]; Faculty of Medicine, Chiang Mai University [021-2563]	Program Management Unit for Human Resources & Institutional Development, Research and Innovation - Chulalongkorn University; Thailand Science Research and Innovation (TSRI) Fund; Faculty of Medicine, Chiang Mai University	This work was supported by the Program Management Unit for Human Resources & Institutional Development, Research and Innovation - Chulalongkorn University [grant number B16F630071] received by NJ; the Thailand Science Research and Innovation (TSRI) Fund [grant number CU_FRB640001_01_30_1] received by NJ, https://www.chula.ac.th/en/, and https:// www.tsri.or.th/; and the Faculty of Medicine, Chiang Mai University [grant number 021-2563] received by PT, https://www.med.cmu.ac.th. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar RB, 2018, NEOTROP ENTOMOL, V47, P668, DOI 10.1007/s13744-018-0587-6; Alencar RB, 2018, ACTA TROP, V187, P182, DOI 10.1016/j.actatropica.2018.07.023; Bahia AC, 2007, J MED ENTOMOL, V44, P903, DOI 10.1603/0022-2585(2007)44[903:UCOEMO]2.0.CO;2; Castillo A, 2015, MED VET ENTOMOL, V29, P393, DOI 10.1111/mve.12127; Chusri S, 2014, SE ASIAN J TROP MED, V45, P13; Pessoa FAC, 2008, ZOOTAXA, P1; Costa Wagner Alexandre, 2012, Revista Pan-Amazonica de Saude, V3, P19; De Almeida DN, 2004, J MED ENTOMOL, V41, P819, DOI 10.1603/0022-2585-41.5.819; Depaquit J, 2019, MED VET ENTOMOL, V33, P521, DOI 10.1111/mve.12393; Depaquit J, 2015, MED VET ENTOMOL, V29, P159, DOI 10.1111/mve.12098; ENDRIS RG, 1987, J MED ENTOMOL, V24, P412, DOI 10.1093/jmedent/24.4.412; Esseghir S, 1997, INSECT MOL BIOL, V6, P211, DOI 10.1046/j.1365-2583.1997.00175.x; Fausto A.M., 1991, Parassitologia (Rome), V33, P225; FAUSTO AM, 1992, MED VET ENTOMOL, V6, P201, DOI 10.1111/j.1365-2915.1992.tb00607.x; Fausto AM, 2001, MEM I OSWALDO CRUZ, V96, P197, DOI 10.1590/S0074-02762001000200011; FELICIANGELI MD, 1993, J MED ENTOMOL, V30, P651, DOI 10.1093/jmedent/30.4.651; Galati E.A.B., 2018, BRAZILIAN SAND FLIES, P9, DOI [10.1007/978, 10.1007/978-3-319-75544-1_2]; Gebre-Michael T., 1991, Parassitologia (Rome), V33, P261; Ghosh KN, 1996, PARASITE, V3, P61, DOI 10.1051/parasite/1996031061; IRUNGU LW, 1986, INSECT SCI APPL, V7, P45, DOI 10.1017/S174275840000309X; Jeffries Claire L, 2018, Wellcome Open Res, V3, P55, DOI 10.12688/wellcomeopenres.14555.2; Kanjanopas K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-333; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lewis D.J., 1978, BULLETIN OF THE BRITISH MUSEUM (NATURAL HISTORY) ENTOMOLOGY SUPPLEMENT, V37, P217; LEWIS DJ, 1987, SYST ENTOMOL, V12, P163, DOI 10.1111/j.1365-3113.1987.tb00194.x; Marialva EF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242163; De Oca-Aguilar ACM, 2017, NEOTROP ENTOMOL, V46, P66, DOI 10.1007/s13744-016-0439-1; Noguera Pedro, 2003, Parasitologia Latinoamericana, V58, P49; Perez JE, 1997, MED VET ENTOMOL, V11, P127, DOI 10.1111/j.1365-2915.1997.tb00301.x; Phumee A, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-05047-z; Phumee A, 2021, T ROY SOC TROP MED H, V115, P1039, DOI 10.1093/trstmh/traa203; Phumee A, 2017, J MED ENTOMOL, V54, P429, DOI 10.1093/jme/tjw161; Phuphisut O, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-04856-6; Polseela R, 2015, SE ASIAN J TROP MED, V46, P425; ROGO LM, 1992, J MED ENTOMOL, V29, P1042, DOI 10.1093/jmedent/29.6.1042; Sierra D, 2000, REV BIOL TROP, V48, P615; Sor-suwan S, 2017, TROP BIOMED, V34, P855; Srisuton P, 2019, INSECTS, V10, DOI 10.3390/insects10080238; Sriwongpan P, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009545; Tyagi V, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1478-5; WARD RD, 1975, J ENTOMOL SER A, V50, P127; ZIMMERMAN JH, 1977, J MED ENTOMOL, V13, P574, DOI 10.1093/jmedent/13.4-5.574	42	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263268	10.1371/journal.pone.0263268	http://dx.doi.org/10.1371/journal.pone.0263268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213563	Green Published, gold			2022-12-26	WOS:000787811000018
J	de Assis, TSM; Freire, ML; Carvalho, JD; Rabello, A; Cota, G				Machado de Assis, Talia Santana; Freire, Mariana Lourenco; Carvalho, Janaina de Pina; Rabello, Ana; Cota, Glaucia			Cost-effectiveness of anti-SARS-CoV-2 antibody diagnostic tests in Brazil	PLOS ONE			English	Article								Background Although serologic tests for COVID-19 diagnosis are rarely indicated nowadays, they remain commercially available and widely used in Brazil. The objective of this study was to evaluate the cost-effectiveness of anti-SARS-CoV-2antibody diagnostic tests for COVID-19 in Brazil. Methods Eleven commercially available diagnostic tests, comprising five lateral-flow immunochromatographic assays (LFAs) and six immunoenzymatic assays (ELISA) were analyzed from the perspective of the Brazilian Unified Health System. Results The direct costs of LFAs ranged from US$ 11.42 to US$ 17.41and of ELISAs, from US$ 6.59 to US$ 10.31. Considering an estimated disease prevalence between 5% and 10%, the anti-SARS-CoV-2 ELISA (IgG) was the most cost-effective test, followed by the rapid One Step COVID-19 Test, at an incremental cost-effectiveness ratio of US$ 2.52 and US$ 1.26 per properly diagnosed case, respectively. Considering only the LFAs, at the same prevalence estimates, two tests, the COVID-19 IgG/IgM and the One Step COVID-19 Test, showed high effectiveness at similar costs. For situations where the estimated probability of disease is 50%, the LFAs are more costly and less effective alternatives. Conclusions Nowadays there are few indications for the use of serologic tests in the diagnosis of COVID-19 and numerous commercially available tests, with marked differences are observed among them. In general, LFA tests are more cost-effective for estimated low-COVID-19-prevalences, while ELISAs are more cost-effective for high-pretest-probability scenarios.	[Machado de Assis, Talia Santana] Ctr Fed Educ Tecnol Minas Gerais, Contagem, MG, Brazil; [Machado de Assis, Talia Santana; Freire, Mariana Lourenco; Carvalho, Janaina de Pina; Rabello, Ana; Cota, Glaucia] Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infectoparasit, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	de Assis, TSM (corresponding author), Ctr Fed Educ Tecnol Minas Gerais, Contagem, MG, Brazil.; de Assis, TSM (corresponding author), Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infectoparasit, Belo Horizonte, MG, Brazil.	talia@cefetmg.br		Freire, Mariana Lourenco/0000-0003-3380-2651; Carvalho, Janaina/0000-0002-0875-3600	Centro Federal de Educacao Tecnologica de Minas Gerais (CEFET-MG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [310938/2017-1, 301384/2019-3]	Centro Federal de Educacao Tecnologica de Minas Gerais (CEFET-MG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Centro Federal de Educacao Tecnologica de Minas Gerais (CEFET-MG) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Ana Rabello grant number 310938/2017-1, Gla ' ucia Cota grant number 301384/2019-3.	[Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, SISTEMA GERENCIAMENT; [Anonymous], 2009, DIRETRIZES METODOL G; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Brasil. Ministerio da Saude do Brasil, 2020, PAINEL CASOS DOENCA; Cota G, 2020, INT J INFECT DIS, V101, P382, DOI 10.1016/j.ijid.2020.10.008; De Soarez PC, 2017, CAD SAUDE PUBLICA, V33, DOI 10.1590/0102-311X00040717; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Frick KD, 2009, MED CARE, V47, pS76, DOI 10.1097/MLR.0b013e31819bc064; Girdwood S, QUANTIFYING RAPID AN; Grassly NC, 2020, LANCET INFECT DIS, V20, P1381, DOI 10.1016/S1473-3099(20)30630-7; Gronvall G., 2020, DEVELOPING NATL STRA, V1, P1; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Instituto Brasileiro de Geografia e Estatistica, 2019, PESQUISA NACL SAUDE; Instituto de Pesquisa Economica Aplicada, 2020, TAXA CAMBIO COMERCIA; Larremore DB, 2021, SCI ADV, V7, DOI [10.1101/2020.06.22.20136309, 10.1126/sciadv.abd5393]; Lee K, 2009, GLOB INST, P1; Lim KL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238417; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117; Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633; Neilan AM, 2020, CLIN INFECT DIS, V18, P1; Pichon-Riviere A, 2017, VALUE HEALTH, V20, pA858, DOI 10.1016/j.jval.2017.08.2466; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; University of Oxford, 2020, COVID 19 CORONAVIRUS; Wontakal Sandeep N, 2021, Open Forum Infect Dis, V8, pofab144, DOI 10.1093/ofid/ofab144	25	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264159	10.1371/journal.pone.0264159	http://dx.doi.org/10.1371/journal.pone.0264159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213578	Green Published, gold			2022-12-26	WOS:000787811000055
J	Nakamura, M; Tsuda, N; Miyata, T; Ikenaga, M				Nakamura, Masayuki; Tsuda, Naoaki; Miyata, Takeshi; Ikenaga, Makoto			Antimicrobial effect and mechanism of bovine lactoferrin against the potato common scab pathogen Streptomyces scabiei	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; IRON-BINDING PROTEIN; ANTIBACTERIAL ACTIVITY; IN-VITRO; ESCHERICHIA-COLI; CANDIDA-ALBICANS; OUTER-MEMBRANE; TEICHOIC-ACIDS; HUMAN-MILK; PEPTIDES	Lactoferrin (LF) is a multifunctional protein with a broad spectrum of antimicrobial activities. In this study, we investigated the antimicrobial activity of LF against the potato common scab pathogen Streptomyces scabiei, which causes severe damage to potato tubers. LF derived from bovine (bLF) had much higher activity against S. scabiei than human LF. The minimal inhibitory concentration of bLF was 3.9 mu M. The effects of both apo-bLF (iron-free) and holo-bLF (iron-saturated) on S. scabiei were not different. Bovine lactoferricin (LFcinB), a short peptide with a length of 25 amino acid residues located in the N-terminal region of bLF, showed antimicrobial activity against S. scabiei, similar to that of bLF. These results indicated that the antimicrobial activity of bLF against S. scabiei cannot be attributed to its iron-chelating effect but to the bioactivity of its peptides. When S. scabiei was treated with the fusion protein of mCherry-LFcinB (red fluorescent protein) expressed in Escherichia colt, the pseudohyphal cells instantly glowed, indicating that the peptide electrostatically binds to the surface of S. scabiei. An assay of synthetic peptides, with modified number of arginine (Arg) and tryptophan (Trp) residues based on the antimicrobial center (RRWQWR) of LFcinB showed that Trp residues are implicated in the antimicrobial activity against S. scabiei; however, Arg residues are also necessary to carry Trp residues to the cell surface to fully exert its activity. Although the single amino acid effect of Trp had low activity, Trp derivatives showed much higher activity against S. scabiei, suggesting that the derivatives effectively bind to the cell surface (cell membrane) by themselves without a carrier. Thus, amino acid derivatives might be considered effective and alternative antimicrobial substances.	[Nakamura, Masayuki; Tsuda, Naoaki; Miyata, Takeshi; Ikenaga, Makoto] Kagoshima Univ, Fac Agr, Kagoshima, Japan	Kagoshima University	Nakamura, M (corresponding author), Kagoshima Univ, Fac Agr, Kagoshima, Japan.	masa@agri.kagoshima-u.ac.jp						Bai XJ, 2010, BIOMETALS, V23, P431, DOI 10.1007/s10534-010-9300-x; Bechinger B, 2017, J DENT RES, V96, P254, DOI 10.1177/0022034516679973; BELLAMY W, 1993, MED MICROBIOL IMMUN, V182, P97, DOI 10.1007/BF00189377; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Berlov MN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P445, DOI 10.1134/S0006297907040128; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Bocchinfuso G, 2009, J PEPT SCI, V15, P550, DOI 10.1002/psc.1144; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Campione E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182010985; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chang CK, 2021, J FUNGI, V7, DOI 10.3390/jof7070519; Cirioni O, 2000, J ANTIMICROB CHEMOTH, V46, P577, DOI 10.1093/jac/46.4.577; Huertas ND, 2017, MOLECULES, V22, DOI 10.3390/molecules22060987; ELLISON RT, 1991, J CLIN INVEST, V88, P1080, DOI 10.1172/JCI115407; Embleton ND, 2020, NESTLE NUTR WORKS SE, V94, P141, DOI 10.1159/000505334; Farnaud S, 2003, MOL IMMUNOL, V40, P395, DOI 10.1016/S0161-5890(03)00152-4; Flores-Villasenor H, 2010, BIOMETALS, V23, P569, DOI 10.1007/s10534-010-9306-4; Frontera LS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36563-1; Goyer C, 1997, PLANT DIS, V81, P901, DOI 10.1094/PDIS.1997.81.8.901; Groenink J, 1999, FEMS MICROBIOL LETT, V179, P217, DOI 10.1016/S0378-1097(99)00414-0; Han JG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-33; Harouna S, 2015, FOOD CONTROL, V47, P520, DOI 10.1016/j.foodcont.2014.07.061; Hossain F, 2021, J BACTERIOL, V203, DOI 10.1128/JB.00021-21; Hwang PM, 1998, BIOCHEMISTRY-US, V37, P4288, DOI 10.1021/bi972323m; Kang JH, 1996, INT J PEPT PROT RES, V48, P357; Kim WS, 2016, KOREAN J FOOD SCI AN, V36, P487, DOI 10.5851/kosfa.2016.36.4.487; Kontro M, 2005, LETT APPL MICROBIOL, V41, P32, DOI 10.1111/j.1472-765X.2005.01727.x; Kuipers ME, 1999, ANTIMICROB AGENTS CH, V43, P2635, DOI 10.1128/AAC.43.11.2635; Kuwata H, 1998, BIOCHEM BIOPH RES CO, V245, P764, DOI 10.1006/bbrc.1998.8466; Latrova K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89883-0; LEGRAND D, 1990, BIOCHEM J, V266, P575; Liepke C, 2002, EUR J BIOCHEM, V269, P712, DOI 10.1046/j.0014-2956.2001.02712.x; Loria R, 1997, PLANT DIS, V81, P836, DOI 10.1094/PDIS.1997.81.8.836; Lu J, 2021, CHEMBIOCHEM, V22, P2124, DOI 10.1002/cbic.202100016; Luna-Castro S, 2014, BIOMETALS, V27, P891, DOI 10.1007/s10534-014-9752-5; MASSON PL, 1966, CLIN CHIM ACTA, V14, P735, DOI 10.1016/0009-8981(66)90004-0; MASSON PL, 1969, J EXP MED, V130, P643, DOI 10.1084/jem.130.3.643; Miotto M, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.607443; Murphy ME, 2000, ARCH VIROL, V145, P1571, DOI 10.1007/s007050070077; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nibbering PH, 2001, INFECT IMMUN, V69, P1469, DOI 10.1128/IAI.69.3.1469-1476.2001; Nishi Y., 2015, Japanese Journal of Phytopathology, V81, P22, DOI 10.3186/jjphytopath.81.22; Omata Y, 2001, J VET MED SCI, V63, P187, DOI 10.1292/jvms.63.187; Orsi N, 2004, BIOMETALS, V17, P189, DOI 10.1023/B:BIOM.0000027691.86757.e2; Pietrantoni A, 2006, ANTIVIR RES, V69, P98, DOI 10.1016/j.antiviral.2005.10.006; Qin HL, 2020, EUR J MED CHEM, V194, DOI 10.1016/j.ejmech.2020.112245; Ramamourthy G, 2021, BIOCHEM CELL BIOL, V99, P138, DOI 10.1139/bcb-2020-0253; ROGERS HJ, 1978, IMMUNOLOGY, V34, P19; Romo TD, 2011, BBA-BIOMEMBRANES, V1808, P2019, DOI 10.1016/j.bbamem.2011.03.017; Salaris C, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020328; Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525; Sepahi M, 2017, IRAN J MICROBIOL, V9, P103; Shestakov A, 2012, ANTIVIR RES, V93, P340, DOI 10.1016/j.antiviral.2012.01.003; Sijbrandij T, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-016-2171-8; Strom MB, 2000, J PEPT RES, V56, P265, DOI 10.1034/j.1399-3011.2000.00770.x; Superti F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010051; TOMITA M, 1991, J DAIRY SCI, V74, P4137, DOI 10.3168/jds.S0022-0302(91)78608-6; Tomita Mamoru, 1994, Acta Paediatrica Japonica, V36, P585; Ueta E, 2001, J PEPT RES, V57, P240, DOI 10.1111/j.1399-3011.2001.00821.x; Ulvatne H, 2004, FEMS MICROBIOL LETT, V237, P377, DOI 10.1016/j.femsle.2004.07.001; Umeyama M, 2006, BBA-BIOMEMBRANES, V1758, P1523, DOI 10.1016/j.bbamem.2006.06.014; van der Kraan MIA, 2005, PEPTIDES, V26, P1537, DOI 10.1016/j.peptides.2005.02.011; van der Kraan MIA, 2004, PEPTIDES, V25, P177, DOI 10.1016/j.peptides.2003.12.006; Vega SC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00329; Wang J, 2013, PESTIC BIOCHEM PHYS, V105, P62, DOI 10.1016/j.pestbp.2012.11.009; Wang XY, 2013, J DAIRY SCI, V96, P33, DOI 10.3168/jds.2012-5692	66	2	2	8	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264094	10.1371/journal.pone.0264094	http://dx.doi.org/10.1371/journal.pone.0264094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213576	gold, Green Published			2022-12-26	WOS:000787811000047
J	Ntontis, E; Vestergren, S; Saavedra, P; Neville, F; Jurstakova, K; Cocking, C; Lay, S; Drury, J; Stott, C; Reicher, S; Vignoles, VL				Ntontis, Evangelos; Vestergren, Sara; Saavedra, Patricio; Neville, Fergus; Jurstakova, Klara; Cocking, Chris; Lay, Siugmin; Drury, John; Stott, Clifford; Reicher, Stephen; Vignoles, Vivian L.			Is it really "panic buying"? Public perceptions and experiences of extra buying at the onset of the COVID-19 pandemic	PLOS ONE			English	Article							PREPAREDNESS	Shopping behaviour in response to extreme events is often characterized as "panic buying" which connotes irrationality and loss of control. However, "panic buying" has been criticized for attributing shopping behaviour to people's alleged psychological frailty while ignoring other psychological and structural factors that might be at play. We report a qualitative exploration of the experiences and understandings of shopping behaviour of members of the public at the onset of the COVID-19 pandemic. Through a thematic analysis of semi-structured interviews with 23 participants, we developed three themes. The first theme addresses people's understandings of "panic buying". When participants referred to "panic buying" they meant observed product shortages (rather than the underlying psychological processes that can lead to such behaviours), preparedness behaviours, or emotions such as fear and worry. The second theme focuses on the influence of the media and other people's behaviour in shaping subsequent shopping behaviours. The third theme addresses the meaningful motivations behind increased shopping, which participants described in terms of preparedness; some participants reported increased shopping behaviours as a response to other people stockpiling, to reduce their trips to supermarkets, or to prepare for product shortages and longer stays at home. Overall, despite frequently using the term 'panic', the irrationalist connotations of "panic buying" were largely absent from participants' accounts. Thus, "panic buying" is not a useful concept and should not be used as it constructs expected responses to threat as irrational or pathological. It can also facilitate such behaviours, creating a self-fulfilling prophecy.	[Ntontis, Evangelos] Open Univ, Sch Psychol & Counselling, Milton Keynes, Bucks, England; [Ntontis, Evangelos; Jurstakova, Klara] Canterbury Christ Church Univ, Sch Psychol & Life Sci, Canterbury, Kent, England; [Vestergren, Sara; Stott, Clifford] Keele Univ, Sch Psychol, Keele, Staffs, England; [Saavedra, Patricio] Univ OHiggins, Inst Ciencias Sociales, Rancagua, Chile; [Neville, Fergus] Univ St Andrews, Sch Management, St Andrews, Fife, Scotland; [Cocking, Chris] Univ Brighton, Sch Humanities & Appl Social Sci, Brighton, E Sussex, England; [Lay, Siugmin] Pontificia Univ Catolica Chile, Ctr Medicion Mide UC, Santiago, Chile; [Drury, John; Vignoles, Vivian L.] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Reicher, Stephen] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	Open University - UK; Canterbury Christ Church University; Keele University; Universidad de O'Higgins; University of St Andrews; University of Brighton; Pontificia Universidad Catolica de Chile; University of Sussex; University of St Andrews	Ntontis, E (corresponding author), Open Univ, Sch Psychol & Counselling, Milton Keynes, Bucks, England.; Ntontis, E (corresponding author), Canterbury Christ Church Univ, Sch Psychol & Life Sci, Canterbury, Kent, England.	evangelos.ntontis@open.ac.uk	; Drury, John/A-6479-2012	Ntontis, Evangelos/0000-0001-8284-6015; Neville, Fergus/0000-0001-7377-4507; Jurstakova, Klara/0000-0002-6212-3140; Vestergren, Sara/0000-0003-0514-6749; Lay, Siugmin/0000-0001-7800-1554; Drury, John/0000-0002-7748-5128	QR seed grant by the School of Psychology and Life Sciences at Canterbury Christ Church University; UKRI grant [ES/V005383/1]	QR seed grant by the School of Psychology and Life Sciences at Canterbury Christ Church University; UKRI grant(UK Research & Innovation (UKRI))	The research presented here was supported by a QR seed grant by the School of Psychology and Life Sciences at Canterbury Christ Church University awarded to Evangelos Ntontis, and by a UKRI grant awarded to John Drury, Clifford Stott, Stephen Reicher, Fergus Neville and Evangelos Ntontis (ES/V005383/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N., 2014, EFFECTS NATURAL DISA; Bentall RP, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246339; Braun V, 2021, QUAL RES PSYCHOL, V18, P328, DOI 10.1080/14780887.2020.1769238; Clarke L., 2002, CONTEXTS, V1, P21, DOI [10.1016/s0035-9203(02)90320-2, DOI 10.1016/S0035-9203(02)90320-2]; Dammeyer J, 2020, PERS INDIV DIFFER, V167, DOI 10.1016/j.paid.2020.110263; Dodgson L., 2020, THE INSIDER; Drury J, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00141; Fahy RF, 2012, FIRE MATER, V36, P328, DOI 10.1002/fam.1083; FRITZ CE, 1957, ANN AM ACAD POLIT SS, V309, P42, DOI 10.1177/000271625730900107; Glisczinski D, 2018, J TRANSFORM EDUC, V16, P175, DOI 10.1177/1541344618777367; Hall MC, 2021, J SERV MANAGE, V32, P113, DOI 10.1108/JOSM-05-2020-0151; Hansman C., 2020, NBER WORKING PAPER N; Henry D., 2020, NZ HERALD; IRI, 2020, COVID 19 IMPACT CONS; Kantar World Panel, 2020, ACCIDENTAL STOCKPILE; Kohn S, 2012, DISASTER MED PUBLIC, V6, P217, DOI 10.1001/dmp.2012.47; Kostev K, 2020, J PSYCHIATR RES, V130, P19, DOI 10.1016/j.jpsychires.2020.07.005; Krueger JI, 2020, EUR REV SOC PSYCHOL, V31, P222, DOI 10.1080/10463283.2020.1778249; Kurihara S., 2012, FOOD RES INT, V18, P415, DOI [10.5874/jfsr.18.415, DOI 10.5874/JFSR.18.415]; Le Bon G., 1895, NORMAN S BERG; Lewis H., 2020, ATLANTIC 0319; Lins S, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04746; Loxton M, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13080166; Lufkin B., 2020, BBC; Manettas G., 2020, ETHNOS; Murphy S., 2020, SCOTSMAN; Nicholson R., 2020, EXPRESS; Paek HJ, 2010, J HEALTH COMMUN, V15, P428, DOI 10.1080/10810731003753083; Pan X., 2019, SSRN J, P1, DOI [10.2139/ssrn.3309457, DOI 10.2139/SSRN.3309457]; Prentice C, 2022, INT J CONSUM STUD, V46, P132, DOI 10.1111/ijcs.12649; Prentice C, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102203; Sim K, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.113015; Sime J., 1990, FIRES HUMAN BEHAV, P63; Sterman JD, 2015, J OPER MANAG, V39-40, P6, DOI 10.1016/j.jom.2015.07.002; Stiff C., 2020, CONVERSATION; Stott C, 2017, PUBLIC UNDERST SCI, V26, P2, DOI 10.1177/0963662516639872; Taylor, 2020, CNBC; Taylor S, 2021, J ANXIETY DISORD, V78, DOI 10.1016/j.janxdis.2021.102364; Wilkens J., 2020, SAN DIEGO UNION TRIB; Yuen KF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103513; Zheng R, 2021, OMEGA-INT J MANAGE S, V101, DOI 10.1016/j.omega.2020.102238	41	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264618	10.1371/journal.pone.0264618	http://dx.doi.org/10.1371/journal.pone.0264618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213639	Green Published, Green Accepted, gold			2022-12-26	WOS:000787811000130
J	Turdo, A; Gaggianesi, M; Di Franco, S; Veschi, V; D'Accardo, C; Porcelli, G; Lo Iacono, M; Pillitteri, I; Verona, F; Militello, G; Zippo, A; Poli, V; Fagnocchi, L; Beyes, S; Stella, S; Lattanzio, R; Faldetta, N; Lentini, VL; Porcasi, R; Pistone, G; Bongiorno, MR; Stassi, G; De Maria, R; Todaro, M				Turdo, Alice; Gaggianesi, Miriam; Di Franco, Simone; Veschi, Veronica; D'Accardo, Caterina; Porcelli, Gaetana; Lo Iacono, Melania; Pillitteri, Irene; Verona, Francesco; Militello, Gabriella; Zippo, Alessio; Poli, Vittoria; Fagnocchi, Luca; Beyes, Sven; Stella, Stefania; Lattanzio, Rossano; Faldetta, Naida; Lentini, Vincenzo L.; Porcasi, Rossana; Pistone, Giuseppe; Bongiorno, Maria Rita; Stassi, Giorgio; De Maria, Ruggero; Todaro, Matilde			Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51	ONCOGENE			English	Article							RESISTANCE; COMBINATION; PROGNOSIS; DYNAMICS; MARKER; GENES	Breast cancer (BC) is the second cause of cancer-related deceases in the worldwide female population. Despite the successful treatment advances, 25% of BC develops resistance to current therapeutic regimens, thereby remaining a major hurdle for patient management. Current therapies, targeting the molecular events underpinning the adaptive resistance, still require effort to improve BC treatment. Using BC sphere cells (BCSphCs) as a model, here we showed that BC stem-like cells express high levels of Myc, which requires the presence of the multifunctional DNA/RNA binding protein Sam68 for the DNA-damage repair. Analysis of a cohort of BC patients displayed that Sam68 is an independent negative factor correlated with the progression of the disease. Genetic inhibition of Sam68 caused a defect in PARP-induced PAR chain synthesis upon DNA-damaging insults, resulting in cell death of TNBC cells. In contrast, BC stem-like cells were able to survive due to an upregulation of Rad51. Importantly, the inhibition of Rad51 showed synthetic lethal effect with the silencing of Sam68, hampering the cell viability of patient-derived BCSphCs and stabilizing the growth of tumor xenografts, including those TNBC carrying BRCA mutation. Moreover, the analysis of Myc, Sam68 and Rad51 expression demarcated a signature of a poor outcome in a large cohort of BC patients. Thus, our findings suggest the importance of targeting Sam68-PARP1 axis and Rad51 as potential therapeutic candidates to counteract the expansion of BC cells with an aggressive phenotype.	[Turdo, Alice; D'Accardo, Caterina; Porcelli, Gaetana; Lo Iacono, Melania; Pillitteri, Irene; Verona, Francesco; Porcasi, Rossana; Pistone, Giuseppe; Bongiorno, Maria Rita; Todaro, Matilde] Univ Palermo, Dept Hlth Promot Mother & Child Care, Internal Med & Med Specialties PROMISE, Palermo, Italy; [Gaggianesi, Miriam; Di Franco, Simone; Veschi, Veronica; Militello, Gabriella; Stassi, Giorgio] Univ Palermo, Dept Surg Oncol & Stomatol Sci DICHIRONS, Palermo, Italy; [Zippo, Alessio; Poli, Vittoria; Fagnocchi, Luca; Beyes, Sven] Univ Trento, Dept Cellular Computat & Integrat Biol, Trento, Italy; [Stella, Stefania] Univ Catania, Ctr Expt Oncol & Hematol, Dept Clin & Expt Med, AOU Policlin Vittorio Emanuele, Catania, Italy; [Lattanzio, Rossano] G dAnnunzio Univ Chieti Pescara, Ctr Adv Studies & Technol Cast, Dept Innovat Technol Med & Dent, Chieti, Italy; [Faldetta, Naida; Lentini, Vincenzo L.] Villa Sofia Cervello Hosp, Palermo, Italy; [De Maria, Ruggero] Univ Cattolica Sacro Cuore, Fac Med & Chirurg, Dipartimento Med & Chirurg Traslaz, Rome, Italy; [De Maria, Ruggero] Fdn Policlin A Gemelli IRCCS, Rome, Lazio, Italy	University of Palermo; University of Palermo; University of Trento; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Catania; G d'Annunzio University of Chieti-Pescara; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Todaro, M (corresponding author), Univ Palermo, Dept Hlth Promot Mother & Child Care, Internal Med & Med Specialties PROMISE, Palermo, Italy.; De Maria, R (corresponding author), Univ Cattolica Sacro Cuore, Fac Med & Chirurg, Dipartimento Med & Chirurg Traslaz, Rome, Italy.; De Maria, R (corresponding author), Fdn Policlin A Gemelli IRCCS, Rome, Lazio, Italy.	ruggero.demaria@unicatt.it; matilde.todaro@unipa.it	Turdo, Alice/ABB-8063-2022; Fagnocchi, Luca/M-2715-2017; di franco, simone/M-3714-2019; Turdo, Alice/AIA-6591-2022	Turdo, Alice/0000-0002-6152-4903; Fagnocchi, Luca/0000-0002-9551-5474; di franco, simone/0000-0002-6217-2161; Turdo, Alice/0000-0002-6152-4903; Veschi, Veronica/0000-0002-6379-7366; GAGGIANESI, Miriam/0000-0002-7810-856X	European Union-FESR FSE, PON Ricerca e Innovazione 2014-2020 (AIM line 1); AIRC fellowship; AIRC [2018-ID. 22911, 2018-ID. 21492]; PSN2015, 6.2 project [CUP176J17000470001]	European Union-FESR FSE, PON Ricerca e Innovazione 2014-2020 (AIM line 1); AIRC fellowship(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); PSN2015, 6.2 project	The authors thank Giorgia Scalici and Antonella Loggia for their contribution to patient data management, and Francesco Cal and Dario Cricchio for statistical analysis and image editing. AT and VV are research fellows funded by European Union-FESR FSE, PON Ricerca e Innovazione 2014-2020 (AIM line 1). G.P., C.D. and F.V. are PhD students in the Molecular and Clinical Medicine program. VP is recipient of an AIRC fellowship. AZ received funding from AIRC under IG 2018-ID. 22911 project. MT received funding from AIRC under IG 2018-ID. 21492 project and from PSN2015, 6.2, CUP176J17000470001 project.	Akashi-Tanaka S, 2015, CLIN BREAST CANCER, V15, P80, DOI 10.1016/j.clbc.2014.08.003; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Benoit YD, 2017, CELL CHEM BIOL, V24, P833, DOI 10.1016/j.chembiol.2017.05.026; Bielli P, 2011, ENDOCR-RELAT CANCER, V18, pR91, DOI 10.1530/ERC-11-0041; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Busa R, 2010, NUCLEIC ACIDS RES, V38, P3005, DOI 10.1093/nar/gkq004; Byrum AK, 2019, TRENDS CELL BIOL, V29, P740, DOI 10.1016/j.tcb.2019.06.005; Caggiano C, 2019, NUCLEIC ACIDS RES, V47, P6160, DOI 10.1093/nar/gkz344; Carey JPW, 2018, CANCER RES, V78, P742, DOI 10.1158/0008-5472.CAN-17-1494; Cerrato A, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0456-2; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cruz C, 2018, ANN ONCOL, V29, P1203, DOI 10.1093/annonc/mdy099; Di Franco S, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102664; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Fagnocchi L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11903; Fu K, 2016, ELIFE, V5, DOI 10.7554/eLife.21957; Fu K, 2016, ELIFE, V5, DOI 10.7554/eLife.15018; Gaggianesi M, 2017, CANCER RES, V77, P3268, DOI 10.1158/0008-5472.CAN-16-3126; Gaytan-Cervantes J, 2017, J BIOL CHEM, V292, P13745, DOI 10.1074/jbc.M117.800318; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Golan H, 2018, STEM CELL REP, V11, P795, DOI 10.1016/j.stemcr.2018.07.010; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Harbeck N, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0122-z, 10.1038/s41572-019-0111-2]; Heijink AM, 2019, CELL REP, V28, P2345, DOI 10.1016/j.celrep.2019.07.070; Huang RX, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0150-x; Johnson SF, 2016, CELL REP, V17, P2367, DOI 10.1016/j.celrep.2016.10.077; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kollareddy M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8389; Lee JH, 2020, BLOOD ADV, V4, P2032, DOI 10.1182/bloodadvances.2019000757; Leroy B, 2014, HUM MUTAT, V35, P756, DOI 10.1002/humu.22556; Liston DR, 2017, CLIN CANCER RES, V23, P3489, DOI 10.1158/1078-0432.CCR-16-3083; Liu YJ, 2017, CLIN CANCER RES, V23, P514, DOI 10.1158/1078-0432.CCR-15-1348; Mangiapane LR, 2022, GUT, V71, P119, DOI 10.1136/gutjnl-2020-323553; Manic G, 2018, GUT, V67, P903, DOI 10.1136/gutjnl-2016-312623; McGill G, 1999, J CLIN INVEST, V104, P223, DOI 10.1172/JCI7861; Misenko SM, 2018, CELL CYCLE, V17, P881, DOI 10.1080/15384101.2018.1456295; Mitri Z, 2015, INVEST NEW DRUG, V33, P890, DOI 10.1007/s10637-015-0244-4; Pak S, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1342-5; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Piggott L, 2018, CLIN CANCER RES, V24, P2452, DOI 10.1158/1078-0432.CCR-17-1381; Poli V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03264-2; Polyak Kornelia, 2012, Cancer Cell, V22, P562, DOI 10.1016/j.ccr.2012.06.021; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; Sachs N, 2018, CELL, V172, P373, DOI 10.1016/j.cell.2017.11.010; Schnitt SJ, 2010, MODERN PATHOL, V23, pS60, DOI 10.1038/modpathol.2010.33; Siegel RL., 2020, CA-CANCER J CLIN, V70; Sniadecki M, 2020, GENES-BASEL, V11, DOI 10.3390/genes11111251; Song LB, 2010, J PATHOL, V222, P227, DOI 10.1002/path.2751; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Turdo A, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00016; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu M, 2019, INT J CLIN EXP PATHO, V12, P1; Zhang JF, 2020, BREAST CANCER RES TR, V182, P719, DOI 10.1007/s10549-020-05730-2; Zhang SP, 2019, P NATL ACAD SCI USA, V116, P1370, DOI 10.1073/pnas.1816262116; Zhu YH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03951-0	59	2	2	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2022	41	15					2196	2209		10.1038/s41388-022-02239-4	http://dx.doi.org/10.1038/s41388-022-02239-4		FEB 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J8DX	35217791	Green Published, hybrid			2022-12-26	WOS:000761867900001
J	Zulkifli, NFNM; Seok-Kian, AY; Seng, LL; Mustafa, S; Kim, YS; Shapawi, R				Zulkifli, Nor Fatin Najihah Mohamad; Seok-Kian, Annita Yong; Seng, Lim Leong; Mustafa, Saleem; Kim, Yang-Su; Shapawi, Rossita			Nutritional value of black soldier fly (Hermetia illucens) larvae processed by different methods	PLOS ONE			English	Article							PRE-PUPAE MEAL; FISH-MEAL; IMMUNE-RESPONSES; ONCORHYNCHUS-MYKISS; PROTEIN-SOURCE; RAINBOW-TROUT; CHITIN; NUCLEOTIDES; RESISTANCE; GROWTH	Nutritional value of black soldier fly (Hermetia illucens) larvae (BSFL) processed by three different methods of treatment was compared. The resulting products were the spray-dried BSFL (SPR), oven-dried BSFL 1 (OVN1) and oven-dried BSFL 2 (OVN2). Proximate chemical composition, and profiles of amino acids, fatty acids, minerals, heavy metals, vitamins and nucleotides were analysed and compared. The tested BSFL meals were considered to have a good profile of essential amino acids (EAAs), with leucine, lysine, valine, and histidine being the dominant EAAs. Their content of saturated fatty acids exceeded that of the unsaturated fatty acids. Vitamins B1, B2, and C were also present in the samples. Minerals such as calcium, potassium, phosphorus, sodium, magnesium, zinc, iron, manganese and copper were found to be in adequate amounts in almost all the samples. Heavy metals in the BSFL meals were mostly below 1 g kg(-1). Nucleotides such as inosine monophosphate and uridine monophosphate occurred in all the BSFL meals. Other nucleotides, including guanosine monophosphate, adenosine monophosphate, xanthosine monophosphate, and cytidine monophosphate were detected in either or both of SPR and OVN2. In general, the nutritional value of the BSFL meals tested in the present study was influenced by the method of processing.	[Zulkifli, Nor Fatin Najihah Mohamad; Seok-Kian, Annita Yong; Seng, Lim Leong; Mustafa, Saleem; Kim, Yang-Su; Shapawi, Rossita] Univ Malaysia Sabah, Borneo Marine Res Inst, Jalan UMS, Kota Kinabalu, Sabah, Malaysia; [Kim, Yang-Su] CJ Cheiljedang Corp, Seoul, South Korea	Universiti Malaysia Sabah	Shapawi, R (corresponding author), Univ Malaysia Sabah, Borneo Marine Res Inst, Jalan UMS, Kota Kinabalu, Sabah, Malaysia.	rossita@ums.edu.my	Lim, Leong Seng/I-5324-2016	Lim, Leong Seng/0000-0002-0404-1083; SHAPAWI, ROSSITA/0000-0003-1548-3327	Ministry of Higher Education Malaysia [NRGS0004]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	R. Shapawi received a research grant to conduct this study (NRGS0004 - Niche Research Grant, Ministry of Higher Education Malaysia) https://jpt.mohe.gov.my/portal/index.php/ms/ The funder provide financial assistance only.	Abd El-Hack ME, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10080339; Abdel-Tawwab M, 2020, AQUACULTURE, V522, DOI 10.1016/j.aquaculture.2020.735136; Adunni Adewolu M., 2009, AM J APPL SCI, V6, P1675, DOI DOI 10.3844/AJASSP.2009.1675.1681; Alvarez D, 2019, J INSECT SCI, V19, DOI 10.1093/jisesa/iez120; Aniebo A. O., 2010, Pakistan Journal of Nutrition, V9, P485; Barroso FG, 2014, AQUACULTURE, V422, P193, DOI 10.1016/j.aquaculture.2013.12.024; Bessa LW, 2020, COMPR REV FOOD SCI F, V19, P2747, DOI 10.1111/1541-4337.12609; BONDARI K, 1981, AQUACULTURE, V24, P103, DOI 10.1016/0044-8486(81)90047-8; Bukkens SGF, 2004, ECOLOGICAL IMPLICATIONS OF MINLIVESTOCK: POTENTIAL OF INSECTS RODENTS FROGS AND SNAILS, P545; Burrells C, 2001, AQUACULTURE, V199, P159, DOI 10.1016/S0044-8486(01)00577-4; CARVER JD, 1995, J NUTR BIOCHEM, V6, P58, DOI 10.1016/0955-2863(94)00019-I; Costello C, 2020, NATURE, V588, P95, DOI 10.1038/s41586-020-2616-y; Cummins VC, 2017, AQUACULTURE, V473, P337, DOI 10.1016/j.aquaculture.2017.02.022; Cunniff P., 1999, OFFICIAL METHODS ANA, V1; English G, 2021, J AGR FOOD RES, V5, DOI 10.1016/j.jafr.2021.100164; Fasakin EA, 2003, AQUAC RES, V34, P733, DOI 10.1046/j.1365-2109.2003.00876.x; Fines BC, 2010, AQUACULTURE, V303, P34, DOI 10.1016/j.aquaculture.2010.03.010; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; Fisher HJ, 2020, AQUACULTURE, V521, DOI 10.1016/j.aquaculture.2020.734978; Franco A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su131810198; Guine R., 2018, INT J FOOD ENG, V4, P93, DOI DOI 10.18178/IJFE.4.2.93-100; Hahn T, 2020, J CHEM TECHNOL BIOT, V95, P2775, DOI 10.1002/jctb.6533; Henry M, 2015, ANIM FEED SCI TECH, V203, P1, DOI 10.1016/j.anifeedsci.2015.03.001; Hoang Do Huu, 2016, Journal of Coastal Life Medicine, V4, P816, DOI 10.12980/jclm.4.2016J6-165; Hossain MS, 2016, AQUACULTURE, V455, P41, DOI 10.1016/j.aquaculture.2016.01.008; Jozefiak A, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2070-y; Kasumyan AO, 2003, FISH FISH, V4, P289, DOI 10.1046/j.1467-2979.2003.00121.x; Kay A. D., 2008, ECOLOGICAL STOICHIOM, P1472; Kourimska L., 2016, NFS Journal, V4, P22, DOI 10.1016/j.nfs.2016.07.001; KRAMER KJ, 1986, INSECT BIOCHEM, V16, P851, DOI 10.1016/0020-1790(86)90059-4; Kroeckel S, 2012, AQUACULTURE, V364, P345, DOI 10.1016/j.aquaculture.2012.08.041; Li P, 2006, AQUACULTURE, V251, P141, DOI 10.1016/j.aquaculture.2005.01.009; Magalhaes R, 2017, AQUACULTURE, V476, P79, DOI 10.1016/j.aquaculture.2017.04.021; Makkar HPS, 2014, ANIM FEED SCI TECH, V197, P1, DOI 10.1016/j.anifeedsci.2014.07.008; Manniello MD, 2021, CELL MOL LIFE SCI, V78, P4259, DOI 10.1007/s00018-021-03784-z; Mateo C, 2004, ALLTECHS 20 ANN S, P1; Moretta A, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.668632; Newton G. L, 2005, BLACK SOLDIER FLY HE; NEWTON GL, 1977, J ANIM SCI, V44, P395, DOI 10.2527/jas1977.443395x; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Panini RL, 2017, AQUACULTURE, V473, P115, DOI 10.1016/j.aquaculture.2017.02.008; Pillay T.V.R., 2005, AQUACULTURE PRINCIPL; Rana K.S., 2015, INT J FISH AQUAC, V5, P41; Raza N, 2019, FOOD SCI NUTR, V7, P2345, DOI 10.1002/fsn3.1081; Sealey WM, 2011, J WORLD AQUACULT SOC, V42, P34, DOI 10.1111/j.1749-7345.2010.00441.x; SHEPPARD DC, 1994, BIORESOURCE TECHNOL, V50, P275, DOI 10.1016/0960-8524(94)90102-3; Sheppard DC, 2002, J MED ENTOMOL, V39, P695, DOI 10.1603/0022-2585-39.4.695; Shiau SY, 2015, AQUACULT REP, V2, P77, DOI 10.1016/j.aqrep.2015.08.002; Shumo M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46603-z; Soetemans L, 2020, INT J BIOL MACROMOL, V165, P3206, DOI 10.1016/j.ijbiomac.2020.11.041; Spranghers T, 2017, J SCI FOOD AGR, V97, P2594, DOI 10.1002/jsfa.8081; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P309, DOI 10.1111/j.1749-7345.2007.00101.x; Tahmasebi-Kohyani A, 2011, FISH SHELLFISH IMMUN, V30, P189, DOI 10.1016/j.fsi.2010.10.005; THOMPSON SN, 1973, COMP BIOCHEM PHYSIOL, V45, P467, DOI 10.1016/0305-0491(73)90078-3; Tippayadara N, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11010193; Triunfo M, 2021, COSMETICS-BASEL, V8, DOI 10.3390/cosmetics8020040; Van Huis A, 2013, EDIBLE INSECTS FUTUR; Wang GX, 2019, AQUACULTURE, V507, P144, DOI 10.1016/j.aquaculture.2019.04.023; Wang YS, 2017, FOODS, V6, DOI 10.3390/foods6100091; Xia J, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11071937	60	2	2	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263924	10.1371/journal.pone.0263924	http://dx.doi.org/10.1371/journal.pone.0263924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213590	Green Published, gold			2022-12-26	WOS:000787811000039
J	Martin, MC; Jimenez, A; Ortega, N; Parrado, A; Page, I; Gonzalez, MI; Blanco-Peris, L				Carmen Martin, M.; Jimenez, Ana; Ortega, Nuria; Parrado, Alba; Page, Isabel; Isabel Gonzalez, M.; Blanco-Peris, Lydia			Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors	PLOS ONE			English	Article							COVID-19	Background The vast majority of COVID-19 cases both symptomatic and asymptomatic develop immunity after COVID-19 contagion. Whether lasting differences exist between infection and vaccination boosted immunity is yet to be known. The aim of this study was to determine how long total anti-SARS-CoV2 antibodies due to past infection persist in peripheral blood and whether sex, age or haematological features can influence their lasting. Material and methods A series of 2421 donations either of SARS-CoV-2 convalescent plasma or whole blood from 1107 repeat donors from January 2020 to March 2021 was analysed. An automated chemiluminescence immunoassay for total antibodies recognizing the nucleocapsid protein of SARS-CoV-2 in human serum and plasma was performed. Sex, age, blood group, blood cell counts and percentages and immunoglobulin concentrations were extracted from electronic recordings. Blood donation is allowed after a minimum of one-month post symptom's relapse. Donors were 69.7% males and their average age was 46. The 250 donors who had later donations after a positive one underwent further analysis. Both qualitative (positivity) and quantitative (rise or decline of optical density regarding consecutive donations) outcomes were evaluated. Results and discussion In 97.6% of donors with follow-up, anti-SARS-CoV-2 protein N total antibodies remained positive at the end of a follow-up period of 12.4 weeks median time (1-46, SD = 9.65) after the first positive determination. The blood group was not related to antibody waning. Lower lymphocyte counts and higher neutrophils would help predict future waning or decay of antibodies. Most recovered donors maintain their total anti-SARS-CoV-2 N protein antibodies for at least 16 weeks (at least one month must have been awaited from infection resolution to blood donation). The 10 individuals that could be followed up longer than 40 weeks (approximately 44 weeks after symptom's relapse) were all still positive.	[Carmen Martin, M.; Jimenez, Ana; Ortega, Nuria; Parrado, Alba; Page, Isabel; Isabel Gonzalez, M.; Blanco-Peris, Lydia] Ctr Hemoterapia & Hemodonac Castilla Y Leon, Valladolid, Castilla Y Leon, Spain		Martin, MC (corresponding author), Ctr Hemoterapia & Hemodonac Castilla Y Leon, Valladolid, Castilla Y Leon, Spain.	cmartinalo@saludcastillayleon.es		Martin, Carmen/0000-0001-8785-4225	Roche Diagnostics International Ltd.	Roche Diagnostics International Ltd.	This work has been supported by Roche Diagnostics International Ltd., who provided free equipment and test reagents and runs with article processing charges as well. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo FJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.33706; dos Santos JDB, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.595343; Busch MP, 2021, CLIN INFECT DIS, V72, P254, DOI 10.1093/cid/ciaa1116; Canete PF, 2020, CELL, V183, P13, DOI 10.1016/j.cell.2020.09.013; Chao YS, 2021, PLATELETS, V32, P1092, DOI 10.1080/09537104.2021.1921721; Fenwick C, 2021, J VIROL, V95, DOI 10.1128/JVI.01828-20; Gallais F, 2021, EMERG INFECT DIS, V27, P113, DOI 10.3201/eid2701.203611; Ibarrondo FJ, 2021, ACS NANO, V15, P11180, DOI 10.1021/acsnano.1c03972; Isho B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe5511; Jurado A, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00194-w; Kohmer N, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104480; Legros V, 2021, CELL MOL IMMUNOL, V18, P318, DOI 10.1038/s41423-020-00588-2; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lozano-Ojalvo D, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109570; Marongiu F, 2021, EUR REV MED PHARMACO, V25, P3886, DOI 10.26355/eurrev_202105_25956; Martin MC, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-021-00237-w; Martin MC., 2021, MEDRXIV2021042821256, pI, DOI [10.1101/2021.04.28.21256242, DOI 10.1101/2021.04.28.21256242]; Netea MG, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145545; Noval MG, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84913-3; Nguyen-Contant P, 2020, MBIO, V11, DOI 10.1128/mBio.01991-20; Qin RD, 2022, CLIN REV ALLERG IMMU, DOI 10.1007/s12016-021-08908-8; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Turner JS, 2021, NATURE, V595, P421, DOI 10.1038/s41586-021-03647-4; Varona JF, 2021, EUR J INTERN MED, V89, P97, DOI 10.1016/j.ejim.2021.05.028; Wang K, 2021, CLIN INFECT DIS, V73, pE531, DOI 10.1093/cid/ciaa1143; Wouters E, 2021, VOX SANG, V116, P493, DOI 10.1111/vox.13060; Xiang TD, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.708523	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264124	10.1371/journal.pone.0264124	http://dx.doi.org/10.1371/journal.pone.0264124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202394	gold, Green Published			2022-12-26	WOS:000773224600021
J	Mello, VM; Eller, CM; Salvio, AL; Nascimento, FF; Figueiredo, CM; Silva, ESRF; Sousa, PSF; Costa, PF; Paiva, AAP; Mares-Guias, MAMM; Lemos, ERS; Horta, MAP				Mello, Vinicius M.; Eller, Cristiane M.; Salvio, Andreza L.; Nascimento, Felipe F.; Figueiredo, Camila M.; Silva, Emanuelle S. R. F.; Sousa, Paulo S. F.; Costa, Pamela F.; Paiva, Anne A. P.; Mares-Guias, Maria A. M. M.; Lemos, Elba R. S.; Horta, Marco A. P.			Effectiveness of face masks in blocking the transmission of SARS-CoV-2: A preliminary evaluation of masks used by SARS-CoV-2-infected individuals	PLOS ONE			English	Article							VIRAL LOAD; COVID-19; INFLUENZA	In 2019, a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted via the airborne route, caused a new pandemic namely, "coronavirus disease 2019" (COVID-19). Although the effectiveness of face masks to prevent the transmission of SARS-CoV-2 is debated, no study has evaluated the virus-blocking efficacy of masks used by patients. We aimed to evaluate this efficacy of masks used by SARS-CoV-2-infected individuals. Data, masks used, and nasopharyngeal swab samples were obtained from these patients. Forty-five paired samples of nasopharyngeal swabs and masks were obtained and processed; the majority of masks were woven. Viral RNAs were amplified using quantitative reverse-transcription polymerase chain reaction and detected only on the inner parts of masks. Median viral load (VL) values of swabs and masks were 1.954x10(6) and 2,51x10(3), respectively. Statistically, there was a difference of approximately 1000 RNA copies/mL between swabs and masks and no significant difference in VL values among different types of masks. There were statistically significant differences in VL values between men and women and between symptomatic and asymptomatic patients. Our findings suggest the blocking of virus transmission by different types of masks and reinforce the use of masks by both infected and non-infected individuals.	[Mello, Vinicius M.; Sousa, Paulo S. F.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Viral Hepatitis Lab, Rio De Janeiro, Brazil; [Eller, Cristiane M.; Horta, Marco A. P.] Fundacao Oswaldo Cruz, Biosafety Level 3, Facil BSL 3, Rio De Janeiro, Brazil; [Salvio, Andreza L.; Nascimento, Felipe F.; Figueiredo, Camila M.; Silva, Emanuelle S. R. F.; Costa, Pamela F.] Fundacao Oswaldo Cruz, COVID 19 Analyt Ctr, Rio De Janeiro, Brazil; [Paiva, Anne A. P.; Mares-Guias, Maria A. M. M.] Inst Oswaldo Cruz, Oswaldo Cruz Fdn, Flavivirus Lab, Rio De Janeiro, Brazil; [Lemos, Elba R. S.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Hantavirosis & Rickettsiosis Lab, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Mello, VM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Viral Hepatitis Lab, Rio De Janeiro, Brazil.	vmello.fiocruz@gmail.com		Mello, Vinicius/0000-0001-7705-5921	Fiocruz Promote Innovation Program, "Inova Fiocruz", through Oswaldo Cruz Foundation and Science, Technology and Strategic Inputs Secretariat of Brazilian Ministry of Health; Brazilian national funding agency "Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior do Brasil -CAPES" [001]	Fiocruz Promote Innovation Program, "Inova Fiocruz", through Oswaldo Cruz Foundation and Science, Technology and Strategic Inputs Secretariat of Brazilian Ministry of Health; Brazilian national funding agency "Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior do Brasil -CAPES"	This study was funded by: The Fiocruz Promote Innovation Program, "Inova Fiocruz", through Oswaldo Cruz Foundation and Science, Technology and Strategic Inputs Secretariat of Brazilian Ministry of Health. (ERSL and MAPH).https://portal.fiocruz.br/inova And funded by the Brazilian national funding agency "Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior do Brasil -CAPES", under finance code 001. (VMM and AAPV) https://www.gov.br/capes/pt-br	Bienvenu LA, 2020, CARDIOVASC RES, V116, P2197, DOI 10.1093/cvr/cvaa284; Brooks JT, 2021, JAMA-J AM MED ASSOC, V325, P998, DOI 10.1001/jama.2021.1505; Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346; Centers for Disease Control and Prevention, 2021, SCI BRIEF COMM US CL; Cheng VCC, 2020, J INFECTION, V81, P107, DOI 10.1016/j.jinf.2020.04.024; Choi S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020011; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Chua MH, 2020, RESEARCH-CHINA, V2020, DOI 10.34133/2020/7286735; Clapham HE, 2021, LANCET DIGIT HEALTH, V3, pE136, DOI 10.1016/S2589-7500(21)00003-0; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Fernandes LAD, 2020, FRONT SOCIOL, V5, DOI 10.3389/fsoc.2020.611990; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Griffith DM, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200247; Guan LL, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00352-2020; Harrison AG, 2020, TRENDS IMMUNOL, V41, P1100, DOI 10.1016/j.it.2020.10.004; Ji Dongxiao, 2020, BMC Mater, V2, P9, DOI 10.1186/s42833-020-00015-w; Lee K, 2009, GLOB INST, P1; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Lindsley WG, 2021, J OCCUP ENVIRON HYG, V18, P409, DOI 10.1080/15459624.2021.1939879; Kibuuka BGL, 2020, INT J LAT AM RELIG, V4, P288, DOI 10.1007/s41603-020-00124-0; Ma QX, 2020, J MED VIROL, V92, P1567, DOI 10.1002/jmv.25805; Massarani L, 2021, FRONT COMMUN, V6, DOI 10.3389/fcomm.2021.643895; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Mitze T, 2020, P NATL ACAD SCI USA, V117, P32293, DOI 10.1073/pnas.2015954117; Morais FG, 2021, AEROSOL SCI TECH, V55, P1028, DOI 10.1080/02786826.2021.1915466; Offeddu V, 2017, CLIN INFECT DIS, V65, P1934, DOI 10.1093/cid/cix681; Ortelan N, 2021, CIENC SAUDE COLETIVA, V26, P669, DOI 10.1590/1413-81232021262.36702020; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Pereira RJ, 2020, PUBLIC HEALTH, V183, P42, DOI 10.1016/j.puhe.2020.04.042; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Santos M, 2020, BRAZ ORAL RES, V34, DOI 10.1590/1807-3107bor-2020.vol34.0123; Silva Ana Cristina de Oliveira e, 2020, Rev. Bras. Enferm., V73, pe20200239, DOI 10.1590/0034-7167-2020-0239; Strizova Z, 2020, CENT EUR J PUBL HEAL, V28, P161, DOI 10.21101/cejph.a6290; Sun PF, 2020, J MED VIROL, V92, P548, DOI 10.1002/jmv.25722; Swain Ian D., 2020, Journal of Medical Engineering & Technology, V44, DOI 10.1080/03091902.2020.1797198; United Nations, BRAZ FAV ORG FIGHT C; Williams CM, 2021, J INFECTION, V82, P253, DOI 10.1016/j.jinf.2021.03.018; World Health Organization, 2021, COVID 19 WORLD WORK; Zangmeister CD, 2020, ACS NANO, V14, P9188, DOI 10.1021/acsnano.0c05025; Zhou SS, 2018, J THORAC DIS, V10, P2059, DOI 10.21037/jtd.2018.03.103; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	43	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264389	10.1371/journal.pone.0264389	http://dx.doi.org/10.1371/journal.pone.0264389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196363	gold, Green Published, Green Submitted			2022-12-26	WOS:000835161600044
J	Masenga, SK; Pilic, L; Malumani, M; Hamooya, BM				Masenga, Sepiso K.; Pilic, Leta; Malumani, Malani; Hamooya, Benson M.			Erythrocyte sodium buffering capacity status correlates with self-reported salt intake in a population from Livingstone, Zambia	PLOS ONE			English	Article							SENSITIVITY; GLYCOCALYX; QUESTIONNAIRE	BackgroundSalt impairs endothelial function and increases arterial stiffness independent of blood pressure. The mechanisms are unknown. Recent evidence suggests that there is a possible link between salt consumption and sodium buffering capacity and cardiovascular disease but there is limited evidence in the populations living in Sub-Saharan Africa. The aim of our study was to explore the relationship between erythrocyte sodium buffering capacity and sociodemographic, clinical factors, and self-reported salt consumption at Livingstone Central Hospital. MethodsWe conducted a cross sectional study at Livingstone Central hospital among 242 volunteers accessing routine medical checkups. Sociodemographic and dietary characteristics were obtained along with clinical measurements to evaluate their health status. Sodium buffering capacity was estimated by erythrocyte sodium sensitivity (ESS) test. We used descriptive and inferential statistics to describe and examine associations between erythrocyte sodium sensitivity and independent variables. ResultsThe median age (interquartile range) of the study sample was 27 (22, 42) years. 54% (n = 202) and 46% (n = 169) were males and females, respectively. The majority (n = 150, 62%) had an ESS of >120%. High salt intake correlated positively with ESS or negatively with vascular sodium buffering capacity. ConclusionsSelf-reported high salt intake was associated with poor vascular sodium buffering capacity or high ESS in the majority of middle-aged Zambians living in Livingstone. The poor vascular sodium buffering capacity implies a damaged vascular glycocalyx which may potentially lead to a leakage of sodium into the interstitium. This alone is a risk factor for the future development of hypertension and cardiovascular disease. However, future studies need to validate vascular function status when using ESS testing by including established vascular function assessments to determine its pathophysiological and clinical implications.	[Masenga, Sepiso K.; Malumani, Malani; Hamooya, Benson M.] Mulungushi Univ, Sch Med & Hlth Sci, HAND Res Grp, Livingstone, Zambia; [Pilic, Leta] St Marys Univ, Fac Sport Allied Hlth & Performance Sci, London, England	St Mary's University Twickenham London	Masenga, SK (corresponding author), Mulungushi Univ, Sch Med & Hlth Sci, HAND Res Grp, Livingstone, Zambia.	sepisomasenga@gmail.com	Malumani, Malan/AAH-4807-2019	Malumani, Malan/0000-0002-9149-002X; Pilic, Leta/0000-0001-8046-1269				Charlton KE, 2008, PUBLIC HEALTH NUTR, V11, P83, DOI 10.1017/S1368980007000146; Chen Y, 2004, BRIT J NUTR, V92, P851, DOI 10.1079/BJN20041277; Choi Hoon Young, 2015, Electrolyte Blood Press, V13, P7, DOI 10.5049/EBP.2015.13.1.7; Elijovich F, 2016, HYPERTENSION, V68, pE7, DOI 10.1161/HYP.0000000000000047; Engberink RHGO, 2015, J AM SOC NEPHROL, V26, P777, DOI 10.1681/ASN.2014050430; Grillo A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11091970; Kirabo A, 2017, AM J PHYSIOL-REG I, V313, pR706, DOI 10.1152/ajpregu.00250.2017; Liu L, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-49; Masenga SK, 2021, CLIN HYPERTENS, V27, DOI 10.1186/s40885-020-00160-0; Mockl L, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00253; Mumu SJ, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00563-7; Oberleithner H, 2016, KIDNEY BLOOD PRESS R, V41, P355, DOI 10.1159/000443438; Oberleithner H, 2015, PFLUG ARCH EUR J PHY, V467, P1319, DOI 10.1007/s00424-014-1577-0; Oberleithner H, 2015, BLOOD PURIFICAT, V39, P7, DOI 10.1159/000368922; Oberleithner H, 2013, PFLUG ARCH EUR J PHY, V465, P1459, DOI 10.1007/s00424-013-1289-x; Oberleithner H, 2011, PFLUG ARCH EUR J PHY, V462, P519, DOI 10.1007/s00424-011-0999-1; Pilic L, 2020, FOOD QUAL PREFER, V84, DOI 10.1016/j.foodqual.2020.103954; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8	18	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264650	10.1371/journal.pone.0264650	http://dx.doi.org/10.1371/journal.pone.0264650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235593	Green Published, Green Accepted, gold			2022-12-26	WOS:000787073100048
J	Zubair, M; Hamzah, R; Griffin, R; Ali, N				Zubair, Mohd; Hamzah, Rabab; Griffin, Robert; Ali, Nawab			Identification and functional characterization of multiple inositol polyphosphate phosphatase1 (Minpp1) isoform-2 in exosomes with potential to modulate tumor microenvironment	PLOS ONE			English	Article							BREAST-CANCER CELLS; ENDOPLASMIC-RETICULUM; IN-VITRO; HEXAPHOSPHATE IP6; ER STRESS; 3-PHOSPHATASE; METABOLISM; PTEN; PYROPHOSPHATES; LOCALIZATION	Inositol polyphosphates (InsPs) play key signaling roles in diverse cellular functions, including calcium homeostasis, cell survival and death. Multiple inositol polyphosphate phosphatase 1 (Minpp1) affects the cellular levels of InsPs and cell functions. The Minpp1 is an endoplasmic reticulum (ER) resident but localizes away from its cytosolic InsPs substrates. The current study examines the heterogeneity of Minpp1 and the potential physiologic impact of Minpp1 isoforms, distinct motifs, subcellular distribution, and enzymatic potential. The NCBI database was used to analyze the proteome diversity of Minpp1 using bioinformatics tools. The analysis revealed that translation of three different Minpp1 variants resulted in three isoforms of Minpp1 of varying molecular weights. A link between the minpp1 variant-2 gene and ER-stress, using real-time PCR, suggests a functional similarity between minpp1 variant-1 and variant-2. A detailed study on motifs revealed Minpp1 isoform-2 is the only other isoform, besides isoform-1, that carries a phosphatase motif for InsPs hydrolysis but no ER-retention signal. The confocal microscopy revealed that the Minpp1 isoform-1 predominantly localized near the nucleus with a GRP-78 ER marker, while Minpp1 isoform-2 was scattered more towards the cell periphery where it co-localizes with the plasma membrane-destined multivesicular bodies biomarker CD63. MCF-7 cells were used to establish that Minpp1 isoform-2 is secreted into exosomes. Brefeldin A treatment resulted in overexpression of the exosome-associated Minpp1 isoform-2, suggesting its secretion via an unconventional route involving endocytic-generated vesicles and a link to ER stress. Results further demonstrated that the exosome-associated Minpp1 isoform-2 was enzymatically active. Overall, the data support the possibility that an extracellular form of enzymatically active Minpp1 isoform-2 mitigates any anti-proliferative actions of extracellular InsPs, thereby also impacting the makeup of the tumor microenvironment.	[Zubair, Mohd; Ali, Nawab] Univ Arkansas, Dept Biol, Little Rock, AR 72204 USA; [Hamzah, Rabab; Griffin, Robert] Univ Arkansas Med Sci, Dept Radiat Oncol, Little Rock, AR 72205 USA; [Hamzah, Rabab] Univ Arkansas, Ctr Integrat Nanotechnol Sci, Little Rock, AR 72204 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Zubair, M; Ali, N (corresponding author), Univ Arkansas, Dept Biol, Little Rock, AR 72204 USA.	mxzubair@ualr.edu; nali@ualr.edu		Zubair, Mohd/0000-0002-4884-5200; Ali, Nawab/0000-0002-0995-4965	NASA-EPSCoR; Arkansas Space Grant Consortium; Center for Advanced Surface Engineering, under the National Science Foundation [OIA-1457888]; Arkansas EPSCoR Program, ASSET III; National Institute of Health (NIH) IDeA Networks of Biomedical Research Excellence (INBRE) [P20GM103429-20]	NASA-EPSCoR(National Aeronautics & Space Administration (NASA)); Arkansas Space Grant Consortium; Center for Advanced Surface Engineering, under the National Science Foundation; Arkansas EPSCoR Program, ASSET III; National Institute of Health (NIH) IDeA Networks of Biomedical Research Excellence (INBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by funds to Nawab Ali from NASA-EPSCoR and Arkansas Space Grant Consortium. We also acknowledge partial support from the Center for Advanced Surface Engineering, under the National Science Foundation Grant No. OIA-1457888 and the Arkansas EPSCoR Program, ASSET III. A partial support to Nawab Ali from the National Institute of Health (NIH) IDeA Networks of Biomedical Research Excellence (INBRE) grant P20GM103429-20 is gracefully acknowledged.	Adepoju OA, 2017, FASEB J, V31; Agarwal R, 2009, MOL CELL BIOCHEM, V328, P155, DOI 10.1007/s11010-009-0085-6; ALI N, 1993, J BIOL CHEM, V268, P6161; ALI N, 1995, BIOCHEM J, V310, P279, DOI 10.1042/bj3100279; Tamayo-Ramos JA, 2012, APPL ENVIRON MICROB, V78, P5013, DOI 10.1128/AEM.00782-12; Appelhof B, 2021, EUR J HUM GENET, V29, P411, DOI 10.1038/s41431-020-00749-x; Badi SA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01610; Batista BS, 2011, J PROTEOME RES, V10, P4624, DOI 10.1021/pr200434y; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Blum M, 2021, NUCLEIC ACIDS RES, V49, pD344, DOI 10.1093/nar/gkaa977; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brehm MA, 2007, BIOCHEM J, V408, P335, DOI 10.1042/BJ20070382; Caffrey JJ, 1999, FEBS LETT, V442, P99, DOI 10.1016/S0014-5793(98)01636-6; Campbell S, 2001, P NATL ACAD SCI USA, V98, P10875, DOI 10.1073/pnas.191224698; Caruso S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01486; Chakraborty A, 2018, BIOL REV, V93, P1203, DOI 10.1111/brv.12392; Chatree S, 2020, MOLECULES, V25, DOI 10.3390/molecules25215079; Chen WB, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-020-01803-8; Chi HB, 1999, GENOMICS, V56, P324, DOI 10.1006/geno.1998.5736; Cho J, 2006, J BIOTECHNOL, V126, P248, DOI 10.1016/j.jbiotec.2006.04.028; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Collett Gavin P, 2018, Oncotarget, V9, P6707, DOI 10.18632/oncotarget.24158; CRAXTON A, 1995, BIOCHEM J, V305, P491, DOI 10.1042/bj3050491; Cypryk W, 2017, J PROTEOME RES, V16, P217, DOI 10.1021/acs.jproteome.6b00596; Dahia PM, 2000, J MED GENET, V37, P715, DOI 10.1136/jmg.37.9.715; Dinicola S, 2016, EXP CELL RES, V345, P37, DOI 10.1016/j.yexcr.2016.05.007; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ESTRADAGARCIA T, 1991, P ROY SOC B-BIOL SCI, V244, P63, DOI 10.1098/rspb.1991.0052; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Gao D, 2018, AM J CANCER RES, V8, P2165; Ge R, 2012, CANCER MICROENVIRON, V5, P323, DOI 10.1007/s12307-012-0110-2; Gimm O, 2001, J CLIN ENDOCR METAB, V86, P1801, DOI 10.1210/jc.86.4.1801; Grases F, 2019, MOLECULES, V24, DOI 10.3390/molecules24244434; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Innis CA, 2000, PROTEIN ENG, V13, P839, DOI 10.1093/protein/13.12.839; Isola AL, 2017, CURR NEUROPHARMACOL, V15, P157, DOI 10.2174/1570159X14666160825160421; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kilaparty SP, 2016, CELL STRESS CHAPERON, V21, P593, DOI 10.1007/s12192-016-0684-6; Kilaparty SP, 2014, EVOL BIOINFORM, V10, P239, DOI 10.4137/EBO.S18948; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Mallery DL, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe4716; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Mehta BD, 2006, PHYTOCHEMISTRY, V67, P1874, DOI 10.1016/j.phytochem.2006.06.008; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Mulquiney PJ, 1999, BIOCHEM J, V342, P581, DOI 10.1042/0264-6021:3420581; Musante L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037279; Ng F, 2016, METHODS MOL BIOL, V1459, P31, DOI 10.1007/978-1-4939-3804-9_2; NOGIMORI K, 1991, J BIOL CHEM, V266, P16499; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Peretti D, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00371; Principe S, 2013, PROTEOMICS, V13, P1667, DOI 10.1002/pmic.201200561; Proietti S, 2017, EUR REV MED PHARMACO, V21, P43; Prunotto M, 2013, J PROTEOMICS, V82, P193, DOI 10.1016/j.jprot.2013.01.012; Rabouille C, 2017, TRENDS CELL BIOL, V27, P230, DOI 10.1016/j.tcb.2016.11.007; Rao F, 2014, MOL CELL, V54, P119, DOI 10.1016/j.molcel.2014.02.020; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Romano PR, 1998, J CELL SCI, V111, P803; Scheffler JM, 2014, METHOD ENZYMOL, V535, P93, DOI 10.1016/B978-0-12-397925-4.00006-7; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; SHEARS SB, 1995, J BIOL CHEM, V270, P10489, DOI 10.1074/jbc.270.18.10489; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Shi LJ, 2019, BMC GENET, V20, DOI 10.1186/s12863-019-0769-1; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Smythies LE, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00104; Soo KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035413; Stentz R, 2014, CELL REP, V6, P646, DOI 10.1016/j.celrep.2014.01.021; Tai YL, 2018, CANCER SCI, V109, P2364, DOI 10.1111/cas.13697; Tan KH, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.038; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Ucuncu E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19919-y; Udenwobele DI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00751; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vidal M, 2019, TRAFFIC, V20, P815, DOI 10.1111/tra.12687; Vucenik I, 2005, BREAST CANCER RES TR, V91, P35, DOI 10.1007/s10549-004-6456-5; Vucenik I, 2003, J NUTR, V133, p3778S, DOI 10.1093/jn/133.11.3778S; Wali JA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.88; Wilson MSC, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150014; Windhorst S, 2013, BIOCHEM J, V450, P115, DOI 10.1042/BJ20121524; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376	87	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264451	10.1371/journal.pone.0264451	http://dx.doi.org/10.1371/journal.pone.0264451			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235602	Green Published, gold			2022-12-26	WOS:000787073100050
J	Molinar-Inglis, O; Wozniak, JM; Grimsey, NJ; Orduna-Castillo, LB; Cheng, N; Lin, Y; Ramirez, MLG; Birch, CA; Lapek, JD; Gonzalez, DJ; Trejo, J				Molinar-Inglis, Olivia; Wozniak, Jacob M.; Grimsey, Neil J.; Orduna-Castillo, Lennis B.; Cheng, Norton; Lin, Ying; Ramirez, Monica L. Gonzalez; Birch, Cierra A.; Lapek, John D.; Gonzalez, David J.; Trejo, JoAnn			Phosphoproteomic analysis of thrombin- and p38 MAPK-regulated signaling networks in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERK ACTIVATION; ALPHA-CATENIN; BETA-CATENIN; KINASE-II; PROTEIN; PHOSPHORYLATION; TRANSACTIVATION; JUNCTIONS; STRATEGY; SWITCH	Endothelial dysfunction is a hallmark of inflammation and is mediated by inflammatory factors that signal through G protein-coupled receptors including protease-activated receptor-1 (PAR1). PAR1, a receptor for thrombin, signals via the small GTPase RhoA and myosin light chain intermediates to facilitate endothelial barrier permeability. PAR1 also induces endothelial barrier disruption through a p38 mitogen-activated protein kinase-dependent pathway, which does not integrate into the RhoA/MLC pathway; however, the PAR1-p38 signaling pathways that promote endothelial dysfunction remain poorly defined. To identify effectors of this pathway, we performed a global phosphoproteome analysis of thrombin signaling regulated by p38 in human cultured endothelial cells using multiplexed quantitative mass spectrometry. We identified 5491 unique phosphopeptides and 2317 phosphoproteins, four distinct dynamic phosphoproteome profiles of thrombin-p38 signaling, and an enrichment of biological functions associated with endothelial dysfunction, including modulators of endothelial barrier disruption and a subset of kinases predicted to regulate p38-dependent thrombin signaling. Using available antibodies to detect identified phosphosites of key p38 regulated proteins, we discovered that inhibition of p38 activity and siRNA-targeted depletion of the p38 alpha isoform increased basal phosphorylation of extracellular signal-regulated protein kinase 1/2, resulting in amplified thrombin-stimulated extra cellular signal-regulated protein kinase 1/2 phosphorylation that was dependent on PAR1. We also discovered a role for p38 in the phosphorylation of alpha-catenin, a component of adherens junctions, suggesting that this phosphorylation may function as an important regulatory process. Taken together, these studies define a rich array of thrombin-and p38-regulated candidate proteins that may serve important roles in endothelial dysfunction.	[Molinar-Inglis, Olivia; Wozniak, Jacob M.; Orduna-Castillo, Lennis B.; Cheng, Norton; Lin, Ying; Ramirez, Monica L. Gonzalez; Birch, Cierra A.; Lapek, John D.; Gonzalez, David J.; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Wozniak, Jacob M.; Cheng, Norton] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Grimsey, Neil J.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Gonzalez, David J.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Georgia; University of Georgia; University of California System; University of California San Diego	Trejo, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		Cheng, Norton/0000-0002-0591-3963; Molinar-Inglis, Olivia/0000-0002-4974-9608	NIH/National Institute of General Medical Sciences (NIGMS) [R35 GM127121]; NIH/NIGMS [T32 GM007752, K12 GM068524]; UC President's Postdoctoral Fellowship Program; NIH/NIAMS [T32 AR064194]; NIH/NHLBI [T32 HL007444]	NIH/National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)General Electric); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UC President's Postdoctoral Fellowship Program; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding and additional information-This work was supported by NIH/National Institute of General Medical Sciences (NIGMS) Grant R35 GM127121 (to J. T.), NIH/NIGMS Grant K12 GM068524 (O. M. I., J. D. L., M. R. G.), UC President's Postdoctoral Fellowship Program (O. M. I.), NIH/NIAMS T32 AR064194 (J. M. W.), NIH/NHLBI T32 HL007444 (C. A. B.), and NIH/NIGMS T32 GM007752 (N. C.). The content is solely the responsibility of the authors and does not necessarily represents the official views of the National institutes of health.	Aslam M, 2010, CARDIOVASC RES, V87, P375, DOI 10.1093/cvr/cvq065; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Chen L, 2010, J PROTEOME RES, V9, P174, DOI 10.1021/pr900338q; Chen X, 2013, BLOOD, V121, P3718, DOI 10.1182/blood-2012-10-461897; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; De Nicola GF, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121144; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Grimsey NJ, 2019, J BIOL CHEM, V294, P5867, DOI 10.1074/jbc.RA119.007495; Grimsey NJ, 2018, CELL REP, V24, P3312, DOI 10.1016/j.celrep.2018.08.061; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Indraccolo S., 2007, J IMMUNOL; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kaur J, 2003, AM J PHYSIOL-HEART C, V284, pH1095, DOI 10.1152/ajpheart.00016.2002; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Komarova Yulia A, 2007, Sci STKE, V2007, pre8; Lake D, 2016, CELL MOL LIFE SCI, V73, P4397, DOI 10.1007/s00018-016-2297-8; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Lapek JD, 2017, MOL CELL PROTEOMICS, V16, P1447, DOI 10.1074/mcp.M116.066019; Lapek JD, 2017, NAT BIOTECHNOL, V35, P983, DOI 10.1038/nbt.3955; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; Lin Y., 2020, PROC NATL ACAD; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; McGough IJ, 2014, J CELL SCI, V127, P4940, DOI 10.1242/jcs.156299; Needham EJ, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau8645; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Rada CC, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.abc1044; Rao HV, 2009, NEUROSCI LETT, V450, P347, DOI 10.1016/j.neulet.2008.12.018; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Serres M, 2000, EXP CELL RES, V257, P255, DOI 10.1006/excr.2000.4895; Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200; Tanno M., 2003, DIVERSE MECH MYOCARD; Theivanthiran B, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005903; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Tolonen AC, 2014, JOVE-J VIS EXP, DOI 10.3791/51416; Wang CW, 2020, GENOM PROTEOM BIOINF, V18, P72, DOI 10.1016/j.gpb.2020.01.001; Wozniak JM, 2019, PEERJ, V7, DOI 10.7717/peerj.7046; Xiao YF, 2014, BIOINFORMATICS, V30, P801, DOI 10.1093/bioinformatics/btr671; Xie LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161397; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200	57	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101801	10.1016/j.jbc.2022.101801	http://dx.doi.org/10.1016/j.jbc.2022.101801			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35257745	Green Published, gold			2022-12-26	WOS:000793502000008
J	Mjaset, C; Zwart, JA; Kolstad, F; Solberg, T; Grotle, M				Mjaset, Christer; Zwart, John-Anker; Kolstad, Frode; Solberg, Tore; Grotle, Margreth			Clinical improvement after surgery for degenerative cervical myelopathy; A comparison of Patient-Reported Outcome Measures during 12-month follow-up	PLOS ONE			English	Article							NECK DISABILITY INDEX; SURGICAL DECOMPRESSION; IMPORTANT DIFFERENCE; SUBSTANTIAL AMOUNT; HEALTH-STATUS; ANTERIOR; PAIN; CRITERIA; RADICULOPATHY; EPIDEMIOLOGY	Object Although many patients report clinical improvement after surgery due to degenerative cervical myelopathy, the aim of intervention is to stop progression of spinal cord dysfunction. We wanted to provide estimates and assess achievement rates of Minimal Clinically Important Difference (MCID) at 3- and 12-month follow-up for Neck Disability Index (NDI), Numeric Rating Scale for arm pain (NRS-AP) and neck pain (NRS-NP), Euro-Qol (EQ-5D-3L), and European Myelopathy Score (EMS). Methods 614 degenerative cervical myelopathy patients undergoing surgery responded to Patient-Reported Outcome Measures (PROMs) prior to, 3 and 12 months after surgery. External criterion was the Global Perceived Effect Scale (1-7), defining MCID as "slightly better", "much better" and "completely recovered". MCID estimates with highest sensitivity and specificity were calculated by Receiver Operating Curves for change and percentage change scores in the whole sample and in anterior and posterior procedural groups. Results The NDI and NRS-NP percentage change scores were the most accurate PROMs with a MCID of 16%. The change score for NDI and percentage change scores for NDI, NRS-AP and NRS-NP were slightly higher in the anterior procedure group compared to the posterior procedure group, while remaining PROM estimates were similar across procedure type. The MCID achievement rates at 12-month follow-up ranged from 51% in EMS to 62% in NRS-NP. Conclusion The NDI and NRS-NP percentage change scores were the most accurate PROMs to measure clinical improvement after surgery for degenerative cervical myelopathy. We recommend using different cut-off estimates for anterior and posterior approach procedures. A MCID achievement rate of 60% or less must be interpreted in the perspective that the main goal of surgery for degenerative cervical myelopathy is to prevent worsening of the condition.	[Mjaset, Christer; Zwart, John-Anker] Univ Oslo, Fac Med, Oslo, Norway; [Mjaset, Christer; Kolstad, Frode] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Mjaset, Christer; Zwart, John-Anker; Grotle, Margreth] Oslo Univ Hosp, Dept Res & Innovat, Div Clin Neurosci, Oslo, Norway; [Solberg, Tore] Arctic Univ Norway, Inst Clin Med, Tromso, Norway; [Solberg, Tore] Univ Hosp North Norway, Dept Neurosurg, Tromso, Norway; [Solberg, Tore] Univ Hosp North Norway, Norwegian Registry Spine Surg, Tromso, Norway; [Grotle, Margreth] Oslo Metropolitan Univ, Fac Hlth Sci, Dept Physiotherapy, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Oslo Metropolitan University (OsloMet)	Mjaset, C (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.; Mjaset, C (corresponding author), Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway.; Mjaset, C (corresponding author), Oslo Univ Hosp, Dept Res & Innovat, Div Clin Neurosci, Oslo, Norway.	chrmja@gmail.com						Auffinger BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067408; Austevoll IM, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-018-2386-y; Badhiwala JH, 2018, SPINE, V43, pE1260, DOI 10.1097/BRS.0000000000002684; Carreon LY, 2010, SPINE J, V10, P469, DOI 10.1016/j.spinee.2010.02.007; Chien A, 2015, SPINE, V40, P1315, DOI 10.1097/BRS.0000000000001005; de Vet HCW, 2007, QUAL LIFE RES, V16, P131, DOI 10.1007/s11136-006-9109-9; Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Fehlings MG, 2015, SPINE, V40, P1322, DOI 10.1097/BRS.0000000000000988; Fehlings MG, 2013, SPINE, V38, P2247, DOI 10.1097/BRS.0000000000000047; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Fekete TF, 2016, SPINE J, V16, pS12, DOI 10.1016/j.spinee.2016.01.180; Goh GSH, 2020, SPINE, V45, P649, DOI 10.1097/BRS.0000000000003354; Gornet MF, 2019, J NEUROSURG-SPINE, V31, P317, DOI 10.3171/2019.2.SPINE1956; Gornet MF, 2017, J NEUROSURG-SPINE, V26, P653, DOI 10.3171/2016.10.SPINE16264; HERDMANN J, 1994, ADV NEUROS, V22, P266; Hermansen E, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2407-5; Hojmark K, 2016, EUR SPINE J, V25, P282, DOI 10.1007/s00586-015-4127-3; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jensen MP., 2011, HDB PAIN ASSESSMENT, P19; KAISER L, 1989, STAT MED, V8, P1183, DOI 10.1002/sim.4780081002; Kamper SJ, 2010, J CLIN EPIDEMIOL, V63, P760, DOI 10.1016/j.jclinepi.2009.09.009; Kato S, 2019, EUR SPINE J, V28, P1234, DOI 10.1007/s00586-019-05945-y; Kato S, 2019, SPINE, V44, P691, DOI 10.1097/BRS.0000000000002928; Kim Paul K, 2006, Spine J, V6, p299S, DOI 10.1016/j.spinee.2006.04.025; Lawrence BD, 2013, SPINE, V38, pS173, DOI 10.1097/BRS.0b013e3182a7eaaf; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; Mannion AF, 2006, EUR SPINE J, V15, pS93, DOI 10.1007/s00586-005-1045-9; Mjaset C, 2020, SPINE J, V20, P1413, DOI 10.1016/j.spinee.2020.05.549; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Nakashima H, 2016, J BONE JOINT SURG AM, V98, P370, DOI 10.2106/JBJS.O.00397; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; Parker SL, 2013, J NEUROSURG-SPINE, V18, P154, DOI 10.3171/2012.10.SPINE12312; Rhee JM, 2013, SPINE, V38, pS55, DOI 10.1097/BRS.0b013e3182a7f41d; Solberg T, 2019, ARSRAPPORT 2018 MED; Solberg T, 2013, ACTA ORTHOP, V84, P196, DOI 10.3109/17453674.2013.786634; Solberg TK, 2011, ACTA ORTHOP, V82, P56, DOI 10.3109/17453674.2010.548024; Steinhaus ME, 2019, CLIN SPINE SURG, V32, P392, DOI 10.1097/BSD.0000000000000895; Stull JD, 2020, SPINE, V45, P1485, DOI 10.1097/BRS.0000000000003613; Terwee CB, 2018, QUAL LIFE RES, V27, P1159, DOI 10.1007/s11136-018-1829-0; Tetreault L, 2015, SPINE, V40, P1653, DOI 10.1097/BRS.0000000000001127; Van Hooff ML, 2015, ACTA ORTHOP, V86, P534, DOI 10.3109/17453674.2015.1043174; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Werner DAT, 2017, EUR SPINE J, V26, P2650, DOI 10.1007/s00586-017-5185-5; Yoshii T, 2020, J ORTHOP SCI, V25, P58, DOI 10.1016/j.jos.2019.03.004	46	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264954	10.1371/journal.pone.0264954	http://dx.doi.org/10.1371/journal.pone.0264954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259164	Green Published, gold			2022-12-26	WOS:000835141200033
J	Disbrow, EA; Glassy, ND; Dressler, EM; Russo, K; Franz, EA; Turner, RS; Ventura, MI; Hinkley, L; Zweig, R; Nagarajan, SS; Ledbetter, CR; Sigvardt, KA				Disbrow, Elizabeth A.; Glassy, Nathaniel D.; Dressler, Elizabeth M.; Russo, Kimberley; Franz, Elizabeth A.; Turner, Robert S.; Ventura, Maria, I; Hinkley, Leighton; Zweig, Richard; Nagarajan, Srikantan S.; Ledbetter, Christina R.; Sigvardt, Karen A.			Cortical oscillatory dysfunction in Parkinson disease during movement activation and inhibition	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DORSOLATERAL PREFRONTAL CORTEX; INFERIOR FRONTAL GYRUS; EVENT-RELATED POTENTIALS; CHOICE-REACTION-TIME; RESPONSE-INHIBITION; BASAL GANGLIA; COGNITIVE CONTROL; GO/NO-GO; ELECTROENCEPHALOGRAPHIC ACTIVITY	Response activation and inhibition are functions fundamental to executive control that are disrupted in Parkinson disease (PD). We used magnetoencephalography to examine event related changes in oscillatory power amplitude, peak latency and frequency in cortical networks subserving these functions and identified abnormalities associated with PD. Participants (N = 18 PD, 18 control) performed a cue/target task that required initiation of an un-cued movement (activation) or inhibition of a cued movement. Reaction times were variable but similar across groups. Task related responses in gamma, alpha, and beta power were found across cortical networks including motor cortex, supplementary and pre-supplementary motor cortex, posterior parietal cortex, prefrontal cortex and anterior cingulate. PD-related changes in power and latency were noted most frequently in the beta band, however, abnormal power and delayed peak latency in the alpha band in the pre-supplementary motor area was suggestive of a compensatory mechanism. PD peak power was delayed in pre-supplementary motor area, motor cortex, and medial frontal gyrus only for activation, which is consistent with deficits in un-cued (as opposed to cued) movement initiation characteristic of PD.	[Disbrow, Elizabeth A.; Glassy, Nathaniel D.; Dressler, Elizabeth M.; Zweig, Richard; Ledbetter, Christina R.] LSU Hlth Shreveport Ctr Brain Hlth, Shreveport, LA 71103 USA; [Disbrow, Elizabeth A.; Zweig, Richard] LSU Hlth Shreveport, Dept Neurol, Shreveport, LA 71103 USA; [Russo, Kimberley] Univ Calif Berkeley, Dept Psychol, Berkeley, CA USA; [Franz, Elizabeth A.] Univ Otago, Dept Psychol, Act Brain & Cognit Lab, Dunedin, New Zealand; [Franz, Elizabeth A.] Univ Otago, fMRlotago, Dunedin, New Zealand; [Turner, Robert S.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Turner, Robert S.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Ventura, Maria, I] Univ Calif Davis, Dept Psychiat, Sacramento, CA USA; [Hinkley, Leighton; Nagarajan, Srikantan S.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Ledbetter, Christina R.] LSU Hlth Shreveport, Dept Neurosurg, Shreveport, LA USA; [Sigvardt, Karen A.] Univ Calif Davis, Dept Neurol, Sacramento, CA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of California System; University of California Berkeley; University of Otago; University of Otago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California San Francisco; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of California System; University of California Davis	Disbrow, EA (corresponding author), LSU Hlth Shreveport Ctr Brain Hlth, Shreveport, LA 71103 USA.; Disbrow, EA (corresponding author), LSU Hlth Shreveport, Dept Neurol, Shreveport, LA 71103 USA.	elizabeth.disbrow@lsuhs.edu	Turner, Robert/A-9695-2008	Turner, Robert/0000-0002-6074-4365	National Institute of Neurological Disorders and Stroke [RO1NS064040]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by a grant (RO1NS064040) from the National Institute of Neurological Disorders and Stroke awarded to EAD, and provided partial salary support to EAD and LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Anninos R, 2007, ACTA NEUROL BELG, V107, P5; Appel-Cresswell S, 2010, CURR OPIN NEUROL, V23, P407, DOI 10.1097/WCO.0b013e32833b6019; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Asada H, 1999, NEUROSCI LETT, V274, P29, DOI 10.1016/S0304-3940(99)00679-5; Babiloni C, 2005, BRAIN RES BULL, V65, P383, DOI 10.1016/j.brainresbull.2005.01.013; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Beste C, 2010, NEUROPSYCHOLOGIA, V48, P366, DOI 10.1016/j.neuropsychologia.2009.09.023; Beste C, 2009, EUR J NEUROSCI, V29, P855, DOI 10.1111/j.1460-9568.2009.06621.x; Blesa J, 2017, EXP NEUROL, V298, P148, DOI 10.1016/j.expneurol.2017.10.002; Bokura H, 2005, NEUROPSYCHOLOGIA, V43, P967, DOI 10.1016/j.neuropsychologia.2004.08.010; Boon LI, 2019, HUM BRAIN MAPP, V40, P2827, DOI 10.1002/hbm.24562; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Brown RG, 1999, ANN NEUROL, V45, P473, DOI 10.1002/1531-8249(199904)45:4<473::AID-ANA9>3.0.CO;2-V; Buhmann C, 2005, BRAIN, V128, P2281, DOI 10.1093/brain/awh572; Caviness JN, 2016, EUR J NEUROL, V23, P387, DOI 10.1111/ene.12878; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chao HHA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-75; Chen KHS, 2019, CLIN PHARMACOL THER, V106, P763, DOI 10.1002/cpt.1542; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chung SJ, 2018, CLIN NUCL MED, V43, P787, DOI 10.1097/RLU.0000000000002251; Cohen MX, 2011, NEUROIMAGE, V55, P1373, DOI 10.1016/j.neuroimage.2010.12.072; Cools AR., 1984, BASAL GANGLIA, P513; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Dalal S S, 2004, Neurol Clin Neurophysiol, V2004, P52; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; de Jong R, 2006, BRAIN RES, V1105, P73, DOI 10.1016/j.brainres.2006.03.030; de la Concha EO., 2018, SCI REP-UK, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Denny-Brown D, 1976, Res Publ Assoc Res Nerv Ment Dis, V55, P115; Dibble LE, 2004, GAIT POSTURE, V19, P215, DOI 10.1016/S0966-6362(03)00065-1; Disbrow EA, 2012, BRAIN RES, V1452, P151, DOI 10.1016/j.brainres.2012.02.073; Disbrow EA, 2013, J PARKINSON DIS, V3, P181, DOI 10.3233/JPD-130181; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fischer P, 2018, J NEUROSCI, V38, P5111, DOI 10.1523/JNEUROSCI.3596-17.2018; Fischer P, 2017, ELIFE, V6, DOI 10.7554/eLife.23947; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Franz E., 2006, RECENT BREAKTHROUGHS, P227; Franz EA, 2002, BRAIN, V125, P1733, DOI 10.1093/brain/awf192; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Georgiades MJ, 2019, BRAIN, V142, P3906, DOI 10.1093/brain/awz325; Geraedts VJ, 2018, NEUROLOGY, V91, P871, DOI 10.1212/WNL.0000000000006473; Goldstein DS, 2017, PARKINSONISM RELAT D, V35, P88, DOI 10.1016/j.parkreldis.2016.12.011; Guggisberg AG, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.014.2007; Guntekin B., 2019, CLIN NEUROPHYSIOL, V130, DOI [10.1016/j.clinph.2019.04.460, DOI 10.1016/J.CLINPH.2019.04.460]; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Harmony T, 2009, INT J PSYCHOPHYSIOL, V71, P9, DOI 10.1016/j.ijpsycho.2008.07.020; Hassan M, 2017, NEUROIMAGE-CLIN, V14, P591, DOI 10.1016/j.nicl.2017.03.002; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Heidema SG, 2020, PROG NEUROBIOL, V184, DOI 10.1016/j.pneurobio.2019.101731; Heilbronner SR, 2016, ANNU REV NEUROSCI, V39, P149, DOI 10.1146/annurev-neuro-070815-013952; HENIK A, 1993, CORTEX, V29, P589, DOI 10.1016/S0010-9452(13)80283-3; Hinkley LBN, 2019, J NEUROSCI, V39, P7321, DOI 10.1523/JNEUROSCI.3001-17.2019; Hinkley LBN, 2011, CEREB CORTEX, V21, P519, DOI 10.1093/cercor/bhq102; Hong XF, 2020, INT J PSYCHOPHYSIOL, V148, P1, DOI 10.1016/j.ijpsycho.2019.11.011; Hsieh YH, 2008, KAOHSIUNG J MED SCI, V24, P197, DOI 10.1016/S1607-551X(08)70117-7; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hughes LE, 2018, BRAIN, V141, P2486, DOI 10.1093/brain/awy176; Hunerli D, 2019, CLIN NEUROPHYSIOL, V130, P1208, DOI 10.1016/j.clinph.2019.04.314; Iijima M, 2015, NEUROPSYCHOBIOLOGY, V71, P17, DOI 10.1159/000363341; Jacobs JV, 2009, NEUROSCIENCE, V164, P877, DOI 10.1016/j.neuroscience.2009.08.002; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; JAHANSHAHI M, 1992, BRAIN, V115, P539, DOI 10.1093/brain/115.2.539; Jankovic J, 2005, MOVEMENT DISORD, V20, pS11, DOI 10.1002/mds.20458; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jokinen P, 2013, J NEUROL SCI, V329, P23, DOI 10.1016/j.jns.2013.03.006; Kamei S, 2010, J CLIN NEUROPHYSIOL, V27, P193, DOI 10.1097/WNP.0b013e3181dd4fdb; Kim C, 2013, BRAIN RES, V1537, P216, DOI 10.1016/j.brainres.2013.08.055; Kirschfeld K, 2005, BIOL CYBERN, V92, P177, DOI 10.1007/s00422-005-0547-1; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klostermann F, 2007, EUR J NEUROSCI, V25, P1604, DOI 10.1111/j.1460-9568.2007.05417.x; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Kramer UM, 2013, CORTEX, V49, P837, DOI 10.1016/j.cortex.2012.05.003; Kubler A, 2006, J COGNITIVE NEUROSCI, V18, P1331, DOI 10.1162/jocn.2006.18.8.1331; Lanciego JL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009621; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lewis SJG, 2005, NEUROPSYCHOLOGIA, V43, P823, DOI 10.1016/j.neuropsychologia.2004.10.001; Lim VK, 2006, BRAIN RES BULL, V71, P245, DOI 10.1016/j.brainresbull.2006.09.009; Logan Gordon D., 1994, P189; Loh KK, 2018, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00753; Lykouras L, 1998, PSYCHOPATHOLOGY, V31, P213, DOI 10.1159/000029042; Mak MK, 2015, MOVEMENT DISORD, V30, pS17; Manza P, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0024-2; Martinu K, 2013, BEHAV NEUROSCI, V127, P222, DOI 10.1037/a0031226; Meziane HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114817; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Miller JO, 2001, J EXP PSYCHOL HUMAN, V27, P266, DOI 10.1037//0096-1523.27.2.266; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mitchell DGV, 2008, BEHAV BRAIN RES, V187, P80, DOI 10.1016/j.bbr.2007.08.034; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; MORRISH PK, 1995, J NEUROL NEUROSUR PS, V59, P597, DOI 10.1136/jnnp.59.6.597; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Narayanan NS, 2013, REV NEUROSCIENCE, V24, P267, DOI 10.1515/revneuro-2013-0004; Nguyen HM, 2020, NEUROREHABILITATION, V46, P311, DOI 10.3233/NRE-192940; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nieuwboer A, 2008, MOVEMENT DISORD, V23, pS475, DOI 10.1002/mds.21978; Obeso I, 2017, BRAIN STIMUL, V10, P944, DOI 10.1016/j.brs.2017.05.008; Obeso I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00150; Obeso I, 2011, EXP BRAIN RES, V212, P371, DOI 10.1007/s00221-011-2736-6; Obeso JA, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00039; Okada Y, 1983, BIOMAGN INTERDISCIP; Onofrj M, 2005, NEUROLOGY, V64, P1162, DOI 10.1212/01.WNL.0000157058.17871.7B; Ortuno F, 2002, NEUROIMAGE, V17, P411, DOI 10.1006/nimg.2002.1168; Ozmus G, 2017, NOROPSIKIYATRI ARS, V54, P21, DOI 10.5152/npa.2016.12455; Pal G, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0205-y; Pelicioni PHS, 2020, NEUROREHAB NEURAL RE, V34, P1088, DOI 10.1177/1545968320969943; Perfetti B, 2011, ATTENTION MODULATION, P15; Pollok B, 2012, J PHYSIOL-LONDON, V590, P3203, DOI 10.1113/jphysiol.2012.231316; Praamstra P, 2007, J NEUROPHYSIOL, V98, P2848, DOI 10.1152/jn.00224.2007; Ray NJ, 2012, NEUROIMAGE, V60, P271, DOI 10.1016/j.neuroimage.2011.12.035; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Robinson SE., 1998, BIOMAG; Roux F, 2013, J NEUROSCI, V33, P17827, DOI 10.1523/JNEUROSCI.5778-12.2013; Rubinstein TC, 2002, MOVEMENT DISORD, V17, P1148, DOI 10.1002/mds.10259; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Sawamoto N, 2007, NEUROLOGY, V68, P1062, DOI 10.1212/01.wnl.0000257821.28992.db; Scheffels JF, 2020, J NEUROL SCI, V412, DOI 10.1016/j.jns.2020.116735; Seer C, 2016, NEUROSCI BIOBEHAV R, V71, P691, DOI 10.1016/j.neubiorev.2016.08.003; Sekihara K, 2008, SER BIOMED ENG, P1; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Shibata T, 1999, NEUROSCI RES, V33, P215, DOI 10.1016/S0168-0102(99)00003-6; Shook SK, 2005, NEUROPSYCHOLOGIA, V43, P1990, DOI 10.1016/j.neuropsychologia.2005.03.024; Singh KD, 2003, NEUROIMAGE, V19, P1589, DOI 10.1016/S1053-8119(03)00249-0; Singh SP, 2014, ANN INDIAN ACAD NEUR, V17, pS107, DOI 10.4103/0972-2327.128676; Solis-Vivanco R, 2018, NEUROIMAGE-CLIN, V18, P923, DOI 10.1016/j.nicl.2018.03.024; Solis-Vivanco R, 2015, CLIN NEUROPHYSIOL, V126, P2142, DOI 10.1016/j.clinph.2014.12.024; Spaulding SJ, 2013, ARCH PHYS MED REHAB, V94, P562, DOI 10.1016/j.apmr.2012.10.026; Stoffers D, 2007, BRAIN, V130, P1847, DOI 10.1093/brain/awm034; Swann N, 2009, J NEUROSCI, V29, P12675, DOI 10.1523/JNEUROSCI.3359-09.2009; Swann NC, 2012, NEUROIMAGE, V59, P2860, DOI 10.1016/j.neuroimage.2011.09.049; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Tabu H, 2011, NEUROSCI RES, V70, P277, DOI 10.1016/j.neures.2011.03.007; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Tollner T, 2017, J NEUROSCI, V37, P2504, DOI 10.1523/JNEUROSCI.1752-16.2017; Tokic Kristina, 2016, Med Arch, V70, P453, DOI 10.5455/medarh.2016.70.453-456; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; van den Wildenberg WPM, 2017, BEHAV NEUROSCI, V131, P372, DOI 10.1037/bne0000210; van den Wildenberg WPM, 2006, J COGNITIVE NEUROSCI, V18, P626, DOI 10.1162/jocn.2006.18.4.626; van Nuenen BFL, 2009, MOVEMENT DISORD, V24, pS703, DOI 10.1002/mds.22635; van Schouwenburg M, 2010, CURR PHARM DESIGN, V16, P2026, DOI 10.2174/138161210791293097; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vogt BA, 2019, HAND CLINIC, V166, P253, DOI 10.1016/B978-0-444-64196-0.00013-3; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010; Vriend C, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102257; Waninger S, 2020, J PARKINSON DIS, V10, P471, DOI 10.3233/JPD-191844; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Woodcock EA, 2015, BEHAV BRAIN RES, V290, P152, DOI 10.1016/j.bbr.2015.04.050; Wu HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39572-w; Wu T, 2011, NEUROIMAGE, V55, P204, DOI 10.1016/j.neuroimage.2010.11.074; Yun JY, 2018, PARKINSONISM RELAT D, V46, pE77	165	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0257711	10.1371/journal.pone.0257711	http://dx.doi.org/10.1371/journal.pone.0257711			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245294	Green Published, gold			2022-12-26	WOS:000799799100001
J	Elhadi, YAM; Ahmed, A; Salih, EB; Abdelhamed, OS; Ahmed, MHH; El Dabbah, NA				Elhadi, Yasir Ahmed Mohammed; Ahmed, Abdelmuniem; Salih, Elhadi B.; Abdelhamed, Osman S.; Ahmed, Mohamed Hayder Hamid; El Dabbah, Noha Ahmed			A cross-sectional survey of burnout in a sample of resident physicians in Sudan	PLOS ONE			English	Article							HEALTH-CARE WORKERS; PREVALENCE; SATISFACTION; CONSEQUENCES; RESILIENCE; DOCTORS; IMPACT; RISK	Background Resident physicians in Sudan face a variety of physical and psychological stressors. Nevertheless, the prevalence of burnout syndrome among this critical population remains unknown. The purpose of this study was to estimate the prevalence rate of burnout and its associated factors in a sample of resident physicians in Sudan. Methods A cross-sectional design was used to assess the burnout syndrome among resident physicians at the teaching hospitals of Wad-Medani in Gezira state, east-central Sudan. Three hundred resident physicians at the dermatology, general surgery, pediatrics, obstetrics and gynecology, psychiatry, ear, nose and throat (ENT), oncology, urology, and internal medicine departments, were approached and invited to participate in the study. The Arabic version of the Maslach Burnout Inventory was distributed to respondents from July to October 2021. Results From the 300 resident physicians, 208 (69.3%) responded. The average age of the study population was 29.99 3.01 years, with more than half were females (56.7%), single (59.6%), and with more than three years of residency experience (50.5%). In total, 86.1% met the criteria for burnout in at least one dimension and 13.9% in all three dimensions. On the dimension of emotional exhaustion (EE), 70.7% reported high levels of burnout. While, 44.2% reported high levels of depersonalization (DP), and 73.1% experienced a sense of decreased professional accomplishment (PA). There were significant differences in burnout, EE, and DP levels among different specialties, with the pediatrics-specialty trainees reported higher levels. Burnout syndrome was associated with the working hours per single duty; participants who reported working for more than 24 hours had experienced higher levels of burnout, EE, and DP. Conclusion Large-scale studies are required to assess the determinants of burnout syndrome among resident physicians in Sudan. In addition, Stakeholders should urgently implement effective remedies to protect the mental health of resident physicians.	[Elhadi, Yasir Ahmed Mohammed; El Dabbah, Noha Ahmed] Alexandria Univ, Dept Hlth Adm & Behav Sci, High Inst Publ Hlth, Alexandria, Egypt; [Elhadi, Yasir Ahmed Mohammed] Sudanese Med Res Assoc, Dept Publ Hlth, Med Res Off, Khartoum, Sudan; [Ahmed, Abdelmuniem] Univ Gezira, Fac Med, Physiol Dept, Wad Madani, Sudan; [Salih, Elhadi B.] Fed Minist Hlth, Khartoum, Sudan; [Abdelhamed, Osman S.] Ahfad Univ Women, Fac Med, Omdurman, Sudan; [Ahmed, Mohamed Hayder Hamid] Sudanese Med Specializat Board, Wad Madani, Sudan	Egyptian Knowledge Bank (EKB); Alexandria University	Elhadi, YAM (corresponding author), Alexandria Univ, Dept Hlth Adm & Behav Sci, High Inst Publ Hlth, Alexandria, Egypt.; Elhadi, YAM (corresponding author), Sudanese Med Res Assoc, Dept Publ Hlth, Med Res Off, Khartoum, Sudan.	hiph.yelhadi@alex.edu.eg	Elhadi, Yasir Ahmed Mohammed/AAH-8884-2021	Elhadi, Yasir Ahmed Mohammed/0000-0003-3649-0374; Abdelhamed, Osman/0000-0001-7528-6291; EL Dabbah, Noha/0000-0001-6321-9219; /0000-0002-9910-0831; SALIH, ELHADI BASHEER ELHADI/0000-0002-8279-6983				Abbas A, 2019, EGYPT J CHEST DIS TU, V68, P514, DOI 10.4103/ejcdt.ejcdt_188_18; Abdulrahman Mahera, 2018, J Family Med Prim Care, V7, P435, DOI 10.4103/jfmpc.jfmpc_199_17; Afzal KI, 2010, SOUTH MED J, V103, P607, DOI 10.1097/SMJ.0b013e3181e20cad; Agha A, 2015, WORK, V51, P839, DOI 10.3233/WOR-141898; Al-Dubai SAR, 2013, SCI WORLD J, DOI 10.1155/2013/137620; Alhaffar BA, 2019, J OCCUP MED TOXICOL, V14, DOI 10.1186/s12995-019-0250-0; [Anonymous], MIND GARDEN; [Anonymous], Sudan Medical Specialization Board | Health Information For All (HIFA.ORG); [Anonymous], DEPRESSION WHAT IS B; Baer TE, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2163; Ben Zid A, 2018, ENCEPHALE, V44, P337, DOI 10.1016/j.encep.2017.06.006; Bin Dahmash A, 2021, OCHSNER J, V21, P152, DOI 10.31486/toj.20.0037; Chaukos D, 2017, ACAD PSYCHIATR, V41, P189, DOI 10.1007/s40596-016-0628-6; Chen KY, 2013, INT J MED SCI, V10, P1471, DOI 10.7150/ijms.6743; Cheng MY, 2020, MED SCI EDUC, V30, P315, DOI 10.1007/s40670-019-00905-z; De Hert S, 2020, LOCAL REG ANESTH, V13, P171, DOI 10.2147/LRA.S240564; del Carmen MG, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0554; Denning M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0238666; El Dabbah NA., 2021, BURNOUT FRONTLINE HL, DOI [10.21203/RS.3.RS-951355/V1, DOI 10.21203/RS.3.RS-951355/V1]; Elhadi YAM, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.supp.2020.35.137.24984; Fadul N, 2021, CURR TROP MED REP, V8, P231, DOI 10.1007/s40475-021-00237-2; Ferguson C, 2020, POSTGRAD MED J, V96, P331, DOI 10.1136/postgradmedj-2019-137314; Fred HL, 2018, TEX HEART I J, V45, P198, DOI 10.14503/THIJ-18-6842; Gan Y, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7755-4; Ghaleb Y, 2021, J PUBLIC HEALTH-UK, V43, P34, DOI 10.1093/pubmed/fdab321; Hameed TK, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1300-5; Hamid AAM, 2020, S AFR J PSYCHOL, V50, P411, DOI 10.1177/0081246319898054; Hu NC, 2016, J OCCUP ENVIRON MED, V58, P514, DOI 10.1097/JOM.0000000000000715; IWANICKI EF, 1981, EDUC PSYCHOL MEAS, V41, P1167, DOI 10.1177/001316448104100425; Jamjoom RS, 2018, SAUDI MED J, V39, P296, DOI 10.15537/smj.2018.3.22328; Lacy BE, 2018, CLIN GASTROENTEROL H, V16, P311, DOI 10.1016/j.cgh.2017.06.043; Lim WY, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010061; Lucero-Prisno Don Eliseo 3rd, 2020, Public Health Pract (Oxf), V1, P100060, DOI 10.1016/j.puhip.2020.100060; Mahan JD, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4233; Mahgoub IM, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.2318; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; McKinley TF., 2017, BURNOUT RES, V6, P9, DOI DOI 10.1016/J.BURN.2017.02.003; Mohamed AS., 2019, PUBLIC HEALTH, V3, P32, DOI [10.7196/SHS.2019.v3i2.88, DOI 10.7196/SHS.2019.V3I2.88, 10.1111/j.1540-4560.1974.tb00706.x]; Nituica C, 2021, AM J SURG, V222, P319, DOI 10.1016/j.amjsurg.2020.12.039; Ofei-Dodoo S, 2019, FAM MED, V51, P766, DOI 10.22454/FamMed.2019.431489; Ogundipe OA, 2014, ASIAN J PSYCHIATR, V10, P27, DOI 10.1016/j.ajp.2014.02.010; Poghosyan L, 2009, INT J NURS STUD, V46, P894, DOI 10.1016/j.ijnurstu.2009.03.004; Portoghese I, 2014, SAF HEALTH WORK-KR, V5, P152, DOI 10.1016/j.shaw.2014.05.004; Rose S., 2009, AM J EPIDEMIOL, V170, P1451, DOI [10.1093/aje/kwp334, DOI 10.1093/AJE/KWP334, 10.1093/AJE/KWP334]; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P432, DOI 10.1016/j.mayocp.2015.01.012; Shanafelt TD, 2014, J CLIN ONCOL, V32, P678, DOI 10.1200/JCO.2013.51.8480; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; TAHA MH., 2019, FUTUR MED ED J, V9, P3, DOI [10.22038/FMEJ.2019.13983, DOI 10.22038/FMEJ.2019.13983]; Taha MH, 2019, J MED EDUC CURRIC DE, V6, DOI 10.1177/2382120519888639; Wang J, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05694-5; World Health Organization, 2019, BURN OUT OCC PHEN IN; World Health Organization, GLOBAL HLTH WORKFORC; Zeijlemaker C, 2019, SAMJ S AFR MED J, V109, P668, DOI [10.7196/samj.2019.v109i9.13667, 10.7196/SAMJ.2019.v109i9.13667]; Zhou ALY, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13761; Zis Panagiotis, 2014, ScientificWorldJournal, V2014, P673279, DOI 10.1155/2014/673279	59	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0265098	10.1371/journal.pone.0265098	http://dx.doi.org/10.1371/journal.pone.0265098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245338	gold, Green Published, Green Submitted			2022-12-26	WOS:000799799100049
J	Velazquez, EJ; Cress, JD; Humpherys, TB; Mortimer, TO; Bellini, DM; Skidmore, JR; Smith, KR; Robison, RA; Weber, SK; O'Neill, KL				Velazquez, Edwin J.; Cress, Jordan D.; Humpherys, Tyler B.; Mortimer, Toni O.; Bellini, David M.; Skidmore, Jonathan R.; Smith, Kathryn R.; Robison, Richard A.; Weber, Scott K.; O'Neill, Kim L.			Selection of human single domain antibodies (sdAb) against thymidine kinase 1 and their incorporation into sdAb-Fc antibody constructs for potential use in cancer therapy	PLOS ONE			English	Article							LYMPHOMA; MARKER; BREAST; HUMAN-THYMIDINE-KINASE-1; LOCALIZATION; IMMUNOTOXINS; DEGRADATION; EXPRESSION; PROGNOSIS; BIOMARKER	Thymidine Kinase 1 (TK1) is primarily known as a cancer biomarker with good prognostic capabilities for both hematological and solid malignancies. However, recent studies targeting TK1 at protein and mRNA levels have shown that TK1 may be useful as a therapeutic target. In order to examine the use of TK1 as a therapeutic target, it is necessary to develop therapeutics specific for it. Single domain antibodies (sdAbs), represent an exciting approach for the development of immunotherapeutics due to their cost-effective production and higher tumor penetration than conventional antibodies. In this study, we isolated sdAb fragments specific to human TK1 from a human sdAb library. A total of 400 sdAbs were screened through 5 rounds of selection by monoclonal phage ELISA. The most sensitive sdAb fragments were selected as candidates for preclinical testing. The sdAb fragments showed specificity for human TK1 in phage ELISA, Western blot analysis and had an estimated limit of detection of 3.9 ng/ml for the antibody fragments 4-H-TK1_A1 and 4-H-TK1_D1. The antibody fragments were successfully expressed and used for detection of membrane associated TK1 (mTK1) through flow cytometry on cancer cells [lung (~95%), colon (~87%), breast (~53%)] and healthy human mononuclear cells (MNC). The most sensitive antibody fragments, 4-H-TK1_A1 and 4-H-TK1_D1 were fused to an engineered IgG1 Fc fragment. When added to cancer cells expressing mTK1 co-cultured with human MNCs, the anti-TK1-sdAb-IgG1_A1 and D1 were able to elicit a significant antibody-dependent cell-mediated cytotoxicity (ADCC) response against lung cancer cells compared to isotype controls (P<0.0267 and P<0.0265, respectively). To our knowledge this is the first time that the isolation and evaluation of human anti-TK1 single domain antibodies using phage display technology has been reported. The antibody fragments isolated here may represent a valuable resource for the detection and the targeting of TK1 on tumor cells.	[Velazquez, Edwin J.; Cress, Jordan D.; Humpherys, Tyler B.; Mortimer, Toni O.; Bellini, David M.; Skidmore, Jonathan R.; Smith, Kathryn R.; Robison, Richard A.; Weber, Scott K.; O'Neill, Kim L.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Brigham Young University	O'Neill, KL (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	kim_oneill@byu.edu	Weber, Scott/O-1022-2014	Weber, Scott/0000-0003-3688-2191; O'Neill, Kim/0000-0002-8747-6217	BYU's Simmons Center for Cancer Research; Department of Microbiology and Molecular Biology at Brigham Young University; Mexican Council of Science and Technology (CONACyT) [411434]	BYU's Simmons Center for Cancer Research; Department of Microbiology and Molecular Biology at Brigham Young University; Mexican Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding for this research was partially obtained from a cancer fellowship from the BYU's Simmons Center for Cancer Research and the Department of Microbiology and Molecular Biology at Brigham Young University to fund the salaries of one graduate student EJV and research assistants JDC, TBH. This research was also partially Dsponsored with a scholarship from the Mexican Council of Science and Technology (CONACyT) #411434 awarded to EVJ. There was no additional external funding received for this study.	Alberts B., 2002, MOL BIOL CELL GARLAN; Alegre MM, 2012, J ONCOL, V2012, DOI 10.1155/2012/575647; Alegre MM, 2014, ANTICANCER RES, V34, P2145; Almagro JC, 2019, ANTIBODIES, V8, DOI 10.3390/antib8030044; Barderas R, 2019, ANAL BIOANAL CHEM, V411, DOI 10.1007/s00216-019-01714-4; Birringer MS, 2006, PROTEIN EXPRES PURIF, V47, P506, DOI 10.1016/j.pep.2006.01.001; Buj R, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00177; Chen Y, 2010, INT J CLIN ONCOL, V15, P359, DOI 10.1007/s10147-010-0067-4; Chen ZH, 2011, SENSORS-BASEL, V11, P11064, DOI 10.3390/s111211064; De Maio A, 2014, CURR PROTEIN PEPT SC, V15, P225, DOI 10.2174/1389203715666140331113057; Desimoni E., 2015, PHARM ANAL ACTA, V6; Eriksson S., 2020, Patent No. [3536713B1, 3536713]; Frenzel A, 2016, MABS-AUSTIN, V8, P1177, DOI 10.1080/19420862.2016.1212149; Gatt ME, 2015, ANTICANCER RES, V35, P3019; HALLEK M, 1992, ANN HEMATOL, V65, P1, DOI 10.1007/BF01715117; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He E, 2010, NUCLEOS NUCLEOT NUCL, V29, P352, DOI 10.1080/15257771003738535; He Q, 2006, ANTICANCER RES, V26, P4753; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jagarlamudi KK, 2018, BIOMARK MED, V12, P1035, DOI 10.2217/bmm-2018-0157; KAUFFMAN MG, 1991, MOL CELL BIOL, V11, P2538, DOI 10.1128/MCB.11.5.2538; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Kumar JK, 2016, TUMOR BIOL, V37, P11937, DOI 10.1007/s13277-016-5024-z; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Li N, 2017, P NATL ACAD SCI USA, V114, pE6623, DOI 10.1073/pnas.1706055114; Liu C, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01475; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Lu RM, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-019-0592-z; Malvi P, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008439; Manis JP, 2020, OVERVIEW THERAPEUTIC; Marintcheva B., 2018, HARNESSING POWER VIR, P133; MUNCHPETERSEN B, 1995, ADV ENZYME REGUL, V35, P69, DOI 10.1016/0065-2571(94)00014-T; O'Neill K L, 2001, Expert Rev Mol Diagn, V1, P428, DOI 10.1586/14737159.1.4.428; Parakh Sagun, 2020, Recent Results Cancer Res, V214, P1, DOI 10.1007/978-3-030-23765-3_1; Schrankel CS, 2019, METHOD CELL BIOL, V151, P353, DOI 10.1016/bs.mcb.2018.11.005; Shojai TM., 2019, THESIS SWEDISH U AGR; Somyajit K, 2017, SCIENCE, V358, P797, DOI 10.1126/science.aao3172; Topolcan Ondrej, 2008, Expert Opin Med Diagn, V2, P129, DOI 10.1517/17530059.2.2.129; Townsend MH, 2021, EXP CELL RES, V403, DOI 10.1016/j.yexcr.2021.112567; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Valadon P, 2019, MABS-AUSTIN, V11, P516, DOI 10.1080/19420862.2019.1571879; Van de Broek B, 2011, ACS NANO, V5, P4319, DOI 10.1021/nn1023363; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Velazquez EJ, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01198-8; Villa E, 2019, CANCERS, V11, DOI 10.3390/cancers11050688; Wang Y, 2018, CANCER BIOMARK, V22, P237, DOI [10.3233/CBM-170846, 10.3233/cbm-170846]; Weagel EG, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0633-9; Weagel EG, 2017, ONCOTARGETS THER, V10, P4355, DOI 10.2147/OTT.S141239; Welin M, 2004, P NATL ACAD SCI USA, V101, P17970, DOI 10.1073/pnas.0406332102; Yu Y, 2017, INT J NANOMED, V12, P1969, DOI 10.2147/IJN.S127575; Zhao AZ, 2016, CRIT REV BIOTECHNOL, V36, P276, DOI 10.3109/07388551.2014.958978; Zhou J, 2013, MOL CLIN ONCOL, V1, P18, DOI 10.3892/mco.2012.19; Zhu XL, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12428	54	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264822	10.1371/journal.pone.0264822	http://dx.doi.org/10.1371/journal.pone.0264822			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239730	gold, Green Submitted, Green Published			2022-12-26	WOS:000776002200080
J	Shabbir, MA; Shaukat, MHS; Ehtesham, M; Murawski, S; Singh, S; Alimohammad, R				Shabbir, Muhammad Asim; Shaukat, Muhammad Hamza Saad; Ehtesham, Moiz; Murawski, Shannon; Singh, Sukhraj; Alimohammad, Rizwan			Bifascicular block in unexplained syncope is underrecognized and under-evaluated: A single-center audit of ESC guidelines adherence	PLOS ONE			English	Article							BUNDLE-BRANCH BLOCK; ACC/AHA/HRS; MANAGEMENT	Background The presence of bifascicular block on electrocardiography suggests that otherwise-unexplained syncope may be due to complete heart block. European Society of Cardiology (ESC) recommends investigating it with electrophysiology study (EPS). PPM is indicated if high-degree atrioventricular block is inducible. Long term rhythm monitoring with implantable loop recorder (ILR) is recommended if EPS is negative. We evaluated adherence to these guidelines. Methods This is a single-center retrospective audit of adult patients with bifascicular block hospitalized for unexplained syncope between January 2018 and August 2019 under general medicine service. Patients with an alternative explanation for syncope were excluded. Guideline adherence was assessed by formal cardiology consult and whether EPS followed by ILR and/or PPM were offered. Results 65 out of 580 adult patients (11.2%) admitted to general medicine service for syncope had a bifascicular block; 29 (5%) were identified to have bifascicular block and unexplained syncope. Median age was 77 10 years; 9 (31%) were female, and 6 (20.7%) patients had at least one prior hospital visit for syncope at our academic medical center. Cardiology was consulted on 17 (58.6%) patients. Two patients were evaluated by EPS (1 refused) followed by ILR. Overall, 3 out of 29 patients (10.3%) received guideline-directed evaluation during the hospitalization based on ESC guidelines. None of the patients received empiric PPM during the index hospitalization. Conclusion Among patients admitted to the general medicine service with unexplained syncope and bifascicular block, a minority (10.3%) underwent guideline-directed evaluation per ESC recommendations. Cardiology was consulted in 58.6% of cases.	[Shabbir, Muhammad Asim; Shaukat, Muhammad Hamza Saad; Ehtesham, Moiz; Murawski, Shannon; Singh, Sukhraj] Albany Med Coll, Dept Internal Med, Albany, NY 12208 USA; [Alimohammad, Rizwan] Albany Med Coll, Dept Cardiol, Capital Cardiol Associates, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Shabbir, MA (corresponding author), Albany Med Coll, Dept Internal Med, Albany, NY 12208 USA.	asimshabbir202@gmail.com		Shabbir, Muhammad Asim/0000-0001-8275-3847				Angus S, 2016, MED CLIN N AM, V100, P1019, DOI 10.1016/j.mcna.2016.04.010; [Anonymous], RACTrac survey: Exploring the impact of the RAC program on hospitals nationwide; Brignole M, 2001, CIRCULATION, V104, P2045, DOI 10.1161/hc4201.097837; Brignole M, 2018, KARDIOL POL, V76, P1119, DOI [10.5603/KP.2018.0161, 10.1016/j.recesp.2018.08.018]; DHINGRA RC, 1974, ANN INTERN MED, V81, P302, DOI 10.7326/0003-4819-81-3-302; Goldberger ZD, 2019, J AM COLL CARDIOL, V74, P2410, DOI 10.1016/j.jacc.2019.09.012; Krahn AD, 2012, EUROPACE, V14, P1044, DOI 10.1093/europace/eus005; MCANULTY JH, 1982, NEW ENGL J MED, V307, P137, DOI 10.1056/NEJM198207153070301; Saad Shaukat M.H, 2020, CASE REPORTS, V4, P1; Santini M, 2013, CIRC-ARRHYTHMIA ELEC, V6, P101, DOI 10.1161/CIRCEP.112.975102; Shen WK, 2017, HEART RHYTHM, V14, pE155, DOI 10.1016/j.hrthm.2017.03.004; Sun BC, 2005, AM J CARDIOL, V95, P668, DOI 10.1016/j.amjcard.2004.11.013; Sun BC, 2014, ANN EMERG MED, V64, P167, DOI 10.1016/j.annemergmed.2013.10.029	13	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0263727	10.1371/journal.pone.0263727	http://dx.doi.org/10.1371/journal.pone.0263727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226666	gold, Green Published			2022-12-26	WOS:000793394000003
J	Landras, A; de Moura, CR; Villoutreix, BO; Battistella, M; Sadoux, A; Dumaz, N; Menashi, S; Fernandez-Recio, J; Lebbe, C; Mourah, S				Landras, Alexandra; de Moura, Coralie Reger; Villoutreix, Bruno O.; Battistella, Maxime; Sadoux, Aurelie; Dumaz, Nicolas; Menashi, Suzanne; Fernandez-Recio, Juan; Lebbe, Celeste; Mourah, Samia			Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction	ONCOGENE			English	Article							METASTATIC MELANOMA; GROWTH-FACTOR; OPEN-LABEL; PHASE-II; MEK INHIBITORS; BRAF; STAT3; MULTICENTER; BIOMARKER; SURVIVAL	More than 70% of human NRAS(mut) melanomas are resistant to MEK inhibitors highlighting the crucial need for efficient therapeutic strategies for these tumors. CD147, a membrane receptor, is overexpressed in most cancers including melanoma and is associated with poor prognosis. We show here that CD147i, a specific inhibitor of CD147/VEGFR-2 interaction represents a potential therapeutic strategy for NRAS(mut) melanoma cells. It significantly inhibited the malignant properties of NRAS(mut) melanomas ex vivo and in vivo. Importantly, NRAS(mut) patient's-derived xenografts, which were resistant to MEKi, became sensitive when combined with CD147i leading to decreased proliferation ex vivo and tumor regression in vivo. Mechanistic studies revealed that CD147i effects were mediated through STAT3 pathway. These data bring a proof of concept on the impact of the inhibition of CD147/VEGFR-2 interaction on melanoma progression and represents a new therapeutic opportunity for NRAS(mut) melanoma when combined with MEKi.	[Landras, Alexandra; de Moura, Coralie Reger; Battistella, Maxime; Dumaz, Nicolas; Lebbe, Celeste; Mourah, Samia] Univ Paris, UMR S976, INSERM, F-75010 Paris, France; [de Moura, Coralie Reger; Sadoux, Aurelie; Menashi, Suzanne; Mourah, Samia] Hop St Louis, AP HP, Pharmacogen Dept, F-75010 Paris, France; [Villoutreix, Bruno O.] Hop Robert Debre, UMR S1141, INSERM, F-75019 Paris, France; [Battistella, Maxime] Hop St Louis, AP HP, Pathol Dept, F-75010 Paris, France; [Fernandez-Recio, Juan] Univ La Rioja, Inst Ciencias & Vino ICVV, CSIC, Gobierno La Rioja, Logrono, Spain; [Lebbe, Celeste] Hop St Louis, AP HP, Dermatol Dept, F-75010 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de La Rioja; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Mourah, S (corresponding author), Univ Paris, UMR S976, INSERM, F-75010 Paris, France.; Mourah, S (corresponding author), Hop St Louis, AP HP, Pharmacogen Dept, F-75010 Paris, France.	samia.mourah@aphp.fr	Battistella, Maxime/K-2949-2012; Landras, Alexandra/GNP-5158-2022; Dumaz, Nicolas/B-5907-2008	Battistella, Maxime/0000-0002-7053-7431; Reger de Moura, Coralie/0000-0002-3728-6722; Villoutreix, Bruno/0000-0002-6456-7730; Mourah, Samia/0000-0002-9283-1068; Dumaz, Nicolas/0000-0003-3511-2160	La Ligue Nationale contre le Cancer; Institut National de la Sante et de la Recherche Medicale (INSERM); La Societe Francaise de Dermatologie; Spanish Ministry of Science and Innovation [PID2019-110167RB-I00]; Ligue Nationale contre le Cancer	La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Societe Francaise de Dermatologie; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported by La Ligue Nationale contre le Cancer, the Institut National de la Sante et de la Recherche Medicale (INSERM) and La Societe Francaise de Dermatologie. AL was supported by a PhD funding from La Ligue Nationale contre le Cancer and the Spanish Ministry of Science and Innovation (PID2019-110167RB-I00). We thank technological platform of the Institut Recherche Saint-Louis (IRSL) for confocal microscopy analyses and Dr Benoit Souquet for technical support.	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; Boespflug A, 2017, THER ADV MED ONCOL, V9, P481, DOI 10.1177/1758834017708160; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Caudron A, 2016, EXP DERMATOL, V25, P618, DOI 10.1111/exd.13022; Chapman PB, 2017, ANN ONCOL, V28, P2581, DOI 10.1093/annonc/mdx339; Chen SH, 2008, CANCER BIOL THER, V7, P1994, DOI 10.4161/cbt.7.12.6967; Davis EJ, 2018, CANCER-AM CANCER SOC, V124, P3490, DOI 10.1002/cncr.31345; de Moura CR, 2020, TRANSL ONCOL, V13, P275, DOI 10.1016/j.tranon.2019.10.003; Decoster L, 2015, ANTICANCER RES, V35, P6893; Delord JP, 2017, CLIN CANCER RES, V23, P5339, DOI 10.1158/1078-0432.CCR-16-2923; Delyon J, 2018, J INVEST DERMATOL, V138, P58, DOI 10.1016/j.jid.2017.07.839; Delyon J, 2016, ONCOTARGET, V7, P13069, DOI 10.18632/oncotarget.7541; Dummer R, 2017, LANCET ONCOL, V18, P435, DOI 10.1016/S1470-2045(17)30180-8; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Echevarria-Vargas IM, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708446; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Fedorenko IV, 2013, ONCOGENE, V32, P3009, DOI 10.1038/onc.2012.453; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Fu ZG, 2016, ONCOTARGET, V7, P9430, DOI 10.18632/oncotarget.6990; Graells J, 2004, J INVEST DERMATOL, V123, P1151, DOI 10.1111/j.0022-202X.2004.23460.x; Grass GD, 2013, J BIOL CHEM, V288, P26089, DOI 10.1074/jbc.M113.497685; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hayes TK, 2019, CANCER RES, V79, P2352, DOI 10.1158/0008-5472.CAN-18-2711; Hillion J, 2008, CANCER RES, V68, P10121, DOI 10.1158/0008-5472.CAN-08-2121; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Jiang TX, 2012, BLOOD, V120, P2330, DOI 10.1182/blood-2012-01-406108; Jouve N, 2015, INT J CANCER, V137, P50, DOI 10.1002/ijc.29370; Khayati F, 2015, ONCOTARGET, V6, P9766, DOI 10.18632/oncotarget.2870; Kim J, 2020, CANCERS, V12, DOI 10.3390/cancers12010119; Kinsey CG, 2019, NAT MED, V25, P620, DOI 10.1038/s41591-019-0367-9; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Landras A, 2019, CANCERS, V11, DOI 10.3390/cancers11111803; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Lebbe C, 2020, CANCERS, V12, DOI 10.3390/cancers12071727; LOCKSHIN A, 1985, CANCER RES, V45, P345; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; Mahapatra DK, 2017, EXPERT OPIN THER PAT, V27, P887, DOI 10.1080/13543776.2017.1339688; Mandala M, 2014, CRIT REV ONCOL HEMAT, V92, P107, DOI 10.1016/j.critrevonc.2014.05.005; Munoz-Couselo E, 2017, ONCOTARGETS THER, V10, P3941, DOI 10.2147/OTT.S117121; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Oladipupo SS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33037-2; Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110; Robinson JP, 2017, MELANOMA RES, V27, P545, DOI 10.1097/CMR.0000000000000403; Sarkisian S, 2018, DRUG DES DEV THER, V12, P2553, DOI 10.2147/DDDT.S131721; Sun C, 2014, TRENDS BIOCHEM SCI, V39, P465, DOI 10.1016/j.tibs.2014.08.010; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Tremmel M, 2009, BLOOD, V114, P5236, DOI 10.1182/blood-2009-04-219204; Trojaniello C, 2019, EXPERT REV CLIN PHAR, V12, P259, DOI 10.1080/17512433.2019.1570847; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Wu PK, 2015, SEMIN ONCOL, V42, P849, DOI 10.1053/j.seminoncol.2015.09.023; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	54	1	1	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2022	41	15					2254	2264		10.1038/s41388-022-02244-7	http://dx.doi.org/10.1038/s41388-022-02244-7		FEB 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J8DX	35217792				2022-12-26	WOS:000761868000002
J	Ito, H; Tsuneki, H; Sasaoka, T; Toyooka, N; Matsuo, M; Yamazaki, M				Ito, Hisakatsu; Tsuneki, Hiroshi; Sasaoka, Toshiyasu; Toyooka, Naoki; Matsuo, Mitsuhiro; Yamazaki, Mitsuaki			Suvorexant and mirtazapine improve chronic pain-related changes in parameters of sleep and voluntary physical performance in mice with sciatic nerve ligation	PLOS ONE			English	Article							NORADRENERGIC NEURONS; BENZODIAZEPINES; EPIDEMIOLOGY; DISTURBANCE; INSOMNIA; SYSTEM; DRUGS	Both chronic pain and sleep disorders are associated with a reduction in the quality of life. They can be both a cause and a consequence of each other, and should therefore be simultaneously treated. However, optimal treatments for chronic pain-related sleep disorders are not well established. Here, we aimed to investigate the effects of suvorexant, a novel sleep drug, and mirtazapine, a noradrenergic and specific serotonergic antidepressant, on painrelated changes in sleep parameters in a preclinical chronic pain mice model, by partial sciatic nerve ligation. We evaluated the quantity, duration, and depth of sleep by analyzing the electroencephalogram and voluntary activity by counting the number of wheel rotations to determine various symptoms of sleep disorders, including reduced total sleep time, fragmentation, low quality, and impaired activity in the daytime. Suvorexant and mirtazapine normalized the reduction in sleep time and fragmented sleep, further regaining the sleep depth at sleep onset in the chronic pain state in nerve-ligated mice. Mirtazapine also increased the percentage of rapid eye movement sleep in mice. Suvorexant decreased voluntary activity, which was prolonged after administration; however, mirtazapine did not decrease it. Although the effects of suvorexant and mirtazapine on sleep and activity are different, both suvorexant and mirtazapine could be potential therapeutic agents for chronic pain-related sleep disorders.	[Ito, Hisakatsu; Matsuo, Mitsuhiro; Yamazaki, Mitsuaki] Univ Toyama, Dept Anesthesiol, Toyama, Japan; [Tsuneki, Hiroshi; Sasaoka, Toshiyasu] Univ Toyama, Dept Clin Pharmacol, Toyama, Japan; [Toyooka, Naoki] Univ Toyama, Fac Engn, Toyama, Japan	University of Toyama; University of Toyama; University of Toyama	Ito, H (corresponding author), Univ Toyama, Dept Anesthesiol, Toyama, Japan.	hisa@med.u-toyama.ac.jp		ITO, HISAKATSU/0000-0002-8492-6550	 [16K20085];  [26462379]	; 	HI received Grant-in-Aid for Young Scientist, No. 16K20085 MY received Grant-in-Aid for Scientific Research (C), No. 26462379 Website: https://kaken.nii.ac.jp/ja/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaadi SM, 2012, EUR SPINE J, V21, P554, DOI 10.1007/s00586-011-1954-8; Dias RCA, 2019, INT J RHEUM DIS, V22, P1961, DOI 10.1111/1756-185X.13713; Atkin T, 2018, PHARMACOL REV, V70, P197, DOI 10.1124/pr.117.014381; Atoui S, 2021, SLEEP MED REV, V57, DOI 10.1016/j.smrv.2021.101426; Bjorvatn B, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.639198; Devoto P, 2004, EUR J PHARMACOL, V487, P105, DOI 10.1016/j.ejphar.2004.01.018; Doghramji K, 2016, SLEEP MED CLIN, V11, P503, DOI 10.1016/j.jsmc.2016.08.001; Emery PC, 2014, PAIN RES MANAG, V19, P35, DOI 10.1155/2014/480859; Enomoto T, 2012, SYNAPSE, V66, P483, DOI 10.1002/syn.21532; Goh Jorming, 2015, Curr Protoc Mouse Biol, V5, P283, DOI 10.1002/9780470942390.mo140295; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Ito H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243325; Ito H, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-59; Karna B., 2021, SLEEP DISORDER; Kent JM, 2000, LANCET, V355, P911, DOI 10.1016/S0140-6736(99)11381-3; Koh K, 2015, NEUROSCI LETT, V589, P200, DOI 10.1016/j.neulet.2014.12.002; Krause AJ, 2019, J NEUROSCI, V39, P2291, DOI 10.1523/JNEUROSCI.2408-18.2018; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Kuriyama A, 2017, SLEEP MED REV, V35, P1, DOI 10.1016/j.smrv.2016.09.004; Lariviere WR, 2001, J PHARMACOL EXP THER, V297, P467; Le Bon O, 2007, J COMP PHYSIOL A, V193, P1021, DOI 10.1007/s00359-007-0253-7; Leary EB, 2020, JAMA NEUROL, V77, P1241, DOI 10.1001/jamaneurol.2020.2108; McCracken LM, 2011, PAIN MED, V12, P904, DOI 10.1111/j.1526-4637.2011.01115.x; Mi WF, 2020, SLEEP, V43, DOI 10.1093/sleep/zsaa092; Millan MJ, 2000, EUR J NEUROSCI, V12, P1079, DOI 10.1046/j.1460-9568.2000.00982.x; Minehira D, 2014, TETRAHEDRON LETT, V55, P5778, DOI 10.1016/j.tetlet.2014.08.086; Nurmi-Luthje I, 2006, DRUG AGING, V23, P27, DOI 10.2165/00002512-200623010-00003; O'Brien CP, 2005, J CLIN PSYCHIAT, V66, P28; Ohno K, 2008, FRONT NEUROENDOCRIN, V29, P70, DOI 10.1016/j.yfrne.2007.08.001; Perogamvros L, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101701; Protti M, 2020, MED RES REV, V40, P1794, DOI 10.1002/med.21671; Reid KJ, 2011, CURR MED RES OPIN, V27, P449, DOI 10.1185/03007995.2010.545813; Reneric JP, 2002, EUR NEUROPSYCHOPHARM, V12, P159, DOI 10.1016/S0924-977X(02)00007-X; Saconi B, 2021, SLEEP MED REV, V56, DOI 10.1016/j.smrv.2020.101411; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Sato H, 2013, PSYCHOPHARMACOLOGY, V230, P227, DOI 10.1007/s00213-013-3146-1; Schmid DA, 2006, NEUROPSYCHOPHARMACOL, V31, P832, DOI 10.1038/sj.npp.1300923; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Simpson NS, 2018, PAIN, V159, P33, DOI 10.1097/j.pain.0000000000001053; Stewart SA, 2005, J CLIN PSYCHIAT, V66, P9; Thomas A, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110456; Thompson JL, 2011, BEHAV BRAIN RES, V217, P446, DOI 10.1016/j.bbr.2010.09.028; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; Tsuneki H, 2018, PHARMACOL THERAPEUT, V186, P25, DOI 10.1016/j.pharmthera.2017.12.010; Tsuneki H, 2016, ENDOCRINOLOGY, V157, P4146, DOI 10.1210/en.2016-1404; van Hecke O, 2013, BRIT J PAIN, V7, P209, DOI 10.1177/2049463713493264; Wadley AL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243366; Watanabe N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006528.pub2; Wichniak A, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0816-4; Winokur A, 2003, J CLIN PSYCHIAT, V64, P1224, DOI 10.4088/JCP.v64n1013; Wright SL, 2020, ADV THER, V37, P2604, DOI 10.1007/s12325-020-01354-6	51	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264386	10.1371/journal.pone.0264386	http://dx.doi.org/10.1371/journal.pone.0264386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213655	Green Published, gold			2022-12-26	WOS:000787811000084
J	Touw, CE; de Jong, Y; Vlieg, AV				Touw, Carolina E.; de Jong, Ype; Vlieg, Astrid van Hylckama			The influence of corn trypsin inhibitor on the contribution of coagulation determinants to the Technoclone Thrombin Generation Assay (TGA) and the Calibrated Automated Thrombogram (CAT)	PLOS ONE			English	Article							CONTACT FACTOR; PLASMA; RISK	In thrombin generation (TG) assays, regarded as global coagulation tests, contact activation is considered a major problem which can be eliminated by adding Corn Trypsin Inhibitor (CTI). In previous studies, however, venous thrombosis risk prediction using TG assays did not improve after CTI addition. However, it is unknown whether CTI addition could help to detect subtle but relevant nuances in determinants of TG, making the assay more suitable to detect disturbances in the coagulation system. This study's objective was to assess whether the addition of CTI is associated with a broader contribution of individual coagulation factors to the total amount of thrombin formed in Calibrated Automated Thrombogram (CAT) and Technoclone Thrombin Generation Assay (TGA). Thrombin generation was measured in 326 healthy individuals from THE VTE study at very low tissue factor concentrations, with and without addition of CTI prior to blood sampling. The influence of several coagulation factors on total amount of thrombin formed, i.e. area under the curve (AUC) or endogenous thrombin potential (ETP), was analysed using multiple linear regression with standardisation of all values resulting in Z-scores with 95% confidence intervals (95%CI). Association between coagulation factors and TG changed minimally after addition of CTI. Largest changes after CTI addition were found for following factors: for CAT: free protein S (from 0.00 (95%CI -0.12 to 0.12) to -0.29 (95%CI -0.43 to -0.15)) and protein S (from -0.05 (95%CI -0.18 to 0.08) to -0.21 (95%CI -0.37 to -0.05)); for TGA: antithrombin (from -0.11 (-0.23 to 0.02) to -0.19 (-0.30 to -0.07)), factor VIII (from 0.15 (0.03 to 0.27) to 0.24 (0.13 to 0.36)) and fibrinogen (from 0.12 (-0.01 to 0.26) to 0.19 (0.06 to 0.32)). In conclusion, there is no clear trend towards a broader contribution of coagulation factors in samples handled with CTI compared with those handled without CTI.	[Touw, Carolina E.; de Jong, Ype; Vlieg, Astrid van Hylckama] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [Touw, Carolina E.] Leiden Univ, Dept Orthopaed Surg, Med Ctr, Leiden, Netherlands; [de Jong, Ype] Leiden Univ, Dept Internal Med, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Touw, CE (corresponding author), Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands.; Touw, CE (corresponding author), Leiden Univ, Dept Orthopaed Surg, Med Ctr, Leiden, Netherlands.	C.E.Touw@lumc.nl		de Jong, Ype/0000-0002-7805-1508; Touw, Carolina/0000-0002-7993-5209	Netherlands Organization for Scientific Research (NWO-VENI) [916.56.157]	Netherlands Organization for Scientific Research (NWO-VENI)(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant from the Netherlands Organization for Scientific Research (NWO-VENI Grant# 916.56.157; https:// www.nwo.nl/en/calls/talent-programme) which was received by AvHV. The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2009, SEMIN THROMB HEMOST, V35, P104, DOI 10.1055/s-0029-1214153; Baglin T, 2005, BRIT J HAEMATOL, V130, P653, DOI 10.1111/j.1365-2141.2005.05612.x; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bertina RM, 2009, THROMB RES, V123, pS41, DOI 10.1016/S0049-3848(09)70142-2; Cvirn G, 2001, THROMB RES, V101, P183, DOI 10.1016/S0049-3848(00)00389-3; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; Dargaud Y, 2006, J THROMB HAEMOST, V4, P1160, DOI 10.1111/j.1538-7836.2006.01905.x; Dargaud Y, 2012, THROMB RES, V130, P929, DOI 10.1016/j.thromres.2012.07.017; De Visser MCH, 2005, J THROMB HAEMOST, V3, P1488; Dielis AWJH, 2008, J THROMB HAEMOST, V6, P125; Duarte Rita Carolina Figueiredo, 2017, Rev. Bras. Hematol. Hemoter., V39, P259, DOI 10.1016/j.bjhh.2017.03.009; Hansson KM, 2014, J THROMB HAEMOST, V12, P1678, DOI 10.1111/jth.12707; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Kintigh J, 2018, RES PRACT THROMB HAE, V2, P42, DOI 10.1002/rth2.12048; Loghmani H, 2018, BLOOD, V132, P148, DOI 10.1182/blood-2017-12-768994; Luddington R, 2004, J THROMB HAEMOST, V2, P1954, DOI 10.1111/j.1538-7836.2004.00964.x; Minnema MC, 1999, SEMIN THROMB HEMOST, V25, P419, DOI 10.1055/s-2007-994944; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Spronk HMH, 2009, THROMB HAEMOSTASIS, V101, P1156, DOI 10.1160/TH08-10-0670; Tripodi A, 2016, CLIN CHEM, V62, P699, DOI 10.1373/clinchem.2015.248625; Van Veen JJ, 2008, BLOOD COAGUL FIBRIN, V19, P183, DOI 10.1097/MBC.0b013e3282f4bb47; Vlieg AV, 2015, J THROMB HAEMOST, V13, P1642, DOI 10.1111/jth.13043; Zentai C, 2016, CLIN APPL THROMB-HEM, V22, P749, DOI 10.1177/1076029615584662	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263960	10.1371/journal.pone.0263960	http://dx.doi.org/10.1371/journal.pone.0263960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213588	gold, Green Published			2022-12-26	WOS:000787811000041
J	Averdijk, M; Ribeaud, D; Eisner, M				Averdijk, Margit; Ribeaud, Denis; Eisner, Manuel			External childcare and socio-behavioral development in Switzerland: Long-term relations from childhood into young adulthood	PLOS ONE			English	Article							1ST 3 YEARS; BEHAVIOR PROBLEMS; TIME SPENT; NONMATERNAL CARE; HISTORY CALENDAR; FAMILY; EDUCATION; QUALITY; INTERVENTIONS; ADOLESCENCE	This study examined early external childcare in relation to development from age 7 to 20. A Swiss sample was used (N = 1,225; 52% male). Development included multi-informant-reported externalizing behavior, internalizing problems, prosocial behavior, delinquency, and substance use. Growth curve models revealed that, dependent on the informant, time in a daycare center was related to increased externalizing and internalizing problems until at least age 11. It was not related to delinquency. Roughly three days per week at a daycare mother or playgroup was related to increased externalizing behavior. External family care was associated with increased prosocial behavior. Finally, time in a daycare center was associated with fewer externalizing but more internalizing problems and substance use for children from vulnerable backgrounds. This relation with substance use lasted to age 20.	[Averdijk, Margit; Ribeaud, Denis; Eisner, Manuel] Univ Zurich, Jacobs Ctr Prod Youth Dev, Zurich, Switzerland; [Eisner, Manuel] Univ Cambridge, Inst Criminol, Violence Res Ctr, Cambridge, England	University of Zurich; University of Cambridge	Averdijk, M (corresponding author), Univ Zurich, Jacobs Ctr Prod Youth Dev, Zurich, Switzerland.	margit.averdijk@jacobscenter.uzh.ch		Ribeaud, Denis/0000-0002-1668-8319	Swiss National Science Foundation [405240-69025, 100013_116829, 100014_132124, 100014_149979, 10FI14_170409/1, 10FI14_170409/2, 10FI14_198052/1]; Jacobs Foundation [2010-888, 2013-1081-1]; Jacobs Center for Productive Youth Development; Swiss Federal Office of Public Health [2.001391, 8.000665]; Canton of Zurich's Department of Education; Swiss Federal Commission on Migration [03-901(IMES), E-05-1076]; Julius Baer Foundation; Visana Foundation; Jacobs Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Jacobs Foundation; Jacobs Center for Productive Youth Development; Swiss Federal Office of Public Health; Canton of Zurich's Department of Education; Swiss Federal Commission on Migration; Julius Baer Foundation; Visana Foundation; Jacobs Foundation	The z-proso study on which the research reported in this manuscript is based was financially supported by the Swiss National Science Foundation (Grants 405240-69025, 100013_116829, 100014_132124, 100014_149979, 100014_149979, 10FI14_170409/1, 10FI14_170409/2, 10FI14_198052/1), the Jacobs Foundation (Grants 2010-888, 2013-1081-1), the Jacobs Center for Productive Youth Development, the Swiss Federal Office of Public Health (Grants 2.001391, 8.000665), the Canton of Zurich's Department of Education, the Swiss Federal Commission on Migration (Grants 03-901(IMES), E-05-1076), the Julius Baer Foundation, and the Visana Foundation. The research reported in this manuscript was supported by a grant from the Jacobs Foundation, awarded to MA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Allhusen V, 2003, CHILD DEV, V74, P976; Ansari A, 2012, EARLY CHILD DEV CARE, V182, P1465, DOI 10.1080/03004430.2011.622755; Appelbaum M, 1999, DEV PSYCHOL, V35, P1399; Averdijk M, 2014, INT REV VICT, V20, P265, DOI 10.1177/0269758014537147; Averdijk M, 2016, J EXP CRIMINOL, V12, P21, DOI 10.1007/s11292-015-9249-4; Averdijk M, 2011, EUR J DEV PSYCHOL, V8, P637, DOI 10.1080/17405629.2011.571846; Bacharach VR, 2003, J APPL DEV PSYCHOL, V23, P527, DOI 10.1016/S0193-3973(02)00140-5; Baker M, 2008, J POLIT ECON, V116, P709, DOI 10.1086/591908; Baker M, 2019, AM ECON J-ECON POLIC, V11, P1, DOI 10.1257/pol.20170603; Barnes J, 2010, EARLY CHILD DEV CARE, V180, P1215, DOI 10.1080/03004430902943959; BATES JE, 1994, DEV PSYCHOL, V30, P690, DOI 10.1037/0012-1649.30.5.690; Baumeister AEE, 2014, LEARN INDIVID DIFFER, V30, P1, DOI 10.1016/j.lindif.2013.11.002; Beijers R, 2013, EARLY CHILD RES Q, V28, P714, DOI 10.1016/j.ecresq.2013.06.002; Belsky J, 2001, J CHILD PSYCHOL PSYC, V42, P845, DOI 10.1111/1469-7610.00782; Bergeron L, 2013, CAN J PSYCHIAT, V58, P466, DOI 10.1177/070674371305800805; Bleiker M, 2019, SWISS J PSYCHOL, V78, P81, DOI 10.1024/1421-0185/a000225; Borge AIH, 2004, J CHILD PSYCHOL PSYC, V45, P367, DOI 10.1111/j.1469-7610.2004.00227.x; Broekhuizen ML, 2018, INFANT CHILD DEV, V27, DOI 10.1002/icd.2043; Broekhuizen ML, 2015, INFANT BEHAV DEV, V40, P216, DOI 10.1016/j.infbeh.2015.06.009; Bronfenbrenner U., 2007, HDB CHILD DEV, V6th ed., P793, DOI DOI 10.1002/9780470147658.CHPSY0114; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV, DOI [10.1016/0006-8993(79)90419-0, DOI 10.1016/0006-8993(79)90419-0]; Brooks F., 2009, DO GRANDPARENTS MATT; Bundesamt fr Statistik, 2014, TABL ANT FAM SCHUL B; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Chzhen Y., 2019, ARE WORLDS RICHEST C; Cote SM, 2008, DEV PSYCHOL, V44, P155, DOI 10.1037/0012-1649.44.1.155; Crosby DA, 2010, DEV PSYCHOL, V46, P1030, DOI 10.1037/a0020384; De Los Reyes A, 2016, J YOUTH ADOLESCENCE, V45, P1957, DOI 10.1007/s10964-016-0533-z; Dearing E, 2017, CHILD DEV PERSPECT, V11, P133, DOI 10.1111/cdep.12224; Del Boca D, 2016, EUR J POPUL, V32, P211, DOI 10.1007/s10680-015-9370-0; Deutscher Olympischer Sportbund, 2018, ANT BEV DEUTSCHL MIT; Driessen G. W. J. M., 2004, EARLY CHILD DEV CARE, V174, P667, DOI [DOI 10.1080/0300443042000187158, 10.1080/0300443042000187158]; Eisner M., 2011, SAGE HDB CRIMINOLOGI, P410; Eisner M, 2009, MONATS KRIMINOL, V92, P137, DOI 10.1515/mks-2009-922-305; Elder G. H., 2006, THEORETICAL MODELS H, P665, DOI DOI 10.1002/9780470147658.CHPSY0112; Eryigit-Madzwamuse S, 2013, CHILD YOUTH CARE FOR, V42, P101, DOI 10.1007/s10566-012-9193-7; Felfe C., 2012, 7100 IZA, DOI [10.1016/j.econedurev.2012.06.008, DOI 10.1016/J.ECONEDUREV.2012.06.008]; Fergusson E, 2008, J CHILD PSYCHOL PSYC, V49, P161, DOI 10.1111/j.1469-7610.2007.01840.x; Gialamas A, 2015, ARCH DIS CHILD, V100, P226, DOI 10.1136/archdischild-2014-306626; Goldstein NE, 2001, J EDUC PSYCHOL, V93, P708, DOI 10.1037/0022-0663.93.4.708; Groeneveld MG, 2013, STRESS, V16, P711, DOI 10.3109/10253890.2013.817553; Groeneveld MG, 2010, EARLY CHILD RES Q, V25, P502, DOI 10.1016/j.ecresq.2009.12.004; Gupta ND, 2012, ECON LETT, V116, P622, DOI 10.1016/j.econlet.2012.06.020; Hallquist MN, 2018, STRUCT EQU MODELING, V25, P621, DOI 10.1080/10705511.2017.1402334; Helmerhorst KOW, 2015, EARLY EDUC DEV, V26, P89, DOI 10.1080/10409289.2014.948784; Hickman LN, 2006, J FAM ISSUES, V27, P652, DOI 10.1177/0192513X05285118; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huston AC, 2015, DEV PSYCHOL, V51, P621, DOI 10.1037/a0038951; Jacob JI, 2009, EARLY CHILD DEV CARE, V179, P559, DOI 10.1080/03004430701292988; Jaffee SR, 2011, CHILD DEV, V82, P1076, DOI 10.1111/j.1467-8624.2011.01611.x; Kottelenberg MJ, 2017, J LABOR ECON, V35, P609, DOI 10.1086/690652; Lalande KM, 2011, PSYCHOL TRAUMA-US, V3, P165, DOI 10.1037/a0020847; Lamb M.E, 2006, HDB CHILD PSYCHOL CH, V5th ed., P950, DOI DOI 10.1002/9780470147658.CHPSY0423; Leifeld P, 2013, J STAT SOFTW, V55, P1; Lemay L, 2012, PROCD SOC BEHV, V55, P115, DOI 10.1016/j.sbspro.2012.09.485; Linberg A, 2020, EARLY CHILD DEV CARE, V190, P2505, DOI 10.1080/03004430.2019.1588891; Loeb S, 2007, ECON EDUC REV, V26, P52, DOI 10.1016/j.econedurev.2005.11.005; Machmutow K., 2013, SCHLUSSBERICHT ZUHAN; Magnuson KA, 2007, ECON EDUC REV, V26, P33, DOI 10.1016/j.econedurev.2005.09.008; Malti T, 2011, J CLIN CHILD ADOLESC, V40, P677, DOI 10.1080/15374416.2011.597084; Masten AS, 2010, DEV PSYCHOPATHOL, V22, P491, DOI 10.1017/S0954579410000222; Murray AL, 2021, ASSESSMENT, V28, P128, DOI 10.1177/1073191119858406; Murray AL, 2019, EUR J PSYCHOL ASSESS, V35, P674, DOI 10.1027/1015-5759/a000442; Murray AL, 2019, ASSESSMENT, V26, P1234, DOI 10.1177/1073191117721741; Murray J., 2007, MPLUS USERS GUIDE, VEighth Edition; Muthen BO, 2000, J STUD ALCOHOL, V61, P290, DOI 10.15288/jsa.2000.61.290; *NICHD EARL CHILD, 2002, APPL DEV SCI, V0006; NICHD Early Child Care Res Network, 2002, PSYCHOL SCI, V13, P199; NICHD Early Child Care Research Network, 1997, Child Dev, V68, P860, DOI 10.1111/j.1467-8624.1997.tb01967.x; Orri M, 2019, J CHILD PSYCHOL PSYC, V60, P1174, DOI 10.1111/jcpp.13065; Perren S, 2016, FRUHE BILD, V5, P3, DOI 10.1026/2191-9186/a000242; Pianta Robert C, 2009, Psychol Sci Public Interest, V10, P49, DOI 10.1177/1529100610381908; Pierrehumbert B, 1996, EUR J PSYCHOL EDUC, V11, P201, DOI 10.1007/BF03172725; Seiler CW, 2017, Z ENTWICKL PADAGOGIS, V49, P1, DOI 10.1026/0049-8637/a000162; Stamm M., 2012, FAMILI RE AUFWACHSBE; Stern S., 2018, WHITEPAPER VEREINBAR; Sweeten G, 2012, J QUANT CRIMINOL, V28, P533, DOI 10.1007/s10940-011-9160-8; TREMBLAY RE, 1991, J ABNORM CHILD PSYCH, V19, P285, DOI 10.1007/BF00911232; TREMBLAY RE, 1992, INT J BEHAV DEV, V15, P227, DOI 10.1177/016502549201500204; Van Beijsterveldt TCEM, 2005, TWIN RES HUM GENET, V8, P250, DOI 10.1375/1832427054253103; van Huizen T, 2018, ECON EDUC REV, V66, P206, DOI 10.1016/j.econedurev.2018.08.001; Vandell D.L., 1990, EARLY CHILD RES Q, V5, P555, DOI [DOI 10.1016/0885-2006(90)90019-W, 10.1016/0885-2006(90)90019-W]; Vandell DL, 2016, DEV PSYCHOL, V52, P1634, DOI 10.1037/dev0000169; Vandell DL, 2010, CHILD DEV, V81, P737, DOI 10.1111/j.1467-8624.2010.01431.x; Yamauchi C, 2011, ECON EDUC REV, V30, P1468, DOI 10.1016/j.econedurev.2011.07.012; Zachrisson HD, 2015, CHILD DEV, V86, P425, DOI 10.1111/cdev.12306; Zachrisson HD, 2013, CHILD DEV, V84, P1152, DOI 10.1111/cdev.12040	88	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263571	10.1371/journal.pone.0263571	http://dx.doi.org/10.1371/journal.pone.0263571			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263329	Green Published, gold			2022-12-26	WOS:000804638700027
J	Yao, JY; Hua, XF; Shi, JW; Hu, XY; Lui, KY; He, KT; Mai, JL; Lan, T; Lu, MQ				Yao, Jiyou; Hua, Xuefeng; Shi, Jiewei; Hu, Xiaoyuan; Lui, Kayin; He, Kaitao; Mai, Jialuo; Lan, Tian; Lu, Minqiang			LncRNA THEMIS2-211, a tumor-originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA	FASEB JOURNAL			English	Article						exosomes; HCC; lncRNA; miR-940; SPOCK1	EXPRESSION; MIR-940; BREAST; SPOCK1; PROTEOGLYCAN; TESTICAN-1; MANAGEMENT; RESISTANCE; PROGNOSIS; DIAGNOSIS	Hepatocellular carcinoma (HCC) is a major challenge for human health. Finding reliable diagnostic biomarkers and therapeutic targets for HCC is highly desired in the clinic. Currently, circulating exosomal lncRNA is a promising biomarker for the diagnosis of cancer and lncRNA is also a potential target in cancer therapy. Here, the diagnostic value of a panel based on exosomal lncRNA THEMIS2-211 and PRKACA-202, superior to that of AFP, was identified for diagnosing human HCC. Besides, the performance of exosomal lncRNA THEMIS2-211 alone exceeds that of AFP in diagnosing early-stage HCC patients (stage I). Furthermore, lncRNA THEMIS2-211 is highly expressed in HCC tissues and correlated with the poor prognosis of HCC patients. LncRNA THEMIS2-211 is upregulated and localized in the cytoplasm of HCC cells. LncRNA THEMIS2-211 exerts its biological function as an oncogene that promotes the proliferation, migration, invasion, EMT of HCC cells by physically interacting with miR-940 and therefore promoting SPOCK1 expressions. Rescue assays show the regulation of SPOCK1 by lncRNA THEMIS2-211 dependents on miR-940. The discovery of lncRNA THEMIS2-211 further illuminates the molecular pathogenesis of HCC and the THEMIS2-211/miR-940/SPOCK1 axis may act as a potential therapeutic target for HCC.	[Yao, Jiyou; Hua, Xuefeng; Shi, Jiewei; Hu, Xiaoyuan; He, Kaitao; Mai, Jialuo; Lu, Minqiang] South China Univ Technol, Affiliated Hosp 2, Sch Med, Dept HBP SURG 2, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China; [Lui, Kayin] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China; [Lan, Tian] Guangdong Pharmaceut Univ, Guangdong Metab Dis Res Ctr Integrated Chinese &, 280 Waihuan East Rd, Guangzhou 510006, Guangdong, Peoples R China	South China University of Technology; Sun Yat Sen University; Guangdong Pharmaceutical University	Lu, MQ (corresponding author), South China Univ Technol, Affiliated Hosp 2, Sch Med, Dept HBP SURG 2, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China.; Lan, T (corresponding author), Guangdong Pharmaceut Univ, Guangdong Metab Dis Res Ctr Integrated Chinese &, 280 Waihuan East Rd, Guangzhou 510006, Guangdong, Peoples R China.	lantian012345@163.com; larrylmq@outlook.com		Lui, Ka Yin/0000-0002-7183-6951	Guangzhou Municipal Science and Technology Project [201704020153, 202002030387]; Guangzhou Basic Research Program [202102010034]; Science Foundation of Guangzhou First People's Hospital [Q2019010]	Guangzhou Municipal Science and Technology Project; Guangzhou Basic Research Program; Science Foundation of Guangzhou First People's Hospital	Guangzhou Municipal Science and Technology Project, Grant/Award Number: 201704020153 and 202002030387; Guangzhou Basic Research Program, Grant/Award Number: 202102010034; Science Foundation of Guangzhou First People's Hospital, Grant/Award Number: Q2019010	BaSalamah MAM, 2001, BIOCHEM BIOPH RES CO, V283, P1083, DOI 10.1006/bbrc.2001.4900; Bollmann J, 2008, J STEROID BIOCHEM, V109, P16, DOI 10.1016/j.jsbmb.2007.12.007; Cheerathodi M, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040675; Cho HJ, 2020, CANCER MED-US, V9, P5459, DOI 10.1002/cam4.3230; Choi J, 2019, HEPATOLOGY, V69, P1983, DOI 10.1002/hep.30233; Ding D, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7618342; Durazo FA, 2008, J GASTROEN HEPATOL, V23, P1541, DOI 10.1111/j.1440-1746.2008.05395.x; Edgell CJS, 2004, INT REV CYTOL, V236, P101, DOI 10.1016/S0074-7696(04)36003-1; Enright AJ, 2004, GENOME BIOL, V5; Essandoh K, 2019, FASEB J, V33, P7451, DOI 10.1096/fj.201802338RR; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo X, 2020, JAMA SURG, V155, P572, DOI 10.1001/jamasurg.2020.1133; Hausser HJ, 2004, OSTEOARTHR CARTILAGE, V12, P870, DOI 10.1016/j.joca.2004.07.008; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Hu YP, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1097-9; Huang WC, 2022, ONCOGENE, V41, P997, DOI 10.1038/s41388-021-02136-2; Jiang PQ, 2020, CANCER MANAG RES, V12, P9087, DOI 10.2147/CMAR.S259243; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kamarajah SK, 2018, J SURG ONCOL, V117, P644, DOI 10.1002/jso.24908; Li HX, 2021, MOL THER-NUCL ACIDS, V25, P53, DOI 10.1016/j.omtn.2021.05.003; Li P, 2019, J CELL MOL MED, V23, P2475, DOI 10.1111/jcmm.14121; Li XY, 2020, J CELL PHYSIOL, V235, P3402, DOI 10.1002/jcp.29230; Li Y, 2013, GASTROENTEROLOGY, V144, P179, DOI 10.1053/j.gastro.2012.09.042; Li YC, 2019, CLIN CHEM, V65, P798, DOI 10.1373/clinchem.2018.301291; Li ZH, 2018, ONCOGENE, V37, P3822, DOI 10.1038/s41388-018-0237-9; Liang ZX, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2077-0; Lin LY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0834-9; Liu XL, 2019, PHYTOMEDICINE, V62, DOI 10.1016/j.phymed.2019.152930; Marr HS, 1997, ENDOTHELIUM-NEW YORK, V5, P209, DOI 10.3109/10623329709053399; Moody SE, 2015, ONCOGENE, V34, P2061, DOI 10.1038/onc.2014.153; Okato A, 2017, INT J ONCOL, V51, P245, DOI 10.3892/ijo.2017.4008; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Peirce MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011465; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarveazad A, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS_1017_18; Song ZG, 2020, MOLECULES, V25, DOI 10.3390/molecules25235585; Strickland M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01426-2; Sun J, 2020, J CELL BIOCHEM, V121, P443, DOI 10.1002/jcb.29206; Tao Y, 2020, INT J BIOL SCI, V16, P471, DOI 10.7150/ijbs.39123; Treeck O, 2005, CYTOKINE, V32, P137, DOI 10.1016/j.cyto.2005.08.008; Turnham RE, 2016, GENE, V577, P101, DOI 10.1016/j.gene.2015.11.052; Tzartzeva K, 2018, GASTROENTEROLOGY, V154, P1706, DOI 10.1053/j.gastro.2018.01.064; von Felden J, 2020, GUT, V69, P2025, DOI 10.1136/gutjnl-2019-320282; Wang CR, 2020, MOL GENET GENOMICS, V295, P251, DOI 10.1007/s00438-019-01620-5; Wang HH, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.11956; Wang XY, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.641526; Witjes CDM, 2013, HEPATOL INT, V7, P59, DOI 10.1007/s12072-012-9374-3; Xu RH, 2017, NAT MATER, V16, P1155, DOI [10.1038/NMAT4997, 10.1038/nmat4997]; Yang GS, 2019, CELL CYCLE, V18, P976, DOI 10.1080/15384101.2019.1601477; Ye ZQ, 2020, AM J CANCER RES, V10, P3127; Yu FB, 2016, CELL PROLIFERAT, V49, P195, DOI 10.1111/cpr.12241; Yuan B, 2015, CANCER SCI, V106, P819, DOI 10.1111/cas.12688; Zhan Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0893-y; Zhang SJ, 2019, J CELL MOL MED, V23, P1396, DOI 10.1111/jcmm.14042; Zhang W, 2020, CANCER LETT, V478, P22, DOI 10.1016/j.canlet.2020.02.014; Zhou C, 2020, CANCER MANAG RES, V12, P3771, DOI 10.2147/CMAR.S246311; Zhu XH, 2021, BIOENGINEERED, V12, P578, DOI 10.1080/21655979.2021.1882133; Zou HB, 2019, CELL CYCLE, V18, P2398, DOI 10.1080/15384101.2019.1618120	62	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22238	10.1096/fj.202101564R	http://dx.doi.org/10.1096/fj.202101564R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0DA	35224785				2022-12-26	WOS:000772946400001
J	Alketbi, AHSB; del Rio, JAJ; Fernandez, AI				Binnashira Alketbi, Amir Hamad Salim; Jimber del Rio, Juan Antonio; Fernandez, Alberto Ibanez			Exploring the role of human resource development functions on crisis management: The case of Dubai-UAE during Covid-19 crisis	PLOS ONE			English	Article							SOCIAL MEDIA; HRD; LEADERSHIP; PERFORMANCE; CULTURE; SYSTEM	Employee welfare represents a critical element of success for companies to remain competitive. Human resources increasingly encompass the management of critical situations that affect the employees' wellbeing. This research analyzes the effect of Human Resource Development (HRD), functions on the effectiveness of crisis management. It is an attempt to include HRD in the theory of Crisis management. Using Structural Equation Models-Partial Least Squares (SEM-PLS) analysis, the study analyzes how training, leadership, organizational strategy, and organizational culture directly positively impact the efficiency of Crisis management (CM) during the Covid-19 crisis in the public entities of Dubai-UAE. In particular, training showed to be the best predictor, followed by the Organizational culture. Organizational structure, Values and uniqueness show no impact on CM within the context of public entities of Dubai-UAE.	[Binnashira Alketbi, Amir Hamad Salim; Jimber del Rio, Juan Antonio] Univ Cordoba, Dept Agr Econ Finance & Accounting, Cordoba, Spain; [Fernandez, Alberto Ibanez] Univ Sci & Technol, Management, Int Relat, Fujairah, U Arab Emirates	Universidad de Cordoba	del Rio, JAJ (corresponding author), Univ Cordoba, Dept Agr Econ Finance & Accounting, Cordoba, Spain.	jjimber@uco.es	Jimber-Del Río, Juan Antonio/Q-4343-2019	Jimber-Del Río, Juan Antonio/0000-0001-6886-7434				Abo-Murad M., 2019, INT J ENTREPRENEURSH, V23; Alseiari H.A.S.M., 2019, INT J RECENT TECHNOL, V8, P860, DOI [DOI 10.35940/IJRTE.D7457.118419, 10.35940/ijrte.D7457.118419]; Alshamsi H.R., 2017, THESIS U SALFORD; Alzaabi S.H.A., 2018, BUSINESS MANAGEMENT, V9, P84, DOI [10.5296/bms.v9i1.13112, DOI 10.5296/BMS.V9I1.13112]; Ampster, 2016, TESLA MOTORS CLUB; Andrianopoulos A, 2016, ESSENTIAL STEPS CRIS; Armitage A, 2018, HUM RESOUR DEV INT, V21, P212, DOI 10.1080/13678868.2017.1366176; Athamneh S, 2018, HUMAN RESOURCE PLANN, DOI [10.5772/intechopen.75233, DOI 10.5772/INTECHOPEN.75233]; Bradshaw A., 2017, 7 STEPS CRISIS MANAG; Bulmahn Guido, 2002, LABOUR, V16, P383, DOI DOI 10.1111/1467-9914.00200; Bundy J, 2017, J MANAGE, V43, P1661, DOI 10.1177/0149206316680030; Calantone RJ, 1998, INT J RES MARK, V15, P19, DOI 10.1016/S0167-8116(97)00028-1; Chaawa M, 2017, ENTERP INF SYST-UK, V11, P534, DOI 10.1080/17517575.2016.1212275; Chin W.W., 2010, HDB PARTIAL LEAST SQ, DOI DOI 10.1007/978-3-540-32827-8_29; Chin WW, 1998, QUANT METH SER, P295; Dirani KM, 2020, HUM RESOUR DEV INT, V23, P380, DOI 10.1080/13678868.2020.1780078; Donovan L.L., 2000, 2000 C P ACAD HUMAN; Duckers MLA, 2017, RISK HAZARDS CRISIS, V8, P94, DOI 10.1002/rhc3.12113; Fener T, 2015, PROC ECON FINANC, V26, P695, DOI 10.1016/S2212-5671(15)00817-5; FMoH, 2016, 5 MUST INCLUDE ITEMS; Freedman L., 2020, DIGITAL COMMERCE 360; Garavan TN, 2007, ADV DEV HUM RESOUR, V9, P11, DOI 10.1177/1523422306294492; Gebba T.R., 2019, J ADV RES MANAGEMENT, V10, P5, DOI [10.14505//jarm.v10.1(19).01, DOI 10.14505//JARM.V10.1(19).01]; Glodzinski E., 2016, EC BUS, V28, P26, DOI [10.1515/eb-2016-0004, DOI 10.1515/EB-2016-0004]; Haak-saheem W., 2018, INT J HUM RESOUR MAN, DOI 10.(09585192.2017),1423366; Hawarna S., 2020, TQM J, DOI [10.1108/TQM-05-2019-0142, DOI 10.1108/TQM-05-2019-0142]; Hayes A., 2019, CRISIS MANAGEMENT DE; Hoskova-Mayerova S., 2016, ED TRAINING CRISIS M; Hutchins HM, 2008, ADV DEV HUM RESOUR, V10, P299, DOI 10.1177/1523422308316181; Hutchins HM, 2008, ADV DEV HUM RESOUR, V10, P310, DOI 10.1177/1523422308316183; ILO, 2020, COVID 19 CRISIS HAS; Karam M.G., 2018, J HOTEL BUSINESS MAN, V7, P171, DOI [https%3A//doi.org/10.4172/2169-0286.1000171, DOI 10.4172/2169-0286.1000171]; Light P.C., 2009, PREDICTING ORG CRISI; Litz D, 2017, EDUC MANAG ADM LEAD, V45, P566, DOI 10.1177/1741143216636112; Mishra S.K, 2016, LEADERSHIP COMPETENC, P153; Mousavi SA, 2015, IRAN J MANAG STUD, V8, P97; NASER M., 2019, INT J EMERGING TECHN, V10, P32; Nizamidou C., 2018, INT J BUSINESS SCI A, V13, P15; Otoo FNK, 2018, EUR J TRAIN DEV, V42, P517, DOI 10.1108/EJTD-07-2017-0061; Painter C, 2017, KNOWL PROCESS MANAG, V24, P204, DOI 10.1002/kpm.1544; Partnership for Evidence-Based COVID-19 Response (PERC), 2020, RESP COVID 19 AFR US; Pearson C.M., 1993, ACAD MANAGE PERSPECT, V7, P48; Pohl D, 2018, EXPERT SYST APPL, V93, P232, DOI 10.1016/j.eswa.2017.10.026; Randel AE, 2018, HUM RESOUR MANAGE R, V28, P190, DOI 10.1016/j.hrmr.2017.07.002; Reuter C, 2018, INT J HUM-COMPUT INT, V34, P280, DOI 10.1080/10447318.2018.1427832; Rudy Sarah J, 2007, J Contin Educ Nurs, V38, P219; Sawalha I. H. S., 2017, INT J CRISIS COMMUNI, V1, P21; Snoeijers EM, 2018, PUBLIC RELAT REV, V44, P65, DOI 10.1016/j.pubrev.2017.12.003; Sumic D, 2019, EKON VJESN, V32, P439; Tapp L., 2020, REDUNDANCY RESTRUCTU; Torraco R.J., 2005, HUMAN RESOURCE DEV R, V4, P251, DOI [10.1177/1534484305278894, DOI 10.1177/1534484305278894]; Ulrich D., 2020, WHAT IS HRS ROLE CRI; UNESCO, 2020, CULT CRIS POL GUID R; Vardarlier P, 2016, PROCD SOC BEHV, V235, P463, DOI 10.1016/j.sbspro.2016.11.057; Wang J., 2009, HUM RESOUR DEV REV, V8, P22, DOI [10.1177/1534484308330018, DOI 10.1177/1534484308330018]; Williams TA, 2017, ACAD MANAG ANN, V11, P733, DOI 10.5465/annals.2015.0134; Zahara Tussoleha Rony Z., 2019, INT J RECENT TECHNOL, V8, P388; Zulkarnaini Nor Amira Syairah, 2020, Advances in Human Factors, Business Management and Leadership. Proceedings of the AHFE 2019 International Conference on Human Factors, Business Management and Society, and the AHFE International Conference on Human Factors in Management and Leadership. Advances in Intelligent Systems and Computing (AISC 961), P542, DOI 10.1007/978-3-030-20154-8_50	58	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0263034	10.1371/journal.pone.0263034	http://dx.doi.org/10.1371/journal.pone.0263034			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259185	Green Published, gold			2022-12-26	WOS:000835141200006
J	Papies, J; Sieberg, A; Ritz, D; Niemeyer, D; Drosten, C; Muller, MA				Papies, Jan; Sieberg, Andrea; Ritz, Daniel; Niemeyer, Daniela; Drosten, Christian; Mueller, Marcel A.			Reduced IFN-beta inhibitory activity of Lagos bat virus phosphoproteins in human compared to Eidolon helvum bat cells	PLOS ONE			English	Article							RABIES VIRUS; P-PROTEIN; INTERFERON ANTAGONIST; IMMUNE EVASION; LYSSAVIRUS; INFECTION; EXPRESSION; GENE; INDUCTION; ALPHA	Eidolon helvum bats are reservoir hosts for highly pathogenic lyssaviruses often showing limited disease upon natural infection. An enhanced antiviral interferon (IFN) response combined with reduced inflammation might be linked to the apparent virus tolerance in bats. Lyssavirus phosphoproteins inhibit the IFN response with virus strain-specific efficiency. To date, little is known regarding the lyssavirus P-dependent anti-IFN countermeasures in bats, mainly due to a lack of in vitro tools. By using E. helvum bat cell cultures in a newly established bat-specific IFN-promoter activation assay, we analyzed the IFN-beta inhibitory activity of multiple lyssavirus P in E. helvum compared to human cells. Initial virus infection studies with a recently isolated E. helvum-borne Lagos bat virus street strain from Ghana showed enhanced LBV propagation in an E. helvum lung cell line compared to human A549 lung cells at later time points suggesting effective viral countermeasures against cellular defense mechanisms. A direct comparison of the IFN-beta inhibitory activity of the LBV-GH P protein with other lyssavirus P proteins showed that LBV-GH P and RVP both strongly inhibited the bat IFN-beta promotor activation (range 75-90%) in EidLu/20.2 and an E. helvum kidney cell line. Conversely, LBV-GH P blocked the activation of the human IFN-beta promoter less efficiently compared to a prototypic Rabies virus P protein (range LBV P 52-68% vs RVP 71-95%) in two different human cell lines (HEK-293T, A549). The same pattern was seen for two prototypic LBV P variants suggesting an overall reduced LBV P IFN-beta inhibitory activity in human cells as compared to E. helvum bat cells. Increased IFN-beta inhibition by lyssavirus P in reservoir host cells might be a result of host-specific adaptation processes towards an enhanced IFN response in bat cells.	[Papies, Jan; Sieberg, Andrea; Niemeyer, Daniela; Drosten, Christian; Mueller, Marcel A.] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Papies, Jan; Sieberg, Andrea; Niemeyer, Daniela; Drosten, Christian; Mueller, Marcel A.] Free Univ Berlin, Berlin, Germany; [Papies, Jan; Sieberg, Andrea; Niemeyer, Daniela; Drosten, Christian; Mueller, Marcel A.] Humboldt Univ, Berlin, Germany; [Ritz, Daniel] Univ Klinikum Bonn, Inst Virol, Bonn, Germany; [Niemeyer, Daniela; Drosten, Christian; Mueller, Marcel A.] German Ctr Infect Res DZIF, Partner Site Berlin, Berlin, Germany; [Mueller, Marcel A.] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; University of Bonn; German Center for Infection Research; Sechenov First Moscow State Medical University	Muller, MA (corresponding author), Charite Univ Med Berlin, Inst Virol, Berlin, Germany.; Muller, MA (corresponding author), Free Univ Berlin, Berlin, Germany.; Muller, MA (corresponding author), Humboldt Univ, Berlin, Germany.; Muller, MA (corresponding author), German Ctr Infect Res DZIF, Partner Site Berlin, Berlin, Germany.; Muller, MA (corresponding author), Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia.	marcel.mueller@charite.de		Mueller, Marcel/0000-0003-2242-5117; Sieberg, Andrea/0000-0003-3716-9996; Papies, Jan/0000-0002-7572-3567	German Research Foundation (DFG) [DR 772/10-2]; Volkswagen Foundation [AZ93345]	German Research Foundation (DFG)(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This study was supported by the German Research Foundation (DFG grant DR 772/10-2 to C.D.; https://www.dfg.de/) and the Volkswagen Foundation (AZ93345 to M.A.M.; https://www.volkswagenstiftung.de/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2019, NAT MICROBIOL, V4, P789, DOI 10.1038/s41564-019-0371-3; Allendorf SD, 2012, VIRUS RES, V165, P119, DOI 10.1016/j.virusres.2012.01.011; Anders HJ, 2010, KIDNEY INT, V77, P848, DOI 10.1038/ki.2010.71; BALACHANDRAN A, 1994, VET PATHOL, V31, P93, DOI 10.1177/030098589403100112; Banerjee A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64264-1; Banerjee A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010041; Banerjee A, 2018, VIRUS RES, V248, P5, DOI 10.1016/j.virusres.2018.02.013; Banerjee A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01513-w; Banyard AC, 2014, VIRUSES-BASEL, V6, P2974, DOI 10.3390/v6082974; Begeman L, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008898; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Binger T, 2015, J VIROL, V89, P4588, DOI 10.1128/JVI.02932-14; Brook CE, 2020, ELIFE, V9, DOI 10.7554/eLife.48401; Brzozka K, 2005, J VIROL, V79, P7673, DOI 10.1128/JVI.79.12.7673-7681.2005; Brzozka K, 2006, J VIROL, V80, P2675, DOI 10.1128/JVI.80.6.2675-2683.2006; Caignard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053881; Chopy D, 2011, J NEUROVIROL, V17, P353, DOI 10.1007/s13365-011-0041-6; De La Cruz-Rivera PC, 2018, J IMMUNOL, V200, P209, DOI 10.4049/jimmunol.1701214; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Dunham EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9000; Dzikwi AA, 2010, J WILDLIFE DIS, V46, P267, DOI 10.7589/0090-3558-46.1.267; Eckerle I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084679; Faul EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001016; Feagins AR, 2015, VIROLOGY, V485, P145, DOI 10.1016/j.virol.2015.07.010; Francis JR, 2014, PEDIATRICS, V133, pE1063, DOI 10.1542/peds.2013-1782; Freuing CM, 2015, VIRUS RES, V210, P42, DOI 10.1016/j.virusres.2015.07.009; Freuling C, 2009, J GEN VIROL, V90, P2493, DOI 10.1099/vir.0.011510-0; Furr SR, 2008, J NEUROVIROL, V14, P503, DOI 10.1080/13550280802337217; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hayman DTS, 2012, EPIDEMIOL INFECT, V140, P2163, DOI 10.1017/S0950268812000167; Hayman DTS, 2019, NAT MICROBIOL, V4, P728, DOI 10.1038/s41564-019-0430-9; Heaton PR, 1997, J CLIN MICROBIOL, V35, P2762, DOI 10.1128/JCM.35.11.2762-2766.1997; Holzer M, 2019, ISCIENCE, V19, P647, DOI 10.1016/j.isci.2019.08.016; Holzer M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34589; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hume A, 2018, J INFECT DIS, V218, pS403, DOI 10.1093/infdis/jiy473; Irving AT, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108345; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Ito N, 2016, J VET MED SCI, V78, P1089, DOI 10.1292/jvms.16-0092; Ito N, 2010, J VIROL, V84, P6699, DOI 10.1128/JVI.00011-10; Johnson N, 2008, J GEN VIROL, V89, P2662, DOI 10.1099/vir.0.2008/003889-0; Kalemba LN, 2017, J WILDLIFE DIS, V53, P408, DOI 10.7589/2016-06-122; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Klar M, 2005, MOL CELL BIOL, V25, P10159, DOI 10.1128/MCB.25.22.10159-10170.2005; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Kuri T, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-50; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li YY, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040405; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long T, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00109; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Markotter W, 2008, VIRUS RES, V135, P10, DOI 10.1016/j.virusres.2008.02.001; Masatani T, 2016, J GEN VIROL, V97, P316, DOI 10.1099/jgv.0.000362; Muller MA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-6; Munster VJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21878; Nathwani D, 2003, CLIN INFECT DIS, V37, P598, DOI 10.1086/376641; O'Shea TJ, 2014, EMERG INFECT DIS, V20, P741, DOI 10.3201/eid2005.130539; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Paulson M, 2002, NAT CELL BIOL, V4, P140, DOI 10.1038/ncb747; Piccinotti S, 2013, J VIROL, V87, P11637, DOI 10.1128/JVI.01648-13; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rieder M, 2011, J VIROL, V85, P842, DOI 10.1128/JVI.01427-10; Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792; Stern-Ginossar N, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033001; Stormer M, 2009, INT J MED MICROBIOL, V299, P291, DOI 10.1016/j.ijmm.2008.08.002; Suu-Ire R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006311; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Turkington HL, 2015, J VIROL, V89, P10696, DOI 10.1128/JVI.01430-15; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; Uchida S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25815-9; Vallo P, 2008, ACTA CHIROPTEROL, V10, P193, DOI 10.3161/150811008X414782; van Thiel PPAM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000428; Vidy A, 2007, J VIROL, V81, P4255, DOI 10.1128/JVI.01930-06; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208; Wiltzer L, 2012, J VIROL, V86, P10194, DOI 10.1128/JVI.01249-12; Wiltzer L, 2014, J INFECT DIS, V209, P1744, DOI 10.1093/infdis/jit829; World Health Organization, COR DIS 2019 COVID 1; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou P, 2016, P NATL ACAD SCI USA, V113, P2696, DOI 10.1073/pnas.1518240113	83	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264450	10.1371/journal.pone.0264450	http://dx.doi.org/10.1371/journal.pone.0264450			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259191	Green Published, gold			2022-12-26	WOS:000835141200015
J	Shen, YY; Levolger, S; Al-Kaylani, AHAZ; Uyttenboogaart, M; van Donkelaar, CE; Van Dijk, JMC; Viddeleer, AR; Bokkers, RPH				Shen, Yuanyuan; Levolger, Stef; Al-Kaylani, Abdallah H. A. Zaid; Uyttenboogaart, Maarten; van Donkelaar, Carlina E.; Van Dijk, J. Marc C.; Viddeleer, Alain R.; Bokkers, Reinoud P. H.			Skeletal muscle atrophy and myosteatosis are not related to long-term aneurysmal subarachnoid hemorrhage outcome	PLOS ONE			English	Article							HOSPITAL ADMISSION; INCREASED LENGTH; ADIPOSE-TISSUE; BODY; MASS; SARCOPENIA; PREDICTION; MORTALITY; DEPLETION; SURVIVAL	The prognosis of aneurysmal subarachnoid hemorrhage (aSAH) is highly variable. This study aims to investigate whether skeletal muscle atrophy and myosteatosis are associated with poor outcome after aSAH. In this study, a cohort of 293 consecutive aSAH-patients admitted during a 4-year period was retrospectively analyzed. Cross-sectional muscle measurements were obtained at the level of the third cervical vertebra. Muscle atrophy was defined by a sex-specific cutoff value. Myosteatosis was defined by a BMI-specific cutoff value. Poor neurological outcome was defined as modified Rankin Scale 4-6 at 2 and 6-month follow-up. Patient survival state was checked until January 2021. Generalized estimating equation was performed to assess the effect of muscle atrophy / myosteatosis on poor neurological outcome after aSAH. Cox regression was performed to analyze the impact of muscle atrophy and myosteatosis on overall survival. The study found that myosteatosis was associated with poor neurological condition (WFNS 4-5) at admission after adjusting for covariates (odds ratio [OR] 2.01; 95%CI 1.05,3.83; P = .03). It was not associated with overall survival (P = .89) or with poor neurological outcomes (P = .18) when adjusted for other prognostic markers. Muscle atrophy was not associated with overall survival (P = .58) or neurological outcome (P = .32) after aSAH. In conclusion, myosteatosis was found to be associated with poor physical condition directly after onset of aSAH. Skeletal muscle atrophy and myosteatosis were however irrelevant to outcome in the Western-European aSAH patient. Future studies are needed to validate these finding.	[Shen, Yuanyuan; van Donkelaar, Carlina E.; Van Dijk, J. Marc C.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands; [Shen, Yuanyuan] Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China; [Levolger, Stef; Al-Kaylani, Abdallah H. A. Zaid; Uyttenboogaart, Maarten; Viddeleer, Alain R.; Bokkers, Reinoud P. H.] Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Radiol, Groningen, Netherlands; [Uyttenboogaart, Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; Zhejiang University; University of Groningen; University of Groningen	Bokkers, RPH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Radiol, Groningen, Netherlands.	r.p.h.bokkers@umcg.nl	Bokkers, Reinoud P H/ABD-2928-2020; van Dijk, J. Marc C./C-1078-2013	Bokkers, Reinoud P H/0000-0001-6130-7311; van Dijk, J. Marc C./0000-0002-0814-5680; Shen, Yuanyuan/0000-0003-0426-5295; Zaid Al-Kaylani, Abdallah/0000-0003-1332-3346	China Scholarship Council (CSC) [201706320024]	China Scholarship Council (CSC)(China Scholarship Council)	YS receives financial support from China Scholarship Council (CSC, File No. 201706320024, https://www.csc.edu.cn/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes D, 2015, STROKE, V46, P1221, DOI 10.1161/STROKEAHA.114.008198; Bozkurt G, 2018, ANN OTO RHINOL LARYN, V127, P841, DOI 10.1177/0003489418798660; Cesar M, 2017, CLIN GERIATR MED, V33, P293, DOI 10.1016/j.cger.2017.02.002; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Ebner N, 2015, ESC HEART FAIL, V2, P58, DOI 10.1002/ehf2.12033; ESSEN P, 1995, ANN SURG, V222, P36, DOI 10.1097/00000658-199507000-00006; Etminan N, 2019, JAMA NEUROL, V76, P588, DOI 10.1001/jamaneurol.2019.0006; Finnerty CC, 2013, JPEN-PARENTER ENTER, V37, p21S, DOI 10.1177/0148607113496117; Friedman J, 2015, NUTR CLIN PRACT, V30, P175, DOI 10.1177/0884533615569888; Ganju RG, 2019, RADIOTHER ONCOL, V137, P117, DOI 10.1016/j.radonc.2019.04.023; Goodpaster BH, 2002, CURR OPIN CLIN NUTR, V5, P481, DOI 10.1097/00075197-200209000-00005; Hausman GJ, 2014, ADIPOCYTE, V3, P242, DOI 10.4161/adip.28546; HIJDRA A, 1988, STROKE, V19, P1250, DOI 10.1161/01.STR.19.10.1250; Hirani V, 2015, J AM MED DIR ASSOC, V16, P607, DOI 10.1016/j.jamda.2015.02.006; Hollig A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00694; Jones SE, 2015, THORAX, V70, P213, DOI 10.1136/thoraxjnl-2014-206440; Katsuki M, 2020, WORLD NEUROSURG, V137, pE526, DOI 10.1016/j.wneu.2020.02.033; Katsuki M, 2019, CLIN NEUROL NEUROSUR, V186, DOI 10.1016/j.clineuro.2019.105535; Kays Joshua K, 2018, JCSM Clin Rep, V3; Kim G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186990; Kyle UG, 2005, CLIN NUTR, V24, P133, DOI 10.1016/j.clnu.2004.08.012; Lee SJ, 2004, AM J CLIN NUTR, V80, P1215; Luetkens JA, 2020, CIRCULATION, V141, P234, DOI 10.1161/CIRCULATIONAHA.119.042927; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Minarich MJ., 2019, HPB, V21, DOI [10.1016/j.hpb.2019.03.046, DOI 10.1016/J.HPB.2019.03.046]; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Nam S, 2016, GERIATR GERONTOL INT, V16, P1324, DOI 10.1111/ggi.12650; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Nyberg C, 2019, UPSALA J MED SCI, V124, P254, DOI 10.1080/03009734.2019.1659888; Onodera H, 2021, CLIN NUTR, V40, P4187, DOI 10.1016/j.clnu.2021.01.040; PEARL RH, 1985, J TRAUMA, V25, P777, DOI 10.1097/00005373-198508000-00008; Perkisas S, 2018, EUR GERIATR MED, V9, P801, DOI 10.1007/s41999-018-0110-y; Pichard C, 2004, AM J CLIN NUTR, V79, P613; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Roquer J, 2020, NEUROLOGY, V95, pE1819, DOI 10.1212/WNL.0000000000010618; Rosen DS., 2009, EUR PSYCHOL, V14, P51; Safer VB, 2020, CLIN NEUROL NEUROSUR, V188, DOI 10.1016/j.clineuro.2019.105600; Sepulveda-Loyola W, 2020, AUSTRALAS J AGEING, V39, P35, DOI 10.1002/jcsm.12600; Sharples L.D., 1989, J R STAT SOC A STAT, V152, P263, DOI [10.2307/2982934, DOI 10.2307/2982934]; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Swartz JE, 2016, ORAL ONCOL, V62, P28, DOI 10.1016/j.oraloncology.2016.09.006; Trestini I, 2019, CRIT REV ONCOL HEMAT, V141, P43, DOI 10.1016/j.critrevonc.2019.06.007; Ufuk F, 2019, CLIN EXP OTORHINOLAR, V12, P317, DOI 10.21053/ceo.2018.01613; van Dijk DPJ, 2017, J CACHEXIA SARCOPENI, V8, P317, DOI 10.1002/jcsm.12155; van Donkelaar CE, 2019, STROKE, V50, P837, DOI 10.1161/STROKEAHA.118.023902; van Donkelaar CE, 2017, J NEUROSURG, V126, P52, DOI 10.3171/2016.1.JNS152136; Venrooij LMW, 2012, NUTRITION, V28, P40, DOI 10.1016/j.nut.2011.02.007; Vedder IR, 2020, J VASC SURG, V72, P2006, DOI 10.1016/j.jvs.2020.03.050; Vestbo J, 2006, AM J RESP CRIT CARE, V173, P79, DOI 10.1164/rccm.200505-969OC; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Williams BA., 2006, TECHNICAL REPORT SER, V79; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; World Health Organization, 2013, OB OV FACT SHEET; Zetterling M, 2011, BRIT J NEUROSURG, V25, P684, DOI 10.3109/02688697.2011.584638	55	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264616	10.1371/journal.pone.0264616	http://dx.doi.org/10.1371/journal.pone.0264616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245308	gold, Green Published			2022-12-26	WOS:000799799100028
J	Duarte, T; Calor, AR; Bispo, PD				Duarte, Tacio; Calor, Adolfo Ricardo; Bispo, Pitagoras da Conceicao			Systematic revision and phylogeny of Paragripopteryx Enderlein, 1909 (Plecoptera: Gripopterygidae)	PLOS ONE			English	Article							STONEFLIES INSECTA PLECOPTERA; BRAZILIAN PLECOPTERA; STATE	Among the Neotropical gripopterygids, the genus Paragripopteryx occurs along the Brazilian Atlantic coast to Uruguay. Since its first recognition by Enderlein in 1909, the genus underwent a confusing taxonomic history with some combinations. In this study, we aim to revise Paragripopteryx and present the first morphology-based phylogeny for the genus. The analysis comprised 38 morphological characters and their respective states in 30 terminal taxa, including 13 Paragripopteryx species, two new species identified as belonging to Paragripopteryx, and 15 outgroup species, among which we can highlight 12 different South American genera and one Australian genus of Gripopterygidae. The cladistic analysis yielded a parsimonious tree for k = 3 (137 steps, consistency index = 0.445, and retention index = 0.591) where most Paragripopteryx are nested, except for Uruguayan Paragripopteryx munoai. We can then infer that in its current circumscription Paragripopteryx is polyphyletic. The following two species are described: Paragripopteryx dasalmas sp. nov. and Paragripopteryx ogum sp. nov. Paragripopteryx baratinii is designated as a nomen dubium. Additionally, we provide a key for species identification, updated geographical records, and illustrations for all species. As a corollary, our study gathers relevant morphological information that can help to better understand this genus and create foundations for the next steps.	[Duarte, Tacio] Univ Fed Integracao Latino Amer UNILA, Inst Latino Amer Ciencias Vida & Nat, Lab Limnol, Foz Do Iguacu, Parana, Brazil; [Calor, Adolfo Ricardo] Univ Fed Bahia UFBA, Inst Biol, Lab Entomol Aquat, Salvador, BA, Brazil; [Bispo, Pitagoras da Conceicao] Univ Estadual Paulista UNESP, Fac Ciencias & Letras Assis, Lab Biol Aquat, Assis, SP, Brazil	Universidade Federal da Integracao Latino-Americana; Universidade Federal da Bahia; Universidade Estadual Paulista	Duarte, T (corresponding author), Univ Fed Integracao Latino Amer UNILA, Inst Latino Amer Ciencias Vida & Nat, Lab Limnol, Foz Do Iguacu, Parana, Brazil.	dutacio@gmail.com	CALOR, ADOLFO RICARDO/F-2375-2013	CALOR, ADOLFO RICARDO/0000-0003-3975-3176; Duarte, Tacio/0000-0002-4150-3857	TD -Sao Paulo Research Foundation [FAPESP: 2015/11580-3, 2016/22213-4]; Itaipu Technological Park Foundation -Brazil [FPTI-BR: 902940/2021]; ARC National Council for Scientific and Technological Development [CNPq: PQ 307794/2015-6]; PCB -Sao Paulo Research Foundation [FAPESP: 2019/22833-0, BIOTA 2021/05986-8]; National Council for Scientific and Technological Development [CNPq: PROTAX 441119/2020-4, PQ 303260/2018-1]; Coordination for the Improvement of Higher Education Personnel (CAPES) [001]	TD -Sao Paulo Research Foundation; Itaipu Technological Park Foundation -Brazil; ARC National Council for Scientific and Technological Development; PCB -Sao Paulo Research Foundation; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	TD -Sao Paulo Research Foundation (FAPESP: 2015/11580-3 and 2016/22213-4) (http://www.fapesp.br/en/); and Itaipu Technological Park Foundation -Brazil (FPTI-BR: 902940/2021) (https://www.pti.org.br).ARC National Council for Scientific and Technological Development (CNPq: PQ 307794/2015-6) (http://www.cnpq.br).PCB -Sao Paulo Research Foundation (FAPESP: 2019/22833-0 and BIOTA 2021/05986-8); and National Council for Scientific and Technological Development (CNPq: PROTAX 441119/2020-4 and PQ 303260/2018-1). The Coordination for the Improvement of Higher Education Personnel (CAPES "Finance Code 001") financed the English revision (https://www.capes.gov.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENEDETTO L, 1983, STUD NEOTROP FAUNA E, V18, P19, DOI 10.1080/01650528309360616; BENEDETTO L A, 1970, Limnologica, V7, P383; Benedetto L. A., 1969, Beitr Neotrop Fauna, V6, P145; Bethoux Olivier, 2005, Illiesia, V1, P52; Bispo PD, 2011, ANN LIMNOL-INT J LIM, V47, P373, DOI 10.1051/limn/2011052; Burmeister H., 1839, PLECOPTERA; DeWalt R. E., 2021, PLECOPTERA SPECIES F; DeWalt RE, 2019, INSECTS, V10, DOI 10.3390/insects10040099; Ding SM, 2019, MOL PHYLOGENET EVOL, V135, P123, DOI 10.1016/j.ympev.2019.03.005; Duarte T, 2019, ZOOTAXA, V4671, P511, DOI 10.11646/zootaxa.4671.4.3; Duarte T, 2014, ZOOTAXA, V3779, P81, DOI 10.11646/zootaxa.3779.1.9; Enderlein G xFCnther, 1909, Zoologischer Anzeiger Leipzig, V34; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Froehlich C. G., 1969, Beitr Neotrop Fauna, V6, P17; FROEHLICH CG, 1990, STUD NEOTROP FAUNA E, V25, P235, DOI 10.1080/01650529009360823; FROEHLICH CG, 1994, AQUAT INSECT, V16, P227, DOI 10.1080/01650429409361559; Froehlich CG, 1998, STUD NEOTROP FAUNA E, V33, P19, DOI 10.1076/snfe.33.1.19.2170; Froehlich CG., 1964, PARAGRIPOTERYGINAE E; Froehlich CG., 1960, LUNDS U ARSSKRIFT; Froehlich Claudio G., 2001, P377; Froehlich Claudio Gilberto, 2015, Illiesia, V11, P175; Froehlich Claudio Gilberto, 2010, Illiesia, V6, P118; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2001, CLADISTICS, V17, pS26, DOI 10.1111/j.1096-0031.2001.tb00102.x; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Goncalves MD, 2017, ZOOTAXA, V4291, P563, DOI 10.11646/zootaxa.4291.3.8; Illies J., 1963, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V36, P145; Illies J., 1966, TIERREICH, V82, P1; INEA-Instituto Estadual do Ambiente/State Environmental Institute, 2021, DAD BRUT MON QUAL GU; INEMA, 2021, EST EC WENC GUIM; JEWETT STANLEY G., 1960, ARQ MUS NAC [RIO DE JANEIRO], V50, P167; Klapalek F., 1904, HAMBURGER MAGALHAENS, P1; Letsch H, 2021, SYST ENTOMOL, V46, P952, DOI 10.1111/syen.12505; Mabille JM., 1891, NEVROPTERES, DOI [10.5962/bhl.title.2480, DOI 10.5962/BHL.TITLE.2480]; Maddison WP, 2019, MESQUITE MODULAR SYS; McCulloch GA, 2016, MOL PHYLOGENET EVOL, V96, P150, DOI 10.1016/j.ympev.2015.10.028; McLellan I. D., 1971, AUSTR J ZOOLOGY S, V2, P1, DOI DOI 10.1071/AJZS002; McLellan Ian D., 2007, Illiesia, V3, P20; MCLELLAN ID, 1977, NEW ZEAL J ZOOL, V4, P119, DOI 10.1080/03014223.1977.9517945; Morrone Juan J., 2001, Biogeographica (Paris), V77, P65; NAVAS LONGINOS, 1928, REV CHILENA HIST NAT PURA Y APLICADA [SANTIAGO], V32, P106; Navas RPL., 1934, PLECOPTEROS REV REAL, V31, P160; Navas RPL., 1936, REV MUS PAUL, V20, P726; Pessacq P, 2020, ZOOL J LINN SOC-LOND, V190, P771; Pessacq P, 2019, ZOOSYMPOSIA, V16, P182, DOI 10.11646/zoosymposia.16.1.15; Pictet FJ, 1841, HIST NATURELLE GENER, DOI [10.5962/bhl.title.124172, DOI 10.5962/BHL.TITLE.124172]; Prendini L, 2003, SYST ENTOMOL, V28, P149, DOI 10.1046/j.1365-3113.2003.00207.x; Restello RM., 2007, AN 8 C EC BRAS, P27; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Romero Fatima, 2017, Acta Zoologica Lilloana, V61, P42; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; Shorthouse DP, 2010, SIMPLEMAPPR ONLINE T; South EJ, 2021, SYST ENTOMOL, V46, P287, DOI 10.1111/syen.12462; Stark BP, 2009, AQUATIC BIODIVERSITY, P154; Suriano M.T., 2004, Acta Limnologica Brasiliensia, V16, P129; Team Q.D., 2020, QGIS GEOGR INF SYST; Vera Alejandro, 2006, Gayana (Concepc.), V70, P168; ZWICK P, 1973, Annales Zoologici (Warsaw), V30, P471; Zwick P, 1973, INSECTA PLECOPTERA P	60	0	0	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264264	10.1371/journal.pone.0264264	http://dx.doi.org/10.1371/journal.pone.0264264			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239689	gold, Green Published			2022-12-26	WOS:000776002200024
J	Szwarc, K; Boryczka, U				Szwarc, Krzysztof; Boryczka, Urszula			A novel approach to the Orienteering Problem based on the Harmony Search algorithm	PLOS ONE			English	Article							NEIGHBORHOOD SEARCH	This article presents a new approach to designing a Harmony Search (HS) algorithm, adapted to solve Orienteering Problem (OP) instances. OP is a significant NP-hard problem that has considerable practical application, requiring the development of an effective method for determining its solutions. The proposed HS has demonstrated its effectiveness through determined optimum results for each task from the six most popular benchmarks; a marginal number approximated the best results, with the average error below 0.01%. The article details the application of this described algorithm, comparing its results with those of state-of-the-art methods, indicating the significant efficiency of the proposed approach.	[Szwarc, Krzysztof; Boryczka, Urszula] Univ Silesia Katowice, Inst Comp Sci, Sosnowiec, Poland	University of Silesia in Katowice	Szwarc, K (corresponding author), Univ Silesia Katowice, Inst Comp Sci, Sosnowiec, Poland.	krzysztof.szwarc@us.edu.pl		Szwarc, Krzysztof/0000-0003-3341-1511				Al-Betar MA, 2012, ANN OPER RES, V194, P3, DOI 10.1007/s10479-010-0769-z; [Anonymous], 2000, THESIS KOREA U; Boryczka U, 2020, ENG OPTIMIZ, V52, P218, DOI 10.1080/0305215X.2019.1579804; Boryczka U, 2019, J INFORM TELECOMMUN, V3, P2, DOI 10.1080/24751839.2018.1503149; Boryczka U, 2018, LECT NOTES ARTIF INT, V10751, P341, DOI 10.1007/978-3-319-75417-8_32; Campos V, 2014, J OPER RES SOC, V65, P1800, DOI 10.1057/jors.2013.156; Carrabs F, 2021, EUR J OPER RES, V292, P830, DOI 10.1016/j.ejor.2020.11.043; Chagas JBC, 2022, OPTIM LETT, V16, P2313, DOI 10.1007/s11590-021-01824-y; Chao IM, 1996, EUR J OPER RES, V88, P464, DOI 10.1016/0377-2217(94)00289-4; Chao IM, 1996, EUR J OPER RES, V88, P475, DOI 10.1016/0377-2217(95)00035-6; Chou XC, 2021, COMPUT OPER RES, V126, DOI 10.1016/j.cor.2020.105107; Degertekin SO, 2007, STRUCT MULTIDISCIP O, V34, P347, DOI [10.1007/S00158-007-0096-4, 10.1007/s00158-007-0096-4]; Faigl J, 2019, APPL SOFT COMPUT, V75, P130, DOI 10.1016/j.asoc.2018.11.005; Faigl J, 2018, NEUROCOMPUTING, V312, P120, DOI 10.1016/j.neucom.2018.05.079; Geem ZW, 2007, LECT NOTES COMPUT SC, V4692, P371; Geem ZW, 2005, LECT NOTES COMPUT SC, V3612, P741; Geem ZW, 2005, LECT NOTES COMPUT SC, V3612, P751; GOLDEN BL, 1987, NAV RES LOG, V34, P307, DOI 10.1002/1520-6750(198706)34:3<307::AID-NAV3220340302>3.0.CO;2-D; GOLDEN BL, 1988, NAV RES LOG, V35, P359, DOI 10.1002/1520-6750(198806)35:3<359::AID-NAV3220350305>3.0.CO;2-H; Hadwan M, 2013, INFORM SCIENCES, V233, P126, DOI 10.1016/j.ins.2012.12.025; Helsgaun K, 2000, EUR J OPER RES, V126, P106, DOI 10.1016/S0377-2217(99)00284-2; KANTOR MG, 1992, J OPER RES SOC, V43, P629, DOI 10.1057/jors.1992.88; Kim JH, 2016, PROCEDIA ENGINEER, V154, P1401, DOI 10.1016/j.proeng.2016.07.510; Kobeaga G., OPLIB; Kobeaga G, 2018, COMPUT OPER RES, V90, P42, DOI 10.1016/j.cor.2017.09.003; Komaki M, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN PRODUCTION AND LOGISTICS SYSTEMS (CIPLS), P1, DOI 10.1109/CIPLS.2014.7007154; KU LEUVEN, OR PROBL TEST INST; LIN S, 1973, OPER RES, V21, P498, DOI 10.1287/opre.21.2.498; Mahdavi M., 2009, SOLVING NP COMPLETE, P53; Nowakowski P, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138726; Peddakapu K., 2021, APPL SOFT COMPUT, V113; Penicka R, 2019, EUR J OPER RES, V276, P816, DOI 10.1016/j.ejor.2019.01.047; Santini A, 2019, EXPERT SYST APPL, V123, P154, DOI 10.1016/j.eswa.2018.12.050; Sarkar SS, 2021, INTEGR MATER MANUF I, V10, P1, DOI 10.1007/s40192-020-00197-x; Schilde Michael, 2009, Swarm Intelligence, V3, P179, DOI 10.1007/s11721-009-0029-5; Sevkli AZ, 2010, TURK J ELECTR ENG CO, V18, P1095, DOI 10.3906/elk-0909-18; Sohrabi S, 2021, EURO J TRANSP LOGIST, V10, DOI 10.1016/j.ejtl.2021.100036; Szwarc K., 2021, THESIS U SILESIA KAT; Szwarc K, 2019, LECT NOTES ARTIF INT, V11432, P203, DOI 10.1007/978-3-030-14802-7_18; Tasgetiren M.F., 2002, J EC SOCIAL RES, V4, P1; Tsakirakis E, 2019, APPL SOFT COMPUT, V80, P776, DOI 10.1016/j.asoc.2019.04.038; TSILIGIRIDES T, 1984, J OPER RES SOC, V35, P797, DOI 10.2307/2582629; Twarog S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249077; Vansteenwegen P, 2011, EUR J OPER RES, V209, P1, DOI 10.1016/j.ejor.2010.03.045; Vansteenwegen P, 2009, EUR J OPER RES, V196, P118, DOI 10.1016/j.ejor.2008.02.037; Vidal T, 2016, TRANSPORT SCI, V50, P720, DOI 10.1287/trsc.2015.0584; Weyland D, 2015, OPER RES PERSPECT, V2, P97, DOI 10.1016/j.orp.2015.04.001; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Yang XS, 2009, STUD COMPUT INTELL, V191, P1, DOI 10.1109/MILCOM.2009.5379772	49	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264584	10.1371/journal.pone.0264584	http://dx.doi.org/10.1371/journal.pone.0264584			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226706	Green Published, gold			2022-12-26	WOS:000793394000034
J	Ahmed, NU; Khair, A; Hassan, J; Khan, MANA; Rahman, AKMA; Hoque, W; Rahman, M; Kobayashi, N; Ward, MP; Alam, MM				Ahmed, Nasir Uddin; Khair, Abul; Hassan, Jayedul; Khan, Md Abu Hadi Noor Ali; Rahman, A. K. M. Anisur; Hoque, Warda; Rahman, Mustafizur; Kobayashi, Nobumichi; Ward, Michael P.; Alam, Md Mahbub			Risk factors for bovine rotavirus infection and genotyping of bovine rotavirus in diarrheic calves in Bangladesh	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; MOLECULAR CHARACTERIZATION; PREVALENCE; VP7; EMERGENCE; WESTERN; INDIA	Bovine rotavirus (BRV) is considered the leading cause of calf diarrhea worldwide, including Bangladesh. In this study we aimed to identify risk factors for BRV infection and determine the G and P genotypes of BRV strains in diarrheic calves. Fecal samples were collected from 200 diarrheic calves in three districts between January 2014 and October 2015. These samples were screened to detect the presence of BRV using rapid test-strips BIO K 152 (RTSBK). The RTSBK positive samples were further tested by polyacrylamide gel electro-phoresis and the silver staining technique to detect rotavirus dsRNA. Risk factors were identified by multivariable logistic regression analysis. The G and P genotypes of BRV were determined by RT-PCR and sequencing. A phylogenetic tree was constructed based on the neighbor-joining method using CLC sequence viewer 8.0. About 23% of the diarrheic calves were BRV positive. The odds of BRV infection were 3.8- (95% confidence interval [95% CI]: 1.0-14.7) and 3.9-times (95% CI:1.1-14.2) higher in Barisal and Madaripur districts, respectively, than Sirrajganj. The risk of BRV infection was 3.1-times (95% CI: 1.5-6.5) higher in calves aged <= 5 weeks than those aged >5 weeks. Moreover, the risk of BRV infection was 2.6-times (95% CI:1.1-5.8) higher in crossbred (Holstein Friesian, Shahiwal) than indigenous calves. G6P[11] was the predominant genotype (94.4%), followed by G10P[11] (5.6%). The BRV G6 strains were found to be closest (98.9-99.9%) to Indian strains, and BRV G10 strains showed 99.9% identities with Indian strain. The VP4 gene of all P[11] strains showed >90% identities to each other and also with Indian strains. The most frequently identified BRV genotype was G6P[11]. About 23% of calf diarrhea cases were associated with BRV. To control disease, high-risk areas and younger crossbred calves should be targeted for surveillance and management. The predominant genotype could be utilized as the future vaccine candidate or vaccines with the dominant genotype should be used to control BRV diarrhea in Bangladesh.	[Ahmed, Nasir Uddin; Khair, Abul; Rahman, A. K. M. Anisur; Alam, Md Mahbub] Bangladesh Agr Univ, Fac Vet Sci, Dept Med, Mymensingh, Bangladesh; [Khair, Abul] IUBAT Int Univ Business Agr & Technol, Dhaka, Bangladesh; [Hassan, Jayedul] Bangladesh Agr Univ, Fac Vet Sci, Dept Microbiol & Hyg, Mymensingh, Bangladesh; [Khan, Md Abu Hadi Noor Ali] Bangladesh Agr Univ, Fac Vet Sci, Dept Pathol, Mymensingh, Bangladesh; [Hoque, Warda; Rahman, Mustafizur] Icddr B, Virol Lab, Infect Dis Div, Dhaka, Bangladesh; [Kobayashi, Nobumichi] Sapporo Med Univ, Sch Med, Dept Hyg, Sapporo, Hokkaido, Japan; [Ward, Michael P.] Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia	Bangladesh Agricultural University (BAU); International University of Business Agriculture & Technology (IUBAT); Bangladesh Agricultural University (BAU); Bangladesh Agricultural University (BAU); International Centre for Diarrhoeal Disease Research (ICDDR); Sapporo Medical University; University of Sydney	Alam, MM (corresponding author), Bangladesh Agr Univ, Fac Vet Sci, Dept Med, Mymensingh, Bangladesh.	asamahbub2003@yahoo.com	Ward, Michael Patrick/GRX-1851-2022; Rahman, Dr. A. K. M. Anisur/P-1998-2017; Ward, Michael/C-5758-2009; Ward, Michael Patrick/W-1897-2019; Khan, Mohammad Abu Hadi Noor Ali/U-4896-2017	Ward, Michael Patrick/0000-0002-9921-4986; Rahman, Dr. A. K. M. Anisur/0000-0001-9660-4949; Ward, Michael/0000-0002-9921-4986; Khan, Mohammad Abu Hadi Noor Ali/0000-0002-8409-4571; Hassan, Jayedul/0000-0003-2895-8950	Bangladesh Agricultural University Research System;  [2015/17/BAU]	Bangladesh Agricultural University Research System; 	MMA received fund to conduct this study [Grant number is: 2015/17/BAU]. The study was funded by Bangladesh Agricultural University Research System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M. M., 1994, Bangladesh Veterinary Journal, V28, P35; Alam M. N., 2011, Bangladesh Journal of Veterinary Medicine, V9, P167; Alam MM, 1999, J DIARRHOEAL DIS RES, V17, P81; Alferi AF, 2004, VET MICROBIOL, V99, P167, DOI 10.1016/j.vetmic.2003.10.029; Ali MS., 2015, ASIAN J MED BIOL RES, V1, P39; Ali YH., 2011, J SCI TECHNOL, V12, P58; Alkan F, 2010, VET MICROBIOL, V141, P231, DOI 10.1016/j.vetmic.2009.09.016; Banyai K, 2017, INFECT GENET EVOL, V48, P19, DOI 10.1016/j.meegid.2016.12.002; Barua SR., 2019, ASIAN J MED BIOL RES, V5, P107, DOI [10.3329/ajmbr.v5i2.42492, DOI 10.3329/AJMBR.V5I2.42492]; Bertoni E, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11092652; Chitambar SD, 2011, VET MICROBIOL, V148, P384, DOI 10.1016/j.vetmic.2010.08.027; Debelo M, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/5778455; Dhama K, 2009, VET RES COMMUN, V33, P1, DOI 10.1007/s11259-008-9070-x; Estes MK, 2007, FIELDS VIROLOGY, P1917; Ezung ZN, 2014, INDIAN J ANIM SCI, V84, P851; Garaicoechea L, 2006, VET MICROBIOL, V118, P1, DOI 10.1016/j.vetmic.2006.06.004; Gill GS., 2017, J ANIM RES, V7, P927; Hassan HA., 2014, AL QADISIYAH J VET M, V13, P20; HERRING AJ, 1982, J CLIN MICROBIOL, V16, P473, DOI 10.1128/JCM.16.3.473-477.1982; Hosmer DW, 1997, STAT MED, V16, P965; Hossain MB, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104170; Howe L, 2008, NEW ZEAL VET J, V56, P218, DOI 10.1080/00480169.2008.36836; ISEGAWA Y, 1993, MOL CELL PROBE, V7, P277, DOI 10.1006/mcpr.1993.1041; Islam MN, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247838; Islam SS, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009394; Izzo MM, 2011, AUST VET J, V89, P167, DOI 10.1111/j.1751-0813.2011.00692.x; Lele S.R., 2019, RESOURCESELECTION RE; Mahmud, 2016, J EXP AGR INT, V13, P1; Malik YS, 2012, J VET SCI, V13, P271, DOI 10.4142/jvs.2012.13.3.271; Miles MG, 2012, VACCINE, V30, pA131, DOI 10.1016/j.vaccine.2011.10.002; Nagashima S, 2009, ARCH VIROL, V154, P1223, DOI 10.1007/s00705-009-0436-3; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; R Core Team, 2020, R LANG ENV STAT COMP; Rahman MF., 1992, BANGLAESH VET, V9, P84; Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910; Rao CD, 2000, VIROLOGY, V276, P104, DOI 10.1006/viro.2000.0472; Samad M. A., 1990, Panel Proceedings Series - International Atomic Energy Agency, P195; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; SELIM SA, 1991, VET RES COMMUN, V15, P327, DOI 10.1007/BF00430039; Singh TC, 2011, BUFFALO BULL, V30, P113; Tatte VS, 2019, ACTA VIROL, V63, P103, DOI 10.4149/av_2019_113; Vlasova AN., ANIMAL ORIGIN VIRAL, P163; Wani SA, 2002, INDIAN J ANIM SCI, V72, P844; Yahaya K., 2018, GSC BIOL PHARM SCI, V5, P82	44	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264577	10.1371/journal.pone.0264577	http://dx.doi.org/10.1371/journal.pone.0264577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213667	Green Published, gold			2022-12-26	WOS:000787811000125
J	Kundrod, KA; Natoli, ME; Chang, MM; Smith, CA; Paul, S; Ogoe, D; Goh, C; Santhanaraj, A; Price, A; Eldin, KW; Patel, KP; Baker, E; Schmeler, KM; Richards-Kortum, R				Kundrod, Kathryn A.; Natoli, Mary E.; Chang, Megan M.; Smith, Chelsey A.; Paul, Sai; Ogoe, Dereq; Goh, Christopher; Santhanaraj, Akshaya; Price, Anthony; Eldin, Karen W.; Patel, Keyur P.; Baker, Ellen; Schmeler, Kathleen M.; Richards-Kortum, Rebecca			Sample-to-answer, extraction-free, real-time RT-LAMP test for SARS-CoV-2 in nasopharyngeal, nasal, and saliva samples: Implications and use for surveillance testing	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; DIAGNOSTICS; INFECTIVITY	The global COVID-19 pandemic has highlighted the need for rapid, accurate and accessible nucleic acid tests to enable timely identification of infected individuals. We optimized a sample-to-answer nucleic acid test for SARS-CoV-2 that provides results in <1 hour using inexpensive and readily available reagents. The test workflow includes a simple lysis and viral inactivation protocol followed by direct isothermal amplification of viral RNA using RT-LAMP. The assay was validated using two different instruments, a portable isothermal fluorimeter and a standard thermocycler. Results of the RT-LAMP assay were compared to traditional RT-qPCR for nasopharyngeal swabs, nasal swabs, and saliva collected from a cohort of patients hospitalized due to COVID-19. For all three sample types, positive agreement with RT-LAMP performed using the isothermal fluorimeter was 100% for samples with Ct <30 and 69-91% for samples with Ct <40. Following validation, the test was successfully scaled to test the saliva of up to 400 asymptomatic individuals per day as part of the campus surveillance program at Rice University. Successful development, validation, and scaling of this sample-to-answer, extraction-free real-time RT-LAMP test for SARS-CoV-2 adds a highly adaptable tool to efforts to control the COVID-19 pandemic, and can inform test development strategies for future infectious disease threats.	[Kundrod, Kathryn A.; Natoli, Mary E.; Chang, Megan M.; Smith, Chelsey A.; Paul, Sai; Richards-Kortum, Rebecca] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Ogoe, Dereq; Goh, Christopher; Santhanaraj, Akshaya] Rice Univ, Rice Inst Global Hlth 360, Houston, TX USA; [Price, Anthony; Baker, Ellen; Schmeler, Kathleen M.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Eldin, Karen W.] Univ Texas Hlth Sci Ctr, McGovern Med Sch, Houston, TX USA; [Patel, Keyur P.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	Rice University; Rice University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Richards-Kortum, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	rkortum@rice.edu		Chang, Megan/0000-0003-3272-8226	USAID through an IAVI research grant [CCID 9204, AID-OAA-A16-00032]; USAID through Rice University	USAID through an IAVI research grant; USAID through Rice University	Funding for this work was provided from the American people by USAID through an IAVI research grant CCID 9204 under award AID-OAA-A16-00032 between IAVI and USAID, and through internal funding by Rice University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95799-6; Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005; Baek YH, 2020, EMERG MICROBES INFEC, V9, P998, DOI 10.1080/22221751.2020.1756698; Bastos ML, 2021, ANN INTERN MED, V174, P501, DOI 10.7326/M20-6569; Basu A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01136-20; Bektas A, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050742; Bhadra S, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00911-20; Bikos DA., 2021, MEDRXIV, DOI [10.1101/2021.03.31.21254634, DOI 10.1101/2021.03.31.21254634]; Bokelmann L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21627-0; Buck MD., 2020, STANDARD OPERATING P, DOI [10.1101/2020.06.29.20142430, DOI 10.1101/2020.06.29.20142430]; Butler-Laporte G, 2021, JAMA INTERN MED, V181, P353, DOI 10.1001/jamainternmed.2020.8876; Cairns E, 2020, EVALUATE VANTAGE; Carter C, 2017, J VIROL METHODS, V244, P32, DOI 10.1016/j.jviromet.2017.02.013; Chen HW, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00415; Chen HW, 2016, MIL MED, V181, P227, DOI 10.7205/MILMED-D-15-00149; Chin ET, 2021, CLIN INFECT DIS, V73, pe3127, DOI [10.1093/cid/ciaa1383, DOI 10.1093/CID/CIAA1383]; Cox RA., 1968, METHODS ENZYMOL, V12, P120, DOI 10.1016/0076-6879(67)12123-X; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; de Almeida Patricia Del Vigna, 2008, J Contemp Dent Pract, V9, P72; Dzung A, 2021, J MOL DIAGN, V23, P691, DOI 10.1016/j.jmoldx.2021.03.003; Edgu G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228741; EMERGENCY USE AUTHORIZATION (EUA), SUMMARY COLOR SARS C; Engelmann I, 2021, ACS OMEGA, V6, P6528, DOI 10.1021/acsomega.1c00166; Goyal A, 2021, ELIFE, V10, DOI 10.7554/eLife.63537; Hanson KE, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01824-20; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hasan HR., 2011, MED J ISLAMIC WORLD, V19, P21; Huang YB, 2020, AM J RESP CRIT CARE, V201, P1435, DOI 10.1164/rccm.202003-0572LE; Iwasaki S, 2020, J INFECTION, V81, pE145, DOI 10.1016/j.jinf.2020.05.071; Jang WS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248042; Janikova M, 2021, MICROB BIOTECHNOL, V14, P307, DOI 10.1111/1751-7915.13737; Jefferson T, 2021, CLIN INFECT DIS, V73, pE3884, DOI 10.1093/cid/ciaa1764; Jiang MH, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00331; Johnson AJ, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00086-21; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Lalli MA, 2021, CLIN CHEM, V67, P415, DOI 10.1093/clinchem/hvaa267; Lamb LE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234682; Landry ML, 2020, J CLIN VIROL, V130, DOI 10.1016/j.jcv.2020.104567; Larremore DB, 2021, SCI ADV, V7, DOI [10.1101/2020.06.22.20136309, 10.1126/sciadv.abd5393]; Lucira, COVID 19 ALL IN ONE; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; Marty FM, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMvcm2010260; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117; Mohon A, 2020, J VIROL METHODS, V286, DOI 10.1016/j.jviromet.2020.113972; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Nagura-Ikeda M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01438-20; Nairz M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81782-8; Natoli Mary E, 2021, J Biomol Tech, V32, P180, DOI 10.7171/jbt.21-3203-013; Nishibata Y, 2021, PATHOL RES PRACT, V220, DOI 10.1016/j.prp.2021.153381; Paltiel AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16818; Paul R, 2020, BIOSENS BIOELECTRON, V169, DOI 10.1016/j.bios.2020.112592; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; Rabe BA, 2020, P NATL ACAD SCI USA, V117, P24450, DOI 10.1073/pnas.2011221117; Robinson-McCarthy L, 2020, NEW RECOMMENDED POLI, DOI [10.1128/mBio.02772-20, DOI 10.1128/MBIO.02772-20]; Schermer B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238612; Singh R, 2013, J INFECTION, V67, P245, DOI 10.1016/j.jinf.2013.04.016; Smithgall MC, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104428; Sullivan R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229791; Turner F., 2021, MEDRXIV, DOI [10.1101/2021.01.26.21250523, DOI 10.1101/2021.01.26.21250523]; Vogels CBF, 2021, MED-CAMBRIDGE, V2, P263, DOI 10.1016/j.medj.2020.12.010; Walsh KA, 2020, J INFECTION, V81, P357, DOI 10.1016/j.jinf.2020.06.067; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Yamazaki W, 2021, J CLIN VIROL, V136, DOI 10.1016/j.jcv.2021.104760; Yan C, 2020, CLIN MICROBIOL INFEC, V26, P773, DOI 10.1016/j.cmi.2020.04.001; Yang Qing, 2021, Elife, V10, DOI [10.1101/2020.07.16.20150250, 10.7554/eLife.65113]; Yu L, 2020, CLIN CHEM, V66, P975, DOI 10.1093/clinchem/hvaa102; Zhang Y., 2020, RAPID MOL DETECTION, V2, P1, DOI [10.1101/2020.02.26.20028373, DOI 10.1101/2020.02.26.20028373]; Zhang Yinhua, 2020, Biotechniques, V69, P178, DOI 10.2144/btn-2020-0078; Zhen W, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00783-20; Zhu JL, 2020, J INFECTION, V81, pE48, DOI 10.1016/j.jinf.2020.06.059; Zhu X, 2020, BIOSENS BIOELECTRON, V166, DOI 10.1016/j.bios.2020.112437	73	6	6	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264130	10.1371/journal.pone.0264130	http://dx.doi.org/10.1371/journal.pone.0264130			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213596	gold, Green Published			2022-12-26	WOS:000787811000050
J	Qi, YL; He, J				Qi, Yilan; He, Jun			Application of LDA and word2vec to detect English off-topic composition	PLOS ONE			English	Article								This paper presents an off-topic detection algorithm combining LDA and word2vec aiming at the problem of the lack of accurate and efficient off-topic detection algorithms in the English composition-assisted review system. The algorithm uses the LDA model to model the document and train the document through the word2vec, and uses the semantic relationship between the document's topics and words to calculate the probability weighted sum for each topic and its feature words in the document, and finally selects the off-topic composition by setting a reasonable threshold. Different F values are obtained by changing the number of topics in the document, and the best number of topics is determined. Experimental results show that the proposed method is more effective than vector space model, can detect more off-topic compositions, and the accuracy is higher, the F value is more than 88%, which realizes the intelligent processing of off-topic detection of composition, and can be effectively applied in English composition teaching.	[Qi, Yilan] Zhejiang Tech Inst Econ, Coll Culture & Art, Hangzhou, Zhejiang, Peoples R China; [He, Jun] Zhejiang Univ Technol, Coll Foreign Languages, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology	Qi, YL (corresponding author), Zhejiang Tech Inst Econ, Coll Culture & Art, Hangzhou, Zhejiang, Peoples R China.	qiyilan@163.com		Qi, Yilan/0000-0003-4539-7091				Arora S., 2012, PRACTICAL ALGORITHM, V12; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Chen DH., 2021, COMPUTER ENG APPL, V3, P1; Farrahi K, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1889681.1889684; Huang GM, 2018, P 2018 2 INT C ELECT, V10, P161; Kang C., 2020, COMPUTER APPL SOFTWA, V11, P127; Link WA, 2012, METHODS ECOL EVOL, V3, P112, DOI 10.1111/j.2041-210X.2011.00131.x; Ma HY, 2011, AUTOMATION INSTRUMEN, V2, P11; Mikolov T., 2013, DISTRIBUTED REPRESEN, V10, P18; Mikolov T., 2013, EFFICIENT ESTIMATION, V10, P18; Pennington J., 2014, P 2014 C EMPIRICAL M, P1532, DOI DOI 10.3115/V1/D14-1162; [唐明 Tang Ming], 2016, [计算机科学, Computer Science], V43, P214; Wang F., 2018, COMPUTER APPL SOFTWA, V1, P97; [王振振 Wang Zhenzhen], 2013, [计算机科学, Computer Science], V40, P229; Wu K., 2015, LIBR INFORM SCI RES, V2, P123; Ying Wang, 2020, MATEC Web of Conferences, V309, DOI 10.1051/matecconf/202030903004	16	1	1	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264552	10.1371/journal.pone.0264552	http://dx.doi.org/10.1371/journal.pone.0264552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213641	Green Published, gold			2022-12-26	WOS:000787811000120
J	Halme, HL; Parkkonen, L				Halme, Hanna-Leena; Parkkonen, Lauri			The effect of visual and proprioceptive feedback on sensorimotor rhythms during BCI training	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; FUNCTIONAL ELECTRICAL-STIMULATION; MOTOR IMAGERY; CORTICAL OSCILLATIONS; ALPHA-FREQUENCY; STROKE; EEG; NEUROREHABILITATION; SYNCHRONIZATION; REHABILITATION	Brain-computer interfaces (BCI) can be designed with several feedback modalities. To promote appropriate brain plasticity in therapeutic applications, the feedback should guide the user to elicit the desired brain activity and preferably be similar to the imagined action. In this study, we employed magnetoencephalography (MEG) to measure neurophysiological changes in healthy subjects performing motor imagery (MI) -based BCI training with two different feedback modalities. The MI-BCI task used in this study lasted 40-60 min and involved imagery of right- or left-hand movements. 8 subjects performed the task with visual and 14 subjects with proprioceptive feedback. We analysed power changes across the session at multiple frequencies in the range of 4-40 Hz with a generalized linear model to find those frequencies at which the power increased significantly during training. In addition, the power increase was analysed for each gradiometer, separately for alpha (8-13 Hz), beta (14-30 Hz) and gamma (30-40 Hz) bands, to find channels showing significant linear power increase over the session. These analyses were applied during three different conditions: rest, preparation, and MI. Visual feedback enhanced the amplitude of mainly high beta and gamma bands (24-40 Hz) in all conditions in occipital and left temporal channels. During proprioceptive feedback, in contrast, power increased mainly in alpha and beta bands. The alpha-band enhancement was found in multiple parietal, occipital, and temporal channels in all conditions, whereas the beta-band increase occurred during rest and preparation mainly in the parieto-occipital region and during MI in the parietal channels above hand motor regions. Our results show that BCI training with proprioceptive feedback increases the power of sensorimotor rhythms in the motor cortex, whereas visual feedback causes mainly a gamma-band increase in the visual cortex. MI-BCIs should involve proprioceptive feedback to facilitate plasticity in the motor cortex.	[Halme, Hanna-Leena; Parkkonen, Lauri] Aalto Univ, Dept Neurosci & Biomed Engn, Sch Sci, Espoo, Finland; [Parkkonen, Lauri] Aalto Univ, MEG Core, Aalto Neuroimaging, Sch Sci, Espoo, Finland	Aalto University; Aalto University	Halme, HL (corresponding author), Aalto Univ, Dept Neurosci & Biomed Engn, Sch Sci, Espoo, Finland.	hanna-leena.halme@aalto.fi	Parkkonen, Lauri/G-6755-2012	Parkkonen, Lauri/0000-0002-0130-0801; Halme, Hanna-Leena/0000-0003-2315-5745	Academy of Finland [295075]	Academy of Finland(Academy of Finland)	The study was supported by Academy of Finland grant #295075 "NeuroFeed" (http://www.aka.fi/) to LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00848; Amo C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186008; Ang KK, 2015, P IEEE, V103, P944, DOI 10.1109/JPROC.2015.2415800; Ang KK, 2015, CLIN EEG NEUROSCI, V46, P310, DOI 10.1177/1550059414522229; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Bai ZF, 2020, J NEUROENG REHABIL, V17, DOI 10.1186/s12984-020-00686-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biasiucci A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04673-z; Cantillo-Negrete J, 2019, BIOCYBERN BIOMED ENG, V39, P263, DOI 10.1016/j.bbe.2018.12.002; Carl C, 2012, NEUROIMAGE, V59, P1657, DOI 10.1016/j.neuroimage.2011.09.020; Cervera MA, 2018, ANN CLIN TRANSL NEUR, V5, P651, DOI 10.1002/acn3.544; Corsi MC, 2020, NEUROIMAGE, V209, DOI 10.1016/j.neuroimage.2019.116500; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Espenhahn S, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa161; Espenhahn S, 2019, NEUROIMAGE, V195, P340, DOI 10.1016/j.neuroimage.2019.03.079; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; Foldes ST, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab7cfb; Frolov AA, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00400; Gehringer JE, 2018, J NEUROPHYSIOL, V120, P239, DOI 10.1152/jn.00020.2018; Gomez-Rodriguez M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036005; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Halme HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168766; Hanna-Leena H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28295-z; Ishihara W., P HUM FACT ERG SOC A, V64, P1186, DOI 10.1177/1071181320641283; Jang YY, 2016, OCCUP THER INT, V23, P175, DOI 10.1002/oti.1422; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kaiser V, 2014, NEUROIMAGE, V85, P432, DOI 10.1016/j.neuroimage.2013.04.097; Khan MA, 2020, COMPUT BIOL MED, V123, DOI 10.1016/j.compbiomed.2020.103843; Kim T, 2016, OCCUP THER INT, V23, P39, DOI 10.1002/oti.1403; Kondo T, 2015, HUM MOVEMENT SCI, V43, P239, DOI 10.1016/j.humov.2014.08.014; Kranczioch C, 2008, CLIN NEUROPHYSIOL, V119, P1419, DOI 10.1016/j.clinph.2008.02.011; Li MF, 2014, INT J NEUROSCI, V124, P403, DOI 10.3109/00207454.2013.850082; Meng JJ, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00128; Mihara M, 2013, STROKE, V44, P1091, DOI 10.1161/STROKEAHA.111.674507; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Moisello C, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.374; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; Pichiorri F, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025020; Pichiorri F, 2015, ANN NEUROL, V77, P851, DOI 10.1002/ana.24390; Pollok B, 2014, NEUROSCIENCE, V275, P47, DOI 10.1016/j.neuroscience.2014.06.008; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Smith ME, 1999, COGNITIVE BRAIN RES, V7, P389, DOI 10.1016/S0926-6410(98)00043-3; Soekadar SR, 2015, CEREB CORTEX, V25, P2409, DOI 10.1093/cercor/bhu043; Sudre G, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/327953; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Teo WP, 2014, PM&R, V6, P723, DOI 10.1016/j.pmrj.2014.01.006; van Dokkum LEH, 2015, ANN PHYS REHABIL MED, V58, P3, DOI 10.1016/j.rehab.2014.09.016; Varkuti B, 2013, NEUROREHAB NEURAL RE, V27, P53, DOI 10.1177/1545968312445910; Vukelic M, 2015, NEUROIMAGE, V111, P1, DOI 10.1016/j.neuroimage.2015.01.058; Wander JD, 2013, P NATL ACAD SCI USA, V110, P10818, DOI 10.1073/pnas.1221127110; Wang ZP, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab377d; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zhuang P, 1997, ELECTROEN CLIN NEURO, V102, P374, DOI 10.1016/S0013-4694(96)96030-7	59	0	0	11	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264354	10.1371/journal.pone.0264354	http://dx.doi.org/10.1371/journal.pone.0264354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196360	Green Published, Green Submitted, gold			2022-12-26	WOS:000835161600042
J	Hsu, CH; Chiu, CL; Lin, YT; Yu, AY; Kang, YT; Cherng, M; Chen, YH; Chuang, TH; Huang, HY; Pao, JL; Chen, KH; Chang, CH				Hsu, Chih-Ho; Chiu, Chen-Lun; Lin, Yi-Ting; Yu, Ann-Yu; Kang, Yen-Te; Cherng, Michael; Chen, Yi-Hui; Chuang, Ting-Hui; Huang, Hsin-Yi; Pao, Jwo-Luen; Chen, Kuo-Hsin; Chang, Chih-Hung			Triage admission protocol with a centralized quarantine unit for patients after acute care surgery during the COVID-19 pandemic: A tertiary center experience in Taiwan	PLOS ONE			English	Article								Background During the COVID-19 surge in Taiwan, the Far East Memorial Hospital established a system including a centralized quarantine unit and triage admission protocol to facilitate acute care surgical inpatient services, prevent nosocomial COVID-19 infection and maintain the efficiency and quality of health care service during the pandemics. Materials and methods This retrospective cohort study included patients undergoing acute care surgery. The triage admission protocol was based on rapid antigen tests, Liat (R) PCR and RT-PCT tests. Type of surgical procedure, patient characteristics, and efficacy indices of the centralized quarantine unit and emergency department (ED) were collected and analyzed before (Phase I: May 11 to July 2, 2021) and after (Phase II: July 3 to July 31, 2021) the system started. Results A total of 287 patients (105 in Phase I and 182 in Phase II) were enrolled. Nosocomial COVID-19 infection occur in 27 patients in phase I but zero in phase II. More patients received traumatological, orthopedic, and neurologic surgeries in phase II than in phase I. The patients' surgical risk classification, median total hospital stay, intensive care unit (ICU) stay, intraoperative blood loss, operation time, and the number of patients requiring postoperative ICU care were similar in both groups. The duration of ED stay and waiting time for acute care surgery were longer in Phase II (397 vs. 532 minutes, p < 0.0001). The duration of ED stay was positively correlated with the number of surgical patients visiting the ED (median = 66 patients, Spearman's rho = 0.207) and the occupancy ratio in the centralized quarantine unit on that day (median = 90.63%, Spearman's rho = 0.191). Conclusions The triage admission protocol provided resilient quarantine needs and sustainable acute care surgical services during the COVID-19 pandemic. The efficiency was related to the number of medical staff dedicated to the centralized quarantine unit and number of surgical patients visited in ED.	[Hsu, Chih-Ho; Chiu, Chen-Lun; Lin, Yi-Ting; Yu, Ann-Yu; Chen, Yi-Hui] Far Eastern Mem Hosp, Dept Surg, Div Gen Surg, New Taipei, Taiwan; [Hsu, Chih-Ho] Natl Yang Ming Chiao Tung Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan; [Kang, Yen-Te; Cherng, Michael; Chen, Kuo-Hsin] Far Eastern Mem Hosp, Dept Surg, New Taipei, Taiwan; [Chuang, Ting-Hui; Huang, Hsin-Yi; Pao, Jwo-Luen; Chang, Chih-Hung] Far Eastern Mem Hosp, Dept Orthoped, New Taipei, Taiwan; [Chen, Kuo-Hsin] Yuan Ze Univ, Div Elect Engn, Taoyuan, Taiwan; [Chang, Chih-Hung] Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Taoyuan, Taiwan	Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Yuan Ze University; Yuan Ze University	Chen, KH (corresponding author), Far Eastern Mem Hosp, Dept Surg, New Taipei, Taiwan.; Chang, CH (corresponding author), Far Eastern Mem Hosp, Dept Orthoped, New Taipei, Taiwan.; Chen, KH (corresponding author), Yuan Ze Univ, Div Elect Engn, Taoyuan, Taiwan.; Chang, CH (corresponding author), Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Taoyuan, Taiwan.	chen.kuohsin@gmail.com; orthocch@mail.femh.org.tw		Hsu, Chih-Ho/0000-0003-3359-5429				[Anonymous], WHO COVID 19 DASHBOA; Burke SA, 2021, CDC 2019 NOVEL CORON; Cano-Valderrama O, 2020, INT J SURG, V80, P157, DOI 10.1016/j.ijsu.2020.07.002; Chen SC, 2021, NAT IMMUNOL, V22, P393, DOI 10.1038/s41590-021-00908-2; Cheng HY, 2021, BIOCHEM BIOPH RES CO, V538, P238, DOI 10.1016/j.bbrc.2020.10.100; Corp. TT, 2021, US MAN VTRUST COVID; Deora H, 2021, WORLD NEUROSURG, V148, pE197, DOI 10.1016/j.wneu.2020.12.111; Don D, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.594831; Dreifuss NH, 2020, BRIT J SURG, V107, pE368, DOI 10.1002/bjs.11806; Erie County Medical Examiner's Office, 2021, CLOS CAS REP THROUGH; Finkelstein P, 2021, J LAPAROENDOSC ADV S, V31, P243, DOI 10.1089/lap.2020.0749; Hansen G, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02811-20; Horvath B, 2021, ANESTHESIOLOGY, V135, P904, DOI 10.1097/ALN.0000000000003947; Jewkes SV, 2020, CLIN MED, V20, pE173, DOI 10.7861/clinmed.2020-0422; Kim J, 2022, NAT PROD RES, V36, P1084, DOI 10.1080/14786419.2020.1849200; Kim PS, 2020, JAMA-J AM MED ASSOC, V324, P2149, DOI 10.1001/jama.2020.22813; Krutsri C, 2021, INT J SURG OPEN, V28, P50, DOI 10.1016/j.ijso.2020.11.021; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li Q., 2020, NEW ENGL J MED, V382, P1199; Liu YC, 2020, BIOMED J, V43, P328, DOI 10.1016/j.bj.2020.04.007; Passarelli VC, 2021, INT J INFECT DIS, V102, P412, DOI 10.1016/j.ijid.2020.10.057; Ritchie H, OUR WORLD DATA; Wake RM, 2020, CLIN MED, V20, pE141, DOI 10.7861/clinmed.2020-0411; Zhang M, 2021, J CLIN NURS, V30, P1584, DOI 10.1111/jocn.15707	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263688	10.1371/journal.pone.0263688	http://dx.doi.org/10.1371/journal.pone.0263688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263347	gold, Green Published			2022-12-26	WOS:000804638700046
J	Moore, C; Santhakumaran, S; Martin, GP; Wilkinson, TJ; Caskey, FJ; Magadi, W; Gair, R; Smith, AC; Wellsted, D; van der Veer, SN				Moore, Currie; Santhakumaran, Shalini; Martin, Glen P.; Wilkinson, Thomas J.; Caskey, Fergus J.; Magadi, Winnie; Gair, Rachel; Smith, Alice C.; Wellsted, David; van der Veer, Sabine N.			Symptom clusters in chronic kidney disease and their association with people's ability to perform usual activities	PLOS ONE			English	Article							BURDEN; HEMODIALYSIS; DIALYSIS; OUTCOMES; PRIORITIES; MORTALITY; PATIENT; PAIN	BackgroundPeople living with a long-term condition, such as chronic kidney disease (CKD), often suffer from multiple symptoms simultaneously, making symptom management challenging. This study aimed to identify symptom clusters in adults with CKD across treatment groups and investigate their association with people's ability to perform their usual activities. MethodsWe conducted a secondary analysis of both cross-sectional and longitudinal data collected as part of a national service improvement programme in 14 kidney centres in England, UK. This data included symptom severity (17 items, POS-S Renal) and the extent to which people had problems performing their usual activities (single item, EQ-5D-5L). We categorised data by treatment group: haemodialysis (n = 1,462), transplantation (n = 866), peritoneal dialysis (n = 127), or CKD without kidney replacement therapy (CKD non-KRT; n = 684). We used principal component analysis to identify symptom clusters per treatment group, and proportional odds models to assess the association between clusters and usual activities. ResultsOverall, clusters related to: lack of energy and mobility; gastrointestinal; skin; and mental health. Across groups, the 'lack of energy and mobility' clusters were associated with having problems with usual activities, with odds ratios (OR) ranging between 1.24 (95% confidence interval [CI], 1.21-1.57) for haemodialysis and 1.56 for peritoneal dialysis (95% CI, 1.28-1.90). This association was confirmed longitudinally in haemodialysis (n = 399) and transplant (n = 249) subgroups. ImplicationsOur findings suggest that healthcare professionals should consider routinely assessing symptoms in the 'lack of energy & mobility' cluster in all people with CKD, regardless of whether they volunteer this information; not addressing these symptoms is likely to be related to them having problems with performing usual activities. Future studies should explore why symptoms within clusters commonly co-occur and how they interrelate. This will inform the development of cluster-level symptom management interventions with enhanced potential to improve outcomes for people with CKD.	[Moore, Currie; Wellsted, David] Univ Hertfordshire, Hlth Res Methods Unit, Hatfield, Herts, England; [Santhakumaran, Shalini; Magadi, Winnie] UK Renal Registry, Bristol, Avon, England; [Martin, Glen P.; van der Veer, Sabine N.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Hlth Informat, Div Informat Imaging & Data Sci, Manchester, Lancs, England; [Wilkinson, Thomas J.; Smith, Alice C.] Univ Leicester, Dept Hlth Sci, Leicester Kidney Lifestyle Team, Leicester, Leics, England; [Caskey, Fergus J.] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England; [Caskey, Fergus J.] North Bristol NHS Trust, Renal Unit, Bristol, Avon, England; [Gair, Rachel] Renal Assoc, Bristol, Avon, England	University of Hertfordshire; University of Manchester; University of Leicester; University of Bristol; North Bristol NHS Trust	Moore, C (corresponding author), Univ Hertfordshire, Hlth Res Methods Unit, Hatfield, Herts, England.	c.moore9@herts.ac.uk		Caskey, Fergus/0000-0002-5199-3925; Wellsted, David/0000-0002-2895-7838; Moore, Currie/0000-0003-4629-6858	Kidney Research UK Innovation grant [IN_013_20160304]; MRC-NIHR Methodology Research Programme [MR/T025085/1]; Stoneygate Trust; NIHR Leicester Biomedical Research Centre	Kidney Research UK Innovation grant; MRC-NIHR Methodology Research Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stoneygate Trust; NIHR Leicester Biomedical Research Centre	This work was supported by a Kidney Research UK Innovation grant (reference IN_013_20160304; https://kidneyresearchuk.org/research/research-grants).GPM's time was partially supported by funding from the MRC-NIHR Methodology Research Programme (grant number: MR/T025085/1; https://mrc.ukri.org/funding/science-areas/methodology-research).ACS and TJW are grateful for funding support from the Stoneygate Trust. Their contribution is independent research supported by the NIHR Leicester Biomedical Research Centre (https://www.leicesterbrc.nihr.ac.uk).The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar M, 2012, J PAIN SYMPTOM MANAG, V44, P229, DOI 10.1016/j.jpainsymman.2011.08.005; Aktas A, 2010, PALLIATIVE MED, V24, P373, DOI 10.1177/0269216310367842; Almutary H, 2017, J ADV NURS, V73, P2450, DOI 10.1111/jan.13303; Almutary H, 2016, J ADV NURS, V72, P2389, DOI 10.1111/jan.12997; Almutary H, 2013, J RENAL CARE, V39, P140, DOI 10.1111/j.1755-6686.2013.12022.x; Alpert CM, 2017, HEART FAIL REV, V22, P25, DOI 10.1007/s10741-016-9581-4; Amro A, 2016, J PAIN SYMPTOM MANAG, V51, P512, DOI 10.1016/j.jpainsymman.2015.10.012; Amro A, 2014, J REN CARE, V40, P23, DOI 10.1111/jorc.12051; [Anonymous], THINK KIDN TRANSF PA; Aresi G, 2019, J PAIN SYMPTOM MANAG, V58, P578, DOI 10.1016/j.jpainsymman.2019.06.010; Artom M, 2014, KIDNEY INT, V86, P497, DOI 10.1038/ki.2014.86; Bringsvor HB, 2018, INT J CHRONIC OBSTR, V13, P365, DOI 10.2147/COPD.S151428; Brown SA, 2017, CLIN KIDNEY J, V10, P788, DOI 10.1093/ckj/sfx057; Claxton RN, 2010, J PAIN SYMPTOM MANAG, V39, P211, DOI 10.1016/j.jpainsymman.2009.07.003; Corwin EJ, 2021, BIOL RES NURS, V23, P270, DOI 10.1177/1099800420958196; Cuthbert CA, 2020, SUPPORT CARE CANCER, V28, P5889, DOI 10.1007/s00520-020-05415-y; Daugirdas JT, 2015, AM J KIDNEY DIS, V66, P884, DOI 10.1053/j.ajkd.2015.07.015; Davison SN, 2019, CLIN J AM SOC NEPHRO, V14, P626, DOI 10.2215/CJN.10510917; Davison SN, 2015, KIDNEY INT, V88, P447, DOI 10.1038/ki.2015.110; Davison SN, 2014, SEMIN DIALYSIS, V27, P188, DOI 10.1111/sdi.12196; Evon DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196908; Flythe JE, 2018, NEPHROL DIAL TRANSPL, V33, P1842, DOI 10.1093/ndt/gfy069; Gair R., 2019, BRIT J RENAL MED, V24, P10; Gomez Alwyn T, 2015, Can J Kidney Health Dis, V2, P34, DOI 10.1186/s40697-015-0068-3; Sanchez DG, 2019, CLIN NURS RES, V28, P583, DOI 10.1177/1054773817740671; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Jablonski Anita, 2007, Nephrol Nurs J, V34, P29; Lee Suk Jeong, 2015, Appl Nurs Res, V28, pe13, DOI 10.1016/j.apnr.2015.03.004; Levey AS, 2020, CLIN KIDNEY J, V13, P485, DOI 10.1093/ckj/sfaa123; Lockwood MB, 2019, WESTERN J NURS RES, V41, P1056, DOI 10.1177/0193945918808766; Maguen S, 2014, DEPRESS ANXIETY, V31, P160, DOI 10.1002/da.22072; Manera KE, 2019, CLIN J AM SOC NEPHRO, V14, P74, DOI 10.2215/CJN.05380518; Manns B, 2014, CLIN J AM SOC NEPHRO, V9, P1813, DOI 10.2215/CJN.01610214; Miaskowski C, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw253; Ministry of Housing CLG Statistics N, 2015, ENGLISH INDICES DEPR; Ng MSN, 2020, J PAIN SYMPTOM MANAG, V59, P67, DOI 10.1016/j.jpainsymman.2019.08.013; NICE Excellence NIfHC, 2018, RENAL REPLACEMENT TH; ORourke Norm, 2013, STEP BY STEP APPROAC; POS, 2017, PALLIATIVE CARE OUTC; Raj R, 2017, NEPHROLOGY, V22, P228, DOI 10.1111/nep.12754; Rayner HC, 2017, CLIN J AM SOC NEPHRO, V12, P2000, DOI 10.2215/CJN.03280317; Registry UR, 2019, UK REN REG 21 ANN RE; Senanayake S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0638-y; Sexton DJ, 2016, HEMODIAL INT, V20, P618, DOI 10.1111/hdi.12415; Thong MSY, 2009, NEPHROL DIAL TRANSPL, V24, P225, DOI 10.1093/ndt/gfn449; Urquhart-Secord R, 2016, AM J KIDNEY DIS, V68, P444, DOI 10.1053/j.ajkd.2016.02.037; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang RP, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0531-6; Weisbord SD, 2014, CLIN J AM SOC NEPHRO, V9, P1594, DOI 10.2215/CJN.00220114	49	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264312	10.1371/journal.pone.0264312	http://dx.doi.org/10.1371/journal.pone.0264312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T6JP	35235567	Green Published, gold			2022-12-26	WOS:000787073100027
J	Sajiki, Y; Konnai, S; Okagawa, T; Maekawa, N; Goto, S; Kohara, J; Nitanai, A; Takahashi, H; Kubota, K; Takeda, H; Murata, S; Ohashi, K				Sajiki, Yamato; Konnai, Satoru; Okagawa, Tomohiro; Maekawa, Naoya; Goto, Shinya; Kohara, Junko; Nitanai, Atsushi; Takahashi, Hirofumi; Kubota, Kentaro; Takeda, Hiroshi; Murata, Shiro; Ohashi, Kazuhiko			Estradiol-induced immune suppression via prostaglandin E-2 during parturition in bovine leukemia virus-infected cattle	PLOS ONE			English	Article							T-CELL PARADIGM; NATURAL TRANSMISSION; PREGNANCY; RESPONSES; PROGESTERONE; TH1/TH2/TH17; EXPRESSION; ESTROGENS; PLASMA; DAIRY	Immune suppression during pregnancy and parturition is considered a risk factor that is related to the progression of bovine chronic diseases, such as bovine leukosis, which is caused by bovine leukemia virus (BLV). Our previous studies have demonstrated that prostaglandin E-2 (PGE(2)) suppresses BLV-specific Th1 responses and contributes to the disease progression during BLV infection. Although PGE(2) reportedly plays important roles in the induction of parturition, PGE(2) involvement in immune suppression during parturition is unknown. To investigate its involvement, we analyzed PGE(2) kinetics and Th1 responses in BLV-infected pregnant cattle. PGE(2) concentrations in sera were increased, whereas IFN-gamma responses were decreased before delivery. PGE(2) is known to suppress Th1 immune responses in cattle. Thus, these data suggest that PGE(2) upregulation inhibits Th1 responses during parturition. We also found that estradiol was important for PGE(2) induction in pregnant cattle. In vitro analyses indicated that estradiol suppressed IFN-gamma production, at least in part, via PGE(2)/EP4 signaling. In vivo analyses showed that estradiol administration significantly influenced the induction of PGE(2) production and impaired Th1 responses. Our data suggest that estradiol-induced PGE(2) is involved in the suppression of Th1 responses during pregnancy and parturition in cattle, which could contribute to the progression of BLV infection.	[Sajiki, Yamato; Konnai, Satoru; Goto, Shinya; Murata, Shiro; Ohashi, Kazuhiko] Hokkaido Univ, Fac Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan; [Konnai, Satoru; Okagawa, Tomohiro; Maekawa, Naoya; Murata, Shiro; Ohashi, Kazuhiko] Hokkaido Univ, Fac Vet Med, Dept Adv Pharmaceut, Sapporo, Hokkaido, Japan; [Kohara, Junko] Hokkaido Res Org, Agr Res Dept, Anim Res Ctr, Shintoku, Hokkaido, Japan; [Nitanai, Atsushi; Takahashi, Hirofumi] Hokkaido Higashi Agr Mutual Aid Assoc, Nakashibetsu, Hokkaido, Japan; [Kubota, Kentaro] Hokkaido Chuo Agr Mutual Aid Assoc, Rumoi Nambu Vet Clin, Tomamae, Japan; [Takeda, Hiroshi] Minami Hokkaido Agr Mutual Aid Assoc, Osyamanbe Vet Clin, Osyamanbe, Japan	Hokkaido University; Hokkaido University	Konnai, S (corresponding author), Hokkaido Univ, Fac Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan.; Konnai, S (corresponding author), Hokkaido Univ, Fac Vet Med, Dept Adv Pharmaceut, Sapporo, Hokkaido, Japan.	Konnai@vetmed.hokudai.ac.jp		Satoru, Konnai/0000-0002-3230-7109	JSPS KAKENHI [19KK0172]; Project of the NARO, Bio-oriented Technology Research Advancement Institution (Research Program on Development of Innovative Technology) [26058 BC]; Special Scheme Project on Regional Developing Strategy [16817557]; Regulatory research projects for food safety,animal health and plant protection; Ministryof Agriculture,Forestryand FisheriesofJapan and Clinical Research Promotion Fund2021by Hokkaido University Veterinary Teaching Hospital;  [JPJ008617.17935709]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project of the NARO, Bio-oriented Technology Research Advancement Institution (Research Program on Development of Innovative Technology); Special Scheme Project on Regional Developing Strategy; Regulatory research projects for food safety,animal health and plant protection; Ministryof Agriculture,Forestryand FisheriesofJapan and Clinical Research Promotion Fund2021by Hokkaido University Veterinary Teaching Hospital; 	This workwas supportedby JSPSKAKENHIgrantnumber19KK0172[to S.K.],grantsfromthe Projectof the NARO,Bio-orientedTechnologyResearch Advancement Institution(ResearchProgramon Development of InnovativeTechnology26058BC [to S.K.]and SpecialSchemeProjecton RegionalDevelopingStrategy,Grant16817557 [to S.K.]),Regulatory research projects for food safety,animal health and plant protection(JPJ008617.17935709)fundedby theMinistryof Agriculture,Forestryand FisheriesofJapanand ClinicalResearchPromotion Fund2021by HokkaidoUniversityVeterinaryTeachingHospital[to S.K.].The fundershad no role in studydesign,data collectionand analysis,decisiontopublish,or preparationof the manuscript.	Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; FEINBERG BB, 1992, J REPROD IMMUNOL, V21, P139, DOI 10.1016/0165-0378(92)90020-5; Figueiredo AS, 2016, IMMUNOLOGY, V148, P13, DOI 10.1111/imm.12595; Frie MC, 2015, VET IMMUNOL IMMUNOP, V163, P103, DOI 10.1016/j.vetimm.2014.11.014; Goff JP, 1997, J DAIRY SCI, V80, P1260, DOI 10.3168/jds.S0022-0302(97)76055-7; Goto S, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00012; Hamilton KL, 2004, J MOL CELL CARDIOL, V36, P577, DOI 10.1016/j.yjmcc.2004.02.005; Hirano S, 2007, AM J PHYSIOL-REG I, V292, pR1465, DOI 10.1152/ajpregu.00778.2006; Hirsbrunner G, 2007, VET REC, V161, P414, DOI 10.1136/vr.161.12.414; Hopkins SG, 1997, VET CLIN N AM-FOOD A, V13, P107; Ikebuchi R, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-59; Jobin C, 1998, IMMUNOLOGY, V95, P537; Kabeya H, 2001, J VET MED SCI, V63, P703, DOI 10.1292/jvms.63.703; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Konnai S, 2017, J VET MED SCI, V79, P1, DOI 10.1292/jvms.16-0354; Maeda Y, 2013, VET RES COMMUN, V37, P43, DOI 10.1007/s11259-012-9545-7; MAGER A, 1994, J GEN VIROL, V75, P2223, DOI 10.1099/0022-1317-75-9-2223; Monti GE, 2007, EPIDEMIOL INFECT, V135, P228, DOI 10.1017/S0950268806006637; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Ohira K, 2016, IMMUN INFLAMM DIS, V4, P52, DOI 10.1002/iid3.93; Oliveira LJ, 2012, REPROD DOMEST ANIM, V47, P384, DOI 10.1111/j.1439-0531.2012.02102.x; Orlik O, 1996, J VIROL, V70, P7584, DOI 10.1128/JVI.70.11.7584-7593.1996; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; Polanczyk MJ, 2004, J IMMUNOL, V173, P2227, DOI 10.4049/jimmunol.173.4.2227; Pyeon D, 2000, J VIROL, V74, P5740, DOI 10.1128/JVI.74.12.5740-5745.2000; ROBERTSON HA, 1974, J REPROD FERTIL, V36, P1, DOI 10.1530/jrf.0.0360001; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Sajiki Y, 2019, J IMMUNOL, V203, P1313, DOI 10.4049/jimmunol.1900342; Sajiki Y, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00910-17, 10.1128/iai.00910-17]; Sajiki Y, 2017, J VET MED SCI, V79, P2036, DOI 10.1292/jvms.17-0391; SCHWARTZ I, 1994, VET RES, V25, P521; SMITH VG, 1973, J ANIM SCI, V36, P391; STELLFLUG JN, 1978, THERIOGENOLOGY, V10, P269, DOI 10.1016/0093-691X(78)90104-8; Subbaramaiah K, 1996, CANCER RES, V56, P4424; Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221	37	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263660	10.1371/journal.pone.0263660	http://dx.doi.org/10.1371/journal.pone.0263660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T3NB	35263339	gold, Green Published			2022-12-26	WOS:000804638700017
J	Soto, A; Quinones-Laveriano, DM; Azanero, J; Chumpitaz, R; Claros, J; Salazar, L; Rosales, O; Nunez, L; Roca, D; Alcantara, A				Soto, Alonso; Quinones-Laveriano, Dante M.; Azanero, Johan; Chumpitaz, Rafael; Claros, Jose; Salazar, Lucia; Rosales, Oscar; Nunez, Liz; Roca, David; Alcantara, Andres			Mortality and associated risk factors in patients hospitalized due to COVID-19 in a Peruvian reference hospital	PLOS ONE			English	Article							AGE	ObjectivesTo determine the risk factors for in-hospital mortality in patients with COVID-19 from a Peruvian national hospital. MethodsRetrospective cohort study of medical records of patients with COVID-19 hospitalized at Hospital Nacional Hipolito Unanue (HNHU) during the months of April to August 2020. The dependent variable was in-hospital mortality. Independent variables included sociodemographic and clinical characteristics, physical examination findings, oxygen saturation (SaO(2)) at admission, treatment received during hospitalization and laboratory results at admission. A Cox regression model was used to evaluate the crude and adjusted hazard ratios for associated factors. ResultsWe included 1418 patients. Median age was 58 years (IQR 47-68 years) and 944 (66.6%) were male. The median length of hospitalization was 7 (4-13) days, and the mortality rate was 46%. The most frequent comorbidities were type 2 diabetes mellitus, hypertension, and obesity. In the adjusted analysis, mortality was associated with age (HR 1.02; 95%CI 1.02-1.03), history of surgery (HR 1.89; 95%CI 1.31-2.74), lower oxygen saturation at admission (HR 4.08; CI95% 2.72-8.05 for SaO(2)94%), the presence of poor general condition (HR 1.81; 95% CI 1.29-2.53), altered state of consciousness (HR 1.58; 95%CI 1.18-2.11) and leukocyte levels (HR 1.01; 95%CI 1.00-1. 02). Treatment with ivermectin (HR 1.44; 95%CI 1.18-1.76) and azithromycin (HR 1.25; 95%CI 1.03-1.52) were associated with higher mortality. Treatment with corticosteroids at low to moderate doses was associated with lower mortality (HR 0.56 95%CI 0. 37-0. 86) in comparison to no steroid use. ConclusionA high mortality was found in our cohort. Low oxygen saturation at admission, age, and the presence of hematological and biochemical alterations were associated with higher mortality. The use of hydroxychloroquine, ivermectin or azithromycin was not useful and was probably associated with unfavorable outcomes. The use of corticosteroids at moderate doses was associated with lower mortality.	[Soto, Alonso; Quinones-Laveriano, Dante M.] Univ Ricardo Palma, Fac Med, Inst Invest Ciencias Biomed INICIB, Lima, Peru; [Soto, Alonso; Azanero, Johan; Chumpitaz, Rafael; Claros, Jose; Salazar, Lucia; Rosales, Oscar; Alcantara, Andres] Hosp Nacl Hipolito Unanue, Dept Internal Med, Lima, Peru; [Azanero, Johan] Univ Cient Sur, Lima, Peru; [Nunez, Liz; Roca, David] Univ Ricardo Palma, Fac Med, Lima, Peru	Universidad Ricardo Palma; Universidad Cientifica del Sur (CIENTIFICA); Universidad Ricardo Palma	Soto, A (corresponding author), Univ Ricardo Palma, Fac Med, Inst Invest Ciencias Biomed INICIB, Lima, Peru.; Soto, A (corresponding author), Hosp Nacl Hipolito Unanue, Dept Internal Med, Lima, Peru.	alonso.soto@urp.edu.pe	Azañero, Johan/AAV-5606-2021	Azañero, Johan/0000-0003-3385-1891; Soto, Alonso/0000-0001-8648-8032; Nunez Munoz, Alison Liz de Azucena/0000-0002-0839-8637				Aggarwal G, 2020, CURR PROB CARDIOLOGY, V45, DOI 10.1016/j.cpcardiol.2020.100617; [Anonymous], 2020, LANCET, V396, P1463, DOI 10.1016/S0140-6736(20)32328-X; Bae S, 2021, HEART, V107, P373, DOI 10.1136/heartjnl-2020-317901; Bahl A, 2020, INTERN EMERG MED, V15, P1485, DOI 10.1007/s11739-020-02509-7; Barbosa Isabelle Ribeiro, 2020, Rev. bras. geriatr. gerontol., V23, pe200171, DOI 10.1590/1981-22562020023.200171; Chen B, 2021, COMPUT STRUCT BIOTEC, V19, P1694, DOI 10.1016/j.csbj.2021.03.012; Cifuentes MP, 2021, J EPIDEMIOL COMMUN H, V75, P610, DOI 10.1136/jech-2020-216275; Corona G, 2021, REV ENDOCR METAB DIS, V22, P275, DOI 10.1007/s11154-021-09630-8; Dana R, 2021, INT J OBESITY, V45, P2028, DOI 10.1038/s41366-021-00872-9; Danwang C, 2020, BIOMARK RES, V8, DOI 10.1186/s40364-020-00217-0; Diaz-Velez Cristian, 2021, F1000Res, V10, P224, DOI 10.12688/f1000research.51474.1; Diendere EA, 2021, INT J INFECT DIS, V108, P289, DOI 10.1016/j.ijid.2021.04.007; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hu CY, 2020, INT J EPIDEMIOL, V49, P1918, DOI 10.1093/ije/dyaa171; Hueda-Zavaleta Miguel, 2021, Rev. perú. med. exp. salud publica, V38, P214, DOI 10.17843/rpmesp.2021.382.7158; Ielapi N, 2020, BIOMARK MED, V14, P713, DOI 10.2217/bmm-2020-0201; Navarrete-Mejia PJ, 2020, REV CUERPO MED HOSP, V13, P361, DOI 10.35434/rcmhnaaa.2020.134.766; Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154; Karampela I, 2020, CURR OBES REP, V9, P231, DOI 10.1007/s13679-020-00394-x; Krinsley James S, 2012, Hosp Pract (1995), V40, P31, DOI 10.3810/hp.2012.04.967; Lee K, 2009, GLOB INST, P1; Marcolino MS, 2021, INT J INFECT DIS, V107, P300, DOI 10.1016/j.ijid.2021.01.019; Mehraeen E, 2020, EUR J INTEGR MED, V40, DOI 10.1016/j.eujim.2020.101226; Mejia F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244171; Ministerio de Salud, 2021, PLATAFORMA DIGITAL N; Neyra-Leon J, 2021, J PUBLIC HEALTH POL, V42, P182, DOI 10.1057/s41271-020-00259-6; Okereke M, 2021, INT J HEALTH PLAN M, V36, P13, DOI 10.1002/hpm.3067; Olivas-Martinez A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245772; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Gomez NFP, 2020, REV ESP QUIM, V33, P267, DOI 10.37201/req/060.2020; la Pena JED, 2021, ARCH MED RES, V52, P443, DOI 10.1016/j.arcmed.2020.12.002; Poly TN, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.620044; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Rodríguez-Zúñiga Milton J.M., 2020, Acta méd. Peru, V37, P437, DOI 10.35663/amp.2020.374.1676; Singh AK, 2020, DIABETES METAB SYND, V14, P971, DOI 10.1016/j.dsx.2020.06.054; Soto Alonso, 2020, Acta méd. Peru, V37, P110, DOI 10.35663/amp.2020.371.914; Soto Alonso, 2020, Acta méd. Peru, V37, P255, DOI 10.35663/amp.2020.373.1548; Soto-Becerra P., 2020, REAL WORLD EFFECTIVE, DOI [10.1101/2020.04.15.20064931, DOI 10.1101/2020.04.15.20064931]; Vences MA, 2021, MEDWAVE, V21, DOI 10.5867/medwave.2021.06.8231; Vial MR, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05665-5; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; World Health Organization, EM SIT UPD; Yanez ND, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09826-8; Yupari-Azabache Irma, 2021, Rev. Fac. Med. Hum., V21, P19, DOI 10.25176/rfmh.v21i1.3264; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	46	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264789	10.1371/journal.pone.0264789	http://dx.doi.org/10.1371/journal.pone.0264789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235613	gold, Green Published			2022-12-26	WOS:000787073100034
J	Miyamoto, D; Takeuchi, K; Chihara, K; Fujieda, S; Sada, K				Miyamoto, Daisuke; Takeuchi, Kenji; Chihara, Kazuyasu; Fujieda, Shigeharu; Sada, Kiyonao			Protein tyrosine kinase Abl promotes hepatitis C virus particle assembly via interaction with viral substrate activator NS5A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED MOTILITY; RNA REPLICATION; FAMILY KINASES; PHOSPHORYLATION; DOMAIN; LEUKEMIA; ENTRY; BCR	Previously, we reported that knockdown of Abl protein tyrosine kinase by shRNA or pharmacological inhibition suppresses particle assembly of J6/JFH1 strain-derived hepatitis C virus (HCV) in Huh-7.5 cells. However, the detailed mechanism by which Abl regulates HCV replication remained unclear. In this study, we established Abl-deficient (Abl(-)) cells through genome editing and compared HCV production between Abl(-) cells expressing WT or kinase-dead Abl and parental Huh-7.5 cells. Our findings revealed that Abl expression was not required from the stages of virus attachment and entry to viral gene expression; however, the kinase activity of Abl was necessary for the assembly of HCV particles. Reconstitution experiments using human embryonic kidney 293T cells revealed that phosphorylation of Tyr(412) in the activation loop of Abl was enhanced by coexpression with the viral nonstructural protein 5A (NS5A) and was abrogated by the substitution of NS5A Tyr(330) with Phe (Y330F), suggesting that NS5A functions as a substrate activator of Abl. Abl-NS5A association was also attenuated by the Y330F mutation of NS5A or the kinase-dead Abl, and Abl Tyr(412) phosphorylation was not enhanced by NS5A bearing a mutation disabling homodime-rization, although the association of Abl with NS5A was still observed. Taken together, these results demonstrate that Abl forms a phosphorylation-dependent complex with dimeric NS5A necessary for viral particle assembly, but that Abl is capable of complex formation with monomeric NS5A regard-less of tyrosine phosphorylation. Our findings provide the foundation of a molecular basis for a new hepatitis C treatment strategy using Abl inhibitors.	[Miyamoto, Daisuke; Fujieda, Shigeharu] Univ Fukui, Dept Otorhinolaryngol Head & Neck Surg, Fac Med Sci, Fukui, Japan; [Miyamoto, Daisuke; Takeuchi, Kenji; Chihara, Kazuyasu; Sada, Kiyonao] Univ Fukui, Dept Genome Sci & Microbiol, Fac Med Sci, Fukui, Japan; [Takeuchi, Kenji; Chihara, Kazuyasu; Fujieda, Shigeharu; Sada, Kiyonao] Univ Fukui, Org Life Sci Adv Programs, Fukui, Japan	University of Fukui; University of Fukui; University of Fukui	Sada, K (corresponding author), Univ Fukui, Dept Genome Sci & Microbiol, Fac Med Sci, Fukui, Japan.; Sada, K (corresponding author), Univ Fukui, Org Life Sci Adv Programs, Fukui, Japan.	ksada@u-fukui.ac.jp	Sada, Kiyonao/H-7373-2015	Sada, Kiyonao/0000-0001-6124-3100	Japan Society for the Promotion of Science KAKENHI grant [21H03086, 17H04344, 18K19734, 17K08656, 20K07354]; Life Science Innovation Center at the University of Fukui; Yakult Honsha Co, Ltd	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Life Science Innovation Center at the University of Fukui; Yakult Honsha Co, Ltd	This work was supported by the Japan Society for the Promotion of Science KAKENHI grant (grant numbers: 17K08656 and 20K07354 [to K. S.]), the Japan Society for the Promotion of Science KAKENHI grant (grant numbers: 21H03086, 17H04344, and 18K19734 [to S. F.]), a grant from the Life Science Innovation Center at the University of Fukui (to K. T.), and a grant from Yakult Honsha Co, Ltd (to K. S.).	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Barouch-Bentov R, 2016, MBIO, V7, DOI 10.1128/mBio.01456-16; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Chihara K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11915-5; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Fan PD, 2003, CANCER RES, V63, P873; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Gomperts BD, 2009, SIGNAL TRANSDUCTION, 2ND EDITION, P1; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Khatri A, 2016, J CELL SCI, V129, P9, DOI 10.1242/jcs.175521; Klinker S, 2019, J BIOL CHEM, V294, P7388, DOI 10.1074/jbc.RA119.007656; Kumar S, 2019, CELL REP, V26, P1800, DOI 10.1016/j.celrep.2019.01.075; Lim PJ, 2012, J BIOL CHEM, V287, P30861, DOI 10.1074/jbc.M112.376822; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Min S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01129; MULLER AJ, 1992, MOL CELL BIOL, V12, P5087, DOI 10.1128/MCB.12.11.5087; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nakashima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046634; Newsome TP, 2006, CELL MICROBIOL, V8, P233, DOI 10.1111/j.1462-5822.2005.00613.x; Noda T., 2006, PLOS PATHOG, V2, P99; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Reeves PM, 2011, J VIROL, V85, P21, DOI 10.1128/JVI.01814-10; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Shanmugam S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007177; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Wang JYJ, 2014, MOL CELL BIOL, V34, P1188, DOI 10.1128/MCB.01454-13; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Yamauchi S, 2015, J BIOL CHEM, V290, P21857, DOI 10.1074/jbc.M115.666859; Yin CH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006834; Zayas M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005376	48	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101804	10.1016/j.jbc.2022.101804	http://dx.doi.org/10.1016/j.jbc.2022.101804			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35257746	Green Published, gold			2022-12-26	WOS:000793560400008
J	Cocucci, TJ; Pulido, M; Aparicio, JP; Ruiz, J; Simoy, MI; Rosa, S				Javier Cocucci, Tadeo; Pulido, Manuel; Pablo Aparicio, Juan; Ruiz, Juan; Ignacio Simoy, Mario; Rosa, Santiago			Inference in epidemiological agent-based models using ensemble-based data assimilation	PLOS ONE			English	Article								To represent the complex individual interactions in the dynamics of disease spread informed by data, the coupling of an epidemiological agent-based model with the ensemble Kalman filter is proposed. The statistical inference of the propagation of a disease by means of ensemble-based data assimilation systems has been studied in previous works. The models used are mostly compartmental models representing the mean field evolution through ordinary differential equations. These techniques allow to monitor the propagation of the infections from data and to estimate several parameters of epidemiological interest. However, there are many important features which are based on the individual interactions that cannot be represented in the mean field equations, such as social network and bubbles, contact tracing, isolating individuals in risk, and social network-based distancing strategies. Agent-based models can describe contact networks at an individual level, including demographic attributes such as age, neighborhood, household, workplaces, schools, entertainment places, among others. Nevertheless, these models have several unknown parameters which are thus difficult to prescribe. In this work, we propose the use of ensemble-based data assimilation techniques to calibrate an agent-based model using daily epidemiological data. This raises the challenge of having to adapt the agent populations to incorporate the information provided by the coarse-grained data. To do this, two stochastic strategies to correct the model predictions are developed. The ensemble Kalman filter with perturbed observations is used for the joint estimation of the state and some key epidemiological parameters. We conduct experiments with an agent based-model designed for COVID-19 and assess the proposed methodology on synthetic data and on COVID-19 daily reports from Ciudad Autonoma de Buenos Aires, Argentina.	[Javier Cocucci, Tadeo; Rosa, Santiago] Univ Nacl Cordoba, FAMAF, Cordoba, Argentina; [Javier Cocucci, Tadeo; Pulido, Manuel; Rosa, Santiago] Univ Nacl Nordeste, FaCENA, Corrientes, Argentina; [Pulido, Manuel] Consejo Nacl Invest Cient & Tecn, IFAECI, Corrientes, Argentina; [Pulido, Manuel] Consejo Nacl Invest Cient & Tecn, IMIT, Corrientes, Argentina; [Pablo Aparicio, Juan; Ignacio Simoy, Mario] Univ Nacl Salta, INENCO, CONICET, Salta, Argentina; [Pablo Aparicio, Juan] Arizona State Univ, Simon A Levin Math Computat & Modeling Sci Ctr, Tempe, AZ USA; [Ruiz, Juan] Univ Buenos Aires, CONICET, CIMA, Buenos Aires, DF, Argentina; [Ruiz, Juan] Univ Buenos Aires, Sci Atmosphere & Oceans Dept, FCEN, Buenos Aires, DF, Argentina; [Ignacio Simoy, Mario] Univ Nacl Ctr Prov Buenos Aires, Inst Multidisciplinario Ecosistemas & Desarrollo, Tandil, Argentina	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Arizona State University; Arizona State University-Tempe; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Comision Nacional de Energia Atomica (CNEA)	Cocucci, TJ (corresponding author), Univ Nacl Cordoba, FAMAF, Cordoba, Argentina.; Cocucci, TJ (corresponding author), Univ Nacl Nordeste, FaCENA, Corrientes, Argentina.	tadeojcocucci@gmail.com		Cocucci, Tadeo Javier/0000-0002-4509-5870; Simoy, Mario Ignacio/0000-0002-8907-5126				Adekola HA, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2306; Aleta A., 2020, MODELING IMPACT SOCI, DOI [10.1101/2020.05.06.20092841, DOI 10.1101/2020.05.06.20092841]; Anderson JL, 1999, MON WEATHER REV, V127, P2741, DOI 10.1175/1520-0493(1999)127<2741:AMCIOT>2.0.CO;2; Annan JD, 2004, TELLUS A, V56, P520, DOI 10.1111/j.1600-0870.2004.00073.x; Arenas A, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.041055; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Burgers G, 1998, MON WEATHER REV, V126, P1719, DOI 10.1175/1520-0493(1998)126<1719:ASITEK>2.0.CO;2; Byrne AW, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039856; CappU O., 2006, INFERENCE HIDDEN MAR; Carrassi A, 2018, WIRES CLIM CHANGE, V9, DOI 10.1002/wcc.535; Din RU, 2020, RESULTS PHYS, V19, DOI 10.1016/j.rinp.2020.103468; Epstein J.M., 1996, GROWING ARTIFICIAL S; EVENSEN G, 1994, J GEOPHYS RES-OCEANS, V99, P10143, DOI 10.1029/94JC00572; Evensen G., 2020, MEDRXIV; Faes C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207560; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Ghostine R, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9060636; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grossmann G, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250050; Guan JX, 2020, J BIOMED RES, V34, P422, DOI 10.7555/JBR.34.20200119; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Helbing D., 2012, SELF ORG PEDESTRIAN; Hooten M, 2020, INT STAT REV, V88, P441, DOI 10.1111/insr.12399; Houtekamer PL, 1998, MON WEATHER REV, V126, P796, DOI 10.1175/1520-0493(1998)126<0796:DAUAEK>2.0.CO;2; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Ivorra B, 2020, COMMUN NONLINEAR SCI, V88, DOI 10.1016/j.cnsns.2020.105303; Ruiz JJ, 2013, J METEOROL SOC JPN, V91, P79, DOI 10.2151/jmsj.2013-201; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kerr C. C., 2020, MEDRXIV; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lopez JAM, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd8750; Miyoshi T, 2011, MON WEATHER REV, V139, P1519, DOI 10.1175/2010MWR3570.1; Munzert S, 2021, NAT HUM BEHAV, V5, P247, DOI 10.1038/s41562-020-01044-x; Qin J, 2020, SCI ADV, V6, DOI [10.1126/sciadv.abc1202, 10.1101/2020.03.06.20032417]; Roche B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-87; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Silva PCL, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110088; Simoy MI, 2022, COMPUT APPL MATH, V41, DOI 10.1007/s40314-021-01705-1; Tesfatsion L., 2006, HDB COMPUTATIONAL EC; Vekaria B, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06371-6; Verity R., 2020, MEDRXIV; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Ward JA, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150703; Wikle CK, 2007, PHYSICA D, V230, P1, DOI 10.1016/j.physd.2006.09.017; Zhao H, 2020, MATH BIOSCI, V326, DOI 10.1016/j.mbs.2020.108405	48	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264892	10.1371/journal.pone.0264892	http://dx.doi.org/10.1371/journal.pone.0264892			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245337	Green Published, Green Submitted, gold			2022-12-26	WOS:000799799100040
J	Kraus, D; Brandl, R; Achilles, S; Bendix, J; Grigusova, P; Larsen, A; Pliscoff, P; Ubernickel, K; Farwig, N				Kraus, Diana; Brandl, Roland; Achilles, Sebastian; Bendix, Jorg; Grigusova, Paulina; Larsen, Annegret; Pliscoff, Patricio; Ubernickel, Kirstin; Farwig, Nina			Vegetation and vertebrate abundance as drivers of bioturbation patterns along a climate gradient	PLOS ONE			English	Article							SMALL MAMMALS; BURROWING ANIMALS; POCKET GOPHERS; SOIL TEXTURE; NAMIB DESERT; BIODIVERSITY; RODENTS; GEOMORPHOLOGY; PRECIPITATION; MECHANISMS	Bioturbators shape their environment with considerable consequences for ecosystem processes. However, both the composition and the impact of bioturbator communities may change along climatic gradients. For burrowing animals, their abundance and composition depend on climatic and other abiotic components, with ants and mammals dominating in arid and semiarid areas, and earthworms in humid areas. Moreover, the activity of burrowing animals is often positively associated with vegetation cover (biotic component). These observations highlight the need to understand the relative contributions of abiotic and biotic components in bioturbation in order to predict soil-shaping processes along broad climatic gradients. In this study, we estimated the activity of animal bioturbation by counting the density of holes and the quantity of bioturbation based on the volume of soil excavated by bioturbators along a gradient ranging from arid to humid in Chile. We distinguished between invertebrates and vertebrates. Overall, hole density (no/ 100 m(2)) decreased from arid (raw mean and standard deviation for invertebrates: 14 +/- 7.8, vertebrates: 2.8 +/- 2.9) to humid (invertebrates: 2.8 +/- 3.1, vertebrates: 2.2 +/- 2.1) environments. However, excavated soil volume did not follow the same clear geographic trend and was 300-fold larger for vertebrates than for invertebrates. The relationship between bioturbating invertebrates and vegetation cover was consistently negative whereas for vertebrates both, positive and negative relationships were determined along the gradient. Our study demonstrates complex relationships between climate, vegetation and the contribution of bioturbating invertebrates and vertebrates, which will be reflected in their impact on ecosystem functions.	[Kraus, Diana; Farwig, Nina] Univ Marburg, Dept Biol, Conservat Ecol, Marburg, Germany; [Brandl, Roland] Univ Marburg, Dept Biol, Anim Ecol, Marburg, Germany; [Achilles, Sebastian; Bendix, Jorg; Grigusova, Paulina] Univ Marburg, Dept Geog, Lab Climatol & Remote Sensing, Marburg, Germany; [Larsen, Annegret] Wageningen Univ & Res, Dept Environm Sci Soil Geog & Landscape, Wageningen, Netherlands; [Pliscoff, Patricio] Catholic Univ Chile, Dept Ecol & Biodivers, Santiago, Chile; [Pliscoff, Patricio] Catholic Univ Chile, Inst Geog, Santiago, Chile; [Ubernickel, Kirstin] Univ Tubingen, Dept Geosci, Earth Syst Dynam, Tubingen, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Wageningen University & Research; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Eberhard Karls University of Tubingen	Kraus, D (corresponding author), Univ Marburg, Dept Biol, Conservat Ecol, Marburg, Germany.	diana.kraus@biologie.uni-marburg.de			German Science Foundation DFG [BE1780/52-1, LA3521/1-1, FA 925/12-1, BR 1293-18-1]	German Science Foundation DFG(German Research Foundation (DFG))	This study was funded by the German Science Foundation DFG Priority Program SPP 1803: EarthShape: Earth Surface Shaping by Biota, sub-project "Effects of bioturbation on rates of vertical and horizontal sediment and nutrient fluxes" [grant numbers BE1780/52-1, LA3521/1-1, FA 925/12-1, BR 1293-18-1].	ABATUROV BD, 1972, PEDOBIOLOGIA, V12, P261; ARMOURCHELU M, 1994, J ARCHAEOL SCI, V21, P433, DOI 10.1006/jasc.1994.1042; Bates D, 2021, PACKAGE LME4; Chambers JM., 2017, STAT MODEL S, P13, DOI [10.1201/9780203738535-2, DOI 10.1201/9780203738535-2]; Corenblit D, 2021, SCI NAT-HEIDELBERG, V108, DOI 10.1007/s00114-021-01760-y; Corenblit D, 2011, EARTH-SCI REV, V106, P307, DOI 10.1016/j.earscirev.2011.03.002; CRAWFORD CS, 1993, REV CHIL HIST NAT, V66, P283; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; DEBRUYN LAL, 1994, PEDOBIOLOGIA, V38, P193; Eldridge DJ, 2007, SOIL BIOL BIOCHEM, V39, P1055, DOI 10.1016/j.soilbio.2006.11.016; Eldridge DJ, 2014, PLANT SOIL, V381, P395, DOI 10.1007/s11104-014-2142-5; Eldridge DJ, 2012, GEOMORPHOLOGY, V157, P131, DOI 10.1016/j.geomorph.2011.04.041; ELLISON L, 1946, ECOLOGY, V27, P101, DOI 10.2307/1932505; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; FORMANOWICZ DR, 1991, CAN J ZOOL, V69, P2916, DOI 10.1139/z91-411; Gabet EJ, 2000, EARTH SURF PROC LAND, V25, P1419, DOI 10.1002/1096-9837(200012)25:13&lt;1419::AID-ESP148&gt;3.0.CO;2-1; Garreaud RD, 2020, INT J CLIMATOL, V40, P421, DOI 10.1002/joc.6219; Gerrard J, 1996, GEOGR J, V162, P225, DOI 10.2307/3059889; Grigusova P., 2022, EARTH SURF DYN DISCU, P1, DOI [10.5194/ESURF-2021-104, DOI 10.5194/ESURF-2021-104]; Grigusova P, 2021, DRONES-BASEL, V5, DOI 10.3390/drones5030086; Hagenah N, 2013, J ZOOL, V289, P19, DOI 10.1111/j.1469-7998.2012.00958.x; Harper W V., 2014, REDUCED MAJOR AXIS R; Hayward MW, 2016, ANIM CONSERV, V19, P490, DOI 10.1111/acv.12269; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; HORN BKP, 1981, P IEEE, V69, P14, DOI 10.1109/PROC.1981.11918; HUMPHREYS G S, 1989, Australian Entomological Magazine, V16, P99; Huxley J, PROBLEMS RELATIVE GR; JIMENEZ JE, 1992, J MAMMAL, V73, P356, DOI 10.2307/1382070; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KACZOR SA, 1990, AM MIDL NAT, V123, P100, DOI 10.2307/2425763; KALISZ PJ, 1984, SOIL SCI SOC AM J, V48, P169, DOI 10.2136/sssaj1984.03615995004800010031x; Kelt DA, 2004, ECOLOGY, V85, P383, DOI 10.1890/02-4065; Kerley GIH, 1997, OECOLOGIA, V111, P422, DOI 10.1007/s004420050254; Klaas BA, 1998, J MAMMAL, V79, P942, DOI 10.2307/1383102; Kugler M., 2022, LIDAR 3D POINT CLOUD; Kurek P, 2014, ECOL RES, V29, P1, DOI 10.1007/s11284-013-1094-1; Larsen A, 2021, EARTH-SCI REV, V218, DOI 10.1016/j.earscirev.2021.103623; Legendre P., 2018, LMODEL2 MODEL 2 REGR; Lima M, 1999, ECOGRAPHY, V22, P213, DOI 10.1111/j.1600-0587.1999.tb00470.x; Lurgi M, 2018, J APPL ECOL, V55, P2396, DOI 10.1111/1365-2664.13188; MARSH AC, 1988, J ARID ENVIRON, V14, P61, DOI 10.1016/S0140-1963(18)31097-8; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Milne T, 2000, BIOL CONSERV, V95, P295, DOI 10.1016/S0006-3207(00)00040-9; Milstead WB, 2007, J MAMMAL, V88, P1532, DOI 10.1644/16-MAMM-A-407R.1; Munoz A, 2009, BASIC APPL ECOL, V10, P151, DOI 10.1016/j.baae.2008.01.003; Nkem JN, 2000, PEDOBIOLOGIA, V44, P609, DOI 10.1078/S0031-4056(04)70075-X; Persico L, 2009, QUATERNARY RES, V71, P340, DOI 10.1016/j.yqres.2008.09.007; PETERS RH, 1983, OECOLOGIA, V60, P89, DOI 10.1007/BF00379325; Plaas E, 2019, ECOL ECON, V159, P291, DOI 10.1016/j.ecolecon.2019.02.003; Platt BF, 2016, SOIL SCI, V181, P175, DOI 10.1097/SS.0000000000000150; POLIS GA, 1986, J ARID ENVIRON, V10, P137, DOI 10.1016/S0140-1963(18)31254-0; PRICE MV, 1989, OECOLOGIA, V81, P267, DOI 10.1007/BF00379814; Richards PJ, 2011, CATENA, V87, P20, DOI 10.1016/j.catena.2011.05.003; ROPER TJ, 1992, MAMMAL REV, V22, P43, DOI 10.1111/j.1365-2907.1992.tb00118.x; Ruiz S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128914; Schmidt-Nielsen K., 1965, DESERT ANIMALS PHYSL; Ubernickel K., 2020, TIME SERIES METEOROL, DOI DOI 10.5880/FIDGEO.2020.043; Ubernickel K, 2021, BIOGEOSCIENCES, V18, P5573, DOI 10.5194/bg-18-5573-2021; Valentine LE, 2017, AUSTRAL ECOL, V42, P265, DOI 10.1111/aec.12428; Viles HA, 2021, EARTH-SCI REV, V213, DOI 10.1016/j.earscirev.2020.103469; VLECK D, 1981, OECOLOGIA, V49, P391, DOI 10.1007/BF00347605; Voeten Cesko C., 2019, R PACKAGE VERSION, V1, P1; White CR, 2005, J ZOOL, V265, P395, DOI 10.1017/S0952836905006473; Whitford WG, 1999, J ARID ENVIRON, V41, P203, DOI 10.1006/jare.1998.0482; Wilkinson MT, 2009, EARTH-SCI REV, V97, P257, DOI 10.1016/j.earscirev.2009.09.005; YAIR A, 1995, GEOMORPHOLOGY, V13, P87, DOI 10.1016/0169-555X(95)00025-Z; YAIR A, 1981, EARTH SURF PROC LAND, V6, P221, DOI 10.1002/esp.3290060304; Yu C, 2017, GEODERMA, V307, P98, DOI 10.1016/j.geoderma.2017.07.041; Zhang D., 2021, RSQ R SQUARED RELATE	69	0	0	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264408	10.1371/journal.pone.0264408	http://dx.doi.org/10.1371/journal.pone.0264408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245302	Green Published, gold			2022-12-26	WOS:000799799100015
J	Li, MR; He, MX; Xu, FS; Guan, YB; Tian, JH; Wan, ZY; Zhou, HB; Gao, M; Chong, T				Li, Mingrui; He, Minxin; Xu, Fangshi; Guan, Yibing; Tian, Juanhua; Wan, Ziyan; Zhou, Haibin; Gao, Mei; Chong, Tie			Abnormal expression and the significant prognostic value of aquaporins in clear cell renal cell carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; WATER PERMEABILITY; DIFFERENTIAL EXPRESSION; KIDNEY-DISEASE; WEB SERVER; PANNEXIN 1; CANCER; HETEROGENEITY; BIOMARKERS; PATTERNS	Aquaporins (AQPs) are a kind of transmembrane proteins that exist in various organs of the human body. AQPs play an important role in regulating water transport, lipid metabolism and glycolysis of cells. Clear cell renal cell carcinoma (ccRCC) is a common malignant tumor of the kidney, and the prognosis is worse than other types of renal cell cancer (RCC). The impact of AQPs on the prognosis of ccRCC and the potential relationship between AQPs and the occurrence and development of ccRCC are demanded to be investigated. In this study, we first explored the expression pattern of AQPs by using Oncomine, UALCAN, and HPA databases. Secondly, we constructed protein-protein interaction (PPI) network and performed function enrichment analysis through STRING, GeneMANIA, and Metascape. Then a comprehensive analysis of the genetic mutant frequency of AQPs in ccRCC was carried out using the cBioPortal database. In addition, we also analyzed the main enriched biological functions of AQPs and the correlation with seven main immune cells. Finally, we confirmed the prognostic value of AQPs throughGEPIA and Cox regression analysis. We found that the mRNA expression levels of AQP0/8/9/10 were up-regulated in patients with ccRCC, while those of AQP1/2/3/4/5/6/7/11 showed the opposite. Among them, the expression differences of AQP1/2/3/4/5/6/7/8/9/11 were statistically significant. The differences in protein expression levels of AQP1/2/3/4/5/6 in ccRCC and normal renal tissues were consistent with the change trends of mRNA. The biological functions of AQPs were mainly concentrated in water transport, homeostasis maintenance, glycerol transport, and intracellular movement of sugar transporters. The high mRNA expression levels of AQP0/8/9 were significantly correlated with worse overall survival (OS), while those of AQP1/4/7 were correlated with better OS. AQP0/1/4/9 were prognostic-related factors, and AQP1/9 were independent prognostic factors. In general, this research has investigated the values of AQPs in ccRCC, which could become new survival markers for ccRCC targeted therapy.	[Li, Mingrui; He, Minxin; Xu, Fangshi; Guan, Yibing; Tian, Juanhua; Wan, Ziyan; Zhou, Haibin; Gao, Mei; Chong, Tie] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Urol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Chong, T (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Urol, Xian, Shaanxi, Peoples R China.	chongtie@mail.xjtu.edu.cn						Alt AL, 2011, CANCER-AM CANCER SOC, V117, P2873, DOI 10.1002/cncr.25836; Arsenijevic T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205052; Atochina-Vasserman EN, 2013, AM J PHYSIOL-RENAL, V304, pF1295, DOI 10.1152/ajprenal.00344.2012; Barbieri I, 2020, NAT REV CANCER, V20, P303, DOI 10.1038/s41568-020-0253-2; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Buccitelli C, 2020, NAT REV GENET, V21, P630, DOI 10.1038/s41576-020-0258-4; Capitanio U, 2016, LANCET, V387, P894, DOI 10.1016/S0140-6736(15)00046-X; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Cheung PW, 2020, ANNU REV PHARMACOL, V60, P175, DOI 10.1146/annurev-pharmtox-010919-023654; Choma DP, 2016, AM J PHYSIOL-RENAL, V310, pF416, DOI 10.1152/ajprenal.00295.2015; da Silva IV, 2020, ARCH BIOCHEM BIOPHYS, V691, DOI 10.1016/j.abb.2020.108481; Dimitrieva S, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0170-1; Gao M, 2015, P NATL ACAD SCI USA, V112, P8397, DOI 10.1073/pnas.1509565112; Geng XQ, 2017, ADV EXP MED BIOL, V969, P51, DOI 10.1007/978-94-024-1057-0_3; Genuth NR, 2018, MOL CELL, V71, P364, DOI 10.1016/j.molcel.2018.07.018; Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hall JE, 2019, CHEM REV, V119, P6015, DOI 10.1021/acs.chemrev.9b00106; Han B, 2019, NEPHROL DIAL TRANSPL, V34, P970, DOI 10.1093/ndt/gfy219; He JZ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020366; Higgins JPT, 2003, AM J PATHOL, V162, P925, DOI 10.1016/S0002-9440(10)63887-4; Huang Y, 2009, EUR UROL, V56, P690, DOI 10.1016/j.eururo.2008.10.014; Iena FM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010154; Ishibashi K, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2021.183617; Ishibashi Kenichi, 2009, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-540-79885-9_13; Jensen MA, 2017, BLOOD, V130, P453, DOI 10.1182/blood-2017-03-735654; Jeyaseelan K, 2006, EXPERT OPIN THER TAR, V10, P889, DOI 10.1517/14728222.10.6.889; Jing JB, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.770565; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kalman K, 2006, BBA-BIOMEMBRANES, V1758, P1094, DOI 10.1016/j.bbamem.2006.01.015; Langlois S, 2014, J BIOL CHEM, V289, P30717, DOI 10.1074/jbc.M114.572131; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Liao SF, 2020, J CANCER, V11, P7348, DOI 10.7150/jca.48970; Linehan WM, 2019, NAT REV UROL, V16, P539, DOI 10.1038/s41585-019-0211-5; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Magouliotis DE, 2020, ADV CLIN CHEM, V98, P149, DOI 10.1016/bs.acc.2020.02.005; Matsuzaki T, 2017, ANAT SCI INT, V92, P187, DOI 10.1007/s12565-016-0325-2; Maynard MA, 2004, AM J NEPHROL, V24, P1, DOI 10.1159/000075346; Meng XG, 2021, INT J GEN MED, V14, P5255, DOI 10.2147/IJGM.S325347; Moosavi MS, 2020, PATHOL ONCOL RES, V26, P615, DOI 10.1007/s12253-019-00646-9; Morris MR, 2017, NAT REV NEPHROL, V13, P47, DOI 10.1038/nrneph.2016.168; Morrissey JJ, 2015, JAMA ONCOL, V1, P204, DOI 10.1001/jamaoncol.2015.0213; Morrissey JJ, 2013, J UROLOGY, V189, P1913, DOI 10.1016/j.juro.2012.11.034; Morrissey JJ, 2010, MAYO CLIN PROC, V85, P413, DOI 10.4065/mcp.2009.0709; Nakazawa Y, 2017, CURR EYE RES, V42, P617, DOI 10.1080/02713683.2016.1217547; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Nussinov R, 2012, TRENDS BIOCHEM SCI, V37, P447, DOI 10.1016/j.tibs.2012.07.001; Okada S, 2008, FASEB J, V22, P3672, DOI 10.1096/fj.08-111872; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Papadopoulos MC, 2015, BBA-BIOMEMBRANES, V1848, P2576, DOI 10.1016/j.bbamem.2014.09.001; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Saito T, 2018, BIOCHEM BIOPHYS REP, V13, P17, DOI 10.1016/j.bbrep.2017.11.003; Shen LZ, 2010, BIOMED PHARMACOTHER, V64, P313, DOI 10.1016/j.biopha.2009.12.003; Shi HH, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01194-6; Sohara E, 2006, BBA-BIOMEMBRANES, V1758, P1106, DOI 10.1016/j.bbamem.2006.04.002; Song L, 2019, J CELL BIOL, V218, P1776, DOI 10.1083/jcb.201902074; Sonneveld S, 2020, TRENDS CELL BIOL, V30, P606, DOI 10.1016/j.tcb.2020.04.008; Soveral G, 2017, EXPERT OPIN THER PAT, V27, P49, DOI 10.1080/13543776.2017.1236085; Su W, 2020, AM J PHYSIOL-RENAL, V318, pF193, DOI 10.1152/ajprenal.00304.2019; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Ticozzi-Valerio D, 2007, PROTEOM CLIN APPL, V1, P588, DOI 10.1002/prca.200601048; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Wang J, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0439-7; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu WH, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2113-y; Yang BX, 2005, AM J PHYSIOL-CELL PH, V288, pC1161, DOI 10.1152/ajpcell.00564.2004; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	76	5	5	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264553	10.1371/journal.pone.0264553	http://dx.doi.org/10.1371/journal.pone.0264553			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245343	gold, Green Published			2022-12-26	WOS:000799799100026
J	van Bilsen, WPH; Bil, JP; Prins, JM; Brinkman, K; Leyten, E; van Sighem, A; Bedert, M; Davidovich, U; Burns, F; Prins, M				van Bilsen, Ward P. H.; Bil, Janneke P.; Prins, Jan M.; Brinkman, Kees; Leyten, Eliane; van Sighem, Ard; Bedert, Maarten; Davidovich, Udi; Burns, Fiona; Prins, Maria			Testing and healthcare seeking behavior preceding HIV diagnosis among migrant and non-migrant individuals living in the Netherlands: Directions for early-case finding	PLOS ONE			English	Article							HIGH-INCOME COUNTRIES; INFECTION; STRATEGIES; INITIATION	Objectives To assess differences in socio-demographics, HIV testing and healthcare seeking behavior between individuals diagnosed late and those diagnosed early after HIV-acquisition. Design Cross-sectional study among recently HIV-diagnosed migrant and non-migrant individuals living in the Netherlands. Methods Participants self-completed a questionnaire on socio-demographics, HIV-testing and healthcare seeking behavior preceding HIV diagnosis between 2013-2015. Using multivariable logistic regression, socio-demographic determinants of late diagnosis were explored. Variables on HIV-infection, testing and access to care preceding HIV diagnosis were compared between those diagnosed early and those diagnosed late using descriptive statistics. Results We included 143 individuals with early and 101 with late diagnosis, of whom respectively 59/143 (41%) and 54/101 (53%) were migrants. Late diagnosis was significantly associated with older age and being heterosexual. Before HIV diagnosis, 89% of those with early and 62% of those with late diagnosis had ever been tested for HIV-infection (p<0.001), and respectively 99% and 97% reported healthcare usage in the Netherlands in the two years preceding HIV diagnosis (p = 0.79). Individuals diagnosed late most frequently visited a general practitioner (72%) or dentist (62%), and 20% had been hospitalized preceding diagnosis. In these settings, only in respectively 20%, 2%, and 6% HIV-testing was discussed. Conclusion A large proportion of people diagnosed late had previously tested for HIV and had high levels of healthcare usage. For earlier-case finding of HIV it therefore seems feasible to successfully roll out interventions within the existing healthcare system. Simultaneously, efforts should be made to encourage future repeated or routine HIV testing among individuals whenever they undergo an HIV test.	[van Bilsen, Ward P. H.; Bil, Janneke P.; Bedert, Maarten; Davidovich, Udi; Prins, Maria] Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands; [Prins, Jan M.; Prins, Maria] Univ Amsterdam, Dept Internal Med, Div Infect Dis, Amsterdam UMC, Amsterdam, Netherlands; [Brinkman, Kees] OLVG, Div Infect Dis, Dept Internal Med, Amsterdam, Netherlands; [Leyten, Eliane] Haaglanden Med Ctr, Dept Internal Med, Div Infect Dis, The Hague, Netherlands; [van Sighem, Ard] Stichting HIV Monitoring, Amsterdam, Netherlands; [Davidovich, Udi] Univ Amsterdam, Dept Social Psychol, Amsterdam, Netherlands; [Burns, Fiona] UCL, Inst Global Hlth, London, England	Public Health Service Amsterdam; University of Amsterdam; Haaglanden Medical Center; University of Amsterdam; University of London; University College London	van Bilsen, WPH (corresponding author), Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands.	wvbilsen@ggd.amsterdam.nl		Bedert, Maarten/0000-0002-5899-0663				Alvarez-del Arco D, 2013, EUR J PUBLIC HEALTH, V23, P1039, DOI 10.1093/eurpub/cks130; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Aung E, 2017, AIDS BEHAV, V21, P2844, DOI 10.1007/s10461-017-1833-3; Bil JP, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4477-2; Davies CF, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0880-9; de Bree GJ, 2019, CURR OPIN HIV AIDS, V14, P455, DOI 10.1097/COH.0000000000000586; Deblonde J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6107-0; Elgalib A, 2018, HIV MED, V19, P195, DOI 10.1111/hiv.12568; European Centre for Disease Prevention and Control (ECDC), 2018, PUBL HLTH GUID HIV H; Fakoya Ibidun, 2017, JMIR Public Health Surveill, V3, pe84, DOI 10.2196/publichealth.7741; Fakoya I, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5085; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Gomez-Ayerbe C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220375; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Heijnen A, 2013, HIV VERDIEPING NAAST; Joore IK, 2017, INT J STD AIDS, V28, P459, DOI 10.1177/0956462416652274; Joore IK, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0723-8; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Op de Cou ELM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009688; Santella AJ, 2016, BRIT DENT J, V220, P229, DOI 10.1038/sj.bdj.2016.172; Stichting HIV Monitoring the Netherlands, ANN REPORT 2020; van Sighem AI, 2020, MONITORING REPORT 20; Willis G.B, 2004, COGNITIVE INTERVIEWI	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264435	10.1371/journal.pone.0264435	http://dx.doi.org/10.1371/journal.pone.0264435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245293	gold, Green Published			2022-12-26	WOS:000799799100018
J	Wen, T; Mao, CY; Gao, L				Wen, Tong; Mao, Chenyu; Gao, Li			Analysis of the gut microbiota composition of myostatin mutant cattle prepared using CRISPR/Cas9	PLOS ONE			English	Article							MUSCLE MASS; SP-NOV.; MUTATION; BACTEROIDES	Myostatin (MSTN) negatively regulates muscle development and positively regulates metabolism through various pathways. Although MSTN function in cattle has been widely studied, the changes in the gut microbiota due to MSTN mutation, which contribute to host health by regulating its metabolism, remain unclear. Here, high-throughput sequencing of the 16S rRNA gene was conducted to analyze the gut microbiota of wild-type (WT) and MSTN mutant (MT) cattle. A total of 925 operational taxonomic units (OTUs) were obtained, which were classified into 11 phyla and 168 genera. Alpha diversity results showed no significant differences between MT and WT cattle. Beta diversity analyses suggested that the microbial composition of WT and MT cattle was different. Three dominant phyla and 21 dominant genera were identified. The most abundant bacterial genus had a significant relationship with the host metabolism. Moreover, various bacteria beneficial for health were found in the intestines of MT cattle. Analysis of the correlation between dominant gut bacteria and serum metabolic factors affected by MSTN mutation indicated that MSTN mutation affected the metabolism mainly by three metabolism-related bacteria, Ruminococcaceae_UCG-013, Clostridium_sensu_stricto_1, and Ruminococcaceae_UCG-010. This study provides further insight into MSTN mutation regulating the host metabolism by gut microbes and provides evidence for the safety of gene-edited animals.	[Wen, Tong; Mao, Chenyu; Gao, Li] Baotou TeachersColl, Fac Biol Sci & Technol, Baotou, Inner Mongolia, Peoples R China		Gao, L (corresponding author), Baotou TeachersColl, Fac Biol Sci & Technol, Baotou, Inner Mongolia, Peoples R China.	gaoli8905@163.com			Inner Mongolia Natural Science Foundation [2021BS08013]; Baotou Teachers College High-level Research Achievement Cultivation Project [BSYKJ2021-ZQ03]; Baotou City Youth Innovative Talents Project [2010,6333]; High-level Talents Introduced Scientific Research Startup Fund Project of Baotou Teacher's College [BTTCRCQD2020-003]	Inner Mongolia Natural Science Foundation; Baotou Teachers College High-level Research Achievement Cultivation Project; Baotou City Youth Innovative Talents Project; High-level Talents Introduced Scientific Research Startup Fund Project of Baotou Teacher's College	This research was funded by Inner Mongolia Natural Science Foundation (2021BS08013), the Baotou Teachers College High-level Research Achievement Cultivation Project (BSYKJ2021-ZQ03), the Baotou City Youth Innovative Talents Project (2010,6333) and the High-level Talents Introduced Scientific Research Startup Fund Project of Baotou Teacher's College (BTTCRCQD2020-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengelsdorf FR, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00346-19; Chen Shuang-ya, 2006, Weishengwu Xuebao, V46, P233; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cui WT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210619; Cruz BCD, 2020, FOOD RES INT, V137, DOI 10.1016/j.foodres.2020.109721; Fallucca F, 2014, DIABETES-METAB RES, V30, P48, DOI 10.1002/dmrr.2518; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gao L, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.791287; Gao L, 2019, BIOSCI BIOTECH BIOCH, V83, P2090, DOI 10.1080/09168451.2019.1644152; Gao XY, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00391-20; Gonai M, 2017, BENEF MICROBES, V8, P705, DOI 10.3920/BM2016.0230; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Ismaeil M, 2018, J MICROBIOL, V56, P619, DOI 10.1007/s12275-018-8187-z; Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kim SE, 2015, J NEUROGASTROENTEROL, V21, P111, DOI 10.5056/jnm14048; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li G., 2020, J INNER MONGOLIA U N, V51, P12; Li N, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1552-1; Li Y, 2020, INT J SYST EVOL MICR, V70, P897, DOI 10.1099/ijsem.0.003841; Liao RR, 2021, APPL MICROBIOL BIOT, V105, P3649, DOI 10.1007/s00253-021-11301-2; Lipina C, 2010, FEBS LETT, V584, P2403, DOI 10.1016/j.febslet.2010.04.039; Logue JB, 2016, ISME J, V10, P533, DOI 10.1038/ismej.2015.131; Mayer EA, 2014, GASTROENTEROLOGY, V146, P1500, DOI 10.1053/j.gastro.2014.02.037; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Menni C, 2019, GUT MICROBES, V10, P688, DOI 10.1080/19490976.2019.1586038; Milosavljevic MN, 2021, REV INST MED TROP SP, V63, DOI [10.1590/S1678-9946202163030, 10.1590/s1678-9946202163030]; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Pichler MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17075-x; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sharma M, 2015, IUBMB LIFE, V67, P589, DOI 10.1002/iub.1392; Simpson PJ, 2004, INT J SYST EVOL MICR, V54, P401, DOI 10.1099/ijs.0.02667-0; Tan HY, 2019, FISH SHELLFISH IMMUN, V92, P265, DOI 10.1016/j.fsi.2019.06.027; Tang L, 2021, BONE, V143, DOI 10.1016/j.bone.2020.115610; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang F, 2012, J HUAZHONG U SCI-MED, V32, P534, DOI 10.1007/s11596-012-0092-9; Wang KK, 2017, TRANSGENIC RES, V26, P799, DOI 10.1007/s11248-017-0044-z; Wang X, 2018, ANIM GENET, V49, P43, DOI 10.1111/age.12626; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Xin XB, 2020, GEN COMP ENDOCR, V291, DOI 10.1016/j.ygcen.2019.113237; Yang Shuping, 2018, Oncotarget, V9, P11352, DOI 10.18632/oncotarget.24250; Yu BL, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0126-9; Zhang J, 2018, FEBS J, V285, P2828, DOI 10.1111/febs.14520; Zhang XM, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.559148	48	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0264849	10.1371/journal.pone.0264849	http://dx.doi.org/10.1371/journal.pone.0264849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245313	Green Published, gold			2022-12-26	WOS:000799799100038
J	Charan, J; Riyad, P; Ram, H; Purohit, A; Ambwani, S; Kashyap, P; Singh, G; Hashem, A; Abd Allah, EF; Gupta, VK; Kumar, A; Panwar, A				Charan, Jaykaran; Riyad, Priyanka; Ram, Heera; Purohit, Ashok; Ambwani, Sneha; Kashyap, Priya; Singh, Garima; Hashem, Abeer; Abd Allah, Elsayed Fathi; Gupta, Vijai Kumar; Kumar, Ashok; Panwar, Anil			Ameliorations in dyslipidemia and atherosclerotic plaque by the inhibition of HMG-CoA reductase and antioxidant potential of phytoconstituents of an aqueous seed extract of Acacia senegal (L.) Willd in rabbits	PLOS ONE			English	Article							ESTERIFICATION RATE; MOLECULAR DOCKING; HDL-CHOLESTEROL; ACTIVATION; DISMUTASE; ASSAY	The assigned work was aimed to examine the capability of phytoconstituents of an aqueous seed extract of Acacia senegal (L.) Willd to inhibit HMG-CoA reductase and regression of the atherosclerotic plaque. The chemical fingerprinting of the test extract was assessed by LC-MS/MS. Consequently, the analyses of in-vitro, in-vivo, and in-silico were executed by using the standard protocols. The in-vitro assessment of the test extract revealed 74.1% inhibition of HMG-CoA reductase. In-vivo assessments of the test extract indicated that treated hypercholesterolemic rabbits exhibited a significant (P <= 0.001) amelioration in the biomarker indices of the dyslipidaemia i.e., atherogenic index, Castelli risk index(I&II), atherogenic coefficient along with lipid profile. Subsequently, significant reductions were observed in the atherosclerotic plaque and antioxidant levels. The in-silico study of molecular docking shown interactions capabilities of the leading phytoconstituents of the test extract i.e., eicosanoic acid, linoleic acid, and flavan-3-ol with target protein of HMG-CoA reductase. The values of RSMF and potential energy of top docked complexes were show significant interactions. Accordingly, the free energy of solvation, interaction angle, radius of gyration and SASA were shown significant stabilities of top docked complex. The cumulative data of results indicate phytoconstituents of an aqueous seed extract of Acacia senegal have capabilities to inhibit the HMG-CoA reductase and improve the levels of antioxidants.	[Charan, Jaykaran; Ambwani, Sneha] All India Inst Med Sci, Dept Pharmacol, Jodhpur, Rajasthan, India; [Riyad, Priyanka; Ram, Heera; Purohit, Ashok] Jai Narain Vyas Univ, Dept Zool, Jodhpur, Rajasthan, India; [Kashyap, Priya] GGS Indraprastha Univ, Univ Sch Biotechnol, New Delhi, India; [Singh, Garima] Pachhunga Univ Coll, Dept Bot, Aizawl, Mizoram, India; [Hashem, Abeer] King Saud Univ, Coll Sci, Bot & Microbiol Dept, Riyadh, Saudi Arabia; [Abd Allah, Elsayed Fathi] King Saud Univ, Coll Food & Agr Sci, Plant Prod Dept, Riyadh, Saudi Arabia; [Gupta, Vijai Kumar] SRUC, Ctr Safe & Improved Food, Kings Bldg, Edinburgh, Midlothian, Scotland; [Gupta, Vijai Kumar] SRUC, Biorefining & Adv Biomat Res Ctr, Kings Bldg, Edinburgh, Midlothian, Scotland; [Kumar, Ashok; Panwar, Anil] Panjab Univ Chandigarh, Ctr Syst Biol & Bioinformat, Chandigarh, Punjab, India	All India Institute of Medical Sciences (AIIMS) Jodhpur; Jai Narain Vyas University Jodhpur; GGS Indraprastha University; Mizoram University; King Saud University; King Saud University; University of Edinburgh; University of Edinburgh; Panjab University	Ram, H (corresponding author), Jai Narain Vyas Univ, Dept Zool, Jodhpur, Rajasthan, India.	hr.zo@jnvu.edu.in	Abd_Allah, Elsayed Fathi/N-6846-2017	Abd_Allah, Elsayed Fathi/0000-0002-8509-8953	King Saud University, Riyadh, Saudi Arabia [RSP-2021/134]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	Researchers Supporting Project Number (RSP-2021/134), King Saud University, Riyadh, Saudi Arabia.	ABELL LL, 1952, J BIOL CHEM, V195, P357; Abu-Serie MM., 2021, SCI REP-UK, V11, P1, DOI [10.1038/s41598-020-79139-8, DOI 10.1038/S41598-020-79139-8]; Ahlawat J., 2014, INT J SCI RES, V3, P466; Al-Dalahmeh Y, 2022, MOLECULES, V27, DOI 10.3390/molecules27030859; Ali SA, 2014, CURR PROTEIN PEPT SC, V15, P456, DOI 10.2174/1389203715666140327114232; Altemimi A, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6040042; Anand SS, 2015, J AM COLL CARDIOL, V66, P1590, DOI 10.1016/j.jacc.2015.07.050; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Babu SR, 2010, PESTIC BIOCHEM PHYS, V98, P349, DOI 10.1016/j.pestbp.2010.07.008; Baskaran G, 2015, DRUG DES DEV THER, V9, P509, DOI 10.2147/DDDT.S75056; Bhardwaj S., 2013, INT J PHARM BIOSCIEN, V3, P359; DIXIT VP, 1992, PHYTOTHER RES, V6, P270, DOI 10.1002/ptr.2650060510; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; El-Garawani I, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020221; Fagg CW, 2004, TROPICAL FORESTRY PA; Frohlich J, 2003, CLIN CHEM, V49, P1873, DOI 10.1373/clinchem.2003.022558; Madariaga YG, 2015, LAB ANIMAL, V44, P139, DOI 10.1038/laban.710; Hadwan MH, 2018, BMC BIOCHEM, V19, DOI 10.1186/s12858-018-0097-5; Hajimahmoodi M, 2010, J APPL PHYCOL, V22, P43, DOI 10.1007/s10811-009-9424-y; Harshlata Chouhan, 2021, Food Frontiers, V3, P300, DOI 10.1002/fft2.122; Hirano T, 2008, J LIPID RES, V49, P1130, DOI 10.1194/jlr.D700027-JLR200; Holdgate GA, 2003, BIOCHEM SOC T, V31, P528, DOI 10.1042/BST0310528; Hwang KA, 2017, J CHIN MED ASSOC, V80, P630, DOI 10.1016/j.jcma.2017.06.007; Iung B., 2020, ESC CARDIOMED; Jarrar AH, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010194; Jose S, 2022, J MOL STRUCT, V1254, DOI 10.1016/j.molstruc.2022.132369; Kalanuria AA, 2012, VASC HEALTH RISK MAN, V8, P549, DOI 10.2147/VHRM.S27764; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; KLOTZSCH SG, 1990, CLIN CHEM, V36, P1605; Kumar A, 2019, NAT PRODUCT BIOPROSP, V9, P175, DOI 10.1007/s13659-019-0202-5; Liang G, 2015, TROP J PHARM RES, V14, P671, DOI 10.4314/tjpr.v14i4.16; Liu YB, 2012, J FUNCT FOODS, V4, P116, DOI 10.1016/j.jff.2011.08.006; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Malekmohammad K, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9080301; Mohamed RE, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00160; Moroy G, 2012, DRUG DISCOV TODAY, V17, P44, DOI 10.1016/j.drudis.2011.10.023; Nigam PK, 2014, INT J LIF SCI MED RE, V4, P25; Noha SM, 2017, ACS CHEM NEUROSCI, V8, P1327, DOI 10.1021/acschemneuro.6b00460; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parveen, 2007, J ETHNOPHARMACOL, V113, P387, DOI 10.1016/j.jep.2007.06.010; Patel BD, 2017, BIOORG CHEM, V72, P345, DOI 10.1016/j.bioorg.2017.03.004; Ram H, 2014, ANTIATHEROSCLEROTIC; Ram H, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-1188-z; Ram H, 2014, BIOCHEM RES INT, V2014, DOI 10.1155/2014/436848; Ramkumar S, 2016, ACTA CARDIOL SIN, V32, P631, DOI 10.6515/ACS20160611A; Rana S., 2014, INT J BIOASSAYS, V3, P1729; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Riyad Priyanka, 2022, Journal of Applied Biology & Biotechnology, V10, P129, DOI 10.7324/JABB.2021.100116; Saravi SSS, 2017, METAB BRAIN DIS, V32, P949, DOI 10.1007/s11011-017-0021-5; Sarkar Preetam, 2015, Journal of Ethnic Foods, V2, P97; Sharma, 2020, CURRENT PHARM REPORT, V6, P373, DOI [10.1007/s40495-020-00246-1, DOI 10.1007/S40495-020-00246-1]; SHARMA RD, 1985, NUTR RES, V5, P1321, DOI 10.1016/S0271-5317(85)80042-7; Shin Jang-Woo, 2010, [Journal of Korean Medicine, 대한한의학회지], V31, P1; Singh U.N., 2017, INT J CONT MED RES, V4, P2454; Son M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083496; Sozmen EY, 2001, ARCH MED RES, V32, P283, DOI 10.1016/S0188-4409(01)00285-5; Tamang Jyoti Prakash, 2016, Journal of Ethnic Foods, V3, P243; Teena Agrawal, 2018, WORLD J PHARM RES, V7, P384; Toppo AL, 2021, INDIAN J BIOCHEM BIO, V58, P127; Tripathi Y C, 1996, Anc Sci Life, V15, P190; Turner S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001826; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Wilson SH, 2000, ATHEROSCLEROSIS, V148, P23, DOI 10.1016/S0021-9150(99)00211-7; Wu N, 2013, BBA-MOL BASIS DIS, V1832, P1560, DOI 10.1016/j.bbadis.2013.04.024; Yadav DK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22972-9; Yang XY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00600; Zhu XW, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0686-8; Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004	68	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264646	10.1371/journal.pone.0264646	http://dx.doi.org/10.1371/journal.pone.0264646			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239727	Green Submitted, gold, Green Published			2022-12-26	WOS:000776002200058
J	Xing, MD; Gao, GR				Xing, Mengdi; Gao, Guorong			An efficient method to remove mixed Gaussian and random-valued impulse noise	PLOS ONE			English	Article							MEDIAN FILTERS; IMAGE; ALGORITHM; RESTORATION; MODEL	Mixed Gaussian and Random-valued impulse noise (RVIN) removal is still a big challenge in the field of image denoising. Existing denoising algorithms have defects in denoising performance and computational complexity. Based on the improved "detecting then filtering" strategy and the idea of inpainting, this paper proposes an efficient method to remove mixed Gaussian and RVIN. The proposed algorithm contains two phases: noise classification and noise removal. The noise classifier is based on Adaptive center-weighted median filter (ACWMF), three-sigma rule and extreme value processing. Different from the traditional "detecting then filtering" strategy, a preliminary RVIN removal step is added to the noise removal phase, which leads to three steps in this phase: preliminary RVIN removal, Gaussian noise removal and final RVIN removal. Firstly, RVIN is processed to obtain a noisy image approximately corrupted by Gaussian noise only. Subsequently, Gaussian noise is re-estimated and then denoised by Block Matching and 3D filtering method (BM3D). At last, the idea of inpainting is introduced to further remove RVIN. Extensive experimental results demonstrate that the proposed method outperforms quantitatively and visually to the state-of-the-art mixed Gaussian and RVIN removal methods. In addition, it greatly shortens the computation time.	[Xing, Mengdi; Gao, Guorong] Northwest A&F Univ, Coll Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Gao, GR (corresponding author), Northwest A&F Univ, Coll Sci, Yangling, Shaanxi, Peoples R China.	guoronggao@163.com			Chinese Universities Scientific Fund [2452016097]	Chinese Universities Scientific Fund	This work was supported by Chinese Universities Scientific Fund, [Grant No.2452016097].	[Anonymous], 2011, ROBUST STAT APPROACH; Astola SMAKOEDZGJT, 1998, OPT ENG; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Cai JF, 2008, INVERSE PROBL IMAG, V2, P187; Chen L, 2016, INFORM SCIENCES, V354, P101, DOI 10.1016/j.ins.2016.03.014; Chen T, 1999, IEEE T IMAGE PROCESS, V8, P1834, DOI 10.1109/83.806630; Chen T, 2001, IEEE SIGNAL PROC LET, V8, P1, DOI 10.1109/97.889633; Chen T, 2001, IEEE T CIRCUITS-II, V48, P784, DOI 10.1109/82.959870; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Dong YQ, 2007, IEEE SIGNAL PROC LET, V14, P193, DOI 10.1109/LSP.2006.884014; Garnett R, 2005, IEEE T IMAGE PROCESS, V14, P1747, DOI 10.1109/TIP.2005.857261; Guo Q, 2016, IEEE T CIRC SYST VID, V26, P868, DOI 10.1109/TCSVT.2015.2416631; Gupta V, 2015, J VIS COMMUN IMAGE R, V26, P296, DOI 10.1016/j.jvcir.2014.10.004; KO SJ, 1991, IEEE T CIRCUITS SYST, V38, P984, DOI 10.1109/31.83870; Li B, 2011, SCI CHINA INFORM SCI, V54, P51, DOI 10.1007/s11432-010-4128-0; Li M, 2014, BAYESIAN ANAL, V9, P733, DOI 10.1214/14-BA871; Mafi M, 2019, SIGNAL PROCESS, V157, P236, DOI 10.1016/j.sigpro.2018.12.006; Maronna R.A., 2006, ROBUST STAT; Nadeem M, 2020, SIGNAL PROCESS, V169, DOI 10.1016/j.sigpro.2019.107403; Rakhshanfar M, 2020, J REAL-TIME IMAGE PR, V17, P1183, DOI 10.1007/s11554-019-00868-9; Schulte S, 2007, FUZZY SET SYST, V158, P270, DOI 10.1016/j.fss.2006.10.010; Shao L, 2014, IEEE T CYBERNETICS, V44, P1001, DOI 10.1109/TCYB.2013.2278548; Thanh DNH, 2019, 2019 JOINT 8TH INTERNATIONAL CONFERENCE ON INFORMATICS, ELECTRONICS & VISION (ICIEV) AND 2019 3RD INTERNATIONAL CONFERENCE ON IMAGING, VISION & PATTERN RECOGNITION (ICIVPR) WITH INTERNATIONAL CONFERENCE ON ACTIVITY AND BEHAVIOR COMPUTING (ABC), P24, DOI 10.1109/ICIEV.2019.8858556; Turkmen I, 2013, AEU-INT J ELECTRON C, V67, P771, DOI 10.1016/j.aeue.2013.03.006; Wan W, 2020, APPL MATH MODEL, V87, P317, DOI 10.1016/j.apm.2020.05.030; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wu GM, 2020, IET IMAGE PROCESS, V14, P1840, DOI 10.1049/iet-ipr.2018.6272; Xiong B, 2012, IEEE T IMAGE PROCESS, V21, P1663, DOI 10.1109/TIP.2011.2172804; Yamaguchi T, 2017, IEICE T FUND ELECTR, VE100A, P2451, DOI 10.1587/transfun.E100.A.2451; Yin X, 2020, IEEE T AUTOMAT CONTR, V65, P376, DOI 10.1109/TAC.2019.2914257; Zhang QC, 2022, IEEE T AUTOMAT CONTR, V67, P1506, DOI 10.1109/TAC.2021.3064991; Zhou YY, 2016, J VIS COMMUN IMAGE R, V41, P74, DOI 10.1016/j.jvcir.2016.09.007; Zhou YY, 2013, J VIS COMMUN IMAGE R, V24, P283, DOI 10.1016/j.jvcir.2013.01.004	33	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264793	10.1371/journal.pone.0264793	http://dx.doi.org/10.1371/journal.pone.0264793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239722	Green Published, gold			2022-12-26	WOS:000776002200078
J	Chen, BB; Jiang, W; Huang, Y; Zhang, J; Yu, P; Wu, LR; Peng, H				Chen, Binbin; Jiang, Wei; Huang, Ying; Zhang, Jian; Yu, Peng; Wu, Lirong; Peng, Hao			N-7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/beta-catenin pathway in nasopharyngeal carcinoma	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; STAGING SYSTEM; CANCER; TRANSLATION; METHYLATION; METASTASIS; EXPRESSION; WNT; WDR4	Treatment selections are very limited for patients with advanced nasopharyngeal carcinoma (NPC) experiencing disease progression. Uncovering mechanisms underlying NPC progression is crucial for the development of novel treatments. Here we show that N-7-methylguanosine (m(7)G) tRNA modification enzyme METTL1 and its partner WDR4 are significantly elevated in NPC and are associated with poor prognosis. Loss-of-function and gain-of-function assays demonstrated that METTL1/WDR4 promotes NPC growth and metastasis in vitro and in vivo. Mechanistically, ARNT was identified as an upstream transcription factor regulating METTL1 expression in NPC. METTL1 depletion resulted in decreased m(7)G tRNA modification and expression, which led to impaired codon recognition during mRNA translation, therefore reducing the translation efficiencies of mRNAs with higher m(7)G codons. METTL1 upregulated the WNT/beta-catenin signaling pathway and promoted NPC cell epithelial-mesenchymal transition (EMT) and chemoresistance to cisplatin and docetaxel in vitro and in vivo. Overexpression of WNT3A bypassed the requirement of METTL1 for EMT and chemoresistance. This work uncovers novel insights into tRNA modification-mediated mRNA translation regulation and highlights the critical function of tRNA modification in cancer progression.	[Chen, Binbin; Peng, Hao] Sun Yat Sen Univ, Affiliated Hosp 1, Precis Med Inst, Ctr Translat Med, Guangzhou 510080, Guangdong, Peoples R China; [Chen, Binbin] Sun Yat Sen Univ, Dept Clin Nutr, Canc Ctr, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Peoples R China; [Jiang, Wei] Guilin Med Univ, Affiliated Hosp, Dept Radiat Oncol, Guilin 541001, Peoples R China; [Huang, Ying] Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Peoples R China; [Zhang, Jian; Yu, Peng] Guangzhou Inst Resp Dis, Dept Radiat Oncol, Affiliated Canc Hosp, Guangzhou 510095, Peoples R China; [Zhang, Jian; Yu, Peng] Inst Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Guangzhou 510095, Peoples R China; [Wu, Lirong] Nanjing Med Univ, Dept Radiat Oncol, Jiangsu Canc Hosp, Nanjing 210009, Peoples R China; [Wu, Lirong] Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing 210009, Peoples R China; [Wu, Lirong] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing 210009, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Guilin Medical University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Laboratory of Respiratory Disease; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Peng, H (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Precis Med Inst, Ctr Translat Med, Guangzhou 510080, Guangdong, Peoples R China.; Wu, LR (corresponding author), Nanjing Med Univ, Dept Radiat Oncol, Jiangsu Canc Hosp, Nanjing 210009, Peoples R China.; Wu, LR (corresponding author), Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing 210009, Peoples R China.; Wu, LR (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, Nanjing 210009, Peoples R China.	wulirong126@126.com; pengh67@mail.sysu.edu.cn			National Natural Science Foundation of China [82002981, 82003232, 82003212]; China Postdoctoral Science Foundation [2020M673003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We sincerely thank professor Jun Ma (Department of Radiation Oncology, Sun Yat-sen University Cancer Center) for kindly donate the NPC cell lines and nasopharyngeal normal cell lines. We sincerely thank Drs. Weidong Ji and Shuibin Lin for kindly sharing us with the plasmids for METTL1 overexpression and depletion. We thank all the patients who generously donate the tissues. The work was funded by National Natural Science Foundation of China (82002981, 82003232 and 82003212) and China Postdoctoral Science Foundation (2020M673003).	Alexandrov A, 2002, RNA, V8, P1253, DOI 10.1017/S1355838202024019; Bernaudo S, 2016, ONCOGENE, V35, P4828, DOI 10.1038/onc.2016.65; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD202, DOI 10.1093/nar/gkx966; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chang GQ, 2020, CANCER CELL, V38, P857, DOI 10.1016/j.ccell.2020.10.004; Chen G, 2020, MOL CARCINOGEN, V59, P897, DOI 10.1002/mc.23201; Chen X, 2018, EUR J MED GENET, V61, P468, DOI 10.1016/j.ejmg.2018.03.007; Chen XY, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1033-z; Chen YP, 2019, LANCET, V394, P64, DOI 10.1016/S0140-6736(19)30956-0; Chou HJ, 2017, MOL CELL, V68, P978, DOI 10.1016/j.molcel.2017.11.002; Dai ZH, 2021, MOL CELL, V81, P3339, DOI 10.1016/j.molcel.2021.07.003; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Guy MP, 2015, HUM MUTAT, V36, P1176, DOI 10.1002/humu.22897; Han X, 2021, SEMIN CANCER BIOL, V75, P97, DOI 10.1016/j.semcancer.2020.11.007; Hong XH, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01149-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huo FC, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12921; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Leick KM, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1665978; Lin S., 2009, NAT PROTOC, V4, P44; Lin SB, 2018, MOL CELL, V71, P244, DOI 10.1016/j.molcel.2018.06.001; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038; Liu J, 2019, TRENDS CELL BIOL, V29, P487, DOI 10.1016/j.tcb.2019.02.008; Liu L, 2020, MOL THER, V28, P2177, DOI 10.1016/j.ymthe.2020.06.024; Liu Y, 2020, LIFE SCI, V249, DOI 10.1016/j.lfs.2020.117480; Ma JY, 2021, MOL THER, V29, P3422, DOI 10.1016/j.ymthe.2021.08.005; Mao YP, 2008, CLIN CANCER RES, V14, P7497, DOI 10.1158/1078-0432.CCR-08-0271; Mao YP, 2009, INT J RADIAT ONCOL, V73, P1326, DOI 10.1016/j.ijrobp.2008.07.062; Michaud J, 2000, GENOMICS, V68, P71, DOI 10.1006/geno.2000.6258; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Okamoto M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004639; Orellana EA, 2021, MOL CELL, V81, P3323, DOI 10.1016/j.molcel.2021.06.031; Pan JJ, 2016, CANCER-AM CANCER SOC, V122, P546, DOI 10.1002/cncr.29795; Pan T, 2018, CELL RES, V28, P395, DOI 10.1038/s41422-018-0013-y; Peng H, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-018-0997-7; Persson CU, 2020, EXP CELL RES, V388, DOI 10.1016/j.yexcr.2020.111845; Pinello N, 2018, CANCER BIOL MED, V15, P323, DOI 10.20892/j.issn.2095-3941.2018.0365; Polakis P, 2000, GENE DEV, V14, P1837; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ren XY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14053; Schimmel P, 2018, NAT REV MOL CELL BIO, V19, P45, DOI 10.1038/nrm.2017.77; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shaheen R, 2016, HUM GENET, V135, P707, DOI 10.1007/s00439-016-1665-7; Shaheen R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0779-x; Shen CQ, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01190-w; Song P, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01244-z; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Terashima J, 2016, CELL BIOL INT, V40, P1187, DOI 10.1002/cbin.10656; Tian QH, 2019, J MOL MED, V97, P1535, DOI 10.1007/s00109-019-01830-9; Trimouille A, 2018, CLIN GENET, V93, P374, DOI 10.1111/cge.13074; Wu LR, 2017, ORAL ONCOL, V69, P26, DOI 10.1016/j.oraloncology.2017.03.015; Zhang J, 2020, AGING-US, V12, P5423, DOI 10.18632/aging.102968; Zhang PP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1224-3; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	64	11	11	5	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2022	41	15					2239	2253		10.1038/s41388-022-02250-9	http://dx.doi.org/10.1038/s41388-022-02250-9		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J8DX	35217794				2022-12-26	WOS:000761868000003
J	Chen, JQ; Li, XM; Wang, K; Zhang, SY; Li, J; Sun, MB				Chen, Jianqu; Li, Xunmeng; Wang, Kai; Zhang, Shouyu; Li, Jun; Sun, Mingbo			Assessment of intertidal seaweed biomass based on RGB imagery	PLOS ONE			English	Article								The Above Ground Biomass (AGB) of seaweeds is the most fundamental ecological parameter as the material and energy basis of intertidal ecosystems. Therefore, there is a need to develop an efficient survey method that has less impact on the environment. With the advent of technology and the availability of popular filming devices such as smartphones and cameras, intertidal seaweed wet biomass can be surveyed by remote sensing using popular RGB imaging sensors. In this paper, 143 in situ sites of seaweed in the intertidal zone of GouQi Island, ShengSi County, Zhejiang Province, were sampled and biomass inversions were performed. The hyperspectral data of seaweed at different growth stages were analyzed, and it was found that the variation range was small (visible light range < 0.1). Through Principal Component Analysis (PCA), Most of the variance is explained in the first principal component, and the load allocated to the three kinds of seaweed is more than 90%. Through Pearson correlation analysis, 24 parameters of spectral features, 9 parameters of texture features (27 in total for the three RGB bands) and parameters of combined spectral and texture features of the images were selected for screening, and regression prediction was performed using two methods: Random Forest (RF), and Gradient Boosted Decision Tree (GBDT), combined with Pearson correlation coefficients. Compared with the other two models, GBDT has better fitting accuracy in the inversion of seaweed biomass, and the highest R-2 was obtained when the top 17, 17 and 11 parameters with strong correlation were selected for the regression prediction by Pearson's correlation coefficient for Ulva australis, Sargassum thunbergii, and Sargassum fusiforme, and the R-2 for Ulva australis was 0.784, RMSE 156.129, MAE 50.691 and MAPE 28.201, the R-2 for Sargassum thunbergii was 0.854, RMSE 790.487, MAE 327.108 and MAPE 19.039, and the R-2 for Sargassum fusiforme was 0.808, RMSE 445.067 and MAPE 28.822. MAE was 180.172 and MAPE was 28.822. The study combines in situ survey with machine learning methods, which has the advantages of being popular, efficient and environmentally friendly, and can provide technical support for intertidal seaweed surveys.	[Chen, Jianqu; Li, Xunmeng; Wang, Kai; Zhang, Shouyu; Sun, Mingbo] Shanghai Ocean Univ, Coll Ecol & Environm, Shanghai, Peoples R China; [Chen, Jianqu; Li, Xunmeng; Wang, Kai; Zhang, Shouyu; Sun, Mingbo] Shanghai Ocean Univ, Engn Technol Res Ctr Marine Ranching, Shanghai, Peoples R China; [Li, Jun] East China Sea Environm Monitoring Ctr, Shanghai, Peoples R China	Shanghai Ocean University; Shanghai Ocean University	Wang, K; Zhang, SY (corresponding author), Shanghai Ocean Univ, Coll Ecol & Environm, Shanghai, Peoples R China.; Wang, K; Zhang, SY (corresponding author), Shanghai Ocean Univ, Engn Technol Res Ctr Marine Ranching, Shanghai, Peoples R China.	kwang@shou.edu.cn; syzhang@shou.edu.cn			China Agriculture Research System [cars-50]; Biomass monitoring technology of seaweed beds in nearshore island [memrt202113]	China Agriculture Research System; Biomass monitoring technology of seaweed beds in nearshore island	We were supported by the "China Agriculture Research System" (cars-50) and the "Biomass monitoring technology of seaweed beds in nearshore island" (memrt202113), but I didn't find them in the Funder Registry.	Al-amri R, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11125320; Bell TW, 2015, REMOTE SENS ENVIRON, V167, P218, DOI 10.1016/j.rse.2015.05.003; Brahma B, 2021, TREES FOREST PEOPLE, V5, DOI 10.1016/j.tfp.2021.100098; Chen C, 2019, THESIS YANGZHOU U YA; Chen Peng, 2019, Transactions of the Chinese Society of Agricultural Engineering, V35, P63; Chen Qidong, 2015, Acta Ecologica Sinica, V35, P3394; Chen Y, 2020, COMPUT COMMUN, V154, P278, DOI 10.1016/j.comcom.2020.02.080; Cheng XP., 2017, THESIS SHANGHAI OCEA, DOI [10.27314/d.cnki.gsscu.2019.000308, DOI 10.27314/D.CNKI.GSSCU.2019.000308]; Cho MA, 2007, INT J APPL EARTH OBS, V9, P414, DOI 10.1016/j.jag.2007.02.001; Deng Lu-Xi, 2021, Plant Science Journal, V39, P467, DOI 10.11913/PSJ.2095-0837.2021.50467; Dumakor-Dupey NK, 2021, MINERALS-BASEL, V11, DOI 10.3390/min11060601; Filbee-Dexter K, 2016, MAR ECOL PROG SER, V543, P141, DOI 10.3354/meps11554; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; HORLER DNH, 1983, INT J REMOTE SENS, V4, P273, DOI 10.1080/01431168308948546; Huang X, 2009, THESIS WUHAN U; Li XM, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13063009; Linardatos P, 2021, ENTROPY-SWITZ, V23, DOI 10.3390/e23010018; Liu YF., 2016, THESIS ZHEJIANG OCEA; Liu YN, 2019, COMPUT ELECTRON AGR, V166, DOI 10.1016/j.compag.2019.105026; Martinez-Rios E, 2021, BIOMED SIGNAL PROCES, V68, DOI 10.1016/j.bspc.2021.102813; Peprah CO, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13122388; Safari A, 2020, INT J REMOTE SENS, V41, P8069, DOI 10.1080/01431161.2020.1771789; Sarker LR, 2011, REMOTE SENS ENVIRON, V115, P968, DOI 10.1016/j.rse.2010.11.010; Selvaraj S, 2021, FRONT ECOL EVOL, V9, DOI 10.3389/fevo.2021.581852; Sinde-Gonzalez I, 2021, INT J APPL EARTH OBS, V101, DOI 10.1016/j.jag.2021.102355; STEPHENSON TA, 1949, J ECOL, V37, P289, DOI 10.2307/2256610; The first Institute of Oceanography of the State Oceanic Administration the third Institute of Oceanography of the State Oceanic Administration, 2008, 1276392007 GBT; The third Institute of Oceanography of the State Oceanic Administration the second Institute of Oceanography of the State Oceanic Administration, 2008, 1276362007 GBT; Thomas B, THESIS IMPERIAL COLL; Wu WM, 2021, INT J HEAT MASS TRAN, V179, DOI 10.1016/j.ijheatmasstransfer.2021.121746; Zhang H, 2021, REMOTE SENS LETT, V12, P1025, DOI 10.1080/2150704X.2021.1875143; Zheng HB, 2019, PRECIS AGRIC, V20, P611, DOI 10.1007/s11119-018-9600-7; Zheng YH, 2018, GEOCARTO INT, V33, P1048, DOI 10.1080/10106049.2017.1333531	33	2	2	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0263416	10.1371/journal.pone.0263416	http://dx.doi.org/10.1371/journal.pone.0263416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202425	Green Published, gold			2022-12-26	WOS:000773224600011
J	Mao, XG; Egli, RAM; Liu, XM; Zhao, LJ				Mao, Xuegang; Egli, Ramon; Liu, Xiuming; Zhao, Lijuan			Magnetotactic advantage in stable sediment by long-term observations of magnetotactic bacteria in Earth's field, zero field and alternating field	PLOS ONE			English	Article							MAGNETITE; MAGNETIZATION; DIVERSITY	Magnetotactic bacteria (MTB) rely on magnetotaxis to effectively reach their preferred living habitats, whereas experimental investigation of magnetotactic advantage in stable sediment is currently lacking. We studied two wild type MTB (cocci and rod-shaped M. bavaricum) in sedimentary environment under exposure to geomagnetic field in the laboratory, zero field and an alternating field whose polarity was switched every 24 hours. The mean concentration of M. bavaricum dropped by similar to 50% during 6 months in zero field, with no clear temporal trend suggesting an extinction. Cell numbers recovered to initial values within similar to 1.5 months after the Earth's field was reset. Cocci displayed a larger temporal variability with no evident population changes in zero field. The alternating field experiment produced a moderate decrease of M. bavaricum concentrations and nearby extinction of cocci, confirming the active role of magnetotaxis in sediment and might point to a different magnetotactic mechanism for M. bavaricum which possibly benefited them to survive field reversals in geological periods. Our findings provide a first quantification of magnetotaxis advantage in sedimentary environment.	[Mao, Xuegang; Liu, Xiuming; Zhao, Lijuan] Fujian Normal Univ, Coll Geog Sci, Fuzhou, Peoples R China; [Mao, Xuegang; Liu, Xiuming] Fujian Normal Univ, Inst Geog, Fuzhou, Peoples R China; [Egli, Ramon] Cent Inst Meteorol & Geodynam, Vienna, Austria; [Liu, Xiuming] Macquarie Univ, Dept Earth & Environm Sci, Sydney, NSW, Australia	Fujian Normal University; Fujian Normal University; Macquarie University	Mao, XG (corresponding author), Fujian Normal Univ, Coll Geog Sci, Fuzhou, Peoples R China.; Mao, XG (corresponding author), Fujian Normal Univ, Inst Geog, Fuzhou, Peoples R China.	maoxuegang1@163.com		Mao, Xuegang/0000-0001-5855-5576	National Natural Science Foundation of China [41602184, 41772180, 42130507]; Natural Science Foundation of Fujian Province [2020J01141]; German Research Foundation [EG 294/1-1, EG294/2-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); German Research Foundation(German Research Foundation (DFG))	This work was financially supported by the National Natural Science Foundation of China (41602184, 41772180, 42130507), Natural Science Foundation of Fujian Province (2020J01141), and German Research Foundation (EG 294/1-1 and EG294/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; CHANG SBR, 1989, ANNU REV EARTH PL SC, V17, P169, DOI 10.1146/annurev.earth.17.1.169; Chen CF, 2011, APPL MICROBIOL BIOT, V90, P269, DOI 10.1007/s00253-010-3017-1; Flies CB, 2005, FEMS MICROBIOL ECOL, V52, P185, DOI 10.1016/j.femsec.2004.11.006; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; Frankel RB, 2009, CONTRIB MICROBIOL, V16, P182, DOI 10.1159/000219380; Hanzlik M, 2002, J MAGN MAGN MATER, V248, P258, DOI 10.1016/S0304-8853(02)00353-0; He K, 2018, GEOPHYS RES LETT, V45, P2294, DOI [10.1002/2018gl077213, 10.1002/2018GL077213]; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; Jogler C, 2010, ENVIRON MICROBIOL, V12, P2466, DOI 10.1111/j.1462-2920.2010.02220.x; Jogler C, 2011, P NATL ACAD SCI USA, V108, P1134, DOI 10.1073/pnas.1012694108; Kim BY, 2005, GEOPHYS J INT, V163, P26, DOI 10.1111/j.1365-246X.2005.02735.x; KIRSCHVINK JL, 1980, J EXP BIOL, V86, P345; Kopp RE., 2007, IDENTIFICATION INTER; Kopp RE, 2008, EARTH-SCI REV, V86, P42, DOI 10.1016/j.earscirev.2007.08.001; Lefevre CT, 2014, BIOPHYS J, V107, P527, DOI 10.1016/j.bpj.2014.05.043; Li JH, 2020, J GEOPHYS RES-BIOGEO, V125, DOI 10.1029/2020JG006012; Lin W, 2017, P NATL ACAD SCI USA, V114, P2171, DOI 10.1073/pnas.1614654114; [毛学刚 Mao Xuegang], 2015, [科学通报, Chinese Science Bulletin], V60, P88; Mao XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102810; Mao XG, 2014, GEOCHEM GEOPHY GEOSY, V15, P255, DOI 10.1002/2013GC005034; Moskowitz BM, 2008, GEOPHYS J INT, V174, P75, DOI 10.1111/j.1365-246X.2008.03789.x; Pan YX, 2005, EARTH PLANET SC LETT, V232, P109, DOI 10.1016/j.epsl.2005.01.006; PETERMANN H, 1993, EARTH PLANET SC LETT, V117, P223, DOI 10.1016/0012-821X(93)90128-V; Petermann H., 1989, LECT NOTES BIOMATH, V89, P387; PETERSEN N, 1986, NATURE, V320, P611, DOI 10.1038/320611a0; Petersen N, 1989, GEOMAGNETISM PALEOMA, P231, DOI DOI 10.1007/978-94-009-0905-2_17; Smith MJ, 2006, BIOPHYS J, V91, P1098, DOI 10.1529/biophysj.106.085167; SPRING S, 1993, APPL ENVIRON MICROB, V59, P2397, DOI 10.1128/AEM.59.8.2397-2403.1993; VALET JP, 1993, NATURE, V366, P234, DOI 10.1038/366234a0	30	1	1	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0263593	10.1371/journal.pone.0263593	http://dx.doi.org/10.1371/journal.pone.0263593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202421	Green Published, gold			2022-12-26	WOS:000773224600014
J	Xu, F; Wheaton, AG; Liu, Y; Greenlund, KJ				Xu, Fang; Wheaton, Anne G.; Liu, Yong; Greenlund, Kurt J.			Major ambulatory surgery among US adults with inflammatory bowel disease, 2017	PLOS ONE			English	Article							UNITED-STATES; RISK; HOSPITALIZATIONS; PREVALENCE	Background Patients with inflammatory bowel disease (IBD) have higher health services use than those without IBD. We investigated patient and hospital characteristics of major ambulatory surgery encounters for Crohn's disease (CD) or ulcerative colitis (UC) vs non-IBD patients. Methods We conducted a cross-sectional study using 2017 Nationwide Ambulatory Surgery Sample. Major ambulatory surgery encounters among patients aged >= 18 years with CD (n = 20,635) or UC (n = 9,894) were compared to 9.4 million encounters among non-IBD patients. Weighted percentages of patient characteristics (age, sex, median household income, primary payers, patient location, selected comorbidities, discharge destination, type of surgeries) and hospital-related characteristics (hospital size, ownership, location and teaching status, region) were compared by IBD status (CD, UC, and no IBD). Linear regression was used to estimate mean total charges, controlling for these characteristics. Results Compared with non-IBD patients, IBD patients were more likely to have private insurance, reside in urban areas and higher income zip codes, and undergo surgeries in hospitals that were private not-for-profit, urban teaching, and in the Northeast. Gastrointestinal surgeries were more common among IBD patients. Some comorbidities associated with increased risk of surgical complications were more prevalent among IBD patients. Total charges were 9% lower for CD patients aged <65 years (Median: $16,462 vs $18,106) and 6% higher for UC patients aged >= 65 years (Median: $16,909 vs $15,218) compared to their non-IBD patient counterparts. Conclusions Differences in characteristics of major ambulatory surgery encounters by IBD status may identify opportunities for efficient resource allocation and positive surgical outcomes among IBD patients.	[Xu, Fang; Wheaton, Anne G.; Liu, Yong; Greenlund, Kurt J.] Ctr Dis Control & Prevent, Div Populat Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Xu, F (corresponding author), Ctr Dis Control & Prevent, Div Populat Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	vmf7@cdc.gov						Advancing Surgical Care, NUMB ASCS STAT; Agency for Healthcare Research and Quality, 2020, INTR HCUP NAT AM SUR; Agency for Healthcare Research and Quality, 2019, NASS DAT DOC; Alatab S, 2020, LANCET GASTROENTEROL, V5, P17, DOI 10.1016/S2468-1253(19)30333-4; Ananthakrishnan AN, 2011, J GASTROINTEST SURG, V15, P267, DOI 10.1007/s11605-010-1396-3; Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; Aniwan S, 2018, MAYO CLIN PROC, V93, P1415, DOI 10.1016/j.mayocp.2018.03.004; Badlani Neil, 2019, J Spine Surg, V5, pS195, DOI 10.21037/jss.2019.04.20; Bernstein CN, 2012, GUT, V61, P622, DOI 10.1136/gutjnl-2011-301397; Carney H, 2021, INFLAMM BOWEL DIS, V27, P58, DOI 10.1093/ibd/izaa014; Centers for Medicare & Medicaid Services, AMB SURG CTR ASC PAY; Chronic Conditions Data Warehouse, 2020, COND CAT; Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3; Davis Kristina K, 2019, J Clin Med Res, V11, P7, DOI 10.14740/jocmr3603w; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Ghoneim MM, 2016, BMC SURG, V16, DOI 10.1186/s12893-016-0120-y; Herrera CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093456; Johnston RD, 2008, INFLAMM BOWEL DIS, V14, pS4, DOI 10.1002/ibd.20545; Ma C, 2020, CLIN GASTROENTEROL H, V18, P2500, DOI 10.1016/j.cgh.2020.01.023; Makanji Heeren S, 2019, J Spine Surg, V5, pS191, DOI 10.21037/jss.2019.08.07; Malarcher CA, 2017, MMWR-MORBID MORTAL W, V66, P377, DOI 10.15585/mmwr.mm6614a1; Mathis MR, 2013, ANESTHESIOLOGY, V119, P1310, DOI 10.1097/ALN.0000000000000005; Neuendorf R, 2016, J PSYCHOSOM RES, V87, P70, DOI 10.1016/j.jpsychores.2016.06.001; Park MD, 2014, PEERJ, V2, DOI 10.7717/peerj.587; Richter DL, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117694352; Sibio S, 2018, GASTROENT RES PRACT, V2018, DOI 10.1155/2018/5249087; Song Y, 2021, ANN SURG, V274, P992, DOI 10.1097/SLA.0000000000003697; Steiner C.A., 2017, SURG HOSP BASED AMBU; Stierer TL, 2015, CHEST, V148, P559, DOI 10.1378/chest.14-3049; Terlizzi Emily P, 2021, NCHS Data Brief, P1; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1982, DOI 10.1097/MIB.0000000000000392; Vester-Andersen MK, 2014, AM J GASTROENTEROL, V109, P705, DOI 10.1038/ajg.2014.45; Warner DO, 2007, CURR OPIN ANESTHESIO, V20, P279, DOI 10.1097/ACO.0b013e3280c60c3b; Xu F, 2022, DIGEST DIS SCI, V67, P3601, DOI 10.1007/s10620-021-07264-z; Xu F, 2019, MMWR-MORBID MORTAL W, V68, P1134, DOI 10.15585/mmwr.mm6849a2; Xu F, 2018, MMWR-MORBID MORTAL W, V67, P190, DOI 10.15585/mmwr.mm6706a4	36	1	1	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264372	10.1371/journal.pone.0264372	http://dx.doi.org/10.1371/journal.pone.0264372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202440	gold, Green Published			2022-12-26	WOS:000773224600037
J	Wang, X; Bernstein, HD				Wang, Xu; Bernstein, Harris D.			The Escherichia coli outer membrane protein OmpA acquires secondary structure prior to its integration into the membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARREL ASSEMBLY MACHINE; PERIPLASMIC PROTEIN; CHAPERONE; SKP; BIOGENESIS; COMPLEX; BAM; VARIANTS; ACCURACY; PEPTIDE	Almost all proteins that reside in the outer membrane (OM) of Gram-negative bacteria contain a membrane-spanning segment that folds into a unique beta barrel structure and inserts into the membrane by an unknown mechanism. To obtain further insight into outer membrane protein (OMP) biogenesis, we revisited the surprising observation reported over 20 years ago that the Escherichia coli OmpA beta barrel can be assembled into a native structure in vivo when it is expressed as two noncovalently linked fragments. Here, we show that disulfide bonds between beta strand 4 in the N-terminal fragment and beta strand 5 in the C-terminal fragment can form in the periplasmic space and greatly increase the efficiency of assembly of "split" OmpA, but only if the cysteine residues are engineered in perfect register (i.e., they are aligned in the fully folded beta barrel). In contrast, we observed only weak disulfide bonding between beta strand 1 in the N-terminal fragment and beta strand 8 in the C-terminal fragment that would form a closed or circularly permutated beta barrel. Our results not only demonstrate that beta barrels begin to fold into a beta-sheet-like structure before they are integrated into the OM but also help to discriminate among the different models of OMP biogenesis that have been proposed.	[Wang, Xu; Bernstein, Harris D.] NIDDKD, NIH, Genet & Biochem Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDKD, NIH, Genet & Biochem Branch, Bethesda, MD USA.	harris_bernstein@nih.gov	Wang, Xu/GLU-4713-2022	Wang, Xu/0000-0003-1309-1848	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Matt Doyle and Thushani Nilaweerafor providing insightful comments on the article. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NationalInstitutes of Health	Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x; Cierpicki T, 2006, J AM CHEM SOC, V128, P6947, DOI 10.1021/ja0608343; Combs AN, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2114997119; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; Doerner PA, 2017, BIOCHEMISTRY-US, V56, P3142, DOI 10.1021/acs.biochem.7b00281; Doyle MT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11230-9; Doyle MT, 2022, CELL, V185, P1143, DOI 10.1016/j.cell.2022.02.016; Doyle MT, 2021, MOL CELL, V81, P2000, DOI 10.1016/j.molcel.2021.02.023; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; FREUDL R, 1986, J BIOL CHEM, V261, P1355; Gao X, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67230-z; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Hagan CL, 2015, P NATL ACAD SCI USA, V112, P2011, DOI 10.1073/pnas.1415955112; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Horne JE, 2020, J BIOL CHEM, V295, P10340, DOI 10.1074/jbc.REV120.011473; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; Ieva R, 2008, MOL MICROBIOL, V67, P188, DOI 10.1111/j.1365-2958.2007.06048.x; Imai Y, 2019, NATURE, V576, P459, DOI 10.1038/s41586-019-1791-1; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kaur H, 2021, NATURE, V593, P125, DOI 10.1038/s41586-021-03455-w; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Koebnik R, 1996, EMBO J, V15, P3529, DOI 10.1002/j.1460-2075.1996.tb00722.x; KOEBNIK R, 1995, J MOL BIOL, V250, P617, DOI 10.1006/jmbi.1995.0403; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lauber F, 2018, NATURE, V564, P77, DOI 10.1038/s41586-018-0693-y; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Lundquist K, 2018, P NATL ACAD SCI USA, V115, pE7942, DOI 10.1073/pnas.1722530115; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Malinverni Juliana C, 2011, EcoSal Plus, V4, DOI 10.1128/ecosalplus.4.3.8; MORONA R, 1985, J BACTERIOL, V164, P539, DOI 10.1128/JB.164.2.539-543.1985; Noinaj N, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.191; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Pavlova O, 2013, P NATL ACAD SCI USA, V110, pE938, DOI 10.1073/pnas.1219076110; Reynolds CR, 2018, J MOL BIOL, V430, P2244, DOI 10.1016/j.jmb.2018.01.013; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Rice JJ, 2006, PROTEIN SCI, V15, P825, DOI 10.1110/ps.051897806; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Schiffrin B, 2017, J MOL BIOL, V429, P3776, DOI 10.1016/j.jmb.2017.09.008; Sikdar R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01246-4; Slusky JSG, 2017, CURR OPIN STRUC BIOL, V45, P45, DOI 10.1016/j.sbi.2016.11.003; Stapleton JA, 2015, P NATL ACAD SCI USA, V112, P9632, DOI 10.1073/pnas.1501836112; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023; Wang X, 2021, MBIO, V12, DOI 10.1128/mBio.00597-21; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Yan Z, 2019, MOL MICROBIOL, V112, P1373, DOI 10.1111/mmi.14358	53	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101802	10.1016/j.jbc.2022.101802	http://dx.doi.org/10.1016/j.jbc.2022.101802			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35257747	Green Published, gold			2022-12-26	WOS:000797895000005
J	Amin, MT; Alazba, AA; Shafiq, M				Amin, M. T.; Alazba, A. A.; Shafiq, M.			Ethylenediaminetetraacetate functionalized MgFe layered double hydroxide/biochar composites for highly efficient adsorptive removal of lead ions from aqueous solutions	PLOS ONE			English	Article							ACTIVATED CARBON; MALACHITE GREEN; PB(II) IONS; PB2+; EQUILIBRIUM; ISOTHERMS; SORPTION; KINETICS; BIOCHAR; CU2+	The application of layered double hydroxides (LDHs) of MgFe and its composites with biochar of Eucalyptus camdulensis (Eb) and ethylenediaminetetraacetic acid (EDTA) was explored in a batch study to mitigate toxic lead ions (Pb2+) from synthetic wastewater solutions. SEM images revealed that MgFe/LDH composites with Eb were successfully formed, while FTIR spectra confirmed the successful adsorption of Pb2+ onto the MgFe/LDH and composite adsorbents. Batch equilibrium was attained after 60 min, then the adsorption capacity gradually increased. An increase in adsorption capacity (and a 60% decrease in the percentage removal) was observed by increasing the initial Pb2+ concentration, and the highest value was 136 mg g(-1) for MgFe/LDH-Eb_EDTA. A 50-60% increase in both the adsorption capacities and percent removal was seen in the pH range of 2-6. The second-order kinetic model had a nearly perfect fitting, suggesting that chemisorption was the mechanism controlling adsorption. The Langmuir isotherm model best presented the adsorption data, suggesting that the Pb2+ adsorption was monolayer, and predicted a better affinity between the adsorbent surface and absorbed Pb2+ for MgFe/LDH-Eb_EDTA in comparison to the other two adsorbents. The D-R isotherm suggested that the adsorption system was physical based on E values for all three adsorbents, while the Temkin isotherm model suggested that Pb2+ adsorption was heterogeneous. Finally, the Sips and R-P isotherms predicted that the adsorption of Pb2+ on the surface of the adsorbents was homogeneous and heterogeneous.	[Amin, M. T.; Alazba, A. A.; Shafiq, M.] King Saud Univ, Alamoudi Water Res Chair, Riyadh, Saudi Arabia; [Amin, M. T.] COMSATS Univ Islamabad, Dept Environm Sci, Abbottabad, Pakistan; [Alazba, A. A.] King Saud Univ, Agr Engn Dept, Riyadh, Saudi Arabia	King Saud University; COMSATS University Islamabad (CUI); King Saud University	Amin, MT (corresponding author), King Saud Univ, Alamoudi Water Res Chair, Riyadh, Saudi Arabia.; Amin, MT (corresponding author), COMSATS Univ Islamabad, Dept Environm Sci, Abbottabad, Pakistan.	mtamin@ksu.edu.sa	Shafiq, Muhammad/GRY-3465-2022; Amin, Muhammad Tahir/G-1525-2011	Shafiq, Muhammad/0000-0003-4732-0338; Amin, Muhammad Tahir/0000-0001-8283-9958	National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [12-WAT2623-02]	National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia	This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award Number (12-WAT2623-02) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahi M, 2013, DESALIN WATER TREAT, V51, P3224, DOI 10.1080/19443994.2012.749034; Adeleye AS, 2016, CHEM ENG J, V286, P640, DOI 10.1016/j.cej.2015.10.105; Amin MT, 2014, ADV MATER SCI ENG, V2014, DOI 10.1155/2014/825910; Amin MT, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13073600; Anwar J, 2010, BIORESOURCE TECHNOL, V101, P1752, DOI 10.1016/j.biortech.2009.10.021; Ayranci E, 2010, CHEM ENG J, V156, P70, DOI 10.1016/j.cej.2009.09.038; Bouhamed F, 2014, DESALIN WATER TREAT, V52, P2261, DOI 10.1080/19443994.2013.806222; Caporale AG, 2011, J HAZARD MATER, V198, P291, DOI 10.1016/j.jhazmat.2011.10.044; Cheng X, 2010, J HAZARD MATER, V177, P516, DOI 10.1016/j.jhazmat.2009.12.063; Chowdhury S, 2011, DESALINATION, V265, P159, DOI 10.1016/j.desal.2010.07.047; Daud MK, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7908183; de Carvalho GC, 2020, J THERM ANAL CALORIM, V140, P2247, DOI 10.1007/s10973-019-08960-9; Duman O, 2019, ENVIRON POLLUT, V244, P723, DOI 10.1016/j.envpol.2018.10.071; Benicio LPF, 2018, MATER RES-IBERO-AM J, V21, DOI [10.1590/1980-5373-MR-2017-1004, 10.1590/1980-5373-mr-2017-1004]; Gimbert F, 2008, J HAZARD MATER, V157, P34, DOI 10.1016/j.jhazmat.2007.12.072; Gunawan P, 2009, CHEM MATER, V21, P781, DOI 10.1021/cm803203x; Gunay A, 2007, J HAZARD MATER, V148, P708, DOI 10.1016/j.jhazmat.2007.03.041; Gunay A, 2007, J HAZARD MATER, V146, P362, DOI 10.1016/j.jhazmat.2006.12.034; Tran HN, 2019, CRIT REV ENV SCI TEC, V49, P2155, DOI 10.1080/10643389.2019.1607442; Hameed BH, 2008, J HAZARD MATER, V154, P237, DOI 10.1016/j.jhazmat.2007.10.017; Hefny R., 2020, J ENG RES REP, V19, P27, DOI [10.9734/jerr/2020/v19i417239, DOI 10.9734/JERR/2020/V19I417239]; Huang GL, 2015, J COLLOID INTERF SCI, V445, P294, DOI 10.1016/j.jcis.2014.12.099; Ji HS, 2017, J HAZARD MATER, V334, P212, DOI 10.1016/j.jhazmat.2017.04.014; Jia Y, 2019, COLLOID SURFACE A, V567, P278, DOI 10.1016/j.colsurfa.2019.01.064; Karapinar N, 2009, DESALINATION, V249, P123, DOI 10.1016/j.desal.2008.12.046; Khan ZU, 2021, J ENVIRON CHEM ENG, V9, DOI 10.1016/j.jece.2021.105916; Kubra KT, 2021, J MOL LIQ, V328, DOI 10.1016/j.molliq.2021.115468; Kumar PS, 2010, J ENG SCI TECHNOL, V5, P232; Li JH, 2019, SCI TOTAL ENVIRON, V672, P572, DOI 10.1016/j.scitotenv.2019.04.003; Li RH, 2018, CARBON, V129, P674, DOI 10.1016/j.carbon.2017.12.070; Liu TQ, 2022, J ENVIRON CHEM ENG, V10, DOI 10.1016/j.jece.2021.106502; Liu Y, 2016, APPL SURF SCI, V369, P267, DOI 10.1016/j.apsusc.2016.02.043; Ma Y, 2018, CHEM ENG J, V347, P953, DOI 10.1016/j.cej.2018.04.172; Malik PK, 2003, DYES PIGMENTS, V56, P239, DOI 10.1016/S0143-7208(02)00159-6; Marlohar DM, 2006, APPL CLAY SCI, V31, P194, DOI 10.1016/j.clay.2005.08.008; Matusik J, 2020, MATERIALS, V13, DOI 10.3390/ma13194344; Matusik J, 2019, MATERIALS, V12, DOI 10.3390/ma12091373; Mireles S, 2019, INT J ENVIRON SCI TE, V16, P5817, DOI 10.1007/s13762-018-02191-5; Naddafi K, 2016, DESALIN WATER TREAT, V57, P5789, DOI 10.1080/19443994.2015.1005693; Nejati K, 2018, NEW J CHEM, V42, P2889, DOI 10.1039/c7nj04469k; Oubagaranadin JUK, 2009, IND ENG CHEM RES, V48, P10627, DOI 10.1021/ie9005047; Pavlovic I, 2009, APPL CLAY SCI, V43, P125, DOI 10.1016/j.clay.2008.07.020; Perez MR, 2006, APPL CLAY SCI, V32, P245, DOI 10.1016/j.clay.2006.01.008; Raji F, 2013, APPL SURF SCI, V282, P415, DOI 10.1016/j.apsusc.2013.05.145; Rajoriya RK, 2007, CHEM BIOCHEM ENG Q, V21, P219; Rezvani Z, 2015, DALTON T, V44, P988, DOI 10.1039/c4dt03152k; Sajid M, 2016, TRAC-TREND ANAL CHEM, V75, P174, DOI 10.1016/j.trac.2015.06.010; Salman M, 2014, KOREAN J CHEM ENG, V31, P467, DOI 10.1007/s11814-013-0264-8; Shafiq M, 2018, SAINS MALAYS, V47, P35, DOI 10.17576/jsm-2018-4701-05; Shahmirzadi MAA, 2016, KOREAN J CHEM ENG, V33, P3529, DOI 10.1007/s11814-016-0218-z; Shen YM, 2017, ARAB J CHEM, V10, pS2295, DOI 10.1016/j.arabjc.2013.08.005; Syed HI, 2022, SCI TOTAL ENVIRON, V807, DOI 10.1016/j.scitotenv.2021.150606; Tan YH, 2022, J HAZARD MATER, V424, DOI 10.1016/j.jhazmat.2021.127349; Tang H, 2012, J HAZARD MATER, V209, P218, DOI 10.1016/j.jhazmat.2012.01.010; Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009; Tchounwou Paul B, 2012, Exp Suppl, V101, P133, DOI 10.1007/978-3-7643-8340-4_6; Verma R., 2018, J ENTOMOL ZOO STUD, V6, P27; Villarreal JS, 2021, INT J SUSTAIN ENG, V14, P970, DOI 10.1080/19397038.2020.1862350; Vithanage M, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.139718; Wang CQ, 2018, CHEMOSPHERE, V192, P1, DOI 10.1016/j.chemosphere.2017.10.125; Wang FY, 2019, APPL CLAY SCI, V175, P115, DOI 10.1016/j.clay.2019.04.013; Wang SL, 2007, COLLOID SURFACE A, V292, P131, DOI 10.1016/j.colsurfa.2006.06.014; Wang SS, 2016, RSC ADV, V6, P17792, DOI 10.1039/c5ra17490b; Wang XX, 2018, CHEM ENG J, V342, P321, DOI 10.1016/j.cej.2018.02.102; Wang YL, 2017, RSC ADV, V7, P35181, DOI 10.1039/c7ra05892f; Yang FC, 2016, APPL CLAY SCI, V123, P134, DOI 10.1016/j.clay.2016.01.026; Yin J, 2018, WATER-SUI, V10, DOI 10.3390/w10020210; Yu JN, 2018, ENVIRON SCI POLLUT R, V25, P24293, DOI 10.1007/s11356-018-2500-6; Zaghouane-Boudiaf H, 2012, CHEM ENG J, V187, P142, DOI 10.1016/j.cej.2012.01.112; Zhang FR, 2015, ACS APPL MATER INTER, V7, P7251, DOI 10.1021/acsami.5b00433; Zhang LX, 2018, ACS APPL MATER INTER, V10, P43013, DOI 10.1021/acsami.8b15049; Zhao DL, 2011, CHEM ENG J, V171, P167, DOI 10.1016/j.cej.2011.03.082; Zhu KR, 2016, ACS SUSTAIN CHEM ENG, V4, P4361, DOI 10.1021/acssuschemeng.6b00922	73	0	0	9	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0265024	10.1371/journal.pone.0265024	http://dx.doi.org/10.1371/journal.pone.0265024			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239747	gold, Green Published			2022-12-26	WOS:000776002200086
J	Amponsem-Boateng, C; Bosu, WK				Amponsem-Boateng, Cecilia; Bosu, William K.			High blood pressure among adolescents in Africa: A systematic review and meta-analysis protocol	PLOS ONE			English	Review							HYPERTENSION; PREVALENCE; CHILDREN; ADULTHOOD; CHILDHOOD; BURDEN; BIAS; RISK	Introduction As high blood pressure (HBP) is often considered an adult disease in Africa, studies on and services for HBP focus on adults to the near-exclusion of adolescents. The dearth of information about the burden of HBP does not favour much attention being paid to it. We, therefore, prepared this protocol to estimate the prevalence and awareness of HBP in adolescents in Africa through a systematic review and meta-analysis. Methods We will search several major databases for published and unpublished articles on population-based studies on adolescents living in Africa, aged 10-19 years produced from the year 2000 to date. The included articles will be those that define HBP according to international guidelines using the blood pressure cut-offs of the 95(th) percentile for age, sex and height or of 130/90 mmHg, depending on the age of the subjects. The study selection as well as the evaluation of the quality of the included articles will be done independently by two reviewers, in line with best practices. We will pool together the prevalence across studies using random effects analysis and assess heterogeneity using meta-regression analysis and sub-group analysis. Sensitivity analysis using a leave-one-out analysis and an evaluation of reporting bias will also be performed. Reporting of our findings will conform to the recommended reporting guidelines. Conclusion The findings from our comprehensive systematic review and meta-analysis will provide an up-to-date information on the prevalence of HBP and its awareness among adolescents in Africa and its sub-regions. They could be used to advocate for increased priority to life course approach to the prevention of cardiovascular diseases. Systematic review registration PROSPERO CRD42020197946.	[Amponsem-Boateng, Cecilia] Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol & Biostat, Zhengzhou, Henan, Peoples R China; [Bosu, William K.] West African Hlth Org, Dept Publ Hlth & Res, Bobo Dioulasso, Burkina Faso	Zhengzhou University	Bosu, WK (corresponding author), West African Hlth Org, Dept Publ Hlth & Res, Bobo Dioulasso, Burkina Faso.	billybosu@gmail.com		Amponsem-Boateng, Cecilia/0000-0003-0403-2555				Aboderin I., 2002, LIFE COURSE PERSPECT; Adeloye D, 2021, J CLIN HYPERTENS, V23, P963, DOI 10.1111/jch.14220; Akbari M, 2017, J HYPERTENS, V35, P1155, DOI 10.1097/HJH.0000000000001261; Amponsem-Boateng C, 2022, J HUM HYPERTENS, V36, P405, DOI 10.1038/s41371-021-00502-x; [Anonymous], 2021, STAND COUNTR AR COD; [Anonymous], 2019, WORLD POPULATION PRO; [Anonymous], 2020, GLOBAL BURDEN DIS ST; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Berhe AK, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1667-7; Booth A., 2016, SYSTEMATIC APPROACHE, V2nd ed.; Migliavaca CB, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-00975-3; Bosu WK, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0585-5; Bosu WK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248137; Bosu WK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214934; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chiolero A, 2017, LANCET PUBLIC HEALTH, V2, pE346, DOI 10.1016/S2468-2667(17)30137-8; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Daniel RA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239929; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ejike CECC, 2017, J TROP PEDIATRICS, V63, P229, DOI 10.1093/tropej/fmw087; Falkner B, 2020, HYPERTENSION, V75, P1142, DOI 10.1161/HYPERTENSIONAHA.119.14059; de Moraes ACF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000232; Flynn JT, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-3035; Fokoua-Maxime CD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252511; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Hunter JP, 2014, J CLIN EPIDEMIOL, V67, P897, DOI 10.1016/j.jclinepi.2014.03.003; Kaze AD, 2017, J HYPERTENS, V35, P1345, DOI 10.1097/HJH.0000000000001345; Kazeem Y, MORE HALF WORLDS POP; Meena J, 2021, INDIAN J PEDIATR, V88, P1107, DOI 10.1007/s12098-021-03686-9; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Noubiap Jean Jacques, 2020, Pan Afr Med J, V37, P341, DOI 10.11604/pamj.2020.37.341.27387; Noubiap JJ, 2017, LANCET PUBLIC HEALTH, V2, pE375, DOI 10.1016/S2468-2667(17)30123-8; NourEldeen N, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12030488; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Goncalves VSS, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S1518-8787.2016050006236; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Song PG, 2019, JAMA PEDIATR, V173, P1154, DOI 10.1001/jamapediatrics.2019.3310; StataCorp, 2019, STAT REL 16 STAT SOF; Steichen T., 2001, ECONPAPERS; Veritas Health Innovation, 2018, COV SYST REV SOFTW; Wallace BC, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i05; Wang LL, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0992-1; Yang LL, 2020, J HYPERTENS, V38, P2346, DOI 10.1097/HJH.0000000000002550	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264728	10.1371/journal.pone.0264728	http://dx.doi.org/10.1371/journal.pone.0264728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239735	gold, Green Published			2022-12-26	WOS:000776002200069
J	Hossin, MZ; Islam, A; Billah, M; Haque, M; Uddin, J				Hossin, Muhammad Zakir; Islam, Azharul; Billah, Masum; Haque, Mahjabeen; Uddin, Jalal			Is there a gradient in the association between internet addiction and health?	PLOS ONE			English	Article							COLLEGE-STUDENTS; GENDER; DEPRESSION; DISORDER; ADOLESCENTS; QUALITY; SLEEP; SCALE	Background Internet Addiction (IA) is often shown to be associated with health issues, but no study explicitly examined a possible gradient in the association between different levels of IA and health. This study aimed to examine if the levels of IA had a graded relationship with poor sleep quality, psychological distress, and self-rated health among university students in Bangladesh. Methods In this cross-sectional study, a sample of 625 students from six universities/colleges responded to an online survey that contained measures of internet addiction test (IAT), general health questionnaire (GHQ-12), sleep quality, and self-rated health. Modified Poisson regression models were fitted to estimate the adjusted risk ratios (RR) and confidence intervals (CI) of the associations between IA and health outcomes. Results The IA levels were associated with each of the three health outcomes in a linear fashion. Compared to the lowest IA quintile, the highest quintile remained associated with an increased risk of poor-quality sleeping (RR: 1.77; 95% CI: 1.26, 2.48), psychological distress (RR: 2.09; 95% CI: 1.55, 2.82), and worse self-rated health (RR: 1.46; 95% CI: 1.09, 1.96) after adjusting for socio-demographic covariates. There were also dose-response associations between IAT z-scores and health outcomes. The association between IAT z-scores and psychological distress was significantly stronger in males compared to females (p-value for interaction<0.05). Conclusions The study found strong gradients between levels of addiction to internet and health outcomes, suggesting that increased health risks may exist even at lower levels of internet addiction. The findings highlight the need for departure of current research from a focus on the classic dichotomy of problematic versus not problematic internet use and a move toward recognizing the potential hierarchical effects of IA on health.	[Hossin, Muhammad Zakir] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden; [Hossin, Muhammad Zakir] Eastern Univ, Dept Gen Educ, Dhaka, Bangladesh; [Islam, Azharul; Haque, Mahjabeen] Univ Dhaka, Dept Educ & Counselling Psychol, Dhaka, Bangladesh; [Billah, Masum] East West Univ, Dept Sociol, Dhaka, Bangladesh; [Uddin, Jalal] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	Karolinska Institutet; Eastern University Bangladesh; University of Dhaka; East West University Bangladesh; University of Alabama System; University of Alabama Birmingham	Hossin, MZ (corresponding author), Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.; Hossin, MZ (corresponding author), Eastern Univ, Dept Gen Educ, Dhaka, Bangladesh.	zakir.hossin@ki.se	BILLAH, MASUM/GQH-2969-2022; Islam, Azharul/AAZ-4054-2021	Islam, Azharul/0000-0001-9509-000X; Hossin, Muhammad Zakir/0000-0002-9078-419X; Billah, Masum/0000-0002-9086-7008				Alimoradi Z, 2019, SLEEP MED REV, V47, P51, DOI 10.1016/j.smrv.2019.06.004; Anderson EL, 2017, INT J ADOLESC YOUTH, V22, P430, DOI 10.1080/02673843.2016.1227716; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Brand M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01256; Brand M, 2011, CYBERPSYCH BEH SOC N, V14, P371, DOI 10.1089/cyber.2010.0222; BTRC, 2021, INT SUBSCR BANGL JUN; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Caplan SE, 2010, COMPUT HUM BEHAV, V26, P1089, DOI 10.1016/j.chb.2010.03.012; Caplan SE, 2002, COMPUT HUM BEHAV, V18, P553, DOI 10.1016/S0747-5632(02)00004-3; Carli V, 2013, PSYCHOPATHOLOGY, V46, P1, DOI 10.1159/000337971; Chang AM, 2015, P NATL ACAD SCI USA, V112, P1232, DOI 10.1073/pnas.1418490112; Chern KC, 2018, COMPUT HUM BEHAV, V84, P460, DOI 10.1016/j.chb.2018.03.011; Davis RA, 2002, CYBERPSYCHOL BEHAV, V5, P331, DOI 10.1089/109493102760275581; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; Dowling NA, 2014, ADDICTION, V109, P1408, DOI 10.1111/add.12554; Dufour M, 2016, CAN J PSYCHIAT, V61, P663, DOI 10.1177/0706743716640755; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; Griffiths M, 2000, CYBERPSYCHOL BEHAV, V3, P211, DOI 10.1089/109493100316067; Ho RC, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-183; Hossin MZ, 2019, J GERONTOL B-PSYCHOL, V74, pE97, DOI 10.1093/geronb/gbx067; Islam Md Azharul, 2016, Asian J Gambl Issues Public Health, V6, P11; Jahan SM, 2019, SLEEP BIOL RHYTHMS, V17, P323, DOI 10.1007/s41105-019-00219-y; Kandell J.J., 1998, CYBERPSYCHOL BEHAV, V1, P11, DOI [10.1089/cpb.1998.1.11, DOI 10.1089/CPB.1998.1.11]; Karim AKMR, 2014, ASIAN J PSYCHIATR, V10, P75, DOI 10.1016/j.ajp.2013.10.011; Kim K, 2006, INT J NURS STUD, V43, P185, DOI 10.1016/j.ijnurstu.2005.02.005; Kim K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174619; Kitazawa M, 2018, PSYCHIAT CLIN NEUROS, V72, P531, DOI 10.1111/pcn.12662; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Kormas G, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-595; Kuss DJ, 2014, CURR PHARM DESIGN, V20, P4026, DOI 10.2174/13816128113199990617; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0508-2; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; Lam LT, 2010, ARCH PEDIAT ADOL MED, V164, P901, DOI 10.1001/archpediatrics.2010.159; Li JB, 2017, J BEHAV ADDICT, V6, P554, DOI 10.1556/2006.6.2017.085; Li N, 2007, COMPUT EDUC, V48, P301, DOI 10.1016/j.compedu.2005.01.007; Liu S, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy213; Lortie CL, 2013, ADDICTION, V108, P1207, DOI 10.1111/add.12202; Machimbarrena JM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112471; Mamun MA, 2020, ASIA-PAC PSYCHIAT, V12, DOI 10.1111/appy.12386; Mamun MA, 2021, INT J MENT HEALTH AD, V19, P2170, DOI 10.1007/s11469-019-00102-4; Mamun MA, 2019, ASIAN J PSYCHIATR, V44, P48, DOI 10.1016/j.ajp.2019.07.005; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Morioka H, 2017, J EPIDEMIOL, V27, P107, DOI 10.1016/j.je.2016.10.004; Petry NM, 2014, ADDICTION, V109, P1399, DOI 10.1111/add.12457; Sayeed A, 2020, CHILD YOUTH SERV REV, V118, DOI 10.1016/j.childyouth.2020.105424; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1407; Sorcar NR., 1990, DHAKA U STUDIES, V11, P55; Su WL, 2019, COMPUT HUM BEHAV, V99, P86, DOI 10.1016/j.chb.2019.04.021; Tan YF, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030313; Tokunaga RS, 2016, HUM COMMUN RES, V42, P165, DOI 10.1111/hcre.12075; Tsai HF, 2009, PSYCHIAT RES, V167, P294, DOI 10.1016/j.psychres.2008.01.015; Vogel EA, 2014, PSYCHOL POP MEDIA CU, V3, P206, DOI 10.1037/ppm0000047; Wang W, 2019, PEERJ, V7, DOI 10.7717/peerj.7357; Weiser EB, 2000, CYBERPSYCHOL BEHAV, V3, P167, DOI 10.1089/109493100316012; Wu SQ, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-320, 10.1186/1471-2458-13-636]; Yen JY, 2009, CYBERPSYCHOL BEHAV, V12, P187, DOI 10.1089/cpb.2008.0113; Young K S., 1999, INNOVATIONS CLIN PRA, P19; Young KS, 2004, AM BEHAV SCI, V48, P402, DOI 10.1177/0002764204270278; Young KS, 1996, PSYCHOL REP, V79, P899, DOI 10.2466/pr0.1996.79.3.899; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	61	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264716	10.1371/journal.pone.0264716	http://dx.doi.org/10.1371/journal.pone.0264716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239733	Green Published, gold			2022-12-26	WOS:000776002200067
J	Kalogeropoulu, SK; Lloyd, EJ; Rauch, H; Redtenbacher, I; Hafner, M; Burgener, IA; Painer-Gigler, J				Kalogeropoulu, Szilvia K.; Lloyd, Emily J.; Rauch, Hanna; Redtenbacher, Irene; Hafner, Michael; Burgener, Iwan A.; Painer-Gigler, Johanna			Chronic cholecystitis: Diagnostic and therapeutic insights from formerly bile-farmed Asiatic black bears (Ursus thibetanus)	PLOS ONE			English	Article							ULTRASOUND-GUIDED CHOLECYSTOCENTESIS; GALLBLADDER BILE; DOGS; ANTIBIOTICS; CHOLANGITIS; RESISTANCE; DISORDERS; VISCOSITY; RUPTURE; DISEASE	Across Southeast Asia and China, more than 17000 Asian bears are kept under suboptimal conditions and farmed for their bile to meet the consumer demand for traditional medicine products. Years of unsterile and repetitive bile extraction contribute to the development of chronic sterile or bacterial cholecystitis, a pathology commonly diagnosed in formerly bile-farmed bears. In both human and veterinary medicine, the diagnostic value of the macroscopic bile examination for assessing gallbladder disease is unclear. The objective of this study is to identify the role of gallbladder bile color, viscosity, and turbidity, while comparing them with established markers of cholecystitis. Moreover, it aims to define the optimal duration of oral antibiotic treatment for chronic bacterial cholecystitis in bears associated with bile farming. Thirty-nine adult, formerly bile-farmed Asiatic black bears (Ursus thibetanus) were examined under anesthesia and underwent percutaneous ultrasound guided cholecystocentesis. A total of 59 bile samples were collected with 20 animals sampled twice to evaluate the therapeutic success. All bile aspirates were assessed macroscopically and microscopically followed by submission for bacterial culture and antimicrobial sensitivity. In the majority of bears, samples with cytological evidence of bactibilia lacked inflammatory cells and did not always correlate with positive bacterial cultures. The most common bacterial isolates were Enterococcus spp, Streptococcus spp and Escherichia coli. Based on our findings, the optimal duration of antibiotic treatment for chronic bacterial cholecystitis is 30 days. Moreover, unlike Gamma-glutamyl Transferase (GGT) and gallbladder wall thickness, the organoleptic properties of bile were found to be reliable markers of chronic gallbladder inflammation with color and turbidity indicating cholestasis. The current study highlights the importance of cholecystocentesis for the management of gallbladder disease and provides initial results on the possible diagnostic value of macroscopic bile examination.	[Kalogeropoulu, Szilvia K.; Rauch, Hanna; Burgener, Iwan A.] Univ Vet Med, Dept Compan Anim & Horses, Div Small Anim Internal Med, Vienna, Austria; [Kalogeropoulu, Szilvia K.; Lloyd, Emily J.] FOUR PAWS Viet, Bear Sanctuary Ninh Binh, Ninh Binh, Vietnam; [Rauch, Hanna; Painer-Gigler, Johanna] Univ Vet Med, Res Inst Wildlife Ecol, Dept Interdisciplinary Life Sci, Vienna, Austria; [Redtenbacher, Irene] FOUR PAWS Int, Wild Anim Dept, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Kalogeropoulu, SK (corresponding author), Univ Vet Med, Dept Compan Anim & Horses, Div Small Anim Internal Med, Vienna, Austria.; Kalogeropoulu, SK (corresponding author), FOUR PAWS Viet, Bear Sanctuary Ninh Binh, Ninh Binh, Vietnam.	kalogsylvia@gmail.com		Kalogeropoulu, Szilvia K/0000-0002-3689-6369; Rauch, Hanna/0000-0002-1677-7039				ACOCELLA G, 1968, GUT, V9, P536, DOI 10.1136/gut.9.5.536; Aguirre A, 2010, TXB VET INTERNAL MED, P4080; Albert Z, 1967, ENZYME HISTOCHEMISTR; [Anonymous], 2002, PERFORMANCE STANDARD; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; BERR F, 1992, J CLIN INVEST, V90, P859, DOI 10.1172/JCI115961; Bourne D. C., 2010, International Zoo Yearbook, V44, P16, DOI 10.1111/j.1748-1090.2009.00097.x; BRAUN JP, 1983, VET RES COMMUN, V6, P77, DOI 10.1007/BF02214900; Carrique-Mas JJ, 2015, ZOONOSES PUBLIC HLTH, V62, P70, DOI 10.1111/zph.12165; Center SA, 2007, VET CLIN N AM-SMALL, V37, P297, DOI 10.1016/j.cvsm.2006.11.009; Center SA, 2009, VET CLIN N AM-SMALL, V39, P543, DOI 10.1016/j.cvsm.2009.01.004; Cianci P, 2017, UPDATES GALLBLADDER; Cocker S, 2010, TXB VET INTERNAL MED, P3942; Crews LJ, 2009, JAVMA-J AM VET MED A, V234, P359, DOI 10.2460/javma.234.3.359; Dang NX, 2007, P 4 INT S TRAD BEAR, P61; Dang Pham Kim, 2013, Food and Public Health, V3, P247; DIAL SM, 1995, VET CLIN N AM-SMALL, V25, P257, DOI 10.1016/S0195-5616(95)50026-9; Ending Bear Farming, 2020, WILDL CRIM B; Feng YB, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-2; Foley K.E., 2011, PILLS POWDERS VIALS; Garshelis D., 2020, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2020-3.RLTS.T22824A166528664.en, DOI 10.2305/IUCN.UK.2020-3.RLTS.T22824A166528664.EN]; Gomi H, 2018, J HEPATO-BIL-PAN SCI, V25, P3, DOI 10.1002/jhbp.518; Gomi H, 2013, J HEPATO-BIL-PAN SCI, V20, P60, DOI 10.1007/s00534-012-0572-0; Grundel D, 2009, DIGESTION, V79, P229, DOI 10.1159/000213828; Haikui H., 2007, P 4 INT S TRADE BEAR, P37; Hittmair KM, 2001, VET RADIOL ULTRASOUN, V42, P149, DOI 10.1111/j.1740-8261.2001.tb00918.x; Huynh M, 2014, J SMALL ANIM PRACT, V55, P479, DOI 10.1111/jsap.12230; Jones MW., 2020, STATPEARLS; Jungst D, 2001, WORLD J GASTROENTERO, V7, P203; Kilpatrick S., 2017, Companion Animal, V22, P534, DOI 10.12968/coan.2017.22.9.534; Van Nguyen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1158; Koster L, 2016, J VET INTERN MED, V30, P787, DOI 10.1111/jvim.13943; Larsson M, 2000, TROP MED INT HEALTH, V5, P711, DOI 10.1046/j.1365-3156.2000.00630.x; LEE SP, 1986, GASTROENTEROLOGY, V90, P677, DOI 10.1016/0016-5085(86)91123-6; Loeffler IK, 2009, ANIM WELFARE, V18, P225; Mills J., 1994, BEARS THEIR BIOL MAN, P161, DOI DOI 10.2307/3872697; NEER TM, 1992, J VET INTERN MED, V6, P186, DOI 10.1111/j.1939-1676.1992.tb00335.x; Cuong NV, 2016, ECOHEALTH, V13, P490, DOI 10.1007/s10393-016-1130-z; Trung NV, 2015, J ANTIMICROB CHEMOTH, V70, P2144, DOI 10.1093/jac/dkv053; O'Neill EJ, 2006, J SMALL ANIM PRACT, V47, P325, DOI 10.1111/j.1748-5827.2006.00012.x; Peters LM, 2016, J VET INTERN MED, V30, P123, DOI 10.1111/jvim.13645; Potier R, 2015, J ZOO WILDLIFE MED, V46, P175, DOI 10.1638/2014-0076R2.1; Rivers BJ, 1997, J AM ANIM HOSP ASSOC, V33, P207, DOI 10.5326/15473317-33-3-207; Rudling M, 2019, J LIPID RES, V60, P498, DOI 10.1194/jlr.S091199; Savary-Bataille KCM, 2003, J VET INTERN MED, V17, P298, DOI 10.1892/0891-6640(2003)017&lt;0298:PUCIHC&gt;2.3.CO;2; Smith RP, 2017, J VET INTERN MED, V31, P1451, DOI 10.1111/jvim.14792; Sukanan D, 2019, J ETHNOBIOL ETHNOMED, V15, DOI 10.1186/s13002-019-0292-5; SWOBODNIK W, 1991, RADIOLOGY, V178, P755, DOI 10.1148/radiology.178.3.1994414; Teare JA., 2013, ISIS PHYSL REFERENCE; TERA H, 1963, ANN SURG, V157, P468, DOI 10.1097/00000658-196303000-00019; Uetsu Y., 2017, Companion Animal, V22, P254, DOI 10.12968/coan.2017.22.5.254; Voros K, 2002, ACTA VET HUNG, V50, P385, DOI 10.1556/AVet.50.2002.4.2; Wagner KA, 2007, J VET INTERN MED, V21, P417, DOI 10.1892/0891-6640(2007)21[417:BCRFLG]2.0.CO;2; Xia YF, 2019, GASTROENT RES PRACT, V2019, DOI 10.1155/2019/5436961; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-9; Zellweger RM, 2017, J ANTIMICROB CHEMOTH, V72, P2963, DOI 10.1093/jac/dkx260	56	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264391	10.1371/journal.pone.0264391	http://dx.doi.org/10.1371/journal.pone.0264391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239687	Green Published, gold			2022-12-26	WOS:000776002200030
J	Winter, F; Campe, A				Winter, Fenja; Campe, Amely			Q fever expertise among human and veterinary health professionals in Germany - A stakeholder analysis of knowledge gaps	PLOS ONE			English	Article							COXIELLA-BURNETII; GOATS; SHEEP; EPIDEMIOLOGY; ANIMALS	Q fever is a zoonosis caused by Coxiella burnetii. In Germany, the common sources of human infections include small ruminants that excrete the pathogen. Q fever in humans can be asymptomatic or nonspecific. However, severe disease progression is also possible, which can lead to death. Q fever in small ruminants is usually asymptomatic, although reproductive disorders may occur. To protect humans from Q fever, it is important that human and veterinary health professionals (practitioners/health authority employees) have comprehensive knowledge of the diagnosis, control and prevention of Q fever, and its zoonotic potential. To ensure and enhance this understanding, this stakeholder analysis assessed Q fever expertise in human and veterinary health professionals in Germany and investigated how these knowledge gaps can best be resolved. For this purpose, an online survey and two focus group discussions were conducted with 836 and 18 participants, respectively. Knowledge gaps are due to a lack of awareness of Q fever, especially among human health practitioners. Moreover, colleagues who have heard about Q fever still lack the necessary cross-species knowledge to successfully diagnose, control and prevent this zoonosis. Additionally, differences exist between stakeholders regarding their work context and the region in which they work. In this study, stakeholders in southwestern Germany had slightly better Q fever knowledge than their colleagues in northeastern Germany. In addition, information sources aimed at resolving knowledge gaps involve direct conversations between the stakeholders, as well as reading materials and seminars. Each of these information sources should focus on interdisciplinary resources to strengthen the cooperation between human and veterinary health professionals and to raise awareness of the strengths of each stakeholder group. These results have already been implemented by the Q-GAPS project, with goals of raising awareness of Q fever and filling knowledge gaps.	[Winter, Fenja; Campe, Amely] Univ Vet Med Hanover, WHO Collaborating Ctr Res & Training Hlth Human A, Dept Biometry Epidemiol & Informat Proc, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Winter, F (corresponding author), Univ Vet Med Hanover, WHO Collaborating Ctr Res & Training Hlth Human A, Dept Biometry Epidemiol & Informat Proc, Hannover, Germany.	fenja.winter@tiho-hannover.de		Winter, Fenja/0000-0001-8612-6744	Federal Ministry of Education and Research (BMBF) as part of the Research Network on Zoonotic Infectious Diseases. [01KI1726B]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [LE 824/10-1]; University of Veterinary Medicine Hannover, Foundation	Federal Ministry of Education and Research (BMBF) as part of the Research Network on Zoonotic Infectious Diseases.(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation	This work is part of the Q fever -GermAn Interdisciplinary Program for reSearch and was funded by the Federal Ministry of Education and Research (BMBF) under project number 01KI1726B as part of the Research Network on Zoonotic Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This Open Access publication was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within the programme LE 824/10-1 "Open Access Publication Costs" and University of Veterinary Medicine Hannover, Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Bauer BU., 2020, BERL MUNCH TIERARZTL; Berri M, 2007, RES VET SCI, V83, P47, DOI 10.1016/j.rvsc.2006.11.001; Berri M, 2001, VET REC, V148, P502, DOI 10.1136/vr.148.16.502; Bouvery NA, 2003, VET RES, V34, P423, DOI 10.1051/vetres:2003017; Brugha R, 2000, HEALTH POLICY PLANN, V15, P239, DOI 10.1093/heapol/15.3.239; Bundesministeriums des Innern fur Bau und Heimat (BMI), 2019, ARZT ZUM 31 DEZ 2018, P1; Bundestierarztekammer e. V, 2019, DTSCH TIERARZTEBLATT, V67, P800; Clark NJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3135-4; De Villiers MR, 2005, MED TEACH, V27, P639, DOI 10.1080/13611260500069947; Doherr MG, 2001, PHILOS T R SOC B, V356, P1097, DOI 10.1098/rstb.2001.0898; Dohoo IR., 2010, VET EPIDEMIOLOGIC RE, P1; European Centre for Disease Prevention and Control (ECDC), 2010, ECDC TECHNICAL REPOR; Georgiev M, 2013, EUROSURVEILLANCE, V18, P13; Greiner M, 2017, DTSCH TIERARZTEBLATT, V65, P158; Hayes L, 2017, PREV VET MED, V144, P89, DOI 10.1016/j.prevetmed.2017.05.026; Hellenbrand W, 2005, TIERAERZTL PRAX G N, V33, P5; Hellenbrand W, 2001, EMERG INFECT DIS, V7, P789, DOI 10.3201/eid0705.010504; Hilbert Angela, 2012, BMC Res Notes, V5, P152, DOI 10.1186/1756-0500-5-152; Kreienbrock L., 2012, EPIDEMIOLOGISCHE MET, DOI [10.1007/978-3-8274-2334-4, DOI 10.1007/978-3-8274-2334-4]; Kuckartz U., 2018, METHODEN PRAXIS, V4, DOI [10.1007/s00391-017-1187-5, DOI 10.1007/S00391-017-1187-5]; Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-22.2.3826]; Morgan DL, 1996, ANNU REV SOCIOL, V22, P129, DOI 10.1146/annurev.soc.22.1.129; Morroy G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155884; PALMER NC, 1983, CAN VET J, V24, P60; Plummer PJ, 2018, J VET INTERN MED, V32, P1481, DOI 10.1111/jvim.15229; Porten K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-147; Pun JKH, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-02558-2; Rahaman MR, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050730; Rodolakis A, 2006, SMALL RUMINANT RES, V62, P121, DOI 10.1016/j.smallrumres.2005.07.038; Rodolakis A, 2009, ANN NY ACAD SCI, V1166, P90, DOI 10.1111/j.1749-6632.2009.04511.x; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Ruiz-Fons F, 2014, ANIM REPROD SCI, V149, P152, DOI 10.1016/j.anireprosci.2014.07.006; Sidi-Boumedine K., 2010, EFSA SUPPORT PUBL, V7, P1, DOI [10.2903/sp.efsa.2010.EN-67, DOI 10.2903/SP.EFSA.2010.EN-67, DOI 10.2903/SP.EFSA.2010.EN-48]; Tissot-Dupont H., 2007, RICKETTSIAL DIS, P291; Todkill D, 2018, EPIDEMIOL INFECT, V146, P665, DOI 10.1017/S095026881700303X; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Varvasovszky Z, 2000, HEALTH POLICY PLANN, V15, P338, DOI 10.1093/heapol/15.3.338; Willis K, 2009, AUST NZ J PUBL HEAL, V33, P131, DOI 10.1111/j.1753-6405.2009.00358.x; Winter F., 2020, DTSCH TIERARZTEBLATT, V68, P992; Winter F, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.623786; World Organization for Animal Health (OIE), 2019, AN TERR HLTH COD; World Organization for Animal Health (OIE), MANUAL DIAGNOSTIC TE	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264629	10.1371/journal.pone.0264629	http://dx.doi.org/10.1371/journal.pone.0264629			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0D4YH	35239742	gold, Green Published			2022-12-26	WOS:000776002200053
J	Zizzo, AR; Kirkegaard, I; Uldbjerg, N; Hansen, J; Molgaard, H				Zizzo, Anne Rahbek; Kirkegaard, Ida; Uldbjerg, Niels; Hansen, John; Molgaard, Henning			Towards better reliability in fetal heart rate variability using time domain and spectral domain analyses. A new method for assessing fetal neurological state?	PLOS ONE			English	Article							BREATHING MOVEMENTS; AUTONOMIC CONTROL; GESTATION; FETUSES; SIGNAL	Objectives Fetal heart rate variability (FHRV) has shown potential in fetal surveillance. Therefore, we aimed to evaluate the reliability of time domain and spectral domain parameters based on non-invasive fetal electrocardiography (NI-FECG). Method NI-FECG, with a sampling frequency of 1 kHz, was obtained in 75 healthy, singleton pregnant women between gestational age (GA) 20(+0) to 41(+0). The recording was divided into a) heart rate pattern (HRP) and b) periods fulfilling certain criteria of stationarity of RR-intervals, termed stationary heart rate pattern (SHRP). Within each recording, the first and the last time series from each HRP with less than 5% artifact correction were analyzed and compared. Standard deviation of normal-to-normal RR-intervals (SDNN), root mean square of successive differences (RMSSD), high frequency power (HF-power), low frequency power (LF-power), and LF-power/HF-power were performed. A multivariate mixed model was used and acceptable reliability was defined as intraclass correlation coefficient (ICC) >= 0.80 and a coefficient of variation (CV) <= 15%. Based on these results, the CV and ICC were computed if the average of two to six time series was used. Results For GA 28(+0) to 34(+6), SDNN and RMSSD exhibited acceptable reliability (CV < 15%; ICC > 90%), whereas GA 35(+0) to 41(+0)and 20(+0) to 27(+6) showed higher CVs. Spectral domain parameters also showed high CVs However, by using the mean value of two to six time series, acceptable reliability in SDNN, RMSSD and HF-power from GA 28(+0) was achieved. Stationarity of RR-intervals showed high influence on reliability and SHRP was superior to HRP, whereas the length of the time series showed minor influence. Conclusion Acceptable reliability seems achievable in SDNN, RMSSD and HF-power from gestational week 28. However, stationarity of RR-intervals should be considered when selecting time series for analyses.	[Zizzo, Anne Rahbek; Kirkegaard, Ida; Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynecol, Aarhus N, Denmark; [Hansen, John] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Molgaard, Henning] Aarhus Univ Hosp, Dept Cardiol, Aarhus N, Denmark	Aarhus University; Aalborg University; Aarhus University	Zizzo, AR (corresponding author), Aarhus Univ Hosp, Dept Obstet & Gynecol, Aarhus N, Denmark.	arz@clin.au.dk	Uldbjerg, Niels/O-2038-2016	Uldbjerg, Niels/0000-0002-6449-6426; Hansen, John/0000-0003-4989-8117	Snedkermester Sophus Jacobsen og hustru	Snedkermester Sophus Jacobsen og hustru	The authors received funding from: Snedkermester Sophus Jacobsen og hustru Astid Jacobsens Fond-BRODRENE HARTMANNS FOND-Grosserer L. F. Foghts Fond-Dagmar Marshallls Fond-A.P.Moller Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen M, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1603-7; [Anonymous], 2013, NONINVASIVE FETAL EC; Arias-Ortega R, 2016, EARLY HUM DEV, V93, P17, DOI 10.1016/j.earlhumdev.2015.11.008; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Brandle J., 2015, HEART RATE VARIABILI, V9; Camm AJ, 1996, CIRCULATION, V93, P1043; DALTON KJ, 1983, AM J OBSTET GYNECOL, V146, P456, DOI 10.1016/0002-9378(83)90828-1; Daskalov I, 1997, MED ENG PHYS, V19, P375, DOI 10.1016/S1350-4533(96)00067-7; DORNAN JC, 1984, BRIT J OBSTET GYNAEC, V91, P31, DOI 10.1111/j.1471-0528.1984.tb05275.x; F J.L, 1986, DESIGN ANAL CLIN EXP; Goncalves H, 2017, EARLY HUM DEV, V115, P38, DOI 10.1016/j.earlhumdev.2017.09.002; Griffin MP, 2001, PEDIATRICS, V107, P97, DOI 10.1542/peds.107.1.97; GROOME LJ, 1994, EARLY HUM DEV, V38, P1, DOI 10.1016/0378-3782(94)90045-0; Gustafson KM, 2012, EARLY HUM DEV, V88, P539, DOI 10.1016/j.earlhumdev.2011.12.017; Gustafson KM, 2011, EARLY HUM DEV, V87, P467, DOI 10.1016/j.earlhumdev.2011.03.012; Hoyer D, 2013, AM J PHYSIOL-REG I, V304, pR383, DOI 10.1152/ajpregu.00120.2012; Javorka K, 2017, PHYSIOL RES, V66, pS203, DOI 10.33549/physiolres.933676; KARINIEMI V, 1984, AM J OBSTET GYNECOL, V149, P575, DOI 10.1016/0002-9378(84)90041-3; Lear CA, 2020, AM J PHYSIOL-REG I, V319, pR541, DOI 10.1152/ajpregu.00186.2020; Mateo J, 2000, IEEE T BIO-MED ENG, V47, P985, DOI 10.1109/10.855925; NIJHUIS JG, 1982, EARLY HUM DEV, V6, P177, DOI 10.1016/0378-3782(82)90106-2; Peterfi I, 2019, J MATERN-FETAL NEO M, V32, P724, DOI 10.1080/14767058.2017.1390560; PILLAI M, 1990, ARCH DIS CHILD-FETAL, V65, P1072, DOI 10.1136/adc.65.10_Spec_No.1072; PILLAI M, 1992, AM J OBSTET GYNECOL, V167, P172, DOI 10.1016/S0002-9378(11)91654-8; Pinna GD, 2007, CLIN SCI, V113, P131, DOI 10.1042/CS20070055; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Saderup R.G., 2019, J J COMP CARDIOTOCOG; Schneider U, 2009, PHYSIOL MEAS, V30, P215, DOI 10.1088/0967-3334/30/2/008; Schneider U, 2008, J PERINAT MED, V36, P433, DOI 10.1515/JPM.2008.059; Sillesen AS, 2019, J AM SOC ECHOCARDIOG, V32, P895, DOI 10.1016/j.echo.2019.02.015; Singh D., 2004, Journal of Medical Engineering & Technology, V28, P263, DOI 10.1080/03091900410001662350; Sookan T, 2012, CARDIOVASC J AFR, V23, P67, DOI 10.5830/CVJA-2011.108; Stinstra J. G., 2002, Archives of Physiology and Biochemistry, V110, P165, DOI 10.1076/apab.110.3.165.8293; Stone PR, 2017, J PHYSIOL-LONDON, V595, P1213, DOI 10.1113/JP273201; Tagliaferri S, 2017, J OBSTET GYNAECOL RE, V43, P281, DOI 10.1111/jog.13213; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Tarvainen MP., KUBIOS HRV VER 3 3 U; Tendais I, 2015, J PERINAT MED, V43, P221, DOI 10.1515/jpm-2014-0031; Van Laar JOEH, 2008, ACTA OBSTET GYN SCAN, V87, P300, DOI 10.1080/00016340801898950; van Laar JOEH, 2011, EARLY HUM DEV, V87, P259, DOI 10.1016/j.earlhumdev.2011.01.028; van Laar JOEH, 2010, BJOG-INT J OBSTET GY, V117, P429, DOI 10.1111/j.1471-0528.2009.02456.x; Van Laar JOEH, 2014, ACTA OBSTET GYN SCAN, V93, P93, DOI 10.1111/aogs.12286; Vergales BD, 2014, AM J PERINAT, V31, P855, DOI 10.1055/s-0033-1361937; Wakai RT, 2000, PHYS MED BIOL, V45, P1989, DOI 10.1088/0031-9155/45/7/320; Zizzo AR, 2022, ACTA OBSTET GYN SCAN, V101, P135, DOI 10.1111/aogs.14294	45	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0263272	10.1371/journal.pone.0263272	http://dx.doi.org/10.1371/journal.pone.0263272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231034	gold, Green Published			2022-12-26	WOS:000849744700008
J	Gowler, CD; Slayton, RB; Reddy, SC; O'Hagan, JJ				Gowler, Camden D.; Slayton, Rachel B.; Reddy, Sujan C.; O'Hagan, Justin J.			Improving mathematical modeling of interventions to prevent healthcare-associated infections by interrupting transmission or pathogens: How common modeling assumptions about colonized individuals impact intervention effectiveness estimates	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CLOSTRIDIUM-DIFFICILE INFECTION; SPREAD; HOSPITALS; COMMUNITY; DYNAMICS; PATTERNS; LENGTH; STAY; ICU	Mathematical models are used to gauge the impact of interventions for healthcare-associated infections. As with any analytic method, such models require many assumptions. Two common assumptions are that asymptomatically colonized individuals are more likely to be hospitalized and that they spend longer in the hospital per admission because of their colonization status. These assumptions have no biological basis and could impact the estimated effects of interventions in unintended ways. Therefore, we developed a model of methicillin-resistant Staphylococcus aureus transmission to explicitly evaluate the impact of these assumptions. We found that assuming that asymptomatically colonized individuals were more likely to be admitted to the hospital or spend longer in the hospital than uncolonized individuals biased results compared to a more realistic model that did not make either assumption. Results were heavily biased when estimating the impact of an intervention that directly reduced transmission in a hospital. In contrast, results were moderately biased when estimating the impact of an intervention that decolonized hospital patients. Our findings can inform choices modelers face when constructing models of healthcare-associated infection interventions and thereby improve their validity.	[Gowler, Camden D.; Slayton, Rachel B.; Reddy, Sujan C.; O'Hagan, Justin J.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Gowler, Camden D.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan	O'Hagan, JJ (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA.	justinohagan@gmail.com		Gowler, Camden/0000-0003-3596-614X				Allegranzi B, 2009, J HOSP INFECT, V73, P305, DOI 10.1016/j.jhin.2009.04.019; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Bellan SE, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001295; Blixt T, 2017, GASTROENTEROLOGY, V152, P1031, DOI 10.1053/j.gastro.2016.12.035; cdc, 2013, BIGGEST ANTIBIOTIC R; Centers for Disease Control and Prevention, HOSP BEDS OCC RAT TY; Centres for Disease Control and Prevention, 2014, ACT BACT COR SURV RE; Chowell G, 2014, EPIDEMICS-NETH, V9, P40, DOI 10.1016/j.epidem.2014.09.011; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Cremin I, 2018, EPIDEMICS-NETH, V23, P42, DOI 10.1016/j.epidem.2017.12.002; D'Agata EMC, 2010, MATH MODEL NAT PHENO, V5, P76, DOI 10.1051/mmnp/20105306; D'Agata EMC, 2005, J INFECT DIS, V192, P2004, DOI 10.1086/498041; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; De Angelis G, 2011, J HOSP INFECT, V78, P86, DOI 10.1016/j.jhin.2011.02.003; den Heijer CDJ, 2013, LANCET INFECT DIS, V13, P409, DOI 10.1016/S1473-3099(13)70036-7; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Doan TN, 2016, VIRULENCE, V7, P141, DOI 10.1080/21505594.2015.1076615; Forrester M, 2005, INFECT CONT HOSP EP, V26, P598, DOI 10.1086/502588; Gorwitz RJ, 2008, J INFECT DIS, V197, P179, DOI 10.1086/523767; Grigg C, 2018, J AM GERIATR SOC, V66, P1581, DOI 10.1111/jgs.15451; Grima DT., 2012, COMP MATH MATH PHYS+, V2012, P1, DOI [10.1155/2012/605861, DOI 10.1155/2012/605861]; Haber M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-254; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hogea C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-291; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Jones M, 2014, CLIN INFECT DIS, V58, P32, DOI 10.1093/cid/cit668; Kouyos R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003134; Kwok KO, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3060-6; Lee BY, 2016, AM J EPIDEMIOL, V183, P480, DOI 10.1093/aje/kww008; Lee BY, 2013, AM J INFECT CONTROL, V41, P668, DOI 10.1016/j.ajic.2013.01.013; Lee BY, 2013, MED CARE, V51, P205, DOI 10.1097/MLR.0b013e3182836dc2; Lee BY, 2011, INFECT CONT HOSP EP, V32, P562, DOI 10.1086/660014; Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217; Lesosky M, 2011, INFECT CONT HOSP EP, V32, P136, DOI 10.1086/657945; Li Jing, 2011, Comput Math Methods Med, V2011, P527610, DOI 10.1155/2011/527610; Marshall AL, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.05.004; McKinnell JA, 2013, INFECT CONT HOSP EP, V34, P1077, DOI 10.1086/673157; McLure A, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/s0950268819000384, 10.1017/S0950268819000384]; Mossong J., 2017, POLYMOD SOCIAL CONTA; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nelson RE, 2015, INFECT CONT HOSP EP, V36, P1089, DOI 10.1017/ice.2015.129; Nouwen J, 2004, INFECT IMMUN, V72, P6685, DOI 10.1128/IAI.72.11.6685-6688.2004; Pedersen AB, 2005, INT J PARASITOL, V35, P647, DOI 10.1016/j.ijpara.2005.01.005; Pelat C, 2016, INFECT CONT HOSP EP, V37, P272, DOI 10.1017/ice.2015.284; Perencevich EN, 2004, CLIN INFECT DIS, V38, P1108, DOI 10.1086/382886; R Core Team, R LANG ENV STAT COMP; Rubin MA, 2018, JAMA-J AM MED ASSOC, V319, P863, DOI 10.1001/jama.2017.21122; Sadsad R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083099; Scott RD, 2009, DIRECT MED COSTS HEA; Starr JM, 2009, J HOSP INFECT, V71, P49, DOI 10.1016/j.jhin.2008.09.013; United States Census Bureau, 2017, QUICKFACTS US; US Census Bureau, NAT POP TOT COMP CHA; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van Kleef Esther, 2017, Wellcome Open Res, V2, P16, DOI 10.12688/wellcomeopenres.11033.1; van Kleef E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-294; Wang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09478; Webb GF., 2009, J BIOL DYNAMICS TAYL, V4, P115; Weiss AJ, 2006, OVERVIEW HOSP STAYS; Wiegand PN, 2012, J HOSP INFECT, V81, P1, DOI 10.1016/j.jhin.2012.02.004; Wyllie DH, 2007, J HOSP INFECT, V67, P301, DOI 10.1016/j.jhin.2007.08.018	62	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264344	10.1371/journal.pone.0264344	http://dx.doi.org/10.1371/journal.pone.0264344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226689	Green Published, gold			2022-12-26	WOS:000793394000017
J	Glober, N; Supples, M; Persaud, S; Kim, D; Liao, M; Glidden, M; O'Donnell, D; Tainter, C; Boustani, M; Alexander, A				Glober, Nancy; Supples, Michael; Persaud, Sarah; Kim, David; Liao, Mark; Glidden, Michele; O'Donnell, Dan; Tainter, Christopher; Boustani, Malaz; Alexander, Andreia			A novel emergency medical services protocol to improve treatment time for large vessel occlusion strokes	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ENDOVASCULAR THROMBECTOMY; CARE	In many systems, patients with large vessel occlusion (LVO) strokes experience delays in transport to thrombectomy-capable centers. This pilot study examined use of a novel emergency medical services (EMS) protocol to expedite transfer of patients with LVOs to a comprehensive stroke center (CSC). From October 1, 2020 to February 22, 2021, Indianapolis EMS piloted a protocol, in which paramedics, after transporting a patient with a possible stroke remained at the patient's bedside until released by the emergency department or neurology physician. In patients with possible LVO, EMS providers remained at the bedside until the clinical assessment and CT angiography (CTA) were complete. If indicated, the paramedics at bedside transferred the patient, via the same ambulance, to a nearby thrombectomycapable CSC with which an automatic transfer agreement had been arranged. This fivemonth mixed methods study included case-control assessment of use of the protocol, number of transfers, safety during transport, and time saved in transfer compared to emergent transfers via conventional interfacility transfer agencies. In qualitative analysis EMS providers, and ED physicians and neurologists at both sending and receiving institutions, completed e-mail surveys on the process, and offered suggestions for process improvement. Responses were coded with an inductive content analysis approach. The protocol was used 42 times during the study period; four patients were found to have LVOs and were transferred to the CSC. There were no adverse events. Median time from decision-to-transfer to arrival at the CSC was 27.5 minutes (IQR 24.5-29.0), compared to 314.5 minutes (IQR 204.0-459.3) for acute non-stroke transfers during the same period. Major themes of provider impressions included: incomplete awareness of the protocol, smooth process, challenges when a stroke alert was activated after EMS left the hospital, greater involvement of EMS in patient care, and comments on communication and efficiency. This pilot study demonstrated the feasibility, safety, and efficiency of a novel approach to expedite endovascular therapy for patients with LVOs.	[Glober, Nancy; Supples, Michael; Persaud, Sarah; Liao, Mark; Glidden, Michele; O'Donnell, Dan; Boustani, Malaz; Alexander, Andreia] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Kim, David] Stanford Univ, Dept Emergency Med, Santa Clara Cty, CA USA; [Tainter, Christopher] Univ Calif San Diego, Dept Anesthesiol Crit Care, San Diego, CA 92103 USA	Indiana University System; Indiana University Bloomington; University of California System; University of California San Diego	Glober, N (corresponding author), Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA.	nglober@iu.edu		Glober, Nancy/0000-0001-5769-3651; Kim, David/0000-0003-0151-5121	Agency for Healthcare Research and Quality [K12 HS026390]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	NG - K12 HS026390 Agency for Healthcare Research and Quality https://www.ahrq. gov/funding/index.html sponsors did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoye O, 2019, STROKE, V50, pE187, DOI 10.1161/STR.0000000000000173; Adeoye O, 2014, STROKE, V45, P3019, DOI 10.1161/STROKEAHA.114.006293; Bernard H. H. R., 2009, ANAL QUALITATIVE DAT; Bureau TUSC, AM FACTFINDER 2020; Campbell BCV, 2017, CIRCULATION, V136, P2322, DOI 10.1161/CIRCULATIONAHA.117.031444; CORBIN J., 1996, BASICS QUALITATIVE R, V4th; Dozois A, 2017, STROKE, V48, P3397, DOI 10.1161/STROKEAHA.117.018925; Dunbar SB, 2018, CIRCULATION, V137, pE558, DOI 10.1161/CIR.0000000000000570; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Froehler MT, 2017, CIRCULATION, V136, P2311, DOI 10.1161/CIRCULATIONAHA.117.028920; Gaynor E, 2022, J NEUROINTERV SURG, V14, P573, DOI 10.1136/neurintsurg-2021-017653; Glaser B., 1967, MILL VALLEY; Goyal M, 2016, RADIOLOGY, V279, P888, DOI 10.1148/radiol.2016160204; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Jayaraman MV, 2020, J NEUROINTERV SURG, V12, P233, DOI 10.1136/neurintsurg-2019-015033; Keenan KJ, 2018, CURR ATHEROSCLER REP, V20, DOI 10.1007/s11883-018-0734-x; Malhotra K, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00651; Menon BK, 2016, CIRCULATION, V133, P2279, DOI 10.1161/CIRCULATIONAHA.115.019983; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Rennert RC, 2019, NEUROSURGERY, V85, pS4, DOI 10.1093/neuros/nyz042; RODGERS BL, 1993, RES NURS HEALTH, V16, P219, DOI 10.1002/nur.4770160309; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Vidale S, 2018, ACTA NEUROL SCAND, V138, P24, DOI 10.1111/ane.12908; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264539	10.1371/journal.pone.0264539	http://dx.doi.org/10.1371/journal.pone.0264539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213646	Green Published, gold			2022-12-26	WOS:000787811000118
J	Dathan-Stumpf, A; Rieger, A; Verlohren, S; Wolf, C; Stepan, H				Dathan-Stumpf, Anne; Rieger, Anna; Verlohren, Stefan; Wolf, Cyrill; Stepan, Holger			sFlt-1/PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation	PLOS ONE			English	Article							GROWTH-FACTOR RATIO; HYPERTENSIVE DISORDERS; ANGIOGENIC FACTORS; ADVERSE OUTCOMES; WOMEN; PREGNANCY; DIAGNOSIS; CLASSIFICATION; MANAGEMENT; RISK	Background We investigated the impact of the soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio to predict short-term risk of preeclampsia on clinical utility and healthcare resource utilisation using real-world data (RWD), and compared findings with health economic modelling from previous studies. Methods and findings This retrospective analysis compared data from the German population of a multicentre clinical study (PROGNOSIS, n = 203; sFlt-1/PlGF ratio blinded and unavailable for decision-making) with RWD from University Hospital Leipzig, Germany (n = 281; sFlt-1/PlGF ratio used to guide clinical decision-making). A subgroup of the RWD cohort with the same inclusion criteria as the PROGNOSIS trial (RWD prediction only, n = 99) was also included. sFlt-1/PlGF ratio was measured using fully automated Elecsys (R) sFlt-1 and PlGF immunoassays (cobas e analyser; Roche Diagnostics). A similar proportion of women in the RWD and PROGNOSIS cohorts experienced preeclampsia (14.95% vs. 13.79%; p = 0.7938); a smaller proportion of women in the RWD prediction only cohort experienced preeclampsia versus PROGNOSIS (6.06%; p = 0.0526). In women with preeclampsia, median gestational age at delivery (weeks) was comparable in the RWD and PROGNOSIS cohorts (34.0 vs. 34.3, p = 0.5895), but significantly reduced in the RWD prediction only cohort versus PROGNOSIS (27.1, p = 0.0038). sFlt-1/PlGF ratio at baseline visit was not statistically significantly different for the RWD and PROGNOSIS cohorts, irrespective of preeclampsia outcome. Hospitalisations for confirmed preeclampsia were significantly shorter in the RWD cohort versus PROGNOSIS (median 1 vs. 4 days, p = 0.0093); there was no significant difference between RWD prediction only and PROGNOSIS (3 days, p = 0.9638). All-cause hospitalisations were significantly shorter in the RWD (median 1 day; p<0.0001) and RWD prediction only (1 day; p<0.0001) cohorts versus PROGNOSIS (3 days). Conclusions This study supports the findings of previous studies, showing that routine clinical use of the sFlt-1/PlGF ratio may result in shorter duration of hospitalisations, with potential economic benefits.	[Dathan-Stumpf, Anne; Stepan, Holger] Univ Hosp Leipzig, Dept Obstet, Leipzig, Germany; [Rieger, Anna] Roche Diagnost GmbH, Biostat Data Sci & Digital Solut, Penzberg, Germany; [Verlohren, Stefan] Charite Univ Med Berlin, Dept Obstet, Berlin, Germany; [Wolf, Cyrill] Roche Diagnost Int Ltd, Market Access & Hlth Policy, Rotkreuz, Switzerland; [Wolf, Cyrill] Roche Diagnost Switzerland AG, Access & Hlth Policy, Rotkreuz, Switzerland	Leipzig University; Roche Holding; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Roche Holding	Stepan, H (corresponding author), Univ Hosp Leipzig, Dept Obstet, Leipzig, Germany.	holger.stepan@medizin.uni-leipzig.de						Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; American College of Obstetricians and Gynecologists, 2020, ACOG PRACT B; [Anonymous], 2019, Obstet Gynecol, V133, P215, DOI 10.1097/AOG.0000000000003021; [Anonymous], 2019, GUIDELINE GERMAN SOC; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bian XM, 2019, HYPERTENSION, V74, P164, DOI 10.1161/HYPERTENSIONAHA.119.12760; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Brown MA, 2018, HYPERTENSION, V72, P24, DOI 10.1161/HYPERTENSIONAHA.117.10803; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Dathan-Stumpf A., 2021, AJOG; Delahaije DHJ, 2014, EUR J OBSTET GYN R B, V179, P240, DOI 10.1016/j.ejogrb.2014.04.033; Droge LA, 2021, HYPERTENSION, V77, P461, DOI 10.1161/HYPERTENSIONAHA.120.15146; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; Fox R, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101625; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; Hund M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-324; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; NICE, 2016, PLGF BAS TEST HELP D; Peguero A, 2021, BJOG-INT J OBSTET GY, V128, P158, DOI 10.1111/1471-0528.16383; Schlembach D, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3406-1; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Stepan H, 2015, ULTRASOUND OBST GYN, V45, P241, DOI 10.1002/uog.14799; Vatish M, 2016, ULTRASOUND OBST GYN, V48, P765, DOI 10.1002/uog.15997; Verlohren S., 2016, PREGNANCY HYPERTENS, V6, P140; Zeisler H, 2016, OBSTET GYNECOL, V128, P261, DOI 10.1097/AOG.0000000000001525; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838; Zhang J, 2001, OBSTET GYNECOL, V97, P261, DOI 10.1016/S0029-7844(00)01125-X	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0263443	10.1371/journal.pone.0263443	http://dx.doi.org/10.1371/journal.pone.0263443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202416	gold, Green Published			2022-12-26	WOS:000773224600012
J	Ye, W; Huang, TP				Ye, Wei; Huang, Tianpeng			Correlation analysis of m(6)A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma	PLOS ONE			English	Article							CANCER; EPIDEMIOLOGY; PD-1/PD-L1	Object Recent studies have demonstrated the epigenetic regulation of immune responses. However, the potential role of N6-methyladenosine methylation (m(6)A) in the tumor microenvironment (TME) remains unknown. Method In this study, the m(6)A modification patterns of LUAD samples were comprehensively evaluated by combining TCGA and GEO data, while these modification patterns were systematically linked to the characteristics of immune infiltrating cells in TME. The m(6)A score was constructed using the principal component analysis algorithm to quantify the m(6)A modification mode of a single tumor. Result There were three distinct patterns of m(6)A modification identified. The characteristics of TME cell infiltration in these three patterns were highly consistent with these three immune phenotypes of the tumors, including immune rejection, immune-inflammatory, and immune inert phenotypes. Low m(6)A scores were characterized by immune activation and poor survival rate. Besides, m(6)A scores were associated with tumor mutational load (TMB) and were able to increase the ability of TMB to predict immunotherapy. Two immunotherapy cohorts confirmed that the patients with lower m(6)A scores demonstrated significant therapeutic advantages and clinical benefits. m(6)A modifications play an important role in the development of TME diversity. Assessing the m(6)A modification pattern of individual tumors can deepen the understanding as to the characteristics of TME infiltration and guide more effective immunotherapy strategies.	[Ye, Wei] Chinese Med Univ, Dept Resp Med, Wenzhou Municipal Hosp Tradit Chinese Med, Wenzhou Hosp Tradit Chinese Med, Wenzhou, Peoples R China; [Huang, Tianpeng] Chinese Med Univ, Dept Clin Lab, Wenzhou Municipal Hosp Tradit Chinese Med, Zhejiang Wenzhou Hosp Tradit Chinese Med, Wenzhou, Peoples R China	China Medical University; China Medical University	Huang, TP (corresponding author), Chinese Med Univ, Dept Clin Lab, Wenzhou Municipal Hosp Tradit Chinese Med, Zhejiang Wenzhou Hosp Tradit Chinese Med, Wenzhou, Peoples R China.	huangtianpeng1993@163.com		Huang, Tianpeng/0000-0002-0057-3306	Zhejiang Wenzhou Science and Technology Program Project [Y20210877]	Zhejiang Wenzhou Science and Technology Program Project	This work was supported by Zhejiang Wenzhou Science and Technology Program Project (Y20210877).	Bade BC, 2020, CLIN CHEST MED, V41, P1, DOI 10.1016/j.ccm.2019.10.001; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chen XY, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1033-z; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; Fiala O, 2017, KLIN ONKOL, V30, pS22, DOI [10.14735/amko20173S22, DOI 10.14735/AMKO20173S22]; Gonzalez-Cao M, 2015, LUNG CANCER-TARGETS, V6, P55, DOI 10.2147/LCTT.S55176; He LE, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1109-9; Hegde PS, 2020, IMMUNITY, V52, P17, DOI 10.1016/j.immuni.2019.12.011; Jones GS, 2018, CLIN MED, V18, pS41, DOI 10.7861/clinmedicine.18-2-s41; Lan Q, 2019, CANCER RES, V79, P1285, DOI 10.1158/0008-5472.CAN-18-2965; Lin XY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09865-9; Ma WJ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0277-y; Mao YS, 2016, SURG ONCOL CLIN N AM, V25, P439, DOI 10.1016/j.soc.2016.02.001; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758; Nasim F, 2019, MED CLIN N AM, V103, P463, DOI 10.1016/j.mcna.2018.12.006; Pan YT, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0590-8; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schulz M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01713; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Visvanathan A, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700093; Wang TY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01204-7; Zhang B, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01170-0	27	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264384	10.1371/journal.pone.0264384	http://dx.doi.org/10.1371/journal.pone.0264384			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196365	gold, Green Published			2022-12-26	WOS:000835161600043
J	Noosak, C; Jantorn, P; Meesane, J; Voravuthikunchai, S; Saeloh, D				Noosak, Chayanee; Jantorn, Pavarish; Meesane, Jirut; Voravuthikunchai, Supayang; Saeloh, Dennapa			Dual-functional bioactive silk sericin for osteoblast responses and osteomyelitis treatment	PLOS ONE			English	Article							OXIDATIVE STRESS; PROTEIN SERICIN; EXTRACTION; SILKWORMS; BACTERIA; COLLAGEN	Sericin, a natural protein from silk cocoon, has been reported for various biological properties in the biomaterials field. Modified forms of sericin have been studied for bone tissue engineering, while its unmodified form has been scarcely reported. Therefore, the purpose of this study was to evaluate physical and biological properties of unmodified sericin for potential use in bone surgery. Sericin was extracted from silk cocoons using a chemical-free boiling method. Sericin extract showed distinct bands with molecular weight ranging from 25 to 42 kDa including smear bands. Fourier transform infrared spectra presented characteristic peaks of amide I, II, and III, confirming the chemical composition of sericin. Based on biological activity, sericin extract at a concentration of 40 mu g/mL increased the proliferation of osteoblast cells up to 135%, compared with the untreated control. Moreover, increase in antibacterial activity against Staphylococcus aureus, both clinical isolates and the reference strain ATCC 29213, was demonstrated for sericin extract with normal saline, while no antibacterial activity was observed for sericin with broth. It was found that sericin with normal saline showed higher zeta potential than sericin without normal saline, indicating higher system stability. This was confirmed by the average particle size of sericin extract with NaCl (3,249.3 +/- 226.1 nm) showing approximately 10 times smaller than sericin solution (29,015.9 +/- 8,085.6 nm). Furthermore, sericin extract at the minimal inhibitory concentration significantly reduced the biofilm formation of S. aureus up to 95%. The study indicates biological activities of sericin, which could be applied as a dual-functional bioactive material to support bone regeneration and treat bone infections.	[Noosak, Chayanee; Jantorn, Pavarish; Voravuthikunchai, Supayang] Prince Songkla Univ, Fac Sci, Div Biol Sci, Hat Yai, Songkhla, Thailand; [Noosak, Chayanee; Voravuthikunchai, Supayang; Saeloh, Dennapa] Prince Songkla Univ, Fac Sci, Nat Prod Res Ctr Excellence, Hat Yai, Songkhla, Thailand; [Meesane, Jirut] Prince Songkla Univ, Fac Med, Inst Biomed Engn, Hat Yai, Songkhla, Thailand; [Voravuthikunchai, Supayang] Prince Songkla Univ, Fac Sci, Ctr Antimicrobial Biomat Innovat Southeast Asia, Hat Yai, Songkhla, Thailand; [Saeloh, Dennapa] Prince Songkla Univ, Fac Med Technol, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Saeloh, D (corresponding author), Prince Songkla Univ, Fac Sci, Nat Prod Res Ctr Excellence, Hat Yai, Songkhla, Thailand.; Saeloh, D (corresponding author), Prince Songkla Univ, Fac Med Technol, Hat Yai, Songkhla, Thailand.	dennapa.sa@psu.ac.th		Sotthibandhu, Dennapa Saeloh/0000-0003-0031-3624	National Research Council of Thailand (NRCT) [NRCT5-RRI63017, N41A640071]; Faculty of Medical Technology, Prince of Songkla University	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Faculty of Medical Technology, Prince of Songkla University	This research project is supported by National Research Council of Thailand (NRCT): NRCT5-RRI63017, Grant No. N41A640071 and the Research Fund from Faculty of Medical Technology, Prince of Songkla University, Fiscal year 2021.	Aramwit P, 2020, J WOUND CARE, V29, pS25, DOI 10.12968/jowc.2020.29.Sup4.S25; Aramwit P, 2012, WASTE MANAGE RES, V30, P217, DOI 10.1177/0734242X11404733; Aramwit P, 2010, INT J BIOL MACROMOL, V47, P668, DOI 10.1016/j.ijbiomac.2010.08.015; Aramwit P, 2010, INT J MOL SCI, V11, P2200, DOI 10.3390/ijms11052200; Aramwit P, 2009, J BIOMAT SCI-POLYM E, V20, P1295, DOI 10.1163/156856209X453006; Arango MC, 2021, INT J POLYM MATER PO, V70, P1115, DOI 10.1080/00914037.2020.1785454; Chaisabai W, 2018, ARTIF CELL NANOMED B, V46, P536, DOI 10.1080/21691401.2017.1328686; Cheng G, 2018, ACS BIOMATER SCI ENG, V4, P2704, DOI 10.1021/acsbiomaterials.8b00150; Cheng Y, 2021, ADV HEALTHC MATER, V10, DOI 10.1002/adhm.202001646; CLSI, 2020, M100ED30 CLSI, DOI DOI 10.1016/S0196-4399(01)88009-0; Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236; Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006; Hong SM, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-018-1558-7; Jantorn P, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14060592; Kim JH, 2021, FOOD CONTROL, V123, DOI 10.1016/j.foodcont.2020.107704; Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002; Lamboni L, 2015, BIOTECHNOL ADV, V33, P1855, DOI 10.1016/j.biotechadv.2015.10.014; Li B, 2008, CARBOHYD POLYM, V72, P287, DOI 10.1016/j.carbpol.2007.08.012; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Nayak S, 2013, BIOMATERIALS, V34, P2855, DOI 10.1016/j.biomaterials.2013.01.019; Padamwar Mahesh N, 2005, J Cosmet Dermatol, V4, P250, DOI 10.1111/j.1473-2165.2005.00200.x; Rangi A., 2015, INT J TEXT SCI, V5, P1, DOI [10.4172/2165-8064.1000188, DOI 10.4172/2165-8064.1000188]; Rocha LKH, 2017, PROCESS BIOCHEM, V61, P163, DOI 10.1016/j.procbio.2017.06.019; Saeloh D, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10121470; Sahu N, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7461041; Scheer A.P., 2014, INT J CHEM ENG APPL, V5, P266, DOI [https://doi.org/10.7763/IJCEA.2014.V5.391, DOI 10.7763/IJCEA.2014.V5.391, 10.7763/IJCEA.2014.V5.391]; Senakoon W., 2009, ASIAN J FOOD AGR IND, V2, P222; Tao G, 2021, MAT SCI ENG C-MATER, V119, DOI 10.1016/j.msec.2020.111597; Tao G, 2019, MATER DESIGN, V180, DOI 10.1016/j.matdes.2019.107940; Tao G, 2019, MAT SCI ENG C-MATER, V101, P341, DOI 10.1016/j.msec.2019.03.111; Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608; Wang P, 2019, CARBOHYD POLYM, V212, P403, DOI 10.1016/j.carbpol.2019.02.069; Wikler M.A., 2012, CLIN LAB STANDARDS I, V26, pM07; Yang MY, 2014, ACS APPL MATER INTER, V6, P13782, DOI 10.1021/am503214g; Yun H, 2013, INT J BIOL MACROMOL, V52, P59, DOI 10.1016/j.ijbiomac.2012.09.017; Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4; Zhaorigetu S, 2003, ONCOL REP, V10, P537	37	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264795	10.1371/journal.pone.0264795	http://dx.doi.org/10.1371/journal.pone.0264795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235612	Green Published, gold			2022-12-26	WOS:000787073100024
J	Zalesak-Kravec, S; Huang, WL; Jones, JW; Yu, JS; Alloush, J; Defnet, AE; Moise, AR; Kane, MA				Zalesak-Kravec, Stephanie; Huang, Weiliang; Jones, Jace W.; Yu, Jianshi; Alloush, Jenna; Defnet, Amy E.; Moise, Alexander R.; Kane, Maureen A.			Role of cellular retinol-binding protein, type 1 and retinoid homeostasis in the adult mouse heart: A multi-omic approach	FASEB JOURNAL			English	Article						cellular retinol-binding protein; type 1; heart; mice; retinoic acid; retinoid metabolism	PARTIAL-BODY RADIATION; VITAMIN-A; GENE-EXPRESSION; ANGIOTENSIN-II; L-CARNITINE; IN-VITRO; ACID SUPPLEMENTATION; CELLS; DISEASE; QUANTIFICATION	The main active metabolite of Vitamin A, all-trans retinoic acid (RA), is required for proper cellular function and tissue organization. Heart development has a well-defined requirement for RA, but there is limited research on the role of RA in the adult heart. Homeostasis of RA includes regulation of membrane receptors, chaperones, enzymes, and nuclear receptors. Cellular retinol-binding protein, type 1 (CRBP1), encoded by retinol-binding protein, type 1 (Rbp1), regulates RA homeostasis by delivering vitamin A to enzymes for RA synthesis and protecting it from non-specific oxidation. In this work, a multi-omics approach was used to characterize the effect of CRBP1 loss using the Rbp1(-/-) mouse. Retinoid homeostasis was disrupted in Rbp1(-/-) mouse heart tissue, as seen by a 33% and 24% decrease in RA levels in the left and right ventricles, respectively, compared to wild-type mice (WT). To further inform on the effect of disrupted RA homeostasis, we conducted high-throughput targeted metabolomics. A total of 222 metabolite and metabolite combinations were analyzed, with 33 having differential abundance between Rbp1(-/-) and WT hearts. Additionally, we performed global proteome profiling to further characterize the impact of CRBP1 loss in adult mouse hearts. More than 2606 unique proteins were identified, with 340 proteins having differential expression between Rbp1(-/-) and WT hearts. Pathway analysis performed on metabolomic and proteomic data revealed pathways related to cellular metabolism and cardiac metabolism were the most disrupted in Rbp1(-/-) mice. Together, these studies characterize the effect of CRBP1 loss and reduced RA in the adult heart.	[Zalesak-Kravec, Stephanie; Huang, Weiliang; Jones, Jace W.; Yu, Jianshi; Alloush, Jenna; Defnet, Amy E.; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 N Pine St,Rm N731, Baltimore, MD 21201 USA; [Moise, Alexander R.] Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada	University System of Maryland; University of Maryland Baltimore; Northern Ontario School of Medicine	Kane, MA (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 N Pine St,Rm N731, Baltimore, MD 21201 USA.	mkane@rx.umaryland.edu	Moise, Alexander R/C-9498-2009	Moise, Alexander R/0000-0003-2307-6035	HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD077260]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [T32 GM066706]; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]	HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center	HHS vertical bar NIH vertical bar Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD077260; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: T32 GM066706; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center, Grant/Award Number: SOP1841-IQB2014	Adeva-Andany MM, 2017, IUBMB LIFE, V69, P578, DOI 10.1002/iub.1646; Aldehlawi H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61640-9; Amengual J, 2012, INT J BIOCHEM CELL B, V44, P2019, DOI 10.1016/j.biocel.2012.07.026; Asson-Batres MA, 2016, AM J PHYSIOL-HEART C, V310, pH1773, DOI 10.1152/ajpheart.00887.2015; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Biocrates, 2017, ANN POT IS IS LIP SP, V2; Boerman MHEM, 1996, J BIOL CHEM, V271, P5610, DOI 10.1074/jbc.271.10.5610; Cannon MV, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-015-0520-7; Chen J, 1996, J NEUROSCI, V16, P5704; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Choudhary R, 2008, J CELL PHYSIOL, V215, P172, DOI 10.1002/jcp.21297; Choudhary R, 2008, AM J PHYSIOL-HEART C, V294, pH633, DOI 10.1152/ajpheart.01301.2007; Cifre M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082269; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; CREMONA O, 1995, EXP CELL RES, V217, P280, DOI 10.1006/excr.1995.1088; de Paiva SAR, 2003, AM J PHYSIOL-HEART C, V284, pH2242, DOI 10.1152/ajpheart.00646.2002; DeLeon-Pennell KY, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0699-5; Diaz-Rua R, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.33554; Distel E, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600920; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Drake KJ, 2012, EXP BIOL MED, V237, P1369, DOI 10.1258/ebm.2012.012025; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; Ferrari R, 2004, ANN NY ACAD SCI, V1033, P79, DOI 10.1196/annals.1320.007; Freire CMM, 2011, NUTRITION, V27, P824, DOI 10.1016/j.nut.2010.08.011; Garcia-Mariscal A., 2016, SMALL GTPASES, V9, P433; Gavrilova R, 2009, AM J MED GENET A, V149A, P2241, DOI 10.1002/ajmg.a.32998; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gianni M, 1997, BLOOD, V89, P1001, DOI 10.1182/blood.V89.3.1001; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; Halade GV, 2019, METABOLISM, V96, P22, DOI 10.1016/j.metabol.2019.04.011; Hochgreb T, 2003, DEVELOPMENT, V130, P5363, DOI 10.1242/dev.00750; Huang WL, 2020, HEALTH PHYS, V119, P621, DOI 10.1097/HP.0000000000001350; Huang WL, 2020, HEALTH PHYS, V119, P604, DOI 10.1097/HP.0000000000001351; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; Irvin MR, 2014, CLIN LIPIDOL, V9, P9, DOI 10.2217/CLP.13.75; Jones JW, 2015, ANAL CHEM, V87, P3222, DOI 10.1021/ac504597q; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2011, MOL CELL BIOL, V31, P3277, DOI 10.1128/MCB.05516-11; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kitsis RN, 2018, CIRCULATION, V138, P692, DOI 10.1161/CIRCULATIONAHA.118.033907; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lin YS, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.009146; Liu Y, 2016, CIRC RES, V119, P557, DOI 10.1161/CIRCRESAHA.116.308781; Mahley RW, 2016, J MOL MED, V94, P739, DOI 10.1007/s00109-016-1427-y; Malik M, 2008, CLIN ENDOCRINOL, V69, P462, DOI 10.1111/j.1365-2265.2008.03207.x; Mao K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04805-5; McDonough CW, 2013, HYPERTENSION, V62, P48, DOI 10.1161/HYPERTENSIONAHA.111.00823; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Miano JM, 1996, CIRCULATION, V93, P1886, DOI 10.1161/01.CIR.93.10.1886; Minicucci MF, 2010, CELL PHYSIOL BIOCHEM, V26, P523, DOI 10.1159/000322320; Nagpal I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153610; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Napoli JL, 2000, PROG NUCLEIC ACID RE, V63, P139, DOI 10.1016/S0079-6603(08)60722-9; Napoli JL, 2017, PHARMACOL THERAPEUT, V173, P19, DOI 10.1016/j.pharmthera.2017.01.004; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Neuville P, 1997, AM J PATHOL, V150, P509; Neuville P, 1999, ARTERIOSCL THROM VAS, V19, P1430, DOI 10.1161/01.ATV.19.6.1430; Paiva SAR, 2005, J NUTR, V135, P2326, DOI 10.1093/jn/135.10.2326; Pan J, 1997, CIRC RES, V81, P611, DOI 10.1161/01.RES.81.4.611; Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5; Park SW, 2019, EUR J PHARMACOL, V858, DOI 10.1016/j.ejphar.2019.172485; Park SW, 2018, J ENDOCRINOL, V236, P151, DOI 10.1530/JOE-17-0613; Paschaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062274; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pierzchalski K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119677; Pierzchalski K, 2013, FASEB J, V27, P1904, DOI 10.1096/fj.12-219410; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Samouillan V, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111471; Sanchez J, 2012, J CLIN ENDOCR METAB, V97, pE648, DOI 10.1210/jc.2011-2209; SANCHEZ M, 1993, BIOCHEM J, V295, P115, DOI 10.1042/bj2950115; Schnackenberg LK, 2016, J APPL TOXICOL, V36, P1486, DOI 10.1002/jat.3307; Stefanovic S, 2017, MECH DEVELOP, V143, P9, DOI 10.1016/j.mod.2016.12.002; Sun HD, 2019, ANAL BIOANAL CHEM, V411, P2273, DOI 10.1007/s00216-019-01668-7; Torma H, 2011, DERM-ENDOCRINOL, V3, P136, DOI 10.4161/derm.3.3.15026; Wang HJ, 2002, J APPL PHYSIOL, V92, P2162, DOI 10.1152/japplphysiol.01192.2001; Wang J, 1999, BIOCHEM J, V338, P23, DOI 10.1042/0264-6021:3380023; Wang S, 2020, PHARMACOL THERAPEUT, V205, DOI 10.1016/j.pharmthera.2019.107415; Wang SY, 2018, DEV DYNAM, V247, P976, DOI [10.1002/dvdy.24639, 10.1002/DVDY.24639]; Wang SY, 2018, FASEB J, V32, P3765, DOI 10.1096/fj.201701038R; Wang ZY, 2018, LIFE SCI, V194, P88, DOI 10.1016/j.lfs.2017.12.015; Wollert KC, 1999, CARDIOVASC RES, V43, P838, DOI 10.1016/S0008-6363(99)00145-5; Wong YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045725; Xavier-Neto J, 2015, BBA-GENE REGUL MECH, V1849, P94, DOI 10.1016/j.bbagrm.2014.08.003; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xiao Y, 2018, DEV CELL, V45, P153, DOI 10.1016/j.devcel.2018.03.019; Xu GX, 1997, AM J PATHOL, V151, P1741; Yang N., 2020, JCI; Yang N, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.137593; Yu MY, 2012, PATHOL INT, V62, P246, DOI 10.1111/j.1440-1827.2012.02802.x; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zalesak-Kravec S, 2021, HEALTH PHYS, V121, P352, DOI 10.1097/HP.0000000000001478; Zhang H, 2015, J TRANSL MED, V13, DOI [10.3969/j.issn.1674-862X.2015.01.012, 10.1186/s12967-015-0432-1]; Zhu S, 2016, J MOL CELL CARDIOL, V99, P100, DOI 10.1016/j.yjmcc.2016.08.009; Zirn B, 2005, ONCOGENE, V24, P5246, DOI 10.1038/sj.onc.1208725; Zizola CF, 2010, MOL CELL BIOL, V30, P3412, DOI 10.1128/MCB.00014-10	102	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22242	10.1096/fj.202100901RRR	http://dx.doi.org/10.1096/fj.202100901RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CN	35253263	Green Accepted			2022-12-26	WOS:000772945100001
J	Olateju, Z; Olufunlayo, T; MacArthur, C; Leung, C; Taylor, B				Olateju, Zahra; Olufunlayo, Tolulope; MacArthur, Christine; Leung, Charlotte; Taylor, Beck			Community health workers experiences and perceptions of working during the COVID-19 pandemic in Lagos, Nigeria-A qualitative study	PLOS ONE			English	Article							STATE	Background Community Health Workers are globally recognised as crucial members of healthcare systems in low and middle-income countries, but their role and experience during COVID-19 is not well-understood. This study aimed to explore factors that influence CHWs' ability and willingness to work in the COVID-19 pandemic in Lagos. Design A generic qualitative study exploring Community Health Workers experiences and perceptions of working during the COVID-19 pandemic in Lagos, Nigeria. Methods 15 semi-structured, in-depth, video interviews were conducted with Community Health Workers purposively sampled across seven of Lagos' Local Government Areas with the highest COVID-19 burden. Interviews explored Community Health Workers' attitudes towards COVID-19, its management, and their experiences working in Lagos. Data was analysed thematically using the framework method. Results Three main themes were identified. 1. Influences on ability to undertake COVID-19 Role: Trust and COVID-19 knowledge were found to aid Community Health Workers in their work. However, challenges included exhaustion due to an increased workload, public misconceptions about COVID-19, stigmatisation of COVID-19 patients, delayed access to care and lack of transportation. 2. Influences on willingness to work in COVID-19 Role: Community Health Workers' perceptions of COVID-19, attitudes towards responsibility for COVID-19 risk at work, commitment and faith appeared to increase willingness to work. 3. Suggested Improvements: Financial incentives, provision of adequate personal protective equipment, transportation, and increasing staff numbers were seen as potential strategies to address many of the challenges faced. Conclusion Despite Community Health Workers being committed to their role, they have faced many challenges during the COVID-19 pandemic in Nigeria. Changes to their working environment may make their role during disease outbreaks more fulfilling and sustainable. International input is required to enhance Nigeria's policies and infrastructure to better support Community Health Workers during both current and future outbreaks.	[Olateju, Zahra; Leung, Charlotte] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Olufunlayo, Tolulope] Univ Lagos, Coll Med, Dept Community Hlth & Primary Care, Yaba, Lagos State, Nigeria; [MacArthur, Christine] Univ Birmingham, Inst Appl Hlth Res, Dept Maternal Hlth, Birmingham, W Midlands, England; [Taylor, Beck] Univ Birmingham, Inst Appl Hlth Res, Dept Publ Hlth, Birmingham, W Midlands, England	University of Birmingham; University of Lagos; University of Birmingham; University of Birmingham	Olateju, Z (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.	zxo775@student.bham.ac.uk		Olateju, Zahra/0000-0002-7437-1459; Taylor, Beck/0000-0002-3559-7922				Abdullahi L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242403; Adeoti O, 2020, IMPLEMENT SCI, V15, DOI 10.1186/s13012-020-0968-1; Ahmed SAKS, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003042; Ajisegiri W. S., 2020, GLOBAL BIOSECURITY, V1, P1, DOI [10.31646/gbio.69/, DOI 10.31646/GBIO.69]; Akoni O, 2020, VANGUARD NEWS; Akseer N, 2020, AM J CLIN NUTR, V112, P251, DOI 10.1093/ajcn/nqaa171; [Anonymous], 2014, TASK SHIFTING TASKSH; [Anonymous], NCDC CORONAVIRUS COV; [Anonymous], 2020, THISDAYLIVE; Bhanot D, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.577018; Bhaumik S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002769; Boyce MR, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00062; Bradbury-Jones C, 2017, INT J SOC RES METHOD, V20, P627, DOI 10.1080/13645579.2016.1270583; Brey Z, 2020, AFR J PRIM HEALTH CA, V12, DOI 10.4102/phcfm.v12i1.2449; Brooks JT, 2021, JAMA-J AM MED ASSOC, V325, P998, DOI 10.1001/jama.2021.1505; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Corburn J, 2020, J URBAN HEALTH, V97, P348, DOI 10.1007/s11524-020-00438-6; Coroiu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239795; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Ebenso B, 2020, LANCET GLOB HEALTH, V8, pE770, DOI 10.1016/S2214-109X(20)30101-7; Etikan I., 2016, AM J THEORETICAL APP, V5, P1, DOI [10.11648/j.ajtas.20160501.11, DOI 10.11648/J.AJTAS.20160501.11]; Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.5.200131e; Fox N., 2009, USING INTERVIEWS RES; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Goldfield NI, 2020, J AMBUL CARE MANAG, V43, P184, DOI 10.1097/JAC.0000000000000337; Haines A, 2020, LANCET, V395, P1173, DOI 10.1016/S0140-6736(20)30735-2; Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Jaguga F, 2020, INT J MENT HEALTH SY, V14, DOI 10.1186/s13033-020-00400-8; Kalu B, 2020, LANCET RESP MED, V8, P556, DOI 10.1016/S2213-2600(20)30220-4; Kerkhoff AD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239400; Lagos State Nigeria Genealogy, 2020, FAM SEARCH WIK; Macbeth D., 2001, QUAL INQ, V7, P35, DOI [10.1177/107780040100700103, DOI 10.1177/107780040100700103]; Mash R, 2020, AFR J PRIM HEALTH CA, V12, DOI 10.4102/phcfm.v12i1.2607; Matuschek C, 2020, EUR J MED RES, V25, DOI 10.1186/s40001-020-00430-5; Mayfield-Johnson S, 2020, J AMBUL CARE MANAG, V43, P268, DOI 10.1097/JAC.0000000000000351; Maciel FBM, 2020, CIENC SAUDE COLETIVA, V25, P4185, DOI [10.1590/1413-812320202510.2.28102020, 10.1590/1413-812320202510.228102020]; Mill J., 2003, INT J QUAL METH, V2, P1, DOI [10.1177/160940690300200201, DOI 10.1177/160940690300200201]; Miller NP, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020601; Nachega JB, 2021, AM J TROP MED HYG, V104, P1179, DOI 10.4269/ajtmh.21-0033; Noy C, 2008, INT J SOC RES METHOD, V11, P327, DOI 10.1080/13645570701401305; Nwachukwu RU., 2021, INT J CURRENT RES RE, V13, P170; Ogolodom MP., 2020, KNOWLEDGE ATTITUDES, DOI [10.3934/Neuroscience.2020017 32995488, DOI 10.3934/NEUROSCIENCE.202001732995488]; Okereke M, 2021, INT J HEALTH PLAN M, V36, P13, DOI 10.1002/hpm.3067; Okuonghae D, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110032; Omoronyia O, 2020, PAN AFR MED J, V37, DOI 10.11604/pamj.2020.37.50.24307; Ordinioha B, 2010, ANN AFR MED, V9, P240, DOI 10.4103/1596-3519.70964; Qiao S., MEDRXIV, DOI [10.1101/2021.01.27.21250654v1.full, DOI 10.1101/2021.01.27.21250654V1.FULL]; Ransome-Kuti O., 1990, STRENGTHENING PRIMAR; Risko N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240503; Sampson H., 2004, QUAL RES, V4, P383, DOI [10.1177/1468794104047236, DOI 10.1177/1468794104047236]; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Schneider CR, 2021, J RISK RES, V24, P294, DOI 10.1080/13669877.2021.1890637; Titus O. B., 2015, Journal of Development and Agricultural Economics, V7, P195; Tongco M. D. C., 2007, Ethnobotany Research and Applications, V5, P147; Verhagen LM, 2020, INT J INFECT DIS, V99, P334, DOI 10.1016/j.ijid.2020.07.069; Wikipedia Contributors, 2019, WIKIPEDIA; Wise T, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200742; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]	59	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0265092	10.1371/journal.pone.0265092	http://dx.doi.org/10.1371/journal.pone.0265092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259204	Green Published, gold			2022-12-26	WOS:000835141200045
J	Wajanga, BMK; Kim, CY; Peck, RN; Bartlett, J; Mabula, D; Juma, A; Muiruri, C				Wajanga, Bahati M. K.; Kim, Christine Yaeree; Peck, Robert N.; Bartlett, John; Mabula, Deodatus; Juma, Adinan; Muiruri, Charles			Is lack of health insurance a predictor of worsening of heart failure among adult patients attending referral hospitals in Northwestern Tanzania?	PLOS ONE			English	Article							AFRICA	Introduction Health insurance coverage is critical for persons living with chronic conditions such as heart failure. Lack of health insurance may affect the ability to access regular healthcare appointments, pay for medication refills which can result in frequent hospitalization that is associated with poor clinical outcomes. In scarce resource locations such as sub-Saharan Africa, where uptake of health insurance is still suboptimal, the effect of health insurance on chronic conditions such as heart failure is poorly understood. The objective of this study was to assess the association of health insurance on the severity of heart failure for patients attending outpatient clinics at tertiary hospitals in Mwanza, Tanzania. Methods As part of alarger cohort study, patients with heart failure were recruited from Bugando Medical Center (BMC) and Sekou Toure Regional Hospital (STRH) in Mwanza City, Tanzania. Heart failure was based on Framingham criteria and the severity was determined by New York Heart Association (NYHA) classification. Descriptive analysis and multivariable logistic regression were used to describe the study participants and to assess the association between health insurance status and the severity of heart failure at baseline. Results 418 patients were enrolled, and majority were female (n = 264, 63%), small scale farmers (n = 278, 66.5%) and were from Mwanza City (n = 299, 71.5%). More than two-thirds of patients did not have health insurance (n = 295, 70.6%) and the majority were in the NYHA I and II classification (n = 267, 64.7%). There was no association between health insurance status and the severity of heart (aOR = 0.97; 95% CI 0.84-1.60). Being male, small-scale businessperson and those seen at STRH was associated with higher odds of being in NYHA Class III/IV (aOR = 1.97; 95% CI: 1.21-3.17), (aOR = 2.61; 95% CI: 1.27-5.34) and (aOR 1.91 95% CI: 1.17-3.13) respectively. Having secondary and college education was associated with lower odds of being in Class III/IV (0.42; 95% CI: 0.18-0.98) and (aOR = 0.23 95% CI: 0.06-0.86) respectively. Conclusion In this study, only a third of the patients had health insurance. Health insurance was not associated with the severity of heart failure. Since heart failure is a chronic condition patients who do not have health insurance may incur out of pocket expenses, future research should focus on the effect of out-of-pocket expenditures on clinical outcomes.	[Wajanga, Bahati M. K.; Peck, Robert N.; Mabula, Deodatus] Bugando Med Ctr, Dept Internal Med, Mwanza, Tanzania; [Wajanga, Bahati M. K.; Peck, Robert N.; Mabula, Deodatus] Catholic Univ Hlth & Allied Sci Bugando, Dept Internal Med, Mwanza, Tanzania; [Kim, Christine Yaeree] Duke Univ, Dept Populat Hlth Sci, Durham, NC USA; [Peck, Robert N.] Weill Cornell Med Coll, Div Hosp Med, Dept Internal Med, New York, NY USA; [Peck, Robert N.] Weill Cornell Med Coll, Ctr Global Hlth, Dept Internal Med, New York, NY USA; [Bartlett, John; Muiruri, Charles] Duke Global Hlth Inst, Durham, NC USA; [Bartlett, John; Muiruri, Charles] Duke Univ, Sch Med, Durham, NC USA; [Bartlett, John; Juma, Adinan; Muiruri, Charles] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania	Duke University; Cornell University; Cornell University; Duke University; Duke University	Wajanga, BMK (corresponding author), Bugando Med Ctr, Dept Internal Med, Mwanza, Tanzania.; Wajanga, BMK (corresponding author), Catholic Univ Hlth & Allied Sci Bugando, Dept Internal Med, Mwanza, Tanzania.	wajangabmk@gmail.com			Fogarty international Center [D43TW010138]	Fogarty international Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Fogarty international Center, Award Number: D43TW010138 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2007, BRIT MED J, V334, P424, DOI 10.1136/bmj.38977.682025.2C; Barbareschi G, 2011, J CARD FAIL, V17, P47, DOI 10.1016/j.cardfail.2010.08.005; Bloomfield GS, 2013, CURR CARDIOL REV, V9, P157, DOI 10.2174/1573403X11309020008; Buabeng KO, 2004, J PHARM PHARM SCI, V7, P350; Cardiovascular diseases (CVDs), 2021, CARDIOVASCULAR DIS C; Damasceno A, 2007, J AM COLL CARDIOL, V50, P1688, DOI 10.1016/j.jacc.2007.07.030; Dolgin M, 1994, NOMENCLATURE CRITERI; Doust JA, 2005, BRIT MED J, V330, P625, DOI 10.1136/bmj.330.7492.625; Etienne CF., 2019, ADDRESSING MASCULINI; Godfrey P, 2018, UNIVERSAL HLTH COVER; Hertz JT, 2022, INT HEALTH, V14, P373, DOI 10.1093/inthealth/ihz095; Home, NATL HLTH INSURANCE; Huffman MD., CROSS SECTIONAL STUD; Karaye KM, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-16; Kavishe B., 2013, HIGH PREVALENCE HYPE; Keates AK, 2017, NAT REV CARDIOL, V14, P273, DOI 10.1038/nrcardio.2017.19; Kingery JR, 2017, INT J CARDIOL, V243, P311, DOI 10.1016/j.ijcard.2017.05.025; Lesyuk W, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0815-3; Makubi A, 2016, INT J CARDIOL, V220, P750, DOI 10.1016/j.ijcard.2016.06.239; Mansi Ishak A, 2011, J La State Med Soc, V163, P268; McWilliams JM, 2009, MILBANK Q, V87, P443, DOI 10.1111/j.1468-0009.2009.00564.x; Pincus T, 1998, ANN INTERN MED, V129, P406, DOI 10.7326/0003-4819-129-5-199809010-00011; Stewart S, 2008, CIRCULATION, V118, P2360, DOI 10.1161/CIRCULATIONAHA.108.786244; WHO (World Health Organization), 2019, UNIVERSAL HLTH COVER	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2022	17	3							e0264352	10.1371/journal.pone.0264352	http://dx.doi.org/10.1371/journal.pone.0264352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0II	35259171	Green Published, gold			2022-12-26	WOS:000835141200014
J	Wang, H; Zhang, DY; Cui, XX; Dai, YB; Wang, CC; Feng, WL; Lv, XQ; Li, YF; Wang, LN; Ru, YX; Zhang, YC; Ren, Q; Zheng, GG				Wang, Hao; Zhang, Dongyue; Cui, Xiaoxi; Dai, Yibo; Wang, Chenchen; Feng, Wenli; Lv, Xiaoqian; Li, Yifei; Wang, Lina; Ru, Yongxin; Zhang, Yingchi; Ren, Qian; Zheng, Guoguang			Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion	ONCOGENE			English	Article							BLOOD-BRAIN-BARRIER; STEM-CELLS; TRANSCRIPTION FACTORS; BONE METASTASIS; CANCER CELLS; MODEL; ESTABLISHMENT; CHALLENGES; REGULATOR; FAMILY	Interferon regulatory factor 7 (IRF7) is widely studied in inflammatory models. Its effects on malignant progression have been documented mainly from the perspective of the microenvironment. However, its role in leukemia has not been established. Here we used MLL-AF9-induced acute myeloid leukemia (AML) mouse models with IRF7 knockout or overexpression and xenograft mouse models to explore the intrinsic effects of IRF7 in AML. AML-IRF7(-/-) mice exhibited accelerated disease progression with intracerebral invasion of AML cells. AML-IRF7(-/-) cells showed increased proliferation and elevated leukemia stem cell (LSC) levels. Overexpression of IRF7 in AML cells decreased cell proliferation and LSC levels. Furthermore, overexpression of transforming growth-interacting factor 1 (TGIF1) rescued the enhanced proliferation and high LSC levels caused by IRF7 deficiency. Moreover, upregulation of vascular cell adhesion molecule 1 (VCAM1), which correlated with high LSC levels, was detected in AML-IRF7(-/-) cells. In addition, blocking VCAM1-very late antigen 4 (VLA-4) axis delayed disease progression and attenuated intracerebral invasion of AML cells. Therefore, our findings uncover the intrinsic effects of IRF7 in AML and provide a potential strategy to control central nervous system myeloid leukemia.	[Wang, Hao; Zhang, Dongyue; Cui, Xiaoxi; Dai, Yibo; Wang, Chenchen; Feng, Wenli; Lv, Xiaoqian; Li, Yifei; Wang, Lina; Ru, Yongxin; Zhang, Yingchi; Ren, Qian; Zheng, Guoguang] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Inst Hematol & Blood Dis Hosp,Haihe Lab Cell Ecos, 288 Nanjing Rd, Tianjin 300020, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College	Zheng, GG (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Inst Hematol & Blood Dis Hosp,Haihe Lab Cell Ecos, 288 Nanjing Rd, Tianjin 300020, Peoples R China.	zhengggtjchn@aliyun.com		Wang, Chenchen/0000-0003-3329-0756	National Natural Science Foundation of China (NSFC) [81970155, 82170174, 81770183]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2021-I<INF>2</INF>M-1-041]; Graduate Student Innovation Fund of Peking Union Medical College [2018-0710-08]; New Century Excellent Talents in University [NCET-08-0329]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences (CIFMS); Graduate Student Innovation Fund of Peking Union Medical College; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants 81970155, 82170174, and 81770183 from the National Natural Science Foundation of China (NSFC); program 2021-I<INF>2</INF>M-1-041 from the CAMS Innovation Fund for Medical Sciences (CIFMS); and the grant 2018-0710-08 from the Graduate Student Innovation Fund of Peking Union Medical College. Z.GG. is a recipient of the New Century Excellent Talents in University (NCET-08-0329).	Bakst RL, 2011, BLOOD, V118, P3785, DOI 10.1182/blood-2011-04-347229; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Chen XM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12850-x; Chen YY, 2021, STEM CELLS, V39, P183, DOI 10.1002/stem.3308; Chen Z, 2021, ONCOGENE, V40, P3786, DOI 10.1038/s41388-021-01818-1; Chu YJ, 2020, ONCOGENE, V39, P7239, DOI 10.1038/s41388-020-01495-6; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Felix A, 2018, J PEDIAT HEMATOL ONC, V40, P43, DOI 10.1097/MPH.0000000000001034; Feng WL, 2021, HAEMATOLOGICA, V106, P1278, DOI 10.3324/haematol.2019.243360; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Grove RA, 2013, EUR J NEUROL, V20, P1032, DOI 10.1111/ene.12097; Guca E, 2018, NUCLEIC ACIDS RES, V46, P9220, DOI 10.1093/nar/gky680; Hamid R, 2009, MOL ONCOL, V3, P451, DOI 10.1016/j.molonc.2009.07.004; Hayakawa Y, 2015, CANCER CELL, V28, P800, DOI 10.1016/j.ccell.2015.10.003; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hu GH, 2020, CL LYMPH MYELOM LEUK, V20, pE813, DOI 10.1016/j.clml.2020.06.009; Kim TH, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040385; Kinstrie R, 2020, LEUKEMIA, V34, P1613, DOI 10.1038/s41375-019-0684-5; Lan Q, 2019, ONCOGENE, V38, P2814, DOI 10.1038/s41388-018-0624-2; Li DF, 2014, ONCOL REP, V32, P684, DOI 10.3892/or.2014.3254; Li YP, 2015, CELL PROLIFERAT, V48, P643, DOI 10.1111/cpr.12223; Li ZJ, 2006, EUR J HAEMATOL, V77, P128, DOI 10.1111/j.1600-0609.2006.00686.x; Li ZZ, 2017, J CANCER, V8, P207, DOI 10.7150/jca.16415; Litzow MR, 2015, BLOOD, V126, P833, DOI 10.1182/blood-2014-10-551895; Liu YX, 2021, INT J ONCOL, V58, P371, DOI 10.3892/ijo.2021.5180; LYNCH RG, 1975, J NATL CANCER I, V55, P611, DOI 10.1093/jnci/55.3.611; Negishi H, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028423; Parajuli P, 2019, EMBO J, V38, DOI 10.15252/embj.2018101067; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Puhalla S, 2015, NEURO-ONCOLOGY, V17, P639, DOI 10.1093/neuonc/nov023; Pui CH, 2008, LANCET ONCOL, V9, P257, DOI 10.1016/S1470-2045(08)70070-6; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Si MY, 2018, CANCER MANAG RES, V10, P305, DOI 10.2147/CMAR.S152419; Soto MS, 2014, NEURO-ONCOLOGY, V16, P541, DOI 10.1093/neuonc/not222; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Wang DY, 2020, STEM CELL REP, V14, P1093, DOI 10.1016/j.stemcr.2020.05.012; Wang R, 2020, CANCER LETT, V469, P151, DOI 10.1016/j.canlet.2019.10.032; Willer A, 2015, LEUKEMIA, V29, P1018, DOI 10.1038/leu.2014.307; Wu MH, 2019, ANN RHEUM DIS, V78, P1583, DOI 10.1136/annrheumdis-2019-215208; Yan L, 2020, J CELL MOL MED, V24, P13472, DOI 10.1111/jcmm.15977; Yan L, 2013, MOL CELL BIOL, V33, P4824, DOI 10.1128/MCB.01076-13; Yanai H, 2012, ONCOIMMUNOLOGY, V1, P1376, DOI 10.4161/onci.22475; Yang Q, 2017, ONCOGENE, V36, P2969, DOI 10.1038/onc.2016.448; Yang X, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1412910; Yu X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07384-7; Zhao Y, 2017, ONCOL RES, V25, P511, DOI 10.3727/096504016X14756226781802; Zhou XX, 2015, BLOOD, V126, P1433, DOI 10.1182/blood-2015-01-624833; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	51	1	1	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2022	41	16					2303	2314		10.1038/s41388-022-02233-w	http://dx.doi.org/10.1038/s41388-022-02233-w		MAR 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0N1NW	35256780	hybrid, Green Published			2022-12-26	WOS:000765674100002
J	Webb, BJ; Levin, NM; Grisel, N; Brown, SM; Peltan, ID; Spivak, ES; Shah, M; Stenehjem, E; Bledsoe, J				Webb, Brandon J.; Levin, Nicholas M.; Grisel, Nancy; Brown, Samuel M.; Peltan, Ithan D.; Spivak, Emily S.; Shah, Mark; Stenehjem, Eddie; Bledsoe, Joseph			Simple scoring tool to estimate risk of hospitalization and mortality in ambulatory and emergency department patients with COVID-19	PLOS ONE			English	Article								Background Accurate methods of identifying patients with COVID-19 who are at high risk of poor outcomes has become especially important with the advent of limited-availability therapies such as monoclonal antibodies. Here we describe development and validation of a simple but accurate scoring tool to classify risk of hospitalization and mortality. Methods All consecutive patients testing positive for SARS-CoV-2 from March 25-October 1, 2020 within the Intermountain Healthcare system were included. The cohort was randomly divided into 70% derivation and 30% validation cohorts. A multivariable logistic regression model was fitted for 14-day hospitalization. The optimal model was then adapted to a simple, probabilistic score and applied to the validation cohort and evaluated for prediction of hospitalization and 28-day mortality. Results 22,816 patients were included; mean age was 40 years, 50.1% were female and 44% identified as non-white race or Hispanic/Latinx ethnicity. 6.2% required hospitalization and 0.4% died. Criteria in the simple model included: age (0.5 points per decade); high-risk comorbidities (2 points each): diabetes mellitus, severe immunocompromised status and obesity (body mass index >= 30); non-white race/Hispanic or Latinx ethnicity (2 points), and 1 point each for: male sex, dyspnea, hypertension, coronary artery disease, cardiac arrythmia, congestive heart failure, chronic kidney disease, chronic pulmonary disease, chronic liver disease, cerebrovascular disease, and chronic neurologic disease. In the derivation cohort (n = 16,030) area under the receiver-operator characteristic curve (AUROC) was 0.82 (95% CI 0.81-0.84) for hospitalization and 0.91 (0.83-0.94) for 28-day mortality; in the validation cohort (n = 6,786) AUROC for hospitalization was 0.8 (CI 0.78-0.82) and for mortality 0.8 (CI 0.69-0.9). Conclusion A prediction score based on widely available patient attributes accurately risk stratifies patients with COVID-19 at the time of testing. Applications include patient selection for therapies targeted at preventing disease progression in non-hospitalized patients, including monoclonal antibodies. External validation in independent healthcare environments is needed.	[Webb, Brandon J.; Stenehjem, Eddie] Intermt Healthcare, Div Infect Dis & Clin Epidemiol, Salt Lake City, UT 84103 USA; [Webb, Brandon J.; Stenehjem, Eddie] Stanford Med, Div Infect Dis & Geog Med, Palo Alto, CA 94304 USA; [Levin, Nicholas M.] Univ Utah, Div Emergency Med, Sch Med, Salt Lake City, UT USA; [Grisel, Nancy] Intermt Healthcare, Enterprise Analyt, Salt Lake City, UT USA; [Brown, Samuel M.; Peltan, Ithan D.] Intermt Med Ctr, Div Pulm & Crit Care Med, Salt Lake City, UT USA; [Brown, Samuel M.; Peltan, Ithan D.] Univ Utah, Salt Lake City, UT USA; [Spivak, Emily S.] Univ Utah, Div Infect Dis, Sch Med, Salt Lake City, UT USA; [Shah, Mark; Bledsoe, Joseph] Intermt Healthcare, Dept Emergency Med, Salt Lake City, UT USA; [Stenehjem, Eddie] Intermt Healthcare, Off Patient Experience, Salt Lake City, UT USA; [Bledsoe, Joseph] Stanford Med, Dept Emergency Med, Palo Alto, CA USA	Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center	Webb, BJ (corresponding author), Intermt Healthcare, Div Infect Dis & Clin Epidemiol, Salt Lake City, UT 84103 USA.; Webb, BJ (corresponding author), Stanford Med, Div Infect Dis & Geog Med, Palo Alto, CA 94304 USA.	Brandon.Webb@imail.org	Bledsoe, Joseph/GLS-8543-2022; Brown, Samuel/E-6846-2015	Bledsoe, Joseph/0000-0002-3005-2878; Levin, Nicholas/0000-0003-4909-6464; Brown, Samuel/0000-0003-1206-6261	National Institutes of Health (U.S.A); Hamilton; Janssen; AHRQ; Centers for Disease Control; Abbvie; Genentech; Gilead; Regeneron; Roche; U.S. National Institutes of Health ACTIV; PETAL clinical trials networks	National Institutes of Health (U.S.A)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hamilton; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Abbvie(AbbVie); Genentech(Roche HoldingGenentech); Gilead(Gilead Sciences); Regeneron(Regeneron); Roche(Roche Holding); U.S. National Institutes of Health ACTIV(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PETAL clinical trials networks	IP reports salary support through a grant from the National Institutes of Health (U.S.A). SB reports salary support from the U.S. NIH, Centers for Disease Control and the Department of Defense; he also reports receiving support for chairing a data and safety monitoring board for a respiratory failure trial sponsored by Hamilton, effort paid to Intermountain for steering committee work for Faron Pharmaceuticals and Sedana Pharmaceuticals for ARDS work, support from Janssen for Influenza research, and royalties for books on religion and ethics from Oxford University Press/Brigham Young University. BW reports partial salary support from a U.S. Federal grant from AHRQ. ES receives partial salary support through grants from the Centers for Disease Control. At the time of submission, Intermountain Healthcare and the University of Utah have participated in COVID-19 trials sponsored by: Abbvie, Genentech, Gilead, Regeneron, Roche, and the U.S. National Institutes of Health ACTIV and PETAL clinical trials networks; several authors (BW, IP, JB, SB, ES) were site investigators on these trials but received no direct or indirect remuneration for their effort. ES, BJW, SMB and MS are members of the Utah crisis standards of care scarce medication committee.	CDC, 2020, COR DIS 2019 COVID 1; Centers for Disease Control and Prevention, 2020, DEF AD OV OB; Dashti Hesam, 2020, medRxiv, DOI 10.1101/2020.09.11.20190520; de Terwangne C, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9110880; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fisman DN, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa463; Jehi L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237419; Maddala G.S., 1986, LTD DEPENDENT QUALIT; Mesas AE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241742; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NQF,, RISK ADJ SOC STAT SO; Pastor-Barriuso R, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4509; Wang D, 2020, J AEROSPACE ENG, V33, DOI 10.1061/(ASCE)AS.1943-5525.0001149; Wollenstein-Betech S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240346; Wollenstein-Betech S, 2020, INT J MED INFORM, V142, DOI 10.1016/j.ijmedinf.2020.104258; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang C, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00318; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0261508	10.1371/journal.pone.0261508	http://dx.doi.org/10.1371/journal.pone.0261508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239664	gold, Green Submitted, Green Published			2022-12-26	WOS:000776002200004
J	Giaddui, D; Porreca, DS; Tiwari, E; Frara, NA; Hobson, LJ; Barbe, MF; Braverman, AS; Brown, JM; Pontari, MA; Sr, MRR				Giaddui, Dania; Porreca, Danielle S.; Tiwari, Ekta; Frara, Nagat A.; Hobson, Lucas J.; Barbe, Mary F.; Braverman, Alan S.; Brown, Justin M.; Pontari, Michel A.; Sr, Michael R. Ruggieri			Lateralization of bladder function in normal female canines	PLOS ONE			English	Article							SPINAL ROOT TRANSECTION; REFLEX PATHWAY; REINNERVATION; NERVE	This study aimed to identify potential lateralization of bladder function. Electrical stimulation of spinal roots or the pelvic nerve's anterior vesical branch was performed bilaterally in female dogs. The percent difference between the left and right stimulation-induced increased detrusor pressure was determined. Bladders were considered left or right-sided if differences were greater or less than 25% or 10%. Based on differences of 25%, upon stimulation of spinal roots, bladders were left-sided in 17/44 (38.6%), right-sided in 12/44 (27.2%) and bilateral in 15/44 (34.2%). Using +/- 10%, 48% had left side dominance (n = 21/44), 39% had right side dominance (n = 17/44), and 14% were bilateral (n = 6/44). With stimulation of the pelvic nerve's anterior vesical branch in 19 dogs, bladders were left-sided in 8 (42.1%), right-sided in 6 (31.6%) and bilateral in 5 (26.3%) using 25% differences and left side dominance in 8 (43%), right sided in 7 (37%) and bilateral in 4 (21%) using 10% differences. These data suggest lateralization of innervation of the female dog bladder with left-and right-sided lateralization occurring at similar rates. Lateralization often varied at different spinal cord levels within the same animal.	[Giaddui, Dania; Porreca, Danielle S.; Tiwari, Ekta; Frara, Nagat A.; Hobson, Lucas J.; Barbe, Mary F.; Braverman, Alan S.; Sr, Michael R. Ruggieri] Temple Univ, Lewis Katz Sch Med, Dept Cardiovasc Sci, Philadelphia, PA 19122 USA; [Giaddui, Dania; Porreca, Danielle S.; Tiwari, Ekta; Frara, Nagat A.; Hobson, Lucas J.; Barbe, Mary F.; Braverman, Alan S.; Sr, Michael R. Ruggieri] Temple Univ, Lewis Katz Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Brown, Justin M.] Massachusetts Gen Hosp, Neurosurg Paralysis Ctr, Dept Neurosurg, Boston, MA 02114 USA; [Pontari, Michel A.] Temple Univ, Lewis Katz Sch Med, Dept Urol, Philadelphia, PA 19122 USA; [Sr, Michael R. Ruggieri] Shriners Hosp Children Philadelphia, Philadelphia, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Barbe, MF (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Cardiovasc Sci, Philadelphia, PA 19122 USA.; Barbe, MF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA.	mary.barbe@temple.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS070267]	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS070267 to Dr. Michael R. Ruggieri and Dr. Mary F. Barbe. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkova J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185243; Barbe MF., 2021, AM J PHYSIOL-REG I; Chai TC, 1996, SCAND J UROL NEPHROL, V30, P87; de Groat William C, 2009, Handb Exp Pharmacol, P91, DOI 10.1007/978-3-540-79090-7_4; Demirbas YS, 2019, BEHAV PROCESS, V165, P4, DOI 10.1016/j.beproc.2019.05.023; Frara N., 2021, AM J PHYSIOL-REG I; Gomez-Amaya SM, 2015, J UROLOGY, V193, P1042, DOI 10.1016/j.juro.2014.07.095; Marshall-Pescini S, 2013, BEHAV PROCESS, V100, P40, DOI 10.1016/j.beproc.2013.07.017; Ruggieri MR, 2008, J NEUROTRAUM, V25, P214, DOI 10.1089/neu.2007.0328; Ruggieri MR, 2008, J NEUROTRAUM, V25, P401, DOI 10.1089/neu.2007.0335; Ruggieri MR, 2006, J NEUROTRAUM, V23, P1125, DOI 10.1089/neu.2006.23.1125; Sadler KE, 2017, PAIN, V158, P747, DOI 10.1097/j.pain.0000000000000830; Salvadeo DM, 2018, NEUROUROL URODYNAM, V37, P2495, DOI 10.1002/nau.23765; Tiwari E, 2020, J NEUROSURG-SPINE, V32, P258, DOI 10.3171/2019.8.SPINE19265; Tiwari E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215036; Xiao CG, 2005, J UROLOGY, V173, P2112, DOI 10.1097/01.ju.0000158072.31086.af; Xiao CG, 1999, J UROLOGY, V162, P936, DOI 10.1097/00005392-199909010-00094	17	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264382	10.1371/journal.pone.0264382	http://dx.doi.org/10.1371/journal.pone.0264382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231045	gold, Green Published			2022-12-26	WOS:000849744700021
J	Mao, J; Liu, JX; Zhou, M; Wang, GQ; Xiong, X; Deng, YQ				Mao, Jing; Liu, Jiexiong; Zhou, Mei; Wang, Guiqiang; Xiong, Xia; Deng, Yongqiong			Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1 alpha/VEGF signaling in systemic sclerosis	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; MYOFIBROBLAST; EXPRESSION; TISSUE; SKIN	Objective The aim of this research was to systematically investigate the effects of endothelial mesenchymal transition (EndMT) induced by hypoxia on the skin microvascular remodeling of systemic sclerosis (SSc) and the underlying mechanism. Methods Skin tissues from SSc patients and controls were collected for isobaric tags for the relative and absolute quantification (iTRAQ)-based proteomics and immunohistochemical test. Human microvascular endothelial cell line-1 (HMEC-1) cultured in hypoxic or normal conditions was treated by tamoxifen or bevacizumab. Results The iTRAQ-based proteomics indicated a significantly upregulated hypoxia-inducible factor-1 (HIF-1) signal in SSc samples. The immunohistochemical results demonstrated the significant downregulation of CD31, the positive staining of alpha-smooth muscle actin (alpha-SMA), HIF-1 alpha, and vascular endothelial growth factor (VEGF-a) in SSc skin tissues, compared with control samples. Consistent with these observations, HMEC-1 cells cultured under hypoxic conditions exhibited a significant decrease in CD31 and VE-cadherin expression, alongside a marked increase in the expression of alpha-SMA and fibronectin, as well as a distinct upregulation of HIF-1 alpha and VEGF-a, when compared with those under normal conditions. It is noteworthy that the inhibition of HIF-1 alpha by tamoxifen effectively downregulated the hypoxic induction of VEGF-a and alpha-SMA while rescuing the hypoxic suppression of CD31. In addition, the VEGF-a inhibitor bevacizumab treatment had the same effect on the hypoxic expression of alpha-SMA and CD31, as a tamoxifen intervention, but did not reduce HIF-1 alpha. Conclusion These results suggest that the HIF-1 alpha/VEGF signaling pathway can have a critical role in mediating the effect of hypoxia-induced EndMT on the skin microvascular remodeling of SSc.	[Mao, Jing; Liu, Jiexiong; Zhou, Mei; Xiong, Xia; Deng, Yongqiong] Southwest Med Univ, Dept Dermatol, Affiliated Hosp, Luzhou, Sichuan, Peoples R China; [Wang, Guiqiang] Peking Univ First Hosp, Dept Infect Dis, Beijing, Peoples R China	Southwest Medical University; Peking University	Xiong, X; Deng, YQ (corresponding author), Southwest Med Univ, Dept Dermatol, Affiliated Hosp, Luzhou, Sichuan, Peoples R China.	xiongxia789@126.com; dengyongqiong1@126.com	Deng, Yongqiong/N-1281-2018	Deng, Yongqiong/0000-0003-2023-830X	Sichuan Science and Technology Program [2018JY0406/2019YFS0537/2020YFS0456]; Natural Science Foundation of China [81970676]	Sichuan Science and Technology Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Sichuan Science and Technology Program (granted number: 2018JY0406/2019YFS0537/2020YFS0456); The Natural Science Foundation of China (granted number: 81970676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami B, 2019, CLIN EXP OPHTHALMOL, V47, P1074, DOI 10.1111/ceo.13579; Beon M, 2004, CLIN EXP RHEUMATOL, V22, P733; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cortes E, 2019, EMBO REP, V20, DOI 10.15252/embr.201846557; Cutolo M, 2019, EXPERT REV CLIN IMMU, V15, P753, DOI 10.1080/1744666X.2019.1614915; Deng W, 2016, CELL IMMUNOL, V303, P7, DOI 10.1016/j.cellimm.2016.04.001; Denton CP, 2017, LANCET, V390, P1685, DOI 10.1016/S0140-6736(17)30933-9; Distler O, 2004, CIRC RES, V95, P109, DOI 10.1161/01.RES.0000134644.89917.96; Haase VH, 2009, ANN NY ACAD SCI, V1177, P57, DOI 10.1111/j.1749-6632.2009.05030.x; Hughes M, 2020, NAT REV RHEUMATOL, V16, P208, DOI 10.1038/s41584-020-0386-4; Ioannou M, 2013, MOD RHEUMATOL, V23, P1245, DOI [10.3109/s10165-012-0787-6, 10.1007/s10165-012-0787-6]; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Liu CF, 2019, RHEUMATOLOGY, V58, P1966, DOI 10.1093/rheumatology/kez159; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; Manetti M, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-210229; Manetti M, 2011, ARTHRITIS RHEUM-US, V63, P2164, DOI 10.1002/art.30316; Meier FMP, 2012, ANN RHEUM DIS, V71, P1355, DOI 10.1136/annrheumdis-2011-200742; Mendoza FA, 2016, ARTHRITIS RHEUMATOL, V68, P210, DOI 10.1002/art.39421; Mona P., 2017, INT J MOL SCI, V18, P307; Nicolosi PA, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4636859; Ota Y, 2020, EUR J RHEUMATOL, V7, pS139, DOI 10.5152/eurjrheum.2019.19158; Rosa I, 2020, EUR J RHEUMATOL, V7, pS157, DOI 10.5152/eurjrheum.2019.19081; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Siao-Pin S, 2016, EXP THER MED, V12, P3459, DOI 10.3892/etm.2016.3782; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; van Hal TW, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/824972; Wirz EG, 2016, ANN RHEUM DIS, V75, P1285, DOI 10.1136/annrheumdis-2015-207271; Xiong AJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00326; Xu XB, 2015, J BIOL CHEM, V290, P16653, DOI 10.1074/jbc.M115.636944; Zhang B, 2018, INT J MOL MED, V42, P270, DOI 10.3892/ijmm.2018.3584; Zhang J, 2020, N-S ARCH PHARMACOL, V393, P469, DOI 10.1007/s00210-019-01746-8	32	1	1	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0263369	10.1371/journal.pone.0263369	http://dx.doi.org/10.1371/journal.pone.0263369			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231032	Green Published, gold			2022-12-26	WOS:000849744700009
J	Turska-Kawa, A; Pilch, I				Turska-Kawa, Agnieszka; Pilch, Irena			Political beliefs and the acceptance of the SARS-CoV-2 pandemic restrictions. The case of Poland	PLOS ONE			English	Article							LEFT-RIGHT ORIENTATION; BASIC PERSONAL VALUES; QUANTILE REGRESSION; BIG 5; EASTERN; WESTERN; CONSERVATISM; IDEOLOGY; TRAITS; ATTITUDES	We investigated the relationships between political beliefs regarding two aspects of the right-left distinction (cultural and economic) and the acceptance of the pandemic restrictions using variable-centred and person-centred approaches. The community sample consisted of 305 participants. Four groups of the restrictions were considered. Religious fundamentalism predicted positively the acceptance of the restrictions associated with the limitations of labour rights and those limiting civil rights without a direct impact on safety. Anti-welfare negatively predicted the acceptance of the restrictions regarding social distancing and those limiting civil rights and increasing safety. These associations were discussed in relation to basic needs and values which motivate persons who endorse right-wing or left-wing political views. The latent profile analysis revealed three profiles of political beliefs, which were termed "Conservative Statists," "Liberal Laissez-fairists," and "Conservative Laissez-fairists." The profiles differed in terms of acceptance of the pandemic restrictions, and the patterns of these relationships were different for particular groups of restrictions.	[Turska-Kawa, Agnieszka] Univ Silesia, Fac Social Sci, Inst Polit Sci, Katowice, Poland; [Pilch, Irena] Univ Silesia, Fac Social Sci, Inst Psychol, Katowice, Poland	University of Silesia in Katowice; University of Silesia in Katowice	Turska-Kawa, A (corresponding author), Univ Silesia, Fac Social Sci, Inst Polit Sci, Katowice, Poland.	agnieszka.turska-kawa@us.edu.pl		Pilch, Irena/0000-0002-4471-1993; Turska-Kawa, Agnieszka/0000-0002-2748-7037	University of Silesia in Katowice	University of Silesia in Katowice	The research activities was co-financed by the funds granted under the Research Excellence Initiative of the University of Silesia in Katowice.	Adorno Theodor W, 1950, AUTHORITARIAN PERSON; Agh A., 2016, POL POLIT SCI YEARB, V46, P32, DOI [DOI 10.15804/PPSY2016003, 10.15804/ppsy2016003]; Allington D, 2021, PSYCHOL MED, V51, P1763, DOI [10.1017/S0033291721000593, 10.1017/S003329172000224X]; Altemeyer B, 1998, ADV EXP SOC PSYCHOL, V30, P47, DOI 10.1016/S0065-2601(08)60382-2; Arafat SMY, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113061; Aspelund A, 2013, POLIT PSYCHOL, V34, P409, DOI 10.1111/pops.12000; Barnea MF, 1998, POLIT PSYCHOL, V19, P17, DOI 10.1111/0162-895X.00090; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calvillo DP, 2020, SOC PSYCHOL PERS SCI, V11, P1119, DOI 10.1177/1948550620940539; Caprara G., 2000, PERSONALITY DETERMIN, DOI DOI 10.1017/CBO9780511812767; Caprara GV, 2008, EUR PSYCHOL, V13, P157, DOI 10.1027/1016-9040.13.3.157; Caprara GV, 2017, CROSS-CULT RES, V51, P388, DOI 10.1177/1069397117712194; Caprara G, 2009, ASIAN J SOC PSYCHOL, V12, P82, DOI 10.1111/j.1467-839X.2009.01274.x; Caprara GV, 2006, POLIT PSYCHOL, V27, P1, DOI 10.1111/j.1467-9221.2006.00447.x; Carlucci L., 2015, RIC PSICOL, DOI DOI 10.3280/RIP2015-002007; Child D, 2006, ESSENTIALS FACTOR AN, V3rd; Chirumbolo A, 2002, PERS INDIV DIFFER, V32, P603, DOI 10.1016/S0191-8869(01)00062-9; Chirumbolo A, 2008, PERS INDIV DIFFER, V44, P1279, DOI 10.1016/j.paid.2007.11.012; Choma BL, 2010, CAN J BEHAV SCI, V42, P24, DOI 10.1037/a0015650; Clark S.L., 2009, RELATING LATENT CLAS; Cohen J, 2020, SCIENCE, V367, P962, DOI 10.1126/science.367.6481.962; Conway III LG, 2020, PREPRINTS; Cooray A, 2016, ROY SOC OPEN SCI, Patent No. 00988; Coughlin RM, 1998, J THEOR POLIT, V10, P33, DOI 10.1177/0951692898010001002; Cui Z, 2021, PREPRINTS; Czarnek G, 2019, PREPRINT; Czarnek G., 2017, PSYCHOL SPO ECZNA, V12, P205, DOI 10.7366/1896180020174108.Polish; Czarnek G, 2019, EUR J SOC PSYCHOL, V49, P807, DOI 10.1002/ejsp.2548; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P751, DOI 10.15585/mmwr.mm6924e1; Deopa N, 2020, CORONAGRABEN CULTURE, DOI 10.2139/ssrn.3635287; Desilets E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242996; Devos T, 2002, BRIT J SOC PSYCHOL, V41, P481, DOI 10.1348/014466602321149849; Duriez B, 2005, POLIT PSYCHOL, V26, P299, DOI 10.1111/j.1467-9221.2005.00419.x; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; FEATHER NT, 1964, J ABNORM SOC PSYCH, V69, P127, DOI 10.1037/h0046290; Federico CM, 2012, J PERS SOC PSYCHOL, V103, P381, DOI 10.1037/a0029063; FELDMAN S, 1988, AM J POLIT SCI, V32, P416, DOI 10.2307/2111130; Feldman S, 2014, POLIT PSYCHOL, V35, P337, DOI 10.1111/pops.12055; Felman A, 2020, MED NEWS TODAY; Field A.P., 2020, DISCOVERING STAT USI, V4th; Fischer K, 2020, PREPRINT; Freire A., 2009, J EUR INTEGR, V31, P665, DOI [10.1080/07036330903145914, DOI 10.1080/07036330903145914]; Georgiou N, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110201; Gerber AS, 2011, ANNU REV POLIT SCI, V14, P265, DOI 10.1146/annurev-polisci-051010-111659; Golec A., 2001, STUD PSYCHOL, V39, P41; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Hadarics M, 2017, EUR J PSYCHOL, V13, P336, DOI 10.5964/ejop.v13i2.1334; Hitlin S, 2003, SOC PSYCHOL QUART, V66, P118, DOI 10.2307/1519843; Hoffmann JP, 2019, J SCI STUD RELIG, V58, P210, DOI 10.1111/jssr.12578; Jaeger MM, 2008, INT J PUBLIC OPIN R, V20, P363, DOI 10.1093/ijpor/edn030; Jost JT, 2009, PSYCHOL INQ, V20, P129, DOI 10.1080/10478400903028599; Jost JT, 2009, ANNU REV PSYCHOL, V60, P307, DOI 10.1146/annurev.psych.60.110707.163600; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Jungmann SM, 2020, J ANXIETY DISORD, V73, DOI 10.1016/j.janxdis.2020.102239; Karic T, 2021, PERS INDIV DIFFER, V175, DOI 10.1016/j.paid.2021.110697; Kilburn HW, 2009, SOC SCI QUART, V90, P868, DOI 10.1111/j.1540-6237.2009.00667.x; KITSCHELT H, 1995, PARTY POLIT, V1, P447, DOI 10.1177/1354068895001004002; Konstantopoulos S, 2019, EDUC PSYCHOL MEAS, V79, P883, DOI 10.1177/0013164419837321; Kossowska M, 2003, POLIT PSYCHOL, V24, P501, DOI 10.1111/0162-895X.00338; Lachat R, 2018, INT POLIT SCI REV, V39, P419, DOI 10.1177/0192512117692644; Latkin Carl, 2022, J Clim Chang Health, V5, P100099, DOI 10.1016/j.joclim.2021.100099; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Lindeman M, 2005, J PERS ASSESS, V85, P170, DOI 10.1207/s15327752jpa8502_09; Malka A, 2019, BRIT J POLIT SCI, V49, P1045, DOI 10.1017/S0007123417000072; Malka A, 2015, CURR DIR PSYCHOL SCI, V24, P137, DOI 10.1177/0963721414556340; Manson JH, 2020, PERS INDIV DIFFER, V167, DOI 10.1016/j.paid.2020.110251; McCann SJH, 2008, J PERS SOC PSYCHOL, V94, P913, DOI 10.1037/0022-3514.94.5.913; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Mellon J., 2020, CORONAVIRUS ATTITUDE; Middendorp C., 1978, FUNDA MENTAL DIMENSI; Mondak J. J., 2010, PERSONALITY FDN POLI; Nilsson A, 2020, CURR OPIN BEHAV SCI, V34, P148, DOI 10.1016/j.cobeha.2020.03.003; Nilsson A, 2019, PERS SOC PSYCHOL B, V45, P1440, DOI 10.1177/0146167219830415; O'Neal M, 2017, INT SPECT, V52, P28, DOI 10.1080/03932729.2017.1277645; Pavan Holur, 2020, Arxiv, DOI arXiv:2004.13783; Piurko Y, 2011, POLIT PSYCHOL, V32, P537, DOI 10.1111/j.1467-9221.2011.00828.x; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Radkiewicz P, 2013, AUTORYTARYZM BRZYTWA; Radkiewicz P., 2017, POL PSYCHOL BULL, V48, P93, DOI [10.1515/ppb-2017-0012, DOI 10.1515/PPB-2017-0012]; Raihani N, 2020, PREPRINTS; Rokeach M., 1960, OPEN CLOSED MIND; Rokeach M., 1973, NATURE HUMAN VALUES; Rothgerber H., 2020, POLITICIZING COVID 1, DOI [10.31234/osf.io/k23cv, DOI 10.31234/OSF.IO/K23CV]; Rzymski P, 2020, J INFECT PUBLIC HEAL, V13, P873, DOI 10.1016/j.jiph.2020.04.013; Sample I, 2020, COVID 19 ARE PANDEMI; Saroglou V., 2002, MENTAL HLTH RELIG CU, V5, P183, DOI 10.1080/13674670210144130; Schoen H, 2007, POLIT PSYCHOL, V28, P471, DOI 10.1111/j.1467-9221.2007.00582.x; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Schwartz SH, 2010, POLIT PSYCHOL, V31, P421, DOI 10.1111/j.1467-9221.2010.00764.x; Singer M, 2016, LAT AM RES REV, V51, P174; Skarzynska K, 2011, STUD SOCJOLOGICZNE, P85; Spector PE, 2019, J BUS PSYCHOL, V34, P125, DOI 10.1007/s10869-018-09613-8; Tatur T., 1991, J COMMUNIST STUDIES, V7, P335; TETLOCK PE, 1983, J PERS SOC PSYCHOL, V45, P118, DOI 10.1037/0022-3514.45.1.118; Thoemmes FJ, 2007, POLIT PSYCHOL, V28, P193, DOI 10.1111/j.1467-9221.2007.00562.x; Thorisdottir H, 2007, PUBLIC OPIN QUART, V71, P175, DOI 10.1093/poq/nfm008; Thorisdottir H, 2011, POLIT PSYCHOL, V32, P785, DOI 10.1111/j.1467-9221.2011.00840.x; Treier S, 2009, PUBLIC OPIN QUART, V73, P679, DOI 10.1093/poq/nfp067; Turska-Kawa A., 2017, RELIGIO REV PRORELIG, V25, P43; Turska-Kawa A., 2010, POLIT PREFER, V1, P123; uk P., 2017, J CONT CENT E EUR, V25, P63, DOI [10.1080/0965156X.2017.1339976, DOI 10.1080/0965156X.2017.1339976]; Geana MV, 2021, SSM-POPUL HLTH, V16, DOI 10.1016/j.ssmph.2021.100950; van Hiel A, 2000, PERS INDIV DIFFER, V28, P741, DOI 10.1016/S0191-8869(99)00135-X; Van Hiel A, 2007, INT J PSYCHOL, V42, P16, DOI 10.1080/00207590500411443; Van Holm E., 2020, IMPACT POLITICAL IDE, DOI 10.2139/ssrn.3573224; Vecchione M, 2011, PERS INDIV DIFFER, V51, P737, DOI 10.1016/j.paid.2011.06.015; Vermunt JK, 2002, APPL LATENT CLASS AN, P89, DOI DOI 10.1017/CBO9780511499531.004; Watson P., 1999, INT J PSYCHOL RELIG, V9, P195, DOI DOI 10.1207/s15327582ijpr0903_3; Wenzel M, 2021, EAST EUR POLITICS, V37, P552, DOI 10.1080/21599165.2020.1839422; White-Ajmani M., 2011, NDIVIDUAL DIFFER RES, V9, P153; Winter T, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00342-9; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; Xu P, 2021, PERS INDIV DIFFER, V175, DOI 10.1016/j.paid.2021.110706; Yu KM, 2003, J ROY STAT SOC D-STA, V52, P331, DOI 10.1111/1467-9884.00363; Zajenkowski M, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110199; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	119	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264502	10.1371/journal.pone.0264502	http://dx.doi.org/10.1371/journal.pone.0264502			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231046	Green Published, gold			2022-12-26	WOS:000849744700025
J	Florentino, JL; Arao, RML; Garfin, AMC; Gaviola, DMG; Tan, CR; Yadav, RP; Hiatt, T; Morishita, F; Siroka, A; Yamanaka, T; Nishikiori, N				Florentino, Jhiedon L.; Arao, Rosa Mia L.; Garfin, Anna Marie Celina; Gaviola, Donna Mae G.; Tan, Carlos R.; Yadav, Rajendra Prasad; Hiatt, Tom; Morishita, Fukushi; Siroka, Andrew; Yamanaka, Takuya; Nishikiori, Nobuyuki			Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines	PLOS ONE			English	Article							TUBERCULOSIS; DIAGNOSIS; BURDEN	Background Tuberculosis (TB) is a disease associated with poverty. Moreover, a significant proportion of TB patients face a substantial financial burden before and during TB care. One of the top targets in the End TB strategy was to achieve zero catastrophic costs due to TB by 2020. To assess patient costs related to TB care and the proportion of TB-affected households that faced catastrophic costs, the Philippines National TB Programme (NTP) conducted a national TB patient cost survey in 2016-2017. Methods A cross-sectional survey of 1,912 TB patients taking treatment in health facilities engaged with the NTP. The sample consists of 786 drug-sensitive TB (DS-TB) patients in urban facilities, 806 DS-TB patients in rural facilities, and 320 drug-resistant TB (DR-TB) patients. Catastrophic cost due to TB is defined as total costs, consisting of direct medical and non-medical costs and indirect costs net of social assistance, exceeding 20% of annual household income. Results The overall mean total cost including pre- and post-diagnostic costs was US$601. The mean total cost was five times higher among DR-TB patients than DS-TB patients. Direct non-medical costs and income loss accounted for 42.7% and 40.4% of the total cost of TB, respectively. More than 40% of households had to rely on dissaving, taking loans, or selling their assets to cope with the costs. Overall, 42.4% (95% confidence interval (95% CI): 40.2-44.6) of TB-affected households faced catastrophic costs due to TB, and it was significantly higher among DR-TB patients (89.7%, 95%CI: 86.3-93.0). A TB enabler package, which 70% of DR-TB patients received, reduced catastrophic costs by 13.1 percentage points (89.7% to 76.6%) among DR-TB patients, but only by 0.4 percentage points (42.4% to 42.0%), overall. Conclusions TB patients in the Philippines face a substantial financial burden due to TB despite free TB services provided by the National TB Programme. The TB enabler package mitigated catastrophic costs to some extent, but only for DR-TB patients. Enhancing the current social and welfare support through multisectoral collaboration is urgently required to achieve zero catastrophic costs due to TB.	[Florentino, Jhiedon L.; Arao, Rosa Mia L.; Tan, Carlos R.] UPecon Fdn Inc, Hlth Policy Dev Program HPDP, Quezon City, Philippines; [Garfin, Anna Marie Celina; Gaviola, Donna Mae G.] Natl TB Control Programme, Dept Hlth, Manila, Philippines; [Yadav, Rajendra Prasad; Hiatt, Tom] WHO, Country Off, Manila, Philippines; [Morishita, Fukushi] WHO, Reg Off Western Pacific, Manila, Philippines; [Siroka, Andrew; Yamanaka, Takuya; Nishikiori, Nobuyuki] WHO, Global TB Programme, Geneva, Switzerland; [Yamanaka, Takuya] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Yamanaka, Takuya] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan	Philippine Department Health; WHO Western Pacific Regional Office; World Health Organization; WHO Western Pacific Regional Office; World Health Organization; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Nagasaki University	Arao, RML (corresponding author), UPecon Fdn Inc, Hlth Policy Dev Program HPDP, Quezon City, Philippines.	rosamia.arao@gmail.com	Gaviola, Donna Mae Geocaniga/GPK-8224-2022	Gaviola, Donna Mae Geocaniga/0000-0003-2393-4343; Nishikiori, Nobuyuki/0000-0003-0962-8868; Yadav, Rajendra Prasad/0000-0002-0398-1313; Yamanaka, Takuya/0000-0002-0807-2370				[Anonymous], 2016, ACT ESTABLISHING COM; Barter DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-980; Carter DJ, 2018, LANCET GLOB HEALTH, V6, pE514, DOI 10.1016/S2214-109X(18)30195-5; Cegielski JP., 2004, RELATIONSHIP MALNUTR; Chittamany P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241862; Department of Health in the Philippines, 2019, REV REP 2019 PHIL TB; Department of Health. Philippines, 2020, NAT TUB CONTR PROGR, V6th; Department of Health. Philippines, 2016, PHIL NAT TUB PREV SU; Department of Health. Philippines, 2014, NAT TUB CONTR PROGR, V5th; Fernandez L, 2011, OVERVIEW PHILIPPINES; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Garfin C, 2017, J INFECT DIS, V216, pS740, DOI 10.1093/infdis/jix391; Grobler L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006086.pub4; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Laurence YV, 2015, PHARMACOECONOMICS, V33, P939, DOI 10.1007/s40273-015-0279-6; Ministry of Health Kenya, 2018, 1 KEN TUB PAT COST S; National TB Control Programme Department of Health Philippines, 2015, TUB FIN PHIL; Nhung NV, 2018, INT J TUBERC LUNG D, V22, P983, DOI 10.5588/ijtld.17.0859; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Paton NI, 2006, NUTRITION, V22, P245, DOI 10.1016/j.nut.2005.06.009; Pedrazzoli D, 2018, TROP MED INT HEALTH, V23, P870, DOI 10.1111/tmi.13085; Philippine Statistics Authority, 2016, 2015 CENS POP MAN PH; Philippines Health Insurance Corporation, 2014, REV GUID PHILH OUTP; Philippines Health Insurance Corporation, 2013, PRIM CAR BEN; Reyes CeliaM., 2012, CONDITIONAL CASH TRA; Solomon Islands Ministry of Health and Medical Services, 2020, EC EV PAT COSTS ASS; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; The World Bank, FAQS PANT PAM PIL PR; The World Health Organization, 2017, PAT COST SURV HDB; Tomeny EM, 2020, INT J TUBERC LUNG D, V24, P420, DOI 10.5588/ijtld.19.0206; Viney K, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4020094; Wells WA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001842; White LV, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60942-2; WHO, 2020, GLOB TB REP 2020; Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675; World Bank, NAT ACC DAT 2019; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization Regional Office for South-East Asia, 2001, INV PRIV MED PRACT T; World Health Organization (WHO), 2018, ENG PRIV HLTH CAR PR; World Health Organization (WHO), 2013, END TB STRAT	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264689	10.1371/journal.pone.0264689	http://dx.doi.org/10.1371/journal.pone.0264689			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226705	Green Published, gold			2022-12-26	WOS:000793394000039
J	Chang, SW; Yoshihara, T; Tsuzuki, T; Natsume, T; Kakigi, R; Machida, S; Naito, H				Chang, Shuo-wen; Yoshihara, Toshinori; Tsuzuki, Takamasa; Natsume, Toshiharu; Kakigi, Ryo; Machida, Shuichi; Naito, Hisashi			Circadian rhythms modulate the effect of eccentric exercise on rat soleus muscles	PLOS ONE			English	Article							SKELETAL-MUSCLE; RESISTANCE EXERCISE; PROTEIN-SYNTHESIS; WISTAR RATS; HYPERTROPHY; EXPRESSION; PHOSPHORYLATION; CORTICOSTERONE; INTENSITY; CLOCK	We investigated whether time-of-day dependent changes in the rat soleus (SOL) muscle size, after eccentric exercises, operate via the mechanistic target of rapamycin (mTOR) signaling pathway. For our first experiment, we assigned 9-week-old male Wistar rats randomly into four groups: light phase (zeitgeber time; ZT6) non-trained control, dark phase (ZT18) non-trained control, light phase-trained, and dark phase-trained. Trained animals performed 90 min of downhill running once every 3 d for 8 weeks. The second experiment involved dividing 9-week-old male Wistar rats to control and exercise groups. The latter were subjected to 15 min of downhill running at ZT6 and ZT1 8. The absolute (+12.8%) and relative (+9.4%) SOL muscle weights were higher in the light phase-trained group. p70S6K phosphorylation ratio was 42.6% higher in the SOL muscle of rats that had exercised only in light (non-trained ZT6). Collectively, the degree of muscle hypertrophy in SOL is time-of-day dependent, perhaps via the mTOR/p70S6K signaling.	[Chang, Shuo-wen; Yoshihara, Toshinori; Tsuzuki, Takamasa; Natsume, Toshiharu; Machida, Shuichi; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Chang, Shuo-wen] Natl Univ Tainan, Dept Phys Educ, Tainan, Taiwan; [Tsuzuki, Takamasa] Meijo Univ, Fac Pharm, Nagoya, Aichi, Japan; [Natsume, Toshiharu] Tokai Univ, Sch Med, Hiratsuka, Kanagawa, Japan; [Kakigi, Ryo] Josai Int Univ, Fac Management & Informat Sci, Chiba, Japan	Juntendo University; National University Tainan; Meijo University; Tokai University	Naito, H (corresponding author), Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan.	hnaitou@juntendo.ac.jp	Machida, Shuichi/AFK-1598-2022		Japan Society for the Promotion of Science KAKENHI [17K13192, 17K01765]; Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities	This work was supported by the Japan Society for the Promotion of Science KAKENHI under Grant number 17K13192 to S.C. and Grant number 17K01765 to T.Y.; and Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Ato S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00406; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Batacan RB, 2016, APPL PHYSIOL NUTR ME, V41, P945, DOI 10.1139/apnm-2016-0037; Burd NA, 2011, J NUTR, V141, P568, DOI 10.3945/jn.110.135038; Burd NA, 2010, J PHYSIOL-LONDON, V588, P3119, DOI 10.1113/jphysiol.2010.192856; Chacon F, 2005, CHRONOBIOL INT, V22, P253, DOI 10.1081/CBI-200053522; Chang Shuo-Wen, 2017, Biochem Biophys Rep, V9, P153, DOI 10.1016/j.bbrep.2016.12.005; Crowley MA, 1996, EUR J APPL PHYSIOL, V73, P66, DOI 10.1007/BF00262811; Dadon-Freiberg M, 2021, MOL CELL ENDOCRINOL, V521, DOI 10.1016/j.mce.2020.111108; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; Djeridane Y, 2005, CHRONOBIOL INT, V22, P975, DOI 10.1080/07420520500395094; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Farrell PA, 2000, J APPL PHYSIOL, V88, P1036, DOI 10.1152/jappl.2000.88.3.1036; GARLICK PJ, 1987, BIOCHEM J, V248, P439, DOI 10.1042/bj2480439; Gomes NF, 2016, BIOL RHYTHM RES, V47, P215, DOI 10.1080/09291016.2015.1103943; GUILLAND JC, 1988, PHYSIOL BEHAV, V42, P365, DOI 10.1016/0031-9384(88)90278-8; Guzzoni V, 2019, STRESS, V22, P377, DOI 10.1080/10253890.2019.1573364; Jager R, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0177-8; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603; Kuusmaa M, 2016, APPL PHYSIOL NUTR ME, V41, P1285, DOI 10.1139/apnm-2016-0271; Levi F, 2002, CHRONOBIOL INT, V19, P1, DOI 10.1081/CBI-120002676; Luciano TF, 2017, PHYSIOL RES, V66, P317, DOI 10.33549/physiolres.933256; McGhee NK, 2009, J NUTR, V139, P828, DOI 10.3945/jn.108.099846; Mohawk JA, 2007, PHYSIOL BEHAV, V92, P800, DOI 10.1016/j.physbeh.2007.06.009; Nader GA, 2001, J APPL PHYSIOL, V90, P1936, DOI 10.1152/jappl.2001.90.5.1936; Ogasawara R, 2018, FASEB J, V32, P5824, DOI 10.1096/fj.201701422R; Ogasawara R, 2017, J APPL PHYSIOL, V123, P710, DOI 10.1152/japplphysiol.01009.2016; Ohdo S, 2001, NAT MED, V7, P356, DOI 10.1038/85507; Rasmussen BB, 2000, J APPL PHYSIOL, V88, P386, DOI 10.1152/jappl.2000.88.2.386; RIVEST S, 1990, BRAIN RES BULL, V25, P169, DOI 10.1016/0361-9230(90)90270-A; Saracino PG, 2019, BIOCHEM BIOPH RES CO, V508, P871, DOI 10.1016/j.bbrc.2018.12.034; Sasaki D, 2007, UPSALA J MED SCI, V112, P175, DOI 10.3109/2000-1967-191; Sedliak M, 2013, BIOL RHYTHM RES, V44, P756, DOI 10.1080/09291016.2012.740314; Sedliak M, 2009, J STRENGTH COND RES, V23, P2451, DOI 10.1519/JSC.0b013e3181bb7388; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; Shavlakadze T, 2013, AM J PHYSIOL-CELL PH, V305, pC26, DOI 10.1152/ajpcell.00027.2013; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Smith HK, 1997, INT J SPORTS MED, V18, P94, DOI 10.1055/s-2007-972602; Takegaki J, 2019, BIOCHEM BIOPH RES CO, V520, P73, DOI 10.1016/j.bbrc.2019.09.050; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Touron J, 2019, MED SCI SPORT EXER, V51, P1944, DOI 10.1249/MSS.0000000000001992; Tsumiyama W, 2014, J PHYS THER SCI, V26, P1623, DOI 10.1589/jpts.26.1623; Tsumiyama W, 2014, J PHYS THER SCI, V26, P125, DOI 10.1589/jpts.26.125; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Widegren U, 2000, PFLUG ARCH EUR J PHY, V441, P317, DOI 10.1007/s004240000417; Williamson D, 2003, J PHYSIOL-LONDON, V547, P977, DOI 10.1113/jphysiol.2002.036673; Wolff G, 2012, MED SCI SPORT EXER, V44, P1663, DOI 10.1249/MSS.0b013e318255cf4c; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoshihara T, 2019, J PHYSIOL SCI, V69, P235, DOI 10.1007/s12576-018-0640-6; You JS, 2019, FASEB J, V33, P4021, DOI 10.1096/fj.201801653RR; Yu T, 2017, INT J SPORTS MED, V38, P959, DOI 10.1055/s-0043-118343	55	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264171	10.1371/journal.pone.0264171	http://dx.doi.org/10.1371/journal.pone.0264171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213577	gold, Green Published			2022-12-26	WOS:000787811000057
J	Gunter, S; Michel, FS; Fourie, SS; Singh, M; le Roux, R; Manilall, A; Mokotedi, LP; Millen, AME				Gunter, Sule; Michel, Frederic S.; Fourie, Serena S.; Singh, Mikayra; le Roux, Regina; Manilall, Ashmeetha; Mokotedi, Lebogang P.; Millen, Aletta M. E.			The effect of TNF-alpha inhibitor treatment on microRNAs and endothelial function in collagen induced arthritis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; RHEUMATOID-ARTHRITIS; PENTRAXIN 3; DYSFUNCTION; EXPRESSION; MARKER; INFLAMMATION; RECEPTOR; ETANERCEPT	Chronic inflammation causes dysregulated expression of microRNAs. Aberrant microRNA expression is associated with endothelial dysfunction. In this study we determined whether TNF-alpha inhibition impacted the expression of miRNA-146a-5p and miRNA-155-5p, and whether changes in the expression of these miRNAs were related to inflammation-induced changes in endothelial function in collagen-induced arthritis (CIA). Sixty-four Sprague-Dawley rats were divided into control (n = 24), CIA (n = 24) and CIA+etanercept (n = 16) groups. CIA and CIA+etanercept groups were immunized with bovine type-II collagen, emulsified in incomplete Freund's adjuvant. Upon signs of arthritis, the CIA+etanercept group received 10mg/kg of etanercept intraperitoneally, every three days. After six weeks of treatment, mesenteric artery vascular reactivity was assessed using wire-myography. Serum concentrations of TNF-alpha, C-reactive protein, interleukin-6, vascular adhesion molecule-1 (VCAM-1) and pentraxin-3 (PTX-3) were measured by ELISA. Relative expression of circulating miRNA-146a-5p and miRNA-155-5p were determined using RT-qPCR. Compared to controls, circulating miRNA-155-5p, VCAM-1 and PTX-3 concentrations were increased, and vessel relaxation was impaired in the CIA (all p<0.05), but not in the CIA+etanercept (all p<0.05) groups. The CIA group had greater miRNA-146a-5p expression compared to the CIA+etanercept group (p = 0.005). Independent of blood pressure, miRNA-146a-5p expression was associated with increased PTX-3 concentrations (p = 0.03), while miRNA-155-5p expression was associated with impaired vessel relaxation (p = 0.01). In conclusion, blocking circulating TNF-alpha impacted systemic inflammation-induced increased expression of miRNA-146a-5p and miRNA-155-5p, which were associated with endothelial inflammation and impaired endothelial dependent vasorelaxation, respectively.	[Gunter, Sule; Michel, Frederic S.; Fourie, Serena S.; Singh, Mikayra; le Roux, Regina; Manilall, Ashmeetha; Mokotedi, Lebogang P.; Millen, Aletta M. E.] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Johannesburg, South Africa	University of Witwatersrand	Gunter, S (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Johannesburg, South Africa.	sule.gunter@wits.ac.za		Millen, Aletta/0000-0002-4831-7336; Fourie, Serena Skye/0000-0001-6443-3946; Gunter (Dreyer), Sule/0000-0002-1711-5934; Mokotedi, Lebogang/0000-0002-1520-7093	National Research Foundation (Thuthuka grant); Faculty of Health Sciences Research Committee at the University of the Witwatersrand [TTK180419322656]	National Research Foundation (Thuthuka grant); Faculty of Health Sciences Research Committee at the University of the Witwatersrand	This work was supported by the National Research Foundation (Thuthuka grant) and the Faculty of Health Sciences Research Committee at the University of the Witwatersrand (Grant number: TTK180419322656; Grant holder: AMEM; URL:https://www.nrf.ac.za/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zeid A, 2011, GENET TEST MOL BIOMA, V15, P807, DOI 10.1089/gtmb.2011.0026; Ait-Aissa K, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01107-3; Alivernini S, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01932; Alom-Ruiz SP, 2008, ANTIOXID REDOX SIGN, V10, P1089, DOI 10.1089/ars.2007.2007; Ambrosino P, 2015, THROMB HAEMOSTASIS, V113, P916, DOI 10.1160/TH14-11-0921; Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; Anderson TJ, 2006, CAN J CARDIOL, V22, p72B, DOI 10.1016/S0828-282X(06)70990-4; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Bae SC, 2018, INT J RHEUM DIS, V21, P1335, DOI 10.1111/1756-185X.13338; Baniaamam M, 2018, EXPERT OPIN BIOL TH, V18, P585, DOI 10.1080/14712598.2018.1462794; Bogunia-Kubik K, 2016, ARCH IMMUNOL THER EX, V64, pS131, DOI 10.1007/s00005-016-0443-5; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Booth AD, 2004, CIRCULATION, V109, P1718, DOI 10.1161/01.CIR.0000124720.18538.DD; Camici GG, 2015, EUR HEART J, V36, P3392, DOI 10.1093/eurheartj/ehv587; Carrizzo A, 2015, CIRCULATION, V131, P1495, DOI 10.1161/CIRCULATIONAHA.114.014822; Castro-Villegas C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0555-z; Chen ZZ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006775; Cheng HS, 2017, CIRC RES, V121, P354, DOI 10.1161/CIRCRESAHA.116.310529; Cheng Y, 2012, INFLAMMATION, V35, P1308, DOI 10.1007/s10753-012-9443-8; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Moran-Moguel MC, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2474529; del Monte A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198932; Deyab G, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1439-1; Fejes Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197890; Gonzalez MA, 2003, AM J MED, V115, P99, DOI 10.1016/j.amjmed.2003.09.016; Gonzalez-Gay MA, 2009, CLIN EXP RHEUMATOL, V27, P452; Guo QY, 2019, MED SCI MONITOR, V25, P8820, DOI 10.12659/MSM.919721; Katagiri H, 2008, SHOCK, V30, P463, DOI 10.1097/SHK.0b013e3181673f54; Le Roux R, 2022, CLIN EXP RHEUMATOL, V40, P24, DOI 10.55563/clinexprheumatol/l4nnv0; Li XC, 2013, INT J MOL SCI, V14, P23910, DOI 10.3390/ijms141223910; Li Y, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/893594; Lin YJ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040880; Lippi G, 2018, CLIN CHEM LAB MED, V56, P718, DOI 10.1515/cclm-2017-1104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann DL, 2008, CTS-CLIN TRANSL SCI, V1, P142, DOI 10.1111/j.1752-8062.2008.00013.x; Mathieu Sylvain, 2013, Semin Arthritis Rheum, V43, pe1, DOI 10.1016/j.semarthrit.2013.05.005; Mensa E, 2018, BRIT J DERMATOL, V179, P787, DOI 10.1111/bjd.16659; Mokotedi L, 2019, EUR J PHARMACOL, V865, DOI 10.1016/j.ejphar.2019.172786; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Olivieri F, 2013, AGE, V35, P1157, DOI 10.1007/s11357-012-9440-8; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Presta M, 2007, J CELL MOL MED, V11, P723, DOI 10.1111/j.1582-4934.2007.00061.x; Ristagno G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00823; Salehi E, 2015, CLIN RHEUMATOL, V34, P615, DOI 10.1007/s10067-015-2898-x; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Serafin Alice, 2014, BMC Res Notes, V7, P715, DOI 10.1186/1756-0500-7-715; Sharma A, 2018, CLIN CHIM ACTA, V480, P65, DOI 10.1016/j.cca.2018.01.035; Sharma AR, 2016, MED RES REV, V36, P425, DOI 10.1002/med.21384; Sidiropoulos PI, 2009, SCAND J RHEUMATOL, V38, P6, DOI 10.1080/03009740802363768; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Steyers CM, 2014, INT J MOL SCI, V15, P11324, DOI 10.3390/ijms150711324; Sun HX, 2012, HYPERTENSION, V60, P1407, DOI 10.1161/HYPERTENSIONAHA.112.197301; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Totoson P, 2016, RHEUMATOLOGY, V55, P1308, DOI 10.1093/rheumatology/kew062; Troncoso MF, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166170; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wang JL, 2016, YONSEI MED J, V57, P298, DOI 10.3349/ymj.2016.57.2.298; Wilson SJ, 2007, ARTERIOSCL THROM VAS, V27, P290, DOI 10.1161/01.ATV.0000252667.53790.4e; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Zheng B, 2017, MOL THER, V25, P1279, DOI 10.1016/j.ymthe.2017.03.031; Zhong L, 2018, FASEB J, V32, P4070, DOI 10.1096/fj.201701536R; Zuchi C, 2020, HEART FAIL REV, V25, P21, DOI 10.1007/s10741-019-09881-3	64	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264558	10.1371/journal.pone.0264558	http://dx.doi.org/10.1371/journal.pone.0264558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213638	gold, Green Published			2022-12-26	WOS:000787811000121
J	Huang, M; Hasan, MK; Rathore, K; Baky, MAH; Lassalle, J; Kraus, J; Burnette, M; Campbell, C; Wang, KP; Jemison, H; Pillai, S; Pharr, M; Staack, D				Huang, Min; Hasan, Md Kamrul; Rathore, Kavita; Baky, Md Abdullah Hil; Lassalle, John; Kraus, Jamie; Burnette, Matthew; Campbell, Christopher; Wang, Kunpeng; Jemison, Howard; Pillai, Suresh; Pharr, Matt; Staack, David			Plasma generated ozone and reactive oxygen species for point of use PPE decontamination system	PLOS ONE			English	Article							DISCHARGE PHYSICS; HYDROGEN-PEROXIDE; CONTACT-ANGLE; INACTIVATION; GAS; AIR; DEGRADATION; SPORES; RUBBER	This paper reports a plasma reactive oxygen species (ROS) method for decontamination of PPE (N95 respirators and gowns) using a surface DBD source to meet the increased need of PPE due to the COVID-19 pandemic. A system is presented consisting of a mobile trailer (35 m3) along with several Dielectric barrier discharge sources installed for generating a plasma ROS level to achieve viral decontamination. The plasma ROS treated respirators were evaluated at the CDC NPPTL, and additional PPE specimens and material functionality testing were performed at Texas A&M. The effects of decontamination on the performance of respirators were tested using a modified version of the NIOSH Standard Test Procedure TEB-APR-STP-0059 to determine particulate filtration efficiency. The treated Prestige Ameritech and BYD brand N95 respirators show filtration efficiencies greater than 95% and maintain their integrity. The overall mechanical and functionality tests for plasma ROS treated PPE show no significant variations.	[Huang, Min; Hasan, Md Kamrul; Rathore, Kavita; Baky, Md Abdullah Hil; Lassalle, John; Kraus, Jamie; Burnette, Matthew; Campbell, Christopher; Pharr, Matt; Staack, David] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA; [Wang, Kunpeng; Jemison, Howard] LTEOIL LLC, Houston, TX USA; [Pillai, Suresh] Texas A&M Univ, Ctr Electron Beam Food Res, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Staack, D (corresponding author), Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.	dstaack@tamu.edu		Hasan, Md Kamrul/0000-0003-3612-7284; Staack, David/0000-0002-8916-1390; Huang, Min/0000-0002-5662-6219; Baky, Md Abdullah Hil/0000-0003-3676-3475				2NIOSH, 2020, ASSESSMENT FILTER PE, P9; Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; ANDREWS EH, 1961, J POLYM SCI, V55, P787, DOI 10.1002/pol.1961.1205516231; [Anonymous], 2019, C61819 ASTM, DOI DOI 10.1520/C0618-19; [Anonymous], 2008, 100 JCGM; [Anonymous], 2021, D412 16 1; [Anonymous], 2014, D770814 ASTM, DOI DOI 10.1520/D7708-14; Aydogan A, 2006, J AIR WASTE MANAGE, V56, P179, DOI 10.1080/10473289.2006.10464443; BAILEY PS, 1958, CHEM REV, V58, P925, DOI 10.1021/cr50023a005; Bayarri B, 2021, J HAZARD MATER, V415, DOI 10.1016/j.jhazmat.2021.125658; Beachell HC., 1959, ADV CHEM SER, V21, P168; Bin Kamaruddin S., 2013, LONG TERM MECH PROPE; Black VJ, 2007, NEW PHYTOL, V176, P150, DOI 10.1111/j.1469-8137.2007.02163.x; Blanchard EL., 2020, MEDRXIV PREPRINT SER; Boast N., 2008, APPARATUS METHOD USI; BOENIGER MF, 1995, AM IND HYG ASSOC J, V56, P590, DOI 10.1202/0002-8894(1995)056<0590:UOOGDT>2.0.CO;2; Burki T, 2020, LANCET INFECT DIS, V20, P785, DOI 10.1016/S1473-3099(20)30501-6; Rubio-Romero JC, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104830; Castillo E, 2017, J OBSTET GYNAECOL CA, V39, P181, DOI 10.1016/j.jogc.2016.11.001; Cataldo F, 2003, POLYM DEGRAD STABIL, V82, P487, DOI 10.1016/S0141-3910(03)00204-0; Celina MC, 2013, POLYM DEGRAD STABIL, V98, P2419, DOI 10.1016/j.polymdegradstab.2013.06.024; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; Dobrynin D, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103033; Dubuis ME, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253022; Filipic A, 2020, TRENDS BIOTECHNOL, V38, P1278, DOI 10.1016/j.tibtech.2020.04.003; Foarde KK., 1997, APPL OCCUP ENVIRON H, V12, P535; Griffiths N, 1993, Med Device Technol, V4, P37; Grignani E., 2021, GASES, V1, P19, DOI DOI 10.3390/GASES1010002; Guceri S., 2008, PLASMA ASSISTED DECO; He HC, 2020, COLLOID SURFACE A, V584, DOI 10.1016/j.colsurfa.2019.123973; Huang FL, 2006, POLYM TEST, V25, P22, DOI 10.1016/j.polymertesting.2005.09.017; Hudson JB, 2007, J HOSP INFECT, V66, P40, DOI 10.1016/j.jhin.2006.12.021; Hudson JB, 2009, OZONE-SCI ENG, V31, P216, DOI 10.1080/01919510902747969; Institute of Medicine of the National Academies, 2006, REUSABILITY FACEMASK; ISHIZAKI K, 1986, J APPL BACTERIOL, V60, P67, DOI 10.1111/j.1365-2672.1986.tb01067.x; Jaya GW., 2018, OISAA J INDONES EMAS, V01, P16; Khadre MA, 2001, INT J FOOD MICROBIOL, V71, P131, DOI 10.1016/S0168-1605(01)00561-X; Kitayama J, 1999, J PHYS D APPL PHYS, V32, P3032, DOI 10.1088/0022-3727/32/23/309; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; KOGELSCHATZ U, 1988, OZONE-SCI ENG, V10, P367; Kowalski WJ, 1998, OZONE-SCI ENG, V20, P205, DOI 10.1080/01919519808547272; Kramer B, 2020, J APPL MICROBIOL, V128, P920, DOI 10.1111/jam.14528; Kumkrong P, 2021, J HOSP INFECT, V111, P117, DOI 10.1016/j.jhin.2021.02.018; Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220; Mahfoudh A, 2010, OZONE-SCI ENG, V32, P180, DOI 10.1080/01919511003791971; Martin S B Jr, 2000, Appl Occup Environ Hyg, V15, P609; Mazyavkina Nina, 2020, EUR J NEUROSCI, DOI [10.1016/j.medj.2022.03.004, DOI 10.1016/0735-1933(85)90003-X]; Middleton J, 2013, POLYM DEGRAD STABIL, V98, P436, DOI 10.1016/j.polymdegradstab.2012.08.018; Moat J, 2009, CAN J MICROBIOL, V55, P928, DOI [10.1139/W09-046, 10.1139/w09-046]; Moisan M, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/28/285404; Nair TM, 2004, J APPL POLYM SCI, V93, P2606, DOI 10.1002/app.20669; Pai K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35166-0; Pekarek S., 2003, ACTA POLYTECH, V43; Perkins DJ, 2020, EXP BIOL MED, V245, P933, DOI 10.1177/1535370220925768; PEYROUS R, 1990, OZONE-SCI ENG, V12, P41; Restagno F, 2009, LANGMUIR, V25, P11188, DOI 10.1021/la901616x; Rice RG, 2009, OZONE-SCI ENG, V31, P357, DOI 10.1080/01919510903170419; Robert Jay R., 2020, J INFECT DIS EPIDEMI, V6, P1; Rowan NJ, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138532; Rubel GO, 1997, J APPL MICROBIOL, V83, P243, DOI 10.1046/j.1365-2672.1997.00222.x; Sakudo A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/694269; SATO H, 1990, EXP ANIM TOKYO, V39, P223, DOI 10.1538/expanim1978.39.2_223; Sharma M, 2008, AM J INFECT CONTROL, V36, P559, DOI 10.1016/j.ajic.2007.10.021; Stalder AF, 2010, COLLOID SURFACE A, V364, P72, DOI 10.1016/j.colsurfa.2010.04.040; Tai C., 2011, COLD PLASMAS AERISA; Terms D., 2004, DEFORMATION RELATED, V98, P1; Tseng C, 2008, J ENVIRON HEALTH, V70, P56; U.S. FOOD & DRUG, 2020, RECOMMENDATIONS SPON; Weiss M, 2017, J MED VIROL, V89, P952, DOI 10.1002/jmv.24701; Westphal AJ, 2003, P NATL ACAD SCI USA, V100, P3461, DOI 10.1073/pnas.232710999; Wickramanayake GB., 1991, DISINFECTION STERILI; Young SB, 2004, J APPL MICROBIOL, V96, P1133, DOI 10.1111/j.1365-2672.2004.02236.x; Zheng BD, 2019, J MATER SCI, V54, P5802, DOI 10.1007/s10853-018-03235-4	73	3	3	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0262818	10.1371/journal.pone.0262818	http://dx.doi.org/10.1371/journal.pone.0262818			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213564	gold, Green Published, Green Submitted			2022-12-26	WOS:000787811000012
J	Oshima, Y; Shinojima, A; Sawa, M; Mori, R; Sekiryu, T; Kato, A; Hara, C; Saito, M; Sugano, Y; Hirano, Y; Asato, H; Nakamura, M; Kimura, E; Yuzawa, M; Ishibashi, T; Ogura, Y; Iida, T; Gomi, F; Yasukawa, T				Oshima, Yuji; Shinojima, Ari; Sawa, Miki; Mori, Ryusaburo; Sekiryu, Tetsuju; Kato, Aki; Hara, Chikako; Saito, Masaaki; Sugano, Yukinori; Hirano, Yoshio; Asato, Hitomi; Nakamura, Mayumi; Kimura, Erika; Yuzawa, Mitsuko; Ishibashi, Tatsuro; Ogura, Yuichiro; Iida, Tomohiro; Gomi, Fumi; Yasukawa, Tsutomu			Progression of age-related macular degeneration in eyes with abnormal fundus autofluorescence in a Japanese population: JFAM study report 3	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION SECONDARY; FELLOW EYES; INTRAVITREAL AFLIBERCEPT; COST-EFFECTIVENESS; RISK-FACTORS; 2ND EYE; RANIBIZUMAB; PATTERNS; ONSET	Purpose To evaluate the progression of early age-related macular degeneration to neovascular age-related macular degeneration (nAMD), and identify the abnormal fundus autofluorescence (FAF) patterns and markers of choroidal neovascularization (CNV) in fellow eyes of patients with unilateral nAMD. Methods Sixty-six patients with unilateral nAMD who developed abnormal FAF in the fellow eyes were enrolled in this multicenter, prospective, observational study, and followed-up for 5 years. FAF images on Heidelberg Retina Angiogram Digital Angiography System (HRA) or HRA2 were classified into eight patterns based on the International Fundus Autofluorescence Classification Group system. The patients in which the fellow eyes progressed to advanced nAMD, including those who did not develop nAMD, were assessed based on the following factors: baseline FAF patterns, age, sex, visual acuity, drusen, retinal pigmentation, baseline retinal sensitivity, family history, smoking, supplement intake, hypertension, body mass index, and hematological parameters. Results Of the 66 patients, 20 dropped out of the study. Of the remaining 46 patients, 14 (30.42%, male: 9, female: 5) progressed to nAMD during the 5-year follow-up. The most common (50% eyes) FAF pattern in the fellow eyes was the patchy pattern. According to the univariate analysis, CNV development was significantly associated with age, supplement intake, and low-density lipoprotein levels (p<0.05). Multivariable analysis revealed that patients who showed non-compliance with the supplement intake were more likely to develop nAMD (p<0.05). No significant association was found between the patchy pattern and CNV development (p = 0.86). Conclusion The fellow eyes (with abnormal FAF) of patients with unilateral nAMD may progress from early to advanced nAMD. However, no FAF pattern was found that predicted progression in nAMD.	[Oshima, Yuji; Asato, Hitomi; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan; [Oshima, Yuji] Fukuoka Dent Coll, Dept Med, Sect Ophthalmol, Fukuoka, Japan; [Shinojima, Ari; Mori, Ryusaburo; Yuzawa, Mitsuko] Nihon Univ, Dept Visual Sci, Div Ophthalmol, Sch Med, Tokyo, Japan; [Shinojima, Ari] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Sawa, Miki; Hara, Chikako; Gomi, Fumi] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan; [Sekiryu, Tetsuju; Saito, Masaaki; Sugano, Yukinori; Iida, Tomohiro] Fukushima Med Univ, Dept Ophthalmol, Sch Med, Fukushima, Japan; [Kato, Aki; Hirano, Yoshio; Ogura, Yuichiro; Yasukawa, Tsutomu] Nagoya City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Saito, Masaaki] Akita Univ, Grad Sch Med, Dept Ophthalmol, Akita, Japan; [Saito, Masaaki] Akita Univ, Fac Med, Akita, Japan; [Nakamura, Mayumi; Kimura, Erika] Santen Pharmaceut Co Ltd, Ikoma, Japan; [Kimura, Erika] Santen SERI Open Innovat Ctr, Singapore, Singapore; [Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Tokyo, Japan; [Gomi, Fumi] Hyogo Coll Med, Dept Ophthalmol, Nishinomiya, Hyogo, Japan	Kyushu University; Fukuoka Dental College (FDC); Nihon University; Keio University; Osaka University; Fukushima Medical University; Nagoya City University; Akita University; Akita University; Santen Pharmaceutical Co Ltd; Tokyo Women's Medical University; Hyogo College of Medicine	Yasukawa, T (corresponding author), Nagoya City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Nagoya, Aichi, Japan.	yasukawa@med.nagoya-cu.ac.jp		Shinojima, Ari/0000-0003-2322-0332	JSPS KAKENHI [21K09677]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by the JSPS KAKENHI Grant Number (Kiban C 21K09677 (to Y. O.). The funders had no role in study design, data collection and analysis, decision to publish, and prepared of the manuscript.	Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Batioglu F, 2014, OPTOMETRY VISION SCI, V91, P950, DOI 10.1097/OPX.0000000000000321; Bindewald A, 2005, INVEST OPHTH VIS SCI, V46, P3309, DOI 10.1167/iovs.04-0430; Bressler NM, 2012, RETINA-J RET VIT DIS, V32, P1821, DOI 10.1097/IAE.0b013e31825db6ba; Cachulo L, 2011, OPHTHALMOLOGICA, V225, P144, DOI 10.1159/000321064; Chakravarthy U, 2006, OPHTHALMOLOGY, V113, P1508, DOI 10.1016/j.ophtha.2006.02.064; Dugel PU, 2020, OPHTHALMOLOGY, V127, P72, DOI 10.1016/j.ophtha.2019.04.017; Einbock W, 2005, GRAEF ARCH CLIN EXP, V243, P300, DOI 10.1007/s00417-004-1027-3; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Francis PJ, 2011, CLIN OPHTHALMOL, V5, P1127, DOI 10.2147/OPTH.S11627; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Hernandez L, 2018, J MANAG CARE SPEC PH, V24, P608, DOI 10.18553/jmcp.2018.24.7.608; Joachim N, 2017, BRIT J OPHTHALMOL, V101, P1185, DOI 10.1136/bjophthalmol-2016-309729; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Maguire MG, 1997, ARCH OPHTHALMOL-CHIC, V115, P741; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Shinojima A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229694; Silva R, 2011, OPHTHALMOLOGICA, V226, DOI 10.1159/000329473; Smith RT, 2006, INVEST OPHTH VIS SCI, V47, P5495, DOI 10.1167/iovs.05-1318; Solomon SD, 2007, ARCH OPHTHALMOL-CHIC, V125, P1323; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Ueta T, 2008, AM J OPHTHALMOL, V146, P96, DOI 10.1016/j.ajo.2008.03.002; Uyama M, 2000, BRIT J OPHTHALMOL, V84, P1018, DOI 10.1136/bjo.84.9.1018; Warrow DJ, 2013, RETINA-J RET VIT DIS, V33, P1659, DOI 10.1097/IAE.0b013e3182953df4; Yanagi Y, 2018, JAMA OPHTHALMOL, V136, P905, DOI 10.1001/jamaophthalmol.2018.2154; Yanagi Y, 2017, INVEST OPHTH VIS SCI, V58, P3488, DOI 10.1167/iovs.16-21167; Yanagi Y, 2017, J MED ECON, V20, P204, DOI 10.1080/13696998.2016.1245196; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017; Yasukawa T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213161	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264703	10.1371/journal.pone.026470	http://dx.doi.org/10.1371/journal.pone.026470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213672				2022-12-26	WOS:000787811000135
J	Muthamilselvan, S; Raghavendran, A; Palaniappan, A				Muthamilselvan, Sangeetha; Raghavendran, Abirami; Palaniappan, Ashok			Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression	PLOS ONE			English	Article							HUMAN-COLON; GENE SET; EXPRESSION; PHENOTYPE; INSTABILITY; REVEALS; DISEASE; MARKERS	Background Aberrant DNA methylation acts epigenetically to skew the gene transcription rate up or down, contributing to cancer etiology. A gap in our understanding concerns the epigenomics of stagewise cancer progression. In this study, we have developed a comprehensive computational framework for the stage-differentiated modelling of DNA methylation landscapes in colorectal cancer (CRC). Methods The methylation beta-matrix was derived from the public-domain TCGA data, converted into M-value matrix, annotated with AJCC stages, and analysed for stage-salient genes using an ensemble of approaches involving stage-differentiated modelling of methylation patterns and/or expression patterns. Differentially methylated genes (DMGs) were identified using a contrast against controls (adjusted p-value <0.001 and vertical bar log fold-change of M-value vertical bar >2), and then filtered using a series of all possible pairwise stage contrasts (p-value <0.05) to obtain stage-salient DMGs. These were then subjected to a consensus analysis, followed by matching with clinical data and performing Kaplan-Meier survival analysis to evaluate the impact of methylation patterns of consensus stage-salient biomarkers on disease prognosis. Results We found significant genome-wide changes in methylation patterns in cancer cases relative to controls agnostic of stage. The stage-differentiated models yielded the following consensus salient genes: one stage-I gene (FBN1), one stage-II gene (FOXG1), one stage-III gene (HCN1) and four stage-IV genes (NELL1, ZNF135, FAM123A, LAMA1). All the biomarkers were significantly hypermethylated in the promoter regions, indicating down-regulation of expression and implying a putative CpG island Methylator Phenotype (CIMP) manifestation. A prognostic signature consisting of FBN1 and FOXG1 survived all the analytical filters, and represents a novel early-stage epigenetic biomarker / target. Conclusions We have designed and executed a workflow for stage-differentiated epigenomic analysis of colorectal cancer progression, and identified several stage-salient diagnostic biomarkers, and an early-stage prognostic biomarker panel. The study has led to the discovery of an alternative CIMP-like signature in colorectal cancer, reinforcing the role of CIMP drivers in tumor pathophysiology.	[Muthamilselvan, Sangeetha; Raghavendran, Abirami; Palaniappan, Ashok] SASTRA Deemed Univ, Sch Chem & BioTechnol, Dept Bioinformat, Thanjavur, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Palaniappan, A (corresponding author), SASTRA Deemed Univ, Sch Chem & BioTechnol, Dept Bioinformat, Thanjavur, India.	apalania@scbt.sastra.edu	Palaniappan, Ashok/AAD-9018-2020	Palaniappan, Ashok/0000-0003-2841-9527	DST-SERB [EMR/2017/000470/BBM]	DST-SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	This work has been funded by DST-SERB grant EMR/2017/000470/BBM to A.P. (Department of Science & Technology -Science & Engineering Research Board, Govt. of India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2015, NUCLEIC ACIDS RES, V43, pD844, DOI 10.1093/nar/gku770; Advani SM, 2018, TRANSL ONCOL, V11, P1188, DOI 10.1016/j.tranon.2018.07.008; Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; [Anonymous], 2013, ANAL READY STANDARDI; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashktorab H, 2014, CURR COLORECT CANC R, V10, P425, DOI 10.1007/s11888-014-0245-2; Ashktorab H, 2013, EPIGENETICS-US, V8, P807, DOI 10.4161/epi.25497; Atwell Lauren L, 2015, Curr Pharmacol Rep, V1, P102; Barfield RT, 2012, BIOINFORMATICS, V28, P1280, DOI 10.1093/bioinformatics/bts124; Berg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086657; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Carethers JM, 2015, GASTROENTEROLOGY, V149, P1177, DOI 10.1053/j.gastro.2015.06.047; Carpenter BL, 2018, P NATL ACAD SCI USA, V115, pE11970, DOI 10.1073/pnas.1815005115; Cedoz PL, 2018, BIOINFORMATICS, V34, P3044, DOI 10.1093/bioinformatics/bty156; Chan DW, 2009, BRIT J CANCER, V101, P1433, DOI 10.1038/sj.bjc.6605316; Chen JJ, 2017, CANCER BIOL MED, V14, P42, DOI 10.20892/j.issn.2095-3941.2016.0082; Chen XD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17316-z; Cho NY, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010051; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Draht MXG, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0461-8; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Ehrlich M, 2019, EPIGENETICS-US, V14, P1141, DOI 10.1080/15592294.2019.1638701; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fang SQ, 2018, J CANCER RES THER, V14, P201, DOI 10.4103/0973-1482.199787; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Feng YY, 2020, CANCER BIOL THER, V21, P1119, DOI 10.1080/15384047.2020.1833811; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Freitas M, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1415-9; Galamb O, 2016, EPIGENETICS-US, V11, P588, DOI 10.1080/15592294.2016.1190894; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Gundert M, 2019, GUT, V68, P101, DOI 10.1136/gutjnl-2017-314711; Guo Q, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0695-4; Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jia M, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0191-8; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kassambara Alboukadel, 2021, CRAN; Kerachian MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59690-0; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Li WH, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/657570; Lieu CH, 2019, CLIN CANCER RES, V25, P5852, DOI 10.1158/1078-0432.CCR-19-0899; Lin SH, 2018, GUT, V67, P1299, DOI 10.1136/gutjnl-2016-313573; Lind GE, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-85; Ma XT, 2013, EPIGENOMICS-UK, V5, P301, DOI [10.2217/EPI.13.26, 10.2217/epi.13.26]; Ma ZY, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/2673543; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Phan NN, 2017, TRANSL CANCER RES, V6, P698, DOI 10.21037/tcr.2017.07.22; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Peters TJ, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-6; R Core Team, 2020, R LANG ENV STAT COMP; Reyes HD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54401-w; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sakai LY, 2016, GENE, V591, P279, DOI 10.1016/j.gene.2016.07.033; Sanz-Pamplona R, 2015, CLIN CANCER RES, V21, P4709, DOI 10.1158/1078-0432.CCR-15-0159; Sarathi A, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5838-3; Schnekenburger M, 2016, CURR TOP MED CHEM, V16, P745, DOI 10.2174/1568026615666150825141330; Siesser PF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002871; Sondka Z, 2018, NAT REV CANCER, V18, P696, DOI 10.1038/s41568-018-0060-1; Stunnenberg HG, 2016, CELL, V167, P1145, DOI 10.1016/j.cell.2016.11.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teng HF, 2018, MOL MED REP, V18, P5361, DOI 10.3892/mmr.2018.9563; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Timp W, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0061-y; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Toyota M, 2000, ELECTROPHORESIS, V21, P329, DOI 10.1002/(SICI)1522-2683(20000101)21:2<329::AID-ELPS329>3.0.CO;2-9; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Vrba L, 2018, EPIGENETICS-US, V13, P61, DOI 10.1080/15592294.2017.1412907; Wang Y, 2019, BIOINFORMATICS, V35, P3635, DOI 10.1093/bioinformatics/btz137; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wu Haixia, 2018, Sheng Wu Gong Cheng Xue Bao, V34, P752, DOI 10.13345/j.cjb.170389; Xi T, 2017, PATHOL RES PRACT, V213, P83, DOI 10.1016/j.prp.2016.12.007; Zhang H, 2020, EXP THER MED, V19, P3042, DOI 10.3892/etm.2020.8565; Zheng XR, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1433-3; Zitt M, 2007, DIS MARKERS, V23, P51, DOI 10.1155/2007/891967	87	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0249151	10.1371/journal.pone.0249151	http://dx.doi.org/10.1371/journal.pone.0249151			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202405	Green Published, gold			2022-12-26	WOS:000773224600001
J	Shaban, M; Amara, AW				Shaban, Mohamed; Amara, Amy W.			Resting-state electroencephalography based deep-learning for the detection of Parkinson's disease	PLOS ONE			English	Article							REM-SLEEP; EEG	Parkinson's disease (PD) is one of the most serious and challenging neurodegenerative disorders to diagnose. Clinical diagnosis on observing motor symptoms is the gold standard, yet by this point nerve cells are degenerated resulting in a lower efficacy of therapeutic treatments. In this study, we introduce a deep-learning approach based on a recently-proposed 20-Layer Convolutional Neural Network (CNN) applied on the visual realization of the Wavelet domain of a resting-state EEG. The proposed approach was able to efficiently and accurately detect PD as well as distinguish subjects with PD on medications from subjects who are off medication. The gradient-weighted class activation mapping (Grad-CAM) was used to visualize the features based on which the approach provided the predictions. A significantly high accuracy, sensitivity, specificity, AUC, and Weighted Kappa Score up to 99.9% were achieved and the visualization of the regions in the Wavelet images that contributed to the deep-learning approach decisions was provided. The proposed framework can then serve as an effective computer-aided diagnostic tool that will support physicians and scientists in further understanding the nature of PD and providing an objective and confident opinion regarding the clinical diagnosis of the disease.	[Shaban, Mohamed] Univ S Alabama, Elect & Comp Engn, Mobile, AL 36688 USA; [Amara, Amy W.] Univ Alabama Birmingham, Neurol, Birmingham, AL USA	University of South Alabama; University of Alabama System; University of Alabama Birmingham	Shaban, M (corresponding author), Univ S Alabama, Elect & Comp Engn, Mobile, AL 36688 USA.	mshaban@southalabama.edu		Amara, Amy/0000-0003-0762-9656; Shaban, Mohamed/0000-0003-4900-1859	Woodrow W. Everett, Jr. SCEEE Development Fund; Southeastern Association of Electrical Engineering Department Heads	Woodrow W. Everett, Jr. SCEEE Development Fund; Southeastern Association of Electrical Engineering Department Heads	Partial support of this research was provided by the Woodrow W. Everett, Jr. SCEEE Development Fund in cooperation with the Southeastern Association of Electrical Engineering Department Heads. There was no additional external funding received for this study.	Aygun D., 2018, SLEEP DISORDERS PARK; Bosboom JLW, 2006, CLIN NEUROPHYSIOL, V117, P2521, DOI 10.1016/j.clinph.2006.06.720; Chahine LM, 2017, SLEEP MED REV, V35, P33, DOI 10.1016/j.smrv.2016.08.001; Christensen JAE, 2016, CLIN NEUROPHYSIOL, V127, P537, DOI 10.1016/j.clinph.2015.03.006; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Drotar P, 2014, COMPUT METH PROG BIO, V117, P405, DOI 10.1016/j.cmpb.2014.08.007; El Maachi I, 2020, EXPERT SYST APPL, V143, DOI 10.1016/j.eswa.2019.113075; Eskofier BM, 2016, IEEE ENG MED BIO, P655, DOI 10.1109/EMBC.2016.7590787; Frid A, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON THE SCIENCE OF ELECTRICAL ENGINEERING (ICSEE); Gunduz H, 2019, IEEE ACCESS, V7, P115540, DOI 10.1109/ACCESS.2019.2936564; Hassoun MH., 1995, FUNDAMENTALS ARTIFIC, DOI 10.1109/JPROC.1996.503146; Karabayir I, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01250-7; Khare S., 2021, BIOCYBERN BIOMED ENG, V41, DOI [10.1016/j.bbe.2021.04.006, DOI 10.1016/J.BBE.2021.04.006]; Khare SK, 2021, IEEE SENS J, V21, P17017, DOI 10.1109/JSEN.2021.3080135; Koch M, 2019, IEEE INT CONF BIG DA, P4845; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Larochelle H., 2007, P 24 INT C MACH LEAR, P473, DOI DOI 10.1145/1273496.1273556; Latreille V, 2016, BRAIN, V139, P1189, DOI 10.1093/brain/aww018; Lee S, 2019, IEEE GLOB CONF SIG; Likas A, 2003, PATTERN RECOGN, V36, P451, DOI 10.1016/S0031-3203(02)00060-2; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Loh HW, 2021, ELECTRONICS-SWITZ, V10, DOI 10.3390/electronics10141740; Moon S, 2020, J NEUROENG REHABIL, V17, DOI 10.1186/s12984-020-00756-5; Muniz AMS, 2010, J BIOMECH, V43, P720, DOI 10.1016/j.jbiomech.2009.10.018; Murugappan M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242014; NEUFELD MY, 1994, DEMENTIA, V5, P23, DOI 10.1159/000106690; O'Shea K., 2016, NEURAL EVOLUTIONARY; Oh SL, 2020, NEURAL COMPUT APPL, V32, P10927, DOI 10.1007/s00521-018-3689-5; Pereira CR, 2018, ARTIF INTELL MED, V87, P67, DOI 10.1016/j.artmed.2018.04.001; Pereira CR, 2016, LECT NOTES COMPUT SC, V9605, P377, DOI 10.1007/978-3-319-50478-0_19; Pereira CR, 2015, COMP MED SY, P171, DOI 10.1109/CBMS.2015.34; Perlmutter Joel S, 2009, Curr Protoc Neurosci, VChapter 10, DOI 10.1002/0471142301.ns1001s49; Pezard L, 2001, CLIN NEUROPHYSIOL, V112, P38, DOI 10.1016/S1388-2457(00)00512-5; Pfister FMJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61789-3; Prasuhn Jannik, 2020, Neurol Res Pract, V2, P46, DOI 10.1186/s42466-020-00092-y; Ramirez V., 2020, 17 IEEE INT S BIOM I; Rasheed J., 2020, INT C DAT AN BUS IND; Ricci M, 2020, IEEE J BIOMED HEALTH, V24, P120, DOI 10.1109/JBHI.2019.2903627; Rizzo G, 2016, NEUROLOGY, V86, P566, DOI 10.1212/WNL.0000000000002350; Rockhill A.P., 2020, OPENNEURO DATASET; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shaban M., 2021, INT IEEE EMBS C NEUR; Shaban M, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21072351; Shaban M, 2020, I S BIOMED IMAGING; Shi X., 2019, AS PAC SIGN INF PROC; SOIKKELI R, 1991, ELECTROEN CLIN NEURO, V79, P159, DOI 10.1016/0013-4694(91)90134-P; Swann NC, 2015, ANN NEUROL, V78, P742, DOI 10.1002/ana.24507; Talitckii A, 2021, IEEE SENS J, V21, P3738, DOI 10.1109/JSEN.2020.3027564; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tsanas A, 2010, IEEE T BIO-MED ENG, V57, P884, DOI 10.1109/TBME.2009.2036000; Vanegas M., 2018, IEEE INT C BIOINF BI; Vincent Pascal, 2008, P INT C MACH LEARN, P1096, DOI 10.1145/1390156.1390294; Wagh N., 2020, MACHINE LEARNING HLT, V136, P367; Wetter TC, 2001, MOVEMENT DISORD, V16, P928, DOI 10.1002/mds.1163; Zeng W, 2016, NEUROSCI LETT, V633, P268, DOI 10.1016/j.neulet.2016.09.043; Zhang XB, 2019, IEEE INT C BIOINFORM, P1018, DOI 10.1109/BIBM47256.2019.8983000; Zhang YN, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/6209703	61	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0263159	10.1371/journal.pone.0263159	http://dx.doi.org/10.1371/journal.pone.0263159			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202420	Green Published, gold			2022-12-26	WOS:000773224600008
J	Ngayo, MO; Oluka, M; Kwena, ZA; Bulimo, WD; Okalebo, FA				Ngayo, Musa Otieno; Oluka, Margaret; Kwena, Zachari Arochi; Bulimo, Wallace Dimbuson; Okalebo, Faith Apolot			Effects of cytochrome P450 2B6 and constitutive androstane receptor genetic variation on Efavirenz plasma concentrations among HIV patients in Kenya	PLOS ONE			English	Article							PHARMACOGENETIC MARKERS; SECONDARY METABOLISM; HAPLOTYPE STRUCTURE; CYP2B6; POLYMORPHISM; NEVIRAPINE; EXPOSURE; RESISTANCE; IDENTIFICATION; ASSOCIATION	The effects of genetic variation of cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) on efavirenz (EFV) plasma concentration was evaluated among 312 HIV patients in Nairobi Kenya. The EFV plasma concentration at steady-state were determined using ultra-high-performance liquid chromatography with a tandem quadruple mass spectrometer (LC-MS/MS). Thirteen CYP2B6 (329G>T, 341T>C, 444 G>T/C, 15582C>T, 516G>T, 548T>G, 637T>C, 785A>G, 18492C>T, 835G>C, 1459C>T and 21563C>T) and one CAR (540C>T) single nucleotide polymorphisms (SNPs) were genotyped using real-time polymerase chain reaction. HIV drug resistance mutations were detected using an in-house genotypic assay. The EFV concentration of patients ranged from 4 ng/mL to 332697 ng/mL (median 2739.5 ng/mL, IQR 1878-4891.5 ng/mL). Overall, 22% patients had EFV concentrations beyond therapeutic range of 1000-4000 ng/mL (4.5%% < 1000 ng/mL and 31.7% > 4000 ng/mL). Five SNPs (15582C>T, 516G>T, 785A>G, 983T>C and 21563C>T) were associated with higher EFV plasma concentration while 18492C>T with lower EFV plasma concentration (p<0.05). Strong linkage disequilibrium (LD) was observed for 15582C>T, 516G>T, 785A>G, 18492C>T, 983T>C, 21563C>T, 1459C>T and CAR 540C>T. Sixteen haplotypes were observed and CTGCTTCC, CTGCTTCT, TTGCTTCT and CGACCCCT were associated with high EFV plasma concentration. In multivariate analysis, factors significantly associated with EFV plasma concentration included; the presence of skin rash (beta = 1379, 95% confidence interval (CI) = 3216.9-3416.3; p < 0.039), T allele of CYP2B6 516G>T (beta = 1868.9, 95% CI 3216.9-3416.3; p < 0.018), the C allele of CYP2B6 983T>C (beta = 2638.3, 95% CI = 1348-3929; p < 0.0001), T allele of CYP2B6 21563C>T (beta = 1737, 95% CI = 972.2-2681.9; p < 0.0001) and the presence of 5 to 7 numbers of SNPs per patient (beta = 570, 95% CI = 362-778; p < 0.0001) and HIV viral load <= 1000 cells/mL (beta = -4199.3, 95% CI = -7914.9 --483.6; p = 0.027). About 36.2% of the patients had EFV plasma concentrations beyond therapeutic window, posing high risk of treatment failure or toxicity. The SNPs of CYP2B6 516G>T, CYP2B6 983T>C, 21563C>T, presence of higher numbers of SNPs per patient and haplotypes CTGCTTCC, CTGCTTCT, TTGCTTCT and CGACCCCT could efficiently serves as genetic markers for EFV plasma concentration and could guide personalization of EFV based ART treatment in Kenya.	[Ngayo, Musa Otieno; Kwena, Zachari Arochi] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Ngayo, Musa Otieno; Oluka, Margaret; Okalebo, Faith Apolot] Univ Nairobi, Sch Pharm, Dept Pharmacol & Pharmacognosy, Nairobi, Kenya; [Bulimo, Wallace Dimbuson] Univ Nairobi, Sch Biol & Phys Sci, Dept Biochem, Nairobi, Kenya	Kenya Medical Research Institute; University of Nairobi; University of Nairobi	Ngayo, MO (corresponding author), Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya.; Ngayo, MO (corresponding author), Univ Nairobi, Sch Pharm, Dept Pharmacol & Pharmacognosy, Nairobi, Kenya.	mngayo@kemri.org	Bulimo, Wallace/B-1982-2014	Bulimo, Wallace/0000-0001-8475-0586	KEMRI-Internal Grant [(IRG/20) 2010/2011]	KEMRI-Internal Grant	We wish to acknowledge all the study patients and staff of FACES-KEMRI program, the Director KEMRI, and all the staff of the Retrovirology, Centre de Recherche Public de la Sant, Luxembourg.	Adkins JC, 1998, DRUGS, V56, P1055, DOI 10.2165/00003495-199856060-00014; Bae SK, 2011, XENOBIOTICA, V41, P437, DOI 10.3109/00498254.2011.551849; Carr DF, 2010, J ANTIMICROB CHEMOTH, V65, P1889, DOI 10.1093/jac/dkq260; Cho JY, 2004, DRUG METAB DISPOS, V32, P1341, DOI 10.1124/dmd.104.001107; Cortes CP, 2013, THER DRUG MONIT, V35, P78, DOI 10.1097/FTD.0b013e318274197e; de Requena DG, 2005, ANTIMICROB AGENTS CH, V49, P3966, DOI 10.1128/AAC.49.9.3966-3969.2005; Desta Z, 2007, PHARMACOGENOMICS, V8, P547, DOI 10.2217/14622416.8.6.547; Donnerer J, 2003, PHARMACOLOGY, V69, P197, DOI 10.1159/000073664; Duong M, 2004, HIV CLIN TRIALS, V5, P216, DOI 10.1310/NXJU-9ERQ-ADWW-UC5X; Faucette SR, 2006, J PHARMACOL EXP THER, V317, P1200, DOI 10.1124/jpet.105.098160; Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136; Giacomelli A, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118780861; Gopalan BP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183080; Gunda DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075118; Haas DW, 2004, AIDS, V18, P2391; Hofmann MH, 2008, J PHARMACOL EXP THER, V325, P284, DOI 10.1124/jpet.107.133306; Honda A, 2012, AIDS RES HUM RETROV, V28, P1627, DOI [10.1089/aid.2011.0309, 10.1089/AID.2011.0309]; Kerubo G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129247; La Porte C, 2006, REV ANTIVIR THER, V3, P4; Lehman DA, 2009, JAIDS-J ACQ IMM DEF, V51, P522, DOI 10.1097/QAI.0b013e3181aa8a22; Li J, 2012, PHARMACOGENOMICS, V13, P555, DOI [10.2217/PGS.11.160, 10.2217/pgs.11.160]; Maimbo M, 2012, EUR J CLIN PHARMACOL, V68, P267, DOI 10.1007/s00228-011-1118-0; Manosuthi W, 2013, ANTIMICROB AGENTS CH, V57, P1019, DOI 10.1128/AAC.02023-12; Matimba A, 2008, EUR J HUM GENET, V16, P780, DOI 10.1038/ejhg.2008.49; Mehlotra RK, 2007, BRIT J CLIN PHARMACO, V64, P391, DOI 10.1111/j.1365-2125.2007.02884.x; Melikian GL, 2014, J ANTIMICROB CHEMOTH, V69, P12, DOI 10.1093/jac/dkt316; Meng XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130583; Muriuki Beatrice Mukami, 2013, BMC Res Notes, V6, P363, DOI 10.1186/1756-0500-6-363; Mutlib AE, 1999, DRUG METAB DISPOS, V27, P1319; NASCOP, 2018, GUIDELINES USE ANTIR; Ngaimisi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067946; Ngayo MO., 2016, INFECTED ADULTS ATTE, V7, P615, DOI [10.4172/2155-6113.1000615, DOI 10.4172/2155-6113.1000615]; Ogburn ET, 2010, DRUG METAB DISPOS, V38, P1218, DOI 10.1124/dmd.109.031393; Oluka MN, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0052-0; Radloff R, 2013, HUM MUTAT, V34, P725, DOI 10.1002/humu.22295; Reddy S, 2016, J ANAL SCI TECHNOL, V7, DOI 10.1186/s40543-016-0097-2; Sarfo FS, 2014, J ANTIMICROB CHEMOTH, V69, P491, DOI 10.1093/jac/dkt372; Soeria-Atmadja S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181316; Sukasem C, 2012, BRIT J CLIN PHARMACO, V74, P1005, DOI 10.1111/j.1365-2125.2012.04288.x; Vardhanabhuti S, 2013, J INFECT DIS, V208, P662, DOI 10.1093/infdis/jit223; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026739; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; Wyen C, 2011, J ANTIMICROB CHEMOTH, V66, P2092, DOI 10.1093/jac/dkr272; Zanger UM, 2007, PHARMACOGENOMICS, V8, P743, DOI 10.2217/14622416.8.7.743; Zhang HM, 2011, J PHARMACOL EXP THER, V338, P803, DOI 10.1124/jpet.111.183111	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0260872	10.1371/journal.pone.0260872	http://dx.doi.org/10.1371/journal.pone.0260872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235559	gold, Green Published			2022-12-26	WOS:000787073100026
J	Aihara, A; Iwawaki, T; Abe-Fukasawa, N; Otsuka, K; Saruhashi, K; Mikashima, T; Nishino, T; Dohlman, H				Aihara, Ayako; Iwawaki, Takumi; Abe-Fukasawa, Natsuki; Otsuka, Keiichiro; Saruhashi, Koichiro; Mikashima, Takumi; Nishino, Taito; Dohlman, Henrik			Small molecule LATS kinase inhibitors block the Hippo signaling pathway and promote cell growth under 3D culture conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; SELF-ORGANIZATION; DRUG DISCOVERY; YAP; TAZ; DOWNSTREAM; DIFFERENTIATION; SUPPRESSES; MECHANISMS; POTENT	Although 3D cell culture models are considered to reflect the physiological microenvironment and exhibit high concordance with in vivo conditions, one disadvantage has been that cell proliferation is slower in 3D culture as compared to 2D culture. However, the signaling differences that lead to this slower proliferation are unclear. Here, we conducted a cell-based high-throughput screening study and identified novel small molecules that promote cell proliferation, particularly under 3D conditions. We found that one of these molecules, designated GA-017, increases the number and size of spheroids of various cell-types in both scaffold-based and scaffoldindependent cultures. In addition, GA-017 also enhances the ex vivo formation of mouse intestinal organoids. Importantly, we demonstrate that GA-017 inhibits the serine/threonine protein kinases large tumor suppressor kinase 1/2, which phosphorylate Yes-associated protein and transcriptional coactivator with PDZ-binding motif , key effectors of the growth- and proliferation-regulating Hippo signaling pathway. We showed that GA-017 facilitates the growth of spheroids and organoids by stabilizing and translocating Yes-associated protein and transcriptional coactivator with PDZ-binding motif into the cell nucleus. Another chemical analog of GA-017 obtained in this screening also exhibited similar activities and functions. We conclude that experiments with these small molecule large tumor suppressor kinase inhibitors will contribute to further development of efficient 3D culture systems for the ex vivo expansion of spheroids and organoids.	[Aihara, Ayako; Iwawaki, Takumi; Abe-Fukasawa, Natsuki; Nishino, Taito] Nissan Chem Corp, Biol Res Labs, Saitama, Japan; [Otsuka, Keiichiro; Saruhashi, Koichiro; Mikashima, Takumi] Nissan Chem Corp, Head Off, Tokyo, Japan	Nissan Chemical Corporation; Nissan Chemical Corporation	Nishino, T (corresponding author), Nissan Chem Corp, Biol Res Labs, Saitama, Japan.	nishino@nissanchem.co.jp		/0000-0001-7531-4061; Nishino, Taito/0000-0001-5298-4353	Nissan Chemical Corporation	Nissan Chemical Corporation	We thank H. Hoshino and H. Konari for technical assistance and Dr A. Iwama and Dr N. Itasaki for reading the article. This work was supported by Nissan Chemical Corporation.	Aihara A, 2016, CANCER SCI, V107, P1858, DOI 10.1111/cas.13095; Ardestani A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12880-5; Aylon Y, 2016, GENE DEV, V30, P786, DOI 10.1101/gad.274167.115; Aylon Y, 2010, GENE DEV, V24, P2420, DOI 10.1101/gad.1954410; Booij TH, 2019, SLAS DISCOV, V24, P615, DOI 10.1177/2472555219830087; Brassard JA, 2019, CELL STEM CELL, V24, P860, DOI 10.1016/j.stem.2019.05.005; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Britschgi A, 2017, NATURE, V541, P541, DOI 10.1038/nature20829; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Cheng XY, 2018, EXP THER MED, V15, P2812, DOI 10.3892/etm.2018.5761; Dasgupta I, 2019, J BIOL CHEM, V294, P17693, DOI 10.1074/jbc.REV119.007963; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Fan FQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2304; Fang Y, 2017, SLAS DISCOV, V22, P456, DOI 10.1177/1087057117696795; Furth N, 2017, CELL DEATH DIFFER, V24, P1488, DOI 10.1038/cdd.2017.99; Gan WJ, 2020, NAT CELL BIOL, V22, P246, DOI 10.1038/s41556-020-0463-6; Gantner F, 1998, BRIT J PHARMACOL, V123, P1031, DOI 10.1038/sj.bjp.0701688; Grimshaw KM, 2010, MOL CANCER THER, V9, P1100, DOI 10.1158/1535-7163.MCT-09-0986; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Kapalczynska M, 2018, ARCH MED SCI, V14, P910, DOI 10.5114/aoms.2016.63743; Kondo J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050470; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lee MJ, 2014, J INVEST DERMATOL, V134, P518, DOI 10.1038/jid.2013.339; Leroux AE, 2018, SEMIN CANCER BIOL, V48, P1, DOI 10.1016/j.semcancer.2017.05.011; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lopes A. P., 2019, MICRORNA 130A; Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829; Mana-Capelli S, 2018, J BIOL CHEM, V293, P18230, DOI 10.1074/jbc.RA118.004187; McKee C, 2017, COLLOID SURFACE B, V159, P62, DOI 10.1016/j.colsurfb.2017.07.051; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Naito K, 2019, BIOL PHARM BULL, V42, P631, DOI 10.1248/bpb.b18-00831; Naqvi S, 2012, BIOCHEM J, V441, P347, DOI 10.1042/BJ20110970; Nava MM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/797410; Nishio M, 2016, P NATL ACAD SCI USA, V113, pE71, DOI 10.1073/pnas.1517188113; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pan WW, 2019, ONCOGENE, V38, P2595, DOI 10.1038/s41388-018-0610-8; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Panciera T, 2016, CELL STEM CELL, V19, P725, DOI 10.1016/j.stem.2016.08.009; Pawitan J. A., 2018, J BIOS MED, V6, P128; Prior N, 2019, GUT, V68, P2228, DOI 10.1136/gutjnl-2019-319256; Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300; Samal RP, 2013, CHEM BIOL DRUG DES, V81, P715, DOI 10.1111/cbdd.12118; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Serra D, 2019, NATURE, V569, P66, DOI 10.1038/s41586-019-1146-y; Sherk A. B., 2008, CANCER RES; Sum TH, 2015, TETRAHEDRON, V71, P4557, DOI 10.1016/j.tet.2015.02.017; Tanaka H., 2020, YAP DEPENDENT NECROS; Thompson BJ, 2015, J CELL BIOL, V210, P871, DOI 10.1083/jcb.201507005; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Watt KI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7048; Xin M., 2013, P NATL ACAD SCI; Xu HX, 2018, EXP HEMATOL ONCOL, V7, DOI 10.1186/s40164-018-0122-9; Yang ZY, 2014, MOL CELL BIOL, V34, P1607, DOI 10.1128/MCB.01346-13; Zhang Y, 2015, MOL CANCER THER, V14, P799, DOI 10.1158/1535-7163.MCT-14-0648	61	6	6	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101779	10.1016/j.jbc.2022.101779	http://dx.doi.org/10.1016/j.jbc.2022.101779			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35231442	Green Published, gold			2022-12-26	WOS:000793692600001
J	Konstantinidi, A; Nason, R; Caval, T; Sun, LB; Sorensen, DM; Furukawa, S; Ye, ZL; Vincentelli, R; Narimatsu, Y; Vakhrushev, SY; Clausen, H				Konstantinidi, Andriana; Nason, Rebecca; Caval, Tomislav; Sun, Lingbo; Sorensen, Daniel M.; Furukawa, Sanae; Ye, Zilu; Vincentelli, Renaud; Narimatsu, Yoshiki; Vakhrushev, Sergey Y.; Clausen, Henrik			Exploring the glycosylation of mucins by use of O-glycodomain reporters recombinantly expressed in glycoengineered HEK293 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; TANDEM REPEAT; SUBMAXILLARY MUCIN; MOLECULAR-CLONING; GALNAC; GLYCOPEPTIDE; PEPTIDE; GLYCAN; GLYCOPROTEOME; PORCINE	Mucins and glycoproteins with mucin-like regions contain densely O-glycosylated domains often found in tandem repeat (TR) sequences. These O-glycodomains have traditionally been difficult to characterize because of their resistance to proteolytic digestion, and knowledge of the precise positions of Oglycans is particularly limited for these regions. Here, we took advantage of a recently developed glycoengineered cell-based platform for the display and production of mucin TR reporters with custom-designed O-glycosylation to characterize O-glycodomains derived from mucins and mucin-like glycoproteins. We combined intact mass and bottom-up site specific analysis for mapping O-glycosites in the mucins, MUC2, MUC20, MUC21, protein P-selectin-glycoprotein ligand 1, and proteoglycan syndecan-3. We found that all the potential Ser/Thr positions in these O-glycodomains were O-glycosylated when expressed in human embryonic kidney 293 SimpleCells (Tn-glycoform). Interestingly, we found that all potential Ser/Thr O-glycosites in TRs derived from secreted mucins and most glycosites from transmembrane mucins were almost fully occupied, whereas TRs from a subset of trans membrane mucins were less efficiently processed. We further used the mucin TR reporters to characterize cleavage sites of glycoproteases StcE (secreted protease of C1 esterase inhibitor from EHEC) and BT4244, revealing more restricted substrate specificities than previously reported. Finally, we conducted a bottom-up analysis of isolated ovine submaxillary mucin, which supported our findings that mucin TRs in general are efficiently O-glycosylated at all potential glycosites. This study provides insight into O-glycosylation of mucins and mucin-like domains, and the strategies developed open the field for wider analysis of native mucins.	[Konstantinidi, Andriana; Nason, Rebecca; Caval, Tomislav; Sun, Lingbo; Sorensen, Daniel M.; Furukawa, Sanae; Ye, Zilu; Narimatsu, Yoshiki; Vakhrushev, Sergey Y.; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular, Copenhagen, Denmark; [Konstantinidi, Andriana; Nason, Rebecca; Caval, Tomislav; Sun, Lingbo; Sorensen, Daniel M.; Furukawa, Sanae; Ye, Zilu; Narimatsu, Yoshiki; Vakhrushev, Sergey Y.; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Mol Med, Copenhagen, Denmark; [Vincentelli, Renaud] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, Marseille, France; [Narimatsu, Yoshiki] GlycoDisplay ApS, Copenhagen, Denmark; [Sun, Lingbo] Yanan Univ, Med Coll, Yanan 716000, Shaanxi, Peoples R China; [Ye, Zilu] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Blegdamsvej 3B, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Yanan University; University of Copenhagen	Vakhrushev, SY; Clausen, H (corresponding author), Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular, Copenhagen, Denmark.; Vakhrushev, SY; Clausen, H (corresponding author), Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Mol Med, Copenhagen, Denmark.	seva@sund.ku.dk; hclau@sund.ku.dk	; Narimatsu, Yoshiki/G-8388-2019	Ye, Zilu/0000-0001-8829-6579; Sorensen, Daniel Madriz/0000-0001-8811-2506; Narimatsu, Yoshiki/0000-0003-1428-5695	Neye Foundation; Lundbeck Foundation; Novo Nordisk Foundation; European Commission [H2020-MSCA-ITN-721297, H2020-MSCA-ITN-722171]; Mizutani Foundation; Danish National Research Foundation [DNRF107]	Neye Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Commission(European CommissionEuropean Commission Joint Research Centre); Mizutani Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the Neye Foundation, Lundbeck Foundation, the Novo Nordisk Foundation, the European Commission (GlycoImaging H2020-MSCA-ITN-721297, BioCapture H2020-MSCA-ITN-722171), the Mizutani Foundation (to Y. N.), and the Danish National Research Foundation (grant no.: DNRF107).	Ali L, 2014, MOL CELL PROTEOMICS, V13, P3396, DOI 10.1074/mcp.M114.040865; Backstrom M, 2003, BIOCHEM J, V376, P677, DOI 10.1042/BJ20031130; Bagdonaite I, 2020, EMBO REP, V21, DOI 10.15252/embr.201948885; Bennett E. P., 1998, CLONING HUMAN UDP N; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; BHARGAVA AS, 1966, BIOCHIM BIOPHYS ACTA, V127, P223, DOI 10.1016/0304-4165(66)90492-2; Bll C., 2021, P NATL ACAD SCI USA, V118, P1; Bull Christian, 2020, STAR Protoc, V1, P100017, DOI 10.1016/j.xpro.2020.100017; Caval T, 2021, J AM SOC MASS SPECTR, V32, P2099, DOI 10.1021/jasms.1c00060; Caval T, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1074/mcp.R120.002093; Caval T, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.608466; Caval T, 2021, CURR OPIN STRUC BIOL, V68, P135, DOI 10.1016/j.sbi.2020.12.010; Caval T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05536-3; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; Corzana F, 2007, J AM CHEM SOC, V129, P9458, DOI 10.1021/ja072181b; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; Daniel EJP, 2020, GLYCOBIOLOGY, V30, P910, DOI 10.1093/glycob/cwaa036; Darula Z, 2018, MOL CELL PROTEOMICS, V17, P2, DOI 10.1074/mcp.MR117.000126; De Las Rivas M., 2018, STRUCTURAL MECHANIST; de las Rivas M, 2020, NAT CHEM BIOL, V16, P351, DOI 10.1038/s41589-019-0444-x; de las Rivas M, 2019, CURR OPIN STRUC BIOL, V56, P87, DOI 10.1016/j.sbi.2018.12.007; Engelmann K, 2005, GLYCOBIOLOGY, V15, P1111, DOI 10.1093/glycob/cwi099; Gerken T. A., 2002, J BIOL CHEM 277; Gerken TA, 1998, J BIOL CHEM, V273, P26580, DOI 10.1074/jbc.273.41.26580; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P9888, DOI 10.1021/bi049178e; Gerken TA, 2002, J BIOL CHEM, V277, P7736, DOI 10.1074/jbc.M111690200; Gerken TA, 1997, J BIOL CHEM, V272, P9709; Goth CK, 2018, TRENDS BIOCHEM SCI, V43, P269, DOI 10.1016/j.tibs.2018.02.005; Guo JM, 2002, FEBS LETT, V524, P211, DOI 10.1016/S0014-5793(02)03007-7; Hanisch FG, 1998, J MASS SPECTROM, V33, P358, DOI 10.1002/(SICI)1096-9888(199804)33:4<358::AID-JMS642>3.0.CO;2-3; Hansson GC, 2019, J INTERN MED, V285, P479, DOI 10.1111/joim.12910; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; HILL HD, 1977, J BIOL CHEM, V252, P3799; HILL HD, 1977, J BIOL CHEM, V252, P3791; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; HOUNSELL EF, 1985, EUR J BIOCHEM, V148, P367, DOI 10.1111/j.1432-1033.1985.tb08848.x; Irimura T, 1999, J BIOCHEM, V126, P975, DOI 10.1093/oxfordjournals.jbchem.a022565; Iwai T, 2005, P NATL ACAD SCI USA, V102, P4572, DOI 10.1073/pnas.0407983102; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Joshi HJ, 2018, GLYCOBIOLOGY, V28, P131, DOI 10.1093/glycob/cwx104; Kato K, 2001, BIOCHEM BIOPH RES CO, V287, P110, DOI 10.1006/bbrc.2001.5562; Khoo KH, 2019, CURR OPIN STRUC BIOL, V56, P146, DOI 10.1016/j.sbi.2019.02.007; KJELDSEN T, 1988, CANCER RES, V48, P2214; Kong Y., 2015, PROBING POLYPEPTIDE; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lavrsen K, 2018, J BIOL CHEM, V293, P1298, DOI 10.1074/jbc.M117.812826; Levery SB, 2015, BBA-GEN SUBJECTS, V1850, P33, DOI 10.1016/j.bbagen.2014.09.026; Lin YH, 2019, MOL CELL PROTEOMICS, V18, P1479, DOI 10.1074/mcp.RA119.001411; Malaker S. A., 2019, PROC NATL ACAD; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; Marcos-Silva L, 2014, J PROTEOME RES, V13, P3349, DOI 10.1021/pr500215g; Mohl JE, 2021, GLYCOBIOLOGY, V31, P168, DOI 10.1093/glycob/cwaa067; Narimatsu Y., 2019, MOL; Narimatsu Y, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100448; Narimatsu Y, 2019, MOL CELL, V75, P394, DOI 10.1016/j.molcel.2019.05.017; Nason R., NAT COMMUN, V12, P1; Noach I., 2017, P NATL ACAD SCI USA; NUMATA Y, 1990, BIOCHEM BIOPH RES CO, V170, P981, DOI 10.1016/0006-291X(90)90488-9; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; OBoyle K. P, 2006, CANC IMMUN, V6, P1; OBoyle K. P., 1992, IMMUNIZATION COLOREC; Olson FJ, 2005, GLYCOBIOLOGY, V15, P177, DOI 10.1093/glycob/cwh158; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Riley N.M, BIORXIV, DOI [10.1101/2021.01.27.428510, DOI 10.1101/2021.01.27.428510]; Riley NM, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1074/mcp.R120.002277; Schjoldager KT, 2020, NAT REV MOL CELL BIO, V21, P729, DOI 10.1038/s41580-020-00294-x; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; Shon DJ, 2021, BIOCHEM J, V478, P1585, DOI 10.1042/BCJ20200607; Shon DJ, 2020, P NATL ACAD SCI USA, V117, P21299, DOI 10.1073/pnas.2012196117; SPRINGER GF, 1985, MOL IMMUNOL, V22, P1303, DOI 10.1016/0161-5890(85)90050-1; Steentoft C, 2019, GLYCOBIOLOGY, V29, P307, DOI 10.1093/glycob/cwz004; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; TETTAMANTI G, 1968, ARCH BIOCHEM BIOPHYS, V124, P41, DOI 10.1016/0003-9861(68)90301-9; Trastoy B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18696-y; Vakhrushev SY, 2009, ANAL CHEM, V81, P3252, DOI 10.1021/ac802408f; Vakhrushev SY, 2013, MOL CELL PROTEOMICS, V12, P932, DOI 10.1074/mcp.O112.021972; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Vinall LE, 1998, HUM GENET, V102, P357, DOI 10.1007/s004390050705; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; WILKINS PP, 1995, J BIOL CHEM, V270, P22677, DOI 10.1074/jbc.270.39.22677; Wohlschlager T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04061-7; Wu D, 2019, CHEM SCI, V10, P5146, DOI 10.1039/c9sc00360f; Wu D, 2018, P NATL ACAD SCI USA, V115, P8763, DOI 10.1073/pnas.1807439115; Yang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12613; Ye ZL, 2019, NAT METHODS, V16, P902, DOI 10.1038/s41592-019-0504-x; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200	94	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101784	10.1016/j.jbc.2022.101784	http://dx.doi.org/10.1016/j.jbc.2022.101784			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35247390	Green Published, gold			2022-12-26	WOS:000793694800007
J	Lu, JC; Chu, RL; Yin, Y; Yu, HJ; Xu, QW; Yang, B; Sun, YF; Song, J; Wang, QB; Xu, JH; Lu, F; Cheng, Y				Lu, Jiachen; Chu, Ruilin; Yin, Yi; Yu, Huijie; Xu, Qinwen; Yang, Bo; Sun, Yifan; Song, Jing; Wang, Qiubo; Xu, Jiahui; Lu, Feng; Cheng, Yang			Glycosylphosphatidylinositol-anchored micronemal antigen (GAMA) interacts with the band 3 receptor to promote erythrocyte invasion by malaria parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM INVASION; BINDING ANTIGEN; ANION-EXCHANGER; HOST RECEPTOR; ANKYRIN; MEMBRANE; DOMAIN; VIVAX; PROTEIN; ANTIBODIES	Glycosylphosphatidylinositol-anchored micronemal antigen (GAMA) is an erythrocyte binding protein known to be involved in malarial parasite invasion. Although anti-GAMA antibodies have been shown to block GAMA attachment to the erythrocyte surface and subsequently inhibit parasite invasion, little is known about the molecular mechanisms by which GAMA promotes the invasion process. In this study, LC-MS analysis was performed on the erythrocyte membrane to identify the specific receptor that interacts with GAMA. We found that ankyrin 1 and the band 3 membrane protein showed affinity for GAMA, and characterization of their binding specificity indicated that both Plasmodium falciparum and Plasmodium vivax GAMA bound to the same extracellular loop of band 3 (loop 5). In addition, we show the interaction between GAMA and band 3 was sensitive to chymotrypsin. Furthermore, antibodies against band 3 loop 5 were able to reduce the binding activity of GAMA to erythrocytes and inhibit the invasion of P. falciparum merozoites into human erythrocytes, whereas antibodies against P. falciparum GAMA (PfGAMA)-Tr3 only slightly reduced P. falciparum invasion. The identification and characterization of the erythrocyte GAMA receptor is a novel finding that identifies an essential mechanism of parasite invasion of host erythrocytes.	[Lu, Jiachen; Chu, Ruilin; Yu, Huijie; Xu, Qinwen; Yang, Bo; Sun, Yifan; Cheng, Yang] Jiangnan Univ, Wuxi Sch Med, Dept Publ Hlth & Prevent Med, Lab Pathogen Infect & Immun, Wuxi, Jiangsu, Peoples R China; [Chu, Ruilin] Shanghai Municipal Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Shanghai, Peoples R China; [Yin, Yi; Xu, Jiahui; Lu, Feng] Yangzhou Univ, Sch Med, Dept Pathogen Biol & Immunol, Yangzhou, Jiangsu, Peoples R China; [Song, Jing] Jiangnan Univ, Dept Gynecol, Affiliated Hosp, Wuxi, Jiangsu, Peoples R China; [Wang, Qiubo] Soochow Univ, Dept Clin Lab, Wuxi Affiliated Hosp 9, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Shanghai Center for Disease Control & Prevention; Yangzhou University; Jiangnan University; Soochow University - China	Cheng, Y (corresponding author), Jiangnan Univ, Wuxi Sch Med, Dept Publ Hlth & Prevent Med, Lab Pathogen Infect & Immun, Wuxi, Jiangsu, Peoples R China.	woerseng@126.com	xu, jia/GSD-6347-2022		National Natural Science Foundation of China [81871681, 81601787]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank all study participants for their participation and support. This work was supported by the National Natural Science Foundation of China [81871681, 81601787].	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Alam MS, 2015, J BIOL CHEM, V290, P20257, DOI 10.1074/jbc.M115.644906; Almukadi H, 2019, BLOOD, V133, P470, DOI 10.1182/blood-2018-07-865451; Arakawa T, 2015, SCIENCE, V350, P680, DOI 10.1126/science.aaa4335; Arumugam T. U., 2011, DISCOVERY GAMA; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Asimakopoulou A., 2013, BR; Baldwin M, 2014, BBA-MOL CELL RES, V1843, P2855, DOI 10.1016/j.bbamcr.2014.08.008; BENNETT V, 1992, J BIOL CHEM, V267, P8703; Burns AL, 2019, FEMS MICROBIOL REV, V43, P223, DOI 10.1093/femsre/fuz005; Changrob S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1967-9; Cheng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35581; CLOUGH B, 1995, MOL BIOCHEM PARASIT, V69, P19, DOI 10.1016/0166-6851(94)00185-P; Cowman AF, 2017, CELL HOST MICROBE, V22, P232, DOI 10.1016/j.chom.2017.07.003; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; DAVIS LH, 1990, J BIOL CHEM, V265, P10589; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; DOLAN SA, 1994, MOL BIOCHEM PARASIT, V64, P55, DOI 10.1016/0166-6851(94)90134-1; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; GROVES JD, 1994, MOL MEMBR BIOL, V11, P31, DOI 10.3109/09687689409161027; Haldar Kasturi, 2007, Annu Rev Pathol, V2, P217; Hinds L, 2009, EUKARYOT CELL, V8, P1869, DOI 10.1128/EC.00218-09; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Krzych U, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00370; Kushwaha A, 2002, MOL BIOCHEM PARASIT, V122, P45, DOI 10.1016/S0166-6851(02)00077-4; Lamarque M., 2011, RON2; Laurens MB, 2018, ANNU REV MICROBIOL, V72, P273, DOI 10.1146/annurev-micro-090817-062427; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Li XR, 2008, MOL BIOCHEM PARASIT, V158, P22, DOI 10.1016/j.molbiopara.2007.11.007; Longley R. J., 2017, ASYMPTOMATIC; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Magowan C, 2000, BBA-MOL BASIS DIS, V1502, P461, DOI 10.1016/S0925-4439(00)00069-7; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Huynh MH, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00012-16; Nagaoka H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02669; Ndegwa DN, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1008864; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Perez-Mazliah D, 2020, IMMUNOL REV, V293, P57, DOI 10.1111/imr.12822; Reithmeier RAF, 2016, BBA-BIOMEMBRANES, V1858, P1507, DOI 10.1016/j.bbamem.2016.03.030; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; Shakya B, 2017, MOL BIOCHEM PARASIT, V216, P5, DOI 10.1016/j.molbiopara.2017.06.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Skwarczynski M, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030373; Srinivasan P., 2011, PROC NATL ACAD; Srinivasan P, 2014, P NATL ACAD SCI USA, V111, P10311, DOI 10.1073/pnas.1409928111; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; Uwase J, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03207-7; Volz JC, 2016, CELL HOST MICROBE, V20, P60, DOI 10.1016/j.chom.2016.06.004; Weng HB, 2014, BBA-BIOMEMBRANES, V1838, P185, DOI 10.1016/j.bbamem.2013.09.014; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Zenonos ZA, 2015, J EXP MED, V212, P1145, DOI 10.1084/jem.20150032; Zhang DC, 2000, BLOOD, V96, P2925	64	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101765	10.1016/j.jbc.2022.101765	http://dx.doi.org/10.1016/j.jbc.2022.101765			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35202655	gold, Green Published			2022-12-26	WOS:000793560400013
J	Wang, QW; Tao, L; Lu, SY; Zhu, CQ; Ai, LL; Luo, YZ; Yu, RB; Lv, H; Zhang, Y; Wang, CC; Tan, WL				Wang, Qiu-Wei; Tao, Li; Lu, Su-Ying; Zhu, Chang-Qiang; Ai, Le-le; Luo, Yizhe; Yu, Rong-Bin; Lv, Heng; Zhang, Yun; Wang, Chong-Cai; Tan, Wei-Long			Genetic and hosts characterization of hantaviruses in port areas in Hainan Province, P. R. China	PLOS ONE			English	Article							SEOUL HANTAVIRUS; RATTUS-NORVEGICUS; EPIDEMIOLOGY; RATS; IDENTIFICATION; INFECTIONS; HUMANS	Background Hantaviruses (HVs) are major zoonotic pathogens in China that cause hemorrhagic fever with renal syndrome (HFRS) posing a major threat to people's health. Hainan Province, an island located in Southeast China, is an ideal region for sea ports. The unique tropical monsoon climate in Hainan provides sufficient living conditions for rodents, which help spread HVs and other rodent-borne diseases. In the routine monitoring of hantavirus, there was no evidence that rodents in Hainan carried hantavirus. No patients infected with hantavirus were found in the past. However, the surveillance of HVs-carrying rodents covering the whole territory of Hainan has not stopped. Methodology/principal findings For the monitoring of the prevalence of HVs in rodents and the search for theoretical reference for rodent control and HFRS prevention, a total of 60 rodents from 6 monitoring spots were trapped around main ports in Hainan between 2016 and 2019. HV positive samples were identified by a specific kit and sequenced. The data indicated that seven rodents (Rattus norvegicus) were positive for hantavirus with a positivity rate of 11.67%. Phylogenetic analysis suggested that the two complete sequence strains HN1 and HN4 in this research were highly similar to the sequence strains GZRn36 and GZRn148 isolated in Guangdong Province, and they located in the same phylogenetic tree branch which belongs to S2 subtype. Although the two partial sequences HT1 and HT2 isolated in Xisha Islands belong to S2 subtype according to the phylogenetic tree of L segment, they showed a great nucleotide difference with HN1 and HN4. We also found 13 amino acid variations compared with SEOV 80-39 and 6 amino acid mutations related to epitope, and the variations may reduce the effectiveness of the current HFRS vaccines used in humans. Conclusions/significance The study indicated HVs carried by rodents found in Hainan Province may be transmitted from Guangdong Province through trading ports and carriage of goods by sea. So it is of great significance to strengthen the surveillance of rodents in port areas especially capture and eliminate rodents on ship. Timely elimination of host animals of hantavirus in port areas is necessary to prevent an outbreak of HVs disease.	[Wang, Qiu-Wei; Luo, Yizhe; Yu, Rong-Bin; Tan, Wei-Long] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Peoples R China; [Wang, Qiu-Wei; Zhu, Chang-Qiang; Ai, Le-le; Luo, Yizhe; Lv, Heng; Zhang, Yun; Tan, Wei-Long] Huadong Res Inst Med & Biotech, Nanjing, Peoples R China; [Tao, Li] Nanjing Univ Chinese Med, Sch Med & Holist Integrat Med, Nanjing, Peoples R China; [Lu, Su-Ying; Wang, Chong-Cai] Hainan Int Travel Healthcare Ctr, Haikou, Hainan, Peoples R China	Nanjing Medical University; Nanjing University of Chinese Medicine	Tan, WL (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Peoples R China.; Tan, WL (corresponding author), Huadong Res Inst Med & Biotech, Nanjing, Peoples R China.; Wang, CC (corresponding author), Hainan Int Travel Healthcare Ctr, Haikou, Hainan, Peoples R China.	395657029@qq.com; njcdc@163.com			National Natural Science Foundation of China [81473036, 81171609, U1602223]; Wuhan University Key Laboratory Open Fund [2020KF003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan University Key Laboratory Open Fund	National Natural Science Foundation of China 81473036, 81171609, U1602223; the Wuhan University Key Laboratory Open Fund 2020KF003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avsic-Zupanc T, 2019, CLIN MICROBIOL INFEC, V21, pE6, DOI 10.1111/1469-0691.12291; Bi ZQ, 2008, J INFECT DEV COUNTR, V2, P3; Chin C, 2000, J MED VIROL, V60, P237, DOI 10.1002/(SICI)1096-9071(200002)60:2&lt;237::AID-JMV21&gt;3.0.CO;2-B; Dragoo JW, 2006, J GEN VIROL, V87, P1997, DOI 10.1099/vir.0.81576-0; Gao Yun-xia, 2016, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V27, P137; Guterres A, 2018, ONE HEALTH-AMSTERDAM, V5, P27, DOI 10.1016/j.onehlt.2017.12.002; He JY, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006554; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Khan A, 2021, INTERDISCIP SCI, V13, P147, DOI 10.1007/s12539-020-00413-4; Knust B, 2013, EMERG INFECT DIS, V19, P1934, DOI 10.3201/eid1912.131217; Li DanDan, 2019, China Tropical Medicine, V19, P225; Li XH, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4547-5; Lin XD, 2012, J VIROL, V86, P972, DOI 10.1128/JVI.00725-11; Lin YZ., 2000, J HAINAN MED COLL, P75, DOI [10.13210/j.cnki.jhmu.2000.02.004, DOI 10.13210/J.CNKI.JHMU.2000.02.004]; McCaughey C, 2000, J MED MICROBIOL, V49, P587, DOI 10.1099/0022-1317-49-7-587; Mittler E, 2019, ADV VIRUS RES, V104, P185, DOI 10.1016/bs.aivir.2019.07.002; Monchatre-Leroy E, 2017, TRANSBOUND EMERG DIS, V64, P1210, DOI 10.1111/tbed.12494; Figueiredo LTM, 2014, VIRUS RES, V187, P43, DOI 10.1016/j.virusres.2014.01.015; Muylaert RL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007655; Ning TT, 2021, VIROL SIN, V36, P104, DOI 10.1007/s12250-020-00237-y; Plyusnina A, 2004, SCAND J INFECT DIS, V36, P356, DOI 10.1080/00365540410019264; Plyusnina A, 2012, J MED VIROL, V84, P1298, DOI 10.1002/jmv.23321; Shang C, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P968, DOI 10.3760/cma.j.cn112338-20190916-00678; Su QQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11121137; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; Wang CC., 2019, CHINESE FRONTIER HLT, V42, P182, DOI [10.16408/j.1004-9770.2019.03.009, DOI 10.16408/J.1004-9770.2019.03.009]; Wang H, 2000, VIROLOGY, V278, P332, DOI 10.1006/viro.2000.0630; Wang QW, 2021, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.584814; Wang Yan, 2014, Academic Journal of Second Military Medical University, V35, P581; Watson DC, 2014, CRIT REV MICROBIOL, V40, P261, DOI 10.3109/1040841X.2013.783555; Weinstein SB, 2020, J MAMMAL, V101, P1680, DOI 10.1093/jmammal/gyaa127; Zhang YZ, 2010, J MED VIROL, V82, P987, DOI 10.1002/jmv.21737	32	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0264859	10.1371/journal.pone.0264859	http://dx.doi.org/10.1371/journal.pone.0264859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239751	gold, Green Published			2022-12-26	WOS:000776002200084
J	Davis, DAS; Mun, S; Smith, JM; Hammill, D; Garrett, J; Gosling, K; Price, J; Elsaleh, H; Syed, FM; Atmosukarto, II; Quah, BJC				Davis, David A. Simon; Mun, Sahngeun; Smith, Julianne M.; Hammill, Dillon; Garrett, Jessica; Gosling, Katharine; Price, Jason; Elsaleh, Hany; Syed, Farhan M.; Atmosukarto, Ines I.; Quah, Benjamin J. C.			Machine learning predicts cancer subtypes and progression from blood immune signatures	PLOS ONE			English	Article							REGULATORY T-CELLS; BREAST-CANCER; SUPPRESSOR-CELLS; SERUM-LEVELS; CXCL1; INTERLEUKIN-6; CHEMOKINES; RECRUITMENT; NEUTROPHILS; METASTASIS	Clinical adoption of immune checkpoint inhibitors in cancer management has highlighted the interconnection between carcinogenesis and the immune system. Immune cells are integral to the tumour microenvironment and can influence the outcome of therapies. Better understanding of an individual's immune landscape may play an important role in treatment personalisation. Peripheral blood is a readily accessible source of information to study an individual's immune landscape compared to more complex and invasive tumour bioipsies, and may hold immense diagnostic and prognostic potential. Identifying the critical components of these immune signatures in peripheral blood presents an attractive alternative to tumour biopsy-based immune phenotyping strategies. We used two syngeneic solid tumour models, a 4T1 breast cancer model and a CT26 colorectal cancer model, in a longitudinal study of the peripheral blood immune landscape. Our strategy combined two highly accessible approaches, blood leukocyte immune phenotyping and plasma soluble immune factor characterisation, to identify distinguishing immune signatures of the CT26 and 4T1 tumour models using machine learning. Myeloid cells, specifically neutrophils and PD-L1-expressing myeloid cells, were found to correlate with tumour size in both the models. Elevated levels of G-CSF, IL-6 and CXCL13, and B cell counts were associated with 4T1 growth, whereas CCL17, CXCL10, total myeloid cells, CCL2, IL-10, CXCL1, and Ly6C(intermediate) monocytes were associated with CT26 tumour development. Peripheral blood appears to be an accessible means to interrogate tumour-dependent changes to the host immune landscape, and to identify blood immune phenotypes for future treatment stratification.	[Davis, David A. Simon; Mun, Sahngeun; Smith, Julianne M.; Syed, Farhan M.; Atmosukarto, Ines I.; Quah, Benjamin J. C.] Irradiat Immun Interact Lab, Canberra, ACT, Australia; [Hammill, Dillon; Garrett, Jessica; Gosling, Katharine; Price, Jason; Atmosukarto, Ines I.] Australian Natl Univ, John Curtin Sch Med Res, Div Genome Sci & Canc, Canberra, ACT, Australia; [Elsaleh, Hany] The Alfred, Radiat Oncol Dept, Melbourne, Vic, Australia; [Syed, Farhan M.; Quah, Benjamin J. C.] Canberra Hosp, Canberra Hlth Serv, Radiat Oncol Dept, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Canberra Hospital	Quah, BJC (corresponding author), Irradiat Immun Interact Lab, Canberra, ACT, Australia.; Quah, BJC (corresponding author), Canberra Hosp, Canberra Hlth Serv, Radiat Oncol Dept, Canberra, ACT, Australia.	ben.quah@anu.edu.au		Elsaleh, Hany/0000-0003-2083-4961				Abtahi S, 2017, J CANCER RES THER, V13, P252, DOI 10.4103/0973-1482.199448; Allen BM, 2020, NAT MED, V26, P1125, DOI 10.1038/s41591-020-0892-6; Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; Bandapalli OR, 2012, CYTOKINE, V57, P46, DOI 10.1016/j.cyto.2011.10.019; Biswas S, 2019, BBA-MOL BASIS DIS, V1865, P502, DOI 10.1016/j.bbadis.2018.12.002; Bocanegra A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071631; Bonnotte B, 2003, CANCER RES, V63, P2145; Breiman L., 2001, MACH LEARN, V45, P5; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Chen J, 2020, CLIN TRANSL ONCOL, V22, P1548, DOI 10.1007/s12094-020-02299-6; Chen LJ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0521-1; Chun E, 2015, CELL REP, V12, P244, DOI 10.1016/j.celrep.2015.06.024; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Dupre SA, 2007, INT J EXP PATHOL, V88, P351, DOI 10.1111/j.1365-2613.2007.00539.x; Fawagreh K, 2014, SYST SCI CONTROL ENG, V2, P602, DOI 10.1080/21642583.2014.956265; Gengenbacher N, 2017, NAT REV CANCER, V17, P751, DOI 10.1038/nrc.2017.92; Grossman JG, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1470729; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Hegde PS, 2020, IMMUNITY, V52, P17, DOI 10.1016/j.immuni.2019.12.011; Hiam-Galvez KJ, 2021, NAT REV CANCER, V21, P345, DOI 10.1038/s41568-021-00347-z; House IG, 2020, CLIN CANCER RES, V26, P487, DOI 10.1158/1078-0432.CCR-19-1868; Iqbal MJ, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01981-1; Kanagawa N, 2007, INT J CANCER, V121, P2013, DOI 10.1002/ijc.22908; Karin N, 2018, CYTOKINE, V109, P24, DOI 10.1016/j.cyto.2018.02.012; Korbecki J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207619; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kumari N, 2016, TUMOR BIOL, V37, P11553, DOI 10.1007/s13277-016-5098-7; Le Rolle AF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0555-4; Liu L, 2020, MOL MED REP, V21, P2019, DOI 10.3892/mmr.2020.11017; Lundberg SM, 2018, NAT BIOMED ENG, V2, P749, DOI 10.1038/s41551-018-0304-0; Ma QZ, 2021, PRECIS CLIN MED, V4, P155, DOI 10.1093/pcmedi/pbab020; Mishalian I, 2014, INT J CANCER, V135, P1178, DOI 10.1002/ijc.28770; Misra D, 2021, J CLIN MED, V10, DOI 10.3390/jcm10020301; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Mukaka MM, 2012, MALAWI MED J, V24, P69; Murciano-Goroff YR, 2020, CELL RES, V30, P507, DOI 10.1038/s41422-020-0337-2; Olingy CE, 2019, J LEUKOCYTE BIOL, V106, P309, DOI 10.1002/JLB.4RI0818-311R; Olson B, 2018, CANCER DISCOV, V8, P1358, DOI 10.1158/2159-8290.CD-18-0044; Ouzounova M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14979; Ozga AJ, 2021, IMMUNITY, V54, P859, DOI 10.1016/j.immuni.2021.01.012; Panse J, 2008, BRIT J CANCER, V99, P930, DOI 10.1038/sj.bjc.6604621; Parsons BL, 2018, MUTAT RES-REV MUTAT, V777, P1, DOI 10.1016/j.mrrev.2018.05.001; Petrovic-Djergovic D, 2015, CLIN EXP IMMUNOL, V180, P305, DOI 10.1111/cei.12579; Rubio AJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.521110; Sawant KV, 2016, SCI REP-UK, V6, DOI 10.1038/srep33123; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schrors B, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01195; Singh S, 2009, CANCER LETT, V283, P29, DOI 10.1016/j.canlet.2009.03.022; Uno T, 2006, NAT MED, V12, P693, DOI 10.1038/nm1405; Venugopalan J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-74399-w; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Wang DZ, 2017, CANCER RES, V77, P3655, DOI 10.1158/0008-5472.CAN-16-3199; Weide B, 2015, CANCER IMMUNOL IMMUN, V64, P1075, DOI 10.1007/s00262-015-1714-4; Welte T, 2016, NAT CELL BIOL, V18, P632, DOI 10.1038/ncb3355; Xu LC, 2018, ONCOL LETT, V15, P9293, DOI 10.3892/ol.2018.8510; Yan B, 2013, J IMMUNOL, V190, P5882, DOI 10.4049/jimmunol.1201881; Yu JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206223; Yuen GJ, 2016, TRENDS CANCER, V2, P747, DOI 10.1016/j.trecan.2016.10.010; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651; Zhong WY, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-019-6344-3	61	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264631	10.1371/journal.pone.0264631	http://dx.doi.org/10.1371/journal.pone.0264631			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226704	gold, Green Published			2022-12-26	WOS:000793394000038
J	Valova, G; Bogomyakova, O; Tulupov, A; Cherevko, A				Valova, Galina; Bogomyakova, Olga; Tulupov, Andrey; Cherevko, Alexander			Influence of interaction of cerebral fluids on ventricular deformation: A mathematical approach	PLOS ONE			English	Article							SPHERICALLY SYMMETRIC MODEL; CHIARI MALFORMATION; HYDROCEPHALUS; PRESSURE; DYNAMICS; BRAIN; FLOW; REABSORPTION; EQUATIONS; DRIVEN	This paper describes the effects of the interaction of cerebral fluids (arterial, capillary and venous blood, cerebrospinal fluid) on ventricular wall displacement and periventricular pressure using a mathematical multiphase poroelasticity model for the cerebral parenchyma. The interaction of cerebral fluids is given by a set of four numerical coefficients. A multiple linear regression with interaction is constructed that allows us to quantify the effect of these coefficients on the average ventricular wall displacement. The prevailing influence of an arterial-liquor component was observed. The sets of coefficients associated with such pathological conditions were found: normal pressure hydrocephalus, intracranial hypertension, and replacement ventriculomegaly under a prolonged hypoperfusion.	[Valova, Galina; Bogomyakova, Olga; Tulupov, Andrey; Cherevko, Alexander] Russian Acad Sci, Lavrentyev Inst Hydrodynam, Siberian Branch, Novosibirsk, Russia; [Bogomyakova, Olga; Tulupov, Andrey] Russian Acad Sci, Int Tomog Ctr, Siberian Branch, Novosibirsk, Russia	Lavrentyev Institute of Hydrodynamics; Russian Academy of Sciences; International Tomography Center, Siberian Branch of Russian Academy of Sciences; Russian Academy of Sciences	Valova, G (corresponding author), Russian Acad Sci, Lavrentyev Inst Hydrodynam, Siberian Branch, Novosibirsk, Russia.	galinayankova2703@gmail.com		Valova, Galina/0000-0002-0782-1819				Agapov P., 2006, COMP MATH MATH PHYS+, V46, P1629, DOI [10.1134/S0965542506090144, DOI 10.1134/S0965542506090144]; Buishas J, 2014, CROAT MED J, V55, P481, DOI 10.3325/cmj.2014.55.481; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Chang HS, 2003, J NEUROL NEUROSUR PS, V74, P344, DOI 10.1136/jnnp.74.3.344; Cheng S., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P151, DOI 10.1080/10255840601124753; Clarke EC, 2013, J BIOMECH, V46, P1801, DOI 10.1016/j.jbiomech.2013.05.013; Coussy O., 2004, POROMECHANICS; Dalla Corte A, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0073-2; Eisentrager Almut, 2013, Poromechanics V. Proceedings of the Fifth Biot Conference on Poromechanics, P2148; Elliott NSJ, 2013, J FLUID STRUCT, V40, P1, DOI 10.1016/j.jfluidstructs.2013.01.010; Elliott NSJ, 2011, MED ENG PHYS, V33, P874, DOI 10.1016/j.medengphy.2010.07.009; Gholampour S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196216; Guo LW, 2019, FRONT COMPUT NEUROSC, V13, DOI 10.3389/fncom.2019.00060; Guo LW, 2018, INTERFACE FOCUS, V8, DOI 10.1098/rsfs.2017.0019; Hakim CA, 2001, NEUROSURG CLIN N AM, V12, P761, DOI 10.1016/S1042-3680(18)30033-0; Hakim S, 1976, Surg Neurol, V5, P187; Hecht F, 2012, J NUMER MATH, V20, P251, DOI 10.1515/jnum-2012-0013; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Johnston I, 2000, CHILD NERV SYST, V16, P776, DOI 10.1007/s003810000383; Kasprowicz M, 2016, ACTA NEUROL SCAND, V134, P168, DOI 10.1111/ane.12541; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; Linninger AA, 2009, ANN BIOMED ENG, V37, P1434, DOI 10.1007/s10439-009-9691-4; Lloyd RA, 2017, J BIOMECH, V65, P185, DOI 10.1016/j.jbiomech.2017.10.007; Marmarou A, 1973, DISSERTATION; Masoumi N, 2013, BASIC CLIN NEUROSCI, V4, P64; Minsuok Kim, 2011, Journal of Biorheology, V25, P78, DOI 10.1007/s12573-011-0041-4; MORI K, 1995, CHILD NERV SYST, V11, P523, DOI 10.1007/BF00822842; Petrov IB., 2020, CONTINUUM MECH APPL, P299; R Core Team, 2021, R LANG ENV STAT; Rekate HL, 2011, CHILD NERV SYST, V27, P1535, DOI 10.1007/s00381-011-1558-y; REKATE HL, 1988, PEDIATR NEUROSCI, V14, P77, DOI 10.1159/000120367; Sivaloganathan S, 2005, INT J NONLIN MECH, V40, P1149, DOI 10.1016/j.ijnonlinmec.2005.04.004; Smillie A, 2005, J FLUID MECH, V539, P417, DOI 10.1017/S0022112005005707; Sobey I, 2006, MATH MED BIOL, V23, P339, DOI 10.1093/imammb/dql015; Sweetman B, 2011, ANN BIOMED ENG, V39, P484, DOI 10.1007/s10439-010-0141-0; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Toro EF, 2022, INT J NUMER METH BIO, V38, DOI 10.1002/cnm.3532; Tully B, 2011, J FLUID MECH, V667, P188, DOI 10.1017/S0022112010004428; Tully B, 2009, IEEE T BIO-MED ENG, V56, P1644, DOI 10.1109/TBME.2009.2016427; Vardakis J., 2012, MULTICOMPARTMENTAL P; Vardakis JC, 2020, P I MECH ENG H, V234, P1223, DOI 10.1177/0954411920964630; Vardakis JC, 2019, J FLUID STRUCT, V91, DOI 10.1016/j.jfluidstructs.2019.04.008; Wirth B, 2009, MATH MED BIOL, V26, P25, DOI 10.1093/imammb/dqn021; Yan'kova GS, 2021, J APPL MECH TECH PH+, V62, P654, DOI 10.1134/S0021894421040155; Yan'kova GS, 2020, J APPL MECH TECH PH+, V61, P14, DOI 10.1134/S0021894420010022; Yankova G, 2021, REV NEUROSCIENCE, V32, P693, DOI 10.1515/revneuro-2020-0106	46	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0264395	10.1371/journal.pone.0264395	http://dx.doi.org/10.1371/journal.pone.0264395			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226657	Green Published, gold			2022-12-26	WOS:000793394000020
J	Ambusaidi, A; Taylor, N; Quinn, F; Rizk, N; Taylor, S				Ambusaidi, Abdullah; Taylor, Neil; Quinn, Frances; Rizk, Nadya; Taylor, Subhashni			Omani senior secondary school students' knowledge of and attitudes to antibiotic resistance	PLOS ONE			English	Article							BACTERIAL-RESISTANCE; SELF-MEDICATION; SAUDI-ARABIA; COMMUNITY	Antibiotic resistance is a worldwide problem that is increasing largely due to the misuse of antibiotics in human health and agriculture. This situation is further exacerbated by a dearth of new antibiotic development, the focus of pharmaceutical companies having shifted to more lucrative treatments for chronic conditions such as elevated blood pressure. To conserve the efficacy of the current crop of antibiotics, it is vital that they are used appropriately by individuals. Effective education may be a means to achieve such appropriate use. This paper reports on a large-scale, mixed methods study, which employed a survey and oral questionnaires, undertaken with senior secondary Omani students. The study explored students' understanding of antibiotic resistance as well as their attitudes to the issue of antibiotic resistance. The study findings indicated that, although some students had a reasonably clear understanding of antibiotic resistance, many had serious misconceptions that could result in misuse of antibiotics. The article concludes with suggestions for amending secondary school pedagogy in Oman to address the misconceptions.	[Ambusaidi, Abdullah] Sultan Qaboos Univ, Muscat, Oman; [Taylor, Neil; Quinn, Frances; Rizk, Nadya] Univ New England, Armidale, NSW, Australia; [Taylor, Subhashni] James Cook Univ, Coll Arts Soc & Educ, Cairns, Qld, Australia	Sultan Qaboos University; University of New England; James Cook University	Taylor, N (corresponding author), Univ New England, Armidale, NSW, Australia.	ntaylor6@une.edu.au	Taylor, Subhashni/Q-6338-2018	Taylor, Subhashni/0000-0002-1624-0901; Quinn, Frances/0000-0002-3144-3416; Taylor, Neil/0000-0001-8438-319X				Al Juma MA., 2018, SELFCARE, V9, P16; Al-Maliky GR, 2018, EUR J HOSP PHARM, V25, P195, DOI 10.1136/ejhpharm-2016-001146; Al-Ramahi R, 2013, INT J CLIN PHARM TH, V51, P562, DOI 10.5414/CP201814; Al-Yamani Abdulrahman, 2016, Oman Med J, V31, P35, DOI 10.5001/omj.2016.07; Alenazi AAH., J YOUNG PHAM, V12, P237; Alkhuzaei AMJB SalamaRE, 2017, INT J COMMUNITY MED, V4, P7, DOI [10.18203/2394-6040.ijcmph20174804, DOI 10.18203/2394-6040.IJCMPH20174804]; Almohammed RA, 2019, J INFECT PUBLIC HEAL, V12, P159, DOI 10.1016/j.jiph.2018.09.002; [Anonymous], 2013, NATURE, V495, P141, DOI 10.1038/495141a; Awad AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117910; Azevedo M-M., 2013, BACTERIAL ANTIBIOTIC, P1542; Belkina T, 2014, J INFECT DEV COUNTR, V8, P424, DOI 10.3855/jidc.3866; Bin Nafisah S, 2017, J INFECT PUBLIC HEAL, V10, P522, DOI 10.1016/j.jiph.2016.09.016; Carter RR, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw112; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Davis ME, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6040023; El Zowalaty ME, 2016, INT J CLIN PHARM-NET, V38, P1261, DOI 10.1007/s11096-016-0362-x; Emeka PM, 2014, SAUDI PHARM J, V22, P550, DOI 10.1016/j.jsps.2014.02.014; Eng JV, 2003, EMERG INFECT DIS, V9, P1128; Finch RG, 2004, LANCET INFECT DIS, V4, P44, DOI 10.1016/S1473-3099(03)00860-0; Fonseca MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044699; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gravetter F.J., 2015, STAT BEHAV SCI; Grigoryan L, 2007, PHARMACOEPIDEM DR S, V16, P1234, DOI 10.1002/pds.1479; Hajibagheri S., 2019, SKY NEWS UK; King S., 2016, RAND HLTH Q, V5; Lecky DM, 2013, J ANTIMICROB CHEMOTH, V68, P2428, DOI 10.1093/jac/dkt361; Luepke KH, 2017, PHARMACOTHERAPY, V37, P71, DOI 10.1002/phar.1868; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; Ministry of Education, 2008, SCI ENV TXB; Mohanna Mabrook, 2010, Oman Med J, V25, P41, DOI 10.5001/omj.2010.10; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Price L, 2018, J ANTIMICROB CHEMOTH, V73, P1464, DOI 10.1093/jac/dky076; Prigitano A, 2018, J INFECT PUBLIC HEAL, V11, P30, DOI 10.1016/j.jiph.2017.02.010; Public Health England, 2020, E BUG; Scaioli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122476; Scalas D, 2017, INT J ANTIMICROB AG, V50, P588, DOI 10.1016/j.ijantimicag.2017.05.008; Supreme Council of Planning, 2019, OMAN VISION 2040 DOC; Towers L, 2016, OMAN DEVELOPING HERB; Ventola C Lee, 2015, P T, V40, P277; World Health Organization (WHO), 2015, ANTIBIOTIC RESISTANC; Yusef D, 2018, INFECT DIS HEALTH, V23, P33, DOI 10.1016/j.idh.2017.11.001	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264500	10.1371/journal.pone.0264500	http://dx.doi.org/10.1371/journal.pone.0264500			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213650	gold, Green Published, Green Accepted			2022-12-26	WOS:000787811000110
J	Zainulabid, UA; Yassim, ASM; Hussain, M; Aslam, A; Soffian, SN; Ibrahim, MSM; Kamarudin, N; Kamarulzaman, MN; Hin, HS; Ahmad, HF				Zainulabid, Ummu Afeera; Yassim, Aini Syahida Mat; Hussain, Mushtaq; Aslam, Ayesha; Soffian, Sharmeen Nellisa; Ibrahim, Mohamad Shafiq Mohd; Kamarudin, Norhidayah; Kamarulzaman, Mohd Nazli; Hin, How Soon; Ahmad, Hajar Fauzan			Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia	PLOS ONE			English	Article							PREDICT	SARS-CoV-2 has spread throughout the world since its discovery in China, and Malaysia is no exception. WGS has been a crucial approach in studying the evolution and genetic diversity of SARS-CoV-2 in the ongoing pandemic. Despite considerable number of SARS-CoV-2 genome sequences have been submitted to GISAID and NCBI databases, there is still scarcity of data from Malaysia. This study aims to report new Malaysian lineages of the virus, responsible for the sustained spikes in COVID-19 cases during the third wave of the pandemic. Patients with nasopharyngeal and/or oropharyngeal swabs confirmed COVID-19 positive by real-time RT PCR with C-T value < 25 were chosen for WGS. The selected SARS-CoV-2 isolates were then sequenced, characterized and analyzed along with 986 sequences of the dominant lineages of D614G variants currently circulating throughout Malaysia. The prevalence of Glade GH and G formed strong ground for the presence of two Malaysian lineages of AU.2 and B.1.524 that has caused sustained spikes of cases in the country. Statistical analysis on the association of gender and age group with Malaysian lineages revealed a significant association (p <0.05). Phylogenetic analysis revealed dispersion of 41 lineages, of these, 22 lineages are still active. Mutational analysis showed presence of unique G1223C missense mutation in transmembrane domain of the spike protein. For better understanding of the SARS-CoV-2 evolution in Malaysia especially with reference to the reported lineages, large scale studies based on WGS are warranted.	[Zainulabid, Ummu Afeera; Soffian, Sharmeen Nellisa; Ahmad, Hajar Fauzan] Univ Malaysia Pahang, Fac Ind Sci & Technol, Gambang, Pahang, Malaysia; [Zainulabid, Ummu Afeera; Hin, How Soon] Int Islamic Univ Malaysia, Dept Internal Med, Kulliyyah Med, Kuantan, Pahang, Malaysia; [Yassim, Aini Syahida Mat] Biovalence Sdn Bhd, Petaling Jaya, Selangor, Malaysia; [Hussain, Mushtaq; Aslam, Ayesha] Dow Univ Hlth Sci, Dow Coll Biotechnol, Dow Res Inst Biotechnol & Biomed Sci, Bioinformat & Mol Med Res Grp, Karachi, Pakistan; [Ibrahim, Mohamad Shafiq Mohd] Int Islamic Univ Malaysia, Dept Paediat & Dent Publ Hlth, Kulliyyah Dent, Kuantan, Pahang, Malaysia; [Kamarudin, Norhidayah] Int Islamic Univ Malaysia, Dept Pathol & Lab Med, Kulliyyah Med, Kuantan, Pahang, Malaysia; [Kamarulzaman, Mohd Nazli] Int Islamic Univ Malaysia, Dept Surg, Kulliyyah Med, Kuantan, Pahang, Malaysia; [Ahmad, Hajar Fauzan] Univ Malaysia Pahang, Ctr Res Adv Trop Biosci Biotrop Ctr, Gambang, Pahang, Malaysia	Universiti Malaysia Pahang; International Islamic University Malaysia; Dow University of Health Sciences; International Islamic University Malaysia; International Islamic University Malaysia; International Islamic University Malaysia; Universiti Malaysia Pahang	Ahmad, HF (corresponding author), Univ Malaysia Pahang, Fac Ind Sci & Technol, Gambang, Pahang, Malaysia.; Hin, HS (corresponding author), Int Islamic Univ Malaysia, Dept Internal Med, Kulliyyah Med, Kuantan, Pahang, Malaysia.; Hussain, M (corresponding author), Dow Univ Hlth Sci, Dow Coll Biotechnol, Dow Res Inst Biotechnol & Biomed Sci, Bioinformat & Mol Med Res Grp, Karachi, Pakistan.	mushtaq.hussain@duhs.edu.pk; joanchua@iium.edu.my; fauzanahmad@ump.edu.my	Ahmad, Hajar Fauzan/AAH-9911-2019	Ahmad, Hajar Fauzan/0000-0003-2985-2496; Hussain, Mushtaq/0000-0001-8862-179X	Ministry of Higher Education Malaysia; Sultan Ahmad Shah Medical Centre @ IIUM;  [FRGS/1/2019/WAB13/UMP/ 03/1];  [SRG21-040-0040]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); Sultan Ahmad Shah Medical Centre @ IIUM; ; 	The authors received funding for this work from the Ministry of Higher Education Malaysia and Sultan Ahmad Shah Medical Centre @ IIUM for supporting this work. Hajar Fauzan Ahmad awarded for FRGS/1/2019/WAB13/UMP/ 03/1 and Ummu Afeera Zainulabid is Principal Investigator for SRG21-040-0040, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Fedaa, 2021, Med Drug Discov, V10, P100086, DOI 10.1016/j.medidd.2021.100086; Allen H, 2022, LANCET REG HEALTH-EU, V12, DOI 10.1016/j.lanepe.2021.100252; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; CDC, 2021, SARS COV 2 VAR CLASS; Chen ZG, 2021, CLIN MICROBIOL INFEC, V27, P750, DOI 10.1016/j.cmi.2021.01.018; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Chong YM, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008744; Corver J, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-230; Covid 19 Host Genetics Initiative, 2020, EUR J HUM GENET, V28, P715, DOI 10.1038/s41431-020-0636-6; Daniloski Z, 2021, ELIFE, V10, DOI 10.7554/eLife.65365; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; DayakDaily, DAYAKDAILY, P202; Deng Xianding, 2021, medRxiv, DOI 10.1101/2021.03.07.21252647; Elengoe Asita, 2020, Osong Public Health Res Perspect, V11, P93, DOI 10.24171/j.phrp.2020.11.3.08; Fu QS, 2021, J AM CHEM SOC, V143, P8543, DOI 10.1021/jacs.1c02394; Geoghegan JL, 2021, NAT IMMUNOL, V22, P262, DOI 10.1038/s41590-021-00872-x; Gozashti L, 2021, BMC RES NOTES, V14, DOI 10.1186/s13104-021-05605-9; Groves DC, 2021, BIOCHEM BIOPH RES CO, V538, P104, DOI 10.1016/j.bbrc.2020.10.109; Gupta RK, 2021, NAT REV IMMUNOL, V21, P340, DOI 10.1038/s41577-021-00556-5; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamed SM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87713-x; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Horby P, UPDATE NOTE B 11 7 S; Huang R, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0941-8; Jackson CB, 2021, BIOCHEM BIOPH RES CO, V538, P108, DOI 10.1016/j.bbrc.2020.11.026; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Khan A, 2021, J CELL PHYSIOL, V236, P7045, DOI 10.1002/jcp.30367; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lane CR, 2021, LANCET PUBLIC HEALTH, V6, pE547, DOI 10.1016/S2468-2667(21)00133-X; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Nelson G., 2021, BIORXIV, DOI [10.1101/2021.01.13.426558, 10.1101/2021.01.13.426558v1]; Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Pires DEV, 2020, NUCLEIC ACIDS RES, V48, pW147, DOI 10.1093/nar/gkaa416; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Rampal L, 2021, Med J Malaysia, V76, P1; Rodrigues CHM, 2019, NUCLEIC ACIDS RES, V47, pW338, DOI 10.1093/nar/gkz383; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salim Syafiqah., 2021, COVID 19 MALAYSIA DE; Sanyaolu A, 2021, THER ADV INFECT DIS, V8, DOI 10.1177/20499361211024372; Sengupta A, 2021, INFECT GENET EVOL, V89, DOI 10.1016/j.meegid.2021.104724; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Starr TN, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100255; Sun KY, 2021, SCIENCE, V371, P254, DOI 10.1126/science.abe2424; Tamura K, 2021, MOL BIOL EVOL, V38, P3022, DOI 10.1093/molbev/msab120; Tan K.-E., 2021, SCI REP-UK, V11, P1, DOI [10.1038/s41598-020-79139-8, DOI 10.1038/S41598-020-79139-8]; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Thomson EC, 2021, CELL, V184, P1171, DOI 10.1016/j.cell.2021.01.037; Volz E, 2021, CELL, V184, P64, DOI 10.1016/j.cell.2020.11.020; Walensky RP, 2021, JAMA-J AM MED ASSOC, V325, P1037, DOI 10.1001/jama.2021.2294; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; WHO, TRACKING VARIANTS CO; WHO, WHO COR COVID 19; Wu K., 2021, BIORXIV, DOI [10.1101/2021.01.25.427948, DOI 10.1101/2021.01.25.427948]; Yassim AS., 2021, MAT TODAY PROC; Young BE, 2021, EBIOMEDICINE, V66, DOI 10.1016/j.ebiom.2021.103319; Yurkovetskiy L, 2020, CELL, V183, P739, DOI 10.1016/j.cell.2020.09.032; Zahradnik J, 2021, NAT MICROBIOL, V6, P1188, DOI 10.1038/s41564-021-00954-4; Zainulabid UA, 2021, MICROBIOL RESOUR ANN, V10, DOI 10.1128/MRA.00657-21; Zhang J, 2021, SCIENCE, V372, P525, DOI 10.1126/science.abf2303; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4	65	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263678	10.1371/journal.pone.0263678	http://dx.doi.org/10.1371/journal.pone.0263678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213571	gold, Green Published			2022-12-26	WOS:000787811000029
J	Hu, J; Zhao, LT; Li, N; Yang, YY; Qu, T; Ren, H; Cui, XM; Tao, HX; Chen, ZY; Peng, Y				Hu, Jing; Zhao, Lintao; Li, Ning; Yang, Yuanyuan; Qu, Tong; Ren, Hui; Cui, Xiaomin; Tao, Hongxun; Chen, Zhiyong; Peng, Yu			Investigation of the active ingredients and pharmacological mechanisms of Porana sinensis Hemsl. Against rheumatoid arthritis using network pharmacology and experimental validation	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ERYCIBE-OBTUSIFOLIA; MASS-SPECTROMETRY; IDENTIFICATION; TARGET; CHROMATOGRAPHY; ANGIOGENESIS; CONSTITUENTS; ANTIOXIDANT; PREDICTION	BackgroundPorana sinensis Hemsl. has been widely used as a substitute for Erycibes Caulis to treat rheumatoid arthritis (RA) in traditional Chinese medicine (TCM). However, little is known about the active ingredients and pharmacological mechanisms that mediate the action of P. sinensis against RA. MethodsThe compounds contained in P. sinensis were analyzed by Q Exactive Focus mass spectrometer. The active constituents and pharmacological mechanism of P. sinensis against RA were clarified using a network pharmacology-based investigation. LPS-induced RAW 264.7 cells was used to verify anti-inflammatory effects of the active compounds screened by network pharmacology. Collagen-induced arthritis model was used to further investigate the mechanism of P. sinensis against RA. ResultsThe potential components and targets of P. sinensis against RA were analyzed using network pharmacology, and five compounds, twenty-five targets, and eight pathways were identified. Experimental validation suggested that P. sinensis extract and five compounds (esculetin, umbelliferone, trans-N-feruloyltyramine, caffeic acid and scopolin) could inhibit the release of inflammatory mediators (NO, TNF-alpha, IL-1 beta and IL-6) in LPS-induced RAW 264.7 cell. P. sinensis extract attenuated the severity, pathological changes, and release of cytokines (IL-6 and HIF-1 alpha) during RA progression by regulating the PI3K/AKT and HIF-1 pathways. ConclusionThe study provides a basis for the application of P. sinensis against RA. Our findings may provide suggestions for developing P. sinensis into a substitute for Erycibes Caulis.	[Hu, Jing; Zhao, Lintao; Li, Ning; Qu, Tong; Ren, Hui; Cui, Xiaomin; Chen, Zhiyong] Shaanxi Acad Tradit Chinese Med, Inst Tradit Chinese Med, Xian, Peoples R China; [Yang, Yuanyuan] Xian Inst Food & Drug Control, Dept Tradit Chinese Med, Xian, Peoples R China; [Tao, Hongxun] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China; [Peng, Yu] Nanjing Med Univ, Sch Pharm, Jiangsu Prov Key Lab Cardiovasc & Cerebrovasc Med, Nanjing, Peoples R China	Shaanxi University of Chinese Medicine; Jiangsu University; Nanjing Medical University	Li, N; Chen, ZY (corresponding author), Shaanxi Acad Tradit Chinese Med, Inst Tradit Chinese Med, Xian, Peoples R China.; Peng, Y (corresponding author), Nanjing Med Univ, Sch Pharm, Jiangsu Prov Key Lab Cardiovasc & Cerebrovasc Med, Nanjing, Peoples R China.	gsshxln@163.com; chenzhiyong0612@sina.com; carlylepeng@gmail.com	Tao, Hongxun/GPX-3973-2022	Chen, Zhiyong/0000-0002-4868-2237	National Natural Science Foundation of China [81973419, 81603264]; Key Research and Development Program of Shaanxi [2020SF-328]; Shaanxi Administration of Traditional Chinese Medicine Projects [2021-PY-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Shaanxi; Shaanxi Administration of Traditional Chinese Medicine Projects	We are thankful to Dr. Xia Du from Shaanxi Academy of Traditional Chinese Medicine for providing technical assistance with network pharmacology.	Abreu JRF, 2010, ARTHRITIS RHEUM-US, V62, P3289, DOI 10.1002/art.27656; Chen DQ, 2019, CARDIOVASC THER, V2019, DOI 10.1155/2019/8490707; Chen ZY, 2019, PHYTOCHEM ANALYSIS, V30, P311, DOI 10.1002/pca.2814; Chen ZY, 2017, PHYTOCHEM ANALYSIS, V28, P137, DOI 10.1002/pca.2650; Chen ZY, 2015, J SEP SCI, V38, P231, DOI 10.1002/jssc.201400861; Chen ZY, 2014, J SEP SCI, V37, P2253, DOI 10.1002/jssc.201400342; Chen ZY, 2013, J ETHNOPHARMACOL, V150, P501, DOI 10.1016/j.jep.2013.08.059; Choi JY, 2021, NAT PROD RES, V35, P3026, DOI 10.1080/14786419.2019.1684285; [杜成成 Du Chengcheng], 2019, [中国实验方剂学杂志, Chinese Journal of Experimental Traditional Medical Formulae], V25, P48; Du X, 2020, J ETHNOPHARMACOL, V252, DOI 10.1016/j.jep.2020.112606; Gfeller D, 2014, NUCLEIC ACIDS RES, V42, pW32, DOI 10.1093/nar/gku293; Gu WT, 2016, RSC ADV, V6, P82774, DOI 10.1039/c6ra07703j; Han JW, 2020, DRUG DES DEV THER, V14, P5235, DOI 10.2147/DDDT.S282112; Li M, 2012, FOOD CHEM, V135, P1653, DOI 10.1016/j.foodchem.2012.06.049; Li WJ, 2020, PHYTOMEDICINE, V67, DOI 10.1016/j.phymed.2019.153156; Liu BoWen, 2019, Journal of China Pharmaceutical University, V50, P585, DOI 10.11665/j.issn.1000-5048.20190512; Malemud CJ, 2015, FUTURE MED CHEM, V7, P1137, DOI [10.4155/FMC.15.55, 10.4155/fmc.15.55]; Mou X, 2020, PHYTOMEDICINE, V69, DOI 10.1016/j.phymed.2020.153192; Ouyang L, 2019, DRUG DES DEV THER, V13, P1163, DOI 10.2147/DDDT.S190155; Park SY, 2015, EUR J IMMUNOL, V45, P1216, DOI 10.1002/eji.201444908; Peng YJ, 2021, PROCEEDINGS OF 2021 2ND INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND INFORMATION SYSTEMS (ICAIIS '21), DOI [10.1002/ptr.7070, 10.1145/3469213.3470357]; Qu Y, 2016, ONCOTARGET, V7, P74217, DOI 10.18632/oncotarget.12487; Ren W, 2020, NAT PROD RES, V34, P2581, DOI 10.1080/14786419.2018.1547292; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Venkatasubramanian P, 2013, CURR SCI INDIA, V105, P1593; Wang QR, 2019, INT IMMUNOPHARMACOL, V72, P292, DOI 10.1016/j.intimp.2019.04.027; [吴立宏 Wu Lihong], 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P1398; Xing R, 2016, CLIN EXP IMMUNOL, V184, P147, DOI 10.1111/cei.12751; Xiong H, 2019, PHYTOMEDICINE, V57, P271, DOI 10.1016/j.phymed.2018.12.023; Xue Q, 2019, INFLAMMOPHARMACOLOGY, V27, P1055, DOI 10.1007/s10787-018-00558-1; Xue Q, 2017, RSC ADV, V7, P51151, DOI 10.1039/c7ra10767f; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Yum S, 2015, FITOTERAPIA, V103, P55, DOI 10.1016/j.fitote.2015.03.013; [张朝凤 ZHANG Chaofeng], 2006, [中国药学杂志, Chinese Pharmaceutical Journal], V41, P94; Zheng YX, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/385352; Zou L, 2016, AM J TRANSL RES, V8, P3141	36	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264786	10.1371/journal.pone.0264786	http://dx.doi.org/10.1371/journal.pone.0264786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235611	Green Published, gold			2022-12-26	WOS:000787073100038
J	Lorente-Canovas, B; Eckrich, S; Lewis, MA; Johnson, SL; Marcotti, W; Steel, KP				Lorente-Canovas, Beatriz; Eckrich, Stephanie; Lewis, Morag A.; Johnson, Stuart L.; Marcotti, Walter; Steel, Karen P.			Grxcr1 regulates hair bundle morphogenesis and is required for normal mechanoelectrical transduction in mouse cochlear hair cells	PLOS ONE			English	Article							PROGRESSIVE HEARING-LOSS; PARALLEL ACTIN BUNDLES; MYOSIN VIIA; CROSS-LINKS; STEREOCILIA; INNER; ESPIN; RECEPTOR; CALCIUM; ADAPTATION	Tasmanian devil (tde) mice are deaf and exhibit circling behaviour. Sensory hair cells of mutants show disorganised hair bundles with abnormally thin stereocilia. The origin of this mutation is the insertion of a transgene which disrupts expression of the Grxcr1 (glutaredoxin cysteine rich 1) gene. We report here that Grxcr1 exons and transcript sequences are not affected by the transgene insertion in tde homozygous (tde/tde) mice. Furthermore, 5'RACE PCR experiments showed the presence of two different transcripts of the Grxcr1 gene, expressed in both tde/tde and in wild-type controls. However, quantitative analysis of Grxcr1 transcripts revealed a significantly decreased mRNA level in tde/tde mice. The key stereociliary proteins ESPN, MYO7A, EPS8 and PTPRQ were distributed in hair bundles of homozygous tde mutants in a similar pattern compared with control mice. We found that the abnormal morphology of the stereociliary bundle was associated with a reduction in the size and Ca2+-sensitivity of the mechanoelectrical transducer (MET) current. We propose that GRXCR1 is key for the normal growth of the stereociliary bundle prior to the onset of hearing, and in its absence hair cells are unable to mature into fully functional sensory receptors.	[Lorente-Canovas, Beatriz; Lewis, Morag A.; Steel, Karen P.] Kings Coll London, Wolfson Ctr Age Related Dis, London, England; [Lorente-Canovas, Beatriz; Lewis, Morag A.; Steel, Karen P.] Wellcome Sanger Inst, Hinxton, England; [Eckrich, Stephanie; Johnson, Stuart L.; Marcotti, Walter] Univ Sheffield, Sch Biosci, Sheffield, S Yorkshire, England; [Johnson, Stuart L.; Marcotti, Walter] Univ Sheffield, Neurosci Inst, Sheffield, S Yorkshire, England; [Eckrich, Stephanie] Saarland Univ, Dept Biophys, Ctr Integrat Physiol & Mol Med CIPMM, Sch Med, Homburg, Germany	University of London; King's College London; Wellcome Trust Sanger Institute; University of Sheffield; University of Sheffield; Universitatsklinikum des Saarlandes	Steel, KP (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London, England.; Steel, KP (corresponding author), Wellcome Sanger Inst, Hinxton, England.	karen.steel@kcl.ac.uk		, Stephanie/0000-0001-6633-9478; Steel, Karen P/0000-0002-8019-5359	Wellcome [102892/Z/13/Z, 100669, 098051]; MRC [G0300212]	Wellcome; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome (102892/Z/13/Z to WM; 100669, 098051 to KPS) and the MRC (G0300212 to KPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenarius MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201713; Barr-Gillespie PG, 2015, MOL BIOL CELL, V26, P2727, DOI 10.1091/mbc.E14-04-0940; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bartles JR, 1998, J CELL BIOL, V143, P107, DOI 10.1083/jcb.143.1.107; Behlouli A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-55; Blanco-Sanchez B, 2018, CELL REP, V25, P1281, DOI 10.1016/j.celrep.2018.10.005; BOSHER SK, 1971, J PHYSIOL-LONDON, V212, P739, DOI 10.1113/jphysiol.1971.sp009354; Bridge PD, 1999, J CLIN EPIDEMIOL, V52, P229, DOI 10.1016/S0895-4356(98)00168-1; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Ceriani F, 2019, EMBO J, V38, DOI 10.15252/embj.201899839; Chen J, 2014, EUR J NEUROSCI, V39, P744, DOI 10.1111/ejn.12484; Corns LF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06307-w; Corns LF, 2014, P NATL ACAD SCI USA, V111, P14918, DOI 10.1073/pnas.1409920111; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; DeRosier DJ, 2000, J CELL BIOL, V148, P1; Drummond MC, 2012, HEARING RES, V288, P89, DOI 10.1016/j.heares.2011.12.003; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Elkon R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9549; Erven A, 2002, EUR J NEUROSCI, V16, P1433, DOI 10.1046/j.1460-9568.2002.02213.x; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Fettiplace R, 2014, PHYSIOL REV, V94, P951, DOI 10.1152/physrev.00038.2013; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; Furness DN, 2013, P NATL ACAD SCI USA, V110, P13898, DOI 10.1073/pnas.1304644110; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; Jeng JY, 2020, J PHYSIOL-LONDON, V598, P151, DOI 10.1113/JP279012; Johnson SL, 2017, J NEUROSCI, V37, P2471, DOI 10.1523/JNEUROSCI.2867-16.2017; Johnson SL, 2013, P NATL ACAD SCI USA, V110, P8720, DOI 10.1073/pnas.1219578110; Johnson SL, 2010, NAT NEUROSCI, V13, P45, DOI 10.1038/nn.2456; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; Kolla L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16113-y; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Marcotti W, 2004, J PHYSIOL-LONDON, V557, P613, DOI 10.1113/jphysiol.2003.060137; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; Marcotti W, 2016, J PHYSIOL-LONDON, V594, P3667, DOI 10.1113/JP272220; McGrath J, 2017, SEMIN CELL DEV BIOL, V65, P88, DOI 10.1016/j.semcdb.2016.08.017; Merritt RC, 2012, CURR BIOL, V22, P320, DOI 10.1016/j.cub.2011.12.053; Mori K, 2015, ANN OTO RHINOL LARYN, V124, p129S, DOI 10.1177/0003489415575061; Odeh H, 2004, AUDIOL NEURO-OTOL, V9, P303, DOI 10.1159/000080701; Odeh H, 2010, AM J HUM GENET, V86, P148, DOI 10.1016/j.ajhg.2010.01.016; Peng AW, 2016, J NEUROSCI, V36, P2945, DOI 10.1523/JNEUROSCI.3011-15.2016; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Prost J, 2007, BIOPHYS J, V93, P1124, DOI 10.1529/biophysj.106.098038; Qi JY, 2020, AM J TRANSL RES, V12, P130; Rzadzinska A, 2005, CELL MOTIL CYTOSKEL, V62, P157, DOI 10.1002/cm.20094; Rzadzinska AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007097; Sakaguchi H, 2008, CELL MOTIL CYTOSKEL, V65, P528, DOI 10.1002/cm.20275; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; SALT AN, 1989, AM J OTOLARYNG, V10, P371, DOI 10.1016/0196-0709(89)90030-6; Schraders M, 2010, AM J HUM GENET, V86, P138, DOI 10.1016/j.ajhg.2009.12.017; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Self T, 1998, DEVELOPMENT, V125, P557; Skynner MJ, 1999, INT J DEV BIOL, V43, P85; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; TILNEY LG, 1986, DEV BIOL, V116, P119, DOI 10.1016/0012-1606(86)90048-5; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Velez-Ortega AC, 2019, HEARING RES, V376, P47, DOI 10.1016/j.heares.2018.12.012; WONG WT, 1994, ONCOGENE, V9, P3057; WOOLLEY GW, 1945, J HERED, V36, P281, DOI 10.1093/oxfordjournals.jhered.a105523; Zampini V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001048; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	76	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0261530	10.1371/journal.pone.0261530	http://dx.doi.org/10.1371/journal.pone.0261530			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T6JP	35235570	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000787073100004
J	Bloch, JS; Sequeira, JM; Ramirez, AS; Quadros, EV; Locher, KP				Bloch, Joel S.; Sequeira, Jeffrey M.; Ramirez, Ana S.; Quadros, Edward, V; Locher, Kaspar P.			Generation of nanobodies targeting the human, transcobalamin-mediated vitamin B-12 uptake route	FASEB JOURNAL			English	Article						crystal structure; drug-delivery; nanobody; TCblR; transcobalamin	CELLULAR UPTAKE; RECEPTOR; TCBLR/CD320; PROTEIN; TRANSPORT; COBALAMIN; DOMAINS; CELLS; GENE; TOOL	Cellular uptake of vitamin B-12 in humans is mediated by the endocytosis of the B-12 carrier protein transcobalamin (TC) via its cognate cell surface receptor TCblR, encoded by the CD320 gene. Because CD320 expression is associated with the cell cycle and upregulated in highly proliferating cells including cancer cells, this uptake route is a potential target for cancer therapy. We developed and characterized four camelid nanobodies that bind holo-TC (TC in complex with B-12) or the interface of the human holo-TC:TCblR complex with nanomolar affinities. We determined X-ray crystal structures of these nanobodies bound to holo-TC:TCblR, which enabled us to map their binding epitopes. When conjugated to the model toxin saporin, three of our nanobodies caused growth inhibition of HEK293T cells and therefore have the potential to inhibit the growth of human cancer cells. We visualized the cellular binding and endocytic uptake of the most potent nanobody (TC-Nb4) using fluorescent light microscopy. The co-crystal structure of holo-TC:TCblR with another nanobody (TC-Nb34) revealed novel features of the interface of TC and the LDLR-A1 domain of TCblR, rationalizing the decrease in the affinity of TC-B-12 binding caused by the Delta 88 mutation in CD320.	[Bloch, Joel S.; Ramirez, Ana S.; Locher, Kaspar P.] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland; [Sequeira, Jeffrey M.; Quadros, Edward, V] SUNY Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Locher, KP (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch		Quadros, Edward/0000-0002-7663-8014; Ramirez, Ana S./0000-0002-1619-0721; Bloch, Joel/0000-0002-5786-0488	Swiss National Science Foundation [310030B_166672]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation, Grant/Award Number: 310030B_166672	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12100; AMAGASAKI T, 1990, BLOOD, V76, P1380; Bloch JS, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2115435118; Bloch JS, 2020, NATURE, V579, P443, DOI 10.1038/s41586-020-2044-z; BRINKLEY M, 1992, BIOCONJUGATE CHEM, V3, P2, DOI 10.1021/bc00013a001; Chapman-Smith A, 1999, BIOMOL ENG, V16, P119, DOI 10.1016/S1050-3862(99)00046-7; Clardy SM, 2011, EXPERT OPIN DRUG DEL, V8, P127, DOI 10.1517/17425247.2011.539200; De Meyer T, 2014, TRENDS BIOTECHNOL, V32, P263, DOI 10.1016/j.tibtech.2014.03.001; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10368-w; Gick GG, 2020, EXP CELL RES, V396, DOI 10.1016/j.yexcr.2020.112256; HALL CA, 1987, J CELL PHYSIOL, V133, P187, DOI 10.1002/jcp.1041330125; Jiang WX, 2013, FASEB J, V27, P2988, DOI 10.1096/fj.13-230185; Jiang WX, 2011, DRUG DELIV, V18, P74, DOI 10.3109/10717544.2010.509745; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kishan KVR, 2001, PROTEIN SCI, V10, P1046, DOI 10.1110/ps.50401; LINDEMANS J, 1989, EXP CELL RES, V184, P449, DOI 10.1016/0014-4827(89)90343-1; Liu YX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09836-0; Martinez-Jothar L, 2019, MOL PHARMACEUT, V16, P1633, DOI 10.1021/acs.molpharmaceut.8b01318; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mireku SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14512-8; Mohanty R, 2019, ONCOL REP, V42, P2183, DOI 10.3892/or.2019.7335; Morrison C, 2019, NAT REV DRUG DISCOV, V18, P485, DOI 10.1038/d41573-019-00104-w; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Polito L, 2013, TOXINS, V5, P1698, DOI 10.3390/toxins5101698; Punjani A, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107702; Quadros Edward V, 2013, J Cancer Ther, V4, P1074; Quadros EV, 2010, MOL CANCER THER, V9, P3033, DOI 10.1158/1535-7163.MCT-10-0513; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Scully M, 2019, NEW ENGL J MED, V380, P335, DOI 10.1056/NEJMoa1806311; Vaneycken I, 2011, FASEB J, V25, P2433, DOI 10.1096/fj.10-180331; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Wang YZ, 2016, INT J NANOMED, V11, P3287, DOI 10.2147/IJN.S107194; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103	41	0	0	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22222	10.1096/fj.202101376RR	http://dx.doi.org/10.1096/fj.202101376RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0DE	35218573	Green Published, Green Submitted			2022-12-26	WOS:000772946800001
J	Fang, Y; Liu, DY; Jiang, JJ; He, AX; Zhu, R; Tian, LJ				Fang, Yuan; Liu, Dongyang; Jiang, Jingjing; He, Axin; Zhu, Rui; Tian, Lijin			Photoprotective energy quenching in the red alga Porphyridium purpureum occurs at the core antenna of the photosystem II but not at its reaction center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEXES; CHLOROPHYLL FLUORESCENCE; CHLAMYDOMONAS-REINHARDTII; STATE TRANSITIONS; EXCESS LIGHT; PROTEIN; DISSIPATION; CYANOBACTERIAL; MECHANISMS; MEMBRANES	Photosynthetic organisms have evolved light-harvesting antennae over time. In cyanobacteria, external phycobilisomes (PBSs) are the dominant antennae, whereas in green algae and higher plants, PBSs have been replaced by proteins of the Lhc family that are integrated in the membrane. Red algae represent an evolutionary intermediate between these two systems, as they employ both PBSs and membrane LHCR proteins as light-harvesting units. Understanding how red algae cope with light is not only interesting for biotechnological applications, but is also of evolutionary interest. For example, energy-dependent quenching (qE) is an essential photoprotective mechanism widely used by species from cyanobacteria to higher plants to avoid light damage; however, the quenching mechanism in red algae remains largely unexplored. Here, we used both pulse amplitude-modulated (PAM) and time-resolved chlorophyll fluorescence to characterize qE kinetics in the red alga Porphyridium purpureum. PAM traces confirmed that qE in P. purpureum is activated by a decrease in the thylakoid lumen pH, whereas time-resolved fluorescence results further revealed the quenching site and ultrafast quenching kinetics. We found that quenching exclusively takes place in the photosystem II (PSII) complexes and preferentially occurs at PSII's core antenna rather than at its reaction center, with an overall quenching rate of 17.6 +/- 3.0 ns(-1). In conclusion, we propose that qE in red algae is not a reaction center type of quenching, and that there might be a membrane-bound protein that resembles PsbS of higher plants or LHCSR of green algae that senses low luminal pH and triggers qE in red algae.	[Fang, Yuan; Liu, Dongyang; Jiang, Jingjing; Tian, Lijin] Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Beijing, Peoples R China; [Fang, Yuan; Liu, Dongyang] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Axin] Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing, Peoples R China; [Zhu, Rui] Peking Univ, Sch Phys, Electron Microscopy Lab, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Peking University	Tian, LJ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Beijing, Peoples R China.	ltian@ibcas.ac.cn			National Key Research and Development Program of China [2019YFA0904604]; National Natural Science Foundation of China [11804172, 31970381, 11605001, 91850104]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr Gert Schansker for useful discussions. This work is supported by grants from the National Key Research and Development Program of China (Grant No. 2019YFA0904604), the National Natural Science Foundation of China (Grant Nos.11804172, 31970381, 11605001, 91850104).	Ago H, 2016, J BIOL CHEM, V291, P5676, DOI 10.1074/jbc.M115.711689; Allorent G, 2016, P NATL ACAD SCI USA, V113, P14864, DOI 10.1073/pnas.1607695114; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Bhattacharya D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2931; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Bruce D, 1997, BIOCHEMISTRY-US, V36, P749, DOI 10.1021/bi962216c; Busch A, 2010, PLANT J, V62, P886, DOI 10.1111/j.1365-313X.2010.04202.x; Calzadilla PI, 2020, PHOTOCH PHOTOBIO SCI, V19, P585, DOI 10.1039/c9pp00451c; Cardol P, 2009, P NATL ACAD SCI USA, V106, P15979, DOI 10.1073/pnas.0908111106; Cian RE, 2015, MAR DRUGS, V13, P5358, DOI 10.3390/md13085358; Croce R, 2020, SCIENCE, V369, P933, DOI 10.1126/science.aay2058; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Dall'Osto L, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.33; Delphin E, 1998, PLANT PHYSIOL, V118, P103, DOI 10.1104/pp.118.1.103; Delphin E, 1996, BIOCHEMISTRY-US, V35, P9435, DOI 10.1021/bi960528+; Dinc E, 2016, P NATL ACAD SCI USA, V113, P7673, DOI 10.1073/pnas.1605380113; Endo T, 1996, PLANT CELL PHYSIOL, V37, P551, DOI 10.1093/oxfordjournals.pcp.a028979; Fan MR, 2015, NAT STRUCT MOL BIOL, V22, P729, DOI 10.1038/nsmb.3068; Farooq S, 2018, NAT PLANTS, V4, P225, DOI 10.1038/s41477-018-0127-8; Fattore N, 2021, PHYSIOL PLANTARUM, V173, P805, DOI 10.1111/ppl.13489; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Gabilly ST, 2019, P NATL ACAD SCI USA, V116, P17556, DOI 10.1073/pnas.1821689116; Gardian Z, 2007, BBA-BIOENERGETICS, V1767, P725, DOI 10.1016/j.bbabio.2007.01.021; Giovagnetti V, 2018, BIOCHEM SOC T, V46, P1263, DOI 10.1042/BST20170304; Girolomoni L, 2019, P NATL ACAD SCI USA, V116, P4212, DOI 10.1073/pnas.1809812116; Guiry MD, 2012, J PHYCOL, V48, P1057, DOI 10.1111/j.1529-8817.2012.01222.x; Ho MY, 2017, CURR OPIN PLANT BIOL, V37, P24, DOI 10.1016/j.pbi.2017.03.006; Hong SH, 2008, PLANT J, V55, P361, DOI 10.1111/j.1365-313X.2008.03508.x; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Kalaji HM, 2014, PHOTOSYNTH RES, V122, P121, DOI 10.1007/s11120-014-0024-6; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; Krishnan-Schmieden M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22530-4; Krupnik T, 2013, J BIOL CHEM, V288, P23529, DOI 10.1074/jbc.M113.484659; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liguori N, 2019, J PHYS CHEM LETT, V10, P1737, DOI 10.1021/acs.jpclett.9b00437; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Luimstra VM, 2019, PHOTOSYNTH RES, V141, P291, DOI 10.1007/s11120-019-00630-z; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murata N, 2009, PHOTOSYNTH RES, V99, P155, DOI 10.1007/s11120-008-9389-8; Murchie EH, 2020, PLANT J, V101, P885, DOI 10.1111/tpj.14601; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Nicol L, 2019, NAT PLANTS, V5, P1177, DOI 10.1038/s41477-019-0526-5; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Pi X, 2018, P NATL ACAD SCI USA, V115, P4423, DOI 10.1073/pnas.1722482115; Pinnola A, 2015, PLANT CELL, V27, P3213, DOI 10.1105/tpc.15.00443; Rochaix JD, 2014, ANNU REV PLANT BIOL, V65, P287, DOI 10.1146/annurev-arplant-050213-040226; Sacharz J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.225; Snellenburg JJ, 2017, BBA-BIOENERGETICS, V1858, P64, DOI 10.1016/j.bbabio.2016.10.001; Snellenburg JJ, 2013, J PHYS CHEM B, V117, P11363, DOI 10.1021/jp4031283; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Su HN, 2010, PHOTOSYNTH RES, V106, P73, DOI 10.1007/s11120-010-9560-x; Szczepaniak M, 2009, BIOPHYS J, V96, P621, DOI 10.1016/j.bpj.2008.09.036; Tian LJ, 2019, P NATL ACAD SCI USA, V116, P8320, DOI 10.1073/pnas.1817796116; Tian LJ, 2013, PHYS CHEM CHEM PHYS, V15, P3146, DOI 10.1039/c3cp43813a; Tian LJ, 2011, J AM CHEM SOC, V133, P18304, DOI 10.1021/ja206414m; Ueno Y, 2015, PHOTOSYNTH RES, V125, P211, DOI 10.1007/s11120-015-0078-0; Usov AI, 2011, ADV CARBOHYD CHEM BI, V65, P115, DOI 10.1016/B978-0-12-385520-6.00004-2; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Wang HMD, 2015, BIORESOURCE TECHNOL, V184, P355, DOI 10.1016/j.biortech.2014.12.001; Wesselhoeft RA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05096-6; Wientjes E, 2012, PHOTOSYNTH RES, V111, P185, DOI 10.1007/s11120-011-9671-z; WOLFE GR, 1994, NATURE, V367, P566, DOI 10.1038/367566a0; Xu PQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13679; Yu P, 2017, CRIT REV FOOD SCI, V57, P3840, DOI 10.1080/10408398.2016.1167668; Zhan J, 2021, PLANT CELL, V33, P358, DOI 10.1093/plcell/koaa030	68	1	1	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101783	10.1016/j.jbc.2022.101783	http://dx.doi.org/10.1016/j.jbc.2022.101783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35245502	gold, Green Published			2022-12-26	WOS:000823106100009
J	Jiang, NH; Huang, R; Zhang, JH; Xu, DX; Li, TL; Sun, ZY; Su, LJ; Peng, ZY				Jiang, Nanhui; Huang, Rong; Zhang, Jiahao; Xu, Dongxue; Li, Tianlong; Sun, Zhongyi; Su, Lianjiu; Peng, Zhiyong			TIMP2 mediates endoplasmic reticulum stress contributing to sepsis-induced acute kidney injury	FASEB JOURNAL			English	Article						acute kidney injury (AKI); apoptosis; endoplasmic reticulum stress (ER stress); sepsis; tissue inhibitor of metalloproteinase 2 (TIMP2)	UNFOLDED PROTEIN RESPONSE; CRITICALLY-ILL PATIENTS; BCL-2 FAMILY-MEMBERS; TISSUE INHIBITOR; KAPPA-B; ER; METALLOPROTEINASE-2; VALIDATION; INDUCTION; SECRETION	Tissue inhibitor of metalloproteinase 2 (TIMP2) has been recognized as an important biomarker for predicting acute kidney injury (AKI) because of its involvement in the process of inflammation and apoptosis in septic AKI. Endoplasmic reticulum (ER) stress, a condition of disrupted ER homeostasis, is implicated in multiple pathophysiological processes, including kidney disease. Herein, we investigated the correlation between ER stress and septic AKI and further explored how TIMP2 regulated ER stress-mediated apoptosis. To assess the role of TIMP2 in sepsis-induced AKI, we used a cecal ligation and puncture (CLP) model in mice with tubule-specific deficiency of TIMP2 (Ksp-Cre/TIMP2(flox)(/)(flox)) and their wild-type counterparts. Compared to the wild-type mice, TIMP2-deficient mice demonstrated lower serum creatinine levels and decreased ER stress-mediated apoptosis when subjected to CLP. Interestingly, in human kidney (HK-2) cells, overexpression of TIMP2 caused ER stress, whereas TIMP2 knockdown attenuated lipopolysaccharide-induced ER stress and apoptosis. TIMP2 interacted with the binding immunoglobulin protein, an ER chaperone, and facilitates its extracellular secretion, thereby triggering ER stress. This study identified that the deletion of TIMP2 in mouse tubules mitigated sepsis-induced AKI by inhibiting ER stress-mediated apoptosis, which might be a potential therapeutic strategy to alleviate renal injury.	[Jiang, Nanhui; Huang, Rong; Zhang, Jiahao; Xu, Dongxue; Li, Tianlong; Sun, Zhongyi; Su, Lianjiu; Peng, Zhiyong] Wuhan Univ, Dept Crit Care Med, Zhongnan Hosp, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China; [Peng, Zhiyong] Univ Pittsburgh, Ctr Crit Nephrol, Dept Crit Care Med, Med Ctr, Pittsburgh, PA USA	Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Su, LJ; Peng, ZY (corresponding author), Wuhan Univ, Dept Crit Care Med, Zhongnan Hosp, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	sulianjiu@whu.edu.cn; pengzy5@hotmail.com			National Natural Science Foundation of China (NSFC) [81772046, 81971816, 82102298]; Major National Science and Technology Projects of China [2020ZX09201007]; Innovation Cultivation Foundation of Wuhan University/Zhongnan Hospital [413000345/CXPY2020017]; Research Project Foundation of Zhongnan Hospital [ZNYB2020013]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major National Science and Technology Projects of China; Innovation Cultivation Foundation of Wuhan University/Zhongnan Hospital; Research Project Foundation of Zhongnan Hospital	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81772046, 81971816 and 82102298; Major National Science and Technology Projects of China, Grant/Award Number: 2020ZX09201007; Innovation Cultivation Foundation of Wuhan University/Zhongnan Hospital, Grant/Award Number: 413000345/CXPY2020017; Research Project Foundation of Zhongnan Hospital, Grant/Award Number: ZNYB2020013	Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Bellomo R, 2017, INTENS CARE MED, V43, P816, DOI 10.1007/s00134-017-4755-7; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bihorac A, 2014, AM J RESP CRIT CARE, V189, P932, DOI 10.1164/rccm.201401-0077OC; Borkan SC, 2016, SEMIN NEPHROL, V36, P237, DOI 10.1016/j.semnephrol.2016.04.001; Carrara M, 2015, ELIFE, V4, DOI 10.7554/eLife.03522; Chen HG, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.106049; Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Frakes AE, 2017, MOL CELL, V66, P761, DOI 10.1016/j.molcel.2017.05.031; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Jin H, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00222; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kimura K, 2008, BIOCHEM BIOPH RES CO, V366, P1048, DOI 10.1016/j.bbrc.2007.12.098; Kopp MC, 2019, NAT STRUCT MOL BIOL, V26, P1053, DOI 10.1038/s41594-019-0324-9; Koyner JL, 2015, J AM SOC NEPHROL, V26, P1747, DOI 10.1681/ASN.2014060556; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Levey AS, 2017, ANN INTERN MED, V167, pITC65, DOI 10.7326/AITC201711070; Li YM, 2019, BBA-MOL BASIS DIS, V1865, P558, DOI 10.1016/j.bbadis.2018.10.041; Liew HK, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111326; Liu ZW, 2020, THERANOSTICS, V10, P11963, DOI 10.7150/thno.50093; Luo CJ, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0157-1; Mami L, 2016, J AM SOC NEPHROL, V27, P863, DOI 10.1681/ASN.2015020196; Mehta RL, 2011, INTENS CARE MED, V37, P241, DOI 10.1007/s00134-010-2089-9; Miyaji T, 2003, KIDNEY INT, V64, P1620, DOI 10.1046/j.1523-1755.2003.00268.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Peerapornratana S, 2019, KIDNEY INT, V96, P1083, DOI 10.1016/j.kint.2019.05.026; Pike F, 2015, CLIN J AM SOC NEPHRO, V10, P1332, DOI 10.2215/CJN.09911014; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Stasi A, 2017, NEPHROL DIAL TRANSPL, V32, P24, DOI 10.1093/ndt/gfw250; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Sunami Y, 2016, HEPATOLOGY, V63, P1592, DOI 10.1002/hep.28435; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Vitale M, 2019, ELIFE, V8, DOI 10.7554/eLife.41168; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xu XH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11417-4; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	45	3	3	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22228	10.1096/fj.202101555RR	http://dx.doi.org/10.1096/fj.202101555RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CQ	35218571				2022-12-26	WOS:000772945400001
J	Antuamwine, BB; Herchel, ED; Bawa, EM				Antuamwine, Benedict Boateng; Herchel, Eddie Delali; Bawa, Eric Mishio			Comparative prevalence of hepatitis B virus infection among pregnant women accessing free maternal care in a tertiary hospital in Ghana	PLOS ONE			English	Article							AFRICA STRATEGIES; VIRAL-HEPATITIS; SEROPREVALENCE; BURDEN	Hepatitis B virus infection is endemic in sub-Saharan Africa, and accounts for a significant proportion of morbidities and mortalities in Ghana. Infection with HBV during pregnancy can result in life-threatening complications to both mother and child. To improve their quality of life, the free maternal care was introduced to grant pregnant women cost-free access to antenatal and postnatal services. The study analysed the prevalence of HBV infection among pregnant women receiving free antenatal care in a tertiary hospital in Ghana. This was a retrospective cross-sectional study, where secondary data of pregnant women who accessed free antenatal services at the Trafalga hospital, Ho, from 2016 to 2017 were retrieved from the hospital's database. Data on hepatitis B surface antigen reactivity test, age and period of turnout were analysed with Microsoft Excel and Graph pad prism version 6. A total of 2,634 pregnant women assessed free antenatal care from January 2016 - December 2017, with 10% rise in turnout in 2017. The age of the study population was fairly young, ranging from 13-52 years and mean of 29.87 +/- 5.83. The prevalence of HBV infection among pregnant women in the entire study was estimated to be 6.0%, while that of 2016 and 2017 were 5.3% and 6.7% respectively. Turnout for antenatal services peaked in July, which also recorded the highest prevalence of HBV infection among the pregnant women. Our study, first of its kind show an HBV prevalence of 6.0% among a large population of pregnant women who accessed free antenatal services at a tertiary hospital in Ghana. The study evaluates the influence of the free maternal care policy on antenatal attendance and HBV infection rates among pregnant women.	[Antuamwine, Benedict Boateng; Herchel, Eddie Delali; Bawa, Eric Mishio] Univ Dev Studies, Sch Allied Hlth Sci, Dept Biomed Lab Sci, Tamale, Ghana	University for Development Studies	Antuamwine, BB (corresponding author), Univ Dev Studies, Sch Allied Hlth Sci, Dept Biomed Lab Sci, Tamale, Ghana.	bantuamwine@uds.edu.gh	MISHIO BAWA, ERIC/HII-3146-2022	Antuamwine, Benedict Boateng/0000-0002-0111-6991				Abesig J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234348; Anabire NG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210365; [Anonymous], 2004, NATL HLTH INSURANCE; [Anonymous], 2009, HLTH SECT PROGR WORK; Asare EO, 2017, CLIMATE, V5, DOI 10.3390/cli5010020; Candotti D, 2007, J GEN VIROL, V88, P2686, DOI 10.1099/vir.0.83102-0; Cho Y, 2012, GUT LIVER, V6, P235, DOI 10.5009/gnl.2012.6.2.235; Dalinjong Philip Ayizem, 2018, BMC Res Notes, V11, P341, DOI 10.1186/s13104-018-3452-0; Damale NKR, 2005, INT J GYNECOL OBSTET, V90, P240, DOI 10.1016/j.ijgo.2005.05.014; Dixon J, 2014, TROP MED INT HEALTH, V19, P98, DOI 10.1111/tmi.12223; Dzotsi HT, 2020, VULNERABLE CHILD YOU, V15, P85, DOI 10.1080/17450128.2020.1719251; Ghana Health Service, 2007, REPR HLTH STRAT PLAN; Ghosh M, 2015, WORLD J HEPATOL, V7, P2482, DOI 10.4254/wjh.v7.i23.2482; Hera Health Partners G, 2013, EVALUATION FREE MATE; IEA, 2015, WORLD EN OUTL 2015 F; Inoue T, 2016, MICROB CELL, V3, P420, DOI 10.15698/mic2016.09.527; Kassa GM, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0640-2; Kukka C., 2017, VALUABLE TOOL CHRONI, DOI [10.1016/j.envpol.2017.06.015, DOI 10.1016/J.ENVPOL.2017.06.015]; Lang'at E, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0048-1; Lemoine M, 2015, J HEPATOL, V62, P469, DOI 10.1016/j.jhep.2014.10.008; Luka SA., 2008, NIGERIAN J PARASITOL, V29, P38; Luuse A, 2016, J PUBLIC HEALTH AFR, V7, P81, DOI 10.4081/jphia.2016.584; Mandal S, 2019, HUM VACC IMMUNOTHER, V15, P440, DOI 10.1080/21645515.2018.1528837; Marzio DHD, 2014, WORLD J GASTROENTERO, V20, P401, DOI 10.3748/wjg.v20.i2.401; Moh, 2014, NAT POL VIR HEP; Moh, 2002, NATL SURVEILLANCE UN; Moh, 2007, NAT HLTH POL CREAT W; Navabakhsh Behrouz, 2011, Middle East J Dig Dis, V3, P92; Ofori-Asenso R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1467-5; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Owusu-Ansah T, 2014, IRAL HEPATITIS GHANA; Sinha S, 2010, HEPATOL RES, V40, P31, DOI 10.1111/j.1872-034X.2009.00597.x; Spearman CW, 2017, LANCET GASTROENTEROL, V2, P900, DOI 10.1016/S2468-1253(17)30295-9; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Teo E-K., 2006, EPIDEMIOLOGY TRANSMI; World Health Organization, 2002, WHO ANT CAR RAND TRI; Yakasai IA., 2012, J BASIC CLIN REPROD, V1, P49	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0263651	10.1371/journal.pone.0263651	http://dx.doi.org/10.1371/journal.pone.0263651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245287	gold, Green Published			2022-12-26	WOS:000799799100004
J	Bouchareb, S; Chrifou, R; Bourik, Z; Nijpels, G; Hassanein, M; Westerman, MJ; Elders, PJM				Bouchareb, Siham; Chrifou, Rabab; Bourik, Zohra; Nijpels, Giel; Hassanein, Mohamed; Westerman, Marjan J.; Elders, Petra J. M.			"I am my own doctor": A qualitative study of the perspectives and decision-making process of Muslims with diabetes on Ramadan fasting	PLOS ONE			English	Article							METHODOLOGICAL CHALLENGES; TYPE-2; MANAGEMENT; EDUCATION; PROGRAM	Background Many Muslims with diabetes choose to fast against medical advice during Ramadan, potentially increasing their risk of acute complications. Patients are often reluctant to disclose fasting to their health care providers, and their needs regarding Ramadan are not met in consultations. For healthcare professionals to provide patient-centred care, it is important to gain more insight into patients' decision-making process. This study therefore aims to explore how Muslims with diabetes decide whether to fast during Ramadan. Methods A qualitative study was conducted consisting of 15 focus groups with Muslims with diabetes within a constructivist paradigm. Convenience sampling was used. All focus groups were transcribed verbatim and analyzed using Braun and Clarke's reflexive thematic analysis. Results Four themes were found to be important in the decision on whether to fast: (1) values and beliefs concerning Ramadan, (2) experiences and emotions concerning Ramadan, (3) the perception of illness, and (4) advice from health care professionals, imams and family. Many participants indicated fasting against medical advice and trusting their subjective assessments on whether they could fast. Moreover, three main stages in the decision-making process for eventually refraining from fasting were identified: (1) the stage where positive experiences with fasting dominate, (2) the stage where one encounters challenges but their determination to fast prevails and (3) the stage where one decides to refrain from fasting after experiencing too many physical difficulties with fasting. Conclusions Muslims with diabetes experience autonomy in their decisions on Ramadan fasting. The decision to refrain from fasting often resulted from a difficult and dynamic decision-making process and was often made after participants reached their physical limits. These findings highlight the importance of not only shared decision-making to empower patients to make well-informed decisions on Ramadan fasting but also pre-Ramadan diabetes education to help people with diabetes have a safe Ramadan.	[Bouchareb, Siham; Nijpels, Giel; Elders, Petra J. M.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Gen Practice, Amsterdam UMC, Amsterdam, Netherlands; [Chrifou, Rabab] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam UMC, Amsterdam, Netherlands; [Chrifou, Rabab] Univ Ghent, Dept Publ Hlth & Primary Care, Unit Hlth Promot, Ghent, Belgium; [Bourik, Zohra] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Eth Law & Humanities, Amsterdam UMC, Amsterdam, Netherlands; [Hassanein, Mohamed] Dubai Hosp, Endocrine Dept, Dubai, U Arab Emirates; [Westerman, Marjan J.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Data Sci, Amsterdam UMC, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Ghent University; Ghent University Hospital; University of Amsterdam; Vrije Universiteit Amsterdam; Dubai Hospital; University of Amsterdam; Vrije Universiteit Amsterdam	Bouchareb, S; Elders, PJM (corresponding author), Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Gen Practice, Amsterdam UMC, Amsterdam, Netherlands.	S.bouchareb@amsterdamumc.nl; P.elders@amsterdamumc.nl		Elders, Petra/0000-0002-5907-7219; Nijpels, Giel/0000-0002-3679-9710; Bouchareb, Siham/0000-0002-8420-1808	Netherlands Organisation for Health Research and Development (ZonMw) [80-84800-98-23016]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	PE received funding for this study (grant number: 80-84800-98-23016) by the Netherlands Organisation for Health Research and Development (ZonMw), https://www.zonmw.nl/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afandi B., 2017, J FASTING HLTH, V5, P133, DOI 10.22038/jfh.2018.27312.1100; Ahmedani MY, 2012, DIABETIC MED, V29, P709, DOI 10.1111/j.1464-5491.2011.03563.x; Ahmedani MY, 2020, J DIABETES METAB DIS, V19, P29, DOI 10.1007/s40200-019-00471-6; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Al Awadi FF, 2020, ADV THER, V37, P1550, DOI 10.1007/s12325-020-01267-4; Ali M, 2016, J PRIM CARE COMMUNIT, V7, P33, DOI 10.1177/2150131915601359; Almansour HA, 2018, ETHNIC HEALTH, V23, P380, DOI 10.1080/13557858.2016.1269156; Amin MEK, 2020, J RELIG HEALTH, V59, P1370, DOI 10.1007/s10943-019-00820-y; [Anonymous], HOLY QURAN, P183; Ataro G, 2020, ANN MED SURG, V49, P19, DOI 10.1016/j.amsu.2019.11.013; Ba-Essa EM, 2019, DIABETES RES CLIN PR, V152, P177, DOI 10.1016/j.diabres.2019.03.031; Babineaux SM, 2015, DIABETIC MED, V32, P819, DOI 10.1111/dme.12685; Beshyah Sa, 2007, Libyan J Med, V2, P185, DOI 10.4176/071008; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braun V, 2021, QUAL RES PSYCHOL, V18, P328, DOI 10.1080/14780887.2020.1769238; Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806; Bravis V, 2010, DIABETIC MED, V27, P327, DOI 10.1111/j.1464-5491.2010.02948.x; Byrne D., 2022, QUAL QUANT, V56, P1391, DOI [10.1007/s11135-021-01182-y, DOI 10.1007/S11135-021-01182-Y]; El Toony LF, 2018, DIABETES METAB SYND, V12, P761, DOI 10.1016/j.dsx.2018.04.036; El-Rahman MA., 2019, J DIABETES NURSING, V23; Gaborit B, 2011, DIABETES METAB, V37, P395, DOI 10.1016/j.diabet.2010.12.010; Graneheim UH, 2017, NURS EDUC TODAY, V56, P29, DOI 10.1016/j.nedt.2017.06.002; Green J, 2014, QUALITATIVE METHODS; Hassanein MM, 2021, DIABETES RES CLIN PR, V172, DOI 10.1016/j.diabres.2020.108584; Hassanein M, 2021, DIABETES RES CLIN PR, V173, DOI 10.1016/j.diabres.2021.108674; Hassanein M, 2021, DIABETES RES CLIN PR, V172, DOI 10.1016/j.diabres.2020.108626; Hassanein M, 2021, DIABETES RES CLIN PR, V173, DOI 10.1016/j.diabres.2021.108678; Hassanein M, 2019, DIABETES RES CLIN PR, V151, P275, DOI 10.1016/j.diabres.2019.02.020; Hassanein M, 2017, DIABETES RES CLIN PR, V126, P303, DOI 10.1016/j.diabres.2017.03.003; Ibrahim M, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001248; Ilkilic I, 2017, MED HEALTH CARE PHIL, V20, P561, DOI 10.1007/s11019-017-9777-y; International Diabetes Federation (IDF) icwtDaRDIA, 2016, DIAB RAM PRACT GUID; Jabbar A, 2017, DIABETES RES CLIN PR, V132, P19, DOI 10.1016/j.diabres.2017.07.014; Kamal S., 2012, J MED RES, V2, P407; Lee JY, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000365; Liao JY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242111; Malek R, 2019, DIABETES RES CLIN PR, V150, P322, DOI 10.1016/j.diabres.2019.02.008; McEwen LN, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000111; Myers PR, 2019, DIABETES RES CLIN PR, V150, P282, DOI 10.1016/j.diabres.2018.12.011; Mygind A, 2013, INT J CLIN PHARM-NET, V35, P281, DOI 10.1007/s11096-012-9716-1; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Padela A., 2011, M HEALTHCARE NEEDS A; Padela AI, 2011, J RELIG HEALTH, V50, P359, DOI 10.1007/s10943-010-9428-6; Patel NR, 2015, HEALTH EXPECT, V18, P1698, DOI 10.1111/hex.12163; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Savas E, 2018, J RELIG HEALTH, V57, P47, DOI 10.1007/s10943-016-0327-3; Shehab A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047615; Siaw MYL, 2016, J DIABETES INVEST, V7, P70, DOI 10.1111/jdi.12374; Stewart DW., 2002, FOCUS GROUPS THEORY; Tourkmani AM, 2016, PATIENT PREFER ADHER, V10, P1709, DOI 10.2147/PPA.S113324; Varpio L, 2017, MED EDUC, V51, P40, DOI 10.1111/medu.13124	51	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2022	17	3							e0263088	10.1371/journal.pone.0263088	http://dx.doi.org/10.1371/journal.pone.0263088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2JD	35245315	Green Published, gold			2022-12-26	WOS:000799799100002
J	Geleto, A; Sinba, E; Ali, MM				Geleto, Aliye; Sinba, Edao; Ali, Musa Mohammed			Dental caries and associated factors among patients visiting Shashamane Comprehensive Specialized Hospital	PLOS ONE			English	Article							GLOBAL BURDEN; DISEASE	Introduction Dental caries is a major public health problem. In Ethiopia, prevention and treatment of oral health-related illness had given little attention and there is limited data on the extent and factors associated with oral health-related illnesses and oral care practices. Objective This study was aimed to investigate the prevalence of dental caries and associated factors among patients visiting Shashamane Comprehensive Specialized Hospital (SCSH). Methods A hospital-based cross-sectional study was conducted among 288 patients who visited SCSH dental clinic from March 1, 2021, to April 15, 2021. A questionnaire was employed to collect the background characteristics of the participants. Dental caries was confirmed as per World Health Organization guidelines. Data were analyzed using SPSS version 24. Bivariable and multivariable logistic regression were used to determine predictors of dental caries. A p-value less than 0.05 was taken as a cut point to determine a significant association. Results The overall prevalence of dental caries was 64.6% with 95% CI (58.870.1). The mean of Decayed, Missing, and Filled Teeth was 1.33. Dental caries was significantly higher among respondents who did not brush their teeth (AOR = 3.589, 95% CI:1.7567.334), who consumed sugary food (AOR = 3.650, 95% CI: 1.7477.628), those with monthly a income of less than 5000.00 Ethiopian Birr (AOR = 2.452, 95% CI (1.1935.042), and those who had poor oral hygiene status (AOR = 1.826, 95% CI: 0.9013.700). Conclusions This study revealed a high prevalence of dental caries among patients visiting the dental clinic. Tooth brushing habits, consumption of sugary food, and poor oral hygiene were significantly associated with dental caries.	[Geleto, Aliye] Shashamane Comprehens Specialized Hosp, Dent Clin, Shashemene, Ethiopia; [Sinba, Edao] Madda Walabu Univ, Coll Hlth Sci, Dept Publ Hlth, Shashamane Campus, Shashemene, Ethiopia; [Ali, Musa Mohammed] Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Ethiopia	Hawassa University	Ali, MM (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Ethiopia.	ysnmss@yhaoo.com	Ali, Musa/AAO-1172-2021	Ali, Musa/0000-0001-7786-3400; Geleto, Aliye/0000-0002-7866-1082				Andayasari L., 2018, CHILDREN, V4; [Anonymous], 2021, OR HLTH NEWS; Ayele FA, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-7; Christian B, 2019, INT DENT J, V69, P113, DOI 10.1111/idj.12419; Colak Hakan, 2013, J Nat Sci Biol Med, V4, P29, DOI 10.4103/0976-9668.107257; Fukuda H., 2014, J DENT ORAL HEA, V1, P1, DOI DOI 10.17303/JDOH.2014.201; Gathecha G, 2012, PAN AFR MED J, V12; Gouda HN, 2019, LANCET GLOB HEALTH, V7, pE1375, DOI 10.1016/S2214-109X(19)30374-2; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Khalifa N, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-5; Mulu Wondemagegn, 2014, BMC Res Notes, V7, P949, DOI 10.1186/1756-0500-7-949; Namal N., 2008, Eastern Mediterranean Health Journal, V14, P110; Negrato CA, 2013, J APPL ORAL SCI, V21, P1, DOI 10.1590/1678-7757201302106; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Petersen Poul Erik, 2013, ORAL HLTH SURVEYS BA, V5; Roberson T., 2006, ELSEVIER HLTH SCI; Shitie A, 2021, INT J DENT, V2021, DOI 10.1155/2021/6637196; Simangwa LD, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1655-8; Tafere Y, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0581-8; Teshome A, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.645091; Teshome A, 2020, CLIN COSMET INV DENT, V12, P191, DOI 10.2147/CCIDE.S247179; United Nations General Assembly, 2011, POL DECL HIGH LEV M; Zero DT, 2016, J AM DENT ASSOC, V147, P295, DOI 10.1016/j.adaj.2015.11.008; Zewdu T, 2021, ENVIRON HEALTH PREV, V26, DOI 10.1186/s12199-021-00943-3	24	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2022	17	3							e0265000	10.1371/journal.pone.0265000	http://dx.doi.org/10.1371/journal.pone.0265000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0D4YH	35239749	Green Published, gold			2022-12-26	WOS:000776002200085
J	Ming, X; Bo, ZY; Miao, YR; Chen, H; Bao, CY; Sun, LM; Xi, R; Zhong, QP; Zhao, P; Jung, YS; Qian, YJ				Ming, Xin; Bo, Zongyi; Miao, Yurun; Chen, Huan; Bao, Chenyi; Sun, Liumei; Xi, Rui; Zhong, Qiuping; Zhao, Pu; Jung, Yong-Sam; Qian, Yingjuan			Pseudorabies virus kinase UL13 phosphorylates H2AX to foster viral replication	FASEB JOURNAL			English	Article						ATM; DNA damage response; pseudorabies virus; UL13; gamma H2AX	DNA-DAMAGE RESPONSE; HISTONE H2AX; ATR; PK; PATHOGENESIS; ACTIVATION; PATHWAY; MODES	The DNA damage response (DDR) pathway is critical for maintaining genomic integrity and sustaining organismal development. Viruses can either utilize or circumvent the DDR to facilitate their replication. Pseudorabies virus (PRV) infection was shown to induce apoptosis via stimulating DDR. However, the underlying mechanisms have not been fully explored to date. This study showed that PRV infection robustly activates the ATM and DNA-PK signaling pathways shortly after infection. However, inhibition of ATM, but not DNA-PK, could dampen PRV replication in cells. Importantly, we found that PRV-encoded serine/threonine kinase UL13 interacts with and subsequently phosphorylates H2AX. Furthermore, we found that UL13 deletion largely attenuates PRV neuroinvasiveness and virulence in vivo. In addtion, we showed that UL13 contributes to H2AX phosphorylation upon PRV infection both in vitro and in vivo, but does not affect ATM phosphorylation. Finally, we showed that knockdown of H2AX reduces PRV replication, while this reduction can be further enhanced by deletion of UL13. Taken together, we conclude that PRV-encoded kinase UL13 regulates DNA damage marker gamma H2AX and UL13-mediated H2AX phosphorylation plays a pivotal role in efficient PRV replication and progeny production.	[Ming, Xin; Bo, Zongyi; Miao, Yurun; Chen, Huan; Bao, Chenyi; Sun, Liumei; Xi, Rui; Zhong, Qiuping; Zhao, Pu; Jung, Yong-Sam; Qian, Yingjuan] Nanjing Agr Univ, Coll Vet Med, MOA Key Lab Anim Bacteriol, MOE Joint Int Res Lab Anim Hlth & Food Safety, Nanjing, Peoples R China; [Bo, Zongyi] Yangzhou Univ, Joint Int Res Lab Agr & Agriprod Safety, Minist Educ China, Yangzhou, Jiangsu, Peoples R China; [Qian, Yingjuan] Jiangsu Agrianim Husb Vocat Coll, Jiangsu Key Lab High Tech Res & Dev Vet Biopharma, Taizhou, Peoples R China; [Sun, Liumei] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China	Nanjing Agricultural University; Ministry of Education, China; Yangzhou University; Jiangsu Agri-animal Husbandry Vocational College; Jiangsu University of Science & Technology	Qian, YJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China.	yqian@njau.edu.cn			National Natural Science Foundation of China (NSFC) [31472218]; Fundamental Research Funds for the Central Universities [Y0201700559]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31472218; Fundamental Research Funds for the Central Universities, Grant/Award Number: Y0201700559; Priority Academic Program Development of Jiangsu Higher Education Institutions	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bo ZY, 2020, VET RES, V51, DOI 10.1186/s13567-020-00843-4; Bo ZY, 2021, TRANSBOUND EMERG DIS, V68, P1454, DOI 10.1111/tbed.13813; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Brittle EE, 2004, J VIROL, V78, P12951, DOI 10.1128/JVI.78.23.12951-12963.2004; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cramer SD, 2011, J VET DIAGN INVEST, V23, P915, DOI 10.1177/1040638711416628; de Heer EC, 2020, J CLIN INVEST, V130, P5074, DOI 10.1172/JCI137552; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; FIELD HJ, 1974, J GEN VIROL, V23, P145, DOI 10.1099/0022-1317-23-2-145; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hollingworth R, 2017, J VIROL, V91, DOI 10.1128/JVI.00930-17; Jacob T, 2011, J VIROL, V85, P1158, DOI 10.1128/JVI.01369-10; Kawaguchi Y, 2003, REV MED VIROL, V13, P331, DOI 10.1002/rmv.402; Klupp BG, 2004, J VIROL, V78, P424, DOI 10.1128/JVI.78.1.424-440.2004; Lai IH, 2019, INTERVIROLOGY, V62, P116, DOI 10.1159/000502047; Laval K, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008087; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Lian X, 2019, J VIROL, V93, DOI 10.1128/JVI.02290-18; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Luftig MA, 2014, ANNU REV VIROL, V1, P605, DOI 10.1146/annurev-virology-031413-085548; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Mettenleiter TC, 2000, VET RES, V31, P99, DOI 10.1051/vetres:2000059; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Rawlinson SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05354-7; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Ryan EL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010002; Smith S, 2015, FUTURE VIROL, V10, P383, DOI 10.2217/FVL.15.18; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sun LM, 2021, J VIROL, V95, DOI 10.1128/JVI.02344-20; Tarakanova VL, 2007, CELL HOST MICROBE, V1, P275, DOI 10.1016/j.chom.2007.05.008; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weitzman MD, 2018, ANNU REV VIROL, V5, P141, DOI 10.1146/annurev-virology-092917-043534; Weller SK, 2012, FASEB J, V26; Weyemi U, 2019, P NATL ACAD SCI USA, V116, P7471, DOI 10.1073/pnas.1820245116; Weyemi U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03948-9; Yedjou CG, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010056; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	48	1	1	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22221	10.1096/fj.202101360RR	http://dx.doi.org/10.1096/fj.202101360RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35199383				2022-12-26	WOS:000761250800027
J	Pfeiffer, C; Wengeler, S; Loquercio, A; Scaramuzza, D				Pfeiffer, Christian; Wengeler, Simon; Loquercio, Antonio; Scaramuzza, Davide			Visual attention prediction improves performance of autonomous drone racing agents	PLOS ONE			English	Article							QUADROTOR; FLIGHT	Humans race drones faster than neural networks trained for end-to-end autonomous flight. This may be related to the ability of human pilots to select task-relevant visual information effectively. This work investigates whether neural networks capable of imitating human eye gaze behavior and attention can improve neural networks' performance for the challenging task of vision-based autonomous drone racing. We hypothesize that gaze-based attention prediction can be an efficient mechanism for visual information selection and decision making in a simulator-based drone racing task. We test this hypothesis using eye gaze and flight trajectory data from 18 human drone pilots to train a visual attention prediction model. We then use this visual attention prediction model to train an end-to-end controller for vision-based autonomous drone racing using imitation learning. We compare the drone racing performance of the attention-prediction controller to those using raw image inputs and image-based abstractions (i.e., feature tracks). Comparing success rates for completing a challenging race track by autonomous flight, our results show that the attention-prediction based controller (88% success rate) outperforms the RGB-image (61% success rate) and feature-tracks (55% success rate) controller baselines. Furthermore, visual attention-prediction and feature-track based models showed better generalization performance than image-based models when evaluated on hold-out reference trajectories. Our results demonstrate that human visual attention prediction improves the performance of autonomous vision-based drone racing agents and provides an essential step towards vision-based, fast, and agile autonomous flight that eventually can reach and even exceed human performances.	[Pfeiffer, Christian; Wengeler, Simon; Loquercio, Antonio; Scaramuzza, Davide] Univ Zurich, Dept Informat, Robot & Percept Grp, Zurich, Switzerland; [Pfeiffer, Christian; Wengeler, Simon; Loquercio, Antonio; Scaramuzza, Davide] Univ Zurich, Dept Neuroinformat, Zurich, Switzerland; [Pfeiffer, Christian; Wengeler, Simon; Loquercio, Antonio; Scaramuzza, Davide] Swiss Fed Inst Technol, Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pfeiffer, C (corresponding author), Univ Zurich, Dept Informat, Robot & Percept Grp, Zurich, Switzerland.; Pfeiffer, C (corresponding author), Univ Zurich, Dept Neuroinformat, Zurich, Switzerland.; Pfeiffer, C (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	christian.pfeiffer@uzh.ch			Ernst Gohner Foundation; University of Zurich Alumni Fonds zur Forderung des Akademischen Nachwuchses (FAN Fellowship); National Centre of Competence in Research (NCCR) Robotics through the Swiss National Science Foundation (SNSF); European Union [871479]; European Research Council (ERC) [864042]	Ernst Gohner Foundation; University of Zurich Alumni Fonds zur Forderung des Akademischen Nachwuchses (FAN Fellowship); National Centre of Competence in Research (NCCR) Robotics through the Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by the Ernst Gohner Foundation and University of Zurich Alumni Fonds zur Forderung des Akademischen Nachwuchses (FAN Fellowship), by the National Centre of Competence in Research (NCCR) Robotics through the Swiss National Science Foundation (SNSF) and the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No. 871479 (AERIAL-CORE) and the European Research Council (ERC) under grant agreement No. 864042 (AGILEFLIGHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barin A, 2017, CHI PLAY'17: PROCEEDINGS OF THE ANNUAL SYMPOSIUM ON COMPUTER-HUMAN INTERACTION IN PLAY, P485, DOI 10.1145/3116595.3116611; Baytas M.A., 2019, HAL OPEN SCI, P9; Bojarski Mariusz, 2016, arXiv; Cauchard JR, 2019, ACMIEEE INT CONF HUM, P153, DOI 10.1109/HRI.2019.8673011; Cocoma-Ortega JA, 2022, J REAL-TIME IMAGE PR, V19, P73, DOI 10.1007/s11554-021-01162-3; Codevilla F, 2018, IEEE INT CONF ROBOT, P4693; Delmerico J, 2019, IEEE INT CONF ROBOT, P6713, DOI 10.1109/ICRA.2019.8793887; Deng J., 2009, 2009 IEEE COMPUTER S, P248, DOI DOI 10.1109/CVPR.2009.5206848; Foehn P, 2021, SCI ROBOT, V6, DOI 10.1126/scirobotics.abh1221; Foehn P, 2020, ROBOTICS: SCIENCE AND SYSTEMS XVI; Guerra W, 2019, IEEE INT C INT ROBOT, P6941, DOI 10.1109/IROS40897.2019.8968116; Hansen J. P., 2014, P S EYE TRACKING RES, P27, DOI DOI 10.1145/2578153.2578156; Harris C., 1988, P ALVEY VISION C, DOI DOI 10.5244/C.2.23; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hussein A, 2017, ACM COMPUT SURV, V50, DOI 10.1145/3054912; Jung S, 2018, IEEE ROBOT AUTOM LET, V3, P2539, DOI 10.1109/LRA.2018.2808368; Kang B, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20072030; Kaufmann E, 2020, DEEP DRONE ACROBATIC; Kaufmann E, 2019, IEEE INT CONF ROBOT, P690, DOI 10.1109/ICRA.2019.8793631; Khan NA, 2022, CMC-COMPUT MATER CON, V70, P601, DOI 10.32604/cmc.2022.019419; Kingma D. P., 2015, P INT C LEARN REPR, P1; Kumar A, 2021, VEH COMMUN, V28, DOI 10.1016/j.vehcom.2020.100313; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Li G, 2018, 2018 IEEE/ACIS 3RD INTERNATIONAL CONFERENCE ON BIG DATA, CLOUD COMPUTING, DATA SCIENCE & ENGINEERING (BCD 2018), P37, DOI 10.1109/BCD2018.2018.00014; Li S, 2020, ROBOT AUTON SYST, V133, DOI 10.1016/j.robot.2020.103621; Liu CC, 2019, ETRA 2019: 2019 ACM SYMPOSIUM ON EYE TRACKING RESEARCH & APPLICATIONS, DOI 10.1145/3314111.3319846; Liu JS, 2020, 2020 FOURTH IEEE INTERNATIONAL CONFERENCE ON ROBOTIC COMPUTING (IRC 2020), P410, DOI 10.1109/IRC.2020.00071; Loianno G, 2017, IEEE ROBOT AUTOM LET, V2, P404, DOI 10.1109/LRA.2016.2633290; Loquercio A, 2021, SCI ROBOT, V6, DOI 10.1126/scirobotics.abg5810; Loquercio A, 2020, IEEE T ROBOT, V36, P1, DOI 10.1109/TRO.2019.2942989; Loquercio A, 2018, IEEE ROBOT AUTOM LET, V3, P1088, DOI 10.1109/LRA.2018.2795643; Lucas B. D., 1981, IJCAI, P121, DOI DOI 10.5555/1623264.1623280; Lygouras E, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19163542; Madaan R, 2020, PLMR POSTPROCEEDINGS; Makrigiorgos A, 2019, ARXIV; Marple-Horvat DE, 2005, EXP BRAIN RES, V163, P411, DOI 10.1007/s00221-004-2192-7; Mellinger D, 2012, INT J ROBOT RES, V31, P664, DOI 10.1177/0278364911434236; Menshchikov A, 2019, IEEE IND ELEC, P5602, DOI 10.1109/IECON.2019.8926635; Mohta K, 2018, J FIELD ROBOT, V35, P101, DOI 10.1002/rob.21774; Moreno S, 2018, 2018 15TH INTERNATIONAL CONFERENCE ON ELECTRICAL ENGINEERING, COMPUTING SCIENCE AND AUTOMATIC CONTROL (CCE); Mueller MW, 2013, IEEE INT C INT ROBOT, P3480, DOI 10.1109/IROS.2013.6696852; Muller M, 2019, ARXIV; Muller M, 2018, P EUROPEAN C COMPUTE; Nagami K, 2021, ROBOTICS SCI SYSTEMS, VXVII; Nayyar A, 2020, ADV INTELL SYST, V1045, P563, DOI 10.1007/978-981-15-0029-9_45; Nguyen H, 2020, ARXIV; Palazzi A, 2019, IEEE T PATTERN ANAL, V41, P1720, DOI 10.1109/TPAMI.2018.2845370; Perrin AF, 2020, DRONES-BASEL, V4, DOI 10.3390/drones4030031; Pfeiffer C, 2021, ARXIV; Pfeiffer C, 2021, IEEE ROBOT AUTOM LET, V6, P3467, DOI 10.1109/LRA.2021.3064282; Puri V, 2017, J STAT MANAG SYST, V20, P507, DOI 10.1080/09720510.2017.1395171; Qin T, 2018, IEEE T ROBOT, V34, P1004, DOI 10.1109/TRO.2018.2853729; Ranftl R, 2018, LECT NOTES COMPUT SC, V11205, P292, DOI 10.1007/978-3-030-01246-5_18; Ross S., 2011, P 14 INT C ART INT S, P627; Schedl DC, 2021, SCI ROBOT, V6, DOI 10.1126/scirobotics.abg1188; Song Y, 2020, C ROB LEARN; Wang Q., 2021, CORR2021ABS210904907; Wang WG, 2018, IEEE T IMAGE PROCESS, V27, P2368, DOI 10.1109/TIP.2017.2787612; Weiss T, 2020, ARXIV; Zhang JK, 2017, AAAI CONF ARTIF INTE, P2891; Zhou BY, 2021, IEEE T ROBOT, V37, P1992, DOI 10.1109/TRO.2021.3071527	61	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0264471	10.1371/journal.pone.0264471	http://dx.doi.org/10.1371/journal.pone.0264471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231038	Green Submitted, Green Published, gold			2022-12-26	WOS:000849744700023
J	Zubair, T; Usman, M; Nisar, KS; Khan, I; Ghamkhar, M; Ahmad, M				Zubair, Tamour; Usman, Muhammad; Nisar, Kottakkaran Sooppy; Khan, Ilyas; Ghamkhar, Madiha; Ahmad, Muhammad			Crank Nicholson scheme to examine the fractional-order unsteady nanofluid flow of free convection of viscous fluids	PLOS ONE			English	Article							NUMERICAL-SIMULATION; NATURAL-CONVECTION; HEAT-TRANSFER; WATER	Fractional fluid models are usually difficult to solve analytically due to complicated mathematical calculations. This difficulty in considering fractional model further increases when one considers nth order chemical reaction. Therefore, in this work an incompressible nanofluid flow as well as the benefits of free convection across an isothermal vertical sheet is examined numerically. An nth order chemical reaction is considered in the chemical species model. The specified velocity (wall's) is time-based, and its motion is translational into mathematical form. The fractional differential equations are used to express the governing flow equations (FDEs). The non-dimensional controlling system is given appropriate transformations. A Crank Nicholson method is used to find solutions for temperature, solute concentration, and velocity. Variation in concentration, velocity, and temperature profiles is produced as a result of changes in discussed parameters for both Ag-based and Cu-based nanofluid values. Water is taken as base fluid. The fractional-order time evaluation has opened the new gateways to study the problem into a new direction and it also increased the choices due to the extended version. It records the hidden figures of the problem between the defined domain of the time evaluation. The suggested technique has good accuracy, dependability, effectiveness and it also cover the better physics of the problem specially with concepts of fractional calculus.	[Zubair, Tamour] Peking Univ, Sch Math Sci, Beijing, Peoples R China; [Usman, Muhammad] Natl Univ Modern Languages NUML, Dept Math, Islamabad, Pakistan; [Nisar, Kottakkaran Sooppy] Prince Sattam Bin Abdulaziz Univ, Coll Arts & Sci, Dept Math, Al Kharj, Saudi Arabia; [Khan, Ilyas] Majmaah Univ, Coll Sci Al Zulfi, Dept Math, Al Majmaah, Saudi Arabia; [Ghamkhar, Madiha; Ahmad, Muhammad] Univ Agr Faisalabad, Faisalabad, Pakistan	Peking University; Prince Sattam Bin Abdulaziz University; Majmaah University; University of Agriculture Faisalabad	Zubair, T (corresponding author), Peking Univ, Sch Math Sci, Beijing, Peoples R China.	tamourzubair@pku.edu.cn	Zubair, Tamour/GZB-0304-2022; Nisar, Kottakkaran Sooppy/F-7559-2015	Zubair, Tamour/0000-0003-1589-8426; Nisar, Kottakkaran Sooppy/0000-0001-5769-4320				Aaiza G, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1144-4; Ahmad B, 2017, EUR PHYS J PLUS, V132, DOI 10.1140/epjp/i2017-11651-1; Ahmed NU., 2013, INT J PHYS SCI, V8, P1788, DOI [10.5897/IJPS12.390, DOI 10.5897/IJPS2013.4028]; Aman S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01358-3; Animasaun IL., 2015, OPEN J FLUID DYN, V5, P106, DOI 10.4236/ojfd.2015.52013; Ankamwar B, 2012, BIOMED ENG TECH APPL, P93; [Anonymous], 2005, STAT ORIGINS FRACTIO; Ashwinkumar GP, 2021, INT COMMUN HEAT MASS, V127, DOI 10.1016/j.icheatmasstransfer.2021.105563; Ashwinkumar GP, 2021, HEAT TRANSF, V50, P1679, DOI 10.1002/htj.21947; Celik C., CRANK NICOLSON METHO; Chalavadi S, 2021, HEAT TRANSF, V50, P8354, DOI 10.1002/htj.22280; CHOI S. U. S., 1995, ENHANCING THERMAL CO; Garoosi F, 2015, APPL MATH COMPUT, V254, P183, DOI 10.1016/j.amc.2014.12.116; Ghoshdastidar P., 2012, HEAT TRANSFER; Gupta A. S., 1979, Revue Roumaine des Sciences Techniques, Serie de Mecanique Appliquee, V24, P561; H. A.-T. J. of E. and Environmental and undefined, 2007, STAGNATION POINT FLO; Hussanan A, 2017, J MOL LIQ, V229, P482, DOI 10.1016/j.molliq.2016.12.040; Hussanan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14046-x; Khalid A., 2015, UNSTEADY MHD FREE CO; Khan MS, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-24; Khan NS, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7030271; Khan U., 2014, THERMODIFFUSION EFFE; Khan U, 2017, NEURAL COMPUT APPL, V28, P2041, DOI 10.1007/s00521-016-2187-x; Kim J, 2004, PHYS FLUIDS, V16, P2395, DOI 10.1063/1.1739247; Kulish VV, 2002, J FLUID ENG-T ASME, V124, P803, DOI 10.1115/1.1478062; Kumar KA, 2018, J NON-EQUIL THERMODY, V43, P327, DOI 10.1515/jnet-2018-0022; Layek G., HEAT MASS TRANSFER A; Mabood F, 2020, INT J AMBIENT ENERGY, DOI 10.1080/01430750.2020.1831593; Mabood F, 2021, J THERM ANAL CALORIM, V146, P227, DOI 10.1007/s10973-020-09943-x; MERKIN JH, 1985, J ENG MATH, V19, P189, DOI 10.1007/BF00042533; Mohyud-Din S., MODIFIED LEGENDRE WA; Mohyud-Din ST, 2017, ENG COMPUTATION, V34, P2330, DOI 10.1108/EC-04-2017-0135; Nagahama H., 2006, IRREVERSIBLE THERMOD; Narahari M., 2011, Journal of Applied Sciences, V11, P1096, DOI 10.3923/jas.2011.1096.1104; Rajesh, 2010, INT J APPL MATH MECH, V6, P1; Raza MA, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6040074; Rosca N., LIE GROUP SYMMETRY M; Rostami Y, 2021, ENG COMPUTATION, V38, P745, DOI 10.1108/EC-03-2020-0162; Rubbab Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078352; Samrat S., 2021, SIMULTANEOUS SOLUTIO, DOI [10.1177/09544089211043605, DOI 10.1177/09544089211043605]; Shah N., EFFECTS FRACTIONAL O; Shah NA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81417-y; Shah NA, 2020, PHYS SCRIPTA, V95, DOI 10.1088/1402-4896/aba8c6; Shah NA, 2018, J MOL LIQ, V249, P980, DOI 10.1016/j.molliq.2017.11.042; Sheikholeslami M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37964-y; Sheikholeslami M., 2016, NANOFLUID CONVECTIVE; Sheikholeslami M, 2017, PHYS LETT A, V381, P494, DOI 10.1016/j.physleta.2016.11.042; SINGH AK, 1984, ASTROPHYS SPACE SCI, V98, P245, DOI 10.1007/BF00651403; Sowmya G, 2021, J THERM ANAL CALORIM, V144, P2369, DOI 10.1007/s10973-021-10550-7; Tlili I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61215-8; Toki CJ, 2007, ZAMM-Z ANGEW MATH ME, V87, P4, DOI 10.1002/zamm.200510291; Toki CJ, 2009, J APPL MECH-T ASME, V76, DOI 10.1115/1.2998758; Usman M., 2018, DIFFERENTIAL TRANSFO; Usman M., 2018, LEAST SQUARE STUDY H	54	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2022	17	3							e0261860	10.1371/journal.pone.0261860	http://dx.doi.org/10.1371/journal.pone.0261860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H2XB	35231029	Green Published, gold			2022-12-26	WOS:000849744700005
J	Yin, HY; Shao, HB; Liu, J; Qin, YJ; Deng, WB				Yin, Heyue; Shao, Haibin; Liu, Jing; Qin, Yujia; Deng, Wenbin			Sex-specific and concentration-dependent influence of Cremophor RH 40 on ampicillin absorption via its effect on intestinal membrane transporters in rats	PLOS ONE			English	Article							P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; EXPRESSION; EXCIPIENTS; PEPT-1; MODEL; BIOAVAILABILITY; RANITIDINE; CEPHALEXIN; PROTEIN	Pharmaceutical excipients are the basic materials and important components of pharmaceutical preparations, and play an important role in improving the efficacy of drugs and reducing adverse reactions. Therefore, selecting suitable excipients for dosage form is an important step in formulation development. An increasing number of studies have revealed that the traditionally regarded "inert" excipients can, however, influence the bioavailability of drugs. Moreover, these effects on the bioavailability of drugs caused by pharmaceutical excipients may differ in between males and females. In this study, the in situ effect of the widely-used pharmaceutical excipient Cremophor RH 40 spanning from 0.001% to 0.1% on the intestinal absorption of ampicillin in male and female rats using closed-loop models was investigated. Cremophor RH 40 ranging from 0.03% to 0.07% increased the absorption of ampicillin in females, however, was decreased in male rats. The mechanism of such an effect on drug absorption is suggested to be due to the interaction between Cremophor RH 40 and two main membrane transporters P-gp and PepT1. Cremophor RH 40 altered the PepT1 protein content in a sex-dependent manner, showing an increase in female rats but a decrease in males. No modification on the PepT1 mRNA abundance was found with Cremophor RH 40, indicating that the excipient may regulate the protein recruitment of the plasma membrane from the preformed cytoplasm pool to alter the PepT1 function. This influence, however, may differ between males and females. As such, the study herein shows that supposedly inert excipient Cremophor RH 40 can influence membrane fluidity, uptake and efflux transporters in a sex- and concentration-dependent manner. These findings, therefore, highlight the need for sex-specific studies in the application of solubilizing excipients in drug formulation development.	[Yin, Heyue; Shao, Haibin; Liu, Jing; Qin, Yujia; Deng, Wenbin] Sun Yat Sen Univ, Dept Pharmaceut Sci Shenzhen, Guangzhou, Peoples R China	Sun Yat Sen University	Deng, WB (corresponding author), Sun Yat Sen Univ, Dept Pharmaceut Sci Shenzhen, Guangzhou, Peoples R China.	dengwb5@mail.sysu.edu.cn		yin, he yue/0000-0003-4095-3044				Ashiru DAI, 2008, PHARM RES-DORDR, V25, P2327, DOI 10.1007/s11095-008-9635-y; Bourdet DL, 2006, PHARM RES-DORDR, V23, P1165, DOI 10.1007/s11095-006-0251-4; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; Dintaman JM, 1999, PHARMACEUT RES, V16, P1550, DOI 10.1023/A:1015000503629; Engel A, 2012, MOL PHARMACEUT, V9, P2577, DOI 10.1021/mp3001815; Ferte J, 2000, EUR J BIOCHEM, V267, P277, DOI 10.1046/j.1432-1327.2000.01046.x; Freire AC, 2011, INT J PHARMACEUT, V415, P15, DOI 10.1016/j.ijpharm.2011.04.069; Gangopadhyay A, 2002, AM J PHYSIOL-GASTR L, V283, pG133, DOI 10.1152/ajpgi.00445.2001; Hodaei D, 2015, BRAZ J PHARM SCI, V51, P745, DOI 10.1590/S1984-82502015000300026; Kasendra M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21201-7; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Lu H, 2006, PEPTIDES, V27, P850, DOI 10.1016/j.peptides.2005.08.012; MacLean C, 2008, DRUG METAB DISPOS, V36, P1249, DOI 10.1124/dmd.108.020859; Mai Y, 2018, EUR J PHARM SCI, V120, P53, DOI 10.1016/j.ejps.2018.04.021; Mai Y, 2018, INT J PHARMACEUT, V542, P280, DOI 10.1016/j.ijpharm.2018.03.002; Mai Y, 2017, EUR J PHARM SCI, V107, P249, DOI 10.1016/j.ejps.2017.07.009; Mei Y, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11050228; Mohammadzadeh R, 2014, ADV PHARM BULL, V4, P219, DOI 10.5681/apb.2014.032; Pocock K, 2017, ACS BIOMATER SCI ENG, V3, P951, DOI 10.1021/acsbiomaterials.7b00023; Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6; Sachs-Barrable K, 2007, J PHARM PHARM SCI, V10, P319; Shimakura J, 2006, AM J PHYSIOL-GASTR L, V291, pG851, DOI 10.1152/ajpgi.00171.2006; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Sugiura T, 2008, DRUG METAB DISPOS, V36, P1181, DOI 10.1124/dmd.107.020321; Thamotharan M, 1999, METABOLISM, V48, P681, DOI 10.1016/S0026-0495(99)90164-6; Thamotharan M, 1999, AM J PHYSIOL-CELL PH, V276, pC821, DOI 10.1152/ajpcell.1999.276.4.C821; Wandel C, 2003, CLIN PHARMACOL THER, V73, P394, DOI 10.1016/S0009-9236(03)00010-9; Wang CY, 2017, DRUG DES DEV THER, V11, P3511, DOI 10.2147/DDDT.S151725; Watanabe K, 2004, EUR J PHARM SCI, V21, P87, DOI 10.1016/j.ejps.2003.10.002; Yunomae K, 2003, FEBS LETT, V536, P225, DOI 10.1016/S0014-5793(03)00059-0; Zhang L, 1998, MOL BRAIN RES, V59, P66, DOI 10.1016/S0169-328X(98)00138-7; Zhao JF, 2017, BASIC CLIN PHARMACOL, V120, P250, DOI 10.1111/bcpt.12680	32	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2022	17	2							e0263692	10.1371/journal.pone.0263692	http://dx.doi.org/10.1371/journal.pone.0263692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C8WU	35226682	gold, Green Published			2022-12-26	WOS:000793394000002
J	Bradley, C; Malaia, EA; Siskind, JM; Wilbur, RB				Bradley, Chuck; Malaia, Evie A.; Siskind, Jeffrey Mark; Wilbur, Ronnie B.			Visual form of ASL verb signs predicts non- signer judgment of transitivity	PLOS ONE			English	Article							CLASSIFIER CONSTRUCTIONS; LANGUAGE; ICONICITY	Longstanding cross-linguistic work on event representations in spoken languages have argued for a robust mapping between an event's underlying representation and its syntactic encoding, such that-for example-the agent of an event is most frequently mapped to subject position. In the same vein, sign languages have long been claimed to construct signs that visually represent their meaning, i.e., signs that are iconic. Experimental research on linguistic parameters such as plurality and aspect has recently shown some of them to be visually universal in sign, i.e. recognized by non-signers as well as signers, and have identified specific visual cues that achieve this mapping. However, little is known about what makes action representations in sign language iconic, or whether and how the mapping of underlying event representations to syntactic encoding is visually apparent in the form of a verb sign. To this end, we asked what visual cues non-signers may use in evaluating transitivity (i.e., the number of entities involved in an action). To do this, we correlated non-signer judgments about transitivity of verb signs from American Sign Language (ASL) with phonological characteristics of these signs. We found that non-signers did not accurately guess the transitivity of the signs, but that non-signer transitivity judgments can nevertheless be predicted from the signs' visual characteristics. Further, non-signers cue in on just those features that code event representations across sign languages, despite interpreting them differently. This suggests the existence of visual biases that underlie detection of linguistic categories, such as transitivity, which may uncouple from underlying conceptual representations over time in mature sign languages due to lexicalization processes.	[Bradley, Chuck; Siskind, Jeffrey Mark; Wilbur, Ronnie B.] Purdue Univ, Dept Linguist, W Lafayette, IN 47907 USA; [Malaia, Evie A.] Univ Alabama, Dept Commun Disorders, Tuscaloosa, AL USA; [Siskind, Jeffrey Mark] Purdue Univ, Elmore Family Sch Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Siskind, Jeffrey Mark; Wilbur, Ronnie B.] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alabama System; University of Alabama Tuscaloosa; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Bradley, C (corresponding author), Purdue Univ, Dept Linguist, W Lafayette, IN 47907 USA.	charles.roger.bradley@gmail.com	Malaia, Evguenia A/R-2606-2018	Malaia, Evguenia A/0000-0002-4700-0257; Bradley, Chuck/0000-0002-9695-1024	NSF [1734938-IIS, 1932547, 1522954IIS]; IARPA contract [D17PC00341]; NIH [108306]	NSF(National Science Foundation (NSF)); IARPA contract; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Preparation of the manuscript has been partially funded by NSF grant #1734938-IIS, "Neuroimaging to Advance Computer Vision, NLP, and AI" to JMS, EM, and RBW, NSF grant #1932547, "RF Sensing for Sign Language Driven Smart Environments" to EM, NSF grant #1522954IIS, "RobotSLANG: Simultaneous Localization, Mapping, and Language Acquisition" to JMS, IARPA contract #D17PC00341, "Intelligent Video Activity Detection and Recognition" from the Department of Interior/Interior Business Center (DOI/IBC) to JMS, and NIH grant #108306, "Computational methods for the study of American Sign Language nonmanuals using very large databases" to RBW. Any opinions, findings, views, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views, official policies, or endorsements, either expressed or implied, of the sponsors. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes, notwithstanding any copyright notation herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff M, 2003, PERSPECTIVES ON CLASSIFIER CONSTRUCTIONS IN SIGN LANGUAGES, P53; Baker Mark C., 1997, ELEMENTS GRAMMAR, P73, DOI DOI 10.1007/978-94-011-5420-8_2; Battison R., 1978, LEXICAL BORROWING AM; BELLUGI U, 1976, ANN NY ACAD SCI, V280, P514, DOI 10.1111/j.1749-6632.1976.tb25514.x; Benedicto E, 2004, NAT LANG LINGUIST TH, V22, P743, DOI 10.1007/s11049-003-4698-2; Benedicto E, 2007, LINGUA, V117, P1202, DOI 10.1016/j.lingua.2005.06.012; Borstell C., 2017, THESIS STOCKHOLM U; Borstell C, 2019, OPEN LINGUIST, V5, P666, DOI 10.1515/opli-2019-0037; Brentari D, 2001, FOREIGN VOCABULARY IN SIGN LANGUAGES: CROSS-LINGUISTIC INVESTIGATION OF WORD FORMATION, P87; Brentari D, 2017, LANG ACQUIS, V24, P283, DOI 10.1080/10489223.2016.1187614; Brentari D, 2015, TOP COGN SCI, V7, P95, DOI 10.1111/tops.12123; Brentari D, 2012, NAT LANG LINGUIST TH, V30, P1, DOI 10.1007/s11049-011-9145-1; Brentari Diane, 1998, PROSODIC MODEL SIGN; Caselli NK, 2017, BEHAV RES METHODS, V49, P784, DOI 10.3758/s13428-016-0742-0; Cassell J., 1999, PRAGMAT COGN, V7, P1, DOI [DOI 10.1075/PC.7.1.03CAS, 10.1075/pc.7.1.03cas]; de Lint V, 2018, SIGN LANG LINGUIST, V21, P3, DOI 10.1075/sll.00011.lin; DOWTY D, 1991, LANGUAGE, V67, P547, DOI 10.2307/415037; Eccarius P, 2008, P 44 ANN M CHICAGO L, V2, P187; Eccarius P, 2007, LINGUA, V117, P1169, DOI 10.1016/j.lingua.2005.04.006; Fernald TB., 2000, SIGN LANG LINGUIST, V3, P3, DOI [10.1075/sll.3.1.03fer, DOI 10.1075/SLL.3.1.03FER]; FRISHBERG N, 1975, LANGUAGE, V51, P696, DOI 10.2307/412894; Frishberg N., 1973, MANUSCRIPT SALK I BI, V2000, P3; Gokgoz K., 2013, THESIS PURDUE U; Goldin-Meadow S, 2015, COGNITION, V136, P381, DOI 10.1016/j.cognition.2014.11.029; Hall ML, 2015, J MEM LANG, V81, P16, DOI 10.1016/j.jml.2014.12.003; Haspelmath M, 2015, COMP HBK LINGUIST, V1, P131; Haspelmath Martin., 1993, CAUSATIVES TRANSITIV, P87, DOI DOI 10.1075/SLCS.23.05HAS; Hassemer J, 2018, COGNITIVE SCI, V42, P3034, DOI 10.1111/cogs.12680; HOPPER PJ, 1980, LANGUAGE, V56, P251, DOI 10.2307/413757; Hout Angeliekvan., 2000, EVENTS GRAMMATICAL O, P239; Jackendoff R., 1993, KNOWLEDGE LANGUAGE, P31; Kayabasi D., 2020, TALK GIVEN FORMAL EX, P23; Kimmelman V, 2018, GLOSSA-UK, V3, DOI 10.5334/gjgl.494; Kimmelman Vadim, 2016, P 7 WORKSH REPR PROC, P117; Kohler W, 1929, GESTALT PSYCHOL INTR; Kuhn J, 2020, PSYARXIV, DOI [10.31234/osf.io/mkwaz, DOI 10.31234/OSF.IO/MKWAZ]; Lepic R., 2017, LOOKING WORDS STRUCT, P489, DOI DOI 10.5281/ZENODO.495463; Lepic R, 2019, GLOSSA-UK, V4, DOI 10.5334/gjgl.840; Lepic R, 2016, SIGN LANG LINGUIST, V19, P37, DOI 10.1075/sll.19.1.02lep; Levin B., 1993, ENGLISH VERB CLASSES; Levin Beth, 2005, ARGUMENT REALIZATION; Lockwood G, 2016, J EXP PSYCHOL LEARN, V42, P1274, DOI 10.1037/xlm0000235; Malaia E., 2013, STUDIES COMPOSITION, P231, DOI DOI 10.1007/978-94-007-5983-1_9; Malaia E, 2012, TELICITY CHANGE STAT, P122; Malaia E, 2018, LANG SPEECH, V61, P97, DOI 10.1177/0023830917708461; Malaia E, 2013, J SPEECH LANG HEAR R, V56, P1677, DOI 10.1044/1092-4388(2013/12-0257); Malaia E, 2012, LANG SPEECH, V55, P407, DOI 10.1177/0023830911422201; Malchukov A, 2015, COMP HBK LINGUIST, V1, P73; Marantz A., 1984, NATURE GRAMMATICAL R; Marshall CR, 2015, TOP COGN SCI, V7, P61, DOI 10.1111/tops.12118; Meir I, 2001, SIGNED LANGUAGE, P74; Meir I, 2002, NAT LANG LINGUIST TH, V20, P413, DOI 10.1023/A:1015041113514; Meir I, 2013, COGN LINGUIST, V24, P309, DOI 10.1515/cog-2013-0010; MIRON MS, 1961, J ABNORM SOC PSYCH, V62, P623, DOI 10.1037/h0045212; Motamedi Y, 2019, COGNITION, V192, DOI 10.1016/j.cognition.2019.05.001; Napoli DJ., 2003, SIGN LANGUAGE LINGUI, V6, P123, DOI [10.1075/sll.6.2.03nap, DOI 10.1075/SLL.6.2.03NAP]; Nygaard LC, 2009, COGNITION, V112, P181, DOI 10.1016/j.cognition.2009.04.001; Occhino C, 2020, LANG COGN, V12, P114, DOI 10.1017/langcog.2020.1; Occhino C, 2017, GESTURE, V16, P99, DOI 10.1075/gest.16.1.04occ; Oomen M, 2017, SIGN LANG LINGUIST, V20, P55, DOI 10.1075/sll.20.1.03oom; Ortega G, 2019, COGNITION, V191, DOI 10.1016/j.cognition.2019.06.008; Ostling R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00725; Papafragou A, 2015, CONCEPTUAL MIND: NEW DIRECTIONS IN THE STUDY OF CONCEPTS, P327; Patschke C., 1999, SIGN LANGUAGE LINGUI, V2, P3, DOI [DOI 10.1075/SLL.2.1.03WIL, 10.1075/sll.2.1.03wil]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perniss P, 2015, TOP COGN SCI, V7, P36, DOI 10.1111/tops.12122; Schlenker P, 2020, NAT LANG LINGUIST TH, V38, P887, DOI 10.1007/s11049-019-09460-z; Schlenker P, 2019, LINGUIST PHILOS, V42, P45, DOI 10.1007/s10988-018-9236-0; Schlenker P, 2018, THEOR LINGUIST, V44, P123, DOI 10.1515/tl-2018-0012; Schlenker P, 2018, NAT LANG LINGUIST TH, V36, P587, DOI 10.1007/s11049-017-9378-8; Schlenker P, 2016, NAT LANG LINGUIST TH, V34, P1067, DOI 10.1007/s11049-015-9323-7; Seabold S., 2010, P 9 PYTHON SCI C, P92, DOI [DOI 10.25080/MAJORA-92BF1922-011, 10.25080/MAJORA-92BF1922-011]; Sehyr ZS, 2019, LANG COGN, V11, P208, DOI 10.1017/langcog.2019.18; Senghas A., 1997, P 21 ANN BOSTON U C, V2, P550; Siple Patricia, 1990, THEORETICAL ISSUES S, V1, P191, DOI DOI 10.1007/978-94-011-3468-2; Sler W., 2010, SIGN LANGUAGES CAMBR, P570; Strickland B, 2015, P NATL ACAD SCI USA, V112, P5968, DOI 10.1073/pnas.1423080112; Wilbur RB, 2003, CHIC LINGUIST SOC, V39, P354; Wilbur RB, 2008, SIGNS TIME SELECTED, P217; Wilbur RB, 2010, SIGN LANG LINGUIST, V13, P203, DOI 10.1075/sll.13.2.05wil; Wilbur RB, 2009, LANG SCI, V31, P325, DOI 10.1016/j.langsci.2008.12.017; Zacks JM, 2009, COGNITION, V112, P201, DOI 10.1016/j.cognition.2009.03.007; Zwitserlood I., 2003, THESIS U UTRECHT	83	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0262098	10.1371/journal.pone.0262098	http://dx.doi.org/10.1371/journal.pone.0262098			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213558	gold, Green Published			2022-12-26	WOS:000787811000007
J	Guo, XQ; Zhi, WF; Feng, YT; Zhou, GS; Zhu, GL				Guo, Xiaoqian; Zhi, Wenfang; Feng, Yuntong; Zhou, Guisheng; Zhu, Guanglong			Seed priming improved salt-stressed sorghum growth by enhancing antioxidative defense	PLOS ONE			English	Article							SALINITY; TOLERANCE; GERMINATION; PROLINE; NACL; L.; ACCUMULATION	Seed priming is regarded as a beneficial and effective method enhancing performance of plants grown under stress conditions. This study illustrated the effect of four seed priming agents (2% H2O2, 52 mM NaCl, 50 mM KCl, 250 mM MgSO4) on two sorghum cultivars (Canada sorghum CFSH-30 and sorghum '1230') grown in saline soils. Sorghum growth characteristics and biochemical parameters were investigated. Seed priming treatments alleviated the adverse effects of salt stress by decreasing MDA content and enhancing antioxidant enzymes (CAT, POD and SOD) activities and proline content, and hence increased sorghum fresh and dry weight. In terms of various parameters, sorghum '1230' was more suitable to be grown in saline soil, and 52 mM NaCl and 50 mM KCl were the optimum priming agents to improve the performance of salt-stressed sorghum.	[Guo, Xiaoqian; Zhi, Wenfang; Feng, Yuntong; Zhou, Guisheng; Zhu, Guanglong] Yangzhou Univ, Joint Int Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China; [Guo, Xiaoqian; Zhi, Wenfang; Feng, Yuntong; Zhou, Guisheng] Yangzhou Univ, Jiangsu Prov Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Zhou, GS (corresponding author), Yangzhou Univ, Joint Int Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China.; Zhou, GS (corresponding author), Yangzhou Univ, Jiangsu Prov Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China.	gszhou@yzu.edu.cn			China National Key R & D Program, Ministry of Science and Technology of the People's Republic of China [2018YFE0108100]; Jiangsu Provincial Forestry Science and Technology Innovation and Extension Program, Department of Forestry, Jiangsu Province, the Peoples' Republic of China [LYKJ(2019)47]	China National Key R & D Program, Ministry of Science and Technology of the People's Republic of China; Jiangsu Provincial Forestry Science and Technology Innovation and Extension Program, Department of Forestry, Jiangsu Province, the Peoples' Republic of China	This study is financially supported by: 1. China National Key R & D Program Grant No.: 2018YFE0108100 Awardee: Zhou, Guisheng Funding agency: Ministry of Science and Technology of the People's Republic of China Initials of authors who received salary or other funding from commercial companies: No URLs to sponsors' websites: http://www.most.gov.cn/ index.html 2. Jiangsu Provincial Forestry Science and Technology Innovation and Extension Program Grant No.: LYKJ(2019)47 Awardee: Zhou, Guisheng Funding agency: Department of Forestry, Jiangsu Province, the Peoples' Republic of China Initials of authors who received salary or other funding from commercial companies: No URLs to sponsors' websites: http://lyj.jiangsu.gov.cn/.	Almodares A., 2007, Journal of Biological Sciences, V7, P1492; Amano T, 1996, JPN J CROP SCI, V65, P16, DOI 10.1626/jcs.65.16; Banu NA, 2009, J PLANT PHYSIOL, V166, P146, DOI 10.1016/j.jplph.2008.03.002; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bergmeyer N., 1970, AKADEMIEVERLAG, P636; Chen KT, 2011, PLANT SCI, V180, P212, DOI 10.1016/j.plantsci.2010.08.007; Daffalla Hussien M, 2014, Int Sch Res Notices, V2014, P134931, DOI 10.1155/2014/134931; de Oliveira DF, 2020, PLANTA, V252, DOI 10.1007/s00425-020-03437-8; Hasna E, 2017, J PLANT PHYSIOL, V210, P38, DOI 10.1016/j.jplph.2016.11.014; ELOUAER MA, 2013, J STRESS PHYSL BIOCH, V8, P135; Farhana Naz, 2014, American-Eurasian Journal of Agricultural & Environmental Sciences, V14, P1304; Farhoudi R, 2011, AFR J AGR RES, V6, P1363; Habib N, 2021, J PLANT GROWTH REGUL, V40, P2433, DOI 10.1007/s00344-021-10378-3; Hala EM., 2015, INT J ADV RES, V3, P878; Hasna E., 2021, SCI HORTIC, V288; Jiang XW, 2020, HORTSCIENCE, V55, P647, DOI 10.21273/HORTSCI14854-20; Jisha K. C., 2014, Journal of Crop Science and Biotechnology, V17, P209, DOI 10.1007/s12892-014-0077-2; Jisha KC, 2013, ACTA PHYSIOL PLANT, V35, P1381, DOI 10.1007/s11738-012-1186-5; Johnson R, 2021, PLANT PHYSIOL BIOCH, V162, P247, DOI 10.1016/j.plaphy.2021.02.034; Khan A, 2021, PAK J BOT, V53, P779, DOI 10.30848/PJB2021-3(12); Kishor PBK, 2014, PLANT CELL ENVIRON, V37, P300, DOI 10.1111/pce.12157; Kumar D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185017; Milica K., 2021, CEREAL RES COMMUN, DOI [10.1007/s42976-021-00214-5, DOI 10.1007/S42976-021-00214-5]; Netondo GW, 2004, CROP SCI, V44, P806, DOI 10.2135/cropsci2004.0806; Paparella S, 2015, PLANT CELL REP, V34, P1281, DOI 10.1007/s00299-015-1784-y; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Punia H, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-02392-1; Reddy PS, 2015, PLANT PHYSIOL BIOCH, V94, P104, DOI 10.1016/j.plaphy.2015.05.014; Rosenow D.T., 2000, SORGHUM ORIGIN HIST; Shah T, 2021, J KING SAUD UNIV SCI, V33, DOI 10.1016/j.jksus.2020.10.004; Shrivastava P, 2015, SAUDI J BIOL SCI, V22, P123, DOI 10.1016/j.sjbs.2014.12.001; Song J, 2015, ANN BOT-LONDON, V115, P541, DOI 10.1093/aob/mcu194; Tari I, 2013, J AGRON CROP SCI, V199, P264, DOI 10.1111/jac.12017; UPADHYAYA A, 1985, J PLANT PHYSIOL, V121, P453, DOI 10.1016/S0176-1617(85)80081-X; Wang HL, 2020, PLANT BREEDING, V139, P455, DOI 10.1111/pbr.12805; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Yadav P. V., 2011, Research Journal of Seed Science, V4, P125, DOI 10.3923/rjss.2011.125.136; Yang Z, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01722; Yuan F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00977; Zhang S, 2007, AUST J AGR RES, V58, P811, DOI 10.1071/AR06253; Zhu ZH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257236	42	2	2	8	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263036	10.1371/journal.pone.0263036	http://dx.doi.org/10.1371/journal.pone.0263036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213549	gold, Green Published			2022-12-26	WOS:000787811000014
J	Mukerjee, N; Das, A; Maitra, S; Ghosh, A; Khan, P; Alexiou, A; Dey, A; Baishya, D; Ahmad, F; Sachdeva, P; Al-Muhanna, MK				Mukerjee, Nobendu; Das, Anubhab; Maitra, Swastika; Ghosh, Arabinda; Khan, Prattusha; Alexiou, Athanasios; Dey, Abhijit; Baishya, Debabrat; Ahmad, Faizan; Sachdeva, Punya; Al-Muhanna, Muhanna K.			Dynamics of natural product Lupenone as a potential fusion inhibitor against the spike complex of novel Semliki Forest Virus	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; NUCLEOTIDE-SEQUENCE; DEDUCED SEQUENCE; MESSENGER-RNA; MEMBRANE; PROTEIN; MUTATIONS; INFECTION	The Semliki Forest Virus (SFV) is an RNA virus with a positive-strand that belongs to the Toga-viridae family's Alphavirus genus. An epidemic was observed among French troops stationed in the Central African Republic, most likely caused by the SFV virus. The two transmembrane proteins E1 and E2 and the peripheral protein E3 make up the viral spike protein. The virus binds to the host cell and is internalized via endocytosis; endosome acidification causes the E1/E2 heterodimer to dissociate and the E1 subunits to trimerize. Lupenone was evaluated against the E1 spike protein of SFV in this study based on state-of-the-art cheminformatics approaches, including molecular docking, molecular dynamics simulation, and binding free energy calculation. The molecular docking study envisaged major interactions of Lupenonen with binding cavity residues involved non-bonded van der Waal's and Pi-alkyl interactions.Molecular dynamic simulation of a time scale 200 ns corroborated interaction pattern with molecular docking studies between Lupenone and E1 spike protein. Nevertheless, Lupenone intearcation with the E1 spike protein conforming into a stable complex substantiated by free energy landscape (FEL), PCA analysis. Free energy decomposition of the binding cavity resdiues of E1 spike protein also ensured the efficient non-bonded van der Waal's interaction contributing most energy to interact with the Lupenone. Therefore, Lupenone interacted strongly at the active site conforming into higher structural stability throughout the dynamice volution of the complex. Thus, this study perhaps comprehend the efficiency of Lupenone as lead molecule against SFV E1 spike protein for future therapeutic purpose.	[Mukerjee, Nobendu; Das, Anubhab] Ramakrishna Mission Vivekananda Centenary Coll, Dept Microbiol, Khardaha, W Bengal, India; [Mukerjee, Nobendu] Novel Global Community Educ Fdn, Dept Hlth Sci, Hebersham, NSW, Australia; [Maitra, Swastika] Adamas Univ, Dept Microbiol, Kolkata, India; [Ghosh, Arabinda] Gauhati Univ, Dept Bot, Microbiol Div, Gauhati, Assam, India; [Khan, Prattusha] St Xaviers Autonomous Coll, Dept Microbiol, Kolkata, India; [Alexiou, Athanasios] Novel Global Community Educ Fdn, Dept Sci & Engn, Hebersham, NSW, Australia; [Alexiou, Athanasios] AFNP Med Austria, Vienna, Austria; [Dey, Abhijit] Presidency Univ, Dept Life Sci, Kolkata, W Bengal, India; [Baishya, Debabrat] Gauhati Univ, Dept Bioengn & Technol, GUIST, Gauhati, Assam, India; [Ahmad, Faizan] Jamia Hamdard, Dept Med Elementol & Toxicol, Delhi, India; [Sachdeva, Punya] Amity Univ, Amity Inst Neuropsychol & Neurosci, Noida, India; [Al-Muhanna, Muhanna K.] King Abdulaziz City Sci & Technol KACST, Mat Sci Res Inst, Riyadh, Saudi Arabia	Gauhati University; Presidency University, Kolkata; Gauhati University; Jamia Hamdard University; Amity University Noida	Mukerjee, N (corresponding author), Ramakrishna Mission Vivekananda Centenary Coll, Dept Microbiol, Khardaha, W Bengal, India.; Mukerjee, N (corresponding author), Novel Global Community Educ Fdn, Dept Hlth Sci, Hebersham, NSW, Australia.; Ghosh, A (corresponding author), Gauhati Univ, Dept Bot, Microbiol Div, Gauhati, Assam, India.; Alexiou, A (corresponding author), Novel Global Community Educ Fdn, Dept Sci & Engn, Hebersham, NSW, Australia.; Alexiou, A (corresponding author), AFNP Med Austria, Vienna, Austria.; Al-Muhanna, MK (corresponding author), King Abdulaziz City Sci & Technol KACST, Mat Sci Res Inst, Riyadh, Saudi Arabia.	nobendumukerjee00@gmail.com; dra.ghosh@gauhati.ac.in; alexiou@ngcef.net; mmuhanna@kacst.edu.sa	Mukerjee, Nobendu/AAT-8758-2021; Maitra, Swastika/AAT-8760-2021; Al-Muhanna, Muhanna/A-6547-2012; Alexiou, Athanasios/AAT-8491-2021	Mukerjee, Nobendu/0000-0002-7129-7003; Al-Muhanna, Muhanna/0000-0001-5060-6658; Alexiou, Athanasios/0000-0002-2206-7236; Das, Anubhab/0000-0003-1000-119X; Khan, Prattusha/0000-0003-4458-2869; Ghosh, Arabinda/0000-0002-3891-5949	Govt. of India; King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia	Govt. of India; King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia	The authors are also grateful to the King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia, for their support and contribution.; Authors are also grateful to DST-FIST support by Govt. of India to the Department of Microbiology, Ramakrishna Mission Vivekananda Centenary College, West Bengal, India and Department of Botany, Gauhati University, Assam, India.	[Anonymous], HUM GENE THER, V5, P401; ATKINS GJ, 1985, J GEN VIROL, V66, P395, DOI 10.1099/0022-1317-66-3-395; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; CHANG GJJ, 1987, J GEN VIROL, V68, P2129, DOI 10.1099/0022-1317-68-8-2129; Chow E., 2008, SHAW RES TECHNICAL R; DALGARNO L, 1983, VIROLOGY, V129, P170, DOI 10.1016/0042-6822(83)90404-X; DUFFUS WA, 1995, J VIROL, V69, P2471, DOI 10.1128/JVI.69.4.2471-2479.1995; GAROFF H, 1980, NATURE, V288, P236, DOI 10.1038/288236a0; HAHN CS, 1988, P NATL ACAD SCI USA, V85, P5997, DOI 10.1073/pnas.85.16.5997; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JUSTMAN J, 1993, J VIROL, V67, P7597, DOI 10.1128/JVI.67.12.7597-7607.1993; Kagami LP, 2020, COMPUT BIOL CHEM, V87, DOI 10.1016/j.compbiolchem.2020.107322; Kielian M, 1996, J CELL BIOL, V134, P863, DOI 10.1083/jcb.134.4.863; KINNEY RM, 1986, VIROLOGY, V152, P400, DOI 10.1016/0042-6822(86)90142-X; KLIMJACK MR, 1994, J VIROL, V68, P6940, DOI 10.1128/JVI.68.11.6940-6946.1994; LEVINSON RS, 1990, VIROLOGY, V175, P110, DOI 10.1016/0042-6822(90)90191-S; LEVYMINTZ P, 1991, J VIROL, V65, P4292, DOI 10.1128/JVI.65.8.4292-4300.1991; LOBIGS M, 1990, J VIROL, V64, P1233, DOI 10.1128/JVI.64.3.1233-1240.1990; Madureira AM, 2003, NAT PROD RES, V17, P375, DOI 10.1080/14786410310001605841; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MATHIOT CC, 1990, AM J TROP MED HYG, V42, P386, DOI 10.4269/ajtmh.1990.42.386; Na M, 2009, J ENZYM INHIB MED CH, V24, P1056, DOI 10.1080/14756360802693312; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Piao LH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010224; RICE CM, 1981, P NATL ACAD SCI-BIOL, V78, P2062, DOI 10.1073/pnas.78.4.2062; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Smithburn KC, 1944, J IMMUNOL, V49, P141; Toukmaji AY, 1996, COMPUT PHYS COMMUN, V95, P73, DOI 10.1016/0010-4655(96)00016-1; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; WHITE J, 1980, J CELL BIOL, V87, P264, DOI 10.1083/jcb.87.1.264; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; WILLEMS WR, 1979, SCIENCE, V203, P1127, DOI 10.1126/science.424742; Winkler William G., 1995, P105; Xu F, 2018, BIOMED PHARMACOTHER, V103, P198, DOI 10.1016/j.biopha.2018.04.019; ZIEMIECKI A, 1978, J MOL BIOL, V122, P259, DOI 10.1016/0022-2836(78)90189-4	37	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0263853	10.1371/journal.pone.0263853	http://dx.doi.org/10.1371/journal.pone.0263853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U7EE	35213606	Green Published, gold			2022-12-26	WOS:000787811000036
J	Ramirez-Madrid, JP; Escobar-Sierra, M; Lans-Vargas, I; Hincapie, JMM				Pablo Ramirez-Madrid, Juan; Escobar-Sierra, Manuela; Lans-Vargas, Isaias; Montes Hincapie, Juan Manuel			Government influence on e-government adoption by citizens in Colombia: Empirical evidence in a Latin American context	PLOS ONE			English	Article							INFORMATION-TECHNOLOGY; INSTITUTIONAL THEORY; SERVICE DELIVERY; DIFFUSION; IMPLEMENTATION; PERSPECTIVES; MOTIVATIONS; ACCEPTANCE; LEGITIMACY; MODEL	This study aims to identify government influence in the adoption of e-government by citizens (AEC) through a case study analyzing actions in Antioquia, Colombia, to increase AEC in annual vehicle tax filing and payment services. We classified these actions employing institutional theory, institutional interventions, and legitimation strategies. An analysis correlating AEC actions (including the COVID-19 containment measures) with over 16 million transactions in these two services during 2015-2020 found a strong government influence on AEC. We established coercive pressure and conformance to the environment as important predictors of AEC, but the COVID-19 containment measures only influenced electronic tax payments. Service type was also an essential predictor for these services; however, mobilization was not. Increasing AEC should be considered a necessary objective for public administrations, especially in developing countries that face shortages of resources and facilities.	[Pablo Ramirez-Madrid, Juan; Lans-Vargas, Isaias] Ctr Studies Digital Govt & Mobil, Medellin, Colombia; [Pablo Ramirez-Madrid, Juan; Escobar-Sierra, Manuela; Montes Hincapie, Juan Manuel] Univ Medellin, Sch Econ & Adm Sci, Medellin, Colombia	Universidad de Medellin	Ramirez-Madrid, JP (corresponding author), Ctr Studies Digital Govt & Mobil, Medellin, Colombia.; Ramirez-Madrid, JP (corresponding author), Univ Medellin, Sch Econ & Adm Sci, Medellin, Colombia.	juan.ramirez@quipux.com		Montes Hincapie, Juan Manuel/0000-0002-2014-2431; RAMIREZ-MADRID, Juan Pablo/0000-0002-6654-310X	CTG at Albany University	CTG at Albany University	The authors would like to thank CTG at Albany University for their support and guidance and the University of Medellin for its ongoing support and advice for this research. Finally, the authors would like to thank the editor and the anonymous reviewers for their constructive comments and suggestions for improvement on earlier versions of this paper.	Acosta T, 2018, INT CONF EDEMOC EGOV, P67; Al Mansoori KA, 2018, INFORM TECHNOL PEOPL, V31, P455, DOI 10.1108/ITP-12-2016-0290; Al-Haddad SA, 2011, AMCIS 17 AM C INF SY, P1605; Al-Hujran O, 2015, COMPUT HUM BEHAV, V53, P189, DOI 10.1016/j.chb.2015.06.025; Al-Mamari Q, 2013, TRANSFORM GOV-PEOPLE, V7, P199, DOI 10.1108/17506161311325369; Alonazi M., 2020, LECT NOTES BUS INF P, P3, DOI [10.1007/978-3-030-43353-6-1, DOI 10.1007/978-3-030-43353-6-1]; Alryalat M, 2012, INT J ELECTRON GOV R, V8, P1, DOI 10.4018/jegr.2012040101; Altayar MS, 2018, GOV INFORM Q, V35, P633, DOI 10.1016/j.giq.2018.09.006; Becker J, 14 AM C INF SYST AMC, P2698; Bhat JM, 2013, IFIP ADV INF COMMUN, DOI [10.1007/978-3-642-38862-0_21, DOI 10.1007/978-3-642-38862-0_21]; Bryman A., 2012, SOCIAL RES METHODOLO, VFourth; Bwalya KJ, 2014, TRANSFORM GOV-PEOPLE, V8, P101, DOI 10.1108/TG-01-2013-0002; Carter L, 2004, PROC HAWAII INT CONF, P1895, DOI 10.1109/hicss.2004.1265306(accessed; Chai S, 2006, INT J ELECTRON GOV R, V2, P1, DOI 10.4018/jegr.2006070101; Congreso de la Republica de Colombia El., 2021, LEY 2108 2021 LEY IN; Cordoba-Pachon JR, 2009, INT J PUBLIC SECT MA, V22, P532, DOI 10.1108/09513550910982887; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Davis F. D., 1986, TECHNOLOGY ACCEPTANC; de la Republica EC de Colombia, 2019, LEY 1955 PLAN NAC DE; DeLone WH, 1992, INFORM SYST RES, V3, P60, DOI 10.1287/isre.3.1.60; Digital Nations, 2020, LEAD DIG NAT, P14; DIMAGGIO PJ, 1983, AM SOCIOL REV, V48, P147, DOI 10.2307/2095101; Distel Bettina, 2018, Electronic Journal of e-Government, V16, P98; Distel Bettina., 2016, 24 EUROPEAN C INFORM, P1; DNP Colombia, 2015, PERC CIUD FRENT CAL; Downey A., 2014, THINK STATS; Dwivedi YK, 2017, GOV INFORM Q, V34, P211, DOI 10.1016/j.giq.2017.03.001; Ebrahim B., 2017, J THEORETICAL APPL I, V95, P2866; Economides Anastasios A., 2008, Electronic Government, V5, P321, DOI 10.1504/EG.2008.018878; Fakhoury Rania, 2014, Proceedings of the 14th European Conference on eGovernment (ECEG2014), P310; Faulkner N, 2019, GOV INFORM Q, V36, P61, DOI 10.1016/j.giq.2018.10.009; Luna-Reyes LF, 2011, GOV INFORM Q, V28, P329, DOI 10.1016/j.giq.2010.08.007; Gasco M., 2011, REV ESTADO, V14, P37; Gasco M, 2005, INT J PUBLIC ADMIN, V28, P683, DOI 10.1081/PAD-200064235; Ghareeb AbeerM., 2019, ELECT GOVT INT J, V15, P1, DOI [10.1504/EG.2019.10017772, DOI 10.1504/EG.2019.10017772]; Gil-Garcia JR., 2012, INTEGRATED SERIES IN, V31, DOI [10.1007/978-1-4614-2015-6, DOI 10.1007/978-1-4614-2015-6]; Gil-Garcia JR., 2012, INTEGRATED SERIES IN, P1, DOI [10.1007/978-1-4614-2015-6_1, DOI 10.1007/978-1-4614-2015-6_1]; Gobierno de Colombia, 2019, GOB DIG IND SEG; Gupta Kriti Priya, 2016, Electronic Government, V12, P160; Hancock DR., 2006, DOING CASE STUDY RES, P122; Henriksen HZ, 2007, J INF TECHNOL-UK, V22, P13, DOI 10.1057/palgrave.jit.2000090; Hinings B, 2018, INFORM ORGAN-UK, V28, P52, DOI 10.1016/j.infoandorg.2018.02.004; Hofmann S, 2012, INT C INF SYST ICIS, P3022; Hwang K, 2017, GOV INFORM Q, V34, P183, DOI 10.1016/j.giq.2017.02.001; IE University, 2020, LISTA IE GOVT ED 202, P19; Ju JR, 2019, GOV INFORM Q, V36, DOI 10.1016/j.giq.2019.101400; Jun KN, 2011, J PUBL ADM RES THEOR, V21, P495, DOI 10.1093/jopart/muq020; Khalil OEM, 2014, ELECT J E GOVT, V12, P1; KING JL, 1994, INFORM SYST RES, V5, P139, DOI 10.1287/isre.5.2.139; Klacaner M, 2014, J INF ORGAN SCI, V38, P55; Kumar V., 2007, ELECT J E GOVT, V5, P63, DOI DOI 10.1128/AAC.03728-14; Lamberti L, 2014, GOV INFORM Q, V31, P596, DOI 10.1016/j.giq.2014.03.002; Lee CP, 2011, PUBLIC ADMIN REV, V71, P444, DOI 10.1111/j.1540-6210.2011.02228.x; Lim SMA, 2016, P 17 INT DIG GOV RES, P212; Lopes KMG, 2019, INT J PUBLIC SECT MA, V32, P553, DOI 10.1108/IJPSM-03-2018-0081; Ma L, 2018, PUBLIC MANAG REV, V20, P1513, DOI 10.1080/14719037.2017.1412117; Maerz SF, 2016, GOV INFORM Q, V33, P727, DOI 10.1016/j.giq.2016.08.008; March JG, 1996, GOVERNANCE, V9, P247, DOI 10.1111/j.1468-0491.1996.tb00242.x; MARCH JG, 1984, AM POLIT SCI REV, V78, P734, DOI 10.2307/1961840; Matheus Ricardo., 2010, ACM INT C PROCEEDING, P31, DOI [10.1145/1930321.1930328, DOI 10.1145/1930321.1930328]; McGrath K, 2010, INFORM TECHNOL DEV, V16, P260, DOI 10.1080/02681102.2010.498408; Medaglia R, 2012, GOV INFORM Q, V29, P346, DOI 10.1016/j.giq.2012.02.010; MEYER JW, 1977, AM J SOCIOL, V83, P340, DOI 10.1086/226550; Ministerio de las Tecnologias de la Informacion y la Comunicacion, 2017, PRIM GRAN ENC TIC 20; MOE TM, 1984, AM J POLIT SCI, V28, P739, DOI 10.2307/2110997; Montealegre R., 1999, Journal of Management Information Systems, V16, P207; Mundkur A, 2009, J INF TECHNOL POLITI, V6, P12, DOI 10.1080/19331680802698943; Mustafa A.A., 2019, J THEORETICAL APPL I, V97, P583; Myatt GJ., 2007, MAKING SENSE DATA PR, P280; Nam T, 2014, GOV INFORM Q, V31, P211, DOI 10.1016/j.giq.2013.09.006; Nawafleh S, 2018, TRANSFORM GOV-PEOPLE, V12, P244, DOI 10.1108/TG-02-2018-0015; Neuman WL., 2014, SOCIAL RES METHODS Q, VSeven, P598; Nurdin N, 2018, INT J ELECTRON GOV R, V14, P44, DOI 10.4018/IJEGR.2018040104; OECD, 2020, DIG GOV IND 2019 RES; Okunola OM, 2017, GOV INFORM Q, V34, P329, DOI 10.1016/j.giq.2017.02.002; Osman IH, 2014, GOV INFORM Q, V31, P243, DOI 10.1016/j.giq.2013.10.009; Ospina M. L. C., 2018, AMCIS 2018 P, P1; Owusu-Oware E, 2017, 23 AM C INF SYST, P1; Papadomichelaki Xenia, 2011, Electronic Government, V8, P290, DOI 10.1504/EG.2011.042808; Pardo TA, 2012, SOC SCI COMPUT REV, V30, P7, DOI 10.1177/0894439310392184; Gil-Garcia JR, 2020, GOV INFORM Q, V37, DOI 10.1016/j.giq.2020.101518; Rana NP, 2015, GOV INFORM Q, V32, P172, DOI 10.1016/j.giq.2015.02.002; Reddick CG, 2005, INT J ELECTRON GOV R, V1, P45, DOI 10.4018/jegr.2005100103; Reddick CG, 2012, GOV INFORM Q, V29, P1, DOI 10.1016/j.giq.2011.03.005; Dominguez LR, 2011, INT PUBLIC MANAG J, V14, P218, DOI 10.1080/10967494.2011.597152; ROGERS EM, 1995, JOINT COMM J QUAL IM, V21, P324, DOI 10.1016/S1070-3241(16)30155-9; Roseth Benjamin., 2018, WAIT NO MORE CITIZEN, DOI [DOI 10.18235/0001150, 10.18235/0001150]; Sanabria-Pulido P., 2014, OPEN GOVT PUBLIC ADM, P17, DOI [10.1007/978-1-4614-9563-5_2, DOI 10.1007/978-1-4614-9563-5_2]; Savoldelli A, 2014, GOV INFORM Q, V31, pS63, DOI 10.1016/j.giq.2014.01.008; Saxena S, 2017, FORESIGHT, V19, P628, DOI 10.1108/FS-05-2017-0013; SCOTT WR, 1987, ADMIN SCI QUART, V32, P493, DOI 10.2307/2392880; Shareef MA, 2011, GOV INFORM Q, V28, P17, DOI 10.1016/j.giq.2010.05.006; Silva L., 2002, Information Technology & People, V15, P8, DOI 10.1108/09593840210421499; Sipior JC, 2011, EUR J INFORM SYST, V20, P308, DOI 10.1057/ejis.2010.64; Sivathanu B, 2018, INT J ELECTRON GOV R, V14, P86, DOI 10.4018/IJEGR.2018010105; Solvak M, 2019, TELEMAT INFORM, V36, P39, DOI 10.1016/j.tele.2018.11.005; SUCHMAN MC, 1995, ACAD MANAGE REV, V20, P571, DOI 10.2307/258788; Susanto Tony Dwi, 2010, Electronic Journal of e-Government, V8, P55; Trakhtenberg A, 2015, ACM INT C P, P89; United Nations, 2018, UN E GOV SURV 2018 G; United Nations, 2018, EGDI COL; Valencia JC, 2019, ELECT GOV INT J, V15, P1; van Dijk JAGM, 2008, GOV INFORM Q, V25, P379, DOI 10.1016/j.giq.2007.09.006; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; West DM, 2004, PUBLIC ADMIN REV, V64, P15, DOI 10.1111/j.1540-6210.2004.00343.x; Wohlers TE, 2009, J INF TECHNOL POLITI, V6, P111, DOI 10.1080/19331680902821593; Yeh HP, 2017, GOV INFORM Q, V34, P556, DOI 10.1016/j.giq.2017.05.001; Yin RK., 2003, INTERPRETIVE INTERAC, VSecond. 1st, P99	108	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2022	17	2							e0264495	10.1371/journal.pone.0264495	http://dx.doi.org/10.1371/journal.pone.0264495			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U7EE	35213659	gold, Green Published			2022-12-26	WOS:000787811000108
J	Akiyama, S; Madan, N; Graham, G; Samura, O; Kitano, R; Yun, HJ; Craig, A; Nakamura, T; Hozawa, A; Grant, E; Im, K; Tarui, T				Akiyama, Shizuko; Madan, Neel; Graham, George; Samura, Osamu; Kitano, Rie; Yun, Hyuk Jin; Craig, Alexa; Nakamura, Tomohiro; Hozawa, Atsushi; Grant, Ellen; Im, Kiho; Tarui, Tomo			Regional brain development in fetuses with Dandy-Walker malformation: A volumetric fetal brain magnetic resonance imaging study	PLOS ONE			English	Article							PRENATAL-DIAGNOSIS; CEREBELLAR MALFORMATIONS; MRI; CHILDREN; APOPTOSIS; SUBPLATE; FOXC1; CLASSIFICATION; PHENOTYPE; OUTCOMES	Dandy-Walker malformation (DWM) is a common prenatally diagnosed cerebellar malformation, characterized by cystic dilatation of the fourth ventricle, upward rotation of the hypoplastic vermis, and posterior fossa enlargement with torcular elevation. DWM is associated with a broad spectrum of neurodevelopmental abnormalities such as cognitive, motor, and behavioral impairments, which cannot be explained solely by cerebellar malformations. Notably, the pathogenesis of these symptoms remains poorly understood. This study investigated whether fetal structural developmental abnormalities in DWM extended beyond the posterior fossa to the cerebrum even in fetuses without apparent cerebral anomalies. Post-acquisition volumetric fetal magnetic resonance imaging (MRI) analysis was performed in 12 fetuses with DWM and 14 control fetuses. Growth trajectories of the volumes of the cortical plate, subcortical parenchyma, cerebellar hemispheres, and vermis between 18 and 33 weeks of gestation were compared. The median (interquartile range) gestational ages at the time of MRI were 22.4 (19.4-24.0) and 23.9 (20.6-29.2) weeks in the DWM and control groups, respectively (p = 0.269). Eight of the 12 fetuses with DWM presented with associated cerebral anomalies, including hydrocephalus (n = 3), cerebral ventriculomegaly (n = 3), and complete (n = 2) and partial (n = 2) agenesis of the corpus callosum (ACC); 7 presented with extracerebral abnormalities. Chromosomal abnormalities were detected by microarray analysis in 4 of 11 fetuses with DWM, using amniocentesis. Volumetric analysis revealed that the cortical plate was significantly larger in fetuses with DWM than in controls (p = 0.040). Even without ACC, the subcortical parenchyma, whole cerebrum, cerebellar hemispheres, and whole brain were significantly larger in fetuses with DWM (n = 8) than in controls (p = 0.004, 0.025, 0.033, and 0.026, respectively). In conclusion, volumetric fetal MRI analysis demonstrated that the development of DWM extends throughout the brain during the fetal period, even without apparent cerebral anomalies.	[Akiyama, Shizuko; Kitano, Rie; Tarui, Tomo] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA 02111 USA; [Madan, Neel] Tufts Med Ctr, Radiol, Boston, MA 02111 USA; [Graham, George] Tufts Med Ctr, Obstet & Gynecol, Boston, MA 02111 USA; [Samura, Osamu] Jikei Univ, Obstet & Gynecol, Sch Med, Tokyo, Japan; [Yun, Hyuk Jin; Grant, Ellen; Im, Kiho] Boston Childrens Hosp, Fetal Neonatal Neuroimaging & Dev Sci Ctr, Boston, MA USA; [Craig, Alexa] Maine Med Ctr, Pediat Neurol, Portland, OR USA; [Nakamura, Tomohiro; Hozawa, Atsushi] Tohoku Univ, Dept Prevent Med & Epidemiol, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Tarui, Tomo] Tufts Childrens Hosp, Pediat Neurol, Boston, MA 02111 USA; [Akiyama, Shizuko] Tohoku Univ Hosp, Ctr Perinatal & Neonatal Med, Sendai, Miyagi, Japan	Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Jikei University; Harvard University; Boston Children's Hospital; Tohoku University; Tohoku University	Akiyama, S; Tarui, T (corresponding author), Tufts Med Ctr, Mother Infant Res Inst, Boston, MA 02111 USA.; Tarui, T (corresponding author), Tufts Childrens Hosp, Pediat Neurol, Boston, MA 02111 USA.	shizuko.akiyama.a1@tohoku.ac.jp; ttarui@tuftsmedicalcenter.org	Tarui, Tomo/GLR-4239-2022	Madan, Neel/0000-0002-3889-7293; Akiyama, Shizuko/0000-0002-6619-451X	National Institutes of Health [K23HD079605, R21HD094130]; Susan Saltonstall Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Saltonstall Foundation	This work was supported by National Institutes of Health K23HD079605 (TT), R21HD094130 (KI), and the Susan Saltonstall Foundation (TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinger KA, 2019, AM J HUM GENET, V105, P606, DOI 10.1016/j.ajhg.2019.07.019; Aldinger KA, 2016, SEMIN FETAL NEONAT M, V21, P321, DOI 10.1016/j.siny.2016.04.008; Aldinger KA, 2009, NAT GENET, V41, P1037, DOI 10.1038/ng.422; ASAI A, 1989, PEDIATR NEUROSCI, V15, P66, DOI 10.1159/000120445; Bianchi DW., 2010, FETOLOGY DIAGNOSIS M, V2nd, P102; Blaas HGK, 2009, PRENATAL DIAG, V29, P312, DOI 10.1002/pd.2170; Blaauw J, 2020, NEURORADIOLOGY, V62, P563, DOI 10.1007/s00234-019-02357-z; Boddaert N, 2003, NEURORADIOLOGY, V45, P320, DOI 10.1007/s00234-003-0980-6; Bolduc ME, 2012, CEREBELLUM, V11, P531, DOI 10.1007/s12311-011-0312-z; Bolduc ME, 2011, DEV MED CHILD NEUROL, V53, P1128, DOI 10.1111/j.1469-8749.2011.04090.x; Bolduc ME, 2009, DEV MED CHILD NEUROL, V51, P256, DOI 10.1111/j.1469-8749.2008.03224.x; Brossard-Racine M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08195-4; Bystron I, 2006, NAT NEUROSCI, V9, P880, DOI 10.1038/nn1726; Clouchoux C, 2012, PEDIATR RADIOL, V42, P24, DOI 10.1007/s00247-011-2178-0; Clouchoux C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.10.002; Clouchoux C, 2012, BRAIN STRUCT FUNCT, V217, P127, DOI 10.1007/s00429-011-0325-x; COURCHESNE E, 1989, AM J ROENTGENOL, V153, P829, DOI 10.2214/ajr.153.4.829; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; D'Antonio F, 2016, ULTRASOUND OBST GYN, V48, P28, DOI 10.1002/uog.15755; Delahaye A, 2012, AM J MED GENET A, V158A, P2430, DOI 10.1002/ajmg.a.35548; Diogo MC, 2019, RADIOLOGY, V292, P159, DOI 10.1148/radiol.2019181976; Dovjak GO, 2020, ULTRASOUND OBST GYN, V56, P78, DOI 10.1002/uog.21890; Dovjak GO, 2018, ULTRASOUND OBST GYN, V52, P623, DOI 10.1002/uog.18826; du Plessis AJ, 2018, VOLPES NEUROLOGY NEW, V6th, P73; du Plessis AJ., 2018, VOLPES NEUROLOGY NEW, VSixth, P34; Fleiss JL., 2003, STAT METHODS RATES P; Forzano F, 2007, PRENATAL DIAG, V27, P495, DOI 10.1002/pd.1722; Ghali R, 2014, FETAL DIAGN THER, V35, P108, DOI 10.1159/000355401; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Has R, 2004, FETAL DIAGN THER, V19, P342, DOI 10.1159/000077963; Hatab MR, 2008, J MAGN RESON IMAGING, V27, P840, DOI 10.1002/jmri.21290; HIRSCH JF, 1984, J NEUROSURG, V61, P515, DOI 10.3171/jns.1984.61.3.0515; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Klein O, 2003, CHILD NERV SYST, V19, P484, DOI 10.1007/s00381-003-0782-5; Kolble N, 2000, PRENATAL DIAG, V20, P318, DOI 10.1002/(SICI)1097-0223(200004)20:4<318::AID-PD805>3.0.CO;2-U; Kostovic I, 2015, CNS NEUROSCI THER, V21, P74, DOI 10.1111/cns.12333; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuklisova-Murgasova M, 2012, MED IMAGE ANAL, V16, P1550, DOI 10.1016/j.media.2012.07.004; Kyriakopoulou V, 2014, CEREB CORTEX, V24, P2141, DOI 10.1093/cercor/bht062; Makropoulos A, 2018, NEUROIMAGE, V170, P231, DOI 10.1016/j.neuroimage.2017.06.074; Manganaro L, 2017, EUR J RADIOL, V93, P273, DOI 10.1016/j.ejrad.2017.06.004; McNiven V, 2019, AM J MED GENET A, V179, P837, DOI 10.1002/ajmg.a.61095; Morris-Rosendahl DJ, 2008, CLIN GENET, V74, P425, DOI 10.1111/j.1399-0004.2008.01093.x; Notaridis G, 2006, NEUROPATH APPL NEURO, V32, P344, DOI 10.1111/j.1365-2990.2006.00719.x; Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010; Patek KJ, 2012, PRENATAL DIAG, V32, P75, DOI 10.1002/pd.2911; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Pearson CA, 2020, CELL REP, V30, P1964, DOI 10.1016/j.celrep.2020.01.034; Poduri A., 2018, VOLPES NEUROLOGY NEW, Vsixth ed, P100; Poretti A, 2014, AM J MED GENET C, V166, P211, DOI 10.1002/ajmg.c.31398; Raybaud C, 2003, CHILD NERV SYST, V19, P455, DOI 10.1007/s00381-003-0769-2; Raybaud C, 2010, NEURORADIOLOGY, V52, P447, DOI 10.1007/s00234-010-0696-3; Santoro M, 2019, NEUROEPIDEMIOLOGY, V53, P169, DOI 10.1159/000501238; Stambolliu E, 2017, J CHILD NEUROL, V32, P886, DOI 10.1177/0883073817712589; Talamonti G, 2011, CHILD NERV SYST, V27, P167, DOI 10.1007/s00381-010-1154-6; Tarui T, 2020, CEREB CORTEX, V30, P382, DOI 10.1093/cercor/bhz094; Tarui T, 2018, CEREB CORTEX, V28, P3192, DOI 10.1093/cercor/bhx191; Tarui T, 2014, ARCH DIS CHILD-FETAL, V99, pF54, DOI 10.1136/archdischild-2013-304054; Teksam M, 2005, FETAL DIAGN THER, V20, P524, DOI 10.1159/000088044; ten Donkelaar HJ, 2014, CLIN NEURO EMBRYOLOG, P1; Ten Donkelaar HJ., 2014, CLIN NEUROEMBRYOLOGY, VSecond, P371; Tonni G, 2014, TAIWAN J OBSTET GYNE, V53, P592, DOI 10.1016/j.tjog.2014.01.005; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Ulm B, 1997, ULTRASOUND OBST GYN, V10, P167, DOI 10.1046/j.1469-0705.1997.10030167.x; Wang WZ, 2010, J ANAT, V217, P368, DOI 10.1111/j.1469-7580.2010.01274.x; Winden KD, 2015, SEMIN NEUROL, V35, P277, DOI 10.1055/s-0035-1552622; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yousem DM., 2010, NEURORADIOLOGY REQUI, Vthird, P263; Yuceer N, 2007, PEDIATR NEUROSURG, V43, P358, DOI 10.1159/000106383; Yun HJ, 2021, CEREB CORTEX, V31, P757, DOI 10.1093/cercor/bhaa255; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104	72	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0263535	10.1371/journal.pone.0263535	http://dx.doi.org/10.1371/journal.pone.0263535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202430	gold, Green Published			2022-12-26	WOS:000773224600013
J	Sserwanja, Q; Mukunya, D; Nabachenje, P; Kemigisa, A; Kiondo, P; Wandabwa, JN; Musaba, MW				Sserwanja, Quraish; Mukunya, David; Nabachenje, Prossy; Kemigisa, Alleluyah; Kiondo, Paul; Wandabwa, Julius N.; Musaba, Milton W.			Continuum of care for maternal health in Uganda: A national cross-sectional study	PLOS ONE			English	Article							MORTALITY; BIRTH	Introduction A continuum of maternal care approach can reduce gaps and missed opportunities experienced by women and newborns. We determined the level of coverage and factors associated with the continuum of maternal care in Uganda. Methods We used weighted data from the Uganda Demographic and Health Survey (UDHS) 2016. We included 10,152 women aged 15 to 49 years, who had had a live birth within five years preceding the survey. Stratified two-stage cluster sampling design was used to select participants. Continuum of maternal care was considered when a woman had at least four antenatal care (ANC) visits, had delivered in a health facility and they had at least one postnatal check-up within six weeks. We conducted multivariable logistic regression analysis to determine factors associated with completion of the continuum of maternal care using SPSS version 25. Results The level of coverage of complete continuum of maternal care was 10.7% (1,091) (95% CI: 10.0-11.2). About 59.9% (6,080) (95% CI: 59.0-60.8) had four or more antenatal visits while 76.6% (7,780) (95% CI: 75.8-77.5) delivered in a health facility and 22.5% (2,280) (95% CI: 21.5-23.2) attended at least one postnatal care visit within six weeks. The following factors were associated with continuum of maternal care; initiating ANC in the first trimester (AOR 1.49, 95% CI: 1.23-1.79), having secondary level of education (AOR 1.60, 95% CI: 1.15-2.22) and tertiary level of education (AOR 2.08 95% CI: 1.38-3.13) compared to no formal education, being resident in Central Uganda (AOR 1.44, 95% CI:1.11-1.89), Northern Uganda (AOR 1.35, 95% CI: 1.06-1.71) and Western Uganda (AOR 0.61, 95% CI: 0.45-0.82) compared to Eastern Uganda, and exposure to newspapers and magazines. Conclusion The level of coverage of the complete continuum of maternal care was low and varied across regions. It was associated with easily modifiable factors such as early initiation of ANC, exposure to mass media and level of education. Interventions to improve utilisation of the continuum of maternal care should leverage mass media to promote services, especially among the least educated and the residents of Western Uganda.	[Sserwanja, Quraish] GOAL, Programs Dept, Khartoum, Sudan; [Mukunya, David] Busitema Univ, Dept Community & Publ Hlth, Mbale, Uganda; [Mukunya, David; Kemigisa, Alleluyah] Sanyu Africa Res Inst, Mbale, Uganda; [Nabachenje, Prossy] Busitema Univ, Dept Paediat & Child Hlth, Mbale, Uganda; [Kiondo, Paul] Makerere Univ, Dept Obstet & Gynaecol, Kampala, Uganda; [Wandabwa, Julius N.; Musaba, Milton W.] Busitema Univ, Dept Obstet & Gynaecol, Mbale, Uganda	Makerere University	Musaba, MW (corresponding author), Busitema Univ, Dept Obstet & Gynaecol, Mbale, Uganda.	miltonmusaba@gmail.com		Sserwanja, Quraish/0000-0003-0576-4627; Musaba, Milton/0000-0003-4145-4044				Adjiwanou V, 2013, SOC SCI MED, V86, P26, DOI 10.1016/j.socscimed.2013.02.047; Ali B, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08480-4; Alkema L, 2019, TRENDS MATERNAL MORT; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Asp G, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.22904; Asratie MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237980; Atukunda EC, 2020, J PREGNANCY, V2020, DOI 10.1155/2020/6596394; Babughirana G, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03385-x; Baqui AH, 2016, B WORLD HEALTH ORGAN, V94, P752, DOI 10.2471/BLT.15.160945; Benova L, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3546-3; Bwalya BB, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1612-1; Camara BS, 2021, TROP MED INT HEALTH, V26, P1446, DOI 10.1111/tmi.13661; Chaka EE, 2019, INT J PREVENTIVE MED, V10, DOI 10.4103/ijpvm.IJPVM_26_19; De Graft-Johnson J., 2006, OPPOR AFRICAS NEWBOR; Devinit.org, 2021, POV UG NAT REG DAT T; Dey T, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004230; Ewunetie AA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1748-7; Group W., 2019, SO YOUR HOME IS BUIL, P41, DOI [10.1061/9780784415214.ch02, DOI 10.1061/9780784415214.CH02]; Haile D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0221670; Hamed A. F., 2018, International Journal of Medical Science and Public Health, V7, P417; Hanekom J., 2002, COMMUNICATION, V28, P49, DOI [10.1080/02500160208537957, DOI 10.1080/02500160208537957]; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Hogberg U, 2005, SCAND J PUBLIC HEALT, V33, P409, DOI 10.1080/14034940500217037; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Iqbal S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2111-9; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Lincetto O., 2018, ANTENATAL CARE; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; Mbonye A K, 2001, Afr J Reprod Health, V5, P47, DOI 10.2307/3583322; Merdad L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189416; MOH, 2016, UG CLIN GUID 2016, P1; MoH Makerere University School of Public Health Health Systems 20/20, 2012, UG HLTH SYST ASS 201, P181; Mohan D, 2017, HEALTH POLICY PLANN, V32, P791, DOI 10.1093/heapol/czx005; Musaba Milton W, 2021, Matern Health Neonatol Perinatol, V7, P13, DOI 10.1186/s40748-021-00133-7; Mwangi W, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1803-4; Ndugga P, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-02866-3; Oh J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036516; Okanlawon K., 2010, AFR J REPROD HEALTH, DOI [10.2307/41329750, DOI 10.2307/41329750]; Okedo-Alex IN, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031890; Osborn D., 2015, UNIVERSAL SUSTAINABL; Owili PO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3075-0; Paudel YR, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00242; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; PMNCH, 2014, PMNCH KNOWL SUMM 02; Rutaremwa G, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0943-8; Sacks E, 2017, MATERN CHILD HLTH J, V21, P599, DOI 10.1007/s10995-016-2144-4; Sacks E, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0042-7; Sakuma S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215635; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Shibanuma A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000786; Sialubanje C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0051-6; Sserwanja Q, 2022, BMC WOMENS HEALTH, V22, DOI 10.1186/s12905-022-01594-4; Sserwanja Q, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-07179-5; Sserwanja Q, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-04080-1; Sserwanja Q, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01206-7; Sserwanja Q, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09775-2; Tamang TM, 2017, INT POP C; Tekelab T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214848; Tetui M, 2012, PAN AFR MED J, V13; The Republic of Uganda, 2014, UG HOSP HLTH CTR IV, P224; The World Bank, 2020, NEW WORLD BANK COUNT; Uganda Bureau of Statistics, 2016, GOV UG UG DEM HLTH S, P625; Victoor A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-272; Waiswa Peter, 2008, BMC Pregnancy Childbirth, V8, P21, DOI 10.1186/1471-2393-8-21; WHO, 2014, WHO TRADITIONAL MED, P1; World Health Organization, 2013, WHO WHO REC POSTN CA, P2; World Health Organization, 2014, EV NEWB ACT PLAN END, P12	67	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2022	17	2							e0264190	10.1371/journal.pone.0264190	http://dx.doi.org/10.1371/journal.pone.0264190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZZ4EP	35202413	Green Published, gold			2022-12-26	WOS:000773224600025
J	Wu, WZ; Wang, LP; Dong, N; Wang, K				Wu, Weizhen; Wang, Luping; Dong, Ning; Wang, Kang			Primary Sjogren's syndrome-related Choroiditis in a Newly Diagnosed Older Adult	OCULAR IMMUNOLOGY AND INFLAMMATION			English	Article; Early Access						Choroidal thickening; multiple focal subretinal fluids; serous retinal detachment; choroiditis; Primary Sjogren's syndrome	RETINAL VASCULITIS; AMERICAN-COLLEGE; CLASSIFICATION; CRITERIA	PurposeTo report a case of secondary bilateral choroiditis in a patient with primary Sjogren's syndrome(pSS).Study DesignCase report.ResultsA 69-year-old woman visited our hospital for consultation due to decreased visual acuity in both eyes for 1 month. At the first visit, best corrected visual acuity (BCVA) was 0.2 and 0.3 in her right and left eyes, respectively. Intraocular pressure values were 15 mmHg and 16 mmHg in her right and left eyes, respectively. Examination revealed edema of the eyelids and conjunctiva,and corneal fluorescence staining was positive. No inflammation in the anterior chamber or vitreous opacities were observed. Bilateral multiple retinal detachments were observed on the posterior fundus, and optical coherence tomography revealed bilateral multiple areas of retinal neuroepithelial detachment, choroidal thickening, and choroidal folds. No abnormal fluorescence leakage was observed on fundus fluorescein angiography or indocyanine green angiography. In addition, systematic manifestations included recurrent bilateral parotid gland enlargement. Labial gland biopsy revealed dilated glandular ducts, scattered interstitial glands, and lymphocytic foci. Salivary gland scintigraphy revealed severe impairment of glandular excretory function. Moreover, blood tests for anti-Ro/SSA and anti-La/SSBantibodies were positive. The patient was diagnosed with primary Sjogren's syndrome. After 2 months treatment with oral prednisolone acetate combined with hydroxychloroquine, her BCVAimproved to 0.8 and 1.0 in the right and left eyes, respectively. The fundus also recovered to normal, and no recurrence was observed during the 1-year follow-up period.ConclusionsThe current case highlights that pSS, which usually manifests with dry eye and keratoconjunctivitis, may manifest with chronic choroiditis in both eyes as well. Based on our experience with this case, patients with clinically suspected bilateral choroiditis should be evaluated for pSS.	[Wu, Weizhen; Wang, Luping; Dong, Ning; Wang, Kang] Capital Med Univ, Beijing Friendship Hosp, Dept Ophthalmol, Beijing, Peoples R China	Capital Medical University	Wu, WZ (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Ophthalmol, Beijing, Peoples R China.	wangkang@ccmu.edu.cn		Wong, Ping Pui/0000-0003-1592-4823; He, Shun-peng/0000-0001-6307-9690	National Natural Science Foundation of China;  [82000899]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	National Natural Science Foundation of China (82000899).	Agarwal A, 2019, EYE, V33, P50, DOI 10.1038/s41433-018-0224-y; Akpek EK, 2019, CORNEA, V38, P658, DOI 10.1097/ICO.0000000000001865; Babu K, 2018, OCUL IMMUNOL INFLAMM, V26, P130, DOI 10.1080/09273948.2016.1199711; Baumann SL, 2018, KLIN MONATSBL AUGENH, V235, P480, DOI 10.1055/s-0043-123641; Bjordal O, 2020, SURV OPHTHALMOL, V65, P119, DOI 10.1016/j.survophthal.2019.10.004; Chen XY, 2018, CLIN RHEUMATOL, V37, P1743, DOI 10.1007/s10067-018-4153-8; Feist E, 2009, Z RHEUMATOL, V68, P305, DOI 10.1007/s00393-008-0400-8; Fox RI, 2006, CLIN DERMATOL, V24, P393, DOI 10.1016/j.clindermatol.2006.07.005; Furukawa Yudai, 2020, Am J Ophthalmol Case Rep, V19, P100829, DOI 10.1016/j.ajoc.2020.100829; Hobsley M, 1970, Ann R Coll Surg Engl, V46, P224; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Joye A, 2021, CURR OPIN OPHTHALMOL, V32, P574, DOI 10.1097/ICU.0000000000000809; Lim BS, 2016, CLIN EXP OPTOM, V99, P87, DOI 10.1111/cxo.12307; Manoussakis MN, 2004, ARTHRITIS RHEUM-US, V50, P882, DOI 10.1002/art.20093; Maslinska M, 2021, RHEUMATOL INT, V41, P643, DOI 10.1007/s00296-020-04782-3; Mavragani CP, 2014, ANNU REV PATHOL-MECH, V9, P273, DOI 10.1146/annurev-pathol-012513-104728; Ramos-Casals M, 2004, MEDICINE, V83, P96, DOI 10.1097/01.md.0000119465.24818.98; Ramos-Casals M, 2020, ANN RHEUM DIS, V79, P3, DOI 10.1136/annrheumdis-2019-216114; Roszkowska AM, 2021, GENES-BASEL, V12, DOI 10.3390/genes12030365; Scofield RH, 2011, CURR RHEUMATOL REP, V13, P482, DOI 10.1007/s11926-011-0207-5; Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1136/annrheumdis-2016-210571, 10.1002/art.39859]; TSOKOS M, 1987, AM J CLIN PATHOL, V88, P26, DOI 10.1093/ajcp/88.1.26; Watanabe T, 2019, RHEUMATOLOGY, V58, P1244, DOI 10.1093/rheumatology/key405; Witte T, 2010, Z RHEUMATOL, V69, P50, DOI 10.1007/s00393-009-0519-2; Yang PZ, 2018, OCUL IMMUNOL INFLAMM, V26, P387, DOI 10.1080/09273948.2016.1241282; Zandbelt M, 2009, CLIN EXP RHEUMATOL, V27, P536; Zappi Daniela C., 2015, Rodriguésia, V66, P1085, DOI 10.1590/2175-7860201566411	27	3	3	5	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0927-3948	1744-5078		OCUL IMMUNOL INFLAMM	Ocul. Immunol. Inflamm.												10.1080/09273948.2022.2109490	http://dx.doi.org/10.1080/09273948.2022.2109490		DEC 2022	5	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	6W6SB	36490380				2022-12-26	WOS:000895856700001
J	Wu, WR; Shi, XD; Zhang, FP; Zhu, K; Zhang, R; Yu, XH; Qin, YF; He, SP; Fu, HW; Zhang, L; Zeng, H; Zhu, MS; Xu, LB; Wong, PP; Liu, C				Wu, Wen-Rui; Shi, Xiang-De; Zhang, Fa-Peng; Zhu, Ke; Zhang, Rui; Yu, Xian-Huan; Qin, Yu-Fei; He, Shun-Peng; Fu, Hou-Wei; Zhang, Lei; Zeng, Hong; Zhu, Man-Sheng; Xu, Lei-Bo; Wong, Ping-Pui; Liu, Chao			Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis	ONCOGENE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; POTENTIAL THERAPEUTIC TARGET; NEOPLASTIC TRANSFORMATION; BREAST-CANCER; STEM-CELLS; VCAM-1; NOTCH1; MACROPHAGES; HEPATOCYTES; EXPRESSION	The cellular origin of hepatocellular carcinomas (HCC) and the role of Notch1 signalling in HCC initiation are controversial. Herein, we establish Notch1 as a regulator of HCC development and progression. Clinically, high Notch1 expression correlates with enhanced cancer progression, elevated lung metastasis, increased cancer stem cell (CSC)-like cells' gene signature expression, and poor overall survival in HCC patients. Notch1 intracellular domain (N1ICD) overexpression spontaneously transforms rat liver progenitor cells (LPC) into CSC-like cells (WBN1ICD C5) under a selective growth environment, while orthotopic injection of these cells generates liver tumors and spontaneous pulmonary metastasis in an isogenic rat model. Mechanistically, the elevated Notch1 activity increases c-myc expression, which then transcriptionally upregulates VCAM1 expression to activate macrophage dependent HCC transendothelial migration. In vivo, silencing c-myc prohibits the tumorigenicity of WBN1ICD C5 cells, while depletion of VCAM1 reduces spontaneous lung metastasis without affecting primary WBN1ICD C5 orthotopic liver tumor growth. Importantly, depletion of macrophage or blockade of macrophage VCAM1 binding receptor alpha 4 beta 1-integrin reduces the number of WBN1ICD C5 lung nodules in an experimental metastasis model. Overall, our work discovers that the Notch1-c-myc-VCAM1 signaling axis initiates LPC-driven hepatocarcinogenesis and metastasis, providing a preclinical model for HCC study and therapeutic targets for an improved HCC treatment.	[Wu, Wen-Rui; Shi, Xiang-De; Zhang, Fa-Peng; Zhu, Ke; Zhang, Rui; Yu, Xian-Huan; Qin, Yu-Fei; He, Shun-Peng; Fu, Hou-Wei; Zhang, Lei; Zeng, Hong; Zhu, Man-Sheng; Xu, Lei-Bo; Liu, Chao] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliary Pancreat Surg, Guangzhou 510120, Peoples R China; [Wu, Wen-Rui; Shi, Xiang-De; Zhang, Fa-Peng; Zhu, Ke; Zhang, Rui; Yu, Xian-Huan; Qin, Yu-Fei; He, Shun-Peng; Fu, Hou-Wei; Zhang, Lei; Zeng, Hong; Zhu, Man-Sheng; Xu, Lei-Bo; Wong, Ping-Pui; Liu, Chao] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangdong Hong Kong Joint Lab RNA Med, Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China; [Wong, Ping-Pui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou 510120, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xu, LB; Liu, C (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliary Pancreat Surg, Guangzhou 510120, Peoples R China.; Xu, LB; Wong, PP; Liu, C (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangdong Hong Kong Joint Lab RNA Med, Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China.; Wong, PP (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou 510120, Peoples R China.	xuleibo3@mail.sysu.edu.cn; huangbp3@mail.sysu.edu.cn; liuchao3@mail.sysu.edu.cn		Wong, Ping Pui/0000-0003-1592-4823; He, Shun-peng/0000-0001-6307-9690	National Natural Science Foundation of China [81972255, 82173195, 81920108028, 81872142, 81772597, 82173229, 81702904, 81972262]; Guangdong Natural Science Foundation [2021A1515010095, 712055485047]; Guangzhou Science and Technology Program Key Project [201904020008]; Sun Yat-sen University Clinical Research 5010 Program [2018008]; Science and Technology Program of Guangzhou [202102010326]; Sun Yat-sen University Fundamental Research Funds [19ykpy113]; Key Training Program for Young Scholars of Sun Yat-sen University [18ykzd07]; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013]163]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes [KLB09001]; Guangdong Science and Technology Department [2020A0505100029, 2020B1212060018, 2020B1212030004]; Guangdong Translational Medicine Public Platform of Guangdong Province [4202037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangzhou Science and Technology Program Key Project; Sun Yat-sen University Clinical Research 5010 Program; Science and Technology Program of Guangzhou; Sun Yat-sen University Fundamental Research Funds; Key Training Program for Young Scholars of Sun Yat-sen University; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes; Guangdong Science and Technology Department; Guangdong Translational Medicine Public Platform of Guangdong Province	Some of the illustrations were created using Biorender.com. This work was supported by grants from the National Natural Science Foundation of China (81972255, 82173195, 81920108028, 81872142, 81772597, 82173229, 81702904, 81972262), Guangdong Natural Science Foundation (2021A1515010095, 712055485047), Guangzhou Science and Technology Program Key Project (201904020008), Sun Yat-sen University Clinical Research 5010 Program (2018008), Science and Technology Program of Guangzhou (202102010326), Sun Yat-sen University Fundamental Research Funds (19ykpy113), the Key Training Program for Young Scholars of Sun Yat-sen University (18ykzd07), grant from the Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology ([2013]163), the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes (KLB09001), Guangdong Science and Technology Department (2020A0505100029, 2020B1212060018, 2020B1212030004), the Guangdong Translational Medicine Public Platform of Guangdong Province (4202037).	Ahn S, 2013, HEPATOB PANCREAT DIS, V12, P286, DOI 10.1016/S1499-3872(13)60046-6; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Byrne GJ, 2000, J NATL CANCER I, V92, P1329, DOI 10.1093/jnci/92.16.1329; Cardoso AP, 2014, ONCOGENE, V33, P2123, DOI 10.1038/onc.2013.154; Chan LH, 2015, MOL CELLS, V38, P202, DOI 10.14348/molcells.2015.2356; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Cook J, 2013, CURR OPIN PHARMACOL, V13, P595, DOI 10.1016/j.coph.2013.05.017; Ding L, 2014, EXP TOXICOL PATHOL, V66, P139, DOI 10.1016/j.etp.2013.11.007; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Gurzu S, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2962580; Harney AS, 2015, CANCER DISCOV, V5, P932, DOI 10.1158/2159-8290.CD-15-0012; Hooth MJ, 1998, AM J PATHOL, V153, P1913, DOI 10.1016/S0002-9440(10)65705-7; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Jin H, 2006, CANCER RES, V66, P2146, DOI 10.1158/0008-5472.CAN-05-2704; Kim MJ, 2018, DEV CELL, V44, P582, DOI 10.1016/j.devcel.2018.02.010; Lai GH, 2005, GASTROENTEROLOGY, V129, P2047, DOI 10.1053/j.gastro.2005.10.010; Lai YS, 2019, J CELL MOL MED, V23, P1257, DOI 10.1111/jcmm.14027; Li XF, 2010, CANCER SCI, V101, P1099, DOI 10.1111/j.1349-7006.2010.01513.x; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Luo ZY, 2020, J MOL CELL BIOL, V12, P345, DOI 10.1093/jmcb/mjz088; Mishra A, 2016, J IMMUNOL, V197, P2828, DOI 10.4049/jimmunol.1501041; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Padilla-Nash HM, 2012, GENE CHROMOSOME CANC, V51, P353, DOI 10.1002/gcc.21921; Qi RZ, 2003, CANCER RES, V63, P8323; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Strazzabosco M, 2012, GASTROENTEROLOGY, V143, P1430, DOI 10.1053/j.gastro.2012.10.025; Sun Q, 2014, ONCOL REP, V31, P933, DOI 10.3892/or.2013.2917; Vandereyken M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185786; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Verginelli F, 2015, ONCOTARGET, V6, P43216, DOI 10.18632/oncotarget.6456; Viatour P, 2011, J EXP MED, V208, P1963, DOI 10.1084/jem.20110198; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Wei C, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0976-4; Wieland E, 2017, CANCER CELL, V31, P355, DOI 10.1016/j.ccell.2017.01.007; Wu K, 2012, HEPATOLOGY, V56, P2255, DOI 10.1002/hep.26007; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Zhang HL, 2019, ONCOL LETT, V17, P4487, DOI 10.3892/ol.2019.10081; Zhang R, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.6; Zhang RL, 2013, NATURE, V498, P497, DOI 10.1038/nature12322; Zhang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08863-5; Zhu WJ, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2005-1	48	3	3	5	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2022	41	16					2340	2356		10.1038/s41388-022-02246-5	http://dx.doi.org/10.1038/s41388-022-02246-5		MAR 2022	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0N1NW	36490380				2022-12-26	WOS:000765674100003
